PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Watanabe, T; Ito, T; Goda, HM; Ishibashi, Y; Miyamoto, T; Ikeda, K; Taguchi, R; Okino, N; Ito, M				Watanabe, Takashi; Ito, Tomoharu; Goda, Hatsumi M.; Ishibashi, Yohei; Miyamoto, Tomofumi; Ikeda, Kazutaka; Taguchi, Ryo; Okino, Nozomu; Ito, Makoto			Sterylglucoside Catabolism in Cryptococcus neoformans with Endoglycoceramidase-related Protein 2 (EGCrP2), the First Steryl-beta-glucosidase Identified in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; PICHIA-PASTORIS; GENE; GLUCOSYLCERAMIDE; VIRULENCE; PURIFICATION; SEQUENCE; CLONING; VACUOLE	Cryptococcosis is an infectious disease caused by pathogenic fungi, such as Cryptococcus neoformans and Cryptococcus gattii. The ceramide structure (methyl-d18: 2/h18: 0) of C. neoformans glucosylceramide (GlcCer) is characteristic and strongly related to its pathogenicity. We recently identified endoglycoceramidase-related protein 1 (EGCrP1) as a glucocerebrosidase in C. neoformans and showed that it was involved in the quality control of GlcCer by eliminating immature GlcCer during the synthesis of GlcCer (Ishibashi, Y., Ikeda, K., Sakaguchi, K., Okino, N., Taguchi, R., and Ito, M. (2012) Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1). J. Biol. Chem. 287, 368-381). We herein identified and characterized EGCrP2, a homologue of EGCrP1, as the enzyme responsible for sterylglucoside catabolism in C. neoformans. In contrast to EGCrP1, which is specific to GlcCer, EGCrP2 hydrolyzed various beta-glucosides, including GlcCer, cholesteryl-beta-glucoside, ergosteryl-beta-glucoside, sitosteryl-beta-glucoside, and para-nitrophenyl-beta-glucoside, but not beta-glucosides or beta-galactosides, under acidic conditions. Disruption of the EGCrP2 gene (egcrp2) resulted in the accumulation of a glycolipid, the structure of which was determined following purification to ergosteryl-3 beta-glucoside, a major sterylglucoside in fungi, by mass spectrometric and two-dimensional nuclear magnetic resonance analyses. This glycolipid accumulated in vacuoles and EGCrP2 was detected in vacuole-enriched fraction. These results indicated that EGCrP2 was involved in the catabolism of ergosteryl-beta-glucoside in the vacuoles of C. neoformans. Distinct growth arrest, a dysfunction in cell budding, and an abnormal vacuole morphology were detected in the egcrp2-disrupted mutants, suggesting that EGCrP2 may be a promising target for anti-cryptococcal drugs. EGCrP2, classified into glycohydrolase family 5, is the first steryl-beta-glucosidase identified as well as a missing link in sterylglucoside metabolism in fungi.	[Watanabe, Takashi; Ito, Tomoharu; Goda, Hatsumi M.; Ishibashi, Yohei; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Kyushu University; Kyushu University; Keio University; Chubu University	Ito, M (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021; Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818	Japanese Ministry of Education, Culture, Science, and Technology [24380058]; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Basic Research B Grant 24380058 from the Japanese Ministry of Education, Culture, Science, and Technology and the Japan Foundation for Applied Enzymology (to M. I.).	Aguirre A, 2014, APPL MICROBIOL BIOT, V98, P4033, DOI 10.1007/s00253-013-5345-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; Cao Y, 2007, AUTOPHAGY, V3, P17, DOI 10.4161/auto.3371; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; COX GM, 1995, J MED VET MYCOL, V33, P261; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Harrison TS, 2002, MED MYCOL, V40, P329, DOI 10.1080/mmy.40.3.329.332; Hayashi Y, 2008, ANAL BIOCHEM, V383, P122, DOI 10.1016/j.ab.2008.07.024; Idnurm A, 2003, PHYSIOL MOL PLANT P, V62, P305, DOI 10.1016/S0885-5765(03)00074-2; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; ITO M, 1986, J BIOL CHEM, V261, P14278; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Johnston DA, 2009, INFECT IMMUN, V77, P2343, DOI 10.1128/IAI.01458-08; KALINOWSKA M, 1978, PHYTOCHEMISTRY, V17, P1533, DOI 10.1016/S0031-9422(00)94637-5; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim YK, 2002, PLANT J, V30, P177, DOI 10.1046/j.1365-313X.2002.01284.x; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nakagawa T, 1999, J BIOCHEM, V126, P604, DOI 10.1093/oxfordjournals.jbchem.a022492; Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1992, GENE, V122, P213, DOI 10.1016/0378-1119(92)90053-R; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Richards A, 2012, J MICROBIOL METH, V91, P155, DOI 10.1016/j.mimet.2012.08.002; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Singh A, 2012, CELL MICROBIOL, V14, P500, DOI 10.1111/j.1462-5822.2011.01735.x; Stasyk OV, 2003, CELL BIOL INT, V27, P947, DOI 10.1016/j.cellbi.2003.08.004; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Zhang YQ, 2012, CURR PROTEIN PEPT SC, V13, P134, DOI 10.2174/138920312800493205; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	44	27	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1005	1019		10.1074/jbc.M114.616300	http://dx.doi.org/10.1074/jbc.M114.616300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25361768	Green Published, hybrid			2022-12-26	WOS:000347778200034
J	Ramon, E; Cordomi, A; Aguila, M; Srinivasan, S; Dong, XY; Moore, AT; Webster, AR; Cheetham, ME; Garriga, P				Ramon, Eva; Cordomi, Arnau; Aguila, Monica; Srinivasan, Sundaramoorthy; Dong, Xiaoyun; Moore, Anthony T.; Webster, Andrew R.; Cheetham, Michael E.; Garriga, Pere			Differential Light-induced Responses in Sectorial Inherited Retinal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RHODOPSIN RETINITIS-PIGMENTOSA; INTERNAL WATER-MOLECULES; CRYSTAL-STRUCTURE; CONFORMATIONAL STABILITY; FRIEDENWALD-LECTURE; METARHODOPSIN-II; BOVINE RHODOPSIN; CELL-DEATH; ACTIVATION	Retinitis pigmentosa (RP) is a group of genetically and clinically heterogeneous inherited degenerative retinopathies caused by abnormalities of photoreceptors or retinal pigment epithelium in the retina leading to progressive sight loss. Rhodopsin is the prototypical G-protein-coupled receptor located in the vertebrate retina and is responsible for dim light vision. Here, novel M39R and N55K variants were identified as causing an intriguing sector phenotype of RP in affected patients, with selective degeneration in the inferior retina. To gain insights into the molecular aspects associated with this sector RP phenotype, whose molecular mechanism remains elusive, the mutations were constructed by site-directed mutagenesis, expressed in heterologous systems, and studied by biochemical, spectroscopic, and functional assays. M39R and N55K opsins had variable degrees of chromophore regeneration when compared with WT opsin but showed no gross structural misfolding or altered trafficking. M39R showed a faster rate for transducin activation than WT rhodopsin with a faster metarhodopsinII decay, whereas N55K presented a reduced activation rate and an altered photobleaching pattern. N55K also showed an altered retinal release from the opsin binding pocket upon light exposure, affecting its optimal functional response. Our data suggest that these sector RP mutations cause different protein phenotypes that may be related to their different clinical progression. Overall, these findings illuminate the molecular mechanisms of sector RP associated with rhodopsin mutations.	[Ramon, Eva; Srinivasan, Sundaramoorthy; Dong, Xiaoyun; Garriga, Pere] Univ Politecn Cataluna, Dept Engn Quim, Ctr Biotecnol Mol, Terrassa 08222, Spain; [Cordomi, Arnau] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Cerdanyola Del Valles 08193, Spain; [Aguila, Monica; Moore, Anthony T.; Webster, Andrew R.; Cheetham, Michael E.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Moore, Anthony T.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England	Universitat Politecnica de Catalunya; Autonomous University of Barcelona; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Garriga, P (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Ctr Biotecnol Mol, Rambla St Nebridi 22, Terrassa 08222, Spain.	pere.garriga@upc.edu	Srinivasan, Sundaramoorthy/A-2753-2016; Cordomí, Arnau/A-1686-2009; Garriga, Pere/C-1949-2017	Cordomí, Arnau/0000-0002-3848-2928; Garriga, Pere/0000-0003-4234-8382; Srinivasan, Sundaramoorthy/0000-0003-4750-0478; Cheetham, Michael/0000-0001-6429-654X	Ministerio de Ciencia e Innovacion [SAF2011-30216-C02-01]; Grups de Recerca Consolidats de la Generalitat de Catalunya Grants [2009 SGR 1402]; RP Fighting Blindness; Wellcome Trust; Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III; Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Chinese Scholarship Council; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Grups de Recerca Consolidats de la Generalitat de Catalunya Grants; RP Fighting Blindness; Wellcome Trust(Wellcome Trust); Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Chinese Scholarship Council(China Scholarship Council); National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported in part by Grant SAF2011-30216-C02-01 from Ministerio de Ciencia e Innovacion and Grups de Recerca Consolidats de la Generalitat de Catalunya Grants 2009 SGR 1402 (to P. G.), and the RP Fighting Blindness and Wellcome Trust (to M. E. C.).; Recipient of Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca.; Recipient of a contract grant from the Instituto de Salud Carlos III.; Recipient of a predoctoral scholarship Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca.; Recipient of a predoctoral fellowship from the Chinese Scholarship Council.; Supported by the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Audo I, 2010, ARCH OPHTHALMOL-CHIC, V128, P1036, DOI 10.1001/archophthalmol.2010.162; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Cabana J, 2013, J BIOL CHEM, V288, P2593, DOI 10.1074/jbc.M112.395939; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Ciarkowski J, 2001, ACTA BIOCHIM POL, V48, P1203; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Sanchez-Martin MJ, 2013, CHEMBIOCHEM, V14, P639, DOI 10.1002/cbic.201200687; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Majumder A, 2013, P NATL ACAD SCI USA, V110, P12468, DOI 10.1073/pnas.1222666110; Matsuyama T, 2010, J BIOL CHEM, V285, P8114, DOI 10.1074/jbc.M109.063875; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orisme W, 2010, CELL SIGNAL, V22, P447, DOI 10.1016/j.cellsig.2009.10.016; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Perusek L, 2013, NUTRIENTS, V5, P2646, DOI 10.3390/nu5072646; Petrs-Silva H, 2014, CLIN OPHTHALMOL, V8, P127, DOI 10.2147/OPTH.S38041; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reyes-Alcaraz A, 2011, BIOPHYS J, V101, P2798, DOI 10.1016/j.bpj.2011.09.049; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz L, 2003, MED HYPOTHESES, V60, P644, DOI 10.1016/S0306-9877(02)00391-2; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Surguchev A, 2010, BRAIN RES BULL, V81, P12, DOI 10.1016/j.brainresbull.2009.09.015; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2014, J NEUROSCI, V34, P13336, DOI 10.1523/JNEUROSCI.1655-14.2014; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Tikhonova IG, 2008, J AM CHEM SOC, V130, P10141, DOI 10.1021/ja0765520; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Van Woerkom Craig, 2005, Optometry, V76, P309; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230	62	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35918	35928		10.1074/jbc.M114.609958	http://dx.doi.org/10.1074/jbc.M114.609958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359768	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000346897900023
J	Macauley, MS; Arlian, BM; Rillahan, CD; Pang, PC; Bortell, N; Marcondes, MCG; Haslam, SM; Dell, A; Paulson, JC				Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Pang, Poh-Choo; Bortell, Nikki; Marcondes, Maria Cecilia G.; Haslam, Stuart M.; Dell, Anne; Paulson, James C.			Systemic Blockade of Sialylation in Mice with a Global Inhibitor of Sialyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation Inhibitor; Glycosyltransferase; Kidney; Podocyte; Sialic Acid; Sialyltransferase	TISSUE-SPECIFIC EXPRESSION; SIALIC-ACID; POLYSIALIC ACID; CELL-ADHESION; SELECTIN; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; LIGANDS; GLYCANS; ALPHA	Sialic acid terminates glycans of glycoproteins and glycolipids that play numerous biological roles in health and disease. Although genetic tools are available for interrogating the effects of decreased or abolished sialoside expression in mice, pharmacological inhibition of the sialyltransferase family has, to date, not been possible. We have recently shown that a sialic acid analog, 2,4,7,8,9-pentaacetyl-3F(ax)-Neu5Ac-CO2Me (3F-NeuAc), added to the media of cultured cells shuts down sialylation by a mechanism involving its intracellular conversion to CMP-3F-NeuAc, a competitive inhibitor of all sialyltransferases. Here we show that administering 3F-NeuAc to mice dramatically decreases sialylated glycans in cells of all tissues tested, including blood, spleen, liver, brain, lung, heart, kidney, and testes. A single dose results in greatly decreased sialoside expression for over 7 weeks in some tissues. Although blockade of sialylation with 3F-NeuAc does not affect viability of cultured cells, its use in vivo has a deleterious on target effect on liver and kidney function. After administration of 3F-NeuAc, liver enzymes in the blood are dramatically altered, and mice develop proteinuria concomitant with dramatic loss of sialic acid in the glomeruli within 4 days, leading to irreversible kidney dysfunction and failure to thrive. These results confirm a critical role for sialosides in liver and kidney function and document the feasibility of pharmacological inhibition of sialyltransferases for in vivo modulation of sialoside expression.	[Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Bortell, Nikki; Marcondes, Maria Cecilia G.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Rillahan, Cory D.] Mem Sloan Kettering Canc Ctr, Div Canc Biol & Genet, New York, NY 10065 USA; [Pang, Poh-Choo; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Memorial Sloan Kettering Cancer Center; Imperial College London	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Dell, Anne/0000-0003-1380-2347; Macauley, Matthew/0000-0003-4579-1048	National Institutes of Health [HL107151]; Johnson and Johnson; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Human Frontiers Fellowship; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontiers Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant HL107151 (to J. C. P.). This work was also supported by grants from Johnson and Johnson (to J. C. P.), Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1 (to A. D. and S. M. H.), and a Human Frontiers Fellowship (to M. S. M.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Burkart MD, 1997, J AM CHEM SOC, V119, P11743, DOI 10.1021/ja9723904; Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gelberg H, 1996, LAB INVEST, V74, P907; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hildebrandt H., 2013, TOP CURR CH IN PRESS; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029873; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Krocher T., 2013, BRAIN STRUC IN PRESS; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Nicholls JM, 2013, ANTIVIR RES, V98, P401, DOI 10.1016/j.antiviral.2013.04.012; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Paulson JC, 2009, NAT STRUCT MOL BIOL, V16, P1121, DOI 10.1038/nsmb1109-1121; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Quaggin SE, 2007, J CLIN INVEST, V117, P1480, DOI 10.1172/JCI32482; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Weinhold B, 2012, J AM SOC NEPHROL, V23, P1319, DOI 10.1681/ASN.2011090947; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zandberg WF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403568	47	64	64	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35149	35158		10.1074/jbc.M114.606517	http://dx.doi.org/10.1074/jbc.M114.606517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368325	Green Published, hybrid			2022-12-26	WOS:000346660200009
J	Bellefeuille, SD; Dorion, S; Rivoal, J; Morse, D				Bellefeuille, Steve Dagenais; Dorion, Sonia; Rivoal, Jean; Morse, David			The Dinoflagellate Lingulodinium polyedrum Responds to N Depletion by a Polarized Deposition of Starch and Lipid Bodies	PLOS ONE			English	Article							RED TIDE DINOFLAGELLATE; HARMFUL ALGAL BLOOMS; NITROGEN LIMITATION; KARENIA-BREVIS; CARBON; PHOTOSYNTHESIS; PHOSPHORUS; NITRATE; GROWTH; AVAILABILITY	Dinoflagellates are important contributors to the marine phytoplankton and global carbon fixation, but are also infamous for their ability to form the spectacular harmful algal blooms called red tides. While blooms are often associated with high available nitrogen, there are instances where they are observed in oligotrophic environments. In order to maintain their massive population in conditions of nitrogen limitation, dinoflagellates must have evolved efficient adaptive mechanisms. Here we report the physiological responses to nitrogen deprivation in Lingulodinium polyedrum. We find that this species reacts to nitrogen stress, as do most plants and microalgae, by stopping cell growth and diminishing levels of internal nitrogen, in particular in the form of protein and chlorophyll. Photosynthesis is maintained at high levels for roughly a week following nitrate depletion, resulting in accumulated photosynthetic products in the form of starch. During the second week, photosynthesis rates decrease due to a reduction in the number of chloroplasts and the accumulation of neutral lipid droplets. Surprisingly, the starch granules and lipid droplets are seen to accumulate at opposite poles of the cell. Lastly, we observe that cells acclimated to nitrogen-depleted conditions resume normal growth after addition of inorganic nitrogen, but are able to maintain high cell densities far longer than cells grown continuously in nitrogen-replete conditions.	[Bellefeuille, Steve Dagenais; Dorion, Sonia; Rivoal, Jean; Morse, David] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada	Universite de Montreal	Morse, D (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada.	david.morse@umontreal.ca	Rivoal, Jean/J-6544-2014	Rivoal, Jean/0000-0002-8991-0566; Dagenais Bellefeuille, Steve/0000-0001-5281-5971; Morse, David/0000-0003-4131-4367	Natural Sciences and Engineering Research Council of Canada (NSERC); Fond de Recherche du Quebec- Nature et Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond de Recherche du Quebec- Nature et Technologies (FQRNT)(FQRNT)	Financial support by the Natural Sciences and Engineering Research Council of Canada (NSERC) for discovery grants to DM and JR and by the Fond de Recherche du Quebec- Nature et Technologies (FQRNT) for a studentship (SD-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; Atkinson M, 1994, J AQUARI AQUA SCI, V8, P39; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Dagenais-Bellefeuille S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00369; Dauvillee D, 2009, P NATL ACAD SCI USA, V106, P21126, DOI 10.1073/pnas.0907424106; Davey MP, 2014, EUKARYOT CELL, V13, P392, DOI 10.1128/EC.00178-13; Deschamps P, 2008, EUKARYOT CELL, V7, P872, DOI 10.1128/EC.00461-07; Deschamps P, 2006, EUKARYOT CELL, V5, P954, DOI 10.1128/EC.00380-05; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Graf A, 2011, TRENDS PLANT SCI, V16, P169, DOI 10.1016/j.tplants.2010.12.003; Hastings JW, 2007, COLD SPRING HARB SYM, V72, P141, DOI 10.1101/sqb.2007.72.026; Heldt H-W, 2011, PLANT BIOCH, P241, DOI DOI 10.1016/B978-0-12-384986-1.00009-0; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; HOLMES RW, 1967, LIMNOL OCEANOGR, V12, P503, DOI 10.4319/lo.1967.12.3.0503; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jiang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087416; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Kudela RM, 2000, AQUAT MICROB ECOL, V21, P31, DOI 10.3354/ame021031; Lei QY, 2011, MAR POLLUT BULL, V62, P2692, DOI 10.1016/j.marpolbul.2011.09.021; Lin SJ, 2004, J PHYCOL, V40, P1062, DOI 10.1111/j.1529-8817.2004.03217.x; Liu BL, 2012, PROTIST, V163, P746, DOI 10.1016/j.protis.2011.11.001; MacKenzie TDB, 2011, PLANT CELL ENVIRON, V34, P669, DOI 10.1111/j.1365-3040.2010.02271.x; Moorthi SD, 2006, MICROB ECOL, V52, P136, DOI 10.1007/s00248-006-9030-3; Morey JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-346; Nassoury N, 2001, PLANT CELL, V13, P923; OLSON RJ, 1986, J PLANKTON RES, V8, P785, DOI 10.1093/plankt/8.4.785; Plancke C, 2008, EUKARYOT CELL, V7, P247, DOI 10.1128/EC.00373-07; Pleissner D, 2012, BIOTECHNOL BIOENG, V109, P2005, DOI 10.1002/bit.24470; PREZELIN BB, 1986, MAR BIOL, V93, P1, DOI 10.1007/BF00428648; RIVOAL J, 1993, PLANT PHYSIOL, V101, P553, DOI 10.1104/pp.101.2.553; Roenneberg T, 1996, FASEB J, V10, P1443, DOI 10.1096/fasebj.10.12.8903515; SCHMITTER RE, 1971, J CELL SCI, V9, P147; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Trethewey RN, 1998, PLANT J, V15, P109, DOI 10.1046/j.1365-313X.1998.00190.x; TURPIN DH, 1991, J PHYCOL, V27, P14, DOI 10.1111/j.0022-3646.1991.00014.x; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Viola R, 2001, P ROY SOC B-BIOL SCI, V268, P1417, DOI 10.1098/rspb.2001.1644; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Walsh JJ, 2009, PROG OCEANOGR, V80, P51, DOI 10.1016/j.pocean.2008.12.005; ZHOU J, 1994, J PHYCOL, V30, P39, DOI 10.1111/j.0022-3646.1994.00039.x	54	17	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111067	10.1371/journal.pone.0111067	http://dx.doi.org/10.1371/journal.pone.0111067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368991	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402000034
J	Day, CP; Carter, J; Ohler, ZW; Bonomi, C; El Meskini, R; Martin, P; Graff-Cherry, C; Feigenbaum, L; Tuting, T; Van Dyke, T; Hollingshead, M; Merlino, G				Day, Chi-Ping; Carter, John; Ohler, Zoe Weaver; Bonomi, Carrie; El Meskini, Rajaa; Martin, Philip; Graff-Cherry, Cari; Feigenbaum, Lionel; Tueting, Thomas; Van Dyke, Terry; Hollingshead, Melinda; Merlino, Glenn			"Glowing Head'' Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts	PLOS ONE			English	Article							IN-VIVO; TRANSGENE EXPRESSION; IMMUNE-RESPONSES; TUMOR-SUPPRESSOR; DRUG DEVELOPMENT; PITUITARY-GLAND; LUNG METASTASIS; BONE-MARROW; CELLS; MOUSE	Preclinical therapeutic assessment currently relies on the growth response of established human cell lines xenografted into immunocompromised mice, a strategy that is generally not predictive of clinical outcomes. Immunocompetent genetically engineered mouse (GEM)-derived tumor allograft models offer highly tractable preclinical alternatives and facilitate analysis of clinically promising immunomodulatory agents. Imageable reporters are essential for accurately tracking tumor growth and response, particularly for metastases. Unfortunately, reporters such as luciferase and GFP are foreign antigens in immunocompetent mice, potentially hindering tumor growth and confounding therapeutic responses. Here we assessed the value of reporter-tolerized GEMs as allograft recipients by targeting minimal expression of a luciferase-GFP fusion reporter to the anterior pituitary gland (dubbed the "Glowing Head'' or GH mouse). The luciferase-GFP reporter expressed in tumor cells induced adverse immune responses in wildtype mouse, but not in GH mouse, as transplantation hosts. The antigenicity of optical reporters resulted in a decrease in both the growth and metastatic potential of the labeled tumor in wildtype mice as compared to the GH mice. Moreover, reporter expression can also alter the tumor response to chemotherapy or targeted therapy in a context-dependent manner. Thus the GH mice and experimental approaches vetted herein provide concept validation and a strategy for effective, reproducible preclinical evaluation of growth and response kinetics for traceable tumors.	[Day, Chi-Ping; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Carter, John; Bonomi, Carrie] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, In Vivo Evaluat, Frederick, MD USA; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Ctr Canc Res, Frederick, MD 21701 USA; [Ohler, Zoe Weaver; El Meskini, Rajaa; Martin, Philip] Leidos Biomed Res Inc, Ctr Adv Preclin Res, Natl Lab Canc Res, Frederick, MD USA; [Graff-Cherry, Cari; Feigenbaum, Lionel] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Anim Sci Program, Frederick, MD USA; [Tueting, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Hollingshead, Melinda] NCI, Biol Testing Branch, Dev Therapeut Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bonn; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	gmerlino@helix.nih.gov	Tüting, Thomas/AAJ-3610-2021	Tüting, Thomas/0000-0001-7146-0934; Weaver Ohler, Zoe/0000-0002-6287-2504	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis; Center for Cancer Research, NCI, NIH; Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE [ZIABC011462] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis; Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. This work was supported in part by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis and Intramural Research Program of the Center for Cancer Research, NCI, NIH. Leidos Biomedical Research Inc. provided support in the form of salaries for authors John Carter, Zoe Weaver-Ohler, Carrie Bonomi, Rajaa El Meskini, Philip Martin, Cari Graff-Cherry, and Lionel Feigenbaum, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	*ADM USFAD, 2004, INN STAGN CHALL OPP; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Andersson G, 2003, MOL THER, V8, P385, DOI 10.1016/S1525-0016(03)00210-7; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Day CP, 2011, FED REGISTER, V76, P40382; de Jersey J, 2002, J IMMUNOL, V169, P6753, DOI 10.4049/jimmunol.169.12.6753; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Herper M, 2012, FORBES; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holzel M, 2013, NAT REV CANCER, V13, P365, DOI 10.1038/nrc3498; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Luque RM, 2007, ENDOCRINOLOGY, V148, P1946, DOI 10.1210/en.2006-1542; MELIEF CJM, 1993, CURR OPIN IMMUNOL, V5, P709, DOI 10.1016/0952-7915(93)90125-C; Merlino G, 2013, PIGMENT CELL MELANOM; Michou AI, 1997, GENE THER, V4, P473, DOI 10.1038/sj.gt.3300412; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Recio JA, 2002, CANCER RES, V62, P6724; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sparreboom A, 1996, CANCER RES, V56, P2112; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Yang Y, 1996, GENE THER, V3, P137; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	38	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109956	10.1371/journal.pone.0109956	http://dx.doi.org/10.1371/journal.pone.0109956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369133	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000013
J	Ko, MC; Lee, MC; Amstislavskaya, TG; Tikhonova, MA; Yang, YL; Lu, KT				Ko, Meng Chang; Lee, Min Chong; Amstislavskaya, Tamara G.; Tikhonova, Maria A.; Yang, Yi-Ling; Lu, Kwok-Tung			Inhibition of NKCC1 Attenuated Hippocampal LTP Formation and Inhibitory Avoidance in Rat	PLOS ONE			English	Article							CATION-CHLORIDE-COTRANSPORTERS; K+-CL-COTRANSPORTER; INDUCED BRAIN EDEMA; PROTEIN-KINASE-C; AREA CA1; BUMETANIDE; INJURY; STIMULATION; HOMEOSTASIS; ACTIVATION	The loop diuretic bumetanide (Bumex) is thought to have antiepileptic properties via modulate GABA(A) mediated signaling through their antagonism of cation-chloride cotransporters. Given that loop diuretics may act as antiepileptic drugs that modulate GABAergic signaling, we sought to investigate whether they also affect hippocampal function. The current study was performed to evaluate the possible role of NKCC1 on the hippocampal function. Brain slice extracellular recording, inhibitory avoidance, and western blot were applied in this study. Results showed that hippocampal Long-term potentiation was attenuated by suprafusion of NKCC1 inhibitor bumetanide, in a dose dependent manner. Sequent experiment result showed that Intravenous injection of bumetanide (15.2 mg/kg) 30 min prior to the training session blocked inhibitory avoidance learning significantly. Subsequent control experiment's results excluded the possible non-specific effect of bumetanide on avoidance learning. We also found the phosphorylation of hippocampal MAPK was attenuated after bumetanide administration. These results suggested that hippocampal NKCC1 may via MAPK signaling cascade to possess its function.	[Ko, Meng Chang; Lee, Min Chong; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Amstislavskaya, Tamara G.; Tikhonova, Maria A.] State Res Inst Physiol & Fundamental Med, Lab Biol Psychiat, SB RAMS, Novosibirsk, Russia; [Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	National Taiwan Normal University; Research Institute for Neurosciences & Medicine; Russian Academy of Medical Sciences; National Chiayi University	Yang, YL (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw; ktlu@ntnu.edu.tw	Tikhonova, Maria A/K-3455-2018; Amstislavskaya, Tamara G/K-4149-2018	Tikhonova, Maria A/0000-0002-4265-8981; 	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Beck J, 2003, J NEUROSCI, V23, P5061; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Busse S, 2005, BRAIN RES, V1046, P116, DOI 10.1016/j.brainres.2005.03.055; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; Deisz RA, 2011, J PHYSIOL-LONDON, V589, P1317, DOI 10.1113/jphysiol.2010.201830; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; HUGHES IW, 1990, CURR MED RES OPIN, V12, P151, DOI 10.1185/03007999009111496; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E22; Kahle KT, 2012, JASPERS BASIC MECH E; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Krystal AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035417; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lu KT, 1999, CHINESE J PHYSIOL, V42, P249; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747, DOI 10.1152/ajpcell.1995.268.3.C747; Panet R, 2006, J CELL PHYSIOL, V206, P578, DOI 10.1002/jcp.20506; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schomberg SL, 2001, J NEUROPHYSIOL, V85, P2563, DOI 10.1152/jn.2001.85.6.2563; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; WARD A, 1984, DRUGS, V28, P426, DOI 10.2165/00003495-198428050-00003; Yang YL, 2005, NEUROSCIENCE, V134, P247, DOI 10.1016/j.neuroscience.2005.04.003	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e106692	10.1371/journal.pone.0106692	http://dx.doi.org/10.1371/journal.pone.0106692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369049	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000003
J	Leem, YE; Ha, HL; Bae, JH; Baek, KH; Kang, JS				Leem, Young-Eun; Ha, Hye-Lim; Bae, Ju-Hyeon; Baek, Kwan-Hyuck; Kang, Jong-Sun			CDO, an Hh-Coreceptor, Mediates Lung Cancer Cell Proliferation and Tumorigenicity through Hedgehog Signaling	PLOS ONE			English	Article							SONIC-HEDGEHOG; PROSTATE-CANCER; IN-VIVO; PATHWAY; MUTATIONS; ACTIVATION; GAS1; REQUIREMENT; RECEPTOR; DROSOPHILA	Hedgehog (Hh) signaling plays essential roles in various developmental processes, and its aberrant regulation results in genetic disorders or malignancies in various tissues. Hyperactivation of Hh signaling is associated with lung cancer development, and there have been extensive efforts to investigate how to control Hh signaling pathway and regulate cancer cell proliferation. In this study we investigated a role of CDO, an Hh co-receptor, in non-small cell lung cancer (NSCLC). Inhibition of Hh signaling by SANT-1 or siCDO in lung cancer cells reduced proliferation and tumorigenicity, along with the decrease in the expression of the Hh components. Histological analysis with NSCLC mouse tissue demonstrated that CDO was expressed in advanced grade of the cancer, and precisely co-localized with GLI1. These data suggest that CDO is required for proliferation and survival of lung cancer cells via Hh signaling.	[Leem, Young-Eun; Ha, Hye-Lim; Bae, Ju-Hyeon; Baek, Kwan-Hyuck; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea	Sungkyunkwan University (SKKU)	Kang, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	kangj01@skku.edu			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2012R1A1A2005448, NRF-2011-0017315]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was funded by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2012R1A1A2005448 to YEL) and (NRF-2011-0017315 to JSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Camp D, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-28; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Delloye-Bourgeois C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001623; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gialmanidis IP, 2009, LUNG CANCER, V66, P64, DOI 10.1016/j.lungcan.2009.01.007; Gonnissen A, 2013, INT J MOL SCI, V14, P13979, DOI 10.3390/ijms140713979; Hahn H, 2004, GENOMICS, V84, P853, DOI 10.1016/j.ygeno.2004.07.002; Hayashi T, 2011, PATHOBIOLOGY, V78, P277, DOI 10.1159/000329588; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hwang JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079634; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Oh JE, 2009, FASEB J, V23, P2088, DOI 10.1096/fj.08-119255; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Raffel C, 1997, CANCER RES, V57, P842; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seppala M, 2007, J CLIN INVEST, V117, P1575, DOI 10.1172/JCI32032; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Shin J, 2014, CANCER LETT, V342, P70, DOI 10.1016/j.canlet.2013.08.047; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Unden AB, 1996, CANCER RES, V56, P4562; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	52	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111701	10.1371/journal.pone.0111701	http://dx.doi.org/10.1371/journal.pone.0111701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369201	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402000086
J	Muller, B; Nienaber, CA; Reis, O; Kropp, P; Meyer, W				Mueller, Britta; Nienaber, Christoph A.; Reis, Olaf; Kropp, Peter; Meyer, Wolfgang			Sexuality and Affection among Elderly German Men and Women in Long-Term Relationships: Results of a Prospective Population-Based Study	PLOS ONE			English	Article							LATER LIFE; MARITAL SATISFACTION; OLDER WOMEN; HEALTH; ATTITUDES; SYMPTOMS; ASSOCIATION; DYSFUNCTION; BEHAVIOR; SEEKING	Satisfaction with sexual activity i.e. sexual satisfaction and the importance of sexuality and affection were analysed using data from the German "Interdisciplinary Longitudinal Study of Adult Development'' (ILSE). At three measurement points, 1993-1995, 1997-1998, and 2004-2006 i.e. subjects' ages of 63, 67, and 74 years, participants' reports about their affection and sexual activity were collected. The sample of completed records used for this study consisted of 194 urban non-institutionalised participants, 68% male, all living with partners. Median levels of sexual satisfaction were reported, fluctuating between the measurement points of ages 63 to 74. Between baseline, first and second follow-up no differences were found in levels of sexual satisfaction, though at measurement points age 63 and 67 women were more satisfied than men. When measured at age 74, affection was given a higher priority than sexual activity. Although men and women reported similar priorities, sexual activity and affection were more important for men than for women. Satisfaction within the relationship can be predicted by the importance of affection, but not by that of sexual activity. Our results confirm the thesis of the 'second language of sexuality': for humans in their later years affection seems to be more important than for younger individuals.	[Mueller, Britta; Kropp, Peter] Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany; [Nienaber, Christoph A.] Univ Rostock, Rostock Univ Hosp, Med Ctr Rostock, Dept Cardiol & Angiol, D-18055 Rostock, Germany; [Reis, Olaf] Univ Rostock, Rostock Univ Hosp, Clin Child & Adolescent Psychiat, D-18055 Rostock, Germany; [Meyer, Wolfgang] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of Rostock; University of Rostock; University of Rostock; University of London; Queen Mary University London	Muller, B (corresponding author), Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany.	britta.mueller@med.uni-rostock.de	Kropp, Peter/B-8132-2012		German Federal Ministry for Families, Senior Citizens, Women and Youth [AZ 314-1722-102/16, AZ 301-1720-295/2]; Ministry for Science, Research and Art Baden-Wurttemberg; University of Rostock [FORUN 989020, 889048]	German Federal Ministry for Families, Senior Citizens, Women and Youth; Ministry for Science, Research and Art Baden-Wurttemberg; University of Rostock	The study was funded by the German Federal Ministry for Families, Senior Citizens, Women and Youth (AZ 314-1722-102/16; AZ 301-1720-295/2), the Ministry for Science, Research and Art Baden-Wurttemberg, and the University of Rostock (FORUN 989020; 889048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SEX ROMANCE RELATION; Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9; Baltes PB, 2003, PSYCHOL HUMAN STRENG, P23; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bomsdorf E, 1993, GENERATIONENSTERBETA; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Bundesamt S, 2011, FOCUS ELDERLY GERMAN; Burgess EO, 2004, HANDBOOK OF SEXUALITY IN CLOSE RELATIONSHIPS, P437; Butler RN, 1996, ALTE LIEBE ROSTET NI; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; CARSTENSEN LL, 1995, PSYCHOL AGING, V10, P140, DOI 10.1037/0882-7974.10.1.140; Clarke LH, 2006, CAN J AGING, V25, P129, DOI 10.1353/cja.2006.0034; DeLamater J, 2007, J AGING HEALTH, V19, P921, DOI 10.1177/0898264307308342; DeLamater J, 2012, J SEX RES, V49, P125, DOI 10.1080/00224499.2011.603168; Dillaway HE, SEX LIFE VIRGINITY V; EDWARDS JN, 1994, SEXUALITY LIFE COURS, P233; Fooken I, 2006, GERONTOLOGIE MEDIZIN, P328; Gades NM, 2009, J SEX MED, V6, P2455, DOI 10.1111/j.1743-6109.2009.01374.x; Gallicchio L, 2007, J PSYCHOSOM RES, V63, P263, DOI 10.1016/j.jpsychores.2007.02.003; Harper JM, 2009, AGING MENT HEALTH, V13, P546, DOI 10.1080/13607860902774485; Heiman JR, 2011, ARCH SEX BEHAV, V40, P741, DOI 10.1007/s10508-010-9703-3; Henry NJM, 2007, PSYCHOL AGING, V22, P428, DOI 10.1037/0882-7974.22.3.428; Hinchliff S, 2011, J SEX RES, V48, P106, DOI 10.1080/00224499.2010.548610; Hopflinger F, 1987, WANDEL FAMILIENBILDU; Howard JR, 2006, CLIMACTERIC, V9, P355, DOI 10.1080/13697130600961870; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; Koch PB, 2005, J SEX RES, V42, P215, DOI 10.1080/00224490509552276; Kruse A, 2008, INTERDISZIPLINARE LA; Laumann EO, 2006, ARCH SEX BEHAV, V35, P145, DOI 10.1007/s10508-005-9005-3; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Leiblum SR, 2006, MENOPAUSE, V13, P46, DOI 10.1097/01.gme.0000172596.76272.06; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Moreira ED, 2008, SEX HEALTH, V5, P227, DOI 10.1071/SH07055; Muller B, 2012, KONSTRUKTE GELINGEND, P207; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rothermund K, 2003, PSYCHOL AGING, V18, P896, DOI 10.1037/0882-7974.18.4.896; Thompson WK, 2011, J AM GERIATR SOC, V59, P1503, DOI 10.1111/j.1532-5415.2011.03495.x; Waite L, 2010, DEMOGRAPHY, V47, pS87; Waite LJ, 2009, J GERONTOL B-PSYCHOL, V64, pI56, DOI 10.1093/geronb/gbp038; Walker R, 2013, INT J AGING HUM DEV, V76, P123, DOI 10.2190/AG.76.2.b; Woloski-Wruble AC, 2010, J SEX MED, V7, P2401, DOI 10.1111/j.1743-6109.2010.01747.x	43	24	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111404	10.1371/journal.pone.0111404	http://dx.doi.org/10.1371/journal.pone.0111404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369193	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000054
J	Correia, IL; Franco, IS; de Sa-Nogueira, I				Correia, Isabel Lopes; Franco, Irina Saraiva; de Sa-Nogueira, Isabel			Towards Novel Amino Acid-Base Contacts in Gene Regulatory Proteins: AraR - A Case Study	PLOS ONE			English	Article							L-ARABINOSE METABOLISM; BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATION; EFFECTOR-BINDING; DNA INTERACTIONS; INDIRECT READOUT; RECOGNITION; INOSINE; IDENTIFICATION; DIAMINOPURINE	AraR is a transcription factor involved in the regulation of carbon catabolism in Bacillus subtilis. This regulator belongs to the vast GntR family of helix-turn-helix (HTH) bacterial metabolite-responsive transcription factors. In this study, AraR-DNA specific interactions were analysed by an in vitro missing-contact probing and validated using an in vivo model. We show that amino acid E30 of AraR, a highly conserved residue in GntR regulators, is indirectly responsible for the specificity of amino acid-base contacts, and that by mutating this residue it will be possible to achieve new specificities towards DNA contacts. The results highlight the importance in DNA recognition and binding of highly conserved residues across certain families of transcription factors that are located in the DNA-binding domain but not predicted to specifically contact bases on the DNA. These new findings not only contribute to a more detailed comprehension of AraR-operator interactions, but may also be useful for the establishment of a framework of rules governing protein-DNA recognition.	[Correia, Isabel Lopes; de Sa-Nogueira, Isabel] Fac Ciencias & Tecnol FCT UNL, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal; [Correia, Isabel Lopes; Franco, Irina Saraiva] Inst Tecnol Quim & Biol ITQB UNL, Oeiras, Portugal		de Sa-Nogueira, I (corresponding author), Fac Ciencias & Tecnol FCT UNL, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal.	isn@fct.unl.pt	Franco, Irina S/I-7247-2013; de Sá-Nogueira, Isabel/B-9139-2011; de Sá-Nogueira, Isabel/AAC-4189-2020	Franco, Irina S/0000-0002-7243-3185; de Sá-Nogueira, Isabel/0000-0001-6665-7994; de Sá-Nogueira, Isabel/0000-0001-6665-7994	Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-MIC/61140/2004, PTDC/AGR-AAM/102345/2008]; Centro de Recursos Microbiologicos [PEst-OE/ BIA/ UI0457/2011];  [SFRH/BD/29469/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Centro de Recursos Microbiologicos; 	This work was supported by the Fundacao para a Ciencia e a Tecnologia [grant numbers PPCDT/BIA-MIC/61140/2004 and PTDC/AGR-AAM/102345/2008 to I.S.N.; PEst-OE/ BIA/ UI0457/2011 to Centro de Recursos Microbiologicos; fellowship SFRH/BD/29469/2006 to I.L.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY C, 1995, EMBO J, V14, P2121, DOI 10.1002/j.1460-2075.1995.tb07204.x; BAILLY C, 1995, J MOL BIOL, V253, P1, DOI 10.1006/jmbi.1995.0530; BRUNELLE A, 1989, J MOL BIOL, V209, P607, DOI 10.1016/0022-2836(89)90598-6; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; EBRIGHT RH, 1991, METHOD ENZYMOL, V208, P620; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Hilchey SP, 1997, J BIOL CHEM, V272, P1646, DOI 10.1074/jbc.272.3.1646; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Lindemose S, 2008, NUCLEIC ACIDS RES, V36, P4797, DOI 10.1093/nar/gkn452; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; Miller J.H., 1972, EXPT MOL GENETICS; Mollegaard NE, 1997, NUCLEIC ACIDS RES, V25, P3497, DOI 10.1093/nar/25.17.3497; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PASCAL M, 1971, BIOCHIMIE, V53, P1059, DOI 10.1016/S0300-9084(71)80193-1; Prochazkova K, 2012, ACTA CRYSTALLOGR D, V68, P176, DOI 10.1107/S090744491105414X; Raposo MP, 2004, J BACTERIOL, V186, P1287, DOI 10.1128/JB.186.5.1287-1296.2004; Sambrook J., 2002, MOL CLONING LAB MANU; SaNogueira I, 1997, J BACTERIOL, V179, P7705, DOI 10.1128/jb.179.24.7705-7711.1997; SaNogueira I, 1997, MICROBIOL-SGM, V143, P957, DOI 10.1099/00221287-143-3-957; SaNogueira I, 1997, J BACTERIOL, V179, P1598, DOI 10.1128/jb.179.5.1598-1608.1997; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	37	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111802	10.1371/journal.pone.0111802	http://dx.doi.org/10.1371/journal.pone.0111802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364981	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100124
J	Forsberg, L; Naver, L; Gustafsson, LL; Wide, K				Forsberg, Lisa; Naver, Lars; Gustafsson, Lars L.; Wide, Katarina			Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants-Clinical Monitoring Using Neonatal Abstinence Score	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; IN-UTERO EXPOSURE; TERM INFANTS; MATERNAL USE; PREGNANCY; SYMPTOMS; HYPOGLYCEMIA; PRETERM; RISK	Background: Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central nervous system, respiratory system and gastrointestinal system. Finnegan score (Neonatal Abstinence Score, NAS) has routinely been used to assess infants exposed to antidepressants in utero. Aim: The purpose was to study neonatal maladaptation syndrome in infants exposed to selective serotonin reuptake inhibitors (SSRI) or serotonin-norepinephrine reuptake inhibitors (SNRI) in utero. Method: Retrospective cohort study of women using antidepressants during pregnancy and their infants. Patients were identified from the electronic health record system at Karolinska University Hospital Huddinge containing pre-, peri-and postnatal information. Information was collected on maternal and infant health, social factors and pregnancy. NAS sheets were scrutinized. Results: 220 women with reported 3 rd trimester exposure to SSRIs or SNRIs and who gave birth between January 2007 and June 2009 were included. Seventy seven women (35%) used citalopram, 76 used (35%) sertraline, 34 (15%) fluoxetine and 33 (15%) other SSRI/SNRI. Twenty-nine infants (13%) were admitted to the neonatal ward, 19 were born prematurely. NAS was analyzed in 205 patients. Severe abstinence was defined as eight points or higher on at least two occasions (on a scale with maximum 40 points), mild abstinence as 4 points or higher on at least two occasions. Seven infants expressed signs of severe abstinence and 46 (22%) had mild abstinence symptoms. Hypoglycemia (plasma glucose,2.6 mmol/L) was found in 42 infants (19%). Conclusion: Severe abstinence in infants prenatally exposed to antidepressants was found to be rare (3%) in this study population, a slightly lower prevalence than reported in previous studies. Neonatal hypoglycemia in infants prenatally exposed to antidepressant may however be more common than previously described.	[Forsberg, Lisa; Naver, Lars; Wide, Katarina] Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden; [Forsberg, Lisa; Naver, Lars; Wide, Katarina] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Gustafsson, Lars L.] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Forsberg, L (corresponding author), Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.	lisa.forsberg.1@ki.se	Navér, Lars/E-5085-2013	Wide, Katarina/0000-0003-3024-0657; Naver, Lars/0000-0001-6027-0211; Gustafsson, Lars Lennart/0000-0002-0063-552X	Swedish Research Council [2011-3440, 2012-3466]; Mayflower Foundation; Samariten Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Mayflower Foundation; Samariten Foundation	Funding provided by Swedish Research Council, grant number 2011-3440 www.vr.se to LLG, Swedish Research Council, grant number 2012-3466, www.vr.se to KW, The Mayflower Foundation, www.majblomman.se to KW LF and The Samariten Foundation, www.stiftelsensamariten.se to LF KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Boardman JP, 2013, ARCH DIS CHILDHOOD-E, V98, P2, DOI 10.1136/archdischild-2012-302569; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; FINNEGAN LP, 1975, ADDICT DIS, V2, P141; HAWDON JM, 1992, ARCH DIS CHILD-FETAL, V67, P357, DOI 10.1136/adc.67.4_Spec_No.357; Hilli J, 2009, EUR NEUROPSYCHOPHARM, V19, P363, DOI 10.1016/j.euroneuro.2009.01.006; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Leibovitch L, 2013, NEONATOLOGY, V104, P65, DOI 10.1159/000350506; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Levison-Castiel R, 2006, ARCH PEDIAT ADOL MED, V160, P173, DOI 10.1001/archpedi.160.2.173; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2004, J CLIN PSYCHIAT, V65, P230; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; ter Horst PGJ, 2008, OBSTET GYNECOL SURV, V63, P267, DOI 10.1097/OGX.0b013e3181676be8; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Warburton W, 2010, ACTA PSYCHIAT SCAND, V121, P471, DOI 10.1111/j.1600-0447.2009.01490.x; Winklbaur B, 2009, EUR ADDICT RES, V15, P150, DOI 10.1159/000216466	24	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111327	10.1371/journal.pone.0111327	http://dx.doi.org/10.1371/journal.pone.0111327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365553	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100060
J	Hold, GL; Berry, S; Saunders, KA; Drew, J; Mayer, C; Brookes, H; Gay, NJ; El-Omar, EM; Bryant, CE				Hold, Georgina L.; Berry, Susan; Saunders, Karin A.; Drew, Janice; Mayer, Claus; Brookes, Heather; Gay, Nick J.; El-Omar, Emad M.; Bryant, Clare E.			The TLR4 D299G and T399I SNPs Are Constitutively Active to Up-Regulate Expression of Trif-Dependent Genes	PLOS ONE			English	Article							RECEPTOR-4 POLYMORPHISMS; ASP299GLY POLYMORPHISM; CYTOKINE RELEASE; WHOLE-BLOOD; LIPID-A; TOLL; LIPOPOLYSACCHARIDE; ENDOTOXIN; DISEASE; HUMANS	Dysregulated Toll-Like Receptor (TLR) signalling and genetic polymorphisms in these proteins are linked to many human diseases. We investigated TLR4 functional variants D299G and T399I to assess the impact on LPS-induced responsiveness in comparison to wild-type TLR4. The mechanism by which this occurs in unclear as these SNPs do not lie within the lipid A binding domain or dimerisation sites of the LPS-TLR4/MD2 receptor complexes. Transfection of TLR4D299G, TLR4T399I or TLR4D299G. T399I into HEK cells resulted in constitutive activation of an NF-kappa B reporter gene and a blunting of the LPS-induced reporter activation compared to WT-TLR4. Unstimulated human monocyte/macrophages, from patients with the D299G and T399I SNPs demonstrated a downregulation of many genes, particularly Tram/Trif signalling pathway constitutents compared to the TLR4 wild-type subjects supporting the concept of basal receptor activity. Monocyte/macrophages from carriers of the TLR4 D299G and T399I polymorphisms stimulated with LPS showed >6 fold lower levels of NF-kappa B and similar to 12 fold higher IFN-beta gene expression levels compared to wild-type subjects (P < 0.05; MWU test) and dramatically altered resultant cytokine profiles. We conclude that these TLR4 SNPs affect constitutive receptor activity which impacts on the hosts ability to respond to LPS challenge leading to a dysregulated sub-optimal immune response to infection.	[Hold, Georgina L.; Berry, Susan; Saunders, Karin A.; El-Omar, Emad M.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Drew, Janice] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Mayer, Claus] Biomath & Stat Scotland, Aberdeen, Scotland; [Brookes, Heather; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Gay, Nick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Aberdeen; University of Aberdeen; James Hutton Institute; University of Cambridge; University of Cambridge	Hold, GL (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mayer, Claus-Dieter/L-9353-2013; El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020	Hold, Georgina Louise/0000-0001-7573-3397; El-Omar, Emad/0000-0002-0011-3924; Mayer, Claus-Dieter/0000-0001-8788-3149	Cancer Research UK; EEO, Tenovus Scotland; Wellcome program; BBSRC [BB/K006436/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K006436/1] Funding Source: researchfish; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EEO, Tenovus Scotland; Wellcome program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Cancer Research UK to GLH and EEO, Tenovus Scotland grant funding to GLH, JD and MRC, and Wellcome program grants to CEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Haag AF, 2011, J BIOL CHEM, V286, P17455, DOI 10.1074/jbc.M111.236356; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Heesen M, 2003, EUR CYTOKINE NETW, V14, P234; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kumpf O, 2006, SHOCK, V25, P123, DOI 10.1097/01.shk.0000190823.44030.e6; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Marsik C, 2005, CLIN CHEM, V51, P2178, DOI 10.1373/clinchem.2005.051649; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Schwartz DA, 2001, J ENDOTOXIN RES, V7, P389, DOI 10.1179/096805101101532972; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	32	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111460	10.1371/journal.pone.0111460	http://dx.doi.org/10.1371/journal.pone.0111460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365308	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100067
J	Occelli, F; Deram, A; Genin, M; Noel, C; Cuny, D; Glowacki, F				Occelli, Florent; Deram, Annabelle; Genin, Michael; Noel, Christian; Cuny, Damien; Glowacki, Francois		Nephronor Network	Mapping End-Stage Renal Disease (ESRD): Spatial Variations on Small Area Level in Northern France, and Association with Deprivation	PLOS ONE			English	Article							REPLACEMENT THERAPY; SOCIOECONOMIC-STATUS; GEOGRAPHICAL VARIATION; RACIAL-DIFFERENCES; KIDNEY-DISEASE; UNITED-STATES; PATTERNS; INEQUALITIES; PREVALENCE; EXPOSURE	Background: Strong geographic variations in the incidence of end-stage renal disease (ESRD) are observed in developed countries. The reasons for these variations are unknown. They may reflect regional inequalities in the population's sociodemographic characteristics, related diseases, or medical practice patterns. In France, at the district level, the highest incidence rates have been found in the Nord-Pas-de-Calais region. This area, with a high population density and homogeneous healthcare provision, represents a geographic situation which is quite suitable for the study, over small areas, of spatial disparities in the incidence of ESRD, together with their correlation with a deprivation index and other risk factors. Methods: The Renal Epidemiology and Information Network is a national registry, which lists all ESRD patients in France. All cases included in the Nord-Pas-de-Calais registry between 2005 and 2011 were extracted. Adjusted and smoothed standardized incidence ratio (SIR) was calculated for each of the 170 cantons, thanks to a hierarchical Bayesian model. The correlation between ESRD incidence and deprivation was assessed using the quintiles of Townsend index. Relative risk (RR) and credible intervals (CI) were estimated for each quintile. Results: Significant spatial disparities in ESRD incidence were found within the Nord-Pas-de-Calais region. The sex- and age-adjusted, smoothed SIRs varied from 0.66 to 1.64. Although no correlation is found with diabetic or vascular nephropathy, the smoothed SIRs are correlated with the Townsend index (RR: 1.18, 95% CI [1.00-1.34] for Q2; 1.28, 95% CI [1.11-1.47] for Q3; 1.30, 95% CI [1.14-1.51] for Q4; 1.44, 95% CI [1.32-1.74] for Q5). Conclusion: For the first time at this aggregation level in France, this study reveals significant geographic differences in ESRD incidence. Unlike the time of renal replacement care, deprivation is certainly a determinant in this phenomenon. This association is probably independent of the patients' financial ability to gain access to healthcare.	[Occelli, Florent; Deram, Annabelle; Cuny, Damien; Glowacki, Francois] Univ Lille Nord France, EA 4483, Fac Pharm Lille, Lille, France; [Deram, Annabelle] Fac Ingn & Management Sante ILIS, Loos, France; [Genin, Michael] Univ Lille Nord France, EA 2694, Fac Med Pole Rech, Lille, France; [Noel, Christian; Glowacki, Francois] CHRU Lille, Hop Huriez, Serv Nephrol, F-59037 Lille, France; [Noel, Christian; Glowacki, Francois; Nephronor Network] CHRU Lille, Hop Huriez, Reseau Nephronor, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Occelli, F (corresponding author), Univ Lille Nord France, EA 4483, Fac Pharm Lille, Lille, France.	florent.occelli@univ-lille2.fr	Genin, Michael/O-3639-2019; Occelli, Florent Angelo/M-6642-2016; Genin, Michael/P-5423-2014	Genin, Michael/0000-0002-9098-7528; Occelli, Florent Angelo/0000-0001-7478-7000; Genin, Michael/0000-0002-9098-7528; Frimat, Marie/0000-0002-7461-8298; Glowacki, Francois/0000-0001-5443-9172; Hazzan, Marc/0000-0002-9863-8840; DERAM, Annabelle/0000-0002-8993-6475	Agence de Biomedecine, Renal Epidemiology and Information Network; Conseil Regional Nord, Pas de Calais, DRESTIC; Universite Lille 2 Droit et Sante [ED446]	Agence de Biomedecine, Renal Epidemiology and Information Network; Conseil Regional Nord, Pas de Calais, DRESTIC(Region Hauts-de-France); Universite Lille 2 Droit et Sante	This work was supported by Agence de Biomedecine, Renal Epidemiology and Information Network (www.soc-nephrologie.org/REIN/); Conseil Regional Nord, Pas de Calais, DRESTIC (www.nordpasdecalais.fr/jcms/c_5001/accueil); and Universite Lille 2 Droit et Sante, ED446 (http://edbsl.univ-lille2.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIS MAPPING WINBUGS; Bell EK, 2012, AM J HYPERTENS, V25, P789, DOI 10.1038/ajh.2012.48; BERNARDINELLI L, 1995, STAT MED, V14, P2411, DOI 10.1002/sim.4780142111; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boyle PJ, 1996, QJM-MON J ASSOC PHYS, V89, P151; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2012, NEPHROL DIAL TRANSPL, V27, P2312, DOI 10.1093/ndt/gfr639; Couchoud C, 2010, NEPHROL DIAL TRANSPL, V25, P1576, DOI 10.1093/ndt/gfp675; Counil E, 2008, AM J KIDNEY DIS, V51, P463, DOI 10.1053/j.ajkd.2007.10.032; Declercq C, 2004, INT SOC MORT REG NOR; Fan ZJ, 2007, HEALTH PLACE, V13, P179, DOI 10.1016/j.healthplace.2005.12.002; FOXMAN B, 1991, J AM SOC NEPHROL, V2, P1144; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gilg J, 2013, 16 UK REN REG, P9; Grace BS, 2012, NEPHROL DIAL TRANSPL, V27, P4173, DOI 10.1093/ndt/gfs361; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Hellstrom L, 2001, AM J KIDNEY DIS, V38, P1001, DOI 10.1053/ajkd.2001.28589; Hodgson S, 2007, AM J EPIDEMIOL, V165, P72, DOI 10.1093/aje/kwj345; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P2624, DOI 10.1093/ndt/gfq110; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lora CM, 2011, AM J KIDNEY DIS, V58, P282, DOI 10.1053/j.ajkd.2011.05.004; Maheswaran R, 2003, J EPIDEMIOL COMMUN H, V57, P523, DOI 10.1136/jech.57.7.523; MOULTON LH, 1992, AM J KIDNEY DIS, V20, P55, DOI 10.1016/S0272-6386(12)80317-9; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Muntner P, 2007, ENVIRON RES, V104, P396, DOI 10.1016/j.envres.2007.04.001; National Kidney andUrologic Diseases Information National, 2012, NIH PUBLICATION; Renal Epidemiology and Information Network (REIN), 2013, GUID REMPL DIAD INF; Reseau Epidemiologie et Information en Nephrologie (REIN), 2012, 2012 REIN; Roderick P, 1999, J Health Serv Res Policy, V4, P139; ROSANSKY SJ, 1990, AM J NEPHROL, V10, P198, DOI 10.1159/000168081; Spiegelhalter DJ, 2003, WINBUGS V 1 4 US MAN; Tanner RM, 2013, AM J KIDNEY DIS, V61, P395, DOI 10.1053/j.ajkd.2012.10.018; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; U.S. Renal Data System (USRDS), 2013, ANN DAT REP ATL CHR, P215; US Renal Data System (USRDS), 2013, ANN DAT REP ATL CHR, P333; Usami T, 2000, JAMA-J AM MED ASSOC, V284, P2622, DOI 10.1001/jama.284.20.2622; van de Luijtgaarden MWM, 2012, AM J KIDNEY DIS, V60, P940, DOI 10.1053/j.ajkd.2012.07.015; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Wakai K, 2004, NEPHROL DIAL TRANSPL, V19, P2044, DOI 10.1093/ndt/gfh317; Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821; Ward MM, 2008, AM J KIDNEY DIS, V51, P563, DOI 10.1053/j.ajkd.2007.11.023; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184; Yan GF, 2013, CLIN J AM SOC NEPHRO, V8, P610, DOI 10.2215/CJN.07780812; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120; Zoccali C, 2010, CLIN KIDNEY J, V3, P213, DOI 10.1093/ndtplus/sfp127	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110132	10.1371/journal.pone.0110132	http://dx.doi.org/10.1371/journal.pone.0110132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365039	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100016
J	Oishi, T; Imai, H; Go, Y; Imamura, M; Hirai, H; Takada, M				Oishi, Takao; Imai, Hiroo; Go, Yasuhiro; Imamura, Masanori; Hirai, Hirohisa; Takada, Masahiko			Sporadic Premature Aging in a Japanese Monkey: A Primate Model for Progeria	PLOS ONE			English	Article							WERNERS-SYNDROME; EXPOSURE; CULTURE; NERVE	In our institute, we have recently found a child Japanese monkey who is characterized by deep wrinkles of the skin and cataract of bilateral eyes. Numbers of analyses were performed to identify symptoms representing different aspects of aging. In this monkey, the cell cycle of fibroblasts at early passage was significantly extended as compared to a normal control. Moreover, both the appearance of senescent cells and the deficiency in DNA repair were observed. Also, pathological examination showed that this monkey has poikiloderma with superficial telangiectasia, and biochemical assay confirmed that levels of HbA1c and urinary hyaluronan were higher than those of other ( child, adult, and aged) monkey groups. Of particular interest was that our MRI analysis revealed expansion of the cerebral sulci and lateral ventricles probably due to shrinkage of the cerebral cortex and the hippocampus. In addition, the conduction velocity of a peripheral sensory but not motor nerve was lower than in adult and child monkeys, and as low as in aged monkeys. However, we could not detect any individual-unique mutations of known genes responsible for major progeroid syndromes. The present results indicate that the monkey suffers from a kind of progeria that is not necessarily typical to human progeroid syndromes.	[Oishi, Takao; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Imai, Hiroo; Imamura, Masanori; Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Mol Biol Sect, Inuyama, Aichi 484, Japan; [Go, Yasuhiro] Natl Inst Nat Sci, Dept Brain Sci, Ctr Novel Sci Initiat, Tokyo, Japan; [Go, Yasuhiro] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Kyoto University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Novel Science Initiatives (CNSI); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Oishi, T (corresponding author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan.	oishi.takao.5e@kyoto-u.ac.jp	Imamura, Masanori/AAV-5743-2021; Go, Yasuhiro/AAD-3313-2020	Imamura, Masanori/0000-0001-7609-2026; Go, Yasuhiro/0000-0003-4581-0325; Oishi, Takao/0000-0003-1067-3746; Imai, Hiroo/0000-0003-0729-0322	Grants-in-Aid for Scientific Research [25250003, 25860222] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arora H, 2014, INT J DERMATOL, V53, P798, DOI 10.1111/ijd.12408; DANES BS, 1971, J CLIN INVEST, V50, P2000, DOI 10.1172/JCI106692; de Magalhaes JP, 2004, ANN NY ACAD SCI, V1019, P375, DOI 10.1196/annals.1297.066; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Epstein C J, 1965, Trans Assoc Am Physicians, V78, P73; EPSTEIN J, 1973, P NATL ACAD SCI USA, V70, P977, DOI 10.1073/pnas.70.4.977; Gordon LB, 2012, J CELL BIOL, V199, P9, DOI 10.1083/jcb.201207072; Goto M, 2004, MED INTELL UNIT, P1; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Hirai H, 2002, CHROMOSOME RES, V10, P313, DOI 10.1023/A:1016523909096; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; HOPKINS AP, 1971, J NEUROL NEUROSUR PS, V34, P415, DOI 10.1136/jnnp.34.4.415; Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168; Marigliano M, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/965605; MCDONALD WI, 1963, BRAIN, V86, P501, DOI 10.1093/brain/86.3.501; McTighe MS, 2011, J AM ASSOC LAB ANIM, V50, P165; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mohaghegh P, 2002, INT J BIOCHEM CELL B, V34, P1496, DOI 10.1016/S1357-2725(02)00039-0; Nishimura T, 2008, AM J PHYS ANTHROPOL, V135, P182, DOI 10.1002/ajpa.20719; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Peters A, 2003, J COMP NEUROL, V462, P139, DOI 10.1002/cne.10715; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; PURSER DA, 1983, BRIT J IND MED, V40, P402; Ramsden CA, 2000, J PEDIATR-US, V136, P62, DOI 10.1016/S0022-3476(00)90051-9; Takemoto M, 2013, GERIATR GERONTOL INT, V13, P475, DOI 10.1111/j.1447-0594.2012.00913.x; Tanabe M, 2001, GERONTOLOGY, V47, P77, DOI 10.1159/000052777; Weimer MB, 2005, MUSCLE NERVE, V32, P185, DOI 10.1002/mus.20350	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111867	10.1371/journal.pone.0111867	http://dx.doi.org/10.1371/journal.pone.0111867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365557	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100131
J	Woo, HD; Shin, A; Kim, J				Woo, Hae Dong; Shin, Aesun; Kim, Jeongseon			Dietary Patterns of Korean Adults and the Prevalence of Metabolic Syndrome: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; RISK-FACTORS; ATHEROSCLEROSIS RISK; NATIONAL-HEALTH; SEX DIFFERENCE; SERUM FERRITIN; FOOD PATTERNS	The prevalence of metabolic syndrome has been increasing in Korea and has been associated with dietary habits. The aim of our study was to identify the relationship between dietary patterns and the prevalence of metabolic syndrome. Using a validated food frequency questionnaire, we employed a cross-sectional design to assess the dietary intake of 1257 Korean adults aged 31 to 70 years. To determine the participants' dietary patterns, we considered 37 predefined food groups in principal components analysis. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III. The abdominal obesity criterion was modified using Asian guidelines. Prevalence ratios and 95% confidence intervals for the metabolic syndrome were calculated across the quartiles of dietary pattern scores using log binomial regression models. The covariates used in the model were age, sex, total energy intake, tobacco intake, alcohol consumption, and physical activity. The prevalence of metabolic syndrome was 19.8% in men and 14.1% in women. The PCA identified three distinct dietary patterns: the 'traditional' pattern, the 'meat' pattern, and the 'snack' pattern. There was an association of increasing waist circumference and body mass index with increasing score in the meat dietary pattern. The multivariate-adjusted prevalence ratio of metabolic syndrome for the highest quartile of the meat pattern in comparison with the lowest quartile was 1.47 (95% CI: 1.00-2.15, p for trend = 0.016). A positive association between the prevalence of metabolic syndrome and the dietary pattern score was found only for men with the meat dietary pattern (2.15, 95% CI: 1.10-4.21, p for trend = 0.005). The traditional pattern and the snack pattern were not associated with an increased prevalence of metabolic syndrome. The meat dietary pattern was associated with a higher prevalence of metabolic syndrome in Korean male adults.	[Woo, Hae Dong; Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea; [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU)	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Stefanadis, Christodoulos/ABH-2232-2020; Shin, Aesun/E-9145-2014	Stefanadis, Christodoulos/0000-0001-5974-6454; Shin, Aesun/0000-0002-6426-1969	National Cancer Center, Korea [1210141]	National Cancer Center, Korea	This study was supported by a grant from the National Cancer Center, Korea (no. 1210141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Amini M, 2010, NUTRITION, V26, P986, DOI 10.1016/j.nut.2010.03.006; [Anonymous], 2005, GUIDELINES DATA PROC; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Azadbakht L, 2009, J NUTR, V139, P335, DOI 10.3945/jn.108.096297; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; Damiao R, 2006, BRIT J NUTR, V96, P532, DOI 10.1079/BJN20061876; de Valk B, 1999, ARCH INTERN MED, V159, P1542, DOI 10.1001/archinte.159.14.1542; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Ferreira Sandra R G, 2002, J Epidemiol, V12, P431; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gimeno SGA, 2002, DIABETOLOGIA, V45, P1635, DOI 10.1007/s00125-002-0963-x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040919; Hong S, 2012, METABOLISM, V61, P883, DOI 10.1016/j.metabol.2011.10.018; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163; Kim S H, 1996, World Rev Nutr Diet, V79, P109; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Mascitelli L, 2011, J CARDIOVASC MED, V12, P64, DOI 10.2459/JCM.0b013e3283403942; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Merchant AT, 2007, AM J CLIN NUTR, V85, P225; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Panagiotakos DB, 2007, J AM DIET ASSOC, V107, P979, DOI 10.1016/j.jada.2007.03.006; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002; SULLIVAN JL, 1981, LANCET, V1, P1293; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Tappel A, 2007, MED HYPOTHESES, V68, P562, DOI 10.1016/j.mehy.2006.08.025; TREVISAN M, 1990, JAMA-J AM MED ASSOC, V263, P688, DOI 10.1001/jama.263.5.688; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; World Health Organization Western Pacific Region, 2000, INT ASS STUD OB TASK, P15	53	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111593	10.1371/journal.pone.0111593	http://dx.doi.org/10.1371/journal.pone.0111593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365577	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558100085
J	Gollhofer, J; Timofeev, R; Lan, P; Schmidt, W; Buckhout, TJ				Gollhofer, Julia; Timofeev, Roman; Lan, Ping; Schmidt, Wolfgang; Buckhout, Thomas J.			Vacuolar-Iron-Transporter1-Like Proteins Mediate Iron Homeostasis in Arabidopsis	PLOS ONE			English	Article							VACUOLAR IRON; DEFICIENCY RESPONSE; METAL HOMEOSTASIS; TRANSPORTER; PLANTS; ROOTS; THALIANA; MOBILIZATION; EXPRESSION; FERRITINS	Iron deficiency is a nutritional problem in plants and reduces crop productivity, quality and yield. With the goal of improving the iron (Fe) storage properties of plants, we have investigated the function of three Arabidopsis proteins with homology to Vacuolar Iron Transporter1 (AtVIT1). Heterologous expression of Vacuolar Iron Transporter-Like1 (AtVTL1; At1g21140), AtVTL2 (At1g76800) or AtVTL5 (At3g25190) in the yeast vacuolar Fe transport mutant, Delta ccc1, restored growth in the presence of 4 mM Fe. Isolated vacuoles from yeast expressing either of the VTL genes in the Delta ccc1 background had a three-to four-fold increase in Fe concentration compared to vacuoles isolated from the untransformed mutant. Transiently expressed GFP-tagged AtVTL1 was localized exclusively and AtVTL2 was localized primarily to the vacuolar membrane of onion epidermis cells. Seedling root growth of the Arabidopsis nramp3/nramp4 and vit1-1 mutants was decreased compared to the wild type when seedlings were grown under Fe deficiency. When expressed under the 35S promoter in the nramp3/nramp4 or vit1-1 backgrounds, AtVTL1, AtVTL2 or AtVTL5 restored root growth in both mutants. The seed Fe concentration in the nramp3/nramp4 mutant overexpressing AtVTL1, AtVTL2 or AtVTL5 was between 50 and 60% higher than in non-transformed double mutants or wild-type plants. We conclude that the VTL proteins catalyze Fe transport into vacuoles and thus contribute to the regulation of Fe homeostasis in planta.	[Gollhofer, Julia; Timofeev, Roman; Buckhout, Thomas J.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Lan, Ping] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Schmidt, Wolfgang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Schmidt, Wolfgang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Schmidt, Wolfgang] Natl Taiwan Univ, Coll Life Sci, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	Humboldt University of Berlin; Chinese Academy of Sciences; Institute of Soil Science, CAS; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan University	Buckhout, TJ (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	thomas.buckhout@rz.hu-berlin.de	Schmidt, Wolfgang/A-3234-2014; Lan, Ping/E-4791-2013; Schmidt, Wolfgang/AAA-2807-2022; lan, ping/T-1708-2017	Lan, Ping/0000-0002-8433-3149; Schmidt, Wolfgang/0000-0002-7850-6832; lan, ping/0000-0002-8433-3149	Deutsche Forschungsgemeinschaft [BU 713:4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft to TJB (BU 713:4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Blair D., 1961, TALANTA LONDON, V7, P163; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohen CK, 1998, PLANT PHYSIOL, V116, P1063, DOI 10.1104/pp.116.3.1063; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Eckhardt U, 1998, J EXP BOT, V49, P1219, DOI 10.1093/jexbot/49.324.1219; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Fourcroy P, 2014, NEW PHYTOL, V201, P155, DOI 10.1111/nph.12471; Gollhofer J, 2011, PLANT PHYSIOL BIOCH, V49, P557, DOI 10.1016/j.plaphy.2011.02.011; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2014, PLANT SCI, V224, P36, DOI 10.1016/j.plantsci.2014.04.002; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Momonoi K, 2009, PLANT J, V59, P437, DOI 10.1111/j.1365-313X.2009.03879.x; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Rampey RA, 2006, GENETICS, V174, P1841, DOI 10.1534/genetics.106.061044; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rodriguez-Celma J, 2013, PLANT PHYSIOL, V162, P1473, DOI 10.1104/pp.113.220426; Rose MD., 1990, METHODS YEAST GENETI; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Schaaf G, 2006, J BIOL CHEM, V281, P25532, DOI 10.1074/jbc.M601062200; Schmid NB, 2014, PLANT PHYSIOL, V164, P160, DOI 10.1104/pp.113.228544; Schmidt W, 2011, PLANT PHYSIOL BIOCH, V49, P462, DOI 10.1016/j.plaphy.2010.12.001; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x	38	55	56	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110468	10.1371/journal.pone.0110468	http://dx.doi.org/10.1371/journal.pone.0110468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360591	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700036
J	Hong, MZ; Zhang, RM; Chen, GL; Huang, WQ; Min, F; Chen, T; Xu, JC; Pan, JS				Hong, Mei-Zhu; Zhang, Ru-Mian; Chen, Guo-Liang; Huang, Wen-Qi; Min, Feng; Chen, Tian; Xu, Jin-Chao; Pan, Jin-Shui			Liver Stiffness Measurement-Based Scoring System for Significant Inflammation Related to Chronic Hepatitis B	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; SERUM MARKERS; FIBROSIS; DIAGNOSIS; CIRRHOSIS; MODEL	Objectives: Liver biopsy is indispensable because liver stiffness measurement alone cannot provide information on intrahepatic inflammation. However, the presence of fibrosis highly correlates with inflammation. We constructed a noninvasive model to determine significant inflammation in chronic hepatitis B patients by using liver stiffness measurement and serum markers. Methods: The training set included chronic hepatitis B patients (n = 327), and the validation set included 106 patients; liver biopsies were performed, liver histology was scored, and serum markers were investigated. All patients underwent liver stiffness measurement. Results: An inflammation activity scoring system for significant inflammation was constructed. In the training set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.964, 91.9%, and 90.8% in the HBeAg(+) patients and 0.978, 85.0%, and 94.0% in the HBeAg(-) patients, respectively. In the validation set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.971, 90.5%, and 92.5% in the HBeAg(+) patients and 0.977, 95.2%, and 95.8% in the HBeAg(-) patients. The liver stiffness measurement-based activity score was comparable to that of the fibrosis-based activity score in both HBeAg(+) and HBeAg(-) patients for recognizing significant inflammation (G >= 3). Conclusions: Significant inflammation can be accurately predicted by this novel method. The liver stiffness measurement-based scoring system can be used without the aid of computers and provides a noninvasive alternative for the prediction of chronic hepatitis B-related significant inflammation.	[Hong, Mei-Zhu; Huang, Wen-Qi; Min, Feng; Chen, Tian; Xu, Jin-Chao] Xiamen Univ, Hosp PLA 174, Chenggong Hosp, Dept Infect Dis, Xiamen, Fujian, Peoples R China; [Zhang, Ru-Mian; Chen, Guo-Liang] Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China; [Zhang, Ru-Mian; Chen, Guo-Liang] Xiamen Hosp Tradit Chinese Med, Dept Infect Dis, Xiamen, Fujian, Peoples R China; [Pan, Jin-Shui] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Pan, JS (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China.	j.s.pan76@gmail.com	huang, wen/GXW-0661-2022; Pan, Jin-Shui/AAL-3125-2020	Pan, Jin-Shui/0000-0002-9586-7760	National Science Foundation for Young Scholars, China [81100285]; Natural Science Foundation of Fujian Province, China [2010J05086]; Science Fund for Distinguished Young Scholars of Xiamen, China [3502Z20105011]; Key Foundation of Health System for Young Talents of Fujian [2013-ZQN-ZD-33]	National Science Foundation for Young Scholars, China; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Science Fund for Distinguished Young Scholars of Xiamen, China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Foundation of Health System for Young Talents of Fujian	The study was funded by National Science Foundation for Young Scholars, China (No. 81100285) http://www.nsfc.gov.cn/Portal0/default152.htm; Natural Science Foundation of Fujian Province, China (No. 2010J05086) http://www.fjkjt.gov.cn/; Science Fund for Distinguished Young Scholars of Xiamen, China (No. 3502Z20105011) http://www.xminfo.net.cn/; Key Foundation of Health System for Young Talents of Fujian (No. 2013-ZQN-ZD-33) http://www.fjjsw.gov.cn/templates/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruni R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-394; Cardoso AC, 2011, GUT, V60, P759, DOI 10.1136/gut.2010.220863; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chen YP, 2008, J GASTROEN HEPATOL, V23, P1228, DOI 10.1111/j.1440-1746.2008.05421.x; Cheong JY, 2011, LIVER INT, V31, P1352, DOI 10.1111/j.1478-3231.2011.02570.x; Cho HJ, 2012, CLIN BIOCHEM, V45, P1564, DOI 10.1016/j.clinbiochem.2012.07.107; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mao QG, 2010, WORLD J GASTROENTERO, V16, P3465, DOI 10.3748/wjg.v16.i27.3465; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111641	10.1371/journal.pone.0111641	http://dx.doi.org/10.1371/journal.pone.0111641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360742	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700137
J	Tijs, C; van Dieen, JH; Baan, GC; Maas, H				Tijs, Chris; van Dieen, Jaap H.; Baan, Guus C.; Maas, Huub			Three-Dimensional Ankle Moments and Nonlinear Summation of Rat Triceps Surae Muscles	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; MUSCULOSKELETAL MODEL; RELATIVE POSITION; ACHILLES-TENDON; SOLEUS MUSCLE; CAT; HINDLIMB; TORQUES; COMPARTMENTS; RECRUITMENT	The Achilles tendon and epimuscular connective tissues mechanically link the triceps surae muscles. These pathways may cause joint moments exerted by each muscle individually not to sum linearly, both in magnitude and direction. The aims were (i) to assess effects of sagittal plane ankle angle (varied between 150 degrees and 70 degrees) on isometric ankle moments, in both magnitude and direction, exerted by active rat triceps surae muscles, (ii) to assess ankle moment summation between those muscles for a range of ankle angles and (iii) to assess effects of sagittal plane ankle angle and muscle activation on Achilles tendon length. At each ankle angle, soleus (SO) and gastrocnemius (GA) muscles were first excited separately to assess ankle-angle moment characteristics and subsequently both muscles were excited simultaneously to investigate moment summation. The magnitude of ankle moment exerted by SO and GA, the SO direction in the transverse and sagittal planes, and the GA direction in the transverse plane were significantly affected by ankle angle. SO moment direction in the frontal and sagittal planes were significantly different from that of GA. Nonlinear magnitude summation varied between 0.6 +/- 2.9% and -3.6 +/- 62.9%, while the nonlinear direction summation varied between 0.3 +/- 0.4 degrees and 20.4 +/- 0.7 degrees in the transverse plane, between 0.5 +/- 0.4 degrees and 0.1 +/- 0.4 degrees in the frontal plane, and between 3.0 +/- 7.9 degrees and 0.3 +/- 2.3 degrees in the sagittal plane. Changes in tendon length caused by SO contraction were significantly lower than those during contraction of GA and GA+SO simultaneously. Thus, moments exerted by GA and SO sum nonlinearly both in the magnitude and direction. The limited degree of nonlinear summation may be explained by different mechanisms acting in opposite directions.	[Tijs, Chris; van Dieen, Jaap H.; Baan, Guus C.; Maas, Huub] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Maas, H (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	h.maas@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Tijs, Chris/0000-0003-4323-3886; Maas, Huub/0000-0002-2304-2735	Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]	Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research	Work supported by the Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Carrasco DI, 1999, MOTOR CONTROL, V3, P436, DOI 10.1123/mcj.3.4.436; DERUITER CJ, 1995, ACTA PHYSIOL SCAND, V153, P313; HOY MG, 1990, J BIOMECH, V23, P157, DOI 10.1016/0021-9290(90)90349-8; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Jarc AM, 2013, IEEE T BIO-MED ENG, V60, P1422, DOI 10.1109/TBME.2013.2237768; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; LAWRENCE JH, 1993, J NEUROPHYSIOL, V69, P282, DOI 10.1152/jn.1993.69.1.282; Lawrence JH, 1999, J APPL BIOMECH, V15, P106, DOI 10.1123/jab.15.2.106; Lee SSM, 2008, J BIOMECH, V41, P3366, DOI 10.1016/j.jbiomech.2008.09.029; Maas H, 2004, J BIOMECH, V37, P99, DOI 10.1016/S0021-9290(03)00235-5; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Maas H, 2003, J MECH MED BIOL, V3, P145, DOI 10.1142/S0219519403000703; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; Markin SN, 2012, J NEUROPHYSIOL, V107, P2057, DOI 10.1152/jn.00865.2011; Mortimer J.T., 2004, NEUROPROSTHETICS THE, P638, DOI DOI 10.1142/4987; Olesen AT, 2014, J APPL PHYSIOL, V117, P989, DOI 10.1152/japplphysiol.00587.2014; Perreault EJ, 2002, P ANN INT IEEE EMBS, P2554, DOI 10.1109/IEMBS.2002.1053423; Prodanov D, 2005, MUSCLE NERVE, V32, P292, DOI 10.1002/mus.20378; Rode C, 2009, J MECH MED BIOL, V9, P105, DOI 10.1142/S0219519409002870; ROY RR, 1991, J APPL PHYSIOL, V70, P2522, DOI 10.1152/jappl.1991.70.6.2522; Sandercock TG, 2000, J APPL PHYSIOL, V89, P2206, DOI 10.1152/jappl.2000.89.6.2206; Sandercock TG, 2005, EXERC SPORT SCI REV, V33, P76, DOI 10.1097/00003677-200504000-00004; Sandercock TG, 2009, MED SCI SPORT EXER, V41, P184, DOI 10.1249/MSS.0b013e318183c0c3; SMITH JL, 1980, J NEUROPHYSIOL, V43, P612, DOI 10.1152/jn.1980.43.3.612; Tamaki H, 2011, J PHYSIOL SCI, V61, P411, DOI 10.1007/s12576-011-0157-8; Tian MY, 2012, J APPL PHYSIOL, V113, P517, DOI 10.1152/japplphysiol.00111.2012; van Antwerp KW, 2007, J BIOMECH, V40, P3570, DOI 10.1016/j.jbiomech.2007.06.001; Vieira TMM, 2013, HUM MOVEMENT SCI, V32, P753, DOI 10.1016/j.humov.2013.03.003; Wakeling JM, 2009, BIOL LETTERS, V5, P30, DOI 10.1098/rsbl.2008.0459; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Yeo SH, 2011, J EXP BIOL, V214, P735, DOI 10.1242/jeb.049163; YOUNG RP, 1993, EXP BRAIN RES, V96, P141, DOI 10.1007/BF00230447; YOUNG RP, 1992, NEUROSCI LETT, V145, P137, DOI 10.1016/0304-3940(92)90005-R	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111595	10.1371/journal.pone.0111595	http://dx.doi.org/10.1371/journal.pone.0111595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360524	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700126
J	Ko, HK; Guo, LW; Su, B; Gao, LQ; Gelman, IH				Ko, Hyun-Kyung; Guo, Li-wu; Su, Bing; Gao, Lingqiu; Gelman, Irwin H.			Suppression of Chemotaxis by SSeCKS via Scaffolding of Phosphoinositol Phosphates and the Recruitment of the Cdc42 GEF, Frabin, to the Leading Edge	PLOS ONE			English	Article							C-KINASE SUBSTRATE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CYTOSKELETAL ARCHITECTURE; ONCOGENIC TRANSFORMATION; MEMBRANE INTERACTIONS; ACTIN-CYTOSKELETON; PROSTATE-CANCER; PLASMA-MEMBRANE; CELL INVASION	Chemotaxis is controlled by interactions between receptors, Rho-family GTPases, phosphatidylinositol 3-kinases, and cytoskeleton remodeling proteins. We investigated how the metastasis suppressor, SSeCKS, attenuates chemotaxis. Chemotaxis activity inversely correlated with SSeCKS levels in mouse embryo fibroblasts (MEF), DU145 and MDA-MB-231 cancer cells. SSeCKS loss induced chemotactic velocity and linear directionality, correlating with replacement of leading edge lamellipodia with fascin-enriched filopodia-like extensions, the formation of thickened longitudinal F-actin stress fibers reaching to filopodial tips, relative enrichments at the leading edge of phosphatidylinositol (3,4,5)P3 (PIP3), Akt, PKC-zeta, Cdc42-GTP and active Src (Src(poY416)), and a loss of Rac1. Leading edge lamellipodia and chemotaxis inhibition in SSeCKS-null MEF could be restored by full-length SSeCKS or SSeCKS deleted of its Src-binding domain (Delta Src), but not by SSeCKS deleted of its three MARCKS (myristylated alanine-rich C kinase substrate) polybasic domains (Delta PBD), which bind PIP2 and PIP3. The enrichment of activated Cdc42 in SSeCKS-null leading edge filopodia correlated with recruitment of the Cdc42-specific guanine nucleotide exchange factor, Frabin, likely recruited via multiple PIP2/3-binding domains. Frabin knockdown in SSeCKS-null MEF restores leading edge lamellipodia and chemotaxis inhibition. However, SSeCKS failed to co-immunoprecipitate with Rac1, Cdc42 or Frabin. Consistent with the notion that chemotaxis is controlled by SSeCKS-PIP (vs. -Src) scaffolding activity, constitutively-active phosphatidylinositol 3-kinase could override the ability of the Src inhibitor, SKI-606, to suppress chemotaxis and filopodial enrichment of Frabin in SSeCKS-null MEF. Our data suggest a role for SSeCKS in controlling Rac1 vs. Cdc42-induced cellular dynamics at the leading chemotactic edge through the scaffolding of phospholipids and signal mediators, and through the reorganization of the actin cytoskeleton controlling directional movement.	[Ko, Hyun-Kyung; Su, Bing; Gao, Lingqiu; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Guo, Li-wu] Natl Ctr Toxicol Res, Div Genet & Reprod Toxicol, Jefferson, AR 72079 USA	Roswell Park Cancer Institute; US Food & Drug Administration (FDA)	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	Irwin.gelman@roswellpark.org	Ko, Hyun-Kyung/H-7596-2017	Ko, Hyun-Kyung/0000-0002-7896-362X	National Cancer Institute [CA94108, CA116430]; Department of Defense grants [PC074228, PC101210]; National Cancer Institute Comprehensive Cancer Center [P30-CA016056]; NATIONAL CANCER INSTITUTE [R55CA094108, R01CA094108, P30CA016056, R01CA116430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grants(United States Department of Defense); National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by National Cancer Institute grants CA94108, CA116430, and Department of Defense grants PC074228, PC101210 to IHG, and in part, through National Cancer Institute Comprehensive Cancer Center funds (P30-CA016056). The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of of the manuscript.	Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garbett D, 2014, MOL BIOL CELL, V25, P2315, DOI 10.1091/mbc.E14-04-0878; Gelman IH, 2006, MOL CANCER RES, V4, P151, DOI 10.1158/1541-7786.MCR-05-0252; Gelman IH, 2008, ADAPTOR PROTEINS CAN, P83; Gelman IH, 2012, CANCER METAST REV, V31, P493, DOI 10.1007/s10555-012-9360-1; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Guo LW, 2011, J BIOL CHEM, V286, P38356, DOI 10.1074/jbc.M111.258830; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hughes-Alford SK, 2012, CURR OPIN CELL BIOL, V24, P284, DOI 10.1016/j.ceb.2012.01.001; Ikeda W, 2001, ONCOGENE, V20, P3457, DOI 10.1038/sj.onc.1204463; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; Maruta H, 1999, MICROSC RES TECHNIQ, V47, P61; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nakanishi H, 2008, J CELL MOL MED, V12, P1169, DOI 10.1111/j.1582-4934.2008.00345.x; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nelson PJ, 1999, J CELL SCI, V112, P361; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Quintela-Fandino M, 2010, CLIN TRANSL ONCOL, V12, P662, DOI 10.1007/s12094-010-0575-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Singh Rajesh, 2011, Front Biosci (Schol Ed), V3, P1569; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Su B, 2013, ONCOGENE, V32, P2016, DOI 10.1038/onc.2012.218; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Weiger Michael C, 2012, Subcell Biochem, V59, P217, DOI 10.1007/978-94-007-3015-1_7; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Xia W, 2001, CANCER RES, V61, P5644; Xia W, 2002, EXP CELL RES, V277, P139, DOI 10.1006/excr.2002.5560; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350	65	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111534	10.1371/journal.pone.0111534	http://dx.doi.org/10.1371/journal.pone.0111534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356636	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000067
J	Polese, D; Martinelli, E; Marco, S; Di Natale, C; Gutierrez-Galvez, A				Polese, Davide; Martinelli, Eugenio; Marco, Santiago; Di Natale, Corrado; Gutierrez-Galvez, Agustin			Understanding Odor Information Segregation in the Olfactory Bulb by Means of Mitral and Tufted Cells	PLOS ONE			English	Article							PERIGLOMERULAR CELLS; IN-VITRO; INHIBITION; SYSTEM; DISCRIMINATION; RECEPTORS; GLOMERULI; NETWORK	Odor identification is one of the main tasks of the olfactory system. It is performed almost independently from the concentration of the odor providing a robust recognition. This capacity to ignore concentration information does not preclude the olfactory system from estimating concentration itself. Significant experimental evidence has indicated that the olfactory system is able to infer simultaneously odor identity and intensity. However, it is still unclear at what level or levels of the olfactory pathway this segregation of information occurs. In this work, we study whether this odor information segregation is performed at the input stage of the olfactory bulb: the glomerular layer. To this end, we built a detailed neural model of the glomerular layer based on its known anatomical connections and conducted two simulated odor experiments. In the first experiment, the model was exposed to an odor stimulus dataset composed of six different odorants, each one dosed at six different concentrations. In the second experiment, we conducted an odor morphing experiment where a sequence of binary mixtures going from one odor to another through intermediate mixtures was presented to the model. The results of the experiments were visualized using principal components analysis and analyzed with hierarchical clustering to unveil the structure of the high-dimensional output space. Additionally, Fisher's discriminant ratio and Pearson's correlation coefficient were used to quantify odor identity and odor concentration information respectively. Our results showed that the architecture of the glomerular layer was able to mediate the segregation of odor information obtaining output spiking sequences of the principal neurons, namely the mitral and external tufted cells, strongly correlated with odor identity and concentration, respectively. An important conclusion is also that the morphological difference between the principal neurons is not key to achieve odor information segregation.	[Polese, Davide] CNR, Ist Microelettron Microsistemi, Rome, Italy; [Martinelli, Eugenio; Di Natale, Corrado] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Marco, Santiago; Gutierrez-Galvez, Agustin] Inst Bioengn Catalonia, Barcelona, Spain; [Marco, Santiago; Gutierrez-Galvez, Agustin] Univ Barcelona, Dept Elect, Barcelona, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR); University of Rome Tor Vergata; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona	Gutierrez-Galvez, A (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	agustin.guti@gmail.com	marco, santiago/H-3203-2019; Polese, Davide/Q-4111-2018; Martinelli, Eugenio/AAA-9105-2019; Di Natale, Corrado/M-8701-2014	marco, santiago/0000-0003-2663-2965; Polese, Davide/0000-0002-6332-5051; Martinelli, Eugenio/0000-0002-6673-2066; Di Natale, Corrado/0000-0002-0543-4348	European Community [216916]	European Community(European Commission)	This work was funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 216916: Biologically inspired computation for chemical sensing (NEUROCHEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bardoni R, 1995, BRAIN RES, V703, P19, DOI 10.1016/0006-8993(95)01039-4; Bardoni R, 1996, NEUROSCI LETT, V210, P95, DOI 10.1016/0304-3940(96)12677-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Cleland TA, 2014, PROG BRAIN RES, V208, P177, DOI 10.1016/B978-0-444-63350-7.00007-3; Cleland Thomas A, 2011, Front Neuroeng, V4, P21, DOI 10.3389/fneng.2011.00021; Duda RO, 1999, PATTERN CLASSIFICATI; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Griff ER, 2008, CHEM SENSES, V33, P779, DOI 10.1093/chemse/bjn041; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Keller H. B., 1994, ANAL NUMERICAL METHO; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Linster C, 2009, NEURAL NETWORKS, V22, P1169, DOI 10.1016/j.neunet.2009.07.013; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SCHILD D, 1988, BIOPHYS J, V54, P1001, DOI 10.1016/S0006-3495(88)83038-8; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Shen K, 2013, NEURON, V80, P1246, DOI 10.1016/j.neuron.2013.08.026; Shepherd WR, 2004, SYPNATIC ORG BRAIN; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wang L., 2002, NEURAL INFORM PROCES, V785, P1; WHITE EL, 1973, BRAIN RES, V60, P299, DOI 10.1016/0006-8993(73)90792-0; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109716	10.1371/journal.pone.0109716	http://dx.doi.org/10.1371/journal.pone.0109716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356586	Green Submitted, gold, Green Published			2022-12-26	WOS:000346765000006
J	Todiere, G; Pisciella, L; Barison, A; Del Franco, A; Zachara, E; Piaggi, P; Re, F; Pingitore, A; Emdin, M; Lombardi, M; Aquaro, GD				Todiere, Giancarlo; Pisciella, Lorena; Barison, Andrea; Del Franco, Annamaria; Zachara, Elisabetta; Piaggi, Paolo; Re, Federica; Pingitore, Alessandro; Emdin, Michele; Lombardi, Massimo; Aquaro, Giovanni Donato			Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; HEART-RATE-VARIABILITY; SUDDEN CARDIAC DEATH; MICROVASCULAR DYSFUNCTION; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; DELAYED ENHANCEMENT; RISK; ARRHYTHMIAS; FIBROSIS	Background: Myocardial hyperintensity on T2-weighted short-tau inversion recovery (STIR) (HyT2) cardiac magnetic resonance (CMR) images has been demonstrated in patients with hypertrophic cardiomyopathy (HCM) and is considered a sign of acute damage. The aim of the current study was to evaluate the relationship between HyT2 and both a) markers of ventricular electrical instability and b) clinical and CMR parameters. Methods: Sixty-five patients underwent a thorough clinical examination, consisting of 24-h ECG recording and CMR examination including functional evaluation, T2-STIR images and late gadolinium enhancement (LGE). Results: HyT2 was detected in 27 patients (42%), and subjects with HyT2 showed a greater left ventricle (LV) mass index (p<0.001), lower LV ejection fraction (p = 0.05) and greater extent of LGE (p<0.001) compared to those without HyT2. Twenty-two subjects (34%) presented non-sustained ventricular tachycardia (NSVT) on the 24-h ECG recording, 21 (95%) of whom exhibited HyT2. Based on the logistic regression analysis, HyT2 (odds ratio [OR]: 165, 95% CI 11-2455, p<0.001) and LGE extent (1.1, 1.0-1.3, p<0.001) served as independent predictors of NSVT, while the presence of LGE was not associated with NSVT occurrence (p = 0.49). The presence of HyT2 was associated with lower heart rate variability (p = 0.006) and a higher number of arrhythmic risk factors (p<0.001). Conclusions: In HCM patients, HyT2 upon CMR examination is associated with more advanced disease and increased arrhythmic burden.	[Todiere, Giancarlo; Barison, Andrea; Del Franco, Annamaria; Emdin, Michele; Aquaro, Giovanni Donato] CNR, Fdn G Monasterio Regione Toscana, I-56100 Pisa, Italy; [Pisciella, Lorena; Zachara, Elisabetta; Re, Federica] Azienda Osped San Camillo Forlanini, Rome, Italy; [Piaggi, Paolo] Univ Hosp, Endocrinol Unit, Pisa, Italy; [Pingitore, Alessandro] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Lombardi, Massimo] Multimodal Imaging Sect, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Azienda Ospedaliera San Camillo-Forlanini; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Todiere, G (corresponding author), CNR, Fdn G Monasterio Regione Toscana, I-56100 Pisa, Italy.	todiere@alice.it	Piaggi, Paolo/E-2539-2011; aquaro, giovanni donato/AAB-8978-2019; Barison, Andrea/J-3609-2016; Pingitore, Alessandro/K-1843-2018	Piaggi, Paolo/0000-0003-2774-9161; Barison, Andrea/0000-0001-9042-340X; Pingitore, Alessandro/0000-0002-4049-184X; aquaro, giovanni donato/0000-0003-0915-915X; Del Franco, Annamaria/0000-0003-1405-9436				Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069; Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2008, J MAGN RESON IMAGING, V28, P242, DOI 10.1002/jmri.21381; Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Aquaro GD, 2011, J CARD FAIL, V17, P384, DOI 10.1016/j.cardfail.2011.01.006; Aquaro GD, 2010, AM J CARDIOL, V105, P392, DOI 10.1016/j.amjcard.2009.09.045; Aquaro GD, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-21; Biagini E, 2005, J AM COLL CARDIOL, V46, P1543, DOI 10.1016/j.jacc.2005.04.062; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Camm AJ, 1996, EUR HEART J, V17, P354; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; COUMEL P, 1993, J CARDIOVASC ELECTR, V4, P338, DOI 10.1111/j.1540-8167.1993.tb01235.x; Doval HC, 1996, CIRCULATION, V94, P3198, DOI 10.1161/01.CIR.94.12.3198; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Frenneaux MP, 2004, HEART, V90, P570, DOI 10.1136/hrt.2003.020529; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Frustaci A, 2007, EUR HEART J, V28, P733, DOI 10.1093/eurheartj/ehl525; Goldberger JJ, 2008, J AM COLL CARDIOL, V52, P1179, DOI 10.1016/j.jacc.2008.05.003; Harrigan CJ, 2011, RADIOLOGY, V258, P128, DOI 10.1148/radiol.10090526; Hen Y, 2013, HEART VESSELS, V28, P742, DOI 10.1007/s00380-012-0300-3; IKEGAWA T, 1987, CLIN CARDIOL, V10, P78, DOI 10.1002/clc.4960100202; Kohorst JJ, 2014, CONGENIT HEART DIS, V9, pE51, DOI 10.1111/chd.12073; La Rovere MT, 2001, CIRCULATION, V103, P2072; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Melacini P, 2008, INT J CARDIOL, V128, P364, DOI 10.1016/j.ijcard.2007.06.023; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; PELLICCIA F, 1990, INT J CARDIOL, V29, P47, DOI 10.1016/0167-5273(90)90272-7; Petersen SE, 2007, CIRCULATION, V115, P2418, DOI 10.1161/CIRCULATIONAHA.106.657023; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; SECHTEM U, 1987, CARDIOVASC INTER RAD, V10, P365, DOI 10.1007/BF02577347; Todiere G, 2012, J AM COLL CARDIOL, V60, P922, DOI 10.1016/j.jacc.2012.03.076; Uemura S, 1997, JPN CIRC J, V61, P819, DOI 10.1253/jcj.61.819; WILLERSON JT, 1977, AM J PATHOL, V87, P159	43	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111366	10.1371/journal.pone.0111366	http://dx.doi.org/10.1371/journal.pone.0111366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356653	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000055
J	Matsumoto, N; Suzuki, E; Ishikawa, M; Shirafuji, T; Hasumi, K				Matsumoto, Naoki; Suzuki, Eriko; Ishikawa, Makoto; Shirafuji, Takumi; Hasumi, Keiji			Soluble Epoxide Hydrolase as an Anti-inflammatory Target of the Thrombolytic Stroke Drug SMTP-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; MICROSPORA TRIPRENYL PHENOL-7; EPOXYEICOSATRIENOIC ACIDS; CEREBRAL INFARCTION; LYSOPHOSPHATIDIC ACIDS; PHOSPHATASE-ACTIVITY; GENE DELETION; SIDE-CHAIN; INHIBITORS	Although ischemic stroke is a major cause of death and disability worldwide, only a small fraction of patients benefit from the current thrombolytic therapy due to a risk of cerebral hemorrhage caused by inflammation. Thus, the development of a new strategy to combat inflammation during thrombolysis is an urgent demand. The small molecule thrombolytic SMTP-7 effectively treats ischemic stroke in several animal models with reducing cerebral hemorrhage. Here we revealed that SMTP-7 targeted soluble epoxide hydrolase (sEH) to suppress inflammation. SMTP-7 inhibited both of the two sEH enzyme activities: epoxide hydrolase (which inactivates anti-inflammatory epoxy-fatty acids) and lipid phosphate phosphatase. SMTP-7 suppressed epoxy-fatty acid hydrolysis in HepG2 cells in culture, implicating the sEH inhibition in the anti-inflammatory mechanism. The sEH inhibition by SMTP-7 was independent of its thrombolytic activity. The simultaneous targeting of thrombolysis and sEH by a single molecule is a promising strategy to revolutionize the current stroke therapy.	[Matsumoto, Naoki; Suzuki, Eriko; Hasumi, Keiji] Tokyo Noko Univ, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Ishikawa, Makoto; Shirafuji, Takumi] Nihon Pharmaceut, Pharmaceut Res Lab, Chiba 2860825, Japan; [Hasumi, Keiji] TMS Co Ltd, Fuchu, Tokyo 1830055, Japan	Tokyo University of Agriculture & Technology	Hasumi, K (corresponding author), Tokyo Noko Univ, Dept Appl Biol Sci, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	hasumi@cc.tuat.ac.jp	Hasumi, Keiji/C-2372-2013; SUZUKI, Eriko/G-1082-2013	Hasumi, Keiji/0000-0002-3340-7312; 	Japan Science and Technology Agency [AS2316911G]; Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program) [C7]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program)	This work was supported in part by Japan Science and Technology Agency Grant AS2316911G (to K. H.) a grant from the Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program C7; to K. H.).	Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414; COOPER HS, 1993, LAB INVEST, V69, P238; Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; Gomez GA, 2006, PROTEIN SCI, V15, P58, DOI 10.1110/ps.051720206; Gomez GA, 2004, BIOCHEMISTRY-US, V43, P4716, DOI 10.1021/bi036189j; Hasegawa K, 2010, J ANTIBIOT, V63, P589, DOI 10.1038/ja.2010.101; Hashimoto T, 2010, J PHARMACOL SCI, V114, P41, DOI 10.1254/jphs.10131FP; Hasumi K, 2007, J ANTIBIOT, V60, P463, DOI 10.1038/ja.2007.60; Hasumi K, 2010, FEBS J, V277, P3675, DOI 10.1111/j.1742-4658.2010.07783.x; Hu WM, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-2; Hu WM, 2003, J ANTIBIOT, V56, P832, DOI 10.7164/antibiotics.56.832; Hu WM, 2000, J ANTIBIOT, V53, P241, DOI 10.7164/antibiotics.53.241; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; Jouihan SA, 2013, J CEREBR BLOOD F MET, V33, P1650, DOI 10.1038/jcbfm.2013.130; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Koide H, 2012, J ANTIBIOT, V65, P361, DOI 10.1038/ja.2012.29; Koide H, 2012, J ANTIBIOT, V65, P91, DOI 10.1038/ja.2011.108; Koyanagi K, 2014, BLOOD COAGUL FIBRIN, V25, P316, DOI 10.1097/MBC.0000000000000032; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Li LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094092; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nadeau JO, 2005, CAN J NEUROL SCI, V32, P433, DOI 10.1017/S0317167100004418; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Nishimura Y, 2012, J ANTIBIOT, V65, P483, DOI 10.1038/ja.2012.47; Oguro A, 2012, J LIPID RES, V53, P505, DOI 10.1194/jlr.M022319; Qiu H, 2011, CARDIOVASC THER, V29, P99, DOI 10.1111/j.1755-5922.2010.00150.x; ROSTAMI A, 1990, J NEUROIMMUNOL, V30, P145, DOI 10.1016/0165-5728(90)90098-8; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sanders WG, 2012, AM J PHYSIOL-CELL PH, V303, pC278, DOI 10.1152/ajpcell.00386.2011; Sasaki M, 2003, FREE RADICAL BIO MED, V35, P1679, DOI 10.1016/j.freeradbiomed.2003.09.016; Sawada H, 2014, J CEREBR BLOOD F MET, V34, P235, DOI 10.1038/jcbfm.2013.191; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shibata K, 2011, N-S ARCH PHARMACOL, V384, P103, DOI 10.1007/s00210-011-0642-x; Shibata K, 2010, N-S ARCH PHARMACOL, V382, P245, DOI 10.1007/s00210-010-0542-5; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Strauss KI, 2013, PROSTAG OTH LIPID M, V104, P18, DOI 10.1016/j.prostaglandins.2012.07.005; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Tran KL, 2005, BIOCHEMISTRY-US, V44, P12179, DOI 10.1021/bi050842g; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zeldin DC, 1996, ARCH BIOCHEM BIOPHYS, V330, P87, DOI 10.1006/abbi.1996.0229; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V316, P443, DOI 10.1006/abbi.1995.1059; Zhang WY, 2012, DIGEST DIS SCI, V57, P2580, DOI 10.1007/s10620-012-2217-1; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	65	29	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35826	35838		10.1074/jbc.M114.588087	http://dx.doi.org/10.1074/jbc.M114.588087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361765	hybrid, Green Published			2022-12-26	WOS:000346897900014
J	Diner, I; Hales, CM; Bishof, I; Rabenold, L; Duong, DM; Yi, H; Laur, O; Gearing, M; Troncoso, J; Thambisetty, M; Lah, JJ; Levey, AI; Seyfried, NT				Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Yi, Hong; Laur, Oskar; Gearing, Marla; Troncoso, Juan; Thambisetty, Madhav; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.			Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurodegenerative Disease; Protein Aggregation; RNA; Spliceosome; Tau Protein (Tau)	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CELL-FREE FORMATION; PRION-LIKE DOMAINS; NEURODEGENERATIVE DISEASE; PROTEIN AGGREGATION; CORTICOBASAL DEGENERATION; TDP-43; GRANULES; PHOSPHORYLATION	Recent evidence indicates that U1-70K and other U1 small nuclear ribonucleoproteins are Sarkosyl-insoluble and associate with Tau neurofibrillary tangles selectively in Alzheimer disease (AD). Currently, the mechanisms underlying the conversion of soluble nuclear U1 small nuclear ribonucleoproteins into insoluble cytoplasmic aggregates remain elusive. Based on the biochemical and subcellular distribution properties of U1-70K in AD, we hypothesized that aggregated U1-70K itself or other biopolymers (e.g. proteins or nucleic acids) interact with and sequester natively folded soluble U1-70K into insoluble aggregates. Here, we demonstrate that total homogenates from AD brain induce soluble U1-70K from control brain or recombinant U1-70K to become Sarkosyl-insoluble. This effect was not dependent on RNA and did not correlate with detergent-insoluble Tau levels as AD homogenates with reduced levels of these components were still capable of inducing U1-70K aggregation. In contrast, proteinase K-treated AD homogenates and Sarkosyl-soluble AD fractions were unable to induce U1-70K aggregation, indicating that aggregated proteins in AD brain are responsible for inducing soluble U1-70K aggregation. It was determined that the C terminus of U1-70K, which harbors two disordered low complexity (LC) domains, is necessary for U1-70K aggregation. Moreover, both LC1 and LC2 domains were sufficient for aggregation. Finally, protein cross-linking and mass spectrometry studies demonstrated that a U1-70K fragment harboring the LC1 domain directly interacts with aggregated U1-70K in AD brain. Our results support a hypothesis that aberrant forms of U1-70K in AD can directly sequester soluble forms of U1-70K into insoluble aggregates.	[Diner, Ian; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Hales, Chadwick M.; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Yi, Hong] Emory Univ, Robert P Apkarian Integrated Electron Microscopy, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Div Microbiol, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Yerkes Res Ctr, Atlanta, GA 30322 USA; [Gearing, Marla] Johns Hopkins Sch Med, Dept Expt Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan] Johns Hopkins Sch Med, Dept Pathol & Neurol, Baltimore, MD 21205 USA; [Thambisetty, Madhav] NIA, NIH, Baltimore, MD 21224 USA; [Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Yi, Hong; Laur, Oskar; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Emory University	Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	nseyfri@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [P50AG025688, P30NS055077, 5T32GM008367]; National Institutes of Health Intramural Research Program; National Institute on Aging; Alzheimer's Association New Investigator Research Award [NIRG-12-242297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014449, P50AG025688, ZIAAG000200, P50AG005146, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association New Investigator Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50AG025688 (to the Emory Alzheimer's Disease Center) and Grant P30NS055077 (to the Emory Neuroscience NINDS Core Facilities), the National Institutes of Health Intramural Research Program, and the National Institute on Aging. This work was also supported by Alzheimer's Association New Investigator Research Award NIRG-12-242297 (to N. T. S.).; Supported by National Institutes of Health Grant 5T32GM008367.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRIDGE E, 1993, J VIROL, V67, P5792, DOI 10.1128/JVI.67.10.5792-5802.1993; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Dammer EB, 2015, PROTEOMICS, V15, P508, DOI 10.1002/pmic.201400189; Dammer EB, 2013, J PROTEOME RES, V12, P3193, DOI 10.1021/pr400246t; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Driscoll I, 2011, CURR ALZHEIMER RES, V8, P330, DOI 10.2174/156720511795745348; Ferguson SM, 2003, J NEUROSCI, V23, P9697; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hales CM, 2014, BRAIN PATHOL, V24, P344, DOI 10.1111/bpa.12133; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Mahapatra RK, 2004, LANCET NEUROL, V3, P736, DOI 10.1016/S1474-4422(04)00936-6; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yi H, 2001, J HISTOCHEM CYTOCHEM, V49, P279, DOI 10.1177/002215540104900301	49	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35296	35313		10.1074/jbc.M114.562959	http://dx.doi.org/10.1074/jbc.M114.562959			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355317	Green Published, hybrid			2022-12-26	WOS:000346660200022
J	Harden, JL; Lewis, SM; Pierson, KC; Suarez-Farinas, M; Lentini, T; Ortenzio, FS; Zaba, LC; Goldbach-Mansky, R; Bowcock, AM; Lowes, MA				Harden, Jamie L.; Lewis, Steven M.; Pierson, Katherine C.; Suarez-Farinas, Mayte; Lentini, Tim; Ortenzio, Francesca S.; Zaba, Lisa C.; Goldbach-Mansky, Raphaela; Bowcock, Anne M.; Lowes, Michelle A.			CARD14 Expression in Dermal Endothelial Cells in Psoriasis	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNITY; INFLAMMATION; PATHOGENESIS; SIGNALOSOME; ACTIVATION; MICROARRAY; MUTATIONS; PATHWAYS; THERAPY	Mutations in the caspase recruitment domain, family member 14 (CARD14) gene have recently been described in psoriasis patients, and explain the psoriasis susceptibility locus 2 (PSORS2). CARD14 is a scaffolding protein that regulates NF-kappa B activation, and psoriasis-associated CARD14 mutations lead to enhanced NF-kappa B signaling. CARD14 is expressed mainly in epidermal keratinocytes, but also in unidentified dermal cells. In this manuscript, the identity of the dermal cell types expressing CARD14, as well the potential functional consequence of overactive CARD14 in these dermal cell types, was determined. Using two-color immunofluorescence, dermal CARD14 did not co-localize with T-cells, dendritic cells, or macrophages. However, dermal CARD14 did highly co-localize with CD31(+) endothelial cells (ECs). CARD14 was also expressed non-dermal endothelial cells, such as aortic endothelial cells, which may indicate a role of CARD14(+) ECs in the systemic inflammation and cardiovascular comorbidities associated with psoriasis. Additionally, phosphorylated NF-kappa B was found in psoriatic CARD14(+) CD31(+) ECs, demonstrating this pathway is active in dermal ECs in psoriasis. Transfection of dermal ECs with psoriasis-associated CARD14 mutations resulted in increased expression of several chemokines, including CXCL10, IL-8, and CCL2. These results provide preliminary evidence that CARD14 expression in ECs may contribute to psoriasis through increased expression of chemokines and facilitating recruitment of immune cells into skin.	[Harden, Jamie L.; Lewis, Steven M.; Pierson, Katherine C.; Suarez-Farinas, Mayte; Lentini, Tim; Ortenzio, Francesca S.; Zaba, Lisa C.; Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Goldbach-Mansky, Raphaela] NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD USA; [Bowcock, Anne M.] Univ London Imperial Coll Sci Technol & Med, London, England	Rockefeller University; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Imperial College London	Lowes, MA (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	lowesm@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012; Zaba, Lisa/Q-9681-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Lowes, Michelle A/G-9585-2016	Suarez-Farinas, Mayte/0000-0001-8712-3553; Lowes, Michelle A/0000-0003-4256-478X; Lewis, Steven/0000-0002-1979-0554; Zaba, Lisa/0000-0001-9036-5465; Bowcock, Anne/0000-0001-8691-9090	National Center for Research Resources [8 UL1 TR000043]; National Center for Advancing Translational Sciences (NCATS); National Institutes of Health [AR050266]; National Psoriasis Foundation; NIH [1R01AR060222]; National Institutes of Health Medical Scientist Training Program (MSTP) [GM07739]; Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060222, ZIAAR041138] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Medical Scientist Training Program (MSTP); Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported in part by grant # 8 UL1 TR000043 from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS), and AR050266 (AMB) from the National Institutes of Health. The CARD14 research project was supported by a National Psoriasis Foundation Discovery grant to MAL. NIH 1R01AR060222 fully or partially supported MAL, JLH, and MSF. At the time of the research, LCZ was supported by National Institutes of Health Medical Scientist Training Program (MSTP) grant GM07739, and the study of aortic specimens was supported by a 2009 Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award. FSO is an RUCCTS-supported medical student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin DA, 2013, JAMA DERMATOL, V149, P178, DOI 10.1001/jamadermatol.2013.1609; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Fuchs-Telem D, 2012, AM J HUM GENET, V91, P163, DOI 10.1016/j.ajhg.2012.05.010; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Madonna S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.69; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Suarez-Farinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084634; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	35	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111255	10.1371/journal.pone.0111255	http://dx.doi.org/10.1371/journal.pone.0111255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369198	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000046
J	Poon, VTW; Kuk, JL; Ardern, CI				Poon, Vivian T. W.; Kuk, Jennifer L.; Ardern, Chris I.			Trajectories of Metabolic Syndrome Development in Young Adults	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; 3RD NATIONAL-HEALTH; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; MIXTURE-MODELS; PREVALENCE; CHILDREN; FITNESS; CARDIA	Background: Metabolic syndrome (MetS) is a constellation of metabolic aberrations that collectively increase the risk for cardiovascular disease and type 2 diabetes. Greater understanding of MetS developments may provide insight into targeted prevention strategies for individuals at greatest risk. The purpose of this study was to i) identify distinct patterns of longitudinal MetS development and; ii) develop a character profile that differentiates groups by level of MetS risk. Methods and Results: Data from the Coronary Artery Risk Development in Young Adults (CARDIA) study (n = 3 804; 18-30 y) was obtained by limited access application from the National Heart, Lung, and Blood Institute and used for this analysis. MetS, as defined by the Harmonized criteria, was assessed over a 20 year follow-up period. Group-level trajectory analysis identified 4 distinct groups with varying rates of component development [No (23.8% of sample); Low (33.5%); Moderate (35.3%); and High MetS (7.4%)]. After adjusting for covariates, individuals in the At-Risk groups (Low, Moderate and High MetS) were more likely to be of black ethnicity (1.37, 1.14-1.66), have a family history of cardiovascular disease (1.61, 1.31-1.97) and history of dieting (1.69, 1.20-2.39) when compared to the No Risk trajectory group (No MetS). Conversely, increasing baseline education (0.76, 0.65-0.89) and aerobic fitness (0.55, 0.47-0.64) was inversely associated with At-Risk group membership. Conclusions: Results suggest distinct profiles of MetS development that can be identified by baseline risk factors. Further research is necessary to understand the clinical implication of intermediate MetS development groups with respect to overall cardiometabolic risk.	[Poon, Vivian T. W.; Kuk, Jennifer L.; Ardern, Chris I.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada	Ardern, CI (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	cardern@yorku.ca			Canadian Institutes of Health Research [131594]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JLK and CIA received funding for this work through the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) (Grant #131594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Arrandale V.H, 2006, THESIS U BRIT COLUMB; Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Carnethon MR, 2004, DIABETES CARE, V27, P2707, DOI 10.2337/diacare.27.11.2707; Chen W, 2007, AM J EPIDEMIOL, V166, P527, DOI 10.1093/aje/kwm105; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DONAHUE RP, 1989, ARTERIOSCLEROSIS, V9, P656, DOI 10.1161/01.ATV.9.5.656; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Field AE, 2007, OBESITY, V15, P456, DOI 10.1038/oby.2007.560; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; MAHONEY LT, 1991, ANN NY ACAD SCI, V623, P120, DOI 10.1111/j.1749-6632.1991.tb43723.x; Nagin DS, 2005, ANN AM ACAD POLIT SS, V602, P82, DOI 10.1177/0002716205280565; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Sumner AE, 2009, J PEDIAT, V155; U.S. Department of Health and Human Services National Heart Lung and Blood Institute, 2007, NIH PUBLICATION; WATTIGNEY WA, 1995, PREV MED, V24, P617, DOI 10.1006/pmed.1995.1097; White HR, 2002, DRUG ALCOHOL DEPEN, V65, P167, DOI 10.1016/S0376-8716(01)00159-4	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111647	10.1371/journal.pone.0111647	http://dx.doi.org/10.1371/journal.pone.0111647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368999	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000082
J	Zhan, GM; Tian, Y; Wang, FP; Chen, XM; Guo, J; Jiao, M; Huang, LL; Kang, ZS				Zhan, Gangming; Tian, Yuan; Wang, Fuping; Chen, Xianming; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng			A Novel Fungal Hyperparasite of Puccinia striiformis f. sp tritici, the Causal Agent of Wheat Stripe Rust	PLOS ONE			English	Article							GENETIC DIVERSITY	Puccinia striiformis f. sp. tritici (Pst), the causal fungus of wheat stripe rust, was previously reported to be infected by Lecanicillium lecanii, Microdochium nivale and Typhula idahoensis. Here, we report a novel hyperparasite on Pst. This hyperparasitic fungus was identified as Cladosporium cladosporioides (Fresen.) GA de Vries based on morphological characteristics observed by light and scanning electron microscopy together with molecular data. The hyperparasite reduced the production and viability of urediniospores and, therefore, could potentially be used for biological control of wheat stripe rust.	[Zhan, Gangming; Tian, Yuan; Wang, Fuping; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhan, Gangming; Tian, Yuan; Wang, Fuping; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China; [Chen, Xianming] Washington State Univ, USDA ARS, Wheat Genet Physiol Qual & Dis Res Unit, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Northwest A&F University - China; Northwest A&F University - China; United States Department of Agriculture (USDA); Washington State University; Washington State University	Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.	kangzs@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122	National Key Basic Research Program of China [2013CB127700]; Special Fund for Agro-scientific Research in the Public Interest [201303023]; Nature Science Foundation of China [31371882]; 111 Project from the Ministry of Education of China [B07049]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by the National Key Basic Research Program of China (2013CB127700), Special Fund for Agro-scientific Research in the Public Interest (No. 201303023), the Nature Science Foundation of China (31371882), and the 111 Project from the Ministry of Education of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; Braun Uwe, 2003, Mycological Progress, V2, P3, DOI 10.1007/s11557-006-0039-2; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; Crous PW, 2007, STUD MYCOL, V58, P3; Dugan FM, 2008, PERSOONIA, V21, P9, DOI 10.3767/003158508X334389; Dugan Frank M., 2004, Schlechtendalia, V11, P1; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gams W, 2007, CBS COURSE MYCOLOGY; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC; Heather W. A., 1977, Australian Forestry, V40, P28; HIJWEGEN T, 1984, NETH J PLANT PATHOL, V90, P79, DOI 10.1007/BF01999956; Inderbitzin P, 2010, MYCOLOGIA, V102, P1350, DOI 10.3852/10-006; KEENER PAUL D., 1954, PLANT DIS REPORTER, V38, P690; Kiss L, 1997, MYCOL RES, V101, P1073, DOI 10.1017/S0953756297003705; Kohl JJ, 2009, EUR J PLANT PATHOL, V123, P401, DOI 10.1007/s10658-008-9377-z; Littlefield LJ., 1981, BIOL PLANT RUSTS INT; Lu NH, 2011, EUR J PLANT PATHOL, V131, P685, DOI 10.1007/s10658-011-9842-y; OMAR M, 1979, T BRIT MYCOL SOC, V72, P225, DOI 10.1016/S0007-1536(79)80036-4; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARMA JK, 1980, EUR J FOREST PATHOL, V10, P360; SRIVASTAVA AK, 1985, PHYTOPATHOL Z, V114, P73; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhang ZY, 2003, FLORA FUNGORUM SINIC, V14, P11	33	19	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111484	10.1371/journal.pone.0111484	http://dx.doi.org/10.1371/journal.pone.0111484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369036	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000059
J	Okuma, H; Gonoi, W; Ishida, M; Shirota, G; Shintani, Y; Abe, H; Fukayama, M; Ohtomo, K				Okuma, Hidemi; Gonoi, Wataru; Ishida, Masanori; Shirota, Go; Shintani, Yukako; Abe, Hiroyuki; Fukayama, Masashi; Ohtomo, Kuni			Comparison of Atternkition of Striated Muscle between Postmort:m and Antemortem Computed Tc-aography: Results of' a Longitudinal Study	PLOS ONE			English	Article							TOMOGRAPHY RELATIONSHIP; MUSCULAR SYSTEM; CT-NUMBERS; DEATH; AUTOPSY; GAS; PHANTOM; MRI	Objective: We evaluated the postmortem changes of striated muscle by comparing computed tomography (CT) images obtained postmortem and antemortem in the same patients. Materials and Methods: We studied 33 consecutive patients who underwent antemortem CT, postmortem CT, and pathological autopsy in our tertiary care hospital between April 2009 and December 2010. Postmortem CT was performed within 20 h after death and was followed by pathological autopsy. Pathological autopsy confirmed the absence of muscular diseases such as amyotrophic lateral sclerosis, muscular dystrophy, myositis, and myasthenia, in all of the patients. The CT attenuation values of four cardiac muscle sites (anterior wall of the left ventricle, left ventricular free wall, posterior wall of the left ventricle, and the ventricular septum) and two skeletal muscle sites (the pectoralis major muscle and the erector spinae muscle) were compared between antemortem and postmortem CT using paired t test. Results: Striated muscle had significantly greater attenuation on postmortem CT than on antemortem CT (P<0.001) in all six tissue sites. No significant association was found between postmortem change in the CT attenuation of striated muscle and gender, age, or elapsed time since death. Conclusion: This is the first longitudinal study to show hyperattenuation of striated muscle on postmortem CT images compared with antemortem CT images in the same patients.	[Okuma, Hidemi; Gonoi, Wataru; Shirota, Go; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan; [Ishida, Masanori] Sanraku Hosp, Dept Radiol, Mututal Aid Assoc Tokyo Metropolitan Teachers & O, Chiyoda Ku, Tokyo, Japan; [Shintani, Yukako; Abe, Hiroyuki; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Okuma, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan.	hokuma-tky@unim.ac.jp	Gonoi, Wataru/AAB-2160-2019; Okuma, Hidemi/M-2660-2018	Gonoi, Wataru/0000-0002-5018-4683; Okuma, Hidemi/0000-0001-5325-2699; Shintani-Domoto, Yukako/0000-0002-8061-6176	Japanese Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [25860264] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japanese Ministry of Health, Labor and Welfare, for research into "Usefulness of Postmortem Images as an Ancillary Method for Autopsy in Evaluation of Death Associated with Medical Practice (2008-2009)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; BULCKE JA, 1979, NEURORADIOLOGY, V17, P127; Cha JG, 2010, KOREAN J RADIOL, V11, P395, DOI 10.3348/kjr.2010.11.4.395; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Flach Patricia M, 2014, AJR Am J Roentgenol, V202, pW325, DOI 10.2214/AJR.12.10283; Groell R, 2000, COMPUT MED IMAG GRAP, V24, P53, DOI 10.1016/S0895-6111(99)00043-9; HADAR H, 1983, AM J ROENTGENOL, V141, P895, DOI 10.2214/ajr.141.5.895; HAWLEY RJ, 1984, ARCH NEUROL-CHICAGO, V41, P383, DOI 10.1001/archneur.1984.04050160045014; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Ishida M, 2014, AM J FOREN MED PATH, V35, P113, DOI 10.1097/PAF.0000000000000083; Ishida M, 2011, LEGAL MED-TOKYO, V13, P280, DOI 10.1016/j.legalmed.2011.09.004; Ishida M, 2011, LEGAL MED-TOKYO, V13, P318, DOI 10.1016/j.legalmed.2011.08.003; Ishida M, 2011, LEGAL MED-TOKYO, V13, P174, DOI 10.1016/j.legalmed.2011.03.002; Jackowski C, 2007, J TRAUMA, V62, P979, DOI 10.1097/01.ta.0000198733.22654.de; LEVI C, 1982, AM J ROENTGENOL, V139, P443, DOI 10.2214/ajr.139.3.443; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Nishihara S, 2002, MED IMAG INFORM SCI, V20, P40; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Okuma H, 2013, INT J LEGA IN PRESS, DOI [10.1007/s00414-013-095S-z, DOI 10.1007/S00414-013-095S-Z]; Okuma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076026; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Shiotani Seiji, 2002, Radiat Med, V20, P201; Shiotani Seiji, 2003, Radiat Med, V21, P29; Singh MKC, 2009, FORENSIC SCI MED PAT, V5, P236, DOI 10.1007/s12024-009-9103-y; SMITH RD, 1950, ANAT RECORD, V108, P207, DOI 10.1002/ar.1091080203; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; TERMOTE JL, 1980, RADIOLOGY, V137, P439, DOI 10.1148/radiology.137.2.7433677; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tsokos M., 2005, ENCY FORENSIC LEGAL, P456, DOI [10.1016/B0-12-369399-3/00091-4, DOI 10.1016/B0-12-369399-3/00091-4]	31	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111457	10.1371/journal.pone.0111457	http://dx.doi.org/10.1371/journal.pone.0111457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365255	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558100066
J	Streifel, KM; Gonzales, AL; De Miranda, B; Mouneimne, R; Earley, S; Tjalkens, R				Streifel, Karin M.; Gonzales, Albert L.; De Miranda, Briana; Mouneimne, Rola; Earley, Scott; Tjalkens, Ronald			Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes	PLOS ONE			English	Article							TRANSIENT RECEPTOR; TRPC3 CHANNELS; SYNAPTIC-TRANSMISSION; ACTIVATION; WAVES; EXPRESSION; PATHWAY; COMPLEX; FAMILY; CELLS	Dopaminergic nuclei in the basal ganglia are highly sensitive to damage from oxidative stress, inflammation, and environmental neurotoxins. Disruption of adenosine triphosphate (ATP)-dependent calcium (Ca2+) transients in astrocytes may represent an important target of such stressors that contributes to neuronal injury by disrupting critical Ca2+-dependent trophic functions. We therefore postulated that plasma membrane cation channels might be a common site of inhibition by structurally distinct cationic neurotoxicants that could modulate ATP-induced Ca2+ signals in astrocytes. To test this, we examined the capacity of two dopaminergic neurotoxicants to alter ATP-dependent Ca2+ waves and transients in primary murine striatal astrocytes: MPP+, the active metabolite of 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and 6-hydroxydopamine (6-OHDA). Both compounds acutely decreased ATP-induced Ca2+ transients and waves in astrocytes and blocked OAG-induced Ca2+ influx at micromolar concentrations, suggesting the transient receptor potential channel, TRPC3, as an acute target. MPP+ inhibited 1-oleoyl-2-acetyl-sn-glycerol (OAG)-induced Ca2+ transients similarly to the TRPC3 antagonist, pyrazole-3, whereas 6-OHDA only partly suppressed OAG-induced transients. RNAi directed against TRPC3 inhibited the ATP-induced transient as well as entry of extracellular Ca2+, which was augmented by MPP+. Whole-cell patch clamp experiments in primary astrocytes and TRPC3-overexpressing cells demonstrated that acute application of MPP+ completely blocked OAG-induced TRPC3 currents, whereas 6-OHDA only partially inhibited OAG currents. These findings indicate that MPP+ and 6-OHDA inhibit ATP-induced Ca2+ signals in astrocytes in part by interfering with purinergic receptor mediated activation of TRPC3, suggesting a novel pathway in glia that could contribute to neurotoxic injury.	[Streifel, Karin M.; De Miranda, Briana; Tjalkens, Ronald] Colorado State Univ, Ctr Environm Med, Ft Collins, CO 80523 USA; [Gonzales, Albert L.; Earley, Scott] Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA; [Mouneimne, Rola] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Colorado State University; Colorado State University; Texas A&M University System; Texas A&M University College Station	Tjalkens, R (corresponding author), Colorado State Univ, Ctr Environm Med, Ft Collins, CO 80523 USA.	Ron.Tjalkens@colostate.edu	Earley, Scott/A-4059-2008	Earley, Scott/0000-0001-9560-2941	National Institutes of Health [ES021656, HL091905, HL094145]; Michael J. Fox Foundation; Monfort Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL094145, R01HL091905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Monfort Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institutes of Health www.nih.gov (ES021656 to RBT, HL091905 to SE, HL094145 to ALG), Rapid Response Innovation research grant from the Michael J. Fox Foundation for Parkinson's Research www.michaeljfox.org (to RBT) and Monfort Excellence Award from the Monfort Family Foundation (to SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; ASCHNER M, 1991, NEUROTOXICOLOGY, V12, P505; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Grimaldi M, 2006, J NEUROSCI RES, V84, P1738, DOI 10.1002/jnr.21064; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kaddour H, 2013, J NEUROCHEM, V125, P620, DOI 10.1111/jnc.12140; Kim KH, 2011, ENVIRON HEALTH PERSP, V119, P519, DOI 10.1289/ehp.1002728; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Moreno JA, 2008, J NEUROSCI RES, V86, P2028, DOI 10.1002/jnr.21640; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Pessah IN, 2006, CHEM RES TOXICOL, V19, P92, DOI 10.1021/tx050196m; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Streifel KM, 2013, NEUROTOXICOLOGY, V34, P160, DOI 10.1016/j.neuro.2012.10.014; Tialkens RB, 2006, BRAIN RES, V1113, P210, DOI 10.1016/j.brainres.2006.07.053; Wouters J, 1996, ACTA CRYSTALLOGR C, V52, P1033, DOI 10.1107/S010827019501362X; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110996	10.1371/journal.pone.0110996	http://dx.doi.org/10.1371/journal.pone.0110996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365260	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100042
J	Tatineni, S; Riethoven, JJM; Graybosch, RA; French, R; Mitra, A				Tatineni, Satyanarayana; Riethoven, Jean-Jack M.; Graybosch, Robert A.; French, Roy; Mitra, Amitava			Dynamics of Small RNA Profiles of Virus and Host Origin in Wheat Cultivars Synergistically Infected by Wheat Streak Mosaic Virus and Triticum Mosaic Virus: Virus Infection Caused a Drastic Shift in the Endogenous Small RNA Profile	PLOS ONE			English	Article							SMALL INTERFERING RNAS; HELPER COMPONENT-PROTEINASE; DOUBLE-STRANDED-RNA; DICER-LIKE PROTEINS; FAMILY POTYVIRIDAE; ANTIVIRAL DEFENSE; DISEASE SYNERGISM; POLYMERASE GENE; PLANT-VIRUSES; CURL MITE	Co-infection of wheat (Triticum aestivum L.) by Wheat streak mosaic virus (WSMV, a Tritimovirus) and Triticum mosaic virus (TriMV, a Poacevirus) of the family Potyviridae causes synergistic interaction. In this study, the effects of the synergistic interaction between WSMV and TriMV on endogenous and virus-derived small interfering RNAs (vsiRNAs) were examined in susceptible ('Arapahoe') and temperature-sensitive resistant ('Mace') wheat cultivars at 18 degrees C and 27 degrees C. Single and double infections in wheat caused a shift in the profile of endogenous small RNAs from 24 nt being the most predominant in healthy plants to 21 nt in infected wheat. Massive amounts of 21 and 22 nt vsiRNAs accumulated in singly and doubly infected Arapahoe at both temperatures and in Mace at 27 degrees C but not 18 degrees C. The plus-and minus-sense vsiRNAs were distributed throughout the genomic RNAs in Arapahoe at both temperature regimens and in Mace at 27 degrees C, although some regions served as hot-spots, spawning an excessive number of vsiRNAs. The vsiRNA peaks were conserved among cultivars, suggesting that the Dicer-like enzymes in susceptible and resistant cultivars similarly accessed the genomic RNAs of WSMV or TriMV. Accumulation of large amounts of vsiRNAs in doubly infected plants suggests that the silencing suppressor proteins encoded by TriMV and WSMV do not prevent the formation of vsiRNAs; thus, the synergistic effect observed is independent from RNA-silencing mediated vsiRNA biogenesis. The high-resolution map of endogenous and vsiRNAs from WSMV-and/or TriMV-infected wheat cultivars may form a foundation for understanding the virus-host interactions, the effect of synergistic interactions on host defense, and virus resistance mechanisms in wheat.	[Tatineni, Satyanarayana; Graybosch, Robert A.; French, Roy] Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA; [Tatineni, Satyanarayana; Mitra, Amitava] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Riethoven, Jean-Jack M.] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Graybosch, Robert A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tatineni, S (corresponding author), Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA.	satya.tatineni@ars.usda.gov		Tatineni, Satyanatayana/0000-0003-0395-6000; Riethoven, Jean-Jack/0000-0002-2709-7880	Nebraska Research Initiative; ARS [ARS-0424225] Funding Source: Federal RePORTER	Nebraska Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Partial support was provided by the Nebraska Research Initiative to J. -J. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brakke MK, 1987, VIRUS DIS WHAET; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burrows M, 2009, PLANT HLTH PROG, DOI 10.1094/PHP-2009-0706-01-RS; Byamukama E, 2013, PLANT DIS, V97, P21, DOI 10.1094/PDIS-06-12-0535-RE; Byamukama E, 2012, PLANT DIS, V96, P859, DOI 10.1094/PDIS-11-11-0957-RE; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Choi IR, 1999, PHYTOPATHOLOGY, V89, P1182, DOI 10.1094/PHYTO.1999.89.12.1182; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; French R, 2004, VIRUSES VIRUS DIS PO, P602; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Gonzalez-Jara P, 2005, PHYTOPATHOLOGY, V95, P894, DOI 10.1094/PHYTO-95-0894; Gonzalez-Jara P, 2004, MOL PLANT PATHOL, V5, P29, DOI 10.1111/j.1364-3703.2004.00202.x; Graybosch RA, 2009, J PLANT REGIST, V3, P51, DOI 10.3198/jpr2008.06.0345crc; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hull R., 2002, MATTHEWS PLANT VIROL; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAY CL, 1971, CROP SCI, V11, P431, DOI 10.2135/cropsci1971.0011183X001100030037x; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McMechan AJ, 2014, PLANT DIS, V98, P806, DOI 10.1094/PDIS-06-13-0582-RE; Mendez-Lozano J, 2003, PHYTOPATHOLOGY, V93, P270, DOI 10.1094/PHYTO.2003.93.3.270; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ruiz-Ruiz S, 2011, PLANT MOL BIOL, V75, P607, DOI 10.1007/s11103-011-9754-4; Seifers DL, 2008, PLANT DIS, V92, P808, DOI 10.1094/PDIS-92-5-0808; Seifers DL, 2009, PLANT DIS, V93, P25, DOI 10.1094/PDIS-93-1-0025; Silva TF, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-40; SLYKHUIS JT, 1955, PHYTOPATHOLOGY, V45, P116; Stenger DC, 1998, PHYTOPATHOLOGY, V88, P782, DOI 10.1094/PHYTO.1998.88.8.782; Stenger DC, 2007, PHYTOPATHOLOGY, V97, P1213, DOI 10.1094/PHYTO-97-10-1213; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tatineni S, 2012, VIROLOGY, V433, P104, DOI 10.1016/j.virol.2012.07.016; Tatineni S, 2010, PHYTOPATHOLOGY, V100, P230, DOI 10.1094/PHYTO-100-3-0230; Tatineni S, 2009, PHYTOPATHOLOGY, V99, P943, DOI 10.1094/PHYTO-99-8-0943; VANCE VB, 1991, VIROLOGY, V182, P486, DOI 10.1016/0042-6822(91)90589-4; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang JB, 2009, VIRUS RES, V144, P163, DOI 10.1016/j.virusres.2009.04.017; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wintermantel WM, 2008, PHYTOPATHOLOGY, V98, P1340, DOI 10.1094/PHYTO-98-12-1340; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046238; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Young BA, 2012, VIRUS RES, V163, P672, DOI 10.1016/j.virusres.2011.12.019; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Ziebell H, 2010, ADV VIRUS RES, V76, P211, DOI 10.1016/S0065-3527(10)76006-1	74	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111577	10.1371/journal.pone.0111577	http://dx.doi.org/10.1371/journal.pone.0111577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365307	Green Published, gold			2022-12-26	WOS:000345558100080
J	Chabane, YN; Marti, S; Rihouey, C; Alexandre, S; Hardouin, J; Lesouhaitier, O; Vila, J; Kaplan, JB; Jouenne, T; De, E				Chabane, Yassine Nait; Marti, Sara; Rihouey, Christophe; Alexandre, Stephane; Hardouin, Julie; Lesouhaitier, Olivier; Vila, Jordi; Kaplan, Jeffrey B.; Jouenne, Thierry; De, Emmanuelle			Characterisation of Pellicles Formed by Acinetobacter baumannii at the Air-Liquid Interface	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS SBW25; AERUGINOSA BIOFILM DEVELOPMENT; ESCHERICHIA-COLI; ABIOTIC SURFACES; GENETIC-ANALYSIS; MATRIX; FEATURES; ATTACHMENT; CELLULOSE; PATHOGEN	The clinical importance of Acinetobacter baumannii is partly due to its natural ability to survive in the hospital environment. This persistence may be explained by its capacity to form biofilms and, interestingly, A. baumannii can form pellicles at the air-liquid interface more readily than other less pathogenic Acinetobacter species. Pellicles from twenty-six strains were morphologically classified into three groups: I) egg-shaped (27%); II) ball-shaped (50%); and III) irregular pellicles (23%). One strain representative of each group was further analysed by Brewster's Angle Microscopy to follow pellicle development, demonstrating that their formation did not require anchoring to a solid surface. Total carbohydrate analysis of the matrix showed three main components: Glucose, GlcNAc and Kdo. Dispersin B, an enzyme that hydrolyzes poly-N-acetylglucosamine (PNAG) polysaccharide, inhibited A. baumannii pellicle formation, suggesting that this exopolysaccharide contributes to pellicle formation. Also associated with the pellicle matrix were three subunits of pili assembled by chaperon-usher systems: the major CsuA/B, A1S_1510 (presented 45% of identity with the main pilin F17-A from enterotoxigenic Escherichia coli pili) and A1S_2091. The presence of both PNAG polysaccharide and pili systems in matrix of pellicles might contribute to the virulence of this emerging pathogen.	[Chabane, Yassine Nait; Marti, Sara; Rihouey, Christophe; Alexandre, Stephane; Hardouin, Julie; Jouenne, Thierry; De, Emmanuelle] Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Unite Mixte Rech 6270, Mont St Aignan, France; [Lesouhaitier, Olivier] Univ Rouen, Lab Microbiol Signaux & Microenvironm, Equipe Accueil 4312, Evreux, France; [Vila, Jordi] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain; [Kaplan, Jeffrey B.] Amer Univ, Dept Biol, Washington, DC 20016 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie; Universite de Rouen Normandie; University of Barcelona; Hospital Clinic de Barcelona; American University	Marti, S (corresponding author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Unite Mixte Rech 6270, Mont St Aignan, France.	saramarti2@yahoo.es; emmanuelle.de@univ-rouen.fr	Nait chabane, Yassine/GNN-0300-2022; Vila, Jordi/P-3613-2016; Marti, Sara/D-4823-2014	Vila, Jordi/0000-0002-8025-3926; Marti, Sara/0000-0002-0405-2305; NAIT CHABANE, Yassine/0000-0002-9528-2105; jouenne, thierry/0000-0003-0994-9944; Hardouin, Julie/0000-0003-4588-9811; ALEXANDRE, Stephane/0000-0003-0717-8592; De, Emmanuelle/0000-0002-9564-1649	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region(Region Normandie)	SM has a post-doctoral fellowship from the Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) and YNC has a doctoral fellowship from the Haute-Normandie region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eijkelkamp BA, 2013, INFECT IMMUN, V81, P2574, DOI 10.1128/IAI.00065-13; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GIRARDEAU JP, 1980, ANN INST PASTEUR MIC, VB131, P31; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Henk MC, 2004, APPL ENVIRON MICROB, V70, P2486, DOI 10.1128/AEM.70.4.2486-2493.2004; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Konopka JB, 2012, SCIENTIFICA CAIRO, V2012; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pamp S.J., 2007, BIOFILM MODE LIFE ME, P37; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Rodriguez-Bano J, 2004, INFECT CONT HOSP EP, V25, P819, DOI 10.1086/502302; Romling U, 1999, FEMS MICROBIOL LETT, V180, P91; ROSENBERG M, 1981, INFECT IMMUN, V33, P29, DOI 10.1128/IAI.33.1.29-33.1981; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x	52	46	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111660	10.1371/journal.pone.0111660	http://dx.doi.org/10.1371/journal.pone.0111660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360550	Green Published, gold			2022-12-26	WOS:000343943700140
J	Corradetti, B; Correani, A; Romaldini, A; Marini, MG; Bizzaro, D; Perrini, C; Cremonesi, F; Lange-Consiglio, A				Corradetti, Bruna; Correani, Alessio; Romaldini, Alessio; Marini, Maria Giovanna; Bizzaro, Davide; Perrini, Claudia; Cremonesi, Fausto; Lange-Consiglio, Anna			Amniotic Membrane-Derived Mesenchymal Cells and Their Conditioned Media: Potential Candidates for Uterine Regenerative Therapy in the Horse	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; STEM-CELLS; BONE-MARROW; WNT GENES; EPITHELIAL-CELLS; INTERFERON-TAU; ESTROUS-CYCLE; STROMAL CELLS; IN-VITRO; PROGESTERONE	Amniotic membrane-derived mesenchymal cells (AMCs) are considered suitable candidates for a variety of cell-based applications. In view of cell therapy application in uterine pathologies, we studied AMCs in comparison to cells isolated from the endometrium of mares at diestrus (EDCs) being the endometrium during diestrus and early pregnancy similar from a hormonal standpoint. In particular, we demonstrated that amnion tissue fragments (AM) shares the same transcriptional profile with endometrial tissue fragments (ED), expressing genes involved in early pregnancy (AbdB-like Hoxa genes), pre-implantantion conceptus development (Er alpha, PR, PGRMC1 and mPR) and their regulators (Wnt7a, Wnt4a). Soon after the isolation, only AMCs express Wnt4a and Wnt7a. Interestingly, the expression levels of prostaglandin-endoperoxide synthase 2 (PTGS2) were found greater in AM and AMCs than their endometrial counterparts thus confirming the role of AMCs as mediators of inflammation. The expression of nuclear progesterone receptor (PR), membrane-bound intracellular progesterone receptor component 1 (PGRMC1) and membrane-bound intracellular progesterone receptor (mPR), known to lead to improved endometrial receptivity, was maintained in AMCs over 5 passages in vitro when the media was supplemented with progesterone. To further explore the potential of AMCs in endometrial regeneration, their capacity to support resident cell proliferation was assessed by co-culturing them with EDCs in a transwell system or culturing in the presence of AMC-conditioned medium (AMC-CM). A significant increase in EDC proliferation rate exhibited the crucial role of soluble factors as mediators of stem cells action. The present investigation revealed that AMCs, as well as their derived conditioned media, have the potential to improve endometrial cell replenishment when low proliferation is associated to pregnancy failure. These findings make AMCs suitable candidates for the treatment of endometrosis in mares.	[Corradetti, Bruna; Correani, Alessio; Romaldini, Alessio; Marini, Maria Giovanna; Bizzaro, Davide] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy; [Perrini, Claudia; Cremonesi, Fausto; Lange-Consiglio, Anna] Univ Milan, Large Anim Hosp, Reprod Unit, Lodi, Italy; [Cremonesi, Fausto] Univ Milan, Dept Vet Sci Anim Hlth Prod & Food Safety, Milan, Italy	Marche Polytechnic University; University of Milan; University of Milan	Cremonesi, F (corresponding author), Univ Milan, Large Anim Hosp, Reprod Unit, Lodi, Italy.	fausto.cremonesi@unimi.it	Lange-Consiglio, Anna/AAI-4146-2021; Cremonesi, Fausto/J-2506-2014	Lange-Consiglio, Anna/0000-0002-7748-3413; Cremonesi, Fausto/0000-0001-8399-4626; corradetti, bruna/0000-0002-0345-4847; CORREANI, ALESSIO/0000-0001-5666-7806; Bizzaro, Davide/0000-0002-8336-1156; Romaldini, Alessio/0000-0003-0524-9000	Universita degli Studi di Milano; Universita Politecnica delle Marche	Universita degli Studi di Milano; Universita Politecnica delle Marche	General funding from Universita degli Studi di Milano and Universita Politecnica delle Marche is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atli MO, 2011, ANIM REPROD SCI, V125, P94, DOI 10.1016/j.anireprosci.2011.04.001; Bartholomew S, 2009, EQUINE VET J, V41, P724, DOI 10.2746/042516409X429446; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Benson GV, 1996, DEVELOPMENT, V122, P2687; BIGSBY RM, 1986, ENDOCRINOLOGY, V119, P390, DOI 10.1210/endo-119-1-390; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; Chong AKS, 2009, FRONT BIOSCI-LANDMRK, V14, P4598, DOI 10.2741/3552; Corradetti B, 2011, CELL PROLIFERAT, V44, P330, DOI 10.1111/j.1365-2184.2011.00759.x; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; Daels PF, 2005, EQUINE REPROD, P121; de Ziegler D, 1998, J REPROD IMMUNOL, V39, P149, DOI 10.1016/S0165-0378(98)00019-9; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Donofrio G, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-65; Dorniak P, 2013, ANIM REPROD, V10, P239; Falkenstein E, 2000, J CLIN ENDOCR METAB, V85, P2072, DOI 10.1210/jc.85.5.2072; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Fischer C, 2010, REPROD FERT DEVELOP, V22, P818, DOI 10.1071/RD09120; GINTHER OJ, 1985, THERIOGENOLOGY, V24, P73, DOI 10.1016/0093-691X(85)90213-4; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Han K, 2008, CELL PROLIFERAT, V41, P709, DOI 10.1111/j.1365-2184.2008.00553.x; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hess AP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P337; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Hwang NS, 2009, WIRES SYST BIOL MED, V1, P97, DOI 10.1002/wsbm.26; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kiewisz J, 2008, REPROD DOMEST ANIM, V43, P92; Kim S, 2003, ENDOCRINOLOGY, V144, P5203, DOI 10.1210/en.2003-0665; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lange-Consiglio A, 2013, STEM CELLS DEV, V22, P3015, DOI 10.1089/scd.2013.0214; Lange-Consiglio A, 2013, CYTOTHERAPY, V15, P1011, DOI 10.1016/j.jcyt.2013.03.002; LeBlanc MM, 2010, REPROD DOMEST ANIM, V45, P21, DOI 10.1111/j.1439-0531.2010.01634.x; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Ma L, 1998, DEV BIOL, V197, P141, DOI 10.1006/dbio.1998.8907; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; MERKT H, 1979, EQUINE VET J, V11, P256, DOI 10.1111/j.2042-3306.1979.tb01359.x; Miller C, 1998, MECH DEVELOP, V76, P91, DOI 10.1016/S0925-4773(98)00112-9; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Paria BC, 2000, SEMIN CELL DEV BIOL, V11, P67, DOI 10.1006/scdb.2000.0153; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Ponsuksili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042402; Rambags BPB, 2008, THERIOGENOLOGY, V69, P366, DOI 10.1016/j.theriogenology.2007.10.011; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Tuohimaa P, 1996, MATURITAS, V23, pS3, DOI 10.1016/0378-5122(96)01004-3; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	53	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111324	10.1371/journal.pone.0111324	http://dx.doi.org/10.1371/journal.pone.0111324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360561	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700084
J	Ha, HJ; Hwang, D; Choi, WR; Baek, J; Lee, SJ				Ha, Hojin; Hwang, Dongha; Choi, Woo-Rak; Baek, Jehyun; Lee, Sang Joon			Fluid-Dynamic Optimal Design of Helical Vascular Graft for Stenotic Disturbed Flow	PLOS ONE			English	Article							SPIRAL LAMINAR-FLOW; WALL SHEAR-STRESS; OF-PLANE GEOMETRY; PULSATILE FLOW; SECONDARY FLOW; STEADY FLOW; ANASTOMOSIS; ARTERY; MECHANICS; ATHEROSCLEROSIS	Although a helical configuration of a prosthetic vascular graft appears to be clinically beneficial in suppressing thrombosis and intimal hyperplasia, an optimization of a helical design has yet to be achieved because of the lack of a detailed understanding on hemodynamic features in helical grafts and their fluid dynamic influences. In the present study, the swirling flow in a helical graft was hypothesized to have beneficial influences on a disturbed flow structure such as stenotic flow. The characteristics of swirling flows generated by helical tubes with various helical pitches and curvatures were investigated to prove the hypothesis. The fluid dynamic influences of these helical tubes on stenotic flow were quantitatively analysed by using a particle image velocimetry technique. Results showed that the swirling intensity and helicity of the swirling flow have a linear relation with a modified Germano number (Gn*) of the helical pipe. In addition, the swirling flow generated a beneficial flow structure at the stenosis by reducing the size of the recirculation flow under steady and pulsatile flow conditions. Therefore, the beneficial effects of a helical graft on the flow field can be estimated by using the magnitude of Gn*. Finally, an optimized helical design with a maximum Gn* was suggested for the future design of a vascular graft.	[Ha, Hojin; Hwang, Dongha; Choi, Woo-Rak; Baek, Jehyun; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea; [Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019		National Research Foundation of Korea (NRF) - Korean government (MSIP) [2008-0061991]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) under a grant funded by the Korean government (MSIP) (No. 2008-0061991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1984, J BIOMECH, V17, P695, DOI 10.1016/0021-9290(84)90123-4; AHMED SA, 1983, J BIOMECH, V16, P505, DOI 10.1016/0021-9290(83)90065-9; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Bluestein D, 1997, ANN BIOMED ENG, V25, P344, DOI 10.1007/BF02648048; CANVER CC, 1995, CHEST, V108, P1150, DOI 10.1378/chest.108.4.1150; Caro CG, 2005, J ROY SOC INTERFACE, V2, P261, DOI 10.1098/rsif.2005.0044; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; Caro CG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0578; Cookson AN, 2010, J COMPUT APPL MATH, V234, P2069, DOI 10.1016/j.cam.2009.08.065; Cookson AN, 2009, ANN BIOMED ENG, V37, P710, DOI 10.1007/s10439-009-9636-y; Coppola G, 2009, J R SOC INTERFACE, V6, P519, DOI 10.1098/rsif.2008.0417; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; DEPAOLA N, 1992, ARTERIOSCLER THROMB, V12, P1254, DOI 10.1161/01.ATV.12.11.1254; Deutsch S, 2006, ANNU REV FLUID MECH, V38, P65, DOI 10.1146/annurev.fluid.38.050304.092022; Einav S, 2004, ANN NY ACAD SCI, V1015, P351, DOI 10.1196/annals.1302.031; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; GERMANO M, 1989, J FLUID MECH, V203, P289, DOI 10.1017/S0022112089001473; Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129; Ha HJ, 2014, MED ENG PHYS, V36, P1106, DOI 10.1016/j.medengphy.2014.06.004; Ha H, 2014, MED ENG PHYS, V36, P119, DOI 10.1016/j.medengphy.2013.10.008; Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x; HE GW, 1995, ANN THORAC SURG, V59, P676, DOI 10.1016/0003-4975(94)01011-0; Houston JG, 2004, NEPHROL DIAL TRANSPL, V19, P1786, DOI 10.1093/ndt/gfh238; IRIBARNE A, 1972, AICHE J, V18, P689, DOI 10.1002/aic.690180405; ISHIBASHI H, 1995, SURGERY, V117, P409, DOI 10.1016/S0039-6060(05)80061-3; Jamison RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075722; Kang YJ, 2012, LAB CHIP, V12, P1881, DOI 10.1039/c2lc21163g; Karri S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000934; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lee J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026301; Li XM, 2001, J BIOMECH ENG-T ASME, V123, P270, DOI 10.1115/1.1372323; LIU SJ, 1993, J FLUID MECH, V251, P315, DOI 10.1017/S002211209300343X; Mari JM, 2012, ULTRASONICS, V52, P294, DOI 10.1016/j.ultras.2011.08.015; Morbiducci U, 2011, BIOMECH MODEL MECHAN, V10, P339, DOI 10.1007/s10237-010-0238-2; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; OJHA M, 1993, J BIOMECH, V26, P1377, DOI 10.1016/0021-9290(93)90089-W; OJHA M, 1990, J VASC SURG, V12, P747, DOI 10.1067/mva.1990.24365; Papaharilaou Y, 2002, J BIOMECH, V35, P1225, DOI 10.1016/S0021-9290(02)00072-6; Paul MC, 2009, MED ENG PHYS, V31, P1195, DOI 10.1016/j.medengphy.2009.07.008; Peterson SD, 2008, J FLUID MECH, V616, P263, DOI 10.1017/S0022112008003625; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Ravensbergen J, 1998, ARTERIOSCL THROM VAS, V18, P708, DOI 10.1161/01.ATV.18.5.708; Rocklage-Marliani G, 2003, FLOW TURBUL COMBUST, V70, P43, DOI 10.1023/B:APPL.0000004913.82057.81; Sherwin SJ, 2000, J BIOMECH ENG-T ASME, V122, P86, DOI 10.1115/1.429630; Stonebridge PA, 2004, INT ANGIOL, V23, P276; STONEBRIDGE PA, 1991, LANCET, V338, P1360, DOI 10.1016/0140-6736(91)92238-W; Stonebridge PA, 1996, CLIN SCI, V91, P17, DOI 10.1042/cs0910017; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Van Canneyt K, 2013, J BIOMECH, V46, P345, DOI 10.1016/j.jbiomech.2012.10.027; Varghese SS, 2007, J FLUID MECH, V582, P253, DOI 10.1017/S0022112007005848; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Vetel J, 2008, J FLUID MECH, V607, P351, DOI 10.1017/S0022112008002188; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449; Yildiz O, 2013, PHARM ARTERIAL GRAFT; Zhan F, 2010, ASAIO J, V56, P172, DOI 10.1097/MAT.0b013e3181d0ea15; Zhan F, 2010, THROMB RES, V125, P413, DOI 10.1016/j.thromres.2009.02.011; Zheng TH, 2009, ASAIO J, V55, P192, DOI 10.1097/MAT.0b013e31819b34f2	59	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111047	10.1371/journal.pone.0111047	http://dx.doi.org/10.1371/journal.pone.0111047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360705	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700059
J	Hwang, TL; Shen, HI; Liu, FC; Tsai, HI; Wu, YC; Chang, FR; Yu, HP				Hwang, Tsong-Long; Shen, Hsin-I; Liu, Fu-Chao; Tsai, Hsin-I; Wu, Yang-Chang; Chang, Fang-Rong; Yu, Huang-Ping			Ursolic Acid Inhibits Superoxide Production in Activated Neutrophils and Attenuates Trauma-Hemorrhage Shock-Induced Organ Injury in Rats	PLOS ONE			English	Article								Neutrophil activation is associated with the development of organ injury after trauma-hemorrhagic shock. In the present study, ursolic acid inhibited the superoxide anion generation and elastase release in human neutrophils. Administration of ursolic acid attenuated trauma-hemorrhagic shock-induced hepatic and lung injuries in rats. In addition, administration of ursolic acid attenuated the hepatic malondialdehyde levels and reduced the plasma aspartate aminotransferase and alanine aminotransferase levels after trauma-hemorrhagic shock. In conclusion, ursolic acid, a bioactive natural compound, inhibits superoxide anion generation and elastase release in human neutrophils and ameliorates trauma-hemorrhagic shock-induced organ injury in rats.	[Hwang, Tsong-Long; Shen, Hsin-I] Chang Gung Univ, Coll Med, Sch Tradit Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Healthy Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Yang-Chang] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Wu, Yang-Chang; Chang, Fang-Rong] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Wu, Yang-Chang/C-5682-2009; Hwang, Tsong-Long/AAE-6944-2020; Liu, Fu-Chao/AAB-3780-2021	Wu, Yang-Chang/0000-0001-7815-2686; Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council [102-2314-B-182A-051-MY3, 100-2628-B-182-001-MY3]; Chang Gung Memorial Hospital [CMRPG3B1052]; Chang Gung University [CMRPD1B0481similar to3, EMRPD1D901]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University	This work was partially supported by grants from the National Science Council (102-2314-B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1052) to Huang-Ping Yu. Support was also provided by the National Science Council (100-2628-B-182-001-MY3) and Chang Gung Memorial Hospital and Chang Gung University (CMRPD1B0481 similar to 3, EMRPD1D901) to Tsong-Long Hwang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Doucet DR, 2010, J TRAUMA, V68, P35, DOI 10.1097/TA.0b013e3181bbbddb; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Hwang TL, 2009, FREE RADICAL BIO MED, V46, P520, DOI 10.1016/j.freeradbiomed.2008.11.014; Jian BX, 2014, MOL MED, V20, P10, DOI 10.2119/molmed.2013.00077; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Liu FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078861; Liu FC, 2013, J TRAUMA ACUTE CARE, V74, P1027, DOI 10.1097/TA.0b013e3182858389; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Sandhaus RA, 2013, COPD, V10, P60, DOI 10.3109/15412555.2013.764403; Shih HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059502; Tsai YF, 2014, TRANSPL P, V46, P1082, DOI 10.1016/j.transproceed.2014.01.009; van Berlo D, 2010, FREE RADICAL BIO MED, V49, P1685, DOI 10.1016/j.freeradbiomed.2010.08.031; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yu HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065916; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2009, BIOCHEM PHARMACOL, V78, P983, DOI 10.1016/j.bcp.2009.06.008	20	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111365	10.1371/journal.pone.0111365	http://dx.doi.org/10.1371/journal.pone.0111365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360589	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700092
J	Sun, J; Zhang, Q; Zhou, J; Wei, QP				Sun, Jian; Zhang, Qiang; Zhou, Jia; Wei, Qinping			Illumina Amplicon Sequencing of 16S rRNA Tag Reveals Bacterial Community Development in the Rhizosphere of Apple Nurseries at a Replant Disease Site and a New Planting Site	PLOS ONE			English	Article							SP-NOV.; MICROBIAL COMMUNITIES; CAUSAL ROLE; GROWTH; SOIL; MANAGEMENT; DIVERSITY; IMPACT; ENZYME; MANURE	We used a next-generation, Illumina-based sequencing approach to characterize the bacterial community development of apple rhizosphere soil in a replant site (RePlant) and a new planting site (NewPlant) in Beijing. Dwarfing apple nurseries of 'Fuji'/SH6/Pingyitiancha trees were planted in the spring of 2013. Before planting, soil from the apple rhizosphere of the replant site (ReSoil) and from the new planting site (NewSoil) was sampled for analysis on the Illumina MiSeq platform. In late September, the rhizosphere soil from both sites was resampled (RePlant and NewPlant). More than 16,000 valid reads were obtained for each replicate, and the community was composed of five dominant groups (Proteobacteria, Acidobacteria, Bacteroidetes, Gemmatimonadetes and Actinobacteria). The bacterial diversity decreased after apple planting. Principal component analyses revealed that the rhizosphere samples were significantly different among treatments. Apple nursery planting showed a large impact on the soil bacterial community, and the community development was significantly different between the replanted and newly planted soils. Verrucomicrobia were less abundant in RePlant soil, while Pseudomonas and Lysobacter were increased in RePlant compared with ReSoil and NewPlant. Both RePlant and ReSoil showed relatively higher invertase and cellulase activities than NewPlant and NewSoil, but only NewPlant soil showed higher urease activity, and this soil also had the higher plant growth. Our experimental results suggest that planting apple nurseries has a significant impact on soil bacterial community development at both replant and new planting sites, and planting on new site resulted in significantly higher soil urease activity and a different bacterial community composition.	[Sun, Jian; Zhang, Qiang; Zhou, Jia; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]; Minister of Agriculture (PRC); Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing	China Agriculture Research System; Minister of Agriculture (PRC); Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing	This work was supported by China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), (http://english.agri.gov.cn/) (QPW), and Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing (http://www.bjld.gov.cn/) (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgarani E, 2000, J RADIAT RES, V41, P19, DOI 10.1269/jrr.41.19; Atucha A, 2014, PLANT SOIL, V376, P337, DOI 10.1007/s11104-013-1977-5; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Covey Jr RP, 1979, PHYTOPATHOLOGY, V69; Drenovsky RE, 2004, SOIL BIOL BIOCHEM, V36, P1793, DOI 10.1016/j.soilbio.2004.05.002; DULLAHIDE SR, 1994, AUST J EXP AGR, V34, P1177, DOI 10.1071/EA9941177; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fan H, 2008, ACTA HORTICULTURAE S, V12, P3; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Golebiewski M, 2014, MICROB ECOL, V67, P635, DOI 10.1007/s00248-013-0344-7; Himani S, 2011, PLANT DIS RES, V26; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Hofmann A, 2009, J APPL BOT FOOD QUAL, V82, P193; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Kaewkla O, 2013, INT J SYST EVOL MICR, V63, P1249, DOI 10.1099/ijs.0.041343-0; Kampfer P, 2003, INT J SYST EVOL MICR, V53, P93, DOI 10.1099/ijs.0.02073-0; Kanso S, 2004, INT J SYST EVOL MICR, V54, P2141, DOI 10.1099/ijs.0.63138-0; Kausar J, 1997, INT J SYST BACTERIOL, V47, P684, DOI 10.1099/00207713-47-3-684; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manici LM, 2013, APPL SOIL ECOL, V72, P207, DOI 10.1016/j.apsoil.2013.07.011; Mao Y, 2014, ENV MICROBIOLOGY REP; Mazzola M, 2005, PLANT DIS, V89, P1207, DOI 10.1094/PD-89-1207; Mazzola M, 2000, PHYTOPATHOLOGY, V90, P114, DOI 10.1094/PHYTO.2000.90.2.114; Mazzola M., 2013, Aspects of Applied Biology, P69; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2002, PHYTOPATHOLOGY, V92, P1363, DOI 10.1094/PHYTO.2002.92.12.1363; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Qian X, 2014, APPL SOIL ECOL, V77, P18, DOI 10.1016/j.apsoil.2014.01.003; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rumberger A, 2004, PLANT SOIL, V264, P247, DOI 10.1023/B:PLSO.0000047760.13004.94; Rumberger A, 2007, SOIL BIOL BIOCHEM, V39, P1645, DOI 10.1016/j.soilbio.2007.01.023; Santoyo G, 2012, BIOCONTROL SCI TECHN, V22, P855, DOI 10.1080/09583157.2012.694413; Sato T, 2013, ISME J; SEWELL GWF, 1981, ANN APPL BIOL, V97, P31, DOI 10.1111/j.1744-7348.1981.tb02992.x; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; St Laurent A, 2010, PLANT SOIL, V337, P259, DOI 10.1007/s11104-010-0522-z; Sun J, 2014, APPL SOIL ECOL, V78, P28, DOI 10.1016/j.apsoil.2014.02.004; Sun Jian, 2013, Journal of Fruit Science, V30, P230; Tian Jia, 2012, Journal of Agricultural Science and Technology (Beijing), V14, P115; Trujillo ME, 2006, INT J SYST EVOL MICR, V56, P407, DOI 10.1099/ijs.0.63745-0; Utkhede RS, 1993, 3 INT S REPL PROBL, V363, P25; Wang D, 2003, J YUNNAN U NATURAL S, V26, P265; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilson S, 2004, SCI HORTIC-AMSTERDAM, V102, P221, DOI 10.1016/j.scienta.2004.01.001; Xie YX, 2012, NAT PROD REP, V29, P1277, DOI 10.1039/c2np20064c; Xu Z, 2012, INT J SYST EVOL MICR, V62, P1081, DOI 10.1099/ijs.0.033290-0; Yang JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046420; Yim B, 2013, PLANT SOIL, P1; Yoon MH, 2007, INT J SYST EVOL MICR, V57, P1834, DOI 10.1099/ijs.0.65011-0; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076937, 10.1371/journal.pone.0082677]	56	46	57	0	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111744	10.1371/journal.pone.0111744	http://dx.doi.org/10.1371/journal.pone.0111744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360786	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700145
J	Waheed, AA; Kuruppu, ND; Felton, KL; D'Souza, D; Freed, EO				Waheed, Abdul A.; Kuruppu, Nishani D.; Felton, Kathryn L.; D'Souza, Darren; Freed, Eric O.			In COS Cells Vpu Can Both Stabilize Tetherin Expression and Counteract Its Antiviral Activity	PLOS ONE			English	Article							PARTICLE RELEASE; INHIBITS HIV-1; RETROVIRUS RELEASE; DOWN-MODULATION; VIRUS; RESTRICTION; PROTEIN; SURFACE; ANTAGONISM; MECHANISM	The interferon-inducible cellular protein tetherin (CD317/BST-2) inhibits the release of a broad range of enveloped viruses. The HIV-1 accessory protein Vpu enhances virus particle release by counteracting this host restriction factor. While the antagonism of human tetherin by Vpu has been associated with both proteasomal and lysosomal degradation, the link between Vpu-mediated tetherin degradation and the ability of Vpu to counteract the antiviral activity of tetherin remains poorly understood. Here, we show that human tetherin is expressed at low levels in African green monkey kidney (COS) cells. However, Vpu markedly increases tetherin expression in this cell line, apparently by sequestering it in an internal compartment that bears lysosomal markers. This stabilization of tetherin by Vpu requires the transmembrane sequence of human tetherin. Although Vpu stabilizes human tetherin in COS cells, it still counteracts the ability of tetherin to suppress virus release. The enhancement of virus release by Vpu in COS cells is associated with a modest reduction in cell-surface tetherin expression, even though the overall expression of tetherin is higher in the presence of Vpu. This study demonstrates that COS cells provide a model system in which Vpu-mediated enhancement of HIV-1 release is uncoupled from Vpu-mediated tetherin degradation.	[Waheed, Abdul A.; Kuruppu, Nishani D.; Felton, Kathryn L.; D'Souza, Darren; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waheed, AA (corresponding author), NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21701 USA.	waheedab@mail.nih.gov			Intramural Research Program of the NIH, National Cancer Institute; Intramural AIDS targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010776] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in the Freed lab is supported by the Intramural Research Program of the NIH, National Cancer Institute, and by the Intramural AIDS targeted Antiviral Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2011, J VIROL, V85, P2611, DOI 10.1128/JVI.02080-10; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blondeau C, 2013, J VIROL, V87, P13124, DOI 10.1128/JVI.02250-13; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Giese S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004189; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hancock J F, 1992, Methods Mol Biol, V8, P153, DOI 10.1385/0-89603-191-8:153; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lemaitre C, 2014, J VIROL; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Morrison JH, 2014, J VIROL, V88, P3255, DOI 10.1128/JVI.03814-13; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Rai T, 2010, J VIROL, V84, P9783, DOI 10.1128/JVI.01584-09; Reed JC, 2012, J CELL BIOL, V198, P439, DOI 10.1083/jcb.201111012; Rollason R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075680; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Shingai M, 2011, J VIROL, V85, P9708, DOI 10.1128/JVI.00626-11; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Tokarev Andrey, 2011, Cell Logist, V1, P90; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Wen X, 2014, J VIROL; YANG WK, 1980, P NATL ACAD SCI-BIOL, V77, P2994, DOI 10.1073/pnas.77.5.2994; Yin X, 2014, J VIROL, V88, P1259, DOI 10.1128/JVI.03148-13; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhang JY, 2010, J VIROL, V84, P12336, DOI 10.1128/JVI.01228-10	71	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111628	10.1371/journal.pone.0111628	http://dx.doi.org/10.1371/journal.pone.0111628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360760	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700131
J	Xu, LJ; Ye, HH; Huang, F; Yang, ZX; Zhu, BA; Xu, Y; Qiu, YQ; Li, LJ				Xu, Lijun; Ye, Hanhui; Huang, Fan; Yang, Zongxing; Zhu, Biao; Xu, Yan; Qiu, Yunqing; Li, Lanjuan			Moderate/Severe Hyponatremia Increases the Risk of Death among Hospitalized Chinese Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TUBERCULOUS MENINGITIS; INDEPENDENT PREDICTOR; HIV-INFECTION; PRIMARY-CARE; MORTALITY; AIDS; HORMONE; DISEASE; COMPLICATIONS	Objectives: To evaluate whether the serum sodium concentration is associated with the progression and long-term prognosis of Chinese HIV/AIDS patients. Methods: Three hundred and eighty seven hospitalized patients were recruited into this retrospective cohort study. The strata of serum sodium concentration were moderate/severe hyponatremia, mild hyponatremia and normonatremia. Disease progression was estimated using CD4 counts and the WHO clinical stage. Correlation analysis was used to evaluate the serum sodium concentration with disease progression. The Kaplan-Meier method and the Cox proportional hazards model were used to analyze the effect of different serum sodium levels on survival. Results: In this study 206 patients (53.2%) had hyponatremia, including 10.6% patients with moderate/severe hyponatremia and 42.6% with mild hyponatremia. The serum sodium concentration was significantly correlated with the HIV/AIDS progression (P<0.001). During the follow-uP, 100 patients (25.6%) died. The cumulative survival rates of HIV/AIDS patients were 47.8%+/- 8.5% in patients with moderate/severe hyponatremia, 59.8%+/- 5.0% with mild hyponatremia and 79.9%+/- 3.4% with normonatremia (log-rank P<0.001). After adjusting for sex, age, WHO stage, CD4 count, hemoglobin and albumin, the relative hazard was 3.5 (95% CI: 1.9-6.5) for patients with moderate/severe hyponatremia (P<0.001), and 1.5 (95% CI: 0.9-2.4) for those with mild hyponatremia (P = 0.161), compared with normonatremic patients. Conclusions: The serum sodium level is closely correlated with the severity of patients. Only moderate/severe hyponatremia affects the prognosis of Chinese HIV/AIDS patients. Earlier intensive medical managements(including HAART) are necessary to increase the survival rates of Chinese HIV/AIDS patients with moderate/severe hyponatremia.	[Xu, Lijun; Yang, Zongxing; Zhu, Biao; Xu, Yan; Qiu, Yunqing; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lijun; Zhu, Biao; Qiu, Yunqing; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Hanhui] Fujian Med Univ, Fuzhou Infect Dis Hosp, Clin Ctr HIV AIDS, Fuzhou, Peoples R China; [Huang, Fan] Jianxin Hosp Fujian Prov, Dept Infect Dis, Fuzhou, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Fujian Medical University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Xu, Lijun/AAY-2968-2020	Xu, Lijun/0000-0001-7352-2086	Ministry of Science and Technology of China [2011ZX09302-003-03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the 12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China (Grant Number 2011ZX09302-003-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; AGARWAL A, 1989, NEPHRON, V53, P317, DOI 10.1159/000185774; Al-Salman J, 2002, WESTERN J MED, V176, P173, DOI 10.1136/ewjm.176.3.173; [Anonymous], 2006, PAT MON GUID HIV CAR; Berggren Ruth, 2005, Curr HIV/AIDS Rep, V2, P109, DOI 10.1007/s11904-005-0002-x; Cardenas A, 2008, NEW ENGL J MED, V359, P1060, DOI 10.1056/NEJMe0805570; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Costa A, 2000, EXP NEUROL, V166, P376, DOI 10.1006/exnr.2000.7502; CUSANO AJ, 1990, J ACQ IMMUN DEF SYND, V3, P949; Dao CN, 2011, AIDS RES HUM RETROV, V27, P1149, DOI [10.1089/aid.2010.0345, 10.1089/AID.2010.0345]; DECAUX G, 1980, JAMA-J AM MED ASSOC, V244, P589, DOI 10.1001/jama.244.6.589; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Li M, 2014, BIOSCI TRENDS, V8, P52, DOI 10.5582/bst.8.52; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Momi J, 2010, J HOSP MED, V5, P193, DOI 10.1002/jhm.516; Moore DM, 2006, HIV MED, V7, P383, DOI 10.1111/j.1468-1293.2006.00397.x; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; NAROTAM PK, 1994, NEUROSURGERY, V34, P982, DOI 10.1227/00006123-199406000-00005; Nettles R, 2002, INFECT DIS CLIN PRAC, V11, P361; Nzerue CM, 2003, J NATL MED ASSOC, V95, P335; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Olawumi HO, 2006, HIV MED, V7, P351, DOI 10.1111/j.1468-1293.2006.00391.x; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Piacenti FJ, 2006, PHARMACOTHERAPY, V26, P1111, DOI 10.1592/phco.26.8.1111; PURBA JS, 1993, BRAIN, V116, P795, DOI 10.1093/brain/116.4.795; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Schambelan M, 2002, JAIDS-J ACQ IMM DEF, V31, P257, DOI 10.1097/00126334-200211010-00001; Smellie WSA, 2007, BMJ-BRIT MED J, V334, P473, DOI 10.1136/bmj.39098.744560.47; TANG WW, 1993, AM J MED, V94, P169, DOI 10.1016/0002-9343(93)90179-S; Uno K, 2007, INTERNAL MED, V46, P617, DOI 10.2169/internalmedicine.46.1886; VITTING KE, 1990, JAMA-J AM MED ASSOC, V263, P973, DOI 10.1001/jama.263.7.973; Wanke CA, 2002, CLIN INFECT DIS, V34, P248, DOI 10.1086/324744; WHO, 2010, ANT THER HIV INF AD; Wong KH, 2011, LANCET INFECT DIS, V11, P491, DOI 10.1016/S1473-3099(11)70118-9; World Health Organization, 2006, ANT THER HIV INF AD; Xu J, 2007, AIDS PATIENT CARE ST, V21, P787, DOI 10.1089/apc.2007.0005; Zhang F, 2012, CHINA FREE ART MANUA; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2007, CHINA FREE ART MANUA; Zhao DC, 2012, CHINESE MED J-PEKING, V125, P3514, DOI 10.3760/cma.j.issn.0366-6999.2012.19.028; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111077	10.1371/journal.pone.0111077	http://dx.doi.org/10.1371/journal.pone.0111077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360785	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700062
J	Brennan, CM; Mazzucca, NQ; Mezoian, T; Hunt, TM; Keane, ML; Leonard, JN; Scola, SE; Beer, EN; Perdue, S; Pellock, BJ				Brennan, Christopher M.; Mazzucca, Nicholas Q.; Mezoian, Taylor; Hunt, Taylor M.; Keane, Meaghan L.; Leonard, Jessica N.; Scola, Shelby E.; Beer, Emma N.; Perdue, Sarah; Pellock, Brett J.			Reduced Heme Levels Underlie the Exponential Growth Defect of the Shewanella oneidensis hfq Mutant	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; RNA; BIOSYNTHESIS; CYTOCHROMES; PROTEIN; GENOME; IDENTIFICATION; EXPRESSION; MANGANESE	The RNA chaperone Hfq fulfills important roles in small regulatory RNA (sRNA) function in many bacteria. Loss of Hfq in the dissimilatory metal reducing bacterium Shewanella oneidensis strain MR-1 results in slow exponential phase growth and a reduced terminal cell density at stationary phase. We have found that the exponential phase growth defect of the hfq mutant in LB is the result of reduced heme levels. Both heme levels and exponential phase growth of the hfq mutant can be completely restored by supplementing LB medium with 5-aminolevulinic acid (5-ALA), the first committed intermediate synthesized during heme synthesis. Increasing expression of gtrA, which encodes the enzyme that catalyzes the first step in heme biosynthesis, also restores heme levels and exponential phase growth of the hfq mutant. Taken together, our data indicate that reduced heme levels are responsible for the exponential growth defect of the S. oneidensis hfq mutant in LB medium and suggest that the S. oneidensis hfq mutant is deficient in heme production at the 5-ALA synthesis step.	[Brennan, Christopher M.; Mazzucca, Nicholas Q.; Mezoian, Taylor; Hunt, Taylor M.; Keane, Meaghan L.; Leonard, Jessica N.; Beer, Emma N.; Perdue, Sarah; Pellock, Brett J.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Scola, Shelby E.] Providence Coll, Dept Chem & Biochem, Providence, RI 02918 USA	Providence College; Providence College	Pellock, BJ (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.	bpellock@providence.edu		Pelletier, Jessica/0000-0003-1494-6764; Beer, Emma/0000-0001-7891-6228; /0000-0002-9399-7174	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [2 P20 GM103430]; Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number 2 P20 GM103430. IDeA website address: http://www.nigms.nih.gov/Training/IDeA/Pages/default.aspx. BJP's funding was awarded as a sub-project of the above grant through Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE, http://web.uri.edu/inbre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Brennan CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-33; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Kane AL, 2013, ACS SYNTH BIOL, V2, P93, DOI 10.1021/sb300042w; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Muffler A, 1997, J BACTERIOL, V179, P445; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Panja S, 2012, J MOL BIOL, V417, P406, DOI 10.1016/j.jmb.2012.02.009; Schobert M, 2002, J MOL MICROB BIOTECH, V4, P287; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Simon R., 1983, NAT BIOTECHNOL, V1, P784, DOI [10.1038/nbt1183-784, DOI 10.1038/NBT1183-784]; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	31	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109879	10.1371/journal.pone.0109879	http://dx.doi.org/10.1371/journal.pone.0109879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356668	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000008
J	Chen, LJ; Phillips, MI; Miao, HL; Zeng, R; Qin, GJ; Kim, IM; Weintraub, NL; Tang, YL				Chen, Lijuan; Phillips, M. Ian; Miao, Hui-Lai; Zeng, Rong; Qin, Gangjian; Kim, Il-Man; Weintraub, Neal L.; Tang, Yaoliang			Infrared Fluorescent Protein 1.4 Genetic Labeling Tracks Engrafted Cardiac Progenitor Cells in Mouse Ischemic Hearts	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; THERAPY; TRANSPLANTATION; CARDIOMYOCYTES; INHIBITION; EXPRESSION; BIOLOGY; DEEPER	Stem cell therapy has a potential for regenerating damaged myocardium. However, a key obstacle to cell therapy's success is the loss of engrafted cells due to apoptosis or necrosis in the ischemic myocardium. While many strategies have been developed to improve engrafted cell survival, tools to evaluate cell efficacy within the body are limited. Traditional genetic labeling tools, such as GFP-like fluorescent proteins (eGFP, DsRed, mCherry), have limited penetration depths in vivo due to tissue scattering and absorption. To circumvent these limitations, a near-infrared fluorescent mutant of the DrBphP bacteriophytochrome from Deinococcus radiodurans, IFP1.4, was developed for in vivo imaging, but it has yet to be used for in vivo stem/progenitor cell tracking. In this study, we incorporated IFP1.4 into mouse cardiac progenitor cells (CPCs) by a lentiviral vector. Live IFP1.4-labeled CPCs were imaged by their near-infrared fluorescence (NIRF) using an Odyssey scanner following overnight incubation with biliverdin. A significant linear correlation was observed between the amount of cells and NIRF signal intensity in in vitro studies. Lentiviral mediated IFP1.4 gene labeling is stable, and does not impact the apoptosis and cardiac differentiation of CPC. To assess efficacy of our model for engrafted cells in vivo, IFP1.4-labeled CPCs were intramyocardially injected into infarcted hearts. NIRF signals were collected at 1-day, 7-days, and 14-days post-injection using the Kodak in vivo multispectral imaging system. Strong NIRF signals from engrafted cells were imaged 1 day after injection. At 1 week after injection, 70% of the NIRF signal was lost when compared to the intensity of the day 1 signal. The data collected 2 weeks following transplantation showed an 88% decrease when compared to day 1. Our studies have shown that IFP1.4 gene labeling can be used to track the viability of transplanted cells in vivo.	[Chen, Lijuan] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Phillips, M. Ian] Keck Grad Inst, Claremont, CA USA; [Miao, Hui-Lai; Zeng, Rong] Guangdong Med Coll, Affiliated Hosp, Zhanjiang, Peoples R China; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Chen, Lijuan; Weintraub, Neal L.; Tang, Yaoliang] Univ Cincinnati, Dept Med, Cincinnati, OH 45220 USA; [Kim, Il-Man; Weintraub, Neal L.; Tang, Yaoliang] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Dept Med, Augusta, GA USA	Southeast University - China; Claremont Colleges; Keck Graduate Institute; Guangdong Medical University; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati; University System of Georgia; Augusta University	Tang, YL (corresponding author), Univ Cincinnati, Dept Med, Cincinnati, OH 45220 USA.	yaotang@gru.edu		Kim, Il-man/0000-0002-9268-8337; Weintraub, Neal/0000-0002-5138-3705; Tang, Yaoliang/0000-0002-8372-1545	American Heart Association Beginning [0765094Y]; National Institutes of Health [HL086555]; NIH [HL076684, HL62984]; National Natural Science Foundation of China [81270203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640, R01HL086555, R01HL076684, P01HL062984, R01HL124251] Funding Source: NIH RePORTER	American Heart Association Beginning(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association Beginning Grant-in-Aid 0765094Y (to Y.T.); National Institutes of Health grant HL086555 (to Y.T.), and NIH grants HL076684 and HL62984 (to N.L.W.). National Natural Science Foundation of China (No. 81270203, to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2011, MOL IMAGING BIOL, V13, P633, DOI 10.1007/s11307-010-0392-z; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Chen LJ, 2012, STEM CELLS DEV, V21, P2122, DOI 10.1089/scd.2011.0463; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Lecoq J, 2011, NAT BIOTECHNOL, V29, P715, DOI 10.1038/nbt.1941; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Nyolczas N, 2009, REGEN MED, V4, P407, DOI 10.2217/RME.09.14; Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tang YLL, 2013, EXP BIOL MED, V238, P294, DOI 10.1177/1535370213477982; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Yang G, 2012, CELL TRANSPLANT, V21, P985, DOI 10.3727/096368911X593145; Yu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4626; Zhang L, 2014, CELL CYCLE, V13, P762, DOI 10.4161/cc.27677	20	6	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e107841	10.1371/journal.pone.0107841	http://dx.doi.org/10.1371/journal.pone.0107841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357000	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000002
J	Day, K; Song, J; Absher, D				Day, Kenneth; Song, Jun; Absher, Devin			Targeted Sequencing of Large Genomic Regions with CATCH-Seq	PLOS ONE			English	Article							ENRICHMENT; DISEASES; AMPLIFICATION; SELECTION; VARIANTS	Current target enrichment systems for large-scale next-generation sequencing typically require synthetic oligonucleotides used as capture reagents to isolate sequences of interest. The majority of target enrichment reagents are focused on gene coding regions or promoters en masse. Here we introduce development of a customizable targeted capture system using biotinylated RNA probe baits transcribed from sheared bacterial artificial chromosome clone templates that enables capture of large, contiguous blocks of the genome for sequencing applications. This clone adapted template capture hybridization sequencing (CATCH-Seq) procedure can be used to capture both coding and non-coding regions of a gene, and resolve the boundaries of copy number variations within a genomic target site. Furthermore, libraries constructed with methylated adapters prior to solution hybridization also enable targeted bisulfite sequencing. We applied CATCH-Seq to diverse targets ranging in size from 125 kb to 3.5 Mb. Our approach provides a simple and cost effective alternative to other capture platforms because of template-based, enzymatic probe synthesis and the lack of oligonucleotide design costs. Given its similarity in procedure, CATCH-Seq can also be performed in parallel with commercial systems.	[Day, Kenneth; Song, Jun; Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA	HudsonAlpha Institute for Biotechnology	Absher, D (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.	dabsher@hudsonalpha.org		Day, Kenneth/0000-0001-8235-8302				Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Borate U, 2012, EXPERT REV ANTICANC, V12, P1289, DOI [10.1586/era.12.116, 10.1586/ERA.12.116]; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johansson H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1005; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050386; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Whitcomb DC, 2012, NAT REV GASTRO HEPAT, V9, P418, DOI 10.1038/nrgastro.2012.100; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081	23	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111756	10.1371/journal.pone.0111756	http://dx.doi.org/10.1371/journal.pone.0111756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357200	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000076
J	Plat, J; Hendrikx, T; Bieghs, V; Jeurissen, MLJ; Walenbergh, SMA; van Gorp, PJ; De Smet, E; Konings, M; Vreugdenhil, ACE; Guichot, YD; Rensen, SS; Buurman, WA; Greve, JWM; Lutjohann, D; Mensink, RP; Shiri-Sverdlov, R				Plat, Jogchum; Hendrikx, Tim; Bieghs, Veerle; Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; De Smet, Els; Konings, Maurice; Vreugdenhil, Anita C. E.; Guichot, Yasmin Dias; Rensen, Sander S.; Buurman, Wim A.; Greve, Jan Willem M.; Lutjohann, Dieter; Mensink, Ronald P.; Shiri-Sverdlov, Ronit			Protective Role of Plant Sterol and Stanol Esters in Liver Inflammation: Insights from Mice and Humans	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; CHOLESTEROL-METABOLISM; ACTIVATION; DISEASE; DESMOSTEROL; INHIBITION; MICROBIOTA; SYSTEM	The inflammatory component of non-alcoholic steatohepatitis (NASH) can lead to irreversible liver damage. Therefore there is an urgent need to identify novel interventions to combat hepatic inflammation. In mice, omitting cholesterol from the diet reduced hepatic inflammation. Considering the effects of plant sterol/stanol esters on cholesterol metabolism, we hypothesized that plant sterol/stanol esters reduces hepatic inflammation. Indeed, adding plant sterol/stanol esters to a high-fat-diet reduced hepatic inflammation as indicated by immunohistochemical stainings and gene expression for inflammatory markers. Finally, adding sterol/stanol esters lowered hepatic concentrations of cholesterol precursors lathosterol and desmosterol in mice, which were highly elevated in the HFD group similarly as observed in severely obese patients with NASH. In vitro, in isolated LPS stimulated bone marrow derived macrophages desmosterol activated cholesterol efflux whereas sitostanol reduced inflammation. This highly interesting observation that plant sterol/stanol ester consumption leads to complete inhibition of HFD-induced liver inflammation opens new venues in the treatment and prevention of hepatic inflammation.	[Plat, Jogchum; De Smet, Els; Konings, Maurice; Mensink, Ronald P.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Hendrikx, Tim; Bieghs, Veerle; Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Guichot, Yasmin Dias; Shiri-Sverdlov, Ronit] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Mol Genet, Maastricht, Netherlands; [Vreugdenhil, Anita C. E.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Pediat, Maastricht, Netherlands; [Rensen, Sander S.; Buurman, Wim A.; Greve, Jan Willem M.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Gen Surg, Maastricht, Netherlands; [Lutjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Greve, Jan Willem M.] Atrium Med Ctr Parkstad, Heerlen, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Bonn; Atrium Medical Center	Plat, J (corresponding author), Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	J.Plat@maastrichtuniversity.nl; R.Sverdlov@maastrichtuniversity.nl	van Gorp, Patrick/S-3892-2019; van Gorp, Patrick/L-9580-2018; Shiri-Sverdlov, Ronit/E-5571-2017; Hendrikx, Tim/AAI-8252-2021; Rensen, Sander/J-3224-2019; Hendrikx, Tim/AAE-2329-2020; Shiri-Sverdlov, Ronit/X-2642-2019	van Gorp, Patrick/0000-0002-0355-5349; van Gorp, Patrick/0000-0002-0355-5349; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Hendrikx, Tim/0000-0002-3381-2107; Rensen, Sander/0000-0001-5054-8400; Shiri-Sverdlov, Ronit/0000-0002-6736-7814				Baumgartner S, 2011, CURR PHARM DESIGN, V17, P922, DOI 10.2174/138161211795428795; Bayard M, 2006, AM FAM PHYSICIAN, V73, P1961; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Brull F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046895; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Simonen M, 2013, HEPATOLOGY, V58, P976, DOI 10.1002/hep.26342; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Thelen KM, 2006, J CLIN PHARMACOL, V46, P812, DOI 10.1177/0091270006289851; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x	22	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110758	10.1371/journal.pone.0110758	http://dx.doi.org/10.1371/journal.pone.0110758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356831	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000024
J	Sundaram, S; Freemerman, AJ; Galanko, JA; McNaughton, KK; Bendt, KM; Darr, DB; Troester, MA; Makowski, L				Sundaram, Sneha; Freemerman, Alex J.; Galanko, Joseph A.; McNaughton, Kirk K.; Bendt, Katharine M.; Darr, David B.; Troester, Melissa A.; Makowski, Liza			Obesity-Mediated Regulation of HGF/c-Met Is Associated with Reduced Basal-Like Breast Cancer Latency in Parous Mice	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; MAMMARY-GLAND; WEIGHT-GAIN; RISK; PREGNANCY; TUMORIGENESIS; EPIDEMIOLOGY; INFLAMMATION; SUBTYPES	It is widely thought that pregnancy reduces breast cancer risk, but this lacks consideration of breast cancer subtypes. While a full term pregnancy reduces risk for estrogen receptor positive (ER+) and luminal breast cancers, parity is associated with increased risk of basal-like breast cancer (BBC) subtype. Basal-like subtypes represent less than 10% of breast cancers and are highly aggressive, affecting primarily young, African American women. Our previous work demonstrated that high fat diet-induced obesity in nulliparous mice significantly blunted latency in C3(1)-T-Ag mice, a model of BBC, potentially through the hepatocyte growth factor (HGF)/c-Met oncogenic pathway. Experimental studies have examined parity and obesity individually, but to date, the joint effects of parity and obesity have not been studied. We investigated the role of obesity in parous mice on BBC. Parity alone dramatically blunted tumor latency compared to nulliparous controls with no effects on tumor number or growth, while obesity had only a minor role in further reducing latency. Obesity-associated metabolic mediators and hormones such as insulin, estrogen, and progesterone were not significantly regulated by obesity. Plasma IL-6 was also significantly elevated by obesity in parous mice. We have previously reported a potential role for stromal-derived hepatocyte growth factor (HGF) via its cognate receptor c-Met in the etiology of obesity-induced BBC tumor onset and in both human and murine primary coculture models of BBC-aggressiveness. Obesity-associated c-Met concentrations were 2.5-fold greater in normal mammary glands of parous mice. Taken together, our studies demonstrate that, parity in C3(1)-T-Ag mice dramatically reduced BBC latency compared to nulliparous mice. In parous mice, c-Met is regulated by obesity in unaffected mammary gland and is associated with tumor onset. C3(1)-T-Ag mice recapitulate epidemiologic findings such that parity drives increased BBC risk and potential microenvironmental alterations in c-Met signaling may play a role in etiology.	[Galanko, Joseph A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, UNC Nutr Obes Res Ctr, Chapel Hill, NC 27599 USA; [Sundaram, Sneha; Freemerman, Alex J.; Galanko, Joseph A.; McNaughton, Kirk K.; Bendt, Katharine M.; Darr, David B.; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bendt, Katharine M.; Darr, David B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Mouse Phase Unit 1, Chapel Hill, NC USA; [Darr, David B.; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [McNaughton, Kirk K.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Galanko, Joseph A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Med, Chapel Hill, NC USA; [Sundaram, Sneha; Freemerman, Alex J.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Makowski, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, UNC Nutr Obes Res Ctr, Chapel Hill, NC 27599 USA.	liza.makowski@unc.edu	, Histology Research Core Facility/ABF-6317-2021	Makowski, Liza/0000-0002-5337-8037	University of North Carolina University Cancer Research Fund (UCRF); National Institutes of Health [AA017376, ES019472, R21CA180134, DK034987, DK056350, RO1-CA138255]; NATIONAL CANCER INSTITUTE [R01CA138255, P50CA058223, R21CA180134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	University of North Carolina University Cancer Research Fund (UCRF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	LM was supported by University of North Carolina University Cancer Research Fund (UCRF (http://unclineberger.org/ucrf), National Institutes of Health AA017376, ES019472, and R21CA180134. LM and JAG were supported by National Institutes of Health grants DK034987 and DK056350. MAT was supported by National Institutes of Health ES019472 and RO1-CA138255 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; Brisken C, 2010, COLD SPRING HARBOR P, P2; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carmichael AR, 2006, BJOG-INT J OBSTET GY, V113, P1160, DOI 10.1111/j.1471-0528.2006.01021.x; Casanova M, 1999, TOXICOL SCI, V51, P236, DOI 10.1093/toxsci/51.2.236; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Engineer DR, 2012, INT J PEPTIDES; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gatenby RA, 2011, NAT REV CANCER, V11, P237, DOI 10.1038/nrc3036; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; INANO H, 1991, CARCINOGENESIS, V12, P1085, DOI 10.1093/carcin/12.6.1085; KEPPEL KG, 1993, AM J PUBLIC HEALTH, V83, P1100, DOI 10.2105/AJPH.83.8.1100; Key TJ, 2001, P NUTR SOC, V60, P81, DOI 10.1079/PNS200068; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Medina D, 1999, J NATL CANCER I, V91, P967, DOI 10.1093/jnci/91.11.967; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Phipps AI, 2008, CANCER EPIDEM BIOMAR, V17, P2078, DOI 10.1158/1055-9965.EPI-08-0206; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; SINHA DK, 1988, BRIT J CANCER, V57, P390, DOI 10.1038/bjc.1988.88; Sivaraman L, 1998, CARCINOGENESIS, V19, P1573, DOI 10.1093/carcin/19.9.1573; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Sundaram S, 2013, CANC PREV R IN PRESS; Sundaram S, 2013, BREAST CANC RES TREA; Sundaram S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00175; Sundaram S, 2013, BREAST CANCER RES TR, V142, P489, DOI 10.1007/s10549-013-2741-5; Tiede B, 2011, CELL RES, V21, P245, DOI 10.1038/cr.2011.11; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	52	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111394	10.1371/journal.pone.0111394	http://dx.doi.org/10.1371/journal.pone.0111394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354395	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200078
J	Watson, HA; Holley, RJ; Langford-Smith, KJ; Wilkinson, FL; van Kuppevelt, TH; Wynn, RF; Wraith, JE; Merry, CLR; Bigger, BW				Watson, H. Angharad; Holley, Rebecca J.; Langford-Smith, Kia J.; Wilkinson, Fiona L.; van Kuppevelt, Toin H.; Wynn, Robert F.; Wraith, J. Edmond; Merry, Catherine L. R.; Bigger, Brian W.			Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; RISK-FACTOR ANALYSIS; GLYCOSAMINOGLYCAN-BINDING; HURLERS-SYNDROME; TRANSPLANTATION; INDUCTION; IMPROVES; CORRECTS; OUTCOMES; DOMAINS	Mucopolysaccharidosis I Hurler (MPSI-H) is a pediatric lysosomal storage disease caused by genetic deficiencies in IDUA, coding for alpha-L-iduronidase. Idua(-/-) mice share similar clinical pathology with patients, including the accumulation of the undegraded glycosaminoglycans (GAGs) heparan sulfate (HS), and dermatan sulfate (DS), progressive neurodegeneration, and dysostosis multiplex. Hematopoietic stem cell transplantation (HSCT) is the most effective treatment for Hurler patients, but reduced intensity conditioning is a risk factor in transplantation, suggesting an underlying defect in hematopoietic cell engraftment. HS is a co-receptor in the CXCL12/CXCR4 axis of hematopoietic stem and progenitor cell (HSPC) migration to the bone marrow (BM), but the effect of HS alterations on HSPC migration, or the functional role of HS in MPSI-H are unknown. We demonstrate defective WT HSPC engraftment and migration in Idua(-/-) recipient BM, particularly under reduced intensity conditioning. Both intra-but especially extracellular Idua(-/-) BM HS was significantly increased and abnormally sulfated. Soluble heparinase-sensitive GAGs from Idua(-/-) BM and specifically 2-O-sulfated HS, elevated in Idua(-/-) BM, both inhibited CXCL12-mediated WT HSPC transwell migration, while DS had no effect. Thus we have shown that excess overly sulfated extracellular HS binds, and sequesters CXCL12, limiting hematopoietic migration and providing a potential mechanism for the limited scope of HSCT in Hurler disease.	[Watson, H. Angharad; Holley, Rebecca J.; Langford-Smith, Kia J.; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Stem Cell & Neurotherapies Grp, Manchester M13 9PT, Lancs, England; [Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Fac Phys & Engn Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Matrix Biochem Grp, NL-6500 HB Nijmegen, Netherlands; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Bone Marrow Transplantat Unit, Manchester M13 9WL, Lancs, England; [Wraith, J. Edmond] St Marys Hosp, Biochem Genet Unit, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; Radboud University Nijmegen; Royal Manchester Children's Hospital; University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.	Brian.bigger@manchester.ac.uk	van Kuppevelt, A.H.M.S.M./L-4463-2015; Bigger, Brian/I-3553-2012	Wilkinson, Fiona/0000-0002-0358-3489; merry, catherine/0000-0002-3490-2809; Wynn, robert/0000-0002-6046-8428; Watson, Angharad/0000-0003-4356-6891; Bigger, Brian/0000-0002-9708-1112	BBSRC; Wellcome; University of Manchester; MRC [G0701165, G0902170] Funding Source: UKRI; Medical Research Council [G0902170, G0701165] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge the help and assistance of the staff at the Manchester BSU. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome, and the University of Manchester Strategic Fund. Special thanks go to Robert Fernandez for help with the microscopy and image processing.	Albanese P, 2009, EXP HEMATOL, V37, P1072, DOI 10.1016/j.exphem.2009.06.005; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Baxter MA, 2005, J INHERIT METAB DIS, V28, P1045, DOI 10.1007/s10545-005-0136-4; Boelens JJ, 2007, BONE MARROW TRANSPL, V40, P225, DOI 10.1038/sj.bmt.1705718; Boelens JJ, 2009, BIOL BLOOD MARROW TR, V15, P618, DOI 10.1016/j.bbmt.2009.01.020; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Gupta P, 2006, THESCIENTIFICWORLDJO, V6, P452, DOI 10.1100/tsw.2006.83; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077632; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Pan CD, 2005, BLOOD, V106, P1956, DOI 10.1182/blood-2005-02-0657; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saif MA, 2012, HAEMATOL-HEMATOL J, V97, P1320, DOI 10.3324/haematol.2011.058644; Sergijenko A, 2013, MOL THER, V21, P1938, DOI 10.1038/mt.2013.141; Siapati EK, 2005, MOL THER, V12, P537, DOI 10.1016/j.ymthe.2005.01.022; Sweeney EA, 2001, ANN NY ACAD SCI, V938, P48; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wilson S, 2009, AM J PATHOL, V175, P2053, DOI 10.2353/ajpath.2009.090211; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith JE, 2005, EXPERT OPIN PHARMACO, V6, P489, DOI 10.1517/14656566.6.3.489; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284	45	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36194	36203		10.1074/jbc.M114.599944	http://dx.doi.org/10.1074/jbc.M114.599944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359774	Green Published, hybrid			2022-12-26	WOS:000346897900045
J	Christiansen, KM; Mossner, BK; Hansen, JF; Jarnbjer, EF; Pedersen, C; Christensen, PB				Christiansen, Karen M.; Mossner, Belinda K.; Hansen, Janne F.; Jarnbjer, Erik F.; Pedersen, Court; Christensen, Peer B.			Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; DISEASE PROGRESSION; NONINVASIVE TESTS; FIBROSIS; DIAGNOSIS; CIRRHOSIS; PERFORMANCE; ACCURACY; OUTCOMES; VIRUS	Liver stiffness measurement (LSM) is widely used to evaluate liver fibrosis, but longitudinal studies are rare. The current study was aimed to monitor LSM during follow-up, and to evaluate the association of LSM data with mortality and liverrelated outcomes. We included all patients with chronic viral hepatitis and valid LSM using Fibroscan. Information about liver biopsy, antiviral treatment, and clinical outcome was obtained from medical records and national registers. The study included 845 patients: 597 (71%) with hepatitis C virus (HCV), 235 (28%) with hepatitis B virus (HBV) and 13 (2%) with dual infection. The initial LSM distribution (<7/7-9.9/10-16.9/>= 17 kPa) was 58%/16%/14%/12%. Among patients with initial LSM values of 7-9.9 kPa, 60% of HCV patients and 83% of HBV patients showed LSM values of <7 kPa at the latest follow-up. Progression rates (defined as >20% and >2 kPa increase, with one measure >7 kPa) were 3.4/100 person years (PY) for HCV and 1.5/100 PY for HBV infected patients. Patients with LSM values of >= 17 kPa had the same liver-related complication incidence as patients with biopsy-proven cirrhosis (11.1 versus 12.1/100 PY). Thirteen liver-related deaths occurred among HCV patients (0.6/100 PY), but none among HBV patients. Among patients who died of liver-related causes, all but one had baseline LSM values of >= 17 kPa. Overall, patients with LSM values <17 kPa were not associated with adverse outcomes. In contrast, LSM values >= 17 kPa were associated with significant risk of liver-related problems. The results of the current study suggest that clinical decisions should not be taken based on a single LSM measurement.	[Christiansen, Karen M.; Mossner, Belinda K.; Hansen, Janne F.; Jarnbjer, Erik F.; Pedersen, Court; Christensen, Peer B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital	Christensen, PB (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	peer.christensen@dadlnet.dk	Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X				Arena U, 2013, HEPATOLOGY, V58, P65, DOI 10.1002/hep.26343; Asrani Sumeet K, 2013, Curr Gastroenterol Rep, V15, P308, DOI 10.1007/s11894-012-0308-y; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Cardoso AC, 2012, LIVER INT, V32, P612, DOI 10.1111/j.1478-3231.2011.02660.x; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Christensen PB, 2012, DAN MED J, V59; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Colombo S, 2011, DIGEST LIVER DIS, V43, P231, DOI 10.1016/j.dld.2010.07.008; de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Fialla AD, 2012, SCAND J GASTROENTERO, V47, P702, DOI 10.3109/00365521.2012.661759; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, J VIRAL HEPATITIS, V18, pE200, DOI 10.1111/j.1365-2893.2010.01428.x; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Lannerstedt H, 2013, SCAND J GASTROENTERO, V48, P93, DOI 10.3109/00365521.2012.746389; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Moessner BK, 2011, ADDICTION, V106, P970, DOI 10.1111/j.1360-0443.2010.03246.x; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; van de Putte DEF, 2011, HAEMOPHILIA, V17, pE975, DOI 10.1111/j.1365-2516.2011.02542.x; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Ydreborg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093601	40	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111912	10.1371/journal.pone.0111912	http://dx.doi.org/10.1371/journal.pone.0111912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369038	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000123
J	Ciccacci, C; Perricone, C; Ceccarelli, F; Rufini, S; Di Fusco, D; Alessandri, C; Spinelli, FR; Cipriano, E; Novelli, G; Valesini, G; Borgiani, P; Conti, F				Ciccacci, Cinzia; Perricone, Carlo; Ceccarelli, Fulvia; Rufini, Sara; Di Fusco, Davide; Alessandri, Cristiano; Spinelli, Francesca Romana; Cipriano, Enrica; Novelli, Giuseppe; Valesini, Guido; Borgiani, Paola; Conti, Fabrizio			A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; CONGENITAL HEART-BLOCK; INFLAMMATORY-BOWEL-DISEASE; AUTOIMMUNE-DISEASES; RHEUMATOID-ARTHRITIS; EPIDERMAL NECROLYSIS; NEONATAL LUPUS; TRAF3IP2 GENE; SUSCEPTIBILITY	Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with complex pathogenesis in which genes and environmental factors are involved. We aimed at analyzing previously identified loci associated with SLE or with other autoimmune and/or inflammatory disorders (STAT4, IL10, IL23R, IRAK1, PSORS1C1, HCP5, MIR146a, PTPN2, ERAP1, ATG16L1, IRGM) in a sample of Italian SLE patients in order to verify or confirm their possible involvement and relative contribution in the disease. Materials and methods: Two hundred thirty-nine consecutive SLE patients and 278 matched healthy controls were enrolled. Study protocol included complete physical examination, and clinical and laboratory data collection. Nineteen polymorphisms were genotyped by allelic discrimination assays. A case-control association study and a genotype-phenotype correlation were performed. Results: STAT4 was the most associated gene [P = 3x10(-7), OR = 2.13 (95% CI: 1.59-2.85)]. IL10 confirmed its association with SLE [rs3024505: P = 0.02, OR = 1.52 (95% CI: 1.07-2.16)]. We describe a novel significant association between HCP5 locus and SLE susceptibility [rs3099844: P = 0.01, OR = 2.06 (95% CI: 1.18-3.6)]. The genotype/phenotype correlation analysis showed several associations including a higher risk to develop pericarditis with STAT4, and an association between HCP5 rs3099844 and anti-Ro/SSA antibodies. Conclusions: STAT4 and IL10 confirm their association with SLE. We found that some SNPs in PSORS1C1, ATG16L1, IL23R, PTPN2 and MIR146a genes can determine particular disease phenotypes. HCP5 rs3099844 is associated with SLE and with anti-Ro/SSA. This polymorphism has been previously found associated with cardiac manifestations of SLE, a condition related with anti-Ro/SSA antibodies. Thus, our results may provide new insights into SLE pathogenesis.	[Ciccacci, Cinzia; Rufini, Sara; Di Fusco, Davide; Novelli, Giuseppe; Borgiani, Paola] Univ Roma Tor Vergata, Sch Med, Dept Biomed & Prevent, Genet Sect, Rome, Italy; [Perricone, Carlo; Ceccarelli, Fulvia; Alessandri, Cristiano; Spinelli, Francesca Romana; Cipriano, Enrica; Valesini, Guido; Conti, Fabrizio] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Lupus Clin, I-00185 Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome	Borgiani, P (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Biomed & Prevent, Genet Sect, Rome, Italy.	borgiani@med.uniroma2.it	Spinelli, Francesca Romana/F-1475-2013; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Ciccacci, Cinzia/Z-6114-2019; Spinelli, Francesca Romana/AAM-7061-2020; Novelli, Giuseppe/A-5195-2013	Novelli, Giuseppe/0000-0002-7781-602X; Spinelli, Francesca Romana/0000-0003-1969-2097; Novelli, Giuseppe/0000-0002-7781-602X; Valesini, Guido/0000-0002-7757-8092; BORGIANI, PAOLA/0000-0003-0859-4328; Di Fusco, Davide/0000-0002-8908-9237; Alessandri, Cristiano/0000-0003-4149-5321; Perricone, Carlo/0000-0003-4771-6981; Ciccacci, Cinzia/0000-0002-3995-7032				Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; ARGOV S, 1991, IMMUNOL LETT, V30, P31, DOI 10.1016/0165-2478(91)90086-P; Billaut-Mulot O, 2001, J CLIN INVEST, V108, P861, DOI 10.1172/JCI13469; Borgiani P, 2014, EUR J CLIN PHARMACOL, V70, P275, DOI 10.1007/s00228-013-1622-5; CHANG YN, 1995, J VIROL, V69, P618, DOI 10.1128/JVI.69.1.618-619.1995; Chang YT, 2005, BRIT J DERMATOL, V153, P90, DOI 10.1111/j.1365-2133.2005.06570.x; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Deas JE, 1998, CLIN DIAGN LAB IMMUN, V5, P181, DOI 10.1128/CDLI.5.2.181-185.1998; Delgado-Vega A, 2010, CURR OPIN IMMUNOL, V22, P698, DOI 10.1016/j.coi.2010.09.002; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Eronen M, 2004, ACTA PAEDIATR, V93, P803, DOI 10.1111/j.1651-2227.2004.tb03022.x; Espino-Paisan L, 2011, IMMUNOGENETICS, V63, P255, DOI 10.1007/s00251-010-0500-x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fritsch C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1848; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033682; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Guerini FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029931; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; JULKUNEN H, 1993, ARTHRITIS RHEUM-US, V36, P1588, DOI 10.1002/art.1780361114; Kariuki SN, 2010, TRANSL RES, V155, P109, DOI 10.1016/j.trsl.2009.08.012; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kaufman KM, 2013, ANN RHEUM DIS, V72, P437, DOI 10.1136/annrheumdis-2012-201851; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069547; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; MULLER S, 1992, AIDS, V6, P933, DOI 10.1097/00002030-199209000-00004; Perricone C, 2013, IMMUNOGENETICS, V65, P703, DOI 10.1007/s00251-013-0717-6; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Perricone R, 2011, AUTOIMMUN REV, V10, P575, DOI 10.1016/j.autrev.2011.05.003; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Salomonsson S, 2011, SCAND J IMMUNOL, V74, P511, DOI 10.1111/j.1365-3083.2011.02610.x; Salomonsson S, 2002, ARTHRITIS RHEUM-US, V46, P1233, DOI 10.1002/art.10232; Schotte H, 2014, LUPUS, V23, P378, DOI 10.1177/0961203314522334; Song GG, 2012, MOL BIOL REP, V39, P10655, DOI 10.1007/s11033-012-1955-7; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun HJ, 2013, IMMUNOL LETT, V153, P9, DOI 10.1016/j.imlet.2013.06.001; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; Wang C, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-201364; Zhai Y, 2012, MOL BIOL REP, V39, P8987, DOI 10.1007/s11033-012-1768-8; Zheng JF, 2013, HUM IMMUNOL, V74, P986, DOI 10.1016/j.humimm.2013.04.034; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	55	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111991	10.1371/journal.pone.0111991	http://dx.doi.org/10.1371/journal.pone.0111991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369137	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000133
J	Dukowska, M; Grzybkowska, M				Dukowska, Malgorzata; Grzybkowska, Maria			Coexistence of Fish Species in a Large Lowland River: Food Niche Partitioning between Small-Sized Percids, Cyprinids and Sticklebacks in Submersed Macrophytes	PLOS ONE			English	Article							RUFFE GYMNOCEPHALUS-CERNUUS; ROACH RUTILUS-RUTILUS; SELF-ORGANIZING MAP; IMPOUNDMENT IMPACT; LONG-TERM; CHIRONOMIDAE DIPTERA; FEEDING EFFICIENCY; JUVENILE FISHES; LITTORAL-ZONE; WARTA RIVER	In the spring and summer of each year, large patches of submersed aquatic macrophytes overgrow the bottom of the alluvial Warta River downstream of a large dam reservoir owing to water management practices. Environmental variables, macroinvertebrates (zoobenthos and epiphytic fauna, zooplankton) and fish abundance and biomass were assessed at this biologically productive habitat to learn intraseasonal dynamics of food types, and their occurrence in the gut contents of small-sized roach, dace, perch, ruffe and three-spined stickleback. Gut fullness coefficient, niche breadth and niche overlap indicated how the fishes coexist in the macrophytes. Chironomidae dominated in the diet of the percids. However, ruffe consumed mostly benthic chironomids, while perch epiphytic chironomids and zooplankton. The diet of dace resembled that in fast flowing water although this rheophilic species occurred at unusual density there. The generalist roach displayed the lowest gut fullness coefficient values and widest niche breadth; consequently, intraspecific rather than interspecific competition decided the fate of roach. Three-spined stickleback differed from the other fishes by consuming epiphytic simuliids and fish eggs. The diet overlap between fishes reaching higher gut fullness coefficient values was rather low when the food associated with the submersed aquatic macrophytes was most abundant; this is congruent with the niche overlap hypothesis that maximal tolerable niche overlap can be higher in less intensely competitive conditions.	[Dukowska, Malgorzata; Grzybkowska, Maria] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90131 Lodz, Poland	University of Lodz	Dukowska, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90131 Lodz, Poland.	mdukow@biol.uni.lodz.pl		Grzybkowska, Maria/0000-0002-0581-3321; Dukowska, Malgorzata/0000-0003-1767-0759	University of Lodz [505/424]	University of Lodz	This work was supported by a grant of the University of Lodz No 505/424. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banbura J, 2000, FRESHWATER FISHES PO, P439; Barili E, 2011, ENVIRON BIOL FISH, V92, P41, DOI 10.1007/s10641-011-9814-2; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; BERGMAN E, 1988, J ANIM ECOL, V57, P443, DOI 10.2307/4916; Borcherding J, 2008, ECOL FRESHW FISH, V17, P207, DOI 10.1111/j.1600-0633.2007.00272.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chick JH, 1997, ECOL FRESHW FISH, V6, P27, DOI 10.1111/j.1600-0633.1997.tb00139.x; Clough S, 1997, J FISH BIOL, V50, P1117, DOI 10.1111/j.1095-8649.1997.tb01635.x; Danchin E., 2008, BEHAV ECOLOGY; de Nie H. W., 1987, 19 EIFACCECPI; Dieterich A, 2004, ECOL FRESHW FISH, V13, P236, DOI 10.1111/j.1600-0633.2004.00059.x; Dukowska M, 2013, ECOL MODEL, V265, P221, DOI 10.1016/j.ecolmodel.2013.06.022; Dukowska Malgorzata, 1999, Acta Hydrobiologica, V41, P219; Dukowska Malgorzata, 2005, Teka Komisji Ochrony i Ksztaltowania Srodowiska Przyrodniczego, V2, P48; Dukowska M, 2009, OCEANOL HYDROBIOL ST, V38, P39, DOI 10.2478/v10009-009-0020-x; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Feld CK, 2011, ADV ECOL RES, V44, P119, DOI 10.1016/B978-0-12-374794-5.00003-1; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Fullerton AH, 2006, ECOL FRESHW FISH, V15, P1, DOI 10.1111/j.1600-0633.2005.00114.x; Glowacki L, 2011, RIVER RES APPL, V27, P612, DOI 10.1002/rra.1380; Grenouillet G, 2001, J FISH BIOL, V59, P939; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; GRZYBKOWSKA M, 1990, ARCH HYDROBIOL, V119, P439; GRZYBKOWSKA M, 1991, Regulated Rivers Research and Management, V6, P257, DOI 10.1002/rrr.3450060404; Grzybkowska M, 2002, ANN ZOOL, V52, P235; Grzybkowska M., 1983, P C POL HYDR SOC LUB, P71; Grzybkowska Maria, 2003, Ecohydrology & Hydrobiology, V3, P399; Grzybkowska Maria, 1996, Acta Universitatis Lodziensis Folia Limnologica, V6, P47; Grzybkowska Maria, 1988, Acta Universitatis Lodziensis Folia Limnologica, V3, P85; Gunderson JL, 1998, J GREAT LAKES RES, V24, P165, DOI 10.1016/S0380-1330(98)70810-X; Horppila J, 2009, J FISH BIOL, V75, P1230, DOI 10.1111/j.1095-8649.2009.02359.x; Ibanez C, 2012, SCI TOTAL ENVIRON, V440, P132, DOI 10.1016/j.scitotenv.2012.07.073; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; Kleeberg A, 2010, FRESHWATER BIOL, V55, P326, DOI 10.1111/j.1365-2427.2009.02277.x; Kohler J, 2010, AQUAT BOT, V92, P129, DOI 10.1016/j.aquabot.2009.10.018; Kornijow R, 2005, FRESHWATER BIOL, V50, P262, DOI 10.1111/j.1365-2427.2004.01318.x; Kornijow R, 1997, HYDROBIOLOGIA, V342, P207, DOI 10.1023/A:1017067621668; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kruk A, 2007, J APPL ICHTHYOL, V23, P9, DOI 10.1111/j.1439-0426.2006.00784.x; Kruk A, 2003, ANN LIMNOL-INT J LIM, V39, P197, DOI 10.1051/limn/2003016; Kucharczyk D, 2008, DACE LEUCISCUS LEUCI; Li JM, 2010, ECOL MODEL, V221, P2076, DOI 10.1016/j.ecolmodel.2010.05.005; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Makino W, 2001, HYDROBIOLOGIA, V442, P309, DOI 10.1023/A:1017532717135; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Marszal Lidia, 1996, Polskie Archiwum Hydrobiologii, V43, P185; Nunn AD, 2007, J FISH BIOL, V70, P726, DOI 10.1111/j.1095-8649.2007.01334.x; Nurminen L, 2010, J FISH BIOL, V76, P1848, DOI 10.1111/j.1095-8649.2010.02600.x; OGLE DH, 1995, T AM FISH SOC, V124, P356, DOI 10.1577/1548-8659(1995)124<0356:DAFPOR>2.3.CO;2; Opuszynski K., 1983, BASICS FISH BIOL; Penczak T, 2005, J APPL ICHTHYOL, V21, P169, DOI 10.1111/j.1439-0426.2005.00649.x; Penczak T, 2000, ECOL FRESHW FISH, V9, P109, DOI 10.1034/j.1600-0633.2000.90113.x; Penczak T, 2012, ECOL MODEL, V227, P64, DOI 10.1016/j.ecolmodel.2011.12.006; Penczak T, 1998, HYDROBIOLOGIA, V368, P157, DOI 10.1023/A:1003246115666; PERSSON L, 1987, OECOLOGIA, V73, P170, DOI 10.1007/BF00377504; PETERSEN RC, 1989, ECOL MONOGR, V59, P21, DOI 10.2307/2937290; Petts G.E., 1984, IMPOUNDED RIVERS PER, DOI [10.1177/030913338601000116., DOI 10.1016/0006-3207(85)90110-7]; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PINDER LCV, 1992, HYDROBIOLOGIA, V248, P39, DOI 10.1007/BF00008884; Raat AJP, 2001, REGUL RIVER, V17, P131, DOI 10.1002/rrr.608; Rezsu E, 2006, ECOL FRESHW FISH, V15, P339, DOI 10.1111/j.1600-0633.2006.00172.x; Rosh R, 1996, ACTA ZOOL LITU, V19, P18; ROZAS LP, 1988, OECOLOGIA, V77, P101, DOI 10.1007/BF00380932; Satora M, 2013, FOOD NICHE OVERLAP 5; Schleuter D, 2008, ECOL FRESHW FISH, V17, P86, DOI 10.1111/j.1600-0633.2007.00262.x; Schleuter D, 2006, FRESHWATER BIOL, V51, P287, DOI 10.1111/j.1365-2427.2005.01495.x; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Schulze T, 2012, LIMNOLOGICA, V42, P56, DOI 10.1016/j.limno.2011.08.001; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Tadajewska M., 2000, FRESHWATER FISHES PO, P311; Tarvainen M, 2005, FRESHWATER BIOL, V50, P447, DOI 10.1111/j.1365-2427.2005.01331.x; TOKESHI M, 1985, HOLARCTIC ECOL, V8, P313; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Ward JS, 1980, P S SURF WAT IMP ASC; Zar JH., 1999, BIOSTAT ANAL	76	13	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109927	10.1371/journal.pone.0109927	http://dx.doi.org/10.1371/journal.pone.0109927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365420	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100011
J	Fazzini, A; D'Antongiovanni, V; Giusti, L; Da Valle, Y; Ciregia, F; Piano, I; Caputo, A; D'Ursi, AM; Gargini, C; Lucacchini, A; Mazzoni, MR				Fazzini, Alessandra; D'Antongiovanni, Vanessa; Giusti, Laura; Da Valle, Ylenia; Ciregia, Federica; Piano, Ilaria; Caputo, Antonella; D'Ursi, Anna Maria; Gargini, Claudia; Lucacchini, Antonio; Mazzoni, Maria Rosa			Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the beta-Catenin Gene	PLOS ONE			English	Article							THROMBIN RECEPTOR; COUPLED RECEPTORS; MOLECULAR-CLONING; LUNG-CANCER; THROMBOMODULIN; CARCINOMA; INVASION; CAVEOLAE; PAR1; INTERNALIZATION	Protease activated receptors (PARs) are G-protein coupled receptors that are activated by an unique proteolytic mechanism. These receptors play crucial roles in hemostasis and thrombosis but also in inflammation and vascular development. PARs have also been implicated in tumor progression, invasion and metastasis. In this study, we investigated expression and signaling of PAR(1) in nonmalignant pleural mesothelial (Met-5A) and malignant pleural mesothelioma (NCI-H28) cells. We found that the expression level of PAR(1) was markedly higher in NCI-H28 cells compared to Met-5A and human primary mesothelial cells. Other three malignant pleural mesothelioma cell lines, i.e. REN, Ist-Mes2, and Mero-14, did not show any significant PAR(1) over-expression compared to Met-5A cell line. Thrombin and PAR(1) activating peptides enhanced Met-5A and NCI-H28 cell proliferation but in NCI-H28 cells higher thrombin concentrations were required to obtain the same proliferation increase. Similarly, thrombin caused extracellular signal-regulated kinase 1/2 activation in both cell lines but NCI-H28 cells responded at higher agonist concentrations. We also determined that PAR(1) signaling through G(q) and G(12/13) proteins is severely altered in NCI-H28 cells compared to Met-5A cells. On the contrary, PAR(1) signaling through G(i) proteins was persistently maintained in NCI-H28 cells. Furthermore, we demonstrated a reduction of cell surface PAR(1) expression in NCI-H28 and malignant pleural mesothelioma REN cells. Thus, our results provide evidences for dysfunctional PAR(1) signaling in NCI-H28 cells together with reduced plasma membrane localization. The role of PAR(1) in mesothelioma progression is just emerging and our observations can promote further investigations focused on this G-protein coupled receptor.	[Fazzini, Alessandra; D'Antongiovanni, Vanessa; Giusti, Laura; Da Valle, Ylenia; Ciregia, Federica; Piano, Ilaria; Caputo, Antonella; Gargini, Claudia; Lucacchini, Antonio; Mazzoni, Maria Rosa] Univ Pisa, Dept Pharm, Pisa, Italy; [D'Ursi, Anna Maria] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy	University of Pisa; University of Salerno	Mazzoni, MR (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	maria.mazzoni@farm.unipi.it	Mazzoni, Maria Rosa/AAA-2366-2022; Ciregia, Federica/K-6612-2016; D'Ursi, Anna M/E-8557-2016	Ciregia, Federica/0000-0002-5851-9249; D'Ursi, Anna M/0000-0001-6814-8472; D'ANTONGIOVANNI, Vanessa/0000-0002-3303-0674; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086; Mazzoni, Maria Rosa/0000-0003-2612-432X; LUCACCHINI, ANTONIO/0000-0002-0917-4491; piano, ilaria/0000-0002-5073-7583; Giusti, Laura/0000-0001-7366-1932	Italian Board of Health [RF-2009-1529895]; University of Pisa grants	Italian Board of Health; University of Pisa grants	This work was supported by Italian Board of Health grant RF-2009-1529895 (A. Lucacchini), and University of Pisa grants (A. Lucacchini and M. R. Mazzoni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Asteriti S, 2012, BRIT J PHARMACOL, V167, P80, DOI 10.1111/j.1476-5381.2012.01974.x; Bar-Shavit R, 2011, IUBMB LIFE, V63, P397, DOI 10.1002/iub.452; Belling F, 2013, INT J ARTIF ORGANS, V36, P97, DOI 10.5301/ijao.5000174; Blackhart BD, 2000, MOL PHARMACOL, V58, P1178, DOI 10.1124/mol.58.6.1178; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; D'Ursi AM, 2006, MOL PHARMACOL, V69, P727, DOI 10.1124/mol.105.017715; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Keshava S, 2013, CANCER RES, V73, P3963, DOI 10.1158/0008-5472.CAN-12-1690; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Li T, 2011, J PATHOL, V223, P519, DOI 10.1002/path.2829; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Matsushita Y, 1998, CANCER LETT, V127, P195, DOI 10.1016/S0304-3835(98)00038-X; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Nguyen D, 2008, ANN THORAC SURG, V85, P1032, DOI 10.1016/j.athoracsur.2007.11.064; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pinton G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014110; Porchia F, 2008, J RECEPT SIG TRANSD, V28, P265, DOI [10.1080/10799890802084515, 10.1080/10799890802084515 ]; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111550	10.1371/journal.pone.0111550	http://dx.doi.org/10.1371/journal.pone.0111550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364818	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100074
J	Liu, DL; Li, Y; Zhao, J; Deng, F; Duan, XM; Kou, C; Wu, T; Li, YJ; Wang, YX; Ma, J; Yang, JH; Hu, ZH; Zhang, FC; Zhang, YJ; Sun, SR				Liu, Dongliang; Li, Yang; Zhao, Jing; Deng, Fei; Duan, Xiaomei; Kou, Chun; Wu, Ting; Li, Yijie; Wang, Yongxing; Ma, Ji; Yang, Jianhua; Hu, Zhihong; Zhang, Fuchun; Zhang, Yujiang; Sun, Surong			Fine Epitope Mapping of the Central Immunodominant Region of Nucleoprotein from Crimean-Congo Hemorrhagic Fever Virus (CCHFV)	PLOS ONE			English	Article							B-CELL EPITOPES; RECOMBINANT NUCLEOPROTEIN; NUCLEOCAPSID PROTEIN; ANTIBODY DETECTION; EPIDEMIOLOGY; INTRABODIES; REPLICATION; EXPRESSION; PREDICTION; INDUCTION	Crimean-Congo hemorrhagic fever (CCHF), a severe viral disease known to have occurred in over 30 countries and distinct regions, is caused by the tick-borne CCHF virus (CCHFV). Nucleocapsid protein (NP), which is encoded by the S gene, is the primary antigen detectable in infected cells. The goal of the present study was to map the minimal motifs of B-cell epitopes (BCEs) on NP. Five precise BCEs (E1, (247)FDEAKK(252); E2a, (254)VEAL(257); E2b, (258)NGYLNKH(264); E3, (267)EVDKA(271); and E4, (DSMITN279)-D-274) identified through the use of rabbit antiserum, and one BCE (E5, (258)NGYL(261)) recognized using a mouse monoclonal antibody, were confirmed to be within the central region of NP and were partially represented among the predicted epitopes. Notably, the five BCEs identified using the rabbit sera were able to react with positive serum mixtures from five sheep which had been infected naturally with CCHFV. The multiple sequence alignment (MSA) revealed high conservation of the identified BCEs among ten CCHFV strains from different areas. Interestingly, the identified BCEs with only one residue variation can apparently be recognized by the positive sera of sheep naturally infected with CCHFV. Computer-generated three-dimensional structural models indicated that all the antigenic motifs are located on the surface of the NP stalk domain. This report represents the first identification and mapping of the minimal BCEs of CCHFV-NP along with an analysis of their primary and structural properties. Our identification of the minimal linear BCEs of CCHFV-NP may provide fundamental data for developing rapid diagnostic reagents and illuminating the pathogenic mechanism of CCHFV.	[Liu, Dongliang; Li, Yang; Zhao, Jing; Duan, Xiaomei; Kou, Chun; Wu, Ting; Li, Yijie; Wang, Yongxing; Ma, Ji; Yang, Jianhua; Zhang, Fuchun; Sun, Surong] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Xinjiang, Peoples R China; [Deng, Fei; Hu, Zhihong] Chinese Acad Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Zhang, Yujiang] Ctr Dis Control & Prevent Xinjiang Uyghur Autonom, Urumqi, Xinjiang, Peoples R China; [Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Xinjiang University; Chinese Academy of Sciences; Baylor College of Medicine; Texas Children's Cancer Center	Zhang, YJ (corresponding author), Ctr Dis Control & Prevent Xinjiang Uyghur Autonom, Urumqi, Xinjiang, Peoples R China.	xjsyzhang@163.com; sr_sun2005@163.com	Hu, Zhihong/AAS-2215-2020; Liu, Dongliang/AAP-6335-2021; Liu, Dongliang/AAM-9595-2021	Hu, Zhihong/0000-0002-1560-0928; Liu, Dongliang/0000-0001-5843-5451; Liu, Dongliang/0000-0001-5843-5451	Science and Technology Basic Work Program from Ministry of Science and Technology of China [2013FY113500]; National Science Foundation of China [81460303, 30860225]; Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering [XJDX020l-2014-04]	Science and Technology Basic Work Program from Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering	This work was supported partly by Science and Technology Basic Work Program 2013FY113500 from Ministry of Science and Technology of China, the National Science Foundation of China (grant no. 81460303, 30860225), and the Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering (grant no. XJDX020l-2014-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Burt FJ, 2013, J VIROL METHODS, V193, P706, DOI 10.1016/j.jviromet.2013.07.055; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chinikar S, 2009, IRAN J MICROBIOL, V1, P7; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Dai Xiang, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1048; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Dowall SD, 2012, J VIROL METHODS, V179, P335, DOI 10.1016/j.jviromet.2011.11.020; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Garcia S, 2006, J CLIN VIROL, V35, P154, DOI 10.1016/j.jcv.2005.02.016; Garnier J., 1989, PREDICTION PROTEIN S, P417; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Gurbuz Yunus, 2009, Int J Infect Dis, V13, pe105, DOI 10.1016/j.ijid.2008.08.002; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KINTS JP, 1989, J IMMUNOL METHODS, V119, P241, DOI 10.1016/0022-1759(89)90402-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladner Robert C, 2007, Biotechnol Genet Eng Rev, V24, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Dongliang, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P838; Lo A. S. -Y., 2008, V181, P343; Lundkvist A, 2002, VIRAL IMMUNOL, V15, P177, DOI 10.1089/088282402317340323; Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; Merrifield RB, 1968, ADV ENZYMOL RELAT AR, V32, P221; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; Moutel Sandrine, 2012, Methods Mol Biol, V907, P667, DOI 10.1007/978-1-61779-974-7_37; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; ROBERTS BL, 1992, P NATL ACAD SCI USA, V89, P2429, DOI 10.1073/pnas.89.6.2429; Saijo M, 2005, J MED VIROL, V75, P295, DOI 10.1002/jmv.20270; Saijo M, 2002, J CLIN MICROBIOL, V40, P1587, DOI 10.1128/JCM.40.5.1587-1591.2002; Samudzi RR, 2012, J VIROL METHODS, V179, P70, DOI 10.1016/j.jviromet.2011.09.023; Schwarz TF, 1996, J MED VIROL, V49, P83, DOI 10.1002/(SICI)1096-9071(199606)49:2&lt;83::AID-JMV2&gt;3.0.CO;2-F; Srinivasan Pappu, 2011, Frontiers in Genetics, V2, P72, DOI 10.3389/fgene.2011.00072; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Sun SR, 2009, J CLIN MICROBIOL, V47, P2536, DOI 10.1128/JCM.00265-09; Tang Q, 2003, CLIN DIAGN LAB IMMUN, V10, P489, DOI 10.1128/CDLI.10.3.489-491.2003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Wei Peng-fei, 2010, Virologica Sinica, V25, P45, DOI 10.1007/s12250-010-3067-7; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; *WHO, 2001, CRIM CONG HAEM FEV; Xu WX, 2012, AM J REPROD IMMUNOL, V68, P465, DOI 10.1111/j.1600-0897.2012.01177.x; Xu WX, 2009, J REPROD IMMUNOL, V81, P9, DOI 10.1016/j.jri.2009.04.004; Xu WX, 2012, MAPPING MINIMAL MOTI; Zhang ZW, 2010, VET MICROBIOL, V140, P25, DOI 10.1016/j.vetmic.2009.07.011; Zhou ZR, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00571-13	58	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e108419	10.1371/journal.pone.0108419	http://dx.doi.org/10.1371/journal.pone.0108419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365026	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100004
J	Chaudhary, VK; Shrivastava, N; Verma, V; Das, S; Kaur, C; Grover, P; Gupta, A				Chaudhary, Vijay K.; Shrivastava, Nimisha; Verma, Vaishali; Das, Shilpi; Kaur, Charanpreet; Grover, Payal; Gupta, Amita			Rapid Restriction Enzyme-Free Cloning of PCR Products: A High-Throughput Method Applicable for Library Construction	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; DNA-POLYMERASE; EXPRESSION; RECOMBINATION; SYSTEM	Herein, we describe a novel cloning strategy for PCR-amplified DNA which employs the type IIs restriction endonuclease Bsal to create a linearized vector with four base-long 5'-overhangs, and T4 DNA polymerase treatment of the insert in presence of a single dNTP to create vector-compatible four base-long overhangs. Notably, the insert preparation does not require any restriction enzyme treatment. The BsaI sites in the vector are oriented in such a manner that upon digestion with BsaI, a stuffer sequence along with both BsaI recognition sequences is removed. The sequence of the four base-long overhangs produced by BsaI cleavage were designed to be non-palindromic, non-compatible to each other. Therefore, only ligation of an insert carrying compatible ends allows directional cloning of the insert to the vector to generate a recombinant without recreating the BsaI sites. We also developed rapid protocols for insert preparation and cloning, by which the entire process from PCR to transformation can be completed in 6-8 h and DNA fragments ranging in size from 200 to 2200 bp can be cloned with equal efficiencies. One protocol uses a single tube for insert preparation if amplification is performed using polymerases with low 3'-exonuclease activity. The other protocol is compatible with any thermostable polymerase, including those with high 3'-exonuclease activity, and does not significantly increase the time required for cloning. The suitability of this method for high-throughput cloning was demonstrated by cloning batches of 24 PCR products with nearly 100% efficiency. The cloning strategy is also suitable for high efficiency cloning and was used to construct large libraries comprising more than 10(8) clones/mu g vector. Additionally, based on this strategy, a variety of vectors were constructed for the expression of proteins in E. coli, enabling large number of different clones to be rapidly generated.	[Chaudhary, Vijay K.; Shrivastava, Nimisha; Verma, Vaishali; Das, Shilpi; Kaur, Charanpreet; Grover, Payal] Univ Delhi, Dept Biochem, New Delhi 110021, India; [Gupta, Amita] Univ Delhi, Dept Microbiol, New Delhi 110021, India	University of Delhi; University of Delhi	Chaudhary, VK (corresponding author), Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi 110021, India.	vkchaudhary@south.du.ac.in; amitagupta@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India to VKC and AG. VV is the recipient of a research fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Berrow Nick S., 2009, V498, P75, DOI 10.1007/978-1-59745-196-3_5; CHOWDHURY PS, 1994, PROTEIN EXPRES PURIF, V5, P89, DOI 10.1006/prep.1994.1013; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Geng LA, 2006, MOL BIOTECHNOL, V33, P23; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075212; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kotera I, 2008, J BIOTECHNOL, V137, P1, DOI 10.1016/j.jbiotec.2008.07.1816; Kumar K, 2012, ARCH VIROL, V157, P1949, DOI 10.1007/s00705-012-1389-5; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhou M Y, 2000, Curr Issues Mol Biol, V2, P1	22	9	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111538	10.1371/journal.pone.0111538	http://dx.doi.org/10.1371/journal.pone.0111538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360695	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700115
J	Gottardo, MF; Jaita, G; Magri, ML; Zarate, S; Ayala, MM; Ferraris, J; Eijo, G; Pisera, D; Candolfi, M; Seilicovich, A				Florencia Gottardo, Maria; Jaita, Gabriela; Laura Magri, Maria; Zarate, Sandra; Moreno Ayala, Mariela; Ferraris, Jimena; Eijo, Guadalupe; Pisera, Daniel; Candolfi, Marianela; Seilicovich, Adriana			Antiapoptotic Factor Humanin Is Expressed in Normal and Tumoral Pituitary Cells and Protects Them from TNF-alpha-Induced Apoptosis	PLOS ONE			English	Article							CYTOPROTECTIVE PEPTIDE HUMANIN; NEUROPROTECTIVE FACTOR; DEATH; GLAND; ESTROGENS; STRESS; BAX; ACTIVATION; RECEPTORS; SURVIVAL	Humanin (HN) is a 24-amino acid peptide with cytoprotective action in several cell types such as neurons and testicular germ cells. Rattin (HNr), a homologous peptide of HN expressed in several adult rat tissues, also has antiapoptotic action. In the present work, we demonstrated by immunocytochemical analysis and flow cytometry the expression of HNr in the anterior pituitary of female and male adult rats as well as in pituitary tumor GH3 cells. HNr was localized in lactotropes and somatotropes. The expression of HNr was lower in females than in males, and was inhibited by estrogens in pituitary cells from both ovariectomized female and orquidectomized male rats. However, the expression of HNr in pituitary tumor cells was not regulated by estrogens. We also evaluated HN action on the proapoptotic effect of TNF-alpha in anterior pituitary cells assessed by the TUNEL method. HN (5 mu M) per se did not modify basal apoptosis of anterior pituitary cells but completely blocked the proapoptotic effect of TNF-alpha in total anterior pituitary cells, lactotropes and somatotropes from both female and male rats. Also, HN inhibited the apoptotic effect of TNF-alpha on pituitary tumor cells. In summary, our results demonstrate that HNr is present in the anterior pituitary gland, its expression showing sexual dimorphism, which suggests that gonadal steroids may be involved in the regulation of HNr expression in this gland. Antiapoptotic action of HN in anterior pituitary cells suggests that this peptide could be involved in the homeostasis of this gland. HNr is present and functional in GH3 cells, but it lacks regulation by estrogens, suggesting that HN could participate in the pathogenesis of pituitary tumors.	[Florencia Gottardo, Maria; Jaita, Gabriela; Laura Magri, Maria; Zarate, Sandra; Moreno Ayala, Mariela; Ferraris, Jimena; Eijo, Guadalupe; Pisera, Daniel; Candolfi, Marianela; Seilicovich, Adriana] Univ Buenos Aires, Inst Invest Biomed, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Seilicovich, A (corresponding author), Univ Buenos Aires, Inst Invest Biomed, CONICET, Buenos Aires, DF, Argentina.	adyseili@fmed.uba.ar		Ferraris, Jimena/0000-0001-7472-0439	Consejo de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 159]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 053]; University of Buenos Aires, Argentina [M054]	Consejo de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); University of Buenos Aires, Argentina(University of Buenos Aires)	This work was funded by the Consejo de Investigaciones Cientificas y Tecnicas (CONICET, grant PIP 159), Agencia Nacional de Promocion Cientifica y Tecnica (grant PICT 053) and University of Buenos Aires (grant M054), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Caricasole A, 2002, FASEB J, V16, P1331, DOI 10.1096/fj.02-0018fje; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Ferraris J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097383; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hanisch A, 2000, J CLIN ENDOCR METAB, V85, P4411, DOI 10.1210/jc.85.11.4411; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2004, EUR J NEUROSCI, V19, P2357, DOI 10.1111/j.1460-9568.2004.03298.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Klein LE, 2013, BIOCHEM BIOPH RES CO, V440, P197, DOI 10.1016/j.bbrc.2013.08.055; Liu W, 2014, CNS NEUROSCI THER, V20, P95, DOI 10.1111/cns.12211; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Maftei M, 2012, J PEPT SCI, V18, P373, DOI 10.1002/psc.2404; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Moretti E, 2010, FERTIL STERIL, V94, P2888, DOI 10.1016/j.fertnstert.2010.04.075; Mottaghi-Dastjerdi N, 2014, DARU, V22, DOI 10.1186/2008-2231-22-14; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Perez-Castro C, 2012, PHYSIOL REV, V92, P1, DOI 10.1152/physrev.00003.2011; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Takeshita Y, 2013, J BIOL CHEM, V288, P24691, DOI 10.1074/jbc.M113.469692; Widmer RJ, 2013, AM J PHYSIOL-HEART C, V304, pH393, DOI 10.1152/ajpheart.00765.2012; Yadav VK, 2004, MOL HUM REPROD, V10, P629, DOI 10.1093/molehr/gah089; Yang ZK, 2008, NEUROCHEM INT, V52, P1176, DOI 10.1016/j.neuint.2007.12.008; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zacharias DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031065; Zapala B, 2010, PHARMACOL REP, V62, P767, DOI 10.1016/S1734-1140(10)70337-6; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zarate S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041299; Zarate S, 2010, NEUROENDOCRINOLOGY, V92, P215, DOI 10.1159/000321683; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	48	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111548	10.1371/journal.pone.0111548	http://dx.doi.org/10.1371/journal.pone.0111548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360890	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700118
J	Marchione, P; Morreale, M; Giacomini, P; Izzo, C; Pontecorvo, S; Altieri, M; Bernardi, S; Frontoni, M; Francia, A				Marchione, Pasquale; Morreale, Manuela; Giacomini, Patrizia; Izzo, Chiara; Pontecorvo, Simona; Altieri, Marta; Bernardi, Silvia; Frontoni, Marco; Francia, Ada			Ultrasonographic Evaluation of Cerebral Arterial and Venous Haemodynamics in Multiple Sclerosis: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR AUTONOMIC DYSFUNCTION; BLOOD-FLOW; WHITE-MATTER; BRAIN; INSUFFICIENCY; PERFUSION; CCSVI; PREVALENCE; VENOGRAPHY; DISABILITY	Objective: Although recent studies excluded an association between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis (MS), controversial results account for some cerebrovascular haemodynamic impairment suggesting a dysfunction of cerebral autoregulation mechanisms. The aim of this cross-sectional, case-control study is to evaluate cerebral arterial inflow and venous outflow by means of a non-invasive ultrasound procedure in Relapsing Remitting (RR), Primary Progressive (PP) Multiple Sclerosis and age and sex-matched controls subjects. Material and Methods: All subjects underwent a complete extra-intracranial arterial and venous ultrasound assessment with a color-coded duplex sonography scanner and a transcranial doppler equipment, in both supine and sitting position by means of a tilting chair. Basal arterial and venous morphology and flow velocities, postural changes in mean flow velocities (MFV) of middle cerebral arteries (MCA), differences between cerebral venous outflow (CVF) in clinostatism and in the seated position (DCVF) and non-invasive cerebral perfusion pressure (CPP) were evaluated. Results: 85 RR-MS, 83 PP-MS and 82 healthy controls were included. DCVF was negative in 45/85 (52.9%) RR-MS, 63/83 (75.9%) PP-MS (p = 0.01) and 11/82 (13.4%) controls (p<0.001), while MFVs on both MCAs in sitting position were significantly reduced in RR-MS and PP-MS patients than in control, particularly in EDSS >= 5 subgroup (respectively, 42/50, 84% vs. 66/131, 50.3%, p<0.01 and 48.3 +/- 2 cm/s vs. 54.6 +/- 3 cm/s, p = 0.01). No significant differences in CPP were observed within and between groups. Conclusions: The quantitative evaluation of cerebral blood flow (CBF) and CVF and their postural dependency may be related to a dysfunction of autonomic nervous system that seems to characterize more disabled MS patients. It's not clear whether the altered postural control of arterial inflow and venous outflow is a specific MS condition or simply an "epiphenomenon'' of neurodegenerative events.	[Marchione, Pasquale; Morreale, Manuela; Giacomini, Patrizia; Izzo, Chiara] Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Neurol Sect, Neurovasc Diag Unit, I-00185 Rome, Italy; [Marchione, Pasquale; Izzo, Chiara] Inst Neurosci, Neurol Ctr Latium, Dept Clin Neurosci, Rome, Italy; [Morreale, Manuela; Pontecorvo, Simona; Altieri, Marta; Bernardi, Silvia; Frontoni, Marco; Francia, Ada] Univ Roma La Sapienza, Multiple Sclerosis Ctr, Dept Neurol & Psychiat, I-00185 Rome, Italy; [Pontecorvo, Simona] Ist Ric & Cura Carattere Sci Neuromed, Pozzilli, Isernia, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed	Morreale, M (corresponding author), Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Neurol Sect, Neurovasc Diag Unit, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	manuelamorreale@yahoo.it	altieri, marta/AAV-6678-2021	Pontecorvo, Simona/0000-0002-4256-2568; Francia, Ada/0000-0002-9550-9082; bernardi, silvia/0000-0002-1050-3096	Merck Serono; Teva; Novartis; Bayer Schering; Sanofi-Aventis; Biogen Idec	Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Novartis(Novartis); Bayer Schering(Bayer AG); Sanofi-Aventis(Sanofi-Aventis); Biogen Idec(Biogen)	PM, CI and PG have no potential conflicts of interest to disclose. MM, SP, MA, SB, MF and AF have no financial activities related to the present article to disclose and received payment for travel, accommodations, or meeting expenses from Merck Serono, Teva, Novartis, Bayer Schering, Sanofi-Aventis, and Biogen Idec. SP, MF and AF received payment for lectures including service on speakers bureaus from Merck Serono, Teva, Novartis, Sanofi-Aventis, and Biogen Idec. Declared financial activities do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALLEN IV, 1981, NEUROPATH APPL NEURO, V7, P169, DOI 10.1111/j.1365-2990.1981.tb00087.x; Baracchini C, 2012, J NEUROL, V259, P2585, DOI 10.1007/s00415-012-6541-3; Charcot JM, 1868, GAZETTE HO PITAUX, V41; Comi G, 2013, NEUROL SCI, V34, P1297, DOI 10.1007/s10072-012-1269-5; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; Dorfler P, 2000, J CEREBR BLOOD F MET, V20, P269; Ertl-Wagner B, 2012, MULT SCLER J, V18, P1000, DOI 10.1177/1352458511432742; Flachenecker P, 1999, J NEUROL, V246, P578, DOI 10.1007/s004150050407; Flachenecker P, 2001, MULT SCLER, V7, P327, DOI 10.1177/135245850100700509; Frontoni M, 1996, ACTA NEUROL SCAND, V93, P241; Garaci FG, 2012, RADIOLOGY, V265, P233, DOI 10.1148/radiol.12112245; Gonul M, 2008, EUR J NEUROL, V15, P725, DOI 10.1111/j.1468-1331.2008.02179.x; Heckmann JG, 1999, NEUROL RES, V21, P457, DOI 10.1080/01616412.1999.11740959; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Labuz-Roszak B, 2007, CLIN AUTON RES, V17, P375, DOI 10.1007/s10286-007-0443-y; LACHENECKER P, 2001, MULT SCLER, V7, P327; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Mancini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092730; Monti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025012; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1933, NEW ENGL J MED, V209, P786, DOI 10.1056/NEJM193310192091604; Reekers J, 2014, CARDIOVASC INTER RAD, V37, P287, DOI 10.1007/s00270-013-0833-6; Saari A, 2004, CLIN NEUROPHYSIOL, V115, P1473, DOI 10.1016/j.clinph.2004.01.012; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; SCHELLING F, 1986, MED HYPOTHESES, V21, P141, DOI 10.1016/0306-9877(86)90003-4; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Stolz E, 2001, J NEUROIMAGING, V11, P385, DOI 10.1111/j.1552-6569.2001.tb00067.x; Sun X, 1998, Ann Nucl Med, V12, P89; Talbert DG, 2008, MED HYPOTHESES, V70, P1112, DOI 10.1016/j.mehy.2007.10.009; Tan IL, 2000, AM J NEURORADIOL, V21, P1039; Traboulsee AL, 2014, LANCET, V383, P138, DOI 10.1016/S0140-6736(13)61747-X; Valdueza JM, 2000, LANCET, V355, P200; Valdueza JM, 2013, J CEREBR BLOOD F MET, V33, P657, DOI 10.1038/jcbfm.2013.31; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; VITA G, 1993, J NEUROL SCI, V120, P82, DOI 10.1016/0022-510X(93)90029-X; Wilson TD, 2005, J CEREBR BLOOD F MET, V25, P136, DOI 10.1038/sj.jcbfm.9600015; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589	41	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111486	10.1371/journal.pone.0111486	http://dx.doi.org/10.1371/journal.pone.0111486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360597	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700106
J	Mychajliw, AM; Harrison, RG				Mychajliw, Alexis M.; Harrison, Richard G.			Genetics Reveal the Origin and Timing of a Cryptic Insular Introduction of Muskrats in North America	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; SOFTWARE; MUTATION; BOTTLENECK; NUMBER; REDUCTIONS; ALLELES; MAMMALS; GROWTH	The muskrat, Ondatra zibethicus, is a semiaquatic rodent native to North America that has become a highly successful invader across Europe, Asia, and South America. It can inflict ecological and economic damage on wetland systems outside of its native range. Anecdotal evidence suggests that, in the early 1900s, a population of muskrats was introduced to the Isles of Shoals archipelago, located within the Gulf of Maine, for the purposes of fur harvest. However, because muskrats are native to the northeastern coast of North America, their presence on the Isles of Shoals could be interpreted as part of the native range of the species, potentially obscuring management planning and biogeographic inferences. To investigate their introduced status and identify a historic source population, muskrats from Appledore Island of the Isles of Shoals, and from the adjacent mainland of Maine and New Hampshire, were compared for mitochondrial cytochrome b sequences and allele frequencies at eight microsatellite loci. Appledore Island muskrats consistently exhibited reduced genetic diversity compared with mainland populations, and displayed signatures of a historic bottleneck. The distribution of mitochondrial haplotypes is suggestive of a New Hampshire source population. The data presented here are consistent with a human-mediated introduction that took place in the early 1900s. This scenario is further supported by the zooarchaeological record and island biogeographic patterns. This is the first genetic study of an introduced muskrat population within US borders and of any island muskrat population, and provides an important contrast with other studies of introduced muskrat populations worldwide.	[Mychajliw, Alexis M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Harrison, Richard G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Stanford University; Cornell University	Mychajliw, AM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	amychajl@stanford.edu			Biology Research Fellowship Program of Cornell University; Hunter R. Rawlings III Cornell Presidential Research Scholarship; Dextra Undergraduate Research Endowment Fund at Cornell University	Biology Research Fellowship Program of Cornell University; Hunter R. Rawlings III Cornell Presidential Research Scholarship; Dextra Undergraduate Research Endowment Fund at Cornell University	The Biology Research Fellowship Program of Cornell University (http://biology.cornell.edu/biology-research-fellows-program), Hunter R. Rawlings III Cornell Presidential Research Scholarship (http://www.commitment.cornell.edu/cprs/default.php), and Dextra Undergraduate Research Endowment Fund at Cornell University (http://cals.cornell.edu/academics/student-research/undergraduate-grants-proposal/) provided funding to AMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery JD, 2013, MOL ECOL, V22, P2313, DOI 10.1111/mec.12236; Barun A, 2013, BIOL INVASIONS, V15, P2243, DOI 10.1007/s10530-013-0447-6; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BLOOM AL, 1963, AM J SCI, V261, P862, DOI 10.2475/ajs.261.9.862; Borror AC, 2009, BORRORS SPECIES CHEC; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conroy Chris J., 1999, Journal of Mammalian Evolution, V6, P221, DOI 10.1023/A:1020561623890; Cook JA, 2010, J MAMMAL, V91, P1401, DOI 10.1644/09-MAMM-A-386.1; Cornuet JM, 1996, GENETICS, V144, P2001; CROWELL KL, 1986, BIOL J LINN SOC, V28, P37, DOI 10.1111/j.1095-8312.1986.tb01748.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fu YX, 1997, GENETICS, V147, P915; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Harrington F, 1988, CONTEXT, V6, P13; Harrington F, 1990, PRELIMINARY REPORT 1; Hartl D., 1989, PRINCIPLES POPULATIO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helgen KM, 2008, J MAMMAL, V89, P282, DOI 10.1644/07-MAMM-A-155R.1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; KIMURA M, 1964, GENETICS, V49, P725; Laurence S, 2009, MOL ECOL RESOUR, V9, P654, DOI 10.1111/j.1755-0998.2008.02501.x; Laurence S, 2011, J HERED, V102, P688, DOI 10.1093/jhered/esr071; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long JL, 2003, INTRO MAMMALS WORLD; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Lyman E, 1984, THESIS U NEW HAMPSHI; Manville Richard H., 1942, JOUR MAMMAL, V23, P391, DOI 10.2307/1375049; Marshall JCJ, 2009, CONSERV GENET, V10, P465, DOI 10.1007/s10592-008-9624-z; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nichols WF, 2008, RHODORA, V110, P245, DOI 10.3119/07-14.1; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider S, 1999, GENETICS, V152, P1079; Simberloff D, 2009, BIOL INVASIONS, V11, P1735, DOI 10.1007/s10530-008-9400-5; SLATKIN M, 1995, GENETICS, V139, P457; Spear SF, 2006, CONSERV GENET, V7, P605, DOI 10.1007/s10592-005-9095-4; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Thaxter C, 1873, ISLES SHOALS; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	56	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111856	10.1371/journal.pone.0111856	http://dx.doi.org/10.1371/journal.pone.0111856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360617	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700155
J	Weaver, J; Watts, T; Li, PW; Rye, HS				Weaver, Jeremy; Watts, Tylan; Li, Pingwei; Rye, Hays S.			Structural Basis of Substrate Selectivity of E. coli Prolidase	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; AMINOPEPTIDASE-P; PROLINE DIPEPTIDASE; ENZYMATIC FUNCTION; PYROCOCCUS; PURIFICATION; GENE; IDENTIFICATION; DEFICIENCY; METABOLISM	Prolidases, metalloproteases that catalyze the cleavage of Xaa-Pro dipeptides, are conserved enzymes found in prokaryotes and eukaryotes. In humans, prolidase is crucial for the recycling of collagen. To further characterize the essential elements of this enzyme, we utilized the Escherichia coli prolidase, PepQ, which shares striking similarity with eukaryotic prolidases. Through structural and bioinformatic insights, we have extended previous characterizations of the prolidase active site, uncovering a key component for substrate specificity. Here we report the structure of E. coli PepQ, solved at 2.0 angstrom resolution. The structure shows an antiparallel, dimeric protein, with each subunit containing N-terminal and C-terminal domains. The C-terminal domain is formed by the pita-bread fold typical for this family of metalloproteases, with two Mg(II) ions coordinated by five amino-acid ligands. Comparison of the E. coli PepQ structure and sequence with homologous structures and sequences from a diversity of organisms reveals distinctions between prolidases from Gram-positive eubacteria and archaea, and those from Gram-negative eubacteria, including the presence of loop regions in the E. coli protein that are conserved in eukaryotes. One such loop contains a completely conserved arginine near the catalytic site. This conserved arginine is predicted by docking simulations to interact with the C-terminus of the substrate dipeptide. Kinetic analysis using both a charge-neutralized substrate and a charge-reversed variant of PepQ support this conclusion, and allow for the designation of a new role for this key region of the enzyme active site.	[Weaver, Jeremy; Watts, Tylan; Li, Pingwei; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM065421) to H. S. R. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberto ME, 2011, INORG CHEM, V50, P3394, DOI 10.1021/ic1022517; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; Besio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058792; BROWNE P, 1983, J BIOL CHEM, V258, P6147; Cheng TC, 1998, ANN NY ACAD SCI, V864, P253, DOI 10.1111/j.1749-6632.1998.tb10316.x; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO F, 1989, J INHERIT METAB DIS, V12, P351, DOI 10.1007/BF01799240; FernandezEspla MD, 1997, APPL ENVIRON MICROB, V63, P314; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forlino A, 2002, HUM GENET, V111, P314, DOI 10.1007/s00439-002-0792-5; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Ghosh M, 1998, J BACTERIOL, V180, P4781, DOI 10.1128/JB.180.18.4781-4789.1998; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hu KK, 2009, BBA-PROTEINS PROTEOM, V1794, P1715, DOI 10.1016/j.bbapap.2009.08.005; ITO Y, 1984, J BIOCHEM-TOKYO, V96, P1; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jalving R, 2002, MOL GENET GENOMICS, V267, P218, DOI 10.1007/s00438-002-0655-8; Jun X, 2011, J BACTERIOL, V193, P4297, DOI 10.1128/JB.05345-11; Jung JH, 2012, J BACTERIOL, V194, P4434, DOI 10.1128/JB.00824-12; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kitchener RL, 2012, J APPL MICROBIOL, V113, P233, DOI 10.1111/j.1365-2672.2012.05310.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecompte O, 2001, GENOME RES, V11, P981, DOI 10.1101/gr.GR1653R; Ledoux P, 1996, AM J HUM GENET, V59, P1035; LEDOUX P, 1994, AM J HUM GENET, V54, P1014; Lee HS, 2011, J BACTERIOL, V193, P3666, DOI 10.1128/JB.05150-11; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Lupi A, 2008, AMINO ACIDS, V35, P739, DOI 10.1007/s00726-008-0055-4; Lupi A, 2006, FEBS J, V273, P5466, DOI 10.1111/j.1742-4658.2006.05538.x; Maeder DL, 1999, GENETICS, V152, P1299; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MILLER CG, 1978, J BACTERIOL, V135, P603, DOI 10.1128/JB.135.2.603-611.1978; MYARA I, 1984, LIFE SCI, V34, P1985, DOI 10.1016/0024-3205(84)90363-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park MS, 2004, ARCH BIOCHEM BIOPHYS, V429, P224, DOI 10.1016/j.abb.2004.06.022; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shao ZX, 1996, CURR OPIN STRUC BIOL, V6, P513, DOI 10.1016/S0959-440X(96)80117-5; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; SJOSTROM H, 1973, BIOCHIM BIOPHYS ACTA, V327, P457, DOI 10.1016/0005-2744(73)90429-4; Stepankova A, 2013, ACTA CRYSTALLOGR F, V69, P346, DOI 10.1107/S1744309113002674; Surazynski A, 2008, AMINO ACIDS, V35, P731, DOI 10.1007/s00726-008-0051-8; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vyas NK, 2010, BIOCHEMISTRY-US, V49, P547, DOI 10.1021/bi9011989; Wang SH, 2005, ARCH TOXICOL, V79, P253, DOI 10.1007/s00204-004-0634-4; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Willingham K, 2001, ACTA CRYSTALLOGR D, V57, P428, DOI 10.1107/S0907444900020187; Zhang LB, 1998, J BIOL INORG CHEM, V3, P470, DOI 10.1007/s007750050257	63	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111531	10.1371/journal.pone.0111531	http://dx.doi.org/10.1371/journal.pone.0111531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354344	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200087
J	Long, J; Li, B; Rodriguez-Blanco, J; Pastori, C; Volmar, CH; Wahlestedt, C; Capobianco, A; Bai, F; Pei, XH; Ayad, NG; Robbins, DJ				Long, Jun; Li, Bin; Rodriguez-Blanco, Jezabel; Pastori, Chiara; Volmar, Claude-Henry; Wahlestedt, Claes; Capobianco, Anthony; Bai, Feng; Pei, Xin-Hai; Ayad, Nagi G.; Robbins, David J.			The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bromodomain-containing Protein 4 (BRD4); Drug Screening; Epigenetics; Hedgehog Signaling Pathway; Medulloblastoma; Gli; I-BET151	MEDULLOBLASTOMA; PATHWAY; EPIGENETICS; ACTIVATION; SUPPRESSOR; CHROMATIN; BRAIN	Epigenetic enzymes modulate signal transduction pathways in different biological contexts. We reasoned that epigenetic regulators might modulate the Hedgehog (HH) signaling pathway, a main driver of cell proliferation in various cancers including medulloblastoma. To test this hypothesis, we performed an unbiased small-molecule screen utilizing an HH-dependent reporter cell line (Light2 cells). We incubated Light2 cells with small molecules targeting different epigenetic modulators and identified four histone deacetylase inhibitors and a bromodomain and extra terminal domain (BET) protein inhibitor (I-BET151) that attenuate HH activity. I-BET151 was also able to inhibit the expression of HH target genes in Sufu(-/-) mouse embryonic fibroblasts, in which constitutive Gli activity is activated in a Smoothened (Smo)-independent fashion, consistent with it acting downstream of Smo. Knockdown of Brd4 (which encodes one of the BET proteins) phenocopies I-BET151 treatment, suggesting that Brd4 is a regulator of the HH signaling pathway. Consistent with this suggestion, Brd4 associates with the proximal promoter region of the Gli1 locus, and does so in a manner that can be reversed by I-BET151. Importantly, I-BET151 also suppressed the HH activity-dependent growth of medulloblastoma cells, in vitro and in vivo. These studies suggest that BET protein modulation may be an attractive therapeutic strategy for attenuating the growth of HH-dependent cancers, such as medulloblastoma.	[Long, Jun; Li, Bin; Rodriguez-Blanco, Jezabel; Capobianco, Anthony; Bai, Feng; Pei, Xin-Hai; Robbins, David J.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Mol Oncol Program, Miami, FL 33136 USA; [Pastori, Chiara; Volmar, Claude-Henry; Wahlestedt, Claes; Ayad, Nagi G.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA; [Wahlestedt, Claes; Capobianco, Anthony; Pei, Xin-Hai; Ayad, Nagi G.; Robbins, David J.] Univ Miami, Sylvester Canc Ctr, Miami, FL 33136 USA; [Capobianco, Anthony; Robbins, David J.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Ayad, NG (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat,LPLC, 1095 NW 14th Terrace,R48, Miami, FL 33136 USA.	nayad@med.miami.edu; drobbins@med.miami.edu	Long, Jun/S-2382-2019; Volmar, C H/AFR-7749-2022; LONG, JUN/N-7270-2015; Rodriguez, Jezabel/B-7613-2019	Long, Jun/0000-0002-8229-9653; Volmar, C H/0000-0001-9437-051X; Rodriguez, Jezabel/0000-0003-1839-6181; Li, Bin/0000-0001-9341-4672; pei, xin-hai/0000-0001-6441-1691	National Institutes of Health [RO1CA082628, RO1NS067289]; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA082628 (to D. J. R.) and RO1NS067289 (to N. G. A.).	Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Batora NV, 2014, NEUROSCIENCE, V264, P171, DOI 10.1016/j.neuroscience.2013.07.030; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Henssen A, 2013, ONCOTARGET, V4, DOI 10.18632/oncotarget.1534; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071455; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tang YJ, 2014, NAT MED, V20, P732, DOI 10.1038/nm.3613; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Venkataraman S, 2014, ONCOTARGET, V5, P2355; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Weaver KL, 2014, CANCER RES, V74, P4741, DOI 10.1158/0008-5472.CAN-14-1547; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	37	86	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35494	35502		10.1074/jbc.M114.595348	http://dx.doi.org/10.1074/jbc.M114.595348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355313	hybrid, Green Published			2022-12-26	WOS:000346660200038
J	Ceravolo, GS; Montezano, AC; Jordao, MT; Akamine, EH; Costa, TJ; Takano, AP; Fernandes, DC; Barreto-Chaves, ML; Laurindo, FR; Tostes, RC; Fortes, ZB; Chopard, RP; Touyz, RM; Carvalho, MHC				Ceravolo, Graziela S.; Montezano, Augusto C.; Jordao, Maria T.; Akamine, Eliana H.; Costa, Tiago J.; Takano, Ana P.; Fernandes, Denise C.; Barreto-Chaves, Maria L.; Laurindo, Francisco R.; Tostes, Rita C.; Fortes, Zuleica B.; Chopard, Renato P.; Touyz, Rhian M.; Carvalho, Maria Helena C.			An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; B1 RECEPTOR EXPRESSION; EXPERIMENTAL RAT MODEL; B-1 RECEPTOR; CELLULAR MECHANISMS; INSULIN-RESISTANCE; ENZYME-INHIBITORS; CONVERTING ENZYME; BLOOD-PRESSURE; NADPH OXIDASE	The kallikrein-kinin and renin-angiotensin systems interact at multiple levels. In the present study, we tested the hypothesis that the B1 kinin receptor (B1R) contributes to vascular hypertrophy in angiotensin II (ANG II)-induced hypertension, through a mechanism involving reactive oxygen species (ROS) generation and extracellular signal-regulated kinase (ERK1/2) activation. Male Wistar rats were infused with vehicle (control rats), 400 ng/Kg/min ANG II (ANG II rats) or 400 ng/Kg/min ANG II plus B1 receptor antagonist, 350 ng/Kg/min des-Arg(9)-Leu(8)-bradykinin (ANGII+DAL rats), via osmotic mini-pumps (14 days) or received ANG II plus losartan (10 mg/Kg, 14 days, gavage - ANG II+LOS rats). After 14 days, ANG II rats exhibited increased systolic arterial pressure [(mmHg) 184 +/- 5.9 vs 115 +/- 2.3], aortic hypertrophy; increased ROS generation [2-hydroxyethidium/dihydroethidium (EOH/DHE): 21.8 +/- 2.7 vs 6.0 +/- 1.8] and ERK1/2 phosphorylation (% of control: 218.3 +/- 29.4 vs 100 +/- 0.25]. B1R expression was increased in aortas from ANG II and ANG II+DAL rats than in aortas from the ANG II+LOS and control groups. B1R antagonism reduced aorta hypertrophy, prevented ROS generation (EOH/DHE: 9.17 +/- 3.1) and ERK1/2 phosphorylation (137 +/- 20.7%) in ANG II rats. Cultured aortic vascular smooth muscle cells (VSMC) stimulated with low concentrations (0.1 nM) of ANG II plus B1R agonist exhibited increased ROS generation, ERK1/2 phosphorylation, proliferating-cell nuclear antigen expression and [H3]leucine incorporation. At this concentration, neither ANG II nor the B1R agonist produced any effects when tested individually. The ANG II/B1R agonist synergism was inhibited by losartan (AT1 blocker, 10 mu M), B1R antagonist (10 mM) and Tiron (superoxide anion scavenger, 10 mM). These data suggest that B1R activation contributes to ANG II-induced aortic hypertrophy. This is associated with activation of redox-regulated ERK1/2 pathway that controls aortic smooth muscle cells growth. Our findings highlight an important cross-talk between the DABK and ANG II in the vascular system and contribute to a better understanding of the mechanisms involved in vascular remodeling in hypertension.	[Ceravolo, Graziela S.; Akamine, Eliana H.; Costa, Tiago J.; Fortes, Zuleica B.; Carvalho, Maria Helena C.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Ceravolo, Graziela S.] Univ Estadual Londrina, Ctr Biol Sci, Dept Physiol Sci, Londrina, Brazil; [Montezano, Augusto C.; Touyz, Rhian M.] Univ Ottawa, Kidney Res Ctr, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Montezano, Augusto C.; Touyz, Rhian M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Jordao, Maria T.; Takano, Ana P.; Barreto-Chaves, Maria L.; Chopard, Renato P.] Univ Sao Paulo, Inst Biomed Sci 3, Dept Anat, Sao Paulo, Brazil; [Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Fernandes, Denise C.; Laurindo, Francisco R.] Univ Sao Paulo, Inst Heart, Vasc Biol Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina; University of Ottawa; Ottawa Hospital Research Institute; University of Glasgow; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, MHC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.	mhcarval@icb.usp.br	Carvalho, Maria Helena C/C-8539-2013; Barreto-Chaves, Maria Luiza/C-4459-2012; Akamine, Eliana Hiromi/C-5231-2012; Ceravolo, Graziela Scalianti/AAQ-8452-2020; Takano, Ana Paula C/P-6657-2016; Tostes, Rita C/C-1025-2012; Costa, Tiago/O-8302-2014; Takano, Ana Paula Cremasco/AAG-6514-2021; Costa, Tiago J/AAZ-2193-2020; Touyz, Rhian/AAM-3564-2020; Laurindo, Francisco R/J-6575-2015; Barreto-Chaves, Maria Luiza/Y-9264-2019	Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; Akamine, Eliana Hiromi/0000-0003-2715-7158; Ceravolo, Graziela Scalianti/0000-0001-7558-6294; Tostes, Rita C/0000-0002-9446-0707; Costa, Tiago/0000-0003-0780-4290; Takano, Ana Paula Cremasco/0000-0002-5057-1560; Costa, Tiago J/0000-0003-0780-4290; Touyz, Rhian/0000-0003-0670-0887; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; de Castro Fernandes, Denise/0000-0003-0213-4291	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 200759278-7]; Canadian Institute of Health Research [44018]; Conselho Nacional de Amparo a Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Conselho Nacional de Amparo a Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 200759278-7), Canadian Institute of Health Research (grant 44018), Conselho Nacional de Amparo a Pesquisa (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; ALVAREZ AL, 1992, CLIN SCI, V82, P513, DOI 10.1042/cs0820513; Basei FL, 2012, PEPTIDES, V37, P216, DOI 10.1016/j.peptides.2012.07.020; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Ceravolo GS, 2007, HYPERTENSION, V50, P756, DOI 10.1161/HYPERTENSIONAHA.107.094706; Christopher J, 2001, HYPERTENSION, V38, P602, DOI 10.1161/01.HYP.38.3.602; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Takano APC, 2013, MOL CELL ENDOCRINOL, V376, P43, DOI 10.1016/j.mce.2013.05.024; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; Duchene J, 2009, ARTERIOSCL THROM VAS, V29, P1757, DOI 10.1161/ATVBAHA.109.191775; Emanueli C, 1999, BRIT J PHARMACOL, V126, P1769, DOI 10.1038/sj.bjp.0702527; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fernandes L, 2006, REGUL PEPTIDES, V136, P92, DOI 10.1016/j.regpep.2006.04.018; Jiang BB, 2002, ARTERIOSCL THROM VAS, V22, P1811, DOI 10.1161/01.ATV.0000037679.60584.3F; Kim S, 2000, PHARMACOL REV, V52, P11; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Laplante MA, 2003, J HYPERTENS, V21, P927, DOI 10.1097/00004872-200305000-00017; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; Marceau F, 1998, PHARMACOL REV, V50, P357; MARTINS DTO, 1991, BRIT J PHARMACOL, V103, P1851, DOI 10.1111/j.1476-5381.1991.tb12341.x; McLean PG, 1999, BRIT J PHARMACOL, V128, P275, DOI 10.1038/sj.bjp.0702743; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Morand-Contant M, 2010, AM J PHYSIOL-HEART C, V299, pH1625, DOI 10.1152/ajpheart.00735.2009; Ohashi N, 2000, ARTERIOSCL THROM VAS, V20, P2521, DOI 10.1161/01.ATV.20.12.2521; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Raidoo DM, 1997, IMMUNOPHARMACOLOGY, V36, P153, DOI 10.1016/S0162-3109(97)00015-5; Rodrigues ES, 2009, BIOL CHEM, V390, P907, DOI 10.1515/BC.2009.081; Shen B, 2006, BIOL CHEM, V387, P145, DOI 10.1515/BC.2006.019; Skatchkov MP, 1999, BIOCHEM BIOPH RES CO, V254, P319, DOI 10.1006/bbrc.1998.9942; Su EJ, 1998, HYPERTENSION, V31, P1331, DOI 10.1161/01.HYP.31.6.1331; Touyz RM, 2000, PHARMACOL REV, V52, P639; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; Zhuo JL, 1998, J HYPERTENS, V16, P2027, DOI 10.1097/00004872-199816121-00026	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111117	10.1371/journal.pone.0111117	http://dx.doi.org/10.1371/journal.pone.0111117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369284	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000344402000039
J	Chinestra, P; Olichon, A; Medale-Giamarchi, C; Lajoie-Mazenc, I; Gence, R; Inard, C; Ligat, L; Faye, JC; Favre, G				Chinestra, Patrick; Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Inard, Cyril; Ligat, Laetitia; Faye, Jean-Charles; Favre, Gilles			Generation of a Single Chain Antibody Variable Fragment (scFv) to Sense Selectively RhoB Activation	PLOS ONE			English	Article							UVB-INDUCED APOPTOSIS; PHAGE-DISPLAY; HIGH-AFFINITY; CRYSTAL-STRUCTURE; EFFECTOR RECOGNITION; EXCHANGE-FACTOR; IN-VIVO; BINDING; GTPASES; CONFORMATION	Determining the cellular level of activated form of RhoGTPases is of key importance to understand their regulatory functions in cell physiopathology. We previously reported scFvC1, that selectively bind to the GTP-bound form of RhoA, RhoB and RhoC. In this present study we generate, by molecular evolution, a new phage library to isolate scFvs displaying high affinity and selectivity to RhoA and RhoB. Using phage display affinity maturation against the GTP-locked mutant RhoAL63, we isolated scFvs against RhoA active conformation that display K-d values at the nanomolar range, which corresponded to an increase of affinity of three orders of magnitude compared to scFvC1. Although a majority of these evolved scFvs remained selective towards the active conformation of RhoA, RhoB and RhoC, we identified some scFvs that bind to RhoA and RhoC but not to RhoB activated form. Alternatively, we performed a substractive panning towards RhoB, and isolated the scFvE3 exhibiting a 10 times higher affinity for RhoB than RhoA activated forms. We showed the peculiar ability of scFvE3 to detect RhoB but not RhoA GTP-bound form in cell extracts overexpressing Guanine nucleotide Exchange Factor XPLN as well as in EGF stimulated HeLa cells. Our results demonstrated the ability of scFvs to distinguish RhoB from RhoA GTP-bound form and provide new selective tools to analyze the cell biology of RhoB GTPase regulation.	[Chinestra, Patrick; Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Inard, Cyril; Faye, Jean-Charles; Favre, Gilles] Fac Med Toulouse, INSERM, UMR CRCT 1037, F-31073 Toulouse, France; [Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Favre, Gilles] Univ Toulouse 3, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Favre, Gilles] Inst Claudius Regaud, Toulouse, France; [Ligat, Laetitia] CRCT, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Favre, G (corresponding author), Fac Med Toulouse, INSERM, UMR CRCT 1037, U317, F-31073 Toulouse, France.	favre.gilles@iuct-oncopole.fr	Lajoie-Mazenc, Isabelle/M-4636-2014; Olichon, Aurelien/Q-5425-2019; Medale Giamarchi, Claire/M-3263-2014; Gence, Rémi/O-8961-2014; FAVRE, Gilles/K-9189-2014; Olichon, Aurelien/M-3115-2014; CHINESTRA, C/M-3266-2014	Gence, Rémi/0000-0003-0747-3540; FAVRE, Gilles/0000-0002-2344-1883; Olichon, Aurelien/0000-0002-0821-3612; 	Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chinestra P, 2012, METHODS MOL BIOL, V827, P283, DOI 10.1007/978-1-61779-442-1_19; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gerald D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3824; Goffinet M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-34; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hoogenboom HR, 1997, TRENDS BIOTECHNOL, V15, P62, DOI 10.1016/S0167-7799(97)84205-9; Horn IR, 1999, FEBS LETT, V463, P115, DOI 10.1016/S0014-5793(99)01617-8; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mamouni K, 2014, MOL CELL BIOL, V34, P3144, DOI 10.1128/MCB.01525-13; Martineau P, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P657, DOI 10.1007/978-3-642-01144-3_41; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Meyer N, 2014, J INVEST DERMATOL, V134, P203, DOI 10.1038/jid.2013.278; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Persson H, 2008, PROTEIN ENG DES SEL, V21, P485, DOI 10.1093/protein/gzn024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Suzuki Y, 2005, BIOSCI BIOTECH BIOCH, V69, P610, DOI 10.1271/bbb.69.610; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Tillement V, 2008, EXP CELL RES, V314, P2811, DOI 10.1016/j.yexcr.2008.06.011; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wright MJ, 2007, MOL IMMUNOL, V44, P2860, DOI 10.1016/j.molimm.2007.01.026	52	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111034	10.1371/journal.pone.0111034	http://dx.doi.org/10.1371/journal.pone.0111034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365345	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100045
J	Fessel, G; Li, YF; Diederich, V; Guizar-Sicairos, M; Schneider, P; Sell, DR; Monnier, VM; Snedeker, JG				Fessel, Gion; Li, Yufei; Diederich, Vincent; Guizar-Sicairos, Manuel; Schneider, Philipp; Sell, David R.; Monnier, Vincent M.; Snedeker, Jess G.			Advanced Glycation End-Products Reduce Collagen Molecular Sliding to Affect Collagen Fibril Damage Mechanisms but Not Stiffness	PLOS ONE			English	Article							X-RAY-DIFFRACTION; HUMAN SERUM-ALBUMIN; CROSS-LINKING; TENDON COLLAGEN; BIOMECHANICAL PROPERTIES; VISCOELASTIC PROPERTIES; NONENZYMATIC GLYCATION; SYNCHROTRON-RADIATION; I COLLAGEN; METHYLGLYOXAL	Advanced glycation end-products (AGE) contribute to age-related connective tissue damage and functional deficit. The documented association between AGE formation on collagens and the correlated progressive stiffening of tissues has widely been presumed causative, despite the lack of mechanistic understanding. The present study investigates precisely how AGEs affect mechanical function of the collagen fibril - the supramolecular functional load-bearing unit within most tissues. We employed synchrotron small-angle X-ray scattering (SAXS) and carefully controlled mechanical testing after introducing AGEs in explants of rat-tail tendon using the metabolite methylglyoxal (MGO). Mass spectrometry and collagen fluorescence verified substantial formation of AGEs by the treatment. Associated mechanical changes of the tissue (increased stiffness and failure strength, decreased stress relaxation) were consistent with reports from the literature. SAXS analysis revealed clear changes in molecular deformation within MGO treated fibrils. Underlying the associated increase in tissue strength, we infer from the data that MGO modified collagen fibrils supported higher loads to failure by maintaining an intact quarter-staggered conformation to nearly twice the level of fibril strain in controls. This apparent increase in fibril failure resistance was characterized by reduced side-by-side sliding of collagen molecules within fibrils, reflecting lateral molecular interconnectivity by AGEs. Surprisingly, no change in maximum fibril modulus (2.5 GPa) accompanied the changes in fibril failure behavior, strongly contradicting the widespread assumption that tissue stiffening in ageing and diabetes is directly related to AGE increased fibril stiffness. We conclude that AGEs can alter physiologically relevant failure behavior of collagen fibrils, but that tissue level changes in stiffness likely occur at higher levels of tissue architecture.	[Fessel, Gion; Li, Yufei; Snedeker, Jess G.] Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland; [Fessel, Gion; Li, Yufei; Schneider, Philipp; Snedeker, Jess G.] ETH, Inst Biomech, Zurich, Switzerland; [Diederich, Vincent] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, Villigen, Switzerland; [Schneider, Philipp] Univ Southampton, Fac Engn & Environm, Southampton, Hants, England; [Sell, David R.; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southampton; Case Western Reserve University; Case Western Reserve University	Snedeker, JG (corresponding author), Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland.	jsnedeker@research.balgrist.ch	Guizar-Sicairos, Manuel/I-4899-2013; Snedeker, Jess/C-2105-2009; Guizar-Sicairos, Manuel/AAB-3793-2019; Snedeker, Jess G./X-2098-2019; Schneider, Philipp/AAP-6133-2021	Guizar-Sicairos, Manuel/0000-0002-8293-3634; Snedeker, Jess/0000-0002-8115-0275; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Snedeker, Jess G./0000-0002-8115-0275; Schneider, Philipp/0000-0001-7499-3576	Swiss National Science Foundation [205321-118036]; National Institutes of Health [EY07099, DK - 79432]; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079432] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Swiss National Science Foundation grant number 205321-118036 and in part by National Institutes of Health grants EY07099 to VMM and DK - 79432 to DRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Dai ZY, 2008, J PROTEOME RES, V7, P2756, DOI 10.1021/pr700874a; DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371; de Oliveira R., 2011, ANN BIOMED ENG, P1; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; Fan XJ, 2010, FREE RADICAL BIO MED, V49, P847, DOI 10.1016/j.freeradbiomed.2010.06.003; Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048; Fessel G, 2011, ANN ANAT, V193, P237, DOI 10.1016/j.aanat.2011.03.007; Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Folkhard E, 1987, INT J BIOL MACROMOL, V9, P169; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Gautieri A, 2013, MATRIX BIOL; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; Gupta HS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158101; Hadley JC, 1998, GLYCOCONJUGATE J, V15, P835, DOI 10.1023/A:1006928403140; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Hull D, 2003, CAMBRIDGE SOLID STAT; JAMES VJ, 1991, DIABETES, V40, P391, DOI 10.2337/diabetes.40.3.391; Klopfer A, 2011, J AGR FOOD CHEM, V59, P394, DOI 10.1021/jf103116c; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Krauss S, 2009, BONE, V44, P1105, DOI 10.1016/j.bone.2009.02.009; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; Layton BE, 2006, ACTA BIOMATER, V2, P595, DOI 10.1016/j.actbio.2006.05.013; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P2499, DOI 10.1016/S0968-0896(99)00212-6; Li Y, 2012, INVESTIGATING AGE RE; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; MCLELLAN AC, 1992, ANAL CHIM ACTA, V263, P137, DOI 10.1016/0003-2670(92)85435-9; Meier M, 2008, J BIOMECHANICS, V41; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; MOSLER E, 1985, J MOL BIOL, V182, P589, DOI 10.1016/0022-2836(85)90244-X; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Sasaki N, 1999, J BIOMECH, V32, P285, DOI 10.1016/S0021-9290(98)00174-2; Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7; Seehra GP, 2006, SKIN RES TECHNOL, V12, P190, DOI 10.1111/j.0909-752X.2006.00150.x; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; Sherwood D, 2011, CRYSTALS XRAYS PROTE; Siegmund T, 2008, J BIOMECH, V41, P1427, DOI 10.1016/j.jbiomech.2008.02.017; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Slatter DA, 2008, INT J BIOCHEM CELL B, V40, P2253, DOI 10.1016/j.biocel.2008.03.006; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Tang Y, 2010, J R SOC INTERFACE, V7, P839, DOI 10.1098/rsif.2009.0390; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3; Zimmermann EA, 2011, P NATL ACAD SCI	63	75	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110948	10.1371/journal.pone.0110948	http://dx.doi.org/10.1371/journal.pone.0110948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364829	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000345558100038
J	Neumayer, G; Nguyen, MD				Neumayer, Gernot; Minh Dang Nguyen			TPX2 Impacts Acetylation of Histone H4 at Lysine 16: Implications for DNA Damage Response	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DEPHOSPHORYLATES GAMMA-H2AX; SPINDLE; PROTEIN; ATM; PHOSPHATASE; CHROMATIN; H2AX; PHOSPHORYLATION; FRAGMENTATION	During interphase, the spindle assembly factor TPX2 is compartmentalized in the nucleus where its roles remain largely uncharacterized. Recently, we found that TPX2 regulates the levels of serine 139-phosphoryated H2AX (gamma-H2AX) at chromosomal breaks induced by ionizing radiation. Here, we report that TPX2 readily associates with the chromatin in the absence of ionizing radiation. Overexpression of TPX2 alters the DAPI staining pattern of interphase cells and depletion of TPX2 constitutively decreases the levels of histone H4 acetylated at lysine16 ( H4K16ac) during G1-phase. Upon ionizing irradiation, this constitutive TPX2 depletion-dependent decrease in H4K16ac levels correlates with increased levels of gamma-H2AX. The inversely correlated levels of H4K16ac and gamma-H2AX can also be modified by altering the levels of SIRT1, herein identified as a novel protein complex partner of TPX2. Furthermore, we find that TPX2 depletion also interferes with formation of 53BP1 ionizing radiation-induced foci, known to depend on gamma-H2AX and the acetylation status of H4K16. In brief, our study is the first indication of a constitutive control of TPX2 on H4K16ac levels, with potential implications for DNA damage response.	[Neumayer, Gernot] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Cell Biol & Anat, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Neumayer, G (corresponding author), Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada.	ggneumay@ucalgary.ca; mdnguyen@ucalgary.ca			Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions (AIHS); Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary; Alberta Cancer Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AIHS); Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary; Alberta Cancer Foundation	MDN receives support from the Canadian Institutes of Health Research (CIHR) and Alberta Innovates-Health Solutions (AIHS). GN received a DOC-scholarship from the Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary and a scholarship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss R, 2004, CELL CYCLE, V3, P404; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; David Allis C., 2007, EPIGENETICS-US; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goshima G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028120; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kahana JA, 2001, SCIENCE, V291, P1718, DOI 10.1126/science.1059765; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Neumayer G, 2012, J BIOL CHEM, V287, P42206, DOI 10.1074/jbc.M112.385674; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Petrovska B, 2013, J EXP BOT, V64, P4575, DOI 10.1093/jxb/ert271; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu JX, 2011, NAT STRUCT MOL BIOL, V18, P761, DOI 10.1038/nsmb.2078; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	66	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110994	10.1371/journal.pone.0110994	http://dx.doi.org/10.1371/journal.pone.0110994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365214	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100041
J	Sollars, PJ; Weiser, MJ; Kudwa, AE; Bramley, JR; Ogilvie, MD; Spencer, RL; Handa, RJ; Pickard, GE				Sollars, Patricia J.; Weiser, Michael J.; Kudwa, Andrea E.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Spencer, Robert L.; Handa, Robert J.; Pickard, Gary E.			Altered Entrainment to the Day/Night Cycle Attenuates the Daily Rise in Circulating Corticosterone in the Mouse	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; CORTICOTROPIN-RELEASING HORMONE; MEDIATED PRESYNAPTIC INHIBITION; RECEPTOR KNOCKOUT MICE; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHM; GLUCOCORTICOID-RECEPTOR; GANGLION-CELLS; CLOCK PROTEIN; OVAL NUCLEUS	The suprachiasmatic nucleus (SCN) is a circadian oscillator entrained to the day/night cycle via input from the retina. Serotonin (5-HT) afferents to the SCN modulate retinal signals via activation of 5-HT1B receptors, decreasing responsiveness to light. Consequently, 5-HT1B receptor knockout (KO) mice entrain to the day/night cycle with delayed activity onsets. Since circulating corticosterone levels exhibit a robust daily rhythm peaking around activity onset, we asked whether delayed entrainment of activity onsets affects rhythmic corticosterone secretion. Wheel-running activity and plasma corticosterone were monitored in mice housed under several different lighting regimens. Both duration of the light: dark cycle (T cycle) and the duration of light within that cycle was altered. 5-HT1B KO mice that entrained to a 9.5L:13.5D (short day in a T = 23 h) cycle with activity onsets delayed more than 4 h after light offset exhibited a corticosterone rhythm in phase with activity rhythms but reduced 50% in amplitude compared to animals that initiated daily activity <4 h after light offset. Wild type mice in 8L:14D (short day in a T = 22 h) conditions with highly delayed activity onsets also exhibited a 50% reduction in peak plasma corticosterone levels. Exogenous adrenocorticotropin (ACTH) stimulation in animals exhibiting highly delayed entrainment suggested that the endogenous rhythm of adrenal responsiveness to ACTH remained aligned with SCN-driven behavioral activity. Circadian clock gene expression in the adrenal cortex of these same animals suggested that the adrenal circadian clock was also aligned with SCN-driven behavior. Under T cycles <24 h, altered circadian entrainment to short day (winter-like) conditions, manifest as long delays in activity onset after light offset, severely reduces the amplitude of the diurnal rhythm of plasma corticosterone. Such a pronounced reduction in the glucocorticoid rhythm may alter rhythmic gene expression in the central nervous system and in peripheral organs contributing to an array of potential pathophysiologies.	[Sollars, Patricia J.; Weiser, Michael J.; Kudwa, Andrea E.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Handa, Robert J.; Pickard, Gary E.] Colorado State Univ, Div Neurosci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Sollars, Patricia J.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Weiser, Michael J.; Spencer, Robert L.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Handa, Robert J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA	Colorado State University; University of Nebraska System; University of Nebraska Lincoln; University of Colorado System; University of Colorado Boulder; University of Arizona	Sollars, PJ (corresponding author), Colorado State Univ, Div Neurosci, Dept Biomed Sci, Ft Collins, CO 80523 USA.	psollars2@unl.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS039951, R01NS077003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077003, R01NS039951] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by RH - R01NS039951, National Institutes of Health, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov); PS & GP - R01NS077003, National Institutes of Health, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; Avery DH, 1997, BIOL PSYCHIAT, V41, P1109, DOI 10.1016/S0006-3223(96)00210-7; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2001, J COMP NEUROL, V432, P371, DOI 10.1002/cne.1109; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bouwknecht JA, 2001, PSYCHOPHARMACOLOGY, V153, P484, DOI 10.1007/s002130000598; Bramley JR, 2005, J NEUROPHYSIOL, V93, P3157, DOI 10.1152/jn.00770.2004; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Buijs RM, 2007, ENDOCRINOLOGY, V148, P5162, DOI 10.1210/en.2007-0926; BURGESS LH, 1992, ENDOCRINOLOGY, V131, P1261, DOI 10.1210/en.131.3.1261; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; Chung S, 2011, ANN NY ACAD SCI, V1220, P71, DOI 10.1111/j.1749-6632.2010.05923.x; Clark JA, 2008, MOL PSYCHIATR, V13, P498, DOI 10.1038/sj.mp.4002041; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dallman MF, 2000, INT J OBESITY, V24, pS40, DOI 10.1038/sj.ijo.0801276; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210, DOI 10.1152/ajpregu.1978.235.5.R210; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Endo T, 1999, JPN J PHYSIOL, V49, P425, DOI 10.2170/jjphysiol.49.425; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Engeland William C, 2013, Handb Clin Neurol, V117, P37, DOI 10.1016/B978-0-444-53491-0.00004-3; Girotti M, 2007, ENDOCRINOLOGY, V148, P2542, DOI 10.1210/en.2006-1304; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hoff J, 2000, LAB ANIMAL, V29, P47; Husse J, 2014, FASEB J; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JOSEPHVANDERPOOL JR, 1991, J CLIN ENDOCR METAB, V72, P1382, DOI 10.1210/jcem-72-6-1382; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kiessling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092959; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lavoie MP, 2009, BIOL PSYCHIAT, V66, P253, DOI 10.1016/j.biopsych.2008.11.020; Leproult R, 2001, J CLIN ENDOCR METAB, V86, P151, DOI 10.1210/jc.86.1.151; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; LEWY AJ, 1990, CHRONOBIOL INT, V7, P15, DOI 10.3109/07420529009056949; Lewy AJ, 1989, SEASONAL AFFECTIVE D, P201; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lilley TR, 2012, ENDOCRINOLOGY, V153, P732, DOI 10.1210/en.2011-1624; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P758, DOI 10.1210/en.140.2.758; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Meier AH, 1976, ENDOCRINOLOGY, V79, P884; Minton GO, 2009, NEUROPSYCHOPHARMACOL, V34, P2265, DOI 10.1038/npp.2009.53; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Muglia LJ, 1997, J CLIN INVEST, V99, P2923, DOI 10.1172/JCI119487; Nexon L, 2011, EUR J NEUROSCI, V33, P1308, DOI 10.1111/j.1460-9568.2010.07586.x; Oren DA, 1996, BIOL PSYCHIAT, V39, P157, DOI 10.1016/0006-3223(95)00079-8; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTENWELLER JE, 1982, ENDOCRINOLOGY, V111, P1334, DOI 10.1210/endo-111-4-1334; Pickard GE, 1999, J NEUROSCI, V19, P4034; Pickard GE, 1996, J NEUROSCI, V16, P8208; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pickard GE, 2008, THE SENSES VISION, P537; Posener JA, 2000, ARCH GEN PSYCHIAT, V57, P755, DOI 10.1001/archpsyc.57.8.755; Rea MA, 2000, BRAIN RES, V858, P424, DOI 10.1016/S0006-8993(99)02462-2; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roecklein KA, 2009, J AFFECT DISORDERS, V114, P279, DOI 10.1016/j.jad.2008.08.005; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Scheer FAJL, 1999, J CLIN ENDOCR METAB, V84, P3395, DOI 10.1210/jc.84.9.3395; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Smith BN, 2001, J BIOL RHYTHM, V16, P25, DOI 10.1177/074873040101600104; Sollars PJ, 2006, NEUROSCI LETT, V401, P209, DOI 10.1016/j.neulet.2006.03.012; Sollars PJ, 2006, J BIOL RHYTHM, V21, P21, DOI 10.1177/0748730405283765; Sollars PJ, 2002, J BIOL RHYTHM, V17, P428, DOI 10.1177/074873002237137; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; SPACKMAN DH, 1978, SCIENCE, V200, P87, DOI 10.1126/science.635580; Spiga F, 2009, BRAIN RES, V1293, P101, DOI 10.1016/j.brainres.2009.02.001; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Terman M., 2005, PRINCIPLES PRACTICE, V4, P1424, DOI [10.1016/B0-72-160797-7/50128-2, DOI 10.1016/B0-72-160797-7/50128-2, 10.1016/B0-72-160797-7/50128-2.]; Thalen BE, 1997, ACTA PSYCHIAT SCAND, V96, P385, DOI 10.1111/j.1600-0447.1997.tb09934.x; Thorn L, 2004, PSYCHONEUROENDOCRINO, V29, P925, DOI 10.1016/j.psyneuen.2003.08.005; Torres-Farfan C, 2008, AM J PRIMATOL, V70, P93, DOI 10.1002/ajp.20461; Tsang AH, 2014, J MOL ENDOCRINOL, V52, pR1, DOI 10.1530/JME-13-0118; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; UNGAR F, 1962, SCIENCE, V137, P1058, DOI 10.1126/science.137.3535.1058; Wei Q, 2007, J NEUROSCI, V27, P8836, DOI 10.1523/JNEUROSCI.0910-07.2007; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352, DOI 10.1210/jcem-56-2-352; Wever AM, 1979, CIRCADIAN SYSTEM MAN; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Yoshida M, 2005, J PHARMACOL EXP THER, V315, P1119, DOI 10.1124/jpet.105.091488	104	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111944	10.1371/journal.pone.0111944	http://dx.doi.org/10.1371/journal.pone.0111944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365210	gold, Green Published			2022-12-26	WOS:000345558100137
J	Bouskila, J; Javadi, P; Palmour, RM; Bouchard, JF; Ptito, M				Bouskila, Joseph; Javadi, Pasha; Palmour, Roberta M.; Bouchard, Jean-Francois; Ptito, Maurice			Standardized Full-Field Electroretinography in the Green Monkey (Chlorocebus sabaeus)	PLOS ONE			English	Article							VERVET MONKEY; CLINICAL ELECTRORETINOGRAPHY; ADAPTED ELECTRORETINOGRAM; CEREBRAL HEMISPHERECTOMY; OPTOKINETIC NYSTAGMUS; ALCOHOL EXPOSURE; PHOTOPIC HILL; B-WAVE; RETINA; PRIMATES	Full-field electroretinography is an objective measure of retinal function, serving as an important diagnostic clinical tool in ophthalmology for evaluating the integrity of the retina. Given the similarity between the anatomy and physiology of the human and Green Monkey eyes, this species has increasingly become a favorable non-human primate model for assessing ocular defects in humans. To test this model, we obtained full-field electroretinographic recordings (ERG) and normal values for standard responses required by the International Society for Clinical Electrophysiology of Vision (ISCEV). Photopic and scotopic ERG recordings were obtained by full-field stimulation over a range of 6 log units of intensity in dark-adapted or light-adapted eyes of adult Green Monkeys (Chlorocebus sabaeus). Intensity, duration, and interval of light stimuli were varied separately. Reproducible values of amplitude and latency were obtained for the a-and b-waves, under well-controlled adaptation and stimulus conditions; the i-wave was also easily identifiable and separated from the a-b-wave complex in the photopic ERG. The recordings obtained in the healthy Green Monkey matched very well with those in humans and other non-human primate species (Macaca mulatta and Macaca fascicularis). These results validate the Green Monkey as an excellent non-human primate model, with potential to serve for testing retinal function following various manipulations such as visual deprivation or drug evaluation.	[Bouskila, Joseph; Javadi, Pasha; Bouchard, Jean-Francois; Ptito, Maurice] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Bouskila, Joseph] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Palmour, Roberta M.] Behav Sci Fdn, Caribbean, St Kitts & Nevi; [Palmour, Roberta M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Palmour, Roberta M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, BRAINlab, Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, Neuropsychiat Lab, Copenhagen, Denmark	Universite de Montreal; Universite de Montreal; McGill University; McGill University; University of Copenhagen; University of Copenhagen	Ptito, M (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	maurice.ptito@umontreal.ca	Ptito, Maurice/G-3422-2013; Bouchard, Jean-Francois/AAI-1229-2021	Ptito, Maurice/0000-0002-5173-5862; Bouchard, Jean-Francois/0000-0001-9622-6239	Natural Science and Engineering Research Council of Canada [6362-2012, 311892-2010]; Canadian Institutes of Health Research [MOP-130337]; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR; "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S)	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR(Canadian Institutes of Health Research (CIHR)); "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S)	The Natural Science and Engineering Research Council of Canada (6362-2012, MP; 311892-2010, JFB) and the Canadian Institutes of Health Research (MOP-130337, JFB) supported this work. JB received support from a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR. JFB is supported by a "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S). MP is Harland Sanders Chair professor in Visual Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CS, 2002, OPHTHALMOLOGY, V109, P575, DOI 10.1016/S0161-6420(01)00981-2; Bee W H, 2001, Curr Opin Drug Discov Devel, V4, P81; BEE WH, 1995, OCULAR TOXICOLOGY, P53; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P207; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Boire D, 2001, PROG BRAIN RES, V134, P379; Boire D, 2002, EXP BRAIN RES, V142, P208, DOI 10.1007/s00221-001-0921-8; Bouskila J, 2012, NEUROSCIENCE, V202, P117, DOI 10.1016/j.neuroscience.2011.11.041; Bouskila J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081080; Bouskila J, 2013, J COMP NEUROL, V521, P2399, DOI 10.1002/cne.23333; BUIST DP, 1982, LAB ANIM SCI, V32, P91; Burke M, 2009, J VIS EXP; Burke MW, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/852423; Burke MW, 2009, NEUROREPORT, V20, P13, DOI 10.1097/WNR.0b013e32831b449c; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Herbin M, 1997, J COMP NEUROL, V383, P459, DOI 10.1002/(SICI)1096-9861(19970714)383:4<459::AID-CNE5>3.0.CO;2-1; Holopigian K, 2001, INVEST OPHTH VIS SCI, V42, P779; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JACOBI PC, 1993, DOC OPHTHALMOL, V85, P95, DOI 10.1007/BF01371126; Jasinska AJ, 2007, MAMM GENOME, V18, P347, DOI 10.1007/s00335-007-9026-4; KNAPP AG, 1988, J NEUROPHYSIOL, V60, P1010, DOI 10.1152/jn.1988.60.3.1010; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Mikula S., 2008, BRAINS MINDS MEDIA, V3; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Osterberg G., 1935, ACTA OPHTHALMOL, V6, P11; Palmour RM, 1997, AM J HUM GENET, V61, P481, DOI 10.1086/515526; Papia MF, 2010, EXP BRAIN RES, V205, P263, DOI 10.1007/s00221-010-2364-6; Ptito M, 1996, PROG BRAIN RES, V112, P385; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Rosolen SG, 2004, VET OPHTHALMOL, V7, P189, DOI 10.1111/j.1463-5224.2004.04022.x; Rotenstreich Y, 2003, BRIT J OPHTHALMOL, V87, P1268, DOI 10.1136/bjo.87.10.1268; Rufiange M, 2003, VISION RES, V43, P1405, DOI 10.1016/S0042-6989(03)00118-4; Rufiange Marianne, 2002, Documenta Ophthalmologica, V104, P231, DOI 10.1023/A:1015265812018; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Steinberg R. H., 1985, PROGR RETINAL RES, P33, DOI 10.1016/0278-4327(85)90004-5; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Theoret H, 2000, BRAIN RES BULL, V53, P239, DOI 10.1016/S0361-9230(00)00345-2; Theoret H, 2001, BRAIN RES, V894, P274, DOI 10.1016/S0006-8993(01)02030-3; TIAN N, 1995, VISION RES, V35, P1359, DOI 10.1016/0042-6989(95)98715-L; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; WALI N, 1992, DOC OPHTHALMOL, V80, P335, DOI 10.1007/BF00154382; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wolf JE, 1996, VISION RES, V36, P2369, DOI 10.1016/0042-6989(95)00316-9; Woods RP, 2011, NEUROIMAGE, V54, P1872, DOI 10.1016/j.neuroimage.2010.09.070	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111569	10.1371/journal.pone.0111569	http://dx.doi.org/10.1371/journal.pone.0111569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360686	gold, Green Published			2022-12-26	WOS:000343943700122
J	Kasper, JR; Andrews, EC; Park, C				Kasper, Joseph R.; Andrews, Elizabeth C.; Park, Chiwook			Product Inhibition in Native-State Proteolysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; AMINOPEPTIDASE-P; THERMOLYSIN; HYDROLYSIS; PROTEINS; DEGRADATION; MECHANISM; SUBSTRATE; PEPTIDES; KINETICS	The proteolysis kinetics of intact proteins by nonspecific proteases provides valuable information on transient partial unfolding of proteins under native conditions. Native-state proteolysis is an approach to utilize the proteolysis kinetics to assess the energetics of partial unfolding in a quantitative manner. In native-state proteolysis, folded proteins are incubated with nonspecific proteases, and the rate of proteolysis is determined from the disappearance of the intact protein. We report here that proteolysis of intact proteins by nonspecific proteases, thermolysin and subtilisin deviates from first-order kinetics. First-order kinetics has been assumed for the analysis of native-state proteolysis. By analyzing the kinetics of proteolysis with varying concentrations of substrate proteins and also with cleavage products, we found that the deviation from first-order kinetics results from product inhibition. A kinetic model including competitive product inhibition agrees well with the proteolysis time course and allows us to determine the uninhibited rate constant for proteolysis as well as the apparent inhibition constant. Our finding suggests that the likelihood of product inhibition must be considered for quantitative assessment of proteolysis kinetics.	[Kasper, Joseph R.; Andrews, Elizabeth C.; Park, Chiwook] Purdue Univ, Bindley Biosci Ctr, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Park, C (corresponding author), Purdue Univ, Bindley Biosci Ctr, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	chiwook@purdue.edu	Park, Chiwook/HIK-2724-2022	Park, Chiwook/0000-0002-2161-6459	National Science Foundation Grant [1021652]	National Science Foundation Grant(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant 1021652 to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold U, 2001, EUR J BIOCHEM, V268, P93, DOI 10.1046/j.1432-1327.2001.01849.x; Chang Y, 2009, J MOL BIOL, V393, P543, DOI 10.1016/j.jmb.2009.08.006; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; FEDER J, 1974, BIOCHEMISTRY-US, V13, P1186, DOI 10.1021/bi00703a600; Hamada Y, 2012, ACS MED CHEM LETT, V3, P193, DOI 10.1021/ml2002373; HOLDEN HM, 1988, J BIOL CHEM, V263, P3256; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; IMOTO T, 1986, J MOL BIOL, V190, P647, DOI 10.1016/0022-2836(86)90250-0; IWAKURA M, 1995, J BIOCHEM, V117, P480, DOI 10.1093/oxfordjournals.jbchem.a124733; Kasper JR, 2014, PROTEIN SCI IN PRESS; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; LINDERSTROMLANG K, 1949, COLD SPRING HARB SYM, V14, P117, DOI 10.1101/SQB.1950.014.01.016; MATSUBARA H, 1966, ARCH BIOCHEM BIOPHYS, V115, P324, DOI 10.1016/0003-9861(66)90282-7; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; MORIHARA K, 1968, ARCH BIOCHEM BIOPHYS, V123, P572, DOI 10.1016/0003-9861(68)90179-3; MORIHARA K, 1970, EUR J BIOCHEM, V15, P374, DOI 10.1111/j.1432-1033.1970.tb01018.x; MORIHARA K, 1971, BIOCHEM BIOPH RES CO, V42, P1000, DOI 10.1016/0006-291X(71)90002-7; NISHINO N, 1980, J BIOL CHEM, V255, P3482; PACE CN, 1984, BIOCHEM J, V219, P411, DOI 10.1042/bj2190411; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; RUPLEY JA, 1960, BIOCHIM BIOPHYS ACTA, V44, P191, DOI 10.1016/0006-3002(60)91547-X; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Spudich G, 2002, PROTEIN SCI, V11, P522, DOI 10.1110/ps.37202; STAUFFER CE, 1971, BIOCHIM BIOPHYS ACTA, V251, P407, DOI 10.1016/0005-2795(71)90129-2; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Wildes D, 2006, PROTEIN SCI, V15, P1769, DOI 10.1110/ps.062136006; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Youn K, 2009, PROTEIN PEPTIDE LETT, V16, P1093, DOI 10.2174/092986609789055287	32	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111416	10.1371/journal.pone.0111416	http://dx.doi.org/10.1371/journal.pone.0111416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360755	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700102
J	Kim, DK; Park, MH; Chang, DY; Eun, KM; Shin, HW; Mo, JH; Shin, EC; Jin, HR; Shin, S; Roh, EY; Han, DH; Kim, DW				Kim, Dong-Kyu; Park, Min-Hyun; Chang, Dong-Yeop; Eun, Kyung Mi; Shin, Hyun-Woo; Mo, Ji-Hun; Shin, Eui-Cheol; Jin, Hong Ryul; Shin, Sue; Roh, Eun Youn; Han, Doo Hee; Kim, Dae Woo			MBP-Positive and CD11c-Positive Cells Are Associated with Different Phenotypes of Korean Patients with Non-Asthmatic Chronic Rhinosinusitis	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; NASAL POLYPS; DENDRITIC CELLS; SINUS MUCOSA; T-CELLS; INFLAMMATION; FEATURES; SUBCLASSIFICATION; ENTEROTOXINS; IMMUNITY	Background: Asthmatic nasal polyps primarily exhibit eosinophilic infiltration. However, the identities of the immune cells that infiltrate non-asthmatic nasal polyps remain unclear. Thus, we thought to investigate the distribution of innate immune cells and its clinical relevance in non-asthmatic chronic rhinosinusitis (CRS) in Korea. Methods: Tissues from uncinate process (UP) were obtained from controls (n = 18) and CRS without nasal polyps (CRSsNP, n = 45). Nasal polyps (NP) and UP were obtained from CRS with nasal polyps (CRSwNP, n = 56). The innate immune cells was evaluated by immunohistochemistry such as, eosinophil major basic protein (MBP), tryptase, CD68, CD163, CD11c, 2D7, human neutrophil elastase (HNE) and its distribution was analyzed according to clinical parameters. Results: In comparisons between UP from each group, CRSwNP had a higher number of MPB+, CD68(+), and CD11c(+) cells relative to CRSsNP. Comparisons between UP and NP from CRSwNP indicated that NP have a higher infiltrate of MBP+, CD163(+), CD11c(+), 2D7(+) and HNE+ cells, whereas fewer CD68(+) cells were found in NP. In addition, MBP+ and CD11c(+) cells were increased from UP of CRSsNP, to UP of CRSwNP, and to NP of CRSwNP. Moreover, in UP from CRSwNP, the number of MBP+ and CD11c(+) cells positively correlated with CT scores. In the analysis of CRSwNP phenotype, allergic eosinophilic polyps had a higher number of MBP+, tryptase(+), CD11c(+), 2D7(+) cells than others, whereas allergic non-eosinophilic polyps showed mainly infiltration of HNE+ and 2D7(+) cells. Conclusions: The infiltration of MBP+ and CD11c(+) innate immune cells show a significant association with phenotype and disease extent of CRS and allergic status also may influences cellular phenotype in non-asthmatic CRSwNP in Korea.	[Kim, Dong-Kyu] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Park, Min-Hyun; Eun, Kyung Mi; Jin, Hong Ryul; Kim, Dae Woo] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea; [Chang, Dong-Yeop; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Mo, Ji-Hun] Dankook Univ, Coll Med, Dept Otorhinolaryngol, Cheonan, South Korea; [Shin, Sue; Roh, Eun Youn] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Lab Med, Seoul, South Korea; [Han, Doo Hee] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Dankook University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, DW (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea.	kicubi@daum.net	Mo, Ji-Hun/E-5586-2011; Shin, Eui-Cheol/C-1690-2011	Mo, Ji-Hun/0000-0003-1331-364X; Shin, Eui-Cheol/0000-0002-6308-9503; Park, Min-Hyun/0000-0003-4156-7639; Kim, Dong-Kyu/0000-0003-4917-0177	SK Telecom Research Fund [06-2012-109]	SK Telecom Research Fund	This work was supported by a clinical research grant-in-aid by grant no. 06-2012-109 from SK Telecom Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarvak T, 2001, SCAND J IMMUNOL, V54, P100, DOI 10.1046/j.1365-3083.2001.00957.x; Ayers CM, 2011, INT FORUM ALLERGY RH, V1, P296, DOI 10.1002/alr.20046; Bachert C, 1998, ALLERGY, V53, P2, DOI 10.1111/j.1398-9995.1998.tb03767.x; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Han JK, 2013, LARYNGOSCOPE, V123, pS15, DOI 10.1002/lary.23979; Ikeda K, 2013, LARYNGOSCOPE, V123, pE1, DOI 10.1002/lary.24154; Kato H, 1999, GENES IMMUN, V1, P97, DOI 10.1038/sj.gene.6363638; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Lin XS, 2013, EXP THER MED, V5, P1476, DOI 10.3892/etm.2013.986; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Mahdavinia M, 2014, J ALLERGY CLIN IMMUN, V133, P1759, DOI 10.1016/j.jaci.2013.12.1092; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mulligan JK, 2012, OTOLARYNG HEAD NECK, V147, P773, DOI 10.1177/0194599812448852; NONAKA M, 1995, J IMMUNOL, V155, P3234; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Polzehl D, 2006, ALLERGY, V61, P1275, DOI 10.1111/j.1398-9995.2006.01132.x; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Robinson S, 2006, AM J RHINOL, V20, P625, DOI 10.2500/ajr.2006.20.2907; Shi J, 2009, J INVEST ALLERG CLIN, V19, P276; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suzuki H, 1996, J ALLERGY CLIN IMMUN, V98, P659, DOI 10.1016/S0091-6749(96)70100-8; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; van Drunen CM, 2012, CURR ALLERGY ASTHM R, V12, P120, DOI 10.1007/s11882-012-0249-4; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Voegels RL, 2001, AM J RHINOL, V15, P9, DOI 10.2500/105065801781329365; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887	37	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111352	10.1371/journal.pone.0111352	http://dx.doi.org/10.1371/journal.pone.0111352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361058	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700090
J	Montgomery, SL; Vorojeikina, D; Huang, W; Mackay, TFC; Anholt, RRH; Rand, MD				Montgomery, Sara L.; Vorojeikina, Daria; Huang, Wen; Mackay, Trudy F. C.; Anholt, Robert R. H.; Rand, Matthew D.			Genome-Wide Association Analysis of Tolerance to Methylmercury Toxicity in Drosophila Implicates Myogenic and Neuromuscular Developmental Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; GENETIC REFERENCE PANEL; MYOBLAST FUSION; MINAMATA DISEASE; ROLLING PEBBLES; ENHANCER FACTOR; METHYL MERCURY; MELANOGASTER; EXPOSURE; FISH	Methylmercury (MeHg) is a persistent environmental toxin present in seafood that can compromise the developing nervous system in humans. The effects of MeHg toxicity varies among individuals, despite similar levels of exposure, indicating that genetic differences contribute to MeHg susceptibility. To examine how genetic variation impacts MeHg tolerance, we assessed developmental tolerance to MeHg using the sequenced, inbred lines of the Drosophila melanogaster Genetic Reference Panel (DGRP). We found significant genetic variation in the effects of MeHg on development, measured by eclosion rate, giving a broad sense heritability of 0.86. To investigate the influence of dietary factors, we measured MeHg toxicity with caffeine supplementation in the DGRP lines. We found that caffeine counteracts the deleterious effects of MeHg in the majority of lines, and there is significant genetic variance in the magnitude of this effect, with a broad sense heritability of 0.80. We performed genome-wide association (GWA) analysis for both traits, and identified candidate genes that fall into several gene ontology categories, with enrichment for genes involved in muscle and neuromuscular development. Overexpression of glutamate-cysteine ligase, a MeHg protective enzyme, in a muscle-specific manner leads to a robust rescue of eclosion of flies reared on MeHg food. Conversely, mutations in kirre, a pivotal myogenic gene identified in our GWA analyses, modulate tolerance to MeHg during development in accordance with kirre expression levels. Finally, we observe disruptions of indirect flight muscle morphogenesis in MeHg-exposed pupae. Since the pathways for muscle development are evolutionarily conserved, it is likely that the effects of MeHg observed in Drosophila can be generalized across phyla, implicating muscle as an additional hitherto unrecognized target for MeHg toxicity. Furthermore, our observations that caffeine can ameliorate the toxic effects of MeHg show that nutritional factors and dietary manipulations may offer protection against the deleterious effects of MeHg exposure.	[Montgomery, Sara L.; Vorojeikina, Daria; Rand, Matthew D.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Huang, Wen; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol Sci, Genet Program, Raleigh, NC 27695 USA; [Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of Rochester; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rand, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA.	matthew_rand@urmc.rochester.edu	Anholt, Robert/S-5977-2019	Huang, Wen/0000-0001-6788-8364	National Institute of Environmental Sciences [P30 ES001247, T32 ES07026]; National Institute of General Medical Sciences [GM045146, R21 ES021719]; NCSU Initiative for Biological Complexity, North Carolina State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021719, T32ES007026, P30ES001247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institute of Environmental Sciences; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCSU Initiative for Biological Complexity, North Carolina State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding by P30 ES001247, T32 ES07026 (http://www.niehs.nih.gov/) National Institute of Environmental Sciences (MDR, SLM), GM045146, R21 ES021719, (http://www.nigms.nih.gov/) National Institute of General Medical Sciences (RRHA, TFCM), and NCSU Initiative for Biological Complexity, North Carolina State University (WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; ALSALEEM T, 1976, B WORLD HEALTH ORGAN, V53, P99; AMINZAKI L, 1974, PEDIATRICS, V54, P587; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Baines RA, 2005, MOL NEUROBIOL, V32, P113, DOI 10.1385/MN:32:2:113; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; CHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719, DOI 10.1097/00005072-197811000-00001; Debes F, 2006, NEUROTOXICOL TERATOL, V28, P363, DOI [10.1016/j.ntt.2006.02.005, 10.1016/j.ntt.2006.02.004]; Devenport D, 2007, DEV BIOL, V308, P294, DOI 10.1016/j.ydbio.2007.02.046; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; DUTCZAK WJ, 1994, J BIOL CHEM, V269, P9746; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Engel GL, 2012, TOXICOL IN VITRO, V26, P485, DOI 10.1016/j.tiv.2011.12.014; Engel GL, 2014, NEUROTOXICOL TERATOL, V43, P11, DOI 10.1016/j.ntt.2014.03.001; Fernandes JJ, 2005, DEV BIOL, V277, P493, DOI 10.1016/j.ydbio.2004.09.038; Fernandes JJ, 1996, DEVELOPMENT, V122, P3755; Gildor B, 2012, DEVELOPMENT, V139, P4040, DOI 10.1242/dev.077495; Goodrich JM, 2013, INT J HYG ENVIR HEAL, V216, P195, DOI 10.1016/j.ijheh.2012.03.001; HARADA M, 1978, TERATOLOGY, V18, P285, DOI 10.1002/tera.1420180216; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; HUGHES WL, 1957, ANN NY ACAD SCI, V65, P454, DOI 10.1111/j.1749-6632.1956.tb36650.x; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Julvez J, 2013, EPIDEMIOLOGY, V24, P643, DOI 10.1097/EDE.0b013e31829d5c93; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; LEVESQUE PC, 1988, TOXICOL APPL PHARM, V94, P55, DOI 10.1016/0041-008X(88)90336-5; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llop S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097172; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mahapatra CT, 2010, TOXICOL SCI, V116, P225, DOI 10.1093/toxsci/kfq097; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Morozova TV, 2011, GENETICS, V187, P1193, DOI 10.1534/genetics.110.125229; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Myers GJ, 2007, J NUTR, V137, P2805, DOI 10.1093/jn/137.12.2805; Myers GJ, 1997, NEUROTOXICOLOGY, V18, P819; Nyland JF, 2011, ENVIRON HEALTH PERSP, V119, P1733, DOI 10.1289/ehp.1103741; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Passos Carlos J. S., 2008, Cad. Saúde Pública, V24, ps503; Prediger RDS, 2010, J ALZHEIMERS DIS, V20, pS205, DOI 10.3233/JAD-2010-091459; Putz M, 2005, MECH DEVELOP, V122, P1206, DOI 10.1016/j.mod.2005.07.001; RABENSTEIN DL, 1978, BIOINORG CHEM, V8, P107, DOI 10.1016/S0006-3061(00)80237-9; Ramon R, 2009, AM J CLIN NUTR, V90, P1047, DOI 10.3945/ajcn.2009.27944; Rand MD, 2012, TOXICOLOGY, V300, P75, DOI 10.1016/j.tox.2012.06.001; SABBAGH K, 1977, BRIT MED J, V2, P1215, DOI 10.1136/bmj.2.6096.1215-a; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Toyama T, 2011, ENVIRON HEALTH PERSP, V119, P1117, DOI 10.1289/ehp.1003123; Valera B, 2013, ENVIRON RES, V120, P102, DOI 10.1016/j.envres.2012.08.002; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Weitkunat M, 2014, METHODS; Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1; Yazdani U, 2008, GENETICS, V178, P919, DOI 10.1534/genetics.107.078030; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	62	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110375	10.1371/journal.pone.0110375	http://dx.doi.org/10.1371/journal.pone.0110375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360876	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700033
J	Tao, WS; Moore, R; Smith, ER; Xu, XX				Tao, Wensi; Moore, Robert; Smith, Elizabeth R.; Xu, Xiang-Xi			Hormonal Induction and Roles of Disabled-2 in Lactation and Involution	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; MAP KINASE PHOSPHORYLATION; BREAST-CANCER; CELL-DEATH; SIGNALING PATHWAY; BINDING PARTNER; 1ST STAGE; MYOSIN-VI; DAB2; GENE	Disabled-2 (Dab2) is a widely expressed endocytic adaptor that was first isolated as a 96 KDa phospho-protein, p96, involved in MAPK signal transduction. Dab2 expression is lost in several cancer types including breast cancer, and Dab2 is thought to have a tumor suppressor function. In mammary epithelia, Dab2 was induced upon pregnancy and further elevated during lactation. We constructed mutant mice with a mosaic Dab2 gene deletion to bypass early embryonic lethality and to investigate the roles of Dab2 in mammary physiology. Loss of Dab2 had subtle effects on lactation, but Dab2-deficient mammary glands showed a strikingly delayed cell clearance during involution. In primary cultures of mouse mammary epithelial cells, Dab2 proteins were also induced by estrogen, progesterone, and/or prolactin. Dab2 null mammary epithelial cells were refractory to growth suppression induced by TGF-beta. However, Dab2 deletion did not affect Smad2 phosphorylation; rather TGF-beta-stimulated MAPK activation was enhanced in Dab2-deficient cells. We conclude that Dab2 expression is induced by hormones and Dab2 plays a role in modulating TGF-beta signaling to enhance apoptotic clearance of mammary epithelial cells during involution.	[Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Grad Program Mol Cell & Dev Biol, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Miami	Xu, XX (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	xxu2@med.miami.edu			National Cancer Institute of the National Institutes of Health (USA) [R01 CA095071, CA79716, CA75389]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA095071, R01CA075389, R01CA079716] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by R01 CA095071, CA79716, and CA75389 to X.X.Xu from National Cancer Institute of the National Institutes of Health (USA). R. Moore was partially supported by funding from the American Cancer Society (2009 Institutional Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalffy G, 2011, BIOCHEM BIOPH RES CO, V410, P322, DOI 10.1016/j.bbrc.2011.05.147; Bagadi SAR, 2007, BREAST CANCER RES TR, V104, P277, DOI 10.1007/s10549-006-9422-6; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bierie B, 2009, J CELL PHYSIOL, V219, P57, DOI 10.1002/jcp.21646; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; BUDAY L, 1995, ONCOGENE, V11, P1327; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Dickson R B, 1988, Cancer Treat Res, V40, P119; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Flanders KC, 2009, J MAMMARY GLAND BIOL, V14, P131, DOI 10.1007/s10911-009-9122-z; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Furth PA, 1999, J MAMMARY GLAND BIOL, V4, P123, DOI 10.1023/A:1018764922082; Furth PA, 1997, APOPTOSIS, V2, P19, DOI 10.1023/A:1026454207398; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Heermeier K, 1996, MECH DEVELOP, V56, P197, DOI 10.1016/0925-4773(96)88032-4; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; LaMarca HL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1740; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li ML, 1997, P NATL ACAD SCI USA, V94, P3425, DOI 10.1073/pnas.94.7.3425; Li ML, 1996, CELL GROWTH DIFFER, V7, P13; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medina D, 2004, CLIN CANCER RES, V10, p380S, DOI 10.1158/1078-0432.CCR-031211; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Monks J, 2009, J MAMMARY GLAND BIOL, V14, P159, DOI 10.1007/s10911-009-9121-0; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Newcomb PA, 1997, J MAMMARY GLAND BIOL, V2, P311, DOI 10.1023/A:1026344707161; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Ohi A, 2011, AM J PHYSIOL-RENAL, V301, pF1105, DOI 10.1152/ajprenal.00663.2010; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; ROZAKISADCOCK M, 1995, ONCOGENE, V11, P1417; Russo Irma H., 2007, V174, P111; Russo IH, 2008, WOMENS HEALTH, V4, P1, DOI 10.2217/17455057.4.1.1; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Schorr K, 1999, CANCER RES, V59, P2541; Schorr K, 1999, J MAMMARY GLAND BIOL, V4, P153, DOI 10.1023/A:1018773123899; Schwahn DJ, 1998, ONCOGENE, V17, P1173, DOI 10.1038/sj.onc.1202038; Sheng ZJ, 2001, GENE, V268, P31, DOI 10.1016/S0378-1119(01)00401-2; Sheng ZJ, 2000, GENOMICS, V70, P381, DOI 10.1006/geno.2000.6383; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Sivaraman L, 2002, J MAMMARY GLAND BIOL, V7, P77, DOI 10.1023/A:1015774524076; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Xu XX, 1998, ONCOGENE, V16, P1561, DOI 10.1038/sj.onc.1201678; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	89	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110737	10.1371/journal.pone.0110737	http://dx.doi.org/10.1371/journal.pone.0110737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360623	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700044
J	Velasquez, JT; Watts, ME; Todorovic, M; Nazareth, L; Pastrana, E; Diaz-Nido, J; Lim, F; Ekberg, JAK; Quinn, RJ; St John, JA				Velasquez, Johana Tello; Watts, Michelle E.; Todorovic, Michael; Nazareth, Lynnmaria; Pastrana, Erika; Diaz-Nido, Javier; Lim, Filip; Ekberg, Jenny A. K.; Quinn, Ronald J.; St John, James A.			Low-Dose Curcumin Stimulates Proliferation, Migration and Phagocytic Activity of Olfactory Ensheathing Cells	PLOS ONE			English	Article							SPINAL-CORD-INJURY; IN-VITRO; OEC TRANSPLANTATION; AXONAL REGENERATION; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; NEURONAL DEBRIS; UP-REGULATION; EXPRESSION; MICROGLIA	One of the promising strategies for neural repair therapies is the transplantation of olfactory ensheathing cells (OECs) which are the glial cells of the olfactory system. We evaluated the effects of curcumin on the behaviour of mouse OECs to determine if it could be of use to further enhance the therapeutic potential of OECs. Curcumin, a natural polyphenol compound found in the spice turmeric, is known for its anti-cancer properties at doses over 10 mu M, and often at 50 mu M, and it exerts its effects on cancer cells in part by activation of MAP kinases. In contrast, we found that low-dose curcumin (0.5 mu M) applied to OECs strikingly modulated the dynamic morphology, increased the rate of migration by up to 4-fold, and promoted significant proliferation of the OECs. Most dramatically, low-dose curcumin stimulated a 10-fold increase in the phagocytic activity of OECs. All of these potently stimulated behavioural characteristics of OECs are favourable for neural repair therapies. Importantly, low-dose curcumin gave a transient activation of p38 kinases, which is in contrast to the high dose curcumin effects on cancer cells in which these MAP kinases tend to undergo prolonged activation. Low-dose curcumin mediated effects on OECs demonstrate cell-type specific stimulation of p38 and ERK kinases. These results constitute the first evidence that low-dose curcumin can modulate the behaviour of olfactory glia into a phenotype potentially more favourable for neural repair and thereby improve the therapeutic use of OECs for neural repair therapies.	[Velasquez, Johana Tello; Watts, Michelle E.; Todorovic, Michael; Nazareth, Lynnmaria; Ekberg, Jenny A. K.; Quinn, Ronald J.; St John, James A.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Nazareth, Lynnmaria; Ekberg, Jenny A. K.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Pastrana, Erika] Nat Commun, New York, NY USA; [Diaz-Nido, Javier] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lim, Filip] Univ Autonoma Madrid, Madrid, Spain	Griffith University; Queensland University of Technology (QUT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	St John, JA (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	j.stjohn@griffith.edu.au	Ekberg, Jenny/AAV-2006-2020; St John, James A/B-4478-2008; Quinn, Ronald J/A-7931-2008; Lim, Filip/C-7412-2011; Velasquez, Johana Tello/ABE-6109-2020; Watts, Michelle/V-8749-2019; St John, James/AAZ-9789-2020; Diaz-Nido, Javier/L-2371-2013	St John, James A/0000-0001-7536-3381; Quinn, Ronald J/0000-0002-4022-2623; Lim, Filip/0000-0001-6570-1017; Velasquez, Johana Tello/0000-0002-0065-4448; Watts, Michelle/0000-0002-3178-3429; St John, James/0000-0001-7536-3381; Pastrana, Erika/0000-0003-1745-8635; Ekberg, Jenny/0000-0001-5151-4966; Diaz-Nido, Javier/0000-0002-0927-7925; Nazareth, Lynn/0000-0002-0354-595X; Todorovic, Michael/0000-0003-0806-5610	Australian Research Council [DP0986294]	Australian Research Council(Australian Research Council)	The author(s) received funding for this work from Australian Research Council, Grant DP0986294 to JE (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Bisht K, 2009, BIOCHEM BIOPH RES CO, V379, P632, DOI 10.1016/j.bbrc.2008.12.135; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072; Chehrehasa F, 2010, MOL CELL NEUROSCI, V45, P277, DOI 10.1016/j.mcn.2010.07.002; Cholfin JA, 2008, J COMP NEUROL, V509, P144, DOI 10.1002/cne.21709; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DOUCETTE R, 1995, HISTOL HISTOPATHOL, V10, P503; Edelmann K, 2013, J COMP NEUROL, V521, P3099, DOI 10.1002/cne.23347; Ekberg JAK, 2011, J NEUROSCI METH, V196, P88, DOI 10.1016/j.jneumeth.2011.01.008; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; He BR, 2014, MOL NEUROBIOL, V49, P1501, DOI 10.1007/s12035-013-8588-2; Huang TY, 2010, J AGR FOOD CHEM, V58, P10639, DOI 10.1021/jf1016303; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kavakli HS, 2011, ULUS TRAVMA ACIL CER, V17, P14, DOI 10.5505/tjtes.2011.31391; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Leung JYK, 2008, CELL MOL LIFE SCI, V65, P2732, DOI 10.1007/s00018-008-8184-1; Li L, 2014, EUROPEAN SPINE J; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2003, J NEUROSCI, V23, P7783; Liao KK, 2012, J AGR FOOD CHEM, V60, P433, DOI 10.1021/jf203290r; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu Y, 2010, MOL VIS, V16, P2903; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x; Mimche PN, 2012, J ANTIMICROB CHEMOTH, V67, P1895, DOI 10.1093/jac/dks132; Moreno-Flores MT, 2003, J NEUROCHEM, V85, P861, DOI 10.1046/j.1471-4159.2003.01729.x; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Panni P, 2013, NEUROSCI LETT, V539, P65, DOI 10.1016/j.neulet.2013.01.052; Patzko A, 2012, BRAIN, V135, P3551, DOI 10.1093/brain/aws299; Ramon-Cueto A, 2000, PROG BRAIN RES, V128, P265; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Sandvig I, 2012, CONTRAST MEDIA MOL I, V7, P403, DOI 10.1002/cmmi.1465; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Simon D, 2011, GLIA, V59, P1458, DOI 10.1002/glia.21189; St John JA, 2003, CHEM SENSES, V28, P773, DOI 10.1093/chemse/bjg068; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Su ZD, 2013, GLIA, V61, P490, DOI 10.1002/glia.22450; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Su ZD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008141; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Windus LCE, 2007, GLIA, V55, P1708, DOI 10.1002/glia.20586; Windus LCE, 2011, CELL MOL LIFE SCI, V68, P3233, DOI 10.1007/s00018-011-0630-9; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Woodhall E, 2003, CELL MOL LIFE SCI, V60, P2241, DOI 10.1007/s00018-003-3265-7; Yamada J, 2013, J COMP NEUROL, V521, P1184, DOI 10.1002/cne.23228; Yan HL, 2003, GLIA, V44, P26, DOI 10.1002/glia.10265; Yang H, 2014, MOL NEUROBIOL; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	73	48	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111787	10.1371/journal.pone.0111787	http://dx.doi.org/10.1371/journal.pone.0111787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360677	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700150
J	Purrier, N; Engeland, WC; Kofuji, P				Purrier, Nicole; Engeland, William C.; Kofuji, Paulo			Mice Deficient of Glutamatergic Signaling from Intrinsically Photosensitive Retinal Ganglion Cells Exhibit Abnormal Circadian Photoentrainment	PLOS ONE			English	Article							CYCLASE-ACTIVATING PEPTIDE; SUPRACHIASMATIC NUCLEUS; PHOTIC ENTRAINMENT; VISUAL FUNCTIONS; PHASE-SHIFTS; LIGHT; MELANOPSIN; PACAP; RHYTHMS; CLOCK	Several aspects of behavior and physiology, such as sleep and wakefulness, blood pressure, body temperature, and hormone secretion exhibit daily oscillations known as circadian rhythms. These circadian rhythms are orchestrated by an intrinsic biological clock in the suprachiasmatic nuclei (SCN) of the hypothalamus which is adjusted to the daily environmental cycles of day and night by the process of photoentrainment. In mammals, the neuronal signal for photoentrainment arises from a small subset of intrinsically photosensitive retinal ganglion cells (ipRGCs) that send a direct projection to the SCN. ipRGCs also mediate other non-image-forming (NIF) visual responses such as negative masking of locomotor activity by light, and the pupillary light reflex (PLR) via co-release of neurotransmitters glutamate and pituitary adenylate cyclase-activating peptide (PACAP) from their synaptic terminals. The relative contribution of each neurotransmitter system for the circadian photoentrainment and other NIF visual responses is still unresolved. We investigated the role of glutamatergic neurotransmission for circadian photoentrainment and NIF behaviors by selective ablation of ipRGC glutamatergic synaptic transmission in mice. Mutant mice displayed delayed re-entrainment to a 6 h phase shift (advance or delay) in the light cycle and incomplete photoentrainment in a symmetrical skeleton photoperiod regimen (1 h light pulses between 11 h dark periods). Circadian rhythmicity in constant darkness also was reduced in some mutant mice. Other NIF responses such as the PLR and negative masking responses to light were also partially attenuated. Overall, these results suggest that glutamate from ipRGCs drives circadian photoentrainment and negative masking responses to light.	[Purrier, Nicole; Engeland, William C.; Kofuji, Paulo] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kofuji, P (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	kofuj001@.umn.edu	Kofuji, Paulo/AAR-7835-2021	Kofuji, Paulo/0000-0002-4840-9986	National Science Foundation grant [IOS1025119]; University of Minnesota Foundation Bridge Grant [B-0314-02]; NATIONAL EYE INSTITUTE [P30EY011374] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); University of Minnesota Foundation Bridge Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Science Foundation grant IOS1025119 (http://www.nsf.gov/div/index.jsp?div=IOS), and the University of Minnesota Foundation Bridge Grant B-0314-02 (http://www.mmf.umn.edu/academic/grants/faculty/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; Delwig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083974; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Engelund A, 2012, BRAIN RES, V1453, P17, DOI 10.1016/j.brainres.2012.03.005; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hatanaka M, 2008, NEUROSCI LETT, V444, P153, DOI 10.1016/j.neulet.2008.08.030; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Johnson J, 2007, J NEUROSCI, V27, P7245, DOI 10.1523/JNEUROSCI.0815-07.2007; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Kriegsfeld LJ, 2008, EUR J NEUROSCI, V27, P2907, DOI 10.1111/j.1460-9568.2008.06239.x; Laemle LK, 1998, PHYSIOL BEHAV, V64, P165, DOI 10.1016/S0031-9384(98)00045-6; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Mintz EM, 1999, J NEUROSCI, V19, P5124; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Sand A, 2012, PROG RETIN EYE RES; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sheely C, 2011, THESIS, P114; SHIRAKAWA T, 1994, NEUROSCI LETT, V178, P47, DOI 10.1016/0304-3940(94)90286-0; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Van Gelder RN, 2005, METHOD ENZYMOL, V393, P746, DOI 10.1016/S0076-6879(05)93039-5; Wassle H, 2006, J COMP NEUROL, V496, P544, DOI 10.1002/cne.20942; Wee R, 2002, J NEUROSCI, V22, P10427; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405	42	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111449	10.1371/journal.pone.0111449	http://dx.doi.org/10.1371/journal.pone.0111449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357191	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000063
J	Xin, JJ; Shang, QL; Desneux, N; Gao, XW				Xin, Juan-Juan; Shang, Qing-Li; Desneux, Nicolas; Gao, Xi-Wu			Genetic Diversity of Sitobion avenae (Homoptera: Aphididae) Populations from Different Geographic Regions in China	PLOS ONE			English	Article							CHERRY-OAT APHID; GRAIN APHID; LIFE-CYCLE; METAPOPULATION STRUCTURE; HEMIPTERA APHIDIDAE; SOYBEAN APHID; MICROSATELLITE; EVOLUTION; SOFTWARE; ARCHITECTURE	Sitobion avenae is a major agricultural pest of wheat in China. Using microsatellite markers, we studied the potential gene flow, genetic diversity, genetic differentiation, and genetic structure of seven S. avenae populations from different regions of China (Beijing, Hebei, Henan, Hubei, Jiangsu, Shandong, and Shanxi provinces). The populations from Henan, Shandong, and Jiangsu showed high levels of genic and genotypic diversity. By contrast, the genic diversity in the Beijing and Hebei populations was much lower. Despite this low genic diversity, the genotypic diversity of the Beijing population was higher than that of all of the other populations, except those from Jiangsu and Shandong. Overall, the genetic divergence among the seven S. avenae populations tested was high, though there was almost no differentiation between the Shandong and Henan populations. We observed significant negative correlation between the strength of gene flow and the geographic distances among populations. Based on genetic analysis, the seven S. avenae populations studied can be divided into four distinct clusters; (i) Hubei, (ii) Shanxi, (iii) Beijing and Hebei, and (iv) Shandong, Henan, and Jiangsu. The present results provide a basis for potentially optimizing integrated pest management (IPM) programs in China, through adapting control methods that target biological traits shared by various populations of the same genotype.	[Xin, Juan-Juan; Gao, Xi-Wu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Shang, Qing-Li] Jilin Univ, Coll Plant Sci & Technol, Changchun 130023, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	China Agricultural University; Jilin University; INRAE	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013		National Basic Research and Development Program of China [2012CB114103]	National Basic Research and Development Program of China(National Basic Research Program of China)	This research was supported by National Basic Research and Development Program of China (Contract No. 2012CB114103) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkhir K., 2004, GENETIX 4 05 LOGICIE; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; BLACKMAN RL, 1971, B ENTOMOL RES, V60, P533, DOI 10.1017/S0007485300042292; BLACKMAN RL, 1972, B ENTOMOL RES, V62, P281, DOI 10.1017/S0007485300047726; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Cai Qing-Nian, 2004, Entomological Knowledge, V41, P285; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Dedryver CA, 1998, ECOL ENTOMOL, V23, P123, DOI 10.1046/j.1365-2311.1998.00113.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Demotte F, 2001, P ROY SOC B, V263, P321; Dixon AFG, 1988, APHID ECOLOGY; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; Guo W, 2005, PROG NAT SCI-MATER, V15, P1000; Hand S. C., 1980, Bulletin SROP, V3, P59; HARDIE J, 1993, J AGR ENTOMOL, V10, P239; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JAMES BD, 1982, ECOL ENTOMOL, V7, P277, DOI 10.1111/j.1365-2311.1982.tb00667.x; Klueken AM, 2012, J APPL ENTOMOL, V135, P347, DOI 10.1111/j.1439-0418.2011.01654.x; Lavandero B, 2009, B ENTOMOL RES, V99, P97, DOI 10.1017/S0007485308006196; LEATHER SR, 1980, ENTOMOL EXP APPL, V27, P96, DOI 10.1007/BF00377245; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lopes-Da-Silva M, 2010, BRAZ ARCH BIOL TECHN, V53, P911, DOI 10.1590/S1516-89132010000400021; LOXDALE HD, 1985, B ENTOMOL RES, V75, P121, DOI 10.1017/S0007485300014218; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; Loxdale HD, 2003, INFECT GENET EVOL, V3, P259, DOI 10.1016/S1567-1348(03)00091-1; Loxdale HD, 2011, BIOL J LINN SOC, V104, P838, DOI 10.1111/j.1095-8312.2011.01761.x; Lu Y, 2009, B ENTOMOL RES, V99, P611, DOI 10.1017/S0007485309006725; Lu YH, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.0901; Lushai G, 2002, GENET RES, V79, P1, DOI 10.1017/S0016672301009582; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Margaritopoulos John T., 2009, BMC Ecology, V9, P13, DOI 10.1186/1472-6785-9-13; Massonnet B, 2002, MOL ECOL, V11, P2511, DOI 10.1046/j.1365-294X.2002.01633.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Ota T, 1993, DISPAN GENETIC DISTA; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Power Alison G., 1995, P259; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rispe C, 1998, J EVOLUTION BIOL, V11, P685, DOI 10.1007/s000360050113; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SIMON JC, 1991, B ENTOMOL RES, V81, P315, DOI 10.1017/S0007485300033599; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; SIMON JC, 1995, HEREDITY, V74, P346, DOI 10.1038/hdy.1995.52; SLATKIN M, 1981, GENETICS, V99, P323; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venette RC, 2004, ANN ENTOMOL SOC AM, V97, P219, DOI 10.1603/0013-8746(2004)097[0219:ATIBSA]2.0.CO;2; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Wilson ACC, 1997, GENET RES, V69, P233, DOI 10.1017/S0016672397002747; Wright S, 1978, EVOLUTION GENETICS P, V4, P79; Wright S., 1969, EVOLUTION GENETICS P; Xu ZH, 2011, AGR SCI CHINA, V10, P1041, DOI 10.1016/S1671-2927(11)60092-8; Xu ZH, 2011, J ECON ENTOMOL, V104, P1080, DOI 10.1603/EC10204; Zhang B, 2012, MOL ECOL, V21, P2130, DOI 10.1111/j.1365-294X.2012.05517.x; Zhang Y, 2008, ENVIRON ENTOMOL, V37, P301, DOI 10.1603/0046-225X(2008)37[301:FPOTSA]2.0.CO;2; Zhang YJ, 2009, CHINA PLANT PROT, V29, P33	70	20	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109349	10.1371/journal.pone.0109349	http://dx.doi.org/10.1371/journal.pone.0109349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356548	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000005
J	Braun, N; Thorne, JD; Hildebrandt, H; Debener, S				Braun, Niclas; Thorne, Jeremy D.; Hildebrandt, Helmut; Debener, Stefan			Interplay of Agency and Ownership: The Intentional Binding and Rubber Hand Illusion Paradigm Combined	PLOS ONE			English	Article							SELF-ATTRIBUTION; PREMOTOR CORTEX; SENSE; BODY; MODEL; CONTRIBUTE; MOVEMENT; BRAIN; THATS; TIME	The sense of agency (SoA) refers to the phenomenal experience of initiating and controlling an action, whereas the sense of ownership (SoO) describes the feeling of myness an agent experiences towards his or her own body parts. SoA has been investigated with intentional binding paradigms, and the sense of ownership (SoO) with the rubber-hand illusion (RHI). We investigated the relationship between SoA and SoO by incorporating intentional binding into the RHI. Explicit and implicit measures of agency (SoA-questionnaire, intentional binding) and ownership (SoO-questionnaire, proprioceptive drift) were used. Artificial hand position (congruent/incongruent) and mode of agent (self-agent/other-agent) were systematically varied. Reported SoO varied mainly with position (higher in congruent conditions), but also with agent (higher in self-agent conditions). Reported SoA was modulated by agent (higher in self-agent conditions), and moderately by position (higher in congruent conditions). Implicit and explicit agency measures were not significantly correlated. Finally, intentional binding tended to be stronger in self-generated than observed voluntary actions. Results provide further evidence for a partial double dissociation between SoA and SoO, empirically distinct agency levels, and moderate intentional binding differences between self-generated and observed voluntary actions.	[Braun, Niclas; Thorne, Jeremy D.; Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-26111 Oldenburg, Germany; [Hildebrandt, Helmut] Klinikum Bremen Ost, Dept Neurol, Bremen, Germany; [Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Klinikum Bremen-Ost; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Braun, N (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-26111 Oldenburg, Germany.	niclas.braun@uni-oldenburg.de						Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Buehner MJ, 2012, PSYCHOL SCI, V23, P1490, DOI 10.1177/0956797612444612; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Carruthers G, 2013, J CONSCIOUSNESS STUD, V20, P33; Chambon V, 2013, CEREB CORTEX, V23, P1031, DOI 10.1093/cercor/bhs059; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gallagher S, 2007, PHILOS COMPASS, V2, P347, DOI 10.1111/j.1747-9991.2007.00067.x; Guterstam A, 2011, PLOS ONE, V6; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore JW, 2012, CONSCIOUS COGN, V21, P1748, DOI 10.1016/j.concog.2012.10.005; Moore JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00023; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Noe A., 2006, ACTION PERCEPTION; Perez-Marcos D, 2012, COGN NEURODYNAMICS, V6, P295, DOI 10.1007/s11571-011-9178-5; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Poonian SK, 2013, EXP BRAIN RES, V229, P419, DOI 10.1007/s00221-013-3505-5; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Siewert C., 2005, PHENOMENOLOGY PHILOS; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Thompson E., 2005, PHENOMENOL COGN SCI, V4/, P407, DOI [10.1007/s11097-005--9003-x, DOI 10.1007/S11097-005-9003-X]; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; Wohlschlager A, 2003, CONSCIOUS COGN, V12, P708, DOI 10.1016/S1053-8100(03)00083-7; Wohlschlager A, 2003, PSYCHOL SCI, V14, P586, DOI 10.1046/j.0956-7976.2003.psci_1469.x; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wong Hong Yu, 2010, COMPANION PHILOS ACT, P227, DOI DOI 10.1002/9781444323528.CH29; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011; [No title captured]	55	49	49	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111967	10.1371/journal.pone.0111967	http://dx.doi.org/10.1371/journal.pone.0111967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369067	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000132
J	Pahr, S; Selb, R; Weber, M; Focke-Tejkl, M; Hofer, G; Dordic, A; Keller, W; Papadopoulos, NG; Giavi, S; Makela, M; Pelkonen, A; Niederberger, V; Vrtala, S; Valenta, R				Pahr, Sandra; Selb, Regina; Weber, Milena; Focke-Tejkl, Margarete; Hofer, Gerhard; Dordic, Andela; Keller, Walter; Papadopoulos, Nikolaos G.; Giavi, Stavroula; Makela, Mika; Pelkonen, Anna; Niederberger, Verena; Vrtala, Susanne; Valenta, Rudolf			Biochemical, Biophysical and IgE-Epitope Characterization of the Wheat Food Allergen, Tri a 37	PLOS ONE			English	Article							EXERCISE-INDUCED ANAPHYLAXIS; MOLECULAR-WEIGHT GLUTENIN; PEPTIDES; PROTEINS; ALPHA-1-PUROTHIONIN; IDENTIFICATION; IMMUNOTHERAPY; DIGESTIBILITY; GLIADIN	Wheat is an important staple food and potent allergen source. Recently, we isolated a cDNA coding for wheat alpha-purothionin which is recognized by wheat food allergic patients at risk for severe wheat-induced allergy. The purpose of the present study was the biochemical, biophysical and IgE epitope characterization of recombinant alpha-purothionin. Synthetic genes coding for alpha-purothionin were expressed in a prokaryotic system using Escherichia coli and in a eukaryotic expression system based on baculovirus-infected Sf9-insect cells. Recombinant proteins were purified and characterized by SDS-PAGE, mass spectrometry, circular dichroism, chemical cross-linking and size exclusion chromatography. Five overlapping peptid were synthesized for epitope mapping. Alpha-purothionin-specific rabbit antibodies were raised to perform IgE-inhibition experiments and to study the resistance to digestion. The IgE reactivity of the proteins and peptides from ten wheat food allergic patients was studied in non-denaturing RAST-based binding assays. Alpha-purothionin was expressed in the prokaryotic (EcTri a 37) and in the eukaryotic system (BvTri a 37) as a soluble and monomeric protein. However, circular dichroism analysis revealed that EcTri a 37 was unfolded whereas BvTri a 37 was a folded protein. Both proteins showed comparable IgE-reactivity and the epitope mapping revealed the presence of sequential IgE epitopes in the N-terminal basic thionin domain (peptide1:KSCCRSTLGRNCYNLCRARGAQKLCAGVCR) and in the C-terminal acidic extension domain (peptide3:KGFPKLALESNSDEPDTIEYCNLGCRSSVC, peptide4:CNLGCRSSVCDYMV-NAAADDEEMKLYVEN). Natural Tri a 37 was digested under gastric conditions but resistant to duodenal digestion. Immunization with EcTri a 37 induced IgG antibodies which recognized similar epitopes as IgE antibodies from allergic patients and inhibited allergic patients' IgE binding. Reactivity to Tri a 37 does not require a folded protein and the presence of sequential IgE epitopes indicates that sensitization to alpha-purothionin occurs via the gut. Both allergens can be used for in-vitro diagnosis of wheat food allergy. The induction of blocking IgG antibodies suggests the usefulness for immunotherapy.	[Pahr, Sandra; Weber, Milena; Focke-Tejkl, Margarete; Vrtala, Susanne; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Pahr, Sandra; Vrtala, Susanne] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria; [Selb, Regina; Niederberger, Verena] Med Univ Vienna, Dept ENT, Vienna, Austria; [Hofer, Gerhard; Dordic, Andela; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Papadopoulos, Nikolaos G.; Giavi, Stavroula] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece; [Makela, Mika; Pelkonen, Anna] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Graz; National & Kapodistrian University of Athens; University of Helsinki; Helsinki University Central Hospital	Valenta, R (corresponding author), Med Univ Vienna, Ctr Pathophysiol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at	Pelkonen, Anna/D-3153-2018; Papadopoulos, Nikolaos/ABE-1774-2021; Keller, Walter/AAW-1501-2021; N.G., Papadopoulos/L-8670-2013	Pelkonen, Anna/0000-0002-1482-8947; Papadopoulos, Nikolaos/0000-0002-4448-3468; Keller, Walter/0000-0002-2261-958X; N.G., Papadopoulos/0000-0002-4448-3468; Valenta, Rudolf/0000-0001-5944-3365; Hofer, Gerhard/0000-0002-9248-6989; Selb, Regina/0000-0001-5531-5198; Vrtala, Susanne/0000-0003-4250-8243	Phadia-Thermo Fisher, Uppsala, Sweden; Christian Doppler Research Association, Austria; Austrian Science Fund (FWF) [F4605]; European Commission [261357]	Phadia-Thermo Fisher, Uppsala, Sweden; Christian Doppler Research Association, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by research grants from Phadia-Thermo Fisher, Uppsala, Sweden, the Christian Doppler Research Association, Austria, project F4605 of the Austrian Science Fund (FWF) and in part by the European Commission's Seventh Framework program under grant agreement no. 261357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asero R, 2009, INT ARCH ALLERGY IMM, V150, P271, DOI 10.1159/000222679; Baar A, 2014, J ALLERGY CLIN IMMUN, V133, P585, DOI 10.1016/j.jaci.2013.10.044; Baar A, 2012, J IMMUNOL, V189, P3018, DOI 10.4049/jimmunol.1200438; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; Campana R, 2011, MOL IMMUNOL, V48, P431, DOI 10.1016/j.molimm.2010.09.016; Chen KW, 2012, J ALLERGY CLIN IMMUN, V130, P435, DOI 10.1016/j.jaci.2012.05.035; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; Cordain L, 1999, World Rev Nutr Diet, V84, P19; Focke M, 2001, FASEB J, V15, P2042, DOI 10.1096/fj.01-0016fje; Helm Ricki M, 2008, Clin Allergy Immunol, V21, P219; Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Marlovits TC, 1998, J MOL RECOGNIT, V11, P49, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<49::AID-JMR388>3.0.CO;2-3; Matsuo H, 2005, J IMMUNOL, V175, P8116, DOI 10.4049/jimmunol.175.12.8116; Matsuo H, 2005, FEBS J, V272, P4431, DOI 10.1111/j.1742-4658.2005.04858.x; Nowak-Wegrzyn A, 2007, NESTLE NUTR WORKS SE, V59, P17, DOI 10.1159/000098510; Pahr S, 2012, CLIN EXP ALLERGY, V42, P597, DOI 10.1111/j.1365-2222.2012.03961.x; Pahr S, 2013, J ALLERGY CLIN IMMUN, V132, P1000, DOI 10.1016/j.jaci.2013.05.016; Palacin A, 2010, INT ARCH ALLERGY IMM, V152, P178, DOI 10.1159/000265539; Pourpak Z, 2004, INT ARCH ALLERGY IMM, V133, P168, DOI 10.1159/000076623; Reese G, 2001, J CHROMATOGR B, V756, P157, DOI 10.1016/S0378-4347(01)00104-9; Roth-Walter F, 2013, MOL NUTR FOOD RES, V57, P536, DOI 10.1002/mnfr.201200612; Sampson HA, 2006, ANN EMERG MED, V47, P373, DOI 10.1016/j.annemergmed.2006.01.018; TEETER MM, 1990, PROTEINS, V8, P118, DOI 10.1002/prot.340080203; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Untersmayr E, 2008, J ALLERGY CLIN IMMUN, V121, P1301, DOI 10.1016/j.jaci.2008.04.025; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Vila L, 2001, CLIN EXP ALLERGY, V31, P1599, DOI 10.1046/j.1365-2222.2001.01218.x; Zuidmeer-Jongejan Laurian, 2012, Clin Transl Allergy, V2, P5, DOI 10.1186/2045-7022-2-5	31	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111483	10.1371/journal.pone.0111483	http://dx.doi.org/10.1371/journal.pone.0111483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368998	Green Submitted, gold, Green Published			2022-12-26	WOS:000344402000058
J	Ramalho, FS; Pachu, JKS; Lira, ACS; Malaquias, JB; Zanuncio, JC; Fernandes, FS				Ramalho, Francisco S.; Pachu, Jessica K. S.; Lira, Aline C. S.; Malaquias, Jose B.; Zanuncio, Jose C.; Fernandes, Francisco S.			Feeding and Dispersal Behavior of the Cotton Leafworm, Alabama argillacea (Hubner) (Lepidoptera: Noctuidae), on Bt and Non-Bt Cotton: Implications for Evolution and Resistance Management	PLOS ONE			English	Article							CORN-BORER LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; TRANSGENIC CORN; SEED MIXTURES; CRAMBIDAE; TEMPERATURE; SURVIVAL; CRY1AC; CROPS; ADAPTATION	The host acceptance of neonate Alabama argillacea (Hubner) (Lepidoptera: Noctuidae) larvae to Bt cotton plants exerts a strong influence on the potential risk that this pest will develop resistance to Bt cotton. This will also determine the efficiency of management strategies to prevent its resistance such as the "refuge-in-the-bag'' strategy. In this study, we assessed the acceptance of neonate A. argillacea larvae to Bt and non-Bt cotton plants at different temperatures during the first 24 h after hatching. Two cotton cultivars were used in the study, one a Bt DP 404 BG (Bollgard) cultivar, and the other, an untransformed isoline, DP 4049 cultivar. There was a greater acceptance by live neonate A. argillacea larvae for the non-Bt cotton plants compared with the Bt cotton plants, especially in the time interval between 18 and 24 h. The percentages of neonate A. argillacea larvae found on Bt or non-Bt plants were lower when exposed to temperatures of 31 and 34 degrees C. The low acceptance of A. argillacea larvae for Bt cotton plants at high temperatures stimulated the dispersion of A. argillacea larvae. Our results support the hypothesis that the dispersion and/or feeding behavior of neonate A. argillacea larvae is different between Bt and non-Bt cotton. The presence of the Cry1Ac toxin in Bt cotton plants, and its probable detection by the A. argillacea larvae tasting or eating it, increases the probability of dispersion from the plant where the larvae began. These findings may help to understand how the A. argillacea larvae detect the Cry1Ac toxin in Bt cotton and how the toxin affects the dispersion behavior of the larvae over time. Therefore, our results are extremely important for the management of resistance in populations of A. argillacea on Bt cotton.	[Ramalho, Francisco S.; Pachu, Jessica K. S.; Lira, Aline C. S.; Malaquias, Jose B.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil.	ramalhohvv@globo.com	Lira, Aline/C-2354-2017; Pachú, Jéssica KS/F-3326-2016; FS, Ramalho/AAC-8058-2019; Pachú, Jéssica/T-2365-2019; Malaquias, José Bruno B/I-1945-2015; Fernandes, Francisco/E-4608-2016	Lira, Aline/0000-0002-8592-2068; Pachú, Jéssica KS/0000-0001-5224-4814; Malaquias, José Bruno B/0000-0003-3937-9575; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Financiadora de Estudos e Projetos - FINEP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos - FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and Financiadora de Estudos e Projetos - FINEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2011, MOL ECOL RESOUR, V11, P219, DOI 10.1111/j.1755-0998.2010.02944.x; Agi A. L., 2001, Journal of Cotton Science, V5, P74; Albernaz KC, 2013, J ECON ENTOMOL, V106, P1819, DOI 10.1603/EC12222; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Andrade CFS, 1984, REV BRAS ZOOL, V2, P55; Askew R.R., 1986, P225; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bleicher E, 1981, 2 EMBRAPACNPA; Carvalho SM, 1981, THESIS ESALQ USP PIR; Chen DH, 2005, ENVIRON EXP BOT, V53, P333, DOI 10.1016/j.envexpbot.2004.04.004; Chen Y, 2013, SPAN J AGRIC RES, V11, P438, DOI 10.5424/sjar/2013112-2854; Chen Y, 2012, FIELD CROP RES, V137, P141, DOI 10.1016/j.fcr.2012.08.015; Davis PM, 1997, J KANSAS ENTOMOL SOC, V70, P31; Davis PM, 2000, J ECON ENTOMOL, V93, P937, DOI 10.1603/0022-0493-93.3.937; Lima MS, 2011, PESQUI AGROPECU BRAS, V46, P451, DOI 10.1590/S0100-204X2011000500001; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Fernandes Marcos G., 1999, Anais da Sociedade Entomologica do Brasil, V28, P695, DOI 10.1590/S0301-80591999000400012; Goldstein JA, 2010, J ECON ENTOMOL, V103, P331, DOI 10.1603/EC09304; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; Gravena S, 1991, B TECNICO; Hardee DD, 2000, USDAARS154; Huang FN, 2002, J ECON ENTOMOL, V95, P614, DOI 10.1603/0022-0493-95.3.614; JOHANSEN DONALD ALEXANDER, 1940; Jongsma MA, 2010, EVOL ECOL, V24, P1017, DOI 10.1007/s10682-010-9368-3; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lopez C, 2013, ENTOMOL EXP APPL, V149, P256, DOI 10.1111/eea.12131; MALLET J, 1992, P ROY SOC B-BIOL SCI, V250, P165, DOI 10.1098/rspb.1992.0145; Medeiros R. S., 2003, Braz. J. Biol., V63, P589, DOI 10.1590/S1519-69842003000400006; Nascimento ARB, 2011, ANN ENTOMOL SOC AM, V104, P613, DOI 10.1603/AN10195; Oliveira J. E. de M., 2008, Cientifica (Jaboticabal), V36, P1; Olsen KM, 2005, J ECON ENTOMOL, V98, P1382, DOI 10.1603/0022-0493-98.4.1382; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Papaj D.R., 1983, P77; RAMALHO FS, 1994, ANNU REV ENTOMOL, V39, P563, DOI 10.1146/annurev.en.39.010194.003023; Razze JM, 2011, J ECON ENTOMOL, V104, P806, DOI 10.1603/EC10287; Santos R. L., 2010, Revista Brasileira de Ciencias Agrarias (Agraria), V5, P509, DOI 10.5039/agraria.v5i4a942; SAS Institute, 2006, SAS STAT US GUID; Schnepf EN, 1999, BIOCONTROL N INFORM, V20, P47; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Silva TBM, 2011, CROP PROT, V30, P1156, DOI 10.1016/j.cropro.2011.05.022; Sousa MEC, 2010, J INSECT PHYSIOL, V56, P1913, DOI 10.1016/j.jinsphys.2010.08.014; Tang JD, 2001, J ECON ENTOMOL, V94, P240, DOI 10.1603/0022-0493-94.1.240; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Walker KA, 2000, J ECON ENTOMOL, V93, P1276, DOI 10.1603/0022-0493-93.4.1276; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220	46	21	21	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111588	10.1371/journal.pone.0111588	http://dx.doi.org/10.1371/journal.pone.0111588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369211	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000070
J	Bennett, AB; Meehan, TD; Gratton, C; Isaacs, R				Bennett, Ashley B.; Meehan, Timothy D.; Gratton, Claudio; Isaacs, Rufus			Modeling Pollinator Community Response to Contrasting Bioenergy Scenarios	PLOS ONE			English	Article							FRUIT-SET; SERVICES; BIOFUELS; DIVERSITY; CROPS; ARTHROPODS; LANDSCAPES; INCREASES; BIOMASS; ENERGY	In the United States, policy initiatives aimed at increasing sources of renewable energy are advancing bioenergy production, especially in the Midwest region, where agricultural landscapes dominate. While policy directives are focused on renewable fuel production, biodiversity and ecosystem services will be impacted by the land-use changes required to meet production targets. Using data from field observations, we developed empirical models for predicting abundance, diversity, and community composition of flower-visiting bees based on land cover. We used these models to explore how bees might respond under two contrasting bioenergy scenarios: annual bioenergy crop production and perennial grassland bioenergy production. In the two scenarios, 600,000 ha of marginal annual crop land or marginal grassland were converted to perennial grassland or annual row crop bioenergy production, respectively. Model projections indicate that expansion of annual bioenergy crop production at this scale will reduce bee abundance by 0 to 71%, and bee diversity by 0 to 28%, depending on location. In contrast, converting annual crops on marginal soil to perennial grasslands could increase bee abundance from 0 to 600% and increase bee diversity between 0 and 53%. Our analysis of bee community composition suggested a similar pattern, with bee communities becoming less diverse under annual bioenergy crop production, whereas bee composition transitioned towards a more diverse community dominated by wild bees under perennial bioenergy crop production. Models, like those employed here, suggest that bioenergy policies have important consequences for pollinator conservation.	[Bennett, Ashley B.; Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Bennett, Ashley B.; Isaacs, Rufus] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Isaacs, R (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	isaacsr@msu.edu	Isaacs, Rufus/AAF-4646-2019	Isaacs, Rufus/0000-0001-7523-4643; Gratton, Claudio/0000-0001-6262-9670	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy and Renewable Energy [DE-AC05-76RL01830]; USDA-NIFA grant [2012-67009-20146]	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy and Renewable Energy(United States Department of Energy (DOE)); USDA-NIFA grant	This work was funded by the Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494), DOE OBP Office of Energy and Renewable Energy (DE-AC05-76RL01830), and by a USDA-NIFA grant to CG and RI(2012-67009-20146). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2012, P ROY SOC B-BIOL SCI, V279, P4845, DOI 10.1098/rspb.2012.1621; Bartomeus I, 2013, ECOL LETT, V16, P1331, DOI 10.1111/ele.12170; Barton K, 2013, MUMIN MULIT MODEL IN; BJORNSTAD ON, 2013, NCF SPATIAL NONPARAM; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Clarke K. R., 2001, CHANGES MARINE COMMU; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gibbs J, 2011, ZOOTAXA, P1; GINSBERG HS, 1983, ECOLOGY, V64, P165, DOI 10.2307/1937338; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jarchow ME, 2012, CROP SCI, V52, P1330, DOI 10.2135/cropsci2011.09.0481; Johnston CA, 2014, LANDSCAPE ECOL, V29, P81, DOI 10.1007/s10980-013-9947-0; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Landis DA, 2010, INSECT SCI, V17, P220, DOI 10.1111/j.1744-7917.2009.01310.x; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACIOR LW, 1968, ECOLOGY, V49, P20, DOI 10.2307/1933556; McCune B, 2002, ANAL ECOLOGICAL COMM; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Meehan TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041728; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rehan SM, 2011, ZOOTAXA, P35; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2013, ECOL APPL, V23, P1113, DOI 10.1890/12-1600.1; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Schubert C, 2006, NAT BIOTECHNOL, V24, P777, DOI 10.1038/nbt0706-777; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tyner WE, 2008, BIOSCIENCE, V58, P646, DOI 10.1641/B580718; Werling BP, 2011, BIOL CONTROL, V59, P304, DOI 10.1016/j.biocontrol.2011.06.014; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wu F, 2013, J ECON DYN CONTROL, V37, P1755, DOI 10.1016/j.jedc.2013.03.013	56	21	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110676	10.1371/journal.pone.0110676	http://dx.doi.org/10.1371/journal.pone.0110676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365559	Green Published, gold			2022-12-26	WOS:000345558100025
J	Bratcher, PE; Gaggar, A				Bratcher, Preston E.; Gaggar, Amit			Factors Influencing the Measurement of Plasma/Serum Surfactant Protein D Levels by ELISA	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL-SIGNIFICANCE; SYSTEMIC-SCLEROSIS; SERUM-LEVELS; RADIATION PNEUMONITIS; RHEUMATOID-ARTHRITIS; BIOMARKER PROFILES; CIRCULATING LEVELS	Background: Extensive variations in human surfactant protein D (SP-D) levels in circulation as measured by ELISA exist in the published literature. In order to determine the source of these variations, factors influencing the measurement by ELISA were explored. Materials and Methods: Peripheral blood from healthy individuals was collected into various vacutainers during the same blood draw. Recombinant SP-D was diluted into different matrices and used for a standard curve. Samples were analyzed by capture ELISA using one of two distinct detection antibodies. Results: The type of matrix had some effects on detection of recombinant SP-D. The type of anticoagulant used and dilution factor had very little effect, except for in plasma collected in EDTA vacutainers. The extent of variation in published values seemed to be due to the ELISA configuration employed, and, in agreement with this, we found that by switching the detection antibody, there was a 50% decrease in the extrapolated SP-D value of serum and plasma samples. Storage of samples resulted in slight changes in measured SP-D levels. Conclusions: The ELISA configuration employed to measure circulating levels of SP-D has a significant effect on the extrapolated values. In both configurations tested, the use of EDTA as a coagulant resulted in inconsistent values, and we, therefore, suggest the avoidance of this anticoagulant when assaying for SP-D by ELISA. While the demonstrated effects of several factors on measurement of SP-D may not account for all the disparities amongst the previous studies, they stress that variations in methodologies for measuring the same protein can result in very inconsistent results.	[Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] US Dept Vet Affairs, Med Serv, Med Ctr, Birmingham, AL USA; [Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Program Protease & Matrix Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; University of Alabama System; University of Alabama Birmingham	Bratcher, PE (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bratcher@uab.edu			National Institutes of Health [HL102371, 5T32HL105346-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, T32HL105346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health (HL102371 to AG and 5T32HL105346-02 to PEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2011, RESP MED, V105, P939, DOI 10.1016/j.rmed.2011.02.016; Al-Salmi QA, 2005, CHEST, V127, P403, DOI 10.1378/chest.127.1.403; Ando M, 2010, LUNG, V188, P247, DOI 10.1007/s00408-009-9223-x; Arai Y, 2001, EUR J PEDIATR, V160, P425, DOI 10.1007/s004310100763; Asano Y, 2001, ARTHRITIS RHEUM-US, V44, P1363, DOI 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; Aul R, 2012, BRIT J CLIN PHARMACO, V74, P1023, DOI 10.1111/j.1365-2125.2012.04287.x; Bejvl I, 2013, TRANSPL INFECT DIS, V15, P645, DOI 10.1111/tid.12132; Bratcher PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073467; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Christensen AF, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2948; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Determann RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-6; Determann Rogier M, 2009, BMC Pulm Med, V9, P49, DOI 10.1186/1471-2466-9-49; Duda I, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-24; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; Elhaj M, 2013, J RHEUMATOL, V40, P1114, DOI 10.3899/jrheum.120997; Engels GE, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-4; Engstrom G, 2012, RESP MED, V106, P1250, DOI 10.1016/j.rmed.2012.05.004; Fernandez-Luna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068447; Gil HW, 2007, CLIN TOXICOL, V45, P463, DOI 10.1080/15563650701338138; Glas J, 2008, TISSUE ANTIGENS, V72, P21, DOI 10.1111/j.1399-0039.2008.01056.x; Gravholt CH, 2004, EUR J ENDOCRINOL, V150, P355, DOI 10.1530/eje.0.1500355; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Greene KE, 2002, EUR RESPIR J, V19, P439, DOI 10.1183/09031936.02.00081102; Haddam N, 2009, BIOMARKERS, V14, P292, DOI 10.1080/13547500902989088; Hant FN, 2009, J RHEUMATOL, V36, P773, DOI 10.3899/jrheum.080633; Heidinger K, 2005, IMMUNOGENETICS, V57, P1, DOI 10.1007/s00251-005-0775-5; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Higashi A, 2005, EUR RESPIR J, V26, P1069, DOI 10.1183/09031936.05.00106104; Hill J, 2011, EUR HEART J, V32, P1918, DOI 10.1093/eurheartj/ehr124; Hoegh SV, 2008, SCAND J IMMUNOL, V67, P71, DOI 10.1111/j.1365-3083.2007.02039.x; Hoegh SV, 2010, IMMUNOBIOLOGY, V215, P314, DOI 10.1016/j.imbio.2009.05.001; Hoegh SV, 2009, J RHEUMATOL, V36, P2449, DOI 10.3899/jrheum.090069; Hoffmann HJ, 2003, ANN AGR ENV MED, V10, P53; Hohwy T, 2006, EXP DERMATOL, V15, P168, DOI 10.1111/j.1600-0625.2006.00406.x; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Ichiyasu H, 2012, RESPIRATION, V83, P190, DOI 10.1159/000326924; Ihn H, 2002, RHEUMATOLOGY, V41, P1268, DOI 10.1093/rheumatology/41.11.1268; Ilumets H, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-19; Janssen R, 2003, CHEST, V124, P2119, DOI 10.1378/chest.124.6.2119; Ju CR, 2012, DIS MARKERS, V32, P281, DOI [10.1155/2012/509063, 10.3233/DMA-2011-0887]; Kamada S, 2000, FORENSIC SCI INT, V109, P51, DOI 10.1016/S0379-0738(99)00214-5; Kawasaki Y, 2011, PEDIATR PULM, V46, P18, DOI 10.1002/ppul.21270; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kobayashi H, 2008, BIOMARKERS, V13, P385, DOI [10.1080/13547500801903651, 10.1080/13547500801903651 ]; Koopmans JG, 2004, CLIN EXP ALLERGY, V34, P1827, DOI 10.1111/j.1365-2222.2004.02083.x; Kotecha S, 2013, THORAX, V68, P460, DOI 10.1136/thoraxjnl-2012-202729; Krane M, 2003, EUR RESPIR J, V22, P592, DOI 10.1183/09031936.03.00060603; Kuwano K, 2002, RESPIROLOGY, V7, P15, DOI 10.1046/j.1440-1843.2002.00369.x; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; Lin FC, 2008, MAYO CLIN PROC, V83, P1344, DOI 10.1016/S0025-6196(11)60782-9; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Maeda M, 2001, J DERMATOL, V28, P467, DOI 10.1111/j.1346-8138.2001.tb00013.x; Fernandez-Real JM, 2010, DIABETES CARE, V33, P847, DOI 10.2337/dc09-0542; Mutti A, 2006, CHEST, V129, P1288, DOI 10.1378/chest.129.5.1288; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nishida S, 2011, PEDIATR INT, V53, P910, DOI 10.1111/j.1442-200X.2011.03398.x; Nybo M, 2007, CLIN IMMUNOL, V123, P333, DOI 10.1016/j.clim.2007.03.001; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; Olesen HV, 2010, J CYST FIBROS, V9, P257, DOI 10.1016/j.jcf.2010.03.011; Ozyurek BA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-36; Sasaki R, 2001, INT J RADIAT ONCOL, V50, P301, DOI 10.1016/S0360-3016(00)01591-1; Shah RJ, 2012, J HEART LUNG TRANSPL, V31, P942, DOI 10.1016/j.healun.2012.05.001; Shakoori TA, 2009, DIS MARKERS, V27, P287, DOI [10.3233/DMA-2009-0674, 10.1155/2009/759304]; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P2262, DOI 10.1158/1055-9965.EPI-11-0326; Sims MW, 2011, CHEST, V140, P489, DOI 10.1378/chest.10-2065; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Sorensen GL, 2006, SCAND J IMMUNOL, V64, P633, DOI 10.1111/j.1365-3083.2006.01853.x; Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014; Takahashi H, 2006, RESPIROLOGY, V11, pS51, DOI 10.1111/j.1440-1843.2006.00809.x; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P258, DOI 10.1164/ajrccm.162.1.9903014; Takahashi H, 2001, EUR RESPIR J, V17, P481, DOI 10.1183/09031936.01.17304810; Tkacova R, 2010, MED SCI MONITOR, V16, pCR540; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Um SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083881; Van Miert E, 2011, EUR RESPIR J, V38, P1287, DOI 10.1183/09031936.00000911; Van Miert E, 2012, PEDIATR PULM, V47, P358, DOI 10.1002/ppul.21554; Vizcaya D, 2013, RESP MED, V107, P673, DOI 10.1016/j.rmed.2013.01.011; Wang SX, 2007, J OCCUP ENVIRON MED, V49, P834, DOI 10.1097/JOM.0b013e318124a927; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13080; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Watkins TR, 2008, CRIT CARE MED, V36, P1493, DOI 10.1097/CCM.0b013e318170a9ce; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29; Wu YP, 2009, SCAND J IMMUNOL, V69, P508, DOI 10.1111/j.1365-3083.2009.02245.x; Wutzler S, 2011, J TRAUMA, V71, pE31, DOI 10.1097/TA.0b013e3181f6f0b4; Yanaba K, 2004, J RHEUMATOL, V31, P1112; Zhao XM, 2007, SCAND J IMMUNOL, V66, P71, DOI 10.1111/j.1365-3083.2007.01943.x	92	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111466	10.1371/journal.pone.0111466	http://dx.doi.org/10.1371/journal.pone.0111466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365324	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100068
J	Garruna-Hernandez, R; Orellana, R; Larque-Saavedra, A; Canto, A				Garruna-Hernandez, Rene; Orellana, Roger; Larque-Saavedra, Alfonso; Canto, Azucena			Understanding the Physiological Responses of a Tropical Crop (Capsicum chinense Jacq.) at High Temperature	PLOS ONE			English	Article							HEAT-STRESS; FRUIT ABORTION; PHOTOSYNTHESIS; ACCLIMATION; RUBISCO; CLIMATE; GROWTH; PEPPER; L.	Temperature is one of the main environmental factors involved in global warming and has been found to have a direct effect on plants. However, few studies have investigated the effect of higher temperature on tropical crops. We therefore performed an experiment with a tropical crop of Habanero pepper (Capsicum Chinense Jacq.). Three growth chambers were used, each with 30 Habanero pepper plants. Chambers were maintained at a diurnal maximum air temperature (DMT) of 30 (chamber 1), 35 (chamber 2) and 40 degrees C (chamber 3). Each contained plants from seedling to fruiting stage. Physiological response to variation in DMT was evaluated for each stage over the course of five months. The results showed that both leaf area and dry mass of Habanero pepper plants did not exhibit significant differences in juvenile and flowering phenophases. However, in the fruiting stage, the leaf area and dry mass of plants grown at 40 degrees C DMT were 51 and 58% lower than plants at 30 degrees C DMT respectively. Meanwhile, an increase in diurnal air temperature raised both stomatal conductance and transpiration rate, causing an increase in temperature deficit (air temperature - leaf temperature). Thus, leaf temperature decreased by 5 degrees C, allowing a higher CO2 assimilation rate in plants at diurnal maximum air temperature (40 degrees C). However, in CO2 measurements when leaf temperature was set at 40 degrees C, physiological parameters decreased due to an increase in stomatal limitation. We conclude that the thermal optimum range in a tropical crop such as Habanero pepper is between 30 and 35 degrees C (leaf temperature, not air temperature). In this range, gas exchange through stomata is probably optimal. Also, the air temperature-leaf temperature relationship helps to explain how temperature keeps the major physiological processes of Habanero pepper healthy under experimental conditions.	[Garruna-Hernandez, Rene; Orellana, Roger; Larque-Saavedra, Alfonso; Canto, Azucena] Ctr Invest Cient Yucatan, Unidad Recursos Nat, Merida, Mexico; [Garruna-Hernandez, Rene] Inst Tecnol Conkal, Div Estudios Posgrad & Invest, Conkal, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan	Garruna-Hernandez, R (corresponding author), Ctr Invest Cient Yucatan, Unidad Recursos Nat, Merida, Mexico.	renegh10@hotmail.com	Canto, Azucena/ABD-3097-2020	Canto, Azucena/0000-0002-0712-2241; LARQUE SAAVEDRA, ALFONSO/0000-0001-9462-5682	Mexican Council of Science and Technology (CONACYT)	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Mexican Council of Science and Technology (CONACYT) supports the doctoral studies of Rene Garruna-Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Lopez JL, 2006, BIOTECHNOL LETT, V28, P1101, DOI 10.1007/s10529-006-9060-4; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Cazares-Sanchez E, 2005, AGROCIENCIA-MEXICO, V39, P627; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Farrar JF, 1996, J EXP BOT, V47, P1273, DOI 10.1093/jxb/47.Special_Issue.1273; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Garruna-Hernandez R, 2013, J SCI FOOD AGR, V93, P1385, DOI 10.1002/jsfa.5904; Garruna-Hernandez R, 2012, J FOOD AGRIC ENVIRON, V10, P802; Haldimann P, 2005, PLANT CELL ENVIRON, V28, P302, DOI 10.1111/j.1365-3040.2005.01289.x; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Jaimez R. E., 2011, Journal of Agricultural Science (Toronto), V3, P134, DOI 10.5539/jas.v3n3p134; Larcher W., 2003, PHYSL PLANT ECOLOGY, DOI DOI 10.1007/978-3-662-05214-3; Lawlor D. W., 1993, P85; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Marcelis LFM, 2004, J EXP BOT, V55, P2261, DOI 10.1093/jxb/erh245; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Nobel P., 1999, PHYSICOCHEMICAL ENV, V2nd; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharkey TD, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P101, DOI 10.1007/1-4020-4225-6_4; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	28	26	28	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111402	10.1371/journal.pone.0111402	http://dx.doi.org/10.1371/journal.pone.0111402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365043	Green Published, gold			2022-12-26	WOS:000345558100064
J	Gillen, JB; Percival, ME; Skelly, LE; Martin, BJ; Tan, RB; Tarnopolsky, MA; Gibala, MJ				Gillen, Jenna B.; Percival, Michael E.; Skelly, Lauren E.; Martin, Brian J.; Tan, Rachel B.; Tarnopolsky, Mark A.; Gibala, Martin J.			Three Minutes of All-Out Intermittent Exercise per Week Increases Skeletal Muscle Oxidative Capacity and Improves Cardiometabolic Health	PLOS ONE			English	Article							VOLUME SPRINT INTERVAL; MITOCHONDRIAL BIOGENESIS; METABOLIC ADAPTATIONS; INSULIN SENSITIVITY; ENDURANCE; ADULTS; FEMALES; MALES	We investigated whether a training protocol that involved 3 min of intense intermittent exercise per week - within a total training time commitment of 30 min including warm up and cool down - could increase skeletal muscle oxidative capacity and markers of health status. Overweight/obese but otherwise healthy men and women (n = 7 each; age = 29 +/- 9 y; BMI = 29.8 +/- 2.7 kg/m(2)) performed 18 training sessions over 6 wk on a cycle ergometer. Each session began with a 2 min warm-up at 50 W, followed by 3x20 s "all-out" sprints against 5.0% body mass (mean power output: similar to 450-500 W) interspersed with 2 min of recovery at 50 W, followed by a 3 min cool-down at 50 W. Peak oxygen uptake increased by 12% after training (32.6 +/- 4.5 vs. 29.1 +/- 4.2 ml/kg/min) and resting mean arterial pressure decreased by 7% (78610 vs. 83610 mmHg), with no difference between groups (both p < 0.01, main effects for time). Skeletal muscle biopsy samples obtained before and 72 h after training revealed increased maximal activity of citrate synthase and protein content of cytochrome oxidase 4 (p < 0.01, main effect), while the maximal activity of beta-hydroxy acyl CoA dehydrogenase increased in men only (p < 0.05). Continuous glucose monitoring measured under standard dietary conditions before and 48-72 h following training revealed lower 24 h average blood glucose concentration in men following training (5.4 +/- 0.6 vs. 5.9 +/- 0.5 mmol/L, p < 0.05), but not women (5.5 +/- 0.4 vs. 5.5 +/- 0.6 mmol/L). This was associated with a greater increase in GLUT4 protein content in men compared to women (138% vs. 23%, p < 0.05). Short-term interval training using a 10 min protocol that involved only 1 min of hard exercise, 3x/wk, stimulated physiological changes linked to improved health in overweight adults. Despite the small sample size, potential sex-specific adaptations were apparent that warrant further investigation.	[Gillen, Jenna B.; Percival, Michael E.; Skelly, Lauren E.; Martin, Brian J.; Tan, Rachel B.; Tarnopolsky, Mark A.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University; McMaster University	Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	gibalam@mcmaster.ca		Tan, Rachel/0000-0001-8669-168X	Natural Sciences and Engineering Research Council (NSERC); McMaster University; NSERC Vanier Canada; NSERC Canada	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University; NSERC Vanier Canada; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by a Natural Sciences and Engineering Research Council (NSERC) operating grant and McMaster University Internally Sponsored Research Grant to MJG. JBG held a NSERC Vanier Canada Graduate Scholarship. MEP was supported by a NSERC Canada Graduate Scholarship (Masters). LES held a NSERC undergraduate student research award and NSERC Canada Graduate Scholarship (Masters). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Skleryk JR, 2013, DIABETES OBES METAB, V15, P1146, DOI 10.1111/dom.12150; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	35	110	110	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111489	10.1371/journal.pone.0111489	http://dx.doi.org/10.1371/journal.pone.0111489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365337	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100069
J	Huang, JN; Tsai, MC; Fang, SL; Chang, MDT; Wu, YR; Tsai, JJ; Fu, LS; Lin, HK; Chen, YJ; Li, TW				Huang, Jing-Ning; Tsai, Ming-Chin; Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou; Tsai, Jaw-Ji; Fu, Lin-Shien; Lin, Heng-Kuei; Chen, Yi-Jun; Li, Tsai-Wei			Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions	PLOS ONE			English	Article							ALLERGIC AIRWAY RESPONSES; EXERCISE-INDUCED ASTHMA; NF-KAPPA-B; INHALED HEPARIN; MOUSE MODEL; TRANSCRIPTION FACTORS; P-SELECTIN; INFLAMMATION; BINDING; CELLS	Background: We evaluated the effects of T helper cell differentiation in a mite-allergic animal model treated with inhaled heparins of different molecular weight. Method: BALB/c mice were divided into four groups: 1. Control, 2. Mite intratracheal (mIT), 3. Inhaled heparin (hIN), 4. Inhaled low-molecular-weight heparin (lmwhIN). Groups 2, 3, and 4 were sensitized twice with Der p allergen subcutaneously on day 1 and day 8. Der p allergen was administered intratracheally on day 15. Groups 3 and 4 were treated with heparin or low-molecular-weight (lmw) heparin intranasally from day 1 to 22. Splenocytes from sacrificed mice stimulated with 16 mu g/ml of Der p were cultured for 72 hours. Supernatants of splenocyte were collected to analyze the effect of Interleukin (IL) 17-A/F, Interferon(IFN)-gamma, IL-4, IL-13, and IL-10. Serum was also collected for Der P-specific IgE level on day 23. Total RNA was extracted from spleen tissue for mRNA expression. Gene expression of Foxp3, IL-10 IFN-gamma, GATA3, IL5, and ROR gamma t were analyzed. Results: Both hIN and lmwhIN groups had lower serum IgE level than that of the mIT group (both p, 0.0001). Both hIN and lmwhIN groups showed significantly decreased transcripts of GATA-3, IFN-gamma, IL-5, and ROR gamma t mRNA in their spleen. Regarding the supernatant of splenocyte culture stimulated with Der p, compared with the mIT group, there were significant decreases in IL-17A/F, IFN-c, IL-4, IL-13, and IL-10 secretion in inhaled hIN and lmwhIN groups. Conclusions: From this balb/c mice study, the analyses of mRNA and cytokines revealed that both intranasal heparin and lmw heparin treatment decreased the expression of Th1, Th2, and Th17 in spleen. The underlying mechanism(s) warrant further studies.	[Huang, Jing-Ning; Tsai, Ming-Chin; Fu, Lin-Shien; Lin, Heng-Kuei; Chen, Yi-Jun; Li, Tsai-Wei] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Jaw-Ji] Taichung Vet Gen Hosp, Taichung, Taiwan; [Fu, Lin-Shien] Natl Yang Ming Med Univ, Dept Pediat, Taipei, Taiwan; [Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Fu, LS (corresponding author), Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan.	linshienfu@yahoo.com.tw			Veterans General Hospitals, University System of Taiwan, Joint Research Program [101DFA0400013, 101DFA0400014, VGHUST100-G6-2-2, VGHUST101-G6-2-2]; National Science Council [100-2622-B-007-001-CC1, 99-3112-B-007002]	Veterans General Hospitals, University System of Taiwan, Joint Research Program; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Veterans General Hospitals, University System of Taiwan, Joint Research Program (grant numbers 101DFA0400013, 101DFA0400014, VGHUST100-G6-2-2, and VGHUST101-G6-2-2), as well as National Science Council (grant numbers 100-2622-B-007-001-CC1 and 99-3112-B-007002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Akimoto H, 1996, CIRCULATION, V93, P810, DOI 10.1161/01.CIR.93.4.810; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; ASA D, 1992, GLYCOBIOLOGY, V2, P395, DOI 10.1093/glycob/2.5.395; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; CEYHAN B, 1995, CHEST, V107, P1009, DOI 10.1378/chest.107.4.1009; CIFONELLI JA, 1974, CARBOHYD RES, V37, P145, DOI 10.1016/S0008-6215(00)87070-6; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Dudas J, 2000, BIOCHEM J, V350, P245, DOI 10.1042/0264-6021:3500245; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Fu LS, 2013, INT J IMMUNOPATH PH, V26, P349, DOI 10.1177/039463201302600208; Garrigo J, 1996, AM J RESP CRIT CARE, V153, P1702, DOI 10.1164/ajrccm.153.5.8630624; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Harris N, 2014, BBA-GEN SUBJECTS, V1840, P245, DOI 10.1016/j.bbagen.2013.09.023; Hasan M, 1999, J IMMUNOL, V162, P1064; Hecht I, 2004, J LEUKOCYTE BIOL, V75, P1139, DOI 10.1189/jlb.1203659; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Jones Sarah A, 2012, Nat Immunol, V13, P1022, DOI 10.1038/ni.2450; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim SJ, 2009, J ASTHMA, V46, P884, DOI 10.3109/02770900903089998; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Krstic A, 2012, J BIOL REG HOMEOS AG, V26, P641; LAURENT TC, 1978, BIOCHEM J, V175, P691, DOI 10.1042/bj1750691; LETOURNEUR D, 1995, J CELL PHYSIOL, V165, P687, DOI 10.1002/jcp.1041650328; Lin LH, 2012, IMMUNOL RES, V52, P276, DOI 10.1007/s12026-012-8339-x; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Martinez-Salas J, 1998, J APPL PHYSIOL, V84, P222, DOI 10.1152/jappl.1998.84.1.222; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; NELSON RM, 1993, BLOOD, V82, P3253; Peysselon F, 2013, MATRIX BIOL; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Vancheri C, 2001, J ALLERGY CLIN IMMUN, V108, P703, DOI 10.1067/mai.2001.118785; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WEILER JM, 1992, J IMMUNOL, V148, P3210; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004; Yagmurdur MC, 2003, TRANSPL P, V35, P2566, DOI 10.1016/j.transproceed.2003.08.076; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x; Young E, 1999, THROMB RES, V96, P373, DOI 10.1016/S0049-3848(99)00125-5; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026; Zhang B, 2012, INT J MOL MED, V30, P248, DOI 10.3892/ijmm.2012.1010	45	72	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109996	10.1371/journal.pone.0109996	http://dx.doi.org/10.1371/journal.pone.0109996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364825	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100014
J	Prevost-Boure, NC; Dequiedt, S; Thioulouse, J; Lelievre, M; Saby, NPA; Jolivet, C; Arrouays, D; Plassart, P; Lemanceau, P; Ranjard, L				Prevost-Boure, Nicolas Chemidlin; Dequiedt, Samuel; Thioulouse, Jean; Lelievre, Melanie; Saby, Nicolas P. A.; Jolivet, Claudy; Arrouays, Dominique; Plassart, Pierre; Lemanceau, Philippe; Ranjard, Lionel			Similar Processes but Different Environmental Filters for Soil Bacterial and Fungal Community Composition Turnover on a Broad Spatial Scale	PLOS ONE			English	Article							TAXA-AREA; BETA-DIVERSITY; DISTANCE-DECAY; LAND-USE; PATTERNS; BIOGEOGRAPHY; MICROBES; EVOLUTIONARY; FRAMEWORK; GRADIENT	Spatial scaling of microorganisms has been demonstrated over the last decade. However, the processes and environmental filters shaping soil microbial community structure on a broad spatial scale still need to be refined and ranked. Here, we compared bacterial and fungal community composition turnovers through a biogeographical approach on the same soil sampling design at a broad spatial scale (area range: 13300 to 31000 km(2)): i) to examine their spatial structuring; ii) to investigate the relative importance of environmental selection and spatial autocorrelation in determining their community composition turnover; and iii) to identify and rank the relevant environmental filters and scales involved in their spatial variations. Molecular fingerprinting of soil bacterial and fungal communities was performed on 413 soils from four French regions of contrasting environmental heterogeneity (Landes<Burgundy <= Brittany<<South-East) using the systematic grid of French Soil Quality Monitoring Network to evaluate the communities' composition turnovers. The relative importance of processes and filters was assessed by distance-based redundancy analysis. This study demonstrates significant community composition turnover rates for soil bacteria and fungi, which were dependent on the region. Bacterial and fungal community composition turnovers were mainly driven by environmental selection explaining from 10% to 20% of community composition variations, but spatial variables also explained 3% to 9% of total variance. These variables highlighted significant spatial autocorrelation of both communities unexplained by the environmental variables measured and could partly be explained by dispersal limitations. Although the identified filters and their hierarchy were dependent on the region and organism, selection was systematically based on a common group of environmental variables: pH, trophic resources, texture and land use. Spatial autocorrelation was also important at coarse (80 to 120 km radius) and/or medium (40 to 65 km radius) spatial scales, suggesting dispersal limitations at these scales.	[Prevost-Boure, Nicolas Chemidlin; Lemanceau, Philippe; Ranjard, Lionel] Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol 1347, Dijon, France; [Dequiedt, Samuel; Lelievre, Melanie; Plassart, Pierre; Ranjard, Lionel] Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol Plateforme GenoSol 2347, Dijon, France; [Thioulouse, Jean] Univ Lyon 1, CNRS, Unite Mixte Rech Lab Biometrie & Biol Evolut 555, F-69622 Villeurbanne, France; [Saby, Nicolas P. A.; Jolivet, Claudy; Arrouays, Dominique] INRA, Unite Serv InfoSol 1106, Orleans, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Prevost-Boure, NC (corresponding author), Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol 1347, Dijon, France.	n.chemidlin@agrosupdijon.fr	Prévost-Bouré, Nicolas Chemidlin/U-7714-2017	Prévost-Bouré, Nicolas Chemidlin/0000-0002-8575-4295; Jolivet, Claudy/0000-0001-5871-6413; Saby, Nicolas/0000-0001-8964-1194; Thioulouse, Jean/0000-0001-7664-0598	ADEME (Energy and Environment Management Agency); French National Research Agency (ANR); French state via the National Agency for Research under the program "Investments for the Future" [ANR-11-INBS-0001]; Regional Council of Burgundy	ADEME (Energy and Environment Management Agency); French National Research Agency (ANR)(French National Research Agency (ANR)); French state via the National Agency for Research under the program "Investments for the Future"(French National Research Agency (ANR)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This study was granted by ADEME (Energy and Environment Management Agency) and by the French National Research Agency (ANR). RMQS soil sampling and physico-chemical analyses were supported by a French Scientific Group of Interest on soils: the "GIS Sol", involving the French Ministry for Ecology and Sustainable Development (MEDAD), the French Ministry of Agriculture (MAP), the French Institute for Environment (IFEN), the French Agency for Energy and Environment (ADEME), the French Institute for Research and Development (IRD) and the National Institute for Agronomic Research (INRA). This work, through the involvement of technical facilities of the GenoSol platform of the infrastructure ANAEE378 Services, received a grant from the French state via the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as a grant from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Brodie E, 2003, FEMS MICROBIOL ECOL, V45, P105, DOI 10.1016/S0168-6496(03)00126-0; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Gilbert J, 2010, EARTH MICROBIOME PRO; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hossain Z, 2011, EUR J SOIL BIOL, V47, P88, DOI 10.1016/j.ejsobi.2010.11.007; Hovatter SR, 2011, ECOLOGY, V92, P57, DOI 10.1890/10-0332.1; Jobe RT, 2008, ECOLOGY, V89, P174, DOI 10.1890/06-1722.1; Kong AYY, 2011, SOIL BIOL BIOCHEM, V43, P20, DOI 10.1016/j.soilbio.2010.09.005; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lienhard P, 2013, AGRON SUSTAIN DEV, V33, P375, DOI 10.1007/s13593-012-0099-4; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MAC ARTHUR ROBERT H., 1967; Maron PA, 2011, CR BIOL, V334, P403, DOI 10.1016/j.crvi.2010.12.003; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Monroy F, 2012, SOIL BIOL BIOCHEM, V45, P1, DOI 10.1016/j.soilbio.2011.10.006; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pasternak Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070576, 10.1371/journal.pone.0069705]; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; R Core Team, 2016, R FDN STAT COMP; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Ranjard L, 2009, ENV MICROBIOL REP, V1, P97, DOI 10.1111/j.1758-2229.2009.00023.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x; Zinger L, 2014, MOL ECOL, V23, P954, DOI 10.1111/mec.12640; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	70	34	34	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111667	10.1371/journal.pone.0111667	http://dx.doi.org/10.1371/journal.pone.0111667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365044	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100100
J	Sytykiewicz, H; Chrzanowski, G; Czerniewicz, P; Sprawka, I; Lukasik, I; Golawska, S; Sempruch, C				Sytykiewicz, Hubert; Chrzanowski, Grzegorz; Czerniewicz, Pawel; Sprawka, Iwona; Lukasik, Iwona; Golawska, Sylwia; Sempruch, Cezary			Expression Profiling of Selected Glutathione Transferase Genes in Zea mays (L.) Seedlings Infested with Cereal Aphids	PLOS ONE			English	Article							PLANT DEFENSE RESPONSES; S-TRANSFERASE; ARABIDOPSIS-THALIANA; NICOTIANA-BENTHAMIANA; RHOPALOSIPHUM-PADI; ENZYME-ACTIVITIES; OXIDATIVE STRESS; RESISTANCE; ANTHOCYANIN; MECHANISMS	The purpose of this report was to evaluate the expression patterns of selected glutathione transferase genes (gst1, gst18, gst23 and gst24) in the tissues of two maize (Zea mays L.) varieties (relatively resistant Ambrozja and susceptible Tasty Sweet) that were colonized with oligophagous bird cherry-oat aphid (Rhopalosiphum padi L.) or monophagous grain aphid (Sitobion avenae L.). Simultaneously, insect-triggered generation of superoxide anion radicals (O-2(.-)) in infested Z. mays plants was monitored. Quantified parameters were measured at 1, 2, 4, 8, 24, 48 and 72 h post-initial aphid infestation (hpi) in relation to the non-infested control seedlings. Significant increases in gst transcript amounts were recorded in aphid-stressed plants in comparison to the control seedlings. Maximal enhancement in the expression of the gst genes in aphid-attacked maize plants was found at 8 hpi (gst23) or 24 hpi (gst1, gst18 and gst24) compared to the control. Investigated Z. mays cultivars formed excessive superoxide anion radicals in response to insect treatments, and the highest overproduction of O-2(.-) was noted 4 or 8 h after infestation, depending on the aphid treatment and maize genotype. Importantly, the Ambrozja variety could be characterized as having more profound increments in the levels of gst transcript abundance and O-2(.-) generation in comparison with the Tasty Sweet genotype.	[Sytykiewicz, Hubert; Chrzanowski, Grzegorz; Czerniewicz, Pawel; Sprawka, Iwona; Lukasik, Iwona; Golawska, Sylwia; Sempruch, Cezary] Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland		Sytykiewicz, H (corresponding author), Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland.	huberts@uph.edu.pl	Czerniewicz, Pawel/V-4916-2017; Sytykiewicz, Hubert/AAC-1431-2020; Chrzanowski, Grzegorz/AAU-7061-2020	Czerniewicz, Pawel/0000-0003-0271-2290; Sytykiewicz, Hubert/0000-0002-6540-0561; Chrzanowski, Grzegorz/0000-0001-9836-1514; Lukasik, Iwona/0000-0002-1585-1866; Sprawka, Iwona/0000-0001-9511-1042; Golawska, Sylwia/0000-0001-9192-6738; Sempruch, Cezary/0000-0002-6389-1766	National Science Centre (NCS, Poland) [N N310 733940]	National Science Centre (NCS, Poland)	This research was financially supported by the National Science Centre (NCS, Poland) under the grant no. N N310 733940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo Timothy O., 2009, Journal of Plant Protection Research, V49, P399, DOI 10.2478/v10045-009-0063-8; Bandopadhyay L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073632; Basantani M, 2011, PESTIC BIOCHEM PHYS, V99, P111, DOI 10.1016/j.pestbp.2010.11.007; Bender RR, 2013, AGRON J, V105, P161, DOI 10.2134/agronj2012.0352; Beres P. K., 2008, Acta Scientiarum Polonorum - Agricultura, V7, P19; Bosak EJ, 2013, ENVIRON ENTOMOL, V42, P1309, DOI 10.1603/EN13079; CHAITANYA KSK, 1994, NEW PHYTOL, V126, P623, DOI 10.1111/j.1469-8137.1994.tb02957.x; Chronopoulou Evangelia G, 2009, Recent Pat Biotechnol, V3, P211; Cummins I, 2013, P NATL ACAD SCI USA, V110, P5812, DOI 10.1073/pnas.1221179110; Czapla A., 2011, Progress in Plant Protection, V51, P787; Czerniewicz P, 2011, ALLELOPATHY J, V27, P309; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2000, ARCH BIOCHEM BIOPHYS, V384, P407, DOI 10.1006/abbi.2000.2125; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Dukowic-Schulze S, 2014, J GENET GENOMICS, V41, P139, DOI 10.1016/j.jgg.2013.11.007; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Halarewicz A, 2012, ARTHROPOD-PLANT INTE, V6, P497, DOI 10.1007/s11829-012-9228-x; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Kitamura S, 2012, J PLANT PHYSIOL, V169, P636, DOI 10.1016/j.jplph.2011.12.011; Krawczyk Agnieszka, 2006, Progress in Plant Protection, V46, P378; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2010, FEBS J, V277, P255, DOI 10.1111/j.1742-4658.2009.07481.x; LUKASIK I, 2006, PESTYCYDY, V3, P67; Lukasik I, 2012, POL J ENVIRON STUD, V21, P1937; Luo M, 2011, TOXINS, V3, P766, DOI 10.3390/toxins3070766; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Morkunas I, 2011, ACTA PHYSIOL PLANT, V33, P2057, DOI 10.1007/s11738-011-0751-7; Morkunas I, 2013, PROTOPLASMA, V250, P63, DOI 10.1007/s00709-012-0374-x; Pienkosz Aneta, 2005, Progress in Plant Protection, V45, P989; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Prince DC, 2014, PLANT PHYSIOL, V164, P2207, DOI 10.1104/pp.114.235598; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Rao SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057413; Rezaei MK, 2013, J PLANT PHYSIOL, V170, P1277, DOI 10.1016/j.jplph.2013.04.005; Rodriguez PA, 2014, MOL PLANT MICROBE IN, V27, P30, DOI 10.1094/MPMI-05-13-0156-R; Rossi GB, 2013, 4 S BRAS GEN MOL PLA, P26; Santamaria ME, 2013, TRANSGENIC RES, V22, P697, DOI 10.1007/s11248-013-9725-4; Seidl-Adams I, 2015, PLANT CELL ENVIRON, V38, P23, DOI 10.1111/pce.12347; Sempruch C, 2012, BIOCHEM SYST ECOL, V40, P162, DOI 10.1016/j.bse.2011.10.004; Sprawka I, 2011, PESTIC BIOCHEM PHYS, V100, P64, DOI 10.1016/j.pestbp.2011.02.006; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Strazynski P, 2008, APHIDS OTHER HOMOPTE, V14, P123; Sytykiewicz H, 2008, 23 INT C ENT DURB RE; Sytykiewicz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094847; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Urbanska A., 2010, Electronic Journal of Polish Agricultural Universities, V13, P26; Urbanska A, 1990, ZESZ PROBL POST NAUK, V392, P201; Urbanska Anna, 2002, Electronic Journal of Polish Agricultural Universities, V5, pUnpaginated; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wang Y, 2012, GENET MOL RES, V11, P4711, DOI 10.4238/2012.September.25.4; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Will T, 2008, PLANT SIGNAL BEHAV, V3, P427, DOI 10.4161/psb.3.6.5473; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Zhao YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094126; Zielinska L, 2012, ACTA BIOL CRACOV BOT, V54, P97, DOI 10.2478/v10182-012-0010-2	67	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111863	10.1371/journal.pone.0111863	http://dx.doi.org/10.1371/journal.pone.0111863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365518	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100130
J	Chen, HL; Hu, CP; Yi, KX; Huang, GX; Gao, JM; Zhang, SQ; Zheng, JL; Liu, QL; Xi, JG				Chen, Helong; Hu, Caiping; Yi, Kexian; Huang, Guixiu; Gao, Jianming; Zhang, Shiqing; Zheng, Jinlong; Liu, Qiaolian; Xi, Jingen			Cloning of Insertion Site Flanking Sequence and Construction of Transfer DNA Insert Mutant Library in Stylosanthes Colletotrichum	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; PATHOGENIC DIVERSITY; GLOEOSPORIOIDES; TUMEFACIENS; MUTAGENESIS; ANTHRACNOSE; GUIANENSIS; VIRULENCE; SPP.	Stylosanthes sp. is the most important forage legume in tropical areas worldwide. Stylosanthes anthracnose, which is mainly caused by Colletotrichum gloeosporioides, is a globally severe disease in stylo production. Little progress has been made in anthracnose molecular pathogenesis research. In this study, Agrobacterium tumefaciens-mediated transformation was used to transform Stylosanthes colletotrichum strain CH008. The major factors of the genetic transformation system of S. colletotrichum were optimized as follows: A. tumefaciens' AGL-1 concentration (OD600), 0.8; concentration of Colletotrichum conidium, 1x10(6) conidia/mL; acetosyringone concentration, 100 mmol/L; induction time, 6 h; co-culture temperature, 25 degrees C; and co-culture time, 3 d. Thus, the transformation efficiency was increased to 300-400 transformants per 106 conidia. Based on the optimized system, a mutant library containing 4616 mutants was constructed, from which some mutants were randomly selected for analysis. Results show that the mutants were single copies that could be stably inherited. The growth rate, spore amount, spore germination rate, and appressorium formation rate in some mutants were significantly different from those in the wild-type strain. We then selected the most appropriate method for the preliminary screening and rescreening of each mutant's pathogenic defects. We selected 1230 transformants, and obtained 23 strains with pathogenic defects, namely, 18 strains with reduced pathogenicity and five strains with lost pathogenicity. Thermal asymmetric interlaced PCR was used to identify the transfer DNA (T-DNA) integration site in the mutant that was coded 2430, and a sequence of 476 bp was obtained. The flanking sequence of T-DNA was compared with the Colletotrichum genome by BLAST, and a sequence of 401 bp was found in Contig464 of the Colletotrichum genome. By predicting the function of the flanking sequence, we discovered that T-DNA insertion in the promoter region of the putative gene had 79% homology with the aspartate aminotransferase gene in Magnaporthe oryzae (XP_003719674.1).	[Chen, Helong; Hu, Caiping; Yi, Kexian; Gao, Jianming; Zhang, Shiqing; Liu, Qiaolian] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Peoples R China; [Yi, Kexian; Huang, Guixiu; Zheng, Jinlong; Xi, Jingen] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Key Lab Integrated Pest Management Trop Crops, Minist Agr, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Yi, KX (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Peoples R China.	yikexian@126.com			National Natural Science Foundation of China (NSFC) [31072076]; Special Fund for Agro-scientific Research in the Public Interest [201303057]; Major Technology Project of Hainan [ZDZX2013023-1]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Major Technology Project of Hainan	We thank the National Natural Science Foundation of China (NSFC, No. 31072076), Special Fund for Agro-scientific Research in the Public Interest (201303057) and The Major Technology Project of Hainan (ZDZX2013023-1) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyong ASM, 2012, J BASIC MICROB, V52, P372, DOI 10.1002/jobm.201100250; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; BRAITHWAITE K S, 1990, Australian Systematic Botany, V3, P733, DOI 10.1071/SB9900733; BRAITHWAITE KS, 1990, MYCOL RES, V94, P1129, DOI 10.1016/S0953-7562(09)81345-2; Cai ZY, 2013, MICROBIOL RES, V168, P340, DOI 10.1016/j.micres.2013.01.005; Campoy S, 2003, CURR GENET, V43, P447, DOI 10.1007/s00294-003-0417-0; Chakraborty S, 2002, PHYTOPATHOLOGY, V92, P553, DOI 10.1094/PHYTO.2002.92.5.553; Chakraborty S, 1999, PLANT DIS, V83, P333, DOI 10.1094/PDIS.1999.83.4.333; DALE JL, 1988, T BRIT MYCOL SOC, V91, P671, DOI 10.1016/S0007-1536(88)80043-3; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Deng Y., 2010, J ANHUI AGR SCI, V38, P2229; Flowers JL, 2005, CURR GENET, V48, P380, DOI 10.1007/s00294-005-0034-1; He ChunPing, 2007, Journal of Agricultural Biotechnology, V15, P877; HOLFORD P, 1992, PLANT CELL REP, V11, P196, DOI 10.1007/BF00232532; [胡新文 Hu Xinwen], 2005, [热带作物学报, Chinese Journal of Tropical Crops], V26, P38; [黄贵修 Huang Guixiu], 2008, [热带作物学报, Chinese Journal of Tropical Crops], V29, P27; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; IRWIN JAG, 1978, AUST J AGR RES, V29, P305, DOI 10.1071/AR9780305; Jia PS, 2012, MIAN HUA XUE BAO, V24, P62; Jiang CS, 2004, ACTA BOT SIN, V46, P480; Kelemu S, 1996, PLANT DIS, V80, P1355, DOI 10.1094/PD-80-1355; Kelemu S, 1997, TROP GRASSLANDS, V31, P387; LENNE JM, 1990, PHYTOPATHOLOGY, V80, P728, DOI 10.1094/Phyto-80-728; Lenne JM, 1984, BIOL AGRONOMY STYLOS, P279; Li Ai-Hong, 2006, Acta Genetica Sinica, V33, P319, DOI 10.1016/S0379-4172(06)60057-7; Li MX, 2005, FEMS MICROBIOL LETT, V243, P323, DOI 10.1016/j.femsle.2004.12.033; [林春花 Lin Chunhua], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P1495; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Liu CP, 2010, ANHUI NONG YE KE XUE, V38, P1141; [刘刚 LIU Gang], 2011, [生物技术, Biotechnology], V21, P44; Liu GD, 1997, TROP GRASSLANDS, V31, P460; Manners J. M., 1993, P233; Manners J. M., 1992, Colletotrichum: biology, pathology and control., P250; Manners JM, 2000, COLLETOTRICHUM, P180; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; Maruthachatam K, 2008, J MICROBIOL BIOTECHN, V18, P234; Meyer V, 2003, CURR GENET, V43, P371, DOI 10.1007/s00294-003-0406-3; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; MIRANDA A, 1992, J BACTERIOL, V174, P2288, DOI 10.1128/JB.174.7.2288-2297.1992; MISHRA NC, 1973, P NATL ACAD SCI USA, V70, P3875, DOI 10.1073/pnas.70.12.3875; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Munaut F, 1998, PLANT PATHOL, V47, P641, DOI 10.1046/j.1365-3059.1998.00287.x; Munaut F, 2002, MYCOL RES, V106, P579, DOI 10.1017/S0953756202005932; Nyilasi I, 2005, FOLIA MICROBIOL, V50, P415, DOI 10.1007/BF02931423; Rao Zhiming, 2007, Chinese Journal of Applied and Environmental Biology, V13, P868; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Segenet K, 2005, AFR J BIOTECHNOL, V4, P1025; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; [Sun Bingyao 孙丙耀], 2004, [生物工程学报, Chinese Journal of Biotechnology], V20, P821; Takahara Hiroyuki, 2004, Journal of General Plant Pathology, V70, P93, DOI 10.1007/s10327-003-0099-y; Tanaka Soichi, 2007, Journal of General Plant Pathology, V73, P242, DOI 10.1007/s10327-007-0021-0; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; [王海艳 Wang Haiyan], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1799; Weeds PL, 2003, PHYTOPATHOLOGY, V93, P176, DOI 10.1094/PHYTO.2003.93.2.176; Williams R. J., 1984, The biology and agronomy of Stylosanthes., P73; Wu XY, 2010, RICE SCI, V17, P129, DOI 10.1016/S1672-6308(08)60115-8; Yi Kexian, 2003, Weishengwu Xuebao, V43, P379; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8	61	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111172	10.1371/journal.pone.0111172	http://dx.doi.org/10.1371/journal.pone.0111172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361073	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700069
J	Gurgel, RQ; Alvarez, AD; Rodrigues, A; Ribeiro, RR; Dolabella, SS; Da Mota, NL; Santos, VS; Iturriza-Gomara, M; Cunliffe, NA; Cuevas, LE				Gurgel, Ricardo Q.; Alvarez, Alberto De Juan; Rodrigues, Alda; Ribeiro, Robergson R.; Dolabella, Silvio S.; Da Mota, Natanael L.; Santos, Victor S.; Iturriza-Gomara, Miren; Cunliffe, Nigel A.; Cuevas, Luis E.			Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil during 7 Years of National Rotavirus Vaccination	PLOS ONE			English	Article							TEMPORAL TRENDS; GASTROENTERITIS; CHILDREN; HOSPITALIZATIONS; PENTAVALENT; EFFICACY; VACCINES; STRAINS; SAFETY; AGE	Background and Aims: Rotavirus causes severe diarrhoea and Brazil introduced the Rotarix G1P[8] vaccine in 2006. We aimed to describe changes in rotavirus incidence and diarrhoea epidemiology before and after vaccine introduction. Methods: Design: (i) hospital-based survey of children with diarrhoea (2006-2012); (ii) diarrhea-mortality and hospitalization surveillance (1999-2012). Setting: (i) Aracaju and (ii) state and national level. Results: 1841 children were enrolled and 231 (12.5%) had rotavirus. Rotavirus was less frequent from January-June than from July-December (9.4% versus 20.9%, p<0.01), but the seasonal variation was less defined after 2009. Very few rotavirus cases (8-3.9%) were detected in 2011, with an increase in 2012 (13-18.5%). In 2006, unvaccinated children were more likely to have rotavirus, but thereafter unvaccinated and vaccinated children had equally low incidence. Older children and those with rotavirus were more likely to have severe diarrhea episodes. The most frequent genotype from 2006 to 2010 was G2P[4]; except in 2009, when most cases were G1P[8]. Very few G2P[4] were detected from 2011 and 50% cases in 2012 were G8P[4]. Diarrhoea-hospitalizations decreased nationally from 89,934 (2003) to 53,705 (2012; 40.3% reduction) and in the state from 1729 to 748 (56.7% reduction). Diarrhoea-deaths decreased nationally from 4368 in 1999 to 697 in 2012 (84% reduction, p<0.001) and in the state from 132 to 18 (86% reduction). These changes were much larger after vaccine introduction. Conclusions: The vaccine was associated with substantial reductions in rotavirus incidence and diarrhoea-hospitalizations and deaths. The G2P[4] genotype predominance disappeared over time and may be replaced by other heterotypic genotypes.	[Gurgel, Ricardo Q.; Rodrigues, Alda; Ribeiro, Robergson R.; Dolabella, Silvio S.; Da Mota, Natanael L.; Santos, Victor S.] Univ Fed Sergipe, Aracaju, Brazil; [Alvarez, Alberto De Juan; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Iturriza-Gomara, Miren; Cunliffe, Nigel A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Universidade Federal de Sergipe; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Cuevas, LE (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	lcuevas@liv.ac.uk	Cuevas, Luis E/I-3697-2015; Dolabella, Silvio/X-4351-2019; Santos, Victor Santana/B-8738-2014; Gurgel, RQ/N-5105-2018; Gomara, Miren Iturriza/B-4351-2013	Cuevas, Luis E/0000-0002-6581-0587; Santos, Victor Santana/0000-0003-0194-7397; Gurgel, RQ/0000-0001-9651-3713; Gomara, Miren Iturriza/0000-0001-5816-6423; Cunliffe, Nigel/0000-0002-5449-4988; Santana Dolabella, Silvio/0000-0001-5576-3214	CNPq/UFS-COPES/PIBIC; calls Edital MCT/CNPq Universal [478082/2006-9]; Edital MCT/CNPq Universal [475914/2011-2]	CNPq/UFS-COPES/PIBIC; calls Edital MCT/CNPq Universal; Edital MCT/CNPq Universal	Financial support for this study was received from CNPq/UFS-COPES/PIBIC - 2008-2012, calls Edital MCT/CNPq Universal 14/2009 (#478082/2006-9), Edital MCT/CNPq Universal 14/2011 (#475914/2011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 2014, PEDIATR INFECT DIS J, V33, pS28, DOI 10.1097/INF.0000000000000048; [Anonymous], 2013, VACCINE, V31, P6170, DOI 10.1016/j.vaccine.2013.05.037; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P2; BROWNING GF, 1992, J CLIN MICROBIOL, V30, P59, DOI 10.1128/JCM.30.1.59-62.1992; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; De Oliveira LH, 2013, VACCINE, V31, pC99, DOI 10.1016/j.vaccine.2013.05.065; Dey A, 2012, MED J AUSTRALIA, V197, P453, DOI 10.5694/mja12.10062; Gurgel RG, 2009, GASTROENTEROLOGY, V137, P1970, DOI 10.1053/j.gastro.2009.07.046; Gurgel RQ, 2008, LANCET, V371, P301, DOI 10.1016/S0140-6736(08)60164-6; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; IBGE IBdGeEP, 2010, CENS DEM 2010; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Linhares AC, 2011, REV MED VIROL; Matthijnssens J., 2014, CLIN MICROBIOL INFEC; Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/ERV.12.105, 10.1586/erv.12.105]; Meloni A, 2011, J MATERN-FETAL NEO M, V24, P49, DOI 10.3109/14767058.2011.601920; Mendes PSD, 2013, J PEDIAT-BRAZIL, V89, P315, DOI 10.1016/j.jped.2012.10.002; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Paulke-Korinek M, 2011, VACCINE, V29, P2791, DOI 10.1016/j.vaccine.2011.01.104; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Rha B, 2014, EXPERT REV VACCINES, V13, P365, DOI 10.1586/14760584.2014.877846; Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015; de Oliveira TCR, 2010, REV SAUDE PUBL, V44, P102, DOI 10.1590/S0034-89102010000100011; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Tsolenyanu E, 2014, PEDIATR INFECT DIS J, V33, pS14, DOI 10.1097/INF.0000000000000046; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Yi JM, 2013, EXPERT REV VACCINES, V12, P585, DOI [10.1586/ERV.13.43, 10.1586/erv.13.43]; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	30	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110217	10.1371/journal.pone.0110217	http://dx.doi.org/10.1371/journal.pone.0110217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360784	gold, Green Accepted, Green Published			2022-12-26	WOS:000343943700026
J	Johnston, JB; Nickerson, JG; Daroszewski, J; Mogg, TJ; Burton, GW				Johnston, James B.; Nickerson, James G.; Daroszewski, Janusz; Mogg, Trevor J.; Burton, Graham W.			Biologically Active Polymers from Spontaneous Carotenoid Oxidation: A New Frontier in Carotenoid Activity	PLOS ONE			English	Article							BETA-CAROTENE; IMMUNE-RESPONSE; RETINOIC ACID; VITAMIN; CANCER	In animals carotenoids show biological activity unrelated to vitamin A that has been considered to arise directly from the behavior of the parent compound, particularly as an antioxidant. However, the very property that confers antioxidant activity on some carotenoids in plants also confers susceptibility to oxidative transformation. As an alternative, it has been suggested that carotenoid oxidative breakdown or metabolic products could be the actual agents of activity in animals. However, an important and neglected aspect of the behavior of the highly unsaturated carotenoids is their potential to undergo addition of oxygen to form copolymers. Recently we reported that spontaneous oxidation of beta-carotene transforms it into a product dominated by beta-carotene-oxygen copolymers. We now report that the polymeric product is biologically active. Results suggest an overall ability to prime innate immune function to more rapidly respond to subsequent microbial challenges. An underlying structural resemblance to sporopollenin, found in the outer shell of spores and pollen, may allow the polymer to modulate innate immune responses through interactions with the pattern recognition receptor system. Oxygen copolymer formation appears common to all carotenoids, is anticipated to be widespread, and the products may contribute to the health benefits of carotenoid-rich fruits and vegetables.	[Johnston, James B.] Natl Res Council Canada, Charlottetown, PE, Canada; [Nickerson, James G.] Avivagen Inc, Charlottetown, PE, Canada; [Daroszewski, Janusz; Mogg, Trevor J.; Burton, Graham W.] Avivagen Inc, Ottawa, ON, Canada	National Research Council Canada	Burton, GW (corresponding author), Avivagen Inc, Ottawa, ON, Canada.	g.burton@avivagen.com			Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund [189074]; Innovation PEI Discovery and Development Fund	Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund; Innovation PEI Discovery and Development Fund	Funding support provided by the Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund, Contract No. 189074. http://www.acoa-apeca.gc.ca/eng/ImLookingFor/ProgramInformation/AtlanticInnovationFund/Pages/AtlanticInnovationFund.aspx to GWB JGN JD TJM and Innovation PEI Discovery and Development Fund (http://www.innovationpei.com/dcfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blackwell LJ, 2007, THESIS U HULL; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Britton George, 2008, V4, P309, DOI 10.1007/978-3-7643-7499-0_15; BROOKS J, 1968, NATURE, V219, P532, DOI 10.1038/219532a0; BROOKS J, 1978, Grana, V17, P91; Brooks J., 1971, POLLEN, P99; Brooks J, 1971, SPOROPOLLENIN P INT, P351; Burton GW, 2014, CAN J CHEM, V92, P305, DOI 10.1139/cjc-2013-0494; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; Chew BP, 2011, VET IMMUNOL IMMUNOP, V140, P199, DOI 10.1016/j.vetimm.2010.12.004; Chew BP, 2009, CAROTENOIDS SER, V5, P363, DOI 10.1007/978-3-7643-7501-0_17; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Chew BP, 2000, J NUTR, V130, P1910, DOI 10.1093/jn/130.8.1910; Duquette SC, 2014, AM J VET RE IN PRESS, P75; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Huang Q, 2013, ANIM SCI J, V84, P247, DOI 10.1111/j.1740-0929.2012.01064.x; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Palozza P, 2009, CAROTENOIDS SER, V5, P211, DOI 10.1007/978-3-7643-7501-0_11; Park JS, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-18; Perez-Fons L, 2011, BBA-MOL CELL BIOL L, V1811, P177, DOI 10.1016/j.bbalip.2010.12.009; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Shaw G., 1971, SPOROPOLLENIN, P305; Wang XD, 2009, CAROTENOIDS SER, V5, P383, DOI 10.1007/978-3-7643-7501-0_18; Yeum KJ, 2009, CAROTENOIDS SER, V5, P235, DOI 10.1007/978-3-7643-7501-0_12	28	14	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111346	10.1371/journal.pone.0111346	http://dx.doi.org/10.1371/journal.pone.0111346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360750	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700087
J	Zhong, W; Yang, BC; He, F; Wang, L; Swami, S; Zeng, GH				Zhong, Wen; Yang, Bicheng; He, Fang; Wang, Liang; Swami, Sunil; Zeng, Guohua			Surgical Management of Urolithiasis in Patients after Urinary Diversion	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; TRACT CALCULI; STONES; CYSTECTOMY; COMPLICATION; CONDUIT; LASER; RISK; KOCK	Objective: To present our experience in surgical management of urolithiasis in patients after urinary diversion. Patients and Methods: Twenty patients with urolithiasis after urinary diversion received intervention. Percutaneous nephrolithotomy, percutaneous based antegrade ureteroscopy with semi-rigid or flexible ureteroscope, transurethral reservoir lithotripsy, percutaneous pouch lithotripsy and open operation were performed in 8, 3, 2, 6, and 1 patients, respectively. The operative finding and complications were retrospectively collected and analyzed. Results: The mean stone size was 4.563.1 (range 1.5-11.2) cm. The mean operation time was 82.0 +/- 11.5 (range 55-120) min. Eighteen patients were rendered stone free with a clearance of 90%. Complications occurred in 3 patients (15%). Two patients (10%) had postoperative fever greater than 38.5 degrees C, and one patient (5%) suffered urine extravasations from percutaneous tract. Conclusions: The percutaneous based procedures, including percutaneous nephrolithotomy, antegrade ureteroscopy with semi-rigid ureteroscope or flexible ureteroscope from percutaneous tract, and percutaneous pouch lithotripsy, provides a direct and safe access to the target stones in patients after urinary diversion, and with high stone free rate and minor complications. The surgical management of urolithiasis in patients after urinary diversion requires comprehensive evaluation and individualized consideration depending upon the urinary diversion type, stone location, stone burden, available resource and surgeon experience.	[Zhong, Wen; Yang, Bicheng; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [He, Fang] Guangzhou Med Univ, Affiliated Hosp 3, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China; [Wang, Liang] E Tennessee State Univ, Coll Publ Hlth, Dept Biostat & Epidemiol, Johnson City, TN USA; [Swami, Sunil] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA	Guangzhou Medical University; Guangzhou Medical University; East Tennessee State University; State University System of Florida; University of Florida	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com	Swami, Sunil/X-7870-2019; Zhong, Wen/L-2138-2017	Swami, Sunil/0000-0003-1592-5279; Zhong, Wen/0000-0003-0540-7195				ARAI Y, 1993, J UROLOGY, V150, P51, DOI 10.1016/S0022-5347(17)35394-6; CASS AS, 1992, J UROLOGY, V148, P1123, DOI 10.1016/S0022-5347(17)36837-4; COHEN TD, 1994, UROLOGY, V43, P865, DOI 10.1016/0090-4295(94)90154-6; Cohen TD, 1996, J UROLOGY, V155, P62, DOI 10.1016/S0022-5347(01)66540-6; Coleman RL, 2002, GYNECOL ONCOL, V84, P473, DOI 10.1006/gyno.2001.6543; Daneshmand S, 2011, EXPERT REV ANTICANC, V11, P941, DOI [10.1586/ERA.11.19, 10.1586/era.11.19]; Delvecchio FC, 2000, J ENDOUROL, V14, P251, DOI 10.1089/end.2000.14.251; Desai M, 2009, J ENDOUROL, V23, P1641, DOI 10.1089/end.2009.1530; El-Assmy A, 2005, UROLOGY, V66, P510, DOI 10.1016/j.urology.2005.04.008; Fais PO, 2011, PROG UROL, V21, P811, DOI 10.1016/j.purol.2011.10.001; Fernandez A, 2011, J ENDOUROL, V25, P1615, DOI 10.1089/end.2011.0045; Franzoni DF, 1999, J UROLOGY, V162, P777, DOI 10.1097/00005392-199909010-00042; GINSBERG D, 1991, J UROLOGY, V145, P956, DOI 10.1016/S0022-5347(17)38499-9; Hautmann RE, 2011, NAT REV UROL, V8, P667, DOI 10.1038/nrurol.2011.147; L'Esperance JO, 2004, CURR OPIN UROL, V14, P129, DOI 10.1097/00042307-200403000-00014; Li X, 2009, J ENDOUROL, V23, P1693, DOI 10.1089/end.2009.1537; Madbouly K, 2010, UROL ANNALS, V2, P96, DOI 10.4103/0974-7796.68856; Manohar T, 2008, J ENDOUROL, V22, P443, DOI 10.1089/end.2007.0288; Okhunov Z, 2011, BJU INT, V108, P330, DOI 10.1111/j.1464-410X.2011.10194.x; ROTH S, 1994, BRIT J UROL, V73, P316, DOI 10.1111/j.1464-410X.1994.tb07527.x; TERAI A, 1995, J UROLOGY, V153, P37, DOI 10.1097/00005392-199501000-00016; Terai A, 1996, J UROLOGY, V155, P66, DOI 10.1016/S0022-5347(01)66541-8; Turk TMT, 1999, WORLD J UROL, V17, P305, DOI 10.1007/s003450050151	23	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111371	10.1371/journal.pone.0111371	http://dx.doi.org/10.1371/journal.pone.0111371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360621	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700093
J	Koller, T; Bent, AF				Koller, Teresa; Bent, Andrew F.			FLS2-BAK1 Extracellular Domain Interaction Sites Required for Defense Signaling Activation	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; RECEPTOR-LIKE KINASES; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; FLAGELLIN PERCEPTION; PLANT IMMUNITY; ARABIDOPSIS; BAK1; FLS2; RESISTANCE	Signaling initiation by receptor-like kinases (RLKs) at the plasma membrane of plant cells often requires regulatory leucinerich repeat (LRR) RLK proteins such as SERK or BIR proteins. The present work examined how the microbe-associated molecular pattern (MAMP) receptor FLS2 builds signaling complexes with BAK1 (SERK3). We first, using in vivo methods that validate separate findings by others, demonstrated that flg22 (flagellin epitope) ligand-initiated FLS2-BAK1 extracellular domain interactions can proceed independent of intracellular domain interactions. We then explored a candidate SERK protein interaction site in the extracellular domains (ectodomains; ECDs) of the significantly different receptors FLS2, EFR (MAMP receptors), PEPR1 (damage-associated molecular pattern (DAMP) receptor), and BRI1 (hormone receptor). Repeat conservation mapping revealed a cluster of conserved solvent-exposed residues near the C-terminus of models of the folded LRR domains. However, site-directed mutagenesis of this conserved site in FLS2 did not impair FLS2-BAK1 ECD interactions, and mutations in the analogous site of EFR caused receptor maturation defects. Hence this conserved LRR C-terminal region apparently has functions other than mediating interactions with BAK1. In vivo tests of the subsequently published FLS2-flg22-BAK1 ECD co-crystal structure were then performed to functionally evaluate some of the unexpected configurations predicted by that crystal structure. In support of the crystal structure data, FLS2-BAK1 ECD interactions were no longer detected in in vivo co-immunoprecipitation experiments after site-directed mutagenesis of the FLS2 BAK1-interaction residues S554, Q530, Q627 or N674. In contrast, in vivo FLS2-mediated signaling persisted and was only minimally reduced, suggesting residual FLS2-BAK1 interaction and the limited sensitivity of co-immunoprecipitation data relative to in vivo assays for signaling outputs. However, Arabidopsis plants expressing FLS2 with the Q530A + Q627A double mutation were impaired both in detectable interaction with BAK1 and in FLS2-mediated responses, lending overall support to current models of FLS2 structure and function.	[Koller, Teresa; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016	Bent, Andrew/0000-0001-6610-9525	U.S. Department of Energy Basic Energy Biosciences [DE-FG02-02ER15342]; University of Wisconsin Hatch Funding	U.S. Department of Energy Basic Energy Biosciences; University of Wisconsin Hatch Funding	This research was funded by U.S. Department of Energy Basic Energy Biosciences Grant DE-FG02-02ER15342 and University of Wisconsin Hatch Funding to AFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2013, PLANT PHYSIOL, V163, P1504, DOI 10.1104/pp.113.227736; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Belkhadir Y., 2014, TRENDS BIOCH SCI; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cao YR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003313; Chen XW, 2014, MOL PLANT, V7, P874, DOI 10.1093/mp/ssu003; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Farid A, 2013, PLANT PHYSIOL, V162, P24, DOI 10.1104/pp.113.215509; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Halter T, 2013, CURR BIOL; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Kim BH, 2013, MOL CELLS, V35, P7, DOI 10.1007/s10059-013-2255-3; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Maki-Yonekura S, 2010, NAT STRUCT MOL BIOL, V17, P417, DOI 10.1038/nsmb.1774; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Robatzek S, 2012, PROTOPLASMA, V21; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Su W, 2012, MOL PLANT, V5, P929, DOI 10.1093/mp/sss042; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; von Numers N, 2010, MOL PLANT, V3, P740, DOI 10.1093/mp/ssq017; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	52	17	18	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111185	10.1371/journal.pone.0111185	http://dx.doi.org/10.1371/journal.pone.0111185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356676	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000044
J	Nigorikawa, K; Hazeki, K; Guo, Y; Hazeki, O				Nigorikawa, Kiyomi; Hazeki, Kaoru; Guo, Ying; Hazeki, Osamu			Involvement of Class II Phosphoinositide 3-Kinase alpha-Isoform in Antigen-Induced Degranulation in RBL-2H3 Cells	PLOS ONE			English	Article							MAST-CELLS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; GRANULE EXOCYTOSIS; MAMMALIAN-CELLS; C2 DOMAIN; ACTIVATION; SECRETION; MEMBRANE; C2-ALPHA; C2-BETA	In this study, we present findings that suggest that PI3K-C2 alpha, a member of the class II phosphoinositide 3-kinase (PI3K) subfamily, regulates the process of FcRI-triggered degranulation. RBL-2H3 cells were transfected with shRNA targeting PI3K-C2 alpha. The knockdown impaired the FceRI-induced release of a lysosome enzyme, beta-hexosaminidase, without affecting the intracellular Ca2+ mobilization. The release of mRFP-tagged neuropeptide-Y, a reporter for the regulated exocytosis, was also decreased in the PI3K-C2 alpha-deficient cells. The release was increased significantly by the expression of the siRNA-resistant version of PI3K-C2a. In wild-type cells, Fc epsilon RI stimulation induced the formation of large vesicles, which were associated with CD63, a marker protein of secretory granules. On the vesicles, the existence of PI3K-C2 alpha and PtdIns3,4) P-2 was observed. These results indicated that PI3K-C2 alpha and its product PtdIns3,4) P-2 may play roles in the secretory process.	[Nigorikawa, Kiyomi; Hazeki, Kaoru; Guo, Ying; Hazeki, Osamu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Nigorikawa, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	knigo@hiroshima-u.ac.jp			(Kakenhi) from the Japan Society for the Promotion of Science [23590078, 22590065]	(Kakenhi) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid (Kakenhi) from the Japan Society for the Promotion of Science (grant number 23590078 to OH and 22590065 to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Azouz NP, 2012, J IMMUNOL, V189, P2169, DOI 10.4049/jimmunol.1200542; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guillemot JC, 1997, J CELL SCI, V110, P2215; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hazeki K, 2012, FEBS LETT, V586, P4010, DOI 10.1016/j.febslet.2012.09.043; Kraft S, 2013, J IMMUNOL, V191, P2871, DOI 10.4049/jimmunol.1202323; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Puri N, 2003, J IMMUNOL, V171, P5345, DOI 10.4049/jimmunol.171.10.5345; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Rozycka M, 1998, GENOMICS, V54, P569, DOI 10.1006/geno.1998.5621; SCHMAUDERCHOCK EA, 1987, HISTOCHEM J, V19, P413, DOI 10.1007/BF01675751; Srivastava S, 2012, MOL CELL BIOL, V32, P3132, DOI 10.1128/MCB.00019-12; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Tuvim MJ, 1999, AM J RESP CELL MOL, V20, P79, DOI 10.1165/ajrcmb.20.1.3279; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Williams RM, 2000, J CELL SCI, V113, P3839	37	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111698	10.1371/journal.pone.0111698	http://dx.doi.org/10.1371/journal.pone.0111698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357130	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000075
J	Tai, DQ; Tian, J; Zhang, J; Song, TT; Yao, YC				Tai, Deqiang; Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong			A Malus Crabapple Chalcone Synthase Gene, McCHS, Regulates Red Petal Color and Flavonoid Biosynthesis	PLOS ONE			English	Article							R2R3-MYB TRANSCRIPTION FACTOR; PROANTHOCYANIDIN BIOSYNTHESIS; ANTHOCYANIN SYNTHESIS; NUCLEOTIDE-SEQUENCE; MOLECULAR ANALYSIS; CAMELLIA-SINENSIS; VITIS-VINIFERA; APPLE FRUIT; EXPRESSION; MYB	Chalcone synthase is a key and often rate-limiting enzyme in the biosynthesis of anthocyanin pigments that accumulate in plant organs such as flowers and fruits, but the relationship between CHS expression and the petal coloration level in different cultivars is still unclear. In this study, three typical crabapple cultivars were chosen based on different petal colors and coloration patterns. The two extreme color cultivars, 'Royalty' and 'Flame', have dark red and white petals respectively, while the intermediate cultivar 'Radiant' has pink petals. We detected the flavoniods accumulation and the expression levels of McCHS during petals expansion process in different cultivars. The results showed McCHS have their special expression patterns in each tested cultivars, and is responsible for the red coloration and color variation in crabapple petals, especially for color fade process in 'Radiant'. Furthermore, tobacco plants constitutively expressing McCHS displayed a higher anthocyanins accumulation and a deeper red petal color compared with control untransformed lines. Moreover, the expression levels of several anthocyanin biosynthetic genes were higher in the transgenic McCHS overexpressing tobacco lines than in the control plants. A close relationship was observed between the expression of McCHS and the transcription factors McMYB4 and McMYB5 during petals development in different crabapple cultivars, suggesting that the expression of McCHS was regulated by these transcription factors. We conclude that the endogenous McCHS gene is a critical factor in the regulation of anthocyanin biosynthesis during petal coloration in Malus crabapple.	[Tai, Deqiang; Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong] Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 100094, Peoples R China; [Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong] Beijing Agr Univ, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China; [Tai, Deqiang] Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Shanxi Agricultural University	Yao, YC (corresponding author), Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 100094, Peoples R China.	yaoyc_20@126.com			Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20140509]; National Natural Science Foundation of China [31301762]; National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project [Z121100007412003]	Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project	Financial support was provided by the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20140509), the National Natural Science Foundation of China (31301762) and the National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project (Z121100007412003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1991, PLANT MOL BIOL, V16, P751, DOI 10.1007/BF00023443; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; BEERHUES L, 1988, PLANTA, V173, P544, DOI 10.1007/BF00958968; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; COURTNEYGUTTERSON N, 1994, BIO-TECHNOL, V12, P268, DOI 10.1038/nbt0394-268; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Dare AP, 2013, PLANT J, V74, P398, DOI 10.1111/tpj.12140; Davies KM, 2007, MUTAT RES-FUND MOL M, V622, P122, DOI 10.1016/j.mrfmmm.2007.02.003; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Debes MA, 2011, AM J BOT, V98, P2077, DOI 10.3732/ajb.1000373; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Deroles SC, 1998, MOL BREEDING, V4, P59, DOI 10.1023/A:1009621903402; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; Feng FJ, 2013, PLANT PHYSIOL BIOCH, V69, P54, DOI 10.1016/j.plaphy.2013.04.020; FRANKEN P, 1991, EMBO J, V10, P2605, DOI 10.1002/j.1460-2075.1991.tb07802.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goto-Yamamoto N, 2002, PLANT SCI, V162, P867, DOI 10.1016/S0168-9452(02)00042-0; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; GUTTERSON N, 1995, HORTSCIENCE, V30, P964, DOI 10.21273/HORTSCI.30.5.964; HARKER CL, 1990, PLANT CELL, V2, P185, DOI 10.1105/tpc.2.3.185; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Horsch R.B., 1989, PLANT MOL BIOL MANUA, P63, DOI [10.1007/978-94-009-0951-9_5, DOI 10.1007/978-94-009-0951-9_5]; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; JUNGHANS H, 1993, PLANT MOL BIOL, V22, P239, DOI 10.1007/BF00014932; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Kuckuck H, 1936, MOL GENET GENOMICS, V71, P429; Kutchan TM, 2005, CURR OPIN PLANT BIOL, V8, P292, DOI 10.1016/j.pbi.2005.03.009; Li BY, 2012, J CELL SCI, V125, P4913, DOI 10.1242/jcs.111922; Li SJ, 2005, PLANT CELL REP, V23, P716, DOI 10.1007/s00299-004-0871-2; Liu XJ, 2012, PLANTA, V236, P401, DOI 10.1007/s00425-012-1616-z; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lunkenbein S, 2006, J AGR FOOD CHEM, V54, P2145, DOI 10.1021/jf052574z; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Nakatsuka T, 2008, PLANT BIOTECHNOL-NAR, V25, P61, DOI 10.5511/plantbiotechnology.25.61; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; PRICE SF, 1995, AM J ENOL VITICULT, V46, P187; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; ROHDE W, 1991, PLANT MOL BIOL, V16, P1103, DOI 10.1007/BF00016087; Schenke D, 2011, PLANT CELL ENVIRON, V34, P1849, DOI 10.1111/j.1365-3040.2011.02381.x; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Shen HX, 2012, ACTA PHYSIOL PLANT, V34, P1353, DOI 10.1007/s11738-012-0932-z; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian J, 2011, SCI HORTIC-AMSTERDAM, V129, P449, DOI 10.1016/j.scienta.2011.04.015; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang CK, 2006, BOT STUD, V47, P71; Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI DOI 10.1111/J.1365-3040.2011.02316.X; Wang WJ, 2014, J EXP BOT, V65, P2147, DOI 10.1093/jxb/eru084; Wang Y, 2012, PLANT CELL PHYSIOL, V53, P1470, DOI 10.1093/pcp/pcs088; Wang YP, 2009, J CELL SCI, V122, P2673, DOI 10.1242/jcs.049023; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang HB, 2012, MOL PLANT, V5, P73, DOI 10.1093/mp/ssr056; Zhang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097904; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-806	83	44	56	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110570	10.1371/journal.pone.0110570	http://dx.doi.org/10.1371/journal.pone.0110570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357207	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000016
J	Verbovsek, U; Motaln, H; Rotter, A; Atai, NA; Gruden, K; Van Noorden, CJF; Lah, TT				Verbovsek, Urska; Motaln, Helena; Rotter, Ana; Atai, Nadia A.; Gruden, Kristina; Van Noorden, Cornelis J. F.; Lah, Tamara T.			Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma	PLOS ONE			English	Article							CANCER; CELLS; DEFICIENCY; MECHANISMS; PHENOTYPE; CYSTATINS; SURVIVAL; GLIOMAS; MATRIX; MODELS	Background: Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed transcriptome analysis of all known genes of peptidases also called proteases and their endogenous inhibitors in glioblastoma multiforme (GBM), which is one of the most aggressive and deadly types of brain cancers, where unbalanced proteolysis is associated with tumor progression. Methods: Comparisons were performed between the transcriptomics of primary GBM tumors and unmatched nonmalignant brain tissue, and between GBM cell lines (U87-MG and U373) and a control human astrocyte cell line (NHA). Publicly-available data sets and our own datasets were integrated and normalized using bioinformatics tools to reveal protease and protease inhibitor genes with deregulated expression in both malignant versus non-malignant tissues and cells. Results: Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression. Seventy five protease inhibitor genes were differentially expressed, of which 3 genes were highly overexpressed, the genes coding for stefin B (CSTB), peptidase inhibitor 3 (PI3 also named elafin) and CD74. Seven out of 8 genes (except CSTB) were validated using RT-qPCR in GBM cell lines. CTSK overexpression was validated using RT-qPCR in GBM tissues as well. Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells. Conclusions: The presence of high levels of inactive proforms of cathepsin K in GBM tissues and cells indicate that in GBM the proteolytic/collagenolytic role is not its primary function but it plays rather a different yet unknown role.	[Verbovsek, Urska; Motaln, Helena; Lah, Tamara T.] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Atai, Nadia A.; Van Noorden, Cornelis J. F.] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Atai, Nadia A.; Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Lah, Tamara T.] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia	National Institute of Biology - Slovenia; National Institute of Biology - Slovenia; University of Amsterdam; Academic Medical Center Amsterdam; University of Ljubljana	Van Noorden, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.vannoorden@amc.uva.nl	Gruden, kristina/AAI-6439-2020; Motaln, Helena/AAD-1507-2022; Motaln, Helena/AAF-3489-2019	Motaln, Helena/0000-0002-0646-7934; Rotter, Ana/0000-0002-6879-0980; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P1-0245]; AMC scholarship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); AMC scholarship	This work was financed by the Slovenian Research Agency (program P1-0245 granted to T. T. L. and the young researcher fellowship granted to U. V.) and by an AMC scholarship of N.A.A. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Affymetrix, 2003, DES PERF GENECHIP HU; Anway MD, 2004, BIOL REPROD, V70, P562, DOI 10.1095/biolreprod.103.018291; Arampatzidou M, 2012, BIOL CHEM, V393, P1391, DOI 10.1515/hsz-2012-0204; Atai NA, 2011, J HISTOCHEM CYTOCHEM, V59, P489, DOI 10.1369/0022155411400606; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Beklen A, 2015, ORAL DIS, V21, P163, DOI 10.1111/odi.12230; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Bromme D, 2011, EXPERT OPIN INV DRUG, V18, P585, DOI DOI 10.1517/13543780902832661.CATHEPSIN; Cherney MM, 2011, J BIOL CHEM, V286, P8988, DOI 10.1074/jbc.M110.126706; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chirasani SR, 2009, CELLULAR MOL MECH GL, P120; Colin C, 2009, ACTA NEUROPATHOL, V118, P745, DOI 10.1007/s00401-009-0592-2; Dauth S, 2012, BIOL CHEM, V393, P959, DOI 10.1515/hsz-2012-0145; Dauth S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-74; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eronen L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-119; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferrone Soldano, 2008, V1, P35, DOI 10.1007/978-1-4020-6750-1_2; Flannery T, 2006, INT J CANCER, V119, P854, DOI 10.1002/ijc.21911; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gole B, 2012, INT J CANCER, V131, P1779, DOI 10.1002/ijc.27453; Gole B, 2009, PATHOL ONCOL RES, V15, P711, DOI 10.1007/s12253-009-9175-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Illumina, 2011, ARR BAS GEN EXPR AN; Illumina, 2010, MRNA EXPR AN DAT SHE; Kitange GJ, 2010, J NEURO-ONCOL, V100, P177, DOI 10.1007/s11060-010-0186-9; Lah TT, 2006, EXPERT OPIN BIOL TH, V6, P257, DOI 10.1517/14712598.6.3.257; LAH TT, 1992, CANCER LETT, V61, P243, DOI 10.1016/0304-3835(92)90295-7; Lah TT, 2008, CANC DEGRADOME; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lemaire PA, 2014, J BIOL CHEM IN PRESS; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Liang J, 2014, CLIN CANCER RES, V20, P187, DOI 10.1158/1078-0432.CCR-13-1279; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mentlein R, 2012, BBA-REV CANCER, V1825, P178, DOI 10.1016/j.bbcan.2011.12.001; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Motaln H, 2012, CELL TRANSPLANT, V21, P1529, DOI 10.3727/096368912X640547; Nallaseth FS, 2013, BIOCHEMISTRY-US, V52, P7742, DOI 10.1021/bi401051j; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Pietschmann P, 2013, CRIT REV EUKAR GENE, V23, P11, DOI 10.1615/CritRevEukarGeneExpr.2013005929; R Core Team, 2018, R LANG ENV STAT COMP; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rauch U, 2007, BIOCHEM SOC T, V35, P656, DOI 10.1042/BST0350656; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strojnik T, 2005, CANCER DETECT PREV, V29, P448, DOI 10.1016/j.cdp.2005.07.006; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00093; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-72; Zhang HL, 2004, J CLIN ENDOCR METAB, V89, P748, DOI 10.1210/jc.2003-031286	65	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111819	10.1371/journal.pone.0111819	http://dx.doi.org/10.1371/journal.pone.0111819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356585	gold, Green Published			2022-12-26	WOS:000346765000078
J	Westhoff, JT; Paukert, CP				Westhoff, Jacob T.; Paukert, Craig P.			Climate Change Simulations Predict Altered Biotic Response in a Thermally Heterogeneous Stream System	PLOS ONE			English	Article							WATER TEMPERATURE MODEL; SMALLMOUTH BASS; AIR-TEMPERATURE; POTENTIAL IMPACTS; BULL TROUT; GROUNDWATER RECHARGE; PREY CONSUMPTION; PATCH DYNAMICS; BROOK TROUT; COHO SALMON	Climate change is predicted to increase water temperatures in many lotic systems, but little is known about how changes in air temperature affect lotic systems heavily influenced by groundwater. Our objectives were to document spatial variation in temperature for spring-fed Ozark streams in Southern Missouri USA, create a spatially explicit model of mean daily water temperature, and use downscaled climate models to predict the number of days meeting suitable stream temperature for three aquatic species of concern to conservation and management. Longitudinal temperature transects and stationary temperature loggers were used in the Current and Jacks Fork Rivers during 2012 to determine spatial and temporal variability of water temperature. Groundwater spring influence affected river water temperatures in both winter and summer, but springs that contributed less than 5% of the main stem discharge did not affect river temperatures beyond a few hundred meters downstream. A multiple regression model using variables related to season, mean daily air temperature, and a spatial influence factor (metric to account for groundwater influence) was a strong predictor of mean daily water temperature (r(2) = 0.98; RMSE = 0.82). Data from two downscaled climate simulations under the A2 emissions scenario were used to predict daily water temperatures for time steps of 1995, 2040, 2060, and 2080. By 2080, peak numbers of optimal growth temperature days for smallmouth bass are expected to shift to areas with more spring influence, largemouth bass are expected to experience more optimal growth days (21 - 317% increase) regardless of spring influence, and Ozark hellbenders may experience a reduction in the number of optimal growth days in areas with the highest spring influence. Our results provide a framework for assessing fine-scale (10 s m) thermal heterogeneity and predict shifts in thermal conditions at the watershed and reach scale.	[Westhoff, Jacob T.] Univ Missouri, Dept Fisheries & Wildlife Sci, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA; [Paukert, Craig P.] Univ Missouri, US Geol Survey, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia	Westhoff, JT (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA.	westhoffj@missouri.edu		Westhoff, Jacob/0000-0002-2347-5098; Paukert, Craig/0000-0002-9369-8545	United States Geological Survey Natural Resources Preservation Project through Missouri Cooperative Fish and Wildlife Research Unit [116]	United States Geological Survey Natural Resources Preservation Project through Missouri Cooperative Fish and Wildlife Research Unit	This project was funded through the United States Geological Survey Natural Resources Preservation Project through Research Work Order 116 of the Missouri Cooperative Fish and Wildlife Research Unit (http://www.nature.nps.gov/challenge/2011/nrpp.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Nedushan B, 2007, HYDROL PROCESS, V21, P21, DOI 10.1002/hyp.6353; Al-Chokhachy R, 2013, GLOBAL CHANGE BIOL, V19, DOI 10.1111/gcb.12262; Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Ayllon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081354; Bartholow J. M., 1989, 8917 US FISH WILDL S; Baxter CV, 2000, CAN J FISH AQUAT SCI, V57, P1470, DOI 10.1139/cjfas-57-7-1470; Benyahya L., 2007, CANADIAN WATER RESOU, V32, P179, DOI DOI 10.4296/CWRJ3203179; Bogan T, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002034; Brewer SK, 2013, RIVER RES APPL, V29, P269, DOI 10.1002/rra.1595; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; Cherkauer KA, 2005, J AM WATER RESOUR AS, V41, P1149, DOI 10.1111/j.1752-1688.2005.tb03790.x; Chu C, 2008, CAN J FISH AQUAT SCI, V65, P297, DOI 10.1139/F08-007; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DeWeber JT, 2014, J HYDROL, V517, P187, DOI 10.1016/j.jhydrol.2014.05.035; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Eby LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098812; Eckhardt K, 2003, J HYDROL, V284, P244, DOI 10.1016/j.jhydrol.2003.08.005; Erickson TR, 2000, J HYDROL ENG, V5, P317, DOI 10.1061/(ASCE)1084-0699(2000)5:3(317); Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Garrett James W., 1998, North American Journal of Fisheries Management, V18, P925, DOI 10.1577/1548-8675(1998)018<0925:EISFKS>2.0.CO;2; Hague MJ, 2014, N AM J FISH MANAGE, V34, P132, DOI 10.1080/02755947.2013.847879; Herb WR, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009586; HILL DK, 1990, T AM FISH SOC, V119, P265, DOI 10.1577/1548-8659(1990)119<0265:PEOGCW>2.3.CO;2; Hostetler S. W., 2011, 20111238 US GEOL SUR; Howell PJ, 2010, ECOL FRESHW FISH, V19, P96, DOI 10.1111/j.1600-0633.2009.00393.x; Hu Q, 2005, ENVIRON MODEL ASSESS, V10, P9, DOI 10.1007/s10666-004-4266-0; HUTCHISON V H, 1976, Herpetologica, V32, P327; Imholt C, 2013, RIVER RES APPL, V29, P403, DOI 10.1002/rra.1608; Intergovernmental Panel on Climate Change, 2000, SUMM POL MAK EM SCEN; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Isaak DJ, 2001, J AM WATER RESOUR AS, V37, P351, DOI 10.1111/j.1752-1688.2001.tb00974.x; Jeong DI, 2013, RIVER RES APPL, V29, P805, DOI 10.1002/rra.2574; JEPPESEN E, 1987, OIKOS, V49, P149, DOI 10.2307/3566020; Jones LA, 2014, RIVER RES APPL, V30, P204, DOI 10.1002/rra.2638; Jourdonnais Jon H., 1992, Rivers, V3, P153; Jyrkama MI, 2007, J HYDROL, V338, P237, DOI 10.1016/j.jhydrol.2007.02.036; Kanno Y, 2014, RIVER RES APPL, V30, P745, DOI 10.1002/rra.2677; King JR, 1999, T AM FISH SOC, V128, P656, DOI 10.1577/1548-8659(1999)128&lt;0656:ELBTHF&gt;2.0.CO;2; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Labbe TR, 2000, ECOL APPL, V10, P1774, DOI 10.1890/1051-0761(2000)010[1774:DOISHR]2.0.CO;2; Lehtonen H., 1996, Fisheries Management and Ecology, V3, P59, DOI 10.1111/j.1365-2400.1996.tb00130.x; Lloyd C., 2010, SPATIAL DATA ANAL IN; Lucas LK, 2009, CONSERV GENET, V10, P1309, DOI 10.1007/s10592-008-9710-2; Madej MA, 2006, CAN J FISH AQUAT SCI, V63, P1384, DOI 10.1139/F06-043; Martin RW, 2009, J FRESHWATER ECOL, V24, P497, DOI 10.1080/02705060.2009.9664323; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Meinzer OE, 1925, CONTRIBUTIONS HYDROG; Mohler HS, 1966, THESIS U MISSOURI CO; Mohseni O, 2003, CLIMATIC CHANGE, V59, P389, DOI 10.1023/A:1024847723344; Mohseni O, 1999, J HYDROL, V218, P128, DOI 10.1016/S0022-1694(99)00034-7; Mugel D. M., 2009, 20095138 US GEOL SUR; Neumann DW, 2003, J ENVIRON ENG-ASCE, V129, P667, DOI 10.1061/(ASCE)0733-9372(2003)129:7(667); Nichols AL, 2014, RIVER RES APPL, V30, P442, DOI 10.1002/rra.2655; Nohara D, 2006, J HYDROMETEOROL, V7, P1076, DOI 10.1175/JHM531.1; O'Driscoll MA, 2006, J HYDROL, V329, P140, DOI 10.1016/j.jhydrol.2006.02.010; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; Ouellet V, 2014, RIVER RES APPL, V30, P733, DOI 10.1002/rra.2664; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Panfil M. S., 2001, USGSBRDBSR20010005; Pease AA, 2014, ECOL FRESHW FISH, V23, P336, DOI 10.1111/eff.12084; Peterson James T., 1996, North American Journal of Fisheries Management, V16, P738, DOI 10.1577/1548-8675(1996)016<0738:NTRFTW>2.3.CO;2; Peterson JT, 2001, T AM FISH SOC, V130, P898, DOI 10.1577/1548-8659(2001)130<0898:ETPCOC>2.0.CO;2; Petty JT, 2012, T AM FISH SOC, V141, P1060, DOI 10.1080/00028487.2012.681102; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Poole GC, 2001, ENVIRON MANAGE, V27, P787, DOI 10.1007/s002670010188; Power G, 1999, HYDROL PROCESS, V13, P401, DOI 10.1002/(SICI)1099-1085(19990228)13:3<401::AID-HYP746>3.3.CO;2-1; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Reese CD, 2002, T AM FISH SOC, V131, P599, DOI 10.1577/1548-8659(2002)131&lt;0599:TDIBJS&gt;2.0.CO;2; REYNOLDS WW, 1979, AM ZOOL, V19, P211; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Sada DW, 2005, DIVERS DISTRIB, V11, P91, DOI 10.1111/j.1366-9516.2005.00131.x; Schmidt C, 2006, HYDROL EARTH SYST SC, V10, P849, DOI 10.5194/hess-10-849-2006; SCHRAMM HL, 1991, FISHERIES, V16, P13, DOI 10.1577/1548-8446(1991)016<0013:SEABAO>2.0.CO;2; Selker J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027979; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; SINOKROT BA, 1995, CLIMATIC CHANGE, V30, P181, DOI 10.1007/BF01091841; Smith H, 2002, HYDROBIOLOGIA, V487, P45, DOI 10.1023/A:1022932303652; SOWA SP, 1995, T AM FISH SOC, V124, P240, DOI 10.1577/1548-8659(1995)124<0240:REOTRO>2.3.CO;2; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Struber RJ, 1982, FWSOBS820116 US DEP; Taylor CA, 2009, J HYDROL, V375, P601, DOI 10.1016/j.jhydrol.2009.07.009; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Tonolla D, 2012, REMOTE SENS ENVIRON, V125, P134, DOI 10.1016/j.rse.2012.07.014; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Wehrly KE, 2003, T AM FISH SOC, V132, P18, DOI 10.1577/1548-8659(2003)132<0018:CRVITR>2.0.CO;2; Westhoff MC, 2007, HYDROL EARTH SYST SC, V11, P1469, DOI 10.5194/hess-11-1469-2007; Whitledge GW, 2006, ECOL APPL, V16, P1461, DOI 10.1890/1051-0761(2006)016[1461:RSAGEG]2.0.CO;2; Whitledge GW, 2002, J FRESHWATER ECOL, V17, P353, DOI 10.1080/02705060.2002.9663908; WILLIAMS J. D., 1982, OCCASIONAL PAPERS MU, V102, P1; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1; WINEMILLER KO, 1987, AM MIDL NAT, V117, P148, DOI 10.2307/2425716; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Zweifel Richard D., 1999, North American Journal of Fisheries Management, V19, P192, DOI 10.1577/1548-8675(1999)019<0192:BIIBBD>2.0.CO;2	104	28	28	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111438	10.1371/journal.pone.0111438	http://dx.doi.org/10.1371/journal.pone.0111438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356982	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000061
J	Chen, Y; Zhang, RH; Shang, L				Chen, Yong; Zhang, Rong Hua; Shang, Lei			A Novel Method of Object Detection from a Moving Camera Based on Image Matching and Frame Coupling	PLOS ONE			English	Article								A new method based on image matching and frame coupling to handle the problems of object detection caused by a moving camera and object motion is presented in this paper. First, feature points are extracted from each frame. Then, motion parameters can be obtained. Sub-images are extracted from the corresponding frame via these motion parameters. Furthermore, a novel searching method for potential orientations improves efficiency and accuracy. Finally, a method based on frame coupling is adopted, which improves the accuracy of object detection. The results demonstrate the effectiveness and feasibility of our proposed method for a moving object with changing posture and with a moving camera.	[Chen, Yong; Zhang, Rong Hua; Shang, Lei] Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Chen, Y (corresponding author), Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610054, Peoples R China.	ychencd@uestc.edu.cn		chen, yong/0000-0003-4580-8655	National Natural Science Foundation of China [61105030]; Fundamental Research Funds for the Central Universities [ZYGX2011J021]; Scientific and Technical Supporting Programs of Sichuan Province [2013GZ0054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific and Technical Supporting Programs of Sichuan Province	Funding was provided by National Natural Science Foundation of China under grant (61105030), The Fundamental Research Funds for the Central Universities (ZYGX2011J021), and the Scientific and Technical Supporting Programs of Sichuan Province (2013GZ0054). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiv G, 2009, IEEE T PATTERN ANAL, V7, P84; Araki S, 2000, IEICE T INF SYST, VE83D, P1583; Berrabah SA, 2006, IEEE IMAGE PROC, P1125, DOI 10.1109/ICIP.2006.312754; Chen Y., 2013, REV SCI INSTRUM, P1; Ghosh A, 2012, IEEE T CIRC SYST VID, V22, P1127, DOI 10.1109/TCSVT.2012.2190476; Peng XM, 2010, IMAGE VISION COMPUT, V28, P1280, DOI 10.1016/j.imavis.2010.01.007; Wang JB, 2008, IEEE T PATTERN ANAL, V30, P477, DOI 10.1109/TPAMI.2007.1178; Yu X, 2011, LASER OPTOELECTRON P, V7, P75	8	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109809	10.1371/journal.pone.0109809	http://dx.doi.org/10.1371/journal.pone.0109809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354301	Green Submitted, gold, Green Published			2022-12-26	WOS:000345204200014
J	Dudley, PN; Bonazza, R; Jones, TT; Wyneken, J; Porter, WP				Dudley, Peter N.; Bonazza, Riccardo; Jones, T. Todd; Wyneken, Jeanette; Porter, Warren P.			Leatherbacks Swimming In Silico: Modeling and Verifying Their Momentum and Heat Balance Using Computational Fluid Dynamics	PLOS ONE			English	Article							DERMOCHELYS-CORIACEA; THERMAL-CONDUCTIVITY; SEA-TURTLES; TISSUE; RANGE; NICHE; WHALE; FLAP; SIZE	As global temperatures increase throughout the coming decades, species ranges will shift. New combinations of abiotic conditions will make predicting these range shifts difficult. Biophysical mechanistic niche modeling places bounds on an animal's niche through analyzing the animal's physical interactions with the environment. Biophysical mechanistic niche modeling is flexible enough to accommodate these new combinations of abiotic conditions. However, this approach is difficult to implement for aquatic species because of complex interactions among thrust, metabolic rate and heat transfer. We use contemporary computational fluid dynamic techniques to overcome these difficulties. We model the complex 3D motion of a swimming neonate and juvenile leatherback sea turtle to find power and heat transfer rates during the stroke. We combine the results from these simulations and a numerical model to accurately predict the core temperature of a swimming leatherback. These results are the first steps in developing a highly accurate mechanistic niche model, which can assists paleontologist in understanding biogeographic shifts as well as aid contemporary species managers about potential range shifts over the coming decades.	[Dudley, Peter N.; Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Bonazza, Riccardo] Univ Wisconsin, Madison, WI 53706 USA; [Jones, T. Todd] NOAA Inouye Reg Ctr, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; Florida Atlantic University	Dudley, PN (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	P.N.D.PhD@gmail.com		Dudley, Peter/0000-0002-3210-634X	NOAA Fisheries (Pacific Islands Fisheries Science Center); Joint Institute for Marine and Atmospheric Research; UW Foundation; Disney Worldwide Conservation Fund grant	NOAA Fisheries (Pacific Islands Fisheries Science Center); Joint Institute for Marine and Atmospheric Research; UW Foundation; Disney Worldwide Conservation Fund grant	Funding for the live neonate force trials was provided by NOAA Fisheries (Pacific Islands Fisheries Science Center), the Joint Institute for Marine and Atmospheric Research, the UW Foundation and a 2012 Disney Worldwide Conservation Fund grant to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JW also contributed substantial personal funds to the live neonate force trials.	Bagge LE, 2012, J EXP BIOL, V215, P4330, DOI 10.1242/jeb.071530; Blake RW, 2007, J EXP BIOL, V210, P2979, DOI 10.1242/jeb.006437; BOISCLAIR D, 1993, J FISH BIOL, V42, P169, DOI 10.1111/j.1095-8649.1993.tb00319.x; Bostrom BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013925; Cedeno FO, 2000, J CHEM ENG DATA, V45, P64, DOI 10.1021/je990164z; Chang Chun-Hsiang, 2003, Collection and Research, V16, P17; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; DAVENPORT J, 1990, J MAR BIOL ASSOC UK, V70, P33, DOI 10.1017/S0025315400034172; Davenport J, 2009, J EXP BIOL, V212, P2753, DOI 10.1242/jeb.026500; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Drucker EG, 1999, J EXP BIOL, V202, P2393; Dudley PN, 2013, J EXP ZOOL PART A, V319A, P319, DOI 10.1002/jez.1796; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOFF GP, 1988, COPEIA, P1071, DOI 10.2307/1445737; GREER AE, 1973, NATURE, V244, P181, DOI 10.1038/244181a0; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kvadsheim PH, 1996, J THERM BIOL, V21, P123, DOI 10.1016/0306-4565(95)00034-8; Liu H, 1997, J EXP BIOL, V200, P2807; Low KH, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P535, DOI 10.1109/ROBIO.2007.4522219; Marom S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P944, DOI 10.1086/505999; Miller DL, 2009, J WILDLIFE DIS, V45, P962, DOI 10.7589/0090-3558-45.4.962; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PARRY DA, 1949, Q J MICROSC SCI, V90, P13; Pavlov VV, 2012, MAR MAMMAL SCI, V28, pE16, DOI 10.1111/j.1748-7692.2011.00476.x; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; Schultz WW, 2002, INTEGR COMP BIOL, V42, P1018, DOI 10.1093/icb/42.5.1018; Skrovan RC, 1999, J EXP BIOL, V202, P2749; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Usherwood JR, 2003, J EXP BIOL, V206, P4051, DOI 10.1242/jeb.00624; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023; Ward S, 1999, J EXP BIOL, V202, P1589; Weber PW, 2009, J EXP BIOL, V212, P2149, DOI 10.1242/jeb.029868; WOLEDGE RC, 1968, J PHYSIOL-LONDON, V197, P685, DOI 10.1113/jphysiol.1968.sp008582; WRIGHT PG, 1984, S AFR J ZOOL, V19, P266	39	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110701	10.1371/journal.pone.0110701	http://dx.doi.org/10.1371/journal.pone.0110701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354303	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200032
J	Jensen, DH; Hedback, N; Specht, L; Hogdall, E; Andersen, E; Therkildsen, MH; Friis-Hansen, L; Norrild, B; von Buchwald, C				Jensen, David Hebbelstrup; Hedback, Nora; Specht, Lena; Hogdall, Estrid; Andersen, Elo; Therkildsen, Marianne Hamilton; Friis-Hansen, Lennart; Norrild, Bodil; von Buchwald, Christian			Human Papillomavirus in Head and Neck Squamous Cell Carcinoma of Unknown Primary Is a Common Event and a Strong Predictor of Survival	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CONTEMPORARY MANAGEMENT; ROBOTIC SURGERY; PRIMARY TUMORS; PRIMARY SITE; CANCER; HPV; DNA; PREVALENCE; ORIGIN	Background: The purpose of this study was to examine the prevalence of human papillomavirus (HPV) in patients with head and neck squamous cell carcinoma of unknown primary (CUP). Methods: All patients diagnosed with and treated for CUP between January 1, 2000, and June 1, 2011, at two Danish medical centers were included. All patients received a thorough diagnostic work-up, including FDG-PET, before being diagnosed as CUP. We determined the HPV status in all patients using a combination of HPV DNA PCR and p16 stain. In addition, clinical information on the study patients was retrieved from clinical records. Results: Of the identified 60 patients with CUP, 13 were shown to be positive for HPV DNA, amounting to 22% of the study population. In addition, we were able to show a clear disease-free and overall-survival benefit in the HPV-positive group, with a hazard ratio of 0.16 (95% CI: 0.038-0.67) for over-all survival. This survival benefit was also apparent when adjusted for advanced age in a multivariate Cox regression analysis. Conclusion: A fairly large percentage of CUP cases are HPV-related, and because this is related to both the location and prognosis, we recommend HPV testing as part of the diagnostic work-up.	[Jensen, David Hebbelstrup; Hedback, Nora; von Buchwald, Christian] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Specht, Lena] Univ Copenhagen, Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Andersen, Elo] Univ Copenhagen, Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark; [Therkildsen, Marianne Hamilton] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Norrild, Bodil] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jensen, DH (corresponding author), Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	david.hebbelstrup.jensen@regionh.dk	von Buchwald, Christian/D-5336-2016; Specht, Lena/J-6422-2019; Andersen, Elo/A-1639-2016	von Buchwald, Christian/0000-0001-6753-8129; Specht, Lena/0000-0002-6902-2190; Andersen, Elo/0000-0002-2476-1037; Friis-Hansen, Lennart/0000-0002-7222-0163; Hogdall, Estrid/0000-0003-4689-5658	Candys Foundation	Candys Foundation	David H. Jensen is supported by a grant from the non-profit foundation Candys Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armas GL, 2008, EUR ARCH OTO-RHINO-L, V265, P1379, DOI 10.1007/s00405-008-0670-4; Barnes L, 2005, PATHOLOGY GENETICS H; Barwad A, 2012, DIAGN CYTOPATHOL, V40, P893, DOI 10.1002/dc.21667; Begum S, 2003, CLIN CANCER RES, V9, P6469; Califano J, 1999, J NATL CANCER I, V91, P599, DOI 10.1093/jnci/91.7.599; Chernock RD, 2009, HEAD NECK PATHOL, V3, P186, DOI 10.1007/s12105-009-0126-1; Compton AM, 2011, OTOLARYNG HEAD NECK, V145, P51, DOI 10.1177/0194599811400385; Desai PC, 2009, EXP MOL PATHOL, V87, P94, DOI 10.1016/j.yexmp.2009.04.003; El-Mofty SK, 2008, HEAD NECK PATHOL, V2, P163, DOI 10.1007/s12105-008-0066-1; El-Mofty SK, 2003, AM J SURG PATHOL, V27, P1463, DOI 10.1097/00000478-200311000-00010; Goldenberg D, 2008, HEAD NECK-J SCI SPEC, V30, P898, DOI 10.1002/hed.20796; Grau C, 2000, RADIOTHER ONCOL, V55, P121, DOI 10.1016/S0167-8140(00)00172-9; Gronhoj Larsen C, 2014, BR J CANC; Groppo ER, 2011, LARYNGOSCOPE, V121, pS118; Hafkamp HC, 2008, INT J CANCER, V122, P2656, DOI 10.1002/ijc.23458; Hoffmann M, 2005, ACTA OTO-LARYNGOL, V125, P415, DOI 10.1080/00016480510028528; Hoffmann M, 2006, ANTICANCER RES, V26, P663; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Johansen J, 2002, LARYNGOSCOPE, V112, P2009, DOI 10.1097/00005537-200211000-00018; Keller LM, 2013, HEAD NECK; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mehta V, 2013, LARYNGOSCOPE, V123, P146, DOI 10.1002/lary.23562; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Patel SA, 2013, JAMA OTOLARYNGOL, V139, P1203, DOI 10.1001/jamaoto.2013.5189; Perkins SM, 2012, ARCH OTOLARYNGOL, V138, P656, DOI 10.1001/archoto.2012.1110; Sivars L, 2014, CANCER MED-US, V3, P376, DOI 10.1002/cam4.199; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Straetmans JMJAA, 2012, HEAD NECK-J SCI SPEC, V34, P1819, DOI 10.1002/hed.23166; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P286, DOI 10.1002/hed.21899; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P123, DOI 10.1002/hed.21898; Tribius S, 2012, ORAL ONCOL, V48, P1178, DOI 10.1016/j.oraloncology.2012.05.022; Weiss D, 2011, HEAD NECK-J SCI SPEC, V33, P856, DOI 10.1002/hed.21548; Westra WH, 2012, HEAD NECK PATHOL, V6, pS48, DOI 10.1007/s12105-012-0371-6; White HN, 2010, ARCH OTOLARYNGOL, V136, P1248, DOI 10.1001/archoto.2010.216; Zengel P, 2012, VIRCHOWS ARCH, V461, P283, DOI 10.1007/s00428-012-1290-3	35	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110456	10.1371/journal.pone.0110456	http://dx.doi.org/10.1371/journal.pone.0110456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369118	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000021
J	Alassaad, A; Bertilsson, M; Gillespie, U; Sundstrom, J; Hammarlund-Udenaes, M; Melhus, H				Alassaad, Anna; Bertilsson, Maria; Gillespie, Ulrika; Sundstrom, Johan; Hammarlund-Udenaes, Margareta; Melhus, Hakan			The Effects of Pharmacist Intervention on Emergency Department Visits in Patients 80 Years and Older: Subgroup Analyses by Number of Prescribed Drugs and Appropriate Prescribing	PLOS ONE			English	Article							STOPP SCREENING TOOL; POTENTIALLY INAPPROPRIATE; ELDERLY-PEOPLE; ALERT DOCTORS; PERSONS PRESCRIPTIONS; CONTROLLED-TRIAL; NURSING-HOMES; MEDICATION; QUALITY; CARE	Background: Clinical pharmacist interventions have been shown to have positive effect on occurrence of drug-related issues as well as on clinical outcomes. However, evidence about which patients benefiting most from the interventions is limited. We aimed to explore whether pharmacist intervention is equally effective in preventing emergency department (ED) visits in patients with few or many prescribed drugs and in those with different levels of inappropriate prescribing. Methods: Patient and outcome data from a randomized controlled trial exploring the clinical effects of a ward-based pharmacist intervention in patients, 80 years and older, were used. The patients were divided into subgroups according to the number of prescribed drugs (< 5 or >= 5 drugs) and the level of inappropriate prescribing [using the Screening Tool Of Older People's potentially inappropriate Prescriptions (STOPP) and the Screening Tool to Alert doctors to Right Treatment (START) with a score of >= 2 (STOPP) and >= 1 (START) as cutoff points]. The effect of the intervention on the number of times the different subgroups visited the ED was analyzed. Results: The pharmacist intervention was more effective with respect to the number of subsequent ED visits in patients taking < 5 drugs on admission than in those taking >= 5 drugs. The rate ratio (RR) for a subsequent ED visit was 0.22 [95% confidence interval (CI) 0.09-0.52] for,5 drugs and 0.70 (95% CI 0.47-1.04) for >= 5 drugs (p = 0.02 for the interaction). The effect of intervention did not differ between patients with high or low STOPP or START scores. Conclusion: In this exploratory study, the pharmacist intervention appeared to be more effective in preventing visits to the ED for patients who were taking fewer drugs before the intervention. Our analysis of STOPP and START scores indicated that the level of inappropriate prescribing on admission had no effect on the outcomes of intervention with respect to ED visits.	[Alassaad, Anna; Sundstrom, Johan; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Alassaad, Anna; Gillespie, Ulrika] Univ Uppsala Hosp, Uppsala, Sweden; [Bertilsson, Maria; Sundstrom, Johan] Uppsala Clin Res Ctr, Uppsala, Sweden; [Hammarlund-Udenaes, Margareta] Uppsala Univ, Dept Pharmaceut Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University	Alassaad, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anna.alassaad@medsci.uu.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454	Swedish Academy for Pharmaceutical Sciences	Swedish Academy for Pharmaceutical Sciences	The study was funded by the non-profit organization Swedish Academy for Pharmaceutical Sciences (one PhD student via scholarship). Uppsala University funded biostatistic consulting. The University Hospital of Uppsala and Uppsala University co-funded the study by letting involved physician and pharmacists participate in meetings during work hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassaad A, 2013, J EVAL CLIN PRACT, V19, P185, DOI 10.1111/j.1365-2753.2011.01798.x; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Dormann H, 2013, DTSCH ARZTEBL INT, V110, P213, DOI 10.3238/arztebl.2013.0213; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2009, AGE AGEING, V38, P603, DOI 10.1093/ageing/afp058; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Gillespie U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062401; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Hughes CM, 2009, DRUG AGING, V26, P505, DOI 10.2165/00002512-200926060-00007; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; KOCH GG, 1982, BIOMETRICS, V38, P563, DOI 10.2307/2530041; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Olsson J, 2010, CLIN DRUG INVEST, V30, P289, DOI 10.2165/11534320-000000000-00000; PARKIN DM, 1976, BMJ-BRIT MED J, V2, P686, DOI 10.1136/bmj.2.6037.686; Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2; Scott I, 2010, INTERN MED J, V40, P7, DOI 10.1111/j.1445-5994.2009.02040.x; Simonson W, 2005, DRUG AGING, V22, P559, DOI 10.2165/00002512-200522070-00002; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Stokes ME, 2000, CATEGORICAL DATA ANA	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111797	10.1371/journal.pone.0111797	http://dx.doi.org/10.1371/journal.pone.0111797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25364817	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100122
J	Franconi, F; Omboni, S; Ambrosioni, E; Reggiardo, G; Campesi, I; Borghi, C				Franconi, Flavia; Omboni, Stefano; Ambrosioni, Ettore; Reggiardo, Giorgio; Campesi, Ilaria; Borghi, Claudio			Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; CORONARY-HEART-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; DOUBLE-BLIND; ANGIOTENSIN; MANAGEMENT; PHARMACOKINETICS; HYPERTENSION; MORTALITY; FRANCE	Background: the SMILE studies proved the prognostic benefit of zofenopril vs. placebo or other ACE-inhibitors (ACEIs) in post-acute myocardial infarction (AMI). In this retrospective pooled analysis of these studies we assessed whether the zofenopril effect is influenced by gender. Methods: the four double-blind, randomized, parallel-group SMILE studies, compared the efficacy and safety of 6-48 week treatment with zofenopril 60 mg/day with that of placebo, lisinopril 10 mg/day or ramipril 10 mg/day in 3630 AMI patients. This pooled analysis compared treatment efficacy (1-year combined occurrence of death or hospitalization for CV causes) in 2733 men and 897 women. Results: women were older than men, had a higher prevalence of diabetes and of other major CV risk factors. The risk of a major CV event was significantly larger for women (23% vs. 17% men, p, 0.001). Between-gender risk difference was more marked for people living in Southern (+ 54%) than in Northern Europe (+ 12%). In both genders zofenopril similarly reduced the 1-year risk of CV morbidity and mortality vs. placebo (-39% men, p = 0.0001; -40% women, p = 0.005). The risk reduction was more marked with zofenopril than with the other ACEIs, particularly in men (-27%, p = 0.012; women: -14%, p = 0.479). The drug safety profile was similar between genders in zofenopril-treated patients, while it was worse in women treated with other ACEIs. Conclusions: post-AMI women are at higher risk of CV complications than men, particularly when living in Mediterranean countries. Their response to ACE-inhibition varies according to the type of drug and is usually better in men.	[Franconi, Flavia; Campesi, Ilaria] Univ Sassari, Lab Gender Med, Natl Inst Biostruct & Biosyst, I-07100 Sassari, Italy; [Franconi, Flavia; Campesi, Ilaria] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Omboni, Stefano] Italian Inst Telemed, Clin Res Unit, Varese, Italy; [Ambrosioni, Ettore; Borghi, Claudio] Univ Bologna, Unit Internal Med, Policlin S Orsola, Bologna, Italy; [Reggiardo, Giorgio] Mediservice, Milan, Italy	University of Sassari; University of Sassari; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Franconi, F (corresponding author), Univ Sassari, Lab Gender Med, Natl Inst Biostruct & Biosyst, I-07100 Sassari, Italy.	franconi@uniss.it	Omboni, Stefano/D-1327-2015; CAMPESI, ILARIA/AAJ-7672-2021; Campesi, Ilaria/AFE-4953-2022; Campesi, Ilaria/AAE-9580-2022	Omboni, Stefano/0000-0002-7124-2096; CAMPESI, ILARIA/0000-0002-1681-6448; 	Menarini International Operations Luxembourg S.A.; Laboratori Guidotti S.p.A.; Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant	Menarini International Operations Luxembourg S.A.; Laboratori Guidotti S.p.A.; Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant	This work was financially supported by Menarini International Operations Luxembourg S.A., Laboratori Guidotti S.p.A. and Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant. The funding source did not influence or commented on planned methods, protocol, data analysis and the draft report.	AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Ambrosioni E, 2007, AM J CARDIOVASC DRUG, V7, P17, DOI 10.2165/00129784-200707010-00002; Borghi C, 2003, AM HEART J, V145, P80, DOI 10.1067/mhj.2003.24; Borghi C, 2012, EXPERT REV CARDIOVAS, V10, P973, DOI [10.1586/ERC.12.81, 10.1586/erc.12.81]; Borghi C, 2012, CLIN CARDIOL, V35, P416, DOI 10.1002/clc.22017; Borghi C, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.12.005; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; Ducimetiere P, 2001, INT J EPIDEMIOL, V30, P1057, DOI 10.1093/ije/30.5.1057; Franconi F, 2014, BRIT J PHARMACOL, V171, P580, DOI 10.1111/bph.12362; Franconi F, 2011, THER DELIV, V2, P1437, DOI 10.4155/TDE.11.117; Franconi F, 2011, CURR PHARM DESIGN, V17, P1095, DOI 10.2174/138161211795656918; Germano G, 2012, EUR HEART J, V33, P137; Hausmann Ricardo, 2011, GLOBAL GENDER GAP RE; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Maas AHEM, 2011, EUR HEART J, V32, P1362, DOI 10.1093/eurheartj/ehr048; Mackay FJ, 1999, BRIT J CLIN PHARMACO, V47, P111; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Montaye M, 2013, EUR J PREV CARDIOL, V20, P275, DOI 10.1177/2047487312438983; Morris RW, 2003, STROKE, V34, P2604, DOI 10.1161/01.STR.0000092489.98235.1D; Omboni S, 2011, THER CLIN RISK MANAG, V7, P459, DOI 10.2147/TCRM.S25976; Papakonstantinou NA, 2013, J CARDIOL, V62, P4, DOI 10.1016/j.jjcc.2013.03.001; Puymirat E, 2013, EUR HEART J-ACUTE CA, V2, P359, DOI 10.1177/2048872613497341; Raz Limor, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-30726-3_7; Schmotzer GL, 2012, ETHNIC DIS, V22, P226; Seeland Ute, 2012, Handb Exp Pharmacol, P211, DOI 10.1007/978-3-642-30726-3_11; Shah MR, 2000, AM J MED, V109, P489, DOI 10.1016/S0002-9343(00)00529-5; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Shepherd J, 1996, LANCET, V348, P1339; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; Solimene MC, 2010, CLINICS, V65, P99, DOI 10.1590/S1807-59322010000100015; von Lueder TG, 2013, CARDIOVASC DRUG THER, V27, P171, DOI 10.1007/s10557-012-6424-y; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Woodard-Grice AV, 2010, PHARMACOGENET GENOM, V20, P532, DOI 10.1097/FPC.0b013e32833d3acb	38	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111558	10.1371/journal.pone.0111558	http://dx.doi.org/10.1371/journal.pone.0111558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364906	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100075
J	Jonsson, U; Alexanderson, K; Kjeldgard, L; Mittendorfer-Rutz, E				Jonsson, Ulf; Alexanderson, Kristina; Kjeldgard, Linnea; Mittendorfer-Rutz, Ellenor			Psychiatric Diagnoses and Risk of Suicidal Behaviour in Young Disability Pensioners: Prospective Cohort Studies of All 19-23 Year Olds in Sweden in 1995, 2000, and 2005, Respectively	PLOS ONE			English	Article							TRENDS; MORTALITY; REGISTER; ADULTS; ADHD	Objective: Increasing rates of disability pension (DP) have been observed among young adults. We studied specific psychiatric DP diagnoses and subsequent risk of suicidal behaviour in a series of three cohorts of young adult in Sweden. Method: In a nationwide register study, we included all young adults who in 1995, 2000, and 2005, respectively, were 19-23 years old and lived in Sweden (n approximate to 500,000 per cohort). Rates of DP and specific psychiatric DP diagnoses were recorded in each cohort. Hazard ratios (HRs) and 95% confidence intervals (CIs) for suicidal behaviour during the following five years, with the corresponding age group as reference, were calculated by Cox proportional hazard regression, adjusted for demographic variables and previous own and parental suicidal behaviour. Results: The overall proportion with DP in this age group increased from 0.92% in 1995 to 2.29% in 2005, with particularly large increases in psychiatric diagnoses such as hyperkinetic disorders, pervasive developmental disorders, and depression/anxiety. The overall proportion of young disability pensioners attempting suicide during the five-year follow-up increased from 2.21% in the 1995 cohort to 3.81% in the 2005 cohort. Within most psychiatric DP diagnoses, the risk of attempted suicide did not change significantly over time, whereas suicide attempts increased in the reference group. Accordingly, the HRs for suicide attempt decreased in some psychiatric DP diagnoses. The highest adjusted HRs were observed for depression/anxiety (16.41; CI: 9.06 to 29.74) and schizophrenia (9.37; 6.13 to 14.31) in the 1995 cohort. The rate of suicide among young disability pensioners during follow-up ranged from 0.19% in 1995 to 0.37% in 2005, mainly occurring in individuals with psychiatric diagnoses. Conclusion: Suicidal behaviour has become more prevalent among young disability pensioners, which co-occurred with an increased tendency to grant DP in psychiatric diagnoses with a known high risk of suicidal behaviour. Preventive measures are warranted.	[Jonsson, Ulf; Alexanderson, Kristina; Kjeldgard, Linnea; Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Jonsson, U (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	ulf.jonsson@ki.se		Kjeldgard, Linnea/0000-0002-4575-7483	Swedish Council for Working Life and Social Research (through the Stockholm Stress Center) [2007-1762, 2009-1758]; Swedish Investigation of Social Insurances; Swedish Research Council [522-2010-2683]	Swedish Council for Working Life and Social Research (through the Stockholm Stress Center); Swedish Investigation of Social Insurances; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Swedish Council for Working Life and Social Research (http://www.forte.se/en/) grant numbers 2007-1762 and 20091758 (through the Stockholm Stress Center) and the Swedish Investigation of Social Insurances (http://www.psfu.se/sv/start). EMR is the recipient of the Assistant Professorship grant from the Swedish Research Council (grant number 522-2010-2683) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bernitz BK, 2013, SCAND J PUBLIC HEALT, V41, P3, DOI 10.1177/1403494813496931; Bolte S, 2013, EUR CHILD ADOLESC PS; Bolte S, 2014, AUTISM RES, V7, P167, DOI 10.1002/aur.1335; Daniel SS, 2009, SUICIDE LIFE-THREAT, V39, P252, DOI 10.1521/suli.2009.39.3.252; Druss BG, 2009, MOL PSYCHIATR, V14, P728, DOI 10.1038/mp.2008.13; Erikson R, 2006, SOC SCI MED, V62, P2151, DOI 10.1016/j.socscimed.2005.09.009; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; JARVISALO J., 2005, MENTAL DISORDERS MAJ; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Lager A, 2012, SCAND J PUBLIC HEALT, V40, P42, DOI 10.1177/1403494812459459; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mandell DS, 2005, PSYCHIAT SERV, V56, P56, DOI 10.1176/appi.ps.56.1.56; Mittendorfer-Rutz E, 2014, PSYCHOL MED, V44, P2331, DOI 10.1017/S0033291713003097; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; OECD, 2013, HLTH GLANC 2013 OECD; OECD, 2003, TRANSF DIS AB POL PR; Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X; Robinson J, 2011, AUST NZ J PSYCHIAT, V45, P3, DOI 10.3109/00048674.2010.511147; Robison LM, 2005, PSYCHIAT SERV, V56, P1497, DOI 10.1176/appi.ps.56.12.1497; Rutz EM, 2004, EUR CHILD ADOLES PSY, V13, P321, DOI 10.1007/s00787-004-0406-y; Social Insurance Agency, 2012, SOC INS FIG 2012; Social Security Administration, 2012, FAST FACTS FIG SOC S; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; *WHO, 1993, INT STAT CLASS DIS	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111618	10.1371/journal.pone.0111618	http://dx.doi.org/10.1371/journal.pone.0111618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365217	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100089
J	Pitta, DW; Parmar, N; Patel, AK; Indugu, N; Kumar, S; Prajapathi, KB; Patel, AB; Reddy, B; Joshi, C				Pitta, Dipti W.; Parmar, Nidhi; Patel, Amrut K.; Indugu, Nagaraju; Kumar, Sanjay; Prajapathi, Karsanbhai B.; Patel, Anand B.; Reddy, Bhaskar; Joshi, Chaitanya			Bacterial Diversity Dynamics Associated with Different Diets and Different Primer Pairs in the Rumen of Kankrej Cattle	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; REAL-TIME PCR; GRADIENT GEL-ELECTROPHORESIS; INTERGENIC SPACER ANALYSIS; POLYMERASE-CHAIN-REACTION; MICROBIAL COMMUNITIES; GASTROINTESTINAL-TRACT; CELLULOLYTIC BACTERIA; PHYLOGENETIC ANALYSIS; RUMINAL ACIDOSIS	The ruminal microbiome in herbivores plays a dominant role in the digestion of lignocellulose and has potential to improve animal productivity. Kankrej cattle, a popular native breed of the Indian subcontinent, were used to investigate the effect of different dietary treatments on the bacterial diversity in ruminal fractions using different primer pairs. Two groups of four cows were assigned to two primary diets of either dry or green forages. Each group was fed one of three dietary treatments for six weeks each. Dietary treatments were; K1 (50% dry/green roughage: 50% concentrate), K2 (75% dry/green roughage: 25% concentrate) and K3 (100% dry/green roughage). Rumen samples were collected using stomach tube at the end of each dietary period and separated into solid and liquid fractions. The DNA was extracted and amplified for V1-V3, V4-V5 and V6-V8 hypervariable regions using P1, P2 and P3 primer pairs, sequenced on a 454 Roche platform and analyzed using QIIME. Community compositions and the abundance of most bacterial lineages were driven by interactions between primer pair, dietary treatment and fraction. The most abundant bacterial phyla identified were Bacteroidetes and Firmicutes however, the abundance of these phyla varied between different primer pairs; in each primer pair the abundance was dependent on the dietary treatment and fraction. The abundance of Bacteroidetes in cattle receiving K1 treatment indicate their diverse functional capabilities in the digestion of both carbohydrate and protein while the predominance of Firmicutes in the K2 and K3 treatments signifies their metabolic role in fibre digestion. It is apparent that both liquid and solid fractions had distinct bacterial community patterns (P<0.001) congruent to changes in the dietary treatments. It can be concluded that the P1 primer pair flanking the V1-V3 hyper-variable region provided greater species richness and diversity of bacterial populations in the rumen of Kankrej cattle.	[Pitta, Dipti W.; Indugu, Nagaraju; Kumar, Sanjay] Univ Penn, Sch Vet Med, Ctr Anim Hlth & Prod, Philadelphia, PA 19104 USA; [Parmar, Nidhi; Patel, Amrut K.; Patel, Anand B.; Reddy, Bhaskar; Joshi, Chaitanya] Anand Agr Univ, Dept Anim Biotechnol, Ome Res Facil, Anand, Gujarat, India; [Prajapathi, Karsanbhai B.] Sardar Krushi Nagar Dantiwada Agr Univ, Coll Vet Sci & Anim Husb, Livestock Prod & Management Dept, Sardar Krushi Nagar, Gujarat, India	University of Pennsylvania; Anand Agricultural University	Pitta, DW (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Hlth & Prod, Philadelphia, PA 19104 USA.	dpitta@vet.upenn.edu	Joshi, Chaitanya G/A-2591-2013; Indugu, Nagaraju/AAT-7497-2021; Gohil, Nidhi Nidhi R Parmar/AAU-9206-2020; Joshi, Chaitanya G/AAK-1842-2020	Joshi, Chaitanya G/0000-0003-4680-2861; Indugu, Nagaraju/0000-0001-9424-2155; Gohil, Nidhi Nidhi R Parmar/0000-0002-3814-0629; Joshi, Chaitanya G/0000-0003-4680-2861; Patel, Amrutlal/0000-0003-1021-4013; Kumar, Sanjay/0000-0002-0937-918X; Reddy, Bhaskar/0000-0002-8177-9305	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	Funding was received from the Indian Council of Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker GC, 2004, BIOCHEM SOC T, V32, P218, DOI 10.1042/BST0320218; Bates D., 2013, LME4 LINEAR MIXED EF; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Chaucheyras-Durand F., 2014, Professional Animal Scientist, V30, P1; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Hernandez-Sanabria E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058461; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jumpponen A, 2007, MICROB ECOL, V53, P233, DOI 10.1007/s00248-004-0006-x; Kale DS, 2010, INDIAN J BIOTECHNOL, V9, P126; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Li ZP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-151; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Michalet-Doreau B, 2002, J ANIM SCI, V80, P790; Michalet-Doreau B, 2001, REPROD NUTR DEV, V41, P187, DOI 10.1051/rnd:2001122; Mona Upreti, 2012, African Journal of Biotechnology, V11, P16313; Morgavi DP, 2013, ANIMAL, V7, P184, DOI 10.1017/S1751731112000419; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Mukesh M, 2009, LIVEST SCI, V121, P72, DOI 10.1016/j.livsci.2008.05.019; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oksanen J., **DATA OBJECT**; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinloche E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067824; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Pitta DW, 2014, ANAEROBE, V25, P31, DOI 10.1016/j.anaerobe.2013.11.008; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RCore Team, 2020, R LANG ENV STAT COMP; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Saro C, 2012, J ANIM SCI, V90, P4487, DOI 10.2527/jas.2012-5265; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Thomas F., 2011, FRONT MICROBIOL, P2, DOI DOI 10.3049/FMICB.2011.00093; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2; Wallace RJ, 1996, J NUTR, V126, pS1326, DOI 10.1093/jn/126.suppl_4.1326S; WALLACE RJ, 1979, NATURE, V279, P424, DOI 10.1038/279424a0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	74	48	68	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111710	10.1371/journal.pone.0111710	http://dx.doi.org/10.1371/journal.pone.0111710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365522	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100109
J	Stidham, TA; Krishan, K; Singh, B; Ghosh, A; Patnaik, R				Stidham, Thomas A.; Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik; Patnaik, Rajeev			A Pelican Tarsometatarsus (Aves: Pelecanidae) from the Latest Pliocene Siwaliks of India	PLOS ONE			English	Article								We report a new fossil specimen of a pelican from the Tatrot Formation of the Siwalik Hills, India. It likely represents Pelecanus sivalensis Davies, 1880, the smaller of the two previously published species from the Siwalik Group stratigraphic sequence. This complete tarsometatarsus is the first fossil bone of a pelican collected in India for over 100 years. It is from the latest Pliocene (similar to 2.6 Ma), and is the youngest pelican fossil from the region. The new specimen exhibits a derived distoplantar 'slant' to the plantar margin of the medial crest of the hypotarsus, and a combination of features related to the morphology of the hypotarsus, the distal foramen, trochleae, and overall size that allow further differentiation from known tarsometatarsi of fossil and extant pelicans, including the three species of extant pelicans that occur in India ( Pelecanus crispus, P. onocrotalus, and P. philippensis). It is of appropriate size for Pelecanus sivalensis, which to date has been known only by fragments of other skeletal elements of the wing, leg, and shoulder girdle. Thus, the observation that this tarsometatarsus is morphologically distinct from those of known pelicans provides further support for the distinctiveness of at least one extinct species of pelican from the Siwalik Group sediments. While the morphology of the tarsometatarsus allows for separation from other taxa known from tarsometatarsi, we found no clear shared derived states to place this taxon with any confidence in a phylogenetic context relative to any other pelican species, or even determine if it is part of the crown group of Pelecanidae. However, published molecular data are consistent with an origin of the crown clade prior to the Pleistocene, suggesting (along with one morphological character) the possibility that this species belongs to the Old World clade of pelican species.	[Stidham, Thomas A.] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Systemat, Beijing, Peoples R China; [Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik] Panjab Univ, Dept Anthropol, Chandigarh 160014, India; [Patnaik, Rajeev] Panjab Univ, Dept Geol, Chandigarh 160014, India	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Panjab University; Panjab University	Stidham, TA (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Systemat, Beijing, Peoples R China.	presbyornis@gmail.com	Singh, Bahadur/H-5783-2019; Ghosh, Abhik/AAH-1277-2020; Krishan, Kewal/I-3285-2014	Singh, Bahadur/0000-0002-5370-6029; Ghosh, Abhik/0000-0003-1161-6364; Krishan, Kewal/0000-0001-5321-0958	Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant [2011Y2ZA01]; Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB03020501]; DST PURSE Grant	Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant; Strategic Priority Research Program of Chinese Academy of Sciences (CAS); DST PURSE Grant	TAS is supported by a Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant (2011Y2ZA01) and Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020501). RP acknowledges funding from the DST PURSE Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry John C., 2013, P373; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Cheneval J., 1984, Palaeovertebrata (Montpellier), V14, P33; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Harrison C.J.O., 1976, Bulletin Br Mus nat Hist (Geol), V27, P315; Harrison C.J.O., 1982, Tertiary Research, V4, P53; Kennedy M, 2013, MOL PHYLOGENET EVOL, V66, P215, DOI 10.1016/j.ympev.2012.09.034; KUMAR R, 1985, SEDIMENT GEOL, V105, P1; Kumaravel V, 2005, CURR SCI INDIA, V88, P1453; Louchart A, 2008, J HUM EVOL, V55, P513, DOI 10.1016/j.jhevol.2008.06.002; Louchart A, 2011, J ORNITHOL, V152, P15, DOI 10.1007/s10336-010-0537-5; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Miller A. H., 1966, Memoirs of the Queensland Museum, V14, P181; Nanda A.C., 1979, Himalayan Geology, V8, P149; Olson S.L., 1985, Avian Biology, V8, P79; Olson SL, 1999, P BIOL SOC WASH, V112, P503; Patnaik Rajeev, 2013, P423; PILBEAM D, 1979, POSTILLA, V179, P1; RICH P V, 1981, Records of the South Australian Museum (Adelaide), V18, P235; SAHNI A, 1980, PALAEOGEOGR PALAEOCL, V31, P39, DOI 10.1016/0031-0182(80)90003-6; Smith ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013354; Tandon SK, 1984, J GEOL SOC INDIA, V46, P429; Tripathi C., 1986, J PALAEONTOL SOC IND, V31, P1; [No title captured]	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111210	10.1371/journal.pone.0111210	http://dx.doi.org/10.1371/journal.pone.0111210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365300	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100055
J	Zhang, J; Ketola, T; Ormala-Odegrip, AM; Mappes, J; Laakso, J				Zhang, Ji; Ketola, Tarmo; Ormala-Odegrip, Anni-Maria; Mappes, Johanna; Laakso, Jouni			Coincidental Loss of Bacterial Virulence in Multi-Enemy Microbial Communities	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; AMEBA ACANTHAMOEBA-CASTELLANII; MEDIA COMPOSITION INFLUENCES; LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; ANTAGONISTIC COEVOLUTION; TETRAHYMENA-THERMOPHILA; LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; SERRATIA-MARCESCENS	The coincidental virulence evolution hypothesis suggests that outside-host selection, such as predation, parasitism and resource competition can indirectly affect the virulence of environmentally-growing bacterial pathogens. While there are some examples of coincidental environmental selection for virulence, it is also possible that the resource acquisition and enemy defence is selecting against it. To test these ideas we conducted an evolutionary experiment by exposing the opportunistic pathogen bacterium Serratia marcescens to the particle-feeding ciliate Tetrahymena thermophila, the surface-feeding amoeba Acanthamoeba castellanii, and the lytic bacteriophage Semad11, in all possible combinations in a simulated pond water environment. After 8 weeks the virulence of the 384 evolved clones were quantified with fruit fly Drosophila melanogaster oral infection model, and several other life-history traits were measured. We found that in comparison to ancestor bacteria, evolutionary treatments reduced the virulence in most of the treatments, but this reduction was not clearly related to any changes in other life-history traits. This suggests that virulence traits do not evolve in close relation with these life-history traits, or that different traits might link to virulence in different selective environments, for example via resource allocation trade-offs.	[Zhang, Ji; Ketola, Tarmo; Mappes, Johanna; Laakso, Jouni] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland; [Zhang, Ji; Ormala-Odegrip, Anni-Maria; Laakso, Jouni] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland	University of Jyvaskyla; University of Helsinki	Zhang, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland.	Ji.Zhang@Helsinki.Fi	Mappes, Johanna/AAZ-3627-2021; Ketola, Tarmo/AAD-2609-2019; Laakso, Jouni/I-7794-2013	Ketola, Tarmo/0000-0001-5151-7980; Zhang, Ji/0000-0003-2582-2978; Laakso, Jouni/0000-0001-8245-9912; Mappes, Johanna/0000-0002-1117-5629	Finnish Academy [1130724, 1255572]; CoE in Biological Interactions [252411]; Finnish Cultural Foundation; Ellen and Artturi Nyyssonen Foundation	Finnish Academy(Academy of Finland); CoE in Biological Interactions; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ellen and Artturi Nyyssonen Foundation	This work was supported by the Finnish Academy to JL, 1130724 and 1255572 (URL: www.aka.fi), which had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the CoE in Biological Interactions to JM, 252411 (URL: https://www.jyu.fi/bioenv/en/divisions/coe-interactions), which had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the Finnish Cultural Foundation to JZ (URL: www.skr.fi), which had a role in data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the Ellen and Artturi Nyyssonen Foundation to JZ (URL: www.eans.fi), which had a role in study design, data collection and analysis.	Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Adiba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011882; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Ali S, 2009, ENTOMOL EXP APPL, V131, P30, DOI 10.1111/j.1570-7458.2009.00833.x; [Anonymous], 1988, NEW KEY FRESHWATER S; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bonifait L, 2011, APPL ENVIRON MICROB, V77, P6271, DOI 10.1128/AEM.00659-11; Boyd EF, 2012, ADV VIRUS RES, V82, P91, DOI 10.1016/B978-0-12-394621-8.00014-5; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; CHESBRO WR, 1969, CAN J MICROBIOL, V15, P723, DOI 10.1139/m69-127; Coombes BK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00090; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Ensminger AW, 2012, PLOS PATHOG, V8; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLYG C, 1980, J GEN MICROBIOL, V120, P173; FRIEDMAN ME, 1962, J BACTERIOL, V83, P456, DOI 10.1128/JB.83.3.456-462.1962; Friman VP, 2011, J EVOLUTION BIOL, V24, P2563, DOI 10.1111/j.1420-9101.2011.02379.x; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Friman VP, 2011, AM NAT, V177, P334, DOI 10.1086/658364; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2004, EMERG INFECT DIS, V10, P470, DOI 10.3201/eid1003.020792; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Hall AR, 2008, J EVOLUTION BIOL, V21, P610, DOI 10.1111/j.1420-9101.2007.01473.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasselbring BM, 2011, INFECT IMMUN, V79, P2079, DOI 10.1128/IAI.01233-10; HECKLY RJ, 1980, APPL ENVIRON MICROB, V39, P541, DOI 10.1128/AEM.39.3.541-543.1980; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; Ketola T, 2013, EVOLUTION, V67, P2936, DOI 10.1111/evo.12148; KIY T, 1992, APPL MICROBIOL BIOT, V37, P576; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Laakso J, 2003, OIKOS, V102, P663, DOI 10.1034/j.1600-0706.2003.12319.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Midelet-Bourdin G, 2006, J APPL MICROBIOL, V101, P300, DOI 10.1111/j.1365-2672.2006.02925.x; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ohno A, 2008, APPL ENVIRON MICROB, V74, P4585, DOI 10.1128/AEM.00083-08; Page F. C, 1976, ILLUSTRATED KEY FRES; Potvin C, 2001, DESIGN ANAL ECOLOGIC, P69; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Safavi SA, 2007, FEMS MICROBIOL LETT, V270, P116, DOI 10.1111/j.1574-6968.2007.00666.x; Sahly H, 2008, INFECT IMMUN, V76, P1322, DOI 10.1128/IAI.00910-07; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wu JH, 2010, PAK J ZOOL, V42, P451; Zhang J, 2012, ECOL EVOL, V2, P2347, DOI 10.1002/ece3.356	82	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111871	10.1371/journal.pone.0111871	http://dx.doi.org/10.1371/journal.pone.0111871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365586	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000345558100133
J	Lan, WZ; Feldkaemper, M; Schaeffel, F				Lan, Weizhong; Feldkaemper, Marita; Schaeffel, Frank			Intermittent Episodes of Bright Light Suppress Myopia in the Chicken More than Continuous Bright Light	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; LENS-INDUCED MYOPIA; DOPAMINE RELEASE; RETINAL DOPAMINE; OUTDOOR ACTIVITY; REFRACTIVE DEVELOPMENT; ENDOGENOUS DOPAMINE; AMBIENT ILLUMINANCE; AMACRINE NEURONS; MUDPUPPY RETINA	Purpose: Bright light has been shown a powerful inhibitor of myopia development in animal models. We studied which temporal patterns of bright light are the most potent in suppressing deprivation myopia in chickens. Methods: Eight-day-old chickens wore diffusers over one eye to induce deprivation myopia. A reference group (n = 8) was kept under office-like illuminance (500 lux) at a 10:14 light:dark cycle. Episodes of bright light (15 000 lux) were superimposed on this background as follows. Paradigm I:exposure to constant bright light for either 1 hour (n = 5), 2 hours (n = 5), 5 hours (n = 4) or 10 hours (n = 4). Paradigm II:exposure to repeated cycles of bright light with 50% duty cycle and either 60 minutes (n = 7), 30 minutes (n = 8), 15 minutes (n = 6), 7 minutes (n = 7) or 1 minute (n = 7) periods, provided for 10 hours. Refraction and axial length were measured prior to and immediately after the 5-day experiment. Relative changes were analyzed by paired t-tests, and differences among groups were tested by one-way ANOVA. Results: Compared with the reference group, exposure to continuous bright light for 1 or 2 hours every day had no significant protective effect against deprivation myopia. Inhibition of myopia became significant after 5 hours of bright light exposure but extending the duration to 10 hours did not offer an additional benefit. In comparison, repeated cycles of 1:1 or 7:7 minutes of bright light enhanced the protective effect against myopia and could fully suppress its development. Conclusions: The protective effect of bright light depends on the exposure duration and, to the intermittent form, the frequency cycle. Compared to the saturation effect of continuous bright light, low frequency cycles of bright light (1:1 min) provided the strongest inhibition effect. However, our quantitative results probably might not be directly translated into humans, but rather need further amendments in clinical studies.	[Lan, Weizhong; Feldkaemper, Marita; Schaeffel, Frank] Univ Tubingen, Ctr Ophthalmol, Sect Neurobiol Eye, Tubingen, Germany; [Lan, Weizhong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lan, Weizhong] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sun Yat Sen University; Eberhard Karls University of Tubingen	Lan, WZ (corresponding author), Univ Tubingen, Ctr Ophthalmol, Sect Neurobiol Eye, Tubingen, Germany.	brucelarm@gmail.com		Feldkaemper, Marita Pauline/0000-0001-6938-3714; Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, Beijing, China [81170871, 81200714]; German Academic Exchange Service (DAAD)	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from National Natural Science Foundation of China, Beijing, China (grant no.: 81170871, 81200714), (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) and a scholarship from German Academic Exchange Service (DAAD), (https://www.daad.de) awarded to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Backhouse S, 2013, OPHTHAL PHYSL OPT, V33, P563, DOI 10.1111/opo.12069; BESHARSE JC, 1992, NEUROCHEM INT, V20, P193, DOI 10.1016/0197-0186(92)90167-P; BOATRIGHT JH, 1989, BRAIN RES, V482, P164, DOI 10.1016/0006-8993(89)90555-6; BRAINARD GC, 1987, BRAIN RES, V424, P199, DOI 10.1016/0006-8993(87)91211-X; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Cohen Y, 2012, EXP EYE RES, V103, P33, DOI 10.1016/j.exer.2012.08.004; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; DONG CJ, 1992, J NEUROPHYSIOL, V67, P364, DOI 10.1152/jn.1992.67.2.364; DONG CJ, 1991, J PHYSIOL-LONDON, V440, P291, DOI 10.1113/jphysiol.1991.sp018709; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; Gandini S, 2011, PROG BIOPHYS MOL BIO, V107, P362, DOI 10.1016/j.pbiomolbio.2011.09.011; Gao QY, 2006, GRAEF ARCH CLIN EXP, V244, P1329, DOI 10.1007/s00417-006-0254-1; GOTTLIEB M D, 1987, Society for Neuroscience Abstracts, V13, P1297; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Hammond DS, 2012, VISION RES, V67, P44, DOI 10.1016/j.visres.2012.06.021; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; IUVONE PM, 1989, VISUAL NEUROSCI, V2, P465, DOI 10.1017/S0952523800012360; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Jobke S, 2008, CLIN OPHTHALMOL, V2, P601; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; KIRSCH M, 1989, VISION RES, V29, P147, DOI 10.1016/0042-6989(89)90120-X; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; LI T, 1995, VISION RES, V35, P1203, DOI 10.1016/0042-6989(94)00231-A; Megaw PL, 2006, NEUROCHEM INT, V48, P17, DOI 10.1016/j.neuint.2005.08.004; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P355, DOI 10.1111/opo.12059; Morgan IG., 2012, INVEST OPHTH VIS SCI, V53, P2735; Mutti DO, 2011, OPTOMETRY VISION SCI, V88, P377, DOI 10.1097/OPX.0b013e31820b0385; Nickla DL, 2010, EXP EYE RES, V91, P715, DOI 10.1016/j.exer.2010.08.021; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; ROHRER B, 1993, VISUAL NEUROSCI, V10, P447, DOI 10.1017/S0952523800004673; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; SCHAEFFEL F, 1995, VISION RES, V35, P1247, DOI 10.1016/0042-6989(94)00221-7; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Schmid KL, 2004, OPTOMETRY VISION SCI, V81, P137, DOI 10.1097/00006324-200402000-00012; Seidemann A, 2002, VISION RES, V42, P2409, DOI 10.1016/S0042-6989(02)00262-6; Siegwart Jr JT, 2011, VITAMIN D3 SUPPLEMEN; Siegwart JT, 2012, ARVO M ABSTR INV OPH, V53, P3457; Smith EL, 2013, INVEST OPHTH VIS SCI, V54, P2959, DOI 10.1167/iovs.13-11713; Smith EL, 2012, INVEST OPHTH VIS SCI, V53, P421, DOI 10.1167/iovs.11-8652; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; UMINO O, 1991, VISUAL NEUROSCI, V7, P451, DOI 10.1017/S0952523800009743; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WEISS S, 1993, J COMP PHYSIOL A, V172, P263, DOI 10.1007/BF00216608; Wolfram C, 2014, BRIT J OPHTHALMOL, V55, P2041; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Yi Jun-Hui, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P32; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhu XY, 2013, INVEST OPHTH VIS SCI, V54, P2634, DOI 10.1167/iovs.12-10514	57	37	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110906	10.1371/journal.pone.0110906	http://dx.doi.org/10.1371/journal.pone.0110906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360635	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700051
J	Lavallee, LT; Schramm, D; Witiuk, K; Mallick, R; Fergusson, D; Morash, C; Cagiannos, I; Breau, RH				Lavallee, Luke T.; Schramm, David; Witiuk, Kelsey; Mallick, Ranjeeta; Fergusson, Dean; Morash, Christopher; Cagiannos, Ilias; Breau, Rodney H.			Peri-Operative Morbidity Associated with Radical Cystectomy in a Multicenter Database of Community and Academic Hospitals	PLOS ONE			English	Article							BLADDER-CANCER; COMPLICATIONS; MORTALITY; RECOVERY; SURGERY; VOLUME; CARE	Objective: To characterize the frequency and timing of complications following radical cystectomy in a cohort of patients treated at community and academic hospitals. Patients and Methods: Radical cystectomy patients captured from NSQIP hospitals from January 1 2006 to December 31 2012 were included. Baseline information and complications were abstracted by study surgical clinical reviewers through a validated process of medical record review and direct patient contact. We determined the incidence and timing of each complication and calculated their associations with patient and operative characteristics. Results: 2303 radical cystectomy patients met inclusion criteria. 1115 (48%) patients were over 70 years old and 1819 (79%) were male. Median hospital stay was 8 days (IQR 7-13 days). 1273 (55.3%) patients experienced at least 1 post-operative complication of which 191 (15.6%) occurred after hospital discharge. The most common complication was blood transfusion (n = 875; 38.0%), followed by infectious complications with 218 (9.5%) urinary tract infections, 193 (8.4%) surgical site infections, and 223 (9.7%) sepsis events. 73 (3.2%) patients had fascial dehiscence, 82 (4.0%) developed a deep vein thrombosis, and 67 (2.9%) died. Factors independently associated with the occurrence of any post-operative complication included: age, female gender, ASA class, pre-operative sepsis, COPD, low serum albumin concentration, pre-operative radiotherapy, pre-operative transfusion >4 units, and operative time >6 hours (all p<0.05). Conclusion: Complications remain common following radical cystectomy and a considerable proportion occur after discharge from hospital. This study identifies risk factors for complications and quality improvement needs.	[Lavallee, Luke T.; Morash, Christopher; Cagiannos, Ilias; Breau, Rodney H.] Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada; [Lavallee, Luke T.; Schramm, David; Witiuk, Kelsey; Mallick, Ranjeeta; Fergusson, Dean; Breau, Rodney H.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Schramm, David] Univ Ottawa, Ottawa Hosp, Dept Otolaryngol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Breau, RH (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada.	rbreau@toh.on.ca		Fergusson, Dean/0000-0002-3389-2485; Schramm, David/0000-0002-6875-3709; Breau, Rodney/0000-0003-2344-9022				Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Cerantola Y, 2013, CLIN NUTR, V32, P879, DOI 10.1016/j.clnu.2013.09.014; Chang SS, 2002, J UROLOGY, V167, P2012, DOI 10.1016/S0022-5347(05)65074-4; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Hollenbeck BK, 2005, J UROLOGY, V174, P1231, DOI 10.1097/01.ju.0000173923.35338.99; Hu M, 2014, CANCER; Karl A, 2014, J UROLOGY, V191, P335, DOI 10.1016/j.juro.2013.08.019; Kulkarni GS, 2013, CANCER-AM CANCER SOC, V119, P3546, DOI 10.1002/cncr.28235; Lawrentschuk N, 2010, EUR UROL, V57, P983, DOI 10.1016/j.eururo.2010.02.024; Lee KL, 2004, UROLOGY, V63, P1095, DOI 10.1016/j.urology.2004.01.029; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Thompson IM, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.06.006; Yu HY, 2012, EUR UROL, V61, P1239, DOI 10.1016/j.eururo.2012.03.032	17	82	82	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111281	10.1371/journal.pone.0111281	http://dx.doi.org/10.1371/journal.pone.0111281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360904	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700083
J	Kawamura, T; Miyagawa, S; Fukushima, S; Yoshida, A; Kashiyama, N; Kawamura, A; Ito, E; Saito, A; Maeda, A; Eguchi, H; Toda, K; Lee, JK; Miyagawa, S; Sawa, Y				Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Yoshida, Akira; Kashiyama, Noriyuki; Kawamura, Ai; Ito, Emiko; Saito, Atsuhiro; Maeda, Akira; Eguchi, Hiroshi; Toda, Koichi; Lee, Jong-Kook; Miyagawa, Shuji; Sawa, Yoshiki			N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							DIFFERENTIATION; MOUSE; GLYCOSYLATION; DISEASE; DISCOVERY; EMBRYOS; ACID	Cell surface glycans vary widely, depending on cell properties. We hypothesized that glycan expression on induced pluripotent stem cells (iPSCs) might change during cardiomyogenic differentiation toward the myocardial phenotype. N-glycans were isolated from iPSCs, iPSC-derived cardiomyocytes (iPSC-CM), and original C57BL/6 mouse myocardium (Heart). Their structures were analyzed by a mapping technique based on HPLC elution times and MALDI-TOF/MS spectra. Sixty-eight different N-glycans were isolated; the structures of 60 of these N-glycans were identified. The quantity of high-mannose type (immature) N-glycans on the iPSCs decreased with cardiomyogenic differentiation, but did not reach the low levels observed in the heart. We observed a similar reduction in neutral N-glycans and an increase in fucosylated or sialyl N-glycans. Some structural differences were detected between iPSC-CM and Heart. No N-glycolyl neuraminic acid (NeuGc) structures were detected in iPSC-CM, whereas the heart contained numerous NeuGc structures, corresponding to the expression of cytidine monophosphate-N-acetylneuraminic acid hydroxylase. Furthermore, several glycans containing Gal alpha 1-6 Gal, rarely identified in the other cells, were detected in the iPSC-CM. The expression of N-glycan on murine iPSCs changed toward the myocardial phenotype during cardiomyogenic differentiation, leaving the structural differences of NeuGc content or Gal alpha 1-6 Gal structures. Further studies will be warranted to reveal the meaning of the difference of N-glycans between the iPSC-CM and the myocardium.	[Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Kashiyama, Noriyuki; Kawamura, Ai; Ito, Emiko; Saito, Atsuhiro; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Yoshida, Akira; Lee, Jong-Kook] Osaka Univ, Grad Sch Med, Dept Cardiovasc Regenerat Med, Suita, Osaka, Japan; [Maeda, Akira; Eguchi, Hiroshi; Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Maeda, Akira/0000-0001-7334-5438; Miyagawa, Shigeru/0000-0003-0015-6569	Research Center Network for Realization of Regenerative Medicine; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26293188, 25670593] Funding Source: KAKEN	Research Center Network for Realization of Regenerative Medicine; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YS received the funding to support this work from the Research Center Network for Realization of Regenerative Medicine managed by Centers for Clinical Application Research on Specific Disease/Organ and funded by Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hasehira K, 2012, MOL CELL PROTEOMICS, V11, P1913, DOI 10.1074/mcp.M112.020586; Hato M, 2006, MOL CELL PROTEOMICS, V5, P2146, DOI 10.1074/mcp.M600213-MCP200; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kraushaar DC, 2012, J BIOL CHEM, V287, P22691, DOI 10.1074/jbc.M112.368241; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Miki K, 2012, STEM CELL TRANSL MED, V1, P430, DOI 10.5966/sctm.2011-0038; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Sinnecker D, 2013, CIRC RES, V112, P961, DOI 10.1161/CIRCRESAHA.112.268623; SURANI MAH, 1979, CELL, V18, P217; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977	32	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111064	10.1371/journal.pone.0111064	http://dx.doi.org/10.1371/journal.pone.0111064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357199	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000039
J	Miyake, A; Chitose, T; Kamei, E; Murakami, A; Nakayama, Y; Konishi, M; Itoh, N				Miyake, Ayumi; Chitose, Tatsuya; Kamei, Eriko; Murakami, Atsuko; Nakayama, Yoshiaki; Konishi, Morichika; Itoh, Nobuyuki			Fgf16 Is Required for Specification of GABAergic Neurons and Oligodendrocytes in the Zebrafish Forebrain	PLOS ONE			English	Article							SONIC HEDGEHOG; PROMOTES NEUROGENESIS; ISTHMIC ORGANIZER; GROWTH-FACTOR; CELL FATE; EXPRESSION; DIFFERENTIATION; HINDBRAIN; GENES; PROLIFERATION	Fibroblast growth factor (Fgf) signaling plays crucial roles in various developmental processes including those in the brain. We examined the role of Fgf16 in the formation of the zebrafish brain. The knockdown of fgf16 decreased cell proliferation in the forebrain and midbrain. fgf16 was also essential for development of the ventral telencephalon and diencephalon, whereas fgf16 was not required for dorsoventral patterning in the midbrain. fgf16 was additionally required for the specification and differentiation of gamma-aminobutyric acid (GABA) ergic interneurons and oligodendrocytes, but not for those of glutamatergic neurons in the forebrain. Cross talk between Fgf and Hedgehog (Hh) signaling was critical for the specification of GABAergic interneurons and oligodendrocytes. The expression of fgf16 in the forebrain was down-regulated by the inhibition of Hh and Fgf19 signaling, but not by that of Fgf3/Fgf8 signaling. The fgf16 morphant phenotype was similar to that of the fgf19 morphant and embryos blocked Hh signaling. The results of the present study indicate that Fgf16 signaling, which is regulated by the downstream pathways of Hh-Fgf19 in the forebrain, is involved in forebrain development.	[Miyake, Ayumi; Chitose, Tatsuya; Kamei, Eriko; Murakami, Atsuko; Nakayama, Yoshiaki; Konishi, Morichika; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto, Japan	Kyoto University	Miyake, A (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto, Japan.	miyakea@pharm.kyoto-u.ac.jp		Nakayama, Yoshiaki/0000-0003-2187-3292	JSPS KAKENHI [23659035, 26460096]; Suzuken Memorial Fundation; Takeda Science Foundation, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Fundation; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was in part supported by JSPS KAKENHI Grant Number 23659035 (to N.I.), 26460096 (to A.M.), the Suzuken Memorial Fundation and the Takeda Science Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Alexandre P, 2003, DEVELOPMENT, V130, P5331, DOI 10.1242/dev.00756; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhat RV, 1996, GLIA, V17, P169; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bosco A, 2013, DEVELOPMENT, V140, P372, DOI 10.1242/dev.089094; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; Farah MH, 2000, DEVELOPMENT, V127, P693; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Guner B, 2007, GENE EXPR PATTERNS, V7, P596, DOI 10.1016/j.modgep.2007.01.002; Hall A, 1996, DEVELOPMENT, V122, P4085; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Hatch EP, 2009, DEV DYNAM, V238, P358, DOI 10.1002/dvdy.21681; Hayes SG, 2003, J COMP NEUROL, V463, P45, DOI 10.1002/cne.10749; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Incardona JP, 1998, DEVELOPMENT, V125, P3553; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jones E. G., 2002, THALAMUS RELAT SYST, V1, P283; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Koshida S, 1998, DEVELOPMENT, V125, P1957; Koshida S, 2002, DEV BIOL, V244, P9, DOI 10.1006/dbio.2002.0581; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lu SY, 2008, AM J PHYSIOL-CELL PH, V294, pC1242, DOI 10.1152/ajpcell.00529.2007; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Maroon H, 2002, DEVELOPMENT, V129, P2099; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Martinez S, 2001, INT J DEV BIOL, V45, P367; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Maves L, 2002, DEVELOPMENT, V129, P3825; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mione M, 2001, MECH DEVELOP, V100, P93, DOI 10.1016/S0925-4773(00)00501-3; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; Miyake A, 2013, BIOL OPEN, V2, P515, DOI 10.1242/bio.20134226; Miyake A, 2012, MECH DEVELOP, V128, P577, DOI 10.1016/j.mod.2012.01.001; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Mueller T, 2006, J COMP NEUROL, V494, P620, DOI 10.1002/cne.20824; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nomura R, 2006, BIOCHEM BIOPH RES CO, V347, P340, DOI 10.1016/j.bbrc.2006.06.108; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Peyron F, 1997, J NEUROSCI RES, V50, P190; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sato T, 2001, DEVELOPMENT, V128, P2461; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimizu S, 2014, GLIA, V62, P709, DOI 10.1002/glia.22636; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sontag DP, 2003, MOL CELL BIOCHEM, V242, P65, DOI 10.1023/A:1021133611130; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TIMSIT S, 1995, J NEUROSCI, V15, P1012; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; Viktorin G, 2009, DEV DYNAM, V238, P1984, DOI 10.1002/dvdy.22031; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Walshe J, 2002, CURR BIOL, V12, P1117, DOI 10.1016/S0960-9822(02)00899-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu JS, 2000, DEVELOPMENT, V127, P1833; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699	85	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110836	10.1371/journal.pone.0110836	http://dx.doi.org/10.1371/journal.pone.0110836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357195	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000028
J	Yang, J; Lin, Q; Ng, TB; Ye, XY; Lin, J				Yang, Jie; Lin, Qi; Ng, Tzi Bun; Ye, Xiuyun; Lin, Juan			Purification and Characterization of a Novel Laccase from Cerrena sp HYB07 with Dye Decolorizing Ability	PLOS ONE			English	Article							WHITE-ROT; BIOCHEMICAL-CHARACTERIZATION; FUNGAL LACCASE; UNICOLOR; GENE; EXPRESSION; CLONING; INDUCTION; SEQUENCES; ISOFORMS	Laccases (EC 1.10.3.2) are a class of multi-copper oxidases with important industrial values. A basidiomycete strain Cerrena sp. HYB07 with high laccase yield was identified. After cultivation in the shaking flask for 4 days, a maximal activity of 210.8 U mL(-1) was attained. A 58.6-kDa laccase (LacA) with 7.2% carbohydrate and a specific activity of 1952.4 U mg(-1) was purified. 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) was the optimal substrate, with K-m and k(cat) being 93.4 mu M and 2468.0 s(-1), respectively. LacA was stable at 60 degrees C, pH 5.0 and above, and in organic solvents. Metal ions Na+, K+, Ca2+, Mg2+, Mn2+, Zn2+ enhanced LacA activity, while Fe2+ and Li+ inhibited LacA activity. LacA decolorized structurally different dyes and a real textile effluent. Its gene and cDNA sequences were obtained. Putative cis-acting transcriptional response elements were identified in the promoter region. The high production yield and activity, robustness and dye decolorizing capacity make LacA and Cerrena sp. HYB07 potentially useful for industrial and environmental applications such as textile finishing and wastewater treatment.	[Yang, Jie; Lin, Qi; Ye, Xiuyun; Lin, Juan] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China; [Yang, Jie; Ye, Xiuyun; Lin, Juan] Natl Engn Lab Enzyme Express, Fuzhou, Fujian, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China.	ljuan@fzu.edu.cn			Natural Science Foundation of China [41306120]; Oceanic Public Welfare Industry Special Research Project of China [201305015]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF12011]; Fujian Provincial Development and Reform Commission Bio-industry Special Project [[2011]1598]; Fuzhou Science and Technology Bureau [2012-G-125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; State Key Laboratory of Pollution Control and Resource Reuse Foundation; Fujian Provincial Development and Reform Commission Bio-industry Special Project; Fuzhou Science and Technology Bureau	This study was funded by Natural Science Foundation of China (41306120), Oceanic Public Welfare Industry Special Research Project of China (201305015), State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRF12011), Fujian Provincial Development and Reform Commission Bio-industry Special Project ([2011]1598) and Fuzhou Science and Technology Bureau (2012-G-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadulla E, 2000, APPL ENVIRON MICROB, V66, P3357, DOI 10.1128/AEM.66.8.3357-3362.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bischoff KM, 1998, ANAL BIOCHEM, V260, P1, DOI 10.1006/abio.1998.2680; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SC, 2012, PROTEIN ENG DES SEL, V25, P761, DOI 10.1093/protein/gzs082; CHUNG KT, 1993, ENVIRON TOXICOL CHEM, V12, P2121, DOI 10.1002/etc.5620121120; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; D'Souza DT, 2006, ENZYME MICROB TECH, V38, P504, DOI 10.1016/j.enzmictec.2005.07.005; D'Souza-Ticlo D, 2009, MAR BIOTECHNOL, V11, P725, DOI 10.1007/s10126-009-9187-0; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dsouza TM, 1996, APPL ENVIRON MICROB, V62, P3739, DOI 10.1128/AEM.62.10.3739-3744.1996; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Fan FF, 2011, BIORESOURCE TECHNOL, V102, P3126, DOI 10.1016/j.biortech.2010.10.079; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Janusz G, 2007, WORLD J MICROB BIOT, V23, P1459, DOI 10.1007/s11274-007-9390-y; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; Kim Y, 2002, B KOREAN CHEM SOC, V23, P985; Lin Juan, 2013, Journal of Chinese Institute of Food Science and Technology, V13, P110; Lisova ZA, 2010, J BASIC MICROB, V50, P72, DOI 10.1002/jobm.200900382; Liu W, 2003, APPL MICROBIOL BIOT, V63, P174, DOI 10.1007/s00253-003-1398-0; Liu Ziyong, 2008, Weishengwu Xuebao, V48, P667; Matijosyte I, 2010, J MOL CATAL B-ENZYM, V62, P142, DOI 10.1016/j.molcatb.2009.09.019; Michniewicz A, 2006, APPL MICROBIOL BIOT, V69, P682, DOI 10.1007/s00253-005-0015-9; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Nozaki K, 2008, J BIOSCI BIOENG, V105, P69, DOI 10.1263/jbb.105.69; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sambrook J., 2001, MOL CLONING LAB MANU; Shin KS, 1998, BIOTECHNOL TECH, V12, P101; Si J, 2013, BIORESOURCE TECHNOL, V128, P49, DOI 10.1016/j.biortech.2012.10.085; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soden DM, 2003, J APPL MICROBIOL, V95, P553, DOI 10.1046/j.1365-2672.2003.02012.x; Songulashvili G, 2012, FUNGAL BIOL-UK, V116, P883, DOI 10.1016/j.funbio.2012.05.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wong YX, 1999, WATER RES, V33, P3512, DOI 10.1016/S0043-1354(99)00066-4; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Yang YC, 2013, PROCESS BIOCHEM, V48, P351, DOI 10.1016/j.procbio.2012.12.011; Zhuo R, 2011, J HAZARD MATER, V192, P855, DOI 10.1016/j.jhazmat.2011.05.106	47	51	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110834	10.1371/journal.pone.0110834	http://dx.doi.org/10.1371/journal.pone.0110834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356987	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000026
J	Jones, A; Kainz, D; Khan, F; Lee, C; Carrithers, MD				Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.			Human Macrophage SCN5A Activates an Innate Immune Signaling Pathway for Antiviral Host Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase; Double-stranded RNA (dsRNA); Innate Immunity; Interferon; Sodium Channel	SODIUM-CHANNEL NAV1.5; EXPRESSION; PROTEIN; RECOGNITION; INFECTION; NUCLEAR; BINDING; SYSTEM; CELLS	Pattern recognition receptors contain a binding domain for pathogen-associated molecular patterns coupled to a signaling domain that regulates transcription of host immune response genes. Here, a novel mechanism that links pathogen recognition to channel activation and downstream signaling is proposed. We demonstrate that an intracellular sodium channel variant, human macrophage SCN5A, initiates signaling and transcription through a calcium-dependent isoform of adenylate cyclase, ADCY8, and the transcription factor, ATF2. Pharmacological stimulation with a channel agonist or treatment with cytoplasmic poly(I:C), a mimic of viral dsRNA, activates this pathway to regulate expression of SP100-related genes and interferon . Electrophysiological analysis reveals that the SCN5A variant mediates nonselective outward currents and a small, but detectable, inward current. Intracellular poly(I:C) markedly augments an inward voltage-sensitive sodium current and inhibits the outward nonselective current. These results suggest human macrophage SCN5A initiates signaling in an innate immune pathway relevant to antiviral host defense. It is postulated that SCN5A is a novel pathogen sensor and that this pathway represents a channel activation-dependent mechanism of transcriptional regulation.	[Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA; [Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Program Cellular & Mol Pathol, Madison, WI 53706 USA; [Carrithers, Michael D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Carrithers, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 1300 Univ Ave,Rm 2679, Madison, WI 53706 USA.	carrithers@neurology.wisc.edu	Lee, Cara/E-5157-2016	Lee, Cara/0000-0003-0614-9060	Department of Veterans Affairs; University of Wisconsin at Madison; Veterans Affairs [I01BX000467] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); University of Wisconsin at Madison; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Award from the Department of Veterans Affairs and the University of Wisconsin at Madison.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Carrithers LM, 2011, FEMS IMMUNOL MED MIC, V63, P319, DOI 10.1111/j.1574-695X.2011.00853.x; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Guldner HH, 1999, J CELL SCI, V112, P733; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Rahgozar K, 2013, J NEUROPATH EXP NEUR, V72, P489, DOI 10.1097/NEN.0b013e318293eb08; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Ronai Z, 1998, ONCOGENE, V16, P523, DOI 10.1038/sj.onc.1201566; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Weiser T, 2002, MOL PHARMACOL, V62, P433, DOI 10.1124/mol.62.3.433; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	24	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35326	35340		10.1074/jbc.M114.611962	http://dx.doi.org/10.1074/jbc.M114.611962			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368329	hybrid, Green Published			2022-12-26	WOS:000346660200024
J	Morley, KI; Wallace, J; Denaxas, SC; Hunter, RJ; Patel, RS; Perel, P; Shah, AD; Timmis, AD; Schilling, RJ; Hemingway, H				Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Hunter, Ross J.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Timmis, Adam D.; Schilling, Richard J.; Hemingway, Harry			Defining Disease Phenotypes Using National Linked Electronic Health Records: A Case Study of Atrial Fibrillation	PLOS ONE			English	Article							MEDICAL-RECORDS; GENERAL-PRACTICE; EMERGE NETWORK; RISK-FACTORS; POPULATION; STROKE; PREDICTORS; WHITES; PREVALENCE; VALIDATION	Background: National electronic health records (EHR) are increasingly used for research but identifying disease cases is challenging due to differences in information captured between sources (e. g. primary and secondary care). Our objective was to provide a transparent, reproducible model for integrating these data using atrial fibrillation (AF), a chronic condition diagnosed and managed in multiple ways in different healthcare settings, as a case study. Methods: Potentially relevant codes for AF screening, diagnosis, and management were identified in four coding systems: Read (primary care diagnoses and procedures), British National Formulary (BNF; primary care prescriptions), ICD-10 (secondary care diagnoses) and OPCS-4 (secondary care procedures). From these we developed a phenotype algorithm via expert review and analysis of linked EHR data from 1998 to 2010 for a cohort of 2.14 million UK patients aged >= 30 years. The cohort was also used to evaluate the phenotype by examining associations between incident AF and known risk factors. Results: The phenotype algorithm incorporated 286 codes: 201 Read, 63 BNF, 18 ICD-10, and four OPCS-4. Incident AF diagnoses were recorded for 72,793 patients, but only 39.6% (N = 28,795) were recorded in primary care and secondary care. An additional 7,468 potential cases were inferred from data on treatment and pre-existing conditions. The proportion of cases identified from each source differed by diagnosis age; inferred diagnoses contributed a greater proportion of younger cases (<= 60 years), while older patients (>= 80 years) were mainly diagnosed in SC. Associations of risk factors (hypertension, myocardial infarction, heart failure) with incident AF defined using different EHR sources were comparable in magnitude to those from traditional consented cohorts. Conclusions: A single EHR source is not sufficient to identify all patients, nor will it provide a representative sample. Combining multiple data sources and integrating information on treatment and comorbid conditions can substantially improve case identification.	[Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London, England; [Morley, Katherine I.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Morley, Katherine I.] Univ Melbourne, Melbourne Sch Global & Populat Hlth, Melbourne, Vic, Australia; [Hunter, Ross J.; Timmis, Adam D.; Schilling, Richard J.] Queen Mary Univ London, Barts NIHR Biomed Res Unit, London, England; [Patel, Riyaz S.] Univ Coll London NHS Trust, Heart Hosp, London, England; [Perel, Pablo] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; University of London; University College London; University of London; King's College London; University of Melbourne; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Morley, KI (corresponding author), UCL, Farr Inst Hlth Informat Res, London, England.	katherine.morley@ucl.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Morley, Katherine I/A-2986-2011; Hemingway, Harry/C-1219-2009	Shah, Anoop Dinesh/0000-0002-8907-5724; Morley, Katherine I/0000-0002-2725-5535; Denaxas, Spiros/0000-0001-9612-7791; /0000-0002-2342-301X; Hemingway, Harry/0000-0003-2279-0624	National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z, MR/K006584/1, 0938/30/Z/10/Z]; Medical Research Council Prognosis Research Strategy (PROGRESS) [G0902393/99558]; Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; PROGRESS Partnership; UCL Provost's Strategic Development Fund Fellowship; Barts and The London NIHR Cardiovascular Biomedical Research Unit - National Institute for Health Research; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [G0902393, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-11-003] Funding Source: researchfish; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [G0902393] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; PROGRESS Partnership; UCL Provost's Strategic Development Fund Fellowship; Barts and The London NIHR Cardiovascular Biomedical Research Unit - National Institute for Health Research; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was carried out on behalf of the ClinicAL research using LInked bespoke studies and Electronic health Records (CALIBER) programme. This study was supported by National Institute for Health Research (ADT, HH, RP-PG-0407-10314), Wellcome Trust (ADT, HH, 086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (PP, ADT, HH, G0902393/99558; www. progress-partnership. org), and by awards to establish the Farr Institute of Health Informatics Research at UCL Partners (HH, SCD, ADT), from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (ADT, HH, grant MR/K006584/1). KIM and JW were supported by the PROGRESS Partnership while undertaking this research. SCD was supported by a UCL Provost's Strategic Development Fund Fellowship. ADS was supported by a clinical research training fellowship from the Wellcome Trust (0938/30/Z/10/Z). ADT was supported by Barts and The London NIHR Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Albers DJ, 2010, PHYS LETT A, V374, P1159, DOI 10.1016/j.physleta.2009.12.067; Albers DJ, 2012, CHAOS WOODBURY NY, V22; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Andersen PK, 2002, STAT MED, V26, P2389; Camm AJ, 2012, EUR HEART J, V33; Chiang CH, 2013, INT J CARDIOL, V164, P201, DOI 10.1016/j.ijcard.2011.06.126; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; COX DR, 1972, J R STAT SOC B, V34, P187; Davis RC, 2012, EUROPACE, V14, P1553, DOI 10.1093/europace/eus087; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Fedorowski A, 2010, J INTERN MED, V268, P383, DOI 10.1111/j.1365-2796.2010.02261.x; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Friberg J, 2003, EPIDEMIOLOGY, V14, P666, DOI 10.1097/01.ede.0000091649.26364.c0; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gillam S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f659; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grosso A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004720; Grundvold I, 2012, AM J CARDIOL, V110, P425, DOI 10.1016/j.amjcard.2012.03.043; Heeringa J, 2008, AM HEART J, V156, P1163, DOI 10.1016/j.ahj.2008.08.003; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Hodgkinson JA, 2011, INT J CLIN PRACT, P44; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, pE311, DOI 10.1136/amiajnl-2013-001922; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Hripcsak G, 2011, J AM MED INFORM ASSN, V18, pI109, DOI 10.1136/amiajnl-2011-000463; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kirchhof P, 2013, EUR HEART J, V34, P1471, DOI 10.1093/eurheartj/ehs446; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lipworth L, 2012, AM J CARDIOL, V110, P1637, DOI 10.1016/j.amjcard.2012.07.032; Maddox TM, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-11; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; National Institute for Health and Care Excellence, 2006, ATR FIBR MAN ATR FIB; National Resource Management Ministerial Council, 2007, AN CURR SIT CAUS SUI, P1; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Nicholson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054878; Nyrnes A, 2012, EUROPEAN J PREVENTIV; Overby CL, 2013, J AM MED INFORM ASSN, P1; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Peissig PL, 2012, J AM MED INFORM ASSN, V19, P225, DOI 10.1136/amiajnl-2011-000456; Perez MV, 2009, AM HEART J, V158, P622, DOI 10.1016/j.ahj.2009.08.002; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Perotte A, 2013, IEEE J BIOMED HEALTH, V17, P477, DOI 10.1109/JBHI.2013.2244610; Pivovarov R, 2014, J AM MED INFORM ASSN, P1; Psaty BM, 1997, CIRCULATION, V96, P2455; R Core Team, 2021, R LANGUAGE ENV STAT; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rea S, 2012, J BIOMED INFORM, V45, P763, DOI 10.1016/j.jbi.2012.01.009; Richesson RL, 2013, J AM MED INFORM ASSN, P1; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Scowcroft ACE, 2014, INT J CARDIOL, V171, P169, DOI 10.1016/j.ijcard.2013.11.086; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Shah AD, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-88; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Wang ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030412; Watanabe H, 2006, AM HEART J, V152, P731, DOI 10.1016/j.ahj.2006.05.032; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	69	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110900	10.1371/journal.pone.0110900	http://dx.doi.org/10.1371/journal.pone.0110900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369203	Green Accepted, Green Published, gold			2022-12-26	WOS:000344402000030
J	Rahman, SU; Lee, MS; Baek, JH; Ryoo, HM; Woo, KM				Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi			The Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Dentin Sialophoshoprotein Expression through VEGF-Induced Runx2 Stabilization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VIVO; CLEIDOCRANIAL DYSPLASIA; SIGNALING PATHWAYS; BONE-DEVELOPMENT; DIABETIC MICE; HIF-ALPHA; CELLS	Prolyl hydroxylase (PHD) inhibitors are suggested as therapeutic agents for tissue regeneration based on their ability to induce pro-angiogenic responses. In this study, we examined the effect of the PHD inhibitor dimethyloxalylglycine (DMOG) on odontoblast maturation and sought to determine the underlying mechanism using MDPC-23 odontoblast-like cells. DMOG significantly enhanced matrix mineralization, confirmed by alizarin red staining and by measurement of the calcium content. DMOG dose-dependently increased alkaline phosphatase activity and the expressions of dentin sialophosphoprotein (Dspp) and osteocalcin. To determine the underlying events leading to DMOG-induced Dspp expression, we analyzed the effect of DMOG on Runx2. Knockdown of Runx2 using siRNAs decreased Dspp expression and prevented DMOG-induced Dspp expression. DMOG enhanced the transcriptional activity and level of Runx2 protein but not Runx2 transcript, and this enhancement was linked to the inhibitory effects of DMOG on the degradation of Runx2 protein. The vascular endothelial growth factor (VEGF) siRNAs profoundly decreased the Runx2 protein levels and inhibited the DMOG-increased Runx2 protein. Recombinant VEGF protein treatment significantly and dose-dependently increased the transcriptional activity and level of the Runx2 protein but not Runx2 transcript. Dspp expression was also enhanced by VEGF. Last, we examined the involvement of the Erk mitogen-activated protein kinase and Pin1 pathway in VEGF-enhanced Runx2 because this pathway can regulate the stability and activity of the Runx2 protein. VEGF stimulated Erk activation, and the inhibitors of Erk and Pin1 hampered VEGF-enhanced Runx2 protein. Taken together, the results of this study provide evidence that DMOG can enhance Dspp expression through VEGF-induced stabilization of Runx2 protein, and thus, suggest that DMOG can be used as a therapeutic tool for enhancing odontoblast maturation in dental procedures.	[Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Mol Genet, Seoul, South Korea; [Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Plus Program BK21, Seoul, South Korea; [Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Woo, KM (corresponding author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Mol Genet, Seoul, South Korea.	kmwoo@snu.ac.kr	Rahman, Saeed Ur/H-1957-2018; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Rahman, Saeed Ur/0000-0003-2234-2274; Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korea Healthcare technology R&D Project from the Ministry for Health, Welfare and Family Affairs [A120815]	Korea Healthcare technology R&D Project from the Ministry for Health, Welfare and Family Affairs	This research was supported by the Korea Healthcare technology R&D Project (A120815; KMW) from the Ministry for Health, Welfare and Family Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Han NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088890; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Hara K, 2011, J ENDODONT, V37, P1647, DOI 10.1016/j.joen.2011.08.023; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu LX, 2008, J CELL PHYSIOL, V217, P319, DOI 10.1002/jcp.21503; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Muller HD, 2012, J ENDODONT, V38, P1498, DOI 10.1016/j.joen.2012.08.003; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Oh JH, 2011, BIOMATERIALS, V32, P5826, DOI 10.1016/j.biomaterials.2011.04.074; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Pashley David H, 2002, Dent Clin North Am, V46, P211, DOI 10.1016/S0011-8532(01)00009-X; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yoon WJ, 2014, J BIOL CHEM, V289, P8828, DOI 10.1074/jbc.M113.516237; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhao C, 2007, ARCH ORAL BIOL, V52, P945, DOI 10.1016/j.archoralbio.2007.04.015	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112078	10.1371/journal.pone.0112078	http://dx.doi.org/10.1371/journal.pone.0112078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369078	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000140
J	Pettinato, G; Vanden Berg-Foels, WS; Zhang, N; Wen, XJ				Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Zhang, Ning; Wen, Xuejun			ROCK Inhibitor Is Not Required for Embryoid Body Formation from Singularized Human Embryonic Stem Cells	PLOS ONE			English	Article							TBX5 TRANSCRIPTION FACTOR; BETA-CELLS; CARDIAC DIFFERENTIATION; MOLECULAR-MECHANISMS; CULTURE; GENERATION; BODIES; LINES; AGGREGATION; SYSTEM	We report a technology to form human embryoid bodies (hEBs) from singularized human embryonic stem cells (hESCs) without the use of the p160 rho-associated coiled-coil kinase inhibitor (ROCKi) or centrifugation (spin). hEB formation was tested under four conditions: +ROCKi/+spin, +ROCKi/-spin, -ROCKi/+spin, and -ROCKi/-spin. Cell suspensions of BG01V/hOG and H9 hESC lines were pipetted into non-adherent hydrogel substrates containing defined microwell arrays. hEBs of consistent size and spherical geometry can be formed in each of the four conditions, including the -ROCKi/-spin condition. The hEBs formed under the -ROCKi/-spin condition differentiated to develop the three embryonic germ layers and tissues derived from each of the germ layers. This simplified hEB production technique offers homogeneity in hEB size and shape to support synchronous differentiation, elimination of the ROCKi xeno-factor and rate-limiting centrifugation treatment, and low-cost scalability, which will directly support automated, large-scale production of hEBs and hESC-derived cells needed for clinical, research, or therapeutic applications.	[Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Wen, Xuejun] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Pettinato, Giuseppe; Zhang, Ning] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA; [Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Zhang, Ning; Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Vanden Berg-Foels, Wendy S.; Wen, Xuejun] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Wen, Xuejun] Tongji Univ, Tongji Med Sch, Shanghai East Hosp, Inst Biomed Engn & Nano Sci iNANO, Shanghai 200092, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Clemson University; Medical University of South Carolina; Tongji University	Zhang, N (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.	nzhang2@vcu.edu; xwen@vcu.edu		Pettinato, Giuseppe/0000-0001-6785-6370; Vanden Berg-Foels, Wendy/0000-0002-1557-3317	Ministry of Science and Technology [2012CB966300, 2014CB964600]; NSFC [81271369]; NSF [0748129, 1055922]; William H. Goodwin Endowment; Div Of Chem, Bioeng, Env, & Transp Sys [1346387] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE023123, R00DE023123] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); William H. Goodwin Endowment; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This publication was supported by the Ministry of Science and Technology (2012CB966300, 2014CB964600), NSFC (81271369), NSF (0748129, 1055922), and William H. Goodwin Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Azarin SM, 2012, BIOMATERIALS, V33, P2041, DOI 10.1016/j.biomaterials.2011.11.070; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Bataille D, 2002, DIABETES METAB, V28, pS7; Bernard AB, 2012, TISSUE ENG PART C-ME, V18, P583, DOI [10.1089/ten.tec.2011.0504, 10.1089/ten.TEC.2011.0504]; Bose B, 2012, CELL BIOL INT, V36, P1013, DOI 10.1042/CBI20120210; BUNN PA, 1993, J NATL CANCER I, V85, P1168, DOI 10.1093/jnci/85.14.1168; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Cai J, 2008, PROTOCOL DIRECTED DI; Chaddah R, 2012, J NEUROSCI, V32, P7771, DOI 10.1523/JNEUROSCI.3286-11.2012; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856; Ferraro GA, 2011, AESTHET PLAST SURG, V35, P341, DOI 10.1007/s00266-010-9613-8; Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Ho PJ, 2012, CELL TRANSPLANT, V21, P801, DOI 10.3727/096368911X627507; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Irion S, 2008, COLD SH Q B, V73, P101, DOI 10.1101/sqb.2008.73.065; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kim J, 2013, EXP HEMATOL, V41, P749, DOI 10.1016/j.exphem.2013.04.003; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; KRAMER PL, 1992, GENOMICS, V13, P904, DOI 10.1016/0888-7543(92)90185-U; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Marzban L, 2004, DIABETES, V53, P141, DOI 10.2337/diabetes.53.1.141; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Parsons XH, 2012, J REGEN MED TISSUE E, V1; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Russell MW, 1998, BBA-GENE STRUCT EXPR, V1443, P393, DOI 10.1016/S0167-4781(98)00237-1; Skeberdis Vytenis Arvydas, 2004, Medicina (Kaunas), V40, P407; Son MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019134; Spelke DP, 2011, METHODS MOL BIOL, V690, P151, DOI 10.1007/978-1-60761-962-8_10; Stolarczyk E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001288; Stover AE, 2011, METHODS MOL BIOL, V767, P391, DOI 10.1007/978-1-61779-201-4_28; Sugiyama T, 2008, DIABETES OBES METAB, V10, P179, DOI 10.1111/j.1463-1326.2008.00954.x; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Walcher T, 2013, DEVELOPMENT, V140, P1123, DOI 10.1242/dev.082875; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watanabe M, 2002, INT REV CYTOL, V213, P1; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292	64	11	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e100742	10.1371/journal.pone.0100742	http://dx.doi.org/10.1371/journal.pone.0100742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365581	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100001
J	Alsaleh, G; Francois, A; Philippe, L; Gong, YZ; Bahram, S; Cetin, S; Pfeffer, S; Gottenberg, JE; Wachsmann, D; Georgel, P; Sibilia, J				Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Cetin, Semih; Pfeffer, Sebastien; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean			MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; B-LYMPHOCYTE STIMULATOR; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; TNF FAMILY; SYNOVIAL FIBROBLASTS; EXPRESSION; SYNOVIOCYTES; MICRORNAS; RELEASE	We evaluated micro (mi) RNA-mediated regulation of BAFF expression in fibroblasts using two concomitant models: (i) synovial fibroblasts (FLS) isolated from healthy controls (N) or Rheumatoid Arthritis (RA) patients; (ii) human dermal fibroblasts (HDF) isolated from healthy controls (N) or Systemic Sclerosis (SSc) patients. Using RT-qPCR and ELISA, we first showed that SScHDF synthesized and released BAFF in response to Poly(I:C) or IFN-gamma treatment, as previously observed in RAFLS, whereas NHDF released BAFF preferentially in response to IFN-gamma. Next, we demonstrated that miR-30a-3p expression was down regulated in RAFLS and SScHDF stimulated with Poly(I:C) or IFN-gamma. Moreover, we demonstrated that transfecting miR-30a-3p mimic in Poly(I:C)- and IFN-gamma-activated RAFLS and SScHDF showed a strong decrease on BAFF synthesis and release and thus B cells survival in our model. Interestingly, FLS and HDF isolated from healthy subjects express higher levels of miR-30a-3p and lower levels of BAFF than RAFLS and SScHDF. Transfection of miR-30a-3p antisense in Poly(I:C)- and IFN-gamma-activated NFLS and NHDF upregulated BAFF secretion, confirming that this microRNA is a basal repressors of BAFF expression in cells from healthy donors. Our data suggest a critical role of miR-30a-3p in the regulation of BAFF expression, which could have a major impact in the regulation of the autoimmune responses occurring in RA and SSc.	[Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean] Univ Strasbourg, FMTS, Fac Med, Ctr Rech Immunol & Hematol,INSERM UMR S 1109, Strasbourg, France; [Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean] Hop Univ Strasbourg, Ctr Natl Reference Malad Syst Autoimmunes Rares, Strasbourg, France; [Cetin, Semih; Pfeffer, Sebastien] Univ Strasbourg, UPR 9002, Strasbourg, France; [Cetin, Semih; Pfeffer, Sebastien] Inst Biol Mol & Cellulaire, CNRS ARN, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Alsaleh, G (corresponding author), Univ Strasbourg, FMTS, Fac Med, Ctr Rech Immunol & Hematol,INSERM UMR S 1109, Strasbourg, France.	galfarhan@unistra.fr	georgel, philippe/P-5676-2016; Pfeffer, Sébastien/H-3212-2019; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Pfeffer, Sébastien/0000-0002-8458-348X; Lucas, Philippe/0000-0003-2704-2676; alsaleh, ghada/0000-0002-4211-3420; Sibilia, Jean/0000-0002-1601-4795; Bahram, Seiamak/0000-0002-6928-9952	Bristol Myers Squibb; Roche; Pfizer; Courtin Foundation; CAMPLP; European Research Council [ERC-StG-260767]; Agence Nationale pour la Recherche (labex netRNA) [ANR-10-LABX-36]	Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Pfizer(Pfizer); Courtin Foundation; CAMPLP; European Research Council(European Research Council (ERC)European Commission); Agence Nationale pour la Recherche (labex netRNA)(French National Research Agency (ANR))	Prof. Jean Sibilia's work was supported by grants from Bristol Myers Squibb, Roche, Pfizer, Courtin Foundation and CAMPLP. Sebastien Pfeffer's work was supported by the European Research Council (ERC-StG-260767) and Agence Nationale pour la Recherche (labex netRNA, ANR-10-LABX-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2007, ARTHRITIS RHEUM, V56, P3202, DOI 10.1002/art.22915; Alsaleh G, 2011, EUR J IMMUNOL, V41, P2113, DOI 10.1002/eji.201041194; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Ceribelli A, 2011, FEBS LETT, V585, P3667, DOI 10.1016/j.febslet.2011.05.020; Chan AC, 2011, MOL IMMUNOL, V48, P1344, DOI 10.1016/j.molimm.2010.11.021; Chugh PK, 2013, INT J RHEUM DIS, V16, P4, DOI 10.1111/1756-185x.12002; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Ferraccioli G, 2007, AUTOIMMUN REV, V7, P109, DOI 10.1016/j.autrev.2007.02.013; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kalled SL, 2005, IMMUNOL REV, V204, P43, DOI 10.1111/j.0105-2896.2005.00219.x; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Li HT, 2012, RHEUMATOL INT, V32, P307, DOI 10.1007/s00296-010-1615-y; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Matsushita T, 2007, J RHEUMATOL, V34, P2056; Matsushita T, 2007, EXP DERMATOL, V16, P87, DOI 10.1111/j.1600-0625.2006.00485.x; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Moisini I, 2009, CLIN EXP IMMUNOL, V158, P155, DOI 10.1111/j.1365-2249.2009.04007.x; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ohata J, 2005, J IMMUNOL, V174, P864, DOI 10.4049/jimmunol.174.2.864; Pers JO, 2005, ANN NY ACAD SCI, V1050, P34, DOI 10.1196/annals.1313.004; Philippe L, 2013, ANN RHEUM DIS, V72, P1071, DOI 10.1136/annrheumdis-2012-201654; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Seyler TM, 2005, J CLIN INVEST, V115, P3083, DOI 10.1172/JCI25265; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stohl W, 2013, J RHEUMATOL, V40, P579, DOI 10.3899/jrheum.120886; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang M, 2005, INT IMMUNOL, V17, P1081, DOI 10.1093/intimm/dxh287; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	42	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111266	10.1371/journal.pone.0111266	http://dx.doi.org/10.1371/journal.pone.0111266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360821	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700082
J	Lacoeuilhe, A; Machon, N; Jullen, JF; Le Bocq, A; Kerbiriou, C				Lacoeuilhe, Aurelie; Machon, Nathalie; Jullen, Jean-Francois; Le Bocq, Agathe; Kerbiriou, Christian			The Influence of Low Intensities of Light Pollution on Bat Communities in a Semi-Natural Context	PLOS ONE			English	Article							FORAGING BEHAVIOR; TIME	Anthropogenic light pollution is an increasingly significant issue worldwide. Over the past century, the use of artificial lighting has increased in association with human activity. Artificial lights are suspected to have substantial effects on the ecology of many species, e.g., by producing discontinuities in the territories of nocturnal animals. We analyzed the potential influence of the intensity and type of artificial light on bat activity in a semi-natural landscape in France. We used a species approach, followed by a trait-based approach, to light sensitivity. We also investigated whether the effect of light could be related to foraging traits. We performed acoustic surveys at sites located along a gradient of light intensities to assess the activity of 15 species of bats. We identified 2 functional response groups of species: one group that was light-tolerant and one group that was light-intolerant. Among the species in the latter group that appear to be disadvantaged by lighting conditions, many are rare and threatened in Europe, whereas the species from the former group are better able to thrive in disturbed habitats such as lighted areas and may actually benefit from artificial lighting. Finally, several methods of controlling light pollution are suggested for the conservation of bat communities. Recommendations for light management and the creation of dim-light corridors are proposed; these strategies may play an important role in protecting against the impact of light pollution on nocturnal animals.	[Lacoeuilhe, Aurelie; Machon, Nathalie; Jullen, Jean-Francois; Kerbiriou, Christian] UPMC, CNRS, Ecol & Sci Conservat Ctr, Natl Museum Nat Hist,CESCO UMR7204, Paris, France; [Lacoeuilhe, Aurelie; Le Bocq, Agathe] Elect France SA EDF, R&D, EPI Dept, Moret Sur Loing, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Electricite de France (EDF)	Lacoeuilhe, A (corresponding author), UPMC, CNRS, Ecol & Sci Conservat Ctr, Natl Museum Nat Hist,CESCO UMR7204, Paris, France.	lacoeuilhe@mnhn.fr			EDF company (Electricite de France S.A.)	EDF company (Electricite de France S.A.)	Funding was provided by the EDF company (Electricite de France S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1999, CAN J ZOOL, V77, P27, DOI 10.1139/cjz-77-1-27; Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; Arthur L, 2009, BIOTOPE MEZE MUSEUM; BLAKE D, 1994, J ZOOL, V234, P453, DOI 10.1111/j.1469-7998.1994.tb04859.x; Burnham K. P., 2002, MODEL SELECTION AND; Burt J, 2006, SYRINX A SOFTWARE FO; Catto CMC, 1996, J ZOOL, V238, P623, DOI 10.1111/j.1469-7998.1996.tb05419.x; CORELA, 2007, HEDGEROWS DATABASE; CORELA, 2007, LAND USE DATABASE; Crawley MJ, 2009, SPATIAL ANALYSIS A G; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Dietz C, 2009, LENCYCLOPEDIE DES CH; Faraway J.J., 2006, EXTENDING THE LINEAR; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; Fox J, 2011, AN R COMPANION TO AP; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; IUCN, 2012, THE IUCN RED LIST OF; Jackman S, 2012, PSCL CLASSES AND MET; JONES G, 1994, PHILOS T R SOC B, V346, P445, DOI 10.1098/rstb.1994.0161; McGuire LP, 2010, ACTA CHIROPTEROL, V12, P247, DOI 10.3161/150811010X504734; Meteo France, 2012, FRENCH NATIONAL METE; Mitchell-Jones A. J., 1999, THE ATLAS OF EUROPEA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainho A, 2007, ACTA CHIROPTEROL, V9, P171, DOI 10.3161/1733-5329(2007)9[171:SFHOBI]2.0.CO;2; Rich C., 2006, ECOLOGICAL CONSEQUEN; Roche N. C., 2005, IRISH WILDLIFE MANUA; Russ J, 1999, ALANA BOOKS; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; RYDELL J, 1995, BIOL J LINN SOC, V54, P183, DOI 10.1006/bijl.1995.0011; Rydell Jens, 2006, P43; Rydell Jens, 1996, Entomologisk Tidskrift, V117, P129; Scanlon AT, 2008, WILDLIFE RES, V35, P821, DOI 10.1071/WR08035; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Stebbings R. E., 1988, THE CONSERVATION OF; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zuur Alain F., 2009, P1	44	55	57	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e103042	10.1371/journal.pone.0103042	http://dx.doi.org/10.1371/journal.pone.0103042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360638	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700002
J	Wang, YQ; Zhu, C; Zhang, JW; Jian, YD				Wang, Yuanquan; Zhu, Ce; Zhang, Jiawan; Jian, Yuden			Convolutional Virtual Electric Field for Image Segmentation Using Active Contours	PLOS ONE			English	Article							GRADIENT VECTOR FLOW; EXTERNAL FORCE; SNAKE; DRIVEN; SYNCHRONIZATION; TRACKING; MUMFORD; MODELS; ENERGY; SHAPE	Gradient vector flow (GVF) is an effective external force for active contours; however, it suffers from heavy computation load. The virtual electric field (VEF) model, which can be implemented in real time using fast Fourier transform (FFT), has been proposed later as a remedy for the GVF model. In this work, we present an extension of the VEF model, which is referred to as CONvolutional Virtual Electric Field, CONVEF for short. This proposed CONVEF model takes the VEF model as a convolution operation and employs a modified distance in the convolution kernel. The CONVEF model is also closely related to the vector field convolution (VFC) model. Compared with the GVF, VEF and VFC models, the CONVEF model possesses not only some desirable properties of these models, such as enlarged capture range, u-shape concavity convergence, subject contour convergence and initialization insensitivity, but also some other interesting properties such as G-shape concavity convergence, neighboring objects separation, and noise suppression and simultaneously weak edge preserving. Meanwhile, the CONVEF model can also be implemented in real-time by using FFT. Experimental results illustrate these advantages of the CONVEF model on both synthetic and natural images.	[Wang, Yuanquan] Tianjin Univ Technol, Sch Comp Sci, Tianjin, Peoples R China; [Zhu, Ce] Univ Elect Sci & Technol China, Sch Elect Engn, Chengdu 610054, Peoples R China; [Zhang, Jiawan] Tianjin Univ, Sch Software Engn, Tianjin 300072, Peoples R China; [Jian, Yuden] Beijing Inst Technol, Sch Comp Sci, Beijing 100081, Peoples R China	Tianjin University of Technology; University of Electronic Science & Technology of China; Tianjin University; Beijing Institute of Technology	Zhang, JW (corresponding author), Tianjin Univ, Sch Software Engn, Tianjin 300072, Peoples R China.	jwzhang@tju.edu.cn	Zhu, Ce/AEN-1875-2022	Wang, Yuanquan/0000-0002-9232-5392				Adam A, 2009, IEEE T PATTERN ANAL, V31, P1708, DOI 10.1109/TPAMI.2009.21; Ben Ayed I, 2009, INT J COMPUT VISION, V85, P115, DOI 10.1007/s11263-009-0249-6; Boukerroui D, 2012, PATTERN RECOGN, V45, P626, DOI 10.1016/j.patcog.2011.07.007; Brox T, 2009, INT J COMPUT VISION, V84, P184, DOI 10.1007/s11263-008-0153-5; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Darolti C, 2008, IEEE T IMAGE PROCESS, V17, P2275, DOI 10.1109/TIP.2008.2006443; De Vylder J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054068; Estellers V, 2014, IEEE T IMAGE PROCESS, V23, P69, DOI 10.1109/TIP.2013.2286326; Fergani K, 2014, COMPUT VIS IMAGE UND, V125, P85, DOI 10.1016/j.cviu.2014.03.011; Fu S, 2010, ELECTRON LETT, V46, P907, DOI 10.1049/el.2010.0027; Fu SJ, 2012, OPT LETT, V37, P422, DOI 10.1364/OL.37.000422; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P3866, DOI 10.1109/TIP.2013.2263147; Ghita O, 2010, PATTERN RECOGN, V43, P2646, DOI 10.1016/j.patcog.2010.02.023; Hassouna MS, 2009, IEEE T PATTERN ANAL, V31, P2257, DOI 10.1109/TPAMI.2008.271; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim W, 2013, IEEE T IMAGE PROCESS, V22, P1665, DOI 10.1109/TIP.2012.2231689; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Li B, 2008, IEEE T IMAGE PROCESS, V17, P1406, DOI 10.1109/TIP.2008.925375; Li B, 2007, IEEE T IMAGE PROCESS, V16, P2096, DOI 10.1109/TIP.2007.899601; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li L, 2014, P NATL ACAD SCI USA; Li P, 2013, INT C COMP VIS ICCV; Li PH, 2013, J MATH IMAGING VIS, V46, P44, DOI 10.1007/s10851-012-0369-4; Lu SP, 2010, LECT NOTES COMPUT SC, V5994, P147; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Muralidhar GS, 2010, IEEE T MED IMAGING, V29, P1768, DOI 10.1109/TMI.2010.2052064; Myronenko A, 2009, PROC CVPR IEEE, P2790; Nakhmani A, 2012, IEEE T IMAGE PROCESS, V21, P3150, DOI 10.1109/TIP.2012.2188808; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P266, DOI 10.1109/34.841758; Paragios N, 2004, IEEE T PATTERN ANAL, V26, P402, DOI 10.1109/TPAMI.2004.1262337; Park HK, 2002, ELECTRON LETT, V38, P1500, DOI 10.1049/el:20021037; Prasad VSN, 2004, IEEE T IMAGE PROCESS, V13, P1559, DOI 10.1109/TIP.2004.837564; Qin LM, 2013, IEEE T CIRC SYST VID, V23, P883, DOI 10.1109/TCSVT.2013.2242554; Ray N, 2004, IEEE T MED IMAGING, V23, P1466, DOI 10.1109/TMI.2004.835603; Ray N, 2003, IEEE T MED IMAGING, V22, P189, DOI 10.1109/TMI.2002.808354; Ren DW, 2013, PATTERN RECOGN LETT, V34, P219, DOI 10.1016/j.patrec.2012.09.017; Rodtook A, 2010, PATTERN RECOGN, V43, P3522, DOI 10.1016/j.patcog.2010.04.003; Shih FY, 2007, COMPUT VIS IMAGE UND, V105, P93, DOI 10.1016/j.cviu.2006.08.007; Shivakumara P, 2013, IEEE T CIRC SYST VID, V23, P1729, DOI 10.1109/TCSVT.2013.2255396; Srikrishnan V, 2011, IMAGE VISION COMPUT, V29, P317, DOI 10.1016/j.imavis.2010.12.004; Srikrishnan V, 2009, IEEE T IMAGE PROCESS, V18, P1859, DOI 10.1109/TIP.2009.2021310; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang WP, 2014, NONLINEAR DYNAM, V76, P591, DOI 10.1007/s11071-013-1153-8; Wang WP, 2014, NEURAL NETWORKS, V53, P8, DOI 10.1016/j.neunet.2014.01.010; Wang Y, 2008, ELECTRON LETT, V44, P105, DOI 10.1049/el:20081650; Wang Y, 2009, P AS C COMP VIS; Wang Y, 2007, LECT NOTES COMPUT SC, V4844, P754; Wang YQ, 2013, COMPUT MATH APPL, V66, P1729, DOI 10.1016/j.camwa.2013.08.034; Wang YQ, 2013, COMPUT ELECTR ENG, V39, P1506, DOI 10.1016/j.compeleceng.2013.03.017; Wang YQ, 2010, IEEE SIGNAL PROC LET, V17, P875, DOI 10.1109/LSP.2010.2060482; Wu H, 2013, IEEE T PATTERN ANAL, V35, P1298, DOI 10.1109/TPAMI.2012.207; Wu YW, 2013, COMPUT VIS IMAGE UND, V117, P1421, DOI 10.1016/j.cviu.2013.05.003; Wu YW, 2013, COMPUT VIS IMAGE UND, V117, P990, DOI 10.1016/j.cviu.2012.12.008; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Yuan D, 2002, INT C PATT RECOG, P83, DOI 10.1109/ICPR.2002.1044618; YUE ZJ, 1995, IEEE T MED IMAGING, V14, P525, DOI 10.1109/42.414618; Zhang KH, 2010, PATTERN RECOGN, V43, P1199, DOI 10.1016/j.patcog.2009.10.010; Zhao DW, 2012, COMPUT MATH APPL, V64, P611, DOI 10.1016/j.camwa.2011.12.067; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	62	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110032	10.1371/journal.pone.0110032	http://dx.doi.org/10.1371/journal.pone.0110032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360586	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700022
J	Zhang, JX; Zheng, L; Zhu, DL; An, HR; Yang, YR; Liang, Y; Zhao, WG; Ding, WJ; Wu, XQ				Zhang, Junxian; Zheng, Li; Zhu, Donglin; An, Huiru; Yang, Yourong; Liang, Yan; Zhao, Weiguo; Ding, Wenjun; Wu, Xueqiong			Polymorphisms in the Interleukin 18 Receptor 1 Gene and Tuberculosis Susceptibility among Chinese	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; GRANULOMA-FORMATION; T-CELLS; INFECTION; ASSOCIATION; MICE; HOST	Tuberculosis (TB), an infectious disease caused by infection of Mycobacterium tuberculosis, is a major public health challenge globally. Genetic epidemiological evidence suggests a genetic basis for TB, but the molecular mechanism for a genetic predisposition to TB remains largely unknown. Thirty-five tag single-nucleotide polymorphisms (SNPs) across 11 candidate cytokines and related genes, including IL-12/IFN-gamma axis genes (IL12B, IL12RB1, IL18R1, IL27, IFNGR1, IFNGR2 and STAT1), the TNF gene locus (TNF and LTA), IL10, and CCL2, were genotyped using Sequenom's iPLEX assays in 1,032 patients with TB and 1,008 controls of Chinese Han origin. We did not find that any of the 35 tag SNPs individually or as haplotypes was significantly associated with susceptibility to TB, on the basis of multivariable logistic regression analysis with adjustment for age and sex. However, stratification analyses showed that, in those with age 46 years or older, carrying the rs1974675 T allele in the IL18R1 gene had a significantly decreased susceptibility to TB occurrence compared with carrying the C/C genotype (OR = 0.57, P = 5.0 x 10(-4)). Further analysis indicated that a SNP in absolute linkage disequilibrium with rs1974675, rs3755276, is located within a CpG dinucleotide and showed hypomethylation in controls than in patients (19.6% vs. 31.4%; P = 1.0 x 10(-4)) and genotype-specific DNA methylation at the IL18R1 promoter and IL18R1 mRNA levels. In addition, DNA methylation levels were significantly inversely correlated with mRNA levels. Thus, decreased mRNA levels of IL18R1 due to rs3755276 may partially mediate the increased susceptibility to TB risk.	[Zhang, Junxian; Zhu, Donglin; An, Huiru; Yang, Yourong; Liang, Yan; Zhao, Weiguo; Wu, Xueqiong] 309th Hosp Chinese PLA, Inst TB Res, Army TB Prevent & Control Key Lab, Beijing, Peoples R China; [Zheng, Li; Ding, Wenjun] Univ Chinese Acad Sci, Coll Life Sci, Lab Environm & Hlth, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ding, WJ (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Lab Environm & Hlth, Beijing, Peoples R China.	dingwj@ucas.ac.cn; wu-xueqiong@263.net			Army "Twelfth Five" Scientific Research Foundation [BWS11J050]	Army "Twelfth Five" Scientific Research Foundation	This work was supported by a grant from the Army "Twelfth Five" Scientific Research Foundation (BWS11J050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Ansari AW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00312; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Bean AGD, 1999, J IMMUNOL, V162, P3504; Ben-Selma W, 2012, INT J INFECT DIS, V16, pE543, DOI 10.1016/j.ijid.2011.11.016; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Grant AV, 2013, AM J HUM GENET, V92, P407, DOI 10.1016/j.ajhg.2013.01.013; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jacobs M, 2000, LAB INVEST, V80, P901, DOI 10.1038/labinvest.3780094; Keeton R, 2014, J CLIN INVEST, V124, P1537, DOI 10.1172/JCI45005; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001; Rajagopalan S, 2000, Z GERONTOL GERIATR, V33, P374, DOI 10.1007/s003910070034; Rajagopalan S, 2000, INFECT CONT HOSP EP, V21, P611, DOI 10.1086/501816; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Senaldi G, 1996, J IMMUNOL, V157, P5022; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yano S, 2003, J IMMUNOL, V171, P2510, DOI 10.4049/jimmunol.171.5.2510; Yu Q, 2008, J IMMUNOL, V181, P3346, DOI 10.4049/jimmunol.181.5.3346	40	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110734	10.1371/journal.pone.0110734	http://dx.doi.org/10.1371/journal.pone.0110734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360588	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700043
J	Ahman, B; Svensson, K; Ronnegard, L				Ahman, Birgitta; Svensson, Kristin; Ronnegard, Lars			High Female Mortality Resulting in Herd Collapse in Free-Ranging Domesticated Reindeer (Rangifer tarandus tarandus) in Sweden	PLOS ONE			English	Article							LYNX-LYNX; EURASIAN LYNX; DENSITY; CARIBOU; REPRODUCTION; SURVIVAL; SNOW; POPULATIONS; LIMITATION; PREDATION	Reindeer herding in Sweden is a form of pastoralism practised by the indigenous Sami population. The economy is mainly based on meat production. Herd size is generally regulated by harvest in order not to overuse grazing ranges and keep a productive herd. Nonetheless, herd growth and room for harvest is currently small in many areas. Negative herd growth and low harvest rate were observed in one of two herds in a reindeer herding community in Central Sweden. The herds (A and B) used the same ranges from April until the autumn gathering in October-December, but were separated on different ranges over winter. Analyses of capture-recapture for 723 adult female reindeer over five years (2007-2012) revealed high annual losses (7.1% and 18.4%, for herd A and B respectively). A continuing decline in the total reindeer number in herd B demonstrated an inability to maintain the herd size in spite of a very small harvest. An estimated breakpoint for when herd size cannot be kept stable confirmed that the observed female mortality rate in herd B represented a state of herd collapse. Lower calving success in herd B compared to A indicated differences in winter foraging conditions. However, we found only minor differences in animal body condition between the herds in autumn. We found no evidence that a lower autumn body mass generally increased the risk for a female of dying from one autumn to the next. We conclude that the prime driver of the on-going collapse of herd B is not high animal density or poor body condition. Accidents or disease seem unlikely as major causes of mortality. Predation, primarily by lynx and wolverine, appears to be the most plausible reason for the high female mortality and state of collapse in the studied reindeer herding community.	[Ahman, Birgitta] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Svensson, Kristin; Ronnegard, Lars] Dalarna Univ, Sch Technol & Business Studies, Falun, Sweden	Swedish University of Agricultural Sciences; Dalarna University	Ahman, B (corresponding author), Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.	birgitta.ahman@slu.se		Ronnegard, Lars/0000-0002-1057-5401	Swedish Board of Agriculture [31-7132/07, 31-5841/08, 31-4347/09, 31-4665/10]	Swedish Board of Agriculture	Funding for the project was granted by the Swedish Board of Agriculture (contract 31-7132/07, 31-5841/08, 31-4347/09 and 31-4665/10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 2002, WILDLIFE BIOL, V8, P299, DOI 10.2981/wlb.2002.027; [Anonymous], 2014, AVSKJUNTINGSRAPPORT; [Anonymous], 1991, UTVECKLINGSPLANERING; [Anonymous], 2002, FORESKRIFTER ANDRING; Arnesson-Westerdahl A, 1995, FORSLAG UTFORMMING N; Bastille-Rousseau G, 2013, CAN J ZOOL, V91, P820, DOI 10.1139/cjz-2013-0154; Bjarvall A., 1990, RENAR ROVDJUR ROVDJU; Caswell H, 1989, MATRIX POPULATION MO; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Cuyler Christine, 2007, Rangifer, P219; Eloranta E., 1986, RANGIFER, V1, P115, DOI DOI 10.7557/2.6.2.635; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gunn Anne, 2003, Rangifer, P105; Haglund B, 1966, J VILTREVY, V4, P81; Hegel Troy M., 2013, Rangifer, V33, P59; HELLE T, 1993, ARCTIC, V46, P72; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Klein DR, 2009, AMBIO, V38, P11, DOI 10.1579/0044-7447-38.1.11; KLEIN DR, 1968, J WILDLIFE MANAGE, V32, P350, DOI 10.2307/3798981; Kumpula J, 1998, CAN J ZOOL, V76, P269, DOI 10.1139/cjz-76-2-269; Kumpula J, 2003, POLAR RES, V22, P225, DOI 10.1111/j.1751-8369.2003.tb00109.x; Landa AJ, 2001, JERV SKANDINAVIA AKT; Lauvergne Jean J., 2010, Rangifer, V30, P11; Lundqvist H, 2007, THESIS SWEDISH U AGR; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mattisson J, 2011, J MAMMAL, V92, P1321, DOI 10.1644/11-MAMM-A-099.1; Miller FL, 2009, ARCTIC, V62, P175; Muuttoranta K, 2012, ACTA AGR SCAND A-AN, V62, P142, DOI 10.1080/09064702.2012.747560; Nieminen M., 2013, Rangifer, V33, P79; Nieminen Mauri, 2011, Rangifer, V31, P71; Norberg H, 2006, WILDLIFE BIOL, V12, P393, DOI 10.2981/0909-6396(2006)12[393:PBGEAC]2.0.CO;2; Nybakk K, 2002, WILDLIFE BIOL, V8, P63, DOI 10.2981/wlb.2002.009; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; Olofsson Anna, 2011, Rangifer, V31, P7; Pape R, 2012, AMBIO, V41, P421, DOI 10.1007/s13280-012-0257-6; Pedersen VA, 1999, WILDLIFE BIOL, V5, P203; Ronnegard L, 2002, CAN J ZOOL, V80, P2047, DOI 10.1139/z02-192; Scoones I., 1993, Economics and ecology: new frontiers and sustainable development., P96; SKOGLAND T, 1989, OIKOS, V55, P101, DOI 10.2307/3565879; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; SKOGLAND T, 1983, OECOLOGIA, V60, P156, DOI 10.1007/BF00379517; SKOGLAND T, 1990, OECOLOGIA, V84, P442, DOI 10.1007/BF00328158; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; Ulvevadet B, 2011, J ENVIRON MANAGE, V92, P2794, DOI 10.1016/j.jenvman.2011.06.026	48	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111509	10.1371/journal.pone.0111509	http://dx.doi.org/10.1371/journal.pone.0111509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356591	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000066
J	Mostaghel, EA; Morgan, A; Zhang, XT; Marck, BT; Xia, J; Hunter-Merrill, R; Gulati, R; Plymate, S; Vessella, RL; Corey, E; Higano, CS; Matsumoto, AM; Montgomery, RB; Nelson, PS				Mostaghel, Elahe A.; Morgan, Andrew; Zhang, Xiaotun; Marck, Brett T.; Xia, Jing; Hunter-Merrill, Rachel; Gulati, Roman; Plymate, Stephen; Vessella, Robert L.; Corey, Eva; Higano, Celestia S.; Matsumoto, Alvin M.; Montgomery, R. Bruce; Nelson, Peter S.			Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis	PLOS ONE			English	Article							INCREASED SURVIVAL; HORMONAL-THERAPY; CARCINOMA; DIHYDROTESTOSTERONE; TESTOSTERONE; PROGRESSION; ABIRATERONE; RESISTANCE; ENZALUTAMIDE; INDEPENDENCE	Background: Factors influencing differential responses of prostate tumors to androgen receptor (AR) axis-directed therapeutics are poorly understood, and predictors of treatment efficacy are needed. We hypothesized that the efficacy of inhibiting DHT ligand synthesis would associate with intra-tumoral androgen ratios indicative of relative dependence on DHT-mediated growth. Methods: We characterized two androgen-sensitive prostate cancer xenograft models after androgen suppression by castration in combination with the SRD5A inhibitor, dutasteride, as well as a panel of castration resistant metastases obtained via rapid autopsy. Results: In LuCaP35 tumors (intra-tumoral T: DHT ratio 2: 1) dutasteride suppressed DHT to 0.02 ng/gm and prolonged survival vs. castration alone (337 vs. 152 days, HR 2.8, p = 0.0015). In LuCaP96 tumors (T: DHT 10: 1), survival was not improved despite similar DHT reduction (0.02 ng/gm). LuCaP35 demonstrated higher expression of steroid biosynthetic enzymes maintaining DHT levels (5-fold higher SRD5A1, 41 fold higher, 99-fold higher RL-HSD, p<0.0001 for both), reconstitution of intra-tumoral DHT (to similar to 30% of untreated tumors), and similar to 2 fold increased expression of full length AR. In contrast, LuCaP96 demonstrated higher levels of steroid catabolizing enzymes (6.9-fold higher AKR1C2, 3000-fold higher UGT2B15, p = 0.002 and p<0.0001 respectively), persistent suppression of intra-tumoral DHT, and 6-8 fold induction of full length AR and the ligand independent V7 AR splice variant. Human metastases demonstrated bio-active androgen levels and AR full length and AR splice-variant expression consistent with the range observed in xenografts. Conclusions: Intrinsic differences in basal steroidogenesis, as well as variable expression of full length and splice-variant AR, associate with response and resistance to pre-receptor AR ligand suppression. Expression of steroidogenic enzymes and AR isoforms may serve as potential biomarkers of sensitivity to potent AR-axis inhibition and should be validated in additional models.	[Mostaghel, Elahe A.; Morgan, Andrew; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Mostaghel, Elahe A.; Marck, Brett T.; Plymate, Stephen; Higano, Celestia S.; Matsumoto, Alvin M.; Montgomery, R. Bruce; Nelson, Peter S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Zhang, Xiaotun; Vessella, Robert L.; Corey, Eva] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA; [Marck, Brett T.; Plymate, Stephen; Matsumoto, Alvin M.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Xia, Jing; Hunter-Merrill, Rachel; Gulati, Roman] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Fred Hutchinson Cancer Center	Mostaghel, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	emostagh@fhcrc.org	Gulati, Roman/AAE-4298-2019; Matsumoto, Alvin/AAH-6096-2020	Gulati, Roman/0000-0002-7592-6567; 	Prostate Cancer Foundation Career Development Award; Challenge Award; Damon Runyon Genentech-Clinical Investigator Award [C-40-08]; NIH grant [1K23 CA122820-01]; DOD New Investigator Award [W81XWH-10-1-0228]; GlaxoSmithKline; NIH/NCI Pacific Northwest Prostate Cancer SPORE [P50CA97186]; Department of Veterans Affairs;  [1RC1 CA146849];  [PC093509];  [PO1 CA 85859]; NATIONAL CANCER INSTITUTE [K23CA122820, RC1CA146849, P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Prostate Cancer Foundation Career Development Award; Challenge Award; Damon Runyon Genentech-Clinical Investigator Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD New Investigator Award; GlaxoSmithKline(GlaxoSmithKline); NIH/NCI Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Prostate Cancer Foundation Career Development Award (E. A. M.) and Challenge Award (E. A. M., S. P., R. L. V., A. M. M., R. B. M., P.S.N.), Damon Runyon Genentech-Clinical Investigator Award C-40-08 (E. A. M.), NIH grant 1K23 CA122820-01 (E. A. M.), DOD New Investigator Award W81XWH-10-1-0228 (E. A. M.); GlaxoSmithKline (A. M. and P.S.N.); 1RC1 CA146849 (P.S.N.); PC093509 (P.S.N.); PO1 CA 85859 (J.X., R. G., R. V., P.S.N.); the NIH/NCI Pacific Northwest Prostate Cancer SPORE P50CA97186 (J.X., R. H., R. G., P.S.N., R. V.); and the Department of Veterans Affairs (B. T. M., S. P. and A. M. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arnold JT, 2007, PROSTATE, V67, P1152, DOI 10.1002/pros.20585; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; Gregory CW, 2001, CANCER RES, V61, P4315; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hobisch A, 1996, PROSTATE, V28, P129; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2011, CLIN CANC RES; Page ST, 2007, J ANDROL JANDROL, V107; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; SADI MV, 1991, CANCER, V67, P3057, DOI 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2009, CLIN CANCER RES, V15, P7099, DOI 10.1158/1078-0432.CCR-09-1722; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Watson PA, 2010, P NATL ACAD SCI; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	39	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111545	10.1371/journal.pone.0111545	http://dx.doi.org/10.1371/journal.pone.0111545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356728	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000069
J	O'Connor, C; Joffe, H				O'Connor, Cliodhna; Joffe, Helene			Gender on the Brain: A Case Study of Science Communication in the New Media Environment	PLOS ONE			English	Article							SOCIAL REPRESENTATIONS; PSYCHOLOGICAL ESSENTIALISM; SYSTEM JUSTIFICATION; STEREOTYPE CONTENT; PRESS RELEASES; MASS-MEDIA; SEX BIAS; NEUROSCIENCE; BIOTECHNOLOGY; JOURNALISM	Neuroscience research on sex difference is currently a controversial field, frequently accused of purveying a 'neurosexism' that functions to naturalise gender inequalities. However, there has been little empirical investigation of how information about neurobiological sex difference is interpreted within wider society. This paper presents a case study that tracks the journey of one high-profile study of neurobiological sex differences from its scientific publication through various layers of the public domain. A content analysis was performed to ascertain how the study was represented in five domains of communication: the original scientific article, a press release, the traditional news media, online reader comments and blog entries. Analysis suggested that scientific research on sex difference offers an opportunity to rehearse abiding cultural understandings of gender. In both scientific and popular contexts, traditional gender stereotypes were projected onto the novel scientific information, which was harnessed to demonstrate the factual truth and normative legitimacy of these beliefs. Though strains of misogyny were evident within the readers' comments, most discussion of the study took pains to portray the sexes' unique abilities as equal and 'complementary'. However, this content often resembled a form of benevolent sexism, in which praise of women's social-emotional skills compensated for their relegation from more esteemed trait-domains, such as rationality and productivity. The paper suggests that embedding these stereotype patterns in neuroscience may intensify their rhetorical potency by lending them the epistemic authority of science. It argues that the neuroscience of sex difference does not merely reflect, but can actively shape the gender norms of contemporary society.	[O'Connor, Cliodhna; Joffe, Helene] UCL, Div Psychol & Language Sci, London, England	University of London; University College London	O'Connor, C (corresponding author), UCL, Div Psychol & Language Sci, London, England.	oconnor.c@ucl.ac.uk	O'Connor, Cliodhna/AAB-3343-2019	O'Connor, Cliodhna/0000-0001-8134-075X	'Uses and Abuses of Biology' grants programme [0025 / UAB 008]	'Uses and Abuses of Biology' grants programme	The research was supported by a grant (ref. TWCF 0025 / UAB 008) awarded under the 'Uses and Abuses of Biology' grants programme administered by the Faraday Institute at St. Edmund's College, Cambridge (http://www.uabgrants.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8; Bair Rita M., 2000, QUALITATIVE RES TEXT, P131, DOI [10.4135/9781849209731.n8, DOI 10.4135]; Bangerter A, 2004, BRIT J SOC PSYCHOL, V43, P605, DOI 10.1348/0144666042565353; Bangerter A, 2000, BRIT J SOC PSYCHOL, V39, P521, DOI 10.1348/014466600164615; Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202; Bauer MW, 2005, INT J PUBLIC OPIN R, V17, P5, DOI 10.1093/ijpor/edh054; Bauer MW, 1999, J THEOR SOC BEHAV, V29, P163, DOI 10.1111/1468-5914.00096; Bauer MW, 2002, PUBLIC UNDERST SCI, V11, P93, DOI 10.1088/0963-6625/11/2/301; Baxter P, 2008, QUAL REP, V13, P544; Becker JC, 2011, J PERS SOC PSYCHOL, V101, P62, DOI 10.1037/a0022615; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bluhm R, 2012, NEW DIR PHILOS COGN, P1, DOI 10.1057/9780230368385; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Brescoll V, 2004, PSYCHOL SCI, V15, P515, DOI 10.1111/j.0956-7976.2004.00712.x; Brescoll VL, 2013, J PERS SOC PSYCHOL, V105, P891, DOI 10.1037/a0034701; Broer C, 2013, SOCIOL HEALTH ILL, V35, P49, DOI 10.1111/j.1467-9566.2012.01477.x; Brossard D, 2009, PUBLIC UNDERST SCI, V18, P258, DOI 10.1177/0963662507084398; Brumfiel G, 2009, NATURE, V458, P274, DOI 10.1038/458274a; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choudhury S, 2012, CRITICAL NEUROSCIENCE: A HANDBOOK OF THE SOCIAL AND CULTURAL CONTEXTS OF NEUROSCIENCE, P1; Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437; Coleman JM, 2008, SELF IDENTITY, V7, P34, DOI 10.1080/15298860600980185; Collins RL, 2011, SEX ROLES, V64, P290, DOI 10.1007/s11199-010-9929-5; Dar-Nimrod I, 2006, SCIENCE, V314, P435, DOI 10.1126/science.1131100; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Dumit Joseph, 2004, PICTURING PERSONHOOD; Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001; Eliot L, 2013, SEX ROLES, V69, P363, DOI 10.1007/s11199-011-0037-y; Fausto-Sterling A, 2000, SEXING BODY GENDER P; Fine C, 2010, DELUSIONS GENDER; Fine C, 2013, TRENDS COGN SCI, V17, P550, DOI 10.1016/j.tics.2013.08.010; Fine C, 2013, NEUROETHICS-NETH, V6, P369, DOI 10.1007/s12152-012-9169-1; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Gerring J, 2007, CASE STUDY RESEARCH: PRINCIPLES AND PRACTICES, P86; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; HILGARTNER S, 1990, SOC STUD SCI, V20, P519, DOI 10.1177/030631290020003006; Holton G, 1996, DAEDALUS, V125, P183; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jacobs J.E., 1985, EDUC RES, V14, P20, DOI DOI 10.3102/0013189X014003020; Jaspal R, 2013, SCI COMMUN, V35, P383, DOI 10.1177/1075547012459274; Joffe H., 1999, RISK AND THE OTHER; Joffe H, 2013, EARTHQ SPECTRA, V29, P367, DOI 10.1193/1.4000138; Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604; Jordan-Young R, 2012, NEUROETHICS-NETH, V5, P305, DOI 10.1007/s12152-011-9134-4; Jordan-Young Rebecca, 2010, BRAIN STORM FLAWS SC; Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Jovchelovitch S, 2008, J THEOR SOC BEHAV, V38, P431, DOI 10.1111/j.1468-5914.2008.00378.x; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x; Krippendorf Klaus, 2004, CONTENT ANAL INTRO I; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laslo E, 2011, JOURNALISM, V12, P847, DOI 10.1177/1464884911412709; Latour B., 1986, LAB LIFE CONSTRUCTIO; Lee EJ, 2010, COMMUN RES, V37, P825, DOI 10.1177/0093650210376189; Matusall S, 2013, SOC STUD SCI, V43, P780, DOI 10.1177/0306312713488843; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Meurk C, 2014, NEUROETHICS-NETH, V7, P51, DOI 10.1007/s12152-013-9180-1; Morton TA, 2006, POLIT PSYCHOL, V27, P823, DOI 10.1111/j.1467-9221.2006.00539.x; Morton TA, 2009, J PERS SOC PSYCHOL, V96, P653, DOI 10.1037/a0012966; MOSCOVICI S, 1993, J THEOR SOC BEHAV, V23, P343, DOI 10.1111/j.1468-5914.1993.tb00540.x; MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303; National Science Board, 2012, SCI ENG IND 2012; Neuendorf KA, 2011, SEX ROLES, V64, P276, DOI 10.1007/s11199-010-9893-0; Noor K., 2008, AM J APPL SCI, V5, P1602, DOI DOI 10.3844/AJASSP.2008.1602.1604; O'Connell G, 2011, EMBO REP, V12, P630, DOI 10.1038/embor.2011.115; O'Connor C, 2014, SCI COMMUN, V36, P617, DOI 10.1177/1075547014549481; O'Connor C, 2013, SOC SCI MED, V97, P297, DOI 10.1016/j.socscimed.2012.09.048; O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785; Pickersgill M, 2013, CURR SOCIOL, V61, P322, DOI 10.1177/0011392113476464; Pickersgill M, 2011, SUBJECTIVITY, V4, P346, DOI 10.1057/sub.2011.10; Prentice DA, 2007, CURR DIR PSYCHOL SCI, V16, P202, DOI 10.1111/j.1467-8721.2007.00504.x; Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Rose N., 2013, NEURO NEW BRAIN SCI; Rowe G, 2008, HEALTH RISK SOC, V10, P361, DOI 10.1080/13698570802166456; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Seale C, 2010, SOC SCI MED, V71, P861, DOI 10.1016/j.socscimed.2010.05.048; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Singh I, 2013, SOCIOL HEALTH ILL, V35, P813, DOI 10.1111/j.1467-9566.2012.01531.x; Smith NW, 2009, J RISK RES, V12, P647, DOI 10.1080/13669870802586512; Smith N, 2013, PUBLIC UNDERST SCI, V22, P16, DOI 10.1177/0963662512440913; Stafford T, 2012, TRENDS COGN SCI, V16, P489, DOI 10.1016/j.tics.2012.08.001; Ten Eyck TA, 2005, PUBLIC UNDERST SCI, V14, P305, DOI 10.1177/0963662505052888; Thoman DB, 2008, SEX ROLES, V58, P702, DOI 10.1007/s11199-008-9390-x; Van Eperen L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-199; Vidal C, 2012, NEUROETHICS-NETH, V5, P295, DOI 10.1007/s12152-011-9121-9; Wagner W, 2002, BRIT J SOC PSYCHOL, V41, P323, DOI 10.1348/014466602760344241; WAGNER W, 1995, EUR J SOC PSYCHOL, V25, P671, DOI 10.1002/ejsp.2420250606; Wagner W, 2007, PUBLIC UNDERST SCI, V16, P7, DOI 10.1177/0963662506071785; Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Whiteley L, 2012, BIOSOCIETIES, V7, P245, DOI 10.1057/biosoc.2012.21; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308; Yin RK., 2013, CASE STUDY RES DESIG	106	37	37	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110830	10.1371/journal.pone.0110830	http://dx.doi.org/10.1371/journal.pone.0110830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25354280	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000345204200041
J	Shin, B; Yu, J; Park, ES; Choi, S; Yu, J; Hwang, JM; Yun, H; Chung, YH; Hong, KS; Choi, JS; Takami, M; Rho, J				Shin, Bongjin; Yu, Jungeun; Park, Eui-Soon; Choi, Seunga; Yu, Jiyeon; Hwang, Jung Me; Yun, Hyeongseok; Chung, Young-Ho; Hong, Kwan Soo; Choi, Jong-Soon; Takami, Masamichi; Rho, Jaerang			Secretion of a Truncated Osteopetrosis-associated Transmembrane Protein 1 (OSTM1) Mutant Inhibits Osteoclastogenesis through Down-regulation of the B Lymphocyte-induced Maturation Protein 1 (BLIMP1)-Nuclear Factor of Activated T Cells c1 (NFATc1) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; SEVERE MALIGNANT OSTEOPETROSIS; INFANTILE OSTEOPETROSIS; BONE METABOLISM; DIFFERENTIATION; MUTATION; OSTEOIMMUNOLOGY; SUBUNIT; IMMUNE; MOUSE	Genetic mutations in osteoclastogenic genes are closely associated with osteopetrotic bone diseases. Genetic defects in OSTM1 (osteopetrosis-associated transmembrane protein 1) cause autosomal recessive osteopetrosis in humans. In particular, OSTM1 mutations that exclude the transmembrane domain might lead to the production of a secreted form of truncated OSTM1. However, the precise role of the secreted form of truncated OSTM1 remains unknown. In this study, we analyzed the functional role of truncated OSTM1 in osteoclastogenesis. Here, we showed that a secreted form of truncated OSTM1 binds to the cell surface of osteoclast (OC) precursors and inhibits the formation of multinucleated OCs through the reduction of cell fusion and survival. Truncated OSTM1 significantly inhibited the expression of OC marker genes through the downregulation of the BLIMP1 (B lymphocyte-induced maturation protein 1)-NFATc1 (nuclear factor of activated T cells c1) axis. Finally, we demonstrated that truncated OSTM1 reduces lipopolysaccharide-induced bone destruction in vivo. Thus, these findings suggest that autosomal recessive osteopetrosis patients with an OSTM1 gene mutation lacking the transmembrane domain produce a secreted form of truncated OSTM1 that inhibits osteoclastogenesis.	[Shin, Bongjin; Yu, Jungeun; Park, Eui-Soon; Choi, Seunga; Yu, Jiyeon; Hwang, Jung Me; Yun, Hyeongseok; Rho, Jaerang] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea; [Hong, Kwan Soo; Choi, Jong-Soon; Rho, Jaerang] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol GRAST, Taejon 305764, South Korea; [Chung, Young-Ho; Hong, Kwan Soo; Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon 305806, South Korea; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Biochem, Shinagawaku 1428555, Japan	Chungnam National University; Chungnam National University; Korea Basic Science Institute (KBSI); Showa University	Rho, J (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, 99 Daehak Ro, Taejon 305764, South Korea.	jrrho@cnu.ac.kr	HONG, Kwan Soo/GXF-6397-2022	HONG, Kwan Soo/0000-0003-4342-5183; Rho, Jaerang/0000-0002-0019-4939; Takami, Masamichi/0000-0002-4506-3975	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2011-0021771]; Korea Basic Science Institute Grant [D33400]; Chungnam National University; Ministry of National Defense Foundation [ADD 14-01-06-06]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Korea Basic Science Institute Grant; Chungnam National University; Ministry of National Defense Foundation	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education Grant NRF-2011-0021771, Korea Basic Science Institute Grant D33400, the research fund of Chungnam National University, and Ministry of National Defense Foundation Grant ADD 14-01-06-06.	Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Feigin ME, 2008, CELL SIGNAL, V20, P949, DOI 10.1016/j.cellsig.2008.01.009; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim T, 2009, J BIOL CHEM, V284, P15308, DOI 10.1074/jbc.M807722200; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ott CE, 2013, BONE, V55, P292, DOI 10.1016/j.bone.2013.04.007; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Pata M, 2008, J BIOL CHEM, V283, P30522, DOI 10.1074/jbc.M805242200; Prinetti A, 2009, GLYCOCONJUGATE J, V26, P623, DOI 10.1007/s10719-008-9179-8; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Ramirez A, 2004, HUM MUTAT, V23, P471, DOI 10.1002/humu.20028; Rho J, 2004, MOL CELLS, V17, P1; Rho J, 2001, MOL CELL BIOL, V21, P8365, DOI 10.1128/MCB.21.24.8365-8370.2001; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Segovia-Silvestre T, 2009, HUM GENET, V124, P561, DOI 10.1007/s00439-008-0583-8; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592; Yu J, 2012, J CLIN IMMUNOL, V32, P1360, DOI 10.1007/s10875-012-9722-z; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	35	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35868	35881		10.1074/jbc.M114.589614	http://dx.doi.org/10.1074/jbc.M114.589614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359771	Green Published, hybrid			2022-12-26	WOS:000346897900019
J	Dernedde, J; Weise, C; Muller, EC; Hagiwara, A; Bachmann, S; Suzuki, M; Reutter, W; Tauber, R; Scherer, H				Dernedde, Jens; Weise, Christoph; Mueller, Eva-Christina; Hagiwara, Akira; Bachmann, Sebastian; Suzuki, Mamoru; Reutter, Werner; Tauber, Rudolf; Scherer, Hans			Cupulin Is a Zona Pellucida-Like Domain Protein and Major Component of the Cupula from the Inner Ear	PLOS ONE			English	Article							RECEPTOR; MODEL; ZP3	The extracellular membranes of the inner ear are essential constituents to maintain sensory functions, the cupula for sensing torsional movements of the head, the otoconial membrane for sensing linear movements and accelerations like gravity, and the tectorial membrane in the cochlea for hearing. So far a number of structural proteins have been described, but for the gelatinous cupula precise data are missing. Here, we describe for the first time a major proteinogenic component of the cupula structure with an apparent molecular mass of 45 kDa from salmon. Analyses of respective peptides revealed highly conserved amino-acid sequences with identity to zona pellucida-like domain proteins. Immunohistochemistry studies localized the protein in the ampulla of the inner ear from salmon and according to its anatomical appearance we identified this glycoprotein as Cupulin. Future research on structure and function of zona pellucida-like domain proteins will enhance our knowledge of inner ear diseases, like sudden loss of vestibular function and other disturbances.	[Dernedde, Jens; Reutter, Werner; Tauber, Rudolf] Charite, Klin Chem & Pathobiochem, Inst Lab Med, D-13353 Berlin, Germany; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Mueller, Eva-Christina] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hagiwara, Akira; Suzuki, Mamoru] Tokyo Med Univ, Dept Otolaryngol, Shinjuku Ku, Tokyo 1608402, Japan; [Bachmann, Sebastian] Charite, Inst Vegetat Anat, D-13353 Berlin, Germany; [Scherer, Hans] Charite, Klin Otorhinolaryngol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Tokyo Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dernedde, J (corresponding author), Charite, Klin Chem & Pathobiochem, Inst Lab Med, D-13353 Berlin, Germany.	jens.dernedde@charite.de	Dernedde, Jens/H-4097-2017	Dernedde, Jens/0000-0001-5319-7677	Charite	Charite	The work was supported by internal funding of Charite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Dohlman G F, 1969, J Laryngol Otol, V83, P43, DOI 10.1017/S0022215100070031; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Helling K, 2000, HNO, V48, P822, DOI 10.1007/s001060050668; Helling K, 2002, ACTA OTO-LARYNGOL, V122, P386, DOI 10.1080/00016480260000067; Iimura Y, 2010, ACTA OTO-LARYNGOL, V130, P1092, DOI 10.3109/00016481003677456; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Konomi U, 2010, ACTA OTO-LARYNGOL, V130, P652, DOI 10.3109/00016480903370779; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; MARCUS DC, 1983, HEARING RES, V12, P17, DOI 10.1016/0378-5955(83)90116-8; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Quint E, 1998, HEARING RES, V118, P157, DOI 10.1016/S0378-5955(98)00026-4; Scherer H, 2001, Biol Sci Space, V15, P350, DOI 10.2187/bss.15.350; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Takumida M, 2001, Biol Sci Space, V15, P356, DOI 10.2187/bss.15.356	25	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111917	10.1371/journal.pone.0111917	http://dx.doi.org/10.1371/journal.pone.0111917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369234	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000126
J	Ren, SX; Lu, G; Ota, A; Zhou, ZH; Vondriska, TM; Lane, TF; Wang, YB				Ren, Shuxun; Lu, Gang; Ota, Asuka; Zhou, Z. Hong; Vondriska, Thomas M.; Lane, Timothy F.; Wang, Yibin			IRE1 Phosphatase PP2Ce Regulates Adaptive ER Stress Response in the Postpartum Mammary Gland	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; MESSENGER-RNA; CARDIOVASCULAR-DISEASE; TRANSLATIONAL CONTROL; ACTIVATION; CASPASE-12; ATF6; XBP1	We recently reported that the PPM1l gene encodes an endoplasmic reticulum (ER) membrane targeted protein phosphatase (named PP2Ce) with highly specific activity towards Inositol-requiring protein-1 (IRE1) and regulates the functional outcome of ER stress. In the present report, we found that the PP2Ce protein is highly expressed in lactating epithelium of the mammary gland. Loss of PP2Ce in vivo impairs physiological unfolded protein response (UPR) and induces stress kinase activation, resulting in loss of milk production and induction of epithelial apoptosis in the lactating mammary gland. This study provides the first in vivo evidence that PP2Ce is an essential regulator of normal lactation, possibly involving IRE1 signaling and ER stress regulation in mammary epithelium.	[Ren, Shuxun; Lu, Gang; Ota, Asuka; Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Lane, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Lane, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu	Zhou, Z Hong/HDN-0747-2022	Lane, Timothy F./0000-0002-0210-970X; Wang, Yibin/0000-0003-0852-0767	NIH [HL070079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108186, R01HL070079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by NIH (HL070079 for YW), an NIH Ruth L. Kirschstein National Research Service Award (AO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bergmann RL, 2013, J PERINAT MED, P1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Invernizzi G, 2012, J DAIRY SCI, V95, P2562, DOI 10.3168/jds.2011-4806; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lu G, 2013, MOL METABOLISM; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thomas SE, 2010, DIABETES-METAB RES, V26, P611, DOI 10.1002/dmrr.1132; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111606	10.1371/journal.pone.0111606	http://dx.doi.org/10.1371/journal.pone.0111606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369058	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000076
J	Tan, YS; Kim, M; Kingsbury, TJ; Civin, CI; Cheng, WC				Tan, Yee Sun; Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.; Cheng, Wen-Chih			Regulation of RAB5C Is Important for the Growth Inhibitory Effects of MiR-509 in Human Precursor-B Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RENAL-CELL CARCINOMA; LARGE GENE LISTS; SMALL GTPASE; MICRORNA SIGNATURES; MESSENGER-RNA; CANCER; EXPRESSION; TARGET; PROLIFERATION	MicroRNAs (miRs) regulate essentially all cellular processes, but few miRs are known to inhibit growth of precursor-B acute lymphoblastic leukemias (B-ALLs). We identified miR-509 via a human genome-wide gain-of-function screen for miRs that inhibit growth of the NALM6 human B-ALL cell line. MiR-509-mediated inhibition of NALM6 growth was confirmed by 3 independent assays. Enforced miR-509 expression inhibited 2 of 2 additional B-ALL cell lines tested, but not 3 non-B-ALL leukemia cell lines. MiR-509-transduced NALM6 cells had reduced numbers of actively proliferating cells and increased numbers of cells undergoing apoptosis. Using miR target prediction algorithms and a filtering strategy, RAB5C was predicted as a potentially relevant target of miR-509. Enforced miR-509 expression in NALM6 cells reduced RAB5C mRNA and protein levels, and RAB5C was demonstrated to be a direct target of miR-509. Knockdown of RAB5C in NALM6 cells recapitulated the growth inhibitory effects of miR-509. Co-expression of the RAB5C open reading frame without its 39 untranslated region (3'UTR) blocked the growth-inhibitory effect mediated by miR-509. These findings establish RAB5C as a target of miR-509 and an important regulator of B-ALL cell growth with potential as a therapeutic target.	[Tan, Yee Sun; Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.; Cheng, Wen-Chih] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Kingsbury, Tami J.; Civin, Curt I.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kim, MinJung; Civin, Curt I.; Cheng, Wen-Chih] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Cheng, WC (corresponding author), Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	WCheng@som.umaryland.edu			National Foundation for Cancer Research; National Institutes of Health [PO1CA70970]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from National Foundation for Cancer Research (http://www.nfcr.org), the National Institutes of Health (http://www.nih.gov) (PO1CA70970) and Maryland Stem Cell Research Foundation/TEDCO (http://www.mscrf.org) (2007-MSCRFII-0114, 2008-MSCRF-303524 and 2010-MSCRFII-0065-00) to CIC, and Gabrielle's Angel Foundation (http://www.gabriellesangels.org) to WCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Candia J, 2014, UNCOVERING IN PRESS; Capalbo L, 2011, P NATL ACAD SCI USA, V108, P17343, DOI 10.1073/pnas.1103720108; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheng WC, 2013, BIOTECHNIQUES, V54, P77, DOI 10.2144/000113991; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dou L, 2012, ONCOGENE, V31, P507, DOI 10.1038/onc.2011.248; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heiser D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094852; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; Izumiya M, 2011, CANCER SCI, V102, P1615, DOI 10.1111/j.1349-7006.2011.02007.x; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Maia S, 2005, CANCER RES, V65, P10050, DOI 10.1158/0008-5472.CAN-05-1574; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; MAY WS, 1985, J MEMBRANE BIOL, V88, P205, DOI 10.1007/BF01871086; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poell JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043569; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schotte D, 2012, LEUKEMIA, V26, P1, DOI 10.1038/leu.2011.151; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang WB, 2013, IRISH J MED SCI, V182, P621, DOI 10.1007/s11845-013-0941-y	72	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111777	10.1371/journal.pone.0111777	http://dx.doi.org/10.1371/journal.pone.0111777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368993	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000098
J	Wolkow, PP; Kosiniak-Kamysz, W; Osmenda, G; Wilk, G; Bujak-Gizycka, B; Ignacak, A; Kanitkar, M; Walus-Miarka, M; Harrison, DG; Korbut, R; Malecki, MT; Guzik, TJ				Wolkow, Pawel P.; Kosiniak-Kamysz, Wladyslaw; Osmenda, Grzegorz; Wilk, Grzegorz; Bujak-Gizycka, Beata; Ignacak, Adam; Kanitkar, Mihir; Walus-Miarka, Malgorzata; Harrison, David G.; Korbut, Ryszard; Malecki, Maciej T.; Guzik, Tomasz J.			GTP Cyclohydrolase I Gene Polymorphisms Are Associated with Endothelial Dysfunction and Oxidative Stress in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							VASCULAR SUPEROXIDE-PRODUCTION; PAIN SENSITIVITY; NAD(P)H OXIDASE; NITRIC-OXIDE; RISK-FACTORS; GCH1; MECHANISMS; ATHEROSCLEROSIS; PANCREAS; DISEASE	Background: The genetic background of atherosclerosis in type 2 diabetes mellitus (T2DM) is complex and poorly understood. Studying genetic components of intermediate phenotypes, such as endothelial dysfunction and oxidative stress, may aid in identifying novel genetic components for atherosclerosis in diabetic patients. Methods: Five polymorphisms forming two haplotype blocks within the GTP cyclohydrolase 1 gene, encoding a rate limiting enzyme in tetrahydrobiopterin synthesis, were studied in the context of flow and nitroglycerin mediated dilation (FMD and NMD), intima-media thickness (IMT), and plasma concentrations of von Willebrand factor (vWF) and malondialdehyde (MDA). Results: Rs841 was associated with FMD (p = 0.01), while polymorphisms Rs10483639, Rs841, Rs3783641 (which form a single haplotype) were associated with both MDA (p = 0.012, p = 0.0015 and p = 0.003, respectively) and vWF concentrations (p = 0.016, p = 0.03 and p = 0.045, respectively). In addition, polymorphism Rs8007267 was also associated with MDA (p = 0.006). Haplotype analysis confirmed the association of both haplotypes with studied variables. Conclusions: Genetic variation of the GCH1 gene is associated with endothelial dysfunction and oxidative stress in T2DM patients.	[Wolkow, Pawel P.; Bujak-Gizycka, Beata] Jagiellonian Univ, Coll Med, Ctr Med Genom OMICRON, Krakow, Poland; [Wolkow, Pawel P.; Bujak-Gizycka, Beata; Korbut, Ryszard] Jagiellonian Univ, Coll Med, Dept Pharmacol, Krakow, Poland; [Kosiniak-Kamysz, Wladyslaw; Osmenda, Grzegorz; Wilk, Grzegorz; Ignacak, Adam; Guzik, Tomasz J.] Jagiellonian Univ, Coll Med, Dept Internal & Agr Med, Krakow, Poland; [Kanitkar, Mihir; Harrison, David G.] Vanderbilt Univ, Dept Clin Pharmacol, Nashville, TN 37235 USA; [Walus-Miarka, Malgorzata; Malecki, Maciej T.] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland; [Malecki, Maciej T.] Univ Hosp, Krakow, Poland; [Guzik, Tomasz J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Vanderbilt University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Glasgow	Guzik, TJ (corresponding author), Jagiellonian Univ, Coll Med, Dept Internal & Agr Med, Krakow, Poland.	t.guzik@uj.edu.pl	Wolkow, Pawel/AAI-4222-2021; Guzik, Tomasz Jan/AAM-5007-2020	Wolkow, Pawel/0000-0002-9322-5545; Guzik, Tomasz/0000-0002-5039-7849	Foundation for Polish Science; Wellcome Trust; Polish National Center of Science (NCN) [N402 096 32/3258, N402 468937]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431] Funding Source: NIH RePORTER	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Polish National Center of Science (NCN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Foundation for Polish Science Welcome/02/09 Grant and by the Wellcome Trust Senior International Research Fellowship. PW and TJG were supported by grants from the Polish National Center of Science (NCN) including No N402 096 32/3258 and No N402 468937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antoniades C, 2008, J AM COLL CARDIOL, V52, P158, DOI 10.1016/j.jacc.2007.12.062; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; COLLINS R, 1995, LANCET, V345, P669; De Cobelli F, 2004, DIABETES CARE, V27, P947, DOI 10.2337/diacare.27.4.947; Doehring A, 2008, MUTAT RES-REV MUTAT, V659, P195, DOI 10.1016/j.mrrev.2008.04.007; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fiorina P, 2001, DIABETES, V50, P496, DOI 10.2337/diabetes.50.3.496; Flossmann E, 2005, CEREBROVASC DIS, V19, P1, DOI 10.1159/000081905; Folli F, 2011, CURR DIABETES REV, V7, P313, DOI 10.2174/157339911797415585; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gesierich A, 2003, BASIC RES CARDIOL, V98, P69, DOI 10.1007/s00395-003-0394-y; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Guzik TJ, 2004, ARTERIOSCL THROM VAS, V24, P1614, DOI 10.1161/01.ATV.0000139011.94634.9d; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; HANSSON GK, 1993, BRIT HEART J, V69, pS38; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim H, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-6; Kishi T, 2012, J AFFECT DISORDERS, V142, P315, DOI 10.1016/j.jad.2012.05.004; Liao YF, 2010, J DIABETES COMPLICAT, V24, P313, DOI 10.1016/j.jdiacomp.2009.04.003; Lotsch J, 2007, CLIN CHEM, V53, P1010, DOI 10.1373/clinchem.2006.082883; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malecki MT, 2008, EUR J CLIN INVEST, V38, P925, DOI 10.1111/j.1365-2362.2008.02051.x; Oertel BG, 2012, HUM MOL GENET, V21, P4751, DOI 10.1093/hmg/dds314; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petrelli A, 2012, EXP DIABETES RES, DOI 10.1155/2012/471823; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; Steinberger D, 1998, ANN NEUROL, V43, P634, DOI 10.1002/ana.410430512; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thony B, 1997, HUM MUTAT, V10, P11; Tie L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1120, DOI 10.1152/ajpendo.00696.2013; Tu YC, 2010, ACTA PHARMACOL SIN, V31, P874, DOI 10.1038/aps.2010.68; WATANABE T, 1985, LAB INVEST, V53, P80; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WERNS SW, 1989, CIRCULATION, V79, P287, DOI 10.1161/01.CIR.79.2.287; Wilk G, 2013, POL ARCH MED WEWN, V123, P443, DOI 10.20452/pamw.1879; Zhang L, 2007, J CLIN INVEST, V117, P2658, DOI 10.1172/JCI31093	41	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108587	10.1371/journal.pone.0108587	http://dx.doi.org/10.1371/journal.pone.0108587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369080	Green Published, Green Accepted, gold			2022-12-26	WOS:000344402000004
J	Borovnik-Lesjak, V; Whitehouse, K; Baetiong, A; Miao, Y; Currie, BM; Velmurugan, S; Radhakrishnan, J; Gazmuri, RJ				Borovnik-Lesjak, Vesna; Whitehouse, Kasen; Baetiong, Alvin; Miao, Yang; Currie, Brian M.; Velmurugan, Sathya; Radhakrishnan, Jeejabai; Gazmuri, Raul J.			Effects of Intraosseous Erythropoietin during Hemorrhagic Shock in Swine	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; COMBAT CASUALTY CARE; RAT MODEL; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; CARDIAC RESUSCITATION; ARGININE-VASOPRESSIN; FLUID RESUSCITATION; ABDOMINAL-SURGERY	Objective: To determine whether erythropoietin given during hemorrhagic shock (HS) ameliorates organ injury while improving resuscitation and survival. Methods: Three series of 24 pigs each were studied. In an initial series, 50% of the blood volume (BV) was removed in 30 minutes and normal saline (threefold the blood removed) started at minute 90 infusing each third in 30, 60, and 150 minutes with shed blood reinfused at minute 330 (HS-50(BV)). In a second series, the same HS-50(BV) protocol was used but removing an additional 15% of BV from minute 30 to 60 (HS-65(BV)). In a final series, blood was removed as in HS-65(BV) and intraosseous vasopressin given from minute 30 (0.04 U/kg min(-1)) until start of shed blood reinfusion at minute 150 (HS-65(BV)+VP). Normal saline was reduced to half the blood removed and given from minute 90 to 120 in half of the animals. In each series, animals were randomized 1:1 to receive erythropoietin (1,200 U/kg) or control solution intraosseously after removing 10% of the BV. Results: In HS-50(BV), O-2 consumption remained near baseline yielding minimal lactate increases, 88% resuscitability, and 60% survival at 72 hours. In HS-65(BV), O-2 consumption was reduced and lactate increased yielding 25% resuscitability. In HS-65(BV)+VP, vasopressin promoted hemodynamic stability yielding 92% resuscitability and 83% survival at 72 hours. Erythropoietin did not affect resuscitability or subsequent survival in any of the series but increased interleukin-10, attenuated lactate increases, and ameliorated organ injury based on lesser troponin I, AST, and ALT increases and lesser neurological deficits in the HS-65(BV)+VP series. Conclusions: Erythropoietin given during HS in swine failed to alter resuscitability and 72 hour survival regardless of HS severity and concomitant treatment with fluids and vasopressin but attenuated acute organ injury. The studies also showed the efficacy of vasopressin and restrictive fluid resuscitation for hemodynamic stabilization and survival.	[Borovnik-Lesjak, Vesna; Whitehouse, Kasen; Baetiong, Alvin; Miao, Yang; Currie, Brian M.; Velmurugan, Sathya; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL USA; [Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL USA; [Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Med, Dept Physiol & Biophys, N Chicago, IL USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, N Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, Dept Physiol & Biophys, N Chicago, IL 60064 USA.	raul.gazmuri@rosalindfranklin.edu	Velmurugan, Sathya/AAD-6646-2021	Gazmuri, Raul J./0000-0002-3848-7227; velmurugan, sathya/0000-0003-0769-8424	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD [W81XWH-11-2-0019]	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD	This research was supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD under contract number: W81XWH-11-2-0019. Funding was received by RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Borovnik-Lesjak V, 2013, TRANSL RES, V162, P110, DOI 10.1016/j.trsl.2013.06.002; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryl E, 1998, ARTIF ORGANS, V22, P177, DOI 10.1046/j.1525-1594.1998.06002.x; Buemi M, 2002, ACTA DERM-VENEREOL, V82, P411, DOI 10.1080/000155502762064520; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Faybik P, 2010, RESUSCITATION, V81, P1584, DOI 10.1016/j.resuscitation.2010.05.024; Grmec S, 2009, RESUSCITATION, V80, P631, DOI 10.1016/j.resuscitation.2009.03.010; GUDIPATI CV, 1990, J APPL PHYSIOL, V68, P1405, DOI 10.1152/jappl.1990.68.4.1405; Guzman JA, 2003, J APPL PHYSIOL, V95, P803, DOI 10.1152/japplphysiol.00017.2003; Huang HH, 2014, AM J CHINESE MED, V42, P79, DOI 10.1142/S0192415X14500050; Jia HB, 2009, CAN J ANAESTH, V56, P597, DOI 10.1007/s12630-009-9111-0; Jonasson R, 2004, J MED MICROBIOL, V53, P267, DOI 10.1099/jmm.0.05359-0; Kao RLC, 2011, J TRAUMA, V71, pS456, DOI 10.1097/TA.0b013e318232e782; Kao RLC, 2010, J TRAUMA, V68, P1342, DOI 10.1097/TA.0b013e3181d27dbe; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KELLEY KW, 1973, J ANIM SCI, V36, P927; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Liu XM, 2006, LIFE SCI, V78, P2255, DOI 10.1016/j.lfs.2005.09.053; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Nandra KK, 2013, DIS MODEL MECH, V6, P701, DOI 10.1242/dmm.011353; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Radhakrishnan J, 2013, AM J TRANSL RES, V5, P316; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Shimoda M, 2009, HEPATO-GASTROENTEROL, V56, P470; Simon F, 2011, INTENS CARE MED, V37, P1525, DOI 10.1007/s00134-011-2303-4; Singh Dinesh, 2007, Am J Ther, V14, P361, DOI 10.1097/01.pap.0000249957.35673.f0; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Vilarinho KAS, 2013, EUR J CARDIO-THORAC, V43, P156, DOI 10.1093/ejcts/ezs254; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Voelckel WG, 2010, J TRAUMA, V69, pS69, DOI 10.1097/TA.0b013e3181e44937; Volta CA, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-29; Wu WT, 2010, INJURY, V41, P724, DOI 10.1016/j.injury.2009.12.006	50	5	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110908	10.1371/journal.pone.0110908	http://dx.doi.org/10.1371/journal.pone.0110908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365317	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100032
J	Chang, L; Wang, YL; Ji, HH; Dai, DJ; Xu, XT; Jiang, DJ; Hong, QX; Ye, HD; Zhang, XN; Zhou, XH; Liu, Y; Li, JF; Chen, ZM; Li, Y; Zhou, DS; Zhuo, RJ; Zhang, YZ; Yin, HL; Mao, CC; Duan, SW; Wang, QW				Chang, Lan; Wang, Yunliang; Ji, Huihui; Dai, Dongjun; Xu, Xuting; Jiang, Danjie; Hong, Qingxiao; Ye, Huadan; Zhang, Xiaonan; Zhou, Xiaohui; Liu, Yu; Li, Jinfeng; Chen, Zhongming; Li, Ying; Zhou, Dongsheng; Zhuo, Renjie; Zhang, Yuzheng; Yin, Honglei; Mao, Congcong; Duan, Shiwei; Wang, Qinwen			Elevation of Peripheral BDNF Promoter Methylation Links to the Risk of Alzheimer's Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; C-REACTIVE PROTEIN; DNA METHYLATION; NEUROTROPHIC FACTOR; SERUM-ALBUMIN; BRAIN; PLASMA; ASSAY; ACID; HYDROXYMETHYLATION	Brain derived neurotrophic factor (BDNF) has been known to play an important role in various mental disorders or diseases such as Alzheimer's disease (AD). The aim of our study was to assess whether BDNF promoter methylation in peripheral blood was able to predict the risk of AD. A total of 44 AD patients and 62 age- and gender-matched controls were recruited in the current case-control study. Using the bisulphite pyrosequencing technology, we evaluated four CpG sites in the promoter of the BDNF. Our results showed that BDNF methylation was significantly higher in AD cases than in the controls (CpG1: p = 10.021; CpG2: p = 0.002; CpG3: p = 0.007; CpG4: p = 0.005; average methylation: p = 0.004). In addition, BDNF promoter methylation was shown to be significantly correlated with the levels of alkaline phosphatase (ALP), glucose, Lp(a), ApoE and ApoA in males (ALP: r = -0.308, p = 0.042; glucose: r = -0.383, p = 0.010; Lp(a): r = 0.333, p = 0.027; ApoE: r = -0.345, p = 0.032;), ApoA levels in females (r = 0.362, p = 0.033), and C Reactive Protein (CRP) levels in both genders (males: r = -0.373, p = 0.016; females: r = -0.399, p = 0.021). Our work suggested that peripheral BDNF promoter methylation might be a diagnostic marker of AD risk, although its underlying function remains to be elaborated in the future.	[Chang, Lan; Ji, Huihui; Dai, Dongjun; Xu, Xuting; Jiang, Danjie; Hong, Qingxiao; Ye, Huadan; Zhang, Xiaonan; Liu, Yu; Zhuo, Renjie; Mao, Congcong; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Yunliang; Li, Jinfeng; Zhang, Yuzheng; Yin, Honglei] 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China; [Zhou, Xiaohui] Xinjiang Med Univ, Dept Internal Med Cadres, Affiliated Hosp 1, Urumqi, Peoples R China; [Chen, Zhongming; Zhou, Dongsheng] Ningbo Kangning Hosp, Ningbo, Zhejiang, Peoples R China; [Li, Ying] Ningbo 1 Hosp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Xinjiang Medical University	Wang, YL (corresponding author), 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China.	wangyunliang81@163.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022; li, jinfeng/GVS-5425-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919, 81371469]; 973 Program from the Ministry of Science and Technology of China [2013CB835100]; Natural Science Foundation of Zhejiang Province [LR13H020003]; Disciplinary Project of Ningbo University [B01350104900]; C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects [2012C50032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program from the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Disciplinary Project of Ningbo University; C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects	The research was supported by grants from: National Natural Science Foundation of China (31100919 and 81371469), 973 Program from the Ministry of Science and Technology of China (2013CB835100), Natural Science Foundation of Zhejiang Province (LR13H020003), Disciplinary Project of Ningbo University (B01350104900), C. Wong Magna Fund in Ningbo University, and Ningbo Social Development Research Projects (2012C50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASROW G, 1969, ANAL BIOCHEM, V28, P130, DOI 10.1016/0003-2697(69)90164-X; Boersma GJ, 2013, EPIGENETICS OFFICIAL, V9; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CAZZOLATO G, 1983, CLIN CHIM ACTA, V135, P203, DOI 10.1016/0009-8981(83)90136-5; Chen C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-199; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089128; Cheng J, 2013, EXP THER MED, V5, P1687, DOI 10.3892/etm.2013.1069; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Coppede F, 2012, CURR ALZHEIMER RES, V9, P550, DOI 10.2174/156720512800618062; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; DACOL P, 1983, CLIN CHEM, V29, P1045; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEYO RA, 1980, J RHEUMATOL, V7, P279; DOUMAS BT, 1975, CLIN CHEM, V21, P1159; Egloff M, 1999, ANN BIOL CLIN-PARIS, V57, P561; Emanuele E, 2004, DEMENT GERIATR COGN, V18, P189, DOI 10.1159/000079200; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Furuya TK, 2012, NEUROCHEM INT, V61, P973, DOI 10.1016/j.neuint.2012.07.014; Girault A, 1981, Ric Clin Lab, V11 Suppl 2, P19; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hosseinzadeh S, 2013, IRAN J PSYCHIATRY BE, V7, P37; HUNZIKER P, 1975, Z KLIN CHEM KLIN BIO, V13, P89; Ikegame T, 2013, NEUROSCI RES, V77, P208, DOI 10.1016/j.neures.2013.08.004; JAYNES PK, 1982, CLIN CHEM, V28, P114; Jiang DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096822; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Kang HJ, 2013, J AFFECT DISORDERS, V151, P679, DOI 10.1016/j.jad.2013.08.001; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Keeney JTR, 2013, PROTEOM CLIN APPL, V7, P109, DOI 10.1002/prca.201200087; KNOB M, 1975, Z KLIN CHEM KLIN BIO, V13, P493; Kubota Takeo, 2013, Rinsho Shinkeigaku, V53, P1339; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Maloney B, 2012, CURR ALZHEIMER RES, V9, P589, DOI 10.2174/156720512800617955; MCPHERSO.IG, 1972, CLIN CHIM ACTA, V37, P117, DOI 10.1016/0009-8981(72)90422-6; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; NATH R. L., 1962, BULL CALCUTTA SCH TROP MED, V10, P71; Nazef K, 2014, ARCH MED RES; Parrish RR, 2013, NEUROSCIENCE, V248, P602, DOI 10.1016/j.neuroscience.2013.06.029; Penaloza CG, 2014, FASEB J, V28, P966, DOI 10.1096/fj.13-233320; Piferrer F, 2013, DEV DYNAM, V242, P360, DOI 10.1002/dvdy.23924; Pradhan V, 2013, Indian J Nephrol, V23, P434, DOI 10.4103/0971-4065.120341; Rao AT, 2014, AM J NEURORADIOL, V35, P457, DOI 10.3174/ajnr.A3545; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; RIFAI N, 1987, CLIN CHIM ACTA, V163, P207, DOI 10.1016/0009-8981(87)90024-6; Roberts RF, 2004, CLIN CHIM ACTA, V344, P95, DOI 10.1016/j.cccn.2004.02.013; Russo-Neustadt Amelia, 2003, Semin Clin Neuropsychiatry, V8, P109, DOI 10.1053/scnp.2003.50014; Solfrizzi V, 2002, J NEUROL NEUROSUR PS, V72, P732, DOI 10.1136/jnnp.72.6.732; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; TABACCO A, 1979, CLIN CHEM, V25, P336; Tang Lin-Lin, 2013, Yichuan, V35, P1143, DOI 10.3724/SP.J.1005.2013.01143; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; WHITLOW K, 1978, CLIN CHEM, V24, P2018; Xu L, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/151723; Xu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073129; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yang XL, 2010, ANAL SCI, V26, P1193, DOI 10.2116/analsci.26.1193; Yarchoan M, 2013, J NEUROL SCI, V333, P9, DOI 10.1016/j.jns.2013.05.028; Zhang GH, 2005, BIOCHEM BIOPH RES CO, V326, P87, DOI 10.1016/j.bbrc.2004.11.005; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063455; Zhang XM, 2008, NEUROTOXICOLOGY, V29, P406, DOI 10.1016/j.neuro.2008.01.006	64	51	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110773	10.1371/journal.pone.0110773	http://dx.doi.org/10.1371/journal.pone.0110773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364831	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100026
J	Kasai, H; Sugiura, T; Tanabe, N; Sakurai, Y; Yahaba, M; Matsuura, Y; Shigeta, A; Kawata, N; Sakao, S; Kasahara, Y; Tatsumi, K				Kasai, Hajime; Sugiura, Toshihiko; Tanabe, Nobuhiro; Sakurai, Yoriko; Yahaba, Misuzu; Matsuura, Yukiko; Shigeta, Ayako; Kawata, Naoko; Sakao, Seiichiro; Kasahara, Yasunori; Tatsumi, Koichiro			Electrocardiogram-Gated 320-Slice Multidetector Computed Tomography for the Measurement of Pulmonary Arterial Distensibility in Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							MAGNETIC-RESONANCE; STIFFNESS; MORTALITY; DISEASE; TRUNK; FLOW	Background: We aimed to study whether pulmonary arterial distensibility (PAD) correlates with hemodynamic parameters in chronic thromboembolic pulmonary hypertension (CTEPH) using electrocardiogram (ECG)-gated 320-slice multidetector computed tomography (MDCT). Methods and Findings: ECG-gated 320-slice MDCT and right heart catheterization (RHC) was performed in 53 subjects (60.6 +/- 11.4 years old; 37 females) with CTEPH. We retrospectively measured the minimum and maximum values of the cross sectional area (CSA) of the main pulmonary artery (mainPA), right pulmonary artery (rtPA), and left pulmonary artery (ltPA) during one heartbeat. PAD was calculated using the following formula: PAD = [(CSAmaximum-CSAminimum)/CSAmaximum] x100(%). The correlation between hemodynamic parameters and PAD was assessed. Mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR) were 40.8 +/- 8.7 mmHg and 8.3 +/- 3.0 wood units, respectively. PAD values were as follows: mainPA (14.0 +/- 5.0%), rtPA (12.8 +/- 5.6%), and ltPA (9.7 +/- 4.6%). Good correlations existed between mainPAD, with mPAP (r = -20.594, p<0.001) and PVR (r = -20.659, p<0.001). The correlation coefficients between rtPAD and ltPAD with pulmonary hemodynamics were all lower or equal than for mainPAD. Conclusions: PAD measured using ECG-gated 320-slice MDCT correlates with pulmonary hemodynamics in subjects with CTEPH. The mainPA is suitable for PAD measurement.	[Kasai, Hajime; Sugiura, Toshihiko; Tanabe, Nobuhiro; Sakurai, Yoriko; Yahaba, Misuzu; Matsuura, Yukiko; Shigeta, Ayako; Kawata, Naoko; Sakao, Seiichiro; Kasahara, Yasunori; Tatsumi, Koichiro] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan; [Tanabe, Nobuhiro; Shigeta, Ayako] Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University	Kasai, H (corresponding author), Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan.	daikasai6075@yahoo.co.jp						BOGREN HG, 1989, AM HEART J, V118, P990, DOI 10.1016/0002-8703(89)90235-4; Botney MD, 1999, AM J RESP CRIT CARE, V159, P361, DOI 10.1164/ajrccm.159.2.9805075; BOUCHARD A, 1985, AM J CARDIOL, V56, P938, DOI 10.1016/0002-9149(85)90408-4; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Fedullo P, 2011, AM J RESP CRIT CARE, V183, P1605, DOI 10.1164/rccm.201011-1854CI; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Gorgulu Sevket, 2003, Anadolu Kardiyol Derg, V3, P92; HARRIS P, 1965, BRIT HEART J, V27, P660; Jardim C, 2007, EUR RESPIR J, V29, P476, DOI 10.1183/09031936.00016806; Jenkins D, 2012, EUR RESPIR REV, V21, P32, DOI 10.1183/09059180.00009211; Kang KW, 2011, CIRC J, V75, P2244, DOI 10.1253/circj.CJ-10-1310; Kim Nick H S, 2006, Proc Am Thorac Soc, V3, P584, DOI 10.1513/pats.200605-106LR; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; PASIERSKI TJ, 1993, CHEST, V103, P1080, DOI 10.1378/chest.103.4.1080; PAZ R, 1993, EUR HEART J, V14, P1524, DOI 10.1093/eurheartj/14.11.1524; REUBEN SR, 1971, CIRC RES, V29, P40, DOI 10.1161/01.RES.29.1.40; Revel MP, 2009, RADIOLOGY, V250, P558, DOI 10.1148/radiol.2502080315; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; SLIFE DM, 1990, AM J PHYSIOL, V258, pH1823, DOI 10.1152/ajpheart.1990.258.6.H1823; Sugiura T, 2013, CHEST, V143, P1070, DOI 10.1378/chest.12-0407; Toshner MR, 2010, J HEART LUNG TRANSPL, V29, P610, DOI 10.1016/j.healun.2009.12.014; Wu DK, 2008, CIRC J, V72, P1454, DOI 10.1253/circj.CJ-08-0223	25	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111563	10.1371/journal.pone.0111563	http://dx.doi.org/10.1371/journal.pone.0111563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365168	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100077
J	Laidlaw, CT; Condon, JM; Belk, MC				Laidlaw, Clinton T.; Condon, Jacob M.; Belk, Mark C.			Viability Costs of Reproduction and Behavioral Compensation in Western Mosquitofish (Gambusia affinis)	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; LIVEBEARING FISH; SWIMMING PERFORMANCE; FEMALE MOSQUITOFISH; FRESH-WATER; GRAVID LIZARDS; SPRINT SPEED; PREDATOR; LOCOMOTOR; PREGNANCY	The cost of reproduction hypothesis suggests that current reproduction has inherent tradeoffs with future reproduction. These tradeoffs can be both in the form of energy allocated to current offspring as opposed to somatic maintenance and future reproduction (allocation costs), or as an increase in mortality as a result of morphological or physiological changes related to reproduction (viability costs). Individuals may be able to decrease viability costs by altering behavior. Female western mosquitofish, Gambusia affinis experience a reduction in swimming ability as a consequence of pregnancy. We test for a viability cost of reproduction, and for behavioral compensation in pregnant female G. affinis by measuring survival of females in early and later stages of pregnancy when exposed to predation. Late-stage pregnant females experience a 70% greater probability of mortality compared to early-stage pregnant females. The presence of a refuge roughly doubled the odds of survival of both early and late-stage pregnant females. However, there was no interaction between refuge availability and stage of pregnancy. These data do not provide evidence for behavioral compensation by female G. affinis for elevated viability costs incurred during later stages of pregnancy. Behavioral compensation may be constrained by other aspects of the cost of reproduction.	[Laidlaw, Clinton T.; Condon, Jacob M.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Laidlaw, CT (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	clintlaidlaw@gmail.com			Department of Biology; Honors Department at Brigham Young University	Department of Biology; Honors Department at Brigham Young University	Funding was provided by The Department of Biology and the Honors Department at Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almbro M, 2012, J INSECT BEHAV, V25, P441, DOI 10.1007/s10905-011-9309-1; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; Belk Mark C., 1995, Bulletin of the Ecological Society of America, V76, P18; Belk MC, 2010, OIKOS, V119, P163, DOI 10.1111/j.1600-0706.2009.17742.x; BELK MC, 1994, COPEIA, P296; BRANA F, 1993, OIKOS, V66, P216, DOI 10.2307/3544807; BRODIE ED, 1989, AM NAT, V134, P225, DOI 10.1086/284977; BROWNPETERSON N, 1990, ENVIRON BIOL FISH, V27, P33, DOI 10.1007/BF00004902; COSTA DP, 1991, AM ZOOL, V31, P111; Courtenay W.R. Jr, 1989, P319; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Cuthill IC, 1997, MANAGING TIME ENERGY, P97; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Downes SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P444, DOI 10.1007/s00265-002-0538-3; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Hassell EMA, 2012, ECOL EVOL, V2, P1738, DOI 10.1002/ece3.278; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HOY JB, 1970, MOSQ NEWS, V30, P222; Husak JF, 2006, OECOLOGIA, V150, P339, DOI 10.1007/s00442-006-0513-1; Johnson JB, 2001, OECOLOGIA, V126, P142, DOI 10.1007/s004420000504; Johnson MA, 2010, ETHOLOGY, V116, P1217, DOI 10.1111/j.1439-0310.2010.01840.x; Koya Y, 1998, ICHTHYOL RES, V45, P241, DOI 10.1007/BF02673922; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Leinonen T, 2011, EVOLUTION, V65, P2916, DOI 10.1111/j.1558-5646.2011.01349.x; Lloyd L.N., 1986, P6; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marsh-Matthews E, 2005, OECOLOGIA, V144, P12, DOI 10.1007/s00442-005-0030-7; Miles DB, 2000, EVOLUTION, V54, P1386; Miller AM, 2009, J ANIM ECOL, V78, P1134, DOI 10.1111/j.1365-2656.2009.01589.x; Noren SR, 2011, J EXP BIOL, V214, P4151, DOI 10.1242/jeb.059121; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Olsson M, 2000, J EVOLUTION BIOL, V13, P263; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Rodewald AD, 1998, J FISH BIOL, V52, P973, DOI 10.1006/jfbi.1998.0646; Roff Derek A., 1992; SCHWARZKOPF L, 1992, BEHAV ECOL SOCIOBIOL, V31, P17, DOI 10.1007/BF00167812; SEIGEL RA, 1987, OECOLOGIA, V73, P481, DOI 10.1007/BF00379404; Shine R, 2003, FUNCT ECOL, V17, P526, DOI 10.1046/j.1365-2435.2003.00756.x; SINERVO B, 1991, J EXP BIOL, V155, P323; Stearns S.C., 1992, pi; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Webb JK, 2004, COPEIA, P357, DOI 10.1643/CH-03-171R1; Weeks SC, 1996, OIKOS, V75, P345, DOI 10.2307/3546263; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson ADM, 2010, ETHOLOGY, V116, P96, DOI 10.1111/j.1439-0310.2009.01719.x	55	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110524	10.1371/journal.pone.0110524	http://dx.doi.org/10.1371/journal.pone.0110524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365426	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100023
J	McCarville, JL; Nisemblat, Y; Galipeau, HJ; Jury, J; Tabakman, R; Cohen, A; Naftali, E; Neiman, B; Halbfinger, E; Murray, JA; Anbazhagan, AN; Dudeja, PK; Varvak, A; Leroux, JC; Verdu, EF				McCarville, Justin L.; Nisemblat, Yotam; Galipeau, Heather J.; Jury, Jennifer; Tabakman, Rinat; Cohen, Ad; Naftali, Esmira; Neiman, Bela; Halbfinger, Efrat; Murray, Joseph A.; Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.; Varvak, Alexander; Leroux, Jean-Christophe; Verdu, Elena F.			BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; CELIAC-DISEASE; LARAZOTIDE ACETATE; VILLOUS EPITHELIUM; IMMUNE-RESPONSE; DOUBLE-BLIND; MICE; SPECTRUM; DIAGNOSIS; COMPLEX	Celiac disease (CD) is an autoimmune disorder in individuals that carry DQ2 or DQ8 MHC class II haplotypes, triggered by the ingestion of gluten. There is no current treatment other than a gluten-free diet (GFD). We have previously shown that the BL-7010 copolymer poly(hydroxyethyl methacrylate-co-styrene sulfonate) (P(HEMA-co-SS)) binds with higher efficiency to gliadin than to other proteins present in the small intestine, ameliorating gliadin-induced pathology in the HLA-HCD4/DQ8 model of gluten sensitivity. The aim of this study was to investigate the efficiency of two batches of BL-7010 to interact with gliadin, essential vitamins and digestive enzymes not previously tested, and to assess the ability of the copolymer to reduce gluten-associated pathology using the NOD-DQ8 mouse model, which exhibits more significant small intestinal damage when challenged with gluten than HCD4/DQ8 mice. In addition, the safety and systemic exposure of BL-7010 was evaluated in vivo (in rats) and in vitro (genetic toxicity studies). In vitro binding data showed that BL-7010 interacted with high affinity with gliadin and that BL-7010 had no interaction with the tested vitamins and digestive enzymes. BL-7010 was effective at preventing gluten-induced decreases in villus-to-crypt ratios, intraepithelial lymphocytosis and alterations in paracellular permeability and putative anion transporter-1 mRNA expression in the small intestine. In rats, BL-7010 was well-tolerated and safe following 14 days of daily repeated administration of 3000 mg/kg. BL-7010 did not exhibit any mutagenic effect in the genetic toxicity studies. Using complementary animal models and chronic gluten exposure the results demonstrate that administration of BL-7010 is effective and safe and that it is able to decrease pathology associated with gliadin sensitization warranting the progression to Phase I trials in humans.	[McCarville, Justin L.; Galipeau, Heather J.; Jury, Jennifer; Verdu, Elena F.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Nisemblat, Yotam; Tabakman, Rinat; Cohen, Ad; Naftali, Esmira; Neiman, Bela; Halbfinger, Efrat] BioLineRx Ltd, Jerusalem, Israel; [Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA; [Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.] Chicago & Jesse Brown VA Med Ctr, Chicago, IL USA; [Varvak, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sci Equipment Ctr, Chromatog Unit, Ramat Gan, Israel; [Leroux, Jean-Christophe] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, Zurich, Switzerland	McMaster University; Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Bar Ilan University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Verdu, EF (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	verdue@mcmaster.ca	Leroux, Jean-Christophe/N-4202-2015	Leroux, Jean-Christophe/0000-0001-5601-1292; McCarville, Justin/0000-0002-3311-5678; Galipeau, Heather/0000-0002-6413-0803	CIHR [MOP-123282]; Canadian Celiac Association; BioLineRx; NIH [DK54016, DK92441]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK081858, R01DK092441] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Celiac Association; BioLineRx; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a CIHR grant to EFV (MOP-123282) and by JA Campbell Young Investigator Awards from the Canadian Celiac Association to HJG and JLM, and a grant by BioLineRx. YN, RT, AC, EN, BN and EH (employees of BioLineRx) were involved in discussions about the dose ratios to be employed in the study and provided feedback to the manuscript's discussion. The funders had no role in data collection and analysis of results performed at McMaster University. EFV holds a Canada Research Chair. Studies in the laboratory of PKD were supported by NIH DK54016, DK92441 and Department of Veterans Affairs.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Barker Jennifer M, 2008, Adv Pediatr, V55, P349, DOI 10.1016/j.yapd.2008.07.001; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Correia JJ, 2008, BIOPHYSICAL TOOLS BI; Perez LC, 2012, EUR J INTERN MED, V23, P9, DOI 10.1016/j.ejim.2011.08.030; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Galipeau HJ, 2011, J IMMUNOL, V187, P4338, DOI 10.4049/jimmunol.1100854; Gopalakrishnan S, 2012, PEPTIDES, V35, P95, DOI 10.1016/j.peptides.2012.02.016; Gopalakrishnan S, 2012, PEPTIDES, V35, P86, DOI 10.1016/j.peptides.2012.02.015; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Leffler DA, 2012, AM J GASTROENTEROL, V107, P1554, DOI 10.1038/ajg.2012.211; Liang L, 2009, BIOPOLYMERS, V91, P169, DOI 10.1002/bip.21109; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Natividad JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006472; Pinier M, 2012, GASTROENTEROLOGY, V142, P316, DOI 10.1053/j.gastro.2011.10.038; Pinier M, 2010, AM J GASTROENTEROL, V105, P2551, DOI 10.1038/ajg.2010.372; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Rubio-Tapia A, 2012, AM J GASTROENTEROLOG; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Simpson JE, 2010, AM J PHYSIOL-GASTR L, V298, pG683, DOI 10.1152/ajpgi.00293.2009; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tye-Din JA, 2010, CLIN IMMUNOL, V134, P289, DOI 10.1016/j.clim.2009.11.001; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Walker NM, 2009, GASTROENTEROLOGY, V136, P893, DOI 10.1053/j.gastro.2008.11.016	36	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109972	10.1371/journal.pone.0109972	http://dx.doi.org/10.1371/journal.pone.0109972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365555	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100013
J	Donnelly, RF; McCrudden, MTC; Alkilani, AZ; Larraneta, E; McAlister, E; Courtenay, AJ; Kearney, MC; Singh, TRR; McCarthy, HO; Kett, VL; Caffarel-Salvador, E; Al-Zahrani, S; Woolfson, AD				Donnelly, Ryan F.; McCrudden, Maeliosa T. C.; Alkilani, Ahlam Zaid; Larraneta, Eneko; McAlister, Emma; Courtenay, Aaron J.; Kearney, Mary-Carmel; Singh, Thakur Raghu Raj; McCarthy, Helen O.; Kett, Victoria L.; Caffarel-Salvador, Ester; Al-Zahrani, Sharifa; Woolfson, A. David			Hydrogel-Forming Microneedles Prepared from "Super Swelling'' Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery	PLOS ONE			English	Article							DISSOLVING MICRONEEDLES; ARRAYS; SKIN; TECHNOLOGIES; INCREASE; SYSTEMS	We describe, for the first time, hydrogel-forming microneedle arrays prepared from "super swelling'' polymeric compositions. We produced a microneedle formulation with enhanced swelling capabilities from aqueous blends containing 20% w/w Gantrez S-97, 7.5% w/w PEG 10,000 and 3% w/w Na2CO3 and utilised a drug reservoir of a lyophilised wafer-like design. These microneedle-lyophilised wafer compositions were robust and effectively penetrated skin, swelling extensively, but being removed intact. In in vitro delivery experiments across excised neonatal porcine skin, approximately 44 mg of the model high dose small molecule drug ibuprofen sodium was delivered in 24 h, equating to 37% of the loading in the lyophilised reservoir. The super swelling microneedles delivered approximately 1.24 mg of the model protein ovalbumin over 24 h, equivalent to a delivery efficiency of approximately 49%. The integrated microneedle-lyophilised wafer delivery system produced a progressive increase in plasma concentrations of ibuprofen sodium in rats over 6 h, with a maximal concentration of approximately 179 mu g/ml achieved in this time. The plasma concentration had fallen to 71 +/- 6.7 mu g/ml by 24 h. Ovalbumin levels peaked in rat plasma after only 1 hour at 42.36 +/- 17.01 ng/ml. Ovalbumin plasma levels then remained almost constant up to 6 h, dropping somewhat at 24 h, when 23.61 +/- 4.84 ng/ml was detected. This work represents a significant advancement on conventional microneedle systems, which are presently only suitable for bolus delivery of very potent drugs and vaccines. Once fully developed, such technology may greatly expand the range of drugs that can be delivered transdermally, to the benefit of patients and industry. Accordingly, we are currently progressing towards clinical evaluations with a range of candidate molecules.	[Donnelly, Ryan F.; McCrudden, Maeliosa T. C.; Alkilani, Ahlam Zaid; Larraneta, Eneko; McAlister, Emma; Courtenay, Aaron J.; Kearney, Mary-Carmel; Singh, Thakur Raghu Raj; McCarthy, Helen O.; Kett, Victoria L.; Caffarel-Salvador, Ester; Al-Zahrani, Sharifa; Woolfson, A. David] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Alkilani, Ahlam Zaid] Zarqa Univ, Sch Pharm, Zarqa, Jordan	Queens University Belfast; Zarqa University	Donnelly, RF (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	r.donnelly@qub.ac.uk	Larrañeta, Eneko/U-9650-2017; Kett, Vicky/V-5222-2019; Zaid Alkilani, Ahlam/J-6214-2019; Kett, Vicky/D-2276-2010; Singh, Raj/HDN-1244-2022	Larrañeta, Eneko/0000-0003-3710-0438; Kett, Vicky/0000-0002-6250-6053; Zaid Alkilani, Ahlam/0000-0002-9646-6328; Kett, Vicky/0000-0002-6250-6053; Courtenay, Aaron/0000-0002-2651-7839; Donnelly, Ryan/0000-0002-0766-4147; Kearney, Mary-Carmel/0000-0002-4752-9943; Caffarel-Salvador, Ester/0000-0002-2844-7598; McCarthy, Helen/0000-0002-1254-3745	Biotechnology and Biological Sciences Research Council grant [BB/FOF/287, BB/E020534/1]; Wellcome Trust [WT094085MA]; BBSRC [BB/E020534/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020534/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Biotechnology and Biological Sciences Research Council grant numbers BB/FOF/287 and BB/E020534/1 (http://www.bbsrc.ac.uk/) and Wellcome Trust grant number WT094085MA (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai SK, 2001, J APPL POLYM SCI, V80, P2782, DOI 10.1002/app.1394; Chandrasekhar S, 2013, EXPERT OPIN DRUG DEL, V10, P1155, DOI 10.1517/17425247.2013.797405; DOLLERY C, 1991, THERAPEUTIC DRUGS; Donnelly RF, 2014, PHOTOCHEM PHOTOBIOL, V90, P641, DOI 10.1111/php.12209; Donnelly RF, 2013, INT J PHARMACEUT, V451, P76, DOI 10.1016/j.ijpharm.2013.04.045; Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864; Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8; FOURTANIER A, 1989, PHOTOCHEM PHOTOBIOL, V50, P771, DOI 10.1111/j.1751-1097.1989.tb02908.x; Gratieri T, 2013, EUR J PHARM SCI, V50, P609, DOI 10.1016/j.ejps.2013.03.019; Hirobe S, 2013, PHARM RES-DORDR, V30, P2664, DOI 10.1007/s11095-013-1092-6; Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401; Ito Y, 2012, INT J PHARMACEUT, V436, P387, DOI 10.1016/j.ijpharm.2012.06.047; Koutsonanos DG, 2013, ADV EXP MED BIOL, V785, P121, DOI 10.1007/978-1-4614-6217-0_13; McCarron PA, 2004, J APPL POLYM SCI, V91, P1576, DOI 10.1002/app.13228; McCrudden MTC, 2014, J CONTROL RELEASE, V180, P71, DOI 10.1016/j.jconrel.2014.02.007; McCrudden MTC, 2015, J PHARM PHARMACOL, V67, P409, DOI 10.1111/jphp.12248; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; Mikolajewska P, 2010, PHARM RES-DORDR, V27, P2213, DOI 10.1007/s11095-010-0227-2; Peniche C, 1997, POLYMER, V38, P5977, DOI 10.1016/S0032-3861(96)01058-0; Peppas N.A., 1987, HYDROGELS MED PHARM, V3, P109; Pierre MBR, 2014, CURR DRUG TARGETS, V15, P281; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; SHEVCHENKO LL, 1963, RUSS CHEM REV, V32, P201, DOI 10.1070/RC1963v032n04ABEH001329; Singh TRR, 2009, EUR POLYM J, V45, P1239, DOI 10.1016/j.eurpolymj.2008.12.019; WOOLFSON AD, 1995, J APPL POLYM SCI, V58, P1291, DOI 10.1002/app.1995.070580810	26	179	185	9	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111547	10.1371/journal.pone.0111547	http://dx.doi.org/10.1371/journal.pone.0111547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360806	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700117
J	Jin, H; Zhang, XR; Li, KP; Niu, YX; Guo, M; Hu, CJ; Wan, X; Gong, YM; Huang, FH				Jin, Hu; Zhang, Xinran; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Hu, Chuanjiong; Wan, Xia; Gong, Yangmin; Huang, Fenghong			Direct Bio-Utilization of Untreated Rapeseed Meal for Effective Iturin A Production by Bacillus subtilis in Submerged Fermentation	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; BIOTECHNOLOGICAL APPLICATIONS; WASTE-WATER; ACID; OIL; BIOCONVERSION; LIPOPEPTIDES; BIOCONTROL; SURFACTIN; SEED	The feasibility of using untreated rapeseed meal as a nitrogen source for iturin A production by Bacillus subtilis 3-10 in submerged fermentation was first evaluated by comparison with two different commercial nitrogen sources of peptone and ammonium nitrate. A significant promoting effect of rapeseed meal on iturin A production was observed and the maximum iturin A concentration of 0.60 g/L was reached at 70 h, which was 20% and 8.0 fold higher than that produced from peptone and ammonium nitrate media, respectively. It was shown that rapeseed meal had a positive induction effect on protease secretion, contributing to the release of soluble protein from low water solubility solid rapeseed meal for an effective supply of available nitrogen during fermentation. Moreover, compared to raw rapeseed meal, the remaining residue following fermentation could be used as a more suitable supplementary protein source for animal feed because of the great decrease of major anti-nutritional components including sinapine, glucosinolate and its degradation products of isothiocyanate and oxazolidine thione. The results obtained from this study demonstrate the potential of direct utilization of low cost rapeseed meal as a nitrogen source for commercial production of iturin A and other secondary metabolites by Bacillus subtilis.	[Jin, Hu; Zhang, Xinran; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Hu, Chuanjiong; Wan, Xia; Gong, Yangmin; Huang, Fenghong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Jin, Hu; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Huang, Fenghong] Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China; [Zhang, Xinran] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Hubei University	Huang, FH (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	jiagongzx@oilcrops.cn	Niu, Yanxing/GLV-2117-2022		National Natural Science Foundation of China [31201461]; National High-tech R&D Program of China (863 Program) [2011AA100904]; National Key Technology Research and Development Program [2012BAD49G00]; Oil Crops Research Institute [1610172014006, 1610172013005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); Oil Crops Research Institute	This work was supported by the National Natural Science Foundation of China (No. 31201461), National High-tech R&D Program of China (863 Program, No. 2011AA100904), National Key Technology Research and Development Program (No. 2012BAD49G00), and Director Fund of Oil Crops Research Institute (Nos. 1610172014006, 1610172013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELQVIST LA, 1967, J SCI FOOD AGR, V18, P510, DOI 10.1002/jsfa.2740181105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai R, 2001, J AM OIL CHEM SOC, V78, P903, DOI 10.1007/s11746-001-0362-4; Chaplin MF, 1990, ENZYME TECHNOLOGY, P40; Chen KQ, 2011, ENZYME MICROB TECH, V48, P339, DOI 10.1016/j.enzmictec.2010.12.009; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Jung J, 2012, BIOTECHNOL BIOENG, V109, P2349, DOI 10.1002/bit.24524; Kachrimanidou V, 2013, WASTE BIOMASS VALORI, V4, P529, DOI 10.1007/s12649-012-9191-x; Kiran EU, 2012, ENZYME MICROB TECH, V50, P337, DOI 10.1016/j.enzmictec.2012.03.004; Koutinas AA, 2007, BIOFUEL BIOPROD BIOR, V1, P24, DOI 10.1002/bbb.6; Lee SC, 2008, BIORESOURCE TECHNOL, V99, P2288, DOI 10.1016/j.biortech.2007.05.020; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Makkar RS, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-5; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Mizumoto S, 2007, APPL MICROBIOL BIOT, V75, P1267, DOI 10.1007/s00253-007-0973-1; Mizumoto S, 2006, APPL MICROBIOL BIOT, V72, P869, DOI 10.1007/s00253-006-0389-3; Mizumoto S, 2007, APPL MICROBIOL BIOT, V76, P101, DOI 10.1007/s00253-007-0994-9; Nitschke M, 2006, BIORESOURCE TECHNOL, V97, P336, DOI 10.1016/j.biortech.2005.02.044; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Ramachandran S, 2007, BIORESOURCE TECHNOL, V98, P2000, DOI 10.1016/j.biortech.2006.08.002; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Thakore Y., 2006, Industrial biotechnology, V2, P194, DOI 10.1089/ind.2006.2.194; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Wang QJ, 2008, BIORESOURCE TECHNOL, V99, P3318, DOI 10.1016/j.biortech.2007.05.052; Wang RH, 2010, ENZYME MICROB TECH, V47, P77, DOI 10.1016/j.enzmictec.2010.05.005; WATHELET JP, 1988, FRESEN Z ANAL CHEM, V332, P689, DOI 10.1007/BF00472670; Whang LM, 2009, J HAZARD MATER, V164, P1045, DOI 10.1016/j.jhazmat.2008.09.006	30	15	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111171	10.1371/journal.pone.0111171	http://dx.doi.org/10.1371/journal.pone.0111171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360892	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700068
J	Xiao, Y; Xiang, TX; Luo, XR; Li, CH; Li, QQ; Peng, WY; Li, LL; Li, SM; Wang, ZY; Tang, LP; Ren, GS; Tao, Q				Xiao, Yun; Xiang, Tingxiu; Luo, Xinrong; Li, Chunhong; Li, Qianqian; Peng, Weiyan; Li, Lili; Li, Shuman; Wang, Zhenyu; Tang, Liping; Ren, Guosheng; Tao, Qian			Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer	PLOS ONE			English	Article							GROWTH; TRANSCRIPTION; IDENTIFICATION; DISEASE	Kruppel-associated box-containing zinc finger proteins (KRAP-ZFPs) are well recognized as key regulators of transcription, which play a crucial role in the regulation of cell proliferation, differentiation, apoptosis and tumorigenesis. We previously identified a KRAP-ZFP protein ZNF545 acting as a tumor suppressor involved in tumor pathogenesis. However, its expression and biological function in breast cancer remain elusive. In this study, we found that ZNF545 was frequently downregulated in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and human epidermal growth factor receptor 2-negative (HER2-) breast tumor tissues compared with paired adjacent non-tumor tissues. We further examined its expression and methylation in breast cancer cell lines by semi-quantitative RT-PCR and methylation-specific PCR. We found that ZNF545 was silenced by promoter methylation in MCF7 cell line, and its expression could be restored by demethylation, concomitant with increased unmethylated alleles. ZNF545 methylation was detected in 29% of breast tumor tissues, but not in normal breast tissues, suggesting tumor-specific methylation of ZNF545 in breast cancer. Ectopic expression of ZNF545 in MCF7 cells inhibited cell proliferation through inducing cell cycle G0/G1 arrest and apoptosis, thus as a tumor suppressor. Moreover, ZNF545 upregulated mRNA and protein levels of c-Jun/AP1, BAX, p53 and Caspase 3. Taken together, these results demonstrate that ZNF545 inhibits breast tumor cell proliferation through inducing apoptosis and is disrupted by promoter methylation in breast cancer.	[Xiao, Yun; Xiang, Tingxiu; Luo, Xinrong; Li, Chunhong; Li, Qianqian; Peng, Weiyan; Li, Shuman; Wang, Zhenyu; Tang, Liping; Ren, Guosheng; Tao, Qian] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Xiao, Yun; Ren, Guosheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Canc Epigenet Lab, Dept Clin Oncol, State Key Lab Oncol South China,Sir YK Pao Ctr Ca, Hong Kong, Hong Kong, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong	Ren, GS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China.	rgs726@163.com; qtao@cuhk.edu.hk	Tao, Qian/T-4743-2018; Li, Lili/Q-5750-2018	Tao, Qian/0000-0001-5383-4808; Li, Lili/0000-0002-0292-5889	National Natural Science Foundation [81372898, 81172582, 31171243, 81000907]; Chinese University of Hong Kong	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by grants from National Natural Science Foundation (#81372898, #81172582, #31171243, #81000907) and The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Y, 2012, MOL CANC RES; Cheng YD, 2012, MOL CANCER RES, V10, P925, DOI 10.1158/1541-7786.MCR-11-0594; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang XQ, 2006, BIOCHEM BIOPH RES CO, V346, P621, DOI 10.1016/j.bbrc.2006.05.109; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Imoto I, 2003, CANCER RES, V63, P5691; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Nonet GH, 2001, CANCER RES, V61, P1250; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Rousseau-Merck MF, 2002, CYTOGENET GENOME RES, V98, P147, DOI 10.1159/000069802; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Urrutia R, 2003, GENOME BIOL; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang Y, 2009, CANCER RES, V69, P5194, DOI 10.1158/0008-5472.CAN-08-3694; Xiang T, 2013, J CELL MOL MED; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yin XD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3399; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108	31	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110990	10.1371/journal.pone.0110990	http://dx.doi.org/10.1371/journal.pone.0110990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360542	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700056
J	August, TA; Nunn, MA; Fensome, AG; Linton, DM; Mathews, F				August, Tom A.; Nunn, Miles A.; Fensome, Amy G.; Linton, Danielle M.; Mathews, Fiona			Sympatric Woodland Myotis Bats Form Tight-Knit Social Groups with Exclusive Roost Home Ranges	PLOS ONE			English	Article							ASSOCIATION PATTERNS; PIPISTRELLE BATS; NETWORKS; FEMALE; DAUBENTONII; SELECTION; RESERVOIR; FISSION; FUSION; RATES	Background: The structuring of wild animal populations can influence population dynamics, disease spread, and information transfer. Social network analysis potentially offers insights into these processes but is rarely, if ever, used to investigate more than one species in a community. We therefore compared the social, temporal and spatial networks of sympatric Myotis bats (M. nattereri (Natterer's bats) and M. daubentonii (Daubenton's bats)), and asked: (1) are there long-lasting social associations within species? (2) do the ranges occupied by roosting social groups overlap within or between species? (3) are M. daubentonii bachelor colonies excluded from roosting in areas used by maternity groups? Results: Using data on 490 ringed M. nattereri and 978 M. daubentonii from 379 colonies, we found that both species formed stable social groups encompassing multiple colonies. M. nattereri formed 11 mixed-sex social groups with few (4.3%) inter-group associations. Approximately half of all M. nattereri were associated with the same individuals when recaptured, with many associations being long-term (. 100 days). In contrast, M. daubentonii were sexually segregated; only a quarter of pairs were associated at recapture after a few days, and inter-sex associations were not long-lasting. Social groups of M. nattereri and female M. daubentonii had small roost home ranges (mean 0.2 km(2) in each case). Intra-specific overlap was low, but inter-specific overlap was high, suggesting territoriality within but not between species. M. daubentonii bachelor colonies did not appear to be excluded from roosting areas used by females. Conclusions: Our data suggest marked species-and sex-specific patterns of disease and information transmission are likely between bats of the same genus despite sharing a common habitat. The clear partitioning of the woodland amongst social groups, and their apparent reliance on small patches of habitat for roosting, means that localised woodland management may be more important to bat conservation than previously recognised.	[August, Tom A.; Nunn, Miles A.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [August, Tom A.; Mathews, Fiona] Univ Exeter, Exeter, Devon, England; [Fensome, Amy G.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Linton, Danielle M.] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England	UK Centre for Ecology & Hydrology (UKCEH); University of Exeter; University of Exeter; University of Oxford	Mathews, F (corresponding author), Univ Exeter, Exeter, Devon, England.	F.Mathews@exeter.ac.uk	August, Tom/F-9047-2019	August, Tom/0000-0003-1116-3385	Natural Environment Research Council [NE/G523571]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by the Natural Environment Research Council Grant no NE/G523571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 1996, BATS BIOL BEHAV; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Dietz M, 2006, ACTA CHIROPTEROL, V8, P403, DOI 10.3161/1733-5329(2006)8[403:SSDPOF]2.0.CO;2; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Encarnacao JA, 2005, MAMMAL REV, V35, P285, DOI 10.1111/j.1365-2907.2005.00066.x; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Garroway CJ, 2007, CAN J ZOOL, V85, P956, DOI 10.1139/Z07-079; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Kelly A, 2008, ANIM WELFARE, V17, P375; Kerth G, 1999, BEHAVIOUR, V136, P1187, DOI 10.1163/156853999501711; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Miller MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000624; Mitchell-Jones A.J., 2004, BAT WORKERS MANUAL, V3rd; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Donnell CFJ, 2000, ANIM CONSERV, V3, P287, DOI 10.1017/S1367943000001013; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; R Core Development Team, 2011, R LANG ENV STAT COMP; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Russo D, 2002, MAMMALIA, V66, P543, DOI 10.1515/mamm.2002.66.4.543; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Shi ZL, 2013, SCI CHINA LIFE SCI, V56, P678, DOI 10.1007/s11427-013-4517-x; Swift SM, 1997, J ZOOL, V242, P375; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	42	18	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e112225	10.1371/journal.pone.0112225	http://dx.doi.org/10.1371/journal.pone.0112225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356770	Green Accepted, gold, Green Published			2022-12-26	WOS:000346765000082
J	Cai, GQ; Yang, QY; Yi, B; Fan, CC; Edwards, D; Batley, J; Zhou, YM				Cai, Guangqin; Yang, Qingyong; Yi, Bin; Fan, Chuchuan; Edwards, David; Batley, Jacqueline; Zhou, Yongming			A Complex Recombination Pattern in the Genome of Allotetraploid Brassica napus as Revealed by a High-Density Genetic Map	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RAPHANUS-SATIVUS; OLERACEA GENOME; CANDIDATE GENES; FLOWERING TIME; OILSEED RAPE; SNP MARKERS; LINKAGE MAP; EVOLUTION; IDENTIFICATION	Polyploidy plays a crucial role in plant evolution. Brassica napus (2n = 38, AACC), the most important oil crop in the Brassica genus, is an allotetraploid that originated through natural doubling of chromosomes after the hybridization of its progenitor species, B. rapa (2n = 20, AA) and B. oleracea (2n = 18, CC). A better understanding of the evolutionary relationship between B. napus and B. rapa, B. oleracea, as well as Arabidopsis, which has a common ancestor with these three species, will provide valuable information about the generation and evolution of allopolyploidy. Based on a high-density genetic map with single nucleotide polymorphism (SNP) and simple sequence repeat (SSR) markers, we performed a comparative genomic analysis of B. napus with Arabidopsis and its progenitor species B. rapa and B. oleracea. Based on the collinear relationship of B. rapa and B. oleracea in the B. napus genetic map, the B. napus genome was found to consist of 70.1% of the skeleton components of the chromosomes of B. rapa and B. oleracea, with 17.7% of sequences derived from reciprocal translocation between homoeologous chromosomes between the A-and C-genome and 3.6% of sequences derived from reciprocal translocation between non-homologous chromosomes at both intra-and inter-genomic levels. The current study thus provides insights into the formation and evolution of the allotetraploid B. napus genome, which will allow for more accurate transfer of genomic information from B. rapa, B. oleracea and Arabidopsis to B. napus.	[Cai, Guangqin; Yang, Qingyong; Yi, Bin; Fan, Chuchuan; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Cai, Guangqin; Zhou, Yongming] Huazhong Agr Univ, Key Lab Rapeseed Genet & Breeding Agr, Minist China, Wuhan, Peoples R China; [Edwards, David; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia	Huazhong Agricultural University; Huazhong Agricultural University; University of Queensland	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ymzhou@mail.hzau.edu.cn	Batley, Jacqueline/A-5723-2008; Edwards, David/H-3710-2015	Batley, Jacqueline/0000-0002-5391-5824; Edwards, David/0000-0001-7599-6760; Yang, Qing-Yong/0000-0002-3510-8906; Fan, Chuchuan/0000-0001-8443-7194	Ministry of Agriculture of China [nycytx-00503]; Ministry of Agriculture of China (948 project) [2011-G23]; National Natural Science Foundation of China [31371659, 31171188]; Huazhong Agricultural University [STSIF 2010YB05]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Agriculture of China (948 project)(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University	The work is financially supported by funding from the Ministry of Agriculture of China (nycytx-00503 and 948 project (2011-G23)), National Natural Science Foundation of China (31371659, 31171188), and Huazhong Agricultural University (STSIF 2010YB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Chen X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-346; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ge XH, 2009, ANN BOT-LONDON, V104, P19, DOI 10.1093/aob/mcp099; Gomez-Campo C, 1999, DEV PL GEN, V4, P3; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Jiang CC, 2011, THEOR APPL GENET, V123, P927, DOI 10.1007/s00122-011-1637-1; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaczmarek M, 2009, GENOME, V52, P620, DOI 10.1139/G09-035; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KOWALSKI SP, 1994, GENETICS, V138, P499; Lagercrantz U, 1998, GENETICS, V150, P1217; Lan TH, 2000, GENOME RES, V10, P776, DOI 10.1101/gr.10.6.776; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Li F, 2011, DNA RES, V18, P401, DOI 10.1093/dnares/dsr027; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Lincoln S, 1993, CONSTRUCTING GENETIC; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Liu XP, 2005, PLANT BREEDING, V124, P9, DOI 10.1111/j.1439-0523.2004.01051.x; Liu Z, 2012, THEOR APPL GENET, V125, P773, DOI 10.1007/s00122-012-1870-2; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lu W, 2013, ANN BOT-LONDON, V111, P305, DOI 10.1093/aob/mcs260; Lukens L, 2003, GENETICS, V164, P359; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; PALMER JD, 1983, THEOR APPL GENET, V65, P181, DOI 10.1007/BF00308062; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Ryder CD, 2001, GENOME, V44, P808, DOI 10.1139/gen-44-5-808; Sarilar V, 2013, NEW PHYTOL, V198, P593, DOI 10.1111/nph.12156; Schmidt R, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054559; Shirasawa K, 2011, DNA RES, V18, P221, DOI 10.1093/dnares/dsr013; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; U. N., 1935, Japanese Journal of Botany, V7, P389; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067740; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	66	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109910	10.1371/journal.pone.0109910	http://dx.doi.org/10.1371/journal.pone.0109910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356735	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000009
J	Titti, F; Maggiorella, MT; Ferrantelli, F; Sernicola, L; Bellino, S; Collacchi, B; Belasio, EF; Moretti, S; Cossut, MRP; Belli, R; Olivieri, E; Farcomeni, S; Compagnoni, D; Michelini, Z; Sabbatucci, M; Sparnacci, K; Tondelli, L; Laus, M; Cafaro, A; Caputo, A; Ensoli, B				Titti, Fausto; Maggiorella, Maria T.; Ferrantelli, Flavia; Sernicola, Leonardo; Bellino, Stefania; Collacchi, Barbara; Belasio, Emanuele Fanales; Moretti, Sonia; Cossut, Maria Rosaria Pavone; Belli, Roberto; Olivieri, Erika; Farcomeni, Stefania; Compagnoni, Daniela; Michelini, Zuleika; Sabbatucci, Michela; Sparnacci, Katia; Tondelli, Luisa; Laus, Michele; Cafaro, Aurelio; Caputo, Antonella; Ensoli, Barbara			Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1 TAT; CYNOMOLGUS MONKEYS; RHESUS MACAQUES; PROTECTIVE EFFICACY; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; TYPE-1 TAT; RECOMBINANT GLYCOPROTEIN; DISEASE PROGRESSION	Here we describe a prime-boost regimen of vaccination in Macaca fascicularis that combines priming with novel anionic microspheres designed to deliver the biologically active HIV-1 Tat protein and boosting with Tat in Alum. This regimen of immunization modulated the IgG subclass profile and elicited a balanced Th1-Th2 type of humoral and cellular responses. Remarkably, following intravenous challenge with SHIV89.6P(cy243), vaccinees significantly blunted acute viremia, as compared to control monkeys, and this control was associated with significantly lower CD4(+) T cell depletion rate during the acute phase of infection and higher ability to resume the CD4(+) T cell counts in the post-acute and chronic phases of infection. The long lasting control of viremia was associated with the persistence of high titers anti-Tat antibodies whose profile clearly distinguished vaccinees in controllers and viremics. Controllers, as opposed to vaccinated and viremic cynos, exhibited significantly higher pre-challenge antibody responses to peptides spanning the glutamine-rich and the RGD-integrin-binding regions of Tat. Finally, among vaccinees, titers of anti-Tat IgG1, IgG3 and IgG4 subclasses had a significant association with control of viremia in the acute and post-acute phases of infection. Altogether these findings indicate that the Tat/H1D/Alum regimen of immunization holds promise for next generation vaccines with Tat protein or other proteins for which maintenance of the native conformation and activity are critical for optimal immunogenicity. Our results also provide novel information on the role of anti-Tat responses in the prevention of HIV pathogenesis and for the design of new vaccine candidates.	[Titti, Fausto; Maggiorella, Maria T.; Ferrantelli, Flavia; Sernicola, Leonardo; Bellino, Stefania; Collacchi, Barbara; Belasio, Emanuele Fanales; Moretti, Sonia; Cossut, Maria Rosaria Pavone; Belli, Roberto; Olivieri, Erika; Farcomeni, Stefania; Compagnoni, Daniela; Michelini, Zuleika; Sabbatucci, Michela; Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Sparnacci, Katia; Laus, Michele] Univ East Piemonte, Dept Environm & Live Sci, Alessandria, Italy; [Tondelli, Luisa] CNR, ISOF, I-40126 Bologna, Italy; [Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy	Istituto Superiore di Sanita (ISS); University of Eastern Piedmont Amedeo Avogadro; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); University of Padua	Ensoli, B (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	barbara.ensoli@iss.it	farcomeni, stefania/K-4640-2016; Caputo, Antonella/ABE-7851-2020; BELASIO, EMANUELE FANALES/C-7718-2016; Michelini, Zuleika/J-9003-2016; COLLACCHI, BARBARA/AAC-4491-2022; michelini, zuleika/Q-4383-2019; Moretti, Sonia/K-5687-2016; Ferrantelli, Flavia/J-7794-2016; Cafaro, Aurelio/K-5314-2016; maggiorella, maria teresa/K-4072-2016; Sparnacci, Katia/Z-1744-2019; tondelli, luisa/C-1414-2012; Ensoli, Barbara/J-9169-2016; Sparnacci, Katia/C-1138-2009; Sabbatucci, Michela/M-9642-2017	farcomeni, stefania/0000-0001-5058-476X; Caputo, Antonella/0000-0002-1241-0299; BELASIO, EMANUELE FANALES/0000-0003-2369-9996; Michelini, Zuleika/0000-0001-6841-7396; COLLACCHI, BARBARA/0000-0001-6330-6283; michelini, zuleika/0000-0001-6841-7396; Moretti, Sonia/0000-0003-4812-1496; Ferrantelli, Flavia/0000-0002-0768-1078; maggiorella, maria teresa/0000-0001-5058-476X; Sparnacci, Katia/0000-0003-2102-9649; tondelli, luisa/0000-0002-3971-3361; Ensoli, Barbara/0000-0002-0545-8737; Sparnacci, Katia/0000-0003-2102-9649; Sabbatucci, Michela/0000-0001-5889-1780; Cafaro, Aurelio/0000-0001-9675-6344; Bellino, Stefania/0000-0003-1149-3835; Laus, Michele/0000-0002-4296-3732	Italian National AIDS Programme [3H/23]; Italy/USA Scientific Cooperation Agreement from Concerted Action on HIV-AIDS Vaccine Development (ICAV) [11US/37]; European Vaccines and Microbicides Enterprise(EUROPRISE) [037611]	Italian National AIDS Programme; Italy/USA Scientific Cooperation Agreement from Concerted Action on HIV-AIDS Vaccine Development (ICAV); European Vaccines and Microbicides Enterprise(EUROPRISE)	This work was supported in part by grants from the from The Italian National AIDS Programme 3H/23, from Italy/USA Scientific Cooperation Agreement 11US/37, from Concerted Action on HIV-AIDS Vaccine Development (ICAV) and part from European Vaccines and Microbicides Enterprise(EUROPRISE) Contract no.: 037611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaoui-Attarki K, 1998, VACCINE, V16, P685, DOI 10.1016/S0264-410X(97)00261-2; Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006; Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Banerjee K, 2010, AIDS RES HUM RETROV, V26, P445, DOI 10.1089/aid.2009.0223; Barillari G, 1999, BLOOD, V94, P663; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Belliard G, 2005, VACCINE, V23, P1399, DOI 10.1016/j.vaccine.2004.08.037; Bellino S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-49; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Borsetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093235; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2001, VACCINE, V19, P2862, DOI 10.1016/S0264-410X(01)00002-0; Cafaro A, 2010, J VIROL, V84, P8953, DOI 10.1128/JVI.00377-10; Caputo A, 2004, VACCINE, V22, P2910, DOI 10.1016/j.vaccine.2003.12.025; Caputo A, 2009, VACCINE, V27, P3605, DOI 10.1016/j.vaccine.2009.03.047; Caputo Antonella, 2008, Current Drug Delivery, V5, P230, DOI 10.2174/156720108785914961; Cavacini LA, 2003, AIDS RES HUM RETROV, V19, P785, DOI 10.1089/088922203769232584; CAVACINI LA, 1995, J IMMUNOL, V155, P3638; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059194; Chesko J, 2005, J PHARM SCI-US, V94, P2510, DOI 10.1002/jps.20472; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Demberg T, 2013, VIROLOGY, V440, P210, DOI 10.1016/j.virol.2013.02.024; Demirhan I, 2000, J HUMAN VIROL, V3, P137; Devadas K, 2007, PEPTIDES, V28, P496, DOI 10.1016/j.peptides.2006.11.007; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Goletti D, 2006, MED SCI MONITOR, V12, pBR330; Gorse GJ, 1999, AIDS RES HUM RETROV, V15, P115, DOI 10.1089/088922299311547; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Himeno A, 2010, VACCINE, V28, P5377, DOI 10.1016/j.vaccine.2010.04.110; Kashi VP, 2009, VACCINE, V27, P6739, DOI 10.1016/j.vaccine.2009.08.078; Lamalle-Bernard D, 2006, J CONTROL RELEASE, V115, P57, DOI 10.1016/j.jconrel.2006.07.006; Laus M, 2001, J BIOMAT SCI-POLYM E, V12, P209, DOI 10.1163/156856201750180933; Lefeber DJ, 2003, INFECT IMMUN, V71, P6915, DOI 10.1128/IAI.71.12.6915-6920.2003; Li JCB, 2010, AIDS, V24, P1609, DOI 10.1097/QAD.0b013e32833ac6a0; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Manocha M, 2005, VACCINE, V23, P5599, DOI 10.1016/j.vaccine.2005.06.031; Manoussaka MS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-59; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Monini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048781; Moreau E, 2004, J GEN VIROL, V85, P2893, DOI 10.1099/vir.0.80365-0; Nayak B, 2009, J MICROENCAPSUL, V26, P154, DOI [10.1080/02652040802211709, 10.1080/02652040802211709 ]; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; Negri DRM, 2001, J MED PRIMATOL, V30, P197, DOI 10.1034/j.1600-0684.2001.d01-53.x; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Otten GR, 2005, J VIROL, V79, P8189, DOI 10.1128/JVI.79.13.8189-8200.2005; Partidos CD, 2005, EUR J IMMUNOL, V35, P1521, DOI 10.1002/eji.200425676; Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; REISS P, 1990, J MED VIROL, V30, P163, DOI 10.1002/jmv.1890300303; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Rodriguez SK, 2006, J INFECT DIS, V194, P760, DOI 10.1086/507042; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Sernicola L, 1999, VIROLOGY, V256, P291, DOI 10.1006/viro.1999.9652; Singh M, 2004, PHARM RES, V21, P2148, DOI 10.1007/s11095-004-7666-6; Singh Manmohan, 2006, Current Drug Delivery, V3, P115, DOI 10.2174/156720106775197565; Sparnacci K, 2005, J BIOMAT SCI-POLYM E, V16, P1557, DOI 10.1163/156856205774576673; Tamber H, 2005, ADV DRUG DELIVER REV, V57, P357, DOI 10.1016/j.addr.2004.09.002; Titti F, 2007, EXPERT OPIN EMERG DR, V12, P23, DOI 10.1517/14728214.12.1.23; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Turbant S, 2009, VACCINE, V27, P5349, DOI 10.1016/j.vaccine.2009.06.083; TURNER GS, 1978, J GEN VIROL, V40, P595, DOI 10.1099/0022-1317-40-3-595; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Voltan R, 2007, PHARM RES-DORDR, V24, P1870, DOI 10.1007/s11095-007-9310-8; Voltan R, 2009, VACCINE, V27, P4498, DOI 10.1016/j.vaccine.2009.05.031; Walter E, 1999, J CONTROL RELEASE, V61, P361, DOI 10.1016/S0168-3659(99)00151-0; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Zagury J F, 1998, J Hum Virol, V1, P282	87	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111360	10.1371/journal.pone.0111360	http://dx.doi.org/10.1371/journal.pone.0111360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356594	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000054
J	Xu, L; Lin, ZY; Tao, Q; Liang, MX; Zhao, GM; Yin, XZ; Fu, RX				Xu, Li; Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin			Multiple NUCLEAR FACTOR Y Transcription Factors Respond to Abiotic Stress in Brassica napus L.	PLOS ONE			English	Article							NF-Y; EXPRESSION ANALYSIS; GENE-EXPRESSION; HIGH-SALINITY; ARABIDOPSIS; DROUGHT; IDENTIFICATION; SUBUNITS; COMPLEX; FAMILY	Members of the plant NUCLEAR FACTOR Y (NF-Y) family are composed of the NF-YA, NF-YB, and NF-YC subunits. In Brassica napus (canola), each of these subunits forms a multimember subfamily. Plant NF-Ys were reported to be involved in several abiotic stresses. In this study, we demonstrated that multiple members of thirty three BnNF-Ys responded rapidly to salinity, drought, or ABA treatments. Transcripts of five BnNF-YAs, seven BnNF-YBs, and two BnNF-YCs were up-regulated by salinity stress, whereas the expression of thirteen BnNF-YAs, ten BnNF-YBs, and four BnNF-YCs were induced by drought stress. Under NaCl treatments, the expression of one BnNF-YA10 and four NF-YBs (BnNF-YB3, BnNF-YB7, BnNF-YB10, and BnNF-YB14) were greatly increased. Under PEG treatments, the expression levels of four NF-YAs (BnNF-YA9, BnNF-YA10, BnNF-YA11, and BnNF-YA12) and five NF-YBs (BnNF-YB1, BnNF-YB8, BnNF-YB10, BnNF-YB13, and BnNF-YB14) were greatly induced. The expression profiles of 20 of the 27 salinity-or drought-induced BnNF-Ys were also affected by ABA treatment. The expression levels of six NF-YAs (BnNF-YA1, BnNF-YA7, BnNF-YA8, BnNF-YA9, BnNF-YA10, and BnNF-YA12) and seven BnNF-YB members (BnNF-YB2, BnNF-YB3, BnNF-YB7, BnNF-YB10, BnNF-YB11, BnNF-YB13, and BnNF-YB14) and two NF-YC members (BnNF-YC2 and BnNF-YC3) were greatly up-regulated by ABA treatments. Only a few BnNF-Ys were inhibited by the above three treatments. Several NF-Y subfamily members exhibited collinear expression patterns. The promoters of all stress-responsive BnNF-Ys harbored at least two types of stress-related cis-elements, such as ABRE, DRE, MYB, or MYC. The cis-element organization of BnNF-Ys was similar to that of Arabidopsis thaliana, and the promoter regions exhibited higher levels of nucleotide sequence identity with Brassica rapa than with Brassica oleracea. This work represents an entry point for investigating the roles of canola NF-Y proteins during abiotic stress responses and provides insight into the genetic evolution of Brassica NF-Ys.	[Xu, Li; Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin] Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liang, MX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	liangmx@njau.edu.cn		Liang, Mingxiang/0000-0002-8530-9714	Natural Science Foundation of Jiangsu province [BK2011635]; Doctoral Program of Higher Education of China [20120097120015]; Fundamental Research Funds for the Central Universities [KYZ201206]; Scientific Research Foundation of the State Human Resource Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program) [809001]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation of the State Human Resource Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program)	This research was supported by grants from the Natural Science Foundation of Jiangsu province (BK2011635), the Doctoral Program of Higher Education of China (20120097120015), Fundamental Research Funds for the Central Universities (KYZ201206), the Scientific Research Foundation of the State Human Resource Ministry, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program (809001)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; [Anonymous], 2013, P IEEE INT C WIR COM, DOI DOI 10.1109/WCSP.2013.6677288; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, INT J MOL SCI, V13, P3458, DOI 10.3390/ijms13033458; Han X, 2013, J EXP BOT; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jules J, 2009, PLANT BREEDING REV; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li Li, 2013, 2013 IEEE Proceedings of 14th International Vacuum Electronics Conference (IVEC2013), P1; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Liang M, 2012, PLANTA, P1; Liang MX, 2014, PLANTA, V239, P107, DOI 10.1007/s00425-013-1964-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; SONG K, 1992, GENOME, V35, P992, DOI 10.1139/g92-152; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; U. N., 1935, Japanese Journal of Botany, V7, P389; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan DH, 2013, PLANT MOL BIOL REP, P1; Zhang XG, 2011, PLANT MOL BIOL REP, V29, P481, DOI 10.1007/s11105-010-0251-8; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	46	30	34	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111354	10.1371/journal.pone.0111354	http://dx.doi.org/10.1371/journal.pone.0111354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356551	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000053
J	de Carvalho, MA; Freitas, FGR; Silva, HT; Bafi, AT; Machado, FR; Pestana, JOM				de Carvalho, Monica Andrade; Rezende Freitas, Flavio Geraldo; Silva Junior, Helio Tedesco; Bafi, Antonio Toneti; Machado, Flavia Ribeiro; Medina Pestana, Jose Osmar			Mortality Predictors in Renal Transplant Recipients with Severe Sepsis and Septic Shock	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE KIDNEY INJURY; INFECTIOUS COMPLICATIONS; ILL PATIENTS; SOFA SCORE; EPIDEMIOLOGY; OUTCOMES; GENDER; DEFINITIONS; SURVIVAL	Introduction: The growing number of renal transplant recipients in a sustained immunosuppressive state is a factor that can contribute to increased incidence of sepsis. However, relatively little is known about sepsis in this population. The aim of this single-center study was to evaluate the factors associated with hospital mortality in renal transplant patients admitted to the intensive care unit (ICU) with severe sepsis and septic shock. Methods: Patient demographics and transplant-related and ICU stay data were retrospectively collected. Multiple logistic regression was conducted to identify the independent risk factors associated with hospital mortality. Results: A total of 190 patients were enrolled, 64.2% of whom received kidneys from deceased donors. The mean patient age was 51 +/- 13 years (males, 115 [60.5%]), and the median APACHE II was 20 (16-23). The majority of patients developed sepsis late after the renal transplantation (2.1 [0.6-2.3] years). The lung was the most common infection site (59.5%). Upon ICU admission, 16.4% of the patients had <= 1 systemic inflammatory response syndrome criteria. Among the patients, 61.5% presented with >= 2 organ failures at admission, and 27.9% experienced septic shock within the first 24 hours of ICU admission. The overall hospital mortality rate was 38.4%. In the multivariate analysis, the independent determinants of hospital mortality were male gender (OR = 5.9; 95% CI, 1.7-19.6; p = 0.004), delta SOFA 24 h (OR = 1.7; 95% CI, 1.2-2.3; p = 0.001), mechanical ventilation (OR = 30; 95% CI, 8.8-102.2; p<0.0001), hematologic dysfunction (OR = 6.8; 95% CI, 2.0-22.6; p = 0.002), admission from the ward (OR = 3.4; 95% CI, 1.2-9.7; p = 0.02) and acute kidney injury stage 3 (OR = 5.7; 95% CI, 1.9-16.6; p = 0.002). Conclusions: Hospital mortality in renal transplant patients with severe sepsis and septic shock was associated with male gender, admission from the wards, worse SOFA scores on the first day and the presence of hematologic dysfunction, mechanical ventilation or advanced graft dysfunction.	[de Carvalho, Monica Andrade; Rezende Freitas, Flavio Geraldo; Silva Junior, Helio Tedesco; Bafi, Antonio Toneti; Medina Pestana, Jose Osmar] Univ Fed Sao Paulo, Unidade Transplante, Disciplina Nefrol, Sao Paulo, Brazil; [Rezende Freitas, Flavio Geraldo; Bafi, Antonio Toneti; Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Disciplina Anestesiol Dor & Terapia Intens, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Carvalho, MA (corresponding author), Univ Fed Sao Paulo, Unidade Transplante, Disciplina Nefrol, Sao Paulo, Brazil.	mactulha@hotmail.com	Bafi, Antonio/H-2015-2012	Bafi, Antonio/0000-0003-2283-9109	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Hospital do Rim	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital do Rim	The project was supported by funding from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) programme and Hospital do Rim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2006, AM J KIDNEY DIS, V47, pS65, DOI 10.1053/j.ajkd.2005.12.043; Adrie C, 2007, CHEST, V132, P1786, DOI 10.1378/chest.07-0420; Ak O, 2013, TRANSPL P, V45, P944, DOI 10.1016/j.transproceed.2013.02.080; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Aldawood A, 2007, SAUDI J KIDNEY DIS T, V18, P536; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; [Anonymous], CRIT CARE MED; Arulkumaran N, 2012, CLIN TRANSPLANT, V26, pE24, DOI 10.1111/j.1399-0012.2011.01520.x; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Candan S, 2006, TRANSPL P, V38, P1354, DOI 10.1016/j.transproceed.2006.02.083; Canet E, 2011, CRIT CARE, V15, DOI 10.1186/cc10091; Davis CL, 2004, AM J KIDNEY DIS, V43, P508, DOI 10.1053/j.ajkd.2003.10.044; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Gallon LG, 2002, SEMIN NEPHROL, V22, P515, DOI 10.1053/snep.2002.35966; Glyda Maciej, 2011, Pol Przegl Chir, V83, P188, DOI 10.2478/v10035-011-0029-1; Ingsathit A, 2010, TRANSPL P, V42, P4014, DOI 10.1016/j.transproceed.2010.09.061; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Klouche K, 2009, TRANSPLANTATION, V87, P889, DOI 10.1097/TP.0b013e31819a688a; KNAUS WA, 1992, CHEST, V101, P1656, DOI 10.1378/chest.101.6.1656; Knoll G, 2008, DRUGS, V68, P3, DOI 10.2165/00003495-200868001-00002; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Lopes JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11911; Medina-Pestana Jose O, 2010, Clin Transpl, P107; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Mouloudi E, 2012, TRANSPL P, V44, P2718, DOI 10.1016/j.transproceed.2012.09.097; Mouloudi E, 2012, TRANSPL P, V44, P2721, DOI 10.1016/j.transproceed.2012.09.023; Nakamura M, 2012, CLIN TRANSPLANT, V26, P520, DOI 10.1111/j.1399-0012.2011.01546.x; Noritomi DT, 2014, INTENS CARE MED, V40, P182, DOI 10.1007/s00134-013-3131-5; Pelletier SJ, 2000, CLIN TRANSPLANT, V14, P401, DOI 10.1034/j.1399-0012.2000.14040802.x; Conde KAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064790; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Pietropaoli AP, 2010, GENDER MED, V7, P422, DOI 10.1016/j.genm.2010.09.005; Pourmand Gholamreza, 2006, Urol J, V3, P23; REIS MA, 1995, J ROY SOC MED, V88, P24; Sakr Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12570; Sam R, 2000, NEW ENGL J MED, V342, P1837; Sawyer RG, 1999, CLIN TRANSPLANT, V13, P260, DOI 10.1034/j.1399-0012.1999.130307.x; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Veroux M, 2008, TRANSPL P, V40, P1873, DOI 10.1016/j.transproceed.2008.05.065; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; [No title captured]	52	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111610	10.1371/journal.pone.0111610	http://dx.doi.org/10.1371/journal.pone.0111610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369197	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000078
J	Dharia, AP; Obla, A; Gajdosik, MD; Simon, A; Nelson, CE				Dharia, Asav P.; Obla, Ajay; Gajdosik, Matthew D.; Simon, Amanda; Nelson, Craig E.			Tempo and Mode of Gene Duplication in Mammalian Ribosomal Protein Evolution	PLOS ONE			English	Article							WHOLE-GENOME; PSEUDOGENES; EXPRESSION; DIVERSITY; FATE	Gene duplication has been widely recognized as a major driver of evolutionary change and organismal complexity through the generation of multi-gene families. Therefore, understanding the forces that govern the evolution of gene families through the retention or loss of duplicated genes is fundamentally important in our efforts to study genome evolution. Previous work from our lab has shown that ribosomal protein (RP) genes constitute one of the largest classes of conserved duplicated genes in mammals. This result was surprising due to the fact that ribosomal protein genes evolve slowly and transcript levels are very tightly regulated. In our present study, we identified and characterized all RP duplicates in eight mammalian genomes in order to investigate the tempo and mode of ribosomal protein family evolution. We show that a sizable number of duplicates are transcriptionally active and are very highly conserved. Furthermore, we conclude that existing gene duplication models do not readily account for the preservation of a very large number of intact retroduplicated ribosomal protein (RT-RP) genes observed in mammalian genomes. We suggest that selection against dominant-negative mutations may underlie the unexpected retention and conservation of duplicated RP genes, and may shape the fate of newly duplicated genes, regardless of duplication mechanism.	[Dharia, Asav P.; Obla, Ajay; Gajdosik, Matthew D.; Simon, Amanda; Nelson, Craig E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Nelson, CE (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	craig.nelson@uconn.edu	Obla, Ajay/GON-8118-2022		National Science Foundation (NSF) [1024803]; NSF	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) Grant Award Number: 1024803 (http://nsf.gov/awardsearch/showAward?AWD_ID = 1024803&HistoricalAwards = false). Author CEN was the principal investigator on the NSF grant who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2006, NATURE MED; Amoutzias GD, 2010, P NATL ACAD SCI USA, V107, P2967, DOI 10.1073/pnas.0911603107; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bailey J, 2002, SCIENCE NEW YORK NY; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bastian F, BGEE INTEGRATING COM, P124, DOI [10.1007/978-3-540-69828-9_12., DOI 10.1007/978-3-540-69828-9_12]; Blanc G, 2004, PLANT CELL ONLINE; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Carnemolla A, 2009, J BIOL; COLOMBO P, 1992, NUCLEIC ACIDS RES, V20, P3367, DOI 10.1093/nar/20.13.3367; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cusack B, 2007, MOL BIOL EVOLUTION; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; Dehal P, 2005, PLOS BIOL; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; DENNIS PP, 1974, P NATL ACAD SCI USA, V71, P3819, DOI 10.1073/pnas.71.10.3819; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Evangelisti AM, 2010, GENOME BIOL EVOL, V2, P826, DOI 10.1093/gbe/evq067; Farfan M, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-23; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Flygare J, 2007, HUMAN RPS19 GENE MUT, P1; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gibson TJ, 1998, TRENDS GENET, V14, P46, DOI 10.1016/S0168-9525(97)01367-X; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Han MV, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P114; Hariharan N, 1989, GENES DEV; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hori H, 1977, J MOL EVOLUTION; Huang X, 2010, HUMAN MOL; Hughes T, 2007, J MOL EVOLUTION; Hughes T, 2007, GENOME; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jiang Z, 2008, CLIN CANC; Jiang Z, 2008, CANCER; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Jun J, 2009, J COMPUT BIOL, V16, P1429, DOI 10.1089/cmb.2009.0073; Jun J, 2009, J COMPUT BIOL, V16, P1253, DOI 10.1089/cmb.2009.0074; Kenmochi N, 1998, GENOME; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kittler R, 2004, NATURE; Konrad A, 2011, GENOME BIOL EVOL, V3, P1197, DOI 10.1093/gbe/evr093; Liberles DA, 2013, GENOME BIOL EVOL, V5, P2008, DOI 10.1093/gbe/evt151; Liberles DA, 2011, P ROY SOC B-BIOL SCI, V278, P1930, DOI 10.1098/rspb.2010.2637; Maere S, 2005, MODELING GENE GENOME; Mager W, 2013, BIOCHIM BIOPHYS ACTA, V949, P1; Marais D, 2008, NATURE; Marygold S, 2007, GENOME; Marygold S, 2005, GENETICS; Meyer A, 1999, CURRENT OPINION CELL; Mikkelsen TS, 2007, NATURE; Nielsen R, 1998, GENETICS, V148, P929; OHNO S, EVOLUTION GENE DUPLI; Panopoulou G, 2003, GENOME; Parker H, 2009, SCIENCE NEW YORK NY; Parker HG, 2009, SCIENCE; Rodriguez V, 2007, GENE CHROMOSOME CANC, V46, P694, DOI 10.1002/gcc.20454; Roman T, 2005, MOLECULAR; Rosengren A, 2010, SCIENCE; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Tan J, 1996, AM J HUMAN; Thorrez L, 2008, POTENTIAL CAPACITY G, P1; Uechi T, 2002, NUCL ACIDS RES; Ureta-Vidal A, 2003, NATURE REV GENETICS; VanRaay TJ, 1996, GENOMICS, V37, P172, DOI 10.1006/geno.1996.0538; Veitia R, 2007, PLANT CELL ONLINE; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wang P, 2004, TRENDS ENDOCRINOLOGY; Wapinski I, 2007, BIOINFORMATICS; WATANABE T, 2008, NATURE; Willig T, 1999, BLOOD; Wolfe K, 1997, NATURE; Wool IG, BIOCH CELL BIOL, V73, P933; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu H, 2006, HUMAN MOL; Yu Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-308; Zhang J, 2003, TRENDS ECOLOGY EVOLU; Zhang L, 2005, MOL BIOL EVOLUTION; Zhang Y, 2013, DEV CELL; Zhang Z, 2006, BIOINFORMATICS OXFOR; Zhang Z, 2002, GENOME RES; Zhao Y, 2006, FINE STRUCTURE ANAL; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072	90	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111721	10.1371/journal.pone.0111721	http://dx.doi.org/10.1371/journal.pone.0111721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369106	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000093
J	Garcia-Martin, A; Reyes-Garcia, R; Garcia-Fontana, B; Morales-Santana, S; Coto-Montes, A; Munoz-Garach, M; Rozas-Moreno, P; Munoz-Torres, M				Garcia-Martin, Antonia; Reyes-Garcia, Rebeca; Garcia-Fontana, Beatriz; Morales-Santana, Sonia; Coto-Montes, Ana; Munoz-Garach, Manuel; Rozas-Moreno, Pedro; Munoz-Torres, Manuel			Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CALCIFIED ATHEROSCLEROTIC PLAQUE; CORONARY-ARTERY CALCIFICATION; MINERAL DENSITY; AFRICAN-AMERICANS; SCLEROSTIN; OSTEOPOROSIS; POPULATION; EXPRESSION; RECEPTORS; PATHWAYS	Objectives: Dickkopf-1 (DKK1) is a potent inhibitor of Wnt signalling, which exerts anabolic effects on bone and also takes part in the regulation of vascular cells. Our aims were to evaluate serum DKK1 in type 2 diabetes (T2DM) patients and to analyze its relationships with cardiovascular disease (CVD). We also evaluated the relationship between DKK1 and bone metabolism. Design: We conducted a cross-sectional study in which we measured serum DKK1 (ELISA, Biomedica) in 126 subjects: 72 patients with T2DM and 54 non-diabetic subjects. We analysed its relationship with clinical CVD, preclinical CVD expressed as carotid intima media thickness (IMT), and bone metabolism. Results: T2DM patients with CVD (P = 0,026) and abnormal carotid IMT (P = 0,038) had higher DKK1 concentrations. DKK1 was related to the presence of CVD in T2DM, independently of the presence of risk factors for atherosclerosis. Therefore, for each increase of 28 pg/ml of serum DKK1 there was a 6,2% increase in the risk of CVD in T2DM patients. The ROC curve analysis to evaluate the usefulness of DKK1 as a marker for high risk of CVD showed an area under the curve of 0,667 (95% CI: 0,538-0,795; P = 0,016). In addition, there was a positive correlation between serum DKK1 and spine bone mineral density in the total sample (r = 0,183; P = 0,048). Conclusion: In summary, circulating DKK1 levels are higher in T2DM with CVD and are associated with an abnormal carotid IMT in this cross-sectional study. DKK1 may be involved in vascular disease of T2DM patients.	[Garcia-Martin, Antonia; Reyes-Garcia, Rebeca; Garcia-Fontana, Beatriz; Morales-Santana, Sonia; Munoz-Torres, Manuel] Hosp Univ San Cecilio, Inst Invest Biosanit Granada, Div Endocrinol, Bone Metab Unit RETICEF, Granada, Spain; [Garcia-Martin, Antonia] Hosp Comarcal Noroeste Caravaca Cruz, Murcia, Spain; [Reyes-Garcia, Rebeca] Univ Rafael Mendez, Gen Hosp, Endocrinol Unit, Murcia, Spain; [Morales-Santana, Sonia] FIBAO, Prote Res Serv, Granada, Spain; [Coto-Montes, Ana] Univ Oviedo, Fac Med, Dept Morphol & Cellular Biol RETICEF, Oviedo, Spain; [Munoz-Garach, Manuel] Hosp Univ San Cecilio, Crit Care & Emergencies Unit, Granada, Spain; [Rozas-Moreno, Pedro] Hosp Gen Ciudad Real, Div Endocrinol, Ciudad Real, Spain	Hospital Universitario San Cecilio; University of Oviedo; Hospital Universitario San Cecilio	Munoz-Torres, M (corresponding author), Hosp Univ San Cecilio, Inst Invest Biosanit Granada, Div Endocrinol, Bone Metab Unit RETICEF, Granada, Spain.	mmt@mamuto.es	Torres, Manuel Muñoz/O-2330-2016; Morales-Santana, Sonia/ABG-8889-2020; coto-montes, ana/D-2544-2016; Garcia-Fontana, Beatriz/AAB-4330-2021	Torres, Manuel Muñoz/0000-0002-9645-3260; Morales-Santana, Sonia/0000-0001-8403-2496; coto-montes, ana/0000-0002-6609-6258; Garcia Fontana, Beatriz/0000-0002-4134-5561; Reyes-Garcia, Rebeca/0000-0003-1729-4431	Consejeria de Salud y Bienestar Social, Junta de Andalucia [PI-0514-2012]; Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF) [RD06/0013/1014-RD12/0043/0014]	Consejeria de Salud y Bienestar Social, Junta de Andalucia(Junta de Andalucia); Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF)	This work was supported in part by Consejeria de Salud y Bienestar Social, Junta de Andalucia (PI-0514-2012) and Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF) (RD06/0013/1014-RD12/0043/0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 1996, CALCIFIED TISSUE INT, V59, P415, DOI 10.1007/BF00369203; Bell NH, 2001, OSTEOPOROSIS INT, V12, P43, DOI 10.1007/s001980170156; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Butler JS, 2011, J ORTHOP RES, V29, P414, DOI 10.1002/jor.21260; Cannata-Andia JB, 2011, NEPHROL DIAL TRANSPL, V26, P3429, DOI 10.1093/ndt/gfr591; Carr JJ, 2008, BONE, V42, P43, DOI 10.1016/j.bone.2007.08.023; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Divers J, 2013, CIRC-CARDIOVASC GENE, V6, P97, DOI 10.1161/CIRCGENETICS.112.964114; Divers J, 2011, J BONE MINER RES, V26, P1554, DOI 10.1002/jbmr.389; Epstein S, 2008, BONE, V43, P3, DOI 10.1016/j.bone.2008.03.017; Fang YF, 2014, J AM SOC NEPHROL, V25, P1760, DOI 10.1681/ASN.2013080818; Freedman BI, 2012, NAT REV NEPHROL, V8, P459, DOI 10.1038/nrneph.2012.112; Freedman BI, 2005, DIABETOLOGIA, V48, P2511, DOI 10.1007/s00125-005-0017-2; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Junyent M, 2005, MED CLIN-BARCELONA, V125, P770, DOI 10.1016/S0025-7753(05)72186-2; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim KI, 2011, J KOREAN MED SCI, V26, P1178, DOI 10.3346/jkms.2011.26.9.1178; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Magnus JH, 2005, OSTEOPOROSIS INT, V16, P2053, DOI 10.1007/s00198-005-1999-9; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Polyzos SA, 2012, OSTEOPOROSIS INT, V23, P1171, DOI 10.1007/s00198-010-1525-6; Register TC, 2013, J CLIN ENDOCR METAB, V98, pE60, DOI 10.1210/jc.2012-3038; Scott EL, 2013, BRAIN RES, V1514, P63, DOI 10.1016/j.brainres.2012.12.015; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Thambiah S, 2012, CALCIFIED TISSUE INT, V90, P473, DOI 10.1007/s00223-012-9595-4; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Wade AN, 2011, DIABETES RES CLIN PR, V91, P101, DOI 10.1016/j.diabres.2010.07.004; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Wylie-Sears J, 2011, ARTERIOSCL THROM VAS, V31, P598, DOI 10.1161/ATVBAHA.110.216184; Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392	43	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111703	10.1371/journal.pone.0111703	http://dx.doi.org/10.1371/journal.pone.0111703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369286	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000087
J	Martin, AC; Johnston, E; Xing, CG; Hegeman, AD				Martin, Amanda C.; Johnston, Ed; Xing, Chengguo; Hegeman, Adrian D.			Measuring the Chemical and Cytotoxic Variability of Commercially Available Kava (Piper methysticum G. Forster)	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; LUNG TUMORIGENESIS; CANCER CELLS; EXTRACTS; CULTIVARS; HEPATOTOXICITY; IDENTIFICATION; CONSTITUENTS; FLAVOKAVINS; CHALCONE	Formerly used world-wide as a popular botanical medicine to reduce anxiety, reports of hepatotoxicity linked to consuming kava extracts in the late 1990s have resulted in global restrictions on kava use and have hindered kava-related research. Despite its presence on the United States Food and Drug Administration consumer advisory list for the past decade, export data from kava producing countries implies that US kava imports, which are not publicly reported, are both increasing and of a fairly high volume. We have measured the variability in extract chemical composition and cytotoxicity towards human lung adenocarcinoma A549 cancer cells of 25 commercially available kava products. Results reveal a high level of variation in chemical content and cytotoxicity of currently available kava products. As public interest and use of kava products continues to increase in the United States, efforts to characterize products and expedite research of this potentially useful botanical medicine are necessary.	[Martin, Amanda C.; Hegeman, Adrian D.] Univ Minnesota, Dept Hort Sci, Plant Biol Sci Grad Program, Dept Plant Biol, Minneapolis, MN USA; [Martin, Amanda C.; Hegeman, Adrian D.] Univ Minnesota, Microbial & Plant Genom Inst, Minneapolis, MN 55455 USA; [Johnston, Ed] Alia Point Awa Nursery, Pepeekeo, HI USA; [Xing, Chengguo] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Xing, CG (corresponding author), Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA.	xingx009@umn.edu; hegem007@umn.edu	; Hegeman, Adrian/D-5984-2013	Martin, Amanda C./0000-0002-6958-6332; Hegeman, Adrian/0000-0003-1008-6066	National Science Foundation Plant Genome Research Program [IOS-0923960, IOS-1238812]; National Science Foundation Graduate Research Fellowship [00006595]; National Cancer Institute, National Institutes of Health [R01 CA142649]; NATIONAL CANCER INSTITUTE [R01CA193278, R01CA142649] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Science Foundation Plant Genome Research Program grants IOS-0923960 and IOS-1238812 (www.nsf.gov)(ACM,ADH), the National Science Foundation Graduate Research Fellowship Program 00006595 (www.nsf.gov) (ACM), and the National Cancer Institute, National Institutes of Health grant R01 CA142649 (www.cancer.gov) (CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anke J, 2004, J ETHNOPHARMACOL, V93, P153, DOI 10.1016/j.jep.2004.04.009; Behl M, 2011, FOOD CHEM TOXICOL, V49, P2820, DOI 10.1016/j.fct.2011.07.067; Dasgupta A., 2011, Herbal supplements: efficacy, toxicity, interactions with Western drugs, and effects on clinical laboratory tests, P155; Dinh LD, 2001, PLANTA MED, V67, P306, DOI 10.1055/s-2001-14334; Discussion paper on the development of a standard for kava products, 2012, DISC PAP DEV STAND K; Dragull K, 2003, PHYTOCHEMISTRY, V63, P193, DOI 10.1016/S0031-9422(03)00111-0; Fiji Bureau of Statistics, 2013, 2011 EXP STAT; He XG, 1997, PLANTA MED, V63, P70, DOI 10.1055/s-2006-957608; Hegeman AD, 2010, BRIEF FUNCT GENOMICS, V9, P139, DOI 10.1093/bfgp/elp053; Jhoo JW, 2006, J AGR FOOD CHEM, V54, P3157, DOI 10.1021/jf051853j; Johansen HN, 1996, J AGR FOOD CHEM, V44, P1470, DOI 10.1021/jf950482b; Johnson BM, 2003, CHEM RES TOXICOL, V16, P733, DOI 10.1021/tx020113r; Johnson TE, 2011, AM J CHINESE MED, V39, P727, DOI 10.1142/S0192415X11009202; Johnson TE, 2008, CANCER PREV RES, V1, P430, DOI 10.1158/1940-6207.CAPR-08-0027; Jokhan A., 2004, S PAC J NAT SCI, V22, P43; Lapornik B, 2005, J FOOD ENG, V71, P214, DOI 10.1016/j.jfoodeng.2004.10.036; Lebot V, 1999, ECON BOT, V53, P407, DOI 10.1007/BF02866720; Lebot V, 2014, FOOD CHEM, V151, P554, DOI 10.1016/j.foodchem.2013.11.120; Lebot V, 2004, ETHNOBOT RES APPL, V2, P19; Lebot V, 2006, HERBALGRAM, V71, P34; Leitzman P, 2014, CANCER PREV RES, V7, P86, DOI 10.1158/1940-6207.CAPR-13-0301; Meissner O, 2005, J CHROMATOGR B, V826, P46, DOI 10.1016/j.jchromb.2005.08.003; Olsen LR, 2011, CHEM RES TOXICOL, V24, P992, DOI 10.1021/tx100412m; Rogers H., 2006, HAWAIIAN AWA VIEWS E, P1; Sarris J, 2011, PLANTA MED, V77, P107, DOI 10.1055/s-0030-1250290; Shaik AA, 2009, BIOORG MED CHEM LETT, V19, P5732, DOI 10.1016/j.bmcl.2009.08.003; Shao Y, 1998, J CHROMATOGR A, V825, P1, DOI 10.1016/S0021-9673(98)00699-2; Simeoni P, 2002, BIOCHEM SYST ECOL, V30, P413, DOI 10.1016/S0305-1978(01)00093-X; SMITH RM, 1984, J CHROMATOGR, V283, P303, DOI 10.1016/S0021-9673(00)96265-4; Steiner G G, 2000, Hawaii Med J, V59, P420; Teschke R, 2003, PHYTOMEDICINE, V10, P440, DOI 10.1078/0944-7113-00314; Teschke R, 2011, AM HERB PROD ASS REP, V26, P8; Teschke R, 2011, PHYTOTHER RES, V25, P1263, DOI 10.1002/ptr.3464; Teschke R, 2011, FOOD CHEM TOXICOL, V49, P2503, DOI 10.1016/j.fct.2011.06.075; Teschke R, 2011, DIGEST LIVER DIS, V43, P676, DOI 10.1016/j.dld.2011.01.018; Teschke R, 2011, BRIT J CLIN PHARMACO, V71, P445, DOI 10.1111/j.1365-2125.2010.03775.x; Teschke R, 2011, PHYTOMEDICINE, V18, P96, DOI 10.1016/j.phymed.2010.10.002; Teschke R, 2009, J ETHNOPHARMACOL, V123, P378, DOI 10.1016/j.jep.2009.03.038; Tonga Statistics Department, 2008, KING TONG ANN FOR TR; U.S. Food and Drug Administration, 2002, US FDA PUBL; Vanuatu National Statistics Office, 2013, STAT UPD OV TRAD; Warmka JK, 2012, BIOCHEM BIOPH RES CO, V424, P488, DOI 10.1016/j.bbrc.2012.06.140; Whitton PA, 2003, PHYTOCHEMISTRY, V64, P673, DOI 10.1016/S0031-9422(03)00381-9; Yang X, 2011, PHYTOMEDICINE, V18, P592, DOI 10.1016/j.phymed.2011.02.006; Zhang LY, 2011, PHYTOTHER RES, V25, P629, DOI 10.1002/ptr.3301; Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803; Zou L, 2004, PHYTOMEDICINE, V11, P285, DOI 10.1078/0944711041495263	48	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111572	10.1371/journal.pone.0111572	http://dx.doi.org/10.1371/journal.pone.0111572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365244	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100078
J	Costabile, A; Santarelli, S; Claus, SP; Sanderson, J; Hudspith, BN; Brostoff, J; Ward, JL; Lovegrove, A; Shewry, PR; Jones, HE; Whitley, AM; Gibson, GR				Costabile, Adele; Santarelli, Sara; Claus, Sandrine P.; Sanderson, Jeremy; Hudspith, Barry N.; Brostoff, Jonathan; Ward, Jane L.; Lovegrove, Alison; Shewry, Peter R.; Jones, Hannah E.; Whitley, Andrew M.; Gibson, Glenn R.			Effect of Breadmaking Process on In Vitro Gut Microbiota Parameters in Irritable Bowel Syndrome	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GASTROINTESTINAL MICROBIOTA; OLIGONUCLEOTIDE PROBES; INTESTINAL MICROBIOTA; BACTERIAL-POPULATIONS; SITU HYBRIDIZATION; PROBIOTICS; SYMPTOMS; FIBER; FERMENTATION	A variety of foods have been implicated in symptoms of patients with Irritable Bowel Syndrome (IBS) but wheat products are most frequently cited by patients as a trigger. Our aim was to investigate the effects of breads, which were fermented for different lengths of time, on the colonic microbiota using in vitro batch culture experiments. A set of in vitro anaerobic culture systems were run over a period of 24 h using faeces from 3 different IBS donors (Rome Criteria-mainly constipated) and 3 healthy donors. Changes in gut microbiota during a time course were identified by fluorescence in situ hybridisation (FISH), whilst the small -molecular weight metabolomic profile was determined by NMR analysis. Gas production was separately investigated in non pH-controlled, 36 h batch culture experiments. Numbers of bifidobacteria were higher in healthy subjects compared to IBS donors. In addition, the healthy donors showed a significant increase in bifidobacteria (P<0.005) after 8 h of fermentation of a bread produced using a sourdough process (type C) compared to breads produced with commercial yeasted dough (type B) and no time fermentation (Chorleywood Breadmaking process) (type A). A significant decrease of delta-Proteobacteria and most Gemmatimonadetes species was observed after 24 h fermentation of type C bread in both IBS and healthy donors. In general, IBS donors showed higher rates of gas production compared to healthy donors. Rates of gas production for type A and conventional long fermentation (type B) breads were almost identical in IBS and healthy donors. Sourdough bread produced significantly lower cumulative gas after 15 h fermentation as compared to type A and B breads in IBS donors but not in the healthy controls. In conclusion, breads fermented by the traditional long fermentation and sourdough are less likely to lead to IBS symptoms compared to bread made using the Chorleywood Breadmaking Process.	[Costabile, Adele; Santarelli, Sara; Claus, Sandrine P.; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Sanderson, Jeremy; Hudspith, Barry N.; Brostoff, Jonathan] Kings Coll London, Dept Nutr & Dietet, London, England; [Ward, Jane L.; Lovegrove, Alison; Shewry, Peter R.] Rothamsted Res, Harpenden, Herts, England; [Shewry, Peter R.] Sch Agr Policy & Dev, Reading, Berks, England; [Whitley, Andrew M.] Bread Matters Ltd, West Linton, Peeblesshire, Scotland	University of Reading; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Reading	Costabile, A (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	a.costabile@reading.ac.uk		Costabile, Adele/0000-0003-3185-030X; Claus, Sandrine/0000-0002-3789-9780	Biotechnology and Biological Sciences of the UK; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004976, BBS/E/C/00005206] Funding Source: researchfish; BBSRC [BBS/E/C/00005206, BBS/E/C/00004976] Funding Source: UKRI	Biotechnology and Biological Sciences of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Miss Meline Bes and Dr Delia-Irina Corol for excellent technical assistance. Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences of the UK.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Camilleri M, 2008, J CLIN GASTROENTEROL, V42, pS123, DOI 10.1097/MCG.0b013e3181574393; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; De Angelis M, 2007, BRIT J NUTR, V98, P1196, DOI 10.1017/S0007114507772689; DICAGNO R, 2008, J FOOD PROTECT, V71, P113; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Ghoshal UC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/151085; Ghoshal UC, 2010, J GASTROEN HEPATOL, V25, P244, DOI 10.1111/j.1440-1746.2009.06133.x; Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Hong YS, 2011, J CLIN GASTROENTEROL, V45, P415, DOI 10.1097/MCG.0b013e318207f76c; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Hunter J. O., 1985, TOPICS GASTROENTEROL, V12, P305; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Katina K, 2005, TRENDS FOOD SCI TECH, V16, P104, DOI 10.1016/j.tifs.2004.03.008; Koide A, 2000, AM J GASTROENTEROL, V95, P1735; Kopecny J, 2002, ACTA VET BRNO, V71, P421, DOI 10.2754/avb200271040421; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252; Lee KJ, 2010, NEUROGASTROENT MOTIL, V22, P493, DOI 10.1111/j.1365-2982.2010.01482.x; Lucker S, 2007, J MICROBIOL METH, V69, P523, DOI 10.1016/j.mimet.2007.02.009; Lyra A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-110; Maccaferri S, 2012, MOL NUTR FOOD RES, V56, P1342, DOI 10.1002/mnfr.201200046; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; MORTENSEN PB, 1987, SCAND J GASTROENTERO, V22, P185, DOI 10.3109/00365528708991878; Parkes GC, 2008, AM J GASTROENTEROL, V103, P1557, DOI 10.1111/j.1572-0241.2008.01869.x; Ponnusamy K, 2011, J MED MICROBIOL, V60, P817, DOI 10.1099/jmm.0.028126-0; Santelmann H, 2005, EUR J GASTROEN HEPAT, V17, P21, DOI 10.1097/00042737-200501000-00005; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; STEFANINI GF, 1995, SCAND J GASTROENTERO, V30, P535, DOI 10.3109/00365529509089786; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Thompson WG, 1999, GUT, V45, P43; Treem WR, 1996, J PEDIATR GASTR NUTR, V23, P280, DOI 10.1097/00005176-199610000-00013; Valeur J, 2010, NEUROGASTROENTEROLY, DOI [10.1111/j.1365-2982.2010.01558.x, DOI 10.1111/J.1365-2982.2010.01558.X]; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005	47	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111225	10.1371/journal.pone.0111225	http://dx.doi.org/10.1371/journal.pone.0111225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356771	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000346765000046
J	Gandolfi, B; Daniel, RJ; O'Brien, DP; Guo, LT; Youngs, MD; Leach, SB; Jones, BR; Shelton, GD; Lyons, LA				Gandolfi, Barbara; Daniel, Rob J.; O'Brien, Dennis P.; Guo, Ling T.; Youngs, Melanie D.; Leach, Stacey B.; Jones, Boyd R.; Shelton, G. Diane; Lyons, Leslie A.			A Novel Mutation in CLCN1 Associated with Feline Myotonia Congenita	PLOS ONE			English	Article							MUSCLE CHLORIDE CHANNEL; REPETITIVE NERVE-STIMULATION; MOLECULAR-BASIS; HEREDITARY MYOTONIA; MISSENSE MUTATION; SPLICE SITES; GENE; DOMINANT; INACTIVATION; DECREMENT	Myotonia congenita (MC) is a skeletal muscle channelopathy characterized by inability of the muscle to relax following voluntary contraction. Worldwide population prevalence in humans is 1:100,000. Studies in mice, dogs, humans and goats confirmed myotonia associated with functional defects in chloride channels and mutations in a skeletal muscle chloride channel (CLCN1). CLCN1 encodes for the most abundant chloride channel in the skeletal muscle cell membrane. Five random bred cats from Winnipeg, Canada with MC were examined. All cats had a protruding tongue, limited range of jaw motion and drooling with prominent neck and proximal limb musculature. All cats had blepharospasm upon palpebral reflex testing and a short-strided gait. Electromyograms demonstrated myotonic discharges at a mean frequency of 300 Hz resembling the sound of a 'swarm of bees'. Muscle histopathology showed hypertrophy of all fiber types. Direct sequencing of CLCN1 revealed a mutation disrupting a donor splice site downstream of exon 16 in only the affected cats. In vitro translation of the mutated protein predicted a premature truncation and partial lack of the highly conserved CBS1 (cystathionine beta-synthase) domain critical for ion transport activity and one dimerization domain pivotal in channel formation. Genetic screening of the Winnipeg random bred population of the cats' origin identified carriers of the mutation. A genetic test for population screening is now available and carrier cats from the feral population can be identified.	[Gandolfi, Barbara; Daniel, Rob J.; O'Brien, Dennis P.; Leach, Stacey B.; Lyons, Leslie A.] Univ Missouri, Sch Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Guo, Ling T.; Shelton, G. Diane] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Youngs, Melanie D.] Winnipeg Humane Soc, Winnipeg, MB, Canada; [Jones, Boyd R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	University of Missouri System; University of Missouri Columbia; University of California System; University of California San Diego; Massey University	Gandolfi, B (corresponding author), Univ Missouri, Sch Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.	gandolfib@missouri.edu		Lyons, Leslie/0000-0002-1628-7726	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs/OD [R24OD010928]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; AMINOFF MJ, 1977, NEUROLOGY, V27, P812, DOI 10.1212/WNL.27.9.812; Beck CL, 1996, P NATL ACAD SCI USA, V93, P11248, DOI 10.1073/pnas.93.20.11248; Bernard G, 2008, J CHILD NEUROL, V23, P163, DOI 10.1177/0883073807307974; Borges AS, 2013, NEUROMUSCULAR DISORD, V23, P206, DOI 10.1016/j.nmd.2012.11.008; BRAUND KG, 1995, AM J VET RES, V56, P349; Brown GL, 1939, BRAIN, V62, P341, DOI 10.1093/brain/62.4.341; Bryant S H, 1979, Ann N Y Acad Sci, V317, P314, DOI 10.1111/j.1749-6632.1979.tb56540.x; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; Colding-Jorgensen E, 2003, MUSCLE NERVE, V27, P449, DOI 10.1002/mus.10347; De Lahunta A., 2015, VET NEUROANATOMY CLI, P214; Deymeer F, 1998, MUSCLE NERVE, V21, P1334, DOI 10.1002/(SICI)1097-4598(199810)21:10<1334::AID-MUS16>3.0.CO;2-1; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Duno M, 2004, EUR J HUM GENET, V12, P738, DOI 10.1038/sj.ejhg.5201218; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ENGEL WK, 1966, ANN NY ACAD SCI, V138, P160; FARROW BRH, 1981, J SMALL ANIM PRACT, V22, P451, DOI 10.1111/j.1748-5827.1981.tb00629.x; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fournier E, 2004, ANN NEUROL, V56, P650, DOI 10.1002/ana.20241; Fournier E, 2006, ANN NEUROL, V60, P356, DOI 10.1002/ana.20905; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gaschen F, 2004, J FELINE MED SURG, V6, P355, DOI 10.1016/j.jfms.2004.02.003; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Hickford FH, 1998, J SMALL ANIM PRACT, V39, P281, DOI 10.1111/j.1748-5827.1998.tb03651.x; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kimura J, 2013, ELECTRODIAGNOSIS DIS, V4th; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KORTZ G, 1989, SEMIN VET MED SURG, V4, P141; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Lossin C, 2008, ADV GENETICS; Malik R, 2008, J SMALL ANIM PRACTIC, V30, P20; McKay OM, 2006, CLIN NEUROPHYSIOL, V117, P2064, DOI 10.1016/j.clinph.2006.05.014; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; Michel P, 2007, MUSCLE NERVE, V36, P643, DOI 10.1002/mus.20856; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; MITCHELL MM, 1978, ANESTHESIOLOGY, V49, P44, DOI 10.1097/00000542-197807000-00014; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Rhodes TH, 1999, FEBS LETT, V456, P54, DOI 10.1016/S0014-5793(99)00926-6; Richardson RC, 2014, MUSCLE NERVE, V49, P593, DOI 10.1002/mus.23976; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Sims M. H., 1990, Progress in Veterinary Neurology, V1, P311; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; STEINBERG S, 1962, SCIENCE, V137, P979, DOI 10.1126/science.137.3534.979; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Sun C, 2001, EUR J HUM GENET, V9, P903, DOI 10.1038/sj.ejhg.5200736; Tang CY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/685328; Toll J, 1998, J SMALL ANIM PRACT, V39, P499, DOI 10.1111/j.1748-5827.1998.tb03690.x; Toll J, 1998, J VET INTERN MED, V12, P116, DOI 10.1111/j.1939-1676.1998.tb02105.x; Treisman R, 1983, Prog Clin Biol Res, V134, P99; Vite CH, 1999, J HERED, V90, P578, DOI 10.1093/jhered/90.5.578; Wentink G H, 1974, Tijdschr Diergeneeskd, V99, P729; White GR, 1904, AM VET REV, V28, P556; WIERINGA B, 1983, NATURE, V301, P38, DOI 10.1038/301038a0; Wijnberg ID, 2012, NEUROMUSCULAR DISORD, V22, P361, DOI 10.1016/j.nmd.2011.10.001	62	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109926	10.1371/journal.pone.0109926	http://dx.doi.org/10.1371/journal.pone.0109926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356766	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000010
J	Kim, KN; Kim, JH; Kwon, HJ; Hong, SJ; Kim, BJ; Lee, SY; Hong, YC; Bae, S				Kim, Kyoung-Nam; Kim, Jin Hee; Kwon, Ho-Jang; Hong, Soo-Jong; Kim, Byoung-Ju; Lee, So-Yeon; Hong, Yun-Chul; Bae, Sanghyuk			Bisphenol A Exposure and Asthma Development in School-Age Children: A Longitudinal Study	PLOS ONE			English	Article							CHILDHOOD ASTHMA; OXIDATIVE STRESS; URINARY CONCENTRATIONS; AIRWAY RESPONSIVENESS; CYTOKINE PRODUCTION; GENDER-DIFFERENCES; FETAL EXPOSURE; RISK; METHACHOLINE; PREVALENCE	Background: Although the effect of bisphenol A on various health outcomes has been extensively examined, few studies have investigated its effect on asthma. Objective: We hypothesized that exposure to bisphenol A in school-age children was associated with wheezing and asthma. Methods: Participants included 127 children aged 7-8 years without a previous asthma diagnosis in an elementary school in Seoul, Korea. Three surveys were conducted, each 2 years apart. Bisphenol A concentration was measured at the baseline survey, and PC20, which is defined as the methacholine concentration that induces a decrease in FEV1 of 20% from baseline, was measured at every survey. Associations between bisphenol A concentration at 7-8 years of age and wheezing, asthma, and PC20 at ages up to 11-12 years were examined using generalized estimating equations, a marginal Cox regression model, and a linear mixed model. Results: The log-transformed creatinine-adjusted urinary bisphenol A concentration at 7-8 years was positively associated with wheezing (odds ratio, 2.48; 95% confidence interval, 1.15-5.31; P =.02) and asthma (hazard ratio, 2.13; 95% confidence interval, 1.51-3.00; P <.001) at ages up to 11-12 years. Bisphenol A was also negatively associated with PC20 (beta = 22.33; P =.02). When stratified by sex, the association between bisphenol A and asthma remained significant only in girls (hazard ratio, 2.45; 95% confidence interval, 2.18-2.76; P <.001). Conclusion: Increased urinary bisphenol A concentrations at 7-8 years old were positively associated with wheezing and asthma and negatively associated with PC20 at ages up to 11-12 years.	[Kim, Kyoung-Nam; Hong, Yun-Chul; Bae, Sanghyuk] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Jin Hee; Hong, Yun-Chul] Inst Environm Med, Med Res Ctr, Seoul, South Korea; [Kwon, Ho-Jang] Dankook Univ, Coll Med, Dept Prevent Med & Publ Hlth, Cheonan, South Korea; [Hong, Soo-Jong] Univ Ulsan, Coll Med, Asan Med Ctr,Dept Pediat, Childhood Asthma Atopy Ctr,Res Ctr Standardizat A, Seoul, South Korea; [Kim, Byoung-Ju] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Pediat, Pusan, South Korea; [Lee, So-Yeon] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Pediat, Anyang, South Korea	Seoul National University (SNU); Dankook University; University of Ulsan; Asan Medical Center; Inje University; Hallym University	Bae, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	sanghyukbae@snu.ac.kr	Hong, Yun-Chul/J-5725-2012; Hong, Soo-Jong/AAR-1788-2020; Bae, Sanghyuk/AAQ-6635-2020	Hong, Soo-Jong/0000-0003-1409-2113; Bae, Sanghyuk/0000-0002-4995-6543; KIM, JIN HEE/0000-0003-1204-7079; Kim, Byoung-Ju/0000-0003-0271-9417	Korean Ministry of Environment	Korean Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research was funded by the Korean Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS JGJV, 1994, EUR RESPIR J, V7, P895; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Alves MFA, 2006, INT J ENVIRON HEAL R, V16, P255, DOI 10.1080/09603120600734147; Anjum S, 2011, FOOD CHEM TOXICOL, V49, P2849, DOI 10.1016/j.fct.2011.07.062; Bae S, 2012, HYPERTENSION, V60, P786, DOI 10.1161/HYPERTENSIONAHA.112.197715; Barr RG, 2004, ARCH INTERN MED, V164, P379, DOI 10.1001/archinte.164.4.379; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Bushnik T, 2010, HEALTH REP, V21; Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Cao XL, 2010, J FOOD PROTECT, V73, P1085, DOI 10.4315/0362-028X-73.6.1085; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Christensen KLY, 2012, ENVIRON INT, V50, P7, DOI 10.1016/j.envint.2012.09.002; Clark NM, 2010, CLIN PEDIATR, V49, P931, DOI 10.1177/0009922809357339; COCKCROFT DW, 1983, THORAX, V38, P55, DOI 10.1136/thx.38.1.55; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31; Ezz HSA, 2015, CYTOTECHNOLOGY, V67, P145, DOI 10.1007/s10616-013-9672-1; Fu Liang, 2014, Ann Am Thorac Soc, V11, P939, DOI 10.1513/AnnalsATS.201402-084OC; Gardner RM, 2010, TOXICOL LETT, V198, P182, DOI 10.1016/j.toxlet.2010.06.015; Gerstenberger SL, 2010, ENVIRON TOXICOL CHEM, V29, P237, DOI 10.1002/etc.32; Hansen TE, 2013, ACTA PAEDIATR, V102, P47, DOI 10.1111/apa.12030; Hassan ZK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/194829; Hong SB, 2013, J CHILD PSYCHOL PSYC, V54, P890, DOI 10.1111/jcpp.12050; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; Jayet PY, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-131; Jing H, 2012, ANAT HISTOL EMBRYOL, V41, P170, DOI 10.1111/j.1439-0264.2011.01120.x; Koh YY, 2002, CLIN EXP ALLERGY, V32, P921, DOI 10.1046/j.1365-2222.2002.01399.x; Kwak Eun Soo, 2009, Open Allergy J, V2, P45; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lee MR, 2014, J EPIDEMIOL COMMUN H, V68, P312, DOI 10.1136/jech-2013-202548; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Lee SI, 2010, ALLERGY ASTHMA IMMUN, V2, P61, DOI 10.4168/aair.2010.2.2.61; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Macsali F, 2011, AM J RESP CRIT CARE, V183, P8, DOI 10.1164/rccm.200912-1886OC; Marcon A, 2014, J ALLERGY CLIN IMMUN, V133, P104, DOI 10.1016/j.jaci.2013.03.040; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Melzer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043378; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Nyland JF, 2011, ENVIRON HEALTH PERSP, V119, P1733, DOI 10.1289/ehp.1103741; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Protudjer JLP, 2014, ANN ALLERG ASTHMA IM, V112, P78, DOI 10.1016/j.anai.2013.10.015; Sakai T, 2010, J NUTR SCI VITAMINOL, V56, P72, DOI 10.3177/jnsv.56.72; Sawai C, 2003, ENVIRON HEALTH PERSP, V111, P1883, DOI 10.1289/ehp.6359; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Song SZ, 2014, INT J ENV RES PUB HE, V11, P3728, DOI 10.3390/ijerph110403728; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888; Sumino K, 2012, J ALLERGY CLIN IMMUN, V130, P69, DOI 10.1016/j.jaci.2012.02.025; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; van Schayck OCP, 2013, PRIM CARE RESP J, V22, P239, DOI 10.4104/pcrj.2013.00052; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Vollmer WM, 1998, AM J RESP CRIT CARE, V157, P1079, DOI 10.1164/ajrccm.157.4.9704140; Vrijheid M, 2014, ENVIRON HEALTH PERSP, V122, P535, DOI 10.1289/ehp.1307204; Weiss ST, 2000, AM J RESP CRIT CARE, V162, P50, DOI 10.1164/ajrccm.162.1.9811005; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Wolff MS, 2008, ENVIRON RES, V107, P393, DOI 10.1016/j.envres.2008.03.006; Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030	86	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111383	10.1371/journal.pone.0111383	http://dx.doi.org/10.1371/journal.pone.0111383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356742	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000057
J	Wang, RS; Chen, RD; Li, JH; Liu, X; Xie, KB; Chen, DW; Yin, YZ; Tao, XY; Xie, D; Zou, JH; Yang, L; Dai, JG				Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui			Molecular Characterization and Phylogenetic Analysis of Two Novel Regio-specific Flavonoid Prenyltransferases from Morus alba and Cudrania tricuspidata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; ISOPRENYLATED FLAVONOIDS; PRENYLATED ISOFLAVONOIDS; REGIOSELECTIVE SYNTHESIS; GLYCYRRHIZA-URALENSIS; DITERPENE METABOLISM; BIOSYNTHESIS; CLONING; PLANT; CHALCONES	Prenylated flavonoids are attractive specialized metabolites with a wide range of biological activities and are distributed in several plant families. The prenylation catalyzed by prenyltransferases represents a Friedel-Crafts alkylation of the flavonoid skeleton in the biosynthesis of natural prenylated flavonoids and contributes to the structural diversity and biological activities of these compounds. To date, all identified plant flavonoid prenyltransferases (FPTs) have been identified in Leguminosae. In the present study two new FPTs, Morus alba isoliquiritigenin 3'-dimethylallyltransferase (MaIDT) and Cudrania tricuspidata isoliquiritigenin 3'-dimethylallyltransferase (CtIDT), were identified from moraceous plants M. alba and C. tricuspidata, respectively. MaIDT and CtIDT shared low levels of homology with the leguminous FPTs. MaIDT and CtIDT are predicted to be membrane-bound proteins with predicted transit peptides, seven transmembrane regions, and conserved functional domains that are similar to other homogentisate prenyltransferases. Recombinant MaIDT and CtIDT were able to regioselectively introduce dimethylallyl diphosphate into the A ring of three flavonoids with different skeleton types (chalcones, isoflavones, and flavones). Phylogenetic analysis revealed thatMaIDT and CtIDT are distantly related to their homologs in Leguminosae, which suggests that FPTs in Moraceae and Leguminosae might have evolved independently. MaIDT and CtIDT represent the first two non-Leguminosae FPTs to be identified in plants and could thus lead to the identification of additional evolutionarily varied FPTs in other non-Leguminosae plants and could elucidate the biosyntheses of prenylated flavonoids in various plants. Furthermore, MaIDT and CtIDT might be used for regiospecific prenylation of flavonoids to produce bioactive compounds for potential therapeutic applications due to their high efficiency and catalytic promiscuity.	[Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui] Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui] Chinese Acad Med Sci, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Dai, JG (corresponding author), Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, 1 Xian Nong Tan St, Beijing 100050, Peoples R China.	jgdai@imm.ac.cn			National Natural Science Foundation of China [81273405]; Fundamental Research Funds for the Central Universities [2012N06]; Program for Doctorate Education Grant [20111106110029]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China [2012X09301002-001-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Doctorate Education Grant; National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China	The study was supported by National Natural Science Foundation of China Grant 81273405, Fundamental Research Funds for the Central Universities Grant 2012N06, Program for Doctorate Education Grant 20111106110029, and National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China Grant 2012X09301002-001-005.	Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5; Boland GM, 1998, NAT PROD REP, V15, P241; Borges-Argaez R, 2002, PHYTOCHEMISTRY, V60, P533, DOI 10.1016/S0031-9422(02)00131-0; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Botta B, 2009, CURR MED CHEM, V16, P3414, DOI 10.2174/092986709789057662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt DR, 2013, TETRAHEDRON, V69, P9994, DOI 10.1016/j.tet.2013.09.068; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen QianQian, 2011, Plant Physiology Communications, V47, P575; Chen RD, 2013, ADV SYNTH CATAL, V355, P1817, DOI 10.1002/adsc.201300196; Crowell AL, 2002, ARCH BIOCHEM BIOPHYS, V405, P112, DOI 10.1016/S0003-9861(02)00348-X; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DELLEMONACHE G, 1995, PHYTOCHEMISTRY, V39, P575, DOI 10.1016/0031-9422(94)00971-U; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; HANO Y, 1990, J CHEM SOC CHEM COMM, P610, DOI 10.1039/c39900000610; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hossain MM, 2006, TETRAHEDRON, V62, P8625, DOI 10.1016/j.tet.2006.06.066; Juvale K, 2012, BIOORGAN MED CHEM, V20, P346, DOI 10.1016/j.bmc.2011.10.074; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Khatib S, 2005, BIOORGAN MED CHEM, V13, P433, DOI 10.1016/j.bmc.2004.10.010; KOBAYASHI M, 1985, CHEM PHARM BULL, V33, P3811; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; LAFLAMME P, 1993, PHYTOCHEMISTRY, V34, P147, DOI 10.1016/S0031-9422(00)90796-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JH, 2014, CHEMBIOCHEM, V15, P1672, DOI 10.1002/cbic.201402160; Li Tian, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau054; Munakata R, 2014, PLANT PHYSIOL, V166, P80, DOI 10.1104/pp.114.246892; NOMURA T, 1994, NAT PROD REP, V11, P205, DOI 10.1039/np9941100205; Nomura T, 1988, Fortschr Chem Org Naturst, V53, P87; Nomura T, 2009, P JPN ACAD B-PHYS, V85, P391, DOI 10.2183/pjab.85.391; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Page J. E., 2012, U. S. Patent, Patent No. 8884100; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Shen GA, 2012, PLANT PHYSIOL, V159, P70, DOI 10.1104/pp.112.195271; TAHARA S, 1995, PHYTOCHEMISTRY, V38, P1073, DOI 10.1016/0031-9422(94)00788-U; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao Xiao-Yu, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3738; Tsukayama M, 2004, CHEM PHARM BULL, V52, P1285, DOI 10.1248/cpb.52.1285; Tsurumaru Y, 2012, BIOCHEM BIOPH RES CO, V417, P393, DOI 10.1016/j.bbrc.2011.11.125; VELIKY IA, 1970, CAN J MICROBIOL, V16, P223, DOI 10.1139/m70-041; Vitali A, 2004, FEBS LETT, V557, P33, DOI 10.1016/S0014-5793(03)01398-X; Vitali A, 2001, PLANTA MED, V67, P475, DOI 10.1055/s-2001-15814; Wang HM, 2014, TETRAHEDRON LETT, V55, P897, DOI 10.1016/j.tetlet.2013.12.044; Yamamoto H, 2000, PHYTOCHEMISTRY, V54, P649, DOI 10.1016/S0031-9422(00)00198-9; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin S, 2004, BIOORGAN MED CHEM, V12, P4387, DOI 10.1016/j.bmc.2004.06.014; Yin Yun-Ze, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3734; Yin YZ, 2013, J MOL CATAL B-ENZYM, V89, P28, DOI 10.1016/j.molcatb.2012.12.009; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	58	35	36	5	71	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35815	35825		10.1074/jbc.M114.608265	http://dx.doi.org/10.1074/jbc.M114.608265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361766	Green Published, hybrid			2022-12-26	WOS:000346897900013
J	Zhang, J; Lu, AR; Kong, LL; Zhang, QL; Ling, EJ				Zhang, Jie; Lu, Anrui; Kong, Lulu; Zhang, Qiaoli; Ling, Erjun			Functional Analysis of Insect Molting Fluid Proteins on the Protection and Regulation of Ecdysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; MANDUCA-SEXTA; BOMBYX-MORI; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; TRIBOLIUM-CASTANEUM; BEAUVERIA-BASSIANA; RNA INTERFERENCE; INNATE IMMUNITY; DUAL OXIDASE	Molting fluid accumulates between the old and new cuticles during periodical ecdysis in Ecdysozoa. Natural defects in insect ecdysis are frequently associated with melanization (an immunity response) occurring primarily in molting fluids, suggesting that molting fluid may impact immunity as well as affect ecdysis. To address this hypothesis, proteomic analysis of molting fluids from Bombyx mori during three different types of ecdysis was performed. Many proteins were newly identified, including immunity-related proteins, in each molting fluid. Molting fluids inhibited the growth of bacteria in vitro. The entomopathogenic fungi Beauveria bassiana, which can escape immune responses in feeding larvae, is quickly recognized by larvae during ecdysis, followed by melanization in molting fluid and old cuticle. Fungal conidia germination was delayed, and no hyphae were detected in the hemocoels of pharate instar insects. Molting fluids protect the delicate pharate instar insects with extremely thin cuticles against microorganisms. To explore the function of molting fluids in ecdysis regulation, based on protein similarity, 32 genes were selected for analysis in ecdysis regulation through RNAi in Tribolium castaneum, a model commonly used to study integument development because RNAi is difficult to achieve in B. mori. We identified 24 molting proteins that affected ecdysis after knockdown, with different physiological functions, including old cuticle protein recycling, molting fluid pressure balance, detoxification, and signal detection and transfer of molting fluids. We report that insects secrete molting fluid for protection and regulation of ecdysis, which indicates a way to develop new pesticides through interrupting insect ecdysis in the future.	[Zhang, Jie; Lu, Anrui; Zhang, Qiaoli; Ling, Erjun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Kong, Lulu] Shanghai Jiao Tong Univ, Coll Agr & Biol, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Ling, EJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	erjunling@sippe.ac.cn			National Basic Research Program of China [2012CB114605]; National Natural Science Foundation of China [31172151]; Ministry of Agriculture of China [2011ZX08009-003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Basic Research Program of China Grant 2012CB114605, National Natural Science Foundation of China Grant 31172151, and Ministry of Agriculture of China Grant 2011ZX08009-003.	Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; Ashida Masaaki, 1998, P135; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Denys A, 1997, IMMUNOLOGY, V91, P609, DOI 10.1046/j.1365-2567.1997.00296.x; Diaz-Albiter H, 2012, J BIOL CHEM, V287, P23995, DOI 10.1074/jbc.M112.376095; Ewer J, 2005, PLOS BIOL, V3, P1696, DOI 10.1371/journal.pbio.0030349; FIRSTENCEL H, 1990, J INVERTEBR PATHOL, V55, P258, DOI 10.1016/0022-2011(90)90061-A; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He FJ, 2003, J RENIN-ANGIO-ALDO S, V4, P11, DOI 10.3317/jraas.2003.001; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Jebara S, 2005, J PLANT PHYSIOL, V162, P929, DOI 10.1016/j.jplph.2004.10.005; Ji MM, 2013, INSECT MOL BIOL, V22, P273, DOI 10.1111/imb.12019; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kaji K, 2009, INSECT BIOCHEM MOLEC, V39, P207, DOI 10.1016/j.ibmb.2008.12.001; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KATZENELLENBOGEN BS, 1971, J INSECT PHYSIOL, V17, P1139, DOI 10.1016/0022-1910(71)90016-3; Ken CF, 2005, J AGR FOOD CHEM, V53, P1470, DOI 10.1021/jf048269f; KUWANO E, 1985, AGR BIOL CHEM TOKYO, V49, P483, DOI 10.1080/00021369.1985.10866750; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Ling Erjun, 2003, Journal of Insect Biotechnology and Sericology, V72, P101; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; OHNISHI E, 1970, ARCH BIOCHEM BIOPHYS, V139, P143, DOI 10.1016/0003-9861(70)90055-X; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Sabotic J, 2012, APPL MICROBIOL BIOT, V93, P1351, DOI 10.1007/s00253-011-3834-x; SAMUELS RI, 1993, J INSECT PHYSIOL, V39, P633, DOI 10.1016/0022-1910(93)90068-3; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shen CR, 2010, J BIOMOL SCREEN, V15, P213, DOI 10.1177/1087057109355057; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; Tan A, 2008, INSECT BIOCHEM MOLEC, V38, P430, DOI 10.1016/j.ibmb.2007.09.012; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Wang P, 2000, INSECT BIOCHEM MOLEC, V30, P135, DOI 10.1016/S0965-1748(99)00108-3; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043769; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Zdybicka-Barabas A, 2011, COMP BIOCHEM PHYS B, V158, P90, DOI 10.1016/j.cbpb.2010.10.001; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	61	71	76	5	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35891	35906		10.1074/jbc.M114.599597	http://dx.doi.org/10.1074/jbc.M114.599597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368323	hybrid, Green Published			2022-12-26	WOS:000346897900021
J	Del Nagro, C; Xiao, Y; Rangell, L; Reichelt, M; O'Brien, T				Del Nagro, Christopher; Xiao, Yang; Rangell, Linda; Reichelt, Mike; O'Brien, Thomas			Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; ATP; Cell Death; Cell Metabolism; Nicotinamide Adenine Dinucleotide (NAD); GNE-617; NAMPT; Oncosis	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; POLY(ADP-RIBOSE) SYNTHESIS; APOPTOSIS; NECROSIS; SIRT1; DEACETYLASE; INHIBITORS; CHROMATIN; CANCER; ACID	Depletion of the central metabolite NAD in cells results in broad metabolic defects leading to cell death and is a proposed novel therapeutic strategy in oncology. There is, however, a limited understanding of the underlying mechanisms that connect disruption of this central metabolite with cell death. Here we utilize GNE-617, a small molecule inhibitor of NAMPT, a rate-limiting enzyme required for NAD generation, to probe the pathways leading to cell death following NAD depletion. In all cell lines examined, NAD was rapidly depleted (average t(1/2) of 8.1 h) following NAMPT inhibition. Concurrent with NAD depletion, there was a decrease in both cell proliferation and motility, which we attribute to reduced activity of NAD-dependent deacetylases because cells fail to deacetylate -tubulin-K40 and histone H3-K9. Following depletion of NAD by >95%, cells lose the ability to regenerate ATP. Cell lines with a slower rate of ATP depletion (average t(1/2) of 45 h) activate caspase-3 and show evidence of apoptosis and autophagy, whereas cell lines with rapid depletion ATP (average t(1/2) of 32 h) do not activate caspase-3 or show signs of apoptosis or autophagy. However, the predominant form of cell death in all lines is oncosis, which is driven by the loss of plasma membrane homeostasis once ATP levels are depleted by >20-fold. Thus, our work illustrates the sequence of events that occurs in cells following depletion of a key metabolite and reveals that cell death caused by a loss of NAD is primarily driven by the inability of cells to regenerate ATP.	[Del Nagro, Christopher; Xiao, Yang; O'Brien, Thomas] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Rangell, Linda; Reichelt, Mike] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	O'Brien, T (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	Obrien.tom@gene.com		O'Brien, Thomas/0000-0002-9161-8070				Berger N A, 1986, Basic Life Sci, V38, P357; Berger N A, 1983, Princess Takamatsu Symp, V13, P219; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; CARSON DA, 1987, J IMMUNOL, V138, P1904; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; CHATTERJEE S, 1989, EXP CELL RES, V184, P1, DOI 10.1016/0014-4827(89)90358-3; Chiarugi A, 2005, FASEB J, V19, P1783, DOI 10.1096/fj.05-4200rev; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Hasmann M, 2003, CANCER RES, V63, P7436; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Jeong YS, 2010, GENES CELLS, V15, P181, DOI 10.1111/j.1365-2443.2009.01375.x; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JURKOWITZALEXANDER MS, 1992, J NEUROCHEM, V59, P344, DOI 10.1111/j.1471-4159.1992.tb08910.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; MAJNO G, 1995, AM J PATHOL, V146, P3; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Brien T, 2013, NEOPLASIA, V15, P1314, DOI [10.1593/neo.131184, 10.1593/neo.131718]; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Orlov SN, 2004, ADV EXP MED BIOL, V559, P219; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; van Horssen R, 2013, CELL MOL LIFE SCI, V70, P2175, DOI 10.1007/s00018-012-1249-1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664	48	51	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35182	35192		10.1074/jbc.M114.580159	http://dx.doi.org/10.1074/jbc.M114.580159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355314	Green Published, hybrid			2022-12-26	WOS:000346660200012
J	Zearfoss, NR; Deveau, LM; Clingman, CC; Schmidt, E; Johnson, ES; Massi, F; Ryder, SP				Zearfoss, N. Ruth; Deveau, Laura M.; Clingman, Carina C.; Schmidt, Eric; Johnson, Emily S.; Massi, Francesca; Ryder, Sean P.			A Conserved Three-nucleotide Core Motif Defines Musashi RNA Binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fluorescence Anisotropy; RNA; RNA-binding Protein; RNA-Protein Interaction; Binding Specificity; RNA Recognition; RRM	MESSENGER-RNA; MYELOID-LEUKEMIA; STEM-CELLS; TRANSLATIONAL REPRESSION; PROTEIN MUSASHI-1; PROGENITOR CELLS; MOLECULAR-BASIS; MAMMALIAN CNS; EXPRESSION; RECOGNITION	Musashi (MSI) family proteins control cell proliferation and differentiation in many biological systems. They are overexpressed in tumors of several origins, and their expression level correlates with poor prognosis. MSI proteins control gene expression by binding RNA and regulating its translation. They contain two RNA recognition motif (RRM) domains, which recognize a defined sequence element. The relative contribution of each nucleotide to the binding affinity and specificity is unknown. We analyzed the binding specificity of three MSI family RRM domains using a quantitative fluorescence anisotropy assay. We found that the core element driving recognition is the sequence UAG. Nucleotides outside of this motif have a limited contribution to binding free energy. For mouse MSI1, recognition is determined by the first of the two RRM domains. The second RRM adds affinity but does not contribute to binding specificity. In contrast, the recognition element for Drosophila MSI is more extensive than the mouse homolog, suggesting functional divergence. The short nature of the binding determinant suggests that protein-RNA affinity alone is insufficient to drive target selection by MSI family proteins.	[Zearfoss, N. Ruth; Deveau, Laura M.; Clingman, Carina C.; Schmidt, Eric; Johnson, Emily S.; Massi, Francesca; Ryder, Sean P.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ryder, SP (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantation St, Worcester, MA 01605 USA.	Sean.Ryder@umassmed.edu			National Institutes of Health [GM098763, GM081422, GM098643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098763, R01GM098643, R01GM081422, T32GM107000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098763 (to F. M.) and GM081422 and GM098643 (to S. P. R.).	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clingman CC, 2014, ELIFE, V3, DOI 10.7554/eLife.02848; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson NR, 2008, GLIA, V56, P318, DOI 10.1002/glia.20615; Goddard D., 2008, SPARKY 3; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kurihara Y, 1997, GENE, V186, P21, DOI 10.1016/S0378-1119(96)00673-7; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; RICHTER K, 1990, New Biologist, V2, P556; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Siddall NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049810; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x	41	49	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35530	35541		10.1074/jbc.M114.597112	http://dx.doi.org/10.1074/jbc.M114.597112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368328	Green Published, hybrid			2022-12-26	WOS:000346660200041
J	Chu, SM; Hsu, JF; Lee, CW; Lien, RY; Huang, HR; Chiang, MC; Fu, RH; Tsai, MH				Chu, Shih-Ming; Hsu, Jen-Fu; Lee, Chiang-Wen; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Tsai, Ming-Horng			Neurological Complications after Neonatal Bacteremia: The Clinical Characteristics, Risk Factors, and Outcomes	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; BACTERIAL-MENINGITIS; SUBDURAL EMPYEMA; INFECTION; DISEASE; INTERVENTION; BURDEN	Background: Neonates with bacteremia are at risk of neurologic complications. Relevant information warrants further elucidation. Study Design: This was a retrospective cohort study of neonates with bacteremia-related neurologic complications (BNCs) in a tertiary-level neonatal intensive care unit (NICU). A systemic chart review was performed conducted to identify clinical characteristics and outcomes. A cohort of related conditions was constructed as the control group. Logistic regression analysis was used to identify independent risk factors for BNC. Results: Of 1037 bacteremia episodes, 36 (3.5%) had BNCs. Twenty-four cases of BNCs were related to meningitis, five were presumed meningitis, and seven occurred after septic shock. The most common causative pathogens were Group B streptococcus (41.7%) and E. coli (16.7%). The major BNCs consisted of seizures (28), hydrocephalus (20), encephalomalacia (11), cerebral infarction (7), subdural empyema (6), ventriculitis (8), and abscess (4). Eight (22.8%) neonates died and six (16.7%) were discharged in critical condition when the family withdrew life-sustaining treatment. Among the 22 survivors, eight had neurologic sequelae upon discharge. After multivariate logistic regression analysis, neonates with meningitis caused by Group B streptococcus (adjusted odds ratio [OR]: 8.90, 95% confidence interval [CI]: 2.20-36.08; p = 0.002) and combined meningitis and septic shock (OR, 5.94; 95% CI: 1.53-23.15; p = 0.010) were independently associated with BNCs. Conclusions: Neonates with bacteremia-related neurologic complications are associated with adverse outcomes or sequelae. Better strategies aimed at early detection and reducing the emergence of neurologic complications and aggressive treatment of Group B streptococcus sepsis are needed in neonates with meningitis and septic shock.	[Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Taoyuan, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Tsai, Ming-Horng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan.	mingmin.tw@yahoo.com.tw						Atif ML, 2008, INFECT CONT HOSP EP, V29, P1066, DOI 10.1086/591858; Berardi A, 2013, PEDIATRICS, V131, pE361, DOI 10.1542/peds.2012-1231; Carter JE, 2008, CLIN NEUROL NEUROSUR, V110, P614, DOI 10.1016/j.clineuro.2008.03.012; Chang YC, 1997, PEDIATR NEUROL, V17, P144, DOI 10.1016/S0887-8994(97)00078-7; de Goede CGEL, 2006, EUR J PAEDIATR NEURO, V10, P31, DOI 10.1016/j.ejpn.2005.10.001; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; GRAY JE, 1992, PEDIATRICS, V90, P561; Ho JJ, 2001, PEDIATR INFECT DIS J, V20, P557, DOI 10.1097/00006454-200106000-00002; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hughes DC, 2010, POSTGRAD MED J, V86, P478, DOI 10.1136/pgmj.2010.097022; Jim KK, 2012, NEUROLOGY, V79, P2133, DOI 10.1212/WNL.0b013e3182752d0e; Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9; Liu ZH, 2010, J NEUROSURG-PEDIATR, V6, P38, DOI 10.3171/2010.4.PEDS09433; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; May M, 2005, ARCH DIS CHILD-FETAL, V90, pF324, DOI 10.1136/adc.2004.066134; Mohan S, 2012, NEUROIMAG CLIN N AM, V22, P557, DOI 10.1016/j.nic.2012.04.003; Nakanishi H, 2010, J PERINATOL, V30, P751, DOI 10.1038/jp.2010.41; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Trijbels-Smeulders MAJM, 2006, PEDIATR INFECT DIS J, V25, P945, DOI 10.1097/01.inf.0000237821.65559.08; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Vasilopoulou VA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-214; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; William Taeusch H, 2006, AVERYS DIS NEWBORN	30	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e105294	10.1371/journal.pone.0105294	http://dx.doi.org/10.1371/journal.pone.0105294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364821	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100002
J	Hermans, C; Anz, D; Engel, J; Kirchner, T; Endres, S; Mayr, D				Hermans, Cecilia; Anz, David; Engel, Jutta; Kirchner, Thomas; Endres, Stefan; Mayr, Doris			Analysis of FoxP3+T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers	PLOS ONE			English	Article							REGULATORY T-CELLS; FOXP3 EXPRESSION; SELF-TOLERANCE; TGF-BETA; CANCER; SUPPRESSION; LYMPHOCYTES; POPULATION; ACCUMULATE; MECHANISM	Purpose: Tumor infiltrating CD4+CD25+FoxP3+ regulatory immune cells (Treg) have been associated with impaired antitumor immune response and unfavorable prognosis for patients affected by ovarian carcinoma, whereas CD8+T-cells have been found to positively influence survival rates in a large panel of solid tumors. Recently, density, location and tumor infiltration patterns of the respective immune cell subtypes have been identified as key prognostic factors for different types of tumors. Patients and Methods: We stained 210 human ovarian carcinoma samples immunhistochemically for FoxP3 and CD8 to identify the impact different immune cell patterns have on generally accepted prognostic variables as well as on overall survival. Results: We found that FoxP3+ cells located within lymphoid aggregates surrounding the tumor were strongly associated with reduced survival time (P = 0.007). Central accumulation of CD8+ effector cells within the tumor bed shows a positive effect on survival (P = 0,001). Conclusion: The distribution pattern of immune cells within the tumor environment strongly influences prognosis and overall survival time of patients with ovarian carcinoma.	[Hermans, Cecilia; Kirchner, Thomas; Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Engel, Jutta] Univ Munich, Inst Med Informat Biometry & Epidemiol, Tumorregister Munich, Munich, Germany; [Anz, David; Endres, Stefan] Univ Munich, Div Clin Pharmacol, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Munich; University of Munich; University of Munich	Hermans, C (corresponding author), Univ Munich, Dept Pathol, Munich, Germany.	Cecilia.Hermans@med.uni-muenchen.de						Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Deutsche Krebsgesellschaft, 2006, INT S2K LEITL DIAGN, P76; Dunn GP, 2005, IMMUNOL RES, V32, P231, DOI 10.1385/IR:32:1-3:231; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Ebelt K, 2009, EUR J CANCER, V45, P1664, DOI 10.1016/j.ejca.2009.02.015; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Fachgesellschaften AdWM, 2007, DIAGN THER MAL OV; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Feyler S, 2009, BRIT J HAEMATOL, V144, P686, DOI 10.1111/j.1365-2141.2008.07530.x; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Koch-Institut R, 2010, VERBREITUNG KREBSERK; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Le DT, 2011, INT J CANCER, V129, P636, DOI 10.1002/ijc.25693; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Rahir G, 2012, CANCER IMMUNOL IMMUN, V61, P751, DOI 10.1007/s00262-012-1253-1; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, EUR J IMMUNOL, V38, P901, DOI 10.1002/eji.200890012; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmalfeldt B, 2007, MANUAL MALIGNE OVARI; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shimizu Y, 1998, GYNECOL ONCOL, V70, P2, DOI 10.1006/gyno.1998.5051; Tavassoli FA, 2004, PATHOLOGY GENETICS T; Wang LC, 2010, WORLD J SURG, V34, P1059, DOI 10.1007/s00268-010-0448-x; WHO WHO, 2009, WORLD HLTH OBS; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Woodward ER, 2007, BJOG-INT J OBSTET GY, V114, P1500, DOI 10.1111/j.1471-0528.2007.01499.x; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	56	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111757	10.1371/journal.pone.0111757	http://dx.doi.org/10.1371/journal.pone.0111757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365237	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100114
J	Mota, S; Vieira, N; Barbosa, S; Delaveau, T; Torchet, C; Le Saux, A; Garcia, M; Pereira, A; Lemoine, S; Coulpier, F; Darzacq, X; Benard, L; Casal, M; Devaux, F; Paiva, S				Mota, Sandra; Vieira, Neide; Barbosa, Sonia; Delaveau, Thierry; Torchet, Claire; Le Saux, Agnes; Garcia, Mathilde; Pereira, Ana; Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier; Benard, Lionel; Casal, Margarida; Devaux, Frederic; Paiva, Sandra			Role of the DHH1 Gene in the Regulation of Monocarboxylic Acids Transporters Expression in Saccharomyces cerevisiae	PLOS ONE			English	Article							PUTATIVE RNA HELICASE; LACTATE-PROTON SYMPORT; DEAD-BOX HELICASE; MESSENGER-RNA; P-BODIES; TRANSLATIONAL REPRESSION; DNA-DAMAGE; YEAST; PROTEIN; TRANSCRIPTION	Previous experiments revealed that DHH1, a RNA helicase involved in the regulation of mRNA stability and translation, complemented the phenotype of a Saccharomyces cerevisiae mutant affected in the expression of genes coding for monocarboxylic-acids transporters, JEN1 and ADY2 (Paiva S, Althoff S, Casal M, Leao C. FEMS Microbiol Lett, 1999, 170:301-306). In wild type cells, JEN1 expression had been shown to be undetectable in the presence of glucose or formic acid, and induced in the presence of lactate. In this work, we show that JEN1 mRNA accumulates in a dhh1 mutant, when formic acid was used as sole carbon source. Dhh1 interacts with the decapping activator Dcp1 and with the deadenylase complex. This led to the hypothesis that JEN1 expression is post-transcriptionally regulated by Dhh1 in formic acid. Analyses of JEN1 mRNAs decay in wild-type and dhh1 mutant strains confirmed this hypothesis. In these conditions, the stabilized JEN1 mRNA was associated to polysomes but no Jen1 protein could be detected, either by measurable lactate carrier activity, Jen1-GFP fluorescence detection or western blots. These results revealed the complexity of the expression regulation of JEN1 in S. cerevisiae and evidenced the importance of DHH1 in this process. Additionally, microarray analyses of dhh1 mutant indicated that Dhh1 plays a large role in metabolic adaptation, suggesting that carbon source changes triggers a complex interplay between transcriptional and post-transcriptional effects.	[Mota, Sandra; Vieira, Neide; Barbosa, Sonia; Pereira, Ana; Casal, Margarida; Paiva, Sandra] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, P-4700 Braga, Portugal; [Mota, Sandra] Polytech Inst Porto, Sch Allied Hlth Sci, Ctr Hlth & Environm Res CISA, Vila Nova De Gaia, Portugal; [Delaveau, Thierry; Garcia, Mathilde; Devaux, Frederic] Univ Paris 06, Sorbonne Univ, UMR7238, Lab Biol Computat & Quantitat, Paris, France; [Delaveau, Thierry; Garcia, Mathilde; Devaux, Frederic] CNRS, Lab Biol Computat & Quantitat, UMR7238, Paris, France; [Torchet, Claire; Benard, Lionel] CNRS, Lab Biol Mol & Cellulaire Eucaryotes, UMR8226, Inst Biol Phys Chim, Paris, France; [Torchet, Claire; Benard, Lionel] Univ Paris 06, Sorbonne Univ, UMR8226, Inst Biol Phys Chim,Lab Biol Mol & Cellulaire Euc, Paris, France; [Le Saux, Agnes] CNRS, Inst Biol Phys Chim, Lab Express Genet Microbienne, FRE3630, Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] Ecole Normale Super, Inst Biol, ENS, IBENS, F-75231 Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] INSERM, U1024, Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] CNRS, UMR 8197, Paris, France	Universidade do Minho; Polytechnic Institute of Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Devaux, F (corresponding author), Univ Paris 06, Sorbonne Univ, UMR7238, Lab Biol Computat & Quantitat, Paris, France.	frederic.devaux@upmc.fr; spaiva@bio.uminho.pt	BENARD, LIONEL/E-4057-2019; DEVAUX, Frédéric/N-2288-2019; CASAL, MARGARIDA/B-6386-2009; Paiva, Sandra Cristina Almeida/H-8864-2013; Vieira, Neide/K-7702-2015	BENARD, LIONEL/0000-0003-1745-1361; DEVAUX, Frédéric/0000-0002-0039-9096; CASAL, MARGARIDA/0000-0002-0143-9758; Paiva, Sandra Cristina Almeida/0000-0003-2270-4546; Vieira, Neide/0000-0002-7166-4336; De Oliveira Barbosa, Sonia/0000-0002-7027-1530; Darzacq, Xavier/0000-0003-2537-8395; TORCHET, Claire/0000-0002-6583-823X; Santos Pereira, Ana/0000-0001-6410-7972; Mota, Sandra/0000-0002-2803-7230	Portuguese grant (Eixo 2, Medida 2.3, QCAIII - FEDER) [POCI/BIA-BCM/57812/2004]; FCT PhD fellowship [SFRH/BD/23503/2005, SFRH/BD/74790/2010]; Agence pour la Recherche contre le Cancer (ARC); FEDER through POFC-COMPETE; Portuguese funds from FCT [PEst-OE/BIA/UI4050/2014]; Fundação para a Ciência e a Tecnologia [POCI/BIA-BCM/57812/2004] Funding Source: FCT	Portuguese grant (Eixo 2, Medida 2.3, QCAIII - FEDER); FCT PhD fellowship(Portuguese Foundation for Science and Technology); Agence pour la Recherche contre le Cancer (ARC); FEDER through POFC-COMPETE; Portuguese funds from FCT(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was supported by the Portuguese grant POCI/BIA-BCM/57812/2004 (Eixo 2, Medida 2.3, QCAIII - FEDER). N.V. received a FCT PhD fellowship (SFRH/BD/23503/2005). S.M. received a FCT PhD fellowship (SFRH/BD/74790/2010). F.D.'s work is supported by a grant from the Agence pour la Recherche contre le Cancer (ARC). Support to C.B.M.A. by FEDER through POFC-COMPETE and by Portuguese funds from FCT through the project PEst-OE/BIA/UI4050/2014 is also acknowledged. The authors thank Josette Banroques and Kyle Tanner for their advice regarding polysome gradients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO Y, 1995, CANCER RES, V55, P3444; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Ausubel F., 1998, CURRENT PROTOCOLS MO, P211; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Beliakova-Bethell N, 2006, RNA, V12, P94, DOI 10.1261/rna.2264806; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Blewett NH, 2012, MOL CELL BIOL, V32, P4181, DOI 10.1128/MCB.00483-12; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Carroll JS, 2011, J CELL BIOL, V194, P527, DOI 10.1083/jcb.201007151; CASAL M, 1995, FEMS MICROBIOL LETT, V128, P279, DOI 10.1016/0378-1097(95)00117-N; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Checkley MA, 2010, MOL CELL BIOL, V30, P382, DOI 10.1128/MCB.00251-09; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; DEVALOIR T, 1991, P NATL ACAD SCI USA, V88, P2113, DOI 10.1073/pnas.88.6.2113; Erez O, 2002, BIOCHEM BIOPH RES CO, V295, P1142, DOI 10.1016/S0006-291X(02)00823-9; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gregori C, 2008, J BIOL CHEM, V283, P25752, DOI 10.1074/jbc.M803095200; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hata H, 1998, GENETICS, V148, P571; Holetz FB, 2010, FEBS J, V277, P3415, DOI 10.1111/j.1742-4658.2010.07747.x; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hurto RL, 2011, RNA, V17, P912, DOI 10.1261/rna.2558511; Ka M, 2008, BIOCHEM BIOPH RES CO, V367, P680, DOI 10.1016/j.bbrc.2007.12.169; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kramer S, 2010, J CELL SCI, V123, P699, DOI 10.1242/jcs.058511; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Kushner N, 2003, P NATL ACAD SCI USA, V100, P6652, DOI 10.1073/pnas.1131930100; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Liu HD, 2005, MOL CELL BIOL, V25, P9764, DOI 10.1128/MCB.25.22.9764-9772.2005; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; MAEKAWA H, 1994, MOL GEN GENET, V244, P456, DOI 10.1007/BF00583896; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Makuc J, 2001, YEAST, V18, P1131, DOI 10.1002/yea.763; Mazzoni C, 2003, MOL BIOL CELL, V14, P721, DOI 10.1091/mbc.E02-05-0258; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Olszewska M, 2012, CELL BIOCHEM FUNCT, V30, P177, DOI 10.1002/cbf.2804; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Paiva S, 1999, FEMS MICROBIOL LETT, V170, P301, DOI 10.1111/j.1574-6968.1999.tb13387.x; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; PARKER R, 1991, P415; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seto M, 1995, GENE, V166, P293, DOI 10.1016/0378-1119(95)00559-5; SHARIF H, 2013, NUCL ACIDS RES; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STRAHLBOLSINGER S, 1993, YEAST, V9, P429, DOI 10.1002/yea.320090414; Stribinskis V, 2007, NUCLEIC ACIDS RES, V35, P1301, DOI 10.1093/nar/gkm023; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Taylor R, 2005, EUKARYOT CELL, V4, P2066, DOI 10.1128/EC.4.12.2066-2077.2005; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	90	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111589	10.1371/journal.pone.0111589	http://dx.doi.org/10.1371/journal.pone.0111589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365506	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100083
J	Singh, V; Gupta, D; Arora, R; Tripathi, RP; Almasan, A; Macklis, RM				Singh, Vijay; Gupta, Damodar; Arora, Rajesh; Tripathi, Rajendra Prashad; Almasan, Alexandru; Macklis, Roger M.			Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; HUMAN B-CELLS; MONOCLONAL-ANTIBODIES; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; DOWN-REGULATION; RITUXIMAB; EXPRESSION; COMPLEMENT	In Background: The sensitivity of human Burkitt's lymphoma cells to rituximab (Rtx) and tositumomab (Tst) was assessed on cells expressing different levels of CD20 on surface. Cells that harbor low CD20 levels may resists against therapeutics response to CD20-specific antibodies. We postulated that, radiation-induced modulation of CD20 surface levels may play a crucial and central role in determining the relative efficacy of rituximab and tositumomab in treating Burkitt's lymphoma disease. Here, we examined the gamma-radiation-induced CD20 expression in the Burkitt lymphoma cell line 'Daudi' and the relation of differential levels of CD20 with anti-CD20 mAbs mediated cell death. Methodology: In this study we examined kinetics of CD20 expression following sub lethal doses of gamma-radiation to Daudi cells and thereafter anti-CD20 mAbs (rituximab and tositumomab) were added in cell suspensions. The correlation of kinetics of CD20 expression and cells treated with anti-CD20 mAbs/or corresponding isotype Abs with special reference to changes in mitochondrial membrane potential and reactive oxygen species generation was also examined. Further, we also investigated the efficacy of anti-CD20 mAbs and possible induction of cell death in relation to levels of CD20 cell surface expression. Conclusion: This report provides evidence that CD20 expression can be induced by exposure of cells to c-radiation. In addition, these findings demonstrated that the efficacy of anti-CD20 mAbs is dependent on the surface levels of CD20. Based on these findings, we hypothesized (i) irradiation just prior to immunotherapy may provide new treatment options even in aggressive B cell tumors, which are resistant to current therapies in vivo (ii) The efficacy of induction of apoptosis varies with type of monoclonal antibodies in vitro.	[Singh, Vijay; Gupta, Damodar; Arora, Rajesh; Tripathi, Rajendra Prashad] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Delhi, India; [Almasan, Alexandru; Macklis, Roger M.] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA; [Almasan, Alexandru] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Cleveland Clinic Foundation; Cleveland Clinic Foundation	Gupta, D (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Brig SK Mazumdar Marg, Delhi, India.	damodar.gupta@gmail.com; macklir@ccf.org	Arora, Rajesh/AAE-4596-2021; Almasan, Alex/C-2715-2008	Arora, Rajesh/0000-0001-7307-9221; Almasan, Alex/0000-0002-8916-6650; SINGH, VIJAY/0000-0002-0789-5551	University Grants Commission; NATIONAL CANCER INSTITUTE [R01CA184137] Funding Source: NIH RePORTER	University Grants Commission(University Grants Commission, India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DG is grateful to University Grants Commission for the award of research fellowship. The authors are also grateful to Director, INMAS for providing opportunity to carry out this research work, and to Defence Research and Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2013, INT J RADIAT BIOL, V89, P200, DOI 10.3109/09553002.2013.741285; Alas S, 2001, CLIN CANCER RES, V7, P709; Alinari L, 2011, BLOOD, V117, P4530, DOI 10.1182/blood-2010-08-303354; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bologna L, 2011, J IMMUNOL, V186, P3762, DOI 10.4049/jimmunol.1000303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chan HTC, 2003, CANCER RES, V63, P5480; Chandna S, 2004, CYTOM PART A, V61A, P127, DOI 10.1002/cyto.a.20071; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Crosby ME, 2007, ONCOGENE, V26, P1897, DOI 10.1038/sj.onc.1209998; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; Dalle S, 2011, MOL CANCER THER, V10, P178, DOI 10.1158/1535-7163.MCT-10-0385; DEANS JP, 1993, J IMMUNOL, V151, P4494; Ge XW, 2011, CLIN CANCER RES, V17, P6702, DOI 10.1158/1078-0432.CCR-11-0647; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Goldenberg DM, 2009, BLOOD, V113, P1062, DOI 10.1182/blood-2008-07-168146; Gomez-Tejedor G. Garcia, 2012, RAD DAMAGE BIOMOLECU; Gupta D, 2008, FREE RADICAL BIO MED, V44, P614, DOI 10.1016/j.freeradbiomed.2007.10.048; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Ivanov A, 2008, CLIN CANCER RES, V14, P4925, DOI 10.1158/1078-0432.CCR-07-5072; Jazirehi AR, 2003, MOL CANCER THER, V2, P1183; Kunala S, 2001, INT J CANCER, V96, P178, DOI 10.1002/ijc.1018; Leach JK, 2001, CANCER RES, V61, P3894; Lim SH, 2010, HAEMATOL-HEMATOL J, V95, P135, DOI 10.3324/haematol.2008.001628; Mattes MJ, 2009, CANCER BIOTHER RADIO, V24, P185, DOI 10.1089/cbr.2008.0567; Mone AP, 2004, BLOOD, V103, P1846, DOI 10.1182/blood-2003-08-2836; OETTGEN HC, 1983, HYBRIDOMA, V2, P17, DOI 10.1089/hyb.1983.2.17; Pedersen IM, 2002, BLOOD, V99, P1314, DOI 10.1182/blood.V99.4.1314; Philippe J, 1997, CYTOMETRY, V29, P242, DOI 10.1002/(SICI)1097-0320(19971101)29:3<242::AID-CYTO7>3.3.CO;2-Z; Pohlman B, 2006, EXPERT REV ANTICANC, V6, P445, DOI 10.1586/14737140.6.3.445; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; STASHENKO P, 1980, J IMMUNOL, V125, P1678; Takei K, 2006, LEUKEMIA RES, V30, P625, DOI 10.1016/j.leukres.2005.09.008; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	40	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111113	10.1371/journal.pone.0111113	http://dx.doi.org/10.1371/journal.pone.0111113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364827	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100050
J	Sun, FL; Wang, YS; Wu, ML; Jiang, ZY; Sun, CC; Cheng, H				Sun, Fu-Lin; Wang, You-Shao; Wu, Mei-Lin; Jiang, Zhao-Yu; Sun, Cui-Ci; Cheng, Hao			Genetic Diversity of Bacterial Communities and Gene Transfer Agents in Northern South China Sea	PLOS ONE			English	Article							ROSEOBACTER CLADE BACTERIA; BACTERIOPLANKTON; ATLANTIC; RHODOBACTERALES; PROCHLOROCOCCUS; EXPRESSION; LINEAGES; WATERS; OCEAN; DNA	Pyrosequencing of the 16S ribosomal RNA gene (rDNA) amplicons was performed to investigate the unique distribution of bacterial communities in northern South China Sea (nSCS) and evaluate community structure and spatial differences of bacterial diversity. Cyanobacteria, Proteobacteria, Actinobacteria, and Bacteroidetes constitute the majority of bacteria. The taxonomic description of bacterial communities revealed that more Chroococcales, SAR11 clade, Acidimicrobiales, Rhodobacterales, and Flavobacteriales are present in the nSCS waters than other bacterial groups. Rhodobacterales were less abundant in tropical water (nSCS) than in temperate and cold waters. Furthermore, the diversity of Rhodobacterales based on the gene transfer agent (GTA) major capsid gene (g5) was investigated. Four g5 gene clone libraries were constructed from samples representing different regions and yielded diverse sequences. Fourteen g5 clusters could be identified among 197 nSCS clones. These clusters were also related to known g5 sequences derived from genome-sequenced Rhodobacterales. The composition of g5 sequences in surface water varied with the g5 sequences in the sampling sites; this result indicated that the Rhodobacterales population could be highly diverse in nSCS. Phylogenetic tree analysis result indicated distinguishable diversity patterns among tropical (nSCS), temperate, and cold waters, thereby supporting the niche adaptation of specific Rhodobacterales members in unique environments.	[Sun, Fu-Lin; Wang, You-Shao; Wu, Mei-Lin; Jiang, Zhao-Yu; Sun, Cui-Ci; Cheng, Hao] Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Sun, Fu-Lin; Wang, You-Shao; Sun, Cui-Ci] Chinese Acad Sci, South China Sea Inst Oceanol, Daya Bay Marine Biol Res Stn, Shenzhen, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Wang, YS (corresponding author), Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	yswang@scsio.ac.cn	Wu, Mei-Lin/G-4776-2011		National Natural Science Foundation of China [41406130, 41176101, 41430966, 31270528, 41206082]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA10020225]; key projects in the National Science & Technology Pillar Program [2012BAC07B0402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); key projects in the National Science & Technology Pillar Program	This research was supported by the National Natural Science Foundation of China (41406130, 41176101, 41430966, 31270528 and 41206082), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA10020225), and the key projects in the National Science & Technology Pillar Program in the Eleventh Five-year Plan Period (2012BAC07B0402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2003, APPL ENVIRON MICROB, V69, P5051, DOI 10.1128/AEM.69.9.5051-5059.2003; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Fu YY, 2013, FEMS MICROBIOL ECOL, V84, P564, DOI 10.1111/1574-6941.12085; Fu YY, 2010, AQUAT MICROB ECOL, V59, P283, DOI 10.3354/ame01398; Giebel HA, 2009, ENVIRON MICROBIOL, V11, P2164, DOI 10.1111/j.1462-2920.2009.01942.x; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Han W.Y., 1998, MARINE CHEM S CHINA; Henriques IS, 2004, FEMS MICROBIOL ECOL, V49, P269, DOI 10.1016/j.femsec.2004.04.003; Hill PG, 2010, FEMS MICROBIOL LETT, V306, P82, DOI 10.1111/j.1574-6968.2010.01940.x; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Lenk S, 2012, ISME J, V6, P2178, DOI 10.1038/ismej.2012.66; Leps J., 2003, MULTIVARIATE ANAL EC; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Lu ZM, 2010, J MARINE SYST, V82, P35, DOI 10.1016/j.jmarsys.2010.03.002; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Moran MA, 2003, GEOMICROBIOL J, V20, P375, DOI 10.1080/01490450303901; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Qu T, 2000, J GEOPHYS RES-OCEANS, V105, P6415, DOI 10.1029/1999JC900323; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SOLIOZ M, 1977, ARCH BIOCHEM BIOPHYS, V181, P300, DOI 10.1016/0003-9861(77)90508-2; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115	36	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111892	10.1371/journal.pone.0111892	http://dx.doi.org/10.1371/journal.pone.0111892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364820	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100134
J	Ma, FJ; Liu, ZB; Hu, X; Ling, H; Li, S; Wu, J; Shao, ZM				Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming			Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients	PLOS ONE			English	Article							INFILTRATING DUCTAL CARCINOMA; IMMUNE CELLS; TUMOR; EXPRESSION; PROLIFERATION; METASTASIS; ACTIVATION; PACLITAXEL; SURVIVAL; GROWTH	Purpose: Breast cancer remains a major cause of death in women worldwide, and tumor metastasis is the leading cause of death in breast cancer patients after conventional treatment. Chronic inflammation is often related to the occurrence and growth of various malignancies. This study evaluated the prognosis of breast cancer patients based on contributors to the innate immune response: myeloid differentiation primary response 88 (MyD88) and Toll-like receptor 4 (TLR4). Methods: We analyzed data from 205 breast invasive ductal carcinoma (IDC) patients who were treated at the Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, from 2002 to 2006. Overall survival (OS) and disease-free survival (DFS) were compared. Results: In total, 152 patients (74.15%) were disease-free without relapse or metastasis, whereas 53 (25.85%) patients developed recurrence or metastasis. A significant positive correlation was observed between MyD88 and TLR4 expression (p<0.001). Patients with high expression were more likely to experience death and recurrence/metastasis events (p<0.05). Patients with low MyD88 or TLR4 expression levels had better DFS and OS than patients with high expression levels (log-rank test: p<0.001). Patients with low MyD88 and TLR4 expression levels had better DFS and OS than patients with high expression levels of either (log-rank test: p<0.001). In a multivariate analysis, high MyD88 expression was an independent predictive factor for decreased DFS (adjusted HR, 3.324; 95% CI, 1.663-6.641; p = 0.001) and OS (adjusted HR, 4.500; 95% CI, 1.546-13.098; p = 0.006). Conclusions: TLR4-MyD88 signaling pathway activation or MyD88 activation alone may be a risk factor for poor prognosis in breast cancer. Therefore, TLR4-MyD88 signaling pathway activation in tumor biology provides a novel potential target for breast cancer therapy.	[Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China; [Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ma, Fang-Jing] Xinjiang Med Univ, Affiliated Hosp 1, Dept Breast Surg, Urumqi, Xinjiang Uygur, Peoples R China	Fudan University; Fudan University; Xinjiang Medical University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [81202080, 81302009, 81201531]; Shanghai Committee of Science and Technology Funds [12ZR1442400, 12DZ2260100, 12ZR1406400, 12ZR1406200, 1241010707700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (Contract grant numbers: 81202080, 81302009, 81201531) and the Shanghai Committee of Science and Technology Funds (Contract grant numbers: 12ZR1442400, 12DZ2260100, 12ZR1406400, 12ZR1406200, 1241010707700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2013, ANN SURG ONCOL, V20, pS389, DOI 10.1245/s10434-012-2595-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Cao AY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-91; Cao AY, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-152; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Costantini S, 2009, IMMUNOL LETT, V126, P91, DOI 10.1016/j.imlet.2009.08.006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Liang BB, 2013, CLIN CANCER RES, V19, P2905, DOI 10.1158/1078-0432.CCR-12-1245; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Molteni M, 2006, CANCER LETT, V235, P75, DOI 10.1016/j.canlet.2005.04.006; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Reed W, 2000, CANCER, V88, P804, DOI 10.1002/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO;2-Y; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Ren T, 2009, PATHOL ONCOL RES, V15, P623, DOI 10.1007/s12253-009-9162-0; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Vaisanen MR, 2010, PROSTATE, V70, P817, DOI 10.1002/pros.21115; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	34	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111639	10.1371/journal.pone.0111639	http://dx.doi.org/10.1371/journal.pone.0111639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360699	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700136
J	Pitt, C; Robert, JA; Bonnett, TR; Keeling, CI; Bohlmann, J; Huber, DPW				Pitt, Caitlin; Robert, Jeanne A.; Bonnett, Tiffany R.; Keeling, Christopher I.; Bohlmann, Joerg; Huber, Dezene P. W.			Proteomics Indicators of the Rapidly Shifting Physiology from Whole Mountain Pine Beetle, Dendroctonus ponderosae (Coleoptera: Curculionidae), Adults during Early Host Colonization	PLOS ONE			English	Article							IPS-PARACONFUSUS COLEOPTERA; JUVENILE-HORMONE; BARK BEETLES; GENE-EXPRESSION; PHEROMONE BIOSYNTHESIS; ENGRAVER BEETLE; RANGE EXPANSION; SCOLYTIDAE; DEFENSE; TRANSCRIPTOME	We developed proteome profiles for host colonizing mountain pine beetle adults, Dendroctonus ponderosae Hopkins (Coleoptera: Curculionidae). Adult insects were fed in pairs on fresh host lodgepole pine, Pinus contorta Dougl. ex Loud, phloem tissue. The proteomes of fed individuals were monitored using iTRAQ and compared to those of starved beetles, revealing 757 and 739 expressed proteins in females and males, respectively, for which quantitative information was obtained. Overall functional category distributions were similar for males and females, with the majority of proteins falling under carbohydrate metabolism (glycolysis, gluconeogenesis, citric acid cycle), structure (cuticle, muscle, cytoskeleton), and protein and amino acid metabolism. Females had 23 proteins with levels that changed significantly with feeding (p<0.05, FDR<0.20), including chaperones and enzymes required for vitellogenesis. In males, levels of 29 proteins changed significantly with feeding (p<0.05, FDR<0.20), including chaperones as well as motor proteins. Only two proteins, both chaperones, exhibited a significant change in both females and males with feeding. Proteins with differential accumulation patterns in females exhibited higher fold changes with feeding than did those in males. This difference may be due to major and rapid physiological changes occurring in females upon finding a host tree during the physiological shift from dispersal to reproduction. The significant accumulation of chaperone proteins, a cytochrome P450, and a glutathione S-transferase, indicate secondary metabolite-induced stress physiology related to chemical detoxification during early host colonization. The females' activation of vitellogenin only after encountering a host indicates deliberate partitioning of resources and a balancing of the needs of dispersal and reproduction.	[Pitt, Caitlin; Robert, Jeanne A.; Bonnett, Tiffany R.; Huber, Dezene P. W.] Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada; [Keeling, Christopher I.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of Northern British Columbia; University of British Columbia	Pitt, C (corresponding author), Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada.	pitt@unbc.ca; huber@unbc.ca	Keeling, Christopher I./I-3371-2012; Huber, Dezene P.W./AAG-9638-2019	Keeling, Christopher I./0000-0001-7885-8558; Huber, Dezene P.W./0000-0002-6495-1759	Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship; Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant; Genome Canada; Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program; Canada Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF); Genome BC	Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship; Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program(Canada Research Chairs); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF); Genome BC	This work was supported by the following: Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (http://www.nserc-crsng.gc.ca/index_eng.asp); Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp); Genome Canada (http://www.genomecanada.ca); Genome British Columbia (http://www.genomebc.ca); Genome Alberta (http://genomealberta.ca); Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca); Canada Foundation for Innovation (CFI) (http://www.innovation.ca; and British Columbia Knowledge Development Fund (BCKDF) (http://www.aved.gov.bc.ca/researchandinnovation/Funding/BCKDF/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by Genome Canada, Genome BC, and Genome Alberta as part of the Tria Project (www.thetriaproject.ca). This does not alter our adherence to PLOS ONE policies on sharing data and materials and no competing interests exist. Information for all proteins in the dataset is provided in the Supplemental Materials file.	Amman GD., 1977, ROLE ARTHROPODS FORE, P3; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Asgari S, 2003, J INSECT PHYSIOL, V49, P545, DOI 10.1016/S0022-1910(03)00025-8; Aw T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-215; Barkawi LS, 2003, INSECT BIOCHEM MOLEC, V33, P773, DOI 10.1016/S0965-1748(03)00069-9; Bearfield JC, 2006, INSECT MOL BIOL, V15, P187, DOI 10.1111/j.1365-2583.2006.00627.x; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Borden J.H., 1985, P257; BULLARD B, 1977, BIOCHEM J, V161, P399, DOI 10.1042/bj1610399; BYERS JA, 1990, NATURWISSENSCHAFTEN, V77, P385, DOI 10.1007/BF01135739; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; CHEN NM, 1988, J CHEM ECOL, V14, P1087, DOI 10.1007/BF01019337; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; Elkin CM, 2005, FUNCT ECOL, V19, P102, DOI 10.1111/j.0269-8463.2005.00935.x; ElMezgueldi M, 1996, INT J BIOCHEM CELL B, V28, P1185, DOI 10.1016/S1357-2725(96)00085-4; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; GOLL DE, 1972, J MOL BIOL, V67, P469, DOI 10.1016/0022-2836(72)90464-0; Graf M, 2012, CAN ENTOMOL, V144, P467, DOI 10.4039/tce.2012.38; Hakimov HA, 2009, PROTEOMICS, V9, P4000, DOI 10.1002/pmic.200900049; Hall DE, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-80; Hall GM, 2002, INSECT BIOCHEM MOLEC, V32, P1525, DOI 10.1016/S0965-1748(02)00073-5; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hojo M, 2005, INSECT BIOCHEM MOLEC, V35, P347, DOI 10.1016/j.ibmb.2005.01.007; Huber DPW, 2009, AGR FOREST ENTOMOL, V11, P83, DOI 10.1111/j.1461-9563.2008.00411.x; Huber DPW, 2003, ENVIRON ENTOMOL, V32, P742, DOI 10.1603/0046-225X-32.4.742; Huber DPW, 2000, CHEMOECOLOGY, V10, P103, DOI 10.1007/PL00001811; Jordal BH, 2011, MOL PHYLOGENET EVOL, V59, P708, DOI 10.1016/j.ympev.2011.03.016; Keeling CI, 2013, P NATL ACAD SCI USA, V110, P18838, DOI 10.1073/pnas.1316498110; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Keeling CI, 2006, INSECT MOL BIOL, V15, P207, DOI 10.1111/j.1365-2583.2006.00629.x; Keeling CI, 2004, NATURWISSENSCHAFTEN, V91, P324, DOI 10.1007/s00114-004-0523-y; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lindgren BS, 1989, P S MAN LODG PIN MIN, P83; Lippert DN, 2009, PROTEOMICS, V9, P350, DOI 10.1002/pmic.200800252; LYON R. L., 1958, CANADIAN ENT, V90, P582; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Oberprieler Rolf G., 2007, Zootaxa, V1668, P491; Ohlund LB, 2011, SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY, P575, DOI 10.1007/978-94-007-0828-0_28; Park K, 2008, ENV TOX, V24, P555; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Robert JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077777; RUDINSKY JA, 1962, ANNU REV ENTOMOL, V7, P327, DOI 10.1146/annurev.en.07.010162.001551; Safranyik L, 1992, J APPL ENTOMOL, V113, P1; SEYBOLD SJ, 1995, P NATL ACAD SCI USA, V92, P8393, DOI 10.1073/pnas.92.18.8393; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; Tittiger C, 1999, CELL MOL LIFE SCI, V55, P121, DOI 10.1007/s000180050275; Tittiger C, 2003, MOL CELL ENDOCRINOL, V199, P11, DOI 10.1016/S0303-7207(02)00358-1; Walton A, 2013, PROVINCIAL LEVEL PRO; Wood SL, 1992, GREAT BASIN NAT, V13, P159	67	24	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110673	10.1371/journal.pone.0110673	http://dx.doi.org/10.1371/journal.pone.0110673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360753	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700040
J	Syed, W; Colaco, M; Misquith, S				Syed, Wajeed; Colaco, Melwin; Misquith, Sandra			Mutational Analysis Gives Insight into Substrate Preferences of a Nucleotidyl Cyclase from Mycobacterium avium	PLOS ONE			English	Article							ADENYLYL-CYCLASE; GUANYLYL CYCLASES; CRYSTAL-STRUCTURE; CYCLIC-GMP; CATALYTIC DOMAIN; TUBERCULOSIS; RV1625C; SPECIFICITY; EVOLUTION	Mutational, crystallographic and phylogenetic analysis of nucleotidyl cyclases have been used to understand how these enzymes discriminate between substrates. Ma1120, a class III adenylyl cyclase (AC) from Mycobacterium avium, was used as a model to study the amino acid residues that determine substrate preference, by systematically replacing ATP specifying residues with those known to specify GTP. This enzyme was found to possess residual guanylyl cyclase (GC) activity at alkaline pH. Replacement of key residues lysine (101) and aspartate (157) with residues conserved across GCs by site directed mutagenesis, led to a marked improvement in GC activity and a decrease in AC activity. This could be correlated to the presence and strength of the hydrogen bond between the second substrate binding residue (157) and the base of the nucleotide triphosphate. This is substantiated by the fact that the pH optimum is highly dependent on the amino acid residues present at positions 101 and 157.	[Syed, Wajeed; Colaco, Melwin; Misquith, Sandra] St Josephs Coll, Dept Chem, Bangalore, Karnataka, India	St. Josephs College	Misquith, S (corresponding author), St Josephs Coll, Dept Chem, Bangalore, Karnataka, India.	s.misquith@sjc.ac.in	Colaço, Melwin/ABD-9691-2021; Wajeed, Syed/ABF-5775-2021	Wajeed, Syed/0000-0002-1382-9972; Colaco, Melwin/0000-0002-6565-0595	CSIR, New Delhi [37(1271)/06/EMR-II]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR, New Delhi: 37(1271)/06/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; An SQ, 2013, EMBO J, V32, P2430, DOI 10.1038/emboj.2013.165; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; BEUVE A, 1992, J MOL BIOL, V225, P933, DOI 10.1016/0022-2836(92)90093-Y; Beuve A, 1999, METHODS, V19, P545, DOI 10.1006/meth.1999.0896; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kasahara M, 2001, J BIOL CHEM, V276, P10564, DOI 10.1074/jbc.M008006200; Ketkar AD, 2004, ACTA CRYSTALLOGR D, V60, P371, DOI 10.1107/S0907444903028002; LARSON JW, 1984, INORG CHEM, V23, P2029, DOI 10.1021/ic00182a010; Linder JU, 2005, IUBMB LIFE, V57, P797, DOI 10.1080/15216540500415636; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2008, CURR OPIN STRUC BIOL, V18, P667, DOI 10.1016/j.sbi.2008.11.008; Marden JN, 2011, MOL MICROBIOL, V79, P600, DOI 10.1111/j.1365-2958.2010.07513.x; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; Roelofs J, 2001, BIOCHEM J, V354, P697, DOI 10.1042/0264-6021:3540697; Sambrook J., 2001, MOL CLONING LAB MANU; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Shan SO, 1996, P NATL ACAD SCI USA, V93, P14474, DOI 10.1073/pnas.93.25.14474; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Shenoy AR, 2003, FEBS LETT, V545, P253, DOI 10.1016/S0014-5793(03)00580-5; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shenoy AR, 2005, BIOCHIMIE, V87, P557, DOI 10.1016/j.biochi.2005.01.017; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109358	10.1371/journal.pone.0109358	http://dx.doi.org/10.1371/journal.pone.0109358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360748	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700012
J	Zhang, J; Wang, LL; Du, W; Yu, YC; Ju, WZ; Man, YL; Li, XR; Chen, Y; Wang, ZD; Gu, WJ; Zhang, FX; Wang, H; Wu, CT; Cao, KJ				Zhang, Jian; Wang, Lin-Lin; Du, Wei; Yu, Yi-Chao; Ju, Wei-Zhu; Man, Yi-Long; Li, Xiao-Rong; Chen, Yan; Wang, Zi-Dun; Gu, Wei-Juan; Zhang, Feng-Xiang; Wang, Hua; Wu, Chu-Tse; Cao, Ke-Jiang			Hepatocyte Growth Factor Modification Enhances the Anti-Arrhythmic Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; CELLULAR CARDIOMYOPLASTY; VENTRICULAR-ARRHYTHMIAS; HEART FUNCTION; ISCHEMIA; MODEL; TRANSPLANTATION; EXPRESSION; DIFFERENTIATION	Background/Aims: Chronic myocardial infarction (MI) results in the formation of arrhythmogenic substrates, causing lethal ventricular arrhythmia (VA). We aimed to determine whether mesenchymal stem cells (MSCs) carrying a hepatocyte growth factor (HGF) gene modification (HGF-MSCs) decrease the levels of arrhythmogenic substrates and reduce the susceptibility to developing VA compared with unmodified MSCs and PBS in a swine infarction model. Methods: The left descending anterior artery was balloon-occluded to establish an MI model. Four weeks later, the randomly grouped pigs were administered MSCs, PBS or HGF-MSCs via thoracotomy. After an additional four weeks, dynamic electrocardiography was performed to assess heart rate variability, and programmed electrical stimulation was conducted to evaluate the risk for VA. Then, the pigs were euthanized for morphometric, immunofluorescence and western blot analyses. Results: The HGF-MSC group displayed the highest vessel density and Cx43 expression levels, and the lowest levels of apoptosis, and tyrosine hydroxylase (TH) and growth associated protein 43 (GAP43) expression. Moreover, the HGF-MSC group exhibited a decrease in the number of sympathetic nerve fibers, substantial decreases in the low frequency and the low-/high-frequency ratio and increases in the root mean square of successive differences (rMSSD) and the percentage of successive normal sinus R-R intervals longer than 50 ms (pNN50), compared with the other two groups. Finally, the HGF-MSC group displayed the lowest susceptibility to developing VA. Conclusion: HGF-MSCs displayed potent antiarrhythmic effects, reducing the risk for VA.	[Zhang, Jian; Wang, Lin-Lin; Du, Wei; Ju, Wei-Zhu; Man, Yi-Long; Li, Xiao-Rong; Chen, Yan; Wang, Zi-Dun; Gu, Wei-Juan; Zhang, Feng-Xiang; Cao, Ke-Jiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Yu, Yi-Chao] Nanjing Med Univ, Affiliated Hosp 2, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Hua; Wu, Chu-Tse] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Academy of Military Medical Sciences - China	Cao, KJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	kjcao_nj@126.com	Zhang, Fengxiang/Z-2807-2019	Wu, Chu-tse/0000-0003-0417-8925	National Natural Science Foundation of China [81170157, 81170160, 81470456]; Six Peak Talents Foundation of Jiangsu Province [2011-WS-071]; Graduate Innovation Foundation of Jiangsu Province [CXZZ 12_0568, JX22013218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Six Peak Talents Foundation of Jiangsu Province; Graduate Innovation Foundation of Jiangsu Province	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81170157, 81170160, 81470456), Six Peak Talents Foundation of Jiangsu Province (Grant No. 2011-WS-071), the Graduate Innovation Foundation of Jiangsu Province (Grant No. CXZZ 12_0568, JX22013218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajijola OA, 2013, AM J PHYSIOL-HEART C, V305, pH1031, DOI 10.1152/ajpheart.00434.2013; Bian L, 2009, IN VIVO, V23, P21; [边莉 BIAN Li], 2006, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V30, P323; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Falcone C, 2005, CIRCULATION, V112, P1959, DOI 10.1161/CIRCULATIONAHA.105.545111; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; FRANZ MR, 1984, CIRCULATION, V69, P593, DOI 10.1161/01.CIR.69.3.593; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; Funatsu T, 2002, J THORAC CARDIOV SUR, V124, P1099, DOI 10.1067/mtc.2002.123809; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Ha X, 2010, ZHONGGUO XIU FU CHON, V24, P613; HELD P, 1989, CARDIOLOGY, V76, P132, DOI 10.1159/000174484; Kocovic DZ, 1999, J AM COLL CARDIOL, V34, P381, DOI 10.1016/S0735-1097(99)00205-3; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Liu Hong-Jun, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P1044; Lohr J. W., 2000, Journal of Medicine (Westbury), V31, P131; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Myerburg RJ, 2006, HEART RHYTHM, V3, P235, DOI 10.1016/j.hrthm.2005.09.023; NORI SL, 1995, CELL MOL BIOL, V41, P799; Oh YS, 2006, HEART RHYTHM, V3, P728, DOI 10.1016/j.hrthm.2006.02.005; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Pinto JMB, 1999, CARDIOVASC RES, V42, P284, DOI 10.1016/S0008-6363(99)00013-9; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Tung R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P264, DOI 10.1161/CIRCEP.111.967976; Wang DG, 2011, INT J CARDIOL, V152, P314, DOI 10.1016/j.ijcard.2010.07.025; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Zhang FX, 2014, J CELL BIOCHEM, V115, P531, DOI 10.1002/jcb.24687	43	14	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111246	10.1371/journal.pone.0111246	http://dx.doi.org/10.1371/journal.pone.0111246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360679	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700079
J	da Silva, PG; Hernandez, MIM				da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel			Local and Regional Effects on Community Structure of Dung Beetles in a Mainland-Island Scenario	PLOS ONE			English	Article							BETA DIVERSITY; COLEOPTERA SCARABAEIDAE; ATLANTIC FOREST; METACOMMUNITY STRUCTURE; ASSEMBLAGES COLEOPTERA; PARTITIONING DIVERSITY; HABITAT ASSOCIATIONS; LANDSCAPE STRUCTURE; SPECIES RICHNESS; FRAGMENTATION	Understanding the ecological mechanisms driving beta diversity is a major goal of community ecology. Metacommunity theory brings new ways of thinking about the structure of local communities, including processes occurring at different spatial scales. In addition to new theories, new methods have been developed which allow the partitioning of individual and shared contributions of environmental and spatial effects, as well as identification of species and sites that have importance in the generation of beta diversity along ecological gradients. We analyzed the spatial distribution of dung beetle communities in areas of Atlantic Forest in a mainland-island scenario in southern Brazil, with the objective of identifying the mechanisms driving composition, abundance and biomass at three spatial scales (mainland-island, areas and sites). We sampled 20 sites across four large areas, two on the mainland and two on the island. The distribution of our sampling sites was hierarchical and areas are isolated. We used standardized protocols to assess environmental heterogeneity and sample dung beetles. We used spatial eigenfunctions analysis to generate the spatial patterns of sampling points. Environmental heterogeneity showed strong variation among sites and a mild increase with increasing spatial scale. The analysis of diversity partitioning showed an increase in beta diversity with increasing spatial scale. Variation partitioning based on environmental and spatial variables suggests that environmental heterogeneity is the most important driver of beta diversity at the local scale. The spatial effects were significant only at larger spatial scales. Our study presents a case where environmental heterogeneity seems to be the main factor structuring communities at smaller scales, while spatial effects are more important at larger scales. The increase in beta diversity that occurs at larger scales seems to be the result of limitation in species dispersal ability due to habitat fragmentation and the presence of geographical barriers.	[da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Hernandez, MIM (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	pedrogiovanidasilva@yahoo.com.br	da Silva, Pedro Giovâni/F-7605-2014; Hernandez, Malva I. M./E-3485-2013	da Silva, Pedro Giovâni/0000-0002-0702-9186; Hernandez, Malva I. M./0000-0002-6820-5980	Coordenacao de Pessoal de Nivel Superior [Proc. 001/2010 MEC/CAPES/PNPD]; Coordenacao de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Proc. 303800/2010-0]	Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of the Project "Biodiversidade de artropodes terrestres e aquaticos em diferentes gradientes ambientais da Mata Atlantica do estado de Santa Catarina,'' and was supported by Coordenacao de Pessoal de Nivel Superior (Proc. 001/2010 MEC/CAPES/PNPD). PGS received a post-graduate fellowship from Coordenacao de Pessoal de Nivel Superior. MIMH received a research grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Research Productivity/PQ/2010, Proc. 303800/2010-0, Project "Comportamento de besouros Scarabaeinae e sua funcao no ciclo de decomposicao da materia organica''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brower J. E., 1984, FIELD LAB METHODS GE; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Caruso MML, 1983, DESMATAMENTO IIHA SA; Cornell HV, 2007, ECOLOGY, V88, P1707, DOI 10.1890/06-0742.1; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; da Silva PG, 2013, AN ACAD BRAS CIENC, V85, P679, DOI 10.1590/S0001-37652013005000033; Davies KF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P170; Davies KF, 2001, ECOLOGY, V82, P1830, DOI 10.1890/0012-9658(2001)082[1830:EOWABP]2.0.CO;2; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 1996, PEDOBIOLOGIA, V40, P260; Davis Andrew J., 1998, Diversity and Distributions, V4, P167, DOI 10.1046/j.1472-4642.1998.00017.x; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Feer F, 2013, REV BIOL TROP, V61, P753; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gianuca AT, 2013, AUSTRAL ECOL, V38, P864, DOI 10.1111/aec.12023; Giladi I, 2011, J VEG SCI, V22, P983, DOI 10.1111/j.1654-1103.2011.01309.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; Halffter Gonzalo, 1993, Biology International, V27, P15; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Heino J, 2014, CURR OPIN INSECT SCI, V2, P7, DOI 10.1016/j.cois.2014.06.002; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Hubbell Stephen P., 2001, V32, pi; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kelt DA, 1999, OIKOS, V85, P320, DOI 10.2307/3546498; Klein A. H. F., 2006, EROSAO PROGRADACAO L, P401; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LOBO JM, 1988, REV ECOL BIOL SOL, V25, P77; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MacNeil MA, 2009, ECOLOGY, V90, P252, DOI 10.1890/07-0487.1; May F, 2013, ECOGRAPHY, V36, P842, DOI 10.1111/j.1600-0587.2012.07793.x; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nouhuys S, 2005, METACOMMUNITIES SPAT, P99; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; de Macedo-Soares LCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091241; R Core Team, 2021, R LANGUAGE ENV STAT; R-Forge Administration and Development Team, 2013, SPAT EC DAT AN R R D; Ramos F.A., 2000, J RES LEPIDOPTERA, V35, P29; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Ricklefs Robert E., 1993, P350; Roslin Tomas, 2011, P220; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Simmons LW, 2011, ECOLOGY EVOLUTION DU, P1, DOI DOI 10.1002/9781444342000; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Spector S, 2003, BIOTROPICA, V35, P394; Spector Sacha, 1998, Conservation Biology Series (Cambridge), V1, P181; Tabarelli M, 2005, MEGADIVERSIDADE, V1, P132; Tack AJM, 2009, OIKOS, V118, P809, DOI 10.1111/j.1600-0706.2008.17397.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Veech JA, 2009, PARTITION SOFTWARE H; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007	98	63	66	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111883	10.1371/journal.pone.0111883	http://dx.doi.org/10.1371/journal.pone.0111883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356729	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000081
J	Ma, J; Song, ZQ; Yan, FH				Ma, Jing; Song, Zhi-Qiang; Yan, Fu-Hua			Separation of Hepatic Iron and Fat by Dual-Source Dual-Energy Computed Tomography Based on Material Decomposition: An Animal Study	PLOS ONE			English	Article							DIFFUSE LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEMOCHROMATOSIS; OVERLOAD; CT; QUANTIFICATION; ACCUMULATION; TOOL	Objective: To explore the feasibility of dual-source dual-energy computed tomography (DSDECT) for hepatic iron and fat separation in vivo. Materials and Methods: All of the procedures in this study were approved by the Research Animal Resource Center of Shanghai Ruijin Hospital. Sixty rats that underwent DECT scanning were divided into the normal group, fatty liver group, liver iron group, and coexisting liver iron and fat group, according to Prussian blue and HE staining. The data for each group were reconstructed and post-processed by an iron-specific, three-material decomposition algorithm. The iron enhancement value and the virtual non-iron contrast value, which indicated overloaded liver iron and residual liver tissue, respectively, were measured. Spearman's correlation and one-way analysis of variance (ANOVA) were performed, respectively, to analyze statistically the correlations with the histopathological results and differences among groups. Results: The iron enhancement values were positively correlated with the iron pathology grading (r = 0.729, p<0.001). Virtual non-iron contrast (VNC) values were negatively correlated with the fat pathology grading (r = 20.642, p<0.0001). Different groups showed significantly different iron enhancement values and VNC values (F = 25.308, p<0.001; F = 10.911, p<0.001, respectively). Among the groups, significant differences in iron enhancement values were only observed between the iron-present and iron-absent groups, and differences in VNC values were only observed between the fat-present and fat-absent groups. Conclusion: Separation of hepatic iron and fat by dual energy material decomposition in vivo was feasible, even when they coexisted.	[Yan, Fu-Hua] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Ma, Jing] Fudan Univ, Shanghai Zhongshan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 200433, Peoples R China; [Ma, Jing; Song, Zhi-Qiang] Shi Hezi Univ, Corps Hosp, Affiliated Hosp 2, Sch Med,Dept Radiol, Urumqi, Xinjiang Prov, Peoples R China	Shanghai Jiao Tong University; Fudan University	Yan, FH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	missingshz@163.com			Shanghai Science and Technology Council Foundation [124119a3000]	Shanghai Science and Technology Council Foundation	This work was supported by Shanghai Science and Technology Council Foundation (NO. 124119a3000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Castiella A, 2011, EUR RADIOL, V21, P137, DOI 10.1007/s00330-010-1899-z; Chook JB, 2011, J MED VIROL, V83, P594, DOI 10.1002/jmv.22016; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; Di Marco V, 2010, BLOOD, V116, P2875, DOI 10.1182/blood-2009-11-248724; Duman DG, 2006, DIGEST DIS SCI, V51, P346, DOI 10.1007/s10620-006-3136-9; Feher Janos, 2010, Orvosi Hetilap, V151, P933, DOI 10.1556/OH.2010.28900; Fischer MA, 2011, EUR RADIOL, V21, P1727, DOI 10.1007/s00330-011-2119-1; Fischer MA, 2011, INVEST RADIOL, V46, P351, DOI 10.1097/RLI.0b013e31820e1486; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; GUYADER D, 1990, ANN GASTROENT HEPATO, V26, P21; Joe E, 2012, RADIOLOGY, V262, P126, DOI 10.1148/radiol.11110060; Kanayama Y, 2013, ULTRASOUND MED BIOL, V39, P692, DOI 10.1016/j.ultrasmedbio.2012.10.021; Mastoi AA, 2010, WORLD J GASTROENTERO, V16, P603, DOI 10.3748/wjg.v16.i5.603; Midiri M, 2002, Radiol Med, V103, P171; Mortele KJ, 2001, SEMIN LIVER DIS, V21, P195, DOI 10.1055/s-2001-15496; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P4673, DOI 10.3748/wjg.v13.i35.4673; Silva M, 2008, NUTR RES, V28, P391, DOI 10.1016/j.nutres.2008.02.009; Sumida Y, 2009, HEPATOL RES, V39, P213, DOI 10.1111/j.1872-034X.2008.00442.x; Tacikowski Tadeusz, 2004, Pol Arch Med Wewn, V111, P571; Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	23	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110964	10.1371/journal.pone.0110964	http://dx.doi.org/10.1371/journal.pone.0110964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356845	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000035
J	Hofstra, LM; Mudrikova, T; Stam, AJ; Otto, S; Tesselaar, K; Nijhuis, M; Wensing, AMJ				Hofstra, Laura Marije; Mudrikova, Tania; Stam, Arjen J.; Otto, Sigrid; Tesselaar, Kiki; Nijhuis, Monique; Wensing, Annemarie M. J.			Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients	PLOS ONE			English	Article							INTERMITTENT VIREMIA; VIROLOGICAL FAILURE; DRUG-RESISTANCE; INFECTED PATIENTS; 50 COPIES/ML; LOAD; RNA; SUPPRESSION; 1ST-LINE; THERAPY	Background: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. Methods: Treated patients with low-level viremia (persistent viral loads (VL) of 50-1000 copies/mL, group A, N = 16) or a blip (single detectable VL, group B, N = 77) were compared to a control group (consistently suppressed viremia since start therapy (<50 copies/mL), N = 79). Residual viremia (detectable viral RNA <50 copies/ml) in the year preceding the first VL above 50 copies/mL (T0) was determined using Roche Cobas-Amplicor v1.5 or CAP-CTM v2.0. Subsequent virologic failure (2 consecutive VLs>500 or 1 VL>1000 copies/mL that was not followed by a VL<50 copies/mL; median follow up 34 months) was assessed. Results: Significantly more patients in groups A and B had residual viremia in the year preceding T0 compared to controls (50% and 19% vs 3% respectively; p<0.001). Residual viremia was associated with development of low-level viremia or blips (OR 10.9 (95% CI 2.9-40.6)). Subsequent virologic failure was seen more often in group A (3/16) and B (2/77) than in the control group (0/79). Conclusion: Residual viremia is associated with development of blips and low-level viremia. Virologic failure occurred more often in patients with low-level viremia. These results suggest that low-level viremia results from viral production/replication rather than only assay variation.	[Hofstra, Laura Marije; Stam, Arjen J.; Nijhuis, Monique; Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Mudrikova, Tania] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Otto, Sigrid; Tesselaar, Kiki] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Wensing, AMJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.m.j.wensing@umcutrecht.nl		Tesselaar, Kiki/0000-0002-9847-0814; Hofstra, Laura Marije/0000-0001-6671-4629	Netherlands Organisation for Scientific Research (NWO) VIDI [91796349]	Netherlands Organisation for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by The Netherlands Organisation for Scientific Research (NWO) VIDI (91796349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding did not cover all expenses; additional costs were covered internal.	Estevez MA, 2013, J CLIN MICROBIOL, V51, P1555, DOI 10.1128/JCM.00100-13; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; European AIDS Clinical Society, 2013, EACS GUID; Geretti AM, 2008, ANTIVIR THER, V13, P927; Gianotti N, 2012, J ANTIMICROB CHEMOTH, V67, P213, DOI 10.1093/jac/dkr422; Gonzalez-Serna A, 2014, CLIN INFECT DIS, V58, P1165, DOI 10.1093/cid/ciu019; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Ibrahim KY, 2012, AIDS PATIENT CARE ST, V26, P512, DOI 10.1089/apc.2012.0199; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Laprise C, 2013, CLIN INFECT DIS; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; Masquelier B, 2005, J CLIN VIROL, V33, P75, DOI 10.1016/j.jcv.2004.11.012; McConnell MJ, 2011, JAIDS-J ACQ IMM DEF, V58, P446, DOI 10.1097/QAI.0b013e3182364513; Mira JA, 2002, ANTIVIR THER, V7, P251; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Podsadecki TJ, 2007, J INFECT DIS, V196, P1773, DOI 10.1086/523704; Pugliese P, 2013, HIV MED, V14, P509, DOI 10.1111/hiv.12041; Raboud JM, 2002, AIDS, V16, P1627, DOI 10.1097/00002030-200208160-00008; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Smit E, 2009, JAIDS-J ACQ IMM DEF, V51, P364, DOI 10.1097/QAI.0b013e3181aa13b3; Sungkanuparph S, 2006, HIV MED, V7, P437, DOI 10.1111/j.1468-1293.2006.00403.x; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Swenson LC, 2014, AIDS; Swenson LC, 2014, J CLIN MICROBIOL, V52, P517, DOI 10.1128/JCM.02461-13; Taiwo B, 2013, JAIDS-J ACQ IMM DEF, V63, P101, DOI 10.1097/QAI.0b013e3182895af4; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Zoufaly A, 2014, HIV MED	39	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110749	10.1371/journal.pone.0110749	http://dx.doi.org/10.1371/journal.pone.0110749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354368	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200033
J	Bernatchez, JA; Paul, R; Tchesnokov, EP; Ngure, M; Beilhartz, GL; Berghuis, AM; Lavoie, R; Li, LH; Auger, A; Melnyk, RA; Grobler, JA; Miller, MD; Hazuda, DJ; Hecht, SM; Gotte, M				Bernatchez, Jean A.; Paul, Rakesh; Tchesnokov, Egor P.; Ngure, Marianne; Beilhartz, Greg L.; Berghuis, Albert M.; Lavoie, Rico; Li, Lianhai; Auger, Anick; Melnyk, Roman A.; Grobler, Jay A.; Miller, Michael D.; Hazuda, Daria J.; Hecht, Sidney M.; Goette, Matthias			Derivatives of Mesoxalic Acid Block Translocation of HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRAND TRANSFER-REACTIONS; DNA-POLYMERASE; NONNUCLEOSIDE INHIBITORS; DRUG-RESISTANCE; RATCHET MODEL; MECHANISM; MUTATIONS; PHOSPHONOFORMATE; NUCLEOTIDES	The pyrophosphate mimic and broad spectrum antiviral phosphonoformic acid (PFA, foscarnet) was shown to freeze the pre-translocational state of the reverse transcriptase (RT) complex of the human immunodeficiency virus type 1 (HIV-1). However, PFA lacks a specificity domain, which is seen as a major reason for toxic side effects associated with the clinical use of this drug. Here, we studied the mechanism of inhibition of HIV-1 RT by the 4-chlorophenylhydrazone of mesoxalic acid (CPHM) and demonstrate that this compound also blocks RT translocation. Hot spots for inhibition with PFA or CPHM occur at template positions with a bias toward pre-translocation. Mutations at active site residue Asp-185 compromise binding of both compounds. Moreover, divalent metal ions are required for the formation of ternary complexes with either of the two compounds. However, CPHM contains both an anchor domain that likely interacts with the catalytic metal ions and a specificity domain. Thus, although the inhibitor binding sites may partly overlap, they are not identical. The K65R mutation in HIV-1 RT, which reduces affinity to PFA, increases affinity to CPHM. Details with respect to the binding sites of the two inhibitors are provided on the basis of mutagenesis studies, structure-activity relationship analyses with newly designed CPHM derivatives, and in silico docking experiments. Together, these findings validate the pre-translocated complex of HIV-1 RT as a specific target for the development of novel classes of RT inhibitors.	[Bernatchez, Jean A.; Berghuis, Albert M.; Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Paul, Rakesh; Hecht, Sidney M.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Paul, Rakesh; Hecht, Sidney M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Tchesnokov, Egor P.; Ngure, Marianne; Beilhartz, Greg L.; Berghuis, Albert M.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Lavoie, Rico; Li, Lianhai; Auger, Anick; Melnyk, Roman A.; Grobler, Jay A.; Miller, Michael D.; Hazuda, Daria J.] Merck Res Labs, West Point, PA 19486 USA; [Goette, Matthias] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; McGill University; Merck & Company; McGill University	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, 6-020 Katz Grp Ctr, Edmonton, AB T6G 2E1, Canada.	gotte@ualberta.ca	Melnyk, Roman/GQA-9908-2022	Berghuis, Albert/0000-0002-2663-025X; Bernatchez, Jean/0000-0002-8309-1627; Paul, Rakesh/0000-0002-9651-1555	Canadian Institutes of Health Research; Quebec Consortium for Drug Discovery; Merck; Fonds de la Recherche en Sante du Quebec; Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Consortium for Drug Discovery; Merck(Merck & Company); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Institutes of Health Research, the Quebec Consortium for Drug Discovery, and Merck (to M. G.).; Recipient of a doctoral training scholarship from the Fonds de la Recherche en Sante du Quebec and a Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research.	Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Chowers M, 2010, EUR J CLIN MICROBIOL, V29, P779, DOI 10.1007/s10096-010-0926-y; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; Cruchaga C, 2006, J BIOL CHEM, V281, P27744, DOI 10.1074/jbc.M603360200; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Davis WR, 2000, BIOCHEMISTRY-US, V39, P14279, DOI 10.1021/bi0015764; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Ehteshami M, 2013, J BIOL CHEM, V288, P17336, DOI 10.1074/jbc.M112.433441; Freisz S, 2010, ANGEW CHEM INT EDIT, V49, P1805, DOI 10.1002/anie.200905651; Gabbara S, 1999, BIOCHEMISTRY-US, V38, P13070, DOI 10.1021/bi991085n; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Gotte M, 2001, J BIOL CHEM, V276, P6711, DOI 10.1074/jbc.M009097200; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kirby KA, 2011, CELL MOL BIOL, V57, P40, DOI 10.1170/T900; Lai MT, 2009, ANTIMICROB AGENTS CH, V53, P2424, DOI 10.1128/AAC.01559-08; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Maga G, 2007, ANGEW CHEM INT EDIT, V46, P1810, DOI 10.1002/anie.200604165; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Michailidis E, 2012, CELL MOL BIOL, V58, P187, DOI 10.1170/T940; Michailidis E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-65; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OBERG B, 1982, PHARMACOL THERAPEUT, V19, P387, DOI 10.1016/0163-7258(82)90074-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radi M, 2008, CHEMMEDCHEM, V3, P573, DOI 10.1002/cmdc.200700198; Rajotte D, 2013, ANTIMICROB AGENTS CH, V57, P2712, DOI 10.1128/AAC.00113-13; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; TACHEDJIAN G, 1995, VIROLOGY, V212, P58, DOI 10.1006/viro.1995.1453; Torres-Madriz G, 2008, CLIN INFECT DIS, V47, P702, DOI 10.1086/590934; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhan P, 2013, MED RES REV, V33, pE1, DOI 10.1002/med.20241; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	47	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1474	1484		10.1074/jbc.M114.614305	http://dx.doi.org/10.1074/jbc.M114.614305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25355312	Green Published, hybrid			2022-12-26	WOS:000348056400018
J	Wang, Y; Yago, T; Zhang, N; Abdisalaam, S; Alexandrakis, G; Rodgers, W; McEver, RP				Wang, Ying; Yago, Tadayuki; Zhang, Nan; Abdisalaam, Salim; Alexandrakis, George; Rodgers, William; McEver, Rodger P.			Cytoskeletal Regulation of CD44 Membrane Organization and Interactions with E-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cytoskeleton; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); Neutrophil; Signal Transduction	EZRIN/RADIXIN/MOESIN ERM PROTEINS; ANKYRIN-BINDING DOMAIN; HYALURONAN-BINDING; P-SELECTIN; CORRELATION SPECTROSCOPY; CYTOPLASMIC DOMAINS; LEUKOCYTE ADHESION; TYROSINE KINASES; LIVE CELLS; NEUTROPHILS	Interactions of CD44 on neutrophils with E-selectin on activated endothelial cells mediate rolling under flow, a prerequisite for neutrophil arrest and migration into perivascular tissues. How CD44 functions as a rolling ligand despite its weak affinity for E-selectin is unknown. We examined the nanometer scale organization of CD44 on intact cells. CD44 on leukocytes and transfected K562 cells was cross-linked within a 1.14-nm spacer. Depolymerizing actin with latrunculin B reduced cross-linking. Fluorescence resonance energy transfer (FRET) revealed tight co-clustering between CD44 fused to yellow fluorescent protein (YFP) and CD44 fused to cyan fluorescent protein on K562 cells. Latrunculin B reduced FRET-reported co-clustering. Number and brightness analysis confirmed actin-dependent CD44-YFP clusters on living cells. CD44 lacking binding sites for ankyrin and for ezrin/radixin/moesin (ERM) proteins on its cytoplasmic domain (ANKERM) did not cluster. Unexpectedly, CD44 lacking only the ankyrin-binding site (ANK) formed larger but looser clusters. Fluorescence recovery after photobleaching demonstrated increased CD44 mobility by latrunculin B treatment or by deleting the cytoplasmic domain. ANKERM mobility increased only modestly, suggesting that the cytoplasmic domain engages the cytoskeleton by an additional mechanism. Ex vivo differentiated CD44-deficient neutrophils expressing exogenous CD44 rolled on E-selectin and activated Src kinases after binding anti-CD44 antibody. In contrast, differentiated neutrophils expressing ANK had impaired rolling and kinase activation. These data demonstrate that spectrin and actin networks regulate CD44 clustering and suggest that ankyrin enhances CD44-mediated neutrophil rolling and signaling.	[Yago, Tadayuki; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Wang, Ying; Zhang, Nan; Rodgers, William; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Abdisalaam, Salim; Alexandrakis, George] Univ Texas Arlington, Dept Biomed Engn, Arlington, TX 76010 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Arlington	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org		Zhang, Nan/0000-0002-6736-2781	National Institutes of Health [HL03463, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363, K08HL003463, P01HL085607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL03463 and HL085607.	Abdisalaam S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt908; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Damjanovich S., 1994, MOBILITY PROXIMITY B; DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Gimferrer I, 2011, J IMMUNOL, V186, P3892, DOI 10.4049/jimmunol.1003505; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Hellriegel C, 2011, FASEB J, V25, P2883, DOI 10.1096/fj.11-181537; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Ilangumaran S, 1998, BLOOD, V91, P3901; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Levi M, 2003, J AM SOC NEPHROL, V14, P1949, DOI 10.1097/01.ASN.0000078768.86317.31; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li RH, 1998, EUR J IMMUNOL, V28, P1745, DOI 10.1002/(SICI)1521-4141(199806)28:06<1745::AID-IMMU1745>3.0.CO;2-5; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nacher M, 2011, AM J PATHOL, V178, P2437, DOI 10.1016/j.ajpath.2011.01.039; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NEAME SJ, 1995, J CELL SCI, V108, P3127; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; PERSCHL A, 1995, J CELL SCI, V108, P1033; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Protin U, 1999, J IMMUNOL, V163, P4917; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Shao BJ, 2012, J BIOL CHEM, V287, P19585, DOI 10.1074/jbc.M112.361519; Sreeramkumar V, 2013, BLOOD, V122, P3993, DOI 10.1182/blood-2013-07-514497; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	53	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35159	35171		10.1074/jbc.M114.600767	http://dx.doi.org/10.1074/jbc.M114.600767			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359776	Green Published, hybrid			2022-12-26	WOS:000346660200010
J	Bogomolnaya, LM; Aldrich, L; Ragoza, Y; Talamantes, M; Andrews, KD; McClelland, M; Andrews-Polymenis, HL				Bogomolnaya, Lydia M.; Aldrich, Lindsay; Ragoza, Yuri; Talamantes, Marissa; Andrews, Katharine D.; McClelland, Michael; Andrews-Polymenis, Helene L.			Identification of Novel Factors Involved in Modulating Motility of Salmonella enterica Serotype Typhimurium	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; SEROVAR TYPHIMURIUM; SWARMING MOTILITY; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; GENE-EXPRESSION; TYPE-1 FIMBRIAE; VIRULENCE; HOST	Salmonella enterica serotype Typhimurium can move through liquid using swimming motility, and across a surface by swarming motility. We generated a library of targeted deletion mutants in Salmonella Typhimurium strain ATCC14028, primarily in genes specific to Salmonella, that we have previously described. In the work presented here, we screened each individual mutant from this library for the ability to move away from the site of inoculation on swimming and swarming motility agar. Mutants in genes previously described as important for motility, such as flgF, motA, cheY are do not move away from the site of inoculation on plates in our screens, validating our approach. Mutants in 130 genes, not previously known to be involved in motility, had altered movement of at least one type, 9 mutants were severely impaired for both types of motility, while 33 mutants appeared defective on swimming motility plates but not swarming motility plates, and 49 mutants had reduced ability to move on swarming agar but not swimming agar. Finally, 39 mutants were determined to be hypermotile in at least one of the types of motility tested. Both mutants that appeared non-motile and hypermotile on plates were assayed for expression levels of FliC and FljB on the bacterial surface and many of them had altered levels of these proteins. The phenotypes we report are the first phenotypes ever assigned to 74 of these open reading frames, as they are annotated as 'hypothetical genes' in the Typhimurium genome.	[Bogomolnaya, Lydia M.; Aldrich, Lindsay; Ragoza, Yuri; Talamantes, Marissa; Andrews, Katharine D.; Andrews-Polymenis, Helene L.] Texas A&M Univ, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA; [Bogomolnaya, Lydia M.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	Texas A&M University System; Texas A&M University College Station; Kazan Federal University; University of California System; University of California Irvine	Andrews-Polymenis, HL (corresponding author), Texas A&M Univ, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA.	handrews@medicine.tamhsc.edu		McClelland, Michael/0000-0003-1788-9347	NIH/NIAID [R01AI083646, R56AI077645, R01 AI075093]; Kazan Federal University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093, R56AI077645, R01AI083646] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kazan Federal University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grants R01AI083646, R56AI077645 awarded to HAP, R01 AI075093 awarded to MM. LMB was supported in part by a subsidy to support the Program of competitive growth of Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; Belas R, 1998, J BACTERIOL, V180, P6126; Berg HC, 2005, CURR BIOL, V15, pR599, DOI 10.1016/j.cub.2005.07.042; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Brinkman FSL, 2001, INFECT IMMUN, V69, P5207, DOI 10.1128/IAI.69.8.5207-5211.2001; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Chandra H, 2008, ENVIRON MICROBIOL, V10, P1285, DOI 10.1111/j.1462-2920.2007.01542.x; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Chen BG, 2007, J BACTERIOL, V189, P8750, DOI 10.1128/JB.01109-07; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Clernmer KM, 2008, J MED MICROBIOL, V57, P931, DOI 10.1099/jmm.0.47778-0; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; GuardPetter J, 1997, FEMS MICROBIOL LETT, V149, P173, DOI 10.1016/S0378-1097(97)00071-2; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kato Y, 2007, BIOSCI BIOTECH BIOCH, V71, P77, DOI 10.1271/bbb.60375; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; Lee J, 2012, MOL MICROBIOL, V84, P550, DOI 10.1111/j.1365-2958.2012.08043.x; Li BQ, 2012, NUCLEIC ACIDS RES, V40, P11073, DOI 10.1093/nar/gks869; Liaw SJ, 2001, J MED MICROBIOL, V50, P1039, DOI 10.1099/0022-1317-50-12-1039; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Reynolds MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015800; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shah DH, 2005, MICROBIOL-SGM, V151, P3957, DOI 10.1099/mic.0.28126-0; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Stafford GP, 2007, MICROBIOL-SGM, V153, P541, DOI 10.1099/mic.0.2006/002576-0; Stewart MW, 2011, EYE REP, V1, P12, DOI [10.4081/eye.2011.e5, 10.1007/978-94-007-0934-8_1]; STOCKER BA, 1961, NATURE, V189, P556, DOI 10.1038/189556a0; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wada T, 2011, J BACTERIOL, V193, P1600, DOI 10.1128/JB.01494-10; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Wang KC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-111; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; Wang WB, 2008, INFECT IMMUN, V76, P2051, DOI 10.1128/IAI.01557-07; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Yeh KS, 2002, MICROBIOL IMMUNOL, V46, P1, DOI 10.1111/j.1348-0421.2002.tb02670.x; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Zhao RB, 1996, J BACTERIOL, V178, P258, DOI 10.1128/jb.178.1.258-265.1996	84	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111513	10.1371/journal.pone.0111513	http://dx.doi.org/10.1371/journal.pone.0111513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369209	Green Published, gold			2022-12-26	WOS:000344402000062
J	Ding, SJ; Niu, GY; Xu, XH; Li, JP; Zhang, XM; Yin, HY; Zhang, NJ; Jiang, XL; Wang, SW; Liang, MF; Wang, XJ; Yu, XJ				Ding, Shujun; Niu, Guoyu; Xu, Xuehua; Li, Jinping; Zhang, Xiaomei; Yin, Haiying; Zhang, Naijie; Jiang, Xiaolin; Wang, Shiwen; Liang, Mifang; Wang, Xianjun; Yu, Xue-jie			Age Is a Critical Risk Factor for Severe Fever with Thrombocytopenia Syndrome	PLOS ONE			English	Article							SYNDROME VIRUS; SHANDONG PROVINCE; BUNYAVIRUS; CHINA	Background: Severe Fever with Thrombocytopenia Syndrome (SFTS) is an emerging infectious disease in East Asia. SFTS is a tick borne hemorrhagic fever caused by SFTSV, a new bunyavirus named after the syndrome. We investigated the epidemiology of SFTS in Laizhou County, Shandong Province, China. Methods: We collected serum specimens of all patients who were clinically diagnosed as suspected SFTS cases in 2010 and 2011 in Laizhou County. The patients' serum specimens were tested for SFTSV by real time fluorescence quantitative PCR (RT-qPCR). We collected 1,060 serum specimens from healthy human volunteers by random sampling in Laizhou County in 2011. Healthy persons' serum specimens were tested for specific SFTSV IgG antibody by ELISA. Results: 71 SFTS cases were diagnosed in Laizhou County in 2010 and 2011, which resulted in the incidence rate of 4.1/100,000 annually. The patients ranged from 15 years old to 87 years old and the median age of the patients were 59 years old. The incidence rate of SFTS was significantly higher in patients over 40 years old and fatal cases only occurred in patients over 50 years old. 3.3% (35/1,060) of healthy people were positive to SFTSV IgG antibody. The SFTSV antibody positive rate was not significantly different among people at different age groups. Conclusion: Our results revealed that seroprevalence of SFTSV in healthy people in Laizhou County was not significantly different among age groups, but SFTS patients were mainly elderly people, suggesting that age is the critical risk factor or determinant for SFTS morbidity and mortality.	[Ding, Shujun; Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Ding, Shujun; Zhang, Xiaomei; Jiang, Xiaolin; Wang, Xianjun] Shandong Ctr Dis Control & Prevent, Dept Viral Infect Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Jinan, Shandong, Peoples R China; [Niu, Guoyu; Wang, Shiwen; Liang, Mifang] China CDC, Natl Inst Viral Dis Control & Prevent, MOH, Key Lab Med Virol, Beijing, Peoples R China; [Niu, Guoyu] Tianjin Int Travel Hlth Care Ctr, Tianjin, Peoples R China; [Xu, Xuehua; Li, Jinping; Yin, Haiying; Zhang, Naijie] Laizhou City Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Laizhou, Shandong, Peoples R China; [Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston	Wang, XJ (corresponding author), Shandong Ctr Dis Control & Prevent, Dept Viral Infect Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Jinan, Shandong, Peoples R China.	xjwang62@163.com; yuxuejie@sdu.edu.cn	Yu, Xuejie/AAP-9246-2021		National Natural Science Foundation of China [81102171]; Shandong Medical Science and Technology Development Program [2011HZ055]; Shandong Province Science and Technology Development Plan [2012GHZ30031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Medical Science and Technology Development Program; Shandong Province Science and Technology Development Plan	This work was supported by the National Natural Science Foundation of China (Grant No. 81102171), (http://www.nsfc.gov.cn) to SJD, Shandong Medical Science and Technology Development Program (Grant No. 2011HZ055), (http://www.sdws.gov.cn) to SJD, and Shandong Province Science and Technology Development Plan (Grant No. 2012GHZ30031), (http://www.sdstc.gov.cn) to XMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Chen K, 2014, LETT BIOTECHNOLOGY, V25, P100; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Y, 2011, VECTOR-BORNE ZOONOT, V12, P160; Liu Y, 2014, J VIROL, V88, P1781, DOI 10.1128/JVI.02277-13; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Wen HL, 2014, EMERG INFECT DIS, V20, P1, DOI 10.3201/eid2001.120532; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	20	51	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111736	10.1371/journal.pone.0111736	http://dx.doi.org/10.1371/journal.pone.0111736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369237	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000095
J	Cui, ZY; Pan, XL; Wang, QR				Cui, Zhaoyang; Pan, Xinliang; Wang, Qirong			LOH Detected by Microsatellite Markers Reveals the Clonal Origin of Recurrent Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK-CANCER; INTRAHEPATIC METASTASIS; FIELD CANCERIZATION; ADVANCED HEAD; HETEROZYGOSITY; PROGRESSION; DIAGNOSIS; MICROMETASTASIS; CHEMOTHERAPY; MUTATIONS	Background: The question of whether "recurrent'' laryngeal carcinoma is truly a new tumour with a clonal origin that differs from that of the primary tumour has remained unanswered. The objective of this study was to determine whether recurrent tumours have the same genetic basis as primary tumours, as the answer to this question is important for the development of treatment strategies. Materials and Methods: Matched samples consisting of primary tumour, recurrent tumour and normal tissue were obtained from the same patient. A total of 37 patients with laryngeal cancer were examined for loss of heterozygosity (LOH) on the 3p, 5p, 7q, 8p, 9p, 13p, 17p and 18q chromosomal arms using PCR to amplify microsatellite markers. All patients were routinely followed up and 5-year survival rates were calculated using directly calculating method and Kaplan-Meier's method. Results: A total of 28 out of 37 (75.6%) patients showed LOH at a minimum of one locus, and 19 out of 37 (51.3%) patients showed LOH at two loci. Primary and recurrent tumours in each patient showed identical allelic loss patterns and incidence rates. Patients without LOH had a longer average time to recurrence than patients with LOH (P<0.05). Additionally, patients with LOH had a longer average smoking duration prior to surgery than patients without LOH (P<0.05). The 5-year survival rates were 32.14% in patients with LOH versus 44.4% in patients without LOH. Conclusions: The data indicate that primary and recurrent tumours have the same clonal origin. This result implies that we failed to radically resect the primary tumours and/or micrometastases in these patients. Consequently, some form of adjunctive therapy may be necessary. Additionally, the data indicate that the recurrence of laryngeal squamous cell carcinoma is closely related to chromosomal aberrations (specifically LOH).	[Cui, Zhaoyang; Wang, Qirong] Shandong Univ, Dept Otorhinolaryngol, Clin Med Coll, Shandong Prov Qianfoshan Hosp, Jinan 250100, Peoples R China; [Pan, Xinliang] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Cui, ZY (corresponding author), Shandong Univ, Dept Otorhinolaryngol, Clin Med Coll, Shandong Prov Qianfoshan Hosp, Jinan 250100, Peoples R China.	ty0261_cn@sina.com			Natural Science Foundation of Shandong [2010HL004]	Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This study was supported by the Natural Science Foundation of Shandong (2010HL004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503; Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081; Califano J, 1996, CANCER RES, V56, P2488; Collaud S, 2010, J BIOMOL TECH, V1, P25; dos RPP, 2002, MED SCI MONITOR, V3, pBR89; Goodwin WJ, 2000, LARYNGOSCOPE, V110, P1, DOI 10.1097/00005537-200003001-00001; Graveland AP, 2011, INT J CANCER, V128, P1852, DOI 10.1002/ijc.25523; Hamakawa H, 1999, CLIN EXP METASTAS, V17, P593, DOI 10.1023/A:1006732911057; Harrison D, 1990, LARYNGOSCOPE, V11, P1191; Jamieson TA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-4; Jia I, 2012, MED RECAPITULATE, V15, P2410; Kamat N, 2013, ONCOL LETT, V6, P1413, DOI 10.3892/ol.2013.1573; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; Martin-Guerrero I, 2013, HAEMATOLOGICA, V98, P1237, DOI 10.3324/haematol.2012.073916; NAWROZ H, 1994, CANCER RES, V54, P1152; Ng IOL, 2003, J PATHOL, V199, P345, DOI 10.1002/path.1287; Okada S, 2012, ANN SURG ONCOL, V19, P1499, DOI 10.1245/s10434-011-2166-5; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Pepinski W, 2009, FOLIA HISTOCHEM CYTO, V47, P105, DOI 10.2478/v10042-009-0019-x; Rawnaq T, 2011, J SURG RES, V169, P31, DOI 10.1016/j.jss.2009.12.032; Robinson WP, 2000, BIOESSAYS, V22, P452; Rube C, 1997, Strahlenther Onkol, V173, P83; Sang-Hyuk LSH, 2011, OTOLARYNGOL HEAD NEC, V1, P64; Sharma A, 2008, ANN OTO RHINOL LARYN, V117, P591, DOI 10.1177/000348940811700807; Shiga K, 2004, TOHOKU J EXP MED, V204, P163, DOI 10.1620/tjem.204.163; Shiga K, 2003, ANTICANCER RES, V23, P3911; SIMONEAU AR, 1994, WORLD J UROL, V12, P89; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Sow FB, 2009, INT J BIOMED SCI, V2, P105; Spurlock G, 2010, J CANCER RES CLIN, V136, P1869, DOI 10.1007/s00432-010-0846-3; Takai N, 2011, ARCH GYNECOL OBSTET, V284, P951, DOI 10.1007/s00404-010-1725-5; Tian YQ, 2002, OTORHINOLARYNGOLOGY; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wendt TG, 1998, J CLIN ONCOL, V16, P1318, DOI 10.1200/JCO.1998.16.4.1318; Yoo WJ, 2004, J KOREAN MED SCI, V19, P345, DOI 10.3346/jkms.2004.19.3.345; Yoshioka S, 2002, SURGERY, V132, P34, DOI 10.1067/msy.2002.125306; YUEN APW, 1995, J LARYNGOL OTOL, V109, P1063; Zhao J, 2008, LIN CHUNG ER BI YAN, V18, P837; Zhu Z, 2013, CHINESE MED J-PEKING, V126, P3187, DOI 10.3760/cma.j.issn.0366-6999.20130656	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111857	10.1371/journal.pone.0111857	http://dx.doi.org/10.1371/journal.pone.0111857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365429	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100129
J	Beyeler, J; Schnyder, I; Katsaros, C; Chiquet, M				Beyeler, Joel; Schnyder, Isabelle; Katsaros, Christos; Chiquet, Matthias			Accelerated Wound Closure In Vitro by Fibroblasts from a Subgroup of Cleft Lip/Palate Patients: Role of Transforming Growth Factor-alpha	PLOS ONE			English	Article							FACTOR RECEPTOR; TGF-ALPHA; CRANIOFACIAL DEVELOPMENT; EGF-RECEPTOR; ORAL CLEFTS; WAVY HAIR; PALATE; LIP; EXPRESSION; MYOFIBROBLASTS	In a fraction of patients surgically treated for cleft lip/palate, excessive scarring disturbs maxillary growth and dento-alveolar development. Since certain genes are involved in craniofacial morphogenesis as well as tissue repair, a primary defect causing cleft lip/palate could lead to altered wound healing. We performed in vitro wound healing assays with primary lip fibroblasts from 16 cleft lip/palate patients. Nine foreskin fibroblast strains were included for comparison. Cells were grown to confluency and scratch wounds were applied; wound closure was monitored morphometrically over time. Wound closure rate showed highly significant differences between fibroblast strains. Statistically, fibroblast strains from the 25 individuals could be divided into three migratory groups, namely "fast", "intermediate", and "slow". Most cleft lip/palate fibroblasts were distributed between the "fast" (5 strains) and the "intermediate" group (10 strains). These phenotypes were stable over different cell passages from the same individual. Expression of genes involved in cleft lip/palate and wound repair was determined by quantitative PCR. Transforming growth factor-alpha mRNA was significantly up-regulated in the "fast" group. 5 ng/ml transforming growth factor-alpha added to the culture medium increased the wound closure rate of cleft lip/palate strains from the "intermediate" migratory group to the level of the "fast", but had no effect on the latter group. Conversely, antibody to transforming growth factor-alpha or a specific inhibitor of its receptor most effectively reduced the wound closure rate of "fast" cleft lip/palate strains. Thus, fibroblasts from a distinct subgroup of cleft lip/palate patients exhibit an increased migration rate into wounds in vitro, which is linked to higher transforming growth factor-alpha expression and attenuated by interfering with its signaling.	[Beyeler, Joel; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Schnyder, Isabelle] Univ Hosp Bern, Univ Clin Childrens Surg, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Chiquet, M (corresponding author), Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch		Chiquet, Matthias/0000-0001-7812-4853; Katsaros, Christos/0000-0001-5545-6740	Swiss National Science Foundation [31003A_146825]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by grant 31003A_146825 from the Swiss National Science Foundation (www.snf.ch) to MC and CK. The funder had no role in study design, data collection and analysis, decision to publish, or peparation of the manuscript. No additional external funding was received for this study.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Baroni T, 2003, J PERIODONTOL, V74, P1447, DOI 10.1902/jop.2003.74.10.1447; Benjamini Y, 2001, ANN STAT, V29, P1165; BERKOWITZ S, 1977, CLEFT PALATE J, V14, P288; Biggs LC, 2014, J CELL SCI, V28, P28; BLUTH RF, 1995, HUM PATHOL, V26, P1333, DOI 10.1016/0046-8177(95)90298-8; Bodnar RJ, 2013, ADV WOUND CARE, V2, P24, DOI 10.1089/wound.2011.0326; Brown GD, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-93; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chanprapaph K, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/734249; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; Cvikl B, 2014, CLIN ORAL INVESTIG; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; DIXON MJ, 1992, ARCH ORAL BIOL, V37, P395, DOI 10.1016/0003-9969(92)90024-3; Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; Fudalej P, 2012, J DENT RES, V91, P47, DOI 10.1177/0022034511425674; Fudalej P, 2010, J CRANIOFAC SURG, V21, P1468, DOI 10.1097/SCS.0b013e3181ecc6c7; Gagliano N, 2010, CLEFT PALATE-CRAN J, V47, P393, DOI 10.1597/07-196.1; Gibson DJ, 2013, ADV WOUND CARE, V2, P18, DOI 10.1089/wound.2011.0359; Gkantidis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047762; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4511, DOI 10.3748/wjg.v11.i29.4511; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Josh F, 2013, J NIPPON MED SCH, V80, P140, DOI 10.1272/jnms.80.140; Jugessur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011493; Khanna R, 2012, INDIAN J PLAST SURG, V45, P68, DOI 10.4103/0970-0358.96590; Kim I, 2001, WOUND REPAIR REGEN, V9, P386, DOI 10.1046/j.1524-475x.2001.00386.x; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Letra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045441; Lu XC, 2014, AM J EPIDEMIOL, V179, P267, DOI 10.1093/aje/kwt262; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinelli M, 2009, INT J PEDIATR OTORHI, V73, P929, DOI 10.1016/j.ijporl.2009.02.013; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; Moreira I, 2014, AM J ORTHOD DENTOFAC, V145, P341, DOI 10.1016/j.ajodo.2013.11.018; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Mossey PA, 2012, FRONT ORAL BIOL, V16, P1, DOI 10.1159/000337464; Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168; Nollet PJPM, 2005, PLAST RECONSTR SURG, V116, P1255, DOI 10.1097/01.prs.0000181652.84855.a3; Park CH, 2011, J DERMATOL SCI, V64, P134, DOI 10.1016/j.jdermsci.2011.07.002; POULIN ML, 1995, DEV DYNAM, V202, P378, DOI 10.1002/aja.1002020407; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Shetye PR, 2004, CLIN PLAST SURG, V31, P361, DOI 10.1016/S0094-1298(03)00137-8; Shetye PR, 2006, ANGLE ORTHOD, V76, pIV; Singh B, 2014, SEMIN CELL DEV BIOL, V28, P12, DOI 10.1016/j.semcdb.2014.03.003; Smith PC, 2009, J PERIODONTAL RES, V44, P73, DOI 10.1111/j.1600-0765.2007.01081.x; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; van Beurden HE, 2005, J DENT RES, V84, P871, DOI 10.1177/154405910508401002; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; Vieira AR, 2006, AM J EPIDEMIOL, V163, P790, DOI 10.1093/aje/kwj103; Wilson ADH, 2008, CLEFT PALATE-CRAN J, V45, P614, DOI 10.1597/07-072.1; Yamamoto T, 2003, DEV BIOL, V260, P512, DOI 10.1016/S0012-1606(03)00275-6; Young DL, 2000, CRIT REV ORAL BIOL M, V11, P304, DOI 10.1177/10454411000110030201	68	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111752	10.1371/journal.pone.0111752	http://dx.doi.org/10.1371/journal.pone.0111752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360592	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700148
J	Gambhira, R; Keele, BF; Schell, JB; Hunter, MJ; Dufour, JP; Montefiori, DC; Tang, H; Rose, JK; Rose, N; Marx, PA				Gambhira, Ratish; Keele, Brandon F.; Schell, John B.; Hunter, Meredith J.; Dufour, Jason P.; Montefiori, David C.; Tang, Haili; Rose, John K.; Rose, Nina; Marx, Preston A.			Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques	PLOS ONE			English	Article							BIOLOGICAL PHENOTYPE; GLYCOSYLATION SITES; GENETIC IDENTITY; PATHOGENIC SIV; HIV; PROTECTION; CHALLENGE; INFECTION; MUCOSAL; COINFECTIONS	Identification of transmitted/founder simian immunodeficiency virus (SIV) envelope sequences responsible for infection may prove critical for understanding HIV/SIV mucosal transmission. We used single genome amplification and phylogenetic analyses to characterize transmitted/founder SIVs both in the inoculum and in immunized-infected rhesus monkeys. Single genome amplification of the SIVsmE660 inoculum revealed a maximum diversity of 1.4%. We also noted that the consensus sequence of the challenge stock differed from the vaccine construct in 10 amino acids including 3 changes in the V4 loop. Viral env was prepared from rhesus plasma in 3 groups of 6 immunized with vesicular stomatitis virus (VSV) vectors and boosted with Semliki forest virus (SFV) replicons expressing (a) SIVsmE660 gag-env (b) SIVsmE660 gag-env plus rhesus GM-CSF and (c) control influenza hemagglutinin protein. Macaques were immunized twice with VSV-vectors and once with SFV vector and challenged intrarectally with 4000 TCID50. Single genome amplification characterized the infections of 2 unprotected animals in the gag-env immunized group, both of which had reduced acute plasma viral loads that ended as transient infections indicating partial immune control. Four of 6 rhesus were infected in the gag-env + GM-CSF group which demonstrated that GM-CSF abrogated protection. All 6 animals from the control group were infected having high plasma viral loads. We obtained 246 full-length envelope sequences from SIVsmE660 infected macaques at the peak of infection and determined the number of transmitted/founder variants per animal. Our analysis found that 2 of 2 gag-env vaccinated but infected macaques exhibited single but distinct virus envelope lineages whereas rhesus vaccinated with gag-env-GM-CSF or HA control exhibited both single and multiple env lineages. Because there were only 2 infected animals in the gagenv vaccinated rhesus compared to 10 infected rhesus in the other 2 groups, the significance of finding single env variants in the gag-env vaccinated group could not be established.	[Gambhira, Ratish; Hunter, Meredith J.; Dufour, Jason P.; Marx, Preston A.] Tulane Univ, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA; [Keele, Brandon F.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Schell, John B.; Rose, John K.; Rose, Nina] Yale Univ, Dept Pathol, New Haven, CT USA; [Montefiori, David C.; Tang, Haili] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Yale University; Duke University	Marx, PA (corresponding author), Tulane Univ, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA.	pmarx@tulane.edu		Schell, John/0000-0001-6707-7051	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH grant [AI45510]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51 RR00164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, T32RR021309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045510, R56AI045510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, T32OD011124, T32OD011064] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part with federal funds from the National Cancer Institute, National Institutes of Health under contract HHSN261200800001E, NIH grant AI45510 and by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164 to the Tulane National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baan E, 2012, AIDS RES HUM RETROV, V28, P715, DOI [10.1089/aid.2011.0023, 10.1089/AID.2011.0023]; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; CHOI WS, 1994, J VIROL, V68, P5395, DOI 10.1128/JVI.68.9.5395-5402.1994; Cruz I, 2006, INDIAN J MED RES, V123, P357; Dittmer U, 1996, J BIOTECHNOL, V44, P105, DOI 10.1016/0168-1656(95)00160-3; Evering T, 2006, PARASITE IMMUNOL, V28, P549, DOI 10.1111/j.1365-3024.2006.00886.x; Funnye AS, 2003, J NATL MED ASSOC, V95, P363; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gnanadurai CW, 2010, J VIROL, V84, P12245, DOI 10.1128/JVI.01603-10; Haigwood NL, 1999, IMMUNOL LETT, V66, P183, DOI 10.1016/S0165-2478(98)00156-4; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ho YS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-14; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295; Letvin NL, 2011, SCI TRANSL MED, V3, P1; Li H, 2010, AIDS RES HUM RETROV, V26, pA168; Lim SY, 2010, PLOS PATHOG, V6, P1; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; OVERBAUGH J, 1992, J VIROL, V66, P5937, DOI 10.1128/JVI.66.10.5937-5948.1992; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Ross AC, 2011, CURR OPIN INFECT DIS, V24, P212, DOI 10.1097/QCO.0b013e3283460d34; Rossenkhan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035491; Ruhnke M, 2004, DRUGS, V64, P1163, DOI 10.2165/00003495-200464110-00002; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schell JB, 2012, VACCINE, V30, P4233, DOI 10.1016/j.vaccine.2012.04.046; Schell JB, 2011, J VIROL, V85, P5764, DOI 10.1128/JVI.00342-11; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Waters L, 2005, EXPERT OPIN PHARMACO, V6, P2633, DOI 10.1517/14656566.6.15.2633; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109678	10.1371/journal.pone.0109678	http://dx.doi.org/10.1371/journal.pone.0109678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360552	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700014
J	Gao, M; Zhang, XX; Chen, X; Mi, CY; Tang, YJ; Zhou, JZ; Li, XH				Gao, Meng; Zhang, Xingxing; Chen, Xin; Mi, Cunyun; Tang, Yujie; Zhou, Jianzhi; Li, Xiaohui			Prenatal Exposure to Lipopolysaccharide Results in Local RAS Activation in the Adipose Tissue of Rat Offspring	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; DEVELOPMENTAL ORIGINS; HYPERTENSION; HEALTH	Background: Adult metabolic syndrome may originate in part during fetal or early life. This study was designed to investigate the effects of prenatal exposure to lipopolysaccharide (LPS) on adipose development and local renin-angiotensin system (RAS) activation in rat offspring. Methods: Pregnant rats were randomly divided into three groups (n = 8 in each), including an NS group (pregnant rats were only treated with 0.5 ml normal saline from the 8th to the 14th day of gestation); an LPS group (pregnant rats were injected intraperitoneally with 0.79 mg/kg LPS on the 8th, 10th and 12th days of pregnancy); and an LPS+pyrrolidine dithiocarbamate (PDTC) group (identical to the LPS group except that 100 mg/kg PDTC was administered from the 8 th to the 14 th day of gestation). Results: Prenatal exposure to LPS resulted in increased blood pressure, adipose coefficient and body weight in rat offspring. Specifically, during the infancy of the offspring rats, the LPS stimulus promoted the differentiation of adipose cells, diminishing their diameters and proportions while simultaneously increasing cell number. In contrast, once the rats were grown, adipose cell differentiation was inhibited, and the diameters and proportions of the cells were increased. Moreover, each component of the RAS was changed and was shown to be activated. PDTC, an inhibitor of NF-kappa B, could reverse the influence of the stimulus during pregnancy. Conclusion: Prenatal exposure to LPS in rats results in increased blood pressure, adipose coefficient, body weight and activation of adipose RAS in offspring.	[Gao, Meng; Chen, Xin; Mi, Cunyun; Tang, Yujie; Zhou, Jianzhi; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China; [Zhang, Xingxing] 159 Hosp PLA, Dept Medicament & Instrument, Zhumadian, Herts, Peoples R China	Army Medical University	Zhou, JZ (corresponding author), Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China.	jazi891@aliyun.com; lpsh008@aliyun.com			National Natural Science Foundation of China [81072630, 81373420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81072630, No. 81373420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biermann D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047916; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Carey RM, 2013, CLIN EXP PHARMACOL P, V40, P527, DOI 10.1111/1440-1681.12059; Girard S, 2009, NEUROSCIENCE, V158, P673, DOI 10.1016/j.neuroscience.2008.10.032; Guron G, 2006, NEPHROL DIAL TRANSPL, V21, P522, DOI 10.1093/ndt/gfi288; Hao XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088127; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; Iwai M, 2011, BIOCHEM BIOPH RES CO, V406, P123, DOI 10.1016/j.bbrc.2011.02.007; Johnson RJ, 2008, J HYPERTENS, V26, P381, DOI 10.1097/HJH.0b013e3282f29876; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lebenthal E, 2007, J NUTR, V137, P1073, DOI 10.1093/jn/137.4.1073; Mao C, 2014, NEUROBIOLOGY BODY FL; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moon Ju-Young, 2013, Electrolyte Blood Press, V11, P41, DOI 10.5049/EBP.2013.11.2.41; Nakatani S, 2014, DIABETES RES CLIN PR, V105, P40, DOI 10.1016/j.diabres.2014.04.019; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Samuelsson AM, 2004, ENDOCRINOLOGY, V145, P4897, DOI 10.1210/en.2004-0742; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Stiefel P, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/685238; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076992; Wang R, 2009, PUBLIC HEALTH, V123, P534, DOI 10.1016/j.puhe.2009.06.009; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010	24	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111376	10.1371/journal.pone.0111376	http://dx.doi.org/10.1371/journal.pone.0111376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360670	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700094
J	Zheng, XL; Xie, ZH; Zhu, ZY; Liu, Z; Wang, Y; Wei, LF; Yang, H; Yang, HN; Liu, YQ; Bi, JZ				Zheng, XiaoLei; Xie, ZhaoHong; Zhu, ZhengYu; Liu, Zhen; Wang, Yun; Wei, LiFei; Yang, Hui; Yang, HongNa; Liu, YiQing; Bi, JianZhong			Methyllycaconitine Alleviates Amyloid-beta Peptides-Induced Cytotoxicity in SH-SY5Y Cells	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; AUTOPHAGY; PROTEIN; NEUROTOXICITY; MECHANISMS; BRAIN; NEURODEGENERATION; INVOLVEMENT	Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder. As the most common form of dementia, it affects more than 35 million people worldwide and is increasing. Excessive extracellular deposition of amyloid-beta peptide (A beta) is a pathologic feature of AD. Accumulating evidence indicates that macroautophagy is involved in the pathogenesis of AD, but its exact role is still unclear. Although major findings on the molecular mechanisms have been reported, there are still no effective treatments to prevent, halt, or reverse Alzheimer's disease. In this study, we investigated whether A beta(25-35) could trigger an autophagy process and inhibit the growth of SH-SY5Y cells. Furthermore, we examined the effect of methyllycaconitine (MLA) on the cytotoxity of A beta(25-35). MLA had a protective effect against cytotoxity of A beta, which may be related to its inhibition of A beta-induced autophagy and the involvement of the mammalian target of rapamycin pathway. Moreover, MLA had a good safety profile. MLA treatment may be a promising therapeutic tool for AD.	[Zheng, XiaoLei; Xie, ZhaoHong; Zhu, ZhengYu; Liu, Zhen; Wang, Yun; Wei, LiFei; Yang, Hui; Yang, HongNa; Liu, YiQing; Bi, JianZhong] Shandong Univ, Hosp 2, Dept Neural Med, Jinan 250100, Peoples R China; [Bi, JianZhong] Shandong Univ, Inst Neurol, Jinan 250100, Peoples R China; [Bi, JianZhong] Shandong Univ, Key Lab Translat Med Neurol Degenerat Dis, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Bi, JZ (corresponding author), Shandong Univ, Hosp 2, Dept Neural Med, Jinan 250100, Peoples R China.	bjz@sdu.edu.cn		wei, li fei/0000-0002-8547-8921	National Natural Science Foundation of China [81171214, 81371420]; Shandong Province Natural Science Foundation [ZR2011HM064]; Jinan Science and Technology Development Foundation [201202048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Jinan Science and Technology Development Foundation	This research was supported by the National Natural Science Foundation of China (No. 81171214, 81371420), Shandong Province Natural Science Foundation (ZR2011HM064) and Jinan Science and Technology Development Foundation (201202048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1992, MOL PHARMACOL, V41, P802; Barnett A, 2011, J ALZHEIMERS DIS, V25, P385, DOI 10.3233/JAD-2011-101989; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Cumming T, 2010, INT J STROKE, V5, P453, DOI 10.1111/j.1747-4949.2010.00527.x; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frozza RL, 2009, NEUROCHEM RES, V34, P295, DOI 10.1007/s11064-008-9776-8; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang H, 2010, J INT MED RES, V38, P1305, DOI 10.1177/147323001003800412; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Liu RT, 2009, ACTA PHARMACOL SIN, V30, P899, DOI 10.1038/aps.2009.74; Lockman PR, 2005, J NEUROCHEM, V94, P37, DOI 10.1111/j.1471-4159.2005.03162.x; Luo SJ, 2012, NEUROCHEM RES, V37, P2787, DOI 10.1007/s11064-012-0872-4; Mancuso M, 2010, ADV EXP MED BIOL, V685, P34; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maycotte P, 2010, J NEUROSCI RES, V88, P73, DOI 10.1002/jnr.22168; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Navarro HA, 2000, J MED CHEM, V43, P142, DOI 10.1021/jm990544f; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Puttfarcken PS, 1996, EXP NEUROL, V138, P73, DOI 10.1006/exnr.1996.0048; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HM, 2010, J ALZHEIMERS DIS, V21, P597, DOI 10.3233/JAD-2010-091207; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Yang SN, 2012, J ALZHEIMERS DIS, V28, P345, DOI 10.3233/JAD-2011-110863; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	47	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111536	10.1371/journal.pone.0111536	http://dx.doi.org/10.1371/journal.pone.0111536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360664	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700114
J	Leonard, A; Paton, AW; El-Quadi, M; Paton, JC; Fazal, F				Leonard, Antony; Paton, Adrienne W.; El-Quadi, Monaliza; Paton, James C.; Fazal, Fabeha			Preconditioning with Endoplasmic Reticulum Stress Ameliorates Endothelial Cell Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; RELA/P65 NUCLEAR TRANSLOCATION; UNFOLDED PROTEIN RESPONSE; TISSUE-FACTOR; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; ICAM-1 EXPRESSION; INDUCED INCREASE	Endoplasmic Reticulum (ER) stress, caused by disturbance in ER homeostasis, has been implicated in several pathological conditions such as ischemic injury, neurodegenerative disorders, metabolic diseases and more recently in inflammatory conditions. Our present study aims at understanding the role of ER stress in endothelial cell (EC) inflammation, a critical event in the pathogenesis of acute lung injury (ALI). We found that preconditioning human pulmonary artery endothelial cells (HPAEC) to ER stress either by depleting ER chaperone and signaling regulator BiP using siRNA, or specifically cleaving (inactivating) BiP using subtilase cytotoxin (SubAB), alleviates EC inflammation. The two approaches adopted to abrogate BiP function induced ATF4 protein expression and the phosphorylation of eIF2 alpha, both markers of ER stress, which in turn resulted in blunting the activation of NF-kappa B, and restoring endothelial barrier integrity. Pretreatment of HPAEC with BiP siRNA inhibited thrombin-induced IkB alpha degradation and its resulting downstream signaling pathway involving NF-kappa B nuclear translocation, DNA binding, phosphorylation at serine536, transcriptional activation and subsequent expression of adhesion molecules. However, TNF alpha-mediated NF-kappa B signaling was unaffected upon BiP knockdown. In an alternative approach, SubAB-mediated inactivation of NF-kappa B was independent of IkB alpha degradation. Mechanistic analysis revealed that pretreatment of EC with SubAB interfered with the binding of the liberated NF-kappa B to the DNA, thereby resulting in reduced expression of adhesion molecules, cytokines and chemokines. In addition, both knockdown and inactivation of BiP stimulated actin cytoskeletal reorganization resulting in restoration of endothelial permeability. Together our studies indicate that BiP plays a central role in EC inflammation and injury via its action on NF-kappa B activation and regulation of vascular permeability.	[Leonard, Antony; El-Quadi, Monaliza; Fazal, Fabeha] Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Rochester; University of Adelaide	Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627 USA.	Fabeha_Fazal@URMC.Rochester.edu			National Heart, Lung and Blood Institute [HL096907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096907] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute Grant HL096907. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2012, ARCH BIOCHEM BIOPHYS, V520, P30, DOI 10.1016/j.abb.2012.01.014; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Anthoni C, 2007, J EXP MED, V204, P1595, DOI 10.1084/jem.20062354; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Harama D, 2009, J IMMUNOL, V183, P1368, DOI 10.4049/jimmunol.0804066; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu CCA, 2009, J EXP MED, V206, P2429, DOI 10.1084/jem.20090782; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Levitt JE, 2006, SEMIN RESP CRIT CARE, V27, P426, DOI 10.1055/s-2006-948296; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Prell T, 2014, J NEUROIMMUNOL, V270, P29, DOI 10.1016/j.jneuroim.2014.03.005; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rath E, 2011, EUR J NUTR, V50, P219, DOI 10.1007/s00394-011-0197-0; Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Undas A, 2010, THROMB HAEMOSTASIS, V104, P224, DOI 10.1160/TH10-02-0091; Usuki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02346; Vaidyula VR, 2009, THROMB RES, V124, P259, DOI 10.1016/j.thromres.2008.12.030; van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783	57	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110949	10.1371/journal.pone.0110949	http://dx.doi.org/10.1371/journal.pone.0110949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356743	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000033
J	Israeli-Rosenberg, S; Chen, C; Li, RX; Deussen, DN; Niesman, IR; Okada, H; Patel, HH; Roth, DM; Ross, RS				Israeli-Rosenberg, Sharon; Chen, Chao; Li, Ruixia; Deussen, Daniel N.; Niesman, Ingrid R.; Okada, Hideshi; Patel, Hemal H.; Roth, David M.; Ross, Robert S.			Caveolin modulates integrin function and mechanical activation in the cardiomyocyte	FASEB JOURNAL			English	Article						caveolae; focal adhesions; mechanotransduction; myocardium	FOCAL ADHESION KINASE; CARDIAC-SPECIFIC OVEREXPRESSION; HYPERTROPHIC RESPONSE; ISCHEMIA/REPERFUSION INJURY; INDUCED PHOSPHORYLATION; SIGNALING COMPONENTS; EXTRACELLULAR-MATRIX; VENTRICULAR MYOCYTES; PRESSURE-OVERLOAD; MUTANT CAVEOLIN-3	beta 1 integrins (beta 1) transduce mechanical signals in many cells, including cardiac myocytes (CM). Given their close localization, as well as their role in mechanotransduction and signaling, we hypothesized that caveolin (Cav) proteins might regulate integrins in the CM. beta 1 localization, complex formation, activation state, and signaling were analyzed using wild-type, Cav3 knockout, and Cav3 CM-specific transgenic heart and myocyte samples. Studies were performed under basal and mechanically loaded conditions. We found that: 1) beta 1 and Cav3 colocalize in CM and coimmunoprecipitate from CM protein lysates; 2) beta 1 is detected in a subset of caveolae; 3) loss of Cav3 caused reduction of beta 1D integrin isoform and active beta 1 integrin from the buoyant domains in the heart; 4) increased expression of myocyte Cav3 correlates with increased active beta 1 integrin in adult CM; 5) in vivo pressure overload of the wild-type heart results in increased activated integrin in buoyant membrane domains along with increased association between active integrin and Cav3; and 6) Cav3-deficient myocytes have perturbed basal and stretch mediated signaling responses. Thus, Cav3 protein can modify integrin function and mechanotransduction in the CM and intact heart.	[Israeli-Rosenberg, Sharon; Chen, Chao; Li, Ruixia; Okada, Hideshi; Ross, Robert S.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Niesman, Ingrid R.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Israeli-Rosenberg, Sharon; Chen, Chao; Li, Ruixia; Niesman, Ingrid R.; Okada, Hideshi; Patel, Hemal H.; Roth, David M.; Ross, Robert S.] US Vet Adm, San Diego Healthcare Syst, San Diego, CA USA; [Deussen, Daniel N.; Patel, Hemal H.; Roth, David M.] Maastricht Univ, NL-6200 MD Maastricht, Netherlands	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Maastricht University	Ross, RS (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Biomed Res Facil 2,Room 2A-17,9500 Gilman Dr, La Jolla, CA 92093 USA.	rross@ucsd.edu	Ross, Robert/ABE-1109-2020; Patel, Hemal/C-7325-2019	Ross, Robert/0000-0003-2195-8982; Niesman, Ingrid/0000-0001-9767-6629; Okada, Hideshi/0000-0002-7775-4308; Patel, Hemal/0000-0001-6722-9625	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL046345, HL088390, HL103566, HL115933, HL091071, HL107200]; U.S. Veterans Administration (VA) Merit [BX001704, BX001963, BX000783]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345, R01HL088390, R01HL103566, R01HL115933, R01HL091071, R01HL107200] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX001963, I01BX001704] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Veterans Administration (VA) Merit; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank A. M. Manso for helpful comments and Drs. M. Humphries and S. Craig (The University of Manchester, Manchester, UK) for the kind gift of an anti-active beta 1 integrin antibody. The authors also thank Drs. A. McCulloch, E. Pfeiffer, and A. Wright for helpful discussions and insight. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL046345, HL088390, HL103566, HL115933 (R.S.R.); U.S. Veterans Administration (VA) Merit Grant BX001704 (R.S.R.); NIH National Heart, Lung, and Blood Institute Grants HL091071 (H.H.P.), HL107200 (H.H.P. and D.M.R.); VA Merit Grant BX001963 (H.H.P.); and VA Merit Grant BX000783 (D.M.R.).	Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001; Armulik A, 2000, EXP CELL RES, V254, P55, DOI 10.1006/excr.1999.4722; Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bellott AC, 2005, J APPL PHYSIOL, V98, P1554, DOI 10.1152/japplphysiol.01070.2004; Burkin DJ, 2005, AM J PATHOL, V166, P253, DOI 10.1016/S0002-9440(10)62249-3; Catteruccia M, 2009, NEUROMUSCULAR DISORD, V19, P779, DOI 10.1016/j.nmd.2009.08.015; de Cavanagh EMV, 2009, AM J PHYSIOL-HEART C, V296, pH550, DOI 10.1152/ajpheart.01176.2008; de Jonge HW, 2007, CELL BIOCHEM BIOPHYS, V47, P21, DOI 10.1385/CBB:47:1:21; Echarri A, 2006, CELL CYCLE, V5, P2179, DOI 10.4161/cc.5.19.3264; Fassler R, 1996, J CELL SCI, V109, P2989; Franchini KG, 2000, CIRC RES, V87, P558, DOI 10.1161/01.RES.87.7.558; Fridolfsson HN, 2014, FASEB J; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Horiguchi K, 2011, J ENDOCRINOL, V210, P29, DOI 10.1530/JOE-11-0103; Horikawa YT, 2008, J MOL CELL CARDIOL, V44, P123, DOI 10.1016/j.yjmcc.2007.10.003; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Jokhadar SZ, 2013, CELL BIOL INT, V37, P1276, DOI 10.1002/cbin.10155; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kohl P, 2003, PROG BIOPHYS MOL BIO, V82, P221, DOI 10.1016/S0079-6107(03)00024-5; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Li RX, 2012, AM J PATHOL, V180, P952, DOI 10.1016/j.ajpath.2011.12.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Ohsawa Y, 2004, HUM MOL GENET, V13, P151, DOI 10.1093/hmg/ddh014; Okada H, 2013, J CLIN INVEST, V123, P4294, DOI 10.1172/JCI64216; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Salanueva IJ, 2007, J CELL MOL MED, V11, P969, DOI 10.1111/j.1582-4934.2007.00109.x; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Swaney JS, 2006, J BIOL CHEM, V281, P17173, DOI 10.1074/jbc.M513097200; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	58	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					374	384		10.1096/fj.13-243139	http://dx.doi.org/10.1096/fj.13-243139			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25366344	Green Published			2022-12-26	WOS:000349370400004
J	Jung, SK; Lee, MH; Lim, DY; Kim, JE; Singh, P; Lee, SY; Jeong, CH; Lim, TG; Chen, HY; Chi, YI; Kundu, JK; Lee, NH; Lee, CC; Cho, YY; Bode, AM; Lee, KW; Dong, ZG				Jung, Sung Keun; Lee, Mee-Hyun; Lim, Do Young; Kim, Jong Eun; Singh, Puja; Lee, Sung-Young; Jeong, Chul-Ho; Lim, Tae-Gyu; Chen, Hanyong; Chi, Young-In; Kundu, Joydeb Kumar; Lee, Nam Hyouck; Lee, Charles C.; Cho, Yong-Yeon; Bode, Ann M.; Lee, Ki Won; Dong, Zigang			Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITORS; MET AMPLIFICATION; RESISTANCE; PROLIFERATION; ANTIOXIDANT; EXPRESSION; GEFITINIB; MUTATION; PATHWAY; ROOTS	Non-small-cell lung cancer (NSCLC) is associated with diverse genetic alterations including mutation of epidermal growth factor receptor (EGFR). Isoliquiritigenin (ILQ), a chalcone derivative, possesses anticancer activities. In the present study, we investigated the effects of ILQ on the growth of tyrosine kinase inhibitor (TKI)-sensitive and -resistant NSCLC cells and elucidated its underlying mechanisms. Treatment with ILQ inhibited growth and induced apoptosis in both TKI-sensitive and -resistant NSCLC cells. ILQ-induced apoptosis was associated with the cleavage of caspase-3 and poly-(ADP-ribose)-polymerase, increased expression of Bim, and reduced expression of Bcl-2. In vitro kinase assay results revealed that ILQ inhibited the catalytic activity of both wild type and double mutant (L858R/T790M) EGFR. Treatment with ILQ inhibited the anchorage-independent growth of NIH3T3 cells stably transfected with either wild type or double-mutant EGFR with or without EGF stimulation. ILQ also reduced the phosphorylation of Akt and ERK1/2 in both TKI-sensitive and -resistant NSCLC cells, and attenuated the kinase activity of Akt1 and ERK2 in vitro. ILQ directly interacted with both wild type and double-mutant EGFR in an ATP-competitive manner. A docking model study showed that ILQ formed two hydrogen bonds (Glu-762 and Met-793) with wild type EGFR and three hydrogen bonds (Lys-745, Met-793, and Asp-855) with mutant EGFR. ILQ attenuated the xenograft tumor growth of H1975 cells, which was associated with decreased expression of Ki-67 and diminished phosphorylation of Akt and ERK1/2. Taken together, ILQ suppresses NSCLC cell growth by directly targeting wild type or mutant EGFR.	[Jung, Sung Keun; Lee, Mee-Hyun; Lim, Do Young; Kim, Jong Eun; Singh, Puja; Lee, Sung-Young; Jeong, Chul-Ho; Lim, Tae-Gyu; Chen, Hanyong; Chi, Young-In; Lee, Charles C.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Jung, Sung Keun; Lee, Nam Hyouck] Korea Food Res Inst, Div Metab & Funct Res, Songnam 463746, Gyeonggi Do, South Korea; [Lee, Mee-Hyun; Cho, Yong-Yeon] Catholic Univ Korea, Coll Pharm, Puchon 420743, Gyeonggi Do, South Korea; [Kim, Jong Eun; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, Gyeonggi Do, South Korea; [Jeong, Chul-Ho; Kundu, Joydeb Kumar] Keimyung Univ, Coll Pharm, Taegu 704701, South Korea; [Lim, Tae-Gyu; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul 151921, South Korea; [Lim, Tae-Gyu; Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151742, South Korea; [Lee, Charles C.] Cornell Univ, Dept Food Sci, Ithaca, NY 14850 USA; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang 232916, South Korea	University of Minnesota System; Korea Food Research Institute (KFRI); Catholic University of Korea; Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Cornell University; Seoul National University (SNU)	Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	kiwon@snu.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Lee, Ki Won/M-4114-2018; kim, jong-eun/B-3550-2017; Lim, Tae-Gyu/AAO-8475-2020	kim, jong-eun/0000-0002-5030-6126; Lim, Tae-Gyu/0000-0001-6930-9565; Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA1669011, CA172457, R37 CA081064, ES016548]; National Research Foundation of Korea (NRF) grant - Korea government (MEST), Republic of Korea [2010-0029233]; Korea Food Research Institute, Republic of Korea; NATIONAL CANCER INSTITUTE [R37CA081064, R21CA172457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) grant - Korea government (MEST), Republic of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Korea Food Research Institute, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institutes of Health CA1669011, CA172457, R37 CA081064, and ES016548, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2010-0029233), Republic of Korea, and by the Korea Food Research Institute, Republic of Korea.	[Anonymous], 2011, SCHROD; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Carrera S, 2014, CLIN TRANSL ONCOL, V16, P339, DOI 10.1007/s12094-013-1143-9; Chen XZ, 2012, J MOL MED, V90, P1311, DOI 10.1007/s00109-012-0910-3; Chin YW, 2007, J AGR FOOD CHEM, V55, P4691, DOI 10.1021/jf0703553; Cuendet M, 2010, CANCER PREV RES, V3, P221, DOI 10.1158/1940-6207.CAPR-09-0049; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Haraguchi H, 1998, BIOORGAN MED CHEM, V6, P339, DOI 10.1016/S0968-0896(97)10034-7; Hsu YL, 2005, LIFE SCI, V77, P279, DOI 10.1016/j.lfs.2004.09.047; Hsu YL, 2004, CLIN EXP PHARMACOL P, V31, P414, DOI 10.1111/j.1440-1681.2004.04016.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kim JY, 2008, EUR J PHARMACOL, V584, P175, DOI 10.1016/j.ejphar.2008.01.032; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Li RC, 2014, INT J BIOL MARKER, V29, pE112, DOI 10.5301/jbm.5000059; Li T, 2004, CANCER LETT, V207, P27, DOI 10.1016/j.canlet.2003.10.023; Li Y, 2013, TOXICOL APPL PHARM, V272, P37, DOI 10.1016/j.taap.2013.05.031; Ma Chunyan, 2011, J Thorac Dis, V3, P10, DOI 10.3978/j.issn.2072-1439.2010.12.02; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Pallis AG, 2013, LUNG CANCER, V80, P120, DOI 10.1016/j.lungcan.2012.12.025; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sacco PC, 2014, FRONT BIOSCI-LANDMRK, V19, P259, DOI 10.2741/4205; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang KL, 2013, EXPERT OPIN THER TAR, V17, P337, DOI 10.1517/14728222.2013.756869; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Yamazaki S, 2002, CANCER LETT, V183, P23, DOI 10.1016/S0304-3835(02)00113-1; Yuan X, 2012, J ASIAN NAT PROD RES, V14, P789, DOI 10.1080/10286020.2012.694873; Zhang XY, 2010, CLIN EXP PHARMACOL P, V37, P841, DOI 10.1111/j.1440-1681.2010.05395.x; Zhou GS, 2013, MOL MED REP, V7, P531, DOI 10.3892/mmr.2012.1218; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	37	75	81	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35839	35848		10.1074/jbc.M114.585513	http://dx.doi.org/10.1074/jbc.M114.585513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368326	hybrid, Green Published			2022-12-26	WOS:000346897900015
J	Djordjevic, D; Yang, A; Zadoorian, A; Rungrugeecharoen, K; Ho, JWK				Djordjevic, Djordje; Yang, Andrian; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.			How Difficult Is Inference of Mammalian Causal Gene Regulatory Networks?	PLOS ONE			English	Article							PACKAGE	Gene regulatory networks (GRNs) play a central role in systems biology, especially in the study of mammalian organ development. One key question remains largely unanswered: Is it possible to infer mammalian causal GRNs using observable gene co-expression patterns alone? We assembled two mouse GRN datasets (embryonic tooth and heart) and matching microarray gene expression profiles to systematically investigate the difficulties of mammalian causal GRN inference. The GRNs were assembled based on >2,000 pieces of experimental genetic perturbation evidence from manually reading > 150 primary research articles. Each piece of perturbation evidence records the qualitative change of the expression of one gene following knock-down or over-expression of another gene. Our data have thorough annotation of tissue types and embryonic stages, as well as the type of regulation (activation, inhibition and no effect), which uniquely allows us to estimate both sensitivity and specificity of the inference of tissue specific causal GRN edges. Using these unprecedented datasets, we found that gene co-expression does not reliably distinguish true positive from false positive interactions, making inference of GRN in mammalian development very difficult. Nonetheless, if we have expression profiling data from genetic or molecular perturbation experiments, such as gene knock-out or signalling stimulation, it is possible to use the set of differentially expressed genes to recover causal regulatory relationships with good sensitivity and specificity. Our result supports the importance of using perturbation experimental data in causal network reconstruction. Furthermore, we showed that causal gene regulatory relationship can be highly cell type or developmental stage specific, suggesting the importance of employing expression profiles from homogeneous cell populations. This study provides essential datasets and empirical evidence to guide the development of new GRN inference methods for mammalian organ development.	[Djordjevic, Djordje; Yang, Andrian; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Djordjevic, Djordje; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.] Univ New S Wales, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Ho, JWK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	j.ho@victorchang.edu.au	Ho, Joshua W. K./AAK-7759-2020	Ho, Joshua W. K./0000-0003-2331-7011; Djordjevic, Djordje/0000-0003-3669-6292	Victor Chang Cardiac Research Institute	Victor Chang Cardiac Research Institute	This project is supported by the Victor Chang Cardiac Research Institute. The funder provided financial support for the research staff and students involved in this project. It had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barzel B, 2013, NAT BIOTECHNOL, V31; Buckingham M, 2005, NATURE REV GENETICS, V6; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Edgar R., 2002, NUCLEIC ACIDS RES, V30; Frhlich H, 2009, BIOMETRICAL J, V51; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Frohlich H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-322; Glass K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064832; Ho Joshua W K, 2012, Biophys Rev, V4, P245, DOI 10.1007/s12551-012-0092-9; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Maathuis MH, 2010, NATURE METHODS, V7; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mora A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-455; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsen C, 2014, GENOMICS, V103, P329, DOI 10.1016/j.ygeno.2014.03.004; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sing T, 2005, BIOINFORMATICS, V21; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Wang Y, 2014, BIOINFORMATICS	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111661	10.1371/journal.pone.0111661	http://dx.doi.org/10.1371/journal.pone.0111661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369032	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000083
J	Quinones-Valles, C; Sanchez-Osorio, I; Martinez-Antonio, A				Quinones-Valles, Cesar; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino			Dynamical Modeling of the Cell Cycle and Cell Fate Emergence in Caulobacter crescentus	PLOS ONE			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; DNA-REPLICATION; MASTER REGULATOR; LOGICAL ANALYSIS; DIVISION; PROTEIN; DIFFERENTIATION; LOCALIZATION; ROBUSTNESS	The division of Caulobacter crescentus, a model organism for studying cell cycle and differentiation in bacteria, generates two cell types: swarmer and stalked. To complete its cycle, C. crescentus must first differentiate from the swarmer to the stalked phenotype. An important regulator involved in this process is CtrA, which operates in a gene regulatory network and coordinates many of the interactions associated to the generation of cellular asymmetry. Gaining insight into how such a differentiation phenomenon arises and how network components interact to bring about cellular behavior and function demands mathematical models and simulations. In this work, we present a dynamical model based on a generalization of the Boolean abstraction of gene expression for a minimal network controlling the cell cycle and asymmetric cell division in C. crescentus. This network was constructed from data obtained from an exhaustive search in the literature. The results of the simulations based on our model show a cyclic attractor whose configurations can be made to correspond with the current knowledge of the activity of the regulators participating in the gene network during the cell cycle. Additionally, we found two point attractors that can be interpreted in terms of the network configurations directing the two cell types. The entire network is shown to be operating close to the critical regime, which means that it is robust enough to perturbations on dynamics of the network, but adaptable to environmental changes.	[Quinones-Valles, Cesar] Natl Polytech Inst Monterrey, Ctr Res & Adv Studies, Engn & Biomed Phys Dept, Apodaca, Nuevo Leon, Mexico; [Quinones-Valles, Cesar; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino] Natl Polytech Inst Irapuato, Ctr Res & Adv Studies, Genet Engn Dept, Guanajuato, Mexico		Martinez-Antonio, A (corresponding author), Natl Polytech Inst Irapuato, Ctr Res & Adv Studies, Genet Engn Dept, Guanajuato, Mexico.	amartinez@ira.cinvestav.mx	Martínez-Antonio, Agustino/GQQ-2363-2022; Antonio, Agustino Martínez/AAG-4309-2021	Martínez-Antonio, Agustino/0000-0003-2231-5014; Antonio, Agustino Martínez/0000-0003-2231-5014	Consejo Nacional de Ciencia y Tecnologia from Mexico [103686, 206011]	Consejo Nacional de Ciencia y Tecnologia from Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by grant 103686 to AM-A and fellowship 206011 to CQ-V, both from the Consejo Nacional de Ciencia y Tecnologia from Mexico (http://www.conacyt.gob.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Aldana-Gonzalez M, 2003, SPRINGER APPL MATH S, P23; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Blinov ML, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-92; Brazhnik P, 2006, CELL CYCLE, V5, P522, DOI 10.4161/cc.5.5.2493; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Furusawa C, 2002, ANAT RECORD, V268, P327, DOI 10.1002/ar.10164; GOBER JW, 1995, MICROBIOL REV, V59, P31, DOI 10.1128/MMBR.59.1.31-47.1995; Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 2006, J BACTERIOL, V188, P2244, DOI 10.1128/JB.188.6.2244-2253.2006; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Li SH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000463; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2011, J MOL BIOL, V409, P28, DOI 10.1016/j.jmb.2011.02.041; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Naldi A, 2009, LECT N BIOINFORMAT, V5688, P266, DOI 10.1007/978-3-642-03845-7_18; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Reisenauer A, 1999, J BACTERIOL, V181, P2430, DOI 10.1128/JB.181.8.2430-2439.1999; Reisinger SJ, 2007, J BACTERIOL, V189, P8308, DOI 10.1128/JB.00868-07; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; SHAPIRO L, 1971, SCIENCE, V173, P884, DOI 10.1126/science.173.4000.884; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003221; Tan MH, 2010, P NATL ACAD SCI USA, V107, P18985, DOI 10.1073/pnas.1014395107; TERRANA B, 1975, DEV BIOL, V44, P380, DOI 10.1016/0012-1606(75)90409-1; THIEFFRY D, 1995, B MATH BIOL, V57, P277, DOI 10.1016/0092-8240(94)00037-D; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Tsokos CG, 2012, CURR OPIN MICROBIOL, V15, P744, DOI 10.1016/j.mib.2012.10.011; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Winzeler E, 1996, J MOL BIOL, V264, P412, DOI 10.1006/jmbi.1996.0650; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	57	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111116	10.1371/journal.pone.0111116	http://dx.doi.org/10.1371/journal.pone.0111116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369202	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000038
J	Upadhyay, M; Sharma, N; Vivekanandan, P				Upadhyay, Mohita; Sharma, Neha; Vivekanandan, Perumal			Systematic CpT (ApG) Depletion and CpG Excess Are Unique Genomic Signatures of Large DNA Viruses Infecting Invertebrates	PLOS ONE			English	Article							CODON USAGE BIAS; BACKGROUND NUCLEOTIDE COMPOSITION; CYTOSINE METHYLATION; PATTERNS; OLIGODEOXYNUCLEOTIDES; HOST; INTERLEUKIN-8; EXPRESSION; EVOLUTION; SEQUENCES	Differences in the relative abundance of dinucleotides, if any may provide important clues on host-driven evolution of viruses. We studied dinucleotide frequencies of large DNA viruses infecting vertebrates (n = 105; viruses infecting mammals = 99; viruses infecting aves = 6; viruses infecting reptiles = 1) and invertebrates (n = 88; viruses infecting insects = 84; viruses infecting crustaceans = 4). We have identified systematic depletion of CpT(ApG) dinucleotides and over-representation of CpG dinucleotides as the unique genomic signature of large DNA viruses infecting invertebrates. Detailed investigation of this unique genomic signature suggests the existence of invertebrate host-induced pressures specifically targeting CpT(ApG) and CpG dinucleotides. The depletion of CpT dinucleotides among large DNA viruses infecting invertebrates is at least in part, explained by non-canonical DNA methylation by the infected host. Our findings highlight the role of invertebrate host-related factors in shaping virus evolution and they also provide the necessary framework for future studies on evolution, epigenetics and molecular biology of viruses infecting this group of hosts.	[Upadhyay, Mohita; Sharma, Neha; Vivekanandan, Perumal] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India.	vperumal@bioschool.iitd.ac.in			Department of Biotechnology (DBT), India [BT/PR15062/GBD/27/295/2011]; Kusuma Trust	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Kusuma Trust	Funding provided by Department of Biotechnology (DBT), India (BT/PR15062/GBD/27/295/2011) Kusuma Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Borsatti F, 2004, CARYOLOGIA, V57, P305, DOI 10.1080/00087114.2004.10589410; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Fuglsang A, 2006, MOL BIOL EVOL, V23, P1345, DOI 10.1093/molbev/msl009; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Jabbari K, 1998, GENE, V224, P123, DOI 10.1016/S0378-1119(98)00474-0; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Kim D, 2011, MOL IMMUNOL, V48, P1494, DOI 10.1016/j.molimm.2011.04.009; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Ottaviani E, 2000, CELL MOL LIFE SCI, V57, P506, DOI 10.1007/PL00000711; Parilla NW, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-84; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Ren LC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r35; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Simmonds P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-610; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takayama S, 2014, GENOME RES; Tidona CA, 1996, VIRUS GENES, V12, P219, DOI 10.1007/BF00284642; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wiebauer K, 1993, EXS, V64, P510; WILLIS DB, 1980, VIROLOGY, V107, P250, DOI 10.1016/0042-6822(80)90290-1; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111793	10.1371/journal.pone.0111793	http://dx.doi.org/10.1371/journal.pone.0111793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369195	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402000102
J	Yang, J; Yang, J; Gao, Y; Zhao, LY; Liu, LY; Qin, YN; Wang, XF; Song, TS; Huang, C				Yang, Juan; Yang, Jin; Gao, Yan; Zhao, Lingyu; Liu, Liying; Qin, Yannan; Wang, Xiaofei; Song, Tusheng; Huang, Chen			Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; CANCER; EXPRESSION; TISSUE; PATHOGENESIS; STABILITY; CANDIDATE; PROGNOSIS; DIAGNOSIS; MARKERS	Objective: To investigate discriminating protein patterns and serum biomarkers between clear cell renal cell carcinoma (ccRCC) patients and healthy controls, as well as between paired pre- and post-operative ccRCC patients. Methods: We used magnetic bead-based separation followed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) to identify patients with ccRCC. A total of 162 serum samples were analyzed in this study, among which there were 58 serum samples from ccRCC patients, 40 from additional paired pre- and post-operative ccRCC patients (n = 20), and 64 from healthy volunteers as healthy controls. ClinProTools software identified several distinct markers between ccRCC patients and healthy controls, as well as between pre- and post-operative patients. Results: Patients with ccRCC could be identified with a mean sensitivity of 88.38% and a mean specificity of 91.67%. Of 67 m/z peaks that differed among the ccRCC, healthy controls, pre- and post-operative ccRCC patients, 24 were significantly different (P<0.05). Three candidate peaks, which were upregulated in ccRCC group and showed a tendency to return to healthy control values after surgery, were identified as peptide regions of RNA-binding protein 6 (RBP6), tubulin beta chain (TUBB), and zinc finger protein 3 (ZFP3) with the m/z values of 1466.98, 1618.22, and 5905.23, respectively. Conclusion: MB-MALDI-TOF-MS method could generate serum peptidome profiles of ccRCC, and provide a new approach to identify potential biomarkers for diagnosis as well as prognosis of this malignancy.	[Yang, Juan; Zhao, Lingyu; Liu, Liying; Qin, Yannan; Wang, Xiaofei; Song, Tusheng; Huang, Chen] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Key Lab Environm & Genes Related Dis,Educ Minist, Xian 710049, Peoples R China; [Yang, Jin; Gao, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Huang, C (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Key Lab Environm & Genes Related Dis,Educ Minist, Xian 710049, Peoples R China.	hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [81200845]; Key Science and Technology Program of Shaanxi province [2012 K13-02-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Program of Shaanxi province	This work was supported by The National Natural Science Foundation of China (grant number: 81200845) and the Key Science and Technology Program of Shaanxi province (grant number: 2012 K13-02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kandari W, 2007, MOL IMMUNOL, V44, P311, DOI 10.1016/j.molimm.2006.02.029; Atrih A, 2014, BRIT J CANCER, V110, P1622, DOI 10.1038/bjc.2014.24; Banville N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105365; Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1; Bhattacharya R, 2004, MOL BIOL CELL, V15, P3123, DOI 10.1091/mbc.E04-01-0060; Brannon A Rose, 2010, Genes Cancer, V1, P152; Cheng L, 2009, HUM PATHOL, V40, P10, DOI 10.1016/j.humpath.2008.09.009; Cho WCS, 2011, EXPERT REV PROTEOMIC, V8, P1, DOI [10.1586/EPR.10.108, 10.3779/j.issn.1009-3419.2011.08.12]; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Craven RA, 2013, CLIN BIOCHEM, V46, P456, DOI 10.1016/j.clinbiochem.2012.11.029; Cremona M, 2014, EXPERT REV PROTEOMIC, V11, P237, DOI 10.1586/14789450.2014.893193; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis VW, 2011, J SURG ONCOL, V103, P451, DOI 10.1002/jso.21831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hosoya N, 2013, BBA-PROTEINS PROTEOM, V1834, P2630, DOI 10.1016/j.bbapap.2013.08.009; Issaq HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/elps.201000588; Jones EE, 2014, PROTEOMICS, V14, P924, DOI 10.1002/pmic.201300434; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; Lam JS, 2006, WORLD J UROL, V24, P255, DOI 10.1007/s00345-006-0055-5; Linge A, 2012, INVEST OPHTH VIS SCI, V53, P4634, DOI 10.1167/iovs.11-9019; Liu AN, 2014, TUMOUR BIOL; Liu JY, 2014, J ETHNOPHARMACOL, V155, P1322, DOI 10.1016/j.jep.2014.07.025; Ljungberg B, 2007, CURR OPIN UROL, V17, P303, DOI 10.1097/MOU.0b013e328277f180; Ma Y, 2012, DIAGN MOL PATHOL, V21, P157, DOI 10.1097/PDM.0b013e31824d3435; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Mustafa A, 2011, J UROLOGY, V186, P1206, DOI 10.1016/j.juro.2011.05.085; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Ohishi Y, 2007, GYNECOL ONCOL, V105, P586, DOI 10.1016/j.ygyno.2007.01.044; Qi YJ, 2014, PROTEOMICS, V14, P186, DOI 10.1002/pmic.201300226; Raimondo F, 2012, MOL BIOSYST, V8, P1040, DOI 10.1039/c2mb05390j; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Schaub NP, 2009, J AM COLL SURGEONS, P1; Seliger B, 2007, PROTEOMICS, V7, P4601, DOI 10.1002/pmic.200700415; Steurer S, 2014, ANTICANCER RES, V34, P2255; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Yang J, 2012, CLIN EXP MED, V12, P79, DOI 10.1007/s10238-011-0149-2; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zigeuner R, 2010, EUR UROL, V57, P102, DOI 10.1016/j.eururo.2008.11.033	42	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111364	10.1371/journal.pone.0111364	http://dx.doi.org/10.1371/journal.pone.0111364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368985	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000050
J	Higashikawa, K; Yagi, K; Watanabe, K; Kamino, S; Ueda, M; Hiromura, M; Enomoto, S				Higashikawa, Kei; Yagi, Katsuharu; Watanabe, Keiko; Kamino, Shinichiro; Ueda, Masashi; Hiromura, Makoto; Enomoto, Shuichi			Cu-64-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; AUTOIMMUNE-DISEASE; ANTITUMOR-ACTIVITY; IMMUNE-SYSTEM; BIODISTRIBUTION; IPILIMUMAB; EXPRESSION; RESPONSES; SIGNALS	Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients. However, it is extremely expensive and potentially produces autoimmune-related adverse effects. Therefore, the development of a method to evaluate CTLA-4 expression prior to CTLA-4-targeted therapy is expected to open doors to evidence-based and cost-efficient medical care and to avoid adverse effects brought about by ineffective therapy. In this study, we aimed to develop a molecular imaging probe for CTLA-4 visualization in tumor. First, we examined CTLA-4 expression in normal colon tissues, cultured CT26 cells, and CT26 tumor tissues from tumor-bearing BALB/c mice and BALB/c nude mice by reverse transcription polymerase chain reaction (RT-PCR) analysis and confirmed whether CTLA-4 is strongly expressed in CT26 tumor tissues. Second, we newly synthesized Cu-64-1,4,7,10-tetraazacyclododecane-N,N',N '',N'''-tetraacetic acid-anti-mouse CTLA-4 mAb (Cu-64-DOTA-anti-CTLA-4 mAb) and evaluated its usefulness in positron emission tomography (PET) and ex-vivo biodistribution analysis in CT26-bearing BALB/c mice. High CTLA-4 expression was confirmed in the CT26 tumor tissues of tumor-bearing BALB/c mice. However, CTLA-4 expression was extremely low in the cultured CT26 cells and the CT26 tumor tissues of tumor-bearing BALB/c nude mice. The results suggested that T cells were responsible for the high CTLA-4 expression. Furthermore, Cu-64-DOTA-anti-CTLA-4 mAb displayed significantly high accumulation in the CT26 tumor, thereby realizing non-invasive CTLA-4 visualization in the tumor. Together, the results indicate that Cu-64-DOTA-anti-CTLA-4 mAb would be useful for the evaluation of CTLA-4 expression in tumor.	[Higashikawa, Kei; Yagi, Katsuharu; Watanabe, Keiko; Ueda, Masashi; Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Higashikawa, Kei] Japan Soc Promot Sci, Tokyo, Japan; [Kamino, Shinichiro; Hiromura, Makoto; Enomoto, Shuichi] RIKEN, Ctr Life Sci Technol, Next Generat Imaging Team, Kobe, Hyogo, Japan	Okayama University; Japan Society for the Promotion of Science; RIKEN	Enomoto, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	semo@riken.jp	Ueda, Masashi/K-4096-2013	Ueda, Masashi/0000-0001-7027-1568; Multhoff, Gabriele/0000-0002-2616-3137	MEXT, Japan; Japan Society for the Promotion of Science [12J06885]; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [12J06885, 23000005] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for COE projects by MEXT, Japan, titled "Center of excellence for molecular and gene targeting therapies with micro-doze molecular imaging modalities.", a grant from Japan Society for the Promotion of Science (grant number: 12J06885, URL: http://www.jsps.go.jp/english/index.html), and a grant form the Ministry of Education, Culture, Sports, Science and Technology ( URL: http://www.pref.okayama.jp/page/287673.html). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Araki M, 2009, J IMMUNOL, V183, P5146, DOI 10.4049/jimmunol.0802610; Bhattacharyya S, 2013, NUCL MED BIOL, V40, P451, DOI 10.1016/j.nucmedbio.2013.01.007; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P850, DOI 10.1007/s00259-006-0361-6; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Gerold KD, 2011, DIABETES, V60, P1955, DOI 10.2337/db11-0130; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Higashikawa K, 2011, BIOCHEM BIOPH RES CO, V410, P416, DOI 10.1016/j.bbrc.2011.05.146; Knowles SM, 2012, J CLIN ONCOL, V30, P3884, DOI 10.1200/JCO.2012.42.4887; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Liu SM, 2012, J IMMUNOL, V188, P155, DOI 10.4049/jimmunol.1102042; Lu SX, 2005, J PHARM SCI-US, V94, P788, DOI 10.1002/jps.20289; Mitsui J, 2010, CLIN CANCER RES, V16, P2781, DOI 10.1158/1078-0432.CCR-09-3243; Nagengast WB, 2010, J NUCL MED, V51, P761, DOI 10.2967/jnumed.109.071043; Niu G, 2009, J NUCL MED, V50, P1116, DOI 10.2967/jnumed.109.061820; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paudyal B, 2011, CANCER SCI, V102, P117, DOI 10.1111/j.1349-7006.2010.01763.x; Ribas A, 2007, ONCOLOGIST, V12, P873, DOI 10.1634/theoncologist.12-7-873; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; Sondak VK, 2011, NAT REV DRUG DISCOV, V10, P411, DOI 10.1038/nrd3463; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Torino F, 2012, ONCOLOGIST, V17, P525, DOI 10.1634/theoncologist.2011-0404; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Yaguchi T, 2011, INT J HEMATOL, V93, P294, DOI 10.1007/s12185-011-0799-6; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	33	76	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109866	10.1371/journal.pone.0109866	http://dx.doi.org/10.1371/journal.pone.0109866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365349	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100010
J	Prakash, O; Ahmad, A; Tripathi, VK; Tandon, S; Pant, AB; Khan, F				Prakash, Om; Ahmad, Ateeque; Tripathi, Vinay Kumar; Tandon, Sudeep; Pant, Aditya Bhusan; Khan, Feroz			In Silico Assay Development for Screening of Tetracyclic Triterpenoids as Anticancer Agents against Human Breast Cancer Cell Line MCF7	PLOS ONE			English	Article							WILD-TYPE P53; OENOTHERA-BIENNIS; EXPRESSION; OENOTHERALANOSTEROL	Experimental activity of a compound on cancer cell line/target is mostly analyzed in the form of percentage inhibition at different concentration gradient and time of incubation. In this study a statistical model has been developed referred as in silico assay using support vector regression model, which can act with change in concentration gradient and time of incubation. This model is a function of concentration gradient, treatment hour and independent components; which calculate the percentage inhibition in combination of above three components. This model is designed to screen tetracyclic triterpenoids active against human breast cancer cell line MCF7. The model has been statistically validated, checked for applicability domain and predicted results were reconfirmed by MTT assay, for example Oenotheranstrol derivatives, OenA & B. Computational SAR, target and docking studies were performed to understand the cytotoxic mechanism of action of Oenotheranstrol compounds. The proposed in silico assay model will work for specific chemical family for which it will be optimized. This model can be used to analyze growth kinetics pattern on different human cancer cell lines for designed compounds.	[Prakash, Om; Khan, Feroz] CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India; [Ahmad, Ateeque; Tandon, Sudeep] CSIR, Cent Inst Med & Aromat Plants, Proc Chem & Chem Engn Dept, Lucknow, Uttar Pradesh, India; [Tripathi, Vinay Kumar; Pant, Aditya Bhusan] CSIR, Indian Inst Toxicol Res, In Vitro Toxicol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Khan, F (corresponding author), CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India.	f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022	Khan, Feroz/0000-0002-2704-5925; PRAKASH, OM/0000-0001-7893-8873	Council of Scientific and Industrial Research (CSIR), New Delhi through CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India [BSC0121, BSC0203]	Council of Scientific and Industrial Research (CSIR), New Delhi through CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India	The authors acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, for financial support through CSIR networking project "GENESIS'' (BSC0121) and "CHEM-BIO'' (BSC0203) at the CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, CHINESE J CHEM, V28, P2474, DOI 10.1002/cjoc.201190024; Alkhalaf M, 2003, J ENDOCRINOL, V179, P55, DOI 10.1677/joe.0.1790055; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Ciolino H, 2003, INT J CANCER, V105, P321, DOI 10.1002/ijc.11075; Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141; FAN SJ, 1995, CANCER RES, V55, P1649; Gasi KMP, 2003, STEROIDS, V68, P667, DOI 10.1016/S0039-128X(03)00097-7; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kim E, 2009, BIOCHEM PHARMACOL, V77, P11, DOI 10.1016/j.bcp.2008.08.030; Leung T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3574; Liao WY, 2012, J NAT PROD, V75, P630, DOI 10.1021/np200866z; Shibahara Y, 2012, J PATHOL, V227, P357, DOI 10.1002/path.4019; Singh R, 2012, J ETHNOPHARMACOL, V141, P357, DOI 10.1016/j.jep.2012.02.046; Teixeira AL, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V346, P161, DOI 10.1006/abbi.1997.0302; Zhang F, 2012, J NAT PROD, V75, P538, DOI 10.1021/np200579b; Zhang YX, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-153	19	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111049	10.1371/journal.pone.0111049	http://dx.doi.org/10.1371/journal.pone.0111049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365399	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100046
J	Sakao, Y; Kuroda, H; Mun, M; Uehara, H; Motoi, N; Ishikawa, Y; Nakagawa, K; Okumura, S				Sakao, Yukinori; Kuroda, Hiroaki; Mun, Mingyon; Uehara, Hirofumi; Motoi, Noriko; Ishikawa, Yuichi; Nakagawa, Ken; Okumura, Sakae			Prognostic Significance of Tumor Size of Small Lung Adenocarcinomas Evaluated with Mediastinal Window Settings on Computed Tomography	PLOS ONE			English	Article							IA PERIPHERAL ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; INDICATOR; SCAR	Background: We aimed to clarify that the size of the lung adenocarcinoma evaluated using mediastinal window on computed tomography is an important and useful modality for predicting invasiveness, lymph node metastasis and prognosis in small adenocarcinoma. Methods: We evaluated 176 patients with small lung adenocarcinomas (diameter, 1-3 cm) who underwent standard surgical resection. Tumours were examined using computed tomography with thin section conditions (1.25 mm thick on high-resolution computed tomography) with tumour dimensions evaluated under two settings: lung window and mediastinal window. We also determined the patient age, gender, preoperative nodal status, tumour size, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and pathological status (lymphatic vessel, vascular vessel or pleural invasion). Recurrence-free survival was used for prognosis. Results: Lung window, mediastinal window, tumour disappearance ratio and preoperative nodal status were significant predictive factors for recurrence-free survival in univariate analyses. Areas under the receiver operator curves for recurrence were 0.76, 0.73 and 0.65 for mediastinal window, tumour disappearance ratio and lung window, respectively. Lung window, mediastinal window, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and preoperative nodal status were significant predictive factors for lymph node metastasis in univariate analyses; areas under the receiver operator curves were 0.61, 0.76, 0.72 and 0.66, for lung window, mediastinal window, tumour disappearance ratio and preoperative serum carcinoembryonic antigen levels, respectively. Lung window, mediastinal window, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and preoperative nodal status were significant factors for lymphatic vessel, vascular vessel or pleural invasion in univariate analyses; areas under the receiver operator curves were 0.60, 0.81, 0.81 and 0.65 for lung window, mediastinal window, tumour disappearance ratio and preoperative serum carcinoembryonic antigen levels, respectively. Conclusions: According to the univariate analyses including a logistic regression and ROCs performed for variables with p-values of <0.05 on univariate analyses, our results suggest that measuring tumour size using mediastinal window on high-resolution computed tomography is a simple and useful preoperative prognosis modality in small adenocarcinoma.	[Sakao, Yukinori; Kuroda, Hiroaki; Mun, Mingyon; Uehara, Hirofumi; Nakagawa, Ken; Okumura, Sakae] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan; [Sakao, Yukinori; Kuroda, Hiroaki] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan; [Motoi, Noriko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan	Japanese Foundation for Cancer Research; Aichi Cancer Center; Japanese Foundation for Cancer Research	Sakao, Y (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan.	ysakao@aichi-cc.jp	Motoi, Noriko/A-9718-2009; Motoi, Noriko/AAO-5642-2020	Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Sakao, Yukinori/0000-0002-6826-2280				Bhure UN, 2010, BRIT J RADIOL, V83, P841, DOI 10.1259/bjr/13711326; Borezuk AC, 2009, AM J SURG PATHOL, V33, P462, DOI 10.1097/PAS.0b013e318190157c; Kulpa J, 2002, CLIN CHEM, V48, P1931; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Nakazono T, 2005, EUR RADIOL, V15, P1563, DOI 10.1007/s00330-004-2595-7; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Okada M, 2004, J THORAC CARDIOV SUR, V127, P857, DOI 10.1016/j.jtcvs.2003.08.048; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Sakao Y, 2004, EUR J CARDIO-THORAC, V26, P1211, DOI 10.1016/j.ejcts.2004.08.021; Sakao Y, 2004, ANN THORAC SURG, V77, P1157, DOI 10.1016/j.athoracsur.2003.09.055; Sakao Y, 2003, ANN THORAC SURG, V75, P1113, DOI 10.1016/S0003-4975(02)04718-5; Sakao Y, 2007, ANN THORAC SURG, V83, P209, DOI 10.1016/j.athoracsur.2006.07.051; Sawabata N, 2004, CANCER-AM CANCER SOC, V101, P803, DOI 10.1002/cncr.20421; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Takashima S, 2002, LUNG CANCER-J IASLC, V36, P289, DOI 10.1016/S0169-5002(01)00489-5; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221	17	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110305	10.1371/journal.pone.0110305	http://dx.doi.org/10.1371/journal.pone.0110305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365326	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100020
J	Wang, SH; Sun, ZY; Dong, SZ; Liu, Y; Liu, Y				Wang, Shihui; Sun, Zeya; Dong, Shengzhao; Liu, Yang; Liu, Yun			Molecular Interactions between (-)-Epigallocatechin Gallate Analogs and Pancreatic Lipase	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; AMYLOID-BETA-PROTEIN; THERMODYNAMIC ANALYSIS; DIFFERENT POLYPHENOLS; GREEN TEA; IN-VITRO; INSULIN; OBESITY; KINETICS; CONFORMATION	The molecular interactions between pancreatic lipase (PL) and four tea polyphenols (EGCG analogs), like (-)epigallocatechin gallate (EGCG), (-)-gallocatechin gallate (GCG), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin (EC), were studied from PL activity, conformation, kinetics and thermodynamics. It was observed that EGCG analogs inhibited PL activity, and their inhibitory rates decreased by the order of EGCG. GCG. ECG. EC. PL activity at first decreased rapidly and then slowly with the increase of EGCG analogs concentrations. alpha-Helix content of PL secondary structure decreased dependent on EGCG analogs concentration by the order of EGCG. GCG. ECG. EC. EGCG, ECG, and EC could quench PL fluorescence both dynamically and statically, while GCG only quenched statically. EGCG analogs would induce PL self-assembly into complexes and the hydrodynamic radii of the complexes possessed a close relationship with the inhibitory rates. Kinetics analysis showed that EGCG analogs non-competitively inhibited PL activity and did not bind to PL catalytic site. DSC measurement revealed that EGCG analogs decreased the transition midpoint temperature of PL enzyme, suggesting that these compounds reduced PL enzyme thermostability. In vitro renaturation through urea solution indicated that interactions between PL and EGCG analogs were weak and non-covalent.	[Wang, Shihui; Sun, Zeya; Dong, Shengzhao; Liu, Yang; Liu, Yun] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Biorefinery Res & Engn Ctr, Minist Educ China,Coll Life Sci & Technol, Beijing 100029, Peoples R China	Beijing University of Chemical Technology; Ministry of Education, China	Liu, Y (corresponding author), Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Biorefinery Res & Engn Ctr, Minist Educ China,Coll Life Sci & Technol, Beijing 100029, Peoples R China.	liuyun@mail.buct.edu.cn			Beijing Municipal Natural Science Foundation [5142013]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was funded by Beijing Municipal Natural Science Foundation (5142013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958; Chen L, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0085771; de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013; Goncalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x; Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Hasni I, 2011, FOOD CHEM, V126, P630, DOI 10.1016/j.foodchem.2010.11.087; Ishii T, 2010, BIOSCI BIOTECH BIOCH, V75, P100; de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924; Lean M, 2006, BMJ-BRIT MED J, V333, P959, DOI 10.1136/bmj.333.7575.959; Liu Y, 2012, ENZYME MICROB TECH, V51, P354, DOI 10.1016/j.enzmictec.2012.08.003; Liu Y, 2010, PROCESS BIOCHEM, V45, P1176, DOI 10.1016/j.procbio.2010.03.023; LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2; Mahapatra P, 2009, BIOCATAL BIOTRANSFOR, V27, P124, DOI 10.1080/10242420802583366; MCGRAW SE, 1990, PHARMACEUT RES, V7, P606, DOI 10.1023/A:1015866127447; Mendes AA, 2012, J MOL CATAL B-ENZYM, V78, P119, DOI 10.1016/j.molcatb.2012.03.004; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Ramos P, 2003, BIOCHEMISTRY-US, V42, P12488, DOI 10.1021/bi034900e; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074; Skrt M, 2012, FOOD CHEM, V135, P2418, DOI 10.1016/j.foodchem.2012.06.114; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Tang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031067; Wang SH, 2012, J PHYS CHEM B, V116, P5803, DOI 10.1021/jp209406t; Wang SH, 2012, INT J BIOL MACROMOL, V50, P1229, DOI 10.1016/j.ijbiomac.2012.04.010; Wang SH, 2012, BIOCHEM ENG J, V63, P38, DOI 10.1016/j.bej.2012.02.002; Wang SH, 2012, BIOCHEM ENG J, V62, P70, DOI 10.1016/j.bej.2012.01.005; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wang SH, 2014, PROCESS BIOCHEM, V49, P237, DOI 10.1016/j.procbio.2013.10.018; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072146; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161	39	35	34	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111143	10.1371/journal.pone.0111143	http://dx.doi.org/10.1371/journal.pone.0111143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365042	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100052
J	Al-Ahmad, A; Zou, P; Solarte, DLG; Hellwig, E; Steinberg, T; Lienkamp, K				Al-Ahmad, Ali; Zou, Peng; Solarte, Diana Lorena Guevara; Hellwig, Elmar; Steinberg, Thorsten; Lienkamp, Karen			Development of a Standardized and Safe Airborne Antibacterial Assay, and Its Evaluation on Antibacterial Biomimetic Model Surfaces	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; SYNTHETIC MIMICS; QUANTIFICATION; ADHESION	Bacterial infection of biomaterials is a major concern in medicine, and different kinds of antimicrobial biomaterial have been developed to deal with this problem. To test the antimicrobial performance of these biomaterials, the airborne bacterial assay is used, which involves the formation of biohazardous bacterial aerosols. We here describe a new experimental set-up which allows safe handling of such pathogenic aerosols, and standardizes critical parameters of this otherwise intractable and strongly user-dependent assay. With this new method, reproducible, thorough antimicrobial data (number of colony forming units and live-dead-stain) was obtained. Poly(oxonorbornene)-based Synthetic Mimics of Antimicrobial Peptides (SMAMPs) were used as antimicrobial test samples. The assay was able to differentiate even between subtle sample differences, such as different sample thicknesses. With this new set-up, the airborne bacterial assay was thus established as a useful, reliable, and realistic experimental method to simulate the contamination of biomaterials with bacteria, for example in an intraoperative setting.	[Al-Ahmad, Ali; Solarte, Diana Lorena Guevara; Hellwig, Elmar] Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany; [Zou, Peng; Lienkamp, Karen] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Zou, Peng; Solarte, Diana Lorena Guevara; Lienkamp, Karen] Univ Freiburg, Dept Microsyst Engn IMTEK, D-79106 Freiburg, Germany; [Steinberg, Thorsten] Univ Freiburg, Univ Med Ctr, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Al-Ahmad, A (corresponding author), Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ali.al-ahmad@uniklinik-freiburg.de		Steinberg, Thorsten/0000-0003-1924-2694	Freiburg Institute for Advanced Studies (FRIAS); German Research Foundation (DFG) [LI 1714/5-1]	Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Freiburg Institute for Advanced Studies (FRIAS) and the German Research Foundation (DFG, LI 1714/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2006, J MED MICROBIOL, V55, P109, DOI 10.1099/jmm.0.46280-0; Al-Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073812; Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Dorner F, 2014, RSC POLYM CHEM SER, V10, P97; FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772; Gabriel GJ, 2008, LANGMUIR, V24, P12489, DOI 10.1021/la802232p; Haenle M, 2010, HIP INT, V20, P248, DOI 10.1177/112070001002000217; Haldar J, 2007, NAT PROTOC, V2, P2412, DOI 10.1038/nprot.2007.353; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Jones D, 1991, MAINTENANCE MICROORG, P45; Karygianni L, 2013, MATERIALS, V6, P5659, DOI 10.3390/ma6125659; Kimmerle H, 2012, ARCH ORAL BIOL, V57, P689, DOI 10.1016/j.archoralbio.2011.11.012; Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea; Lienkamp K, 2008, J AM CHEM SOC, V130, P9836, DOI 10.1021/ja801662y; Lienkamp K, 2009, CHEM-EUR J, V15, P11784, DOI 10.1002/chem.200900049; Lienkamp K, 2009, CHEM-EUR J, V15, P11715, DOI 10.1002/chem.200900606; Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044; Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; Steinberg T., 2013, TEST APPARATUS TESTI; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zou P, 2012, J MATER CHEM, V22, P19579, DOI 10.1039/c2jm31695a	28	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111357	10.1371/journal.pone.0111357	http://dx.doi.org/10.1371/journal.pone.0111357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360525	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700091
J	Funk, K; Scheerer, N; Verhaegh, R; Putter, C; Fandrey, J; de Groot, H				Funk, Kristina; Scheerer, Nina; Verhaegh, Rabea; Puetter, Carolin; Fandrey, Joachim; de Groot, Herbert			Severe Blunt Muscle Trauma in Rats: Only Marginal Hypoxia in the Injured Area	PLOS ONE			English	Article							SOFT-TISSUE INJURY; OXYGEN-PRESSURE FIELDS; SKELETAL-MUSCLE; CIRCULATORY PATHOPHYSIOLOGY; SECONDARY INJURY; INDUCIBLE FACTOR; IN-VIVO; MICROCIRCULATION; INFLAMMATION; CRYOTHERAPY	Background: After severe muscle trauma, hypoxia due to microvascular perfusion failure is generally believed to further increase local injury and to impair healing. However, detailed analysis of hypoxia at the cellular level is missing. Therefore, in the present work, spectroscopic measurements of microvascular blood flow and O-2 supply were combined with immunological detection of hypoxic cells to estimate O-2 conditions within the injured muscle area. Materials and Methods: Severe blunt muscle trauma was induced in the right Musculus gastrocnemius of male Wistar rats by a standardized "weight-drop'' device. Microvascular blood flow, relative hemoglobin amount, and hemoglobin O-2 saturation were determined by laser Doppler and white-light spectroscopy. Hypoxic cells were detected by histologic evaluation of covalent binding of pimonidazole and expression of HIF-1 alpha. Results: Directly after trauma and until the end of experiment (480 minutes), microvascular blood flow and relative hemoglobin amount were clearly increased. In contrast to blood flow and relative hemoglobin amount, there was no immediate but a delayed increase of microvascular hemoglobin O-2 saturation. Pimonidazole immunostaining revealed a hypoxic fraction (percentage area of pimonidazole-labelled muscle cells within the injured area) between 8 to 3%. There was almost no HIF-1 alpha expression detectable in the muscle cells under each condition studied. Conclusions: In the early phase (up to 8 hours) after severe blunt muscle trauma, the overall microvascular perfusion of the injured area and thus its O-2 supply is clearly increased. This increased O-2 supply is obviously sufficient to ensure normoxic (or even hyperoxic) conditions in the vast majority of the cells.	[Funk, Kristina; Verhaegh, Rabea; de Groot, Herbert] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany; [Scheerer, Nina; Fandrey, Joachim] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol, Essen, Germany; [Puetter, Carolin] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	de Groot, H (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany.	herbert.de-groot@uni-duisburg-essen.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for taking over the publication fee. The Deutsche Forschungsgemeinschaft had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon M, 2006, J TRAUMA, V61, P924, DOI 10.1097/01.ta.0000195979.25659.fe; Blalock A, 1930, ARCH SURG-CHICAGO, V20, P26, DOI 10.1001/archsurg.1930.01150070029004; Bliss M R, 1998, J Tissue Viability, V8, P4; Brookes ZLS, 2000, BRIT J ANAESTH, V85, P901, DOI 10.1093/bja/85.6.901; CHAPMAN JD, 1981, BRIT J CANCER, V43, P546, DOI 10.1038/bjc.1981.79; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; FRANK KH, 1989, PHYS MED BIOL, V34, P1883, DOI 10.1088/0031-9155/34/12/011; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Gaehtgens P, 1977, UNTERSUCHUNGEN BEZIE; Gierer P, 2008, J SURG RES, V147, P68, DOI 10.1016/j.jss.2007.07.025; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Gradl G, 2005, SHOCK, V24, P219, DOI 10.1097/01.shk.0000174022.33182.4b; HOLMSTROM A, 1985, MICROCIRC ENDOTH LYM, V2, P293; Kang S, 2013, WOUND REPAIR REGEN, V21, P730, DOI 10.1111/wrr.12081; Kapral S, 2006, INTENSIVMED, P1362; KELLETT J, 1986, MED SCI SPORT EXER, V18, P489; Kerkweg U, 2010, SHOCK, V33, P513, DOI 10.1097/SHK.0b013e3181c4f56e; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Knappe T, 2005, CRIT CARE MED, V33, P1805, DOI 10.1097/01.CCM.0000172613.74775.C5; Knight KL, 1995, CRYOTHERAPY SPORTS I, P3; KNIGHT KL, 1976, ATHL TRAIN, V11, P7; LEWIS DH, 1970, ACTA ORTHOP SCAND, V41, P17, DOI 10.3109/17453677008991975; LEWIS DH, 1970, ACTA ORTHOP SCAND, V41, P37, DOI 10.3109/17453677008991976; LIU CT, 1968, J TRAUM, V8, P75, DOI 10.1097/00005373-196801000-00008; LUND N, 1980, ACTA ANAESTH SCAND, V24, P155, DOI 10.1111/j.1399-6576.1980.tb01525.x; Merrick MA, 1999, MED SCI SPORT EXER, V31, P1516, DOI 10.1097/00005768-199911000-00004; Merrick MA, 2010, J SPORT REHABIL, V19, P380, DOI 10.1123/jsr.19.4.380; Reikeras O, 2010, INFLAMM RES, V59, P409, DOI 10.1007/s00011-010-0167-7; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Rotter R, 2012, J TRAUMA ACUTE CARE, V73, P73, DOI 10.1097/TA.0b013e31824afddd; Rubinstein I, 1998, J CLIN INVEST, V101, P1325, DOI 10.1172/JCI810; SANDEGARD J, 1975, ACTA RADIOL DIAGN, V16, P279, DOI 10.1177/028418517501600308; Schaser KD, 1999, J ORTHOP RES, V17, P678, DOI 10.1002/jor.1100170509; Schaser KD, 2007, AM J SPORT MED, V35, P93, DOI 10.1177/0363546506294569; Scheerer N, 2013, J IMMUNOL, V191, P407, DOI 10.4049/jimmunol.1103779; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shuler MS, 2009, J BONE JOINT SURG AM, V91A, P1360, DOI 10.2106/JBJS.H.00347; SMITH TL, 1993, MICROSURG, V14, P487, DOI 10.1002/micr.1920140805; Szczesny G, 2001, J TRAUMA, V51, P508, DOI 10.1097/00005373-200109000-00014; Toumi H, 2003, BRIT J SPORT MED, V37, P284, DOI 10.1136/bjsm.37.4.284; Williams DT, 2003, CRIT CARE MED, V31, pS547, DOI 10.1097/01.CCM.0000081430.34066.1D; Xing DM, 2011, WOUND REPAIR REGEN, V19, P205, DOI 10.1111/j.1524-475X.2010.00656.x	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111151	10.1371/journal.pone.0111151	http://dx.doi.org/10.1371/journal.pone.0111151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360779	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700066
J	Manson, GA; Sayenko, DG; Masani, K; Goodman, R; Wong, L; Popovic, MR; Tremblay, L; Welsh, TN				Manson, Gerome A.; Sayenko, Dimitry G.; Masani, Kei; Goodman, Rachel; Wong, Lokman; Popovic, Milos R.; Tremblay, Luc; Welsh, Timothy N.			Action Possibility Judgments of People with Varying Motor Abilities Due to Spinal Cord Injury	PLOS ONE			English	Article							ACTION PERCEPTION; FITTSS LAW; HEIGHT	Predictions about one's own action capabilities as well as the action capabilities of others are thought to be based on a simulation process involving linked perceptual and motor networks. Given the central role of motor experience in the formation of these networks, one's present motor capabilities are thought to be the basis of their perceptual judgments about actions. However, it remains unknown whether the ability to form these action possibility judgments is affected by performance related changes in the motor system. To determine if judgments of action capabilities are affected by long-term changes in one's own motor capabilities, participants with different degrees of upper-limb function due to their level (cervical vs. below cervical) of spinal cord injury (SCI) were tested on a perceptual-motor judgment task. Participants observed apparent motion videos of reciprocal aiming movements with varying levels of difficulty. For each movement, participants determined the shortest movement time (MT) at which they themselves and a young adult could perform the task while maintaining accuracy. Participants also performed the task. Analyses of MTs revealed that perceptual judgments for participant's own movement capabilities were consistent with their actual performance-people with cervical SCI had longer judged and actual MTs than people with below cervical SCI. However, there were no between-group differences in judged MTs for the young adult. Although it is unclear how the judgments were adjusted (altered simulation vs. threshold modification), the data reveal that people with different motor capabilities due to SCI are not completely biased by their present capabilities and can effectively adjust their judgments to estimate the actions of others.	[Manson, Gerome A.; Goodman, Rachel; Wong, Lokman; Tremblay, Luc; Welsh, Timothy N.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Manson, Gerome A.; Masani, Kei; Goodman, Rachel; Tremblay, Luc; Welsh, Timothy N.] Univ Toronto, Ctr Motor Control, Toronto, ON, Canada; [Sayenko, Dimitry G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Masani, Kei; Popovic, Milos R.; Welsh, Timothy N.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Masani, Kei; Popovic, Milos R.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Manson, GA (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	gerome.manson@utoronto.ca	Sayenko, Dimitry/AAP-4936-2020; Masani, Kei/B-4991-2010	Sayenko, Dimitry/0000-0002-4154-6873; Masani, Kei/0000-0002-0207-3241; , Luc/0000-0002-1148-1722; Popovic, Milos R/0000-0002-2837-2346	Early Research Award from the Ontario Ministry of Research and Innovation; Discovery Grants from the Natural Sciences and Engineering Research Council of Canada	Early Research Award from the Ontario Ministry of Research and Innovation; Discovery Grants from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an Early Research Award from the Ontario Ministry of Research and Innovation and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosbach S, 2005, NAT NEUROSCI, V8, P1295, DOI 10.1038/nn1535; Chandrasekharan S, 2012, Q J EXP PSYCHOL, V65, P976, DOI 10.1080/17470218.2011.638720; Cordovil R, 2011, HUM MOVEMENT SCI, V30, P976, DOI 10.1016/j.humov.2010.08.011; Cordovil R, 2012, J EXP CHILD PSYCHOL, V111, P319, DOI 10.1016/j.jecp.2011.09.005; Eskenazi T, 2012, SOC NEUROSCI-UK, V7, P30, DOI 10.1080/17470919.2011.576871; Eskenazi T, 2009, PSYCHOL RES-PSYCH FO, V73, P477, DOI 10.1007/s00426-009-0231-5; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Ramenzoni VC, 2008, COGNITION, V106, P1059, DOI 10.1016/j.cognition.2007.04.008; Ramenzoni V, 2008, J EXP PSYCHOL HUMAN, V34, P919, DOI 10.1037/0096-1523.34.4.919; Ramenzoni VC, 2008, Q J EXP PSYCHOL, V61, P1487, DOI 10.1080/17470210802100073; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Welsh TN, 2013, ACTA PSYCHOL, V143, P235, DOI 10.1016/j.actpsy.2013.04.003; Wong L, 2013, BEHAV BRAIN RES, V257, P242, DOI 10.1016/j.bbr.2013.09.045; Zar JH., 1999, BIOSTAT ANAL	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110250	10.1371/journal.pone.0110250	http://dx.doi.org/10.1371/journal.pone.0110250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360601	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700029
J	Nathan, AM; Rani, F; Lee, RJY; Zaki, R; Westerhout, C; Sam, IC; Lum, LCS; de Bruyne, J				Nathan, Anna Marie; Rani, Fairuz; Lee, Rachel Jiun Yi; Zaki, Rafdzah; Westerhout, Caroline; Sam, I-Ching; Lum, Lucy Chai See; de Bruyne, Jessie			Clinical Risk Factors for Life-Threatening Lower Respiratory Tract Infections in Children: A Retrospective Study in an Urban City in Malaysia	PLOS ONE			English	Article							PNEUMONIA; MORTALITY; ETIOLOGY; EPIDEMIOLOGY; ADMISSION; OUTCOMES; VIRUS	Aim: Lower respiratory tract infections (LRTIs) are an important cause of morbidity and mortality, especially in low income countries. The aim of this study was to determine risk factors of life-threatening LRTIs in hospitalised children in Malaysia. Methods: This retrospective study included children aged less than 18 years admitted for LRTIs over 13 months in a tertiary referral centre in Kuala Lumpur, Malaysia. Neonates, children with asthma and those with either no or a normal chest radiograph were excluded. Life-threatening infection was defined as that needing non-invasive ventilation or admission to the paediatric intensive care unit. Routine blood investigations and nasopharyngeal secretion results (bacterial and viral) were obtained. Chest radiographs were reviewed by a designated radiologist. Environmental data (rainfall, particulate matter <= 10 mu m [PM10] and air pollution index [API]) was obtained from the respective government departments. Results: Three hundred and ninety-one episodes of LRTIs were included. Viruses were implicated in 48.5% of LRTIs, with respiratory syncytial virus (RSV) being detected in 44% of viral LRTIs. Forty-six (11.8%) children had life-threatening disease and the overall mortality rate was 1.3% (5 children). RSV was detected in 26% of children with life-threatening LRTIs. In multivariate logistic regression, chronic lung disease, presenting history of apnoea and signs of hypoxia, was associated with life threatening LRTIs. Increased LRTI admissions were associated with low rainfall but not PM10 nor API. Of those on follow-up, 39% had persistent respiratory symptoms. Conclusion: One in nine children admitted with LRTI had a life-threatening LRTI. The aetiology was viral in almost half of admitted children. RSV was detected in a quarter of children with life-threatening LRTIs. Children who present with LRTIs and either have chronic lung disease, presenting history of apnoea or signs of hypoxia, should be observed carefully as the risk of deterioration to life-threatening illness is high.	[Nathan, Anna Marie; Lum, Lucy Chai See; de Bruyne, Jessie] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia; [Nathan, Anna Marie; Lum, Lucy Chai See; de Bruyne, Jessie] Univ Malaya, Paediat & Child Hlth Res Grp, Kuala Lumpur, Malaysia; [Rani, Fairuz] Hosp Sultan Haji Ahmad Shah, Dept Obstet & Gynaecol, Temerloh, Pahang, Malaysia; [Lee, Rachel Jiun Yi] Raigmore Hosp, Dept Med, Inverness, Scotland; [Zaki, Rafdzah] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Westerhout, Caroline] Univ Malaya, Med Ctr, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Sam, I-Ching] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Nathan, AM (corresponding author), Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia.	psr9900@hotmail.com	Nathan, Anna/ABH-2362-2021; ZAKI, RAFDZAH AHMAD/B-9520-2010; Sam, Jamal I-Ching/B-8688-2010; de Bruyne, Jessie/B-8710-2010; Nathan, Anna M/G-4148-2015; Lum, Lucy/Q-9871-2017	Nathan, Anna/0000-0003-3618-5820; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Sam, Jamal I-Ching/0000-0002-1296-7898; de Bruyne, Jessie/0000-0002-3388-6173; Lum, Lucy/0000-0002-7452-4208	University Malaya [UM.C/625/1/HIR/MOHE/MED/42]; UMR by University Malaya [UM.TNC2/RC/HTM/RP026-14HTM]	University Malaya(Universiti Malaya); UMR by University Malaya	This study was partly funded by a High Impact Research Grant (no. UM.C/625/1/HIR/MOHE/MED/42) awarded to AMN, ICS and JdB by University Malaya and by the UMR Grant (no. UM.TNC2/RC/HTM/RP026-14HTM) awarded to AMN, RZ, CW, and JdB by University Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PWK, 1999, J PAEDIATR CHILD H, V35, P287, DOI 10.1046/j.1440-1754.1999.00359.x; Chang AB, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00029; Chen Z, 2013, ARCH VIROL; Goyet S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089637; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hon KL, 2008, PEDIATR PULM, V43, P275, DOI 10.1002/ppul.20768; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Khamapirad T, 1987, Semin Respir Infect, V2, P130; Lai HK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-360; Li Feng, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P664; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Moreno L, 2006, PEDIATR PULM, V41, P331, DOI 10.1002/ppul.20364; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Trenholme AA, 2013, PEDIATR PULM, V48, P772, DOI 10.1002/ppul.22661; Wilkins Tyler R, 2005, Radiol Technol, V77, P106; Zamberi S, 2003, Med J Malaysia, V58, P681; Zhang Qingli, 2013, BMC Res Notes, V6, P447, DOI 10.1186/1756-0500-6-447; Zhang QL, 2013, PEDIATR PULM, V48, P390, DOI 10.1002/ppul.22608	24	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111162	10.1371/journal.pone.0111162	http://dx.doi.org/10.1371/journal.pone.0111162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360811	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700067
J	Schmidt, A; Lenzig, P; Oslender-Bujotzek, A; Kusch, J; Lucas, SD; Grunder, S; Wiemuth, D				Schmidt, Axel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Kusch, Jana; Lucas, Susana Dias; Gruender, Stefan; Wiemuth, Dominik			The Bile Acid-Sensitive Ion Channel (BASIC) Is Activated by Alterations of Its Membrane Environment	PLOS ONE			English	Article							NA+ CHANNEL; K+ CHANNELS; FUNCTIONAL EXPRESSION; BIOLOGICAL-MEMBRANES; NUCLEAR RECEPTOR; BILAYER COUPLES; LIGAND-BINDING; INTESTINE; CHOLESTEROL; INHIBITION	The bile acid-sensitive ion channel (BASIC) is a member of the DEG/ENaC family of ion channels. Channels of this family are characterized by a common structure, their physiological functions and modes of activation, however, are diverse. Rat BASIC is expressed in brain, liver and intestinal tract and activated by bile acids. The physiological function of BASIC and its mechanism of bile acid activation remain a puzzle. Here we addressed the question whether amphiphilic bile acids activate BASIC by directly binding to the channel or indirectly by altering the properties of the surrounding membrane. We show that membrane-active substances other than bile acids also affect the activity of BASIC and that activation by bile acids and other membrane-active substances is non-additive, suggesting that BASIC is sensitive for changes in its membrane environment. Furthermore based on results from chimeras between BASIC and ASIC1a, we show that the extracellular and the transmembrane domains are important for membrane sensitivity.	[Schmidt, Axel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Gruender, Stefan; Wiemuth, Dominik] Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany; [Kusch, Jana] Univ Jena, Univ Hosp Jena, Inst Physiol 2, Jena, Germany; [Lucas, Susana Dias] Univ Lisbon, Fac Farm, Inst Invest Medicamento iMed ULisboa, P-1699 Lisbon, Portugal	RWTH Aachen University; Friedrich Schiller University of Jena; Universidade de Lisboa	Wiemuth, D (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany.	dwiemuth@ukaachen.de	Gründer, Stefan/I-2495-2019; Schmidt, Axel/GLR-2893-2022; Lucas, Susana D/D-6201-2011; Kusch, Jana/ABC-9738-2020	Gründer, Stefan/0000-0002-7635-9883; Schmidt, Axel/0000-0002-9780-7243; Lucas, Susana D/0000-0002-5555-5594; Kusch, Jana/0000-0001-7206-8133	Deutsche Forschungsgemeinschaft [WI 4176/1-1]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/64265/2009]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by a grant of the Deutsche Forschungsgemeinschaft to DW (WI 4176/1-1). SDL is supported by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/64265/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akare S, 2005, BBA-MOL CELL BIOL L, V1735, P59, DOI 10.1016/j.bbalip.2005.04.006; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Boiko N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091326; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; DEUTICKE B, 1968, BIOCHIM BIOPHYS ACTA, V163, P494, DOI 10.1016/0005-2736(68)90078-3; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; HOFMANN AF, 1994, SCAND J GASTROENTE S, V204, P1; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Lefevre CM, 2013, PFLUGERS ARCH, V466, P256; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Macchiarulo A, 2013, ACS MED CHEM LETT, V4, P1158, DOI 10.1021/ml400247k; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wiemuth D., 2013, CHANNELS AUSTIN, V8, P29; Wiemuth D, 2012, CHANNELS AUSTIN, V7, P38; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111549	10.1371/journal.pone.0111549	http://dx.doi.org/10.1371/journal.pone.0111549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360526	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700119
J	Sgobio, C; Kupferschmidt, DA; Cui, GH; Sun, LX; Li, Z; Cai, HB; Lovinger, DM				Sgobio, Carmelo; Kupferschmidt, David A.; Cui, Guohong; Sun, Lixin; Li, Zheng; Cai, Huaibin; Lovinger, David M.			Optogenetic Measurement of Presynaptic Calcium Transients Using Conditional Genetically Encoded Calcium Indicator Expression in Dopaminergic Neurons	PLOS ONE			English	Article							MUTANT ALPHA-SYNUCLEIN; KNOCK-OUT MICE; CHOLINERGIC INTERNEURONS; PARKINSONS-DISEASE; NEUROTRANSMITTER RELEASE; STRIATAL SYNAPTOSOMES; 5-HT1B RECEPTORS; DORSAL STRIATUM; NEURAL ACTIVITY; TRANSMISSION	Calcium triggers dopamine release from presynaptic terminals of midbrain dopaminergic (mDA) neurons in the striatum. However, calcium transients within mDA axons and axon terminals are difficult to study and little is known about how they are regulated. Here we use a newly-developed method to measure presynaptic calcium transients (PreCaTs) in axons and terminals of mDA neurons with a genetically encoded calcium indicator (GECI) GCaMP3 expressed in transgenic mice. Using a photomultiplier tube-based system, we measured electrical stimulation-induced PreCaTs of mDA neurons in dorsolateral striatum slices from these mice. Single-pulse stimulation produced a transient increase in fluorescence that was completely blocked by a combination of N- and P/Q-type calcium channel blockers. DA and cholinergic, but not serotoninergic, signaling pathways modulated the PreCaTs in mDA fibers. These findings reveal heretofore unexplored dynamic modulation of presynaptic calcium in nigrostriatal terminals.	[Sgobio, Carmelo; Sun, Lixin; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Kupferschmidt, David A.; Cui, Guohong; Lovinger, David M.] Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, NIH, Rockville, MD USA; [Li, Zheng] NIMH, Unit Synapse Dev & Plast, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cai, HB (corresponding author), NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	caih@mail.nih.gov; lovindav@mail.nih.gov	Sgobio, Carmelo/AAD-7207-2021; Cui, Guohong/E-4089-2019; Sgobio, Carmelo/AAH-3257-2020; Li, Zheng/I-8016-2014; Cai, Huaibin/H-3359-2013; Sgobio, Carmelo/AAU-4652-2021	Sgobio, Carmelo/0000-0002-6282-369X; Cui, Guohong/0000-0002-4555-028X; Li, Zheng/0000-0002-2978-2531; Cai, Huaibin/0000-0002-8596-6108; 	National Institute on Aging [Z01-000928, 000929]; Division of Intramural Clinical and Biological Research of NIAAA [ZIA AA000407]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division of Intramural Clinical and Biological Research of NIAAA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by the intramural program of National Institute on Aging (Z01-000928, 000929) and the Division of Intramural Clinical and Biological Research of NIAAA (ZIA AA000407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; BIGORNIA L, 1990, J PHARMACOL EXP THER, V252, P586; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; CALABRESI P, 1993, BRAIN, V116, P433; Carlsson A, 2002, J NEURAL TRANSM, V109, P777, DOI 10.1007/s007020200064; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen BT, 2006, J NEUROCHEM, V96, P645, DOI 10.1111/j.1471-4159.2005.03519.x; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; De Groote L, 2003, EUR J PHARMACOL, V476, P71, DOI 10.1016/S0014-2999(03)02154-X; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gibb A.J., 1994, MICROELECTRODE TECHN, P225; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Phillips PEM, 2000, BRAIN RES, V884, P139, DOI 10.1016/S0006-8993(00)02958-9; RAPIER C, 1988, J NEUROCHEM, V50, P1123, DOI 10.1111/j.1471-4159.1988.tb10582.x; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Sarhan H, 2000, N-S ARCH PHARMACOL, V361, P12, DOI 10.1007/s002109900163; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	44	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111749	10.1371/journal.pone.0111749	http://dx.doi.org/10.1371/journal.pone.0111749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360513	gold, Green Published			2022-12-26	WOS:000343943700147
J	Wang, Q; Peng, JM; Sun, Y; Chen, JZ; An, TQ; Leng, CL; Li, L; Zhao, HY; Guo, X; Ge, XN; Yang, HC; Tian, ZJ				Wang, Qian; Peng, Jinmei; Sun, Yan; Chen, Jiazeng; An, Tongqing; Leng, Chaoliang; Li, Lin; Zhao, Hongyuan; Guo, Xin; Ge, Xinna; Yang, Hanchun; Tian, Zhijun			Unique Epitopes Recognized by Monoclonal Antibodies against HP-PRRSV: Deep Understanding of Antigenic Structure and Virus-Antibody Interaction	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PROTEINS; REGION; STRAIN	Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) is a member of the genus Arterivirus within the family Arteriviridae. N and GP3 proteins are the immunodominance regions of the PRRSV viral proteins. To identify the B-cell linear antigenic epitopes within HP-PRRSV N and GP3 proteins, two monoclonal antibodies (mAbs) against N and GP3 proteins were generated and characterized, designated as 3D7 and 1F10 respectively. The mAb 3D7 recognized only HuN4-F112 not the corresponding virulent strain (HuN4-F5). It also recognized two other commercial vaccines (JXA1-R and TJM-F92), but not two other HP-PRRSV strains (HNZJJ-F1 and HLJMZ-F2). The B-cell epitope recognized by the mAb 3D7 was localized to N protein amino acids 7-33. Western blot showed that the only difference amino acid between HuN4-F112-N and HuN4-F5-N did not change the mAb 3D7 recognization to N protein. The epitope targeted by the mAb 1F10 was mapped by truncated proteins. We found a new epitope (68-76aa) can be recognized by the mAb. However, the epitope could not be recognized by the positive sera, suggesting the epitope could not induce antibody in pigs. These results should extend our understanding of the antigenic structure of the N protein and antigen-antibody reactions of the GP3 protein in different species.	[Wang, Qian; Peng, Jinmei; Sun, Yan; Chen, Jiazeng; An, Tongqing; Leng, Chaoliang; Li, Lin; Zhao, Hongyuan; Tian, Zhijun] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Swine Infect Dis, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Wang, Qian; Guo, Xin; Ge, Xinna; Yang, Hanchun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China; [Wang, Qian; Guo, Xin; Ge, Xinna; Yang, Hanchun] China Agr Univ, State Key Lab Agribiotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn; tzj@hvri.ac.cn			National Natural Science Foundation of China [31001050]; Heilongjiang National Funds for Distinguished Young Scientists [JC201314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang National Funds for Distinguished Young Scientists	This study was supported by the National Natural Science Foundation of China (grant No. 31001050) and the Heilongjiang National Funds for Distinguished Young Scientists (No. JC201314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017; Cavanagh D, 1997, ARCH VIROL, V142, P629; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; DREW TW, 1995, J GEN VIROL, V76, P1361, DOI 10.1099/0022-1317-76-6-1361; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Gonin P, 1998, ARCH VIROL, V143, P1927, DOI 10.1007/s007050050430; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; KATZ JB, 1995, VET MICROBIOL, V44, P65, DOI 10.1016/0378-1135(94)00113-B; Larochelle R, 1997, VET MICROBIOL, V58, P1, DOI 10.1016/S0378-1135(97)00150-8; Leng CL, 2012, VET MICROBIOL, V159, P273, DOI 10.1016/j.vetmic.2012.06.018; Li Y, 2013, VET IMMUNOL IMMUNOP, V151, P331, DOI 10.1016/j.vetimm.2012.11.011; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Loemba HD, 1996, ARCH VIROL, V141, P751, DOI 10.1007/BF01718333; Meulenberg J J, 1995, Adv Exp Med Biol, V380, P271; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; NELSON EA, 1993, J CLIN MICROBIOL, V31, P3184, DOI 10.1128/JCM.31.12.3184-3189.1993; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Oleksiewicz MB, 2002, J GEN VIROL, V83, P1407, DOI 10.1099/0022-1317-83-6-1407; Rodriguez MJ, 1997, J GEN VIROL, V78, P2269, DOI 10.1099/0022-1317-78-9-2269; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; vanNieuwstadt AP, 1996, J VIROL, V70, P4767, DOI 10.1128/JVI.70.7.4767-4772.1996; Yang HC, 2007, SWINE IND SCI, V1, P77; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zhou YJ, 2006, VIRUS RES, V118, P98, DOI 10.1016/j.virusres.2005.11.019; Zhou YJ, 2011, CHINESE J ANIMAL INF, V19, P1	33	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111633	10.1371/journal.pone.0111633	http://dx.doi.org/10.1371/journal.pone.0111633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360600	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700134
J	Zhang, HM; Peng, C; Duan, XD; Shen, D; Lan, GH; Xiao, WT; Tan, H; Wang, L; Hou, JL; Zhu, JC; He, RW; Zhang, HB; Zheng, LL; Yang, JY; Zhang, Z; Zhou, ZW; Li, WH; Hu, ML; Zhong, JH; Chen, YH				Zhang, Haiming; Peng, Cong; Duan, Xiaodong; Shen, Dan; Lan, Guanghua; Xiao, Wutao; Tan, Hai; Wang, Ling; Hou, Jialei; Zhu, Jiancui; He, Riwen; Zhang, Haibing; Zheng, Lilan; Yang, Jianyu; Zhang, Zhen; Zhou, Zhiwei; Li, Wenhua; Hu, Mailing; Zhong, Jinhui; Chen, Yuhua			A Cross-Sectional Study of Avian Influenza in One District of Guangzhou, 2013	PLOS ONE			English	Article							LIVE-BIRD MARKETS; A H7N9 VIRUS; HUMAN INFECTION; HONG-KONG; POULTRY; CHINA; H9N2; H5N1; PATHOGENICITY; ORIGIN	Since Feb, 2013, more than 100 human beings had been infected with novel H7N9 avian influenza virus. As of May 2013, several H7N9 viruses had been found in retail live bird markets (LBMs) in Guangdong province of southern China where several human cases were confirmed later. However, the real avian influenza virus infection status especially H7N9 in Guangzhou remains unclear. Therefore, a cross-sectional study of avian influenza in commercial poultry farms, the wholesale LBM and retail LBMs in one district of Guangzhou was conducted from October to November, 2013. A total of 1505 cloacal and environmental samples from 52 commercial poultry farms, 1 wholesale LBM and 18 retail LBMs were collected and detected using real-time RT-PCR for type A, H7, H7N9 and H9 subtype avian influenza virus, respectively. Of all the flocks randomly sampled, 6 farms, 12 vendors of the wholesale LBM and 18 retail LBMs were type A avian influenza virus positive with 0, 3 and 11 positive for H9, respectively. The pooled prevalence and individual prevalence of type A avian influenza virus were 33.9% and 7.9% which for H9 subtype was 7.6% and 1.6%, respectively. None was H7 and H7N9 subtype virus positive. Different prevalence and prevalence ratio were found in different poultry species with partridges having the highest prevalence for both type A and H9 subtype avian influenza virus. Our results suggest that LBM may have a higher risk for sustaining and transmission of avian influenza virus than commercial poultry farms. The present study also indicates that different species may play different roles in the evolution and transmission of avian influenza virus. Therefore, risk-based surveillance and management measures should be conducted in future in this area.	[Zhang, Haiming; Peng, Cong; Duan, Xiaodong; Shen, Dan; Tan, Hai; Wang, Ling; Hou, Jialei; Zhu, Jiancui; He, Riwen; Zhang, Haibing; Zheng, Lilan; Yang, Jianyu; Zhang, Zhen; Zhou, Zhiwei; Li, Wenhua; Hu, Mailing; Zhong, Jinhui; Chen, Yuhua] Guangzhou Anim Dis Prevent & Control Ctr, Guangzhou, Guangdong, Peoples R China; [Lan, Guanghua; Xiao, Wutao] Huadu Anim Hlth Inspect Inst, Huadu, Peoples R China		Peng, C (corresponding author), Guangzhou Anim Dis Prevent & Control Ctr, Guangzhou, Guangdong, Peoples R China.	pc13902493400@163.com			preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture	preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture	This work was financially supported by the preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture. The funders had no role in study design, data collection and analysis, publishing decision or manuscript preparation.	Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen Z, 2014, EMERG INFECT DIS; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garber L, 2007, AVIAN DIS, V51, P417, DOI 10.1637/7571-033106R.1; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077132; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Trock SC, 2008, AVIAN DIS, V52, P160, DOI 10.1637/7980-040607-Reg; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; World Organization for Animal Health, 2011, TERR AN HLTH COD 201; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Yu X, 2014, J VIROL	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111218	10.1371/journal.pone.0111218	http://dx.doi.org/10.1371/journal.pone.0111218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356738	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000045
J	Zhen, Y; Knobel, PA; Stracker, TH; Reverter, D				Zhen, Yang; Knobel, Philip A.; Stracker, Travis H.; Reverter, David			Regulation of USP28 Deubiquitinating Activity by SUMO Conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteolytic Enzyme; SUMO-interacting Motif (SIM); Sumoylation; Ubiquitin; Ubiquitin-dependent Protease	DNA-DAMAGE; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; ENZYME; SPECIFICITY; MECHANISMS; PROTEINS; DOMAINS; IDENTIFICATION; POLYUBIQUITIN	Background: USP28 is a deubiquitinating enzyme implicated in the DNA damage response, Myc stabilization, and cancer progression. Results: USP28 activity is regulated by SUMO conjugation on the N-terminal region. Conclusion: The N-terminal ubiquitin-binding domains of USP28 are not required for polyubiquitin processing. Significance: Cross-talk exists between SUMO and ubiquitin in the regulation of USP28 enzymatic activity. USP28 (ubiquitin-specific protease 28) is a deubiquitinating enzyme that has been implicated in the DNA damage response, the regulation of Myc signaling, and cancer progression. The half-life stability of major regulators of critical cellular pathways depends on the activities of specific ubiquitin E3 ligases that target them for proteosomal degradation and deubiquitinating enzymes that promote their stabilization. One function of the post-translational small ubiquitin modifier (SUMO) is the regulation of enzymatic activity of protein targets. In this work, we demonstrate that the SUMO modification of the N-terminal domain of USP28 negatively regulates its deubiquitinating activity, revealing a role for the N-terminal region as a regulatory module in the control of USP28 activity. Despite the presence of ubiquitin-binding domains in the N-terminal domain, its truncation does not impair deubiquitinating activity on diubiquitin or polyubiquitin chain substrates. In contrast to other characterized USP deubiquitinases, our results indicate that USP28 has a chain preference activity for Lys(11), Lys(48), and Lys(63) diubiquitin linkages.	[Zhen, Yang; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain; [Zhen, Yang; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain; [Knobel, Philip A.; Stracker, Travis H.] Inst Res Biomed, Barcelona 08028, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Bellaterra 08193, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015; Stracker, Travis H/I-2815-2015	Reverter, David/0000-0002-5347-0992; Stracker, Travis H/0000-0002-8650-2081; Knobel, Philip/0000-0003-1587-1530	Ministerio de Economia y Competitividad of Spain [BFU2012-37116, BFU2012-39521]; Chinese government; Swiss National Science Foundation	Ministerio de Economia y Competitividad of Spain(Spanish Government); Chinese government; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants BFU2012-37116 (to D. R.) and BFU2012-39521 (to T. H. S.) from the Ministerio de Economia y Competitividad of Spain.; Supported by a scholarship to the Chinese Research Council program from the Chinese government.; Supported by an Early Postdoc Mobility fellowship from the Swiss National Science Foundation.	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Diefenbacher ME, 2014, J CLIN INVEST, V124, P3407, DOI 10.1172/JCI73733; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knobel PA, 2014, MOL CELL BIOL, V34, P2062, DOI 10.1128/MCB.00197-14; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lemak A., 2012, NE STRUCTUR IN PRESS; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Valero R, 2001, GENOME BIOL, V2; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	48	17	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34838	34850		10.1074/jbc.M114.601849	http://dx.doi.org/10.1074/jbc.M114.601849			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359778	Green Published, hybrid			2022-12-26	WOS:000346260800035
J	Mezger, A; Ohrmalm, C; Herthnek, D; Blomberg, J; Nilsson, M				Mezger, Anja; Ohrmalm, Christina; Herthnek, David; Blomberg, Jonas; Nilsson, Mats			Detection of Rotavirus Using Padlock Probes and Rolling Circle Amplification	PLOS ONE			English	Article							LATEX AGGLUTINATION; ASSAY	Rotavirus infections are one of the most common reasons for hospitalizations due to gastrointestinal diseases. Rotavirus is often diagnosed by latex agglutination assay, chromatography immunoassay, or by electron microscopy, which are all quite insensitive. Reverse transcription polymerase chain reaction, on the other hand, is very sensitive to variations at the genomic level. We developed a novel assay based on a set of 58 different padlock probes with a detection limit of 1,000 copies. Twenty-two patient samples were analyzed and the assay showed high concordance with a PCR-based assay. In summary, we present a new assay for sensitive and variation tolerant detection of rotavirus.	[Mezger, Anja; Herthnek, David; Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden; [Ohrmalm, Christina; Blomberg, Jonas] Univ Uppsala Hosp, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden	Stockholm University; Uppsala University; Uppsala University Hospital	Nilsson, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden.	Mats.Nilsson@scilifelab.se		Blomberg, Jonas/0000-0001-6492-2491; Mezger, Anja/0000-0002-7337-9547; Ohrmalm, Christina/0000-0002-3287-3549	Swedish Research Council; VINNOVA; Science for Life Laboratory, Stockholm	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Science for Life Laboratory, Stockholm	This work was supported by the Swedish Research Council (www.vr.se), VINNOVA (www.vinnova.se), and the Science for Life Laboratory, Stockholm (www.scilifelab.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocs Mary, 2011, Morbidity and Mortality Weekly Report, V60, P514; Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Engstrom A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062015; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Ke RQ, 2011, J CLIN MICROBIOL, V49, P4279, DOI 10.1128/JCM.00713-11; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf065; Ohrmalm C, 2012, J CLIN MICROBIOL, V50, P3208, DOI 10.1128/JCM.06382-11; Ohrmalm C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq777; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Raboni SM, 2002, AM J CLIN PATHOL, V117, P392; SANDERS RC, 1986, J VIROL METHODS, V13, P285, DOI 10.1016/0166-0934(86)90053-4; Tate JE, 2013, PEDIATR INFECT DIS J, V32, P741, DOI 10.1097/INF.0b013e31828d639c	15	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111874	10.1371/journal.pone.0111874	http://dx.doi.org/10.1371/journal.pone.0111874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369034	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000115
J	An, FM; Zhan, Q; Xia, M; Jiang, LS; Lu, GM; Huang, MD; Guo, JZ; Liu, SD				An, Fangmei; Zhan, Qiang; Xia, Min; Jiang, Lisha; Lu, Guoming; Huang, Mindan; Guo, Jizhong; Liu, Side			From Moderately Severe to Severe Hypertriglyceridemia Induced Acute Pancreatitis: Circulating MiRNAs Play Role as Potential Biomarkers	PLOS ONE			English	Article							FREE FATTY-ACIDS; CANCER; MICRORNA; PROCALCITONIN; EXPRESSION; DIAGNOSIS; CALCIUM; CELLS; SERUM; TOOL	The incidence of hypertriglyceridemia induced acute pancreatitis (HTAP) continues to rise in China. It has systemic complications and high mortality, making the early assessment of the severity of this disease even more important. Circulating microRNAs (miRNAs) could be novel, non-invasive biomarkers for disease progression judgment. This study aimed to identify the potential role of serum miRNAs as novel biomarkers of HTAP progression. HTAP patients were divided into two groups: moderately severe (HTMSAP) and severe (HTSAP), healthy people were used as control group. The serum miRNA expression profiles of these three groups were determined by microarray and verified by qRT-PCR. The functions and pathways of the targeted genes of deregulated miRNAs were predicted, using bioinformatics analysis; miRNA-mRNA network was generated. Moreover, the correlation between miR-181a-5p and pancreatitis metabolism related substances were studied and the serum concentration of inflammatory cytokines and miRNAs at different time points during the MSAP and SAP were investigated, respectively. Finally, the receiver operating characteristic (ROC) curve of miRNAs was studied. Significant changes in the serum concentration of the following miRNAs of HTAP patients (P<0.05) were discovered: miR24-3p, 361-5p, 1246, and 222-3p (constantly upregulated), and 181a-5p (constantly downregulated) (P<0.05). Bioinformatics analysis predicted that 13 GOs and 36 pathways regulated by overlap miRNAs were involved in glucose, fat, calcium (Ca++), and insulin metabolism (P<0.001). miRNA-mRNA network revealed that the overlap miRNAs targeted genes participating in pancreas metabolism and miR-181a-5p, the only downregulated miRNA, had good negative correlation with triglyceride (TG), total cholesterol (TC), and fast blood glucose (FBG), but a positive correlation with Ca++. When compared with inflammatory cytokines, the changes of all five overlap miRNAs were more stable. It was found that when used for evaluating the progression of HTAP, miRNAs showed good AUC. These data suggested that serum miRNAs have the potential to be excellent HTAP biomarkers.	[An, Fangmei; Zhan, Qiang; Xia, Min; Jiang, Lisha; Lu, Guoming; Huang, Mindan; Guo, Jizhong] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China; [Zhan, Qiang; Liu, Side] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China	Jiangnan University; Nanjing Medical University; Southern Medical University - China	An, FM (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China.	wdf8025@163.com; liuside2011@163.com	An, Fangmei/AAV-6977-2021		Science and Technology grant of Jiangsu Province [BK20120098]; Wuxi Municipal Science and Technology Development Plan [CSZ00N1304]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Science and Technology grant of Jiangsu Province; Wuxi Municipal Science and Technology Development Plan; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This project was supported by the grant of Science and Technology grant of Jiangsu Province (BK20120098), by the grant of Wuxi Municipal Science and Technology Development Plan (CSZ00N1304), by the grant of Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger F, 2013, THERANOSTICS, V3, P932, DOI 10.7150/thno.7445; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Cugnet-Anceau Christine, 2011, Rev Prat, V61, P1110; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; deBeaux AC, 1996, BRIT J SURG, V83, P1071, DOI 10.1002/bjs.1800830811; Devaraj Saranya, 2011, In Silico Biology, V11, P281, DOI 10.3233/ISB-2012-0444; DOMSCHKE S, 1993, INT J PANCREATOL, V13, P105; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du YQ, 2013, CANCER BIOTHER RADIO, V28, P361, DOI 10.1089/cbr.2012.1389; Farina NH, 2013, J CELL BIOCH; Frick TW, 2012, SURGERY, V152, pS157, DOI 10.1016/j.surg.2012.05.013; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Gerasimenko JV, 2013, J PHYSL; Gurda-Duda A, 2008, PANCREAS, V37, P449, DOI 10.1097/MPA.0b013e3181706d67; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karpavicius A, 2012, WORLD J GASTROENTERO, V18, P6620, DOI 10.3748/wjg.v18.i45.6620; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kusnierz-Cabala Beata, 2013, Przegl Lek, V70, P392; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macha MA, 2014, CURR PHARM DES; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Modrau IS, 2005, AM J GASTROENTEROL, V100, P1593, DOI 10.1111/j.1572-0241.2005.41456.x; Nagayama Daiji, 2013, Nihon Rinsho, V71, P1602; Orabi AI, 2013, J BIOL CHEM, V288, P27128, DOI 10.1074/jbc.M113.494534; Rau BM, 2007, ANN SURG, V245, P745, DOI 10.1097/01.sla.0000252443.22360.46; Sarr MG, 2013, SURG CLIN N AM, V93, P549, DOI 10.1016/j.suc.2013.02.012; Shi CM, 2014, J INTERF CYTOK RES, V34, P342, DOI 10.1089/jir.2013.0078; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Volante E, 2004, J Matern Fetal Neonatal Med, V16 Suppl 2, P13, DOI 10.1080/14767050410001727116; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Yang F, 2009, ACTA PHYSIOL, V195, P13, DOI 10.1111/j.1748-1716.2008.01933.x; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30	42	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111058	10.1371/journal.pone.0111058	http://dx.doi.org/10.1371/journal.pone.0111058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365448	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100047
J	Choi, J; Lee, HE; Kim, MA; Jang, BG; Lee, HS; Kim, WH				Choi, Jiwoon; Lee, Hee Eun; Kim, Min A.; Jang, Bo Gun; Lee, Hye Seung; Kim, Woo Ho			Analysis of MET mRNA Expression in Gastric Cancers Using RNA In Situ Hybridization Assay: Its Clinical Implication and Comparison with Immunohistochemistry and Silver In Situ Hybridization	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; THERAPEUTIC TARGET; FACTOR RECEPTOR; AMPLIFICATION; CARCINOMAS; GENE; OVEREXPRESSION; ONCOGENE; PROTEIN	We investigated MET mRNA expression status using RNA in situ hybridization (ISH) technique in primary and metastatic lesions of 535 surgically resected gastric carcinoma (GC) cases. We compared the results with those of immunohistochemistry and silver in situ hybridization, and examined the association with clinicopathologic characteristics and prognosis. Among 535 primary GCs, 391 (73.1%) were scored 0, 87 (16.3%) were scored 1, 38 (7.1%) were scored 2, 12 (2.2%) were scored 3 and 7 (1.3%) were scored 4 by RNA ISH. High MET mRNA expression (score >= 3) was associated with lymph node metastasis (P = .014), distant metastasis (P = .001), and higher TNM stage (P<.001). MET mRNA expression was correlated with protein expression (r = 0.398; P<.001) and gene copy number (r = 0.345; P<.001). The patients showing high-MET mRNA in primary or metastatic lesions had shorter overall survival than those showing low-MET mRNA (primary tumors, P = .002; metastatic lymph nodes, P<.001). The patients showing positive conversion of MET mRNA status in metastatic lymph node had shorter overall survival than those with no conversion (P = .011). Multivariate analysis demonstrated that high MET mRNA expression in metastatic lymph node was an independent prognostic factor for overall survival (P = .007). Therefore, this study suggests that MET mRNA expression assessed by RNA ISH could be useful as a potential marker to identify MET oncogene-addicted GC.	[Choi, Jiwoon; Lee, Hee Eun; Kim, Min A.; Jang, Bo Gun; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	woohokim@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	National Research Foundation of Korea (NRF) A3 Foresight program	National Research Foundation of Korea (NRF) A3 Foresight program	This work was supported by the National Research Foundation of Korea (NRF) A3 Foresight program (http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2002, ONCOLOGY-BASEL, V63, P286, DOI 10.1159/000065477; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Drebber U, 2008, ONCOL REP, V19, P1477; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Hara T, 1998, LAB INVEST, V78, P1143; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Kaji M, 1996, CANCER GENE THER, V3, P393; Kim MA, 2013, HUM PATHOL, V44, P487, DOI 10.1016/j.humpath.2012.06.022; KUNIYASU H, 1993, INT J CANCER, V55, P72, DOI 10.1002/ijc.2910550114; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Nakajima M, 1999, CANCER, V85, P1894; Park WS, 2000, APMIS, V108, P195, DOI 10.1034/j.1600-0463.2000.d01-44.x; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	28	15	17	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111658	10.1371/journal.pone.0111658	http://dx.doi.org/10.1371/journal.pone.0111658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364819	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100098
J	Santos, VC; Vale, VF; Silva, SM; Nascimento, AAS; Saab, NAA; Soares, RPP; Michalick, MSM; Araujo, RN; Pereira, MH; Fujiwara, RT; Gontijo, NF				Santos, Vania Cristina; Vale, Vladimir Fazito; Silva, Sydnei Magno; Sousa Nascimento, Alexandre Alves; Araujo Saab, Natalia Alvim; Pinto Soares, Rodrigo Pedro; Marques Michalick, Marilene Suzan; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Fujiwara, Ricardo Toshio; Gontijo, Nelder Figueiredo			Host Modulation by a Parasite: How Leishmania infantum Modifies the Intestinal Environment of Lutzomyia longipalpis to Favor Its Development	PLOS ONE			English	Article							PHLEBOTOMUS-PAPATASI DIPTERA; DIGESTIVE ENZYMES; SAND FLIES; MIDGUT; TRYPSIN; LIPOPHOSPHOGLYCAN; MOSQUITO; DONOVANI; PROTEIN; PH	Some reports have described the interference of Leishmania on sand flies physiology, and such behavior most likely evolved to favor the development and transmission of the parasite. Most of these studies showed that Leishmania could modulate the level of proteases in the midgut after an infective blood meal, and decreased proteolytic activity is indeed beneficial for the development of promastigotes in the gut of sand flies. In the present study, we performed a detailed investigation of the intestinal pH in Lutzomyia longipalpis females naturally infected with Leishmania infantum and investigated the production of trypsin by these insects using different approaches. Our results allowed us to propose a mechanism by which these parasites interfere with the physiology of L. longipalpis to decrease the production of proteolytic enzymes. According to our hypothesis L. infantum promastigotes indirectly interfere with the production of trypsin by modulating the mechanism that controls the intestinal pH via the action of a yet non- identified substance released by promastigote forms inside the midgut. This substance is not an acid, whose action would be restrict on to release H+ to the medium, but is a substance that is able to interfere with midgut physiology through a mechanism involving pH control. According to our hypothesis, as the pH decreases, the proteolytic enzymes efficiency is also reduced, leading to a decline in the supply of amino acids to the enterocytes: this decline reduces the stimulus for protease production because it is regulated by the supply of amino acids, thus leading to a delay in digestion.	[Santos, Vania Cristina; Vale, Vladimir Fazito; Sousa Nascimento, Alexandre Alves; Araujo Saab, Natalia Alvim; Marques Michalick, Marilene Suzan; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Fujiwara, Ricardo Toshio; Gontijo, Nelder Figueiredo] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Silva, Sydnei Magno] Univ Fed Uberlandia, Inst Biomed Sci, BR-38400 Uberlandia, MG, Brazil; [Pinto Soares, Rodrigo Pedro] Ctr Pesquisas Rene Rachou CPqRR, Lab Med Entomol, Belo Horizonte, MG, Brazil; [Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Natl Inst Sci & Technol Mol Entomol, Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Uberlandia; Fundacao Oswaldo Cruz	Gontijo, NF (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	nelder@icb.ufmg.br	Soares, Rodrigo/S-5191-2019; Araujo, Ricardo N/O-1967-2017; Pereira, Marcos Horácio/AAE-7076-2021; Gontijo, Nelder F/D-2539-2013; Pereira, Marcos H/A-3774-2012; Fujiwara, Ricardo Toshio/J-7579-2012	Soares, Rodrigo/0000-0002-7966-3629; Araujo, Ricardo N/0000-0002-1272-4386; Pereira, Marcos Horácio/0000-0003-4843-0088; Gontijo, Nelder F/0000-0003-3357-2497; Pereira, Marcos H/0000-0003-4843-0088; Fujiwara, Ricardo Toshio/0000-0002-4713-575X	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1938, HAREFUAH, V14, P1; BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; BEACH R, 1985, AM J TROP MED HYG, V34, P278, DOI 10.4269/ajtmh.1985.34.278; BOROVSKY D, 1987, MED VET ENTOMOL, V1, P235, DOI 10.1111/j.1365-2915.1987.tb00349.x; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Caroci AS, 2003, J INSECT PHYSIOL, V49, P839, DOI 10.1016/S0022-1910(03)00134-3; Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; DILLON RJ, 1993, PARASITOL RES, V79, P492, DOI 10.1007/BF00931590; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; GOODING RH, 1972, COMP BIOCHEM PHYSIOL, V43, P815, DOI 10.1016/0305-0491(72)90228-3; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; Graf R, 1998, J INSECT PHYSIOL, V44, P451, DOI 10.1016/S0022-1910(98)00042-0; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; LEHANE MJ, 1995, COMP BIOCHEM PHYS B, V110, P285, DOI 10.1016/0305-0491(94)00157-P; MCCONVILLE MJ, 1995, BIOCHEM J, V310, P807, DOI 10.1042/bj3100807; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Santos VC, 2008, J EXP BIOL, V211, P2792, DOI 10.1242/jeb.019836; Santos VC, 2011, J EXP BIOL, V214, P1411, DOI 10.1242/jeb.051490; SCHLEIN Y, 1990, T ROY SOC TROP MED H, V84, P353, DOI 10.1016/0035-9203(90)90315-6; Schlein Y, 1998, PARASITOLOGY, V117, P467, DOI 10.1017/S0031182098003321; SCHLEIN Y, 1986, EXP PARASITOL, V62, P376, DOI 10.1016/0014-4894(86)90045-7; Secundino N, 2010, CELL MICROBIOL, V12, P906, DOI 10.1111/j.1462-5822.2010.01439.x; Soares R. P., 2010, Journal of Biomedicine & Biotechnology, V2010, P439174, DOI 10.1155/2010/439174; Soares RPP, 2002, MOL BIOCHEM PARASIT, V121, P213, DOI 10.1016/S0166-6851(02)00033-6; Telleria EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010697; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Vaidyanathan R, 2005, J MED ENTOMOL, V42, P142, DOI 10.1603/0022-2585(2005)042[0142:IOAMPF]2.0.CO;2; Vaidyanathan R, 2004, J INVERTEBR PATHOL, V87, P123, DOI 10.1016/j.jip.2004.09.001; Volf P, 2008, PARASITE, V15, P237, DOI 10.1051/parasite/2008153237	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111241	10.1371/journal.pone.0111241	http://dx.doi.org/10.1371/journal.pone.0111241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365351	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100057
J	Dhoubhadel, BG; Yasunami, M; Nguyen, HAT; Suzuki, M; Vu, TH; Nguyen, ATT; Dang, DA; Yoshida, LM; Ariyoshi, K				Dhoubhadel, Bhim Gopal; Yasunami, Michio; Hien Anh Thi Nguyen; Suzuki, Motoi; Thu Huong Vu; Ai Thi Thuy Nguyen; Duc Anh Dang; Yoshida, Lay-Myint; Ariyoshi, Koya			Bacterial Load of Pneumococcal Serotypes Correlates with Their Prevalence and Multiple Serotypes Is Associated with Acute Respiratory Infections among Children Less Than 5 Years of Age	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; KILIFI DISTRICT; IN-VITRO; COLONIZATION; COMPETITION; ACQUISITION; DISEASE; TRANSMISSION; CLEARANCE	Background: Among pneumococcal serotypes, some serotypes are more prevalent in the nasopharynx than others; determining factors for higher prevalence remain to be fully explored. As non-vaccine serotypes have emerged after the introduction of 7-valent conjugate vaccines, study of serotype specific epidemiology is in need. When two or more serotypes co-colonize, they evolve rapidly to defend host's immune responses; however, a clear association of co-colonization with a clinical outcome is lacking. Methods: Children less than 5 years old who were admitted to hospital due to acute respiratory infections (ARI) (n = 595) and healthy children (n = 350) were recruited. Carriage of pneumococcus was determined by culture and lytA PCR in the nasopharyngeal samples. Serotype/serogroup detection and its quantification were done by the nanofluidic real time PCR system. Spearman's correlation and logistic regression were used to examine a correlation of serotype/serogroup specific bacterial load with its prevalence and an association of co-colonization with ARI respectively. Results: Serotype/serogroup specific bacterial load was correlated with its prevalence, both in ARI cases (Spearman's rho = 0.44, n = 186; P<0.0001) and healthy children (Spearman's rho = 0.41, n = 115; P<0.0001). The prevalence of multiple serotypes was more common in ARI cases than in healthy children (18.5% vs 7.1%; aOR 2.92, 95% CI: 1.27-6.71; P = 0.01). The dominant serotype in the co-colonization had a 2 log10 higher bacterial load than the subdominant serotype, both in ARI cases (P<0.001) and healthy children (P<0.05). Conclusions: High bacterial load in the nasopharynx may help transmit pneumococci among hosts, and increase the chance of successful acquisition and colonization. Co-colonization of multiple serotypes of pneumococci is linked with ARI, which infers the interactions of multiple serotypes may increase their pathogenicity; however, they may compete for growth in number.	[Dhoubhadel, Bhim Gopal; Yasunami, Michio; Suzuki, Motoi; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Hien Anh Thi Nguyen; Thu Huong Vu; Duc Anh Dang] Natl Inst Hyg & Epidemiol, Dept Bacteriol, Hanoi, Vietnam; [Ai Thi Thuy Nguyen] Khanh Hoa Gen Hosp, Dept Microbiol, NhaTrang, Vietnam; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan; [Ariyoshi, Koya] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University; National Institute of Hygiene & Epidemiology (NIHE); Nagasaki University; Nagasaki University	Yoshida, LM (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan.	lmyoshi@nagasaki-u.ac.jp		Dhoubhadel, Bhim Gopal/0000-0001-5279-2044; Suzuki, Motoi/0000-0002-8340-0880; YOSHIDA, LAYMYINT/0000-0002-7567-3248	Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Japan Science and Technology, Japan; Grants-in-Aid for Scientific Research [25257509] Funding Source: KAKEN	Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology, Japan(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	BGD received scholarship from the Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship. The study was funded by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and Japan Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Azzari C, 2008, CLIN INFECT DIS, V47, P997, DOI 10.1086/591967; Battig P, 2006, MICROBES INFECT, V8, P2612, DOI 10.1016/j.micinf.2006.07.013; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; HANSMAN D, 1985, J HYG-CAMBRIDGE, V95, P677, DOI 10.1017/S0022172400060782; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Leung MHY, 2011, INFECT GENET EVOL, V11, P1989, DOI 10.1016/j.meegid.2011.09.002; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Zhang Y, 2004, EPIDEMIOL INFECT, V132, P1073, DOI 10.1017/S0950268804002894	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110777	10.1371/journal.pone.0110777	http://dx.doi.org/10.1371/journal.pone.0110777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360707	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700046
J	Kohler, PK; Okanda, J; Kinuthia, J; Mills, LA; Olilo, G; Odhiambo, F; Laserson, KF; Zierler, B; Voss, J; John-Stewart, G				Kohler, Pamela K.; Okanda, John; Kinuthia, John; Mills, Lisa A.; Olilo, George; Odhiambo, Frank; Laserson, Kayla F.; Zierler, Brenda; Voss, Joachim; John-Stewart, Grace			Community-Based Evaluation of PMTCT Uptake in Nyanza Province, Kenya	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; ANTENATAL CARE; PREVENTION; TANZANIA; SERVICES; MOTHERS; HEALTH	Introduction: Facility-based assessments of prevention of mother-to-child HIV transmission (PMTCT) programs may overestimate population coverage. There are few community-based studies that evaluate PMTCT coverage and uptake. Methods: During 2011, a cross-sectional community survey among women who gave birth in the prior year was performed using the KEMRI-CDC Health and Demographic Surveillance System in Western Kenya. A random sample (n = 405) and a sample of women known to be HIV-positive through previous home-based testing (n = 247) were enrolled. Rates and correlates of uptake of antenatal care (ANC), HIV-testing, and antiretrovirals (ARVs) were determined. Results: Among 405 women in the random sample, 379 (94%) reported accessing ANC, most of whom (87%) were HIV tested. Uptake of HIV testing was associated with employment, higher socioeconomic status, and partner HIV testing. Among 247 known HIV-positive women, 173 (70%) self-disclosed their HIV status. Among 216 self-reported HIV-positive women (including 43 from the random sample), 82% took PMTCT ARVs, with 54% completing the full antenatal, peripartum, and postpartum course. Maternal ARV use was associated with more ANC visits and having an HIV tested partner. ARV use during delivery was lowest (62%) and associated with facility delivery. Eighty percent of HIV infected women reported having their infant HIV tested, 11% of whom reported their child was HIV infected, 76% uninfected, 6% declined to say, 7% did not recall; 79% of infected children were reportedly receiving HIV care and treatment. Conclusions: Community-based assessments provide data that complements clinic-based PMTCT evaluations. In this survey, antenatal HIV test uptake was high; most HIV infected women received ARVs, though many women did not self-disclose HIV status to field team. Community-driven strategies that encourage early ANC, partner involvement, and skilled delivery, and provide PMTCT education, may facilitate further reductions in vertical transmission.	[Kohler, Pamela K.] Univ Washington, Seattle, WA 98195 USA; [Okanda, John; Olilo, George; Odhiambo, Frank] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Kinuthia, John] Univ Nairobi, Kenyatta Natl Hosp, Nairobi, Kenya; [Mills, Lisa A.; Laserson, Kayla F.] KEMRI, CDC Res & Publ Hlth Collaborat, Ctr Dis Control & Prevent, Kisumu, Kenya; [Mills, Lisa A.; Laserson, Kayla F.] CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Zierler, Brenda; Voss, Joachim] Univ Washington, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Kenyatta National Hospital; University of Nairobi; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kohler, PK (corresponding author), Univ Washington, Seattle, WA 98195 USA.	pkohler2@uw.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019; Voss, Joachim/AAA-1277-2020; Kohler, Pamela/GYE-0155-2022	Kohler, Pamela/0000-0001-6176-6374; John-Stewart, Grace/0000-0002-4301-1573; Kinuthia, John/0000-0001-6571-8927; Voss, Joachim/0000-0002-8072-6244	National Institutes of Health: A Kenya Free of AIDS [R24 HD056799]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health: A Kenya Free of AIDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institutes of Health (www.nih.gov): A Kenya Free of AIDS (R24 HD056799); and received assistance from the University of Washington Center for AIDS Research (P30 AI027757 and K24 HD054314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 2013 PROGR REP GLOB; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Chamla Dick D, 2007, Confl Health, V1, P12, DOI 10.1186/1752-1505-1-12; Chiasson MA, 2010, JAIDS-J ACQ IMM DEF, V55, pS94, DOI 10.1097/QAI.0b013e3181fcb878; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Jasseron C, 2011, AIDS BEHAV; Jehu-Appiah C, 2010, HEALTH POLICY, V95, P166, DOI 10.1016/j.healthpol.2009.11.017; Karanja S, 2011, PAN AFR MED J, V10; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Kiarie J, 2012, 19 C RETR OPP INF SE; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kinuthia J, 2010, 17 C RETR OPP INF SA; Kinuthia J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-61; Larsson EC, 2009, AIDS, V23, P1924, DOI 10.1097/QAD.0b013e32832eff81; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Marazzi MC, 2009, PEDIATR INFECT DIS J, V28, P483, DOI 10.1097/INF.0b013e3181950c56; Mbonye AK, 2010, J BIOSOC SCI, V42, P271, DOI 10.1017/S002193200999040X; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; NACC NASCOP, 2012, KEN AIDS EP UPD 2011; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; National AIDS Control Council, 2010, UN GEN ASS SPEC SESS; Nguyen Thu Anh, 2008, AIDS Res Ther, V5, P7, DOI 10.1186/1742-6405-5-7; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Otieno PA, 2010, AIDS CARE, P1; Otim R, 2012, DAILY MONITOR; Peltzer Karl, 2007, Afr J Reprod Health, V11, P57, DOI 10.2307/30032488; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sirengo M, 2014, JAIDS-J ACQ IMM DEF, V66, pS66, DOI 10.1097/QAI.0000000000000115; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer Jeffrey S A, 2013, PLoS Med, V10, pe1001424, DOI 10.1371/journal.pmed.1001424; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNICEF, 2008, 2 UNICEF; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110110	10.1371/journal.pone.0110110	http://dx.doi.org/10.1371/journal.pone.0110110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360758	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700025
J	Matheson, NJ; Peden, AA; Lehner, PJ				Matheson, Nicholas J.; Peden, Andrew A.; Lehner, Paul J.			Antibody-Free Magnetic Cell Sorting of Genetically Modified Primary Human CD4+T Cells by One-Step Streptavidin Affinity Purification	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; I HEAVY-CHAINS; RECOMBINANT PROTEINS; BINDING PEPTIDE; GENE-TRANSFER; CAS9; INTERNALIZATION; DISLOCATION; LYMPHOCYTES; THERAPY	Existing methods for phenotypic selection of genetically modified mammalian cells suffer disadvantages of time, cost and scalability and, where antibodies are used to bind exogenous cell surface markers for magnetic selection, typically yield cells coated with antibody-antigen complexes and beads. To overcome these limitations we have developed a method termed Antibody-Free Magnetic Cell Sorting in which the 38 amino acid Streptavidin Binding Peptide (SBP) is displayed at the cell surface by the truncated Low Affinity Nerve Growth Receptor (LNGFRF) and used as an affinity tag for one-step selection with streptavidin-conjugated magnetic beads. Cells are released through competition with the naturally occurring vitamin biotin, free of either beads or antibody-antigen complexes and ready for culture or use in downstream applications. Antibody-Free Magnetic Cell Sorting is a rapid, cost-effective, scalable method of magnetic selection applicable to either viral transduction or transient transfection of cell lines or primary cells. We have optimised the system for enrichment of primary human CD4+ T cells expressing shRNAs and exogenous genes of interest to purities of >99%, and used it to isolate cells following Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome editing.	[Matheson, Nicholas J.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Cambridge; University of Sheffield	Matheson, NJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge, England.	njm25@cam.ac.uk; pjl30@cam.ac.uk		Peden, Andrew/0000-0003-0144-7712; Lehner, Paul Joseph/0000-0001-9383-1054; Matheson, Nicholas/0000-0002-3318-1851	Wellcome Trust; National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council [G120/952] Funding Source: researchfish; MRC [G120/952] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Research Centre. NM is a Wellcome Trust Research Training Fellow (093964/Z/10/Z) and Raymond and Beverly Sackler student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard F, 2002, J IMMUNOL METHODS, V271, P99, DOI 10.1016/S0022-1759(02)00412-X; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brent R., 2001, CURR PROTOC PROTEIN; Burr ML, 2013, P NATL ACAD SCI USA, V110, P14290, DOI 10.1073/pnas.1303380110; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dainiak MB, 2007, ADV BIOCHEM ENG BIOT, V106, P1, DOI 10.1007/10_2007_069; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Gotoh H, 2007, GENE, V389, P146, DOI 10.1016/j.gene.2006.10.019; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Han HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026380; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Helman D, 2014, CYTOM PART A, V85, P162, DOI 10.1002/cyto.a.22308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Lee Mathia Y, 2012, J Biomol Tech, V23, P69, DOI 10.7171/jbt.12-2302-003; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mahmoudi M, 2012, CHEM REV, V112, P2323, DOI 10.1021/cr2002596; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, V106, P41, DOI 10.1007/10_2007_072; Peterson CW, 2013, GENE THER, V20, P695, DOI 10.1038/gt.2012.98; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Rogers ML, 2008, J BIOL REG HOMEOS AG, V22, P1; Ruggieri L, 1997, HUM GENE THER, V8, P1611, DOI 10.1089/hum.1997.8.13-1611; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Winnard PT, 2007, CANCER BIOL THER, V6, P1889, DOI 10.4161/cbt.6.12.4963; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	39	13	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111437	10.1371/journal.pone.0111437	http://dx.doi.org/10.1371/journal.pone.0111437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360777	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000343943700103
J	Pouliopoulos, J; Chik, W; Byth, K; Wallace, E; Kovoor, P; Thiagalingam, A				Pouliopoulos, Jim; Chik, William; Byth, Karen; Wallace, Elizabeth; Kovoor, Pramesh; Thiagalingam, Aravinda			Spatial Characterization of Electrogram Morphology from Transmural Recordings in the Intact Normal Heart	PLOS ONE			English	Article							VENTRICULAR ACTIVATION; CARDIAC-MUSCLE; MYOCARDIUM; POTENTIALS; UNIPOLAR; MODEL; EXCITATION; TISSUE; STIMULATION; PROPAGATION	Purpose: Unipolar (UE) and bipolar electrograms (BE) are utilized to identify arrhythmogenic substrate. We quantified the effect of increasing distance from the source of propagation on local electrogram amplitude; and determined if transmural electrophysiological gradients exist with respect to propagation and stimulation depth. Methods: Mapping was performed on 5 sheep. Deployment of>50 quadripolar transmural needles in the LV were located in Cartesian space using Ensite. Contact electrograms from all needles were recorded during multisite bipolar pacing from epicardial then endocardial electrodes. Analysis was performed to determine stimulus distance to local activation time, peak negative amplitude (V-P), and peak-peak amplitude (VP-P) for (1) unfiltered UE, and (2) unfiltered and 30 Hz high-pass filtered BEs. Each sheep was analysed using repeated ANOVA. Results: Increasing distance from the pacing sites led to significant (p<0.01) attenuation of UEs (V-P = 7.0 +/- 0.5%; VP-P = 5.4 +/- 0.3% per cm). Attenuation of BE with distance was insignificant (Vp-p unfiltered = 2.2 +/- 0.5%; filtered = 1.7 +/- 1.4% per cm). Independent of pacing depth, significant (p<0.01) transmural electrophysiological gradients were observed, with highest amplitude occurring at epicardial layers for UE and endocardial layers for BE. Furthermore, during pacing, propagation was earlier at the epicardium than endocardial layer by 1.6 +/- 2.0 ms (UE) and 1.4 +/- 2.8 ms (BE) (all p>0.01) during endocardial stimulation, and 2.3 +/- 2.4 ms (UE) and 1.8 +/- 3.7 ms (BE) during epicardal stimulation (all p<0.01). Conclusions: Electrogram amplitude is inversely proportional to propagation distance for unipolar modalities only, which affected V-P>VP-P. Conduction propagates preferentially via the epicardium during stimulation and is believed to contribute to a transmural amplitude gradient.	[Pouliopoulos, Jim; Chik, William; Byth, Karen; Wallace, Elizabeth; Kovoor, Pramesh; Thiagalingam, Aravinda] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia; [Pouliopoulos, Jim; Chik, William; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Pouliopoulos, J (corresponding author), Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.	jim.pouliopoulos@sydney.edu.au		Thiagalingam, Aravinda/0000-0002-7763-7806; Pouliopoulos, Jim/0000-0002-9160-8630; Byth Wilson, Karen/0000-0002-1253-6393	Westmead Hospital Charitable Trust; National Health and Medical Research Council of Australia	Westmead Hospital Charitable Trust; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Westmead Hospital Charitable Trust and the National Health and Medical Research Council of Australia awarded to Associate Professor Pramesh Kovoor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JS, 2007, J CARDIOVASC ELECTR, V18, P1306, DOI 10.1111/j.1540-8167.2007.00963.x; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Caldwell BJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P433, DOI 10.1161/CIRCEP.108.830133; COLLI-FRANZONE P, 1982, CIRC RES, V51, P330, DOI 10.1161/01.RES.51.3.330; COLLI-FRANZONE P, 1993, J CARDIOVASC ELECTR, V4, P144, DOI 10.1111/j.1540-8167.1993.tb01219.x; CORBIN LV, 1977, CIRC RES, V41, P58, DOI 10.1161/01.RES.41.1.58; FRAZIER DW, 1988, CIRC RES, V63, P135, DOI 10.1161/01.RES.63.1.135; GESELOWITZ DB, 1982, CIRC RES, V51, P602, DOI 10.1161/01.RES.51.5.602; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Horner SM, 1996, CIRCULATION, V94, P1131, DOI 10.1161/01.CIR.94.5.1131; Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957; Jacobson JT, 2006, HEART RHYTHM, V3, P189, DOI 10.1016/j.hrthm.2005.11.007; Jalife J, 2009, IMPULSE INITIATION P, P92; Jalife J M D, 2000, INTRO CARDIAC ELECTR, P83; Jouk PS, 2000, ANAT EMBRYOL, V202, P103, DOI 10.1007/s004290000103; Kavanagh KM, 2008, CARDIOVASC RES, V77, P81, DOI 10.1093/cvr/cvm036; Kimber S, 1996, PACE, V19, P1196, DOI 10.1111/j.1540-8159.1996.tb04189.x; Kovoor P, 2003, PACE, V26, P1979, DOI 10.1046/j.1460-9592.2003.00305.x; Kucera JP, 1998, CIRC RES, V83, P795, DOI 10.1161/01.RES.83.8.795; MASHIMA S, 1978, CIRC RES, V42, P757, DOI 10.1161/01.RES.42.6.757; PLONSEY R, 1987, BIOPHYS J, V51, P547, DOI 10.1016/S0006-3495(87)83380-5; Potse M, 2004, J ELECTROCARDIOL, V37, P1, DOI 10.1016/j.jelectrocard.2003.10.008; Sivagangabalan G, 2008, CIRCULATION ARHYTHMI; SPACH MS, 1975, CIRC RES, V37, P243, DOI 10.1161/01.RES.37.2.243; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Taccardi B, 1998, J CARDIOVASC ELECTR, V9, P1062, DOI 10.1111/j.1540-8167.1998.tb00884.x; TACCARDI B, 1994, CIRCULATION, V90, P3076, DOI 10.1161/01.CIR.90.6.3076; Taccardi B, 2008, AM J PHYSIOL-HEART C, V294, pH1753, DOI 10.1152/ajpheart.01400.2007; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Thiagalingam A, 2004, CIRCULATION, V110, P3175, DOI 10.1161/01.CIR.0000147234.82755.90; Thiagalingam A, 2004, PACE, V27, P570, DOI 10.1111/j.1540-8159.2004.00489.x; Trew ML, 2006, EXP PHYSIOL, V91, P355, DOI 10.1113/expphysiol.2005.031054	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110399	10.1371/journal.pone.0110399	http://dx.doi.org/10.1371/journal.pone.0110399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361049	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700034
J	Siddiqui, S; Anderson, P; Al-Jawad, M				Siddiqui, Samera; Anderson, Paul; Al-Jawad, Maisoon			Recovery of Crystallographic Texture in Remineralized Dental Enamel	PLOS ONE			English	Article							CARIES-LIKE LESIONS; CRYSTAL-STRUCTURE; APATITE CRYSTALS; DEMINERALIZATION; GROWTH; MICRORADIOGRAPHY; NANOSTRUCTURE; ARRANGEMENT; FUSION	Dental caries is the most prevalent disease encountered by people of all ages around the world. Chemical changes occurring in the oral environment during the caries process alter the crystallography and microstructure of dental enamel resulting in loss of mechanical function. Little is known about the crystallographic effects of demineralization and remineralization. The motivation for this study was to develop understanding of the caries process at the crystallographic level in order to contribute towards a long term solution. In this study synchrotron X-ray diffraction combined with scanning electron microscopy and scanning microradiography have been used to correlate enamel crystallography, microstructure and mineral concentration respectively in enamel affected by natural caries and following artificial demineralization and remineralization regimes. In particular, the extent of destruction and re-formation of this complex structure has been measured. 2D diffraction patterns collected at the European Synchrotron Radiation Facility were used to quantify changes in the preferred orientation (crystallographic texture) and position of the (002) Bragg reflection within selected regions of interest in each tooth slice, and then correlated with the microstructure and local mineral mass. The results revealed that caries and artificial demineralization cause a large reduction in crystallographic texture which is coupled with the loss of mineral mass. Remineralization restores the texture to the original level seen in healthy enamel and restores mineral density. The results also showed that remineralization promotes ordered formation of new crystallites and growth of pre-existing crystallites which match the preferred orientation of healthy enamel. Combining microstructural and crystallographic characterization aids the understanding of caries and erosion processes and assists in the progress towards developing therapeutic treatments to allow affected enamel to regain structural integrity.	[Siddiqui, Samera; Anderson, Paul; Al-Jawad, Maisoon] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England	University of London; Queen Mary University London	Al-Jawad, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	m.al-jawad@qmul.ac.uk		Al-Jawad, Maisoon/0000-0002-5832-7925	EPSRC	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was performed on the EPSRC-funded XMaS beamline at the ESRF, directed by M.J. Cooper, C.A. Lucas and T.P.A. Hase. We are grateful to the beam line team of S. D. Brown, O. Bikondoa, D. Wermeille, L. Bouchenoire and P. Thompson for their invaluable assistance, and to K. Lampard and J. Kervin for additional support. The authors thank Dr Rory Wilson for his help and support during beamtime.	Al-Jawad M, 2007, BIOMATERIALS, V28, P2908, DOI 10.1016/j.biomaterials.2007.02.019; Al-Jawad M, 2012, J DENT, V40, P1074, DOI 10.1016/j.jdent.2012.08.020; Anderson P, 2004, ARCH ORAL BIOL, V49, P199, DOI 10.1016/j.archoralbio.2003.10.001; Anderson P, 1998, ARCH ORAL BIOL, V43, P649, DOI 10.1016/S0003-9969(98)00052-1; Applebaum E., 1932, J DENT RES, V12, P619, DOI [10.1177/00220345320120040901, DOI 10.1177/00220345320120040901]; ARENDS J, 1986, J DENT RES, V65, P2, DOI 10.1177/00220345860650010201; Banerjee A., 2011, PICKARDS MANUAL OPER; Cochrane NJ, 2012, J DENT RES, V91, P185, DOI 10.1177/0022034511429570; Czajka-Jakubowska A, 2009, MED SCI MONITOR, V15, pMT84; DARLING A I, 1961, Ann R Coll Surg Engl, V29, P354; DARLING AI, 1961, ARCH ORAL BIOL, V4, P80, DOI 10.1016/0003-9969(61)90083-8; Deyhle H, 2014, ACTA BIOMATER, V10, P355, DOI 10.1016/j.actbio.2013.08.024; Deyhle H, 2011, NANOMED-NANOTECHNOL, V7, P694, DOI 10.1016/j.nano.2011.09.005; Dowker SEP, 2006, EUR J ORAL SCI, V114, P353, DOI 10.1111/j.1600-0722.2006.00315.x; Elliott J C, 1994, J Xray Sci Technol, V4, P102, DOI 10.3233/XST-1994-4204; Elliott JC, 2005, MINERAL MAG, V69, P643, DOI 10.1180/0026461056950276; Featherstone J D B, 2008, Aust Dent J, V53, P286, DOI 10.1111/j.1834-7819.2008.00064.x; Gaiser S, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0004-8; GAO XJ, 1993, J CHEM SOC FARADAY T, V89, P2907, DOI 10.1039/ft9938902907; Hammersley A. P., 1997, ESRF97HA02T; HICKS MJ, 1984, CARIES RES, V18, P315, DOI 10.1159/000260782; HIROTA F, 1982, ARCH ORAL BIOL, V27, P931, DOI 10.1016/0003-9969(82)90099-1; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Kidd E A M, 2004, J Dent Res, V83 Spec No C, pC35; Leventouri T, 2009, INT J BIOMATER, V2009, DOI 10.1155/2009/698547; Low IM, 2004, J AM CERAM SOC, V87, P2125, DOI 10.1111/j.1151-2916.2004.tb06369.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; POOLE DFG, 1961, ARCH ORAL BIOL, V5, P14, DOI 10.1016/0003-9969(61)90110-8; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; Robinson C., 1995, DENT ENAMEL FORMATIO, P223; Shah S, 2011, EUR J ORAL SCI, V119, P13, DOI 10.1111/j.1600-0722.2011.00899.x; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P975, DOI 10.1016/0003-9969(84)90144-4; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Simmons LM, 2013, ARCH ORAL BIOL, V58, P1726, DOI 10.1016/j.archoralbio.2013.08.012; Simmons LM, 2011, EUR J ORAL SCI, V119, P19, DOI 10.1111/j.1600-0722.2011.00909.x; Tanaka T, 2010, CARIES RES, V44, P253, DOI 10.1159/000314672; Thewlis J, 1940, Proc R Soc Med, V33, P387; TOHDA H, 1990, J ELECTRON MICROSC, V39, P238; TOHDA H, 1987, J DENT RES, V66, P1647, DOI 10.1177/00220345870660110901; TOHDA H, 1989, J ELECTRON MICROSC, V38, P309; VOEGEL JC, 1977, CALC TISS RES, V24, P19, DOI 10.1007/BF02223292; Wcislak L, 2002, J APPL CRYSTALLOGR, V35, P82, DOI 10.1107/S0021889801019902; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Yagi N, 2009, J SYNCHROTRON RADIAT, V16, P398, DOI 10.1107/S090904950900449X; Yanagisawa T, 2003, J ELECTRON MICROSC, V52, P605, DOI 10.1093/jmicro/52.6.605	45	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e108879	10.1371/journal.pone.0108879	http://dx.doi.org/10.1371/journal.pone.0108879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360532	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700007
J	Yan, WQ; Li, JF; Chai, RJ; Guo, WT; Xu, L; Han, YC; Bai, XH; Wang, HB				Yan, Wenqing; Li, Jianfeng; Chai, Renjie; Guo, Wentao; Xu, Lei; Han, Yuechen; Bai, Xiaohui; Wang, Haibo			Combining Use of Captopril and Losartan Attenuates the Progress of Streptococcus pneumoniae-Induced Tympanosclerosis through the Suppression of TGF-beta 1 Expression	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); ANGIOTENSIN-II; TGF-BETA; OTITIS-MEDIA; DIFFERENTIATION; INHIBITION; FIBROSIS; MATRIX	Objectives: In this study, using an Streptococcus pneumoniae-induced tympanosclerosis (TS) model, we explored the effects of captopril and losartan in the treatment of TS and the possible mechanisms. Study Design: A prospective experimental animal study. Methods: We set up the TS models in both guinea pig and wistar rat by inoculation of type-3 Streptococcus pneumoniae microorganisms and then treated the animals with the combining use of captopril and losartan. Otomicroscopy was employed to observe the development of TS. Auditory brainstem response was used to test the hearing function of animals. Hematoxylin-eosin and von Kossa staining were performed to determine the morphological changes and calcium depositions. The protein expressions of transforming growth factor beta 1 (TGF-beta 1) were assessed by western blot and immunohistochemistry staining, and the mRNA level of TGF-beta 1 was measured by quantitative reverse transcription-polymerase chain reaction. Results: The combining use of captopril and losartan attenuated TS responses in terms of a decrease in the TS incidence and the ABR threshold, a reduction of hyalinization and calcification in the middle ear mucosa and the thickness of the mucosa. In addition, the TGF-beta 1 expression was decreased at both protein and mRNA levels. Conclusion: Our data indicate, for the first time, that the combining use of captopril and losartan obviously attenuates TS progress through inhibiting the overexpressing of TGF-beta 1.	[Yan, Wenqing; Li, Jianfeng; Guo, Wentao; Xu, Lei; Han, Yuechen; Bai, Xiaohui; Wang, Haibo] Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China; [Yan, Wenqing; Li, Jianfeng; Bai, Xiaohui; Wang, Haibo] Shandong Inst Otolaryngol, Jinan, Peoples R China; [Li, Jianfeng; Bai, Xiaohui; Wang, Haibo] Shandong Prov Key Lab Otol, Jinan, Peoples R China; [Chai, Renjie] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China	Shandong University; Southeast University - China	Bai, XH (corresponding author), Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China.	sphbaixiaohui@hotmail.com; wang.hb7585@hotmail.com			National Natural Science Foundation of China [81000407, 81100711]; Outstanding Young Scientist Research Award Foundation of Province [BS2010YY051]; Science and Technology Development Program of Shandong province [2012G0021838]; Fundamental Research Funds for the Central Universities [2242014R30022, NO2013WSN085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientist Research Award Foundation of Province; Science and Technology Development Program of Shandong province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (81000407, 81100711), Outstanding Young Scientist Research Award Foundation of Province (BS2010YY051), The Science and Technology Development Program of Shandong province (2012G0021838), and Fundamental Research Funds for the Central Universities (2242014R30022, NO2013WSN085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2011, J LARYNGOL OTOL, V125, P142, DOI 10.1017/S002221511000201X; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Cooter MS, 1998, LARYNGOSCOPE, V108, P1066, DOI 10.1097/00005537-199807000-00021; Cordeiro MF, 2002, PROG RETIN EYE RES, V21, P75, DOI 10.1016/S1350-9462(01)00021-0; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; FERLITO A, 1979, J LARYNGOL OTOL, V93, P25, DOI 10.1017/S0022215100086680; Fukuda D, 2009, BIOMED PHARMACOTHER, V63, P754, DOI 10.1016/j.biopha.2009.02.006; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Guo WT, 2012, LARYNGOSCOPE, V122, P2037, DOI 10.1002/lary.23415; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Iriz A, 2011, J LARYNGOL OTOL, V125, P1121, DOI 10.1017/S0022215111002301; KIM SK, 1995, J PHARMACOL EXP THER, V273, P509; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lora CM, 2013, ETHNIC DIS, V23, P189; Melhus A, 2000, INFECT IMMUN, V68, P4024, DOI 10.1128/IAI.68.7.4024-4031.2000; Opelz G, 2011, AM J TRANSPLANT, V11, P2483, DOI 10.1111/j.1600-6143.2011.03681.x; Ozcan I, 2008, LARYNGOSCOPE, V118, P1051, DOI 10.1097/MLG.0b013e31816770ba; Paclik D, 2011, INFLAMM BOWEL DIS, V17, P1449, DOI 10.1002/ibd.21743; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; SHEEHY JL, 1962, ARCHIV OTOLARYNGOL, V76, P151; Siegert A, 1999, J MOL MED-JMM, V77, P437, DOI 10.1007/s001090050374; SORENSEN H, 1972, ACTA OTO-LARYNGOL, V73, P18, DOI 10.3109/00016487209138189; Uneri C, 2006, LARYNGOSCOPE, V116, P140, DOI 10.1097/01.mlg.0000191460.32862.bf; WIELINGA EWJ, 1993, CLIN OTOLARYNGOL, V18, P341, DOI 10.1111/j.1365-2273.1993.tb00590.x; Xaubet A, 2003, AM J RESP CRIT CARE, V168, P431, DOI 10.1164/rccm.200210-1165OC	26	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111620	10.1371/journal.pone.0111620	http://dx.doi.org/10.1371/journal.pone.0111620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360706	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700129
J	Dang, VTA; Tanabe, K; Tanaka, Y; Tokumoto, N; Misumi, T; Saeki, Y; Fujikuni, N; Ohdan, H				Dang, Vu T. A.; Tanabe, Kazuaki; Tanaka, Yuka; Tokumoto, Noriaki; Misumi, Toshihiro; Saeki, Yoshihiro; Fujikuni, Nobuaki; Ohdan, Hideki			Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; APOPTOSIS-INDUCING LIGAND; NK CELLS; HEPATOCELLULAR-CARCINOMA; ANTITUMOR RESPONSES; TUMOR-METASTASIS; STRESS-PROTEINS; CANCER-THERAPY; IMMUNE-SYSTEM; MICE	Acute starvation, which is frequently observed in clinical practice, sometimes augments the cytolytic activity of natural killer cells against neoplastic cells. In this study, we investigated the molecular mechanisms underlying the enhancement of natural killer cell function by fasting in mice. The total number of liver resident natural killer cells in a unit weight of liver tissue obtained from C57BL/6J mice did not change after a 3-day fast, while the proportions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)(+) and CD69(+) natural killer cells were significantly elevated (n = 7, p <0.01), as determined by flow cytometric analysis. Furthermore, we found that TRAIL(-) natural killer cells that were adoptively transferred into Rag-2(-/-) gamma chain(-/-) mice could convert into TRAIL(+) natural killer cells in fasted mice at a higher proportion than in fed mice. Liver natural killer cells also showed high TRAIL-mediated antitumor function in response to 3-day fasting. Since these fasted mice highly expressed heat shock protein 70 (n = 7, p <0.05) in liver tissues, as determined by western blot, the role of this protein in natural killer cell activation was investigated. Treatment of liver lymphocytes with 50 mu g/mL of recombinant heat shock protein 70 led to the upregulation of both TRAIL and CD69 in liver natural killer cells (n = 6, p <0.05). In addition, HSP70 neutralization by intraperitoneally injecting an anti- heat shock protein 70 monoclonal antibody into mice prior to fasting led to the downregulation of TRAIL expression (n = 6, p <0.05). These findings indicate that acute fasting enhances TRAIL-mediated liver natural killer cell activity against neoplastic cells through upregulation of heat shock protein 70.	[Dang, Vu T. A.; Tanabe, Kazuaki; Tanaka, Yuka; Misumi, Toshihiro; Saeki, Yoshihiro; Fujikuni, Nobuaki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan; [Tokumoto, Noriaki] Hiroshima City Hosp, Dept Surg, Hiroshima, Japan	Hiroshima University; Hiroshima City Hospital	Tanabe, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan.	ktanabe2@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019; tanabe, kazuaki/S-6282-2019; Tanaka, Yuka/G-9580-2019	Ohdan, Hideki/0000-0002-9066-1288; 	Japan Society for the Promotion of Science and Research on Hepatitis [25461949, 25462023]; Japanese Ministry of Health, Labor, and Welfare	Japan Society for the Promotion of Science and Research on Hepatitis; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research C (25461949 and 25462023) from the Japan Society for the Promotion of Science and Research on Hepatitis, and BSE grant from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; BOUWENS L, 1987, EUR J IMMUNOL, V17, P37, DOI 10.1002/eji.1830170107; Clinthorne JF, 2013, J IMMUNOL, V190, P712, DOI 10.4049/jimmunol.1201837; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Giuliano Jr JS, 2011, OPEN INFLAMMATION J, V4, P12; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Juhasz K, 2013, CURR PHARM DESIGN, V19, P430, DOI 10.2174/138161213804143644; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Maksimovic-Ivanic D, 2012, IMMUNOL RES, V52, P157, DOI 10.1007/s12026-012-8284-8; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Nishihara M, 1998, TRANSPLANT P, V30, P3697, DOI 10.1016/S0041-1345(98)01200-7; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Schmid TE, 2012, CURR MED CHEM, V19, P1765; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shen JW, 2009, CELL IMMUNOL, V259, P66, DOI 10.1016/j.cellimm.2009.05.015; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Takahashi Y, 1998, TRANSPL P, V30, P3700, DOI 10.1016/S0041-1345(98)01201-9; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	35	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110748	10.1371/journal.pone.0110748	http://dx.doi.org/10.1371/journal.pone.0110748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356750	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000022
J	Wang, L; Xing, JN; Chen, FF; Yan, RX; Ge, L; Qin, QQ; Wang, LY; Ding, ZW; Guo, W; Wang, N				Wang, Lu; Xing, Jiannan; Chen, Fangfang; Yan, Ruixue; Ge, Lin; Qin, Qianqian; Wang, Liyan; Ding, Zhengwei; Guo, Wei; Wang, Ning			Spatial Analysis on Hepatitis C Virus Infection in Mainland China: From 2005 to 2011	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; B-VIRUS; EPIDEMIOLOGY; PREVALENCE; PROVINCE; YUNNAN; HIV-1; RISK	Background: The burden of Hepatitis C virus (HCV) has become more and more considerable in China. A macroscopic spatial analysis of HCV infection that can provide scientific information for further intervention and disease control is lacking. Methods: All geo-referenced HCV cases that had been recorded by the China Information System for Disease Control and Prevention (CISDCP) during 2005-2011 were included in the study. In order to learn about the changes of demographic characteristics and geographic distribution, trend test and spatial analysis were conducted to reflect the changing pattern of HCV infection. Results: Over 770,000 identified HCV infection cases had specific geographic information during the study period (2005-2011). Ratios of gender (Male/Female, Z-value = 218.53, P<0.001), age group (<= 30 years old/>= 31 years old, Z-value = -51.03, P<0.001) and diagnosis type (Clinical diagnosis/Laboratory diagnosis, Z-value = -130.47, P<0.001) declined. HCV infection was not distributed randomly. Provinces Henan, Guangdong, Guangxi, Xinjiang, and Jilin reported more than 40,000 HCV infections during 2005 to 2011, accounting for 43.91% of all cases. The strength of cluster of disease was increasing in China during the study period. Overall, 11 provinces had once been detected as hotspots during 7 years, most of which were located in the central or border parts of China. Tibet, Qinghai, Jiangxi were the regions that had coldspots. Conclusions: The number of clustering of HCV infection among older adults increased in recent years. Specific interventions and prevention programs targeting at main HCV epidemic areas are urgently in need in mainland China.	[Wang, Lu; Xing, Jiannan; Chen, Fangfang; Yan, Ruixue; Ge, Lin; Qin, Qianqian; Wang, Liyan; Ding, Zhengwei; Guo, Wei; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xing, Jiannan] Beijing Human Resources & Social Secur Bur, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022	chen, fang fang/0000-0002-0854-1667	mega-projects of national scientific research under the 12th Five-Year Plan of China [2012ZX10001001]	mega-projects of national scientific research under the 12th Five-Year Plan of China	This study was supported by the mega-projects of national scientific research under the 12th Five-Year Plan of China (2012ZX10001001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Chen X, 2013, ARCH VIROL, V158, P1889, DOI 10.1007/s00705-013-1681-z; Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Huang B, 2013, PRACTICAL PREVENTIVE, V20, P556; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Kuang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082304; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Peng ZH, 2011, GEOSPATIAL HEALTH, V5, P177, DOI 10.4081/gh.2011.169; [秦倩倩 Qin Qianqian], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P548; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050343; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; WHO, 2013, HEP C FACT SHEET; Williams CT, 2011, AIDS BEHAV, V15, P1011, DOI 10.1007/s10461-010-9764-2; Wu SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040872; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	23	11	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110861	10.1371/journal.pone.0110861	http://dx.doi.org/10.1371/journal.pone.0110861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356554	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000029
J	Wu, HL; Yu, YB; David, L; Ho, YS; Lou, MF				Wu, Hongli; Yu, Yibo; David, Larry; Ho, Ye-Shih; Lou, Marjorie F.			Glutaredoxin 2 (Grx2) Gene Deletion Induces Early Onset of Age-dependent Cataracts in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS EPITHELIAL-CELLS; GLUTATHIONE MIXED DISULFIDE; PROTEIN S-GLUTATHIONYLATION; OXIDATIVE STRESS; REDOX REGULATION; THIOL-DISULFIDE; THIOLTRANSFERASE; MITOCHONDRIAL; THIOREDOXIN; CRYSTALLINS	Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, alpha A-crystallin, and beta B2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency.	[Wu, Hongli; Yu, Yibo; Lou, Marjorie F.] Univ Nebraska Lincoln, Sch Vet Med & Biomed Sci, Redox Biol Ctr, Lincoln, NE 68583 USA; [Wu, Hongli] Univ N Texas, Dept Pharmaceut Sci, Coll Pharm, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Yu, Yibo] Zhejiang Univ, Ctr Eye, Affiliated Hosp 2, Dept Ophthalmol,Med Coll, Hangzhou 310009, Zhejiang, Peoples R China; [David, Larry] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA; [Lou, Marjorie F.] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of North Texas System; University of North Texas Health Science Center; Zhejiang University; Oregon Health & Science University; Wayne State University; University of Nebraska System; University of Nebraska Medical Center		mlou1@unl.edu			National Institutes of Health [RO1 EY10595]; NIEHS Pilot Grant [P30 ES06639]; American Heart Association Greater Midwest Affiliate Grants [0455876Z, 0655631Z]; NATIONAL EYE INSTITUTE [P30EY010572, R01EY010595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Pilot Grant; American Heart Association Greater Midwest Affiliate Grants(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY10595 (to M. F. L.) and NIEHS Pilot Grant P30 ES06639 (to Y. S. H.). This work was also supported by American Heart Association Greater Midwest Affiliate Grants 0455876Z and 0655631Z.	[Anonymous], P NATL ACAD SCI US, V100, P3913; Augusteyn R., 1981, MECH CATARACT FORMAT, P72; AXELSSON K, 1983, FEBS LETT, V152, P114, DOI 10.1016/0014-5793(83)80494-3; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Cherian M, 1997, J BIOL CHEM, V272, P29099, DOI 10.1074/jbc.272.46.29099; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; FECONDO JV, 1983, EXP EYE RES, V36, P15, DOI 10.1016/0014-4835(83)90085-4; Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje; Fernando MR, 2004, INVEST OPHTH VIS SCI, V45, P230, DOI 10.1167/iovs.03-0545; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hanson SRA, 1999, J BIOL CHEM, V274, P4735, DOI 10.1074/jbc.274.8.4735; Harding J. J., 1984, LENS DEV PROTEINS ME, V1, p207 ; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; KONO M, 1990, BIOCHEMISTRY-US, V29, P464, DOI 10.1021/bi00454a022; LIANG JN, 1988, EXP EYE RES, V47, P17, DOI 10.1016/0014-4835(88)90020-6; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Loefgren S, 2008, INVEST OPHTH VIS SCI, V49, P4497, DOI 10.1167/iovs.07-1404; Lou M., 2004, REDOX GENOME INTERAC, P325; LOU MF, 1989, CURR EYE RES, V8, P883; LOU MF, 1986, EXP EYE RES, V42, P607, DOI 10.1016/0014-4835(86)90050-3; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; LOU MF, 1988, EXP EYE RES, V46, P517, DOI 10.1016/S0014-4835(88)80009-5; Lou MF, 1999, EXP EYE RES, V68, P547, DOI 10.1006/exer.1998.0638; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Moon S, 2005, INVEST OPHTH VIS SCI, V46, P3783, DOI 10.1167/iovs.05-0237; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Qiao FY, 2000, EXP EYE RES, V70, P745, DOI 10.1006/exer.2000.0836; Raghavachari N, 1996, EXP EYE RES, V63, P433, DOI 10.1006/exer.1996.0133; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Taylor HR, 2001, BRIT J OPHTHALMOL, V85, P261, DOI 10.1136/bjo.85.3.261; Tian X. L., 2013, INVEST OPHTHALMOL VI, V54; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wolf N, 2005, EXP EYE RES, V81, P276, DOI 10.1016/j.exer.2005.01.024; Wu H. L., 2009, ARVO M; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xing KY, 2002, EXP EYE RES, V74, P113, DOI 10.1006/exer.2001.1103; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yegorova S, 2003, INVEST OPHTH VIS SCI, V44, P3263, DOI 10.1167/iovs.02-1322	58	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36125	36139		10.1074/jbc.M114.620047	http://dx.doi.org/10.1074/jbc.M114.620047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25362663	Green Published, hybrid			2022-12-26	WOS:000346897900039
J	Huang, LQ; Wong, CC; Cheng, KW; Rigas, B				Huang, Liqun; Wong, Chi C.; Cheng, Ka W.; Rigas, Basil			Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUGS; OXIDATIVE STRESS; PIK3CA MUTATION; COLORECTAL-CANCER; ASPIRIN INTAKE; P53; SURVIVAL; THERAPY; MDC-917	Phospho-aspirin (PA-2) is a novel aspirin derivative that exhibits promising anticancer properties and is considerably safer than conventional aspirin. In this study, we investigated the chemotherapeutic efficacy of PA-2 in preclinical models of estrogen receptor positive (ER+) breast cancer and elucidated its mechanism of action. PA-2 inhibited the growth of ER+ cells more potently than aspirin in vitro, and exerted a triple cytokinetic effect that includes induction of apoptosis and cell cycle arrest as well as the inhibition of cell proliferation. PA-2 is highly efficacious in vivo, as treatment of established MCF7 xenografts with PA-2 induced tumor stasis (98.2% inhibition, p<0.01). PA-2 triggered the activation of p53-dependent apoptosis via two distinct mechanisms: 1) acetylation of p53 (at K373), which disrupts its interaction with its transcription repressor MDM2, and 2) translocation of p53 to the mitochondria leading to the dissipation of mitochondrial transmembrane potential (Delta Psi(m)). Consistent with these observations, both the RNAi-mediated knockdown of p53 and forced deactylation via HDAC1 over-expression attenuated the anticancer effect of PA-2 in MCF7 cells. An upstream mediator of the signaling effects of PA-2 is RONS. PA-2 induced oxidative stress in vitro and in mice bearing MCF7 xenografts; its induction effect appears to be tumor-specific. Crucially, administration of N-acetylcysteine, a ROS scavenger, abrogated the effect of PA-2 on p53 acetylation and mitochondria translocation, thus identifying RONS as proximal molecules mediating the anticancer effect of PA-2. In summary, our findings demonstrate that PA-2 is a promising antineoplastic compound against ER+ breast cancer, warranting further evaluation as an anticancer agent.	[Huang, Liqun; Wong, Chi C.; Cheng, Ka W.; Rigas, Basil] SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA; [Rigas, Basil] Medicon Pharmaceut Inc, Setauket, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rigas, B (corresponding author), SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu	Wong, Chi Chun/C-4636-2016; Cheng, Ka Wing/V-9433-2019		NIH [R01CA13945402, 1N01CN43302WA22]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH grants R01CA13945402 and 1N01CN43302WA22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2004, JNCI-J NATL CANCER I, V96, P4, DOI 10.1093/jnci/djh027; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bond S, 2010, J MIDWIFERY WOM HEAL, V55, P389, DOI 10.1016/j.jmwh.2010.04.002; Cheng KW, 2013, MOL CANCER THER, V12, P1417, DOI 10.1158/1535-7163.MCT-13-0006-T; Cheng KW, 2012, INT J ONCOL, V41, P1199, DOI 10.3892/ijo.2012.1577; Choi BH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.91; Coates AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3348; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Fink M, 2011, STRAHLENTHER ONKOL, V187, P151; Fuchs CS, 2013, J CLIN ONCOL, V31, P4358, DOI 10.1200/JCO.2013.52.0080; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang L, 2011, BRIT J PHARMACOL, V162, P1521, DOI 10.1111/j.1476-5381.2010.01162.x; Huang LQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-141; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Nie T, 2012, BRIT J PHARMACOL, V166, P991, DOI 10.1111/j.1476-5381.2011.01799.x; Peuget S, 2014, CELL DEATH DIFFER; Rinsema TJ, 1999, MED HIST, V43, P502, DOI 10.1017/S0025727300065728; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stanley P, 2000, Biologist (London), V47, P269; Sun Y, 2011, J PHARMACOL EXP THER, V338, P775, DOI 10.1124/jpet.111.183533; Sun Y, 2009, CARCINOGENESIS, V30, P93, DOI 10.1093/carcin/bgn242; Tacconelli S, 2010, METHODS MOL BIOL, V644, P165, DOI 10.1007/978-1-59745-364-6_14; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Vaseva Angelina V, 2013, Methods Mol Biol, V962, P75, DOI 10.1007/978-1-62703-236-0_6; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wong CC, 2012, J PHARMACOL EXP THER, V340, P422, DOI 10.1124/jpet.111.188508; Zhao WP, 2009, CARCINOGENESIS, V30, P512, DOI 10.1093/carcin/bgp015; Zhu R, PHARM RES, V29, P3090	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111720	10.1371/journal.pone.0111720	http://dx.doi.org/10.1371/journal.pone.0111720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369051	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000092
J	van Diggelen, JMH; Lamers, LPM; van Dijk, G; Schaafsma, MJ; Roelofs, JGM; Smolders, AJP				van Diggelen, Josepha M. H.; Lamers, Leon P. M.; van Dijk, Gijs; Schaafsma, Maarten J.; Roelofs, Jan G. M.; Smolders, Alfons J. P.			New Insights into Phosphorus Mobilisation from Sulphur-Rich Sediments: Time-Dependent Effects of Salinisation	PLOS ONE			English	Article							FRESH-WATER; INTERNAL EUTROPHICATION; PHOSPHATE; SULFATE; EXCHANGE; RELEASE; ACCUMULATION; ECOSYSTEMS; SALINITY; INLET	Internal phosphorus (P) mobilisation from aquatic sediments is an important process adding to eutrophication problems in wetlands. Salinisation, a fast growing global problem, is thought to affect P behaviour. Although several studies have addressed the effects of salinisation, interactions between salinity changes and nutrient cycling in freshwater systems are not fully understood. To tackle eutrophication, a clear understanding of the interacting effects of sediment characteristics and surface water quality is vital. In the present study, P release from two eutrophic sediments, both characterized by high pore water P and very low pore water iron (Fe2+) concentrations, was studied in a long-term aquarium experiment, using three salinity levels. Sediment P release was expected to be mainly driven by diffusion, due to the eutrophic conditions and low iron availability. Unexpectedly, this only seemed to be the driving mechanism in the short term (0-10 weeks). In the long term (>80 weeks), P mobilisation was absent in most treatments. This can most likely be explained by the oxidation of the sediment-water interface where Fe2+ immobilises P, even though it is commonly assumed that free Fe2+ concentrations need to be higher for this. Therefore, a controlling mechanism is suggested in which the partial oxidation of iron-sulphides in the sediment plays a key role, releasing extra Fe2+ at the sediment-water interface. Although salinisation was shown to lower short-term P mobilisation as a result of increased calcium concentrations, it may increase long-term P mobilisation by the interactions between sulphate reduction and oxygen availability. Our study showed time-dependent responses of sediment P mobilisation in relation to salinity, suggesting that sulphur plays an important role in the release of P from FeSx- rich sediments, its biogeochemical effect depending on the availability of Fe2+ and O-2.	[van Diggelen, Josepha M. H.; van Dijk, Gijs; Schaafsma, Maarten J.; Smolders, Alfons J. P.] Radboud Univ Nijmegen, B WARE Res Ctr, NL-6525 ED Nijmegen, Netherlands; [van Diggelen, Josepha M. H.; Lamers, Leon P. M.; van Dijk, Gijs; Roelofs, Jan G. M.; Smolders, Alfons J. P.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Diggelen, JMH (corresponding author), Radboud Univ Nijmegen, B WARE Res Ctr, Mercator 3, NL-6525 ED Nijmegen, Netherlands.	J.vanDiggelen@b-ware.eu	Smolders, Alfons J.P./H-2583-2012; Roelofs, Jan GM/C-1243-2011; Lamers, Leon P.M./A-8718-2012	Lamers, Leon P.M./0000-0003-3769-2154	Dutch Ministry of Agriculture, Nature and Food Quality (LNV)	Dutch Ministry of Agriculture, Nature and Food Quality (LNV)	This study was part of the National Research Programme "Wormer- en Jisperwater,'' funded by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV), within the framework of "Nota Ruimte.'' The water management authority "Hoogheemraadschap Hollands Noorderkwartier'' facilitated this programme. The authors did not require further external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltman B, 2000, BIOGEOCHEMISTRY, V50, P183, DOI 10.1023/A:1006374018558; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; BOSTROM B, 1988, HYDROBIOLOGIA, V170, P229, DOI 10.1007/BF00024907; BOSTROM B, 1982, HYDROBIOLOGIA, V91-2, P415, DOI 10.1007/BF02391957; Boxman AW, 2008, ENVIRON POLLUT, V156, P1252, DOI 10.1016/j.envpol.2008.03.017; CARACO NF, 1993, HYDROBIOLOGIA, V253, P275, DOI 10.1007/BF00050748; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carpenter PD, 1984, ENVIRON TECHNOL LETT, V6, P65; DEINEMA MH, 1980, FEMS MICROBIOL LETT, V9, P275; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Einsele W, 1936, ARCH HYDROBIOL, V29, P664; Geurts JJM, 2010, WATER RES, V44, P3487, DOI 10.1016/j.watres.2010.03.030; Geurts JJM, 2009, ENVIRON POLLUT, V157, P2072, DOI 10.1016/j.envpol.2009.02.024; Golterman HL, 1996, HYDROBIOLOGIA, V335, P87, DOI 10.1007/BF00013687; GRASSHOFF K, 1972, J CONSEIL, V34, P516; Gunnars A, 1997, BIOGEOCHEMISTRY, V37, P203, DOI 10.1023/A:1005744610602; Gunnars A, 2002, GEOCHIM COSMOCHIM AC, V66, P745, DOI 10.1016/S0016-7037(01)00818-3; HENRIKSEN A, 1965, ANALYST, V90, P29, DOI 10.1039/an9659000029; House WA, 1999, ENVIRON TECHNOL, V20, P727, DOI 10.1080/09593332008616867; HUPFER M, 1991, PROC INT ASSOC THE 5, V24, P2999; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; IMHOFF JF, 1995, HELGOLANDER MEERESUN, V49, P223, DOI 10.1007/BF02368352; Jordan TE, 2008, LIMNOL OCEANOGR, V53, P172, DOI 10.4319/lo.2008.53.1.0172; KAMPHAKE LJ, 1967, WATER RES, V1, P205, DOI 10.1016/0043-1354(67)90011-5; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Lamers LPM, 2002, LIMNOL OCEANOGR, V47, P585, DOI 10.4319/lo.2002.47.2.0585; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reigersman CJA, 1946, ONTZILTING NOORD HOL; Roden EE, 2012, BIOCHEM SOC T, V40, P1249, DOI 10.1042/BST20120202; ROELOFS JGM, 1991, AQUAT BOT, V39, P267, DOI 10.1016/0304-3770(91)90004-O; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; SMOLDERS A, 1995, ARCH HYDROBIOL, V133, P349; Smolders AJP, 2006, CHEM ECOL, V22, P93, DOI 10.1080/02757540600579730; Smolders AJP, 2001, BIOGEOCHEMISTRY, V54, P219, DOI 10.1023/A:1010660401527; Suzumura M., 2000, J OCEANOGRAPHY, V56, P667, DOI [DOI 10.1023/A:1011125700301, 10.1023/a:1011125700301]; Van Dijk G, 2013, H2O, V46, P1; VANGEMERDEN H, 1984, ARCH MICROBIOL, V139, P289, DOI 10.1007/BF00408368; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wu YH, 2014, KSCE J CIV ENG, V18, P323, DOI 10.1007/s12205-014-0192-0; [No title captured]	41	20	20	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111106	10.1371/journal.pone.0111106	http://dx.doi.org/10.1371/journal.pone.0111106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369128	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000037
J	Young, NA; Bruss, MS; Gardner, M; Willis, WL; Mo, XK; Valiente, GR; Cao, Y; Liu, ZF; Jarjour, WN; Wu, LC				Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Mo, Xiaokui; Valiente, Giancarlo R.; Cao, Yu; Liu, Zhongfa; Jarjour, Wael N.; Wu, Lai-Chu			Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NF kappa B Signaling and Macrophage Migration	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CLINICAL-TRIAL; IN-VITRO; CELLS; ACTIVATION; EXPRESSION; RECEPTOR; GENE; LIPOPOLYSACCHARIDE; BIOAVAILABILITY	Despite the widespread use of curcumin for centuries in Eastern medicine as an anti-inflammatory agent, its molecular actions and therapeutic viability have only recently been explored. While curcumin does have potential therapeutic efficacy, both solubility and bioavailability must be improved before it can be more successfully translated to clinical care. We have previously reported a novel formulation of nano-emulsion curcumin (NEC) that achieves significantly greater plasma concentrations in mice after oral administration. Here, we confirm the immunosuppressive effects of NEC in vivo and further examine its molecular mechanisms to better understand therapeutic potential. Using transgenic mice harboring an NF kappa B-luciferase reporter gene, we demonstrate a novel application of this in vivo inflammatory model to test the efficacy of NEC administration by bioluminescent imaging and show that LPS-induced NF kappa B activity was suppressed with NEC compared to an equivalent amount of curcumin in aqueous suspension. Administration of NEC by oral gavage resulted in a reduction of blood monocytes, decreased levels of both TLR4 and RAGE expression, and inhibited secretion of MCP-1. Mechanistically, curcumin blocked LPS-induced phosphorylation of the p65 subunit of NF kappa B and IkB alpha in murine macrophages. In a mouse model of peritonitis, NEC significantly reduced macrophage recruitment, but not T-cell or B-cell levels. In addition, curcumin treatment of monocyte derived cell lines and primary human macrophages in vitro significantly inhibited cell migration. These data demonstrate that curcumin can suppress inflammation by inhibiting macrophage migration via NF kappa B and MCP-1 inhibition and establish that NEC is an effective therapeutic formulation to increase the bioavailability of curcumin in order to facilitate this response.	[Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Valiente, Giancarlo R.; Jarjour, Wael N.; Wu, Lai-Chu] Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Columbus, OH 43210 USA; [Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Valiente, Giancarlo R.; Jarjour, Wael N.; Wu, Lai-Chu] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Cao, Yu; Liu, Zhongfa] Ohio State Univ, Wexner Med Ctr, Coll Pharm, Columbus, OH 43210 USA; [Liu, Zhongfa] Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wu, LC (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Columbus, OH 43210 USA.	LaiChu.Wu@osumc.edu	Wu, Lai-Chu/E-4328-2011	Wu, Lai-Chu/0000-0002-1348-269X; Young, Nicholas/0000-0002-9323-9437	Ohio State University's Wexner Medical Center; Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH [P30 CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University's Wexner Medical Center; Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided through The Ohio State University's Wexner Medical Center and Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH, P30 CA16058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; CHANDRASEKARAN AN, 1995, BAILLIERE CLIN RHEUM, V9, P45, DOI 10.1016/S1521-6942(06)80019-7; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Dhanasekaran S, 2013, BIOCHIMIE, V95, P1567, DOI 10.1016/j.biochi.2013.04.004; Fu Y, 2014, INT IMMUNOPHARMACOL; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Hoekstra M, 2004, J RHEUMATOL, V31, P645; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hsu J., 1996, MULTIPLE COMP THEORY; Jacob A, 2013, IMMUNOLOGY, V139, P328, DOI 10.1111/imm.12079; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Kim DC, 2011, INFLAMM RES, V60, P1161, DOI 10.1007/s00011-011-0381-y; Kipari T, 2009, INFLAMM RES, V58, P553, DOI 10.1007/s00011-009-0019-5; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Li Xinjian, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P137; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Lubbad A, 2009, MOL CELL BIOCHEM, V322, P127, DOI 10.1007/s11010-008-9949-4; Luster AD, 1997, J LEUKOCYTE BIOL, V62, P620, DOI 10.1002/jlb.62.5.620; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Ngwuluka N, 2010, EXPERT OPIN DRUG DEL, V7, P203, DOI 10.1517/17425240903483166; Pae HO, 2008, MOL NUTR FOOD RES, V52, P1082, DOI 10.1002/mnfr.200700333; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Parodi FE, 2006, ANN VASC SURG, V20, P360, DOI 10.1007/s10016-006-9054-7; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Verbeke G, 2000, LINEAR MIXED MODELS; Verderio P, 2013, BIOMACROMOLECULES, V14, P672, DOI 10.1021/bm3017324; WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86; Wan H, 2009, J LEUKOCYTE BIOL, V86, P361, DOI 10.1189/jlb.0208126; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Young NA, 2013, MOL IMMUNOL, V54, P23, DOI 10.1016/j.molimm.2012.10.026; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	40	44	45	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111559	10.1371/journal.pone.0111559	http://dx.doi.org/10.1371/journal.pone.0111559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369140	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000069
J	Durant, JM; Skern-Mauritzen, M; Krasnov, YV; Nikolaeva, NG; Lindstrom, U; Dolgov, A				Durant, Joel M.; Skern-Mauritzen, Mette; Krasnov, Yuri V.; Nikolaeva, Natalia G.; Lindstrom, Ulf; Dolgov, Andrey			Temporal Dynamics of Top Predators Interactions in the Barents Sea	PLOS ONE			English	Article							COD GADUS-MORHUA; WHALE BALAENOPTERA-ACUTOROSTRATA; CAPELIN MALLOTUS-VILLOSUS; URIA-AALGE; TROPHIC INTERACTIONS; SPAWNING STOCK; DIET-OVERLAP; FOOD WEBS; ECOSYSTEM; RECRUITMENT	The Barents Sea system is often depicted as a simple food web in terms of number of dominant feeding links. The most conspicuous feeding link is between the Northeast Arctic cod Gadus morhua, the world's largest cod stock which is presently at a historical high level, and capelin Mallotus villosus. The system also holds diverse seabird and marine mammal communities. Previous diet studies may suggest that these top predators (cod, bird and sea mammals) compete for food particularly with respect to pelagic fish such as capelin and juvenile herring (Clupea harengus), and krill. In this paper we explored the diet of some Barents Sea top predators (cod, Black-legged kittiwake Rissa tridactyla, Common guillemot Uria aalge, and Minke whale Balaenoptera acutorostrata). We developed a GAM modelling approach to analyse the temporal variation diet composition within and between predators, to explore intra-and inter-specific interactions. The GAM models demonstrated that the seabird diet is temperature dependent while the diet of Minke whale and cod is prey dependent; Minke whale and cod diets depend on the abundance of herring and capelin, respectively. There was significant diet overlap between cod and Minke whale, and between kittiwake and guillemot. In general, the diet overlap between predators increased with changes in herring and krill abundances. The diet overlap models developed in this study may help to identify inter-specific interactions and their dynamics that potentially affect the stocks targeted by fisheries.	[Durant, Joel M.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Skern-Mauritzen, Mette] Inst Marine Res, N-5024 Bergen, Norway; [Krasnov, Yuri V.] Murmansk Marine Biol Inst, Murmansk, Russia; [Nikolaeva, Natalia G.] Moscow MV Lomonosov State Univ, Dept Biol, White Sea Biol Stn, Moscow, Russia; [Lindstrom, Ulf] Inst Marine Res, Tromso, Norway; [Dolgov, Andrey] Knipovich Polar Res Inst Marine Fisheries & Ocean, Murmansk, Russia	University of Oslo; Institute of Marine Research - Norway; Russian Academy of Sciences; Lomonosov Moscow State University; Institute of Marine Research - Norway; Research lnstitute of Fisheries & Oceanography	Durant, JM (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	joel.durant@ibv.uio.no	Skern-Mauritzen, Mette/ABA-8173-2020; Dolgov, Andrey/D-3708-2012; Krasnov, Yuri V/H-1581-2016; Durant, Joël/D-3821-2013; Lindstrom, Ulf/AAU-1327-2020	Dolgov, Andrey/0000-0002-4806-3284; Durant, Joël/0000-0002-1129-525X; 	Research Council of Norway through the ADMAR project [200497/130).]	Research Council of Norway through the ADMAR project	This work was supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_ page/1177315753906) through the ADMAR project (grant no. 200497/130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker-Nilssen T., 2000, STATUS MARINE BIRDS; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; Barrett RT, 1997, POLAR RES, V16, P73, DOI 10.1111/j.1751-8369.1997.tb00249.x; Barrett RT, 2002, MAR ECOL PROG SER, V230, P275, DOI 10.3354/meps230275; Berenboim B.I., 2000, Journal of Northwest Atlantic Fishery Science, V27, P69, DOI 10.2960/J.v27.a6; Blanchard JL, 2002, EXPLORING MARINE MAM, V117; Bogstad B, 2000, NAMMCO SCI PUBL, V2, P98, DOI 10.7557/3.2975; Dalpadado P, 2001, ICES J MAR SCI, V58, P876, DOI 10.1006/jmsc.2001.1078; Dalpadado P, 2012, J CONSEIL; Dolgov A. V., 2008, LONG TERM BILATERAL, P44; Dolgov AV, 1999, BIOL REGULATION FISH, P5; Durant JM, 2012, OECOLOGIA, V169, P685, DOI 10.1007/s00442-011-2226-3; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Erikstad KE, 2013, MAR ECOL PROG SER, V475, P267, DOI 10.3354/meps10084; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Gjosaeter H, 1998, FISH RES, V38, P57, DOI 10.1016/S0165-7836(98)00114-3; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Haug T, 2002, SARSIA, V87, P409, DOI 10.1080/0036482021000155715; HAUG T, 1995, ICES J MAR SCI, V52, P77, DOI 10.1016/1054-3139(95)80017-4; Haug T, 2011, BARENTS SEA ECOSYSTE, P485; Haug T, 1994, INT S BIOL MAR MAMM, P545; Hilton GM, 2000, EVOL ECOL RES, V2, P207; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; Hjermann DO, 2010, CAN J FISH AQUAT SCI, V67, P1363, DOI 10.1139/F10-064; Hjermann DO, 2004, CAN J FISH AQUAT SCI, V61, P1747, DOI 10.1139/F04-115; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2012, BOBLME2012ECOLOGY10; Jakobsen T., 2011, BARENTS SEA ECOSYSTE, P825; Johannesen E, 2012, MAR ECOL PROG SER, V458, P181, DOI 10.3354/meps09818; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Krasnov JV, 1995, ECOLOGY OF FJORDS AND COASTAL WATERS, P443; Krasnov Yu.V., 2007, Ornitologiya, V34, P65; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Link JS, 2009, FISH FISH, V10, P58, DOI 10.1111/j.1467-2979.2008.00295.x; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Mehl S., 1991, INTERRELATIONS FISH, P5; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nilssen KT, 2000, NAMMCO SCI PUBL, V2, P9, DOI 10.7557/3.2968; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Ottersen G, 2008, CAN J FISH AQUAT SCI, V65, P523, DOI 10.1139/F07-185; PAINE RT, 1980, J ANIM ECOL, V49, P667; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIMM SL, 1982, FOOD WEBS; Prozorkevich DV, 2010, DEV RUSSIAN FISHERIE, P248; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RISSB, 2020, SPAD WORK GROUP; Sakshaug E., 2009, ECOSYSTEM BARENTS SE; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sivertsen SP, 2006, MAR BIOL RES, V2, P89, DOI 10.1080/17451000600670952; Skern-Mauritzen M, 2011, MAR ECOL PROG SER, V426, P289, DOI 10.3354/meps09027; Spellerberg I.F, 2008, ENCY ECOLOGY, P3249, DOI DOI 10.1016/B978-008045405-4.00132-4; Stige LC, 2009, LIMNOL OCEANOGR, V54, P1025, DOI 10.4319/lo.2009.54.4.1025; Tereschenko VV, 1996, 1996C11 ICES CM; Vader W., 1990, Studies in Avian Biology, P175; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Yaragina NA, 2000, ICES J MAR SCI, V57, P42, DOI 10.1006/jmsc.1999.0493; Zatsepin VJ, 1939, T PINRO, P5; Zhukova NG, 2009, DEEP-SEA RES PT II, V56, P1959, DOI 10.1016/j.dsr2.2008.11.007	65	21	21	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110933	10.1371/journal.pone.0110933	http://dx.doi.org/10.1371/journal.pone.0110933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365430	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100036
J	Emerson, RO; Mathew, JM; Konieczna, IM; Robins, HS; Leventhal, JR				Emerson, Ryan O.; Mathew, James M.; Konieczna, Iwona M.; Robins, Harlan S.; Leventhal, Joseph R.			Defining the Alloreactive T Cell Repertoire Using High-Throughput Sequencing of Mixed Lymphocyte Reaction Culture	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CROSS-REACTIVITY; TOLERANCE; RECEPTOR; NAIVE; TRANSPLANTATION; ANTIGEN; HUMANS; GENERATION; INFECTION	The cellular immune response is the most important mediator of allograft rejection and is a major barrier to transplant tolerance. Delineation of the depth and breadth of the alloreactive T cell repertoire and subsequent application of the technology to the clinic may improve patient outcomes. As a first step toward this, we have used MLR and high-throughput sequencing to characterize the alloreactive T cell repertoire in healthy adults at baseline and 3 months later. Our results demonstrate that thousands of T cell clones proliferate in MLR, and that the alloreactive repertoire is dominated by relatively high-abundance T cell clones. This clonal make up is consistently reproducible across replicates and across a span of three months. These results indicate that our technology is sensitive and that the alloreactive TCR repertoire is broad and stable over time. We anticipate that application of this approach to track donor-reactive clones may positively impact clinical management of transplant patients.	[Emerson, Ryan O.] Adapt Biotechnol Corp, Seattle, WA USA; [Mathew, James M.; Konieczna, Iwona M.; Leventhal, Joseph R.] Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Robins, Harlan S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Northwestern University; Northwestern University; Fred Hutchinson Cancer Center	Leventhal, JR (corresponding author), Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA.	jleventh@nmh.org						Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; BAIN B, 1964, SCIENCE, V145, P1315, DOI 10.1126/science.145.3638.1315; BAIN B, 1964, BLOOD, V23, P108, DOI 10.1182/blood.V23.1.108.108; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; D'Orsogna LJ, 2012, IMMUNOGENETICS, V64, P77, DOI 10.1007/s00251-011-0590-0; D'Orsogna LJA, 2011, TRANSPLANTATION, V91, P645, DOI 10.1097/TP.0b013e318208c071; D'Orsogna LJA, 2011, TRANSPL IMMUNOL, V24, P141, DOI 10.1016/j.trim.2010.12.001; Danziger-Isakov L, 2010, TRANSPLANTATION, V89, P838, DOI 10.1097/TP.0b013e3181ca56f8; Ely LK, 2008, CURR OPIN IMMUNOL, V20, P575, DOI 10.1016/j.coi.2008.07.006; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Griesemer AD, 2010, TRANSPLANTATION, V90, P465, DOI 10.1097/TP.0b013e3181e7e54f; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Levitsky J, 2013, TRANSPLANTATION, V96, P689, DOI 10.1097/TP.0b013e31829f1607; Levitsky J, 2012, HUM IMMUNOL, V73, P141, DOI 10.1016/j.humimm.2011.11.008; Macedo C, 2009, AM J TRANSPLANT, V9, P2057, DOI 10.1111/j.1600-6143.2009.02742.x; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; Mathew JM, 2003, TRANSPL IMMUNOL, V11, P307, DOI 10.1016/S0966-3274(03)00056-X; Mifsud NA, 2010, TRANSPLANTATION, V90, P1439, DOI 10.1097/TP.0b013e3181ff4ff3; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHILD H, 1990, SCIENCE, V247, P1587, DOI 10.1126/science.2321019; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Wang TM, 2008, J IMMUNOL, V180, P5991, DOI 10.4049/jimmunol.180.9.5991; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	34	27	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111943	10.1371/journal.pone.0111943	http://dx.doi.org/10.1371/journal.pone.0111943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365040	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100136
J	Schanz, M; Liechti, T; Zagordi, O; Miho, E; Reddy, ST; Gunthard, HF; Trkola, A; Huber, M				Schanz, Merle; Liechti, Thomas; Zagordi, Osvaldo; Miho, Enkelejda; Reddy, Sai T.; Guenthard, Huldrych F.; Trkola, Alexandra; Huber, Michael			High-Throughput Sequencing of Human Immunoglobulin Variable Regions with Subtype Identification	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HIV-1-NEUTRALIZING ANTIBODIES; HIV-1 INFECTION; B-CELLS; GENERATION; VIRUS; TYPE-1; POTENT; REPERTOIRE; SUBCLASSES	The humoral immune response plays a critical role in controlling infection, and the rapid adaptation to a broad range of pathogens depends on a highly diverse antibody repertoire. The advent of high-throughput sequencing technologies in the past decade has enabled insights into this immense diversity. However, not only the variable, but also the constant region of antibodies determines their in vivo activity. Antibody isotypes differ in effector functions and are thought to play a defining role in elicitation of immune responses, both in natural infection and in vaccination. We have developed an Illumina MiSeq high-throughput sequencing protocol that allows determination of the human IgG subtype alongside sequencing full-length antibody variable heavy chain regions. We thereby took advantage of the Illumina procedure containing two additional short reads as identifiers. By performing paired-end sequencing of the variable regions and customizing one of the identifier sequences to distinguish IgG subtypes, IgG transcripts with linked information of variable regions and IgG subtype can be retrieved. We applied our new method to the analysis of the IgG variable region repertoire from PBMC of an HIV-1 infected individual confirmed to have serum antibody reactivity to the Membrane Proximal External Region (MPER) of gp41. We found that IgG3 subtype frequencies in the memory B cell compartment increased after halted treatment and coincided with increased plasma antibody reactivity against the MPER domain. The sequencing strategy we developed is not restricted to analysis of IgG. It can be adopted for any Ig subtyping and beyond that for any research question where phasing of distant regions on the same amplicon is needed.	[Schanz, Merle; Liechti, Thomas; Zagordi, Osvaldo; Trkola, Alexandra; Huber, Michael] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Miho, Enkelejda; Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Huber, M (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.	huber.michael@virology.uzh.ch	Trkola, Alexandra/K-2115-2012; Huber, Michael/B-8509-2015; Zagordi, Osvaldo/H-2879-2019; gunthard, huldrych f/F-1724-2011; Reddy, Sai/B-4190-2012	Trkola, Alexandra/0000-0003-1013-876X; Huber, Michael/0000-0002-0384-0000; Zagordi, Osvaldo/0000-0002-9082-8607; gunthard, huldrych f/0000-0002-1142-6723; Miho, Enkelejda/0000-0001-6461-0519; Liechti, Thomas/0000-0001-8738-6679; Reddy, Sai/0000-0002-9177-0857	Swiss National Science Foundation [310000-120739, 310030-152663]; SystemsX.ch RTD grant (AntibodyX); University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD grant (AntibodyX); University of Zurich	Funding was provided by the Swiss National Science Foundation (www.snf.ch) grant 310000-120739 and 310030-152663 to AT, a SystemsX.ch RTD grant (AntibodyX), and the Clinical Research Priority Program Viral Infectious Diseases of the University of Zurich (http://www.viralinfectiousdiseases.uzh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beenhouwer DO, 2007, INFECT IMMUN, V75, P1424, DOI 10.1128/IAI.01161-06; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Di Giallonardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074249; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mathonet P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00265; Menzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096727; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Roux KH, 1997, J IMMUNOL, V159, P3372; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315	33	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111726	10.1371/journal.pone.0111726	http://dx.doi.org/10.1371/journal.pone.0111726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364977	Green Published, gold, Green Accepted			2022-12-26	WOS:000345558100112
J	Tang, KW; Norberg, P; Holmudden, M; Elias, P; Liljeqvist, JA				Tang, Ka-Wei; Norberg, Peter; Holmudden, Martin; Elias, Per; Liljeqvist, Jan-Ake			Rad51 and Rad52 Are Involved in Homologous Recombination of Replicating Herpes Simplex Virus DNA	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; TEMPERATURE-SENSITIVE MUTANTS; MISMATCH REPAIR PROTEINS; IN-VITRO; GENETIC-RECOMBINATION; REITERATED SEQUENCES; STRAND EXCHANGE; INFECTED CELLS; LIGASE-I; TYPE-1	Replication of herpes simplex virus 1 is coupled to recombination, but the molecular mechanisms underlying this process are poorly characterized. The role of Rad51 and Rad52 recombinases in viral recombination was examined in human fibroblast cells 1BR.3.N (wild type) and in GM16097 with replication defects caused by mutations in DNA ligase I. Intermolecular recombination between viruses, tsS and tsK, harboring genetic markers gave rise to similar to 17% recombinants in both cell lines. Knock-down of Rad51 and Rad52 by siRNA reduced production of recombinants to 11% and 5%, respectively, in wild type cells and to 3% and 5%, respectively, in GM16097 cells. The results indicate a specific role for Rad51 and Rad52 in recombination of replicating herpes simplex virus 1 DNA. Mixed infections using clinical isolates with restriction enzyme polymorphisms in the US4 and US7 genes revealed recombination frequencies of 0.7%/kbp in wild type cells and 4%/kbp in GM16097 cells. Finally, tandem repeats in the US7 gene remained stable upon serial passage, indicating a high fidelity of recombination in infected cells.	[Tang, Ka-Wei; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Norberg, Peter; Holmudden, Martin; Liljeqvist, Jan-Ake] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis,Sect Virol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Tang, KW (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	kawei.tang@medkem.gu.se		Tang, Ka-Wei/0000-0003-1189-5092; Liljeqvist, Jan-Ake/0000-0002-1226-9870	ALF Foundation at Sahlgrenska University Hospital; Swedish Research Council; Magnus Bergvalls Foundation; Swedish Cancer Foundation; Goteborg Medical Society	ALF Foundation at Sahlgrenska University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magnus Bergvalls Foundation; Swedish Cancer Foundation; Goteborg Medical Society	This work was supported by grants to JAL from the ALF Foundation at Sahlgrenska University Hospital, the Swedish Research Council, Magnus Bergvalls Foundation, to PE from the Swedish Cancer Foundation, the Swedish Research Council and from the ALF Foundation at Sahlgrenska University Hospital and to KWT from the Goteborg Medical Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; BONE DR, 1978, J VIROL, V28, P14, DOI 10.1128/JVI.28.1.14-19.1978; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Bower JR, 1999, J VIROL, V73, P3843, DOI 10.1128/JVI.73.5.3843-3853.1999; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; DASGUPTA UB, 1980, MOL GEN GENET, V178, P617, DOI 10.1007/BF00337869; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; DUTCH RE, 1994, J VIROL, V68, P3733, DOI 10.1128/JVI.68.6.3733-3741.1994; FRENKEL N, 1975, J VIROL, V16, P153, DOI 10.1128/JVI.16.1.153-167.1975; Fujita K, 1998, ARCH VIROL, V143, P25, DOI 10.1007/s007050050265; Hughes AL, 2007, VIRUS RES, V130, P28, DOI 10.1016/j.virusres.2007.05.008; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; LEWIS ME, 1984, J VIROL, V52, P300, DOI 10.1128/JVI.52.1.300-305.1984; Liljeqvist JA, 2009, J GEN VIROL, V90, P559, DOI 10.1099/vir.0.007070-0; Lingen M, 1997, MED MICROBIOL IMMUN, V185, P217, DOI 10.1007/s004300050033; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Maertzdorf J, 1999, J CLIN MICROBIOL, V37, P3518, DOI 10.1128/JCM.37.11.3518-3523.1999; MARSDEN HS, 1976, J GEN VIROL, V31, P347, DOI 10.1099/0022-1317-31-3-347; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; McGeoch DJ, 2009, J GEN VIROL, V90, P963, DOI 10.1099/vir.0.007658-0; Meurens F, 2004, J VIROL, V78, P9828, DOI 10.1128/JVI.78.18.9828-9836.2004; Mohni KN, 2011, J VIROL, V85, P12241, DOI 10.1128/JVI.05487-11; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Norberg P, 2007, J GEN VIROL, V88, P1683, DOI 10.1099/vir.0.82500-0; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Norberg P, 2006, J CLIN MICROBIOL, V44, P4511, DOI 10.1128/JCM.00421-06; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; SARISKY RT, 1994, J VIROL, V68, P34, DOI 10.1128/JVI.68.1.34-47.1994; Schmidt-Chanasit J, 2011, INFECT GENET EVOL, V11, P1, DOI 10.1016/j.meegid.2010.08.014; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Umene K, 1999, REV MED VIROL, V9, P171, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;171::AID-RMV243&gt;3.0.CO;2-A; Umene K, 2003, J GEN VIROL, V84, P917, DOI 10.1099/vir.0.18809-0; Umene K, 2007, J CLIN VIROL, V39, P266, DOI 10.1016/j.jcv.2007.05.012; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; Yao XD, 1997, J VIROL, V71, P6842, DOI 10.1128/JVI.71.9.6842-6849.1997; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; Yao XD, 1999, REPLICATION RECOMBIN; Zell R, 2012, J VIROL, V86, P1608, DOI 10.1128/JVI.06233-11; Zhu YL, 2010, J VIROL, V84, P7459, DOI 10.1128/JVI.01875-09	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111584	10.1371/journal.pone.0111584	http://dx.doi.org/10.1371/journal.pone.0111584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365323	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100081
J	Parida, L; Neogi, S; Padmanabhan, V				Parida, Lipika; Neogi, Sudarsan; Padmanabhan, Venkat			Effect of Temperature Pre-Exposure on the Locomotion and Chemotaxis of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; PLASTICITY; AVOIDANCE; THERMOTAXIS; DOPAMINE; BEHAVIOR; CIRCUIT; SYSTEM	The effect of temperature pre-exposure on locomotion and chemotaxis of the soil-dwelling nematode Caenorhabditis elegans has been extensively studied. The behavior of C. elegans was quantified using a simple harmonic curvature-based model. Animals showed increased levels of activity, compared to control worms, immediately after pre-exposure to 30 degrees C. This high level of activity in C. elegans translated into frequent turns by making 'complex' shapes, higher velocity of locomotion, and higher chemotaxis index (CI) in presence of a gradient of chemoattractant. The effect of pre-exposure was observed to be persistent for about 20 minutes after which the behavior (including velocity and CI) appeared to be comparable to that of control animals (maintained at 20 degrees C). Surprisingly, after 30 minutes of recovery, the behavior of C. elegans continued to deteriorate further below that of control worms with a drastic reduction in the curvature of the worms' body. A majority of these worms also showed negative chemotaxis index indicating a loss in their chemotaxis ability.	[Parida, Lipika; Neogi, Sudarsan; Padmanabhan, Venkat] Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Padmanabhan, V (corresponding author), Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India.	venkatp@che.iitkgp.ernet.in		Parida, Lipika/0000-0002-8251-0148	Department of Science and Technology, New Delhi, India	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	Funding provided by Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW PA, 1976, NEMATOLOGICA, V22, P451, DOI 10.1163/187529276X00454; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; CHALFIE M, 1985, J NEUROSCI, V5, P956; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Frankel G. S., 1961, ORIENTATION ANIMALS; GRAY J, 1964, J EXP BIOL, V41, P135; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HANCOCK GJ, 1953, PROC R SOC LON SER-A, V217, P96, DOI 10.1098/rspa.1953.0048; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; MacMillan K, 2012, EXPEDITION, V1; Matsuura T, 2010, ZOOL SCI, V27, P629, DOI 10.2108/zsj.27.629; Matsuura T, 2009, J EXP ZOOL PART A, V311A, P483, DOI 10.1002/jez.545; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Padmanabhan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040121; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramnanan CJ, 2006, J EXP BIOL, V209, P677, DOI 10.1242/jeb.02052; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rose JK, 2001, LEARN MEMORY, V8, P63, DOI 10.1101/lm.37801; Saeki S, 2001, J EXP BIOL, V204, P1757; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Sidorov AV, 2003, ZH VYSSH NERV DEYAT+, V53, P513; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Yamada Y, 2003, J EXP BIOL, V206, P2581, DOI 10.1242/jeb.00477; Zhao B, 2003, J NEUROSCI, V23	37	9	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111342	10.1371/journal.pone.0111342	http://dx.doi.org/10.1371/journal.pone.0111342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360667	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700086
J	Penman, TD; Collins, L; Syphard, AD; Keeley, JE; Bradstock, RA				Penman, Trent D.; Collins, Luke; Syphard, Alexandra D.; Keeley, Jon E.; Bradstock, Ross A.			Influence of Fuels, Weather and the Built Environment on the Exposure of Property to Wildfire	PLOS ONE			English	Article							BAYESIAN BELIEF NETWORKS; WILDLAND-URBAN INTERFACE; SOUTHERN CALIFORNIA; SYDNEY REGION; RELATIVE IMPORTANCE; SPATIAL-PATTERNS; EXPERT-JUDGMENT; SIERRA-NEVADA; FIRE BEHAVIOR; MANAGEMENT	Wildfires can pose a significant risk to people and property. Billions of dollars are spent investing in fire management actions in an attempt to reduce the risk of loss. One of the key areas where money is spent is through fuel treatment - either fuel reduction (prescribed fire) or fuel removal (fuel breaks). Individual treatments can influence fire size and the maximum distance travelled from the ignition and presumably risk, but few studies have examined the landscape level effectiveness of these treatments. Here we use a Bayesian Network model to examine the relative influence of the built and natural environment, weather, fuel and fuel treatments in determining the risk posed from wildfire to the wildland-urban interface. Fire size and distance travelled was influenced most strongly by weather, with exposure to fires most sensitive to changes in the built environment and fire parameters. Natural environment variables and fuel load all had minor influences on fire size, distance travelled and exposure of assets. These results suggest that management of fuels provided minimal reductions in risk to assets and adequate planning of the changes in the built environment to cope with the expansion of human populations is going to be vital for managing risk from fire under future climates.	[Penman, Trent D.; Bradstock, Ross A.] Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW 2522, Australia; [Collins, Luke] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Keeley, Jon E.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of Wollongong; Western Sydney University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles	Penman, TD (corresponding author), Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne, Vic 3010, Australia.	trent.penman@unimelb.edu.au	Penman, Trent D/A-7242-2012	Penman, Trent D/0000-0002-5203-9818; Collins, Luke/0000-0001-8059-0925; Syphard, Alexandra/0000-0003-3070-0596	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Funding from the U.S. Geological Survey was provided to University of Wollongong to cover salary of LC for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2000, FOREST ECOL MANAG, V127, P55, DOI 10.1016/S0378-1127(99)00116-4; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; Bar Massada A, 2011, ENVIRON MODELL SOFTW, V26, P583, DOI 10.1016/j.envsoft.2010.11.016; Bar Massada A, 2009, FOREST ECOL MANAG, V258, P1990, DOI 10.1016/j.foreco.2009.07.051; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; Boustras G, 2012, WILDFIRE COMMUNITY F, P151; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Bradstock RA, 2009, INT J WILDLAND FIRE, V18, P932, DOI 10.1071/WF08133; Bradstock RA, 1998, J ENVIRON MANAGE, V52, P259, DOI 10.1006/jema.1997.0177; Cary GJ, 2009, INT J WILDLAND FIRE, V18, P147, DOI 10.1071/WF07085; CBC, 2007, CAL BUILD COD MAT CO, V1 of 2; Chen SH, 2012, ENVIRON MODELL SOFTW, V37, P134, DOI 10.1016/j.envsoft.2012.03.012; Cohen JD, 2004, CAN J FOREST RES, V34, P1616, DOI 10.1139/X04-049; Cohen JD, 2000, J FOREST, V98, P15; Collins BM, 2007, LANDSCAPE ECOL, V22, P545, DOI 10.1007/s10980-006-9047-5; Collins L, 2013, INT J IN PRESS  0403; Dennison PE, 2008, INT J WILDLAND FIRE, V17, P18, DOI 10.1071/WF07017; Dennison PE, 2009, INT J WILDLAND FIRE, V18, P1021, DOI 10.1071/WF08055; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Finney M.A., 1998, FARSITE FIRE AREA SI; Finney MA, 2001, FOREST SCI, V47, P219; Fule PZ, 2012, FOREST ECOL MANAG, V269, P68, DOI 10.1016/j.foreco.2011.12.025; Ganewatta G., 2008, Community bushfire safety, P151; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Gill AM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034014; Hammer RB, 2007, INT J WILDLAND FIRE, V16, P255, DOI 10.1071/WF05077; Hering AS, 2009, ENVIRON ECOL STAT, V16, P225, DOI 10.1007/s10651-007-0080-6; Hirsch KG, 2004, CAN J FOREST RES, V34, P705, DOI [10.1139/x03-237, 10.1139/X03-237]; Hirsch KG, 1998, FOREST SCI, V44, P539; Johnson S, 2010, ECOL MODEL, V221, P641, DOI 10.1016/j.ecolmodel.2009.11.012; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2003, ECOL STU AN, V160, P218; Keeley JE, 2004, J FOREST, V102, P26; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2013, NATURAL DISASTERS AND ADAPTATION TO CLIMATE CHANGE, P42; Keeley JE, 2009, J FOREST, V107, P287; Keeley JE, 2009, ECOL APPL, V19, P69, DOI 10.1890/08-0281.1; Korb KB, 2011, COMPUTER SCI DATA AN; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Langley AK, 2005, FIRE TECHNOL, V41, P125, DOI 10.1007/s10694-005-6387-7; Leonard J., 2009, REPORT 2009 VICTORIA; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; McCaffrey SM, 2009, J FOREST, V107, P9; McFarlane AC, 1997, SOC PSYCH PSYCH EPID, V32, P261, DOI 10.1007/BF00789038; McLennan J, 2013, FIRE SAFETY J, V61, P175, DOI 10.1016/j.firesaf.2013.09.003; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Moritz MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041735; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Papadatou D, 2012, J TRAUMA STRESS, V25, P57, DOI 10.1002/jts.21656; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; Penman TD, 2014, ENVIRON MODELL SOFTW, V52, P166, DOI 10.1016/j.envsoft.2013.09.030; Penman TD, 2013, J ENVIRON MANAGE, V131, P325, DOI 10.1016/j.jenvman.2013.10.007; Penman TD, 2013, INT J WILDLAND FIRE, V22, P469, DOI 10.1071/WF12027; Penman TD, 2011, INT J WILDLAND FIRE, V20, P909, DOI 10.1071/WF10076; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; Plucinski MP, 2012, INT J WILDLAND FIRE, V21, P219, DOI 10.1071/WF11063; Plucinski MP, 2012, FOREST SCI, V58, P390, DOI 10.5849/forsci.10-096; Price OF, 2013, NATURAL HAZARDS ENV, V1, P4539; Price OE, 2012, J ENVIRON MANAGE, V113, P301, DOI 10.1016/j.jenvman.2012.08.042; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Price OF, 2010, INT J WILDLAND FIRE, V19, P35, DOI 10.1071/WF08167; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Standards Australia, 2009, AS39592009 SAI GLOB, P129; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Syphard AD, 2012, PLOS ONE, V7; Syphard AD, 2008, INT J WILDLAND FIRE, V17, P602, DOI 10.1071/WF07087; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071708; Syphard AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033954; Syphard AD, 2011, INT J WILDLAND FIRE, V20, P764, DOI 10.1071/WF10065; Syphard AD, 2011, FOREST ECOL MANAG, V261, P2038, DOI 10.1016/j.foreco.2011.02.030; Syphard AD, 2011, INT J WILDLAND FIRE, V20, P364, DOI 10.1071/WF09125; Thompson JR, 2009, FOREST ECOL MANAG, V258, P1684, DOI 10.1016/j.foreco.2009.07.031	78	27	27	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111414	10.1371/journal.pone.0111414	http://dx.doi.org/10.1371/journal.pone.0111414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360741	Green Published, gold			2022-12-26	WOS:000343943700101
J	Schrameyer, V; Wangpraseurt, D; Hill, R; Kuhl, M; Larkum, AWD; Ralph, PJ				Schrameyer, Verena; Wangpraseurt, Daniel; Hill, Ross; Kuehl, Michael; Larkum, Anthony W. D.; Ralph, Peter J.			Light Respiratory Processes and Gross Photosynthesis in Two Scleractinian Corals	PLOS ONE			English	Article							INORGANIC CARBON CONCENTRATION; REEF-BUILDING CORALS; STYLOPHORA-PISTILLATA; SYMBIODINIUM SP; SEA-WATER; CALCIFICATION; PHOTOINHIBITION; ZOOXANTHELLAE; MECHANISMS; SYMBIONTS	The light dependency of respiratory activity of two scleractinian corals was examined using O-2 microsensors and CO2 exchange measurements. Light respiration increased strongly but asymptotically with elevated irradiance in both species. Light respiration in Pocillopora damicornis was higher than in Pavona decussata under low irradiance, indicating species-specific differences in light-dependent metabolic processes. Overall, the coral P. decussata exhibited higher CO2 uptake rates than P. damicornis over the experimental irradiance range. P. decussata also harboured twice as many algal symbionts and higher total protein biomass compared to P. damicornis, possibly resulting in self-shading of the symbionts and/or changes in host tissue specific light distribution. Differences in light respiration and CO2 availability could be due to host-specific characteristics that modulate the symbiont microenvironment, its photosynthesis, and hence the overall performance of the coral holobiont.	[Schrameyer, Verena; Wangpraseurt, Daniel; Hill, Ross; Kuehl, Michael; Larkum, Anthony W. D.; Ralph, Peter J.] Univ Technol Sydney, Sch Environm, Ultimo, NSW, Australia; [Hill, Ross] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney Inst Marine Sci, Sydney, NSW, Australia; [Kuehl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuehl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Sch Biol Sci, Singapore 639798, Singapore	University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kuhl, M (corresponding author), Univ Technol Sydney, Sch Environm, Ultimo, NSW, Australia.	a.larkum@sydney.edu.au	Hill, Ross/E-6075-2013; Ralph, Peter J/C-5029-2009; Kühl, Michael/A-1977-2009; Ralph, Peter/L-1527-2019	Hill, Ross/0000-0002-4623-1563; Ralph, Peter J/0000-0002-3103-7346; Kühl, Michael/0000-0002-1792-4790; Ralph, Peter/0000-0002-3103-7346; Wangpraseurt, Daniel/0000-0003-4834-8981	Australian Research Council [DP110105200]; Danish Council for Independent Research\ Natural Science; University of Technology, Sydney	Australian Research Council(Australian Research Council); Danish Council for Independent Research\ Natural Science(Det Frie Forskningsrad (DFF)); University of Technology, Sydney	This work was funded by grant #DP110105200 awarded by the Australian Research Council, http://www.arc.gov.au to PR and the Danish Council for Independent Research vertical bar Natural Science, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council- 1/the-danish-council-for-independent-research-natural-sciences to MK, as well as Postgraduate scholarships from the University of Technology, Sydney to VS and DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 2013, AQUAT BIOL, V18, P125, DOI 10.3354/ab00496; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2009, J PHYCOL, V45, P357, DOI 10.1111/j.1529-8817.2009.00659.x; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Furla P, 2000, J EXP BIOL, V203, P3445; Gattuso JP, 1999, AM ZOOL, V39, P160; GLUD RN, 1992, J PHYCOL, V28, P51, DOI 10.1111/j.0022-3646.1992.00051.x; Godish T., 2004, AIR QUALITY, V4th; Goiran C, 1996, J EXP MAR BIOL ECOL, V199, P207, DOI 10.1016/0022-0981(95)00201-4; Graham D, 1976, AUSTR J PLANT PHYSL, V3, P153; Hennige SJ, 2011, MAR BIOL, V158, P2515, DOI 10.1007/s00227-011-1752-1; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Hill R, 2012, CORAL REEFS, V31, P963, DOI 10.1007/s00338-012-0914-z; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; Hill R, 2009, B MAR SCI, V85, P223; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; JENSEN J, 1989, FEMS MICROBIOL ECOL, V62, P29, DOI 10.1111/j.1574-6968.1989.tb03655.x; JOKIEL PL, 1986, MAR BIOL, V91, P15, DOI 10.1007/BF00397566; Kramer WE, 2012, PHOTOCHEM PHOTOBIOL, V88, P398, DOI 10.1111/j.1751-1097.2011.01048.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Leggat W, 2002, FUNCT PLANT BIOL, V29, P309, DOI 10.1071/PP01202; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lilley RM, 2010, PLANT CELL ENVIRON, V33, P995, DOI 10.1111/j.1365-3040.2010.02121.x; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Muller-Parker Gisele, 1997, P96; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Muscatine L., 1990, P75; Parys E, 2006, J PLANT PHYSIOL, V163, P638, DOI 10.1016/j.jplph.2005.05.009; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Pernice M, 2012, ISME J, V6, P1314, DOI 10.1038/ismej.2011.196; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; RANDS ML, 1993, P ROY SOC B-BIOL SCI, V253, P161, DOI 10.1098/rspb.1993.0097; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P225; Raven JA, 1992, BIOL PLANTS; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; Reynaud S, 2002, MAR ECOL PROG SER, V238, P81, DOI 10.3354/meps238081; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Schrameyer V, 2013, DEFINING BIOENERGETI; Schreiber U, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P813; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tremblay P, 2014, CORAL REEFS, V33, P1, DOI 10.1007/s00338-013-1100-7; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Wangpraseurt D, 2014, J EXP BIOL, V217, P489, DOI 10.1242/jeb.091116; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; WEIS VM, 1993, J EXP MAR BIOL ECOL, V174, P209, DOI 10.1016/0022-0981(93)90018-J; WHITNEY SM, 1995, J PHYCOL, V31, P138, DOI 10.1111/j.0022-3646.1995.00138.x; Yellowlees D, 2003, PHOTOSYNTHESIS ALGAE; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	77	18	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110814	10.1371/journal.pone.0110814	http://dx.doi.org/10.1371/journal.pone.0110814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360746	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700047
J	Yoon, SJ; Kim, DH; Nam, GE; Yoon, YJ; Han, KD; Jung, DW; Park, SW; Kim, YE; Lee, SH; Lee, SS; Kim, YH				Yoon, Su-Jung; Kim, Do-Hoon; Nam, Ga-Eun; Yoon, Yeo-Joon; Han, Kyung-Do; Jung, Dong-Wook; Park, Sang-Woon; Kim, Young-Eun; Lee, Sung-Ho; Lee, Sang-Su; Kim, Yang-Hyun			Prevalence and Control of Hypertension and Albuminuria in South Korea: Focus on Obesity and Abdominal Obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ISOLATED SYSTOLIC HYPERTENSION; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; BODY-MASS INDEX; BLOOD-PRESSURE; METABOLIC SYNDROME; RENAL-FUNCTION; INCIDENT MICROALBUMINURIA	Background: Albuminuria is associated with cardiovascular disease, and the relationship between albuminuria and hypertension is well established in many studies. So the control of hypertension is critical for decreasing cardiovascular events and albuminuria. Obesity and abdominal obesity are also associated with hypertension and albuminuria. Therefore, we analyzed the relationship between albuminuria and the prevalence and control of hypertension in the general Korean population according to obesity status. Methods: We analyzed data from the 2011-2012 Korea National Health and Nutrition Examination Survey, and 9,519 subjects were included. Subjects were divided into four groups: non-obese/normal waist circumference, non-obese/high waist circumference, obese/normal waist circumference, and obese/high waist circumference. Results: Systolic blood pressure and diastolic blood pressure were positively associated with albumin-creatinine ratio in all groups (all p values <0.005). Non-obese/normal waist circumference group were more likely to have hypertension (odds ratios [95% confidential intervals (CIs)] were 3.20 [2.21-4.63] in microalbuminuria level and 3.09 [1.05-9.14] in macroalbuminuria level), and less likely to have controlled hypertension (odds ratios <1 for both albuminuria levels) after adjusting for all covariates. Obese/normal waist circumference group were also more likely to have hypertension (odds ratio [95% CI] were 3.10 [1.56-6.15] in microalbuminuria level and 21.75 [3.66-129.04] in macroalbuminuria level), and less likely to have controlled hypertension in macroalbuminuria level (odds ratio [95% CI], 0.04 [0.01-0.15]). Conclusions: Non-obese and normal waist circumference subjects have an increased prevalence and decreased control of hypertension in microalbuminuria and macroalbuminuria levels. Screening for albuminuria may provide helpful information about hypertension and blood pressure control, particularly in the non-obese and normal waist circumference subjects.	[Yoon, Su-Jung; Kim, Do-Hoon; Nam, Ga-Eun; Yoon, Yeo-Joon; Jung, Dong-Wook; Park, Sang-Woon; Kim, Young-Eun; Lee, Sung-Ho; Lee, Sang-Su; Kim, Yang-Hyun] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Kyung-Do] Catholic Univ, Coll Med, Dept Med Stat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea	Kim, YH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.	mrchir@naver.com	Nam, Ga Eun/AAA-1577-2021; Nam, Ga Eun/AAU-6055-2020	Nam, Ga Eun/0000-0002-6739-9904; Kim, Yang-Hyun/0000-0003-3548-8758; Kim, Do Hoon/0000-0001-7421-4501; Kim, Young-Eun/0000-0003-0694-6844				Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; ASSMANN G, 1989, AM J CARDIOL, V63, pH33; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bianchi S, 1999, AM J KIDNEY DIS, V34, P973, DOI 10.1016/S0272-6386(99)70002-8; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Chico A, 2005, ENDOCRINE, V27, P213, DOI 10.1385/ENDO:27:3:213; Chobanian AV, 2007, NEW ENGL J MED, V357, P789, DOI 10.1056/NEJMcp071137; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi HJ, 2012, KOREAN J FAM MED, V33, P330, DOI 10.4082/kjfm.2012.33.6.330; Cirillo M, 2000, KIDNEY INT, V58, P1211, DOI 10.1046/j.1523-1755.2000.00276.x; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deen WM, 2004, J CLIN INVEST, V114, P1412, DOI 10.1172/JCI200423577; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Flack JM, 2007, VASC HEALTH RISK MAN, V3, P1029; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta NK, 2012, J AM COLL CARDIOL, V60, P1148, DOI 10.1016/j.jacc.2012.04.050; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hoffmann IS, 2001, J HUM HYPERTENS, V15, P407, DOI 10.1038/sj.jhh.1001193; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Kim BJ, 2007, CIRC J, V71, P1283, DOI 10.1253/circj.71.1283; Kim BJ, 2011, J HYPERTENS, V29, P2091, DOI 10.1097/HJH.0b013e32834b5627; Kim YS, 2013, HYPERTENS RES, V36, P807, DOI 10.1038/hr.2013.44; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Knight EL, 2003, AM J KIDNEY DIS, V41, P588, DOI 10.1053/ajkd.2003.50120; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lin WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047960; Liu XF, 2013, HYPERTENS RES, V36, P1100, DOI 10.1038/hr.2013.87; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Mohamed-Ali V, 1999, AM J PHYSIOL-ENDOC M, V277, pE971, DOI 10.1152/ajpendo.1999.277.6.E971; Nam GE, 2013, J WOMENS HLTH LARCHM; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Pini R, 2002, J AM COLL CARDIOL, V40, P1283, DOI 10.1016/S0735-1097(02)02159-9; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Roest M, 2001, CIRCULATION, V103, P3057, DOI 10.1161/hc2501.091353; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Rutkowski B, 2013, NEPHROL DIAL TRANSPL, V28, P204, DOI 10.1093/ndt/gft328; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Shin DI, 2013, J KOREAN MED SCI, V28, P252, DOI 10.3346/jkms.2013.28.2.252; Smulyan H, 1997, J AM COLL CARDIOL, V29, P1407, DOI 10.1016/S0735-1097(97)00081-8; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Weir Matthew R, 2004, J Clin Hypertens (Greenwich), V6, P134; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; WILLIAMS SA, 1990, CLIN SCI, V79, P5, DOI 10.1042/cs0790005; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yuyun MF, 2005, CURR OPIN NEPHROL HY, V14, P271, DOI 10.1097/01.mnh.0000165895.90748.3b; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	71	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111179	10.1371/journal.pone.0111179	http://dx.doi.org/10.1371/journal.pone.0111179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360593	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700071
J	Singh, I; Bard, I; Jackson, J				Singh, Ilina; Bard, Imre; Jackson, Jonathan			Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement among University Students in the UK and Ireland	PLOS ONE			English	Article							HEALTHY-INDIVIDUALS; STIMULANT USE; ADHD; NEUROENHANCEMENT; CHALLENGES; MOTIVES; MISUSE; USERS; DRUGS	Use of 'smart drugs' among UK students is described in frequent media reports as a rapidly increasing phenomenon. This article reports findings from the first large-scale survey of pharmacological cognitive enhancement (PCE) among students in the UK and Ireland. Conducted from February to September 2012, a survey of a convenience sample of 877 students measured PCE prevalence, attitudes, sources, purposes and ethics. Descriptive and logistic regression statistical methods were used to analyse the data. Lifetime prevalence of PCE using modafinil, methylphenidate or Adderall was under 10%, while past regular and current PCE users of these substances made up between 0.3%-4% of the survey population. A substantial majority of students was unaware of and/or uninterested in PCE; however about one third of students were interested in PCE. PCE users were more likely to be male, British and older students; predictors of PCE use included awareness of other students using PCEs, ADHD symptomatology, ethical concerns, and alcohol and cannabis use. The survey addresses the need for better evidence about PCE prevalence and practices among university students in the UK. We recommend PCE-related strategies for universities based on the survey findings.	[Singh, Ilina] Kings Coll London, Dept Social Sci Hlth & Med, London, England; [Bard, Imre; Jackson, Jonathan] London Sch Econ & Polit Sci, Dept Methodol, London, England	University of London; King's College London; University of London; London School Economics & Political Science	Singh, I (corresponding author), Kings Coll London, Dept Social Sci Hlth & Med, London, England.	ilina.singh@kcl.ac.uk	Bard, Imre/I-2073-2019; Jackson, Jonathan/C-5156-2008	Bard, Imre/0000-0001-6395-0335; Jackson, Jonathan/0000-0003-2426-2219; Singh, Ilina/0000-0003-4497-3587	LSE Sticerd Foundation; LSE Personal Research Fund	LSE Sticerd Foundation; LSE Personal Research Fund	The survey was funded by the LSE Sticerd Foundation and LSE Personal Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, SKY NEWS        0928; [Anonymous], 2013, AUSTRALIAN; Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; DeSantis A, 2010, J DRUG EDUC, V40, P157, DOI 10.2190/DE.40.2.d; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; DeSantis AD, 2010, SUBST USE MISUSE, V45, P31, DOI 10.3109/10826080902858334; Eickenhorst P, 2012, J PSYCHOACTIVE DRUGS, V44, P418, DOI 10.1080/02791072.2012.736845; EMCDDA, 2002, HDB SURV DRUG US GEN; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Hildt E., 2013, COGNITIVE ENHANCEMEN; Holloway K, 2012, DRUG-EDUC PREV POLIC, V19, P137, DOI 10.3109/09687637.2011.594114; Ilumle T., 2010, STUDY DRUGS VINDER F; Italian Committee for Bioethics,, 2013, NEUR PHARM COGN ENH; Lennard N., 2009, VARSITY STUDENT 0306; Ly C, 2013, PSYCHIAT RES, V210, P1310, DOI 10.1016/j.psychres.2013.08.003; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Parliamentary Office of Science and Technology (POST), 2007, BETT BRAINS NO 285; Partridge B.J., 2013, COGNITIVE ENHANCEMEN, V1, P39, DOI DOI 10.1007/978-94-007-6253-4_; Paton G., 2013, TELEGRAPH; Peterkin AL, 2010, J ATTEN DISORD, DOI [10.1177/1089054710365980, DOI 10.1177/1089054710365980]; Pustovrh T, 2014, NEUROETHICS-NETH, V7, P137, DOI 10.1007/s12152-013-9192-x; Ragan CI, 2013, NEUROPHARMACOLOGY, V64, P588, DOI 10.1016/j.neuropharm.2012.06.016; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Scheske C, 2012, BASIC APPL SOC PSYCH, V34, P508, DOI 10.1080/01973533.2012.711692; Singh I, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0385-0; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; The President's Council on Bioethics, 2003, THER BIOT PURS HAPP; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Workman TA, 2010, ASSESSING RISKS ISSU	33	101	104	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e105969	10.1371/journal.pone.0105969	http://dx.doi.org/10.1371/journal.pone.0105969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25356917	gold, Green Published			2022-12-26	WOS:000346765000001
J	Tao, SY; Duanmu, YQ; Dong, HB; Ni, YD; Chen, J; Shen, XZ; Zhao, RQ				Tao, Shiyu; Duanmu, Yongqian; Dong, Haibo; Ni, Yingdong; Chen, Jie; Shen, Xiangzhen; Zhao, Ruqian			High Concentrate Diet Induced Mucosal Injuries by Enhancing Epithelial Apoptosis and Inflammatory Response in the Hindgut of Goats	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; NF-KAPPA B; DAIRY-COWS; RUMEN; LIPOPOLYSACCHARIDE; ENDOTOXIN; EXPRESSION; HEALTH; CATTLE; COLON	Purpose: It is widely accepted that lipopolysaccharide and volatile fatty acids (VFA) accumulate in the digestive tract of ruminants fed diets containing high portions of grain. Compared to the ruminal epithelium, the hindgut epithelium is composed of a monolayer structure that is more "leaky'' for lipopolysaccharide and susceptible to organic acid-induced damage. The aim of this study was to investigate changes in epithelial structure, apoptosis and inflammatory response in the hindgut of goats fed a high-concentrate diet for 6 weeks. Experimental Design: Eight local Chinese goats with rumen cannulas were randomly assigned to two groups: one group was fed a high-concentrate diet (65% concentrate of dry matter, HC) and the other group was fed a low-concentrate diet (35% concentrate of dry matter, LC) for 6 wks. Ruminal fluid, plasma, and hindgut mucosa tissues were collected. Histological techniques, real-time PCR and western blotting were used to evaluate the tissues structure, cell apoptosis and local inflammation in the hindguts. Results: Feeding HC diet for 6 wks resulted in a significant decrease of ruminal pH (p<0.01), and ruminal lipopolysaccharide concentrations were significantly increased in HC goats (p<0.05). Obvious damage was observed to mucosal epithelium of the hindgut and the intercellular tight junctions in HC, but not in LC, goats. The expression of MyD88 and caspase-8 mRNA was increased in colonic epithelium of HC goats compared to LC (p<0.05), and the expression of TLR-4 and caspase-3 showed a tendency to increase. In the cecum, interleukin-1 beta mRNA expression was decreased (p<0.05), and caspase-3 showed a potential increase (p = 0.07) in HC goats. The level of NF-kB protein was increased in colonic epithelium of HC goats. Caspase-3 activity was elevated in both colon and cecum, whereas caspase-8 activity was statistically increased only in colon. Conclusions: Feeding a high-concentrate diet to goats for 6 wks led to hindgut mucosal injuries via activating epithelial cells apoptosis and local inflammatory response.	[Tao, Shiyu; Duanmu, Yongqian; Dong, Haibo; Ni, Yingdong; Chen, Jie; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Inst Small Anim Dis, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Ni, YD (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Minist Agr, Nanjing, Jiangsu, Peoples R China.	niyingdong@njau.edu.cn		Tao, Shiyu/0000-0003-2600-3309; Dong, Haibo/0000-0001-6520-3739	National Basic Research Program of China [2011CB100802]; National Nature Science Foundation of China [31272470]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (Project No. 2011CB100802) and National Nature Science Foundation of China (Project No. 31272470) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2009, P JPN ACAD A-MATH, V85, P216, DOI 10.2183/pjab.85.216; ANDERSEN PH, 1994, ACTA VET SCAND, V35, P223; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Chin AC, 2006, CAN J PHYSIOL PHARM, V84, P1043, DOI 10.1139/Y06-056; ELAM CJ, 1976, J ANIM SCI, V43, P898, DOI 10.2527/jas1976.434898x; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Emmanuel DGV, 2007, J DAIRY SCI, V90, P5552, DOI 10.3168/jds.2007-0257; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; GAEBEL G, 1989, Q J EXP PHYSIOL CMS, V74, P35, DOI 10.1113/expphysiol.1989.sp003237; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gozho GN, 2005, J DAIRY SCI, V88, P1399, DOI 10.3168/jds.S0022-0302(05)72807-1; Graham C, 2005, AM J PHYSIOL-REG I, V288, pR173, DOI 10.1152/ajpregu.00425.2004; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081602; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Khafipour E, 2009, J DAIRY SCI, V92, P1712, DOI 10.3168/jds.2008-1656; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Klevenhusen F, 2013, J DAIRY SCI, V96, P2293, DOI 10.3168/jds.2012-6187; Krause KM, 2005, J DAIRY SCI, V88, P3633, DOI 10.3168/jds.S0022-0302(05)73048-4; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Li S, 2012, J DAIRY SCI, V95, P294, DOI 10.3168/jds.2011-4447; Liu JH, 2013, AM J PHYSIOL-REG I, V305, pR232, DOI 10.1152/ajpregu.00068.2013; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; MacCallum A, 2005, MICROBIOL-SGM, V151, P2451, DOI 10.1099/mic.0.27950-0; Metzler-Zebeli BU, 2013, J ANIM SCI, V91, P4256, DOI 10.2527/jas.2012-5570; Metzler-Zebeli BU, 2013, ANAEROBE, V20, P65, DOI 10.1016/j.anaerobe.2013.02.005; MOTOI Y, 1993, J VET MED SCI, V55, P19, DOI 10.1292/jvms.55.19; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Penner GB, 2011, J ANIM SCI, V89, P1108, DOI 10.2527/jas.2010-3378; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Plaizier JC, 2012, ANIM FEED SCI TECH, V172, P9, DOI 10.1016/j.anifeedsci.2011.12.004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Satoh M, 2008, INNATE IMMUN-LONDON, V14, P51, DOI 10.1177/1753425907087267; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; Yue C, 2012, INFLAMMATION, V35, P1880, DOI 10.1007/s10753-012-9510-1; Zebeli Q, 2012, RES VET SCI, V93, P1099, DOI 10.1016/j.rvsc.2012.02.004; Zebeli Q, 2009, J DAIRY SCI, V92, P3800, DOI 10.3168/jds.2009-2178; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	48	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111596	10.1371/journal.pone.0111596	http://dx.doi.org/10.1371/journal.pone.0111596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356790	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000071
J	Guo, JT; Zhang, JH; Zhang, XJ; Zhang, ZM; Wei, XD; Zhou, XY				Guo, Jitao; Zhang, Jianhua; Zhang, Xuejie; Zhang, Zhongmei; Wei, Xundong; Zhou, Xuyu			Constitutive Activation of MEK1 Promotes Treg Cell Instability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Cell Signaling; Immunology; Inflammation; T Cell; Treg Cell; Instability; Foxp3; COT; MEK; ERK	REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; CIS-ELEMENT; CORD BLOOD; EXPRESSION; DIFFERENTIATION; GENERATION; INHIBITION; DISRUPTION; MECHANISMS	The instability of regulatory T (Treg) cells is involved in the pathogenesis of autoimmune diseases and also highlights safety concerns with regard to clinical Treg cell therapy. Cell-intrinsic molecular events linked to this Treg cell instability in vivo cells, which leads to safety concerns regardingare still obscure. Here we developed a novel luciferase-based reporter system and performed an unbiased screening for kinases that potentially modulate Foxp3 function. We found that the active form of COT/Tpl2 specifically inhibits the DNA binding activity of Foxp3 through a MEK-ERK-dependent pathway. Moreover, Treg cell-specific expression of activated MEK1 led to dysregulation of Treg function and instability of Foxp3 expression in vivo. Our results support the hypothesis that outside inflammatory signals act through the COT/Tpl2-MEK-ERK signaling pathway to destabilize the Treg lineage.	[Guo, Jitao; Zhang, Jianhua; Zhang, Xuejie; Zhang, Zhongmei; Wei, Xundong; Zhou, Xuyu] Chinese Acad Sci CASPMI, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhou, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhouxy@im.ac.cn	Guo, Jitao/AAP-4971-2020; Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; zhang, zhongmei/0000-0001-7450-8040; Guo, Jitao/0000-0002-0927-4249	National Key Basic Research and Development 973 Program of China [2012CB917102]; National Natural Science Foundation of China [31070804]; China Postdoctoral Science Foundation [2011M500422]	National Key Basic Research and Development 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Key Basic Research and Development 973 Program of China Grant 2012CB917102, by National Natural Science Foundation of China Grant 31070804, and by China Postdoctoral Science Foundation Grant 2011M500422.	Bagnyukova TV, 2013, BRIT J CANCER, V109, P1063, DOI 10.1038/bjc.2013.353; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lin J, 2001, J CELL SCI, V114, P243; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mocci S, 2000, CURR OPIN IMMUNOL, V12, P725, DOI 10.1016/S0952-7915(00)00169-2; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	43	10	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35139	35148		10.1074/jbc.M114.589192	http://dx.doi.org/10.1074/jbc.M114.589192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25361764	Green Published, hybrid			2022-12-26	WOS:000346660200008
J	Romero-Saavedra, F; Laverde, D; Wobser, D; Michaux, C; Budin-Verneuil, A; Bernay, B; Benachour, A; Hartke, A; Huebner, J				Romero-Saavedra, Felipe; Laverde, Diana; Wobser, Dominique; Michaux, Charlotte; Budin-Verneuil, Aurelie; Bernay, Benoit; Benachour, Abdellah; Hartke, Axel; Huebner, Johannes			Identification of Peptidoglycan-Associated Proteins as Vaccine Candidates for Enterococcal Infections	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; PREDICTING SUBCELLULAR-LOCALIZATION; PENICILLIN-BINDING PROTEINS; GROUP-A STREPTOCOCCUS; CELL-WALL ENVELOPE; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; RESISTANT ENTEROCOCCI; FAECIUM; FAECALIS	Infections by opportunistic bacteria have significant contributions to morbidity and mortality of hospitalized patients and also lead to high expenses in healthcare. In this setting, one of the major clinical problems is caused by Gram-positive bacteria such as enterococci and staphylococci. In this study we extract, purify, identify and characterize immunogenic surface-exposed proteins present in the vancomycin resistant enterococci (VRE) strain Enterococcus faecium E155 using three different extraction methods: trypsin shaving, biotinylation and elution at high pH. Proteomic profiling was carried out by gel-free and gel-nanoLC-MS/MS analyses. The total proteins found with each method were 390 by the trypsin shaving, 329 by the elution at high pH, and 45 using biotinylation. An exclusively extracytoplasmic localization was predicted in 39 (10%) by trypsin shaving, in 47 (15%) by elution at high pH, and 27 (63%) by biotinylation. Comparison between the three extraction methods by Venn diagram and subcellular localization predictors (CELLO v.2.5 and Gpos-mPLoc) allowed us to identify six proteins that are most likely surface-exposed: the SCP-like extracellular protein, a low affinity penicillin-binding protein 5 (PBP5), a basic membrane lipoprotein, a peptidoglycan-binding protein LysM (LysM), a D-alanyl-D-alanine carboxypeptidase (DdcP) and the peptidyl-prolyl cis-trans isomerase (PpiC). Due to their close relationship with the peptidoglycan, we chose PBP5, LysM, DdcP and PpiC to test their potential as vaccine candidates. These putative surface-exposed proteins were overexpressed in Escherichia coli and purified. Rabbit polyclonal antibodies raised against the purified proteins were able to induce specific opsonic antibodies that mediated killing of the homologous strain E. faecium E155 as well as clinical strains E. faecium E1162, Enterococcus faecalis 12030, type 2 and type 5. Passive immunization with rabbit antibodies raised against these proteins reduced significantly the colony counts of E. faecium E155 in mice, indicating the effectiveness of these surface-related proteins as promising vaccine candidates to target different enterococcal pathogens.	[Romero-Saavedra, Felipe; Laverde, Diana; Wobser, Dominique; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Romero-Saavedra, Felipe; Laverde, Diana; Michaux, Charlotte; Budin-Verneuil, Aurelie; Benachour, Abdellah; Hartke, Axel] Univ Caen Lower Normandy, EA4655 U2RM Stress Virulence, Caen, France; [Huebner, Johannes] Univ Munich, Dr Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany; [Bernay, Benoit] Univ Caen Lower Normandy, Proteogen Platform SFR ICORE 4206, Caen, France; [Huebner, Johannes] German Ctr Infect Res DZIF, Munich, Germany	University of Freiburg; Universite de Caen Normandie; University of Munich; Universite de Caen Normandie; German Center for Infection Research	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@med.uni-muenchen.de		Michaux, Charlotte/0000-0003-1089-7846; Huebner, Johannes/0000-0003-1232-4646; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X				Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Assaad U, 2012, CLIN INTERV AGING, V7, P453, DOI 10.2147/CIA.S29675; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Burnie J, 2002, FEMS IMMUNOL MED MIC, V33, P179, DOI 10.1111/j.1574-695X.2002.tb00589.x; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; GILLIS TP, 1985, INFECT IMMUN, V49, P371, DOI 10.1128/IAI.49.2.371-377.1985; Giombini E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-39; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; Hempel K, 2010, J PROTEOME RES, V9, P1579, DOI 10.1021/pr901143a; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2003, INT J FOOD MICROBIOL, V88, P263, DOI 10.1016/S0168-1605(03)00189-2; Hyyrylainen HL, 2010, MOL MICROBIOL, V77, P108, DOI 10.1111/j.1365-2958.2010.07188.x; Janulczyk R, 2001, INFECT IMMUN, V69, P4019, DOI 10.1128/IAI.69.6.4019-4026.2001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kropec A, 2011, MICROBIOL-SGM, V157, P3429, DOI 10.1099/mic.0.053207-0; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; Modun B, 1999, INFECT IMMUN, V67, P1086, DOI 10.1128/IAI.67.3.1086-1092.1999; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Morsczeck C, 2008, CLIN MICROBIOL INFEC, V14, P74, DOI 10.1111/j.1469-0691.2007.01878.x; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Olaya-Abril A, 2014, J PROTEOMICS, V97, P164, DOI 10.1016/j.jprot.2013.03.035; Olaya-Abril A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070365; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Repp C, 2012, ENTEROCOCCUS SAFETY, P305; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P39, DOI 10.1093/protein/gzl053; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07; Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; Werner G., 2008, EURO SURVEILL, V13, P19046; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zarb P, 2012, EURO SURVEILL, P17; Zervosen A, 2012, MOLECULES, V17, P12478, DOI 10.3390/molecules171112478; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000	73	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111880	10.1371/journal.pone.0111880	http://dx.doi.org/10.1371/journal.pone.0111880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369230	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000118
J	Gopal, A; Iyer, SC; Gopal, U; Devaraj, N; Halagowder, D				Gopal, Ashidha; Iyer, Soumya Chidambaram; Gopal, Udhayakumar; Devaraj, Niranjali; Halagowder, Devaraj			Shigella dysenteriae Modulates BMP Pathway to Induce Mucin Gene Expression In Vivo and In Vitro	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN CDX2; EPITHELIAL-CELLS; REGULATE CDX2; BILE-ACIDS; ACTIVATION; INFECTION; MUC5AC; MODEL; PATHOGENESIS; METAPLASIA	Mucosal epithelial cells in the intestine act as the first line of host defense against pathogens by increasing mucin production for clearance. Despite this fact, the underlying molecular mechanisms by which Shigella dysenteriae transduce mucin gene expression remain poorly defined. The goal of this study was to determine the role of Bone morphogenetic protein (BMP) pathway in mucin gene expression during S. dysenteriae infection. In this study we demonstrate that S. dysenteriae activates BMP signaling to induce MUC2 and MUC5AC gene expression in rat ileal loop model and in vitro. We also observed that BMP pathway regulates CDX2 expression which plays a critical role in induction of MUC2 gene during S. dysenteriae infection. In SMAD4 silenced cells S. dysenteriae infection did not abrogate MUC2 and MUC5AC gene expression whereas in CDX2 silenced cells it induces differential expression of MUC5AC gene. These results suggest that SMAD4-CDX2 induces MUC2 gene expression whereas SMAD4 directly influences differential expression of MUC5AC gene. Altogether, our results show that during S. dysenteriae infection the BMP pathway modulates inflammatory transcription factors CDX2 and SMAD4 to induce MUC2 and MUC5AC gene expression which plays a key role in the regulation of host mucosal defense thereby paving a cue for therapeutic application.	[Gopal, Ashidha; Iyer, Soumya Chidambaram; Halagowder, Devaraj] Univ Madras, Dept Zool, Sch Life Sci, Biochem Unit, Madras 600025, Tamil Nadu, India; [Gopal, Udhayakumar] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Devaraj, Niranjali] Univ Madras, Dept Biochem, Madras 600025, Tamil Nadu, India	University of Madras; Duke University; University of Madras	Halagowder, D (corresponding author), Univ Madras, Dept Zool, Sch Life Sci, Biochem Unit, Guindy Campus, Madras 600025, Tamil Nadu, India.	hdrajum@yahoo.com	Gopal, Udhayakumar/K-9092-2019		Department of Biotechnology [BT/PR1440/AAQ/03/532/2010]	Department of Biotechnology	The authors acknowledge Department of Biotechnology Project No. BT/PR1440/AAQ/03/532/2010 for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARM HG, 1965, J BACTERIOL, V89, P803, DOI 10.1128/JB.89.3.803-809.1965; Barros R, 2008, J PATHOL, V215, P411, DOI 10.1002/path.2369; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Camilo V, 2012, CARCINOGENESIS, V33, P1985, DOI 10.1093/carcin/bgs233; Castillo D, 2012, J GASTROINTEST SURG, V16, P227, DOI 10.1007/s11605-011-1758-5; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Fernandez MI, 2003, CELL MICROBIOL, V5, P481, DOI 10.1046/j.1462-5822.2003.00295.x; Forgue-Lafitte ME, 2007, INT J CANCER, V121, P1543, DOI 10.1002/ijc.22865; Hasnain SZ, 2011, PARASITE IMMUNOL, V33, P45, DOI 10.1111/j.1365-3024.2010.01258.x; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hong SM, 2005, AM J CLIN PATHOL, V124, P361, DOI 10.1309/GTU1Y77MVR4DX5A2; Ikeda H, 2007, LAB INVEST, V87, P559, DOI 10.1038/labinvest.3700556; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; Raja SB, 2012, J CELL SCI, V125, P703, DOI 10.1242/jcs.092148; Shimada T, 2007, REGUL PEPTIDES, V140, P81, DOI 10.1016/j.regpep.2006.11.014; Takeda K, 2010, PARASITE IMMUNOL, V32, P420, DOI 10.1111/j.1365-3024.2010.01200.x; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2	37	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111408	10.1371/journal.pone.0111408	http://dx.doi.org/10.1371/journal.pone.0111408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365201	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100065
J	Hui, FR; Nguyen, CTO; Bedggood, PA; He, Z; Fish, RL; Gurrell, R; Vingrys, AJ; Bui, BV				Hui, Flora; Nguyen, Christine T. O.; Bedggood, Phillip A.; He, Zheng; Fish, Rebecca L.; Gurrell, Rachel; Vingrys, Algis J.; Bui, Bang V.			Quantitative Spatial and Temporal Analysis of Fluorescein Angiography Dynamics in the Eye	PLOS ONE			English	Article							RETINAL BLOOD-FLOW; VEIN OCCLUSION; OCULAR FUNDUS; CIRCULATION; DISEASE; MICROANEURYSMS; QUANTIFICATION; PRESSURE; GLAUCOMA; RATS	Purpose: We describe a novel approach to analyze fluorescein angiography to investigate fluorescein flow dynamics in the rat posterior retina as well as identify abnormal areas following laser photocoagulation. Methods: Experiments were undertaken in adult Long Evans rats. Using a rodent retinal camera, videos were acquired at 30 frames per second for 30 seconds following intravenous introduction of sodium fluorescein in a group of control animals (n = 14). Videos were image registered and analyzed using principle components analysis across all pixels in the field. This returns fluorescence intensity profiles from which, the half-rise (time to 50% brightness), half-fall (time for 50% decay) back to an offset (plateau level of fluorescence). We applied this analysis to video fluorescein angiography data collected 30 minutes following laser photocoagulation in a separate group of rats (n = 7). Results: Pixel-by-pixel analysis of video angiography clearly delineates differences in the temporal profiles of arteries, veins and capillaries in the posterior retina. We find no difference in half-rise, half-fall or offset amongst the four quadrants (inferior, nasal, superior, temporal). We also found little difference with eccentricity. By expressing the parameters at each pixel as a function of the number of standard deviation from the average of the entire field, we could clearly identify the spatial extent of the laser injury. Conclusions: This simple registration and analysis provides a way to monitor the size of vascular injury, to highlight areas of subtle vascular leakage and to quantify vascular dynamics not possible using current fluorescein angiography approaches. This can be applied in both laboratory and clinical settings for in vivo dynamic fluorescent imaging of vasculature.	[Hui, Flora; Nguyen, Christine T. O.; Bedggood, Phillip A.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Fish, Rebecca L.; Gurrell, Rachel] Pfizer Res & Dev, Neusentis, Cambridge, England	University of Melbourne; Pfizer	Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	bvb@unimelb.edu.au	Hui, Flora/Z-5420-2019; Bui, Bang/AAD-2679-2021	Hui, Flora/0000-0003-2218-9951; Bui, Bang/0000-0001-7298-1352; Bedggood, Phillip/0000-0001-5144-3694; Nguyen, Christine/0000-0002-3298-3086; Vingrys, Algis/0000-0001-5920-4604; He, Zheng/0000-0001-6496-3971	Australia Research Council [LP100200129, FT130100388]	Australia Research Council(Australian Research Council)	RLF and RG are employees of Pfizer Neusentis and Pfizer Global Research and Development. CTN, PAB, AJV and BVB are employees of University of Melbourne, supported by Australia Research Council Linkage Project Grant (LP100200129). FH received an Australian postgraduate award. BVB received an Australia Research Council Future Fellowship (FT130100388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abelsdorff G, 1909, VOGEL ARCH AUGENHEIL, V64, P65; Arend O, 2004, BRAIN RES BULL, V62, P517, DOI 10.1016/j.brainresbull.2003.07.008; Arend O, 2002, BRIT J OPHTHALMOL, V86, P429, DOI 10.1136/bjo.86.4.429; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; Comander J, 2011, SEMIN OPHTHALMOL, V26, P329, DOI 10.3109/08820538.2011.588661; DAVID NJ, 1967, ARCH OPHTHALMOL-CHIC, V77, P619; FFYTCHE TJ, 1980, J ROY SOC MED, V73, P362, DOI 10.1177/014107688007300512; Guthrie MJ, 2014, MICROVASC RES, V91, P1, DOI 10.1016/j.mvr.2013.11.005; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HICKAM JB, 1966, CIRCULATION, V33, P302, DOI 10.1161/01.CIR.33.2.302; HILL DW, 1970, BRIT MED BULL, V26, P161, DOI 10.1093/oxfordjournals.bmb.a070769; Hipwell JH, 1998, PHYSIOL MEAS, V19, P165, DOI 10.1088/0967-3334/19/2/004; Hong BK, 2013, CAN J OPHTHALMOL, V48, P489, DOI 10.1016/j.jcjo.2013.05.009; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ieki Y, 2002, CURR EYE RES, V25, P317, DOI 10.1076/ceyr.25.5.317.13490; KOHNER EM, 1970, BRIT MED BULL, V26, P166, DOI 10.1093/oxfordjournals.bmb.a070770; Kong Mingui, 2012, Korean J Ophthalmol, V26, P428, DOI 10.3341/kjo.2012.26.6.428; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; KOYAMA T, 1990, GRAEF ARCH CLIN EXP, V228, P442, DOI 10.1007/BF00927258; Lee J, 2014, INVEST OPHTH VIS SCI, V55, P2191, DOI 10.1167/iovs.14-13897; Leskova W, 2013, INVEST OPHTH VIS SCI, V54, P2992, DOI 10.1167/iovs.13-11915; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Nagai N, 2014, INVEST OPHTHALMOL VI; NH&MRC, 2013, AUSTR COD CAR US AN; Nichols JJ, 2012, INVEST OPHTH VIS SCI, V53, P5426, DOI 10.1167/iovs.12-10033; Patel M, 2014, CURR OPIN OPHTHALMOL, V25, P213, DOI 10.1097/ICU.0000000000000042; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Richard G., 1990, FLUORESCEIN ANGIOGRA; SCOTT D J, 1963, Br J Ophthalmol, V47, P588, DOI 10.1136/bjo.47.10.588; Spencer T, 1996, COMPUT BIOMED RES, V29, P284, DOI 10.1006/cbmr.1996.0021; SPENCER T, 1992, GRAEF ARCH CLIN EXP, V230, P36, DOI 10.1007/BF00166760; Sun C, 2013, EXP EYE RES, V113, P105, DOI 10.1016/j.exer.2013.05.018; Canas RV, 2012, P I MECH ENG C-J MEC, V226, P2521, DOI 10.1177/0954406211435195; VIDT DG, 1959, CIRC RES, V7, P759, DOI 10.1161/01.RES.7.5.759; WOLF S, 1989, GRAEF ARCH CLIN EXP, V227, P145, DOI 10.1007/BF02169788; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	39	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111330	10.1371/journal.pone.0111330	http://dx.doi.org/10.1371/journal.pone.0111330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365578	Green Published, gold			2022-12-26	WOS:000345558100061
J	Mandal, A; Mandal, S; Park, MH				Mandal, Ajeet; Mandal, Swati; Park, Myung Hee			Genome-Wide Analyses and Functional Classification of Proline Repeat-Rich Proteins: Potential Role of eIF5A in Eukaryotic Evolution	PLOS ONE			English	Article							ELONGATION-FACTOR-P; FACTOR EF-P; SYNTHESIS INITIATION-FACTORS; AMINO-ACID; POSTTRANSLATIONAL SYNTHESIS; DEOXYHYPUSINE HYDROXYLASE; PROMOTES TRANSLATION; FACTOR 5A; HYPUSINE; RESOURCE	The eukaryotic translation factor, eIF5A has been recently reported as a sequence-specific elongation factor that facilitates peptide bond formation at consecutive prolines in Saccharomyces cerevisiae, as its ortholog elongation factor P (EF-P) does in bacteria. We have searched the genome databases of 35 representative organisms from six kingdoms of life for PPP (Pro-Pro- Pro) and/or PPG (Pro-Pro-Gly)-encoding genes whose expression is expected to depend on eIF5A. We have made detailed analyses of proteome data of 5 selected species, Escherichia coli, Saccharomyces cerevisiae, Drosophila melanogaster, Mus musculus and Homo sapiens. The PPP and PPG motifs are low in the prokaryotic proteomes. However, their frequencies markedly increase with the biological complexity of eukaryotic organisms, and are higher in newly derived proteins than in those orthologous proteins commonly shared in all species. Ontology classifications of S. cerevisiae and human genes encoding the highest level of polyprolines reveal their strong association with several specific biological processes, including actin/cytoskeletal associated functions, RNA splicing/turnover, DNA binding/transcription and cell signaling. Previously reported phenotypic defects in actin polarity and mRNA decay of eIF5A mutant strains are consistent with the proposed role for eIF5A in the translation of the polyproline-containing proteins. Of all the amino acid tandem repeats (>= 3 amino acids), only the proline repeat frequency correlates with functional complexity of the five organisms examined. Taken together, these findings suggest the importance of proline repeat-rich proteins and a potential role for eIF5A and its hypusine modification pathway in the course of eukaryotic evolution.	[Mandal, Ajeet; Mandal, Swati; Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Park, MH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	mhpark@nih.gov			intramural program of the National Institute of Dental and Craniofacial Research; National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	intramural program of the National Institute of Dental and Craniofacial Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by the intramural program of the National Institute of Dental and Craniofacial Research, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; BENNE R, 1978, J BIOL CHEM, V253, P3078; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; de Almeida OP, 2014, CURR PHARM DESIGN, V20, P284; DEVER TE, 2014, CRIT REV BIOCHEM MOL, P1; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elam WA, 2013, PROTEIN SCI, V22, P405, DOI 10.1002/pro.2217; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; KANG HA, 1994, J BIOL CHEM, V269, P3934; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; LI T, 2014, GENETICS; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SIEVERT H, 2014, DIS MODEL MECH; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wang DY, 2005, MOL BIOL EVOL, V22, P142, DOI 10.1093/molbev/msh263; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	57	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111800	10.1371/journal.pone.0111800	http://dx.doi.org/10.1371/journal.pone.0111800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364902	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100123
J	Sitges, M; Gomez, CD; Aldana, BI				Sitges, Maria; Gomez, Carlos D.; Aldana, Blanca I.			Sertraline Reduces IL-1 beta and TNF-alpha mRNA Expression and Overcomes Their Rise Induced by Seizures in the Rat Hippocampus	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INFLAMMATORY CYTOKINES; DEPRESSION; EPILEPSY; PATHOPHYSIOLOGY; INHIBITION; MECHANISM; MODELS; DRUGS; EEG	We recently discovered that the antidepressant sertraline is an effective inhibitor of hippocampus presynaptic Na+ channel permeability in vitro and of tonic-clonic seizures in animals in vivo. Several studies indicate that the pro-inflammatory cytokines in the central nervous system are increased in epilepsy and depression. On the other hand inhibition of Na+ channels has been shown to decrease pro-inflammatory cytokines in microglia. Therefore, the possibility that sertraline could overcome the rise in pro-inflammatory cytokine expression induced by seizures has been investigated. For this purpose, IL-1 beta and TNF-alpha mRNA expression was determined by RT-PCR in the hippocampus of rats administered once, or for seven consecutive days with sertraline at a low dose (0.75 mg/kg). The effect of sertraline at doses within the range of 0.75 to 25 mg/kg on the increase in IL-1 beta and TNF-alpha mRNA expression accompanying generalized tonic-clonic seizures, and increase in the pro-inflammatory cytokines expression induced by lipopolysaccharide was also investigated. We found that under basal conditions, a single 0.75 mg/kg sertraline dose decreased IL-1 beta mRNA expression, and also TNF-alpha expression after repeated doses. The increase in IL-1 beta and TNF-alpha expression induced by the convulsive agents and by the inoculation of lipopolysaccharide in the hippocampus was markedly reduced by sertraline also. Present results indicate that a reduction of brain inflammatory processes may contribute to the anti-seizure sertraline action, and that sertraline can be safely and successfully used at low doses to treat depression in epileptic patients.	[Sitges, Maria; Gomez, Carlos D.; Aldana, Blanca I.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Sitges, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico.	sitges@biomedicas.unam.mx		Aldana, Blanca/0000-0002-5027-1218; Gomez, Carlos/0000-0002-7065-8612	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico [IN200614]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was financially supported by project IN200614 from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico. Carlos D. Gomez and Blanca I. Aldana are PhD students in the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and were awarded with a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana BI, 2012, J NEUROCHEM, V121, P197, DOI 10.1111/j.1471-4159.2012.07674.x; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; FIESCHI C, 1980, LIFE SCI, V27, P239, DOI 10.1016/0024-3205(80)90143-5; Galvan E, 2004, NEUROCHEM RES, V29, P347, DOI 10.1023/B:NERE.0000013737.17288.ce; Hamid H, 2013, EPILEPSY BEHAV, V26, P261, DOI 10.1016/j.yebeh.2012.10.009; Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Janssen DGA, 2010, HUM PSYCHOPHARM CLIN, V25, P201, DOI 10.1002/hup.1103; Kanner AM, 2008, CURR OPIN NEUROL, V21, P190, DOI 10.1097/WCO.0b013e3282f4e978; Kanner AM, 2010, EPILEPSY BEHAV, V19, P156, DOI 10.1016/j.yebeh.2010.06.024; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; MACDONALD RL, 1977, NATURE, V267, P720, DOI 10.1038/267720a0; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Maes M, 1993, Rev Neurosci, V4, P407; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mula M, 2012, NAT REV NEUROL, V8, P252, DOI 10.1038/nrneurol.2012.69; Noe KH, 2011, CURR TREAT OPTION NE, V13, P371, DOI 10.1007/s11940-011-0127-8; Plata-Salaman CR, 2000, MOL BRAIN RES, V75, P248, DOI 10.1016/S0169-328X(99)00306-X; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Sheehan DV, 2009, INT CLIN PSYCHOPHARM, V24, P43, DOI 10.1097/YIC.0b013e3282f4b616; Sinha S, 2008, EPILEPSY RES, V82, P171, DOI 10.1016/j.eplepsyres.2008.07.018; Sitges M, 2011, EPILEPSY RES, V96, P257, DOI 10.1016/j.eplepsyres.2011.06.006; Sitges M, 2012, EPILEPSY BEHAV, V25, P511, DOI 10.1016/j.yebeh.2012.09.005; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Stevanovic D, 2011, EPILEPSIA, V52, pE75, DOI 10.1111/j.1528-1167.2011.03133.x; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002	38	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111665	10.1371/journal.pone.0111665	http://dx.doi.org/10.1371/journal.pone.0111665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364907	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100099
J	Venkata, C; Forster, MJ; Howe, PWA; Steinbeck, C				Venkata, Chandrasekhar; Forster, Mark J.; Howe, Peter W. A.; Steinbeck, Christoph			The Potential Utility of Predicted One Bond Carbon-Proton Coupling Constants in the Structure Elucidation of Small Organic Molecules by NMR Spectroscopy	PLOS ONE			English	Article								NMR spectroscopy is the most popular technique used for structure elucidation of small organic molecules in solution, but incorrect structures are regularly reported. One-bond proton-carbon J-couplings provide additional information about chemical structure because they are determined by different features of molecular structure than are proton and carbon chemical shifts. However, these couplings are not routinely used to validate proposed structures because few software tools exist to predict them. This study assesses the accuracy of Density Functional Theory for predicting them using 396 published experimental observations from a diverse range of small organic molecules. With the B3LYP functional and the TZVP basis set, Density Functional Theory calculations using the open-source software package NWChem can predict one-bond CH J-couplings with good accuracy for most classes of small organic molecule. The root-mean-square deviation after correction is 1.5 Hz for most sp(3) CH pairs and 1.9 Hz for sp(2) pairs; larger errors are observed for sp(3) pairs with multiple electronegative substituents and for sp pairs. These results suggest that prediction of one-bond CH J-couplings by Density Functional Theory is sufficiently accurate for structure validation. This will be of particular use in strained ring systems and heterocycles which have characteristic couplings and which pose challenges for structure elucidation.	[Venkata, Chandrasekhar; Steinbeck, Christoph] European Bioinformat Inst, Cambridge, England; [Forster, Mark J.] Syngenta, Jealotts Hill Res Ctr, Chem Res, Bracknell, Berks, England; [Howe, Peter W. A.] Syngenta, Jealotts Hill Res Ctr, Prod Safety, Bracknell, Berks, England	European Molecular Biology Laboratory (EMBL); Syngenta; Syngenta	Howe, PWA (corresponding author), Syngenta, Jealotts Hill Res Ctr, Prod Safety, Bracknell, Berks, England.	peter.howe@syngenta.com		Steinbeck, Christoph/0000-0001-6966-0814; Nainala, Venkata Chandrasekhar/0000-0002-2564-3243	Syngenta	Syngenta(Syngenta)	CV's internship at the EBI was funded by Syngenta. Syngenta approved the publication of this manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	BARFIELD M, 1973, CHEM REV, V73, P53, DOI 10.1021/cr60281a004; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Crews P., 2009, ORGANIC STRUCTURE AN; Dracinsky M, 2010, J CHEM THEORY COMPUT, V6, P288, DOI 10.1021/ct900498b; Elyashberg M, 2012, MAGN RESON CHEM, V50, P22, DOI 10.1002/mrc.2849; Elyashberg M, 2010, NAT PROD REP, V27, P1296, DOI 10.1039/c002332a; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; HANSEN PE, 1981, PROG NUCL MAG RES SP, V14, P175, DOI 10.1016/0079-6565(81)80001-5; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Harris R., 1986, NUCL MAGNETIC RESONA; Helgaker T, 2008, PROG NUCL MAG RES SP, V53, P249, DOI 10.1016/j.pnmrs.2008.02.002; Kalinowski H.O., 1988, CARBON 13 NMR SPECTR; LUNAZZI L, 1967, SPECTROCHIM ACTA A-M, VA 23, P841, DOI 10.1016/0584-8539(67)80011-4; Macias FA, 1998, PHYTOCHEMISTRY, V48, P631, DOI 10.1016/S0031-9422(97)00995-3; MACIEL GE, 1970, J AM CHEM SOC, V92, P11, DOI 10.1021/ja00704a002; MALINOWSKI E, 1961, J AM CHEM SOC, V83, P4479, DOI 10.1021/ja01482a050; MALINOWSKI ER, 1962, J AM CHEM SOC, V84, P2649, DOI 10.1021/ja00872a041; Maximoff SN, 2005, J CHEM THEORY COMPUT, V1, P541, DOI 10.1021/ct050083f; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1012, DOI 10.1002/anie.200460864; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Sahakyan AB, 2008, MAGN RESON CHEM, V46, P63, DOI 10.1002/mrc.2137; Sakuno E, 2000, J NAT PROD, V63, P1677, DOI 10.1021/np000194w; San Fabian J, 2013, MAGN RESON CHEM, V51, P775, DOI 10.1002/mrc.4014; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; SZALONTAI G, 1983, TETRAHEDRON, V39, P1783, DOI 10.1016/S0040-4020(01)88688-9; Takikawa H, 2003, TETRAHEDRON LETT, V44, P7023, DOI 10.1016/S0040-4039(03)01782-9; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wipf P, 2003, J NAT PROD, V66, P716, DOI 10.1021/np0300277; Yu BW, 2012, J MAGN RESON, V215, P10, DOI 10.1016/j.jmr.2011.09.037; Zhang Y, 2004, P UK E SCI ALL HANDS, P930	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e11157	10.1371/journal.pone.0111576	http://dx.doi.org/10.1371/journal.pone.0111576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365289	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100079
J	Monti, S; Palma, G; Ragucci, M; Mannelli, L; Mancini, M; Prinster, A				Monti, Serena; Palma, Giuseppe; Ragucci, Monica; Mannelli, Lorenzo; Mancini, Marcello; Prinster, Anna			Optimization of Tagged MRI for Quantification of Liver Stiffness Using Computer Simulated Data	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATIC-FIBROSIS; NONINVASIVE ASSESSMENT; MOTION; CIRRHOSIS; TRACKING; IMAGES; HEART	The heartbeat has been proposed as an intrinsic source of motion that can be used in combination with tagged Magnetic Resonance Imaging (MRI) to measure displacements induced in the liver as an index of liver stiffness. Optimizing a tagged MRI acquisition protocol in terms of sensitivity to these displacements, which are in the order of pixel size, is necessary to develop the method as a quantification tool for staging fibrosis. We reproduced a study of cardiac-induced strain in the liver at 3T and simulated tagged MR images with different grid tag patterns to evaluate the performance of the Harmonic Phase (HARP) image analysis method and its dependence on the parameters of tag spacing and grid angle. The Partial Volume Effect (PVE), T1 relaxation, and different levels of noise were taken into account. Four displacement fields of increasing intensity were created and applied to the tagged MR images of the liver. These fields simulated the deformation at different liver stiffnesses. An Error Index (EI) was calculated to evaluate the estimation accuracy for various parameter values. In the absence of noise, the estimation accuracy of the displacement fields increased as tag spacings decreased. EIs for each of the four displacement fields were lower at 0 degrees and the local minima of the EI were found to correspond to multiples of pixel size. The accuracy of the estimation decreased for increasing levels of added noise; as the level increased, the improved estimation caused by decreasing the tag spacing tended to zero. The optimal tag spacing turned out to be a compromise between the smallest tag period that is a multiple of the pixel size and is achievable in a real acquisition and the tag spacing that guarantees an accurate liver displacement measure in the presence of realistic levels of noise.	[Monti, Serena; Ragucci, Monica; Prinster, Anna] IRCCS SDN Fdn, Naples, Italy; [Palma, Giuseppe; Mancini, Marcello; Prinster, Anna] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Mannelli, Lorenzo] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Memorial Sloan Kettering Cancer Center	Monti, S (corresponding author), IRCCS SDN Fdn, Naples, Italy.	smonti@sdn-napoli.it	Monti, Serena/C-1062-2015; Prinster, Anna/AAW-3129-2020; Palma, Giuseppe/AAX-1413-2020; Prinster, Anna/B-8414-2015; Mannelli, Lorenzo/A-7165-2012; Palma, Giuseppe/GXV-0228-2022	Monti, Serena/0000-0002-8777-7837; Prinster, Anna/0000-0003-2706-3071; Mannelli, Lorenzo/0000-0002-9102-4176; Palma, Giuseppe/0000-0002-0210-268X				ATALAR E, 1994, IEEE T MED IMAGING, V13, P152, DOI 10.1109/42.276154; AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Chung S, 2014, J MAGN RESON IMAGING, V39, P1301, DOI 10.1002/jmri.24260; Chung SH, 2011, MAGN RESON MED, V65, P949, DOI 10.1002/mrm.22785; Crum WR, 1997, JMRI-J MAGN RESON IM, V7, P416, DOI 10.1002/jmri.1880070228; Crum WR, 1998, J MAGN RESON IMAGING, V8, P1040, DOI 10.1002/jmri.1880080507; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Kim BH, 2011, J MAGN RESON IMAGING, V34, P1110, DOI 10.1002/jmri.22723; KUMAR S, 1994, IEEE T MED IMAGING, V13, P122, DOI 10.1109/42.276150; Mannelli L, 2012, J MAGN RESON IMAGING, V36, P1490, DOI 10.1002/jmri.23743; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Montillo A, 2004, PRO BIOMED OPT IMAG, V5, P1, DOI 10.1117/12.536860; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Papoulis A., 1991, PROBABILITY RANDOM V, V3; REEDER SB, 1994, MAGNET RESON MED, V31, P521, DOI 10.1002/mrm.1910310508; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Rustogi R, 2012, J MAGN RESON IMAGING, V35, P1356, DOI 10.1002/jmri.23585; Ryf S, 2002, P INT SOC MAG RESON, V10; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111852	10.1371/journal.pone.0111852	http://dx.doi.org/10.1371/journal.pone.0111852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360557	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700154
J	Caierao, J; Hawkins, P; Sant'anna, FH; da Cunha, GR; d'Azevedo, PA; McGee, L; Dias, C				Caierao, Juliana; Hawkins, Paulina; Sant'anna, Fernando Hayashi; da Cunha, Gabriela Rosa; d'Azevedo, Pedro Alves; McGee, Lesley; Dias, Cicero			Serotypes and Genotypes of Invasive Streptococcus pneumoniae Before and After PCV10 Implementation in Southern Brazil	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; CLONE ST320; DISEASE; CHILDREN; CARRIAGE; 19A; POPULATION; MENINGITIS	To reduce the burden of pneumococcal diseases, different formulations of pneumococcal conjugate vaccines (PCV) have been introduced in many countries. In Brazil, PCV10 has been available since 2010. We aimed to analyze the serotype and genetic composition of invasive pneumococci from Brazil in pre- and post-vaccination periods (2007-2012). Antibiotic susceptibility was determined and genotypes of macrolide and fluoroquinolone resistance were characterized. The genotypes of isolates of the most frequent serotypes were determined by multilocus sequence typing. The study included 325 isolates, which were primarily recovered from blood. The most common serotypes recovered were 14, 3, 4, 23F, 7F, 9V, 12F, 20, 19F, 8, 19A, and 5. Thirty-eight pneumococci (11.7%) were from children <= 5 years old. Considering the overall population, PCV10 and PCV13 serotype coverage was 50.1% and 64.9%, respectively. During the pre-vaccine period, isolates with serotypes belonging to the PVC10 represented 51.5% (100/194), whereas in the post vaccine they represented 48.0% (63/131). PCV13 serotypes represented 67.5% (131/194) and 59.2% (77/131) of total for pre- and post-vaccination periods, respectively. Seventy different sequence types [STs] were found, accounting for 9 clonal complexes [CCs] and 45 singletons. Eight STs (156, 180, 218, 8889, 53, 191, 770, and 4967) represented the majority (51.5%) of isolates. Fifty STs were associated with the pre-vaccination period (27 exclusive) and 43 (20 exclusive) with the post-vaccination period; 23 STs were identified in both periods. Some serotypes were particularly clonal (7F, 8, 12F, 20). Non-susceptibility to penicillin was associated with serotype 19A, CC320. Erythromycin resistance was heterogeneous when considering serotype and ST. A single serotype 23F (ST4967) isolate was resistant to levofloxacin. Continued surveillance is required to determine vaccine impact and to monitor changes in pneumococcal population biology post-PCV10 introduction in Brazil.	[Caierao, Juliana; Sant'anna, Fernando Hayashi; da Cunha, Gabriela Rosa; d'Azevedo, Pedro Alves; Dias, Cicero] Fed Univ Hlth Sci, Porto Alegre, RS, Brazil; [Hawkins, Paulina] Emory Univ, Atlanta, GA 30322 USA; [McGee, Lesley] Ctr Dis Control & Prevent, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Dias, C (corresponding author), Fed Univ Hlth Sci, Porto Alegre, RS, Brazil.	cicero@ufcspa.edu.br	Dias, Cicero A G/A-1451-2017; CAIERÃO, JULIANA/K-8038-2018; Sant'Anna, Fernando H Hayashi/I-9129-2016	Dias, Cicero A G/0000-0002-8358-1183; Sant'Anna, Fernando H Hayashi/0000-0001-7767-8168	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [CNPq: Edital MCT/CNPq14/2008, 473607/2008-5]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CNPq: Edital MCT/CNPq14/2008, 473607/2008-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Alvares JR, 2011, BRAZ J INFECT DIS, V15, P22, DOI 10.1590/S1413-86702011000100005; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Barroso DE, 2012, PEDIATR INFECT DIS J, V31, P30, DOI 10.1097/INF.0b013e31822f8a92; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Birtles A, 2005, J CLIN MICROBIOL, V43, P2004, DOI 10.1128/JCM.43.4.2004-2008.2005; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2002, ANTIMICROB AGENTS CH, V46, P680, DOI 10.1128/AAC.46.3.680-688.2002; Casado-Flores J, 2008, PEDIATR INFECT DIS J, V27, P1020, DOI 10.1097/INF.0b013e31817bd2dc; CLSI, 2013, PERFORMANCE STANDARD; de Quadros CA, 2009, VACCINE, V27, pC29, DOI 10.1016/j.vaccine.2009.06.006; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gene A, 2013, PEDIATR INFECT DIS J, V32, pE128, DOI 10.1097/INF.0b013e31827c54dc; Neves FPG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-318; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Inverarity D, 2011, T ROY SOC TROP MED H, V105, P445, DOI 10.1016/j.trstmh.2011.04.013; Inverarity D, 2011, J MED MICROBIOL, V60, P793, DOI 10.1099/jmm.0.028803-0; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Laval CB, 2006, CLIN MICROBIOL INFEC, V12, P50, DOI 10.1111/j.1469-0691.2005.01304.x; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Lucarevschi Bianca R., 2003, J. Pediatr. (Rio J.), V79, P215, DOI 10.1590/S0021-75572003000300006; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mendes C., 2003, Braz J Infect Dis, V7, P44, DOI 10.1590/S1413-86702003000100006; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; PAHO, 2013, INF REG SIREVA 2 201; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pimenta FC, 2011, J MED MICROBIOL, V60, P1455, DOI 10.1099/jmm.0.031450-0; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Rossi F, 2012, J BRAS PNEUMOL, V38, P66, DOI 10.1590/S1806-37132012000100010; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spellerberg B, 2011, MANUAL CLIN MICROBIO, P331; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; Vestrheim DF, 2010, VACCINE, V28, P2214, DOI 10.1016/j.vaccine.2009.12.054; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Widdowson CA, 1998, EMERG INFECT DIS, V4, P277, DOI 10.3201/eid0402.980216; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Zemlickova H, 2005, MICROB DRUG RESIST, V11, P195, DOI 10.1089/mdr.2005.11.195; Zulz T, 2013, J CLIN MICROBIOL, V51, P1402, DOI 10.1128/JCM.02880-12	55	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111129	10.1371/journal.pone.0111129	http://dx.doi.org/10.1371/journal.pone.0111129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356595	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000042
J	Dainty, JR; Berry, R; Lynch, SR; Harvey, LJ; Fairweather-Tait, SJ				Dainty, Jack R.; Berry, Rachel; Lynch, Sean R.; Harvey, Linda J.; Fairweather-Tait, Susan J.			Estimation of Dietary Iron Bioavailability from Food Iron Intake and Iron Status	PLOS ONE			English	Article							PLASMA FERRITIN CONCENTRATIONS; SERUM FERRITIN; NONHEME-IRON; ABSORPTION; DEFICIENCY; STORES; PREDICTION; ALGORITHM; EXCRETION; WOMEN	Currently there are no satisfactory methods for estimating dietary iron absorption (bioavailability) at a population level, but this is essential for deriving dietary reference values using the factorial approach. The aim of this work was to develop a novel approach for estimating dietary iron absorption using a population sample from a sub-section of the UK National Diet and Nutrition Survey (NDNS). Data were analyzed in 873 subjects from the 2000-2001 adult cohort of the NDNS, for whom both dietary intake data and hematological measures (hemoglobin and serum ferritin (SF) concentrations) were available. There were 495 men aged 19-64 y (mean age 42.7 +/- 12.1 y) and 378 pre-menopausal women (mean age 35.7 +/- 8.2 y). Individual dietary iron requirements were estimated using the Institute of Medicine calculations. A full probability approach was then applied to estimate the prevalence of dietary intakes that were insufficient to meet the needs of the men and women separately, based on their estimated daily iron intake and a series of absorption values ranging from 1-40%. The prevalence of SF concentrations below selected cut-off values (indicating that absorption was not high enough to maintain iron stores) was derived from individual SF concentrations. An estimate of dietary iron absorption required to maintain specified SF values was then calculated by matching the observed prevalence of insufficiency with the prevalence predicted for the series of absorption estimates. Mean daily dietary iron intakes were 13.5 mg for men and 9.8 mg for women. Mean calculated dietary absorption was 8% in men (50th percentile for SF 85 mu g/L) and 17% in women (50th percentile for SF 38 mu g/L). At a ferritin level of 45 mu g/L estimated absorption was similar in men (14%) and women (13%). This new method can be used to calculate dietary iron absorption at a population level using data describing total iron intake and SF concentration.	[Dainty, Jack R.; Berry, Rachel; Harvey, Linda J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lynch, Sean R.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Fairweather-Tait, Susan J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Eastern Virginia Medical School; University of East Anglia	Fairweather-Tait, SJ (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.fairweather-tait@uea.ac.uk		Dainty, Jack/0000-0002-0056-1233; Fairweather-Tait, Susan/0000-0002-1413-5569	UK Biotechnology and Biological Sciences Research Council; EURRECA Network of Excellence Sixth Framework Programme [036196]	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EURRECA Network of Excellence Sixth Framework Programme	This work was supported by UK Biotechnology and Biological Sciences Research Council (JRD), and EURRECA Network of Excellence (www.eurreca.org) Sixth Framework Programme, contract 036196 (RB, LJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; Armah SM, 2013, J NUTR, V143, P1136, DOI 10.3945/jn.112.169904; Beard JL, 2007, J NUTR, V137, P1741, DOI 10.1093/jn/137.7.1741; BEZWODA WR, 1979, SCAND J HAEMATOL, V22, P113; Bothwell T.H., 1979, IRON METABOLISM MAN; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; COOK JD, 1991, AM J CLIN NUTR, V54, P717, DOI 10.1093/ajcn/54.4.717; COOK JD, 1974, AM J CLIN NUTR, V27, P681, DOI 10.1093/ajcn/27.7.681; GREEN R, 1968, AM J MED, V45, P336, DOI 10.1016/0002-9343(68)90069-7; HALLBERG L, 1993, BRIT J HAEMATOL, V85, P787, DOI 10.1111/j.1365-2141.1993.tb03225.x; Hallberg L, 2000, AM J CLIN NUTR, V71, P1147; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; Hallberg L, 1998, EUR J CLIN NUTR, V52, P623, DOI 10.1038/sj.ejcn.1600623; Harvey LJ, 2013, CRIT REV FOOD SCI, V53, P1064, DOI 10.1080/10408398.2012.742860; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Hefnawi F, 1980, Int J Gynaecol Obstet, V17, P343; Henderson L., 2003, NATL DIET NUTR SURVE, V3, P14; Hoare J, 2004, NATL DIET NUTR SURVE, V5; Hunt JR, 2009, AM J CLIN NUTR, V89, P1792, DOI 10.3945/ajcn.2009.27439; Institute of Medicine, 2001, DIETARY REFERENCE IN; Lader D, 2009, 41 OFF NAT STAT OFF; LAYRISSE M, 1969, BLOOD-J HEMATOL, V33, P430, DOI 10.1182/blood.V33.3.430.430; LYNCH SR, 1989, BLOOD, V74, P2187; MAGNUSSON B, 1981, SCAND J HAEMATOL, V27, P201; MILMAN N, 1993, ACTA OBSTET GYN SCAN, V72, P601, DOI 10.3109/00016349309021150; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Roughead ZK, 2000, AM J CLIN NUTR, V72, P982; Ruston D, 2004, NUTR DIET NUTR SURVE; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Skouby SO, 2010, EUR J CONTRACEP REPR, V15, pS42, DOI 10.3109/13625187.2010.533002; TAYLOR P, 1988, J NUTR, V118, P1110, DOI 10.1093/jn/118.9.1110; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WALTERS GO, 1975, GUT, V16, P188, DOI 10.1136/gut.16.3.188; World Health Organization, 2001, IR DEF AN ASS PREV C; Zafon C, 2010, OBES REV, V11, P322, DOI 10.1111/j.1467-789X.2009.00638.x; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	39	27	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111824	10.1371/journal.pone.0111824	http://dx.doi.org/10.1371/journal.pone.0111824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356629	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000346765000079
J	Alamo, P; Gallardo, A; Di Nicolantonio, F; Pavon, MA; Casanova, I; Trias, M; Mangues, MA; Lopez-Pousa, A; Villaverde, A; Vazquez, E; Bardelli, A; Cespedes, MV; Mangues, R				Alamo, Patricia; Gallardo, Alberto; Di Nicolantonio, Federica; Pavon, Miguel Angel; Casanova, Isolda; Trias, Manuel; Mangues, Maria Antonia; Lopez-Pousa, Antonio; Villaverde, Antonio; Vazquez, Esther; Bardelli, Alberto; Cespedes, Maria Virtudes; Mangues, Ramon			Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model	FASEB JOURNAL			English	Article						KRas mutants; in vivo models aggressiveness	CHEMOKINE RECEPTOR CXCR4; LYMPH-NODE METASTASIS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; KIRSTEN RAS MUTATIONS; COLON-CANCER; KI-RAS; TUMOR-METASTASIS; POINT MUTATIONS; CELL-MIGRATION; NUDE-MICE	Although all KRas (protein that in humans is encoded by the KRas gene) point mutants are considered to have a similar prognostic capacity, their transformation and tumorigenic capacities vary widely. We compared the metastatic efficiency of KRas G12V (Kirsten rat sarcoma viral oncogene homolog with valine mutation at codon 12) and KRas G13D (Kirsten rat sarcoma viral oncogene homolog with aspartic mutation at codon 13) oncogenes in an orthotopic colorectal cancer (CRC) model. Following subcutaneous preconditioning, recombinant clones of the SW48 CRC cell line [ Kras wild- type (Kras WT)] expressing the KRas G12V or KRas G13D allele were microinjected in the mouse cecum. The percentage of animals developing lymph node metastasis was higher in KRas G12V than in KRas G13D mice. Microscopic, macroscopic, and visible lymphatic foci were 1.5- to 3.0- fold larger in KRas G12V than in KRas G13D mice (P < 0.05). In the lung, only microfoci were developed in both groups. KRas G12V primary tumors had lower apoptosis (7.0 6 1.2 vs. 7.4 6 1.0 per field, P = 0.02), higher tumor budding at the invasion front (1.2 6 0.2 vs. 0.6 6 0.1, P = 0.04), and a higher percentage of C- X- C chemokine receptor type 4 (CXCR4)- overexpressing intravasated tumor emboli (49.869.4% vs. 12.864.4%, P < 0.001) than KRas G13D tumors. KRas G12V primary tumors showed Akt activation, and b5 integrin, vascular endothelial growth factor A (VEGFA), and Serpine- 1 overexpression, whereas KRas G13D tumors showed integrin b1 and angiopoietin 2 (Angpt2) overexpression. The increased cell survival, invasion, intravasation, and specific molecular regulation observed in KRasG12Vtumors is consistent with the higher aggressiveness observed in patients with CRC expressing this oncogene.-	[Alamo, Patricia; Pavon, Miguel Angel; Casanova, Isolda; Cespedes, Maria Virtudes; Mangues, Ramon] Hosp Santa Creu & Sant Pau, Biomed Res Inst St Pau, Oncogenesis & Antitumor Drug Grp, Barcelona 08025, Spain; [Alamo, Patricia; Gallardo, Alberto; Pavon, Miguel Angel; Casanova, Isolda; Trias, Manuel; Lopez-Pousa, Antonio; Villaverde, Antonio; Vazquez, Esther; Cespedes, Maria Virtudes; Mangues, Ramon] CIBER Bioingn Biomat & Nanomed, Barcelona, Spain; [Gallardo, Alberto] Clin Girona, Dept Pathol, Girona, Spain; [Di Nicolantonio, Federica; Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy; [Di Nicolantonio, Federica; Bardelli, Alberto] Ist Ricovero & Cura Carattere Sci, Candiolo Canc Inst Fdn Piemonte Oncol, Turin, Italy; [Trias, Manuel] Hosp Santa Creu & Sant Pau, Dept General & Digest Surg, Barcelona, Spain; [Mangues, Maria Antonia] Hosp Santa Creu & Sant Pau, Dept Pharm, Barcelona, Spain; [Lopez-Pousa, Antonio] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain; [Villaverde, Antonio; Vazquez, Esther] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Bardelli, Alberto] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Bardelli, Alberto] FIRC, Inst Mol Oncol, Milan, Italy	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; IFOM - FIRC Institute of Molecular Oncology	Mangues, R (corresponding author), Hosp Santa Creu & Sant Pau, Biomed Res Inst St Pau IIB St Pau, C St Antoni Maria Claret,167, Barcelona 08025, Spain.	rmangues@santpau.cat	Mangues, Ramon/J-6396-2014; PAVON RIBAS, MIGUEL ANGEL/N-3538-2014; CASANOVA RIGAT, ISOLDA/I-5393-2014; Di Nicolantonio, Federica/A-2503-2011; Villaverde, Antonio/N-3986-2018; PAVON, MIGUEL ANGEL/N-3538-2014; BARDELLI, Alberto/J-9721-2018	Mangues, Ramon/0000-0003-2661-9525; PAVON RIBAS, MIGUEL ANGEL/0000-0003-3677-5329; CASANOVA RIGAT, ISOLDA/0000-0002-1196-4724; Di Nicolantonio, Federica/0000-0001-9618-2010; Villaverde, Antonio/0000-0002-2615-4521; Gallardo, Alberto/0000-0002-2514-2027; PAVON, MIGUEL ANGEL/0000-0001-7992-8626; Vazquez, Esther/0000-0003-1052-0424; Lopez Pousa, Antonio/0000-0003-1066-3951; BARDELLI, Alberto/0000-0003-1647-5070	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M; Alamo P, 2014, DIS MODEL MECH, V7, P387, DOI 10.1242/dmm.013995; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Cao YT, 2007, CANCER RES, V67, P3835, DOI 10.1158/0008-5472.CAN-06-4056; Cespedes M V, 2006, Clin Transl Oncol, V8, P318; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Defilles C, 2009, EXP CELL RES, V315, P1840, DOI 10.1016/j.yexcr.2009.03.014; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; Folkman J, 1983, Symp Fundam Cancer Res, V36, P201; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; George ML, 2001, NEOPLASIA, V3, P420, DOI 10.1038/sj.neo.7900186; Giger OT, 2012, MODERN PATHOL, V25, P1048, DOI 10.1038/modpathol.2012.56; Guerrero S, 2000, CANCER RES, V60, P6750; Guerrero S, 2002, FASEB J, V16, P1642, DOI 10.1096/fj.02-0050fje; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; Kazama S, 2006, BRIT J CANCER, V94, P293, DOI 10.1038/sj.bjc.6602927; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kye BH, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-16; Lee C.C., 2005, J CANC MOLECULES, V1, P26; Lim SB, 2010, DIS COLON RECTUM, V53, P377, DOI 10.1007/DCR.0b013e3181cf8ae5; Malinowsky K, 2014, BRIT J CANCER, V110, P2081, DOI 10.1038/bjc.2014.100; Margolin DA, 2011, NEOPLASIA, V13, P874, DOI 10.1593/neo.11324; Minami T, 2013, CELL REP, V4, P709, DOI 10.1016/j.celrep.2013.07.021; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; MOERKERK P, 1994, CANCER RES, V54, P3376; Monaco R, 1995, J PROTEIN CHEM, V14, P721, DOI 10.1007/BF01886911; Nielsen H, 1998, BRIT MED J, V316, P829, DOI 10.1136/bmj.316.7134.829; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Resch A, 2013, WORLD J GASTROENTERO, V19, P8515, DOI 10.3748/wjg.v19.i46.8515; Rigamonti N, 2013, CELL REP, V4, P621, DOI 10.1016/j.celrep.2013.07.034; Sakakibara T, 2005, BRIT J CANCER, V93, P799, DOI 10.1038/sj.bjc.6602743; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Son HJ, 2008, HEPATO-GASTROENTEROL, V55, P1293; Span M, 1996, INT J CANCER, V69, P241, DOI 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.3.CO;2-D; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yan ZF, 1997, J BIOL CHEM, V272, P30928, DOI 10.1074/jbc.272.49.30928; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshioka T, 2010, CANCER SCI, V101, P2011, DOI 10.1111/j.1349-7006.2010.01640.x; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zlobec I, 2014, BRIT J CANCER, V110, P1008, DOI 10.1038/bjc.2013.797	51	39	40	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					464	476		10.1096/fj.14-262303	http://dx.doi.org/10.1096/fj.14-262303			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25359494	Green Submitted			2022-12-26	WOS:000349370400012
J	Attarwala, AA; Molina-Duran, F; Busing, KA; Schonberg, SO; Bailey, DL; Willowson, K; Glatting, G				Attarwala, Ali Asgar; Molina-Duran, Flavia; Buesing, Karen-Anett; Schoenberg, Stefan O.; Bailey, Dale L.; Willowson, Kathy; Glatting, Gerhard			Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging	PLOS ONE			English	Article							INTERNAL PAIR PRODUCTION; HEPATOCELLULAR-CARCINOMA; RADIONUCLIDE THERAPY; COMPUTED-TOMOGRAPHY; DOSE-RESPONSE; MICROSPHERES; EMISSION; DOSIMETRY; TIME	Yttrium-90 is known to have a low positron emission decay of 32 ppm that may allow for personalized dosimetry of liver cancer therapy with Y-90 labeled microspheres. The aim of this work was to image and quantify Y-90 so that accurate predictions of the absorbed dose can be made. The measurements were performed within the QUEST study (University of Sydney, and Sirtex Medical, Australia). A NEMA IEC body phantom containing 6 fillable spheres (10-37 mm) was used to measure the Y-90 distribution with a Biograph mCT PET/CT (Siemens, Erlangen, Germany) with time-of-flight (TOF) acquisition. A sphere to background ratio of 8:1, with a total Y-90 activity of 3 GBq was used. Measurements were performed for one week (0, 3, 5 and 7 d). he acquisition protocol consisted of 30 min-2 bed positions and 120 min-single bed position. mages were reconstructed with 3D ordered subset expectation maximization (OSEM) and point spread function (PSF) for iteration numbers of 1-12 with 21 (TOF) and 24 (non-TOF) subsets and CT based attenuation and scatter correction. Convergence of algorithms and activity recovery was assessed based on regions-of-interest (ROI) analysis of the background (100 voxels), spheres (4 voxels) and the central low density insert (25 voxels). For the largest sphere, the recovery coefficient (RC) values for the 30 min-2-bed position, 30 min-single bed and 120 min-single bed were 1.12 +/- 0.20, 1.14 +/- 0.13, 0.97 +/- 0.07 respectively. For the smaller diameter spheres, the PSF algorithm with TOF and single bed acquisition provided a comparatively better activity recovery. Quantification of Y-90 using Biograph mCT PET/CT is possible with a reasonable accuracy, the limitations being the size of the lesion and the activity concentration present. At this stage, based on our study, it seems advantageous to use different protocols depending on the size of the lesion.	[Attarwala, Ali Asgar; Molina-Duran, Flavia; Glatting, Gerhard] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim, Germany; [Buesing, Karen-Anett; Schoenberg, Stefan O.] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Bailey, Dale L.] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia; [Willowson, Kathy] Univ Sydney, Sch Phys, Inst Med Phys, Sydney, NSW 2006, Australia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Royal North Shore Hospital; University of Sydney; University of Sydney	Glatting, G (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim, Germany.	gerhard.glatting@medma.uni-heidelberg.de	Bailey, Dale L/A-3359-2012; Glatting, Gerhard/ABF-2506-2020	Glatting, Gerhard/0000-0001-7916-1576	Sirtex (Sydney, Australia); "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research); Australian Research Council [LP110201109]	Sirtex (Sydney, Australia); "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research); Australian Research Council(Australian Research Council)	The studies reported in this publication were financially supported by Sirtex (Sydney, Australia), which is developing products related to research described in this publication. The authors (F.M. and G.G.) gratefully acknowledge a grant by the "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research). KW is supported by an Australian Research Council Linkage Grant (LP110201109), of which Sirtex is a contributor as one of the linkage partners. The funder provided support in the form of salaries for authors (KW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Attarwala, 2014, QUAL QUANT ASS YTTR; Berger F, 2002, EUR J NUCL MED MOL I, V29, P1225, DOI 10.1007/s00259-002-0850-1; Buther F, 2013, EUR J NUCL MED MOL I, V40, P602, DOI 10.1007/s00259-012-2313-7; Campbell JM, 2009, INT J RADIAT ONCOL, V74, P313, DOI 10.1016/j.ijrobp.2008.12.058; Carlier T, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-11; Cherubal S., 2006, Proceedings. 14th Asian Test Symposium, DOI 10.1007/0-387-34946-4_1; Clifford Mark A, 2002, Comput Aided Surg, V7, P291, DOI 10.3109/10929080209146038; D'Arienzo M, 2013, ATOMS, V1, P2, DOI 10.3390/atoms1010002; Elschot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055742; Elschot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026174; FORD KW, 1955, PHYS REV, V98, P1516, DOI 10.1103/PhysRev.98.1516; Garin E, 2013, EUR J NUCL MED MOL I, V40, P1057, DOI 10.1007/s00259-013-2395-x; Glatting G, 2011, Z MED PHYS, V21, P246, DOI 10.1016/j.zemedi.2011.07.005; Gobel T, 2013, Dtsch Med Wochenschr, V138, P1425, DOI 10.1055/s-0033-1343232; Goedicke A, 2013, IEEE T MED IMAGING, V32, P485, DOI 10.1109/TMI.2012.2221135; GREENBERG JS, 1956, PHYS REV, V102, P415, DOI 10.1103/PhysRev.102.415; Healthcare S, 2008, BIOGRAPH MCT TECHNOL; Jelic S, 2010, ANN ONCOL, V21, P59, DOI DOI 10.1093/ANN0NC/MDQ166); Kao YH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-57; Kao YH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-56; Kennedy AS, 2010, CANCER J, V16, P163, DOI 10.1097/PPO.0b013e3181d7e8cf; Kim Greer CNMT, 2002, NEMA IEC BOD PHANT U; Kucuk ON, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-86; Lambert B, 2010, ACTA GASTRO-ENT BELG, V73, P484; Lau WY, 2011, INT J RADIAT ONCOL, V81, P460, DOI 10.1016/j.ijrobp.2010.06.010; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Mamawan MD, 2013, J NUCL MED TECHNOL, V41, P42, DOI 10.2967/jnmt.112.114413; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; Minarik D, 2010, J NUCL MED, V51, P1974, DOI 10.2967/jnumed.110.079897; Molina-Duran F, 2014, Z MED PHYS, V24, P73, DOI [10.1016/j.zemedi.2013.03.002, 10.1016/j.zemedi.201.3.03.002]; Nickles RJ, 2004, ASSAYING PET IMAGING, V3416; Preylowski V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071729; Rietzel E, 2005, MED PHYS, V32, P874, DOI 10.1118/1.1869852; Selwyn RG, 2007, APPL RADIAT ISOTOPES, V65, P318, DOI 10.1016/j.apradiso.2006.08.009; Sirtex Technology Pty Ltd S A The University of Sydney and Royal North Shore Hospital, 2013, QUEST SIT ASS PROT S; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stubbs R S, 2004, HPB (Oxford), V6, P133, DOI 10.1080/13651820410025084; Walrand S, 2011, EUR J NUCL MED MOL I, V38, P57, DOI 10.1007/s00259-011-1771-7; Willowson K, 2012, MED PHYS, V39, P7153, DOI 10.1118/1.4762403; Wink NM, 2006, J APPL CLIN MED PHYS, V7, P77, DOI 10.1120/jacmp.2027.25373; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	41	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110401	10.1371/journal.pone.0110401	http://dx.doi.org/10.1371/journal.pone.0110401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369020	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000019
J	Geiger, TR; Ha, NH; Faraji, F; Michael, HT; Rodriguez, L; Walker, RC; Green, JE; Simpson, RM; Hunter, KW				Geiger, Thomas R.; Ngoc-Han Ha; Faraji, Farhoud; Michael, Helen T.; Rodriguez, Loren; Walker, Renard C.; Green, Jeffery E.; Simpson, R. Mark; Hunter, Kent W.			Functional Analysis of Prognostic Gene Expression Network Genes in Metastatic Breast Cancer Models	PLOS ONE			English	Article							KINASE AURORA-A; TPX2 GENE; CARCINOMA; TUMORS; SUSCEPTIBILITY; COMPLEX; PROTEIN; SYSTEM; TARGET; CELLS	Identification of conserved co-expression networks is a useful tool for clustering groups of genes enriched for common molecular or cellular functions [1]. The relative importance of genes within networks can frequently be inferred by the degree of connectivity, with those displaying high connectivity being significantly more likely to be associated with specific molecular functions [2]. Previously we utilized cross-species network analysis to identify two network modules that were significantly associated with distant metastasis free survival in breast cancer. Here, we validate one of the highly connected genes as a metastasis associated gene. Tpx2, the most highly connected gene within a proliferation network specifically prognostic for estrogen receptor positive (ER+) breast cancers, enhances metastatic disease, but in a tumor autonomous, proliferation-independent manner. Histologic analysis suggests instead that variation of TPX2 levels within disseminated tumor cells may influence the transition between dormant to actively proliferating cells in the secondary site. These results support the co-expression network approach for identification of new metastasis-associated genes to provide new information regarding the etiology of breast cancer progression and metastatic disease.	[Geiger, Thomas R.; Ngoc-Han Ha; Faraji, Farhoud; Michael, Helen T.; Rodriguez, Loren; Walker, Renard C.; Green, Jeffery E.; Simpson, R. Mark; Hunter, Kent W.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov	Faraji, Farhoud/AAG-2417-2019; Michael, Helen/GVS-8802-2022	Faraji, Farhoud/0000-0001-5078-813X; Michael, Helen/0000-0002-8326-0806	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010953, ZIGBC010931] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; [Anonymous], 2003, NATURE, V426, P789; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu Y, 2012, P NATL ACAD SCI USA, V109, P3184, DOI 10.1073/pnas.1117872109; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Liu HC, 2013, BIOMED PHARMACOTHER, V67, P751, DOI 10.1016/j.biopha.2013.04.004; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Neumayer G, 2014, CELL MOL LIFE SCI; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wei P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-313; Yan L, 2013, TUMOR BIOL, V34, P4089, DOI 10.1007/s13277-013-1000-z; Yang X, 2014, PATHOL ONCOL RES; Yao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045894	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111813	10.1371/journal.pone.0111813	http://dx.doi.org/10.1371/journal.pone.0111813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368990	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000106
J	Komala, MG; Gross, S; Mudaliar, H; Huang, CL; Pegg, K; Mather, A; Shen, S; Pollock, CA; Panchapakesan, U				Komala, Muralikrishna Gangadharan; Gross, Simon; Mudaliar, Harshini; Huang, Chunling; Pegg, Katherine; Mather, Amanda; Shen, Sylvie; Pollock, Carol A.; Panchapakesan, Usha			Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); PPAR-GAMMA AGONISTS; CELLS; DISEASE; INJURY; SGLT2; HYPERGLYCEMIA; TRANSPORTERS; INFLAMMATION; PROGRESSION	Background and Objective: Sodium glucose cotransporter 2 (SGLT2) is the main luminal glucose transporter in the kidney. SGLT2 inhibition results in glycosuria and improved glycaemic control. Drugs inhibiting this transporter have recently been approved for clinical use and have been suggested to have potential renoprotective benefits by limiting glycotoxicity in the proximal tubule. We aimed to determine the renoprotective benefits of empagliflozin, an SGLT2 inhibitor, independent of its glucose lowering effect. Research Design and Methods: We induced diabetes using a low dose streptozotocin protocol in 7-8 week old endothelial nitric oxide (eNOS) synthase knockout mice. We measured fasting blood glucose on a monthly basis, terminal urinary albumin/creatinine ratio. Renal histology was assessed for inflammatory and fibrotic changes. Renal cortical mRNA transcription of inflammatory and profibrotic cytokines, glucose transporters and protein expression of SGLT2 and GLUT1 were determined. Outcomes were compared to diabetic animals receiving the angiotensin receptor blocker telmisartan (current best practice). Results: Diabetic mice had high matched blood glucose levels. Empagliflozin did not attenuate diabetes-induced albuminuria, unlike telmisartan. Empagliflozin did not improve glomerulosclerosis, tubular atrophy, tubulointerstitial inflammation or fibrosis, while telmisartan attenuated these. Empagliflozin did not modify tubular toll-like receptor-2 expression in diabetic mice. Empagliflozin did not reduce the upregulation of macrophage chemoattractant protein-1 (MCP-1), transforming growth factor beta 1 and fibronectin mRNA observed in the diabetic animals, while telmisartan decreased transcription of MCP-1 and fibronectin. Empagliflozin increased GLUT1 mRNA expression and telmisartan increased SGLT2 mRNA expression in comparison to untreated diabetic mice. However no significant difference was found in protein expression of GLUT1 or SGLT2 among the different groups. Conclusion: Hence SGLT2 inhibition does not have renoprotective benefits independent of glucose lowering.	[Komala, Muralikrishna Gangadharan; Gross, Simon; Mudaliar, Harshini; Huang, Chunling; Pegg, Katherine; Mather, Amanda; Shen, Sylvie; Pollock, Carol A.; Panchapakesan, Usha] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Lab, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Lab, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au	Gangadharan Komala, Muralikrishna/ABH-3183-2021; Gangadharan Komala, Muralikrishna/ABA-5078-2021	Gangadharan Komala, Muralikrishna/0000-0003-0534-0584	National Health and Medical Research Council, Australia [APP1004926]; Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians; Boehringer Ingelheim, Germany	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians; Boehringer Ingelheim, Germany(Boehringer Ingelheim)	The study was funded by a Research Grant from the National Health and Medical Research Council, Australia (APP1004926, https://www.nhmrc.gov.au). MGK received Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians. The study drug empagliflozin and telmisartan was supplied by Boehringer Ingelheim, Germany, and they partially funded the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PW, 1996, KIDNEY INT, V50, P745, DOI 10.1038/ki.1996.372; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Evans M, 2012, NEPHROL DIAL TRANSPL, V27, P2255, DOI 10.1093/ndt/gfr696; Ghezzi C, 2012, AM J PHYSIOL-CELL PH, V303, pC348, DOI 10.1152/ajpcell.00115.2012; Ghosh RK, 2012, J CLIN PHARMACOL, V52, P457, DOI 10.1177/0091270011400604; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Johnson DW, 1998, KIDNEY INT, V53, P1601, DOI 10.1046/j.1523-1755.1998.00916.x; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; Mather A, 2011, KIDNEY INT S, DOI [10.1038/ki.2010.509:S1-6, DOI 10.1038/KI.2010.509:S1-6]; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Panchapakesan U, 2004, AM J PHYSIOL-RENAL, V287, pF528, DOI 10.1152/ajprenal.00445.2003; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; POLLOCK CA, 1991, AM J PHYSIOL, V260, pF946, DOI 10.1152/ajprenal.1991.260.6.F946; POLLOCK CA, 1991, PFLUG ARCH EUR J PHY, V418, P14, DOI 10.1007/BF00370446; Powell DR, 2013, AM J PHYSIOL-ENDOC M, V304, pE117, DOI 10.1152/ajpendo.00439.2012; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Sarafidis PA, 2006, AM J NEPHROL, V26, P232, DOI 10.1159/000093632; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vallon V, 2010, CURR OPIN NEPHROL HY, V19, P425, DOI 10.1097/MNH.0b013e32833bec06; Yale JF, 2013, DIABETES OBES METAB, V15, P463, DOI 10.1111/dom.12090; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	33	40	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108994	10.1371/journal.pone.0108994	http://dx.doi.org/10.1371/journal.pone.0108994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369239	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000006
J	Nguyen, M; Boutinaud, M; Petridou, B; Gabory, A; Pannetier, M; Chat, S; Bouet, S; Jouneau, L; Jaffrezic, F; Laloe, D; Klopp, C; Brun, N; Kress, C; Jammes, H; Charlier, M; Devinoy, E				Nguyen, Minh; Boutinaud, Marion; Petridou, Barbara; Gabory, Anne; Pannetier, Maelle; Chat, Sophie; Bouet, Stephan; Jouneau, Luc; Jaffrezic, Florence; Laloe, Denis; Klopp, Christophe; Brun, Nicolas; Kress, Clemence; Jammes, Helene; Charlier, Madia; Devinoy, Eve			DNA Methylation and Transcription in a Distal Region Upstream from the Bovine AlphaS1 Casein Gene after Once or Twice Daily Milking	PLOS ONE			English	Article							ONCE-DAILY MILKING; MAMMARY EPITHELIAL-CELLS; EXPRESSION ANALYSIS; STAT5; BINDING; LACTATION; PROTEIN; PROMOTER; SEQUENCE; GLAND	Once daily milking (ODM) induces a reduction in milk production when compared to twice daily milking (TDM). Unilateral ODM of one udder half and TDM of the other half, enables the study of underlying mechanisms independently of inter-individual variability (same genetic background) and of environmental factors. Our results show that in first-calf heifers three CpG, located 10 kb upstream from the CSN1S1 gene were methylated to 33, 34 and 28%, respectively, after TDM but these levels were higher after ODM, 38, 38 and 33%, respectively. These methylation levels were much lower than those observed in the mammary gland during pregnancy (57, 59 and 50%, respectively) or in the liver (74, 78 and 61%, respectively). The methylation level of a fourth CpG (CpG4), located close by (29% during TDM) was not altered after ODM. CpG4 methylation reached 39.7% and 59.5%, during pregnancy or in the liver, respectively. CpG4 is located within a weak STAT5 binding element, arranged in tandem with a second high affinity STAT5 element. STAT5 binding is only marginally modulated by CpG4 methylation, but it may be altered by the methylation levels of the three other CpG nearby. Our results therefore shed light on mechanisms that help to explain how milk production is almost, but not fully, restored when TDM is resumed (15.1 +/- 0.2 kg/day instead of 16.2 +/- 0.2 kg/day, p<0.01). The STAT5 elements are 100 bp away from a region transcribed in the antisense orientation, in the mammary gland during lactation, but not during pregnancy or in other reproductive organs (ovary or testes). We now need to clarify whether the transcription of this novel RNA is a consequence of STAT5 interacting with the CSN1S1 distal region, or whether it plays a role in the chromatin structure of this region.	[Nguyen, Minh; Petridou, Barbara; Chat, Sophie; Bouet, Stephan; Jaffrezic, Florence; Laloe, Denis; Brun, Nicolas; Charlier, Madia; Devinoy, Eve] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Boutinaud, Marion] INRA, Physiol Environm & Genet Anim & Syst Elevage UMR1, St Gilles, France; [Pannetier, Maelle; Jouneau, Luc; Jammes, Helene] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Klopp, Christophe] INRA, Sigenae, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Kress, Clemence] Univ Lyon 1, INRA, INSERM,U846,UMR S 846, AGROBIOSYSTEM,Stem Cell & Brain Res Inst,USC1361, Bron, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Devinoy, E (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	eve.devinoy@jouy.inra.fr	Jouneau, Luc/AAC-4711-2020; Klopp, Christophe/J-3164-2019; Laloe, Denis/O-7045-2019; Pannetier, Maëlle/AAQ-1626-2020	Klopp, Christophe/0000-0001-7126-5477; Laloe, Denis/0000-0001-8359-0760; Gabory, Anne/0000-0002-0059-7375; Chat, Sophie/0000-0003-0671-5229	INRA PHASE Division (CI "Epigenetique"); French ANR; APIS-GENE [PCS-09-GENM-022]	INRA PHASE Division (CI "Epigenetique"); French ANR(French National Research Agency (ANR)); APIS-GENE	This project and Minh Nguyen's position were funded by the INRA PHASE Division (CI "Epigenetique" 2011-2013) and the French ANR with the support of APIS-GENE (PCS-09-GENM-022, 2010-2014). The funders agreed with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ben Chedly H, 2013, ANIMAL, V7, P124, DOI 10.1017/S1751731112001176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Boutinaud M, 2004, DOMEST ANIM ENDOCRIN, V27, P363, DOI 10.1016/j.domaniend.2004.04.002; Boutinaud M, 2013, PHYSIOL GENOMICS, V45, P973, DOI 10.1152/physiolgenomics.00059.2013; Buser AC, 2011, MOL ENDOCRINOL, V25, P955, DOI 10.1210/me.2011-0064; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Davis SR, 1999, LIVEST PROD SCI, V59, P77, DOI 10.1016/S0301-6226(98)00204-8; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; Delamaire E, 2006, J DAIRY SCI, V89, P3439, DOI 10.3168/jds.S0022-0302(06)72381-5; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Farr VC, 2000, AM J PHYSIOL-HEART C, V279, pH1813, DOI 10.1152/ajpheart.2000.279.4.H1813; Farrar MA, 2011, NAT IMMUNOL, V12, P1139, DOI 10.1038/ni.2163; Foster JS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-227; Gerencser A, 2002, GENET SEL EVOL, V34, P117, DOI [10.1186/1297-9686-34-1-117, 10.1051/gse:2001007]; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Imamura Y, 2009, J BIOCHEM, V145, P279, DOI 10.1093/jb/mvn165; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kress C, 2011, CHROMOSOME RES, V19, P979, DOI 10.1007/s10577-011-9249-9; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Millot B, 2003, BIOCHEM J, V372, P41, DOI 10.1042/BJ20021894; Montazer-Torbati MB, 2008, EXP CELL RES, V314, P975, DOI 10.1016/j.yexcr.2008.01.001; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; PIERRE S, 1994, MOL ENDOCRINOL, V8, P1720, DOI 10.1210/me.8.12.1720; Platenburg GJ, 1996, TRANSGENIC RES, V5, P421, DOI 10.1007/BF01980207; Remond B, 2007, LIVEST SCI, V110, P192, DOI 10.1016/j.livsci.2006.12.009; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; SABATINI LM, 1989, J DENT RES, V68, P1138, DOI 10.1177/00220345890680070101; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sakurada K, 2011, LEGAL MED-TOKYO, V13, P309, DOI 10.1016/j.legalmed.2011.07.002; Seyfert HM, 2000, J MOL EVOL, V50, P550, DOI 10.1007/s002390010058; Sigl T, 2014, J ANIM PHYSIOL AN N, V98, P84, DOI 10.1111/jpn.12039; Singh K, 2008, J DAIRY SCI, V91, P2236, DOI 10.3168/jds.2007-0900; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; STEWART AF, 1984, NUCLEIC ACIDS RES, V12, P3895, DOI 10.1093/nar/12.9.3895; Tost Jorg, 2007, V373, P89; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Wheeler TT, 1997, MOL CELL ENDOCRINOL, V133, P141, DOI 10.1016/S0303-7207(97)00161-5; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Yandell BS, 1997, PRACTICAL DATA ANAL; Yang J, 2000, J ANIM SCI, V78, P3126; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	63	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111556	10.1371/journal.pone.0111556	http://dx.doi.org/10.1371/journal.pone.0111556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369064	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000068
J	Schnitzler, F; Friedrich, M; Wolf, C; Angelberger, M; Diegelmann, J; Olszak, T; Beigel, F; Tillack, C; Stallhofer, J; Goke, B; Glas, J; Lohse, P; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Wolf, Christiane; Angelberger, Marianne; Diegelmann, Julia; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Goeke, Burkhard; Glas, Juergen; Lohse, Peter; Brand, Stephan			The NOD2 p.Leu1007fsX1008 Mutation (rs2066847) Is a Stronger Predictor of the Clinical Course of Crohn's Disease than the FOXO3A Intron Variant rs12212067	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; TRANSCRIPTION FACTORS; ULCERATIVE-COLITIS; FRAMESHIFT MUTATION; SUSCEPTIBILITY; HOMOZYGOSITY; METAANALYSIS; EXPRESSION; RISK	Background: Very recently, a sub-analysis of genome-wide association scans revealed that the non-coding single nucleotide polymorphism (SNP) rs12212067 in the FOXO3A gene is associated with a milder course of Crohn's disease (CD) (Cell 2013; 155: 57-69). The aim of our study was to evaluate the clinical value of the SNP rs12212067 in predicting the severity of CD by correlating CD patient genotype status with the most relevant complications of CD such as stenoses, fistulas, and CD-related surgery. Methodology/Principal Findings: We genotyped 550 CD patients for rs12212067 (FOXO3A) and the three common CD-associated NOD2 mutations rs2066844, rs2066847, and rs2066847 and performed genotype-phenotype analyses. Results: No significant phenotypic differences were found between the wild-type genotype TT of the FOXO3A SNP rs12212067 and the minor genotypes TG and GG independently from NOD2 variants. The allele frequency of the minor G allele was 12.7%. Age at diagnosis, disease duration, body mass index, surgery rate, stenoses, fistula, need for immunosuppressive therapy, and disease course were not significantly different. In contrast, the NOD2 mutant p. Leu1007fsX1008 (rs2066847) was highly associated with penetrating CD (p = 0.01), the development of fistulas (p = 0.01) and stenoses (p = 0.01), and ileal disease localization (p = 0.03). Importantly, the NOD2 SNP rs2066847 was a strong separator between an aggressive and a mild course of CD (p = 2.99 x 10(-5)), while the FOXO3A SNP rs12212067 did not separate between mild and aggressive CD behavior in our cohort (p = 0.35). 96.2% of the homozygous NOD2 p. Leu1007fsX1008 carriers had an aggressive disease behavior compared to 69.3% of the patients with the NOD2 wildtype genotype (p = 0.007). Conclusion/Significance: In clinical practice, the NOD2 variant p. Leu1007fsX1008 (rs2066847), in particular in homozygous form, is a much stronger marker for a severe clinical phenotype than the FOXO3A rs12212067 SNP for a mild disease course on an individual patient level despite its important impact on the inflammatory response of monocytes.	[Schnitzler, Fabian; Friedrich, Matthias; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] LMU, Dept Prevent Dent & Periodontol, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Lohse, Peter] LMU, Dept Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; Max Planck Society; RWTH Aachen University; University of Munich	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de		Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; DFG [BE 4490/2-1]; Ludwig-Maximilians University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG) [OL/324-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); DFG(German Research Foundation (DFG)); Ludwig-Maximilians University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG)(German Research Foundation (DFG))	S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR 1912/6-1) and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). F. Beigel was supported by DFG (BE 4490/2-1). C. Tillack was supported by a grant of the Ludwig-Maximilians University Munich (FoFoLe program). T. Olszak was supported by a grant of the German Research Council (Deutsche Forschungsgemeinschaft/DFG, OL/324-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Brand S, 2013, GUT, V62, P1531, DOI 10.1136/gutjnl-2012-304151; Brand S, 2012, INFLAMM BOWEL DIS, V18, P393, DOI 10.1002/ibd.21914; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076	31	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e108503	10.1371/journal.pone.0108503	http://dx.doi.org/10.1371/journal.pone.0108503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365249	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100006
J	Zhang, J; Huang, WJ; Zhou, QF				Zhang, Jing; Huang, Wenjiang; Zhou, Qifa			Reflectance Variation within the In-Chlorophyll Centre Waveband for Robust Retrieval of Leaf Chlorophyll Content	PLOS ONE			English	Article							RED EDGE POSITION; REMOTE ESTIMATION; SPECTRAL REFLECTANCE; INDEXES; NITROGEN; FLUORESCENCE; RATIO; CAROTENOIDS	The in-chlorophyll centre waveband (ICCW) (640-680 nm) is the specific chlorophyll (Chl) absorption band, but the reflectance in this band has not been used as an optimal index for non-destructive determination of plant Chl content in recent decades. This study develops a new spectral index based solely on the ICCW for robust retrieval of leaf Chl content for the first time. A glasshouse experiment for solution-culture of one chlorophyll-deficient rice mutant and six wild types of rice genotypes was conducted, and the leaf reflectance (400-900 nm) was measured with a high spectral resolution (1 nm) spectrophotometer and the contents of chlorophyll a (Chla), chlorophyll b (Chlb) and chlorophyll a+b (Chlt) of the rice leaves were determined. It was found that the reflectance curves from 640 nm to 674 nm and from 675 nm to 680 nm of the low-chlorophyll mutant leaf were drastically steeper than that of the wild types in the ICCW. The new index based on the reflectance variation within ICCW, the difference of the first derivative sum within the ICCW (DFDS_ICCW), was highly sensitive (r = -0.77, n = 93, P < 0.01) to Chlt while the mean reflectance (R_ICCW) in the ICCW became insensitive (r = -0.12, n = 93, P > 0.05) to Chlt when the leaf Chlt was higher than 200 mg/m(2). The best equations of R-ICCW and DFDS_ICCW yielded an RMSE of 78.7, 32.9 and 107.3 mg/m(2), and an RMSE of 37.4, 16.0 and 45.3 mg/m(-2), respectively, for predicting Chla, Chlb and Chlt. The new index could rank in the top 10 for prediction of Chla and Chlt as compared with the 55 existing indices. Additionally, most of the 55 existing Chl-related VIs performed robustly or strongly in simultaneous prediction of leaf Chla, Chlb and Chlt.	[Zhang, Jing; Zhou, Qifa] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Wenjiang] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China	Zhejiang University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Zhou, QF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zqifa2002@yahoo.com	huang, wenjiang/AAM-6844-2021		National Natural Science Foundation of China [41271363, 41271412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant numbers 41271363 and 41271412). QFZ received 41271363 and WJH received 41271412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Blackburn GA, 1998, REMOTE SENS ENVIRON, V66, P273, DOI 10.1016/S0034-4257(98)00059-5; Blackburn GA, 1999, REMOTE SENS ENVIRON, V70, P224, DOI 10.1016/S0034-4257(99)00048-6; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Carter GA, 1996, J PLANT PHYSIOL, V148, P515, DOI 10.1016/S0176-1617(96)80070-8; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Datt B, 1998, REMOTE SENS ENVIRON, V66, P111, DOI 10.1016/S0034-4257(98)00046-7; Feret JB, 2011, REMOTE SENS ENVIRON, V115, P2742, DOI 10.1016/j.rse.2011.06.016; FILELLA I, 1994, INT J REMOTE SENS, V15, P1459, DOI 10.1080/01431169408954177; GITELSON A, 1994, J PHOTOCH PHOTOBIO B, V22, P247, DOI 10.1016/1011-1344(93)06963-4; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Guyot G., 1988, J CHEM INF MODEL, P279; Hatfield JL, 2008, AGRON J, V100, pS117, DOI 10.2134/agronj2006.0370c; He QX, 2005, J SCI FOOD AGR, V85, P1197, DOI 10.1002/jsfa.2109; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Jin XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072736; Kim M.S., 1994, USE HIGH SPECTRAL RE, P299; le Maire G, 2004, REMOTE SENS ENVIRON, V89, P1, DOI 10.1016/j.rse.2003.09.004; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lichtenthaler HK, 1996, J PLANT PHYSIOL, V148, P599, DOI 10.1016/S0176-1617(96)80081-2; Maccioni A, 2001, J PHOTOCH PHOTOBIO B, V61, P52, DOI 10.1016/S1011-1344(01)00145-2; Main R, 2011, ISPRS J PHOTOGRAMM, V66, P751, DOI 10.1016/j.isprsjprs.2011.08.001; MCMURTREY JE, 1994, REMOTE SENS ENVIRON, V47, P36, DOI 10.1016/0034-4257(94)90125-2; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; PENUELAS J, 1994, REMOTE SENS ENVIRON, V48, P135, DOI 10.1016/0034-4257(94)90136-8; PENUELAS J, 1995, INT J REMOTE SENS, V16, P2727, DOI 10.1080/01431169508954588; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Read JJ, 2002, J ENVIRON QUAL, V31, P1442, DOI 10.2134/jeq2002.1442; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Schlemmer M, 2013, INT J APPL EARTH OBS, V25, P47, DOI 10.1016/j.jag.2013.04.003; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Steddom K, 2003, PHYTOPATHOLOGY, V93, P720, DOI 10.1094/PHYTO.2003.93.6.720; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; THOMAS JR, 1971, AGRON J, V63, P845, DOI 10.2134/agronj1971.00021962006300060007x; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Zarco-Tejada PJ, 1999, J GEOPHYS RES-ATMOS, V104, P27921, DOI 10.1029/1999JD900161	42	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110812	10.1371/journal.pone.0110812	http://dx.doi.org/10.1371/journal.pone.0110812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365207	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100029
J	Zhang, P; Liu, XD; Tong, HH; Lu, YG; Li, JQ				Zhang, Peng; Liu, Xiangdong; Tong, Hanhua; Lu, Yonggen; Li, Jinquan			Association Mapping for Important Agronomic Traits in Core Collection of Rice (Oryza sativa L.) with SSR Markers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADVANCED BACKCROSS POPULATION; LINKAGE DISEQUILIBRIUM; PLANT HEIGHT; DEVELOPMENTAL BEHAVIOR; YIELD COMPONENTS; COMPLEX TRAITS; GENE ACTIONS; WILD-RICE; P-VALUES	Mining elite genes within rice landraces is of importance for the improvement of cultivated rice. An association mapping for 12 agronomic traits was carried out using a core collection of rice consisting of 150 landraces (Panel 1) with 274 simple sequence repeat (SSR) markers, and the mapping results were further verified using a Chinese national rice micro-core collection (Panel 2) and a collection from a global molecular breeding program (Panel 3). Our results showed that (1) 76 significant (P<0.05) trait-marker associations were detected using mixed linear model (MLM) within Panel 1 in two years, among which 32% were identical with previously mapped QTLs, and 11 significant associations had >10% explained ratio of genetic variation; (2) A total of seven aforementioned trait-marker associations were verified within Panel 2 and 3 when using a general linear model (GLM) and 55 SSR markers of the 76 significant trait-marker associations. However, no significant trait-marker association was found to be identical within three panels when using the MLM model; (3) several desirable alleles of the loci which showed significant trait-marker associations were identified. The research provided important information for further mining these elite genes within rice landraces and using them for rice breeding.	[Zhang, Peng; Liu, Xiangdong; Lu, Yonggen; Li, Jinquan] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Zhang, Peng; Tong, Hanhua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Li, Jinquan] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany	South China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Max Planck Society	Lu, YG (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	yglu@scau.edu.cn; lijinquan@scau.edu.cn			National Natural Science Foundation of China [30700494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fund of the National Natural Science Foundation of China grant 30700494. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama HA, 2009, PLANT BREEDING, V128, P551, DOI 10.1111/j.1439-0523.2009.01631.x; Brown A. H. D., 1995, P3; Cao G, 2001, THEOR APPL GENET, V103, P153, DOI 10.1007/s001220100536; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Frankel OH, 1984, GENETICS NEW FRONTIE, V4, P1; Gao Yong-ming, 2004, J Zhejiang Univ Sci, V5, P371, DOI 10.1631/jzus.2004.0371; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; HUANG CF, 2003, THESIS S CHINA AGR U; Huang N, 1996, HEREDITY, V77, P130, DOI 10.1038/hdy.1996.117; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jiang Gong-Hao, 2004, Acta Genetica Sinica, V31, P63; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Kobayashi S, 2003, THEOR APPL GENET, V107, P1350, DOI 10.1007/s00122-003-1388-8; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li JQ, 2012, ASSESSMENT UTILIZATI; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Mei HW, 2003, THEOR APPL GENET, V107, P89, DOI 10.1007/s00122-003-1192-5; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Xiao JH, 1998, GENETICS, V150, P899; Xing YZ, 2001, ACTA BOT SIN, V43, P840; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang GH, 2006, HEREDITAS, V143, P236, DOI 10.1111/j.2006.0018-0661.01959.x; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yoshida S, 2002, BREEDING SCI, V52, P309, DOI 10.1270/jsbbs.52.309; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang N, 2005, THEOR APPL GENET, V110, P721, DOI 10.1007/s00122-004-1898-z; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; ZHENG K, 1994, THEOR APPL GENET, V88, P65, DOI 10.1007/BF00222395; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	65	56	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111508	10.1371/journal.pone.0111508	http://dx.doi.org/10.1371/journal.pone.0111508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360796	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700111
J	Park, MS; Bitto, E; Kim, KR; Bingman, CA; Miller, MD; Kim, HJ; Han, BW; Phillips, GN				Park, Mi Seul; Bitto, Eduard; Kim, Kyung Rok; Bingman, Craig A.; Miller, Mitchell D.; Kim, Hyun-Jung; Han, Byung Woo; Phillips, George N., Jr.			Crystal Structure of Human Protein N-Terminal Glutamine Amidohydrolase, an Initial Component of the N-End Rule Pathway	PLOS ONE			English	Article							UBIQUITIN LIGASE; MICE LACKING; DEGRADATION; AMIDASE; AUTOINDUCTION; PROTEOLYSIS; APOPTOSIS; ENZYME	The N-end rule states that half-life of protein is determined by their N-terminal amino acid residue. N-terminal glutamine amidohydrolase (Ntaq) converts N-terminal glutamine to glutamate by eliminating the amine group and plays an essential role in the N-end rule pathway for protein degradation. Here, we report the crystal structure of human Ntaq1 bound with the N-terminus of a symmetry-related Ntaq1 molecule at 1.5 angstrom resolution. The structure reveals a monomeric globular protein with alpha-beta-alpha three-layer sandwich architecture. The catalytic triad located in the active site, Cys-His-Asp, is highly conserved among Ntaq family and transglutaminases from diverse organisms. The N-terminus of a symmetry-related Ntaq1 molecule bound in the substrate binding cleft and the active site suggest possible substrate binding mode of hNtaq1. Based on our crystal structure of hNtaq1 and docking study with all the tripeptides with N-terminal glutamine, we propose how the peptide backbone recognition patch of hNtaq1 forms nonspecific interactions with N-terminal peptides of substrate proteins. Upon binding of a substrate with N-terminal glutamine, active site catalytic triad mediates the deamination of the N-terminal residue to glutamate by a mechanism analogous to that of cysteine proteases.	[Park, Mi Seul; Kim, Kyung Rok; Han, Byung Woo] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Bitto, Eduard] Georgian Court Univ, Dept Chem & Biochem, Lakewood, NJ USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Gen, Dept Biochem, Madison, WI USA; [Miller, Mitchell D.; Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison; Rice University; Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.	bwhan@snu.ac.kr; georgep@rice.edu		Miller, Mitchell/0000-0003-1626-4943; Park, Mi Seul/0000-0003-2519-7121	National Institutes of Health Protein Structure Initiative [GM064598, GNPGM094816, GNP GM074901]; BioXFEL Science and Technology Center under National Science Foundation [GNP1231306]; Ministry of Science, ICT and Future Planning of Korea [MDM2013-043695, BWH 2014-001848]; Ministry of Health and Welfare of Korea [BWH A092006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098248, U54GM074901, P50GM064598, R01GM094816] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioXFEL Science and Technology Center under National Science Foundation; Ministry of Science, ICT and Future Planning of Korea; Ministry of Health and Welfare of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by GM064598, National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx), GNP GM074901, National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx, GNPGM094816), National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx), GNP1231306, The BioXFEL Science and Technology Center under National Science Foundation, (https://www.bioxfel.org/), MDM2013-043695, Ministry of Science, ICT and Future Planning of Korea, (www.msip.go.kr), BWH 2014-001848, Ministry of Science, ICT and Future Planning of Korea, (www.msip.go.kr), BWH A092006, Ministry of Health and Welfare of Korea, (www.mw.go.kr), BWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; Bhaskaran SS, 2012, ACTA CRYSTALLOGR D, V68, P1613, DOI 10.1107/S0907444912039042; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chatterjee D, 2012, J BACTERIOL, V194, P4415, DOI 10.1128/JB.00640-12; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hashizume R, 2011, J BIOL CHEM, V286, P38691, DOI 10.1074/jbc.M111.255133; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032	30	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111142	10.1371/journal.pone.0111142	http://dx.doi.org/10.1371/journal.pone.0111142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356641	gold, Green Published			2022-12-26	WOS:000346765000043
J	Horbelt, D; Boergermann, JH; Chaikuad, A; Alfano, I; Williams, E; Lukonin, I; Timmel, T; Bullock, AN; Knaus, P				Horbelt, Daniel; Boergermann, Jan H.; Chaikuad, Apirat; Alfano, Ivan; Williams, Eleanor; Lukonin, Ilya; Timmel, Tobias; Bullock, Alex N.; Knaus, Petra			Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GROSS MUSCLE HYPERTROPHY; TGF-BETA; SKELETAL-MUSCLE; SMAD1/5 PHOSPHORYLATION; CRYSTAL-STRUCTURE; RECEPTOR; MUTATION; DOMAIN; MASS	GDF8, or myostatin, is a member of the TGF-beta superfamily of secreted polypeptide growth factors. GDF8 is a potent negative regulator of myogenesis both in vivo and in vitro. We found that GDF8 signaling was inhibited by the small molecule ATP competitive inhibitors dorsomorphin and LDN-193189. These compounds were previously shown to be potent inhibitors of BMP signaling by binding to the BMP type I receptors ALK1/2/3/6. We present the crystal structure of the type II receptor ActRIIA with dorsomorphin and demonstrate that dorsomorphin or LDN-193189 target GDF8 induced Smad2/3 signaling and repression of myogenic transcription factors. As a result, both inhibitors rescued myogenesis in myoblasts treated with GDF8. As revealed by quantitative live cell microscopy, treatment with dorsomorphin or LDN-193189 promoted the contractile activity of myotubular networks in vitro. We therefore suggest these inhibitors as suitable tools to promote functional myogenesis.	[Horbelt, Daniel; Boergermann, Jan H.; Lukonin, Ilya; Knaus, Petra] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Chaikuad, Apirat; Alfano, Ivan; Williams, Eleanor; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Timmel, Tobias] Expt & Clin Res Ctr, Muscle Res Unit, D-13125 Berlin, Germany	Free University of Berlin; University of Oxford	Knaus, P (corresponding author), Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany.	knaus@chemie.fu-berlin.de	Williams, Eleanor/AAL-9937-2021	Chaikuad, Apirat/0000-0003-1120-2209	Freie Universitat Berlin; Myograd Program Grant [GK1631]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	Freie Universitat Berlin; Myograd Program Grant; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by an FK grant from the Freie Universitat Berlin (to P. K.) and Myograd Program Grant GK1631 (to P. K. and T. T.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (Grant 092809/Z/10/Z).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Chinga G, 2007, NORD PULP PAP RES J, V22, P441, DOI 10.3183/npprj-2007-22-04-p441-446; Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Furutani Y, 2011, J CELL BIOCHEM, V112, P614, DOI 10.1002/jcb.22953; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Johnson PL, 2005, J ANIM SCI, V83, P1988; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mohedas AH, 2013, ACS CHEM BIOL, V8, P1291, DOI 10.1021/cb300655w; Mouisel E, 2014, AM J PHYSIOL-REG I, V307, pR444, DOI 10.1152/ajpregu.00377.2013; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Philippi Susanne, 2012, PLoS Curr, V4, pRRN1298, DOI 10.1371/currents.RRN1298; Qaisar R, 2012, FASEB J, V26, P1077, DOI 10.1096/fj.11-192195; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; Rodgers BD, 2014, ENDOCRINOLOGY, V155, P670, DOI 10.1210/en.2013-2107; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Schwaerzer GK, 2012, J BONE MINER RES, V27, P429, DOI 10.1002/jbmr.532; Shelton GD, 2007, NEUROMUSCULAR DISORD, V17, P721, DOI 10.1016/j.nmd.2007.06.008; Shi S, 2011, NEUROBIOL DIS, V41, P353, DOI 10.1016/j.nbd.2010.10.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wang Y, 2014, ENDOCRINOLOGY, V155, P1970, DOI 10.1210/en.2013-1741; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	74	39	42	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3390	3404		10.1074/jbc.M114.604397	http://dx.doi.org/10.1074/jbc.M114.604397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25368322	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000349456000016
J	Agrawal, YO; Sharma, PK; Shrivastava, B; Ojha, S; Upadhya, HM; Arya, DS; Goyal, SN				Agrawal, Yogeeta O.; Sharma, Pankaj Kumar; Shrivastava, Birendra; Ojha, Shreesh; Upadhya, Harshita M.; Arya, Dharamvir Singh; Goyal, Sameer N.			Hesperidin Produces Cardioprotective Activity via PPAR-gamma Pathway in Ischemic Heart Disease Model in Diabetic Rats	PLOS ONE			English	Article							REPERFUSION INJURY; HYPERTENSIVE-RATS; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ORANGE JUICE; ROSIGLITAZONE; BIOAVAILABILITY; PIOGLITAZONE; TELMISARTAN; AGONIST	The present study investigated the effect of hesperidin, a natural flavonoid, in cardiac ischemia and reperfusion (I/R) injury in diabetic rats. Male Wistar rats with diabetes were divided into five groups and were orally administered saline once daily (IR-sham and IR-control), Hesperidin (100 mg/kg/day; IR-Hesperidin), GW9962 (PPAR-gamma receptor antagonist), or combination of both for 14 days. On the 15th day, in the IR-control and IR-treatment groups, rats were subjected to left anterior descending (LAD) coronary artery occlusion for 45 minutes followed by a one-hour reperfusion. Haemodynamic parameters were recorded and rats were sacrificed; hearts were isolated for biochemical, histopathological, ultrastructural and immunohistochemistry. In the IR-control group, significant ventricular dysfunctions were observed along with enhanced expression of pro-apoptotic protein Bax. A decline in cardiac injury markers lactate dehydrogenase activity, CK-MB and increased content of thiobarbituric acid reactive substances, a marker of lipid peroxidation, and TNF-alpha were observed. Hesperidin pretreatment significantly improved mean arterial pressure, reduced left ventricular end-diastolic pressure, and improved both inotropic and lusitropic function of the heart (+LVdP/dt and -LVdP/dt) as compared to IR-control. Furthermore, hesperidin treatment significantly decreased the level of thiobarbituric acid reactive substances and reversed the activity of lactate dehydrogenase towards normal value. Hesperidin showed anti-apoptotic effects by upregulating Bcl-2 protein and decreasing Bax protein expression. Additionally, histopathological and ultrastructural studies reconfirmed the protective action of hesperidin. On the other hand, GW9662, selective PPAR-gamma receptor antagonist, produced opposite effects and attenuated the hesperidin induced improvements. The study for the first time evidence the involvement of PPAR-gamma pathway in the cardioprotective activity of hesperidin in I/R model in rats.	[Agrawal, Yogeeta O.; Sharma, Pankaj Kumar; Shrivastava, Birendra] Jaipur Natl Univ, Sch Pharmaceut Sci, Jaipur, Rajasthan, India; [Agrawal, Yogeeta O.; Arya, Dharamvir Singh] All India Inst Med Sci, Dept Pharmacol, New Delhi, India; [Agrawal, Yogeeta O.; Goyal, Sameer N.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut & Pharmacol, Shirpur, Maharashtra, India; [Ojha, Shreesh] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Upadhya, Harshita M.] Sunils Daibet & Res Ctr, Nagpur, Maharashtra, India	Jaipur National University; All India Institute of Medical Sciences (AIIMS) New Delhi; United Arab Emirates University	Sharma, PK (corresponding author), Jaipur Natl Univ, Sch Pharmaceut Sci, Jaipur, Rajasthan, India.	jnupharmacyresearch@gmail.com; goyal.aiims@gmail.com	Shrivastava, Birendra/AAW-8735-2020; sharma, pankaj/HGE-4423-2022	Goyal, sameer/0000-0002-5241-7049; OJHA, SHREESH/0000-0001-7801-2966; Agrawal (Goyal), Yogeeta/0000-0002-3293-5607; Shrivastava, Birendra/0000-0001-5914-1762				Ameer B, 1996, CLIN PHARMACOL THER, V60, P34, DOI 10.1016/S0009-9236(96)90164-2; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bolten Charles W, 2007, Diab Vasc Dis Res, V4, P117; Cao ZL, 2007, PHARMACOLOGY, V79, P184, DOI 10.1159/000100870; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; De Biase L, 2003, THROMB HAEMOSTASIS, V90, P317, DOI 10.1160/TH03-02-0105; De Bono D.P., 1992, DAVIDSONS PRINCIPLE, P249; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; Geng DF, 2006, INT J CARDIOL, V113, P86, DOI 10.1016/j.ijcard.2006.03.060; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Gumieniczek A, 2003, LIFE SCI, V74, P553, DOI 10.1016/j.lfs.2003.03.004; Hagar HH, 2002, PHARMACOL RES, V46, P213, DOI 10.1016/S1043-6618(02)00095-6; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Huang EJ, 2006, CLIN CHIM ACTA, V366, P293, DOI 10.1016/j.cca.2005.10.025; Ikejima H, 2008, J HYPERTENS, V26, P964, DOI 10.1097/HJH.0b013e3282f52c36; Ipseeta Mohanty, 2007, International Journal of Integrative Biology, V1, P178; Ito H, 2003, LAB INVEST, V83, P1715, DOI 10.1097/01.LAB.0000106724.29121.DA; Kakadiya J, 2010, INT J BIOL TECH, V1, P57; Kakadiya Jagdish, 2010, J Basic Clin Pharm, V1, P85; Kobayashi N, 2008, AM J HYPERTENS, V21, P576, DOI 10.1038/ajh.2008.27; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Loh HK, 2007, BASIC CLIN PHARMACOL, V100, P233, DOI 10.1111/j.1742-7843.2007.00022.x; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Matsumoto H, 2004, J AGR FOOD CHEM, V52, P6653, DOI 10.1021/jf0491411; Mohanty IR, 2008, CLIN NUTR, V27, P635, DOI 10.1016/j.clnu.2008.05.006; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Nakamura T, 2000, CHEM PHARM BULL, V48, P235; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Rajadurai M, 2006, TOXICOLOGY, V228, P259, DOI 10.1016/j.tox.2006.09.005; Sahoo KC, 2009, J RENIN-ANGIO-ALDO S, V10, P201, DOI 10.1177/1470320308353059; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Silva GD, 2011, EXP TOXICOL PATHOL, V63, P1, DOI 10.1016/j.etp.2009.09.001; Singh AD, 2006, BASIC CLIN PHARMACOL, V98, P604, DOI 10.1111/j.1742-7843.2006.pto_405.x; Vanden Heuvel JP, 1999, TOXICOL SCI, V47, P1, DOI 10.1093/toxsci/47.1.1; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Wilmsen PK, 2005, J AGR FOOD CHEM, V53, P4757, DOI 10.1021/jf0502000; Wu LY, 2004, AM J HYPERTENS, V17, P749, DOI 10.1016/j.amjhyper.2004.04.010; Yamamoto M, 2013, FOOD FUNCT, V4, P1346, DOI 10.1039/c3fo60030k	43	70	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111212	10.1371/journal.pone.0111212	http://dx.doi.org/10.1371/journal.pone.0111212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369053	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000044
J	Alymova, IV; York, IA; McCullers, JA				Alymova, Irina V.; York, Ian A.; McCullers, Jonathan A.			Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers	PLOS ONE			English	Article							HUMAN INFECTION; VIRUS; GENE; H3N2; TRANSMISSION; EXPRESSION; ORIGIN; PATHOGENICITY; EVOLUTION; CANINE	PB1-F2 protein, expressed from an alternative reading frame of most influenza A virus (IAV) PB1 segments, may possess specific residues associated with enhanced inflammation (L62, R75, R79, and L82) and cytotoxicity (I68, L69, and V70). These residues were shown to increase the pathogenicity of primary viral and secondary bacterial infections in a mouse model. In contrast to human seasonal influenza strains, virulence-associated residues are present in PB1-F2 proteins from pandemic H1N1 1918, H2N2 1957, and H3N2 1968, and highly pathogenic H5N1 strains, suggesting their contribution to viruses' pathogenic phenotypes. Non-human influenza strains may act as donors of virulent PB1-F2 proteins. Previously, avian influenza strains were identified as a potential source of inflammatory, but not cytotoxic, PB1-F2 residues. Here, we analyze the frequency of virulence-associated residues in PB1-F2 sequences from IAVs circulating in mammalian species in close contact with humans: pigs, horses, and dogs. All four inflammatory residues were found in PB1-F2 proteins from these viruses. Among cytotoxic residues, I68 was the most common and was especially prevalent in equine and canine IAVs. Historically, PB1-F2 from equine (about 75%) and canine (about 20%) IAVs were most likely to have combinations of the highest numbers of residues associated with inflammation and cytotoxicity, compared to about 7% of swine IAVs. Our analyses show that, in addition to birds, pigs, horses, and dogs are potentially important sources of pathogenic PB1-F2 variants. There is a need for surveillance of IAVs with genetic markers of virulence that may be emerging from these reservoirs in order to improve pandemic preparedness and response.	[Alymova, Irina V.; York, Ian A.] Centers Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA; [Alymova, Irina V.; McCullers, Jonathan A.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [McCullers, Jonathan A.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA	Centers for Disease Control & Prevention - USA; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	McCullers, JA (corresponding author), Centers Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA.	jon.mccullers@stjude.org	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Anhlan D, 2011, RNA, V17, P64, DOI 10.1261/rna.2395211; Brockmeier S. L, 2002, POLYMICROBIAL DIS; Buehler J, 2013, J VIROL, V87, P10687, DOI 10.1128/JVI.01520-13; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Chen GW, 2004, EMERG INFECT DIS, V10, P630, DOI 10.3201/eid1004.030412; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Harder TC, 2010, VET IMMUNOL IMMUNOP, V134, P54, DOI 10.1016/j.vetimm.2009.10.009; Huber VC, 2012, VIRULENCE, V3, P523, DOI 10.4161/viru.21811; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Kang YM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-92; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pena L, 2012, J GEN VIROL, V93, P2204, DOI 10.1099/vir.0.045005-0; Pena L, 2012, J VIROL, V86, P5523, DOI 10.1128/JVI.00134-12; Quinlivan M, 2007, VACCINE, V25, P7056, DOI 10.1016/j.vaccine.2007.07.059; Rivailler P, 2010, VIROLOGY, V408, P71, DOI 10.1016/j.virol.2010.08.022; SARASOLA P, 1992, VET REC, V131, P441, DOI 10.1136/vr.131.19.441; Smith AM, 2013, VIRUS RES MAR, V14; Smith AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001081; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song D, 2008, EMERG INFECT DIS, V14, P741, DOI 10.3201/eid1405.071471; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vincent A, 2013, ZOONOSES PUBLIC HLTH, DOI [10.1111/zph.12049, DOI 10.1111/ZPH.12049.[]; WADDELL GH, 1963, J AM VET MED ASSOC, V143, P587; Wattrang E, 2003, VIRAL IMMUNOL, V16, P57, DOI 10.1089/088282403763635456; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111603	10.1371/journal.pone.0111603	http://dx.doi.org/10.1371/journal.pone.0111603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368997	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000074
J	Bouchut, A; Geiger, JA; DeRocher, AE; Parsons, M				Bouchut, Anne; Geiger, Jennifer A.; DeRocher, Amy E.; Parsons, Marilyn			Vesicles Bearing Toxoplasma Apicoplast Membrane Proteins Persist Following Loss of the Relict Plastid or Golgi Body Disruption	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASMODIUM-FALCIPARUM; MOLECULAR CHARACTERIZATION; BINDING PROTEIN; LIPID DROPLETS; GONDII; TRAFFICKING; TRANSPORT; PATHWAY; CHLOROPLAST	Toxoplasma gondii and malaria parasites contain a unique and essential relict plastid called the apicoplast. Most apicoplast proteins are encoded in the nucleus and are transported to the organelle via the endoplasmic reticulum (ER). Three trafficking routes have been proposed for apicoplast membrane proteins: (i) vesicular trafficking from the ER to the Golgi and then to the apicoplast, (ii) contiguity between the ER membrane and the apicoplast allowing direct flow of proteins, and (iii) vesicular transport directly from the ER to the apicoplast. Previously, we identified a set of membrane proteins of the T. gondii apicoplast which were also detected in large vesicles near the organelle. Data presented here show that the large vesicles bearing apicoplast membrane proteins are not the major carriers of luminal proteins. The vesicles continue to appear in parasites which have lost their plastid due to mis-segregation, indicating that the vesicles are not derived from the apicoplast. To test for a role of the Golgi body in vesicle formation, parasites were treated with brefeldin A or transiently transfected with a dominant-negative mutant of Sar1, a GTPase required for ER to Golgi trafficking. The immunofluorescence patterns showed little change. These findings were confirmed using stable transfectants, which expressed the toxic dominant-negative sar1 following Cre-loxP mediated promoter juxtaposition. Our data support the hypothesis that the large vesicles do not mediate the trafficking of luminal proteins to the apicoplast. The results further show that the large vesicles bearing apicoplast membrane proteins continue to be observed in the absence of Golgi and plastid function. These data raise the possibility that the apicoplast proteome is generated by two novel ER to plastid trafficking pathways, plus the small set of proteins encoded by the apicoplast genome.	[Bouchut, Anne; Geiger, Jennifer A.; DeRocher, Amy E.; Parsons, Marilyn] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Geiger, Jennifer A.; Parsons, Marilyn] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Parsons, M (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Marilyn.parsons@seattlebiomed.org		Parsons, Marilyn/0000-0003-3994-8096	National Institute of Allergy and Infectious Diseases [T32AI007509]; National Institutes of Health [R01AI50506]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050506, T32AI007509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAG was supported by a training grant from the National Institute of Allergy and Infectious Diseases (Grant T32AI007509). The work was supported by a grant from the National Institutes of Health R01AI50506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa A, 2007, INT J PARASITOL, V37, P1127, DOI 10.1016/j.ijpara.2007.02.009; Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; BANGS JD, 1993, J CELL SCI, V105, P1101; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Budimulja AS, 1997, MOL BIOCHEM PARASIT, V84, P137, DOI 10.1016/S0166-6851(96)02781-8; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; Chaudhari R, 2012, FEBS J, V279, P3872, DOI 10.1111/j.1742-4658.2012.08746.x; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; DeRocher A, 2005, J CELL SCI, V118, P565, DOI 10.1242/jcs.01627; DeRocher A, 2000, J CELL SCI, V113, P3969; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; DeRocher AE, 2012, TRAFFIC, V13, P694, DOI 10.1111/j.1600-0854.2012.01335.x; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Glaser S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405100; Gorelick FS, 2001, MOL CELL ENDOCRINOL, V177, P13, DOI 10.1016/S0303-7207(01)00438-5; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; He CY, 2001, J BIOL CHEM, V276, P28436, DOI 10.1074/jbc.M102000200; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Karnataki A, 2007, TRAFFIC, V8, P1543, DOI 10.1111/j.1600-0854.2007.00637.x; Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x; Karnataki A, 2009, MOL BIOCHEM PARASIT, V166, P126, DOI 10.1016/j.molbiopara.2009.03.004; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; McConkey GA, 1997, J BIOL CHEM, V272, P2046, DOI 10.1074/jbc.272.4.2046; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243, DOI 10.1093/oxfordjournals.jbchem.a124513; Nassoury N, 2003, J CELL SCI, V116, P2867, DOI 10.1242/jcs.00517; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Sulli C, 1999, J BIOL CHEM, V274, P457, DOI 10.1074/jbc.274.1.457; SULLI C, 1995, J BIOL CHEM, V270, P13084, DOI 10.1074/jbc.270.22.13084; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Poppel NFJ, 2006, INT J PARASITOL, V36, P443, DOI 10.1016/j.ijpara.2006.01.005; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang Z, 2012, BIOCHEM SOC T, V40, P457, DOI 10.1042/BST20110752; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x	75	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112096	10.1371/journal.pone.0112096	http://dx.doi.org/10.1371/journal.pone.0112096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369183	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000141
J	Bouhaddioui, W; Provost, PR; Tremblay, Y				Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves			Identification of Most Stable Endogenous Control Genes for MicroRNA Quantification in the Developing Mouse Lung	PLOS ONE			English	Article							PULMONARY SURFACTANT; EXPRESSION PROFILE; PCR DATA; RT-PCR; LET-7; RNAS; DIFFERENTIATION; NORMALIZATION; MURINE; PROLIFERATION	MicroRNAs (miRNAs) are endogenous small non coding RNAs acting as negative regulators. miRNA are involved in lung development and pulmonary diseases. Measurement of their levels by qPCR is directly influenced by the stability of normalization gene(s), which can be affected by the experimental conditions. The developing lung is a changing tissue and one normalization gene showing stability on one developmental day may be modulated over time. Moreover, some developmental events are affected by sex, which also has to be considered. In this study, we compared stability of five putative control genes in the lung between sexes from the pseudoglandular to the alveolar stages and in adult lungs. Expression of sno135, sno142, sno202, sno234, and sno251 was studied by qPCR in male and female lung samples collected at seven time points from GD 15.5 to PN 30. Cq values of sno251 showed the highest variation across the different developmental stages, while sno234 was the most stable gene. Gene expression stability was studied by geNorm, NormFinder and BestKeeper. Our data showed that ranking of genes based on expression stability changed according to developmental time and sex. sno135/sno234 and sno142/sno234 were proposed as best combinations of normalization genes when both sexes and all the studied developmental stages are considered. Normalization of let7-a RNA levels with different pairs of control genes proposed by geNorm and NormFinder gave similar data, while the use of less stable genes introduced a statistically significant difference on PN 0. In conclusion, variations in stability of normalization gene expression are observed over time and according to sex during lung development. Best pairs of normalization genes are presented for specific developmental stages, and for the period extending from the pseudoglandular to the alveolar stages. The use of normalization genes selected for their expression stability is essential in lung development studies.	[Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves] Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Provost, Pierre R.; Tremblay, Yves] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada; [Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves] Univ Laval, Fac Med, CRBR, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Tremblay, Y (corresponding author), Ctr Rech CHU Quebec, Quebec City, PQ, Canada.	yves.tremblay@crchudequebec.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [171140-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Number 171140-2010 to YT (http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bhaskaran M, 2012, PHYSIOL GENOMICS, V44, P970, DOI 10.1152/physiolgenomics.00145.2011; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bresson E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-2; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; HE L, 2004, NAT REV GENET, V5, P522; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; NIELSEN HC, 1985, J CLIN INVEST, V76, P177, DOI 10.1172/JCI111943; NIELSEN HC, 1981, PEDIATR RES, V15, P1245, DOI 10.1203/00006450-198109000-00004; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Provost PR, 2004, AM J RESP CRIT CARE, V170, P296, DOI 10.1164/rccm.200312-1680OC; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shin JI, 2014, NAT REV CANCER, V14, P70, DOI DOI 10.1038/nrc3477-c1; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Simard M, 2007, ANAL BIOCHEM, V362, P142, DOI 10.1016/j.ab.2006.12.036; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong LLK, 2010, 2010 APPL BIOS; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111855	10.1371/journal.pone.0111855	http://dx.doi.org/10.1371/journal.pone.0111855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368994	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000114
J	Choi, JA; Han, K; Park, YM; Park, CK				Choi, Jin A.; Han, Kyungdo; Park, Yong-Moon; Park, Chan Kee			Age-Related Association of Refractive Error with Intraocular Pressure in the Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; SYSTEMIC FACTORS; RISK-FACTORS; SOUTH-KOREA; GLAUCOMA; MYOPIA; EYE; POPULATION; PREVALENCE; BIOMECHANICS	Background: To investigate the distribution of intraocular pressure (IOP) and refractive errors according to age group in a representative sample of non-glaucomatous Korean adults. Methods: A total of 7,277 adults (>= 19 years) who participated in the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011 underwent ophthalmic examination were divided into three groups according to age: the young- (19-39 years), middle- (40-59 years), and old- (>= 60 years) age groups. Simple and multiple regression analyses between IOP and various parameters (including the refractive error) were conducted. Results: The mean IOP of the total population was 14.0 +/- 0.1 mmHg [young: 13.9 +/- 0.1 mmHg; middle: 14.1 +/- 0.1 mmHg; old: 13.8 +/- 0.2 mmHg (P for trend = 0.085)]. Myopia and high myopia were more prevalent in the young- (70.8% and 16.1%, respectively), compared to the middle- (44.6% and 10.9%) and old- (8.9% and 2.2%) age groups. Univariate analysis in the total population showed that higher IOP was associated with myopic refractive error, the female gender, higher body mass index (BMI), diabetes, hypertension, and hypercholesterolemia (all P<0.05). In the young- and middle-age groups, higher IOP was associated with myopic refractive error, the female gender, higher BMI, hypercholesterolemia and diabetes (all P<0.05). In the old-age group, the association between IOP and refractive error was not significant (P = 0.828). In multiple linear regression analysis, similar significant relationships between the refractive error and IOP were found in the young- and middle-age groups (beta = -0.08 and -0.12; P = 0.002 and <0.001 for young- and middle-age group, respectively), but not in the old-age group (beta = 0.03; P = 0.728), after adjusting for age, gender, BMI, region of habitation, diabetes, hypertension, and hypercholesterolemia. Conclusions: Myopic refractive error was an independent predictor of higher IOP in non-glaucomatous eyes, and the association between refractive error and IOP differed according to age.	[Choi, Jin A.] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol, Suwon, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Suwon, South Korea; [Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Suwon, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	ckpark@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879				Astrom S, 2014, ACTA OPHTHALMOL, V92, P417, DOI 10.1111/aos.12232; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Cheng CY, 2013, OPTOMETRY VISION SCI, V90, P400, DOI 10.1097/OPX.0b013e3182873449; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Fazio MA, 2012, INVEST OPHTH VIS SCI, V53, P5326, DOI 10.1167/iovs.12-9668; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Hashemi H, 2005, BRIT J OPHTHALMOL, V89, P652, DOI 10.1136/bjo.2004.058057; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Kim EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080361; Kim MJ, 2014, ACTA OPHTHALMOL; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Lee JH, 2013, INVEST OPHTH VIS SCI, V54, P5466, DOI 10.1167/iovs.13-12478; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Park BJ, 2013, MENOPAUSE, V20, P742, DOI [10.1097/gme.0b013e31827ce3c6, 10.1097/GME.0b013e31827ce3c6]; Suh W, 2012, AM J OPHTHALMOL, V154, P99, DOI 10.1016/j.ajo.2012.01.009; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Wang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077180; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	29	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111879	10.1371/journal.pone.0111879	http://dx.doi.org/10.1371/journal.pone.0111879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369147	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000117
J	Domingues-Hamdi, E; Vasseur, C; Fournier, JB; Marden, MC; Wajcman, H; Baudin-Creuza, V				Domingues-Hamdi, Elisa; Vasseur, Corinne; Fournier, Jean-Baptiste; Marden, Michael C.; Wajcman, Henri; Baudin-Creuza, Veronique			Role of alpha-Globin H Helix in the Building of Tetrameric Human Hemoglobin: Interaction with alpha-Hemoglobin Stabilizing Protein (AHSP) and Heme Molecule	PLOS ONE			English	Article							ESCHERICHIA-COLI; BETA-HEMOGLOBIN; BINDING; THALASSEMIA; CHAPERONE; VARIANTS; EXPRESSION; STATE; ERYTHROPOIESIS; MUTATIONS	Alpha-Hemoglobin Stabilizing Protein (AHSP) binds to alpha-hemoglobin (alpha-Hb) or alpha-globin and maintains it in a soluble state until its association with the beta-Hb chain partner to form Hb tetramers. AHSP specifically recognizes the G and H helices of alpha-Hb. To investigate the degree of interaction of the various regions of the alpha-globin H helix with AHSP, this interface was studied by stepwise elimination of regions of the alpha-globin H helix: five truncated alpha-Hbs alpha-Hb1-138, alpha-Hb1-134, alpha-Hb1-126, alpha-Hb1-123, alpha-Hb1-117 were co-expressed with AHSP as two glutathione-S-transferase (GST) fusion proteins. SDS-PAGE and Western Blot analysis revealed that the level of expression of each truncated alpha-Hb was similar to that of the wild type alpha-Hb except the shortest protein alpha-Hb1-117 which displayed a decreased expression. While truncated GST-alpha-Hb1-138 and GST-alpha-Hb1- 134 were normally soluble; the shorter globins GST-alpha-Hb1-126 and GST-alpha-Hb1-117 were obtained in very low quantities, and the truncated GST-alpha-Hb1-123 provided the least material. Absorbance and fluorescence studies of complexes showed that the truncated alpha-Hb1-134 and shorter forms led to modified absorption spectra together with an increased fluorescence emission. This attests that shortening the H helix leads to a lower affinity of the alpha-globin for the heme. Upon addition of beta-Hb, the increase in fluorescence indicates the replacement of AHSP by beta-Hb. The CO binding kinetics of different truncated AHSP(WT)/alpha-Hb complexes showed that these Hbs were not functionally normal in terms of the allosteric transition. The N-terminal part of the H helix is primordial for interaction with AHSP and C-terminal part for interaction with heme, both features being required for stability of alpha-globin chain.	[Domingues-Hamdi, Elisa; Vasseur, Corinne; Fournier, Jean-Baptiste; Marden, Michael C.; Baudin-Creuza, Veronique] Univ Paris 11, INSERM, U779, Paris, France; [Wajcman, Henri] UPEC, Hop Henri Mondor, INSERM, U955, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Baudin-Creuza, V (corresponding author), Univ Paris 11, INSERM, U779, Paris, France.	veronique.baudin-creuza@inserm.fr	Vasseur, Corinne/AAV-1384-2021; BAUDIN-CREUZA, Véronique/K-7309-2017; Marden, Michael/AAA-5923-2020; Marden, Michael C/G-3139-2012	Vasseur, Corinne/0000-0002-4422-7069; BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Marden, Michael C/0000-0002-5254-6385	Institut National de la Sante et de la Recherche Medicale; University Paris XI	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris XI	This work was supported by the Institut National de la Sante et de la Recherche Medicale and the University Paris XI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI E, 1971, DERIVATIVES FERROUS, P13; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; Bunn F. H., 1986, HEMOGLOBIN MOL GENET; Chiu F, 1998, BIOCHEM BIOPH RES CO, V242, P365, DOI 10.1006/bbrc.1997.7955; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Fermi G., 1981, HAEMOGLOBIN MYOGLOBI; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; Harteveld CL, 2001, HAEMATOLOGICA, V86, P36; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kiger L, 2014, BBA-GEN SUBJECTS, V1840, P277, DOI 10.1016/j.bbagen.2013.09.015; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Komar AA, 1997, J BIOL CHEM, V272, P10646; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lacerra G, 2007, HAEMATOLOGICA, V93, P141, DOI 10.3324/haematol.11789; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARDEN MC, 1988, BIOCHEMISTRY-US, V27, P1659, DOI 10.1021/bi00405a041; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Rachmilewitz E A, 1976, Birth Defects Orig Artic Ser, V12, P123; SACK JS, 1978, HEMOGLOBIN, V2, P153, DOI 10.3109/03630267809074782; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Turbpaiboon C, 2006, BRIT J HAEMATOL, V132, P370, DOI 10.1111/j.1365-2141.2005.05865.x; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vasseur C, 2009, CLIN BIOCHEM, V42, P1818, DOI 10.1016/j.clinbiochem.2009.05.011; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vasseur-Godbillon C, 2006, BLOOD CELL MOL DIS, V37, P173, DOI 10.1016/j.bcmd.2006.09.002; Wajcman H, 2008, HEMOGLOBIN, V32, P327, DOI 10.1080/03630260802173833; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; WEISS IM, 1994, MOL CELL BIOL, V14, P8123, DOI 10.1128/MCB.14.12.8123; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030	32	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111395	10.1371/journal.pone.0111395	http://dx.doi.org/10.1371/journal.pone.0111395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369055	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000052
J	Koleva, P; Ketabi, A; Valcheva, R; Ganzle, MG; Dieleman, LA				Koleva, Petya; Ketabi, Ali; Valcheva, Rosica; Ganzle, Michael G.; Dieleman, Levinus A.			Chemically Defined Diet Alters the Protective Properties of Fructo-Oligosaccharides and Isomalto-Oligosaccharides in HLA-B27 Transgenic Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REAL-TIME PCR; BUTYRATE-PRODUCING BACTERIA; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; FECAL SAMPLES; FATTY-ACIDS; LACTOBACILLUS; METABOLISM; PRIMERS	Non-digestible oligosaccharides (NDO) were shown to reduce inflammation in experimental colitis, but it remains unclear whether microbiota changes mediate their colitis-modulating effects. This study assessed intestinal microbiota and intestinal inflammation after feeding chemically defined AIN-76A or rat chow diets, with or without supplementation with 8 g/kg body weight of fructo-oligosaccharides (FOS) or isomalto-oligosaccharides (IMO). The study used HLA-B27 transgenic rats, a validated model of inflammatory bowel disease (IBD), in a factorial design with 6 treatment groups. Intestinal inflammation and intestinal microbiota were analysed after 12 weeks of treatment. FOS and IMO reduced colitis in animals fed rat chow, but exhibited no anti-inflammatory effect when added to AIN-76A diets. Both NDO induced specific but divergent microbiota changes. Bifidobacteria and Enterobacteriaceae were stimulated by FOS, whereas copy numbers of Clostridium cluster IV were decreased. In addition, higher concentrations of total short-chain fatty acids (SCFA) were observed in cecal contents of rats on rat chow compared to the chemically defined diet. AIN-76A increased the relative proportions of propionate, iso-butyrate, valerate and iso-valerate irrespective of the oligosaccharide treatment. The SCFA composition, particularly the relative concentration of iso-butyrate, valerate and iso-valerate, was associated (P <= 0.004 and r >= 0.4) with increased colitis and IL-1 beta concentration of the cecal mucosa. This study demonstrated that the protective effects of fibres on colitis development depend on the diet. Although diets modified specific cecal microbiota, our study indicates that these changes were not associated with colitis reduction. Intestinal inflammation was positively correlated to protein fermentation and negatively correlated with carbohydrate fermentation in the large intestine.	[Koleva, Petya; Ketabi, Ali; Ganzle, Michael G.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Koleva, Petya; Valcheva, Rosica; Dieleman, Levinus A.] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Ganzle, Michael G.] Hubei Univ Technol, Sch Food & Pharmaceut Engn, Wuhan, Peoples R China	University of Alberta; University of Alberta; Hubei University of Technology	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Dieleman, Levinus/AAT-8198-2021; Gänzle, Michael/F-1432-2017	Gänzle, Michael/0000-0003-0972-928X; Dieleman, Levinus/0000-0001-7852-2122	National Science and Engineering Council of Canada (NSERC); Alberta Advanced Education and Technology; Faculty of ALES, University of Alberta; Canada Research Chair Program; Faculty of Medicine	National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Advanced Education and Technology; Faculty of ALES, University of Alberta; Canada Research Chair Program(Canada Research Chairs); Faculty of Medicine	This study was supported by the National Science and Engineering Council of Canada (NSERC) and Alberta Advanced Education and Technology. PK is supported by an Interfaculty Student Scholarship of the Faculty of Medicine and the Faculty of ALES, University of Alberta. MG acknowledges the Canada Research Chair Program for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Benjamin JL, 2011, GUT, V60, P923, DOI 10.1136/gut.2010.232025; Bornet FRJ, 2002, DIGEST LIVER DIS, V34, pS111, DOI 10.1016/S1590-8658(02)80177-3; Casellas F, 2007, ALIMENT PHARM THER, V25, P1061, DOI 10.1111/j.1365-2036.2007.03288.x; Castagnini C, 2009, BRIT J NUTR, V102, P1620, DOI 10.1017/S0007114509990936; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen X, 2013, DIGEST DIS SCI, V58, P1560, DOI 10.1007/s10620-013-2563-7; Cummings JH, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80252-X; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; Cummings JH, 1997, EUR J GASTROEN HEPAT, V9, P149, DOI 10.1097/00042737-199702000-00008; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8; Ferguson LR, 2007, GENES NUTR, V2, P71, DOI 10.1007/s12263-007-0046-1; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Geier MS, 2007, DIS COLON RECTUM, V50, P1061, DOI 10.1007/s10350-007-0213-x; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goto H, 2010, J NUTR, V140, P2121, DOI 10.3945/jn.110.125948; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Han WQ, 2007, APPL ENVIRON MICROB, V73, P4082, DOI 10.1128/AEM.01820-06; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hoentjen F, 2005, INFLAMM BOWEL DIS, V11, P977, DOI 10.1097/01.MIB.0000183421.02316.d5; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Htoo JK, 2007, J ANIM SCI, V85, P3303, DOI 10.2527/jas.2007-0105; Hu Y, 2013, LETT APPL MICROBIOL, V57, P108, DOI 10.1111/lam.12076; Huda-Faujan N, 2010, Open Biochem J, V4, P53, DOI 10.2174/1874091X01004010053; Issa M, 2011, NUTR CLIN PRACT, V26, P151, DOI 10.1177/0884533611400233; Iwaya H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050658; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; KOHMOTO T, 1992, BIOSCI BIOTECH BIOCH, V56, P937, DOI 10.1271/bbb.56.937; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Le Bourhis AG, 2005, APPL ENVIRON MICROB, V71, P29, DOI 10.1128/AEM.71.1.29-38.2005; Le Leu R, 2013, DIGEST DIS SCI, V58, P3475, DOI 10.1007/s10620-013-2844-1; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marteau P, 2009, DIGEST DIS, V27, P99, DOI 10.1159/000268128; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Meister D, 2005, WORLD J GASTROENTERO, V11, P7466, DOI 10.3748/wjg.v11.i47.7466; Messelhausser U, 2007, J VERBRAUCH LEBENSM, V2, P194, DOI 10.1007/s00003-007-0173-z; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; Ooi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086366; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Roberfroid MB, 1998, J NUTR, V128, P11, DOI 10.1093/jn/128.1.11; Ross AB, 2011, BRIT J NUTR, V105, P1492, DOI 10.1017/S0007114510005209; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thompson-Chagoyan OC, 2005, CLIN NUTR, V24, P339, DOI 10.1016/j.clnu.2005.02.009; Tieking M, 2005, J AGR FOOD CHEM, V53, P2456, DOI 10.1021/jf048307v; USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340; van den Berg RJ, 2006, CLIN MICROBIOL INFEC, V12, P184, DOI 10.1111/j.1469-0691.2005.01301.x; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	62	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111717	10.1371/journal.pone.0111717	http://dx.doi.org/10.1371/journal.pone.0111717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369019	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000091
J	Bressel, PJRD; McNally, GP				Bressel, Philip Jean-Richard Dit; McNally, Gavan P.			The Role of the Lateral Habenula in Punishment	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINE; NEURONS; REWARD; TRANSMISSION; ACTIVATION; SEEKING; INPUT	The lateral habenula (LHb) is a small epithalamic structure that projects via the fasciculus retroflexus to the midbrain. The LHb is known to modulate midbrain dopamine (DA) neurons, including inhibition of ventral tegmental area (VTA) neurons via glutamatergic excitation of the GABAergic rostromedial tegmental nucleus (RMTg). A variety of lines of evidence show activity in LHb and the LHb-RMTg pathway is correlated with, and is sufficient to support, punishment learning. However, it is not immediately clear whether LHb is necessary for punishment. Here we used a within-subjects punishment task to assess the role of LHb in the acquisition and expression of punishment as well as in aversive choice. Rats that pressed two individually presented levers for pellet rewards rapidly suppressed responding to one lever if it also caused footshock deliveries (punished lever) but continued pressing a second lever that did not cause footshock (unpunished lever). Infusions of an AMPA receptor antagonist (NBQX) into LHb had no effect on the acquisition or expression of this punishment, or on aversive choice, but did increase locomotion. Infusion of the sodium channel blocker bupivacaine likewise had no effect on expression of punishment. However, infusion of the calcium channel blocker mibefradil did affect expression of punishment by significantly decreasing the latency with which rats responded on the punished lever and significantly increasing unpunished lever-pressing. Taken together, these findings indicate that the LHb plays a limited role in punishment, influencing only latency to respond. This role is linked to calcium channel permeability and not AMPA receptor or sodium channel permeability.	[Bressel, Philip Jean-Richard Dit; McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	McNally, GP (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	g.mcnally@unsw.edu.au	Jean-Richard-dit-Bressel, Philip/AAR-6185-2020; Jean-Richard, Philip/AAK-2006-2021	Jean-Richard-dit-Bressel, Philip/0000-0002-0898-8987; McNally, Gavan/0000-0001-9061-6463	Australian Research Council [FT120100250, DP130100310]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council FT120100250, Australian Research Council DP130100310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Brown PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060678; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gifuni AJ, 2012, NEUROPHARMACOLOGY, V63, P945, DOI 10.1016/j.neuropharm.2012.07.032; Haack AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092701; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; HUGUENARD JR, 1993, J NEUROPHYSIOL, V70, P158, DOI 10.1152/jn.1993.70.1.158; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Meye FJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00860; Millan EZ, 2011, LEARN MEMORY, V18, P414, DOI 10.1101/lm.2144411; Mirrione MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00029; Nair SG, 2013, BRAIN RES, V1511, P93, DOI 10.1016/j.brainres.2012.10.011; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stoetzer C, 2014, BR J ANAESTH; Stopper CM, 2014, NAT NEUROSCI, V17, P33, DOI 10.1038/nn.3587; Tomaiuolo M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00170; Yadid Gal, 2013, Front Hum Neurosci, V7, P806, DOI 10.3389/fnhum.2013.00806; Zuo WH, 2013, NEUROPHARMACOLOGY, V70, P180, DOI 10.1016/j.neuropharm.2013.01.008	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111699	10.1371/journal.pone.0111699	http://dx.doi.org/10.1371/journal.pone.0111699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365401	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100107
J	Campbell, IC; Suever, JD; Timmins, LH; Veneziani, A; Vito, RP; Virmani, R; Oshinski, JN; Taylor, WR				Campbell, Ian C.; Suever, Jonathan D.; Timmins, Lucas H.; Veneziani, Alessandro; Vito, Raymond P.; Virmani, Renu; Oshinski, John N.; Taylor, W. Robert			Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women	PLOS ONE			English	Article							SUDDEN CORONARY DEATH; CIRCUMFERENTIAL STRESS; CAP THICKNESS; LIPID CORE; THROMBOSIS; STABILITY; MORPHOLOGY; ARTERIES; LESIONS; PREVENTION	Objective: Although plaque erosion causes approximately 40% of all coronary thrombi and disproportionally affects women more than men, its mechanism is not well understood. The role of tissue mechanics in plaque rupture and regulation of mechanosensitive inflammatory proteins is well established, but their role in plaque erosion is unknown. Given obvious differences in morphology between plaque erosion and rupture, we hypothesized that inflammation in general as well as the association between local mechanical strain and inflammation known to exist in plaque rupture may not occur in plaque erosion. Therefore, our objective was to determine if similar mechanisms underlie plaque rupture and plaque erosion. Methods and Results: We studied a total of 74 human coronary plaque specimens obtained at autopsy. Using lesion-specific computer modeling of solid mechanics, we calculated the stress and strain distribution for each plaque and determined if there were any relationships with markers of inflammation. Consistent with previous studies, inflammatory markers were positively associated with increasing strain in specimens with rupture and thin-cap fibroatheromas. Conversely, overall staining for inflammatory markers and apoptosis were significantly lower in erosion, and there was no relationship with mechanical strain. Samples with plaque erosion most closely resembled those with the stable phenotype of thick-cap fibroatheromas. Conclusions: In contrast to classic plaque rupture, plaque erosion was not associated with markers of inflammation and mechanical strain. These data suggest that plaque erosion is a distinct pathophysiological process with a different etiology and therefore raises the possibility that a different therapeutic approach may be required to prevent plaque erosion.	[Campbell, Ian C.; Suever, Jonathan D.; Timmins, Lucas H.; Veneziani, Alessandro; Vito, Raymond P.; Oshinski, John N.; Taylor, W. Robert] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Timmins, Lucas H.; Taylor, W. Robert] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Veneziani, Alessandro] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Vito, Raymond P.] Georgia Inst Technol, George W Woodruff Dept Mech Engn, Atlanta, GA 30332 USA; [Virmani, Renu] CVPath Inst Inc, Gaithersburg, MD USA; [Oshinski, John N.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Div Cardiol, Decatur, GA USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; CVPath Institute; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Taylor, WR (corresponding author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	wtaylor@emory.edu	Campbell, Ian/J-4432-2012	Campbell, Ian/0000-0002-4640-2692	American Heart Association Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0644493]; National Institutes of Health Bioengineering Research Partnership [R01 HL70531]; NIH Program of Excellence in Nanotechnology Award [HHSN268201000043C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070531] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Bioengineering Research Partnership(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Program of Excellence in Nanotechnology Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by an American Heart Association Predoctoral Fellowship (ICC), an American Heart Association Postdoctoral Fellowship (LHT), by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-0644493 (ICC and JDS), by the National Institutes of Health Bioengineering Research Partnership Grant No. R01 HL70531, and a NIH Program of Excellence in Nanotechnology Award (HHSN268201000043C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie D, 1998, J BIOMECH ENG-T ASME, V120, P602, DOI 10.1115/1.2834750; Campbell Ian C, 2013, Cardiovasc Eng Technol, V4, DOI 10.1007/s13239-013-0165-3; Campbell IC, 2013, AM J PHYSIOL-HEART C, V304, pH473, DOI 10.1152/ajpheart.00620.2012; Canfeld T, 1987, HDB BIOENGINEERING; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Chodorowski A, 2005, PROC SPIE, V5747, P1589, DOI 10.1117/12.594944; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Finet G, 2004, CORONARY ARTERY DIS, V15, P13, DOI 10.1097/00019501-200402000-00003; Fung Y. C., 1997, BIOMECHANICS CIRCULA; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; Fuster V, 1996, MAYO CLIN PRACTICE C, P1056; Hallow KM, 2009, BIOMECH MODEL MECHAN, V8, P473, DOI 10.1007/s10237-009-0151-8; Holzapfel GA, 2005, AM J PHYSIOL-HEART C, V289, pH2048, DOI 10.1152/ajpheart.00934.2004; Holzapfel GA, 1998, COMPUT BIOL MED, V28, P377, DOI 10.1016/S0010-4825(98)00022-5; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Humphrey JD, 2002, MATH MOD METH APPL S, V12, P407, DOI 10.1142/S0218202502001714; Kilpatrick D, 2001, J BIOMECH ENG-T ASME, V123, P635, DOI 10.1115/1.1406037; Kolodgie FD, 2004, CURR OPIN LIPIDOL, V15, P575, DOI 10.1097/00041433-200410000-00012; Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007; Lee RT, 2000, Z KARDIOL, V89, P80; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Mayranpaa MI, 2007, ENDOTHELIUM-J ENDOTH, V14, P81, DOI 10.1080/10623320701346783; Ohayon J, 2008, AM J PHYSIOL-HEART C, V295, pH717, DOI 10.1152/ajpheart.00005.2008; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Sumi T, 2010, J THROMB HAEMOST, V8, P1394, DOI 10.1111/j.1538-7836.2010.03843.x; Timmins LH, 2013, IEEE T MED IMAGING; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Weber M, 2011, HEART, V97, P626, DOI 10.1136/hrt.2010.210419; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775	40	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111785	10.1371/journal.pone.0111785	http://dx.doi.org/10.1371/journal.pone.0111785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365517	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100121
J	Lee, DV; Li, DM; Yan, QY; Zhu, YM; Goodwin, B; Calle, R; Brenner, MB; Talukdar, S				Lee, Darwin V.; Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Goodwin, Bryan; Calle, Roberto; Brenner, Martin B.; Talukdar, Saswata			Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes	PLOS ONE			English	Article							ENERGY-EXPENDITURE; FGF21; MICE; MOUSE; METABOLISM; PEPTIDES; TISSUE; BROWN	Fibroblast growth factor 21 (FGF21) has evolved as a major metabolic regulator, the pharmacological administration of which causes weight loss, insulin sensitivity and glucose control in rodents and humans. To understand the molecular mechanisms by which FGF21 exerts its metabolic effects, we developed a human in vitro model of adipocytes to examine crosstalk between FGF21 and insulin signaling. Human adipose stem cell-derived (hASC) adipocytes were acutely treated with FGF21 alone, insulin alone, or in combination. Insulin signaling under these conditions was assessed by measuring tyrosine phosphorylation of insulin receptor (InsR), insulin receptor substrate-1 (IRS-1), and serine 473 phosphorylation of Akt, followed by a functional assay using 14C-2-deoxyglucose [C-14]-2DG to measure glucose uptake in these cells. FGF21 alone caused a modest increase of glucose uptake, but treatment with FGF21 in combination with insulin had a synergistic effect on glucose uptake in these cells. The presence of FGF21 also effectively lowered the insulin concentration required to achieve the same level of glucose uptake compared to the absence of FGF21 by 10-fold. This acute effect of FGF21 on insulin signaling was not due to IR, IGF-1R, or IRS-1 activation. Moreover, we observed a substantial increase in basal S473-Akt phosphorylation by FGF21 alone, in contrast to the minimal shift in basal glucose uptake. Taken together, our data demonstrate that acute co-treatment of hASC-adipocytes with FGF21 and insulin can result in a synergistic improvement in glucose uptake. These effects were shown to occur at or downstream of Akt, or separate from the canonical insulin signaling pathway.	[Lee, Darwin V.; Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Goodwin, Bryan; Calle, Roberto; Brenner, Martin B.; Talukdar, Saswata] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA USA	Pfizer	Talukdar, S (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA USA.	Saswata.Talukdar@pfizer.com		Calle, Roberto/0000-0001-6577-5657	Pfizer, CVMED	Pfizer, CVMED	The study was paid for by Pfizer, CVMED. The funder provided support in the form of salaries for authors [D.V.L., D.L., Q.Y., Y.Z., B.G., R.C., M.B.B., S.T.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang J, 2013, J PHARMACOL EXP THER, V346, P270, DOI 10.1124/jpet.113.204420; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Muise ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073011; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Owen BM, 2014, CELL METAB; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yang C. F., 2012, BIOCH PHYSL OPEN ACC, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0033870; Yie JM, 2012, CHEM BIOL DRUG DES, V79, P398, DOI 10.1111/j.1747-0285.2012.01325.x; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	32	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111767	10.1371/journal.pone.0111767	http://dx.doi.org/10.1371/journal.pone.0111767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365322	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100117
J	Marwaha, S; Schumacher, MA; Zavros, Y; Eghbalnia, HR				Marwaha, Shruti; Schumacher, Michael A.; Zavros, Yana; Eghbalnia, Hamid R.			Crosstalks between Cytokines and Sonic Hedgehog in Helicobacter pylori Infection: A Mathematical Model	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; SIGNALING PATHWAY; SYSTEMS BIOLOGY; INTERLEUKIN-8 PRODUCTION; GAMMA-INTERFERON; IMMUNE-RESPONSE; PANCREATIC-CANCER; HUMAN MONOCYTES; T-LYMPHOCYTES	Helicobacter pylori infection of gastric tissue results in an immune response dominated by Th1 cytokines and has also been linked with dysregulation of Sonic Hedgehog (SHH) signaling pathway in gastric tissue. However, since interactions between the cytokines and SHH during H. pylori infection are not well understood, any mechanistic understanding achieved through interpretation of the statistical analysis of experimental results in the context of currently known circuit must be carefully scrutinized. Here, we use mathematical modeling aided by restraints of experimental data to evaluate the consistency between experimental results and temporal behavior of H. pylori activated cytokine circuit model. Statistical analysis of qPCR data from uninfected and H. pylori infected wild-type and parietal cell-specific SHH knockout (PC-SHHKO) mice for day 7 and 180 indicate significant changes that suggest role of SHH in cytokine regulation. The experimentally observed changes are further investigated using a mathematical model that examines dynamic crosstalks among proinflammatory (IL1 beta, IL-12, IFN gamma, MIP-2) cytokines, anti-inflammatory (IL-10) cytokines and SHH during H. pylori infection. Response analysis of the resulting model demonstrates that circuitry, as currently known, is inadequate for explaining of the experimental observations; suggesting the need for additional specific regulatory interactions. A key advantage of a computational model is the ability to propose putative circuit models for in-silico experimentation. We use this approach to propose a parsimonious model that incorporates crosstalks between NF kappa B, SHH, IL-1 beta and IL-10, resulting in a feedback loop capable of exhibiting cyclic behavior. Separately, we show that analysis of an independent time-series GEO microarray data for IL-1 beta, IFN gamma and IL-10 in mock and H. pylori infected mice further supports the proposed hypothesis that these cytokines may follow a cyclic trend. Predictions from the in-silico model provide useful insights for generating new hypothesis and design of subsequent experimental studies.	[Marwaha, Shruti; Schumacher, Michael A.; Zavros, Yana; Eghbalnia, Hamid R.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Marwaha, S (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA.	marwahsi@mail.uc.edu	Schumacher, Michael/GYV-4197-2022; Marwaha, Shruti/ABF-5360-2020	Marwaha, Shruti/0000-0002-1877-2629; Schumacher, Michael/0000-0003-3353-0414	Department of Molecular and Cellular Physiology, University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Department of Molecular and Cellular Physiology, University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by start-up funds from the Department of Molecular and Cellular Physiology, University of Cincinnati (Hamid R. Eghbalnia). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Anderson J, 2011, AUTOMATICA, V47, P1165, DOI 10.1016/j.automatica.2011.03.010; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Badger K, 1997, GUT, V40, P739, DOI 10.1136/gut.40.6.739; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bimczok D, 2013, J IMMUNOL, V190, P6626, DOI 10.4049/jimmunol.1203330; Bisset K, 2012, INT PARALL DISTRIB P, P48, DOI 10.1109/IPDPS.2012.15; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLASER MJ, 1995, CANCER RES, V55, P562; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bliss CM, 1998, INFECT IMMUN, V66, P5357, DOI 10.1128/IAI.66.11.5357-5363.1998; Brazhnik P, 2006, CELL CYCLE, V5, P522, DOI 10.4161/cc.5.5.2493; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, BIOPHYS CHEM, V104, P573, DOI 10.1016/S0301-4622(03)00060-7; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Jonge R, 2001, FEMS MICROBIOL LETT, V196, P235, DOI 10.1016/S0378-1097(01)00074-X; Dunaeva M, 2010, BASIC RES CARDIOL, V105, P61, DOI 10.1007/s00395-009-0047-x; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Ernst P, 1999, ALIMENT PHARM THER, V13, P13, DOI 10.1046/j.1365-2036.1999.00003.x; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Franke R, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-4; Franks NR, 2001, SELF ORG BIOL SYSTEM; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jhala NC, 2003, AM J CLIN PATHOL, V119, P101, DOI 10.1309/YDTXKE06XHTHFNP2; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kim JH, 2010, ONCOL REP, V23, P1523, DOI 10.3892/or_00000791; KIRSCHNER DE, 1995, J THEOR BIOL, V176, P281, DOI 10.1006/jtbi.1995.0198; Koschorreck M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-336; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Kundu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016306; Lacy BE, 2001, J NUTR, V131, p2789S, DOI 10.1093/jn/131.10.2789S; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee KM, 2010, CANCER LETT, V287, P44, DOI 10.1016/j.canlet.2009.05.032; Lee SY, 2007, ONCOL REP, V17, P1051; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lindgren A, 2011, INNATE IMMUN-LONDON, V17, P191, DOI 10.1177/1753425909357970; Lohoff M, 2000, J BIOTECHNOL, V83, P33, DOI 10.1016/S0168-1656(00)00295-9; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Luzza F, DIG LIVER DIS, V33, P14; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Martin J, 2010, DIGEST DIS SCI, V55, P1516, DOI 10.1007/s10620-010-1252-z; Maurya MR, 2005, IEE P SYST BIOL, V152, P229, DOI 10.1049/ip-syb:20050014; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Mueller A, 2004, GASTROENTEROLOGY, V127, P1446, DOI 10.1053/j.gastro.2004.08.054; Naito Y, 2002, FREE RADICAL BIO MED, V33, P323, DOI 10.1016/S0891-5849(02)00868-7; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Nakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200; Noto JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054344; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Nozawa Y, 2002, BIOCHEM PHARMACOL, V64, P21, DOI 10.1016/S0006-2952(02)01030-4; Pellicano A, 2007, INFECT IMMUN, V75, P1738, DOI 10.1128/IAI.01446-06; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Reinard JC, 2006, COMMUNICATION RES ST, P218; Remick DG, 2001, AM J PATHOL, V159, P1149, DOI 10.1016/S0002-9440(10)61791-9; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; Romano MF, 1996, J IMMUNOL, V156, P2119; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Thompson LJ, 2004, INFECT IMMUN, V72, P4668, DOI 10.1128/IAI.72.8.4668-4679.2004; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wan JH, 2014, BIORESEARCH OPEN ACC, V3, P53, DOI 10.1089/biores.2014.0001; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Xiao C, 2010, GASTROENTEROLOGY, V138, P550, DOI 10.1053/j.gastro.2009.11.002; Yamada H, 2001, BIOCHEM PHARMACOL, V61, P1595, DOI 10.1016/S0006-2952(01)00628-1; Yun CH, 2005, INFECT IMMUN, V73, P1482, DOI 10.1128/IAI.73.3.1482-1490.2005; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053	90	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111338	10.1371/journal.pone.0111338	http://dx.doi.org/10.1371/journal.pone.0111338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364910	gold, Green Published			2022-12-26	WOS:000345558100063
J	Nimmanee, P; Woo, PCY; Vanittanakom, P; Youngchim, S; Vanittanakom, N				Nimmanee, Panjaphorn; Woo, Patrick C. Y.; Vanittanakom, Pramote; Youngchim, Sirida; Vanittanakom, Nongnuch			Functional Analysis of atfA Gene to Stress Response in Pathogenic Thermal Dimorphic Fungus Penicillium marneffei	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ASPERGILLUS-ORYZAE; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS; EXPRESSION; PROTEINS; PATHWAY	Penicillium marneffei, the pathogenic thermal dimorphic fungus is a causative agent of a fatal systemic disease, penicilliosis marneffei, in immunocompromised patients especially HIV patients. For growth and survival, this fungus has to adapt to environmental stresses outside and inside host cells and this adaptation requires stress signaling pathways and regulation of gene expression under various kinds of stresses. In this report, P. marneffei activating transcription factor (atfA) gene encoding bZip-type transcription factor was characterized. To determine functions of this gene, atfA isogenic mutant strain was constructed using the modified split marker recombination method. The phenotypes and susceptibility to varieties of stresses including osmotic, oxidative, heat, UV, cell wall and cell membrane stresses of the mutant strain were compared with the wild type and the atfA complemented strains. Results demonstrated that the mRNA expression level of P. marneffei atfA gene increased under heat stress at 42 degrees C. The atfA mutant was more sensitive to sodium dodecyl sulphate, amphotericin B and tert-butyl hydroperoxide than the wild type and complemented strains but not hydrogen peroxide, menadione, NaCl, sorbitol, calcofluor white, itraconazole, UV stresses and heat stress at 39 degrees C. In addition, recovery of atfA mutant conidia after mouse and human macrophage infections was significantly decreased compared to those of wild type and complemented strains. These results indicated that the atfA gene was required by P. marneffei under specific stress conditions and might be necessary for fighting against host immune cells during the initiation of infection.	[Nimmanee, Panjaphorn; Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Woo, Patrick C. Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Vanittanakom, Pramote] Univ Phayao, Fac Med, Phayao, Thailand	Chiang Mai University; University of Hong Kong; University of Hong Kong; University of Phayao	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	drnongnuch@gmail.com	Woo, Patrick Chiu Yat/AAJ-6112-2020	Woo, Patrick Chiu Yat/0000-0001-9401-1832	Royal Golden Jubilee PhD Research Assistant Fellowship; Faculty of Medicine, Chiang Mai University; Faculty of Medicine, the University of Hong Kong	Royal Golden Jubilee PhD Research Assistant Fellowship; Faculty of Medicine, Chiang Mai University; Faculty of Medicine, the University of Hong Kong(University of Hong Kong)	This work was supported by: 1) a Royal Golden Jubilee PhD Research Assistant Fellowship, 2) Faculty of Medicine, Chiang Mai University, and 3) Faculty of Medicine, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana David M., 2008, P151; Boyce KJ, 2011, MOL MICROBIOL, V82, P1164, DOI 10.1111/j.1365-2958.2011.07878.x; Boyce KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000678; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Canovas David, 2007, P213, DOI 10.1007/978-1-4020-6397-8_9; Cao CW, 2009, MYCOPATHOLOGIA, V168, P23, DOI 10.1007/s11046-009-9192-x; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Cardoza RE, 2006, J MICROBIOL, V44, P383; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Cooper CR, 2008, FUTURE MICROBIOL, V3, P43, DOI 10.2217/17460913.3.1.43; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jin FH, 2004, BIOSCI BIOTECH BIOCH, V68, P656, DOI 10.1271/bbb.68.656; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kummasook A, 2007, DNA SEQUENCE, V18, P385, DOI 10.1080/10425170701309012; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lau SKP, 2013, FEBS J, V280, P6613, DOI 10.1111/febs.12566; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Liu D, 2009, MYCOSES, V54, P113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DM, 2013, MYCOPATHOLOGIA, V175, P13, DOI 10.1007/s11046-012-9600-5; Rodriguez-Pena JM, 2010, YEAST, V27, P495, DOI 10.1002/yea.1792; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Sakamoto K, 2008, FUNGAL GENET BIOL, V45, P922, DOI 10.1016/j.fgb.2008.03.009; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom N, 2002, J CLIN MICROBIOL, V40, P1739, DOI 10.1128/JCM.40.5.1739-1742.2002; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Woo PCY, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001871; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x	43	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111200	10.1371/journal.pone.0111200	http://dx.doi.org/10.1371/journal.pone.0111200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365258	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100054
J	Vinay-Lara, E; Hamilton, JJ; Stahl, B; Broadbent, JR; Reed, JL; Steele, JL				Vinay-Lara, Elena; Hamilton, Joshua J.; Stahl, Buffy; Broadbent, Jeff R.; Reed, Jennifer L.; Steele, James L.			Genome -Scale Reconstruction of Metabolic Networks of Lactobacillus casei ATCC 334 and 12A	PLOS ONE			English	Article							MODEL; PLANTARUM; GROWTH; OPTIMIZATION; PATHWAYS	Lactobacillus casei strains are widely used in industry and the utility of this organism in these industrial applications is strain dependent. Hence, tools capable of predicting strain specific phenotypes would have utility in the selection of strains for specific industrial processes. Genome-scale metabolic models can be utilized to better understand genotype-phenotype relationships and to compare different organisms. To assist in the selection and development of strains with enhanced industrial utility, genome-scale models for L. casei ATCC 334, a well characterized strain, and strain 12A, a corn silage isolate, were constructed. Draft models were generated from RAST genome annotations using the Model SEED database and refined by evaluating ATP generating cycles, mass-and-charge-balances of reactions, and growth phenotypes. After the validation process was finished, we compared the metabolic networks of these two strains to identify metabolic, genetic and ortholog differences that may lead to different phenotypic behaviors. We conclude that the metabolic capabilities of the two networks are highly similar. The L. casei ATCC 334 model accounts for 1,040 reactions, 959 metabolites and 548 genes, while the L. casei 12A model accounts for 1,076 reactions, 979 metabolites and 640 genes. The developed L. casei ATCC 334 and 12A metabolic models will enable better understanding of the physiology of these organisms and be valuable tools in the development and selection of strains with enhanced utility in a variety of industrial applications.	[Vinay-Lara, Elena; Steele, James L.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Hamilton, Joshua J.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [Stahl, Buffy] DuPont Nutr & Hlth, Madison, WI USA; [Broadbent, Jeff R.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; DuPont; Utah System of Higher Education; Utah State University	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	jlsteele@wisc.edu	Broadbent, Jeff R/A-9626-2010; Reed, Jennifer L/E-5137-2011	Broadbent, Jeff R/0000-0002-0751-0877; Reed, Jennifer L/0000-0001-7854-6220; Hamilton, Joshua/0000-0001-9790-3609	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-67009-30043]; CONACyT; National Science Foundation Graduate Research Fellowship [DGE-0718123]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and by the National Research Initiative Competitive Grant no. 2011-67009-30043 from the USDA National Institute of Food and Agriculture. Elena Vinay-Lara gratefully acknowledges the scholarship from CONACyT to pursue her postgraduate studies. Josh J. Hamilton received support through a National Science Foundation Graduate Research Fellowship (DGE-0718123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bringel F, 2003, APPL ENVIRON MICROB, V69, P2674, DOI 10.1128/AEM.69.5.2674-2683.2003; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; DeJongh M, 2012, BIOINFORMATICS, V28, P891, DOI 10.1093/bioinformatics/btr719; Flahaut NAL, 2013, APPL MICROBIOL BIOT, V97, P8729, DOI 10.1007/s00253-013-5140-2; Goldin B. R., 1992, Probiotics: the scientific basis., P355; Hamilton JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034670; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mayra-Makinen A, 1998, LACTIC ACID BACTERIA, P73; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pastink MI, 2009, APPL ENVIRON MICROB, V75, P3627, DOI 10.1128/AEM.00138-09; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Vermeulen N, 2007, J APPL MICROBIOL, V103, P1197, DOI 10.1111/j.1365-2672.2007.03333.x; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005	28	25	26	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110785	10.1371/journal.pone.0110785	http://dx.doi.org/10.1371/journal.pone.0110785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365062	Green Published, gold			2022-12-26	WOS:000345558100028
J	Xu, L; Chen, YQ; Yang, K; Wang, YF; Tian, LC; Zhang, J; Wang, EW; Sun, DJ; Lu, WJ; Wang, J				Xu, Lei; Chen, Yuqin; Yang, Kai; Wang, Yingfeng; Tian, Lichun; Zhang, Jie; Wang, Elizabeth Wenqian; Sun, Dejun; Lu, Wenju; Wang, Jian			Chronic Hypoxia Increases TRPC6 Expression and Basal Intracellular Ca2+ Concentration in Rat Distal Pulmonary Venous Smooth Muscle	PLOS ONE			English	Article							RECEPTOR POTENTIAL EXPRESSION; CAPACITATIVE CALCIUM-ENTRY; UP-REGULATION; CELL PROLIFERATION; ARTERIAL; VEINS; SILDENAFIL; MIGRATION; PROTEINS; CHANNELS	Background: Hypoxia causes remodeling and contractile responses in both pulmonary artery (PA) and pulmonary vein (PV). Here we explore the effect of hypoxia on PV and pulmonary venous smooth muscle cells (PVSMCs). Methods: Chronic hypoxic pulmonary hypertension (CHPH) model was established by exposing rats to 10% O-2 for 21 days. Rat distal PVSMCs were isolated and cultured for in vitro experiments. The fura-2 based fluorescence calcium imaging was used to measure the basal intracellular Ca2+ concentration ([Ca2+](i)) and store-operated Ca2+ entry (SOCE). Quantitative RTPCR and western blotting were performed to measure the expression of mRNA and levels of canonical transient receptor potential (TRPC) protein respectively. Results: Hypoxia increased the basal [Ca2+](i) and SOCE in both freshly dissociated and serum cultured distal PVSMCs.Moreover, hypoxia increased TRPC6 expression at mRNA and protein levels in both cultured PVSMCs exposed to prolonged hypoxia (4% O-2, 60 h) and distal PV isolated from CHPH rats. Hypoxia also enhanced proliferation and migration of rat distal PVSMCs. Conclusions: Hypoxia induces elevation of SOCE in distal PVSMCs, leading to enhancement of basal [Ca2+](i) in PVSMCs. This enhancement is potentially correlated with the increased expression of TRPC6. Hypoxia triggered intracellular calcium contributes to promoted proliferation and migration of PVSMCs.	[Xu, Lei; Chen, Yuqin; Yang, Kai; Wang, Yingfeng; Tian, Lichun; Zhang, Jie; Lu, Wenju; Wang, Jian] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Xu, Lei; Yang, Kai; Lu, Wenju; Wang, Jian] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sun, Dejun; Wang, Jian] Inner Mongolia Peoples Hosp, Div Pulm & Crit Care Med, Hohhot, Inner Mongolia, Peoples R China; [Wang, Elizabeth Wenqian] Geisinger Med Ctr, Danville, PA 17822 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Johns Hopkins University; Geisinger Medical Center	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com; jwang31@jhmi.edu	Yang, Kai/I-6524-2019	Yang, Kai/0000-0003-3044-2240; Chen, Yuqin/0000-0002-7011-7250	NIH Research Grants [R01HL093020]; National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B03160030]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant [cxzd1025]; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	NIH Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Research Grants (R01HL093020), National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), Changjiang Scholars and Innovative Research Team in University grant (IRT0961), Guangdong Department of Science and Technology of China (2009B050700041, 2010B03160030), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, Guangdong Department of Education research grant (cxzd1025), Guangdong Natural Science Foundation team grant (2010), Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). Lei Xu was supported by the Guangzhou Elite Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; CHAZOVA I, 1995, AM J PATHOL, V146, P389; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; DINGEMANS KP, 1978, AM J PATHOL, V93, P353; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; FINNEGAN P, 1977, IRISH J MED SCI, V146, P233, DOI 10.1007/BF03030965; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hillier SC, 1997, J APPL PHYSIOL, V82, P1084, DOI 10.1152/jappl.1997.82.4.1084; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Leggett K, 2012, AM J PHYSIOL-LUNG C, V303, pL343, DOI 10.1152/ajplung.00130.2012; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Michelakis ED, 2001, AM J PHYSIOL-LUNG C, V280, pL1138, DOI 10.1152/ajplung.2001.280.6.L1138; MIGALLY N, 1982, J SUBMICR CYTOL PATH, V14, P239; Ng LC, 2012, AM J PHYSIOL-CELL PH, V303, pC1156, DOI 10.1152/ajpcell.00065.2012; Peng GY, 2013, J THORAC DIS, V5, P605, DOI 10.3978/j.issn.2072-1439.2013.08.68; Peng GY, 2010, AM J PHYSIOL-LUNG C, V299, pL621, DOI 10.1152/ajplung.00176.2009; Peng GY, 2010, HYPERTENS RES, V33, P308, DOI 10.1038/hr.2009.234; RAJ JU, 1990, J APPL PHYSIOL, V69, P2183; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Remillard CV, 2006, MICROCIRCULATION, V13, P671, DOI 10.1080/10739680600930313; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Takahashi H, 2001, AM J PHYSIOL-LUNG C, V280, pL1104, DOI 10.1152/ajplung.2001.280.6.L1104; Wang C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-123; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wang J, 2013, AM J RESP CELL MOL, V49, P231, DOI 10.1165/rcmb.2012-0185OC; Wang J, 2013, AM J RESP CELL MOL, V48, P125, DOI 10.1165/rcmb.2012-0071OC; Yang QW, 2012, AM J PHYSIOL-LUNG C, V303, pL1001, DOI 10.1152/ajplung.00092.2012; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zhang S, 2005, AM J PHYSIOL-CELL PH, V288, pC245, DOI 10.1152/ajpcell.00411.2004; Zhang Y, 2013, AM J PHYSIOL-CELL PH, V304, pC833, DOI 10.1152/ajpcell.00036.2012; ZHAO Y, 1993, AM J PHYSIOL, V265, pL87; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G	39	17	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e112007	10.1371/journal.pone.0112007	http://dx.doi.org/10.1371/journal.pone.0112007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365342	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100142
J	Chang, YH; Sun, YH				Chang, Yung-Heng; Sun, Yi Henry			Carrier of Wingless (Cow), a Secreted Heparan Sulfate Proteoglycan, Promotes Extracellular Transport of Wingless	PLOS ONE			English	Article							MORPHOGEN GRADIENT FORMATION; FRIZZLED-RELATED PROTEINS; LONG-RANGE ACTION; DROSOPHILA EMBRYOS; DALLY-LIKE; ORGAN DEVELOPMENT; IMAGINAL DISKS; WNT PROTEINS; EXPRESSION; GENE	Morphogens are signaling molecules that regulate growth and patterning during development by forming a gradient and activating different target genes at different concentrations. The extracellular distribution of morphogens is tightly regulated, with the Drosophila morphogen Wingless (Wg) relying on Dally-like (Dlp) and transcytosis for its distribution. However, in the absence of Dlp or endocytic activity, Wg can still move across cells along the apical (Ap) surface. We identified a novel secreted heparan sulfate proteoglycan (HSPG) that binds to Wg and promotes its extracellular distribution by increasing Wg mobility, which was thus named Carrier of Wg (Cow). Cow promotes the Ap transport of Wg, independent of Dlp and endocytosis, and this function addresses a previous gap in the understanding of Wg movement. This is the first example of a diffusible HSPG acting as a carrier to promote the extracellular movement of a morphogen.	[Chang, Yung-Heng; Sun, Yi Henry] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Yung-Heng; Sun, Yi Henry] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Sun, YH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	mbyhsun@gate.sinica.edu.tw	Sun, Y. Henry/ABC-4614-2021; Sun, Y. Henry/AAZ-7966-2021	Sun, Y. Henry/0000-0001-8279-5270; CHANG, YUNG-HENG/0000-0001-9459-0790	Academia Sinica, Taiwan, Republic of China [AS-91-IMB-4PP, AS-95-TP-B04]; National Science Council, Taiwan, Republic of China [NSC 96-2321-B-001-002, NSC 97-2321-B-001-002, NSC 98-2321-B-001-034, NSC 99-2321-B-001-016, NSC 100-2321-B-001-012]	Academia Sinica, Taiwan, Republic of China(Academia Sinica - Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	YHS is supported by grants from Academia Sinica, Taiwan, Republic of China (AS-91-IMB-4PP, AS-95-TP-B04; http://www.sinica.edu.tw/index.shtml), and National Science Council, Taiwan, Republic of China (NSC 96-2321-B-001-002, NSC 97-2321-B-001-002, NSC 98-2321-B-001-034, NSC 99-2321-B-001-016, NSC 100-2321-B-001-012; http://www.most.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Baeg GH, 2001, DEVELOPMENT, V128, P87; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; BAKER NE, 1988, DEVELOPMENT, V102, P489; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; BaSalamah MAM, 2001, BIOCHEM BIOPH RES CO, V283, P1083, DOI 10.1006/bbrc.2001.4900; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Berger EA, 2011, INVEST OPHTH VIS SCI, V52, P5339, DOI 10.1167/iovs.10-6920; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chou TB, 1996, GENETICS, V144, P1673; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; Crozatier M, 2004, TRENDS GENET, V20, P498, DOI 10.1016/j.tig.2004.07.013; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Hartmann U, 2001, MATRIX BIOL, V20, P23, DOI 10.1016/S0945-053X(00)00137-2; Hausser HJ, 2004, OSTEOARTHR CARTILAGE, V12, P870, DOI 10.1016/j.joca.2004.07.008; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Jafar-Nejad H, 2006, DEVELOPMENT, V133, P1683, DOI 10.1242/dev.02338; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Morata G, 2014, NATURE, V505, P162, DOI 10.1038/nature12848; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nakada M, 2003, CANCER RES, V63, P3364; Nakada M, 2001, CANCER RES, V61, P8896; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Solis GP, 2013, INT J MOL SCI, V14, P5130, DOI 10.3390/ijms14035130; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yao JG, 2005, EMBO J, V24, P2602, DOI 10.1038/sj.emboj.7600725; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang J, 1998, DEVELOPMENT, V125, P3075	68	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111573	10.1371/journal.pone.0111573	http://dx.doi.org/10.1371/journal.pone.0111573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360738	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700123
J	Stock, W; Heylen, K; Sabbe, K; Willems, A; De Troch, M				Stock, Willem; Heylen, Kim; Sabbe, Koen; Willems, Anne; De Troch, Marleen			Interactions between Benthic Copepods, Bacteria and Diatoms Promote Nitrogen Retention in Intertidal Marine Sediments	PLOS ONE			English	Article							COUPLED NITRIFICATION-DENITRIFICATION; HARPACTICOID COPEPODS; NITRATE; ESTUARINE; NUTRIENT; COMMUNITIES; REDUCTION; MEIOFAUNA; CARBON; EUTROPHICATION	The present study aims at evaluating the impact of diatoms and copepods on microbial processes mediating nitrate removal in fine-grained intertidal sediments. More specifically, we studied the interactions between copepods, diatoms and bacteria in relation to their effects on nitrate reduction and denitrification. Microcosms containing defaunated marine sediments were subjected to different treatments: an excess of nitrate, copepods, diatoms (Navicula sp.), a combination of copepods and diatoms, and spent medium from copepods. The microcosms were incubated for seven and a half days, after which nutrient concentrations and denitrification potential were measured. Ammonium concentrations were highest in the treatments with copepods or their spent medium, whilst denitrification potential was lowest in these treatments, suggesting that copepods enhance dissimilatory nitrate reduction to ammonium over denitrification. We hypothesize that this is an indirect effect, by providing extra carbon for the bacterial community through the copepods' excretion products, thus changing the C/N ratio in favour of dissimilatory nitrate reduction. Diatoms alone had no effect on the nitrogen fluxes, but they did enhance the effect of copepods, possibly by influencing the quantity and quality of the copepods' excretion products. Our results show that small-scale biological interactions between bacteria, copepods and diatoms can have an important impact on denitrification and hence sediment nitrogen fluxes.	[Stock, Willem; Sabbe, Koen; De Troch, Marleen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Heylen, Kim; Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Ghent University; Ghent University	Stock, W (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	Willem.Stock@Ugent.be	De Troch, Marleen/AAB-9809-2019; Willems, Anne/B-2872-2010	De Troch, Marleen/0000-0002-6800-0299; Willems, Anne/0000-0002-8421-2881; Stock, Willem/0000-0001-7648-6404	Ghent University (BOF-UGent) [GOA 01GA1911W]; Flemish Fund for Scientific Research [FWO11/PDO/084]	Ghent University (BOF-UGent)(Ghent University); Flemish Fund for Scientific Research(FWO)	This research was conducted within the frame of research project GOA 01GA1911W of the Special Research Fund at Ghent University (BOF-UGent) on "Understanding biodiversity effects on the functioning of marine benthic ecosystems". M. De Troch is a postdoctoral researcher financed by the same project. Kim Heylen is supported by the Flemish Fund for Scientific Research (FWO11/PDO/084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2001, LIMNOL OCEANOGR, V46, P62, DOI 10.4319/lo.2001.46.1.0062; An S, 2002, MARINE ECOLOGY PROGR, V237; Bartoli M, 2012, J EXP MAR BIOL ECOL, V438, P41, DOI 10.1016/j.jembe.2012.09.011; BERNER RA, 1985, AM J SCI, V285, P193, DOI 10.2475/ajs.285.3.193; Beyst B, 2001, J SEA RES, V46, P281, DOI 10.1016/S1385-1101(01)00087-9; BINNERUP SJ, 1992, APPL ENVIRON MICROB, V58, P303, DOI 10.1128/AEM.58.1.303-313.1992; Braeckman U, 2009, MARINE ECOLOGY PROGR, V399, P173; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; CHRISTENSEN PB, 1990, LIMNOL OCEANOGR, V35, P640, DOI 10.4319/lo.1990.35.3.0640; Cnudde C, UNPUB; Cnudde C, 2013, ENV MICROBIOL REP, V5, P301, DOI 10.1111/1758-2229.12018; Cornwell Jeffrey C., 1999, Aquatic Ecology, V33, P41, DOI 10.1023/A:1009921414151; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; De Troch M, 2006, MAR ENVIRON RES, V61, P265, DOI 10.1016/j.marenvres.2005.10.004; De Troch M, 2005, AQUAT MICROB ECOL, V39, P135, DOI 10.3354/ame039135; De Troch M, 2012, AQUAT MICROB ECOL, V67, P47, DOI 10.3354/ame01587; De Troch M, 2010, MICROB ECOL, V60, P581, DOI 10.1007/s00248-010-9669-7; Ferguson A, 2013, BIOGEOCHEMISTRY, V112, P423, DOI 10.1007/s10533-012-9736-x; Frangoulis C, 2005, ADV MAR BIOL, V47, P253; Giblin AE, 2013, IMPORTANCE DISSIMILA; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; KOCH MS, 1992, ESTUAR COAST SHELF S, V34, P471, DOI 10.1016/S0272-7714(05)80118-0; Koop-Jakobsen K, 2010, LIMNOL OCEANOGR, V55, P789, DOI 10.4319/lo.2009.55.2.0789; Lau M, 2009, DTK DUNNETT TUKEY KR; Leach AM, 2012, ENVIRON DEV, V1, P40, DOI 10.1016/j.envdev.2011.12.005; Magalhaes CM, 2011, FEMS MICROBIOL ECOL, V77, P274, DOI 10.1111/j.1574-6941.2011.01107.x; Martin P, 2005, GLOBAL PLANET CHANGE, V46, P87, DOI 10.1016/j.gloplacha.2004.11.012; MONTAGNA PA, 1984, MAR ECOL PROG SER, V18, P119, DOI 10.3354/meps018119; Nascimento FJA, 2012, LIMNOL OCEANOGR, V57, P338, DOI 10.4319/lo.2012.57.1.0338; Navarro-Gonzalvez JA, 1998, CLIN CHEM, V44, P679; Nilsson P, 1991, MARINE ECOLOGY PROGR, V71; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Patsch J, 2010, CONT SHELF RES, V30, P203, DOI 10.1016/j.csr.2009.11.003; Parent S, 1999, CAN J FISH AQUAT SCI, V56, P1639, DOI 10.1139/cjfas-56-9-1639; Risgaard-Petersen N, 2004, APPL ENVIRON MICROB, V70, P5528, DOI 10.1128/AEM.70.9.5528-5537.2004; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR, V48, P93; Schreiber F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00372; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Stenstrom J, 1991, SWEDISH J AGR RES SW; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Sundback K, 1996, ESTUAR COAST SHELF S, V43, P689, DOI 10.1006/ecss.1996.0097; Sundback K, 2006, ESTUAR COAST, V29, P1196, DOI 10.1007/BF02781820; Teixeira C, 2012, AQUAT MICROB ECOL, V66, P23, DOI 10.3354/ame01548; Vadstein O, 2012, MAR ECOL PROG SER, V447, P55, DOI 10.3354/meps09473; Wheeler B., 2010, IMPERM PERMUTATION T	50	12	12	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111001	10.1371/journal.pone.0111001	http://dx.doi.org/10.1371/journal.pone.0111001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360602	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700057
J	Berkner, H; von Loetzen, CS; Hartl, M; Randow, S; Gubesch, M; Vogel, L; Husslik, F; Reuter, A; Lidholm, J; Ballmer-Weber, B; Vieths, S; Rosch, P; Schiller, D				Berkner, Hanna; von Loetzen, Christian Seutter; Hartl, Maximilian; Randow, Stefanie; Gubesch, Michaela; Vogel, Lothar; Husslik, Felix; Reuter, Andreas; Lidholm, Jonas; Ballmer-Weber, Barbara; Vieths, Stefan; Roesch, Paul; Schiller, Dirk			Enlarging the Toolbox for Allergen Epitope Definition with an Allergen-Type Model Protein	PLOS ONE			English	Article							BET V 1; BIRCH-POLLEN ALLERGEN; SITE-DIRECTED MUTAGENESIS; X-RAY CRYSTALLOGRAPHY; MAJOR CHERRY ALLERGEN; IGE-BINDING EPITOPES; CROSS-REACTIVITY; FOOD ALLERGENS; IMMUNOLOGICAL CHARACTERIZATION; NORCOCLAURINE SYNTHASE	Background: Birch pollen-allergic subjects produce polyclonal cross-reactive IgE antibodies that mediate pollen-associated food allergies. The major allergen Bet v 1 and its homologs in plant foods bind IgE in their native protein conformation. Information on location, number and clinical relevance of IgE epitopes is limited. We addressed the use of an allergen-related protein model to identify amino acids critical for IgE binding of PR-10 allergens. Method: Norcoclaurine synthase (NCS) from meadow rue is structurally homologous to Bet v 1 but does not bind Bet v 1-reactive (IgE). NCS was used as the template for epitope grafting. NCS variants were tested with sera from 70 birch pollen allergic subjects and with monoclonal antibody BV16 reported to compete with IgE binding to Bet v 1. Results: We generated an NCS variant (Delta 29NCS(N57/I58E/D60N/V63P/D68K)) harboring an IgE epitope of Bet v 1. Bet v 1-type protein folding of the NCS variant was evaluated by H-1-(15) N-HSQC NMR spectroscopy. BV16 bound the NCS variant and 71% (50/70 sera) of our study population showed significant IgE binding. We observed IgE and BV16 cross-reactivity to the epitope presented by the NCS variant in a subgroup of Bet v 1-related allergens. Moreover BV16 blocked IgE binding to the NCS variant. Antibody cross-reactivity depended on a defined orientation of amino acids within the Bet v 1-type conformation. Conclusion: Our system allows the evaluation of patient-specific epitope profiles and will facilitate both the identification of clinically relevant epitopes as biomarkers and the monitoring of therapeutic outcomes to improve diagnosis, prognosis, and therapy of allergies caused by PR-10 proteins.	[Berkner, Hanna; von Loetzen, Christian Seutter; Hartl, Maximilian] Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany; [Randow, Stefanie; Gubesch, Michaela; Vogel, Lothar; Husslik, Felix; Reuter, Andreas] Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany; [Lidholm, Jonas] Thermo Fisher Sci Inc, Div Immunodiagnost, Uppsala, Uppsala Ian, Sweden; [Ballmer-Weber, Barbara] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland	University of Bayreuth; Paul Ehrlich Institute; Thermo Fisher Scientific; University of Zurich; University Zurich Hospital	Schiller, D (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany.	Dirk.Schiller@pei.de		Lidholm, Jonas/0000-0002-7779-3411; Reuter, Andreas/0000-0002-6082-9000				Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; AXEN RE, 1988, NEW ENG REG ALLERGY, V9, P503; Ballmer-Weber BK, 2005, CLIN EXP ALLERGY, V35, P970, DOI 10.1111/j.1365-2222.2005.02294.x; Berkner H, 2008, BIOCHEM J, V413, P281, DOI 10.1042/BJ20080306; Berkner H, 2007, PROTEIN EXPRES PURIF, V56, P197, DOI 10.1016/j.pep.2007.07.010; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeWitt AM, 2002, CLIN EXP ALLERGY, V32, P1329, DOI 10.1046/j.1365-2222.2002.01467.x; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; Ilari A, 2009, J BIOL CHEM, V284, P897, DOI 10.1074/jbc.M803738200; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jimenez-Lopez JC, 2012, MOL BIOL REP, V39, P123, DOI 10.1007/s11033-011-0717-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN JN, 1993, INT ARCH ALLERGY IMM, V102, P249, DOI 10.1159/000236533; Lauer I, 2008, MOL NUTR FOOD RES, V52, pS262, DOI 10.1002/mnfr.200700426; Lebecque S, 1997, J ALLERGY CLIN IMMUN, V99, P374, DOI 10.1016/S0091-6749(97)70056-3; Levin M, 2014, CLIN EXP ALLERGY, V44, P288, DOI 10.1111/cea.12230; Ma Y, 2006, INT ARCH ALLERGY IMM, V139, P53, DOI 10.1159/000089756; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Spangfort MD, 1999, ACTA CRYSTALLOGR D, V55, P2035, DOI 10.1107/S0907444999011804; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wangorsch A, 2007, MOL IMMUNOL, V44, P2518, DOI 10.1016/j.molimm.2006.12.023; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842	50	12	12	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111691	10.1371/journal.pone.0111691	http://dx.doi.org/10.1371/journal.pone.0111691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356997	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000346765000074
J	Pedersen, C; Slepenkin, A; Andersson, SBE; Fagerberg, JH; Bergstrom, CAS; Peterson, EM				Pedersen, Christian; Slepenkin, Anatoly; Andersson, Sara B. E.; Fagerberg, Jonas H.; Bergstroem, Christel A. S.; Peterson, Ellena M.			Formulation of the Microbicide INP0341 for In Vivo Protection against a Vaginal Challenge by Chlamydia trachomatis	PLOS ONE			English	Article							SALICYLIDENE ACYLHYDRAZIDE; DRUG-DELIVERY; III SECRETION; GEL; PREVENTION; SOLUBILITY; INHIBITORS; INFECTION; BUFFERGEL; MODELS	The salicylidene acylhydrazide (SA) compounds have exhibited promising microbicidal properties. Previous reports have shown the SA compounds, using cell cultures, to exhibit activity against Chlamydia trachomatis, herpes simplex virus and HIV-1. In addition, using an animal model of a vaginal infection the SA compound INP0341, when dissolved in a liquid, was able to significantly protect mice from a vaginal infection with C. trachomatis. To expand upon this finding, in this report INP0341 was formulated as a vaginal gel, suitable for use in humans. Gelling agents (polymers) with inherent antimicrobial properties were chosen to maximize the total antimicrobial effect of the gel. In vitro formulation work generated a gel with suitable rheology and sustained drug release. A formulation containing 1 mM INP0341, 1.6 wt% Cremophor ELP (solubility enhancer) and 1.5 wt% poly(acrylic acid) (gelling and antimicrobial agent), was chosen for studies of efficacy and toxicity using a mouse model of a vaginal infection. The gel formulation was able to attenuate a vaginal challenge with C. trachomatis, serovar D. Formulations with and without INP0341 afforded protection, but the inclusion of INP0341 increased the protection. Mouse vaginal tissue treated with the formulation showed no indication of gel toxicity. The lack of toxicity was confirmed by in vitro assays using EpiVaginal tissues, which showed that a 24 h exposure to the gel formulation did not decrease the cell viability or the barrier function of the tissue. Therefore, the gel formulation described here appears to be a promising vaginal microbicide to prevent a C. trachomatis infection with the potential to be expanded to other sexually transmitted diseases.	[Pedersen, Christian; Andersson, Sara B. E.; Fagerberg, Jonas H.; Bergstroem, Christel A. S.] Uppsala Univ, Biomed Ctr, Dept Pharm, Uppsala, Sweden; [Slepenkin, Anatoly; Peterson, Ellena M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Uppsala University; University of California System; University of California Irvine	Peterson, EM (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	epeterso@uci.edu		Fagerberg, Jonas/0000-0002-3260-8067	National Institute of Allergy and Infectious Diseases [R33AI079775]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079775] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by grant number R33AI079775 (EMP) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028; Balakrishnan A, 2004, J PHARM SCI-US, V93, P2064, DOI 10.1002/jps.20118; Bergstrom CAS, 2002, PHARMACEUT RES, V19, P182, DOI 10.1023/A:1014224900524; Chu H, 2010, CHARACTERIZATION INH, P141; Chu H, 2010, INT J ANTIMICROB AG, V36, P145, DOI 10.1016/j.ijantimicag.2010.03.018; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Evans EB, 2012, SOC TOX 52 ANN M SAN; Forthal DN, 2012, INT J ANTIMICROB AG, V40, P354, DOI 10.1016/j.ijantimicag.2012.05.023; Garg S, 2001, PHARM TECHNOL, V25, P14; Holmberg K., 2003, SURFACTANTS POLYM AQ; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KHAMESIPOUR A, 1994, J REPROD FERTIL, V101, P287, DOI 10.1530/jrf.0.1010287; Kieweg SL, 2006, J BIOMECH ENG-T ASME, V128, P540, DOI 10.1115/1.2206198; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Owen DH, 2000, CONTRACEPTION, V62, P321, DOI 10.1016/S0010-7824(00)00184-0; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Peterson EM, 1999, VACCINE, V17, P2901, DOI 10.1016/S0264-410X(99)00131-0; PETERSON EM, 1988, INFECT IMMUN, V56, P885, DOI 10.1128/IAI.56.4.885-891.1988; Shukla NB, 2009, POLYM DEGRAD STABIL, V94, P1238, DOI 10.1016/j.polymdegradstab.2009.04.020; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Slepenkin A, 2011, J INFECT DIS, V204, P1313, DOI 10.1093/infdis/jir552; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010	25	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110918	10.1371/journal.pone.0110918	http://dx.doi.org/10.1371/journal.pone.0110918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356686	Green Published, gold			2022-12-26	WOS:000346765000032
J	Xu, MY; Li, YH; Zhang, QX; Xu, T; Qiu, LJ; Fan, YL; Wang, L				Xu, Miaoyun; Li, Yinghui; Zhang, Qiuxue; Xu, Tao; Qiu, Lijuan; Fan, Yunliu; Wang, Lei			Novel MiRNA and PhasiRNA Biogenesis Networks in Soybean Roots from Two Sister Lines That Are Resistant and Susceptible to SCN Race 4	PLOS ONE			English	Article							SMALL RNAS; REGULATORY ROLES; SIRNA BIOGENESIS; MICRORNAS; IDENTIFICATION; TARGETS; GENES; EVOLUTION	The soybean cyst nematode (SCN), Heterodera glycines, is the most devastating pathogen of soybean worldwide. SiRNAs (small interfere RNAs) have been proven to induce the silencing of cyst nematode genes. However, whether small RNAs from soybean root have evolved a similar mechanism against SCN is unknown. Two genetically related soybean sister lines (ZP03-5373 and ZP03-5413), which are resistant and susceptible, respectively, to SCN race 4 infection were selected for small RNA deep sequencing to identify small RNAs targeted to SCN. We identified 71 less-conserved miRNAs-miRNAs* counterparts belonging to 32 families derived from 91 loci, and 88 novel soybean-specific miRNAs with distinct expression patterns. The identified miRNAs targeted 42 genes representing a wide range of enzymatic and regulatory activities. Roots of soybean conserved one TAS (Trans-acting siRNA) gene family with a similar but unique trans- acting small interfering RNA (tasiRNA) biogenesis profile. In addition, we found that six miRNAs (gma-miR393, 1507, 1510, 1515, 171, 2118) guide targets to produce secondary phasiRNAs (phased, secondary, small interfering RNAs) in soybean root. Multiple targets of these phasiRNAs were predicted and detected. Importantly, we also found that the expression of 34 miRNAs differed significantly between the two lines. Seven ZP03-5373-specific miRNAs were differentially expressed after SCN infection. Forty-four transcripts from SCN were predicted to be potential targets of ZP03-5373-specific differential miRNAs. These findings suggest that miRNAs play an important role in the soybean response to SCN.	[Xu, Miaoyun; Zhang, Qiuxue; Xu, Tao; Fan, Yunliu; Wang, Lei] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Li, Yinghui; Qiu, Lijuan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, L (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	wanglei01@caas.cn	xu, miaoyun/AAF-3676-2021		National Key Basic Research Program [2010CB125903]; National Natural Science Foundation of China [31271801, 31171575]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program (Grant Number 2010CB125903). And the National Natural Science Foundation of China (Grant Number 31271801, 31171575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fan Yuan, 2007, Zhonghua Nan Ke Xue, V13, P660; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; Hofmann NR, 2010, PLANT CELL, V22, P994, DOI 10.1105/tpc.110.220411; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-3; Newmark PA, 1997, DEVELOPMENT, V124, P3197; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schwach Frank, 2009, Briefings in Functional Genomics & Proteomics, V8, P472, DOI 10.1093/bfgp/elp024; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Sobczak M GW, 2009, STRUCTURE CYST NEMAT, P153; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Thadani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S20; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL HOST MICROBE, V6, P99, DOI 10.1016/j.chom.2009.08.002; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wrather JA, 2009, PLANT HLTH PROGR; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xia HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044206; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhao XF, 2000, GENOMICS, V63, P145, DOI 10.1006/geno.1999.6064	55	24	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110051	10.1371/journal.pone.0110051	http://dx.doi.org/10.1371/journal.pone.0110051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356812	gold, Green Submitted, Green Published			2022-12-26	WOS:000346765000011
J	Gerbier, R; Leroux, V; Couvineau, P; Alvear-Perez, R; Maigret, B; Llorens-Cortes, C; Iturrioz, X				Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier			New structural insights into the apelin receptor: identification of key residues for apelin binding	FASEB JOURNAL			English	Article						APJ; G protein-coupled receptor; homology models; molecular modeling; site-directed mutagenesis	PROTEIN-COUPLED RECEPTORS; ENDOGENOUS LIGAND APELIN; HUMAN APJ RECEPTOR; ANGIOTENSIN-II; EXTRACELLULAR LOOP; CARDIAC CONTRACTILITY; HIV-1 CORECEPTOR; OSMOTIC STIMULI; RAT-BRAIN; PEPTIDE	Apelin is the endogenous ligand of the orphan7-transmembrane domain GPCRAPJ, now named the apelin receptor (ApelinR). Apelin plays a prominent role in body fluid and cardiovascular homeostasis. To better understand the structural organization of the ApelinR, we built 3 homology 3-dimensional (3D) models of the human ApelinR using the validated cholecystokinin receptor-1 3D model or the X-ray structures of the beta(2)-adrenergic and CXCR4 receptors as templates. Docking of the pyroglutamyl form of apelin 13 (pE13F) into these models revealed the conservation at the bottom of the binding site of a hydrophobic cavity in which the C-terminal Phe of pE13F was embedded. In contrast, at the top of the binding site, depending on the model, different interactions were visualized between acidic residues of the ApelinR and the basic residues of pE13F. Using site-directed mutagenesis, we showed that Asp 92, Glu 172, and Asp 282 of rat ApelinR are key residues in apelin binding by interacting with Lys 8, Arg 2, and Arg 4 of pE13F, respectively. These residues are only seen in the CXCR4-based ApelinR 3D model, further validating this model. These findings bring new insights into the structural organization of the ApelinR and the mode of apelin binding.	[Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] Coll France, CIRB, Lab Cent Neuropeptides Regulat Body Fluid Homeost, F-75005 Paris, France; [Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] CNRS, UMR 7241, Paris, France; [Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] INSERM, U1050, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Iturrioz, X (corresponding author), Coll France, CIRB, Lab Cent Neuropeptides Regulat Body Fluid Homeost, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	c.llorens-cortes@college-de-france.fr; xavier.iturrioz@college-de-france.fr	Llorens-Cortès, catherine/AAL-3893-2021; Iturrioz, Xavier/AAS-3555-2020; GERBIER, Romain/ABF-2481-2020; ITURRIOZ, Xavier/Q-4406-2017; Llorens-Cortes, Catherine/E-5839-2016	Llorens-Cortès, catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; ITURRIOZ, Xavier/0000-0001-7143-8323; Llorens-Cortes, Catherine/0000-0002-7667-0401; Couvineau, Pierre/0000-0002-4905-7740; Leroux, Vincent/0000-0002-4142-0883; Gerbier, Romain/0000-0003-4617-4850				Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Berman HM, 2013, FEBS LETT, V587, P1036, DOI 10.1016/j.febslet.2012.12.029; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Correa SAA, 2006, REGUL PEPTIDES, V134, P132, DOI 10.1016/j.regpep.2006.02.008; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Galanth C, 2012, CURR PHARM DESIGN, V18, P789, DOI 10.2174/138161212799277770; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Henin J, 2006, BIOPHYS J, V90, P1232, DOI 10.1529/biophysj.105.070599; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Howl J, 1996, BIOCHEM J, V317, P577, DOI 10.1042/bj3170577; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Iturrioz X, 2010, J BIOL CHEM, V285, P32627, DOI 10.1074/jbc.M110.127167; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Langelaan DN, 2013, BBA-BIOMEMBRANES, V1828, P1471, DOI 10.1016/j.bbamem.2013.02.005; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lenkei Z, 2000, J HISTOCHEM CYTOCHEM, V48, P1553, DOI 10.1177/002215540004801112; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mesmin C, 2011, J PROTEOME RES, V10, P5222, DOI 10.1021/pr200725x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Millar RP, 2004, ENDOCRINOLOGY, V145, P3590, DOI 10.1210/en.2004-0461; Nicastro G, 2003, J PEPT SCI, V9, P229, DOI 10.1002/psc.449; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P661, DOI 10.1046/j.1365-2826.2003.01044.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zhou NM, 2003, VIROLOGY, V317, P84, DOI 10.1016/j.virol.2003.08.026; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1; Zhu X, 2012, WIRES COMPUT MOL SCI, V2, P167, DOI 10.1002/wcms.74	53	33	39	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					314	322		10.1096/fj.14-256339	http://dx.doi.org/10.1096/fj.14-256339			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25359495				2022-12-26	WOS:000347378600029
J	Huang, H; Langenkamp, E; Georganaki, M; Loskog, A; Fuchs, PF; Dieterich, LC; Kreuger, J; Dimberg, A				Huang, Hua; Langenkamp, Elise; Georganaki, Maria; Loskog, Angelica; Fuchs, Peder Fredlund; Dieterich, Lothar C.; Kreuger, Johan; Dimberg, Anna			VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-kappa B-induced endothelial activation	FASEB JOURNAL			English	Article						leukocyte recruitment; adhesion molecule	STIMULATED RESPONSE ELEMENT; GROWTH-FACTOR; IKK-BETA; LEUKOCYTE ADHESION; INTERFERON-BETA; BLOOD-VESSELS; CELL-ADHESION; IFN-GAMMA; ANGIOGENESIS; EXPRESSION	Antiangiogenic treatment targeting the vascular endothelial growth factor (VEGF) signaling pathway is in clinical use, but its effect on vascular function and the tumor microenvironment is poorly understood. Here, we investigate cross-talk between VEGF and proinflammatory TNF-alpha signaling in endothelial cells and its impact on leukocyte recruitment. We found that cotreatment with VEGF decreased TNF-alpha-induced Jurkat cell adhesion to human microvascular endothelial cells by 40%. This was associated with inhibition of TNF-alpha-mediated regulation of 86 genes, including 2 T-lymphocyte-attracting chemokines, CXCL10 and CXCL11 [TNF-alpha concentration 1 ng/ml; 50% inhibition/inhibitory concentration (IC50) VEGF, 3 ng/ml]. Notably, VEGF directly suppressed TNF-alpha-induced gene expression through negative cross-talk with the NF-kappa B-signaling pathway, leading to an early decrease in IFN regulatory factor 1 (IRF-1) expression and reduced phosphorylation of signal transducer andactivatorof transcription 1 (p-Stat1) at later times. Inhibition of VEGF signaling in B16 melanomatumor-bearingmicebysunitinib treatmentresulted in up-regulation of CXCL10 and CXCL11 in tumor vessels, accompanied by up to 18-fold increased infiltration of CD3+ T-lymphocytes in B16 tumors. Our results demonstrate a novel role of VEGF in negative regulation of NF kappa B signaling and endothelial activation in the tumor microenvironment and provide evidence that pharmacological inhibition of VEGF signaling enhances T-lymphocyte recruitment through up-regulation of chemokinesCXCL10 and CXCL11.	[Huang, Hua; Langenkamp, Elise; Georganaki, Maria; Loskog, Angelica; Dieterich, Lothar C.; Dimberg, Anna] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Fuchs, Peder Fredlund; Kreuger, Johan] Uppsala Univ, Sci Life Lab, Biomed Ctr, Dept Med Biochem & Microbiol, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University	Dimberg, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	anna.dimberg@igp.uu.se	Kreuger, Johan/HDM-1503-2022	Dieterich, Lothar/0000-0001-7908-5710; Dimberg, Anna/0000-0003-4422-9125				Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Barkefors I, 2009, LAB CHIP, V9, P529, DOI 10.1039/b814691h; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Bose A, 2011, INT J CANCER, V129, P2158, DOI 10.1002/ijc.25863; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Darwech I, 2010, J BIOL CHEM, V285, P25522, DOI 10.1074/jbc.M110.121533; Dieterich LC, 2012, J PATHOL, V228, P378, DOI 10.1002/path.4072; Dimberg A, 2010, CURR TOP MICROBIOL, V341, P59, DOI 10.1007/82_2010_21; Dirkx AEM, 2003, CANCER RES, V63, P2322; Dirkx AEM, 2006, FASEB J, V20, P621, DOI 10.1096/fj.05-4493com; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Flati V, 2006, INT J IMMUNOPATH PH, V19, P761, DOI 10.1177/039463200601900406; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Griffioen AW, 1996, CANCER RES, V56, P1111; Griffioen AW, 1999, INT J CANCER, V80, P315, DOI 10.1002/(SICI)1097-0215(19990118)80:2<315::AID-IJC23>3.0.CO;2-L; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Majumder S, 1998, J IMMUNOL, V161, P4736; McDonald DM, 2005, CHEST, V128, p602S, DOI 10.1378/chest.128.6_suppl.602S-a; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; St Croix B, 2000, SCIENCE, V289, P1197; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; WU CQ, 1994, J INTERFERON RES, V14, P357, DOI 10.1089/jir.1994.14.357; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	48	119	120	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					227	238		10.1096/fj.14-250985	http://dx.doi.org/10.1096/fj.14-250985			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25361735				2022-12-26	WOS:000347378600022
J	Kurko, J; Vida, A; Ocsko, T; Tryniszewska, B; Rauch, TA; Glant, TT; Szekanecz, Z; Mikecz, K				Kurko, Julia; Vida, Andras; Ocsko, Timea; Tryniszewska, Beata; Rauch, Tibor A.; Glant, Tibor T.; Szekanecz, Zoltan; Mikecz, Katalin			Suppression of Proteoglycan-Induced Autoimmune Arthritis by Myeloid-Derived Suppressor Cells Generated In Vitro from Murine Bone Marrow	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-BEARING MICE; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; SYNOVIAL-FLUID; CANCER; TRANSPLANTATION; ACTIVATION; MECHANISMS; DISEASE	Background: Myeloid-derived suppressor cells (MDSCs) are innate immune cells capable of suppressing T-cell responses. We previously reported the presence of MDSCs with a granulocytic phenotype in the synovial fluid (SF) of mice with proteoglycan (PG)-induced arthritis (PGIA), a T cell-dependent autoimmune model of rheumatoid arthritis (RA). However, the limited amount of SF-MDSCs precluded investigations into their therapeutic potential. The goals of this study were to develop an in vitro method for generating MDSCs similar to those found in SF and to reveal the therapeutic effect of such cells in PGIA. Methods: Murine bone marrow (BM) cells were cultured for 3 days in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), and granulocyte colony-stimulating factor (G-CSF). The phenotype of cultured cells was analyzed using flow cytometry, microscopy, and biochemical methods. The suppressor activity of BM-MDSCs was tested upon co-culture with activated T cells. To investigate the therapeutic potential of BM-MDSCs, the cells were injected into SCID mice at the early stage of adoptively transferred PGIA, and their effects on the clinical course of arthritis and PG-specific immune responses were determined. Results: BM cells cultured in the presence of GM-CSF, IL-6, and G-CSF became enriched in MDSC-like cells that showed greater phenotypic heterogeneity than MDSCs present in SF. BM-MDSCs profoundly inhibited both antigen-specific and polyclonal T-cell proliferation primarily via production of nitric oxide. Injection of BM-MDSCs into mice with PGIA ameliorated arthritis and reduced PG-specific T-cell responses and serum antibody levels. Conclusions: Our in vitro enrichment strategy provides a SF-like, but controlled microenvironment for converting BM myeloid precursors into MDSCs that potently suppress both T-cell responses and the progression of arthritis in a mouse model of RA. Our results also suggest that enrichment of BM in MDSCs could improve the therapeutic efficacy of BM transplantation in RA.	[Kurko, Julia; Vida, Andras; Ocsko, Timea; Tryniszewska, Beata; Rauch, Tibor A.; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL 60612 USA; [Kurko, Julia; Szekanecz, Zoltan] Univ Debrecen, Fac Med, Dept Rheumatol, Debrecen, Hungary	Rush University; University of Debrecen	Mikecz, K (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL 60612 USA.	Katalin_Mikecz@rush.edu	Szekanecz, Zoltán/GXN-0235-2022	Mikecz, Katalin/0000-0003-1506-4296	National Institute of Health [AR062332, AR064206, AR064948]; National Excellence Program - European Union [TAMOP 4.2.4.A/2-11-1-2012-0001]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064948, R01AR064206, R21AR062332] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Excellence Program - European Union; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants AR062332 and AR064206 (to KM) and AR064948 (to TAR) from the National Institute of Health http://www.nih.gov., and by the TAMOP 4.2.4.A/2-11-1-2012-0001 National Excellence Program co-financed by the European Union and Hungary (to ZS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Angyal A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2954; Bardos T, 2002, J IMMUNOL, V168, P6013, DOI 10.4049/jimmunol.168.12.6013; Berlo SE, 2006, ARTHRITIS RHEUM-US, V54, P2423, DOI 10.1002/art.22013; Bingisser RM, 1998, J IMMUNOL, V160, P5729; BJELLE A, 1982, SCAND J RHEUMATOL, V11, P124, DOI 10.3109/03009748209098176; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Brinkman DMC, 2007, ARTHRITIS RHEUM-US, V56, P2410, DOI 10.1002/art.22656; Charles JF, 2012, J CLIN INVEST, V122, P4592, DOI 10.1172/JCI60920; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Egelston C, 2012, ARTHRITIS RHEUM-US, V64, P3179, DOI 10.1002/art.34494; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Faust N, 2000, BLOOD, V96, P719; Firestein GS, 2005, KELLEYS TXB RHEUMATO, P996; Forghani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064837; Fox DA, 2005, ARTHRITIS ALLIED CON, P1085; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Glant TT, 2011, ARTHRITIS RHEUM-US, V63, P1312, DOI 10.1002/art.30261; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; HOLMDAHL R, 1988, LAB INVEST, V58, P53; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Kurko J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-281; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Moore JJ, 2003, BONE MARROW TRANSPL, V32, pS53, DOI 10.1038/sj.bmt.1703944; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Pastula A, 2011, INT J EXP PATHOL, V92, P73, DOI 10.1111/j.1365-2613.2010.00754.x; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Roord STA, 2008, BLOOD, V111, P5233, DOI 10.1182/blood-2007-12-128488; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; SUBIZA JL, 1989, INT J CANCER, V44, P307, DOI 10.1002/ijc.2910440220; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Yamamoto Tetsuro, 1996, Seminars in Thrombosis and Hemostasis, V22, P507, DOI 10.1055/s-2007-999052; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47	54	31	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111815	10.1371/journal.pone.0111815	http://dx.doi.org/10.1371/journal.pone.0111815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369029	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000107
J	Uddin, N; Hasan, MR; Hasan, MM; Hossain, MM; Alam, MR; Hasan, MR; Islam, AFMM; Rahman, T; Rana, MS				Uddin, Nizam; Hasan, Md. Rakib; Hasan, Md. Mahadi; Hossain, Md. Monir; Alam, Md. Robiul; Hasan, Mohammad Raquibul; Islam, A. F. M. Mahmudul; Rahman, Tasmina; Rana, Md. Sohel			Assessment of Toxic Effects of the Methanol Extract of Citrus macroptera Montr. Fruit via Biochemical and Hematological Evaluation in Female Sprague-Dawley Rats	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; PLASMA; RISK; HYPERTENSION; CHOLESTEROL; METABOLISM; PARAMETERS; ANIMALS; INSULIN	Citrus macroptera Montr. (C. macroptera) is locally known as Satkara. The fruit of this plant is used as appetite stimulant and in the treatment of fever. This study therefore aimed to evaluate the toxic effects of the fruit extract using some biochemical and hematological parameters in rat model. The effects of methanol extract of Citrus macroptera Montr. fruit administered at 250, 500 and 1000 mg/kg body weight were investigated on hematological and biochemical parameters in Sprague-Dawley female rats. Moreover, histopathological study was performed to observe the presence of pathological lesions in primary body organs. The extract presented no significant effect on body weight, percent water content, relative organ weight and hematological parameters in rat. Significant decrease from control group was observed in the levels of triglyceride, total cholesterol, low density lipoprotein and very low density lipoprotein; thus leading to significant decrease of cardiac risk ratio, castelli's risk index-2, atherogenic coefficient and atherogenic index of plasma at all doses. 500 mg/kg dose significantly decreased alkaline phosphatase (P<0.05), 1000 mg/kg dose significantly increased high density lipoprotein cholesterol (P<0.05) and 250 mg/kg dose significantly decreased the level of glycated hemoglobin (P<0.05) from the control group. There were no significant alterations observed with other serum biochemical parameters. Histopathological study confirmed the absence of inflammatory and necrotic features in the primary body organs. Study results indicate that methanolic fruit extract is unlikely to have significant toxicity. Moreover, these findings justified the cardio-protective, moderate hepato-protective and glucose controlling activities of the fruit extract.	[Uddin, Nizam; Hasan, Md. Rakib; Hasan, Md. Mahadi; Hossain, Md. Monir; Alam, Md. Robiul; Hasan, Mohammad Raquibul; Islam, A. F. M. Mahmudul; Rahman, Tasmina; Rana, Md. Sohel] Jahangirnagar Univ, Dept Pharm, Dhaka 1342, Bangladesh	Jahangirnagar University	Uddin, N (corresponding author), Jahangirnagar Univ, Dept Pharm, Dhaka 1342, Bangladesh.	sami.pharm22@gmail.com			Jahangirnagar University Annual Research Grant [JU-ARG-2012-005]	Jahangirnagar University Annual Research Grant	This study was supported with funding from Jahangirnagar University Annual Research Grant (Grant no: JU-ARG-2012-005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa Oladipo, 2005, Lipids Health Dis, V4, P19, DOI 10.1186/1476-511X-4-19; Ashafa AOT, 2009, AFR J BIOTECHNOL, V8, P1425; Ayhan S, 2013, EXP CLIN CARDIOL, V18, pE12; Brehm A, 2004, CLIN CHEM, V50, P2316, DOI 10.1373/clinchem.2004.037556; CASTELLI WP, 1983, CIRCULATION, V67, P730, DOI 10.1161/01.CIR.67.4.730; Chowdhury SA, 2008, BANG J SCI IND RES, V43, P449; Das S, 1999, BIOTECHNOLOGY MED PL, P126; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Drury R.A.B., 1980, CARLETON HISTOLOGICA; Dybing E, 2002, FOOD CHEM TOXICOL, V40, P237, DOI 10.1016/S0278-6915(01)00115-6; Elevitch CR, 2006, TRADITIONAL TREES PA, P243; Endler G, 2002, BRIT J HAEMATOL, V117, P399, DOI 10.1046/j.1365-2141.2002.03441.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaillard E., 1995, Annales Pharmaceutiques Francaises, V53, P75; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grotto HZW, 2004, CLIN LAB HAEMATOL, V26, P347, DOI 10.1111/j.1365-2257.2004.00634.x; Gupta S. S., 1994, Indian Journal of Pharmacology, V26, P1; Guyton CA, 1986, TXB MED PHYSL, P2; Jaroszynska J, 2003, POL J ENVIRON STUD, V12, P481; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Martins AC, 2006, CLINICAL CHEMISTRY A, P7; Martirosyan DM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-1; McBride P, 2008, CURR ATHEROSCLER REP, V10, P386, DOI 10.1007/s11883-008-0060-9; Newman D. J., 1998, TIETZ TXB CLIN CHEM, P1204; ODUTOLA AAA, 1992, RAPID INTERPRETATION, P1; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Pari L, 2004, DIABETES OBES METAB, V6, P286, DOI 10.1111/j.1462-8902.2004.0349.x; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Rahmatullah M., 2010, ADV NAT APPL SCI, V4, P52; Rana VS, 2012, NAT PROD COMMUN, V7, P1371; Ringer D.H., 1979, LABORATORY RAT, V1, P105; Ruot B, 2000, AM J PHYSIOL-ENDOC M, V279, pE244, DOI 10.1152/ajpendo.2000.279.2.E244; Shen GX, 2007, CURR PHARM ANAL, V3, P17, DOI 10.2174/157341207779802386; Shepherd J, 1998, EUR HEART J, V19, P1776, DOI 10.1053/euhj.1998.1122; Tennant B. C., 1997, Clinical biochemistry of domestic animals., P337, DOI 10.1016/B978-012396305-5/50014-2; Uddin Nizam, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P473, DOI 10.12980/APJTB.4.2014C1173; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Waikedre J, 2010, CHEM BIODIVERS, V7, P871, DOI 10.1002/cbdv.200900196; WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859; Zicha J, 1999, AM J HYPERTENS, V12, P315, DOI 10.1016/S0895-7061(98)00178-2	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111101	10.1371/journal.pone.0111101	http://dx.doi.org/10.1371/journal.pone.0111101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369061	gold, Green Submitted, Green Published			2022-12-26	WOS:000344402000036
J	Fodor, A; Segura, V; Denis, M; Neuenschwander, S; Fournier-Level, A; Chatelet, P; Homa, FAA; Lacombe, T; This, P; Le Cunff, L				Fodor, Agota; Segura, Vincent; Denis, Marie; Neuenschwander, Samuel; Fournier-Level, Alexandre; Chatelet, Philippe; Homa, Felix Abdel Aziz; Lacombe, Thierry; This, Patrice; Le Cunff, Loic			Genome-Wide Prediction Methods in Highly Diverse and Heterozygous Species: Proof-of-Concept through Simulation in Grapevine	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC ARCHITECTURE; QUANTITATIVE TRAITS; SELECTION GAIN; UNIT TIME; ASSOCIATION; ACCURACY; WINE; CONSERVATION; INFORMATION	Nowadays, genome-wide association studies (GWAS) and genomic selection (GS) methods which use genome-wide marker data for phenotype prediction are of much potential interest in plant breeding. However, to our knowledge, no studies have been performed yet on the predictive ability of these methods for structured traits when using training populations with high levels of genetic diversity. Such an example of a highly heterozygous, perennial species is grapevine. The present study compares the accuracy of models based on GWAS or GS alone, or in combination, for predicting simple or complex traits, linked or not with population structure. In order to explore the relevance of these methods in this context, we performed simulations using approx 90,000 SNPs on a population of 3,000 individuals structured into three groups and corresponding to published diversity grapevine data. To estimate the parameters of the prediction models, we defined four training populations of 1,000 individuals, corresponding to these three groups and a core collection. Finally, to estimate the accuracy of the models, we also simulated four breeding populations of 200 individuals. Although prediction accuracy was low when breeding populations were too distant from the training populations, high accuracy levels were obtained using the sole core-collection as training population. The highest prediction accuracy was obtained (up to 0.9) using the combined GWAS-GS model. We thus recommend using the combined prediction model and a core-collection as training population for grapevine breeding or for other important economic crops with the same characteristics.	[Fodor, Agota; This, Patrice; Le Cunff, Loic] IFV INRA Montpellier Supagro, UMT Genovigne, Montpellier, France; [Fodor, Agota; Chatelet, Philippe; Lacombe, Thierry; This, Patrice; Le Cunff, Loic] INRA, UMR AGAP, F-34060 Montpellier, France; [Segura, Vincent] INRA, UR AGPF 588, Orleans, France; [Denis, Marie; Homa, Felix Abdel Aziz] CIRAD, UMR AGAP, Montpellier, France; [Neuenschwander, Samuel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Neuenschwander, Samuel] Univ Lausanne, Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Fournier-Level, Alexandre] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia	INRAE; Institut Agro; Montpellier SupAgro; INRAE; Universite de Montpellier; INRAE; CIRAD; Universite de Montpellier; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Melbourne	Le Cunff, L (corresponding author), IFV INRA Montpellier Supagro, UMT Genovigne, Montpellier, France.	loic.lecunff@supagro.inra.fr	Segura, Vincent/B-4656-2013	Segura, Vincent/0000-0003-1860-2256; Neuenschwander, Samuel/0000-0002-4080-5546; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164	Swiss National Science Foundation [31003A_138180]; French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries (project CAS DAR) [10AAPIT, 1009]; French Grapevine and Wine Institute (IFV)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries (project CAS DAR); French Grapevine and Wine Institute (IFV)	S.N. was supported by Swiss National Science Foundation grant 31003A_138180 to Dr. J. Goudet. This work was funded in part by the French Ministry of Research and Higher Education and the French Ministry of Food, Agriculture and Fisheries (project CAS DAR no 10AAPIT no 1009) and a PhD grant from the French Grapevine and Wine Institute (IFV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Beaumont MA, 2002, GENETICS, V162, P2025; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bowers J, 1999, SCIENCE, V285, P1562, DOI 10.1126/science.285.5433.1562; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carrier G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032973; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; Fournier-Level A, 2010, HEREDITY, V104, P351, DOI 10.1038/hdy.2009.148; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2008, IMPACT GENETIC RELAT; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Houel C, 2011, CARACTERISATION VARI; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lacombe T, 2012, CONTRIBUTION ETUDE H; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Le Paslier M-C, 2013, GRAPERESEQ 18K VITIS; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Meuwissen THE, 2001, GENETICS, V157, P1819; Moriondo M, 2013, CLIMATIC CHANGE, V119, P825, DOI 10.1007/s10584-013-0739-y; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Neuenschwander S, 2008, BIOINFORMATICS, V24, P1552, DOI 10.1093/bioinformatics/btn219; Ollat N, 2011, MULTIDISCIPLINARY RE; Park SDE, 2001, TRYPANOTOLERANCE W A; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; SPITZE K, 1993, GENETICS, V135, P367; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zohary D, 1996, ORIGINS ANCIENT HIST, P31	81	23	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110436	10.1371/journal.pone.0110436	http://dx.doi.org/10.1371/journal.pone.0110436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365338	Green Published, gold			2022-12-26	WOS:000345558100021
J	Hoang, LT; Tolfvenstam, T; Ooi, EE; Khor, CC; Naim, ANM; Ho, EXP; Ong, SH; Wertheim, HF; Fox, A; Nguyen, CVV; Nghiem, NM; Ha, TM; Tran, ATN; Tambayah, P; Lin, R; Sangsajja, C; Manosuthi, W; Chuchottaworn, C; Sansayunh, P; Chotpitayasunondh, T; Suntarattiwong, P; Chokephaibulkit, K; Puthavathana, P; de Jong, MD; Farrar, J; van Doorn, HR; Hibberd, ML				Long Truong Hoang; Tolfvenstam, Thomas; Ooi, Eng Eong; Khor, Chiea Chuen; Naim, Ahmand Nazri Mohamed; Ho, Eliza Xin Pei; Ong, Swee Hoe; Wertheim, Heiman F.; Fox, Annette; Chau Van Vinh Nguyen; Ngoc My Nghiem; Tuan Manh Ha; Anh Thi Ngoc Tran; Tambayah, Paul; Lin, Raymond; Sangsajja, Chariya; Manosuthi, Weerawat; Chuchottaworn, Chareon; Sansayunh, Piamlarp; Chotpitayasunondh, Tawee; Suntarattiwong, Piyarat; Chokephaibulkit, Kulkanya; Puthavathana, Pilaipan; de Jong, Menno D.; Farrar, Jeremy; van Doorn, H. Rogier; Hibberd, Martin Lloyd			Patient-Based Transcriptome-Wide Analysis Identify Interferon and Ubiquination Pathways as Potential Predictors of Influenza A Disease Severity	PLOS ONE			English	Article							RIG-I; RESPONSES; VIRUS; INFECTION; INDUCTION; PATHOLOGY; H1N1; H5N1	Background: The influenza A virus is an RNA virus that is responsible for seasonal epidemics worldwide with up to five million cases of severe illness and 500,000 deaths annually according to the World Health Organization estimates. The factors associated with severe diseases are not well defined, but more severe disease is more often seen among persons aged.65 years, infants, pregnant women, and individuals of any age with underlying health conditions. Methodology/Principal Findings: Using gene expression microarrays, the transcriptomic profiles of influenza-infected patients with severe (N = 11), moderate (N = 40) and mild (N = 83) symptoms were compared with the febrile patients of unknown etiology (N = 73). We found that influenza-infected patients, regardless of their clinical outcomes, had a stronger induction of antiviral and cytokine responses and a stronger attenuation of NK and T cell responses in comparison with those with unknown etiology. More importantly, we found that both interferon and ubiquitination signaling were strongly attenuated in patients with the most severe outcomes in comparison with those with moderate and mild outcomes, suggesting the protective roles of these pathways in disease pathogenesis. Conclusion/Significances: The attenuation of interferon and ubiquitination pathways may associate with the clinical outcomes of influenza patients.	[Long Truong Hoang; Khor, Chiea Chuen; Naim, Ahmand Nazri Mohamed; Ho, Eliza Xin Pei; Ong, Swee Hoe; Hibberd, Martin Lloyd] Genome Inst Singapore, Singapore, Singapore; [de Jong, Menno D.; Farrar, Jeremy; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wertheim, Heiman F.; Fox, Annette] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Natl Hosp Trop Dis, Hanoi, Vietnam; [Wertheim, Heiman F.; Fox, Annette] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Chau Van Vinh Nguyen; Ngoc My Nghiem] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tuan Manh Ha; Anh Thi Ngoc Tran] Children Hosp 2, Ho Chi Minh City, Vietnam; [Tambayah, Paul; Lin, Raymond] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Sangsajja, Chariya; Manosuthi, Weerawat] Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Chuchottaworn, Chareon; Sansayunh, Piamlarp] Chest Dis Inst, Nonthaburi, Thailand; [Chotpitayasunondh, Tawee; Suntarattiwong, Piyarat] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Chokephaibulkit, Kulkanya; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Tolfvenstam, Thomas] Karolinska Inst, Solna, Sweden	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; National Hospital of Tropical Diseases; University of Oxford; University of Oxford; National University of Singapore; Chest Disease Research Institute - Thailand; Mahidol University; Karolinska Institutet	Hoang, LT (corresponding author), Genome Inst Singapore, Singapore, Singapore.	hoangtl@gis.a-star.edu.sg	Hoang, Long/ABC-7442-2020; Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016; van Doorn, H. Rogier/H-3080-2019	Hoang, Long/0000-0002-6808-6758; Wertheim, Heiman FL/0000-0002-5003-5565; van Doorn, H. Rogier/0000-0002-9807-1821; Tolfvenstam, Thomas/0000-0003-3549-8083; Khor, Chiea Chuen/0000-0002-1128-4729; Ong, Swee Hoe/0000-0002-3629-5387; Farrar, Jeremy/0000-0002-2700-623X; Fox, Annette/0000-0002-0565-7146; Hibberd, Martin/0000-0001-8587-1849; Ooi, Eng Eong/0000-0002-0520-1544; Ha Manh, Tuan/0000-0002-4998-2581	South East Asia Infectious Disease Clinical Research Network [N01-A0-50042]; Wellcome Trust of Great Britain [077078/Z/05/Z]; Singapore Agency for Science, Technology and Research (A-STAR)	South East Asia Infectious Disease Clinical Research Network; Wellcome Trust of Great Britain(Wellcome Trust); Singapore Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was funded by the South East Asia Infectious Disease Clinical Research Network (N01-A0-50042, www.seaicrn.org), and the Wellcome Trust of Great Britain (Grant 077078/Z/05/Z) and the Singapore Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Juno J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/797180; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Marquez ME, 2010, CELL IMMUNOL, V264, P86, DOI 10.1016/j.cellimm.2010.05.002; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Rajsbaum R, 2013, TRENDS MICROBIOL, V21, P421, DOI 10.1016/j.tim.2013.06.006; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; South East Asia Infectious Disease Clinical Research Network, 2013, BMJ, V346, pf3039, DOI 10.1136/bmj.f3039; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111640	10.1371/journal.pone.0111640	http://dx.doi.org/10.1371/journal.pone.0111640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365328	Green Accepted, Green Published, gold			2022-12-26	WOS:000345558100093
J	Maghsoudi, A; Baneshi, MR; Neydavoodi, M; Haghdoost, A				Maghsoudi, Ahmad; Baneshi, Mohammad Reza; Neydavoodi, Mojtaba; Haghdoost, AliAkbar			Network Scale-Up Correction Factors for Population Size Estimation of People Who Inject Drugs and Female Sex Workers in Iran	PLOS ONE			English	Article							PERSONAL NETWORK; HIV/AIDS; STIGMA; RISK; HIV	Introduction: The results of the network scale-up (NSU) method in estimating the size of key populations for HIV might be biased if the recruited subjects are not fully informed of the risky behaviors of people in their networks (low visibility), or key populations have a smaller social network (low popularity). We aimed to measure such biases in the size estimation of people who inject drugs (PWIDs), and female sex workers (FSWs) in Iran. Methods: We interviewed 163 male PWIDs, 76 FSWs (known as egos) and 600 subjects from the general population. We selected twenty first-names (ten males and ten females) and asked the study subjects separately how many people they knew with one of these names (known as alters). Visibility Factor (VF) was defined as the percentage of FSW or PWID alters that were aware of their behavior. In addition, the popularity factor (PF) was calculated by dividing the number of alters reported by FSWs and PWIDs into that of the general population. The 95% uncertainty intervals (UI) were calculated using bootstrap technique. Results: The VF was estimated at 54% (95% UI: 52%-56%) for PWID and 45% (95% UI: 42%-48%) for FSW. The VF among the peer alters was significantly higher than non-peer ones. The PF for PWID and FSW was 69% (95% UI: 66%-73%) and 77% (95% UI: 72%-83%), respectively. The cross-validation and name splitting analysis showed that our estimates were not influenced by any single name. Conclusions: Both correction factors, particularly VF were far from one, and NSU results without correction, could lead to up to 4 times underestimation of the sizes. Therefore, applying these coefficients is necessary in NSU projects.	[Maghsoudi, Ahmad] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Maghsoudi, Ahmad] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Baneshi, Mohammad Reza; Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Dept Biostat & Epidemiol, Res Ctr Modeling Hlth, Kerman, Iran; [Neydavoodi, Mojtaba] Shiraz Univ Med Sci, Fac Publ Hlth, Shiraz, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Shiraz University of Medical Science	Haghdoost, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Dept Biostat & Epidemiol, Res Ctr Modeling Hlth, Kerman, Iran.	ahaghdoost@kmu.ac.ir	Baneshi, Mohammad Reza/C-2586-2017; Haghdoost, Ali Akbar/C-2823-2009	Baneshi, Mohammad Reza/0000-0002-6405-8688; Haghdoost, Ali Akbar/0000-0003-4628-4849	Student Research Committee of Kerman University of Medical Sciences	Student Research Committee of Kerman University of Medical Sciences	Support was provided by the Student Research Committee of Kerman University of Medical Sciences. The funder had no role in study design, data collection and analysis, descison to publish, or preparation of the manuscript.	Abadia-Barrero CE, 2006, SOC SCI MED, V62, P1219, DOI 10.1016/j.socscimed.2005.07.006; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; BERNARD HR, 1991, SOC SCI RES, V20, P109; Dhsprogram Website, 2012, EST SIZ POP HOUS SUR; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Jackson D, 2005, CONNECTIONS, V26, P49; Killworth PD, 2003, ATTEMPTING QUANTIFY; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; McCormick TH, 2010, J AM STAT ASSOC, V105, P59, DOI 10.1198/jasa.2009.ap08518; Paniotto V, 2009, ESTIMATING SIZE POPU; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Sabin K, 2010, METHODOL INNOV ONLIN, V5, P38, DOI [10.4256/mio.2010.0017, DOI 10.4256/MIO.2010.0017]; Salganik MJ, 2011, AM J EPIDEMIOL, V174, P1190, DOI 10.1093/aje/kwr246; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; SHELLEY GA, 1995, SOC NETWORKS, V17, P189, DOI 10.1016/0378-8733(95)00262-M; Shokoohi M, 2011, ADDICTION HLTH, V2, P81; Shokoohi M, 2012, INT J PREVENTIVE MED, V3, P471; Stroup DF, 2010, SIZE ESTIMATIO UNPUB; UNAIDS the US Office of the Global AIDS Coordinator, 2012, CONS NETW SCAL UP OT; Zolala F., 2011, EXPLORING ROUTINE DA	20	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110917	10.1371/journal.pone.0110917	http://dx.doi.org/10.1371/journal.pone.0110917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365341	Green Published, gold			2022-12-26	WOS:000345558100034
J	Yukawa, H; Nakagawa, S; Yoshizumi, Y; Watanabe, M; Saito, H; Miyamoto, Y; Noguchi, H; Oishi, K; Ono, K; Sawada, M; Kato, I; Onoshima, D; Obayashi, M; Hayashi, Y; Kaji, N; Ishikawa, T; Hayashi, S; Baba, Y				Yukawa, Hiroshi; Nakagawa, Shingo; Yoshizumi, Yasuma; Watanabe, Masaki; Saito, Hiroaki; Miyamoto, Yoshitaka; Noguchi, Hirofumi; Oishi, Koichi; Ono, Kenji; Sawada, Makoto; Kato, Ichiro; Onoshima, Daisuke; Obayashi, Momoko; Hayashi, Yumi; Kaji, Noritada; Ishikawa, Tetsuya; Hayashi, Shuji; Baba, Yoshinobu			Novel Positively Charged Nanoparticle Labeling for In Vivo Imaging of Adipose Tissue-Derived Stem Cells	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MEDIATED GENE-TRANSFER; MAGNETIC NANOPARTICLES; CONTRAST AGENTS; STROMAL CELLS; PROTEIN TRANSDUCTION; MRI; MOUSE; CYTOTOXICITY; EFFICIENCY	Stem cell transplantation has been expected to have various applications for regenerative medicine. However, in order to detect and trace the transplanted stem cells in the body, non-invasive and widely clinically available cell imaging technologies are required. In this paper, we focused on magnetic resonance (MR) imaging technology, and investigated whether the trimethylamino dextran-coated magnetic iron oxide nanoparticle -03 (TMADM-03), which was newly developed by our group, could be used for labeling adipose tissue-derived stem cells (ASCs) as a contrast agent. No cytotoxicity was observed in ASCs transduced with less than 100 mu g-Fe/mL of TMADM-03 after a one hour transduction time. The transduction efficiency of TMADM-03 into ASCs was about four-fold more efficient than that of the alkali-treated dextran-coated magnetic iron oxide nanoparticle (ATDM), which is a major component of commercially available contrast agents such as ferucarbotran (Resovist), and the level of labeling was maintained for at least two weeks. In addition, the differentiation ability of ASCs labeled with TMADM-03 and their ability to produce cytokines such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and prostaglandin E2 (PGE2), were confirmed to be maintained. The ASCs labeled with TMADM-03 were transplanted into the left kidney capsule of a mouse. The labeled ASCs could be imaged with good contrast using a 1T MR imaging system. These data suggest that TMADM-03 can therefore be utilized as a contrast agent for the MR imaging of stem cells.	[Yukawa, Hiroshi; Obayashi, Momoko; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nakagawa, Shingo; Yoshizumi, Yasuma; Hayashi, Yumi; Ishikawa, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Watanabe, Masaki; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Saito, Hiroaki; Kato, Ichiro] MEITO Sangyo Co Ltd, Nagoya Res Lab, Kiyosu 4520067, Japan; [Miyamoto, Yoshitaka; Hayashi, Shuji] Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Higashi Ku, Nagoya, Aichi 4610047, Japan; [Noguchi, Hirofumi] Univ Ryukyus, Grad Sch Med, Dept Regenerat Med, Nishihara, Okinawa 9030215, Japan; [Oishi, Koichi; Ono, Kenji; Sawada, Makoto] Nagoya Univ, Res Inst Environm Med Stress Adapt & Protect, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Onoshima, Daisuke] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; University of the Ryukyus; Nagoya University; Nagoya University; National Institute of Advanced Industrial Science & Technology (AIST)	Yukawa, H (corresponding author), Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	hiroshiy@med.nagoya-u.ac.jp	Miyamoto, Yoshitaka/X-6637-2018; Kaji, Noritada/M-8432-2019; Ono, Kenji/I-6163-2014; Kaji, Noritada/K-5623-2016	Ono, Kenji/0000-0002-5402-6535; Kaji, Noritada/0000-0002-9828-873X; Miyamoto, Yoshitaka/0000-0001-6697-7453; Noguchi, Hirofumi/0000-0002-0880-6805	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24681027, 26750146, 24390316] Funding Source: KAKEN	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and partially supported by the Japan Science and Technology Agency (JST) through its "Research Center Network for Realization of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Bae JE, 2011, BIOMATERIALS, V32, P9401, DOI 10.1016/j.biomaterials.2011.08.075; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f; BULL BS, 1975, J THORAC CARDIOV SUR, V69, P685; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chen R, 2011, INT J NANOMED, V6, P511, DOI 10.2147/IJN.S16934; Chien LY, 2011, BIOMATERIALS, V32, P3275, DOI 10.1016/j.biomaterials.2011.01.042; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Hart C, 2011, METHODS MOL BIOL, V698, P459, DOI 10.1007/978-1-60761-999-4_33; Hu SL, 2009, J CELL BIOCHEM, V108, P529, DOI 10.1002/jcb.22283; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Kazemi T, 2008, INT J CANCER, V123, P2113, DOI 10.1002/ijc.23751; Kim HM, 2011, ACS NANO, V5, P8230, DOI 10.1021/nn202912b; Kim JI, 2012, BIOMATERIALS, V33, P218, DOI 10.1016/j.biomaterials.2011.09.033; Kim TH, 2010, MAGN RESON IMAGING, V28, P1004, DOI 10.1016/j.mri.2010.03.047; Kim T, 2011, J AM CHEM SOC, V133, P2955, DOI 10.1021/ja1084095; Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25; Liu G, 2009, J MATER RES, V24, P1317, DOI 10.1557/JMR.2009.0179; Liu KY, 2011, STEM CELLS DEV, V20, P1679, DOI 10.1089/scd.2010.0447; Mailander V, 2008, MOL IMAGING BIOL, V10, P138, DOI 10.1007/s11307-007-0130-3; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Nohroudi K, 2010, CELL TRANSPLANT, V19, P431, DOI 10.3727/096368909X484699; Oishi K, 2008, CELL TRANSPLANT, V17, P35, DOI 10.3727/000000008783906937; Oishi K, 2012, CELL MED, V3, P43, DOI 10.3727/215517912X639397; Oishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057046; Oishi K, 2010, CELL TRANSPLANT, V19, P887, DOI 10.3727/096368910X509013; Patel D, 2011, BIOMATERIALS, V32, P1167, DOI 10.1016/j.biomaterials.2010.10.013; Phelan A, 1998, NAT BIOTECHNOL, V16, P440, DOI 10.1038/nbt0598-440; Pierzchalski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074745; Rosen JE, 2010, NANOMEDICINE, V8, P275; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Son KR, 2010, WORLD J GASTROENTERO, V16, P5611, DOI 10.3748/wjg.v16.i44.5611; Sponarova D, 2011, J BIOMED NANOTECHNOL, V7, P384, DOI 10.1166/jbn.2011.1289; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tseng CL, 2010, BIOMATERIALS, V31, P5427, DOI 10.1016/j.biomaterials.2010.03.049; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Xiao L, 2011, ACS NANO, V5, P6315, DOI 10.1021/nn201348s; Yukawa H, 2008, CELL TRANSPLANT, V17, P43, DOI 10.3727/000000008783907071; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Yukawa H, 2009, CELL TRANSPLANT, V18, P601, DOI 10.1177/096368970901805-616; Zhang B, 2013, BIOMATERIALS, V34, P5843, DOI 10.1016/j.biomaterials.2013.04.021	46	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110142	10.1371/journal.pone.0110142	http://dx.doi.org/10.1371/journal.pone.0110142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365191	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100017
J	Dong, BQ; Liang, DB; Lin, M; Wang, ML; Zeng, J; Liao, HZ; Zhou, LY; Huang, J; Wei, XL; Zou, GY; Jing, HQ				Dong, Baiqing; Liang, Dabin; Lin, Mei; Wang, Mingliu; Zeng, Jun; Liao, Hezhuang; Zhou, Lingyun; Huang, Jun; Wei, Xiaolin; Zou, Guanyang; Jing, Huaiqi			Bacterial Etiologies of Five Core Syndromes: Laboratory-Based Syndromic Surveillance Conducted in Guangxi, China	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZAE TYPE-B; STREPTOCOCCUS-SUIS; ENTEROPATHOGENIC BACTERIA; ACUTE DIARRHEA; RISK-FACTORS; INFECTION; CHILDREN; EPIDEMIOLOGY; PROVINCE	Background: Under the existing national surveillance system in China for selected infectious diseases, bacterial cultures are performed for only a small percentage of reported cases. We set up a laboratory-based syndromic surveillance system to elucidate bacterial etiologic spectrum and detect infection by rare etiologies (or serogroups) for five core syndromes in the given study area. Methods: Patients presenting with one of five core syndromes at nine sentinel hospitals in Guagnxi, China were evaluated using laboratory-based syndrome surveillance to elucidate bacterial etiologies. We collected respiratory and stool specimens, as well as CSF, blood and other related samples for bacterial cultures and pulse field gel electrophoresis (PFGE) assays. Results: From February 2009 to December 2011, 2,964 patients were enrolled in the study. Etiologies were identified in 320 (10.08%) patients. Streptococcus pneumonia (37 strains, 24.18%), Klebsiella pneumonia (34, 22.22%), Pseudomonas aeruginosa (19, 12.42%) and Haemophilus influenza (18, 11.76%) were the most frequent pathogens for fever and respiratory syndrome, while Salmonella (77, 81.05%) was most often seen in diarrhea syndrome cases. Salmonella paratyphi A (38, 86.36%) occurred in fever and rash syndrome, with Cryptococcus neoformans (20, 35.09%), Streptococcus pneumonia (5, 8.77%), Klebsiella pneumonia (5, 8.77%), streptococcus suis (3, 5.26%) and Neisseria meningitides group B (2, 3.51%) being the most frequently detected in encephalitis-meningitis syndrome. To date no pathogen was isolated from the specimens from fever and hemorrhage patients. Conclusions: In addition to common bacterial pathogens, opportunistic pathogens and fungal infections require more attention. Our study contributes to the strengthening of the existing national surveillance system and provides references for other regions that are similar to the study area.	[Dong, Baiqing] Guagnxi Zhuang Autonomous Reg Hlth Bur, Dept Emergency Response, Nanning, Guangxi, Peoples R China; [Liang, Dabin; Lin, Mei; Wang, Mingliu; Zeng, Jun; Liao, Hezhuang; Zhou, Lingyun; Huang, Jun] Guagnxi Zhuang Autonomous Reg Ctr Dis Prevent, Div Bacterial Infect Dis Control, Nanning, Guangxi, Peoples R China; [Wang, Mingliu; Wei, Xiaolin] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Zou, Guanyang] Univ Leeds, Nuffield Ctr Int Hlth & Dev, COMDIS Hlth Serv Delivery Res Consortium, China Program, Shenzhen, Peoples R China; [Jing, Huaiqi] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Jing, Huaiqi] Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Lin, M (corresponding author), Guagnxi Zhuang Autonomous Reg Ctr Dis Prevent, Div Bacterial Infect Dis Control, Nanning, Guangxi, Peoples R China.	gxlinmei@126.com			Chinese Center for Disease Control and Prevention [2009ZX10004203-003]; Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China [2012GXNSFAA053159]	Chinese Center for Disease Control and Prevention; Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China	BQD received funding by the Chinese Center for Disease Control and Prevention (2009ZX10004203-003) (http://www.chinacdc.cn/). The Chinese Center for Disease Control and Prevention played a role in study design. ML received the funding by the Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China (2012GXNSFAA053159) (http://www.gxst.gov.cn/). The Department of Science and Technology of Guangxi has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abio A, 2013, PATHOG GLOB HEALTH, V107, P373, DOI 10.1179/2047773213Y.0000000119; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Barr W, 2014, AM FAM PHYSICIAN, V89, P180; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Cai J, 2014, J MED VIROL, V86, P1602, DOI 10.1002/jmv.23884; Chaisuksant S, 2013, SE ASIAN J TROP MED, V44, P289; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Favaro M, 2013, MOL BIOTECHNOL, V53, P74, DOI 10.1007/s12033-012-9534-7; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Jafari F, 2008, JPN J INFECT DIS, V61, P269; Jefferies JMC, 2012, J MED MICROBIOL, V61, P1052, DOI 10.1099/jmm.0.044818-0; Kim SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-310; Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003; Levine OS, 2000, EMERG INFECT DIS, V6, P165, DOI 10.3201/eid0602.000209; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li YX, 2014, EMERG INFECT DIS, V20, P61, DOI 10.3201/eid2001.120375; Liu YF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-309; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Makoka MH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-67; Mengistu Mebratenesh, 2011, Ethiop Med J, V49, P349; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Negroni R, 2012, CLIN DERMATOL, V30, P599, DOI 10.1016/j.clindermatol.2012.01.005; Owusu M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-28; Pachirat O, 2012, CLIN MED INSIGHTS-CA, V6, P119, DOI 10.4137/CMC.S9793; Panatto D, 2013, INDIAN J MED RES, V138, P835; Pavic I, 2013, COLLEGIUM ANTROPOL, V37, P619; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Qu M, 2012, J INFECTION, V65, P214, DOI 10.1016/j.jinf.2012.04.010; Ran L, 2011, FOODBORNE PATHOG DIS, V8, P921, DOI 10.1089/fpd.2010.0827; Sabiiti W, 2012, FUTURE MICROBIOL, V7, P1297, DOI [10.2217/FMB.12.102, 10.2217/fmb.12.102]; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Tudose C, 2010, MAEDICA BUCUR, V5, P258; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Weil-Olivier C, 2014, VACCINE, V32, P2022, DOI 10.1016/j.vaccine.2014.02.008; Weinberger M, 2013, EMERG INFECT DIS, V19, P1828, DOI 10.3201/eid1911.120900; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; Yan Youwang, 2005, J Chin Med Assoc, V68, P571, DOI 10.1016/S1726-4901(09)70096-6; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247; Zhang QL, 2011, PEDIATR INFECT DIS J, V30, P7, DOI 10.1097/INF.0b013e3181ec6245; Zhu M, 2013, EPIDEMIOL INFECT, V141, P540, DOI 10.1017/S0950268812000970	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110876	10.1371/journal.pone.0110876	http://dx.doi.org/10.1371/journal.pone.0110876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360596	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700050
J	Ferguson, LR; Grover, S; Dominguez, JM; Balaiya, S; Chalam, KV				Ferguson, Lee R.; Grover, Sandeep; Dominguez, James M., II; Balaiya, Sankarathi; Chalam, Kakarla V.			Retinal Thickness Measurement Obtained with Spectral Domain Optical Coherence Tomography Assisted Optical Biopsy Accurately Correlates with Ex Vivo Histology	PLOS ONE			English	Article							EYES; REPRODUCIBILITY; DEGENERATION; MODEL; MICE	Background: This study determines 'correlation constants' between the gold standard histological measurement of retinal thickness and the newer spectral-domain optical coherence tomography (SD-OCT) technology in adult C57BL/6 mice. Methods: Forty-eight eyes from adult mice underwent SD-OCT imaging and then were histologically prepared for frozen sectioning with H&E staining. Retinal thickness was measured via 10x light microscopy. SD-OCT images and histological sections were standardized to three anatomical sites relative to the optic nerve head (ONH) location. The ratios between SD-OCT to histological thickness for total retinal thickness (TRT) and six sublayers were defined as 'correlation constants'. Results: Mean (+/- SE) TRT for SD-OCT and histological sections was 210.95 mu m (+/- 1.09) and 219.58 mu m (+/- 2.67), respectively. The mean 'correlation constant' for TRT between the SD-OCT and histological sections was 0.96. The retinal thickness for all sublayers measured by SD-OCT vs. histology were also similar, the 'correlation constant' values ranged from 0.70 to 1.17. All SD-OCT and histological measurements demonstrated highly significant (p<0.01) strong positive correlations. Conclusion: This study establishes conversion factors for the translation of ex vivo data into in vivo information; thus enhancing the applicability of SD-OCT in translational research.	[Ferguson, Lee R.; Grover, Sandeep; Balaiya, Sankarathi; Chalam, Kakarla V.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA; [Dominguez, James M., II] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chalam, KV (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA.	Kakarla.Chalam@jax.ufl.edu	Chalam, kakarla/K-7507-2019	Chalam, K V/0000-0002-0004-9416	Department of Ophthalmology Jacksonville, Jacksonville, Florida	Department of Ophthalmology Jacksonville, Jacksonville, Florida	The Department of Ophthalmology Jacksonville, Jacksonville, Florida provided all financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown NH, 2009, GRAEF ARCH CLIN EXP, V247, P1069, DOI 10.1007/s00417-009-1044-3; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; Curcio CA, 2011, INVEST OPHTH VIS SCI, V52, P3943, DOI 10.1167/iovs.10-6377; Ferguson LR, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-9; Ferguson LR, 2013, PLOS ONE, V27, P8; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; Gloesmann M, 2003, INVEST OPHTH VIS SCI, V44, P1696, DOI 10.1167/iovs.02-0654; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Yehoshua Z, 2012, OPHTHALMIC RES, V48, P6, DOI 10.1159/000339841; Zhou XT, 2008, VISION RES, V48, P1137, DOI 10.1016/j.visres.2008.01.030	21	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111203	10.1371/journal.pone.0111203	http://dx.doi.org/10.1371/journal.pone.0111203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360629	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700072
J	Lu, Y; Roy, R				Lu, Yu; Roy, Richard			Centrosome/Cell Cycle Uncoupling and Elimination in the Endoreduplicating Intestinal Cells of C. elegans	PLOS ONE			English	Article							CENTRIOLE DUPLICATION; PHOSPHORYLATION SITES; POLO KINASE; PROTEIN; MATURATION; SEPARATION; DIVISION; ENCODES; ORGANIZATION; CILIOGENESIS	The centrosome cycle is most often coordinated with mitotic cell division through the activity of various essential cell cycle regulators, consequently ensuring that the centriole is duplicated once, and only once, per cell cycle. However, this coupling can be altered in specific developmental contexts; for example, multi-ciliated cells generate hundreds of centrioles without any S-phase requirement for their biogenesis, while Drosophila follicle cells eliminate their centrosomes as they begin to endoreduplicate. In order to better understand how the centrosome cycle and the cell cycle are coordinated in a developmental context we use the endoreduplicating intestinal cell lineage of C. elegans to address how novel variations of the cell cycle impact this important process. In C. elegans, the larval intestinal cells undergo one nuclear division without subsequent cytokinesis, followed by four endocycles that are characterized by successive rounds of S-phase. We monitored the levels of centriolar/centrosomal markers and found that centrosomes lose their pericentriolar material following the nuclear division that occurs during the L1 stage and is thereafter never re-gained. The centrioles then become refractory to S phase regulators that would normally promote duplication during the first endocycle, after which they are eliminated during the L2 stage. Furthermore, we show that SPD-2 plays a central role in the numeral regulation of centrioles as a potential target of CDK activity. On the other hand, the phosphorylation on SPD-2 by Polo-like kinase, the transcriptional regulation of genes that affect centriole biogenesis, and the ubiquitin/proteasome degradation pathway, contribute collectively to the final elimination of the centrioles during the L2 stage.	[Lu, Yu; Roy, Richard] McGill Univ, Dept Biol, Dev Biol Res Initiat, Montreal, PQ H3A 1B1, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, Dev Biol Res Initiat, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	richard.roy@mcgill.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 1999, DEVELOPMENT, V126, P1947; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bobinnec Y, 2000, J CELL SCI, V113, P3747; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Boxem M, 1999, DEVELOPMENT, V126, P2227; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; BRENNER S, 1974, GENETICS, V77, P71; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Enjolras C, 2012, J CELL BIOL, V197, P313, DOI 10.1083/jcb.201109148; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Inglis P, 2006, SENSORY CILIA CAENOR; Kais Z, 2008, CANCER BIOL THER, V7, P1540, DOI 10.4161/cbt.7.10.7053; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kim DY, 2006, J CELL BIOL, V174, P751, DOI 10.1083/jcb.200512160; Kipreos ET, 2005, NAT REV MOL CELL BIO, V6, P766, DOI 10.1038/nrm1738; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2011, DEV CELL, V20, P550, DOI 10.1016/j.devcel.2011.02.005; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; MAHOWALD AP, 1979, EXP CELL RES, V118, P404, DOI 10.1016/0014-4827(79)90167-8; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; McMahon L, 2001, J CELL SCI, V114, P2265; Mikeladze-Dvali T, 2012, DEVELOPMENT, V139, P1670, DOI 10.1242/dev.075440; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 1998, GENETICS, V149, P1303; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Toole E, 2012, PLOS ONE, V7, P140, DOI 10.1371/journal.pone.0029795; Ouellet J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-38; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pepper ASR, 2004, DEVELOPMENT, V131, P2049, DOI 10.1242/dev.01098; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schvarzstein M, 2013, P NATL ACAD SCI USA, V110, pE898, DOI 10.1073/pnas.1213888110; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Song MH, 2011, DEV CELL, V20, P563, DOI 10.1016/j.devcel.2011.03.007; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k	78	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110958	10.1371/journal.pone.0110958	http://dx.doi.org/10.1371/journal.pone.0110958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360893	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700055
J	Zheng, TC; Li, S; Zang, LN; Dai, LJ; Yang, CP; Qu, GZ				Zheng, Tangchun; Li, Shuang; Zang, Lina; Dai, Lijuan; Yang, Chuanping; Qu, Guan-Zheng			Overexpression of Two PsnAP1 Genes from Populus simonii x P. nigra Causes Early Flowering in Transgenic Tobacco and Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL MERISTEM IDENTITY; CONSTITUTIVE EXPRESSION; ECTOPIC EXPRESSION; APETALA1; TIME; CHLOROPHYLLS; PRENYLATION; ACTIVATION; TRANSITION	In Arabidopsis, AP1 is a floral meristem identity gene and plays an important role in floral organ development. In this study, PsnAP1-1 and PsnAP1-2 were isolated from the male reproductive buds of poplar (Populus simonii x P. nigra), which are the orthologs of AP1 in Arabidopsis, by sequence analysis. Northern blot and qRT-PCR analysis showed that PsnAP1-1 and PsnAP1-2 exhibited high expression level in early inflorescence development of poplar. Subcellular localization showed the PsnAP1-1 and PsnAP1-2 proteins are localized in the nucleus. Overexpression of PsnAP1-1 and PsnAP1-2 in tobacco under the control of a CaMV 35S promoter significantly enhanced early flowering. These transgenic plants also showed much earlier stem initiation and higher rates of photosynthesis than did wild-type tobacco. qRT-PCR analysis further indicated that overexpression of PsnAP1-1 and PsnAP1-2 resulted in up-regulation of genes related to flowering, such as NtMADS4, NtMADS5 and NtMADS11. Overexpression of PsnAP1-1 and PsnAP1-2 in Arabidopsis also induced early flowering, but did not complement the ap1-10 floral morphology to any noticeable extent. This study indicates that PsnAP1-1 and PsnAP1-2 play a role in floral transition of poplar.	[Zheng, Tangchun; Li, Shuang; Zang, Lina; Dai, Lijuan; Yang, Chuanping; Qu, Guan-Zheng] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Northeast Forestry University - China	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	yangchuanpingnefu@yahoo.com; quguanzheng@yahoo.com			Program for New Century Excellent Talents in University [NCET-12-0808]; National Natural Science Foundation of China [31370661]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by Program for New Century Excellent Talents in University (No. NCET-12-0808) and National Natural Science Foundation of China (No. 31370661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Berbel A, 2001, PLANT J, V25, P441, DOI 10.1046/j.1365-313x.2001.00974.x; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Calonje M, 2004, PLANT PHYSIOL, V135, P1491, DOI 10.1104/pp.104.040832; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Davies B, 1994, Results Probl Cell Differ, V20, P235; Elo A, 2001, PHYSIOL PLANTARUM, V112, P95, DOI 10.1034/j.1399-3054.2001.1120113.x; Fernando DD, 2006, DEV GENES EVOL, V216, P19, DOI 10.1007/s00427-005-0026-7; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Huang HJ, 2014, PHYSIOL PLANTARUM, V151, P495, DOI 10.1111/ppl.12123; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Jang S, 1999, MOL CELLS, V9, P576; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kotoda N, 2002, PLANT SCI, V162, P679, DOI 10.1016/S0168-9452(02)00024-9; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma GY, 2011, PLANT MOL BIOL REP, V29, P573, DOI 10.1007/s11105-010-0263-4; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Niwa Y., 2003, PLANT BIOTECHNOL-NAR, V20, P1, DOI [10.5511/plantbiotechnology.20.1, DOI 10.5511/PLANTBIOTECHNOLOGY.20.1]; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pena L, 2001, NAT BIOTECHNOL, V19, P263, DOI 10.1038/85719; Pomar F, 2002, PROTOPLASMA, V220, P17, DOI 10.1007/s00709-002-0030-y; Qu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063398; Rodriguez-Concepcion M, 1999, PLANT MOL BIOL, V39, P865, DOI 10.1023/A:1006170020836; Shinano T, 1996, PHOTOSYNTHETICA, V32, P409; Smykal P, 2007, PLANT MOL BIOL, V65, P233, DOI 10.1007/s11103-007-9211-6; Sung SK, 1999, PLANT PHYSIOL, V120, P969, DOI 10.1104/pp.120.4.969; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Zhang BY, 2008, TREE PHYSIOL, V28, P929, DOI 10.1093/treephys/28.6.929	42	13	15	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111725	10.1371/journal.pone.0111725	http://dx.doi.org/10.1371/journal.pone.0111725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360739	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700144
J	Leite, C; Silva, NT; Mendes, S; Ribeiro, A; de Faria, JP; Lourenco, T; dos Santos, F; Andrade, PZ; Cardoso, CMP; Vieira, M; Paiva, A; da Silva, CL; Cabral, JMS; Relvas, JB; Graos, M				Leite, Cristiana; Silva, N. Tatiana; Mendes, Sandrine; Ribeiro, Andreia; de Faria, Joana Paes; Lourenco, Tania; dos Santos, Francisco; Andrade, Pedro Z.; Cardoso, Carla M. P.; Vieira, Margarida; Paiva, Artur; da Silva, Claudia L.; Cabral, Joaquim M. S.; Relvas, Joao B.; Graos, Mario			Differentiation of Human Umbilical Cord Matrix Mesenchymal Stem Cells into Neural-Like Progenitor Cells and Maturation into an Oligodendroglial-Like Lineage	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; SPINAL-CORD; ADIPOSE-TISSUE; NESTIN; EXPRESSION; NEURONS; MYELIN; PRECURSORS; GENERATION	Mesenchymal stem cells (MSCs) are viewed as safe, readily available and promising adult stem cells, which are currently used in several clinical trials. Additionally, their soluble-factor secretion and multi-lineage differentiation capacities place MSCs in the forefront of stem cell types with expected near-future clinical applications. In the present work MSCs were isolated from the umbilical cord matrix (Wharton's jelly) of human umbilical cord samples. The cells were thoroughly characterized and confirmed as bona-fide MSCs, presenting in vitro low generation time, high proliferative and colony-forming unit-fibroblast (CFU-F) capacity, typical MSC immunophenotype and osteogenic, chondrogenic and adipogenic differentiation capacity. The cells were additionally subjected to an oligodendroglial-oriented step-wise differentiation protocol in order to test their neural-and oligodendroglial-like differentiation capacity. The results confirmed the neural-like plasticity of MSCs, and suggested that the cells presented an oligodendroglial-like phenotype throughout the differentiation protocol, in several aspects sharing characteristics common to those of bona-fide oligodendrocyte precursor cells and differentiated oligodendrocytes.	[Leite, Cristiana; Silva, N. Tatiana; Lourenco, Tania; Graos, Mario] Biocant Pk, Biocant Technol Transfer Assoc, Cantanhede, Portugal; [Mendes, Sandrine; Ribeiro, Andreia; Paiva, Artur] Portuguese Inst Blood & Transplantat, Blood & Transplantat Ctr Coimbra, Coimbra, Portugal; [de Faria, Joana Paes; Relvas, Joao B.] Inst Biol Mol & Celular, Oporto, Portugal; [dos Santos, Francisco; Andrade, Pedro Z.; da Silva, Claudia L.; Cabral, Joaquim M. S.] Univ Lisbon, Inst Biotechnol & Bioengn, P-1699 Lisbon, Portugal; [dos Santos, Francisco; Andrade, Pedro Z.; da Silva, Claudia L.; Cabral, Joaquim M. S.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Cardoso, Carla M. P.; Vieira, Margarida] Biocant Pk, Crioestaminal Saude & Tecnol SA, Cantanhede, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Graos, M (corresponding author), Biocant Pk, Biocant Technol Transfer Assoc, Biocant Pk, Cantanhede, Portugal.	mgraos@biocant.pt	Ribeiro, Andreia/C-1557-2019; Paiva, Artur/AAH-2330-2022; Relvas, Joao B/A-1142-2008; Cabral, Joaquim M S/G-2052-2010; Andrade, Pedro/A-2471-2010; da Silva, Claudia L./K-6104-2012; de Faria, Joana Paes/M-8815-2014; Grãos, Mário/O-7273-2017; Paiva, Artur/AFM-0035-2022; Santos, Francisco F dos/N-9832-2016	Ribeiro, Andreia/0000-0001-6539-6649; Paiva, Artur/0000-0002-6562-5859; Relvas, Joao B/0000-0001-7636-0924; Cabral, Joaquim M S/0000-0002-2405-5845; da Silva, Claudia L./0000-0002-1091-7651; de Faria, Joana Paes/0000-0001-7046-6197; Grãos, Mário/0000-0002-2707-1488; Paiva, Artur/0000-0002-6562-5859; Santos, Francisco F dos/0000-0002-2046-2742; Pires Lourenco, Tania Milene/0000-0003-1198-8117; Almeida Silva, Neuza Tatiana/0000-0003-0542-9677; Cardoso, Carla/0000-0002-0985-7487	Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro [CENTRO -07-0202 -FEDER -005547]; European Regional Development Fund (ERDF); ERDF through Programa Operacional Factores de Competitividade - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) [FCOMP-01-0124-FEDER-021150 - PTDC/SAU-ENB/119292/2010]; COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'') [Centro-07-ST24-FEDER-002008]; FCT [SFRH/BPD/81861/2011, SFRH/BPD/81909/2011, SFRH/BPD/34834/2007]	Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro; European Regional Development Fund (ERDF)(European Commission); ERDF through Programa Operacional Factores de Competitividade - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology); COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine''); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Authors acknowledge "ISOCORD'' project, led by Crioestaminal - Saude e Tecnologia S.A., supported by the Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro (project nr. CENTRO -07-0202 -FEDER -005547) and co-funded by the European Regional Development Fund (ERDF). This work was partially funded by the ERDF through Programa Operacional Factores de Competitividade - COMPETE and by national funds by FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) through grant FCOMP-01-0124-FEDER-021150 - PTDC/SAU-ENB/119292/2010, which included a research fellowship awarded to TL, and COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'', Centro-07-ST24-FEDER-002008). FCT financially supported FS, PZA, and JPF through fellowships SFRH/BPD/81861/2011, SFRH/BPD/81909/2011 and SFRH/BPD/34834/2007, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan G, 2001, MICROSC RES TECHNIQ, V52, P753, DOI 10.1002/jemt.1060; Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Boggs JM, 2011, BBA-BIOMEMBRANES, V1808, P761, DOI 10.1016/j.bbamem.2010.12.016; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Ciavarella S, 2009, STEM CELLS DEV, V18, P1211, DOI 10.1089/scd.2008.0340; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Corotchi MC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt232; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Harris VK, 2012, STEM CELL TRANSL MED, V1, P536, DOI 10.5966/sctm.2012-0015; Hayashi T, 2013, J CLIN INVEST, V123, P272, DOI 10.1172/JCI62516; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hoffmann SA, 2014, DEVELOPMENT, V141, P39, DOI 10.1242/dev.098418; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kennea NL, 2009, CELL CYCLE, V8, P1069, DOI 10.4161/cc.8.7.8121; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; La Rocca G, 2012, OPEN TISSUE ENG REGE, V5, P50, DOI DOI 10.2174/1875043501205010050; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; Lee JC, 2000, GLIA, V30, P105, DOI 10.1002/(SICI)1098-1136(200004)30:2<105::AID-GLIA1>3.0.CO;2-H; Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106; Margossian T, 2012, BIO-MED MATER ENG, V22, P243, DOI 10.3233/BME-2012-0714; Martins AA, 2009, TRANSPL P, V41, P943, DOI 10.1016/j.transproceed.2009.01.059; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reinisch Andreas, 2009, J Vis Exp, DOI 10.3791/1525; Ribeiro A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt336; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Scheers I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071374; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Turnovcova K, 2009, CYTOTHERAPY, V11, P874, DOI 10.3109/14653240903188947; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wang Z, 2007, GLIA, V55, P537, DOI 10.1002/glia.20480; Whittaker MT, 2012, GLIA, V60, P281, DOI 10.1002/glia.21262; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Zhang HT, 2010, DIFFERENTIATION, V79, P15, DOI 10.1016/j.diff.2009.09.002	65	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111059	10.1371/journal.pone.0111059	http://dx.doi.org/10.1371/journal.pone.0111059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357129	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000038
J	Tangiisuran, B; Scutt, G; Stevenson, J; Wright, J; Onder, G; Petrovic, M; van der Cammen, TJ; Rajkumar, C; Davies, G				Tangiisuran, Balamurugan; Scutt, Greg; Stevenson, Jennifer; Wright, Juliet; Onder, G.; Petrovic, M.; van der Cammen, T. J.; Rajkumar, Chakravarthi; Davies, Graham			Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model	PLOS ONE			English	Article							EVENTS; SURVEILLANCE; DEFINITIONS; METHODOLOGY; ADMISSION; FAILURE	Background: Older patients are at an increased risk of developing adverse drug reactions (ADR). Of particular concern are the oldest old, which constitute an increasingly growing population. Having a validated clinical tool to identify those older patients at risk of developing an ADR during hospital stay would enable healthcare staff to put measures in place to reduce the risk of such an event developing. The current study aimed to (1) develop and (2) validate an ADR risk prediction model. Methods: We used a combination of univariate analysis and multivariate binary logistic regression to identify clinical risk factors for developing an ADR in a population of older people from a UK teaching hospital. The final ADR risk model was then validated in a European population (European dataset). Results: Six-hundred-ninety patients (median age 85 years) were enrolled in the development stage of the study. Ninety-five reports of ADR were confirmed by independent review in these patients. Five clinical variables were identified through multivariate analysis and included in our final model; each variable was attributed a score of 1. Internal validation produced an AUROC of 0.74, a sensitivity of 80%, and specificity of 55%. During the external validation stage the AUROC was 0.73, with sensitivity and specificity values of 84% and 43% respectively. Conclusions: We have developed and successfully validated a simple model to use ADR risk score in a population of patients with a median age of 85, i.e. the oldest old. The model is based on 5 clinical variables (>= 8 drugs, hyperlipidaemia, raised white cell count, use of anti-diabetic agents, length of stay >12 days), some of which have not been previously reported.	[Tangiisuran, Balamurugan] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Scutt, Greg; Stevenson, Jennifer; Davies, Graham] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Wright, Juliet; van der Cammen, T. J.; Rajkumar, Chakravarthi] Brighton & Sussex Med Sch, Dept Med, Brighton, E Sussex, England; [Onder, G.] Univ Cattolica Sacro Cuore, Dept Geriatr, I-00168 Rome, Italy; [Petrovic, M.] Ghent Univ Hosp, Dept Geriatr & Gerontol, Ghent, Belgium; [van der Cammen, T. J.] Erasmus Univ, Med Ctr, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands; [van der Cammen, T. J.] Delft Univ Technol, Fac Ind Design Engn, Delft, Netherlands	Universiti Sains Malaysia; University of London; King's College London; University of Brighton; University of Sussex; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Scutt, G (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England.	g.scutt@brighton.ac.uk	Tangiisuran, Balamurugan/E-2708-2012	Tangiisuran, Balamurugan/0000-0002-4354-3342; Stevenson, Jennifer/0000-0001-5664-1737				Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Catananti C, 2009, CLIN PHARMACOL THER, V86, P307, DOI 10.1038/clpt.2009.89; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Corsonello A, 2005, J GERONTOL A-BIOL, V60, P1147, DOI 10.1093/gerona/60.9.1147; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Handler SM, 2008, J AM GERIATR SOC, V56, P808, DOI 10.1111/j.1532-5415.2008.01665.x; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511, DOI 10.1093/gerona/61.5.511; HOSMER DW, 1989, APPL LOGISTIC REGRES; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannesse CK, 1997, BRIT MED J, V315, P1057, DOI 10.1136/bmj.315.7115.1057; McElnay JC, 1997, CLIN DRUG INVEST, V13, P47, DOI 10.2165/00044011-199713010-00006; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; O'Connor MN, 2012, AGE AGEING, V41, P771, DOI 10.1093/ageing/afs046; Office for National Statistics, 2007, NAT POP PROJ 2006 BA; Onder G, 2002, EUR J CLIN PHARMACOL, V58, P371, DOI 10.1007/s00228-002-0493-y; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; SCHNEIDER JK, 1992, AM J HOSP PHARM, V49, P90, DOI 10.1093/ajhp/49.1.90; Tangiisuran B, 2012, DRUG AGING, V29, P669, DOI 10.2165/11632630-000000000-00000; Trivalle C, 2010, J NUTR HEALTH AGING, V14, P57, DOI 10.1007/s12603-010-0010-4; U. S. Census Bureau, 2012, PROJ POP SEL AG GROU; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; World Health Organization, 2004, INT STAT CLASS DIS R; Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829; Zhang M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2752; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	33	58	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111254	10.1371/journal.pone.0111254	http://dx.doi.org/10.1371/journal.pone.0111254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356898	Green Published, gold, Green Accepted			2022-12-26	WOS:000346765000048
J	Vanuytsel, T; Vanormelingen, C; Vanheel, H; Masaoka, T; Rasoel, SS; Toth, J; Houben, E; Verbeke, K; De Hertogh, G; Vanden Berghe, P; Tack, J; Farre, R				Vanuytsel, Tim; Vanormelingen, Christophe; Vanheel, Hanne; Masaoka, Tatsuhiro; Rasoel, Shadea Salim; Toth, Joran; Houben, Els; Verbeke, Kristin; De Hertogh, Gert; Vanden Berghe, Pieter; Tack, Jan; Farre, Ricard			From Intestinal Permeability to Dysmotility: The Biobreeding Rat as a Model for Functional Gastrointestinal Disorders	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TIGHT JUNCTION PROTEINS; BARRIER DYSFUNCTION; EPITHELIAL PERMEABILITY; IMMUNE ACTIVATION; INTERFERON-GAMMA; MYENTERIC PLEXUS; BB-RAT; INFLAMMATION; EXPRESSION	Background: Impaired intestinal barrier function, low-grade inflammation and altered neuronal control are reported in functional gastrointestinal disorders. However, the sequence of and causal relation between these events is unclear, necessitating a spontaneous animal model. The aim of this study was to describe the natural history of intestinal permeability, mucosal and neuromuscular inflammation and nitrergic motor neuron function during the lifetime of the BioBreeding (BB) rat. Methods: Normoglycemic BB-diabetes prone (DP) and control rats were sacrificed at different ages and jejunum was harvested to characterize intestinal permeability, inflammation and neuromuscular function. Results: Both structural and functional evidence of increased intestinal permeability was found in young BB-DP rats from the age of 50 days. In older animals, starting in the mucosa from 70 days and in half of the animals also in the muscularis propria from 110 days, an inflammatory reaction, characterized by an influx of polymorphonuclear cells and higher myeloperoxidase activity, was observed. Finally, in animals older than 110 days, coinciding with a myenteric ganglionitis, a loss of nitrergic neurons and motor function was demonstrated. Conclusion: In the BB-rat, mucosal inflammatory cell infiltration is preceded by intestinal barrier dysfunction and followed by myenteric ganglionitis and loss of nitrergic function. This sequence supports a primary role for impaired barrier function and provides an insightful model for the pathogenesis of functional gastrointestinal disorders.	[Vanuytsel, Tim; Vanormelingen, Christophe; Vanheel, Hanne; Masaoka, Tatsuhiro; Rasoel, Shadea Salim; Toth, Joran; Houben, Els; Verbeke, Kristin; Vanden Berghe, Pieter; Tack, Jan; Farre, Ricard] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [De Hertogh, Gert] Univ Leuven, Univ Hosp, Dept Pathol, Leuven, Belgium; [Farre, Ricard] Inst Salud Carlos II, CIBERehd, Barcelona, Spain	KU Leuven; KU Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Tack, J (corresponding author), Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium.	jan.tack@med.kuleuven.be	Farre, Ricard/O-4549-2016; Farre, Ricard/M-9275-2013; Vanuytsel, Tim/O-9972-2016	Farre, Ricard/0000-0001-7158-171X; Farre, Ricard/0000-0001-7158-171X; Verbeke, Kristin/0000-0002-5352-7565; Vanden Berghe, Pieter/0000-0002-0009-2094; Tack, Jan/0000-0002-3206-6704; Vanuytsel, Tim/0000-0001-8728-0903	Methusalem grant from Leuven University; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO)	Methusalem grant from Leuven University; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO)(FWO)	Funding was provided by a Methusalem grant from Leuven University to JT and by the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO) through doctoral (TV and HV) and post-doctoral (RF) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Biesiekierski J.R., 2013, GASTROENTEROLOGY; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Camilleri M, 2007, NEUROGASTROENT MOTIL, V19, P545, DOI 10.1111/j.1365-2982.2007.00925.x; Camilleri M, 2012, NEW ENGL J MED, V367, P1626, DOI 10.1056/NEJMra1207068; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Demedts I, 2006, NEUROGASTROENT MOTIL, V18, P1102, DOI 10.1111/j.1365-2982.2006.00857.x; Demedts I, 2013, J NEUROGASTROENTEROL, V19, P161, DOI 10.5056/jnm.2013.19.2.161; Depoortere I, 2002, BRIT J PHARMACOL, V135, P2011, DOI 10.1038/sj.bjp.0704648; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Graham S, 2004, GUT, V53, P1437, DOI 10.1136/gut.2004.042481; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Kindt S, 2008, GASTROENTEROLOGY, V134, pA533; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kristjansson G, 2004, GUT, V53, P1806, DOI 10.1136/gut.2003.036418; Lindberg G, 2009, GUT, V58, P1084, DOI 10.1136/gut.2008.148296; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Martinez C, 2013, GUT, V62, P1160, DOI 10.1136/gutjnl-2012-302093; Matricon J, 2012, ALIMENT PHARM THER, V36, P1009, DOI 10.1111/apt.12080; Meddings JB, 1999, AM J PHYSIOL-GASTR L, V276, pG951, DOI 10.1152/ajpgi.1999.276.4.G951; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Odenwald MA, 2013, CLIN GASTROENTEROL H; Patrick C, 2013, DIABETES, V62, P2036, DOI 10.2337/db12-1243; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Takahashi T, 1997, GASTROENTEROLOGY, V113, P1535, DOI 10.1053/gast.1997.v113.pm9352855; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Vanheel H, 2013, NAT REV GASTRO HEPAT, V10, P142, DOI 10.1038/nrgastro.2012.255; Vanormelingen C, 2013, GASTROENTEROLOGY, V144, pS542; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Visser J, 2003, METABOLISM, V52, P333, DOI 10.1053/meta.2003.50052; Visser JTJ, 2010, DIABETOLOGIA, V53, P2621, DOI 10.1007/s00125-010-1903-9; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; YOUNG HM, 1992, HISTOCHEMISTRY, V97, P375, DOI 10.1007/BF00270041; Zandecki M, 2008, NEUROGASTROENT MOTIL, V20, P818, DOI 10.1111/j.1365-2982.2008.01091.x; Zandecki M, 2006, NEUROGASTROENT MOTIL, V18, P307, DOI 10.1111/j.1365-2982.2005.00755.x	57	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111132	10.1371/journal.pone.0111132	http://dx.doi.org/10.1371/journal.pone.0111132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354336	gold, Green Submitted, Green Published			2022-12-26	WOS:000345204200059
J	Xu, Y; Miriyala, S; Fang, F; Bakthavatchalu, V; Noel, T; Schell, DM; Wang, C; St Clair, WH; St Clair, DK				Xu, Y.; Miriyala, S.; Fang, F.; Bakthavatchalu, V.; Noel, T.; Schell, D. M.; Wang, C.; St Clair, W. H.; St Clair, D. K.			Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect	ONCOGENE			English	Article							SKIN CARCINOGENESIS MODEL; LIPID-PEROXIDATION; CANCER METABOLISM; OXIDATIVE STRESS; EPITHELIAL-CELLS; PROTEIN-2; OVEREXPRESSION; EXPRESSION; GLUCOSE; ALPHA	Manganese superoxide dismutase (MnSOD) is a mitochondrially localized primary antioxidant enzyme, known to be essential for the survival of aerobic life and to have important roles in tumorigenesis. Here, we show that MnSOD deficiency in skin tissues of MnSOD-heterozygous knockout (Sod2(+/) (-)) mice leads to increased expresson of uncoupling proteins (UCPs). When MnSOD is deficient, superoxide radical and its resulting reactive oxygen species (ROS) activate ligand binding to peroxisome proliferator-activated receptor alpha (PPAR alpha), suggesting that the activation of PPAR alpha signaling is a major mechanism underlying MnSOD-dependent UCPs expression that consequently triggers the PI3K/Akt/mTOR pathway, leading to increased aerobic glycolysis. Knockdown of UCPs and mTOR suppresses lactate production and increases ATP levels, suggesting that UCPs contribute to increased glycolysis. These results highlight the existence of a free radical-mediated mechanism that activates mitochondria uncoupling to reduce ROS production, which precedes the glycolytic adaptation described as the Warburg Effect.	[Xu, Y.] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Miriyala, S.; Bakthavatchalu, V.; Noel, T.; Schell, D. M.; St Clair, D. K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Fang, F.; St Clair, W. H.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA; [Wang, C.; St Clair, D. K.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA	Nanjing Medical University; University of Kentucky; University of Kentucky; University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, 1095 VA Dr, Lexington, KY 40536 USA.	yxu03558@yahoo.com; dstcl00@uky.edu		Miriyala, Sumitra/0000-0001-7158-9295	National Institutes of Health [CA 049797, CA 143428]; Edward P. Evans Foundation grant; National Nature Science Foundation of China [81372199];  [CA 073599]; NATIONAL CANCER INSTITUTE [R01CA049797, R01CA143428, R29CA049797, R01CA073599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants CA 049797 and CA 143428, and an Edward P. Evans Foundation grant to Daret K. St Clair; CA 073599 and CA 143428 to William H. St Clair; and National Nature Science Foundation of China grant 81372199 to Yong Xu. We would like to thank Dr Ronald M. Evans, Howard Hughes Medical Institute, San Diego, California 92186, USA, for providing the PPREx3-TK-luciferase construct for this study.	Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Criscuolo F, 2006, BBA-BIOENERGETICS, V1757, P1284, DOI 10.1016/j.bbabio.2006.06.002; Dhar SK, 2011, CANCER RES, V71, P6684, DOI 10.1158/0008-5472.CAN-11-1233; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Holley AK, 2014, ANTIOXID REDOX SIGN, V20, P2347, DOI 10.1089/ars.2013.5204; Holley AK, 2013, MITOCHONDRION, V13, P170, DOI 10.1016/j.mito.2012.07.104; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Ilizarov AM, 2001, AM J RESP CELL MOL, V24, P436, DOI 10.1165/ajrcmb.24.4.4240; Jansen S, 2009, REPRODUCTION, V138, P493, DOI 10.1530/REP-09-0038; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Keller JN, 1998, J NEUROSCI, V18, P687; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; KLINGENBERG M, 1990, TRENDS BIOCHEM SCI, V15, P108, DOI 10.1016/0968-0004(90)90194-G; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lin J, 2010, CANCER PREV RES, V3, P505, DOI 10.1158/1940-6207.CAPR-09-0263; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Miriyala S, 2011, ANTI-CANCER AGENT ME, V11, P181, DOI 10.2174/187152011795255920; Nagano Y, 2012, J PHYSIOL PHARMACOL, V63, P137; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; OBERLEY LW, 1979, CANCER RES, V39, P1141; Oberley TD, 2004, ANTIOXID REDOX SIGN, V6, P537, DOI 10.1089/152308604773934297; Okiyama W, 2009, J HEPATOL, V50, P1236, DOI 10.1016/j.jhep.2009.01.025; Patterson AD, 2012, HEPATOLOGY, V56, P281, DOI 10.1002/hep.25645; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Porter RK, 2001, BBA-BIOENERGETICS, V1504, P120, DOI 10.1016/S0005-2728(00)00246-2; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; Valle Adamo, 2010, Cancers (Basel), V2, P567, DOI 10.3390/cancers2020567; Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Zhao YF, 2001, CANCER RES, V61, P6082; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	50	25	25	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4229	4237		10.1038/onc.2014.355	http://dx.doi.org/10.1038/onc.2014.355			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25362851	Green Accepted			2022-12-26	WOS:000359199800009
J	Pollitt, AY; Poulter, NS; Gitz, E; Navarro-Nunez, L; Wang, YJ; Hughes, CE; Thomas, SG; Nieswandt, B; Douglas, MR; Owen, DM; Jackson, DG; Dustin, ML; Watson, SP				Pollitt, Alice Y.; Poulter, Natalie S.; Gitz, Eelo; Navarro-Nunez, Leyre; Wang, Ying-Jie; Hughes, Craig E.; Thomas, Steven G.; Nieswandt, Bernhard; Douglas, Michael R.; Owen, Dylan M.; Jackson, David G.; Dustin, Michael L.; Watson, Steve P.			Syk and Src Family Kinases Regulate C-type Lectin Receptor 2 (CLEC-2)-mediated Clustering of Podoplanin and Platelet Adhesion to Lymphatic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SYNAPSE FORMATION; LIPID RAFTS; CLEC-2; ACTIVATION; MICROCLUSTERS; AGGREGATION; SEPARATION; ANTIGEN; ACTIN	The interaction of C-type lectin receptor 2 (CLEC-2) on platelets with Podoplanin on lymphatic endothelial cells initiates platelet signaling events that are necessary for prevention of blood-lymph mixing during development. In the present study, we show that CLEC-2 signaling via Src family and Syk tyrosine kinases promotes platelet adhesion to primary mouse lymphatic endothelial cells at low shear. Using supported lipid bilayers containing mobile Podoplanin, we further show that activation of Src and Syk in platelets promotes clustering of CLEC-2 and Podoplanin. Clusters of CLEC-2-bound Podoplanin migrate rapidly to the center of the platelet to form a single structure. Fluorescence lifetime imaging demonstrates that molecules within these clusters are within 10 nm of one another and that the clusters are disrupted by inhibition of Src and Syk family kinases. CLEC-2 clusters are also seen in platelets adhered to immobilized Podoplanin using direct stochastic optical reconstruction microscopy. These findings provide mechanistic insight by which CLEC-2 signaling promotes adhesion to Podoplanin and regulation of Podoplanin signaling, thereby contributing to lymphatic vasculature development.	[Pollitt, Alice Y.; Poulter, Natalie S.; Gitz, Eelo; Navarro-Nunez, Leyre; Hughes, Craig E.; Thomas, Steven G.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Gitz, Eelo] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Wang, Ying-Jie; Jackson, David G.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; [Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97080 Wurzburg, Germany; [Douglas, Michael R.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Douglas, Michael R.] Dudley Grp Natl Hlth Serv Fdn Trust, Dept Neurol, Dudley DY1 2HQ, W Midlands, England; [Owen, Dylan M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Headington OX3 7FY, England; [Dustin, Michael L.] NYU, Dept Mol Pathogenesis, Skirball Inst Biomol Med, Sch Med,New York Univ Langone Med Ctr, New York, NY 10016 USA	University of Birmingham; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Wurzburg; University of Birmingham; University of London; King's College London; University of Oxford; New York University	Pollitt, AY (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	a.y.pollitt@bham.ac.uk; s.p.watson@bham.ac.uk	Dustin, Michael/AAM-4611-2020; engelmann, florent/A-9058-2011; Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820; Thomas, Steven/0000-0001-8733-7842; Poulter, Natalie/0000-0002-3187-2130; Dustin, Michael/0000-0003-4983-6389; Pollitt, Alice/0000-0001-8706-5154; , david/0000-0002-4133-9364	Wellcome Trust [088410/Z/09/Z, 100262/Z/12/Z]; NIH [R37AI43542]; MRC; Medical Research Council; Advantage West Midlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542] Funding Source: NIH RePORTER; Medical Research Council [G1100134, MC_U137884182, MC_UU_12010/2] Funding Source: researchfish; MRC [MC_U137884182, MC_UU_12010/2, G1100134] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Advantage West Midlands(General Electric); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust; programme numbers 088410/Z/09/Z (S. P. W.) and 100262/Z/12/Z. This work was also supported by NIH research grant R37AI43542 (to M. L. D.), and by funds from the MRC (D. G. J.) and by funds from the Medical Research Council (to D. G. J.) and Advantage West Midlands (to the Birmingham Advanced Light Microscopy Unit).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bohmer R, 2010, DEV CELL, V18, P437, DOI 10.1016/j.devcel.2010.01.009; Borgognone A, 2014, J THROMB HAEMOST, V12, P550, DOI 10.1111/jth.12514; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cueni LN, 2010, AM J PATHOL, V177, P1004, DOI 10.2353/ajpath.2010.090703; Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Fleire Sebastian J., 2009, V462, P145, DOI 10.1007/978-1-60327-115-8_9; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gitz E, 2012, HAEMATOL-HEMATOL J, V97, P1873, DOI 10.3324/haematol.2012.066290; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Hou TZ, 2010, FEBS LETT, V584, P3955, DOI 10.1016/j.febslet.2010.07.053; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Hughes CE, 2015, BLOOD, V125, P144, DOI 10.1182/blood-2014-05-579375; Hughes CE, 2013, J BIOL CHEM, V288, P5127, DOI 10.1074/jbc.M112.411462; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Navarro A, 2008, AM J PHYSIOL-LUNG C, V295, pL543, DOI 10.1152/ajplung.90262.2008; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Watson SP, 2014, ADV ANAT EMBRYOL CEL, V214, P93, DOI 10.1007/978-3-7091-1646-3_8; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	63	49	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35695	35710		10.1074/jbc.M114.584284	http://dx.doi.org/10.1074/jbc.M114.584284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368330	hybrid, Green Published			2022-12-26	WOS:000346897900003
J	Wang, Y; Yang, Y; Wu, SF; Pan, S; Zhou, CD; Ma, YJ; Ru, YX; Dong, SX; He, B; Zhang, CZ; Cao, YJ				Wang, Yu; Yang, Yin; Wu, Songfang; Pan, Shuang; Zhou, Chaodong; Ma, Yijie; Ru, Yongxin; Dong, Shuxu; He, Bin; Zhang, Cuizhu; Cao, Youjia			p32 Is a Novel Target for Viral Protein ICP34.5 of Herpes Simplex Virus Type 1 and Facilitates Viral Nuclear Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMIN-B-RECEPTOR; GAMMA(1)34.5 PROTEIN; INFECTED-CELLS; IN-VITRO; PRODUCTIVE INFECTION; CELLULAR-PROTEIN; SPLICING FACTOR; KINASE-C; CYTOMEGALOVIRAL PROTEINS; MITOCHONDRIAL PROTEIN	As a large double-stranded DNA virus, herpes simplex virus type 1 (HSV-1) assembles capsids in the nucleus where the viral particles exit by budding through the inner nuclear membrane. Although a number of viral and host proteins are involved, the machinery of viral egress is not well understood. In a search for host interacting proteins of ICP34.5, which is a virulence factor of HSV-1, we identified a cellular protein, p32 (gC1qR/HABP1), by mass spectrophotometer analysis. When expressed, ICP34.5 associated with p32 in mammalian cells. Upon HSV-1 infection, p32 was recruited to the inner nuclear membrane by ICP34.5, which paralleled the phosphorylation and rearrangement of nuclear lamina. Knockdown of p32 in HSV-1-infected cells significantly reduced the production of cell-free viruses, suggesting that p32 is a mediator of HSV-1 nuclear egress. These observations suggest that the interaction between HSV-1 ICP34.5 and p32 leads to the disintegration of nuclear lamina and facilitates the nuclear egress of HSV-1 particles.	[Wang, Yu; Yang, Yin; Wu, Songfang; Pan, Shuang; Zhang, Cuizhu; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Zhou, Chaodong] Inst Drug Control, Dept Biochem, Tianjin 300070, Peoples R China; [Ma, Yijie; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Ru, Yongxin; Dong, Shuxu] Peking Union Coll, Inst Hematol & Blood Dis Hosp, Dept Electron Microscopy, Tianjin 300020, Peoples R China	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS	He, B (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol MC 790, 835 S Wolcott Ave, Chicago, IL 60612 USA.	tshuo@uic.edu; czz912@aliyun.com; caoyj@nankai.edu.cn			National Institutes of Health from the NIAID [AI092230]; National Natural Science Foundation of China Grants [81171556, 31370862]; Ministry of Science and Technology of China Grant [BE091561]; Program of Introducing Talents of Discipline to Universities [B08011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092230] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China Grant; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI092230 from the NIAID (to B. H.). This work was also supported by National Natural Science Foundation of China Grants 81171556 and 31370862 (to Y. C.), Ministry of Science and Technology of China Grant BE091561 (to Y. C.), and Program of Introducing Talents of Discipline to Universities Grant B08011.	Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; BROWN SM, 1994, J GEN VIROL, V75, P3679, DOI 10.1099/0022-1317-75-12-3679; Bruni R, 1996, P NATL ACAD SCI USA, V93, P10423, DOI 10.1073/pnas.93.19.10423; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Chouljenko DV, 2012, J VIROL, V86, P4262, DOI 10.1128/JVI.06766-11; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; Dedio J, 1998, J IMMUNOL, V160, P3534; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HUTCHINSON L, 1995, J VIROL, V69, P5401, DOI 10.1128/JVI.69.9.5401-5413.1995; Jin HL, 2009, J VIROL, V83, P4984, DOI 10.1128/JVI.02535-08; Jing XH, 2004, J VIROL, V78, P7653, DOI 10.1128/JVI.78.14.7653-7666.2004; JOHNSON DC, 1982, J VIROL, V43, P1102, DOI 10.1128/JVI.43.3.1102-1112.1982; Kato A, 2006, J VIROL, V80, P1476, DOI 10.1128/JVI.80.3.1476-1486.2006; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Li YP, 2011, J BIOL CHEM, V286, P24785, DOI 10.1074/jbc.M111.232439; Liu ZM, 2014, J VIROL, V88, P4657, DOI 10.1128/JVI.00137-14; MACLEAN AR, 1991, J GEN VIROL, V72, P631, DOI 10.1099/0022-1317-72-3-631; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Sagou K, 2010, J VIROL, V84, P2110, DOI 10.1128/JVI.02007-09; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; SIMOS G, 1994, FEBS LETT, V346, P225, DOI 10.1016/0014-5793(94)00479-X; Simpson-Holley M, 2004, J VIROL, V78, P5591, DOI 10.1128/JVI.78.11.5591-5600.2004; STACKPOLE CW, 1969, J VIROL, V4, P75, DOI 10.1128/JVI.4.1.75-93.1969; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHITLEY RJ, 1993, J CLIN INVEST, V91, P2837, DOI 10.1172/JCI116527; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Wild P, 2005, J VIROL, V79, P1071, DOI 10.1128/JVI.79.2.1071-1083.2005; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995	58	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35795	35805		10.1074/jbc.M114.603845	http://dx.doi.org/10.1074/jbc.M114.603845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25355318	hybrid, Green Published			2022-12-26	WOS:000346897900011
J	Chen, YY; Soman, R; Shanmugam, K; Kuhn, A; Dalbey, RE				Chen, Yuanyuan; Soman, Raunak; Shanmugam, Karthika; Kuhn, Andreas; Dalbey, Ross E.			The Role of the Strictly Conserved Positively Charged Residue Differs among the Gram-positive, Gram-negative, and Chloroplast YidC Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Biogenesis; Membrane Enzyme; Membrane Function; Membrane Protein; Membrane Structure; Alb3; YidC; YidC Mechanism; Membrane Insertion; Structure-Function	ESCHERICHIA-COLI YIDC; M13 PROCOAT PROTEIN; MEMBRANE INSERTION; PERIPLASMIC DOMAIN; CRYSTAL-STRUCTURE; BACTERIAL YIDC; TRANSLOCATION; BIOGENESIS; EVOLUTION; SUBSTRATE	Recently, the structure of YidC2 from Bacillus halodurans revealed that the conserved positively charged residue within transmembrane segment one (at position 72) is located in a hydrophilic groove that is embedded in the inner leaflet of the lipid bilayer. The arginine residue was essential for the Bacillus subtilis SpoIIIJ (YidC1) to insert MifM and to complement a SpoIIIJ mutant strain. Here, we investigated the importance of the conserved positively charged residue for the function of the Escherichia coli YidC, Streptococcus mutans YidC2, and the chloroplast Arabidopsis thaliana Alb3. Like the Gram-positive B. subtilis SpoIIIJ, the conserved arginine was required for functioning of the Gram-positive S. mutans YidC2 and was necessary to complement the E. coli YidC depletion strain and to promote insertion of a YidC-dependent membrane protein synthesized with one but not two hydrophobic segments. In contrast, the conserved positively charged residue was not required for the E. coli YidC or the A. thaliana Alb3 to functionally complement the E. coli YidC depletion strain or to promote insertion of YidC-dependent membrane proteins. Our results also show that the C-terminal half of the helical hairpin structure in cytoplasmic loop C1 is important for the activity of YidC because various deletions in the region either eliminate or impair YidC function. The results here underscore the importance of the cytoplasmic hairpin region for YidC and show that the arginine is critical for the tested Gram-positive YidC homolog but is not essential for the tested Gram-negative and chloroplast YidC homologs.	[Chen, Yuanyuan; Soman, Raunak; Shanmugam, Karthika; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University System of Ohio; Ohio State University; University Hohenheim	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu	Chen, Yuanyuan/GXG-2130-2022		National Science Foundation Grant [MCB-1052033]; Deutsche Forschungsgemeinschaft [Ku749/6]	National Science Foundation Grant(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Science Foundation Grant MCB-1052033 (to R. E. D.) and Deutsche Forschungsgemeinschaft Ku749/6 (to A. K.).	CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; Eisenhawer M, 2001, BIOCHEMISTRY-US, V40, P12321, DOI 10.1021/bi0107694; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Hennon SW, 2014, BIOCHEMISTRY-US, V53, P3278, DOI 10.1021/bi500257u; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x	30	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35656	35667		10.1074/jbc.M114.595082	http://dx.doi.org/10.1074/jbc.M114.595082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359772	hybrid, Green Published			2022-12-26	WOS:000346660200051
J	Hanoun, N; Fritsch, S; Gayet, O; Gigoux, V; Cordelier, P; Dusetti, N; Torrisani, J; Dufresne, M				Hanoun, Naima; Fritsch, Samuel; Gayet, Odile; Gigoux, Veronique; Cordelier, Pierre; Dusetti, Nelson; Torrisani, Jerome; Dufresne, Marlene			The E3 Ubiquitin Ligase Thyroid Hormone Receptor-interacting Protein 12 Targets Pancreas Transcription Factor 1a for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Basic Helix-Loop-Helix Transcription Factor (bHLH); E3 Ubiquitin Ligase; Pancreas; Pancreatic Cancer; Proteasome; Protein Degradation; Protein-Protein Interaction; Transcription Factor; Ubiquitylation (Ubiquitination); Yeast Two-Hybrid	CELL-PROLIFERATION; PTF1A MUTATION; EXPRESSION; COMPLEX; EXOCRINE; CANCER; FATES; P53; DIFFERENTIATION; AUTOREGULATION	Pancreas transcription factor 1a (PTF1a) plays a crucial role in the early development of the pancreas and in the maintenance of the acinar cell phenotype. Several transcriptional mechanisms regulating expression of PTF1a have been identified. However, regulation of PTF1a protein stability and degradation is still unexplored. Here, we report that inhibition of proteasome leads to elevated levels of PTF1a and to the existence of polyubiquitinated forms of PTF1a. We used the Sos recruitment system, an alternative two-hybrid system method to detect protein-protein interactions in the cytoplasm and to map the interactome of PTF1a. We identified TRIP12 (thyroid hormone receptor-interacting protein 12), an E3 ubiquitin-protein ligase as a new partner of PTF1a. We confirmed PTF1a/TRIP12 interaction in acinar cell lines and in co-transfected HEK-293T cells. The protein stability of PTF1a is significantly increased upon decreased expression of TRIP12. It is reduced upon overexpression of TRIP12 but not a catalytically inactive TRIP12-C1959A mutant. We identified a region of TRIP12 required for interaction and identified lysine 312 of PTF1a as essential for proteasomal degradation. We also demonstrate that TRIP12 down-regulates PTF1a transcriptional and antiproliferative activities. Our data suggest that an increase in TRIP12 expression can play a part in PTF1a down-regulation and indicate that PTF1a/TRIP12 functional interaction may regulate pancreatic epithelial cell homeostasis.	[Hanoun, Naima; Fritsch, Samuel; Cordelier, Pierre; Torrisani, Jerome; Dufresne, Marlene] Univ Toulouse 3, INSERM UMR1037, CRCT, F-31037 Toulouse, France; [Gigoux, Veronique] Univ Toulouse 3, EA 4552, F-31432 Toulouse, France; [Gayet, Odile; Dusetti, Nelson] Univ Aix Marseille, Canc Res Ctr Marseille, INSERM UMR1068, Inst J Paoli I Calmettes,CNRS UMR7258, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Dufresne, M (corresponding author), UMR1037 INSERM, CRCT, 2 Ave Hubert Curien,Oncopole Entree C,CS 53717, F-31037 Toulouse 1, France.	marlene.dufresne@inserm.fr	Dufresne, Marlène/M-6332-2014; Cordelier, Pierre/D-1150-2014; Gigoux, Véronique/AAE-6090-2020; Dusetti, Nelson/O-7919-2017; Torrisani, Jérôme/M-6203-2014	Cordelier, Pierre/0000-0003-2096-7967; Gigoux, Véronique/0000-0003-1408-5335; Dusetti, Nelson/0000-0002-6161-8483; Torrisani, Jérôme/0000-0001-6880-9357	INSERM; Agence Nationale pour la Recherche; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by INSERM, Agence Nationale pour la Recherche, and Association pour la Recherche contre le Cancer.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Al-Shammari M, 2011, CLIN GENET, V80, P196, DOI 10.1111/j.1399-0004.2010.01613.x; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Ghosh B, 2006, BIOCHEM J, V393, P679, DOI 10.1042/BJ20051063; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kajiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025871; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lelievre EC, 2011, DEV BIOL, V358, P296, DOI 10.1016/j.ydbio.2011.07.033; Lu CK, 2012, DNA CELL BIOL, V31, P1245, DOI 10.1089/dna.2012.1619; Masui T, 2008, MOL CELL BIOL, V28, P5458, DOI 10.1128/MCB.00549-08; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Meredith DM, 2009, J NEUROSCI, V29, P11139, DOI 10.1523/JNEUROSCI.2303-09.2009; Molero X, 2007, EUR J CLIN INVEST, V37, P791, DOI 10.1111/j.1365-2362.2007.01856.x; Nakajima D, 2005, DNA RES, V12, P257, DOI 10.1093/dnares/dsi010; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Rodolosse A, 2004, GASTROENTEROLOGY, V127, P937, DOI 10.1053/j.gastro.2004.06.058; Rodolosse A, 2009, BIOCHEM J, V418, P463, DOI 10.1042/BJ20080293; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Tutak E, 2009, GENET COUNSEL, V20, P147; Yang YK, 2012, FEBS LETT, V586, P422, DOI 10.1016/j.febslet.2012.01.015	39	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35593	35604		10.1074/jbc.M114.620104	http://dx.doi.org/10.1074/jbc.M114.620104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355311	hybrid, Green Published			2022-12-26	WOS:000346660200046
J	Krammer, R; Heinzerling, L				Krammer, Ramona; Heinzerling, Lucie			Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls	PLOS ONE			English	Article							CELL LUNG-CANCER; IPILIMUMAB; CARE; CHEMOTHERAPY; COST; MELANOGENESIS; DECISIONS; VIEWS; AGE	Background: New melanoma therapies, like e. g. ipilimumab, improve survival. However, only a small subset of patients benefits while 60% encounter side effects. Furthermore, these marginal benefits come at a very high price of (sic)110'000 per treatment. This study examines attitudes towards melanoma therapy options of physicians, healthy individuals and patients, their willingness to pay and preference of quality versus length of life. Methods: Based on findings from a focus group questionnaires were developed and pretested. After obtaining ethical approval and informed consent surveys were conducted in a total of 90 participants (n = 30 for each group). Statistical analyses were conducted using R. Findings: Attitudes vastly differed between healthy participants, physicians and melanoma patients. Whereas melanoma patients show a high willingness to endure side effects despite very small survival gains (down to 1 extra week) or even only hope with no survival benefit, healthy controls are more critical, while physicians are the most therapy adverse. Consequently, if given (sic)100'000 and the free decision what to spend the money on the willingness to pay for therapy was much higher in the patient group (68%) compared to 28% of healthy controls and only 43% of the physicians, respectively. When lowering the amount of cash that could be received instead of ipilimumab to (sic)50'000 or (sic)10'000 to test price sensitivity 69% (+1%) and 76% (+8%) of melanoma patients, respectively, preferred ipilimumab over cash. When judging on societal spending even melanoma patients opted for spending on ipilimumab in only 21%. Conclusion: The judgment about the benefits of new treatment options largely differs between groups, physicians being the most critical against therapy. Price elasticity was low.	[Krammer, Ramona] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Krammer, Ramona; Heinzerling, Lucie] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Heinzerling, L (corresponding author), Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany.	lheinzer@post.harvard.edu		, lucie/0000-0003-4587-007X	'Verein zur Forderung des Tumorzentrums', Germany	'Verein zur Forderung des Tumorzentrums', Germany	This work was supported by the 'Verein zur Forderung des Tumorzentrums', Germany. This is a small non-profit organization that sponsors research projects in cancer. None of the authors have a financial relationship with the organization that sponsored the research. RK has received grants for material used for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni T, 2011, CANCER-AM CANCER SOC, V117, P5383, DOI 10.1002/cncr.26221; Bisht M, 2010, INDIAN J MED PAEDIAT, V31, P121, DOI 10.4103/0971-5851.76194; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Bridges JFP, 2012, LUNG CANCER, V77, P224, DOI 10.1016/j.lungcan.2012.01.016; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Dranitsaris G, 2004, PHARMACOECONOMICS, V22, P375, DOI 10.2165/00019053-200422060-00004; Farolfi A, 2012, MELANOMA RES, V22, P263, DOI 10.1097/CMR.0b013e328353e65c; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Foster JA, 2010, ONCOLOGIST, V15, P584, DOI 10.1634/theoncologist.2009-0198; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurley KE, 2005, ONCOLOGIST, V10, P739, DOI 10.1634/theoncologist.10-9-739; Jenkins Valerie A, 2011, JRSM Short Rep, V2, P69, DOI 10.1258/shorts.2011.011050; Kuchuk I, 2013, BREAST CANCER RES TR, V142, P101, DOI 10.1007/s10549-013-2727-3; Lakdawalla DN, 2012, HEALTH AFFAIR, V31, P676, DOI 10.1377/hlthaff.2011.1300; Leonard RC, 2010, ONCOLOGIST, V15, P657, DOI 10.1634/theoncologist.2009-0284; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Maciejewski PK, 2012, PSYCHO-ONCOLOGY, V21, P714, DOI 10.1002/pon.1967; Mullins CD, 2010, ONCOLOGIST, V15, P58, DOI 10.1634/theoncologist.2010-S1-58; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Ramers-Verhoeven CW, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.349; Ramsey S, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S1-1; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schickedanz A, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2010-S1-73; Schildmann J, 2013, ONCOLOGIST, V18, P90, DOI 10.1634/theoncologist.2012-0206; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Stiggelbout AM, 1996, MED DECIS MAKING, V16, P184, DOI 10.1177/0272989X9601600211; Sun CC, 2002, GYNECOL ONCOL, V87, P118, DOI 10.1006/gyno.2002.6807; Tarhini A, 2010, CANCER BIOTHER RADIO, V25, P601, DOI 10.1089/cbr.2010.0865; Voskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053745	36	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111237	10.1371/journal.pone.0111237	http://dx.doi.org/10.1371/journal.pone.0111237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369124	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000045
J	Verdonck, P; Kalmar, AF; Suy, K; Geeraerts, T; Vercauteren, M; Mottrie, A; De Wolf, AM; Hendrickx, JFA				Verdonck, Philip; Kalmar, Alain F.; Suy, Koen; Geeraerts, Thomas; Vercauteren, Marcel; Mottrie, Alex; De Wolf, Andre M.; Hendrickx, Jan F. A.			Optic Nerve Sheath Diameter Remains Constant during Robot Assisted Laparoscopic Radical Prostatectomy	PLOS ONE			English	Article							INCREASED INTRACRANIAL-PRESSURE; STEEP TRENDELENBURG POSITION; HEAD-DOWN TILT; CEREBRAL OXYGENATION; CO2 PNEUMOPERITONEUM; OCULAR SONOGRAPHY; ANIMAL-MODEL; BRAIN-INJURY; ULTRASONOGRAPHY; HEMODYNAMICS	Background: During robot assisted laparoscopic radical prostatectomy (RALRP), a CO2 pneumoperitoneum (CO2PP) is applied and the patient is placed in a head-down position. Intracranial pressure (ICP) is expected to acutely increase under these conditions. A non-invasive method, the optic nerve sheath diameter (ONSD) measurement, may warn us that the mechanism of protective cerebrospinal fluid (CSF) shifts becomes exhausted. Methods: After obtaining IRB approval and written informed consent, ONSD was measured by ocular ultrasound in 20 ASA I-II patients at various stages of the RALRP procedure: baseline awake, after induction, after applying the CO2PP, during head-down position, after resuming the supine position, in the postoperative anaesthesia care unit, and on day one postoperatively. Cerebral perfusion pressure (CPP) was calculated as the mean arterial (MAP) minus central venous pressure (CVP). Results: The ONSD did not change during head-down position, although the CVP increased from 4.2(2.5) mm Hg to 27.6(3.8) mm Hg. The CPP was decreased 70 min after assuming the head-down position until 15 min after resuming the supine position, but remained above 60 mm Hg at all times. Conclusion: Even though ICP has been documented to increase during CO2PP and head-down positioning, we did not find any changes in ONSD during head-down position. These results indicate that intracranial blood volume does not increase up to a point that CSF migration as a compensation mechanism becomes exhausted, suggesting any increases in ICP are likely to be small.	[Verdonck, Philip; Vercauteren, Marcel] Univ Antwerp Hosp, Dept Anaesthesiol, Edegem, Belgium; [Kalmar, Alain F.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands; [Suy, Koen; Hendrickx, Jan F. A.] OLV Clin, Dept Anaesthesiol & Intens Care Med, Aalst, Belgium; [Geeraerts, Thomas] Univ Paul Sabatier, Univ Hosp Toulouse, Dept Anaesthesiol & Crit care, Toulouse, France; [Mottrie, Alex] OLV Clin, Dept Urol, Aalst, Belgium; [De Wolf, Andre M.] Northwestern Univ, Feinberg Sch Med, Dept Anaesthesiol, Chicago, IL 60611 USA; [Mottrie, Alex] OLV Vattikuti Robot Surg Inst, Melle, Belgium	University of Antwerp; University of Groningen; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Northwestern University; Feinberg School of Medicine	Kalmar, AF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands.	A.Kalmar@umcg.nl		mottrie, alexandre/0000-0002-1253-1592; Kalmar, Alain/0000-0003-2036-9019	Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium	Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium	The authors received no specific funding for this work. This study was solely supported by departmental and institutional funding: Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium. Moorselbaan 164, 9300 Aalst, Belgium. No individuals other than the named authors played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current funding sources for this study were used other than institutional fundings.	Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Brosnan RJ, 2002, J APPL PHYSIOL, V92, P2542, DOI 10.1152/japplphysiol.00055.2002; Closhen D, 2014, EUR J ANAESTH, V31, P104, DOI 10.1097/EJA.0000000000000000; Danic MJ, 2007, J ROBOT SURG, V1, P119, DOI 10.1007/s11701-007-0024-z; Doi M, 1998, JPN J PHYSIOL, V48, P63, DOI 10.2170/jjphysiol.48.63; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Haas S, 2011, INT J MED ROBOT COMP, V7, P408, DOI 10.1002/rcs.410; Halverson A, 1998, SURG ENDOSC, V12, P266, DOI 10.1007/s004649900648; Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P797, DOI 10.1007/s004649901102; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Jeong H, 2012, ACTA ANAESTH SCAND, V56, P872, DOI 10.1111/j.1399-6576.2012.02716.x; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Kalmar AF, 2012, BRIT J ANAESTH, V108, P478, DOI 10.1093/bja/aer448; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; Kalmar AF, 2009, BRIT J ANAESTH, V102, P361, DOI 10.1093/bja/aen381; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kim MS, 2014, J ENDOUROL, V28, P801, DOI 10.1089/end.2014.0019; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kotani J, 1992, Anesth Prog, V39, P209; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; MUNK PL, 1991, AM J ROENTGENOL, V157, P1079, DOI 10.2214/ajr.157.5.1927796; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Pandey R, 2010, Acta Anaesthesiol Belg, V61, P163; Rollins M, 2012, ANESTHESIOLOGY, V116, P983, DOI 10.1097/ALN.0b013e31824c16e4; Rosenthal RJ, 1997, SURG ENDOSC, V11, P376, DOI 10.1007/s004649900367; Shimoyama R, 2000, JPN J PHYSIOL, V50, P141, DOI 10.2170/jjphysiol.50.141; Shimoyama R, 2000, J GRAVIT PHYSL, V7, P83; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tatebayashi K, 2003, BRAIN RES, V977, P55, DOI 10.1016/S0006-8993(03)02723-9; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040	38	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111916	10.1371/journal.pone.0111916	http://dx.doi.org/10.1371/journal.pone.0111916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369152	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000125
J	Perez, R; Calleros, L; Marandino, A; Sarute, N; Iraola, G; Grecco, S; Blanc, H; Vignuzzi, M; Isakov, O; Shomron, N; Carrau, L; Hernandez, M; Francia, L; Sosa, K; Tomas, G; Panzera, Y				Perez, Ruben; Calleros, Lucia; Marandino, Ana; Sarute, Nicolas; Iraola, Gregorio; Grecco, Sofia; Blanc, Herve; Vignuzzi, Marco; Isakov, Ofer; Shomron, Noam; Carrau, Lucia; Hernandez, Martin; Francia, Lourdes; Sosa, Katia; Tomas, Gonzalo; Panzera, Yanina			Phylogenetic and Genome-Wide Deep-Sequencing Analyses of Canine Parvovirus Reveal Co-Infection with Field Variants and Emergence of a Recent Recombinant Strain	PLOS ONE			English	Article							GENETIC DIVERSITY; VP2 GENE; EVOLUTION; FELINE; VIRUS; TYPE-2; REPLICATION; REPLACEMENT; INFECTIONS; ALIGNMENT	Canine parvovirus (CPV), a fast-evolving single-stranded DNA virus, comprises three antigenic variants (2a, 2b, and 2c) with different frequencies and genetic variability among countries. The contribution of co-infection and recombination to the genetic variability of CPV is far from being fully elucidated. Here we took advantage of a natural CPV population, recently formed by the convergence of divergent CPV-2c and CPV-2a strains, to study co-infection and recombination. Complete sequences of the viral coding region of CPV-2a and CPV-2c strains from 40 samples were generated and analyzed using phylogenetic tools. Two samples showed co-infection and were further analyzed by deep sequencing. The sequence profile of one of the samples revealed the presence of CPV-2c and CPV-2a strains that differed at 29 nucleotides. The other sample included a minor CPV-2a strain (13.3% of the viral population) and a major recombinant strain (86.7%). The recombinant strain arose from inter-genotypic recombination between CPV-2c and CPV-2a strains within the VP1/VP2 gene boundary. Our findings highlight the importance of deep-sequencing analysis to provide a better understanding of CPV molecular diversity.	[Perez, Ruben; Calleros, Lucia; Marandino, Ana; Sarute, Nicolas; Iraola, Gregorio; Grecco, Sofia; Carrau, Lucia; Hernandez, Martin; Francia, Lourdes; Sosa, Katia; Tomas, Gonzalo; Panzera, Yanina] Univ Republica, Fac Ciencias, Inst Biol, Secc Genet Evolut, Montevideo, Uruguay; [Blanc, Herve; Vignuzzi, Marco] CNRS, Viral Populat & Pathogenesis Unit, Inst Pasteur, Paris, France; [Isakov, Ofer; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Universidad de la Republica, Uruguay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Tel Aviv University; Sackler Faculty of Medicine	Perez, R (corresponding author), Univ Republica, Fac Ciencias, Inst Biol, Secc Genet Evolut, Montevideo, Uruguay.	rperez@fcien.edu.uy	Perez, Ruben/AAU-1516-2020; Iraola, Gregorio/L-6539-2019; Sarute, Nicolas/AAK-4259-2020; Tomás, Gonzalo/ABA-1513-2020	Iraola, Gregorio/0000-0002-6516-3404; Vignuzzi, Marco/0000-0002-4400-771X; Perez, Ruben/0000-0003-4961-4743; Calleros, Lucia/0000-0003-1456-6112; Grecco, Sofia/0000-0002-4091-5526; Sarute, Nicolas/0000-0001-6432-1880; Carrau, Lucia/0000-0003-0260-2841	Comision Sectorial de Investigacion Cientifica (CSIC) [2206]; French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]	Comision Sectorial de Investigacion Cientifica (CSIC); French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR))	Grant number: 2206, Comision Sectorial de Investigacion Cientifica (CSIC) (http://www.csic.edu.uy/) to KS. Grant number ANR-10-LABX-62-IBEID, French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (http://www.agence-nationale-recherche.fr/investissementsdavenir/) to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBANDJE M, 1995, SEMIN VIROL, V6, P299, DOI 10.1006/smvy.1995.0036; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Battilani M, 2007, VET RES COMMUN, V31, P209, DOI 10.1007/s11259-007-0007-6; Battilani M, 2006, VIROLOGY, V352, P22, DOI 10.1016/j.virol.2006.06.002; Battilani M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-43; Bay RA, 2011, J MOL EVOL, V73, P273, DOI 10.1007/s00239-011-9473-0; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Clegg SR, 2011, J VIROL, V85, P7892, DOI 10.1128/JVI.01576-10; Cotmore SF, 2006, PARVOVIRUSES, P171; Decaro N, 2005, J VET DIAGN INVEST, V17, P133, DOI 10.1177/104063870501700206; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Doki M, 2006, COMP IMMUNOL MICROB, V29, P199, DOI 10.1016/j.cimid.2006.05.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoelzer K, 2008, J VIROL, V82, P11096, DOI 10.1128/JVI.01003-08; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson MK, 1996, AM J VET RES, V57, P1753; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin Chao-Nan, 2014, Taiwan Veterinary Journal, V40, P1, DOI 10.1142/S1682648514500012; Lopez-Bueno A, 2006, CURR TOP MICROBIOL, V299, P349; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Mengeling WL, 2000, ANIM REPROD SCI, V60, P199, DOI 10.1016/S0378-4320(00)00135-4; Mochizuki M, 2008, J VET MED SCI, V70, P1305, DOI 10.1292/jvms.70.1305; Moon HS, 2008, VET MICROBIOL, V131, P47, DOI 10.1016/j.vetmic.2008.02.016; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2009, J VET MED SCI, V71, P403, DOI 10.1292/jvms.71.403; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1988, J GEN VIROL, V69, P1111, DOI 10.1099/0022-1317-69-5-1111; PARRISH CR, 1988, VIROLOGY, V166, P293, DOI 10.1016/0042-6822(88)90500-4; Perez R, 2012, VET MICROBIOL, V155, P214, DOI 10.1016/j.vetmic.2011.09.017; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE VER 1 3 1 TR; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Wang D, 1998, VIROLOGY, V240, P273, DOI 10.1006/viro.1997.8946; Wang JK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-252	48	61	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111779	10.1371/journal.pone.0111779	http://dx.doi.org/10.1371/journal.pone.0111779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365348	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100119
J	Garcia, RA; Yan, MJ; Search, D; Zhang, R; Carson, NL; Ryan, CS; Smith-Monroy, C; Zheng, J; Chen, J; Kong, Y; Tang, HP; Hellings, SE; Wardwell-Swanson, J; Dinchuk, JE; Psaltis, GC; Gordon, DA; Glunz, PW; Gargalovic, PS				Garcia, Ricardo A.; Yan, Mujing; Search, Debra; Zhang, Rongan; Carson, Nancy L.; Ryan, Carol S.; Smith-Monroy, Constance; Zheng, Joanna; Chen, Jian; Kong, Yan; Tang, Huaping; Hellings, Samuel E.; Wardwell-Swanson, Judith; Dinchuk, Joseph E.; Psaltis, George C.; Gordon, David A.; Glunz, Peter W.; Gargalovic, Peter S.			P2Y(6) Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development	PLOS ONE			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; SMOOTH-MUSCLE-CELLS; CHEMOKINES; UDP; APOPTOSIS; CYTOKINES; ADHESION	Background: P2Y(6), a purinergic receptor for UDP, is enriched in atherosclerotic lesions and is implicated in pro-inflammatory responses of key vascular cell types and macrophages. Evidence for its involvement in atherogenesis, however, has been lacking. Here we use cell-based studies and three murine models of atherogenesis to evaluate the impact of P2Y(6) deficiency on atherosclerosis. Methodology/Principal Findings: Cell-based studies in 1321N1 astrocytoma cells, which lack functional P2Y(6) receptors, showed that exogenous expression of P2Y(6) induces a robust, receptor-and agonist-dependent secretion of inflammatory mediators IL-8, IL-6, MCP-1 and GRO1. P2Y(6)-mediated inflammatory responses were also observed, albeit to a lesser extent, in macrophages endogenously expressing P2Y(6) and in acute peritonitis models of inflammation. To evaluate the role of P2Y(6) in atherosclerotic lesion development, we used P2Y(6)-deficient mice in three mouse models of atherosclerosis. A 43% reduction in aortic arch plaque was observed in high fat-fed LDLR knockout mice lacking P2Y(6) receptors in bone marrow-derived cells. In contrast, no effect on lesion development was observed in fat-fed whole body P2Y(6)xLDLR double knockout mice. Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency enhanced formation of aneurysms and exhibited a trend towards increased atherosclerosis in the aorta of LDLR knockout mice. Conclusions: P2Y(6) receptor augments pro-inflammatory responses in macrophages and exhibits a pro-atherogenic role in hematopoietic cells. However, the overall impact of whole body P2Y(6) deficiency on atherosclerosis appears to be modest and could reflect additional roles of P2Y(6) in vascular disease pathophysiologies, such as aneurysm formation.	[Garcia, Ricardo A.; Yan, Mujing; Search, Debra; Zhang, Rongan; Carson, Nancy L.; Ryan, Carol S.; Hellings, Samuel E.; Gordon, David A.; Gargalovic, Peter S.] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA; [Smith-Monroy, Constance; Chen, Jian; Dinchuk, Joseph E.] Bristol Myers Squibb Co, Appl Genom, Pennington, NJ USA; [Zheng, Joanna] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Toxicol, Pennington, NJ USA; [Kong, Yan; Tang, Huaping] Bristol Myers Squibb Co, Lead Evaluat, Pennington, NJ USA; [Psaltis, George C.] Bristol Myers Squibb Co, Vet Sci, Pennington, NJ USA; [Glunz, Peter W.] Bristol Myers Squibb Co, Discovery Chem, Pennington, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Gargalovic, PS (corresponding author), Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA.	peter.gargalovic@bms.com		Glunz, Peter/0000-0001-9921-2385	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	All studies were supported by Bristol-Myers Squibb Company. The authors agree with the following statement regarding organizational support: The funder provided support in the form of salaries for authors [RAG, MY, DS, RZ, NLC, CSR, CSM, JZ, JC, YK, HT, SEH, JWS, JED, GCP, DAG, PWG, PSG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Boisvert WA, 1999, J LIPID RES, V40, P806; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; El-Tayeb A, 2006, J MED CHEM, V49, P7076, DOI 10.1021/jm060848j; Garcia RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053192; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Hou MY, 2002, AM J PHYSIOL-HEART C, V282, pH784, DOI 10.1152/ajpheart.00997.2000; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Rowe VL, 2000, J VASC SURG, V31, P567; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; SCHWARTZ D, 1994, J CLIN INVEST, V94, P1968, DOI 10.1172/JCI117548; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02	31	44	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111385	10.1371/journal.pone.0111385	http://dx.doi.org/10.1371/journal.pone.0111385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360548	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700098
J	Hamaneh, MB; Yu, YK				Hamaneh, Mehdi Bagheri; Yu, Yi-Kuo			Relating Diseases by Integrating Gene Associations and Information Flow through Protein Interaction Network	PLOS ONE			English	Article							MUTATIONS; IDENTIFICATION; ONTOLOGY; DATABASE; LRP5	Identifying similar diseases could potentially provide deeper understanding of their underlying causes, and may even hint at possible treatments. For this purpose, it is necessary to have a similarity measure that reflects the underpinning molecular interactions and biological pathways. We have thus devised a network-based measure that can partially fulfill this goal. Our method assigns weights to all proteins (and consequently their encoding genes) by using information flow from a disease to the protein interaction network and back. Similarity between two diseases is then defined as the cosine of the angle between their corresponding weight vectors. The proposed method also provides a way to suggest disease-pathway associations by using the weights assigned to the genes to perform enrichment analysis for each disease. By calculating pairwise similarities between 2534 diseases, we show that our disease similarity measure is strongly correlated with the probability of finding the diseases in the same disease family and, more importantly, sharing biological pathways. We have also compared our results to those of MimMiner, a text-mining method that assigns pairwise similarity scores to diseases. We find the results of the two methods to be complementary. It is also shown that clustering diseases based on their similarities and performing enrichment analysis for the cluster centers significantly increases the term association rate, suggesting that the cluster centers are better representatives for biological pathways than the diseases themselves. This lends support to the view that our similarity measure is a good indicator of relatedness of biological processes involved in causing the diseases. Although not needed for understanding this paper, the raw results are available for download for further study at ftp://ftp.ncbi.nlm.nih.gov/pub/qmbpmn/DiseaseRelations/.	[Hamaneh, Mehdi Bagheri; Yu, Yi-Kuo] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA.	yyu@ncbi.nlm.nih.gov			National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Library of Medicine at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldahmesh MA, 2011, J MED GENET, V48, P597, DOI 10.1136/jmedgenet-2011-100306; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317, DOI 10.1136/jamia.2001.0080317; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Seven M, 2000, GENET COUNSEL, V11, P41; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; Stojmircivic A, 2007, J COMPUT BIOL, V14, P1115, DOI 10.1089/cmb.2007.0069; Stojmirovic A, 2012, J COMPUT BIOL, V19, P379, DOI 10.1089/cmb.2010.0228; Stojmirovic A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar036; Stojmirovic A, 2010, BIOINFORMATICS, V26, P2752, DOI 10.1093/bioinformatics/btq511; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Voermans NC, 2009, AM J MED GENET A, V149A, P2311, DOI 10.1002/ajmg.a.32997; Zhang XH, 2011, EUR J HUM GENET, V19, P783, DOI 10.1038/ejhg.2011.30; Zitnik M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03202	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110936	10.1371/journal.pone.0110936	http://dx.doi.org/10.1371/journal.pone.0110936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360770	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700053
J	Pang, MH; Wu, G; Hou, XL; Hou, NY; Liang, LQ; Jia, GQ; Shuai, P; Luo, B; Wang, K; Li, GX				Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Shuai, Ping; Luo, Bin; Wang, Kang; Li, Guoxin			LIN28B Promotes Colon Cancer Migration and Recurrence	PLOS ONE			English	Article							MYC; IDENTIFICATION; TRANSFORMATION; GENES	LIN28B is involved in "stemness'' and tumourigenesis by negatively regulating the maturation of let-7 microRNA family members. In this study, we showed that LIN28B expression promotes migration and recurrence of colon cancer. Immunohistochemistry and reverse-transcription polymerase chain reactions were performed to detect LIN28B expression in colon cancer tissue microarrays, paraffin-embedded surgical resected tissues and cancer cells. Loss-of-function, migration and proliferation analyses were performed to delineate the potential roles of LIN28B in colon cancer. LIN28B was upregulated in colon cancer tissue compared to normal mucosa, and its overexpression correlated with reduced patient survival and increased tumour recurrence. LIN28B suppression inhibited the migration of SW480 colon cancer cells and facilitated the cytotoxicity induced by oxaliplatin in SW480 and HCT116 colon cancer cells. In conclusion, LIN28B overexpression contributes to colon tumourigenesis, and LIN28B may serve as a diagnostic tool and therapeutic target for colon cancer.	[Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Luo, Bin; Wang, Kang] Sichuan Acad Med Sci, Dept Gen Surg, Chengdu, Peoples R China; [Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Shuai, Ping; Luo, Bin; Wang, Kang] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Shuai, Ping] Sichuan Acad Med Sci, Dept Hlth, Ctr Management, Chengdu, Peoples R China; [Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southern Medical University - China	Wang, K (corresponding author), Sichuan Acad Med Sci, Dept Gen Surg, Chengdu, Peoples R China.	wangk_kwang@163.com; wugang5544@hotmail.com			Department of Public Health of Sichuan Province [110167]	Department of Public Health of Sichuan Province	This work was supported by grants from the Department of Public Health of Sichuan Province (110167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; CERDA AP, 1993, REV INVEST CLIN, V45, P493; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Guo J, 2009, BIOCHEM BIOPH RES CO, V390, P1081, DOI 10.1016/j.bbrc.2009.11.017; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jeanteur P, 1998, B CANCER, V85, P925; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; ROTHBERG PG, 1987, SEMIN SURG ONCOL, V3, P152, DOI 10.1002/ssu.2980030305; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	27	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109169	10.1371/journal.pone.0109169	http://dx.doi.org/10.1371/journal.pone.0109169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360631	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700009
J	Ren, DR; Chin, KR; French, JA				Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.			Molecular Variation in AVP and AVPR1a in New World Monkeys (Primates, Platyrrhini): Evolution and Implications for Social Monogamy	PLOS ONE			English	Article							V-1A VASOPRESSIN RECEPTOR; NONNEUTRAL EVOLUTION; N-TERMINUS; OXYTOCIN; SUBSTITUTION; PRECURSORS; GENES; SITES; BRAIN; RATES	The neurohypophysial hormone arginine vasopressin (AVP) plays important roles in fluid regulation and vascular resistance. Differences in AVP receptor expression, particularly mediated through variation in the noncoding promoter region of the primary receptor for AVP (AVPR1a), may play a role in social phenotypes, particularly social monogamy, in rodents and humans. Among primates, social monogamy is rare, but is common among New World monkeys (NWM). AVP is a nonapeptide and generally conserved among eutherian mammals, although a recent paper demonstrated that some NWM species possess a novel form of the related neuropeptide hormone, oxytocin. We therefore characterized variation in the AVP and AVPR1a genes in 22 species representing every genus in the three major platyrrhine families (Cebidae, Atelidae and Pitheciidae). For AVP, a total of 16 synonymous substitutions were detected in 15 NWM species. No non-synonymous substitutions were noted, hence, AVP is conserved in NWM. By contrast, relative to the human AVPR1a, 66 predicted amino acids (AA) substitutions were identified in NWM. The AVPR1a N-terminus (ligand binding domain), third intracellular (G-protein binding domain), and C-terminus were variable among species. Complex evolution of AVPR1a is also apparent in NWM. A molecular phylogenetic tree inferred from AVPR1a coding sequences revealed some consensus taxonomic separation by families, but also a mixed group composed of genera from all three families. The overall dN/dS ratio of AVPR1a was 0.11, but signals of positive selection in distinct AVPR1a regions were observed, including the N-terminus, in which we identified six potential positive selection sites. AA substitutions at positions 241, 319, 399 and 409 occurred uniquely in marmosets and tamarins. Our results enhance the appreciation of genetic diversity in the mammalian AVP/AVPR1a system, and set the stage for molecular modeling of the neurohypophyseal hormones and social behavior in primates.	[Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.] Univ Nebraska, Callitrichid Res Ctr, Dept Psychol, Omaha, NE 68182 USA; [Ren, Dongren] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Ren, Dongren] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	University of Nebraska System; Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; University of Nebraska System	Ren, DR (corresponding author), Univ Nebraska, Callitrichid Res Ctr, Dept Psychol, Omaha, NE 68182 USA.	dren@unomaha.edu		French, Jeffrey/0000-0001-5304-1592	NIH [HD042882]; Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071998, R01HD053555, R01HD042882] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, P51OD011133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by funds from the NIH (HD042882) and the Nebraska Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHER R, 1995, FRONT NEUROENDOCRIN, V16, P237, DOI 10.1006/frne.1995.1009; Acher R, 1995, ADV EXP MED BIOL, V395, P615; Anacker AMJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00185; Babb PL, 2010, J MOL EVOL, V71, P279, DOI 10.1007/s00239-010-9383-6; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Berrada K, 2000, J BIOL CHEM, V275, P27229; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Donaldson ZR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-180; FERGUSON DR, 1969, GEN COMP ENDOCR, V12, P609, DOI 10.1016/0016-6480(69)90181-6; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Fink S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-176; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fleagle JG, 1998, PRIMATE ADAPTATION E, P596; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hawtin SR, 2002, MOL ENDOCRINOL, V16, P600, DOI 10.1210/me.16.3.600; Hawtin SR, 2000, BIOCHEMISTRY-US, V39, P13524, DOI 10.1021/bi0013400; Huck M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0195; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Koshimizu TA, 2012, PHYSIOL REV, V92, P1813, DOI 10.1152/physrev.00035.2011; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Nair HP, 2006, PHYSIOLOGY, V21, P146, DOI 10.1152/physiol.00049.2005; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Shoshani J, 1996, MOL PHYLOGENET EVOL, V5, P102, DOI 10.1006/mpev.1996.0009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibonnier M, 2001, AM J PHYSIOL-ENDOC M, V281, pE81, DOI 10.1152/ajpendo.2001.281.1.E81; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; Wallis M, 2012, GEN COMP ENDOCR, V179, P313, DOI 10.1016/j.ygcen.2012.07.030; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	49	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111638	10.1371/journal.pone.0111638	http://dx.doi.org/10.1371/journal.pone.0111638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360668	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700135
J	Andrei, C; Lestini, E; Crosbie, S; de Frein, C; O'Reilly, T; Zerulla, D				Andrei, Codrin; Lestini, Elena; Crosbie, Stephen; de Frein, Caoimhe; O'Reilly, Thomas; Zerulla, Dominic			Plasmonic Enhancement of Dye Sensitized Solar Cells via a Tailored Size-Distribution of Chemically Functionalized Gold Nanoparticles	PLOS ONE			English	Article							CONVERSION EFFICIENCY; LIGHT; DESIGN; PHOTOCATALYSTS; RECOMBINATION; ALKANETHIOLS	A substantial and stable increase of the current density Jsc of ruthenium (Ru) dye sensitized solar cells (DSC) of up to 16.18% and of the power efficiency of up to 25.5% is demonstrated in this article via plasmonic enhancement. The key aspect of this work is the use of a tailored bimodal size distribution of functionalized gold nanoparticles (AuNPs) that have been chemically immobilized onto the mesoporous titanium dioxide (TiO2) layer via short, stable dithiodibutyric acid linkers. The size distribution of the AuNPs is a result of theoretical calculations that aimed at the perfection of the absorption characteristics of the complete solar cell system over a wide range of wavelengths. The functionalization of the AuNPs serves to bind them at a close but defined distance to TiO2-particles and additionally to chemically protect them against potential corrosion by the electrolyte. Simulations of near field (enhanced absorption) and far field (scattering) contributions have been used to tailor a complex AuNPs bimodal size distribution that had subsequently demonstrated experimentally a close to optimum improvement of the absorbance over a wide wavelength range (500-675 nm) and therefore an impressive DSC efficiency enhancement. Finally, the modified DSCs are exhibiting pronounced longevity and stable performance as confirmed via long time measurements. In summary, the presented systems show increased performance compared to non plasmonic enhanced cells with otherwise identical composition, and are demonstrating a previously unpublished longevity for iodide electrolyte/AuNPs combinations.	[Andrei, Codrin; Lestini, Elena; Crosbie, Stephen; de Frein, Caoimhe; O'Reilly, Thomas; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Grp, Dublin 2, Ireland; [Andrei, Codrin] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland	University College Dublin; University College Dublin	Andrei, C (corresponding author), Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Grp, Dublin 2, Ireland.	codrin.andrei@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Irish Research Council (IRC) [RS/2010/2943]; Science Foundation Ireland (SFI) [11/RFP/MTR/3113]	Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors acknowledge and thank Irish Research Council (IRC) scholarship funding (RS/2010/2943) and Science Foundation Ireland (SFI) research funding number 11/RFP/MTR/3113. They also acknowledge and thank Science Foundation Ireland for their funding of the Strategic Research Cluster in Advanced Biomimetic Materials for Solar Energy Conversion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 2010, PHYS CHEM CHEM PHYS, V12, P7241, DOI 10.1039/c000072h; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Beck FJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3140609; Becquerel E, 1839, CR HEBD ACAD SCI, P561; Bessho T, 2010, ANGEW CHEM INT EDIT, V49, P6646, DOI 10.1002/anie.201002118; Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086; Deceglie MG, 2012, NANO LETT, V12, P2894, DOI 10.1021/nl300483y; Derkacs D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336629; Ding IK, 2011, ADV ENERGY MATER, V1, P52, DOI 10.1002/aenm.201000041; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Ferry VE, 2011, NANO LETT, V11, P4239, DOI 10.1021/nl202226r; Ferry VE, 2010, ADV MATER, V22, P4794, DOI 10.1002/adma.201000488; Ferry VE, 2008, NANO LETT, V8, P4391, DOI 10.1021/nl8022548; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Gratzel M, 2012, MAGIC WORLD NANOCRYS; Gratzel M, 2007, PHILOS T R SOC A, V365, P993, DOI 10.1098/rsta.2006.1963; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P320, DOI 10.1002/pip.911; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Ho CI, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739289; Ito S, 2006, CHEM COMMUN, P4004, DOI 10.1039/b608279c; Kume T, 1995, JPN J APPL PHYS 1, V34, P6448, DOI 10.1143/JJAP.34.6448; Lee JY, 2010, NANO LETT, V10, P1276, DOI 10.1021/nl903892x; Lim SH, 2007, J APPL PHYS, V101; Liu Y, 2010, J PHYS CHEM C, V114, P1641, DOI 10.1021/jp910500c; Mishra A, 2009, ANGEW CHEM INT EDIT, V48, P2474, DOI 10.1002/anie.200804709; Nakayama K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988288; Nogueira AF, 2004, COORDIN CHEM REV, V248, P1455, DOI 10.1016/j.ccr.2004.05.018; OHSAKA T, 1978, J RAMAN SPECTROSC, V7, P321, DOI 10.1002/jrs.1250070606; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Pillai S, 2010, SOL ENERG MAT SOL C, V94, P1481, DOI 10.1016/j.solmat.2010.02.046; Polman A, 2012, NAT MATER, V11, P174, DOI 10.1038/nmat3263; Schaadt DM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1855423; Smestad GP, 1998, J CHEM EDUC, V75, P752, DOI 10.1021/ed075p752; Snaith HJ, 2007, NANO LETT, V7, P3372, DOI 10.1021/nl071656u; STENZEL O, 1995, SOL ENERG MAT SOL C, V37, P337, DOI 10.1016/0927-0248(95)00027-5; Temple TL, 2009, SOL ENERG MAT SOL C, V93, P1978, DOI 10.1016/j.solmat.2009.07.014; Wang P, 2003, NAT MATER, V2, P402, DOI 10.1038/nmat904; Wang P, 2012, PHYS CHEM CHEM PHYS, V14, P9813, DOI 10.1039/c2cp40823f; Wang XD, 2011, J MATER CHEM, V21, P20, DOI 10.1039/c0jm02620d; Williamson A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3633349; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Yum JH, 2011, ENERG ENVIRON SCI, V4, P842, DOI 10.1039/c0ee00536c; Zedler L, 2012, RSC ADV, V2, P4463, DOI 10.1039/c2ra01248k; Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i; Zerulla D, 2009, J ELECTRON SPECTROSC, V172, P78, DOI 10.1016/j.elspec.2009.03.017; Zhang Y, 2012, ADV MATER, V24, P2485, DOI 10.1002/adma.201103991; Zhang Y, 2011, LANGMUIR, V27, P15292, DOI 10.1021/la203863p; Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+	50	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109836	10.1371/journal.pone.0109836	http://dx.doi.org/10.1371/journal.pone.0109836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354362	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200015
J	Su, WM; Han, GS; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Yeast Nem1-Spo7 Protein Phosphatase Activity on Pah1 Phosphatidate Phosphatase Is Specific for the Pho85-Pho80 Protein Kinase Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipid; Phosphatidate; Phospholipid; Protein Phosphatase; Triacylglycerol; Yeast	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; MEDIATED REGULATION; ORTHOLOGUE PAH1P; PHO85P-PHO80P; LIPODYSTROPHY; BIOSYNTHESIS; BIOGENESIS	Background: Pah1 phosphatidate phosphatase translocates to the membrane through its dephosphorylation by the membrane-associated Nem1-Spo7 phosphatase complex. Results: Nem1-Spo7 phosphatase was characterized for its enzymological, kinetic, and regulatory properties with phosphorylated forms of Pah1. Conclusion: Nem1-Spo7 phosphatase exhibits the highest specificity for Pah1 phosphorylated by the Pho85-Pho80 protein kinase complex. Significance: The Nem1-Spo7-mediated dephosphorylation regulates the function of Pah1 in lipid metabolism. Pah1 is the phosphatidate phosphatase in the yeast Saccharomyces cerevisiae that produces diacylglycerol for triacylglycerol synthesis and concurrently controls the levels of phosphatidate used for phospholipid synthesis. Phosphorylation and dephosphorylation of Pah1 regulate its subcellular location and phosphatidate phosphatase activity. Compared with its phosphorylation by multiple protein kinases, Pah1 is dephosphorylated by a protein phosphatase complex consisting of Nem1 (catalytic subunit) and Spo7 (regulatory subunit). In this work, we characterized the Nem1-Spo7 phosphatase complex for its enzymological, kinetic, and regulatory properties with phosphorylated Pah1. The dephosphorylation of Pah1 by Nem1-Spo7 phosphatase resulted in the stimulation (6-fold) of phosphatidate phosphatase activity. For Pah1 phosphorylated by the Pho85-Pho80 kinase complex, maximum Nem1-Spo7 phosphatase activity required Mg2+ ions (8 mm) and Triton X-100 (0.25 mm) at pH 5.0. The energy of activation for the reaction was 8.4 kcal/mol, and the enzyme was thermally labile at temperatures above 40 degrees C. The enzyme activity was inhibited by sodium vanadate, sodium fluoride, N-ethylmaleimide, and phenylglyoxal but was not significantly affected by lipids or nucleotides. Nem1-Spo7 phosphatase activity was dependent on the concentrations of Pah1 phosphorylated by Pho85-Pho80, Cdc28-cyclin B, PKA, and PKC with k(cat) and K-m values of 0.29 s(-1) and 81 nm, 0.11 s(-1) and 127 nm, 0.10 s(-1) and 46 nm, and 0.02 s(-1) and 38 nm, respectively. Its specificity constant (k(cat)/K-m) for Pah1 phosphorylated by Pho85-Pho80 was 1.6-, 4-, and 6-fold higher, respectively, than that phosphorylated by PKA, Cdc28-cyclin B, and PKC.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from the United States Public Health Service [GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM050679 from the United States Public Health Service.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROT FE, 1969, J AM CHEM SOC, V91, P7187, DOI 10.1021/ja01053a050; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Lussier M, 1997, GENETICS, V147, P435; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	76	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34699	34708		10.1074/jbc.M114.614883	http://dx.doi.org/10.1074/jbc.M114.614883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359770	Green Published, hybrid			2022-12-26	WOS:000346260800026
J	Biedermann, A; Kriebel, K; Kreikemeyer, B; Lang, H				Biedermann, Anne; Kriebel, Katja; Kreikemeyer, Bernd; Lang, Hermann			Interactions of Anaerobic Bacteria with Dental Stem Cells: An In Vitro Study	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; HUMAN PERIODONTAL-LIGAMENT; PORPHYROMONAS-GINGIVALIS; IMMUNE-RESPONSE; PRECURSOR CELLS; STROMAL CELLS; WISDOM TEETH; MULTIPOTENT; INTERLEUKIN-10; RECOGNITION	Background: In patients with periodontitis, it is highly likely that local (progenitor) cells encounter pathogenic bacteria. The purpose of this in vitro study was to elucidate how human dental follicle stem cells (hDFSC) react towards a direct challenge with anaerobic periodontal pathogens under their natural oxygen-free atmosphere. HDFSC were compared to human bone marrow mesenchymal stem cells (hBMSC) and differentiated primary human gingival fibroblasts (hGiF), as well as permanent gingival carcinoma cells (Ca9-22). Methodology/Principal Findings: The different cell types were investigated in a co-culture system with Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum). The viability of the cells and pathogens under anaerobic conditions, as well as interactions in terms of adherence and internalization, were examined. Additionally, the release of pro-inflammatory interleukin-8 (IL-8) and anti-inflammatory interleukin-10 (IL-10) was quantified via enzyme-linked immunosorbent assay. The bacteria adhered less efficiently to hDFSC compared to Ca9-22 (P. gingivalis: 0.18% adherence to hDFSC; 3.1% adherence to Ca9-22). Similar results were observed for host cell internalization (F. nucleatum: 0.002% internalization into hDFSC; 0.09% internalization into Ca9-22). Statistically significantly less IL-8 was secreted from hDFSC after stimulation with F. nucleatum and P. gingivalis in comparison with hGiF (F. nucleatum: 2080.0 pg/ml - hGiF; 19.7 pg/ml - hDFSC). The IL-10 response of the differentiated cells was found to be low in relation to their pro-inflammatory IL-8 response. Conclusions/Significance: The results indicate that dental stem cells are less prone to interactions with pathogenic bacteria than differentiated cells in an anaerobic environment. Moreover, during bacterial challenge, the stem cell immune response seems to be more towards an anti-inflammatory reaction. For a potential future therapeutic use of hDFSC, these findings support the idea of a save application.	[Biedermann, Anne; Kriebel, Katja; Lang, Hermann] Univ Rostock, Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Kreikemeyer, Bernd] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Lang, H (corresponding author), Univ Rostock, Dept Operat Dent & Periodontol, D-18055 Rostock, Germany.	hermann.lang@uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Belton C, 2001, CELLULAR MICROBIOLOG, V1, P215; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BICKEL M, 1993, J PERIODONTOL, V64, P456; Chung WO, 2004, INFECT IMMUN, V72, P352, DOI 10.1128/IAI.72.1.352-358.2004; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DZINK JL, 1985, J CLIN PERIODONTOL, V12, P648, DOI 10.1111/j.1600-051X.1985.tb00936.x; Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071; Haddouti EM, 2009, MATERIALWISS WERKST, V40, P732, DOI 10.1002/mawe.200900505; Hajishengallis G, 2004, IMMUNOL INVEST, V33, P157, DOI 10.1081/IMM-120030917; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Huard-Delcourt A, 1998, EUR J ORAL SCI, V106, P938, DOI 10.1046/j.0909-8836.1998.eos106506.x; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Kriebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078226; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichert S, 2008, J PERIODONTAL RES, V43, P40, DOI 10.1111/j.1600-0765.2007.00992.x; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; TAKASHIBA S, 1992, INFECT IMMUN, V60, P5253, DOI 10.1128/IAI.60.12.5253-5258.1992; Tomic S, 2011, STEM CELLS DEV, V20, P695, DOI 10.1089/scd.2010.0145; Wada N, 2013, PERIODONTOL 2000, V63, P198, DOI 10.1111/prd.12024; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; Zhang J, 1999, MICROB PATHOGENESIS, V26, P275, DOI 10.1006/mpat.1998.0277	36	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110616	10.1371/journal.pone.0110616	http://dx.doi.org/10.1371/journal.pone.0110616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369260	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000023
J	Kohler, E; Villiger, J; Posch, T; Derlon, N; Shabarova, T; Morgenroth, E; Pernthaler, J; Blom, JF				Kohler, Esther; Villiger, Joerg; Posch, Thomas; Derlon, Nicolas; Shabarova, Tanja; Morgenroth, Eberhard; Pernthaler, Jakob; Blom, Judith F.			Biodegradation of Microcystins during Gravity-Driven Membrane (GDM) Ultrafiltration	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; DEGRADATION; LAKE; CYANOBACTERIA; DIVERSITY; LR; HEPATOTOXIN; BIOFILMS; REMOVAL; TOXINS	Gravity-driven membrane (GDM) ultrafiltration systems require little maintenance: they operate without electricity at ultra-low pressure in dead-end mode and without control of the biofilm formation. These systems are already in use for water purification in some regions of the world where adequate treatment and distribution of drinking water is not readily available. However, many water bodies worldwide exhibit harmful blooms of cyanobacteria that severely lower the water quality due to the production of toxic microcystins (MCs). We studied the performance of a GDM system during an artificial Microcystis aeruginosa bloom in lake water and its simulated collapse (i.e., the massive release of microcystins) over a period of 21 days. Presence of live or destroyed cyanobacterial cells in the feed water decreased the permeate flux in the Microcystis treatments considerably. At the same time, the microbial biofilms on the filter membranes could successfully reduce the amount of microcystins in the filtrate below the critical threshold concentration of 1 mu g L (-1) MC for human consumption in three out of four replicates after 15 days. We found pronounced differences in the composition of bacterial communities of the biofilms on the filter membranes. Bacterial genera that could be related to microcystin degradation substantially enriched in the biofilms amended with microcystin-containing cyanobacteria. In addition to bacteria previously characterized as microcystin degraders, members of other bacterial clades potentially involved in MC degradation could be identified.	[Kohler, Esther; Villiger, Joerg; Posch, Thomas; Shabarova, Tanja; Pernthaler, Jakob; Blom, Judith F.] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Derlon, Nicolas; Morgenroth, Eberhard] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Morgenroth, Eberhard] ETH, Inst Environm Engn, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Blom, JF (corresponding author), Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland.	blom@limnol.uzh.ch	Morgenroth, Eberhard/G-1723-2010; , Tanja/B-5327-2015	Morgenroth, Eberhard/0000-0002-1217-269X; , Tanja/0000-0003-4526-3587; derlon, nicolas/0000-0003-4240-9827; Blom, Judith/0000-0001-5000-1528; Posch, Thomas/0000-0001-5145-3761	ProDoc program "Predictive Toxicology'' - Swiss National Science Foundation [PDFMP3_132466]; Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA) [PSPB-036/2010]	ProDoc program "Predictive Toxicology'' - Swiss National Science Foundation; Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA)	This research was supported by the ProDoc program "Predictive Toxicology'' (PDFMP3_132466), funded by the Swiss National Science Foundation. J. Villiger was supported by the Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, project PSPB-036/2010: Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Blom JF, 2010, APPL ENVIRON MICROB, V76, P6156, DOI 10.1128/AEM.01455-10; Campinas M, 2010, SEP PURIF TECHNOL, V71, P114, DOI 10.1016/j.seppur.2009.11.010; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Christoffersen K, 2002, AQUAT MICROB ECOL, V27, P125, DOI 10.3354/ame027125; Derlon N, 2013, WATER RES, V47, P2085, DOI 10.1016/j.watres.2013.01.033; Dyble J, 2008, ENVIRON TOXICOL, V23, P507, DOI 10.1002/tox.20370; Dziga D, 2013, CHEM RES TOXICOL, V26, P841, DOI 10.1021/tx4000045; Grutzmacher G, 2010, ENVIRON SCI TECHNOL, V44, P657, DOI 10.1021/es9016816; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Ho LN, 2007, TOXICON, V50, P438, DOI 10.1016/j.toxicon.2007.03.021; Hoeger SJ, 2002, ENVIRON HEALTH PERSP, V110, P1127, DOI 10.1289/ehp.021101127; Holst T, 2003, WATER RES, V37, P4748, DOI 10.1016/S0043-1354(03)00413-5; Jiang YG, 2011, FEMS MICROBIOL LETT, V322, P108, DOI 10.1111/j.1574-6968.2011.02337.x; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Leclerc H, 2002, FEMS MICROBIOL REV, V26, P207, DOI [10.1111/j.1574-6976.2002.tb00611.x, 10.1016/S0168-6445(02)00097-9]; Li JM, 2012, BIORESOURCE TECHNOL, V106, P27, DOI 10.1016/j.biortech.2011.11.099; Mou XZ, 2013, J GREAT LAKES RES, V39, P352, DOI 10.1016/j.jglr.2013.03.014; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Peter-Varbanets M, 2009, WATER RES, V43, P245, DOI 10.1016/j.watres.2008.10.030; Peter-Varbanets M, 2010, WATER RES, V44, P3607, DOI 10.1016/j.watres.2010.04.020; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/nclimate1581, 10.1038/NCLIMATE1581]; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rapala J, 2005, INT J SYST EVOL MICR, V55, P1563, DOI 10.1099/ijs.0.63599-0; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Roberts L, 2001, B WORLD HEALTH ORGAN, V79, P280; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Shabarova T, 2014, FEMS MICROBIOL ECOL, V89, P111, DOI 10.1111/1574-6941.12339; Shimizu K, 2013, MAEJO INT J SCI TECH, V7, P22; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Sibille I, 1998, APPL ENVIRON MICROB, V64, P197; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Van den Wyngaert S, 2011, LIMNOL OCEANOGR, V56, P97, DOI 10.4319/lo.2011.56.1.0097; WHO, 2011, GUID DRINK WAT QUAL; Yamaguchi N, 2011, APPL ENVIRON MICROB, V77, P1536, DOI 10.1128/AEM.01765-10	39	30	31	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111794	10.1371/journal.pone.0111794	http://dx.doi.org/10.1371/journal.pone.0111794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369266	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000344402000103
J	Lou, XD; Zhai, SQ; Kang, B; Hu, YL; Hu, LL				Lou, Xue-Dong; Zhai, Sheng-Qiang; Kang, Bing; Hu, Ya-Lin; Hu, Li-Le			Rapid Response of Hydrological Loss of DOC to Water Table Drawdown and Warming in Zoige Peatland: Results from a Mesocosm Experiment	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; CLIMATE-CHANGE; FRESH-WATER; TEMPORAL VARIABILITY; CHEMICAL-COMPOSITION; METHANE EMISSIONS; TIBETAN PLATEAU; EXPORT; TEMPERATURE; DIOXIDE	A large portion of the global carbon pool is stored in peatlands, which are sensitive to a changing environment conditions. The hydrological loss of dissolved organic carbon (DOC) is believed to play a key role in determining the carbon balance in peatlands. Zoige peatland, the largest peat store in China, is experiencing climatic warming and drying as well as experiencing severe artificial drainage. Using a fully crossed factorial design, we experimentally manipulated temperature and controlled the water tables in large mesocosms containing intact peat monoliths. Specifically, we determined the impact of warming and water table position on the hydrological loss of DOC, the exported amounts, concentrations and qualities of DOC, and the discharge volume in Zoige peatland. Our results revealed that of the water table position had a greater impact on DOC export than the warming treatment, which showed no interactive effects with the water table treatment. Both DOC concentration and discharge volume were significantly increased when water table drawdown, while only the DOC concentration was significantly promoted by warming treatment. Annual DOC export was increased by 69% and 102% when the water table, controlled at 0 cm, was experimentally lowered by -10 cm and -20 cm. Increases in colored and aromatic constituents of DOC (measured by Abs(254 nm), SUVA(254 nm), Abs(400 nm), and SUVA(400 nm)) were observed under the lower water tables and at the higher peat temperature. Our results provide an indication of the potential impacts of climatic change and anthropogenic drainage on the carbon cycle and/or water storage in a peatland and simultaneously imply the likelihood of potential damage to downstream ecosystems. Furthermore, our results highlight the need for local protection and sustainable development, as well as suggest that more research is required to better understand the impacts of climatic change and artificial disturbances on peatland degradation.	[Lou, Xue-Dong; Zhai, Sheng-Qiang; Hu, Li-Le] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Lou, Xue-Dong; Kang, Bing] Northwest Agr Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Hu, Ya-Lin] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Research Academy of Environmental Sciences; Northwest A&F University - China; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Hu, LL (corresponding author), Chinese Res Inst Environm Sci, Beijing, Peoples R China.	hulile@craes.org.cn			Nature Science Foundation of China [41103041, 41271318]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding from the Nature Science Foundation of China under Grant Nos. 41103041 and 41271318 to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, OIKOS, V84, P44, DOI 10.2307/3546865; [Anonymous], SICHUAN ENV; Arnosti C, 2003, ESTUAR COAST SHELF S, V58, P197, DOI 10.1016/S0272-7714(03)00077-5; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Billett MF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002058; Blodau C, 2012, BIOGEOCHEMISTRY, V107, P107, DOI 10.1007/s10533-010-9535-1; Bohrer G, 2013, PLOS ONE, V8; Bridgham SD, 2008, ECOLOGY, V89, P3041, DOI 10.1890/08-0279.1; Bridgham SD, 1999, ECOL APPL, V9, P1345, DOI 10.1890/1051-0761(1999)009[1345:ECOTAE]2.0.CO;2; Briggs J, 2007, EARTH PLANET SC LETT, V253, P445, DOI 10.1016/j.epsl.2006.11.010; Carpenter SR, 1997, OIKOS, V78, P3, DOI 10.2307/3545794; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Cheng HL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078838, 10.1371/journal.pone.0053878]; Chin W-C, 2013, PLOS ONE, V8; Chivers MR, 2009, ECOSYSTEMS, V12, P1329, DOI 10.1007/s10021-009-9292-y; Clair TA, 2002, ENVIRON POLLUT, V116, pS143, DOI 10.1016/S0269-7491(01)00267-6; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; [戴洋 DAI Yang], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P35; DEBEVEC EM, 1993, ARCTIC ALPINE RES, V25, P56, DOI 10.2307/1551481; deMars H, 1996, VEGETATIO, V126, P59; Dinsmore KJ, 2013, GLOBAL CHANGE BIOL, V19, P2133, DOI 10.1111/gcb.12209; Ellis T, 2009, ECOL ENG, V35, P978, DOI 10.1016/j.ecoleng.2008.10.011; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Evans CD, 2006, GLOBAL CHANGE BIOL, V12, P2044, DOI 10.1111/j.1365-2486.2006.01241.x; Fraser CJD, 2001, HYDROL PROCESS, V15, P3151, DOI 10.1002/hyp.322; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Froberg M, 2006, BIOGEOCHEMISTRY, V77, P1, DOI 10.1007/s10533-004-0564-5; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Grayson R, 2012, HYDROL PROCESS, V26, P27, DOI 10.1002/hyp.8106; Guo XJ, 2013, SCI TOTAL ENVIRON, V445, P231, DOI 10.1016/j.scitotenv.2012.12.048; Guo YD, 2010, J ENVIRON SCI, V22, P84, DOI 10.1016/S1001-0742(09)60078-4; Hao YB, 2008, ACTA OECOL, V33, P133, DOI 10.1016/j.actao.2007.07.002; Harrison AF, 2008, GLOBAL CHANGE BIOL, V14, P687, DOI 10.1111/j.1365-2486.2007.01504.x; HOBBIE JE, 1992, HYDROBIOLOGIA, V229, P169, DOI 10.1007/BF00006999; HOGG EH, 1992, ECOL APPL, V2, P298, DOI 10.2307/1941863; Jager DF, 2009, SCI TOTAL ENVIRON, V407, P1373, DOI 10.1016/j.scitotenv.2008.10.005; Kim SY, 2012, APPL SOIL ECOL, V57, P23, DOI 10.1016/j.apsoil.2012.02.015; Li GY, 2011, J APPL ECOL, V48, P659, DOI 10.1111/j.1365-2664.2011.01965.x; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Luo CY, 2009, SOIL BIOL BIOCHEM, V41, P2493, DOI 10.1016/j.soilbio.2009.09.006; MITCHELL G, 1992, WATER RES, V26, P321, DOI 10.1016/0043-1354(92)90029-4; MITCHELL GN, 1990, PROG PHYS GEOG, V14, P317, DOI 10.1177/030913339001400302; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; MOORE TR, 1989, WATER RESOUR RES, V25, P1321, DOI 10.1029/WR025i006p01321; Moore TR, 1998, CLIMATIC CHANGE, V40, P229, DOI 10.1023/A:1005408719297; MOORE TR, 1993, J SOIL SCI, V44, P651, DOI 10.1111/j.1365-2389.1993.tb02330.x; Morris PJ, 2011, J ECOL, V99, P1190, DOI 10.1111/j.1365-2745.2011.01842.x; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; Price JS, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001302; SAFS (Sichuan Academy of Forest Science), 2006, SCI INV REP ZOIG MAR; Sapek A, 2009, INT J ENVIRON POLLUT, V37, P398, DOI 10.1504/IJEP.2009.026057; Scanlon D, 2000, SOIL SCI, V165, P153, DOI 10.1097/00010694-200002000-00006; Shi C-c, 2009, SW CHINA J AGR SCI, V6; Sommer M, 2006, GEODERMA, V133, P107, DOI 10.1016/j.geoderma.2006.03.040; Steinberg, 2003, ECOLOGY HUMIC SUBSTA; Strack M, 2008, HYDROL PROCESS, V22, P3373, DOI 10.1002/hyp.6931; Strack M, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002209; Strakova P, 2012, GLOBAL CHANGE BIOL, V18, P322, DOI 10.1111/j.1365-2486.2011.02503.x; Tang R, 2013, ENVIRON POLLUT, V173, P270, DOI 10.1016/j.envpol.2012.09.022; Trettin CC, 2006, CAN J SOIL SCI, V86, P269, DOI 10.4141/S05-089; Turetsky M.R., 2008, J GEOPHYS RES-BIOGEO, V113; Turunen J, 2008, DEV FINNISH PEATLAND; URBAN NR, 1989, WATER RESOUR RES, V25, P1619, DOI 10.1029/WR025i007p01619; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wallage ZE, 2010, SCI TOTAL ENVIRON, V408, P6235, DOI 10.1016/j.scitotenv.2010.09.009; Wallage ZE, 2006, SCI TOTAL ENVIRON, V367, P811, DOI 10.1016/j.scitotenv.2006.02.010; Walling D. E., 1981, RELIABILITY SUSPENDE; [王铭 Wang Ming], 2012, [湿地科学, Wetland Science], V10, P156; Watts CD, 2001, SCI TOTAL ENVIRON, V278, P57, DOI 10.1016/S0048-9697(00)00888-3; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Weltzin JF, 2000, ECOLOGY, V81, P3464, DOI 10.1890/0012-9658(2000)081[3464:ROBAFP]2.0.CO;2; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; Whittington PN, 2006, HYDROL PROCESS, V20, P3589, DOI 10.1002/hyp.6376; Wilson L, 2011, SCI TOTAL ENVIRON, V409, P2010, DOI 10.1016/j.scitotenv.2011.02.036; Worrall F, 2007, J HYDROL, V339, P1, DOI 10.1016/j.jhydrol.2006.12.025; Worrall F, 2003, SCI TOTAL ENVIRON, V312, P133, DOI 10.1016/S0048-9697(03)00226-2; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Yu Z, 2013, SENSITIVITY NO PEATL, P55; Zhang GS, 2008, ENVIRON MICROBIOL, V10, P1850, DOI 10.1111/j.1462-2920.2008.01606.x; Zhang X, 2005, WETLAND SCI, V3, P292; Zhang XH, 2012, ECOL ENG, V38, P86, DOI 10.1016/j.ecoleng.2011.09.004	84	13	15	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109861	10.1371/journal.pone.0109861	http://dx.doi.org/10.1371/journal.pone.0109861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369065	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000012
J	Mandorfer, M; Bota, S; Schwabl, P; Bucsics, T; Pfisterer, N; Summereder, C; Hagmann, M; Blacky, A; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M; Reiberger, T				Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Hagmann, Michael; Blacky, Alexander; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas			Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites	PLOS ONE			English	Article							PORTAL-HYPERTENSION; LIVER-DISEASE; OVERGROWTH; ASSOCIATION; THERAPY; RISK; DEFINITION; MANAGEMENT; PROGNOSIS; DIAGNOSIS	Background and Aim: The aim of this study was to assess the impact of proton pump inhibitor (PPI) intake on the development of spontaneous bacterial peritonitis (SBP) or other infections, as well as on mortality, in a thoroughly documented cohort of patients with cirrhosis and ascites. Patients and Methods: We performed a retrospective analysis of follow-up data from 607 consecutive patients with cirrhosis undergoing their first paracentesis at a tertiary center. A binary logistic regression model investigating the association between PPI intake and SBP at the first paracentesis was calculated. Competing risk analyses and Cox models were used to investigate the effect of PPIs on the cumulative incidence of SBP or other infections and transplant-free survival, respectively. Adjustments were made for age, hepatocellular carcinoma, history of variceal bleeding, varices and model of end-stage liver disease score. Results: Eighty-six percent of patients were receiving PPIs. After adjusting for potential confounding factors, PPI intake was neither associated with increased SBP prevalence at the first paracentesis (odds ratio (OR): 1.11,95% confidence interval (95% CI): 0.6-2.06; P = 0.731) nor cumulative incidence of SBP (subdistribution hazard ratio (SHR): 1.38; 95% CI: 0.63-3.01; P = 0.42) and SBP or other infections (SHR: 1.71; 95% CI: 0.85-3.44; P = 0.13) during follow-up. Moreover, PPI intake had no impact on transplant-free survival in both the overall cohort (hazard ratio (HR): 0.973,95% CI: 0.719-1.317; P = 0.859) as well as in the subgroups of patients without SBP (HR: 1.01,95% CI: 0.72-1.42; P = 0.971) and without SBP or other infections at the first paracentesis (HR: 0.944,95% CI: 0.668-1.334; P = 0.742). Conclusions: The proportion of cirrhotic patients with PPI intake was higher than in previous reports, suggesting that PPI indications were interpreted liberally. In our cohort with a particularly high prevalence of PPI intake, we observed no association between PPIs and SBP or other infections, as well as mortality. Thus, the severity of liver disease and other factors, rather than PPI treatment per se may predispose for infectious complications.	[Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria; [Blacky, Alexander] Vienna Gen Hosp, Hosp Hyg, Inst Clin, Vienna, Austria; [Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Reiberger, T (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019	Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Schwabl, Philipp/0000-0002-7183-8076; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Trauner, Michael/0000-0002-1275-6425				[Anonymous], 1992, CRITICAL CARE MED, V20, P864; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Bajaj JS, 2012, ALIMENT PHARM THER, V36, P866, DOI 10.1111/apt.12045; Bajaj JS, 2009, AM J GASTROENTEROL, V104, P1130, DOI 10.1038/ajg.2009.80; Bauer TM, 2001, AM J GASTROENTEROL, V96, P2962, DOI 10.1111/j.1572-0241.2001.04668.x; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Campbell MS, 2008, DIGEST DIS SCI, V53, P394, DOI 10.1007/s10620-007-9899-9; Chang CS, 1998, HEPATOLOGY, V28, P1187, DOI 10.1002/hep.510280504; Child C, 1964, SURG PORTAL HYPERTEN, P50; Choi EJ, 2011, SCAND J GASTROENTERO, V46, P616, DOI 10.3109/00365521.2011.551891; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; de Vos M, 2013, LIVER INT, V33, P1316, DOI 10.1111/liv.12210; Deshpande A, 2013, J GASTROEN HEPATOL, V28, P235, DOI 10.1111/jgh.12065; EAftSot Liver, 2010, J HEPATOL, V53, P397; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goel GA, 2012, CLIN GASTROENTEROL H, V10, P422, DOI 10.1016/j.cgh.2011.11.019; Gunnarsdottir SA, 2003, AM J GASTROENTEROL, V98, P1362, DOI 10.1016/S0002-9270(03)00250-8; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jun DW, 2010, DIGEST DIS SCI, V55, P1465, DOI 10.1007/s10620-009-0870-9; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kwon JH, 2014, J GASTROEN HEPATOL, V29, P775, DOI 10.1111/jgh.12426; Lodato F, 2008, WORLD J GASTROENTERO, V14, P2980, DOI 10.3748/wjg.14.2980; Mandorfer M, 2014, GASTROENTEROLOGY, V146, P1680, DOI 10.1053/j.gastro.2014.03.005; MORENCOS FC, 1995, DIGEST DIS SCI, V40, P1252; Peck-Radosavljevic M, 2005, ENDOSCOPY, V37, P667, DOI 10.1055/s-2005-861464; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2013, J HEPATOL, V58, P911, DOI 10.1016/j.jhep.2012.12.011; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; SIRINGO S, 1995, J HEPATOL, V22, P633, DOI 10.1016/0168-8278(95)80219-3; van Vlerken LG, 2012, EUR J CLIN INVEST, V42, P760, DOI 10.1111/j.1365-2362.2011.02643.x	35	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110503	10.1371/journal.pone.0110503	http://dx.doi.org/10.1371/journal.pone.0110503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369194	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000022
J	Martinez, CS; Torres, JGD; Pecanha, FM; Anselmo-Franci, JA; Vassallo, DV; Salaices, M; Alonso, MJ; Wiggers, GA				Martinez, Caroline S.; Torres, Joao Guilherme D.; Pecanha, Franck M.; Anselmo-Franci, Janete A.; Vassallo, Dalton V.; Salaices, Mercedes; Alonso, Maria J.; Wiggers, Giulia A.			60-Day Chronic Exposure to Low Concentrations of HgCl2 Impairs Sperm Quality: Hormonal Imbalance and Oxidative Stress as Potential Routes for Reproductive Dysfunction in Rats	PLOS ONE			English	Article							INORGANIC MERCURY; TESTICULAR TOXICITY; LIPID-PEROXIDATION; METHYL MERCURY; CHLORIDE; METHYLMERCURY; CADMIUM; MECHANISM; SYSTEM; TISSUE	Mercury is a toxic and bio-accumulative heavy metal of global concern. While good deals of research have been conducted on the toxic effects of mercury, little is known about the mechanisms involved in the pathogenesis of male reproductive dysfunction induced by mercury. Therefore, the purpose of this study was to assess the effects and underlying mechanisms of chronic mercury exposure at low levels on male reproductive system of rats. Three-month-old male Wistar rats were divided into two groups and treated for 60 days with saline (i.m., Control) and HgCl2 (i.m. 1st dose: 4.6 mu g/kg, subsequent doses 0.07 mu g/kg/day). We analyzed sperm parameters, hormonal levels and biomarkers of oxidative stress in testis, epididymis, prostate and vas deferens. Mercury treatment decreased daily sperm production, count and motility and increased head and tail morphologic abnormalities. Moreover, mercury treatment decreased luteinizing hormone levels, increased lipid peroxidation on testis and decreased antioxidant enzymes activities (superoxide dismutase and catalase) on reproductive organs. Our data demonstrate that 60-day chronic exposure to low concentrations of HgCl2 impairs sperm quality and promotes hormonal imbalance. The raised oxidative stress seems to be a potential mechanism involved on male reproductive toxicity by mercury.	[Martinez, Caroline S.; Torres, Joao Guilherme D.; Pecanha, Franck M.; Wiggers, Giulia A.] Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil; [Anselmo-Franci, Janete A.] Univ Sao Paulo, Sch Dent, Dept Morphol Stomatol & Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Espirito Santo, Spain; [Salaices, Mercedes] Univ Autonoma Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain	Universidade Federal do Pampa; Universidade de Sao Paulo; Autonomous University of Madrid; Universidad Rey Juan Carlos	Wiggers, GA (corresponding author), Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil.	giuliawp@gmail.com	Alonso, María/AAB-4309-2019; Martinez, Caroline S/B-2184-2019; Anselmo-Franci, Janete/E-7124-2012; Wiggers, Giulia/AAG-2039-2019; Vassallo, Dalton/K-8289-2016	Alonso, María/0000-0003-4912-1121; Martinez, Caroline S/0000-0001-5742-3635; Anselmo-Franci, Janete/0000-0002-6480-1187; Wiggers, Giulia/0000-0001-5401-828X; Vassallo, Dalton/0000-0002-4463-4174; Salaices Sanchez, Mercedes/0000-0003-3323-1692	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia [39767531/07]; Ministerio de Ciencia e Innovacion [SAF 2012-36400, PHB2011-0001-PC]; Instituto de Salud Carlos III - ISCIII [RIC RD12/0042/0024]; Pro-reitoria de Pesquisa - Universidade Federal do Pampa [Nu 10.0010.13]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III - ISCIII(Instituto de Salud Carlos IIIEuropean Commission); Pro-reitoria de Pesquisa - Universidade Federal do Pampa	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia [39767531/07]; Ministerio de Ciencia e Innovacion [SAF 2012-36400 and PHB2011-0001-PC]; Instituto de Salud Carlos III - ISCIII [RIC RD12/0042/0024]; Pro-reitoria de Pesquisa - Universidade Federal do Pampa [Nu 10.0010.13]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Birch RJ, 2014, ENVIRON RES, V14; Boujbiha MA, 2009, REPROD TOXICOL, V28, P81, DOI 10.1016/j.reprotox.2009.03.011; Boujbiha MAM, 2011, BIOL TRACE ELEM RES, V142, P598, DOI 10.1007/s12011-010-8774-2; CARMIGNANI M, 1992, BRIT J IND MED, V49, P226; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Choy CMY, 2002, BJOG-INT J OBSTET GY, V109, P1121, DOI 10.1111/j.1471-0528.2002.02084.x; Cornett CR, 1998, BIOL TRACE ELEM RES, V62, P107, DOI 10.1007/BF02820026; Corvelo TCD, 2014, B ENVIRON CONTAM TOX, V93, P42, DOI 10.1007/s00128-014-1279-5; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ERFURTH EM, 1990, BRIT J IND MED, V47, P639; Farina M, 2003, TOXICOLOGY, V184, P179, DOI 10.1016/S0300-483X(02)00576-0; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Ghaffari Mohammad Ali, 2011, Iranian Biomedical Journal, V15, P38; Goyer RA, 2004, BIOMETALS, V17, P555, DOI 10.1023/B:BIOM.0000045738.59708.20; Homma-Takeda S, 2001, TOXICOLOGY, V169, P25, DOI 10.1016/S0300-483X(01)00487-5; Kalender S, 2013, FOOD CHEM TOXICOL, V55, P456, DOI 10.1016/j.fct.2013.01.024; KECK C, 1993, REPROD TOXICOL, V7, P469, DOI 10.1016/0890-6238(93)90092-L; Khan AT, 2004, FOOD CHEM TOXICOL, V42, P571, DOI 10.1016/j.fct.2003.10.018; Kumar Banothu Anil, 2013, J Nat Sci Biol Med, V4, P414, DOI 10.4103/0976-9668.117021; Laks DR, 2009, BIOMETALS, V22, P1103, DOI 10.1007/s10534-009-9261-0; Louis GMB, 2014, REPRODUCTION, V147, pR97, DOI 10.1530/REP-13-0472; Martinez CS, 2014, J TOXICOL ENV HEAL A, V77, P143, DOI 10.1080/15287394.2014.867202; McKelvey W, 2007, ENVIRON HEALTH PERSP, V115, P1435, DOI 10.1289/ehp.10056; Mello-Carpes PB, 2013, INT J DEV NEUROSCI, V31, P468, DOI 10.1016/j.ijdevneu.2013.05.009; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mocevic E, 2013, ASIAN J ANDROL, V15, P97, DOI 10.1038/aja.2012.121; MOHAMED MK, 1987, PHARMACOL TOXICOL, V60, P29, DOI 10.1111/j.1600-0773.1987.tb01715.x; National Academy of Sciences, 2000, TOX EFF METH; Nyland JF, 2012, TOXICOL SCI, V125, P134, DOI 10.1093/toxsci/kfr264; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omura M, 1996, FUND APPL TOXICOL, V32, P72, DOI 10.1006/faat.1996.0108; Perottoni J, 2004, FOOD CHEM TOXICOL, V42, P17, DOI 10.1016/j.fct.2003.08.002; Popescu HI, 1978, BMJ-BRIT MED J, V1, P23; Ramalingam V, 2003, J ENVIRON BIOL, V24, P401; Rana SVS, 2014, BIOL TRACE ELEM RES, V160, P1, DOI 10.1007/s12011-014-0023-7; Rao MV, 2008, TOXICOL IN VITRO, V22, P935, DOI 10.1016/j.tiv.2008.01.014; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Santos FW, 2005, CHEM-BIOL INTERACT, V151, P159, DOI 10.1016/j.cbi.2005.01.001; Sharma AK, 1996, REPROD TOXICOL, V10, P153, DOI 10.1016/0890-6238(95)02058-6; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang YB, 2011, TOXICOL SCI, V119, P270, DOI 10.1093/toxsci/kfq334	49	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111202	10.1371/journal.pone.0111202	http://dx.doi.org/10.1371/journal.pone.0111202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368988	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000042
J	Azevedo, H; Fujita, A; Bando, SY; Iamashita, P; Moreira, CA				Azevedo, Hatylas; Fujita, Andre; Bando, Silvia Yumi; Iamashita, Priscila; Moreira-Filho, Carlos Alberto			Transcriptional Network Analysis Reveals that AT1 and AT2 Angiotensin II Receptors Are Both Involved in the Regulation of Genes Essential for Glioma Progression	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME TUMORS; GROWTH-FACTOR RECEPTORS; SMOOTH-MUSCLE-CELLS; CROSS-TALK; MALIGNANT GLIOMA; BRAIN-TUMORS; EXPRESSION; ACTIVATION; PROTEIN; CANCER	Gliomas are aggressive primary brain tumors with high infiltrative potential. The expression of Angiotensin II (Ang II) receptors has been associated with poor prognosis in human astrocytomas, the most common type of glioma. In this study, we investigated the role of Angiotensin II in glioma malignancy through transcriptional profiling and network analysis of cultured C6 rat glioma cells exposed to Ang II and to inhibitors of its membrane receptor subtypes. C6 cells were treated with Ang II and specific antagonists of AT1 and AT2 receptors. Total RNA was isolated after three and six hours of Ang II treatment and analyzed by oligonucleotide microarray technology. Gene expression data was evaluated through transcriptional network modeling to identify how differentially expressed (DE) genes are connected to each other. Moreover, other genes co-expressing with the DE genes were considered in these analyses in order to support the identification of enriched functions and pathways. A hub-based network analysis showed that the most connected nodes in Ang II-related networks exert functions associated with cell proliferation, migration and invasion, key aspects for glioma progression. The subsequent functional enrichment analysis of these central genes highlighted their participation in signaling pathways that are frequently deregulated in gliomas such as ErbB, MAPK and p53. Noteworthy, either AT1 or AT2 inhibitions were able to down-regulate different sets of hub genes involved in protumoral functions, suggesting that both Ang II receptors could be therapeutic targets for intervention in glioma. Taken together, our results point out multiple actions of Ang II in glioma pathogenesis and reveal the participation of both Ang II receptors in the regulation of genes relevant for glioma progression. This study is the first one to provide systems-level molecular data for better understanding the protumoral effects of Ang II in the proliferative and infiltrative behavior of gliomas.	[Azevedo, Hatylas; Bando, Silvia Yumi; Iamashita, Priscila; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Dept Comp Sci, Inst Matemat & Estat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Moreira, CA (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	carlos.moreira@hc.fm.usp.br	moreira-filho, carlos alberto/J-2551-2014; Fujita, Andre/Q-1271-2019; Azevedo, Hatylas FZ/M-5332-2013	moreira-filho, carlos alberto/0000-0003-3433-4714; Fujita, Andre/0000-0002-7756-7051; Azevedo, Hatylas FZ/0000-0001-9233-0696; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2005/56446-0, 2009/53443-1, 2011/50761-2, 2011/07762-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [305635/2009-3]; NAP e-Science USP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NAP e-Science USP	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Grants 2005/56446-0, 2009/53443-1, 2011/50761-2, 2011/07762-8), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (Grant 305635/2009-3) and NAP e-Science USP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Ager EI, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-19; Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Arrieta O, 2008, BRIT J CANCER, V99, P160, DOI 10.1038/sj.bjc.6604431; Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banakh I, 2002, EUR J IMMUNOGENET, V29, P307, DOI 10.1046/j.1365-2370.2002.00330.x; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bredel M, 1998, NEUROSURGERY, V43, P124, DOI 10.1097/00006123-199807000-00081; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Campos AH, 2003, CIRC RES, V92, P111, DOI 10.1161/01.RES.0000049100.22673.F6; Carpentier AF, 2012, EUR J NEUROL, V19, P1337, DOI 10.1111/j.1468-1331.2012.03766.x; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Hua, 2007, Zhonghua Zhongliu Zazhi, V29, P484; Chen WY, 2001, ONCOGENE, V20, P7686, DOI 10.1038/sj.onc.1204989; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Crea F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-265; De Godoy MAF, 2002, J PHARMACOL EXP THER, V303, P333, DOI 10.1124/jpet.102.036970; de Godoy MAF, 2006, J PHARMACOL EXP THER, V319, P1088, DOI 10.1124/jpet.106.108084; De Paolis P, 2002, J HYPERTENS, V20, P693, DOI 10.1097/00004872-200204000-00027; De S, 2009, CANCER RES, V69, P8035, DOI 10.1158/0008-5472.CAN-09-1224; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Deng XB, 2013, J NEURO-ONCOL, V114, P263, DOI 10.1007/s11060-013-1179-2; Droit A, 2005, J MOL ENDOCRINOL, V34, P263, DOI 10.1677/jme.1.01693; Du L, 2013, ONCOGENE; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ehtesham M, 2005, NEUROSURG FOCUS, V19, P5; Erten S, 2010, LECT NOTES COMPUT SC, V6023, P13, DOI 10.1007/978-3-642-12211-8_2; Facoetti A, 2006, ANTICANCER RES, V26, P3513; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Fogarty DJ, 2002, GLIA, V39, P304, DOI 10.1002/glia.10117; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Gallagher PE, 2011, CURR CANCER DRUG TAR, V11, P394; Glass TL, 2000, NEURO-ONCOLOGY, V2, P151, DOI 10.1093/neuonc/2.3.151; Godin CM, 2012, MINI-REV MED CHEM, V12, P812; Gunther W, 2003, ACTA NEUROCHIR, V145, P1029, DOI 10.1007/s00701-003-0099-x; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Honjho Y, 1996, NEUROL SURG TOKYO, V24, P143; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Huang ZX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-308; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Inagami T, 1999, J AM SOC NEPHROL, V10, pS57; Ino K, 2011, CURR CANCER DRUG TAR, V11, P405, DOI 10.2174/156800911795538057; Itabashi H, 2008, HEPATOL RES, V38, P601, DOI 10.1111/j.1872-034X.2007.00304.x; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Jones DTW, 2012, CELL MOL LIFE SCI, V69, P1799, DOI 10.1007/s00018-011-0898-9; Jones DTW, 2011, ACTA NEUROPATHOL, V121, P753, DOI 10.1007/s00401-011-0810-6; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Ke HL, 2013, J NEURO-ONCOL, V113, P327, DOI 10.1007/s11060-013-1121-7; KEISER JA, 1992, J PHARMACOL EXP THER, V262, P1154; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim YC, 2012, AM J PHYSIOL-LUNG C, V303, pL228, DOI 10.1152/ajplung.00087.2012; Kosaka T, 2007, PROSTATE, V67, P41, DOI 10.1002/pros.20486; Kozlowski L, 2000, ARCH DERMATOL RES, V292, P68, DOI 10.1007/s004030050012; Kurella M, 2001, J AM SOC NEPHROL, V12, P1072, DOI 10.1681/ASN.V1251072; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; L'Esperance S, 2006, INT J ONCOL, V29, P5; Li JH, 2003, J BIOL CHEM, V278, P52355, DOI 10.1074/jbc.M305232200; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049915; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Lo HW, 2010, CURR CANCER DRUG TAR, V10, P840, DOI 10.2174/156800910793357970; Ma ZY, 2013, INT J CLIN EXP PATHO, V6, P862; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Merlo A, 2003, NEUROSURG REV, V26, P145, DOI 10.1007/s10143-003-0267-8; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Miura S, 2013, CURR PHARM DESIGN, V19, P2981; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Naville D, 2001, EUR J BIOCHEM, V268, P1802, DOI 10.1046/j.1432-1327.2001.02055.x; Nawashiro Hiroshi, 2005, Brain Tumor Pathol, V22, P89, DOI 10.1007/s10014-005-0188-z; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024; Ohira K, 2006, BIOCHEM BIOPH RES CO, V342, P867, DOI 10.1016/j.bbrc.2006.02.033; Ono R, 2008, INT J MOL MED, V22, P199, DOI 10.3892/ijmm_00000009; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Poirel CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S14; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rekers NH, 2011, J CHEMOTHERAPY, V23, P187, DOI 10.1179/joc.2011.23.4.187; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rivera E, 2001, BRIT J CANCER, V85, P1396, DOI 10.1054/bjoc.2001.2102; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Romero DG, 2007, PHYSIOL GENOMICS, V30, P26, DOI 10.1152/physiolgenomics.00187.2006; Romero DG, 2004, PHYSIOL GENOMICS, V19, P106, DOI 10.1152/physiolgenomics.00097.2004; Roos WP, 2009, MOL PHARMACOL, V76, P927, DOI 10.1124/mol.109.058131; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Sanderson RJ, 1998, J BIOL CHEM, V273, P24822, DOI 10.1074/jbc.273.38.24822; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smith Gary Robert, 2004, J Inflamm (Lond), V1, P3, DOI 10.1186/1476-9255-1-3; Soni D, 2005, J CLIN NEUROSCI, V12, P1, DOI 10.1016/j.jocn.2004.04.001; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szekeres M, 2009, MOL CELL ENDOCRINOL, V302, P244, DOI 10.1016/j.mce.2008.12.015; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Thiel G, 2011, ENDOCRINOLOGY, V152, P4211, DOI 10.1210/en.2011-1243; Thomas CY, 2003, INT J CANCER, V104, P19, DOI 10.1002/ijc.10880; Trojan J, 2007, NEUROSCIENCE, V145, P795, DOI 10.1016/j.neuroscience.2007.01.021; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vinson GP, 2012, ENDOCR-RELAT CANCER, V19, pR1, DOI 10.1530/ERC-11-0335; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Yamaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01160; Yamamura M, 2013, INT J ONCOL, V42, P873, DOI 10.3892/ijo.2013.1761; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yang W, 2013, CANCER SCI, V104, P70, DOI 10.1111/cas.12047; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zagzag D, 2000, PEDIATR NEUROSURG, V33, P49, DOI 10.1159/000028975; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010; Zheng PP, 2004, AM J PATHOL, V164, P2217, DOI 10.1016/S0002-9440(10)63778-9; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	136	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110934	10.1371/journal.pone.0110934	http://dx.doi.org/10.1371/journal.pone.0110934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365520	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100037
J	Liang, YT; Li, L; Luo, TW; Zhang, Y; Zhang, R; Jiao, NZ				Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi			Horizontal and Vertical Distribution of Marine Virioplankton: A Basin Scale Investigation Based on a Global Cruise	PLOS ONE			English	Article							BATHYPELAGIC WATERS; VIRAL ABUNDANCE; SPATIAL-DISTRIBUTION; MEDITERRANEAN SEA; COUNTING VIRUSES; ORGANIC-MATTER; FLOW-CYTOMETRY; ADRIATIC SEA; DEEP WATERS; OCEAN	Despite the fact that marine viruses have been increasingly studied in the last decade, there is little information on viral abundance and distribution on a global scale. In this study, we report on a global-scale survey covering the Pacific, Atlantic, and Indian Oceans on viral distribution using flow cytometry. Viruses were stained with the SYBR Green I, which targets only dsDNA viruses. The average viral abundance was 1.10 +/- 0.73x10(7) ml(-1) in global surface oceans and decreased from the areas with high chlorophyll concentration (on average, 1.47 +/- 0.78x10(7) ml(-1)) to the oligotrophic subtropical gyres (on average, 6.34 +/- 2.18x10(6) ml(-1)). On a large-spatial-scale, viruses displayed significant relationships with both heterotrophic and autotrophic picoplankton abundance, suggesting that viral distribution is dependent on their host cell abundance. Our study provided a basin scale pattern of marine viral distributions and their relationship with major host cells, indicating that viruses play a significant role in the global marine ecosystem.	[Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China; [Liang, Yantao] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Qingdao, Peoples R China	Xiamen University; Xiamen University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Zhang, R (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	ruizhang@xmu.edu.cn; jiao@xmu.edu.cn	Luo, Tingwei/B-7425-2012		National Key Basic Research Program of China [2013CB955700]; SOA project [GASI-03-01-02-05]; 863 Program [2012AA092003]; NSFC [41376132]; Fundamental Research Funds for the Central Universities [2012121052]	National Key Basic Research Program of China(National Basic Research Program of China); SOA project; 863 Program(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Basic Research Program of China (grant No. 2013CB955700), the SOA project (GASI-03-01-02-05), and the 863 Program (2012AA092003). R. Z. was supported by NSFC (41376132) and the Fundamental Research Funds for the Central Universities (2012121052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MC, 2001, MICROB ECOL, V42, P407, DOI 10.1007/s00248-001-0015-y; Anderson MJ, 2004, MAR ECOL PROG SER, V272, P33, DOI 10.3354/meps272033; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Brussaard CPD, 2008, DEEP-SEA RES PT II, V55, P752, DOI 10.1016/j.dsr2.2007.12.034; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; De Corte D, 2012, ISME J, V6, P1566, DOI 10.1038/ismej.2011.214; De Corte D, 2010, ISME J, V4, P1431, DOI [10.1038/ISMEJ.2010.65, 10.1038/ismej.2010.65]; FIEDLER PC, 1991, LIMNOL OCEANOGR, V36, P1834, DOI 10.4319/lo.1991.36.8.1834; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; Hwang CY, 2002, AQUAT MICROB ECOL, V30, P1, DOI 10.3354/ame030001; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; Li Y, 2014, BIOGEOSCIENCES, V11, P2531, DOI 10.5194/bg-11-2531-2014; Magagnini M, 2007, DEEP-SEA RES PT I, V54, P1209, DOI 10.1016/j.dsr.2007.05.006; Magiopoulos I, 2012, DEEP-SEA RES PT I, V66, P1, DOI 10.1016/j.dsr.2012.03.009; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Weinbauer MG, 1997, AQUAT MICROB ECOL, V13, P225, DOI 10.3354/ame013225; WEINBAUER MG, 1993, APPL ENVIRON MICROB, V59, P4074, DOI 10.1128/AEM.59.12.4074-4082.1993; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yang YH, 2014, AQUAT MICROB ECOL, V71, P193, DOI 10.3354/ame01677; Yang YH, 2010, AQUAT MICROB ECOL, V60, P233, DOI 10.3354/ame01428	39	18	20	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111634	10.1371/journal.pone.0111634	http://dx.doi.org/10.1371/journal.pone.0111634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365318	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100092
J	Llana, MN; Sarnacki, SH; Castaneda, MDA; Pustovrh, MC; Gartner, AS; Buzzola, FR; Cerquetti, MC; Giacomodonato, MN				Noto Llana, Mariangeles; Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Carolina Pustovrh, Maria; Sonia Gartner, Alejandra; Roxana Buzzola, Fernanda; Cristina Cerquetti, Maria; Nancy Giacomodonato, Monica			Salmonella enterica Serovar Enteritidis Enterocolitis during Late Stages of Gestation Induces an Adverse Pregnancy Outcome in the Murine Model	PLOS ONE			English	Article							INFECTION; TYPHIMURIUM; EXPRESSION; MICE; INFLAMMATION; MECHANISMS; RESISTANCE; INDUCTION; APOPTOSIS; PATHOLOGY	Foodborne diseases caused by Salmonella enterica serovar Enteritidis (S. Enteritidis) are a significant health problem. Pregnancy, state of immunological tolerance, is a predisposing condition for the development of infections with intracellular pathogens. Salmonella species can cause pregnancy complications such as chorioamnionitis, transplacental fetal infection, pre term labor, abortions, neonatal and maternal septicemia. However, the specific mechanisms by which Salmonella infections trigger these alterations are not clear. In the present work, using a self-limiting enterocolitis murine model, we show that the ingestion of a low dose of S. Enteritidis at late stages of pregnancy (day 15 of gestation) is sufficient to induce massive maternal infection. We found that Salmonella infection leads to 40% of pre term delivery, 33% of abortion and fetal growth restriction. Placental dysfunction during S. Enteritidis enterocolitis was confirmed through cellular infiltration and hypoxia markers (MPO activity and COX-1 and COX-2 expression, respectively). Apoptosis in placental tissue due to Salmonella infection was also evident at day 18 of gestation when investigated by morphometric procedure, DNA fragmentation and Fas/FasL expression. Also, the expression of IFN-gamma, TNF-alpha, IL-17 and IL-10 was up regulated in response to Salmonella not only in placenta, but also in amniotic fluid and maternal serum. Altogether, our results demonstrate that S. Enteritidis enterocolitis during late stages of gestation causes detrimental effect on pregnancy outcome.	[Noto Llana, Mariangeles; Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Sonia Gartner, Alejandra; Roxana Buzzola, Fernanda; Cristina Cerquetti, Maria; Nancy Giacomodonato, Monica] Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, Consejo Nacl Invest Cient & Tecn, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina; [Carolina Pustovrh, Maria] Univ Valle, Dept Morfol, Cali, Colombia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad del Valle	Giacomodonato, MN (corresponding author), Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, Consejo Nacl Invest Cient & Tecn, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina.	monicagiaco@yahoo.com.ar	Buzzola, Fernanda/AAC-3352-2019	Buzzola, Fernanda/0000-0001-5900-4901; PUSTOVRH, MARIA CAROLINA/0000-0002-2909-1941	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP) [GI 11220110100911]; Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT) [20020120200021BA, 20020130200189BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP); Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT)	This work was supported in part by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 2012-2014 GI 11220110100911) (http://www.conicet.gov.ar) (to MNG) and Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT 20020120200021BA and 20020130200189BA) (http://www.uba.ar) (to MNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo OM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-122; AWADALLA SG, 1985, OBSTET GYNECOL, V65, pS30; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bennett SD, 2012, SURVEILLANCE FOODBOR; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Cerquetti MC, 2008, MICROBES INFECT, V10, P1431, DOI 10.1016/j.micinf.2008.08.008; Donnet-Hughes A, 2010, P NUTR SOC, V69, P407, DOI 10.1017/S0029665110001898; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Erel CT, 2001, INT J GYNECOL OBSTET, V73, P229, DOI 10.1016/S0020-7292(01)00373-3; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Font-Nieves M, 2012, J BIOL CHEM, V287, P6454, DOI 10.1074/jbc.M111.327874; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; HEDRIANA HL, 1995, J REPROD MED, V40, P157; Hovsepian E, 2010, SHOCK, V34, P60, DOI 10.1097/SHK.0b013e3181cdc398; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Krishnan L, 1996, J IMMUNOL, V156, P644; Kusakabe K, 2005, J REPROD DEVELOP, V51, P333, DOI 10.1262/jrd.16086; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; LUFT BJ, 1982, INFECT IMMUN, V38, P1164, DOI 10.1128/IAI.38.3.1164-1171.1982; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Negi VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009139; Nguyen T, 2013, PLACENTA, V34, P765, DOI 10.1016/j.placenta.2013.06.003; Llana MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082588; Llana MN, 2012, INFECT IMMUN, V80, P2231, DOI 10.1128/IAI.00324-12; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; Sarr D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-45; Schloesser RL, 2004, SCAND J INFECT DIS, V36, P773, DOI 10.1080/00365540410020802a; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.010; Whitehead CL, 2014, EXPERT REV MOL DIAGN, V14, P509, DOI 10.1586/14737159.2014.915749; Zhou HR, 2000, TOXICOL SCI, V53, P253, DOI 10.1093/toxsci/53.2.253	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111282	10.1371/journal.pone.0111282	http://dx.doi.org/10.1371/journal.pone.0111282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365504	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100059
J	Salehzadeh-Yazdi, A; Asgari, Y; Saboury, AA; Masoudi-Nejad, A				Salehzadeh-Yazdi, Ali; Asgari, Yazdan; Saboury, Ali Akbar; Masoudi-Nejad, Ali			Computational Analysis of Reciprocal Association of Metabolism and Epigenetics in the Budding Yeast: A Genome-Scale Metabolic Model (GSMM) Approach	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; EXPRESSION DATA; AMINO TERMINI; HISTONE H2A; NETWORK; RECONSTRUCTION; INTEGRATION; VALIDATION; OPTIMALITY	Metaboloepigenetics is a newly coined term in biological sciences that investigates the crosstalk between epigenetic modifications and metabolism. The reciprocal relation between biochemical transformations and gene expression regulation has been experimentally demonstrated in cancers and metabolic syndromes. In this study, we explored the metabolism-histone modifications crosstalk by topological analysis and constraint-based modeling approaches in the budding yeast. We constructed nine models through the integration of gene expression data of four mutated histone tails into a genome-scale metabolic model of yeast. Accordingly, we defined the centrality indices of the lowly expressed enzymes in the undirected enzyme-centric network of yeast by CytoHubba plug-in in Cytoscape. To determine the global effects of histone modifications on the yeast metabolism, the growth rate and the range of possible flux values of reactions, we used constraint-based modeling approach. Centrality analysis shows that the lowly expressed enzymes could affect and control the yeast metabolic network. Besides, constraint-based modeling results are in a good agreement with the experimental findings, confirming that the mutations in histone tails lead to non-lethal alterations in the yeast, but have diverse effects on the growth rate and reveal the functional redundancy.	[Salehzadeh-Yazdi, Ali; Asgari, Yazdan; Saboury, Ali Akbar; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran	University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Salehzadeh-Yazdi, Ali/J-9510-2019; Masoudi-Nejad, Ali/ABH-2078-2021; asgari, yazdan/AAL-9037-2020; Saboury, Ali Akbar/L-6136-2019	Salehzadeh-Yazdi, Ali/0000-0002-1678-0051; asgari, yazdan/0000-0001-6993-6956; 				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Barrett Tanya, 2006, V338, P175; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choi JK, 2010, IET SYST BIOL, V4, P289, DOI 10.1049/iet-syb.2010.0008; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Colyer Hilary A A, 2012, Methods Mol Biol, V863, P319, DOI 10.1007/978-1-61779-612-8_20; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Gossett AJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002771; Gruning NM, 2010, TRENDS BIOCHEM SCI, V35, P220, DOI 10.1016/j.tibs.2009.12.001; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Herrgard MJ, 2006, GENOME RES, V16, P627, DOI 10.1101/gr.4083206; Horne AB, 2004, BIOINFORMATICS, V20, P2050, DOI 10.1093/bioinformatics/bth199; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r78; Kim JA, 2012, P NATL ACAD SCI USA, V109, P5779, DOI 10.1073/pnas.1203453109; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2005, BIOPHYS J, V88, pL7, DOI 10.1529/biophysj.104.055723; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Nag R, 2010, NUCLEIC ACIDS RES, V38, P1450, DOI 10.1093/nar/gkp1074; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; SCHUSTER T, 1986, CELL, V45, P445, DOI 10.1016/0092-8674(86)90330-2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2009, EPIGENETICS-US, V4, P43, DOI 10.4161/epi.4.1.7603; Tang HL, 2012, BIOCHEM BIOPH RES CO, V424, P7, DOI 10.1016/j.bbrc.2012.06.085; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Yun J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00163; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	55	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111686	10.1371/journal.pone.0111686	http://dx.doi.org/10.1371/journal.pone.0111686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365344	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100106
J	Burke-Gaffney, A; Svermova, T; Mumby, S; Finney, SJ; Evans, TW				Burke-Gaffney, Anne; Svermova, Tatiana; Mumby, Sharon; Finney, Simon J.; Evans, Timothy W.			Raised Plasma Robo4 and Cardiac Surgery-Associated Acute Kidney Injury	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ROUNDABOUT RECEPTOR; INFLAMMATORY RESPONSE; BARRIER DYSFUNCTION; MAGIC ROUNDABOUT; BIOMARKERS; ANGIOPOIETIN-2; ACTIVATION; EXPRESSION; NETWORK	Objective: Endothelial dysfunction associated with systemic inflammation can contribute to organ injury/failure following cardiac surgery requiring cardiopulmonary bypass (CPB). Roundabout protein 4 (Robo4), an endothelial-expressed transmembrane receptor and regulator of cell activation, is an important inhibitor of endothelial hyper-permeability. We investigated the hypothesis that plasma levels of Robo4 are indicative of organ injury, in particular acute kidney injury (AKI), after cardiac surgery. Methods: Patients (n = 32) undergoing elective cardiac surgery with CPB were enrolled, prospectively. Plasma Robo4 concentrations were measured pre-, 2 and 24 h post-operatively, using a commercially available ELISA. Plasma and endothelial markers of inflammation [interleukin (IL) -6, -8, -10: von Willibrand factor (vWF) and angiopoeitin-2 (Ang-2)] and the AKI marker, neutrophil gelatinase-associated lipocalin (NGAL), were also measured by ELISA. Results: Plasma Robo4 increased significantly (p<0.001) from pre-operative levels of 2515 +/- 904 pg/ml to 4473 +/- 1915 pg/ml, 2 h after surgery; and returned to basal levels (2682 +/- 979 pg/ml) by 24 h. Plasma cytokines, vWF and NGAL also increased 2 h post-operatively and remained elevated at 24 h. Ang-2 increased 24 h post-operatively, only. There was a positive, significant correlation (r = 0.385, p = 0.0298) between Robo-4 and IL-10, but not other cytokines, 2 h post-operatively. Whilst raised Robo4 did not correlate with indices of lung dysfunction or other biomarkers of endothelial activation; there was a positive, significant correlation between raised (2 h) plasma NGAL and Robo4 (r = 0.4322, p = 0.0135). When patients were classed as AKI or non-AKI either using NGAL cut-off of 150 ng/ml, or the AKI Network (AKIN) clinical classification; plasma Robo4 was significantly higher (p = 0.0073 and 0.003, respectively) in AKI vs. non-AKI patients (NGAL cut-off: 535062191 ng/ml, n = 16 vs. 359561068 pg/ml, n = 16; AKIN: 6546 pg/ml, IQR 5025-8079, n = 6; vs. 3727 pg/ml, IQR 1962-3727, n = 26) subjects. Conclusion: Plasma Robo4 levels are increased, transiently, following cardiac surgery requiring CPB; and higher levels in patients with AKI suggest a link between endothelial dysregulation and onset of AKI.	[Burke-Gaffney, Anne; Svermova, Tatiana; Mumby, Sharon] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst Div, London, England; [Finney, Simon J.; Evans, Timothy W.] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Resp Biomed Res Unit, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Burke-Gaffney, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst Div, London, England.	a.burke-gaffney@imperial.ac.uk	Finney, Simon/A-2168-2012	Finney, Simon/0000-0001-8219-1952	British Heart Foundation PhD studentship [FS/14/6/30573]; Royal Brompton Hospital; Doverdale Trust; NIHR Respiratory Diseases Biomedical Research Unit; Rosetrees Trust; British Heart Foundation [FS/14/6/30573] Funding Source: researchfish	British Heart Foundation PhD studentship; Royal Brompton Hospital; Doverdale Trust; NIHR Respiratory Diseases Biomedical Research Unit; Rosetrees Trust(Rosetrees Trust); British Heart Foundation(British Heart Foundation)	Tatiana Svermova is the recipient of a British Heart Foundation PhD studentship (FS/14/6/30573). The authors also thank the Royal Brompton Hospital, Doverdale Trust and NIHR Respiratory Diseases Biomedical Research Unit; and the Rosetrees Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak R, 2014, J STRUCT BIOL, V186, P283, DOI 10.1016/j.jsb.2014.02.019; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Blockus H, 2014, CURR OPIN NEUROBIOL, V27, P82, DOI 10.1016/j.conb.2014.03.003; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheng Y, 2013, CURR EYE RES, V38, P128, DOI 10.3109/02713683.2012.738844; Clajus C, 2012, CYTOKINE, V60, P352, DOI 10.1016/j.cyto.2012.04.002; Coleman HA, 2010, DEVELOPMENT, V137, P2417, DOI 10.1242/dev.047993; Costa ELV, 2013, CURR OPIN CRIT CARE, V19, P16, DOI 10.1097/MCC.0b013e32835c50b1; Creagh-Brown BC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/496031; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Giuliano JS, 2008, INTENS CARE MED, V34, P1851, DOI 10.1007/s00134-008-1174-9; Gorbunova EE, 2013, ANTIVIR RES, V99, P108, DOI 10.1016/j.antiviral.2013.05.004; Goto-Koshino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050849; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Jouan J, 2012, J THORAC CARDIOV SUR, V144, P467, DOI 10.1016/j.jtcvs.2011.12.022; Klinger JR, 2006, EXP CELL RES, V312, P401, DOI 10.1016/j.yexcr.2005.11.001; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Maccallum NS, 2014, CHEST; Mao H, 2013, CARDIORENAL MED, V3, P178, DOI 10.1159/000353134; Moreira RS, 2014, AM J PHYSIOL-REG I, V307, pR514, DOI 10.1152/ajpregu.00445.2013; Mulik S, 2011, J IMMUNOL, V186, P7195, DOI 10.4049/jimmunol.1100014; Ning YY, 2011, TOXICOLOGY, V283, P32, DOI 10.1016/j.tox.2011.01.026; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Panagiotopoulos I, 2010, J CLIN LAB ANAL, V24, P389, DOI 10.1002/jcla.20416; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pintar Tatjana, 2003, Anesthesiol Clin North Am, V21, P453, DOI 10.1016/S0889-8537(03)00039-7; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Tsang GMK, 1998, EUR J CARDIO-THORAC, V13, P385, DOI 10.1016/S1010-7940(98)00022-0; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Zhang XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002461; Zhao HL, 2014, J IMMUNOL, V192, P385, DOI 10.4049/jimmunol.1302021	39	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111459	10.1371/journal.pone.0111459	http://dx.doi.org/10.1371/journal.pone.0111459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360813	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700104
J	Chen, QH; Chen, K; Guo, GJ; Li, F; Chen, C; Wang, S; Nalepa, G; Huang, SL; Chen, JL				Chen, Qinghuang; Chen, Ke; Guo, Guijie; Li, Fang; Chen, Chao; Wang, Song; Nalepa, Grzegorz; Huang, Shile; Chen, Ji-Long			A Critical Role of CDKN3 in Bcr-Abl-Mediated Tumorigenesis	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA-CELLS; KINASE-ASSOCIATED PHOSPHATASE; CHRONIC MYELOID-LEUKEMIA; PROTEIN PHOSPHATASE; MOLECULAR PATHWAYS; DOWN-REGULATION; CANCER CELLS; APOPTOSIS; CYCLE; KAP	CDKN3 (cyclin-dependent kinase inhibitor 3), a dual specificity protein phosphatase, dephosphorylates cyclin-dependent kinases (CDKs) and thus functions as a key negative regulator of cell cycle progression. Deregulation or mutations of CDNK3 have been implicated in various cancers. However, the role of CDKN3 in Bcr-Abl-mediated chronic myelogenous leukemia (CML) remains unknown. Here we found that CDKN3 acts as a tumor suppressor in Bcr-Abl-mediated leukemogenesis. Overexpression of CDKN3 sensitized the K562 leukemic cells to imanitib-induced apoptosis and dramatically inhibited K562 xenografted tumor growth in nude mouse model. Ectopic expression of CDKN3 significantly reduced the efficiency of Bcr-Abl-mediated transformation of FDCP1 cells to growth factor independence. In contrast, depletion of CDKN3 expression conferred resistance to imatinib-induced apoptosis in the leukemic cells and accelerated the growth of xenograph leukemia in mice. In addition, we found that CDKN3 mutant (CDKN3-C140S) devoid of the phosphatase activity failed to affect the K562 leukemic cell survival and xenografted tumor growth, suggesting that the phosphatase of CDKN3 was required for its tumor suppressor function. Furthermore, we observed that overexpression of CDKN3 reduced the leukemic cell survival by dephosphorylating CDK2, thereby inhibiting CDK2-dependent XIAP expression. Moreover, overexpression of CDKN3 delayed G1/S transition in K562 leukemic cells. Our results highlight the importance of CDKN3 in Bcr-Abl-mediated leukemogenesis, and provide new insights into diagnostics and therapeutics of the leukemia.	[Chen, Qinghuang; Chen, Chao; Wang, Song; Chen, Ji-Long] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China; [Chen, Ke; Guo, Guijie; Li, Fang; Chen, Ji-Long] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Chen, JL (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China.	chenjl@im.ac.cn	Huang, Shile/I-1632-2019; Chen, Ji-Long/AAJ-2134-2021	Huang, Shile/0000-0002-3239-1072; Chen, Ji-Long/0000-0002-4274-0563; Nalepa, Grzegorz/0000-0002-5779-9103; Lab, Nalepa/0000-0002-7560-1906; Chao, Chen/0000-0002-3191-0838; Guo, Guijie/0000-0002-9031-1915	National Basic Research Program (973) of China [2015CB910502]; National Key Technologies Research and Development Program of China [2013ZX10004-611]; Natural Science Foundation of China [U1305212, 81171943, 81472611]; Chinese Academy of Sciences [KJZD-EW-L01-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068371] Funding Source: NIH RePORTER	National Basic Research Program (973) of China(National Basic Research Program of China); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program (973) of China (2015CB910502), National Key Technologies Research and Development Program of China (2013ZX10004-611), Natural Science Foundation of China (U1305212, 81171943, 81472611), Intramural grant of the Chinese Academy of Sciences (KJZD-EW-L01-3) to JLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Chen Y, 2010, LEUKEMIA, V24, P1545, DOI 10.1038/leu.2010.143; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; DEMETRICK DJ, 1995, CYTOGENET CELL GENET, V69, P190, DOI 10.1159/000133960; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Dong FQ, 2006, CANCER BIOL THER, V5, P165, DOI 10.4161/cbt.5.2.2316; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Guo G, 2014, ONCOGENE; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Li H., 2014, ONCOGENE; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MANDANAS RA, 1992, LEUKEMIA, V6, P796; Nalepa G, 2013, J CELL BIOL, V201, P997, DOI 10.1083/jcb.201205125; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Nimmanapalli R, 2001, CLIN CANCER RES, V7, P350; Qiu XX, 2012, NEOPLASIA, V14, P547, DOI 10.1596/neo.12230; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Silva KL, 2013, LEUKEMIA RES, V37, P1350, DOI 10.1016/j.leukres.2013.06.014; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Wang S, 2012, J BIOL CHEM, V287, P9804, DOI 10.1074/jbc.M111.312959; Wei HT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003845; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wright RHG, 2012, GENE DEV, V26, P1972, DOI 10.1101/gad.193193.112; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yeh CT, 2000, CANCER RES, V60, P4697; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478	44	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111611	10.1371/journal.pone.0111611	http://dx.doi.org/10.1371/journal.pone.0111611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360622	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700128
J	Hou, XG; Wang, C; Wang, SY; Yang, WF; Ma, ZQ; Wang, YL; Li, CQ; Li, M; Zhang, XP; Zhao, XM; Sun, Y; Song, J; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, SH; Chen, L				Hou, Xinguo; Wang, Chuan; Wang, Shaoyuan; Yang, Weifang; Ma, Zeqiang; Wang, Yulian; Li, Chengqiao; Li, Mei; Zhang, Xiuping; Zhao, Xiangmin; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Shihong; Chen, Li			Fluctuation between Fasting and 2-H Postload Glucose State Is Associated with Glomerular Hyperfiltration in Newly Diagnosed Diabetes Patients with HbA1c < 7%	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; HBA(1C) VARIABILITY; RISK; NEPHROPATHY; GLYCEMIA	Objective: To investigate whether fluctuations between the fasting and 2-h postload glucose ([2-hPBG]-fasting blood glucose [FBG]) states are associated with glomerular hyperfiltration (GHF) in middle-aged and elderly Chinese patients with newly diagnosed diabetes. Design and Methods: In this study, we included 679 newly diagnosed diabetes patients who were >= 40 years old. All the subjects were divided into two groups; those with HbA1c<7% and >= 7%. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the glomerular filtration rate (GFR). GHF was defined as an eGFR >= the 90th percentile. First, a multiple linear regression analysis was used to estimate the association of 2-hPBG-FBG with eGFR. Then, a generalized additive model was used to explore the possible nonlinear relationship between 2-hPBG-FBG and eGFR. Next, the 2-hPBG-FBG values were divided into four groups as follows: 0-36, 36-72, 72-108 and >= 108 mg/dl. Finally, a multiple logistic regression analysis was used to investigate the association of 2-hPBG-FBG with the risk of GHF. Results: For the group with HbA1c<7%, the eGFR and the percentage of GHF were significantly higher compared with the group with HbA1c >= 7%. After adjusting for age, gender, body mass index (BMI), systolic blood pressure (BP), diastolic BP, fasting insulin, cholesterol, triglycerides, smoking, drinking and glycated hemoglobin (HbA1c), 2-hPBG-FBG was significantly associated with increased eGFR and an increased risk of GHF (the GHF risk increased by 64.9% for every 36.0 mg/dl [2.0 mmol/L] 2-hPBG-FBG increase) only in those patients with HbA1c<7%. Additionally, 2-hPBG-FBG and eGFR showed a nonlinear association (P<0.001). Conclusions: Increased fluctuations between the fasting and 2-h postload glucose states are closely associated with increased eGFR and an increased risk of GHF in newly diagnosed diabetes patients with HbA1c<7%.	[Hou, Xinguo; Wang, Chuan; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Wang, Shaoyuan; Yang, Weifang] Shandong Univ, Lukang Hosp Jining, Jinan, Shandong, Peoples R China; [Ma, Zeqiang] China Natl Heavy Duty Truck Grp Corp Hosp, Jinan, Shandong, Peoples R China; [Wang, Yulian; Li, Chengqiao; Li, Mei] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Zhang, Xiuping; Zhao, Xiangmin] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China; [Chen, Shihong] Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China.	wangchuansdu.edu@163.com		hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association [12030420342]	Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association (12030420342). The funders had no roles in the study design, data collection or analysis, in the decision to publish, or in the preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; BRENNER BM, 1981, ACTA ENDOCRINOL-COP, V97, P7; BRUCE R, 1994, DIABETES RES CLIN PR, V25, P155, DOI 10.1016/0168-8227(94)90003-5; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Ge QM, 2010, ACTA DIABETOL, V47, pS97, DOI 10.1007/s00592-009-0140-5; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Heine RJ, 2004, DIABETIC MED, V21, P208, DOI 10.1111/j.1464-5491.2004.01149.x; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Keller CK, 1996, J AM SOC NEPHROL, V7, P2627; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; LEBOVITZ HE, 1990, DIABETES CARE, V13, P1186, DOI 10.2337/diacare.13.11.1186; LEE KU, 1995, AM J KIDNEY DIS, V26, P722, DOI 10.1016/0272-6386(95)90434-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Wang Huanjun, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P818, DOI 10.3969/j.issn.1672-7347.2013.08.010; Wang JS, 2013, CHIN J INTEGR MED, V19, P217, DOI 10.1007/s11655-012-1093-z; Zelmanovitz T, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-10	30	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111173	10.1371/journal.pone.0111173	http://dx.doi.org/10.1371/journal.pone.0111173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360521	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700070
J	Liu, LL; Dong, XS				Liu, Liangliang; Dong, Xuesen			Complex Impacts of PI3K/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells	PLOS ONE			English	Article							SPLICE VARIANTS; AKT; AMPLIFICATION; PROGRESSION; PROTEIN; GROWTH; POTENT; MECHANISM; LY294002; 3-KINASE	Background: Androgen deprivation therapy (ADT) is the first-line treatment to metastatic prostate cancer (PCa). However, sustained expression and function of the androgen receptor (AR) gene contribute to the progression of castration resistant prostate cancers (CRPC). Additionally, tumors can adapt the PI3K/AKT survival pathway to escape ADT. Co-targeting AR and PI3K/AKT signaling has been proposed to be a more effective therapeutic means for CRPC patients. Many clinical trials are ongoing to test whether PI3K/AKT inhibitors are beneficial to PCa patients. However whether these inhibitors have any impacts on the expressions of full length AR (AR-FL) and its splice variant (AR-V7) remains unclear. Methods: Four human prostate cancer cell lines (LNCaP, LNCaP95, VCaP and 22Rv1) with different genetic backgrounds were treated with five PI3K/AKT inhibitors (LY294002, Wortmannin, BKM120, AKTi and AZD5363) and or AKT siRNA. AR and AR-V7 protein and mRNA levels were measured by immunoblotting and real-time PCR assays. AR gene transcription initiation, alternative RNA splicing and AR mRNA degradation rates were also determined. Results: PI3K/AKT inhibitors had various impacts on AR protein expressions primarily through alterations of AR gene transcription initiation and RNA splicing. However, these effects remained unchanged in the presence RNA silencing of the AKT genes. Conclusion: PI3K/AKT inhibitors have off-target effects on AR gene expression in prostate cancer cells, which shall be considered when applying these inhibitors to PCa patients, particularly patients under ADT treatment.	[Liu, Liangliang; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Dong, Xuesen] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of British Columbia; University of Toronto	Dong, XS (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	xdong@prostatecentre.com	Dong, Xuesen/AGF-9228-2022		Canadian Institutes of Health Research [MOP-137007]; Rising Star Award from Prostate Cancer Canada [RS2013-58]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rising Star Award from Prostate Cancer Canada	This work received an operating grant from Canadian Institutes of Health Research (MOP-137007) and a Rising Star Award from Prostate Cancer Canada (RS2013-58) to Xuesen Dong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Velasco MA, 2014, CARCINOGENESIS; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; HOBISCH A, 1995, CANCER RES, V55, P3068; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Linja MJ, 2001, CANCER RES, V61, P3550; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Liu LL, 2013, J CLIN ENDOCR METAB, V98, P218, DOI 10.1210/jc.2012-2451; Lorente D, 2014, EUR J CANCER, V50, P753, DOI 10.1016/j.ejca.2013.12.004; Marcelli M, 2000, CANCER RES, V60, P944; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092714; Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	42	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e108780	10.1371/journal.pone.0108780	http://dx.doi.org/10.1371/journal.pone.0108780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360799	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700006
J	Pollmacher, J; Figge, MT				Pollmaecher, Johannes; Figge, Marc Thilo			Agent-Based Model of Human Alveoli Predicts Chemotactic Signaling by Epithelial Cells during Early Aspergillus fumigatus Infection	PLOS ONE			English	Article							FUNGAL-INFECTIONS; MACROPHAGES; TIME; EPIDEMIOLOGY; NEUTROPHILS; DEFENSE; NUMBERS; CONIDIA; SINGLE; SPORES	Aspergillus fumigatus is one of the most important human fungal pathogens, causing life-threatening diseases. Since humans inhale hundreds to thousands of fungal conidia every day, the lower respiratory tract is the primary site of infection. Current interaction networks of the innate immune response attribute fungal recognition and detection to alveolar macrophages, which are thought to be the first cells to get in contact with the fungus. At present, these networks are derived from in vitro or in situ assays, as the peculiar physiology of the human lung makes in vivo experiments, including imaging on the cell-level, hard to realize. We implemented a spatio-temporal agent-based model of a human alveolus in order to perform in silico experiments of a virtual infection scenario, for an alveolus infected with A. fumigatus under physiological conditions. The virtual analog captures the three-dimensional alveolar morphology consisting of the two major alveolar epithelial cell types and the pores of Kohn as well as the dynamic process of respiration. To the best of our knowledge this is the first agent-based model of a dynamic human alveolus in the presence of respiration. A key readout of our simulations is the first-passage-time of alveolar macrophages, which is the period of time that elapses until the first physical macrophage-conidium contact is established. We tested for random and chemotactic migration modes of alveolar macrophages and varied their corresponding parameter sets. The resulting first-passage-time distributions imply that randomly migrating macrophages fail to find the conidium before the start of germination, whereas guidance by chemotactic signals derived from the alveolar epithelial cell associated with the fungus enables a secure and successful discovery of the pathogen in time.	[Pollmaecher, Johannes; Figge, Marc Thilo] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany; [Pollmaecher, Johannes; Figge, Marc Thilo] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Figge, MT (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany.	thilo.figge@hki-jena.de	Figge, Marc Thilo/J-7547-2017	Figge, Marc Thilo/0000-0002-4044-9166	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG) [CRC/TR124 FungiNet]	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the excellence graduate school Jena School for Microbial Communication (JSMC: https://www.jsmc.uni-jena.de/) and the CRC/TR124 FungiNet (http://www.funginet.de/), Project B4, which are both funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashazy I, 2008, INHAL TOXICOL, V20, P611, DOI [10.1080/08958370801915291, 10.1080/08958370801915291 ]; Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; BASTACKY J, 1992, J APPL PHYSIOL, V73, P88, DOI 10.1152/jappl.1992.73.1.88; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; CHARNICK SB, 1991, B MATH BIOL, V53, P591; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Entschladen F, 2005, EXP CELL RES, V307, P418, DOI 10.1016/j.yexcr.2005.03.029; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; GLASGOW JE, 1989, AM REV RESPIR DIS, V139, P320, DOI 10.1164/ajrccm/139.2.320; HANSEN JE, 1975, J APPL PHYSIOL, V38, P990, DOI 10.1152/jappl.1975.38.6.990; Harvey I, 1997, FROM ANIM ANIMAT, P67; Hasenberg M, 2013, IMMUNOL REV, V251, P189, DOI 10.1111/imr.12020; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Horn Fabian, 2012, Front Microbiol, V3, P108, DOI 10.3389/fmicb.2012.00108; Hunniger K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003479; KAWAKAMI M, 1987, J APPL PHYSIOL, V63, P1866, DOI 10.1152/jappl.1987.63.5.1866; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Latge JP, 2009, ASPERGILLUS FUMIGATU; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Mokhtari Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080808; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Tokarski C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00129; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111630	10.1371/journal.pone.0111630	http://dx.doi.org/10.1371/journal.pone.0111630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360787	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700132
J	Saha, M; Rempt, M; Stratil, SB; Wahl, M; Pohnert, G; Weinberger, F				Saha, Mahasweta; Rempt, Martin; Stratil, Stephanie B.; Wahl, Martin; Pohnert, Georg; Weinberger, Florian			Defence Chemistry Modulation by Light and Temperature Shifts and the Resulting Effects on Associated Epibacteria of Fucus vesiculosus	PLOS ONE			English	Article							BACTERIAL COMMUNITY; CHEMICAL DEFENSE; DMSP; SURFACE; DIMETHYLSULFONIOPROPIONATE; SETTLEMENT; ECOLOGY	The goals of this study were (1) to investigate whether Fucus vesiculosus regulates the production of its antifouling defence chemicals against epibacteria in response to light limitation and temperature shifts and (2) to investigate if different surface concentrations of defence compounds shape epibacterial communities. F. vesiculosus was incubated in indoor mesocosms at five different temperature conditions (5 to 25 degrees C) and in outdoor mesocosms under six differently reduced sunlight conditions (0 to 100%), respectively. Algal surface concentrations of previously identified antifouling compounds - dimethylsulphopropionate (DMSP), fucoxanthin and proline - were determined and the bacterial community composition was characterized by in-depth sequencing of the 16S-rRNA gene. Altogether, the effect of different treatment levels upon defence compound concentrations was limited. Under all conditions DMSP alone appeared to be sufficiently concentrated to warrant for at least a partial inhibitory action against epibiotic bacteria of F. vesiculosus. In contrast, proline and fucoxanthin rarely reached the necessary concentration ranges for self-contained inhibition. Nonetheless, in both experiments along with the direct influence of temperature and light, all three compounds apparently affected the overall bacterial community composition associated with F. vesiculosus since tendencies for insensitivity towards all three compounds were observed among bacterial taxa that typically dominate those communities. Given that the concentrations of at least one of the compounds (in most cases DMSP) were always high enough to inhibit bacterial settlement, we conclude that the capacity of F. vesiculosus for such defence will hardly be compromised by shading or warming to temperatures up to 25 degrees C.	[Saha, Mahasweta; Stratil, Stephanie B.; Wahl, Martin; Weinberger, Florian] Helmholtz Zentrum Ozeanforsch GEOMAR, Dept Benth Ecol, Kiel, Germany; [Rempt, Martin; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem Bioorgan Analyt, Jena, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Friedrich Schiller University of Jena	Saha, M (corresponding author), Helmholtz Zentrum Ozeanforsch GEOMAR, Dept Benth Ecol, Kiel, Germany.	sahamahasweta@gmail.com	Weinberger, Florian/O-5554-2015; Wahl, Martin/D-2038-2016; Pohnert, Georg/D-3721-2013; Saha, Mahasweta/K-4867-2014	Weinberger, Florian/0000-0003-3366-6880; Wahl, Martin/0000-0001-8703-3857; Pohnert, Georg/0000-0003-2351-6336; Saha, Mahasweta/0000-0001-9308-1054	German academic exchange service (DAAD) [A077 1469]; Volkswagen Foundation; DFG; DFG cluster of excellence "The Future Ocean''	German academic exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); DFG cluster of excellence "The Future Ocean''(German Research Foundation (DFG))	This study was supported by a PhD scholarship (A077 1469) to MS from the German academic exchange service (DAAD). MR acknowledges funding by the Volkswagen Foundation and the DFG. FW was supported financially by the DFG cluster of excellence "The Future Ocean''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Bornland T, 1989, CHLOROPHYTE ALGAE PR, P37; Brock E, 2007, MAR ECOL PROG SER, V337, P165, DOI 10.3354/meps337165; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Cronin G, 2001, CRC MAR SCI, P325; Dickschat JS, 2010, CHEMBIOCHEM, V11, P417, DOI 10.1002/cbic.200900668; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; Ferreira JG, 2014, NEW PHYTOL, DOI [10.1111/nph.12749, DOI 10.1111/NPH.12749)]; Fisher LD, 1993, SAMPLE SIZES OBSERVA, P844; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Jennings JG, 1997, OECOLOGIA, V109, P461, DOI 10.1007/s004420050106; Jormalainen V, 2009, OIKOS, V118, P713, DOI 10.1111/j.1600-0706.2008.17178.x; KARSTEN U, 1992, POLAR BIOL, V12, P603; Kasamatsu N, 2004, J PHYCOL, V40, P874, DOI 10.1111/j.1529-8817.2004.03122.x; Kim SJ, 2009, INT J SYST EVOL MICR, V59, P3030, DOI 10.1099/ijs.0.009134-0; Kirst GO, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P121; Lachnit T, 2010, BIOFOULING, V26, P247, DOI 10.1080/08927010903474189; Lyons DA, 2010, MAR ECOL PROG SER, V417, P51, DOI 10.3354/meps08818; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Nylund GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061291; Saha M, 2012, BIOFOULING, V28, P593, DOI 10.1080/08927014.2012.698615; Saha M, 2011, BIOFOULING, V27, P423, DOI 10.1080/08927014.2011.580841; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Spielmeyer A, 2010, J CHROMATOGR B, V878, P3238, DOI 10.1016/j.jchromb.2010.09.031; Stratil S, 2013, THESIS U KIEL KIEL; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; Sudatti DB, 2011, MAR BIOL, V158, P1439, DOI 10.1007/s00227-011-1660-4; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P306; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; VAS'KOVSKII V E, 1972, Khimiya Prirodnykh Soedinenii, V8, P596; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9; Weinberger F, 2011, MAR ECOL PROG SER, V427, P83, DOI 10.3354/meps09044	36	33	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e105333	10.1371/journal.pone.0105333	http://dx.doi.org/10.1371/journal.pone.0105333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360717	Green Published, Green Accepted, gold			2022-12-26	WOS:000343943700003
J	Thomson, G; Morgan, H; Crossland, N; Bauld, L; Dykes, F; Hoddinott, P				Thomson, Gill; Morgan, Heather; Crossland, Nicola; Bauld, Linda; Dykes, Fiona; Hoddinott, Pat		BIBS Team	Unintended Consequences of Incentive Provision for Behaviour Change and Maintenance around Childbirth	PLOS ONE			English	Article							FINANCIAL INCENTIVES; SMOKING-CESSATION; QUALITY; REWARDS; CARE; PAY	Financial (positive or negative) and non-financial incentives or rewards are increasingly used in attempts to influence health behaviours. While unintended consequences of incentive provision are discussed in the literature, evidence syntheses did not identify any primary research with the aim of investigating unintended consequences of incentive interventions for lifestyle behaviour change. Our objective was to investigate perceived positive and negative unintended consequences of incentive provision for a shortlist of seven promising incentive strategies for smoking cessation in pregnancy and breastfeeding. A multi-disciplinary, mixed-methods approach included involving two service-user mother and baby groups from disadvantaged areas with experience of the target behaviours as study co-investigators. Systematic reviews informed the shortlist of incentive strategies. Qualitative semi-structured interviews and a web-based survey of health professionals asked open questions on positive and negative consequences of incentives. The participants from three UK regions were a diverse sample with and without direct experience of incentive interventions: 88 pregnant women/recent mothers/partners/family members; 53 service providers; 24 experts/decision makers and interactive discussions with 63 conference attendees. Maternity and early years health professionals (n = 497) including doctors, midwives, health visitors, public health and related staff participated in the survey. Qualitative analysis identified ethical, political, cultural, social and psychological implications of incentive delivery at population and individual levels. Four key themes emerged: how incentives can address or create inequalities; enhance or diminish intrinsic motivation and wellbeing; have a positive or negative effect on relationships with others within personal networks or health providers; and can impact on health systems and resources by raising awareness and directing service delivery, but may be detrimental to other health care areas. Financial incentives are controversial and generated emotive and oppositional responses. The planning, design and delivery of future incentive interventions should evaluate unexpected consequences to inform the evidence for effectiveness, cost-effectiveness and future implementation.	[Thomson, Gill; Crossland, Nicola; Dykes, Fiona] Univ Cent Lancashire, Sch Hlth, Maternal & Infant Nutr & Nurture Unit MAINN, Preston PR1 2HE, Lancs, England; [Morgan, Heather] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Bauld, Linda; Hoddinott, Pat] Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland	University of Central Lancashire; University of Aberdeen; University of Stirling	Thomson, G (corresponding author), Univ Cent Lancashire, Sch Hlth, Maternal & Infant Nutr & Nurture Unit MAINN, Preston PR1 2HE, Lancs, England.	gthomson@uclan.ac.uk	Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko F/0000-0003-1738-4269; Dykes, Fiona/0000-0002-2728-7967; Thomson, Gill/0000-0003-3392-8182; Moran, Victoria Hall/0000-0003-3165-4448; Morgan, Heather/0000-0002-6118-8911	NIHR HTA Programme [10/31/02]; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish; Chief Scientist Office [HSRU2, NMAHP2] Funding Source: researchfish	NIHR HTA Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This report was commissioned by the NIHR HTA Programme as project number 10/31/02. http://www.nets.nihr.ac.uk/projects/hta/103102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BREASTF NHS BOARD RE; Ashcroft RE, 2011, HEALTH EXPECT, V14, P191, DOI 10.1111/j.1369-7625.2011.00664.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cahill K, 2008, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD004307.PUB3; Cahill K, 2008, COCHRANE DB SYST REV, V4; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub3; Cattaneo A, 2001, EUR J PUBLIC HEALTH, V11, P397, DOI 10.1093/eurpub/11.4.397; Chamberlain LB, 2006, J HUM LACT, V22, P94, DOI 10.1177/0890334405284226; Cinciripini PM, 2010, J CONSULT CLIN PSYCH, V78, P44, DOI 10.1037/a0018168; Coleman T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-167; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Edinburgh: Information Statistics Division, BREASTF STAT FIN YEA; Edinburgh: Information Statistics Division, DAT TABL BIRTHS SCOT; Fiszbein Ariel, 2009, 47603 WORLD BANK; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Frey B., 1997, NOT JUST MONEY EC TH; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Graham H, 2012, USING QUALITATIVE RE; Gulliver Suzy Bird, 2004, Med Health R I, V87, P9; Heil SH, 2008, ADDICTION, V103, P1009, DOI 10.1111/j.1360-0443.2008.02237.x; Hoddinott P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000504corr1; Hoddinott P, 2013, LANCET S3, V380, pS48, DOI DOI 10.1016/S0140-6736(13)60404-3; Hoddinott P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005524; Jepson RG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-538; Johnston M, 2010, J HEALTH SERV RES PO, V15, P131, DOI 10.1258/jhsrp.2010.010048; Kane R L, 2004, Evid Rep Technol Assess (Summ), P1; Kavanagh J, 2006, SYSTEMATIC REV EVIDE; Kavanagh J, 2009, INCENTIVES IMPROVE S; Marmot M, 2004, STATUS SYNDROME; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McAndrew F, 2012, INFANT FEEDING SURVE; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Morgan H, HLTH TECHNO IN PRESS; National Institute of Health and Clinical Excellence, 2010, US INC IMPR HLTH CIT; Park JD, 2012, PREV MED, V55, pS41, DOI 10.1016/j.ypmed.2012.06.013; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Pugh LC, 1998, APPL NURS RES, V11, P190, DOI 10.1016/S0897-1897(98)80318-2; Radley A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-343; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Schmied V, 2011, BIRTH-ISS PERINAT C, V38, P49, DOI 10.1111/j.1523-536X.2010.00446.x; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tappin DM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-113; Thaler R.H., 2021, NUDGE FINAL EDITION; Thomson G, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-22; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Volpe E M, 2000, J Hum Lact, V16, P196, DOI 10.1177/089033440001600303; Walsh RA, 1997, AM J PUBLIC HEALTH, V87, P1201, DOI 10.2105/AJPH.87.7.1201	53	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111322	10.1371/journal.pone.0111322	http://dx.doi.org/10.1371/journal.pone.0111322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25357121	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000050
J	Coluzzi, E; Colamartino, M; Cozzi, R; Leone, S; Meneghini, C; O'Callaghan, N; Sgura, A				Coluzzi, Elisa; Colamartino, Monica; Cozzi, Renata; Leone, Stefano; Meneghini, Carlo; O'Callaghan, Nathan; Sgura, Antonella			Oxidative Stress Induces Persistent Telomeric DNA Damage Responsible for Nuclear Morphology Change in Mammalian Cells	PLOS ONE			English	Article							HUMAN PRIMARY FIBROBLASTS; CHROMOSOME INSTABILITY; GENOMIC INSTABILITY; GGG SEQUENCE; COMET ASSAY; BASE DAMAGE; LENGTH; CANCER; REPAIR; MICRONUCLEUS	One main function of telomeres is to maintain chromosome and genome stability. The rate of telomere shortening can be accelerated significantly by chemical and physical environmental agents. Reactive oxygen species are a source of oxidative stress and can produce modified bases (mainly 8-oxoG) and single strand breaks anywhere in the genome. The high incidence of guanine residues in telomeric DNA sequences makes the telomere a preferred target for oxidative damage. Our aim in this work is to evaluate whether chromosome instability induced by oxidative stress is related specifically to telomeric damage. We treated human primary fibroblasts (MRC-5) in vitro with hydrogen peroxide (100 and 200 mu M) for 1 hr and collected data at several time points. To evaluate the persistence of oxidative stress-induced DNA damage up to 24 hrs after treatment, we analysed telomeric and genomic oxidative damage by qPCR and a modified comet assay, respectively. The results demonstrate that the genomic damage is completely repaired, while the telomeric oxidative damage persists. The analysis of telomere length reveals a significant telomere shortening 48 hrs after treatment, leading us to hypothesise that residual telomere damage could be responsible for the telomere shortening observed. Considering the influence of telomere length modulation on genomic stability, we quantified abnormal nuclear morphologies (Nucleoplasmic Bridges, Nuclear Buds and Micronuclei) and observed an increase of chromosome instability in the same time frame as telomere shortening. At subsequent times (72 and 96 hrs), we observed a restoration of telomere length and a reduction of chromosome instability, leaving us to conjecture a correlation between telomere shortening/dysfunction and chromosome instability. We can conclude that oxidative base damage leads to abnormal nuclear morphologies and that telomere dysfunction is an important contributor to this effect.	[Coluzzi, Elisa; Colamartino, Monica; Cozzi, Renata; Leone, Stefano; Meneghini, Carlo; Sgura, Antonella] Univ Roma Tre, Dept Sci, Rome, Italy; [O'Callaghan, Nathan] CSIRO Food & Nutr Sci, Nutr Genom Lab, Adelaide, SA, Australia	Italfarmaco; Roma Tre University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sgura, A (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	antonella.sgura@uniroma3.it	Sgura, Antonella/H-3274-2019; o'callaghan, nathan j/E-8363-2011; meneghini, carlo/F-7761-2013	meneghini, carlo/0000-0003-4846-8422; Leone, Stefano/0000-0001-6339-6397; O'Callaghan, Nathan/0000-0002-8879-1542				Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Berardinelli F, 2010, RADIAT RES, V174, P539, DOI 10.1667/RR2127.1; Berardinelli F, 2013, ENVIRON MOL MUTAGEN, V54, P172, DOI 10.1002/em.21761; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Blackburn EH, 2000, COLD SPRING HARB SYM, V65, P253, DOI 10.1101/sqb.2000.65.253; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Durante M, 1998, INT J RADIAT BIOL, V74, P457, DOI 10.1080/095530098141320; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2002, MUTAT RES-FUND MOL M, V504, P131, DOI 10.1016/S0027-5107(02)00086-6; Festa F, 2003, ENVIRON RES, V91, P54, DOI 10.1016/S0013-9351(02)00003-8; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffin CS, 2002, MUTAT RES-FUND MOL M, V504, P149, DOI 10.1016/S0027-5107(02)00088-X; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KirschVolders M, 1996, MUTAGENESIS, V11, P307, DOI 10.1093/mutage/11.4.307; KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; O'Callaghan N, 2011, BIOTECHNIQUES, V51, P403, DOI 10.2144/000113788; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Perner S, 2003, AM J PATHOL, V163, P1751, DOI 10.1016/S0002-9440(10)63534-1; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; SAITO M, 1995, EUR J PHARM-MOLEC PH, V291, P217, DOI 10.1016/0922-4106(95)90147-7; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shimizu N, 2000, MUTAT RES-FUND MOL M, V448, P81, DOI 10.1016/S0027-5107(00)00003-8; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; Slijepcevic Predrag, 2001, Methods in Cell Science, V23, P17, DOI 10.1023/A:1013177128297; Ting APL, 2010, J CELL MOL MED, V14, P403, DOI 10.1111/j.1582-4934.2009.00945.x; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wong HP, 2004, CYTOGENET GENOME RES, V105, P464, DOI 10.1159/000078220	56	108	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110963	10.1371/journal.pone.0110963	http://dx.doi.org/10.1371/journal.pone.0110963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354277	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200050
J	Thrane, S; Pedersen, AM; Thomsen, MBH; Kirkegaard, T; Rasmussen, BB; Duun-Henriksen, AK; Laenkholm, AV; Bak, M; Lykkesfeldt, AE; Yde, CW				Thrane, S.; Pedersen, A. M.; Thomsen, M. B. H.; Kirkegaard, T.; Rasmussen, B. B.; Duun-Henriksen, A. K.; Laenkholm, A. V.; Bak, M.; Lykkesfeldt, A. E.; Yde, C. W.			A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; D ANALOG EB1089; ESTROGEN-RECEPTOR; TAMOXIFEN-RESISTANT; POSTMENOPAUSAL WOMEN; PREDICTIVE MARKERS; SIGNALING PATHWAY; SMALL-MOLECULE; HISTONE H3; PHOSPHORYLATION	Antiestrogen resistance is a major problem in breast cancer treatment. Therefore, the search for new therapeutic targets and biomarkers for antiestrogen resistance is crucial. In this study, we performed a kinase inhibitor screen on antiestrogen responsive MCF-7 cells and a panel of MCF-7-derived tamoxifen- and fulvestrant-resistant cell lines. Our focus was to identify common and distinct molecular mechanisms involved in tamoxifen- and fulvestrant-resistant cell growth. We identified 18 inhibitors, of which the majority was common for both tamoxifen- and fulvestrant-resistant cell lines. Two compounds, WP1130 and JNJ-7706621, exhibiting prominent preferential growth inhibition of antiestrogen-resistant cell lines, were selected for further studies. WP1130, a deubiquitinase inhibitor, induced caspase-mediated cell death in both tamoxifen- and fulvestrant-resistant cell lines by destabilization of the anti-apoptotic protein Mcl-1. Mcl-1 expression was found upregulated in the antiestrogen-resistant cell lines and depletion of Mcl-1 in resistant cells caused decreased viability. JNJ-7706621, a dual Aurora kinase and cyclin-dependent kinase inhibitor, specifically inhibited growth and caused G2 phase cell cycle arrest of the tamoxifen-resistant cell lines. Knockdown studies showed that Aurora kinase A is essential for growth of the tamoxifen-resistant cells and inhibition of Aurora kinase A resensitized tamoxifen-resistant cells to tamoxifen treatment. Preferential growth inhibition by WP1130 and JNJ-7706621 was also found in T47D-derived tamoxifen-resistant cell lines, pointing at Mcl-1 and Aurora kinase A as potential treatment targets. In addition, tumor samples from 244 estrogen receptor-positive breast cancer patients treated with adjuvant tamoxifen showed that higher expression level of Aurora kinase A was significantly associated with shorter disease-free and overall survival, demonstrating the potential of Aurora kinase A as a biomarker for tamoxifen resistance.	[Thrane, S.; Pedersen, A. M.; Thomsen, M. B. H.; Kirkegaard, T.; Lykkesfeldt, A. E.; Yde, C. W.] Danish Canc Soc Res Ctr, Unit Cell Death & Metab, Breast Canc Grp, DK-2100 Copenhagen O, Denmark; [Rasmussen, B. B.] Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Duun-Henriksen, A. K.] Danish Canc Soc Res Ctr, Stat Bioinformat & Registry, Copenhagen, Denmark; [Laenkholm, A. V.] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Bak, M.] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark	Danish Cancer Society; University of Copenhagen; Herlev & Gentofte Hospital; Danish Cancer Society; University of Southern Denmark; Odense University Hospital	Yde, CW (corresponding author), Danish Canc Soc Res Ctr, Unit Cell Death & Metab, Breast Canc Grp, Strandblvd 49, DK-2100 Copenhagen O, Denmark.	cwy@cancer.dk	Bak, Martin/D-1392-2012	Thrane, Susan/0000-0001-6596-3527; Laenkholm, Anne-Vibeke/0000-0003-2166-8686	Race Against Breast Cancer, Astrid Thaysen's grant [ATL12/01]; A.P. Moller Foundation for the Advancement of Medical Science [12-374]; Danish Cancer Research Foundation; Danish Cancer Society; Danske Bank Foundation; Hede Nielsen Family Foundation; Leo Nielsen's grant [LN12/07]; Novo Nordisk Foundation; Sigvald and Edith Rasmussen's grant	Race Against Breast Cancer, Astrid Thaysen's grant; A.P. Moller Foundation for the Advancement of Medical Science; Danish Cancer Research Foundation; Danish Cancer Society(Danish Cancer Society); Danske Bank Foundation; Hede Nielsen Family Foundation; Leo Nielsen's grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigvald and Edith Rasmussen's grant	We thank Jane Lind Christensen and Birgit Reiter for excellent technical assistance and Klaus Kaae Andersen and Ann-Sophie Sogaard for help with statistical analysis. This study was supported by A Race Against Breast Cancer, Astrid Thaysen's grant (ATL12/01), A.P. Moller Foundation for the Advancement of Medical Science (12-374), Danish Cancer Research Foundation, Danish Cancer Society, Danske Bank Foundation, Hede Nielsen Family Foundation, Leo Nielsen's grant (LN12/07), Novo Nordisk Foundation and Sigvald and Edith Rasmussen's grant.	Ali HR, 2012, BRIT J CANCER, V106, P1798, DOI 10.1038/bjc.2012.167; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Bartholomeusz GA, 2007, BLOOD, V109, P3470, DOI 10.1182/blood-2006-02-005579; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; BRIAND P, 1984, CANCER RES, V44, P1114; Chan SK, 2006, J MAMMARY GLAND BIOL, V11, P3, DOI 10.1007/s10911-006-9008-2; Christensen GL, 2004, BREAST CANCER RES TR, V85, P53, DOI 10.1023/B:BREA.0000021047.37869.95; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Emanuel S, 2005, CANCER RES, V65, P9038, DOI 10.1158/0008-5472.CAN-05-0882; Frankel LB, 2007, BREAST CANCER RES TR, V104, P165, DOI 10.1007/s10549-006-9399-1; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henriksen KL, 2007, J CLIN PATHOL, V60, P397, DOI 10.1136/jcp.2005.034447; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; HOWELL A, 1995, LANCET, V345, P29, DOI 10.1016/S0140-6736(95)91156-1; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Hutcheson IR, 2003, BREAST CANCER RES TR, V81, P81, DOI 10.1023/A:1025484908380; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Larsen SS, 2001, BRIT J CANCER, V84, P686, DOI 10.1054/bjoc.2000.1646; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; Lundholt BK, 2001, BREAST CANCER RES TR, V67, P199, DOI 10.1023/A:1017977406429; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; LYKKESFELDT AE, 1995, INT J CANCER, V61, P529, DOI 10.1002/ijc.2910610417; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nahta R, 2012, BREAST CANCER RES TR, V135, P39, DOI 10.1007/s10549-012-2067-8; Palmieri C, 2014, MOL CELL ENDOCRINOL, V382, P695, DOI 10.1016/j.mce.2013.08.001; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Rasmussen BB, 2008, LANCET ONCOL, V9, P23, DOI 10.1016/S1470-2045(07)70386-8; Robertson JFR, 2003, CANCER, V98, P229, DOI 10.1002/cncr.11468; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Siggelkow W, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-562; Sonne-Hansen K, 2010, BREAST CANCER RES TR, V121, P601, DOI 10.1007/s10549-009-0506-y; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; TEIXEIRA C, 1995, CANCER RES, V55, P3902; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Yde CW, 2008, ONCOGENE, V27, P4986, DOI 10.1038/onc.2008.146; Yde CW, 2012, BREAST CANCER RES TR, V135, P67, DOI 10.1007/s10549-012-2053-1; Yde CW, 2007, MOL CANCER THER, V6, P1869, DOI 10.1158/1535-7163.MCT-07-0072; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zheng XQ, 2014, ONCOGENE, V33, P4985, DOI 10.1038/onc.2013.444	57	39	39	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4199	4210		10.1038/onc.2014.351	http://dx.doi.org/10.1038/onc.2014.351			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25362855				2022-12-26	WOS:000359199800006
J	Gao, J; Li, N; Dong, Y; Li, S; Xu, L; Li, X; Li, Y; Li, Z; Ng, SS; Sung, JJ; Shen, L; Yu, J				Gao, J.; Li, N.; Dong, Y.; Li, S.; Xu, L.; Li, X.; Li, Y.; Li, Z.; Ng, S. S.; Sung, J. J.; Shen, L.; Yu, J.			miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer	ONCOGENE			English	Article							COLON-CANCER; INHIBITS MIGRATION; P53; EXPRESSION; INVASION; MIR-21; CELLS; SIRT1; COMBINATION; RELAPSE	Although surgery remains the mainstay of curative treatment for colorectal cancer (CRC), many patients still have high chance to experience disease relapse. It is therefore imperative to identify prognostic markers that can help predict the clinical outcomes of CRC. Aberrant microRNA expression holds great potential as diagnostic and prognostic biomarker for CRC. Here we aimed to investigate clinical potential of miR-34a-5p as a prognostic marker for CRC recurrence and its functional significance. First, we validated that miR-34a-5p was downregulated in CRC tumour tissues (P<0.05). The expression level of tissue miR-34a-5p was then evaluated in two independent cohorts of 268 CRC patients. miR-34a-5p expression was positively correlated with disease-free survival in two independent cohorts (cohort I: n = 205, P<0.001; cohort II: n = 63, P = 0.006). Moreover, the expression of miR-34a-5p was an independent prognostic factor for CRC recurrence by multivariate analysis (P<0.001 for cohort I, P = 0.007 for cohort II). Ectopic expression of miR-34a-5p in p53 wild-type colon cancer cell HCT116 significantly inhibited cell growth, migration, invasion and metastasis. miR-34a-5p induced cell apoptosis, cell cycle arrest at G1 phase and p53 transcription activity in HCT116 cells, but not in the HCT116 p53 knockout (p53(-/-))cells. miR-34a-5p significantly suppressed the HCT116 growth in vivo, whereas it showed no effect on the HCT116 p53(-/-) xenograft, indicating that the growth-inhibiting effect by miR-34a-5p was dependent on p53. In addition, the expression level of miR-34a-5p in patients with p53-positive expression was higher than that in patients with p53-negative expression (P<0.01). In conclusion, miR-34a-5p inhibits recurrence of CRC through inhibiting cell growth, migration and invasion, inducing cell apoptosis and cell cycle arrest in a p53-dependent manner.	[Gao, J.; Li, N.; Li, S.; Li, Y.; Shen, L.] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res,Dept Gastro, Beijing 100871, Peoples R China; [Gao, J.; Dong, Y.; Xu, L.; Li, X.; Sung, J. J.; Yu, J.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, State Key Lab Digest Dis,Inst Digest Dis,Dept Med, Shatin, Hong Kong, Peoples R China; [Dong, Y.; Ng, S. S.] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Li, Z.] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res,Dept Pathol, Beijing 100871, Peoples R China	Peking University; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci,CUHK Shenzhen Res Inst, Inst Digest Dis,Dept Med & Therapeut,State Key La, Shatin, Hong Kong, Peoples R China.	lin100@medmail.com.cn; junyu@cuhk.edu.hk	Li, Xiao-xing/B-9114-2008; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015	Li, Xiao-xing/0000-0001-8791-7505; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153	National Natural Science Foundation of China [81301853, 81072034]; National High Technology Research and Development Program [2012AA 02A 504, 2012AA 02A 506]; Shenzhen Technology and Innovation Project Fund, Shenzhen [JSGG20130412171021059]; China 863 program [2012AA02A506]; Shenzhen Municipal Science and Technology R D fund [JCYJ20120619152326450]; Shenzhen Virtual University Park Support Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Shenzhen Technology and Innovation Project Fund, Shenzhen; China 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Science and Technology R D fund; Shenzhen Virtual University Park Support Scheme	This work was supported by National Natural Science Foundation of China (No. 81301853, 81072034), National High Technology Research and Development Program (No. 2012AA 02A 504, 2012AA 02A 506), Shenzhen Technology and Innovation Project Fund, Shenzhen (JSGG20130412171021059), China 863 program (2012AA02A506), Shenzhen Municipal Science and Technology R & D fund (JCYJ20120619152326450) and Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute.	Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen Q, 2014, CELL MOL BIOL LETT, V19, P52, DOI 10.2478/s11658-013-0115-y; Christensen LL, 2013, INT J CANCER, V133, P67, DOI 10.1002/ijc.28010; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; Dong YJ, 2013, MOL CANCER RES, V11, P1051, DOI 10.1158/1541-7786.MCR-13-0061; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Kjaer-Frifeldt S, 2012, BRIT J CANCER, V107, P1169, DOI 10.1038/bjc.2012.365; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Ma YM, 2013, CURR PHARM DESIGN, V19, P1253; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Mirakhorli M, 2013, MOL MED REP, V7, P613, DOI 10.3892/mmr.2012.1226; Mitrea DM, 2012, BIOL CHEM, V393, P259, DOI 10.1515/hsz-2011-0254; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Tobiume Kei, 2005, J Nippon Med Sch, V72, P192, DOI 10.1272/jnms.72.192; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Wu CW, 2014, CLIN CANCER RES, V20, P2994, DOI 10.1158/1078-0432.CCR-13-1750; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yang IP, 2012, CARCINOGENESIS, V33, P1522, DOI 10.1093/carcin/bgs166; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	37	130	136	1	33	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4142	4152		10.1038/onc.2014.348	http://dx.doi.org/10.1038/onc.2014.348			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25362853				2022-12-26	WOS:000358780500012
J	Little, DJ; Bamford, NC; Pokrovskaya, V; Robinson, H; Nitz, M; Howell, PL				Little, Dustin J.; Bamford, Natalie C.; Pokrovskaya, Varvara; Robinson, Howard; Nitz, Mark; Howell, P. Lynne			Structural Basis for the De-N-acetylation of Poly-beta-1,6-N-acetyl-D-glucosamine in Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PGAB; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; CARBOHYDRATE ESTERASE; BPS POLYSACCHARIDE; PROTEIN-STRUCTURE; MOLECULAR-BASIS; EXOPOLYSACCHARIDE; DEACETYLASE; ELECTROSTATICS	Exopolysaccharides are required for the development and integrity of biofilms produced by a wide variety of bacteria. In staphylococci, partial de-N-acetylation of the exopolysaccharide poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) by the extra-cellular protein IcaB is required for biofilm formation. To understand the molecular basis for PNAG de-N-acetylation, the structure of IcaB from Ammonifex degensii (IcaB(Ad)) has been determined to 1.7 angstrom resolution. The structure of IcaB(Ad) reveals a (beta/alpha)(7) barrel common to the family four carbohydrate esterases (CE4s) with the canonical motifs circularly permuted. The metal dependence of IcaB(Ad) is similar to most CE4s showing the maximum rates of de-N-acetylation with Ni2+, Co2+, and Zn2+. From docking studies with beta-1,6-GlcNAc oligomers and structural comparison to PgaB from Escherichia coli, the Gram-negative homologue of IcaB, we identify Arg-45, Tyr-67, and Trp180 as key residues for PNAG binding during catalysis. The absence of these residues in PgaB provides a rationale for the requirement of a C-terminal domain for efficient deacetylation of PNAG in Gram-negative species. Mutational analysis of conserved active site residues suggests that IcaB uses an altered catalytic mechanism in comparison to other characterized CE4 members. Furthermore, we identified a conserved surface-exposed hydrophobic loop found only in Gram-positive homologues of IcaB. Our data suggest that this loop is required for membrane association and likely anchors IcaB to the membrane during polysaccharide biosynthesis. The work presented herein will help guide the design of IcaB inhibitors to combat biofilm formation by staphylococci.	[Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pokrovskaya, Varvara; Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; United States Department of Energy (DOE); Brookhaven National Laboratory	Nitz, M (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mnitz@chem.utoronto.ca; howell@sickkids.ca		Bamford, Natalie/0000-0003-1959-856X	United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Centre for Research Resources; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Centre for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patrick Yip for technical assistance and the Trimble laboratory at The Hospital for Sick Children for the use of their micro-ultracentrifuge. The National Synchrotron Light Source beam line X29A is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Centre for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Atkin KE, 2014, FEBS LETT, V588, P1869, DOI 10.1016/j.febslet.2014.04.002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; CHRISTIANSON DW, 1987, P NATL ACAD SCI USA, V84, P1512, DOI 10.1073/pnas.84.6.1512; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little D. J., 2014, ENCY INORGANIC BIOIN, P1; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Little DJ, 2012, ACTA CRYSTALLOGR F, V68, P842, DOI 10.1107/S1744309112022075; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nishiyama T, 2013, ACTA CRYSTALLOGR D, V69, P44, DOI 10.1107/S0907444912042059; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pokrovskaya V, 2013, BIOCHEMISTRY-US, V52, P5463, DOI 10.1021/bi400836g; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods Group, 2005, GLYCAM WEB; Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	61	18	18	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35907	35917		10.1074/jbc.M114.611400	http://dx.doi.org/10.1074/jbc.M114.611400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359777	Green Published, hybrid			2022-12-26	WOS:000346897900022
J	Hwang, S; Li, Z; Bar-Peled, Y; Aronov, A; Ericson, J; Bar-Peled, M				Hwang, Soyoun; Li, Zi; Bar-Peled, Yael; Aronov, Avi; Ericson, Jaime; Bar-Peled, Maor			The Biosynthesis of UDP-D-FucNAc-4N-(2)-oxoglutarate (UDP-Yelosamine) in Bacillus cereus ATCC 14579 Pat AND Pyl, AN AMINOTRANSFERASE AND AN ATP-DEPENDENT Grasp PROTEIN THAT LIGATES 2-OXOGLUTARATE TO UDP-4-AMINO-SUGARS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Biofilm; Carbohydrate Biosynthesis; Enzyme Catalysis; Glycobiology	CELL-WALL POLYSACCHARIDE; D-ALANINE LIGASE; ESCHERICHIA-COLI; GLUTATHIONE SYNTHETASE; H-1-NMR SPECTRA; HUMAN PATHOGEN; SPECTROSCOPY; ATP; ENZYMES; 4-AMINO-4-DEOXY-L-ARABINOSE	Surface glycan switching is often observed when micro-organisms transition between different biotic and abiotic niches, including biofilms, although the advantages of this switching to the organism are not well understood. Bacillus cereus grown in a biofilm-inducing medium has been shown to synthesize an unusual cell wall polysaccharide composed of the repeating subunit 6)Gal(1-2)(2-R-hydroxyglutar-5-ylamido)Fuc2NAc4N(1-6)GlcNAc(1, where galactose is linked to the hydroxyglutarate moiety of FucNAc-4-amido-(2)-hydroxyglutarate. The molecular mechanism involved in attaching 2-hydroxyglutarate to 4-amino-FucNAc has not been determined. Here, we show two genes in B. cereus ATCC 14579 encoding enzymes involved in the synthesis of UDP-FucNAc-4-amido-(2)-oxoglutarate (UDP-Yelosamine), a modified UDP-sugar not previously reported to exist. Using mass spectrometry and real time NMR spectroscopy, we show that Bc5273 encodes a C4-aminotransferase (herein referred to as Pat) that, in the presence of pyridoxal phosphate, transfers the primary amino group of l-Glu to C-4 of UDP-4-keto-6-deoxy-d-GlcNAc to form UDP-4-amino-FucNAc and 2-oxoglutarate. Pat also converts 4-keto-xylose, 4-keto-glucose, and 4-keto-2-acetamido-altrose to their corresponding UDP-4-amino-sugars. Bc5272 encodes a carboxylate-amine ligase (herein referred as Pyl) that, in the presence of ATP and Mg(II), adds 2-oxoglutarate to the 4-amino moiety of UDP-4-amino-FucNAc to form UDP-Yelosamine and ADP. Pyl is also able to ligate 2-oxoglutarate to other 4-amino-sugar derivatives to form UDP-Yelose, UDP-Solosamine, and UDP-Aravonose. Characterizing the metabolic pathways involved in the formation of modified nucleotide sugars provides a basis for understanding some of the mechanisms used by bacteria to modify or alter their cell surface polysaccharides in response to changing growth and environmental challenges.	[Hwang, Soyoun; Li, Zi; Bar-Peled, Yael; Aronov, Avi; Ericson, Jaime; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Aronov, Avi/0000-0003-1781-6068	NIH grant [S10 RR027097]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027097] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Malcolm O'Neill of the Complex Carbohydrate Research Center for constructive comments on the manuscript. We also thank Dr. John Glushka of the Complex Carbohydrate Research Center for NMR technical assistance. Our research benefitted from instrumentation provided by an NIH grant, S10 RR027097.	Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; BERNASSAU JM, 1994, J MAGN RESON SER B, V103, P77, DOI 10.1006/jmrb.1994.1011; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Cook PD, 2008, BIOCHEMISTRY-US, V47, P2833, DOI 10.1021/bi702430d; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Raetz CRH, 2002, BIOCHEMISTRY-US, V41, P8962; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Suzuki M, 2012, ACTA CRYSTALLOGR D, V68, P1535, DOI 10.1107/S0907444912038103; Vilain S, 2006, J PROTEOME RES, V5, P1924, DOI 10.1021/pr050402b; Vinogradov E, 2003, EUR J BIOCHEM, V270, P1810, DOI 10.1046/j.1432-1033.2003.03543.x	32	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35620	35632		10.1074/jbc.M114.614917	http://dx.doi.org/10.1074/jbc.M114.614917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368324	Green Published, hybrid			2022-12-26	WOS:000346660200048
J	Liu, C; Yang, Y; Chen, L; Lin, YL; Li, F				Liu, Chang; Yang, Yang; Chen, Lang; Lin, Yi-Lun; Li, Fang			A Unified Mechanism for Aminopeptidase N-based Tumor Cell Motility and Tumor-homing Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cancer Therapy; Cell Motility; Crystallography; Extracellular Matrix Protein; Tumor Marker; Tumor Metastases	RECEPTOR-BINDING DOMAIN; ADVANCED SOLID TUMORS; CRYSTAL-STRUCTURE; INTEGRIN ALPHA-V-BETA-3; EXTRACELLULAR SEGMENT; CD13/AMINOPEPTIDASE N; SEMINAL PLASMA; DRUG-DELIVERY; CD13; CANCER	Background: Aminopeptidase N (APN) mediates tumor cell motility and is a receptor for tumor-homing peptides containing NGR motifs. Results: Using crystallographic and biochemical methods, we investigated how APN interacts with NGR motifs in tumor-homing peptides and extracellular matrix proteins. Conclusion: APN forms specific and stable interactions with these NGR motifs, accounting for APN's functions. Significance: This study facilitates development of APN-targeting cancer therapies. Tumor cell surface aminopeptidase N (APN or CD13) has two puzzling functions unrelated to its enzymatic activity: mediating tumor cell motility and serving as a receptor for tumor-homing peptides (peptides that bring anti-cancer drugs to tumor cells). To investigate APN-based tumor-homing therapy, we determined the crystal structure of APN complexed with a tumor-homing peptide containing a representative Asn-Gly-Arg (NGR) motif. The tumor-homing peptide binds to the APN enzymatic active site, but it resists APN degradation due to a distorted scissile peptide bond. To explore APN-based tumor cell motility, we examined the interactions between APN and extracellular matrix (ECM) proteins. APN binds to, but does not degrade, NGR motifs in ECM proteins that share similar conformations with the NGR motif in the APN-bound tumor-homing peptide. Therefore, APN-based tumor cell motility and tumor-homing therapy rely on a unified mechanism in which both functions are driven by the specific and stable interactions between APN and the NGR motifs in ECM proteins and tumor-homing peptides. This study further implicates APN as an integrin-like molecule that functions broadly in cell motility and adhesion by interacting with its signature NGR motifs in the extracellular environment.	[Liu, Chang; Yang, Yang; Chen, Lang; Lin, Yi-Lun; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-121 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu	Yang, Yang/R-7215-2016	Yang, Yang/0000-0001-9061-3828				Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUITRAGO JMG, 1985, ANDROLOGIA, V17, P139; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Carlsson L, 2006, INT J ANDROL, V29, P331, DOI 10.1111/j.1365-2605.2005.00601.x; Chang YW, 2005, INT J CANCER, V116, P243, DOI 10.1002/ijc.21089; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; Eskens FALM, 2003, EUR J CANCER, V39, P917, DOI 10.1016/S0959-8049(03)00057-1; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Gregorc V, 2009, BRIT J CANCER, V101, P219, DOI 10.1038/sj.bjc.6605162; Gregorc V, 2010, J CLIN ONCOL, V28, P2604, DOI 10.1200/JCO.2009.27.3649; Gregorc V, 2010, EUR J CANCER, V46, P198, DOI 10.1016/j.ejca.2009.10.005; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Irazusta J, 2004, J ANDROL, V25, P733; Kehlen A, 2003, CANCER RES, V63, P8500; MENRAD A, 1993, CANCER RES, V53, P1450; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Mina-Osorio P, 2006, J LEUKOCYTE BIOL, V79, P719, DOI 10.1189/jlb.0705425; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasqualini R, 2000, CANCER RES, V60, P722; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Shimizu T, 2002, ARTHRITIS RHEUM-US, V46, P2330, DOI 10.1002/art.10517; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Tani K, 2000, AM J RESP CRIT CARE, V161, P1636, DOI 10.1164/ajrccm.161.5.9902008; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang Y, 2013, J BIOL CHEM, V288, P25638, DOI 10.1074/jbc.M113.494955	45	32	33	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34520	34529		10.1074/jbc.M114.566802	http://dx.doi.org/10.1074/jbc.M114.566802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359769	Green Published, hybrid			2022-12-26	WOS:000346260800012
J	Akhvlediani, T; Bautista, CT; Shakarishvili, R; Tsertsvadze, T; Imnadze, P; Tatishvili, N; Davitashvili, T; Samkharadze, T; Chlikadze, R; Dvali, N; Dzigua, L; Karchava, M; Gatserelia, L; Macharashvili, N; Kvirkvelia, N; Habashy, EE; Farrell, M; Rowlinson, E; Sejvar, J; Hepburn, M; Pimentel, G; Dueger, E; House, B; Rivard, R				Akhvlediani, Tamar; Bautista, Christian T.; Shakarishvili, Roman; Tsertsvadze, Tengiz; Imnadze, Paata; Tatishvili, Nana; Davitashvili, Tamar; Samkharadze, Tamar; Chlikadze, Rusudan; Dvali, Natia; Dzigua, Lela; Karchava, Mariam; Gatserelia, Lana; Macharashvili, Nino; Kvirkvelia, Nana; Habashy, Engy Emil; Farrell, Margaret; Rowlinson, Emily; Sejvar, James; Hepburn, Matthew; Pimentel, Guillermo; Dueger, Erica; House, Brent; Rivard, Robert			Etiologic Agents of Central Nervous System Infections among Febrile Hospitalized Patients in the Country of Georgia	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; VIRAL-INFECTIONS; EPIDEMIOLOGY; DIAGNOSIS	Objectives: There is a large spectrum of viral, bacterial, fungal, and prion pathogens that cause central nervous system (CNS) infections. As such, identification of the etiological agent requires multiple laboratory tests and accurate diagnosis requires clinical and epidemiological information. This hospital-based study aimed to determine the main causes of acute meningitis and encephalitis and enhance laboratory capacity for CNS infection diagnosis. Methods: Children and adults patients clinically diagnosed with meningitis or encephalitis were enrolled at four reference health centers. Cerebrospinal fluid (CSF) was collected for bacterial culture, and in-house and multiplex RT-PCR testing was conducted for herpes simplex virus (HSV) types 1 and 2, mumps virus, enterovirus, varicella zoster virus (VZV), Streptococcus pneumoniae, HiB and Neisseria meningitidis. Results: Out of 140 enrolled patients, the mean age was 23.9 years, and 58% were children. Bacterial or viral etiologies were determined in 51% of patients. Five Streptococcus pneumoniae cultures were isolated from CSF. Based on in-house PCR analysis, 25 patients were positive for S. pneumoniae, 6 for N. meningitidis, and 1 for H. influenzae. Viral multiplex PCR identified infections with enterovirus (n = 26), VZV (n = 4), and HSV-1 (n = 2). No patient was positive for mumps or HSV-2. Conclusions: Study findings indicate that S. pneumoniae and enteroviruses are the main etiologies in this patient cohort. The utility of molecular diagnostics for pathogen identification combined with the knowledge provided by the investigation may improve health outcomes of CNS infection cases in Georgia.	[Akhvlediani, Tamar] Javakhishvili Tbilisi State Univ, Dept Neurol & Neurosurg, Tbilisi, Georgia; [Akhvlediani, Tamar] US Army, Med Res Unit Georgia, Tbilisi, Georgia; [Bautista, Christian T.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Shakarishvili, Roman] Sarajishvili Inst Clin Neurol & Neurosurg, Tbilisi, Georgia; [Tsertsvadze, Tengiz; Davitashvili, Tamar; Dvali, Natia; Dzigua, Lela; Karchava, Mariam; Gatserelia, Lana; Macharashvili, Nino] Sci Res Ctr Infect Pathol AIDS & Clin Immunol, Tbilisi, Georgia; [Imnadze, Paata; Chlikadze, Rusudan] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Tatishvili, Nana; Samkharadze, Tamar] Iashvili Childrens Hosp, Dept Neurol, Tbilisi, Georgia; [Habashy, Engy Emil; Farrell, Margaret; Rowlinson, Emily; Pimentel, Guillermo; Dueger, Erica; House, Brent] US Naval, Global Dis Detect & Response Program, Med Res Unit 3, Cairo, Egypt; [Sejvar, James] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Dueger, Erica] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Hepburn, Matthew; Rivard, Robert] US Army, Med Res Inst Infect Dis, Frederick, MD USA	Ivane Javakhishvili Tbilisi State University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Center for Disease Control & Public Health - Georgia; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Akhvlediani, T (corresponding author), Javakhishvili Tbilisi State Univ, Dept Neurol & Neurosurg, Tbilisi, Georgia.	t_akhvlediani@yahoo.com	Tsertsvadze, Tengiz/GXG-5822-2022	Tsertsvadze, Tengiz/0000-0002-4986-7874; Bautista, Christian/0000-0002-1228-0754; Tatishvili, Nana Nino/0000-0002-4292-264X	U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program; U.S. Centers for Disease Control and Prevention	U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program and supported by the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuzawa N, 2013, J MED CASES, V4, P4; Big C, 2009, CLIN MED RES, V7, P142, DOI 10.3121/cmr.2009.864; Bottomley MJ, 2012, VACCINE, V30, pB78, DOI 10.1016/j.vaccine.2011.12.099; Butsashvili M, 2013, J COMMUN HEALTH, V38, P724, DOI 10.1007/s10900-013-9670-4; Demina AA, 1998, INT MED J, V2, P315; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620; Griffiths UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021472; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Kasanmoentalib ES, 2013, CURR OPIN NEUROL, V26, P282, DOI 10.1097/WCO.0b013e328360415c; Ludwig E, 2012, CENT EUR J PUBL HEAL, V20, P121, DOI 10.21101/cejph.a3744; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Seehusen DA, 2003, AM FAM PHYSICIAN, V68, P1103; Spiro CE, 2004, CLIN REV, V14, P53; Sundaram C, 2011, PATHOLOG RES INT, V2011, P8782; Taylor WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042099; TEASDALE G, 1974, LANCET, V2, P81; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	21	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111393	10.1371/journal.pone.0111393	http://dx.doi.org/10.1371/journal.pone.0111393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369023	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000051
J	Boyer, S; Miarinjara, A; Elissa, N				Boyer, Sebastien; Miarinjara, Adelaide; Elissa, Nohal			Xenopsylla cheopis (Siphonaptera: Pulicidae) Susceptibility to Deltamethrin in Madagascar	PLOS ONE			English	Article							YERSINIA-PESTIS; PLAGUE; RESISTANCE; EMERGENCE; HISTORY; MAMMALS; RISK	The incidence of bubonic plague in Madagascar is high. This study reports the susceptibility of 32 different populations of a vector, the flea Xenopsylla cheopis (Siphonaptera: Pulicidae), to the insecticide Deltamethrin. Despite the use of Deltamethrin against fleas, plague epidemics have re-emerged in Madagascar. The majority of the study sites were located in the Malagasy highlands where most plague cases have occurred over the last 10 years. X. cheopis fleas were tested for susceptibility to Deltamethrin (0.05%): only two populations were susceptible to Deltamethrin, four populations were tolerant and 26 populations were resistant. KD50 (50% Knock-Down) and KD90 (90% Knock-Down) times were determined, and differed substantially from 9.4 to 592.4 minutes for KD50 and 10.4 min to 854.3 minutes for KD90. Susceptibility was correlated with latitude, but not with longitude, history of insecticide use nor date of sampling. Combined with the number of bubonic plague cases, our results suggest that an immediate switch to an insecticide other than Deltamethrin is required for plague vector control in Madagascar.	[Boyer, Sebastien; Miarinjara, Adelaide; Elissa, Nohal] Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar; [Miarinjara, Adelaide] Univ Antananarivo, Ecole Doctorale Sci Vie & Environm, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo	Boyer, S (corresponding author), Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar.	seboyer@pasteur.mg	Miarinjara, Adélaïde/AGF-1036-2022; Miarinjara, Adelaide/AGJ-9381-2022	Miarinjara, Adelaide/0000-0001-6251-8890; Boyer, Sebastien/0000-0002-2946-586X				Andrianaivoarimanana V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002382; [Anonymous], 1998, TEST PROC INS RES MO; BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Carniel E, 2002, CR BIOL, V325, P851, DOI 10.1016/S1631-0691(02)01493-2; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COULANGES P, 1984, Archives de l'Institut Pasteur de Madagascar, V51, P253; COULANGES P, 1984, B SOC PATHOL EXOT, V77, P705; Coulanges P, 1982, Arch Inst Pasteur Madagascar, V49, P171; Duchemin J-B, 2003, THESIS U PARIS 12 VA; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Fontenille D, 1987, ARCH I PASTEUR MADAG, V53, P249; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gratz NG, 1980, P INT C FLEAS ROTT, P217; GUEDES RNC, 1994, INT J PEST MANAGE, V40, P103, DOI 10.1080/09670879409371863; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2; Migliani R, 2001, B SOC PATHOL EXOT, V94, P115; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Rahelinirina S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014111; Ratovonjato J., 1998, Archives de l'Institut Pasteur de Madagascar, V64, P25; Ratsitorahina M., 2002, Archives de l'Institut Pasteur de Madagascar, V68, P51; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Tollenaere C, 2010, J BIOGEOGR, V37, P398, DOI 10.1111/j.1365-2699.2009.02228.x; WHO, 2010, RELEVE PIDEMIOLOGIQU, P40; WHO, 1976, REP WHO EXP COMM RES; WHO, 1970, RES INS LUTT ANT DIX; WHO (World Health Organization), 2011, TECHN BAS COORD ACT; World Health Organization, 1981, WHOVBC81815; World health organization, 2013, WORLD HLTH STAT 2013	32	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111998	10.1371/journal.pone.0111998	http://dx.doi.org/10.1371/journal.pone.0111998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369291	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000135
J	Kuhn, N; Abello, C; Godoy, F; Delrot, S; Arce-Johnson, P				Kuehn, Nathalie; Abello, Carlos; Godoy, Francisca; Delrot, Serge; Arce-Johnson, Patricio			Differential Behavior within a Grapevine Cluster: Decreased Ethylene-Related Gene Expression Dependent on Auxin Transport Is Correlated with Low Abscission of First Developed Berries	PLOS ONE			English	Article							VITIS-VINIFERA L.; APPLE FRUITLET ABSCISSION; SIGNALING PATHWAYS; SYNTHASE GENES; BIOSYNTHESIS; TOMATO; ACID; GROWTH; ARABIDOPSIS; SET	In grapevine, fruit abscission is known to occur within the first two to three weeks after flowering, but the reason why some berries in a cluster persist and others abscise is not yet understood. Ethylene sensitivity modulates abscission in several fruit species, based on a mechanism where continuous polar auxin transport across the pedicel results in a decrease in ethylene perception, which prevents abscission. In grapevine, flowering takes about four to seven days in a single cluster, thus while some flowers are developing into berries, others are just starting to open. So, in this work it was assessed whether uneven flowering accounted for differences in berry abscission dependent on polar auxin transport and ethylene-related gene expression. For this, flowers that opened in a cluster were tagged daily, which allowed to separately analyze berries, regarding their ability to persist. It was found that berries derived from flowers that opened the day that flowering started named as "first berries'' - had lower abscission rate than berries derived from flowers that opened during the following days - named as "late berries''. Use of radiolabeled auxin showed that "first berries'' had higher polar auxin transport, correlated with lower ethylene content and lower ethylene-related transcript abundance than "late berries''. When "first berries'' were treated with a polar auxin transport inhibitor they showed higher ethylene-related transcript abundance and were more prone to abscise than control berries. This study provides new insights on fruit abscission control. Our results indicate that polar auxin transport sustains the ability of "first berries'' to persist in the cluster during grapevine abscission and also suggest that this could be associated with changes in ethylene-related gene expression.	[Kuehn, Nathalie; Abello, Carlos; Godoy, Francisca; Arce-Johnson, Patricio] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile; [Delrot, Serge] Univ Bordeaux, ISVV, INRA, EGFV,UMR 1287, Villenave Dornon, France	Pontificia Universidad Catolica de Chile; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Arce-Johnson, P (corresponding author), Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	parce@bio.puc.cl	Kuhn, Nathalie/ABD-4529-2021	Kuhn, Nathalie/0000-0002-4980-6211; Delrot, Serge/0000-0001-9602-0441; Godoy Santin, Maria Francisca/0000-0002-3270-2299	ECOS-CONICYT [C11B01]; Millennium Nucleus Center for Plant Functional Genomics [P10-062]; FONDECYT [1100709]; CONICYT Fellowships	ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Nucleus Center for Plant Functional Genomics; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Fellowships	Funding provided by ECOS-CONICYT, project number C11B01, http://www.conicyt.cl/pci/category/lineas-del-programa/movilidad-lineas-del-programa/?anio=2011, Millennium Nucleus Center for Plant Functional Genomics P10-062, FONDECYT 1100709, http://w1.conicyt.cl/bases/fondecyt/proyectos/01/2010/1100709.html, CONICYT Fellowships, http://www.conicyt.cl/becas-conicyt/sobre-becas-conicyt/que-es-becas-conicyt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteca JM, 1999, PLANT MOL BIOL, V39, P209, DOI 10.1023/A:1006177902093; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bennett M, 2005, PHYSIOL PLANTARUM, V123, P109, DOI 10.1111/j.1399-3054.2005.00483.x; BESSIS R, 1992, VITIS, V31, P9; Bessis R., 2000, Australian Journal of Grape and Wine Research, V6, P125, DOI 10.1111/j.1755-0238.2000.tb00170.x; Blanusa T, 2005, PLANT GROWTH REGUL, V45, P189, DOI 10.1007/s10725-005-3568-9; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Serrani JC, 2010, PLANT PHYSIOL, V153, P851, DOI 10.1104/pp.110.155424; Chervin C, 2010, VITIS, V49, P129; Ciardi J, 2001, ANN BOT-LONDON, V88, P813, DOI 10.1006/anbo.2001.1523; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Costantini E, 2007, PLANT PHYSIOL, V143, P1689, DOI 10.1104/pp.106.095232; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; Dal Cin V, 2006, POSTHARVEST BIOL TEC, V42, P125, DOI 10.1016/j.postharvbio.2006.06.008; Dauelsberg P, 2011, J PLANT PHYSIOL, V168, P1667, DOI 10.1016/j.jplph.2011.03.006; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Dokoozlian NK, 2001, HORTSCIENCE, V36, P706, DOI 10.21273/HORTSCI.36.4.706; Downey MO, 2003, AUST J GRAPE WINE R, V9, P110, DOI 10.1111/j.1755-0238.2003.tb00261.x; Else MA, 2004, J EXP BOT, V55, P2099, DOI 10.1093/jxb/erh208; Friend AP, 2003, AM J ENOL VITICULT, V54, P313; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; GRUBER J, 1990, PHYSIOL PLANTARUM, V79, P354; Hilt C, 2003, VITIS, V42, P1; Iannetta PPM, 2000, PHYSIOL PLANTARUM, V110, P535, DOI [10.1111/j.1399-3054.2000.1100417.x, 10.1034/j.1399-3054.2000.1100417.x]; Intrigliolo DS, 2009, VITIS, V48, P53; LEE JS, 1990, PLANT PHYSIOL, V94, P1770, DOI 10.1104/pp.94.4.1770; Lijavetzky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039547; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Llop-Tous I, 2000, PLANT PHYSIOL, V123, P971, DOI 10.1104/pp.123.3.971; Mariotti L, 2011, J PLANT GROWTH REGUL, V30, P405, DOI 10.1007/s00344-011-9204-1; Meir S, 2006, PLANT PHYSIOL, V141, P1604, DOI 10.1104/pp.106.079277; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; MORGAN PW, 1966, PLANT PHYSIOL, V41, P45, DOI 10.1104/pp.41.1.45; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Ojeda H, 1999, VITIS, V38, P145; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; Perez FJ, 2000, AM J ENOL VITICULT, V51, P315; Petruzzelli L, 2000, PLANTA, V211, P144, DOI 10.1007/s004250000274; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; PRATT C, 1973, J AM SOC HORTIC SCI, V98, P489; PRATT C, 1971, AM J ENOL VITICULT, V22, P92; Ruperti B, 1998, PLANT CELL ENVIRON, V21, P731, DOI 10.1046/j.1365-3040.1998.00305.x; SEXTON R, 1982, ANNU REV PLANT PHYS, V33, P133, DOI 10.1146/annurev.pp.33.060182.001025; SUTTLE JC, 1988, PLANT PHYSIOL, V88, P795, DOI 10.1104/pp.88.3.795; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang NN, 2005, J EXP BOT, V56, P909, DOI 10.1093/jxb/eri083; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012	55	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111258	10.1371/journal.pone.0111258	http://dx.doi.org/10.1371/journal.pone.0111258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365421	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100058
J	Li, SY; Zhai, X; Rong, PJ; McCabe, MF; Wang, X; Zhao, JJ; Ben, H; Wang, SX				Li, Shaoyuan; Zhai, Xu; Rong, Peijing; McCabe, Michael F.; Wang, Xing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing			Therapeutic Effect of Vagus Nerve Stimulation on Depressive-Like Behavior, Hyperglycemia and Insulin Receptor Expression in Zucker Fatty Rats	PLOS ONE			English	Article							ACUPUNCTURE; MELATONIN; DISORDER; OBESITY; MEMORY; TRIAL	Depression and type 2 diabetes (T2D) are common comorbid diseases and highly prevalent in the clinical setting with an unclarified mechanism. Zucker diabetic fatty (ZDF, fa/fa) rats natively develop T2D with hyperglycemia and hyperinsulinemia. Here we studied whether ZDF rats also innately develop depression, what a correlation is between depression and T2D, whether insulin receptor (IR) expression is involved in, and whether transcutaneous auricular vagus nerve stimulation (taVNS) would be beneficial in amelioration of the comorbidity. Six week old male ZDF and Zucker lean (ZL, fa/+) littermates were randomly divided into naive (ZDF, n = 6; ZL, n = 7) and taVNS (ZDF-taVNS, n = 8; ZL-taVNS, n = 6) groups. Once daily 30 min-taVNS sessions were administrated under anesthesia for 34 consecutive days in taVNS groups. Blood glucose levels were tested weekly, and plasma glycosylated hemoglobin (HbAlc) level and immobility time in forced swimming test were determined on day 35 in all groups. The expression of insulin receptor (IR) in various tissues was also detected by immunostaining and Western blot. We found that naive ZDF rats developed hyperglycemia steadily. These ZDF rats showed a strong positive correlation between longer immobility time and higher plasma HbAlC level. Long term taVNS treatment simultaneously prevented the development of depression-like behavior and progression of hyperglycemia in ZDF rats. The expression of IR in various tissues of naive ZDF rats is lower than in naive ZL and long-term taVNS treated ZDF rats. Collectively, our results indicate that in ZDF rats, i) depression and T2D develop simultaneously, ii) immobility time and HbAlc concentrations are highly and positively correlated, iii) a low expression of IR may be involved in the comorbidity of depression and T2D, and iv) taVNS is antidiabetic and antidepressive possibly through IR expression upregulation.	[Li, Shaoyuan; Zhai, Xu; Rong, Peijing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Li, Shaoyuan; Wang, Xing; Wang, Shuxing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan, Peoples R China; [McCabe, Michael F.; Wang, Shuxing] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Wang, Shuxing] Guangdong Entomol Inst, Primate Res Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Shuxing] Guangdong Landau Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Xinxiang Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Rong, PJ (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China.	rongpj@hotmail.com; 13718103762@139.com	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81271243]; National Basic Research Program of China (973 Program) [2012CB518503]; Project Supported National Science and Technology Ministry [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Project Supported National Science and Technology Ministry	This work was supported by National Natural Science Foundation of China, 81271243; National Basic Research Program of China (973 Program), 2012CB518503; and Project Supported National Science and Technology Ministry, 2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Belivani M, 2013, ACUPUNCT MED, V31, P88, DOI 10.1136/acupmed-2012-010247; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Cline BH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-110; Foran E, 2014, IR J MED SCI; Frese T, 2009, LIFE SCI, V85, P526, DOI 10.1016/j.lfs.2009.08.004; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Grillo CA, 2011, BEHAV BRAIN RES, V222, P230, DOI 10.1016/j.bbr.2011.03.052; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/615476; Huang F, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-203; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Lyons Zaza, 2012, Complement Ther Clin Pract, V18, P216, DOI 10.1016/j.ctcp.2012.06.003; MAURIZI CP, 1984, SOUTH MED J, V77, P1516, DOI 10.1097/00007611-198412000-00010; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Mendenhall E, 2014, DIABETES RES CLIN PR, V103, P276, DOI 10.1016/j.diabres.2014.01.001; Mischoulon D, 2012, J AFFECT DISORDERS, V141, P469, DOI 10.1016/j.jad.2012.03.023; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Wang Q, 2012, AM J CHINESE MED, V40, P1157, DOI 10.1142/S0192415X12500851; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Ward KR, 2011, HYPERTENSION, V57, P435, DOI 10.1161/HYPERTENSIONAHA.110.160671; Wilding JPH, 2014, INT J CLIN PRACT, V68, P682, DOI 10.1111/ijcp.12384; Yeung AS, 2011, J AFFECT DISORDERS, V130, P285, DOI 10.1016/j.jad.2010.07.025; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	35	19	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e112066	10.1371/journal.pone.0112066	http://dx.doi.org/10.1371/journal.pone.0112066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365428	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100144
J	Reikeras, O; Borgen, P				Reikeras, Olav; Borgen, Pal			Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma	PLOS ONE			English	Article							MULTIPLE ORGAN DYSFUNCTION; HIP-REPLACEMENT SURGERY; FEMORAL FRACTURES; INTERLEUKIN-6; CYTOKINES; INSTRUMENTATION; THROMBOSIS; INJURY; IL-8	Background: Traumatic injury induces changes in mediators of inflammation and coagulation, but the pivotal roles of inflammation and coagulation has not been precisely clarified. Therefore we have studied markers of inflammation and coagulation after a standardized musculoskeletal trauma like total hip replacement surgery. Methods: We allocated 21 patients aged 50 to 84 years who underwent total hip replacement surgery. Releases of TNF-alpha, IL-1 beta, IL-6, IL-8 and IL-10 and protrombin fragment F1.2 and plasmin-antiplasmin complex (PAP) were examined during surgery and up 6 days postoperatively, and systemic releases were compared to pre-operative values. Surgery induced significant increments in serum levels of IL-6 at 6 hours and at 1 day after surgery and in levels of IL-8 at 6 hours after surgery. There were no significant changes in serum levels of TNF-alpha, IL-1 beta or IL-10. There were significant increments in blood levels of F1.2 and PAP up to 6 days postoperatively with highest levels at 6 hours after surgery. There were only week correlations between IL-6 and IL-8 and F1.2 and PAP. Conclusion: Major musculoskeletal surgery causes changes of the inflammatory, coagulatory and fibrinolytic cascades in stable patients, but with no correlations between inflammation and coagulation and fibrinolysis.	[Reikeras, Olav] Oslo Univ Hosp, Rikshosp, Inst Clin Med, Oslo, Norway; [Borgen, Pal] Martina Hansens Hosp, Oslo, Norway	University of Oslo; National Hospital Norway	Reikeras, O (corresponding author), Oslo Univ Hosp, Rikshosp, Inst Clin Med, Oslo, Norway.	olav.reikeras@ous-hf.no						Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Arnesen H, 2003, J THROMB HAEMOST, V1, P971, DOI 10.1046/j.1538-7836.2003.00111.x; BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813; Bastian D, 2008, EUR SURG RES, V41, P334, DOI 10.1159/000157176; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; Dahl OE, 1995, BLOOD COAGUL FIBRIN, V6, P709, DOI 10.1097/00001721-199512000-00003; Easton R, 2014, INJURY, V45, P934, DOI 10.1016/j.injury.2013.12.002; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Flohe S, 2004, INTENS CARE MED, V30, P96, DOI 10.1007/s00134-003-2041-3; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Giannoudis PV, 2010, INJURY, V41, pS57, DOI 10.1016/S0020-1383(10)70011-5; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; HEIM D, 1995, J TRAUMA, V38, P899, DOI 10.1097/00005373-199506000-00013; Horn F, 2000, IMMUNOBIOLOGY, V202, P151, DOI 10.1016/S0171-2985(00)80061-3; JORGENSEN LN, 1990, THROMB RES, V59, P69, DOI 10.1016/0049-3848(90)90272-E; KWAAN HC, 1984, SEMIN THROMB HEMOST, V10, P71, DOI 10.1055/s-2007-1004409; Lee CC, 2001, ANN EMERG MED, V38, P170, DOI 10.1067/mem.2001.114313; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Mimasaka S, 2007, INJURY, V38, P1047, DOI 10.1016/j.injury.2007.02.045; Neunaber C, 2013, IMMUNOL LETT, V152, P159, DOI 10.1016/j.imlet.2013.05.012; Ozturk H, 2008, PEDIATR SURG INT, V24, P235, DOI 10.1007/s00383-007-2083-7; Pape HC, 1998, J TRAUMA, V45, P720, DOI 10.1097/00005373-199810000-00017; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Pape HC, 2003, J TRAUMA, V55, P7, DOI 10.1097/01.TA.0000075787.69695.4E; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; RISEBOROUGH EJ, 1976, CLIN ORTHOP RELAT R, P248; SAKAMOTO K, 1994, CYTOKINE, V6, P181, DOI 10.1016/1043-4666(94)90040-X; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e107881	10.1371/journal.pone.0107881	http://dx.doi.org/10.1371/journal.pone.0107881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364904	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100003
J	Cella, L; Palma, G; Deasy, JO; Oh, JH; Liuzzi, R; D'Avino, V; Conson, M; Pugliese, N; Picardi, M; Salvatore, M; Pacelli, R				Cella, Laura; Palma, Giuseppe; Deasy, Joseph O.; Oh, Jung Hun; Liuzzi, Raffaele; D'Avino, Vittoria; Conson, Manuel; Pugliese, Novella; Picardi, Marco; Salvatore, Marco; Pacelli, Roberto			Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role?	PLOS ONE			English	Article							RELATIVE SERIALITY MODEL; TERM CARDIAC MORTALITY; HODGKINS LYMPHOMA; CARDIOVASCULAR-DISEASE; DOSE-VOLUME; MEDIASTINAL IRRADIATION; INDUCED HYPOTHYROIDISM; BREAST-CANCER; NTCP MODELS; RADIOTHERAPY	Purpose: The purpose of this study is to compare different normal tissue complication probability (NTCP) models for predicting heart valve dysfunction (RVD) following thoracic irradiation. Methods: All patients from our institutional Hodgkin lymphoma survivors database with analyzable datasets were included (n = 90). All patients were treated with three-dimensional conformal radiotherapy with a median total dose of 32 Gy. The cardiac toxicity profile was available for each patient. Heart and lung dose-volume histograms (DVHs) were extracted and both organs were considered for Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) NTCP model fitting using maximum likelihood estimation. Bootstrap refitting was used to test the robustness of the model fit. Model performance was estimated using the area under the receiver operating characteristic curve (AUC). Results: Using only heart-DVHs, parameter estimates were, for the LKB model: D-50 = 32.8 Gy, n = 0.16 and m = 0.67; and for the RS model: D-50 = 32.4 Gy, s = 0.99 and gamma = 0.42. AUC values were 0.67 for LKB and 0.66 for RS, respectively. Similar performance was obtained for models using only lung-DVHs (LKB: D-50 = 33.2 Gy, n = 0.01, m = 0.19, AUC = 0.68; RS: D-50 = 24.4 Gy, s = 0.99, gamma = 2.12, AUC = 0.66). Bootstrap result showed that the parameter fits for lung-LKB were extremely robust. A combined heart-lung LKB model was also tested and showed a minor improvement (AUC = 0.70). However, the best performance was obtained using the previously determined multivariate regression model including maximum heart dose with increasing risk for larger heart and smaller lung volumes (AUC = 0.82). Conclusions: The risk of radiation induced valvular disease cannot be modeled using NTCP models only based on heart dose-volume distribution. A predictive model with an improved performance can be obtained but requires the inclusion of heart and lung volume terms, indicating that heart-lung interactions are apparently important for this endpoint.	[Cella, Laura; Palma, Giuseppe; Liuzzi, Raffaele; D'Avino, Vittoria; Conson, Manuel; Pacelli, Roberto] CNR, CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Cella, Laura; Liuzzi, Raffaele; Conson, Manuel; Salvatore, Marco; Pacelli, Roberto] Univ Naples Federico II, Sch Med, Dept Adv Biomed Sci, Naples, Italy; [Deasy, Joseph O.; Oh, Jung Hun] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Pugliese, Novella; Picardi, Marco] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; Memorial Sloan Kettering Cancer Center; University of Naples Federico II	Cella, L (corresponding author), CNR, CNR, Inst Biostruct & Bioimaging, Naples, Italy.	laura.cella@cnr.it	Palma, Giuseppe/AAX-1413-2020; Pacelli, Roberto/AFS-0333-2022; Liuzzi, Raffaele/AIC-0886-2022; D'Avino, Vittoria/ABG-1242-2020; Cella, Laura/L-5802-2019; Palma, Giuseppe/GXV-0228-2022; Salvatore, Marco/K-8083-2016	Liuzzi, Raffaele/0000-0002-2350-6691; D'Avino, Vittoria/0000-0001-8925-1022; Cella, Laura/0000-0003-0058-4029; Palma, Giuseppe/0000-0002-0210-268X; Oh, Jung Hun/0000-0001-8791-2755; CONSON, Manuel/0000-0002-0495-3656; Salvatore, Marco/0000-0001-9734-7702; Deasy, Joseph/0000-0002-9437-266X; PICARDI, Marco/0000-0001-8508-2524; Pacelli, Roberto/0000-0002-2048-7675	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [RBFR10Q0PT_001, RBNE08YFN3]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) in the framework of Fondo per gli Interventi alla Ricerca di Base (FIRB, RBFR10Q0PT_001 and RBNE08YFN3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Andratschke N, 2010, RADIOTHER ONCOL; BENTZEN SM, 1994, RADIOTHER ONCOL, V31, P85, DOI 10.1016/0167-8140(94)90416-2; Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448; Cella L, 2013, INT J RADIAT ONCOL, V87, P304, DOI 10.1016/j.ijrobp.2013.05.049; Cella L, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-22; Cella L, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-224; Cella L, 2012, INT J RADIAT ONCOL, V82, P1802, DOI 10.1016/j.ijrobp.2010.09.054; Cella L, 2011, RADIOTHER ONCOL, V101, P316, DOI 10.1016/j.radonc.2011.08.040; Cella L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-33; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Deasy JO, 2001, INT J RADIAT ONCOL, V51, P1389, DOI 10.1016/S0360-3016(01)02659-1; Di Biase A, 2014, RADIOTHER ONCOL, V11, P423; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Eriksson F, 2000, RADIOTHER ONCOL, V55, P153, DOI 10.1016/S0167-8140(00)00166-3; Feng M, 2011, INT J RADIAT ONCOL, V79, P10, DOI 10.1016/j.ijrobp.2009.10.058; Gagliardi G, 1996, BRIT J RADIOL, V69, P839, DOI 10.1259/0007-1285-69-825-839; Gagliardi G, 2001, SEMIN RADIAT ONCOL, V11, P224, DOI 10.1053/srao.2001.23483; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Ghobadi G, 2012, INT J RADIAT ONCOL, V84, pE639, DOI 10.1016/j.ijrobp.2012.07.2362; Heidenreich PA, 2003, J AM COLL CARDIOL, V42, P743, DOI 10.1016/S0735-1097(03)00759-9; Huang EX, 2011, ACTA ONCOL, V50, P51, DOI 10.3109/0284186X.2010.521192; JOINER MC, 2002, BASIC CLIN RADIOBIOL, P120; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kong FM, 2007, SEMIN RADIAT ONCOL, V17, P108, DOI 10.1016/j.semradonc.2006.11.007; Kong FM, 2011, INT J RADIAT ONCOL, V81, P1442, DOI 10.1016/j.ijrobp.2010.07.1977; KUTCHER GJ, 1989, INT J RADIAT ONCOL, V16, P1623, DOI 10.1016/0360-3016(89)90972-3; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P721, DOI 10.1093/ehjci/jet123; Lee TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089700; Louwe RJW, 2007, MED PHYS, V34, P1354, DOI 10.1118/1.2713216; Maraldo MV, 2013, ANN ONCOL, V24, P2113, DOI 10.1093/annonc/mdt156; Maraldo MV, 2012, INT J RADIAT ONCOL, V83, P1232, DOI 10.1016/j.ijrobp.2011.09.020; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Schellong G, 2010, PEDIATR BLOOD CANCER, V55, P1145, DOI 10.1002/pbc.22664; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; SCHULTZHECTOR S, 1992, RADIOTHER ONCOL, V23, P33, DOI 10.1016/0167-8140(92)90303-C; Semenenko VA, 2008, PHYS MED BIOL, V53, P737, DOI 10.1088/0031-9155/53/3/014; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Trott KR, 2012, RADIOTHER ONCOL, V105, P79, DOI 10.1016/j.radonc.2012.05.008; van Luijk P, 2005, CANCER RES, V65, P6509, DOI 10.1158/0008-5472.CAN-05-0786; van Luijk P, 2007, INT J RADIAT ONCOL, V69, P552, DOI 10.1016/j.ijrobp.2007.05.065; [No title captured], DOI DOI 10.2307/2347496)	42	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111753	10.1371/journal.pone.0111753	http://dx.doi.org/10.1371/journal.pone.0111753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360627	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943700149
J	Hill, NA; Barrett, N; Lawrence, E; Hulls, J; Dambacher, JM; Nichol, S; Williams, A; Hayes, KR				Hill, Nicole A.; Barrett, Neville; Lawrence, Emma; Hulls, Justin; Dambacher, Jeffrey M.; Nichol, Scott; Williams, Alan; Hayes, Keith R.			Quantifying Fish Assemblages in Large, Offshore Marine Protected Areas: An Australian Case Study	PLOS ONE			English	Article							UNDERWATER VIDEO STATIONS; CONTINENTAL-SHELF; SPECIES RICHNESS; NEW-ZEALAND; REEF FISH; PERFORMANCE; MANAGEMENT; RESOURCES; ABUNDANCE; HOTSPOTS	As the number of marine protected areas (MPAs) increases globally, so does the need to assess if MPAs are meeting their management goals. Integral to this assessment is usually a long-term biological monitoring program, which can be difficult to develop for large and remote areas that have little available fine-scale habitat and biological data. This is the situation for many MPAs within the newly declared Australian Commonwealth Marine Reserve (CMR) network which covers approximately 3.1 million km(2) of continental shelf, slope, and abyssal habitat, much of which is remote and difficult to access. A detailed inventory of the species, types of assemblages present and their spatial distribution within individual MPAs is required prior to developing monitoring programs to measure the impact of management strategies. Here we use a spatially-balanced survey design and non-extractive baited video observations to quantitatively document the fish assemblages within the continental shelf area (a multiple use zone, IUCN VI) of the Flinders Marine Reserve, within the Southeast marine region. We identified distinct demersal fish assemblages, quantified assemblage relationships with environmental gradients (primarily depth and habitat type), and described their spatial distribution across a variety of reef and sediment habitats. Baited videos recorded a range of species from multiple trophic levels, including species of commercial and recreational interest. The majority of species, whilst found commonly along the southern or south-eastern coasts of Australia, are endemic to Australia, highlighting the global significance of this region. Species richness was greater on habitats containing some reef and declined with increasing depth. The trophic breath of species in assemblages was also greater in shallow waters. We discuss the utility of our approach for establishing inventories when little prior knowledge is available and how such an approach may inform future monitoring efforts within the CMR network.	[Hill, Nicole A.; Barrett, Neville; Hulls, Justin] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Hill, Nicole A.; Barrett, Neville; Hulls, Justin; Dambacher, Jeffrey M.; Hayes, Keith R.] CSIRO, Digital Prod Flagship, Brisbane, Qld, Australia; [Nichol, Scott] Geosci Australia, Canberra, ACT, Australia; [Williams, Alan] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Geoscience Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hill, NA (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Nicole.Hill@utas.edu.au	Hill, Nicole/AAI-7323-2021; Barrett, Neville S/J-7593-2014; Hill, Nicole A/J-7856-2014; Hayes, Keith R/A-4550-2009; Williams, Alan/C-6999-2012; Lawrence, Emma/A-5584-2009	Hill, Nicole/0000-0001-9329-6717; Barrett, Neville S/0000-0002-6167-1356; Hill, Nicole A/0000-0001-9329-6717; Hayes, Keith R/0000-0003-4094-3575; Williams, Alan/0000-0002-2867-7713; 	Australian Government's National Environmental Research Program (NERP)	Australian Government's National Environmental Research Program (NERP)(Australian Government)	This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2012, GUIDELINES APPL IUCN; [Anonymous], 1995, MARINE PROTECTED ARE; ANZECC TFMPA, 1998, GUID EST NAT REPR SY; Bailey DM, 2007, MAR ECOL PROG SER, V350, P179, DOI 10.3354/meps07187; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bax NJ, 2001, MAR FRESHWATER RES, V52, P451, DOI 10.1071/MF00001; Bruce BD, 2001, ICES J MAR SCI, V58, P1072, DOI 10.1006/jmsc.2001.1099; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; CBD, 1995, 2 M C PART CONV BIOL; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Commonwealth of Australia, 2006, GUID INT MAR COAST R; Currie DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030138; Dambacher JM, 2009, N AM J FISH MANAGE, V29, P1091, DOI 10.1577/M08-077.1; Director of National Parks, 2013, S E COMM MAR RES NET; Edgar G.J., 2008, AUSTR MARINE LIFE PL, V2nd; Edgar G. J., 2014, NATURE; Fandry C, 1983, MARINE FRESHWATER RE, V34, P121, DOI DOI 10.1071/MF9830121; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Gomon MF, 2008, FISHES AUSTR SE COAS; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; HARRIS G, 1987, AUST J MAR FRESH RES, V38, P569; Harvey E. S., 2013, PLOS ONE, V8; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Kemp J, 2012, OCEANOGR MAR BIOL, V50, P287; Kloser RJ, 2006, MAPPING SEAFLOOR HAB, P93; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Larsen DP, 2008, J AGR BIOL ENVIR ST, V13, P243, DOI 10.1198/108571108X336593; Last PR, 2011, J BIOGEOGR, V38, P1484, DOI 10.1111/j.1365-2699.2011.02484.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Lucieer V, 2011, CONT SHELF RES, V31, P1236, DOI 10.1016/j.csr.2011.04.016; Maechler M., 2013, CLUSTER CLUSTER ANAL; National Tidal Centre, 2014, TID PRED AUSTR S PAC; Olsen A.R., 2012, DESIGN ANAL LONG TER, P126, DOI [10.1017/CBO9781139022422.010, DOI 10.1017/CBO9781139022422.010]; Phillips JA, 2001, BIODIVERS CONSERV, V10, P1555, DOI 10.1023/A:1011813627613; R Core Team, 2018, R LANG ENV STAT COMP; Schultz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049437; Seager J, 2014, TRANSECT MEASURE; Spalding MD, 2013, OCEAN YEARB, V27, P213, DOI 10.1163/22116001-90000160; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens DL, 2003, ENVIRONMETRICS, V14, P593, DOI 10.1002/env.606; Venables WN., 2002, MODERN APPL STAT S 4; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Whiteway TG, 2009, AUSTR BATHMETRY TOPO; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Zintzen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048522	51	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110831	10.1371/journal.pone.0110831	http://dx.doi.org/10.1371/journal.pone.0110831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360763	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700048
J	Lin, YL; Hu, YC; Liang, CC; Lin, SY; Liang, YC; Yuan, HP; Chiang, BL				Lin, Yu-Li; Hu, Yu-Chen; Liang, Cheng-Chao; Lin, Shih-Yeh; Liang, Yu-Chih; Yuan, Hui-Ping; Chiang, Bor-Luen			Enterovirus-71 Virus-Like Particles Induce the Activation and Maturation of Human Monocyte-Derived Dendritic Cells through TLR4 Signaling	PLOS ONE			English	Article							PAPILLOMAVIRUS-LIKE PARTICLES; NF-KAPPA-B; IMMUNE; EXPRESSION; RECEPTORS; LIPOPOLYSACCHARIDE; IMMUNIZATION; BLOOD; ENDOTOXINS; INFECTION	Enterovirus 71 (EV71) causes seasonal epidemics of hand-foot-and-mouth disease and has a high mortality rate among young children. We recently demonstrated potent induction of the humoral and cell-mediated immune response in monkeys immunized with EV71 virus-like particles (VLPs), with a morphology resembling that of infectious EV71 virions but not containing a viral genome, which could potentially be safe as a vaccine for EV71. To elucidate the mechanisms through which EV71 VLPs induce cell-mediated immunity, we studied the immunomodulatory effects of EV71 VLPs on human monocyte-derived dendritic cells (DCs), which bind to and incorporate EV71 VLPs. DC treatment with EV71 VLPs enhanced the expression of CD80, CD86, CD83, CD40, CD54, and HLA-DR on the cell surface; increased the production of interleukin (IL)-12 p40, IL-12 p70, and IL-10 by DCs; and suppressed the capacity of DCs for endocytosis. Treatment with EV71 VLPs also enhanced the ability of DCs to stimulate naive T cells and induced secretion of interferon (IFN)-gamma by T cells and Th1 cell responses. Neutralization with antibodies against Toll-like receptor (TLR) 4 suppressed the capacity of EV71 VLPs to induce the production of IL-12 p40, IL-12 p70, and IL-10 by DCs and inhibited EV71 VLPs binding to DCs. Our study findings clarified the important role for TLR4 signaling in DCs in response to EV71 VLPs and showed that EV71 VLPs induced inhibitor of kappaB alpha (I kappa B alpha) degradation and nuclear factor of kappaB (NF-kappa B) activation.	[Lin, Yu-Li; Yuan, Hui-Ping; Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Hsinchu, Taiwan; [Hu, Yu-Chen; Lin, Shih-Yeh] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan; [Liang, Cheng-Chao] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; Far Eastern Memorial Hospital; Taipei Medical University; National Taiwan University	Chiang, BL (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Hsinchu, Taiwan.	gicmbor@ntu.edu.tw		CHIANG, BOR-LUEN/0000-0002-6705-0286	National Science Council Taiwan [NSC 101-2321-B-002-093, NSC 101-2321-B-002-094]; National Taiwan University Hospital [102-S2200]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by grants (NSC 101-2321-B-002-093 and NSC 101-2321-B-002-094) from the National Science Council Taiwan (http://web1.nsc.gov.tw/) and from the National Taiwan University Hospital (102-S2200) (http://www.ntuh.gov.tw/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Ausiello CM, 2002, J INFECT DIS, V186, P351, DOI 10.1086/341510; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Buonaguro FM, 2009, EXPERT REV VACCINES, V8, P1379, DOI 10.1586/ERV.09.81; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chen JG, 2012, J MED VIROL, V84, P763, DOI 10.1002/jmv.23254; Chou NT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/735396; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Duenas AI, 2004, INT IMMUNOL, V16, P1467, DOI 10.1093/intimm/dxh148; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Korokhov N, 2005, MOL PHARMACEUT, V2, P218, DOI 10.1021/mp050002w; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Petsch D, 1998, ANAL BIOCHEM, V259, P42, DOI 10.1006/abio.1998.2655; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Ramqvist T, 2007, EXPERT OPIN BIOL TH, V7, P997, DOI 10.1517/14712598.7.7.997; Ren XX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-47; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Schulte BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062502; Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055; Szarewski A, 2010, EXPERT OPIN BIOL TH, V10, P477, DOI 10.1517/14712591003601944; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Vacher G, 2013, MOL PHARMACEUT, V10, P1596, DOI 10.1021/mp300597g; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083711; Yamayoshi S, 2013, J VIROL, V87, P3335, DOI 10.1128/JVI.02070-12; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan MY, 2005, IMMUNOL CELL BIOL, V83, P83, DOI 10.1111/j.1440-1711.2004.01291.x; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Yoshimoto T, 1996, J IMMUNOL, V156, P1082; Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4	49	15	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111496	10.1371/journal.pone.0111496	http://dx.doi.org/10.1371/journal.pone.0111496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360749	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700109
J	O'Hara, NN; Mugarura, R; Slobogean, GP; Bouchard, M				O'Hara, Nathan N.; Mugarura, Rodney; Slobogean, Gerard P.; Bouchard, Maryse			The Orthopaedic Trauma Patient Experience: A Qualitative Case Study of Orthopaedic Trauma Patients in Uganda	PLOS ONE			English	Article							GLOBAL BURDEN; INJURIES; KAMPALA	The disability adjusted life years (DALYs) associated with injuries have increased by 34% from 1990 to 2010, making it the 10 th leading cause of disability worldwide, with most of the burden affecting low-income countries. Although disability from injuries is often preventable, limited access to essential surgical services contributes to these increasing DALY rates. Similar to many other low-and middle-income countries (LMIC), Uganda is plagued by a growing volume of traumatic injuries. The aim of this study is to explore the orthopaedic trauma patient's experience in accessing medical care in Uganda and what affects the injury might have on the socioeconomic status for the patient and their dependents. We also evaluate the factors that impact an individual's ability to access an appropriate treatment facility for their traumatic injury. Semi-structured interviews were conducted with patients 18 year of age or older admitted with a fractured tibia or femur at Mulago National Referral Hospital in Kampala, Uganda. As limited literature exists on the socioeconomic impacts of disability from trauma, we designed a descriptive qualitative case study, using thematic analysis, to extract unique information for which little has been previously been documented. This methodology is subject to less bias than other qualitative methods as it imposes fewer preconceptions. Data analysis of the patient interviews (n = 35) produced over one hundred codes, nine sub-themes and three overarching themes. The three overarching categories revealed by the data were: 1) the importance of social supports; 2) the impact of and on economic resources; and 3) navigating the healthcare system. Limited resources to fund the treatment of orthopaedic trauma patients in Uganda leads to reliance of patients on their friends, family, and hospital connections, and a tremendous economic burden that falls on the patient and their dependents.	[O'Hara, Nathan N.; Slobogean, Gerard P.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Mugarura, Rodney] Makerere Univ, Dept Orthopaed, Kampala, Uganda; [Bouchard, Maryse] Seattle Childrens Hosp, Dept Orthopaed, Seattle, WA USA	University of British Columbia; Makerere University; Seattle Children's Hospital	O'Hara, NN (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada.	nathan.ohara@vch.ca	O'Hara, Nathan/O-7168-2018; O'Hara, Nathan/AAD-2819-2019	O'Hara, Nathan/0000-0003-0537-3474; O'Hara, Nathan/0000-0003-0537-3474; Bouchard, Maryse/0000-0003-1321-2478	Uganda Sustainable Trauma Orthopaedic Program	Uganda Sustainable Trauma Orthopaedic Program	This study was funded by the Uganda Sustainable Trauma Orthopaedic Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg S, 2003, GLOBAL BURDEN INJURY; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bouchard M, 2011, THESIS U TORONTO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Galukande M., 2009, East and Central African Journal of Surgery, V14, P33; Grimes CE, 2011, WORLD J SURG, V35, P941, DOI 10.1007/s00268-011-1010-1; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; International Labour Organization, 2012, RES GUID INF EC; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Mock C, 2008, CLIN ORTHOP RELAT R, V466, P2306, DOI 10.1007/s11999-008-0416-z; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Sandelowski M, 1991, Image J Nurs Sch, V23, P161, DOI 10.1111/j.1547-5069.1991.tb00662.x; The World Bank, 2011, UG 2011 12 NAT PAN S; The World Bank, 2013, WORK INF EC; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	17	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110940	10.1371/journal.pone.0110940	http://dx.doi.org/10.1371/journal.pone.0110940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360815	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943700054
J	Sekulic, V; Lawrence, JJ; Skinner, FK				Sekulic, Vladislav; Lawrence, J. Josh; Skinner, Frances K.			Using Multi-Compartment Ensemble Modeling As an Investigative Tool of Spatially Distributed Biophysical Balances: Application to Hippocampal Oriens-Lacunosum/Moleculare (O-LM) Cells	PLOS ONE			English	Article							I-H; GLOBUS-PALLIDUS; INHIBITORY INTERNEURONS; CHANNEL EXPRESSION; NEURON MODELS; THETA-RHYTHM; VARIABILITY; MODULATION; DENDRITES; COMPENSATION	Multi-compartmental models of neurons provide insight into the complex, integrative properties of dendrites. Because it is not feasible to experimentally determine the exact density and kinetics of each channel type in every neuronal compartment, an essential goal in developing models is to help characterize these properties. To address biological variability inherent in a given neuronal type, there has been a shift away from using hand-tuned models towards using ensembles or populations of models. In collectively capturing a neuron's output, ensemble modeling approaches uncover important conductance balances that control neuronal dynamics. However, conductances are never entirely known for a given neuron class in terms of its types, densities, kinetics and distributions. Thus, any multi-compartment model will always be incomplete. In this work, our main goal is to use ensemble modeling as an investigative tool of a neuron's biophysical balances, where the cycling between experiment and model is a design criterion from the start. We consider orienslacunosum/moleculare (O-LM) interneurons, a prominent interneuron subtype that plays an essential gating role of information flow in hippocampus. O-LM cells express the hyperpolarization-activated current (I-h). Although dendritic I-h could have a major influence on the integrative properties of O-LM cells, the compartmental distribution of I-h on O-LM dendrites is not known. Using a high-performance computing cluster, we generated a database of models that included those with or without dendritic I-h. A range of conductance values for nine different conductance types were used, and different morphologies explored. Models were quantified and ranked based on minimal error compared to a dataset of OLM cell electrophysiological properties. Co-regulatory balances between conductances were revealed, two of which were dependent on the presence of dendritic I-h. These findings inform future experiments that differentiate between somatic and dendritic I-h, thereby continuing a cycle between model and experiment.	[Sekulic, Vladislav; Skinner, Frances K.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Sekulic, Vladislav; Skinner, Frances K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Skinner, Frances K.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Lawrence, J. Josh] Univ Montana, NIH, COBRE Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Lawrence, J. Josh] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); University of Montana System; University of Montana; University of Montana System; University of Montana	Sekulic, V (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	vlad.sekulic@utoronto.ca		Skinner, Frances/0000-0001-7819-4202	National Institutes of Health; SciNet HPC Consortium; NIH [R01 NS069689]; NSERC [RGPIN203700-11]; University of Toronto Fellowship; Natural Sciences and Engineering Research Council; Dept. of Physiology; University of Toronto; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SciNet HPC Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Fellowship(University of Toronto); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dept. of Physiology; University of Toronto(University of Toronto); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, Natural Sciences and Engineering Research Council, a Dept. of Physiology, University of Toronto Fellowship, and the SciNet HPC Consortium. The relevant grant numbers and websites for the funding agencies are: NIH R01 NS069689 http://www.nih.gov; NSERC RGPIN203700-11 http://www.nserc-crsng.gc.ca/; University of Toronto Fellowship http://www.physiology.utoronto.ca; SciNet HPC Consortium http://www.scinethpc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Bartos M, 2011, NEUROPHARMACOLOGY, V60, P730, DOI 10.1016/j.neuropharm.2010.12.017; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; Cutsuridis V, 2012, HIPPOCAMPUS, V22, P1597, DOI 10.1002/hipo.21002; Cutsuridis V, 2010, HIPPOCAMPUS, V20, P423, DOI 10.1002/hipo.20661; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Druckmann S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002133; Edgerton JR, 2011, J NEUROSCI, V31, P10919, DOI 10.1523/JNEUROSCI.6062-10.2011; Edgerton JR, 2010, J NEUROSCI, V30, P15146, DOI 10.1523/JNEUROSCI.2662-10.2010; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Gunay C, 2009, NEUROINFORMATICS, V7, P93, DOI 10.1007/s12021-009-9048-z; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kispersky TJ, 2012, J NEUROSCI, V32, P3637, DOI 10.1523/JNEUROSCI.1361-11.2012; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lawrence JJ, 2006, J PHYSIOL-LONDON, V571, P555, DOI 10.1113/jphysiol.2005.103218; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1113/jphysiol.2001.013066; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Matt L, 2011, CELL MOL LIFE SCI, V68, P125, DOI 10.1007/s00018-010-0446-z; model Rall, 2009, SCHOLARPEDIA, V4, P1369; Morse TM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00016; Nemri A, 2010, SCHOLARPEDIA, V5, P8577, DOI DOI 10.4249/SCHOLARPEDIA.8577; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; Pangalos M, 2013, P NATL ACAD SCI USA, V110, P4398, DOI 10.1073/pnas.1215496110; Peng W, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P89; Peng W, 2005, THESIS WORCESTER POL; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Ransdell JL, 2013, J NEUROSCI, V33, P9950, DOI 10.1523/JNEUROSCI.1095-13.2013; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Saraga F, 2003, J PHYSIOL-LONDON, V552, P673, DOI 10.1113/jphysiol.2003.046177; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; SIK A, 1995, J NEUROSCI, V15, P6651; Skinner F, 2010, SPR SER COMPUT NEURO, V5, P399, DOI 10.1007/978-1-4419-0996-1_14; Smolinski Tomasz G., 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P2964, DOI 10.1109/IJCNN.2009.5178722; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Temporal S, 2012, J NEUROPHYSIOL, V107, P718, DOI 10.1152/jn.00622.2011; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Van Geit W, 2008, BIOL CYBERN, V99, P241, DOI 10.1007/s00422-008-0257-6	75	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e106567	10.1371/journal.pone.0106567	http://dx.doi.org/10.1371/journal.pone.0106567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360752	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700004
J	Benck, JD; Pinaud, BA; Gorlin, Y; Jaramillo, TF				Benck, Jesse D.; Pinaud, Blaise A.; Gorlin, Yelena; Jaramillo, Thomas F.			Substrate Selection for Fundamental Studies of Electrocatalysts and Photoelectrodes: Inert Potential Windows in Acidic, Neutral, and Basic Electrolyte	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODES; INDIUM-TIN OXIDE; TRANSPARENT CONDUCTING OXIDES; SCANNING-TUNNELING-MICROSCOPY; HYDROGEN EVOLUTION REACTION; ORDERED PYROLYTIC-GRAPHITE; ELECTROCHEMICAL OXIDATION; SURFACE-STRUCTURE; OXYGEN REDUCTION; GOLD	The selection of an appropriate substrate is an important initial step for many studies of electrochemically active materials. In order to help researchers with the substrate selection process, we employ a consistent experimental methodology to evaluate the electrochemical reactivity and stability of seven potential substrate materials for electrocatalyst and photoelectrode evaluation. Using cyclic voltammetry with a progressively increased scan range, we characterize three transparent conducting oxides (indium tin oxide, fluorine-doped tin oxide, and aluminum-doped zinc oxide) and four opaque conductors (gold, stainless steel 304, glassy carbon, and highly oriented pyrolytic graphite) in three different electrolytes (sulfuric acid, sodium acetate, and sodium hydroxide). We determine the inert potential window for each substrate/electrolyte combination and make recommendations about which materials may be most suitable for application under different experimental conditions. Furthermore, the testing methodology provides a framework for other researchers to evaluate and report the baseline activity of other substrates of interest to the broader community.	[Benck, Jesse D.; Pinaud, Blaise A.; Gorlin, Yelena; Jaramillo, Thomas F.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Jaramillo, TF (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jaramillo@stanford.edu	Jaramillo, Thomas F/C-4174-2014; Gorlin, Yelena/O-3423-2014	Jaramillo, Thomas F/0000-0001-9900-0622; 	Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0001060]; CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation [CHE-1305124]; National Science Foundation Graduate Research Fellowship Program; Stanford Graduate Fellowship; United Technologies Research Center fellowship in Sustainable Energy; Natural Sciences and Engineering Research Council of Canada graduate award	Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); United Technologies Research Center fellowship in Sustainable Energy; Natural Sciences and Engineering Research Council of Canada graduate award(Natural Sciences and Engineering Research Council of Canada (NSERC))	JDB and YG were supported as part of the Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under Award No. DE-SC0001060. Funding source websites: (http://cneec.stanford.edu/) and (http://science.energy.gov/bes/). BAP was supported by CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation under Grant No. CHE-1305124. Funding source websites: (http://www.ccisolar.caltech.edu/) and (http://www.nsf.gov/). JDB received support from the National Science Foundation Graduate Research Fellowship Program and a Stanford Graduate Fellowship. Funding source websites: (http://www.nsfgrfp.org/) and (http://sgf. stanford.edu/). BAP received funding from a United Technologies Research Center fellowship in Sustainable Energy and a Natural Sciences and Engineering Research Council of Canada graduate award. Funding source websites: (http://www.utrc.utc.com/about-fellows.html) and (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, CARBON ELECTROCHEMIC, DOI DOI 10.1016/j.jpowsour.2007.12.091; ARMSTRONG NR, 1976, ANAL CHEM, V48, P741, DOI 10.1021/ac60368a035; Azom: Stainless Steel-Grade 304, 2013, GRADE 304 STAINLESS; Bard A. J., 1980, ELECTROCHEMICAL METH; BARNARTT S, 1959, J ELECTROCHEM SOC, V106, P991, DOI 10.1149/1.2427196; BEILBY AL, 1995, ANAL CHEM, V67, P976, DOI 10.1021/ac00101a027; BELLINGHAM JR, 1992, J MATER SCI LETT, V11, P263, DOI 10.1007/BF00729407; Benck JD, 2014, ADV ENERGY IN PRESS; Bio-Logic Science Instruments, 2013, 28 BIOL SCI INSTR; BOND AM, 1990, Z CHEM, V30, P117; BOWERS ML, 1991, ANAL CHIM ACTA, V243, P43, DOI 10.1016/S0003-2670(00)82538-6; BOWERS ML, 1991, ANAL CHIM ACTA, V248, P127, DOI 10.1016/S0003-2670(00)80877-6; BOWLING RJ, 1989, J AM CHEM SOC, V111, P1217, DOI 10.1021/ja00186a008; BURKE LD, 1992, ELECTROCHIM ACTA, V37, P2087, DOI 10.1016/0013-4686(92)87126-K; BURKE LD, 1992, J ELECTROCHEM SOC, V139, P399, DOI 10.1149/1.2069230; BURKE LD, 1992, ELECTROCHIM ACTA, V37, P585, DOI 10.1016/0013-4686(92)80058-T; Cai M, 1996, J ELECTROCHEM SOC, V143, P2125, DOI 10.1149/1.1836970; Chen FY, 2012, INT J ELECTROCHEM SC, V7, P3750; Chen Z., 2013, PHOTOELECTROCHEMICAL; Chen ZB, 2011, NANO LETT, V11, P4168, DOI 10.1021/nl2020476; CHOPRA KL, 1983, THIN SOLID FILMS, V102, P1, DOI 10.1016/0040-6090(83)90256-0; Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1; ENGSTROM RC, 1984, ANAL CHEM, V56, P136, DOI 10.1021/ac00266a005; ENGSTROM RC, 1982, ANAL CHEM, V54, P2310, DOI 10.1021/ac00250a038; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Ginley DS, 2010, HANDBOOK OF TRANSPARENT CONDUCTORS, P1, DOI 10.1007/978-1-4419-1638-9; Gordon RG, 2000, MRS BULL, V25, P52, DOI 10.1557/mrs2000.151; GOSS CA, 1993, ANAL CHEM, V65, P1378, DOI 10.1021/ac00058a014; Goyal RN, 2010, TALANTA, V83, P149, DOI 10.1016/j.talanta.2010.08.054; Guenther G, 2008, J APPL PHYS, V104, DOI 10.1063/1.2958323; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; Han J, 2010, J HAZARD MATER, V178, P115, DOI 10.1016/j.jhazmat.2010.01.050; HAUPT S, 1995, CORROS SCI, V37, P43, DOI 10.1016/0010-938X(94)00104-E; HOARE JP, 1984, J ELECTROCHEM SOC, V131, P1808, DOI 10.1149/1.2115966; HU IF, 1985, J ELECTROANAL CHEM, V188, P59, DOI 10.1016/S0022-0728(85)80050-4; Huang CA, 2003, ELECTROCHIM ACTA, V48, P3599, DOI 10.1016/S0013-4686(03)00480-8; IZUMI T, 1991, J ELECTROANAL CHEM, V303, P151, DOI 10.1016/0022-0728(91)85122-6; JAKSIC MM, 1993, INT J HYDROGEN ENERG, V18, P91, DOI 10.1016/0360-3199(93)90196-H; Jaramillo TF, 2008, J PHYS CHEM C, V112, P17492, DOI 10.1021/jp802695e; Jegdic B, 2006, J SERB CHEM SOC, V71, P543, DOI 10.2298/JSC0605543J; Ji XB, 2006, J PHYS CHEM B, V110, P22306, DOI 10.1021/jp065776m; Juodkazis K, 2000, ELECTROCHEM COMMUN, V2, P503, DOI 10.1016/S1388-2481(00)00069-2; JURGEN D, 1992, J ELECTROANAL CHEM, V333, P177, DOI 10.1016/0022-0728(92)80390-P; KAMAU GN, 1988, ANAL CHIM ACTA, V207, P1, DOI 10.1016/S0003-2670(00)80777-1; KAMAU GN, 1985, ANAL CHEM, V57, P545, DOI 10.1021/ac50001a049; KEPLEY LJ, 1988, ANAL CHEM, V60, P1459, DOI 10.1021/ac00165a022; Kibsgaard J, 2006, J AM CHEM SOC, V128, P13950, DOI 10.1021/ja0651106; Kiema GK, 2003, J ELECTROANAL CHEM, V540, P7, DOI 10.1016/S0022-0728(02)01264-0; Klein A, 2013, J AM CERAM SOC, V96, P331, DOI 10.1111/jace.12143; KRAFT A, 1994, J ELECTROANAL CHEM, V365, P191, DOI 10.1016/0022-0728(93)03056-U; Kuhl K, 2013, ELECTROCHEMICAL REDU; Lee HBR, 2013, NANO LETT, V13, P457, DOI 10.1021/nl303803p; Li G., 2013, ELECTROCHEMICAL ANAL, P5, DOI DOI 10.1007/978-3-642-34252-3; Ling Y, 1997, J ELECTROCHEM SOC, V144, P2689, DOI 10.1149/1.1837883; Liu HY, 2010, SUPERLATTICE MICROST, V48, P458, DOI 10.1016/j.spmi.2010.08.011; MARTINEZ MA, 1992, ELECTROCHIM ACTA, V37, P2565, DOI 10.1016/0013-4686(92)87053-3; Matveeva E, 2005, J ELECTROCHEM SOC, V152, pH138, DOI 10.1149/1.1984348; McNaught A.D., 1997, COMPENDIUM CHEM TERM; Michalkiewicz S, 2004, CHEM ANAL-WARSAW, V49, P121; Minami T, 2005, SEMICOND SCI TECH, V20, pS35, DOI 10.1088/0268-1242/20/4/004; Moore RR, 2004, ANAL CHEM, V76, P2677, DOI 10.1021/ac040017q; OGURA K, 1971, J ELECTROCHEM SOC, V118, P531, DOI 10.1149/1.2408105; Olivares-Ramirez JM, 2007, INT J HYDROGEN ENERG, V32, P3170, DOI 10.1016/j.ijhydene.2006.03.017; Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1; Olsson J, 2002, TRANSPASSIVE CORROSI; Orlik M., 2007, ELECTROCHEMISTRY GOL; Paulauskas IE, 2011, INT J ELECTROCHEM, V2011, DOI 10.4061/2011/563427; Pourbaix M., 1966, ATLAS ELECTROCHEMICA, Vfirst English; Qiao LJ, 1998, CORROSION, V54, P281, DOI 10.5006/1.3284854; Qiao Q, 2006, SOL ENERG MAT SOL C, V90, P1034, DOI 10.1016/j.solmat.2005.05.020; Revie RW, 2008, IRON STEEL CORROSION; Revie RW, 2008, PASSIVITY CORROSION; Senthilkumar M, 2008, MATER CHEM PHYS, V108, P403, DOI 10.1016/j.matchemphys.2007.10.030; SPI Supplies, 2013, HIGHL ORD PYR GRAPH; Stadler A, 2012, MATERIALS, V5, P661, DOI 10.3390/ma5040661; Steel AK., 2007, 304 304L STAINL STEE; The Economist, 2014, THE ECONOMIST; THORNTON DC, 1985, ANAL CHEM, V57, P150, DOI 10.1021/ac00279a037; Timperman L, 2010, ELECTROCHIM ACTA, V55, P7558, DOI 10.1016/j.electacta.2009.09.076; VANDERLINDEN WE, 1980, ANAL CHIM ACTA, V119, P1, DOI 10.1016/S0003-2670(00)00025-8; Vanysek P., 2012, CRC HDB CHEM PHYS, V93rd; Vesborg PCK, 2012, RSC ADV, V2, P7933, DOI 10.1039/c2ra20839c; Wang H, 2009, ACTA PHYS-CHIM SIN, V25, P835, DOI 10.3866/PKU.WHXB20090504; YAMADA S, 1962, NATURE, V193, P261, DOI 10.1038/193261b0; Yeo BS, 2010, CHEMPHYSCHEM, V11, P1854, DOI 10.1002/cphc.201000294; ZHANG BL, 1995, ELECTROCHIM ACTA, V40, P2627, DOI 10.1016/0013-4686(95)00111-Q; Zhang JD, 1996, BIOELECTROCH BIOENER, V39, P267, DOI 10.1016/0302-4598(95)01893-X; Zhang JL, 2005, ANGEW CHEM INT EDIT, V44, P2132, DOI 10.1002/anie.200462335; Zhao QL, 2008, ELECTROCHEM COMMUN, V10, P181, DOI 10.1016/j.elecom.2007.11.017; Zhao QL, 2009, BIOSENS BIOELECTRON, V24, P3003, DOI 10.1016/j.bios.2009.03.005; ZITTEL HE, 1965, ANAL CHEM, V37, P200, DOI 10.1021/ac60221a006; Zoski CG, 2007, HANDBOOK OF ELECTROCHEMISTRY, pV, DOI 10.1016/B978-044451958-0.50000-8	92	160	161	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e107942	10.1371/journal.pone.0107942	http://dx.doi.org/10.1371/journal.pone.0107942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357131	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000003
J	Gomez, M; Perez-Gallardo, RV; Sanchez, LA; Diaz-Perez, AL; Cortes-Rojo, C; Carmen, VM; Saavedra-Molina, A; Lara-Romero, J; Jimenez-Sandoval, S; Rodriguez, F; Rodriguez-Zavala, JS; Campos-Garcia, J				Gomez, Mauricio; Perez-Gallardo, Rocio V.; Sanchez, Luis A.; Diaz-Perez, Alma L.; Cortes-Rojo, Christian; Meza Carmen, Victor; Saavedra-Molina, Alfredo; Lara-Romero, Javier; Jimenez-Sandoval, Sergio; Rodriguez, Francisco; Rodriguez-Zavala, Jose S.; Campos-Garcia, Jesus			Malfunctioning of the Iron-Sulfur Cluster Assembly Machinery in Saccharomyces cerevisiae Produces Oxidative Stress via an Iron-Dependent Mechanism, Causing Dysfunction in Respiratory Complexes	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; ELECTRON-TRANSPORT; PROTEIN BIOGENESIS; YEAST; ETHANOL; MITOCHONDRIA; LIVER; DEHYDROGENASE; MATURATION; GENE	Biogenesis and recycling of iron-sulfur (Fe-S) clusters play important roles in the iron homeostasis mechanisms involved in mitochondrial function. In Saccharomyces cerevisiae, the Fe-S clusters are assembled into apoproteins by the iron-sulfur cluster machinery (ISC). The aim of the present study was to determine the effects of ISC gene deletion and consequent iron release under oxidative stress conditions on mitochondrial functionality in S. cerevisiae. Reactive oxygen species (ROS) generation, caused by H2O2, menadione, or ethanol, was associated with a loss of iron homeostasis and exacerbated by ISC system dysfunction. ISC mutants showed increased free Fe2+ content, exacerbated by ROS-inducers, causing an increase in ROS, which was decreased by the addition of an iron chelator. Our study suggests that the increment in free Fe2+ associated with ROS generation may have originated from mitochondria, probably Fe-S cluster proteins, under both normal and oxidative stress conditions, suggesting that Fe-S cluster anabolism is affected. Raman spectroscopy analysis and immunoblotting indicated that in mitochondria from SSQ1 and ISA1 mutants, the content of [Fe-S] centers was decreased, as was formation of Rieske protein-dependent supercomplex III2IV2, but this was not observed in the iron-deficient ATX1 and MRS4 mutants. In addition, the activity of complexes II and IV from the electron transport chain (ETC) was impaired or totally abolished in SSQ1 and ISA1 mutants. These results confirm that the ISC system plays important roles in iron homeostasis, ROS stress, and in assembly of supercomplexes III2IV2 and III2IV1, thus affecting the functionality of the respiratory chain.	[Gomez, Mauricio; Perez-Gallardo, Rocio V.; Sanchez, Luis A.; Diaz-Perez, Alma L.; Meza Carmen, Victor; Campos-Garcia, Jesus] Univ Michoacana, Inst Invest Quim Biol, Lab Biotecnol Microbiana, Morelia, Michoacan, Mexico; [Cortes-Rojo, Christian; Saavedra-Molina, Alfredo] Univ Michoacana, Inst Invest Quim Biol, Lab Bioquim, Morelia, Michoacan, Mexico; [Lara-Romero, Javier] Univ Michoacana, Fac Ingn Quim, Morelia, Michoacan, Mexico; [Jimenez-Sandoval, Sergio; Rodriguez, Francisco] IPN, Ctr Invest & Estudios Avanzados, Unidad Queretaro, Queretaro, Mexico; [Rodriguez-Zavala, Jose S.] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; National Institute of Cardiology - Mexico	Campos-Garcia, J (corresponding author), Univ Michoacana, Inst Invest Quim Biol, Lab Biotecnol Microbiana, Morelia, Michoacan, Mexico.	jcgarcia@umich.mx	Rodriguez-Zavala, Jose S/AAI-3604-2020; Cortes, Christian./ABF-4312-2021; Campos-Garcia, Jesus/A-9368-2013; Sandoval, Sergio Joaquín Jiménez/A-9627-2015; Saavedra-Molina, Alfredo/AAH-5607-2020	Rodriguez-Zavala, Jose S/0000-0002-7094-5523; Campos-Garcia, Jesus/0000-0002-8337-5830; Sandoval, Sergio Joaquín Jiménez/0000-0002-2143-3759; Cortes-Rojo, Christian/0000-0002-4850-772X; MEZA-CARMEN, VICTOR/0000-0003-2838-7211; Gomez Gallardo, Mauricio/0000-0001-8132-7854	CONACYT [106567]; Universidad Michoacana de San Nicolas de Hidalgo (UMSNH) [C.I.C. 2.14];  [FOMIX-C01-117130]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Michoacana de San Nicolas de Hidalgo (UMSNH); 	This research was funded by CONACYT (106567), FOMIX-C01-117130, and C.I.C. 2.14/Universidad Michoacana de San Nicolas de Hidalgo (UMSNH) grants. RVPG, MG, and LAS received a scholarship by CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; Bakker BM, 2000, J BACTERIOL, V182, P4730, DOI 10.1128/JB.182.17.4730-4737.2000; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Conte L, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/363941; Cortes-Rojo C, 2009, J BIOENERG BIOMEMBR, V41, P15, DOI 10.1007/s10863-009-9200-3; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Esfandiari N, 2003, J ANDROL, V24, P862; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; GUIARD B, 1985, EMBO J, V4, P3265, DOI 10.1002/j.1460-2075.1985.tb04076.x; HENSON CP, 1967, J BIOL CHEM, V242, P3833; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HIRANO T, 1992, HEPATOLOGY, V16, P1423; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Lange H, 2004, J BIOL CHEM, V279, P29101, DOI 10.1074/jbc.M403721200; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; NELSON MJ, 1991, J AM CHEM SOC, V113, P7072, DOI 10.1021/ja00018a074; NORDMANN R, 1987, ENZYME, V37, P57, DOI 10.1159/000469241; Pahlman IL, 2002, J BIOL CHEM, V277, P27991, DOI 10.1074/jbc.M204079200; Perez-Gallardo RV, 2013, FEMS YEAST RES, V13, P804, DOI 10.1111/1567-1364.12090; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; STAL P, 1993, J HEPATOL, V17, P108, DOI 10.1016/S0168-8278(05)80530-6; Stames EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077234; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; THAYER WS, 1981, J BIOL CHEM, V256, P6090; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Xu N, 2012, FEMS YEAST RES, V12, P844, DOI 10.1111/j.1567-1364.2012.00835.x; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	62	35	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111585	10.1371/journal.pone.0111585	http://dx.doi.org/10.1371/journal.pone.0111585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356756	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000070
J	Zhang, L; Ye, L; Ojcius, DM; Lou, XY; Wang, CW; Feng, C; Sun, Y; Wang, ZF; Li, SB; Zhang, YJ				Zhang, Lei; Ye, Ling; Ojcius, David M.; Lou, Xiuyu; Wang, Chengwei; Feng, Cen; Sun, Yi; Wang, Zhongfa; Li, Shibo; Zhang, Yanjun			Characterization of Severe Fever with Thrombocytopenia Syndrome in Rural Regions of Zhejiang, China	PLOS ONE			English	Article							SYNDROME VIRUS; SHANDONG PROVINCE; RISK-FACTORS; BUNYAVIRUS; SEROPREVALENCE; INFECTIONS; ANTIBODIES; JIANGSU	Severe fever with thrombocytopenia syndrome virus (SFTSV) infections have recently been found in rural regions of Zhejiang. A severe fever with thrombocytopenia syndrome (SFTS) surveillance and sero-epidemiological investigation was conducted in the districts with outbreaks. During the study period of 2011-2014, a total of 51 SFTSV infection cases were identified and the case fatality rate was 12% (6/51). Ninety two percent of the patients (47/51) were over 50 years of age, and 63% (32/51) of laboratory confirmed cases occurred from May to July. Nine percent (11/120) of the serum samples from local healthy people without symptoms were found to be positive for antibodies to the SFTS virus. SFTSV strains were isolated by culture using Vero, and the whole genomic sequences of two SFTSV strains (01 and Zhao) were sequenced and submitted to the GenBank. Homology analysis showed that the similarity of the target nucleocapsid gene from the SFTSV strains from different geographic areas was 94.2-100%. From the constructed phylogenetic tree, it was found that all the SFTSV strains diverged into two main clusters. Only the SFTSV strains from the Zhejiang (Daishan) region of China and the Yamaguchi, Miyazakj regions of Japan, were clustered into lineage II, consistent with both of these regions being isolated areas with similar geographic features. Two out of eight predicted linear B cell epitopes from the nucleocapsid protein showed mutations between the SFTSV strains of different clusters, but did not contribute to the binding ability of the specific SFTSV antibodies. This study confirmed that SFTSV has been circulating naturally and can cause a seasonal prevalence in Daishan, China. The results also suggest that the molecular characteristics of SFTSV are associated with the geographic region and all SFTSV strains can be divided into two genotypes.	[Zhang, Lei; Lou, Xiuyu; Feng, Cen; Sun, Yi; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhang, Lei] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Ye, Ling; Wang, Chengwei; Wang, Zhongfa] Ctr Dis Control & Prevent Daishan, Zhoushan, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Li, Shibo] Zhoushan Hosp, Zhoushan, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; University of Alberta; University of California System; University of California Merced; University of California System; University of California Merced	Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	yjzhang@cdc.zj.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81401370]; Zhejiang Provincial Natural Science Foundation of China [LY14H260005]; Science and Technology department of Zhejiang, China [2012C33063, 2011R50021]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Medical Research Program [2014KYB058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science and Technology department of Zhejiang, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Medical Research Program	Support from National Natural Science Foundation of China (81401370) (http://www.nsfc.gov.cn/), ZL; Zhejiang Provincial Natural Science Foundation of China (LY14H260005) (http://www.zjnsf.gov.cn/), ZL. Grants from Science and Technology department of Zhejiang, China (2012C33063) (2011R50021) (http:// www.zjkjt.gov.cn/), YZ; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents (http://www.zjwst.gov.cn/), YZ; and Zhejiang Provincial Medical Research Program (2014KYB058) (http://www.zjwst.gov.cn/), XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Cui N, 2014, J CLIN VIROL, V59, P12, DOI 10.1016/j.jcv.2013.10.024; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Guo XL, 2013, CLIN VACCINE IMMUNOL, V20, P1426, DOI 10.1128/CVI.00222-13; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liang SY, 2014, AM J TROP MED HYG, V90, P256, DOI 10.4269/ajtmh.13-0423; Liu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002820; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L, 2013, INT J INFECT DIS, V17, pE137, DOI 10.1016/j.ijid.2012.07.007; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	20	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111127	10.1371/journal.pone.0111127	http://dx.doi.org/10.1371/journal.pone.0111127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356556	Green Published, gold			2022-12-26	WOS:000346765000041
J	Liang, Y; Gao, H; Lin, SY; Goss, JA; Du, C; Li, K				Liang, Y.; Gao, H.; Lin, S-Y; Goss, J. A.; Du, C.; Li, K.			Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; LI-FRAUMENI-SYNDROME; INDUCED CELL-DEATH; BREAST-CANCER; MITOTIC ENTRY; CENTROSOME AMPLIFICATION; MCPH1 PROTEIN; BRCT DOMAIN; P53; MICROCEPHALIN	MCPH1, also known as BRIT1, has recently been identified as a novel key regulatory gene of the DNA damage response pathway. MCPH1 is located on human chromosome 8p23.1, where human cancers frequently show loss of heterozygosity. As such, MCPH1 is aberrantly expressed in many malignancies, including breast and ovarian cancers, and the function of MCPH1 has been implicated in tumor suppression. However, it remains poorly understood whether MCPH1 deficiency leads to tumorigenesis. Here we generated and studied both Mcph1(-/-) and Mcph1(-/-)p53(-/-) mice; we showed that Mcph1(-/-) mice developed tumors with long latency, and that primary lymphoma developed significantly earlier in Mcph1(-/-)p53(-/-) mice than in Mcph11(+/+)p53(-/-) and Mcph1(+/-)p53(-/-) mice. The Mcph1(-/-)p53(-/-) lymphomas and derived murine embryonic fibroblasts (MEFs) were both more sensitive to irradiation. Mcph1 deficiency resulted in remarkably increased chromosome and chromatid breaks in Mcph1(-/-)p53(-/-) lymphomas and MEFs, as determined by metaphase spread assay and spectral karyotyping analysis. In addition, Mcph1 deficiency significantly enhanced aneuploidy as well as abnormal centrosome multiplication in Mcph1(-/-)p53(-/-) cells. Meanwhile, Mcph1 deficiency impaired double strand break (DSB) repair in Mcph1(-/-)p53(-/-) MEFs as demonstrated by neutral Comet assay. Compared with Mcph1(+/+)p53(-/-) MEFs, homologous recombination and non-homologous end-joining activities were significantly decreased in Mcph1(-/-)p53(-/-) MEFs. Notably, reconstituted MCPH1 rescued the defects of DSB repair and alleviated chromosomal aberrations in Mcph1(-/-)p53(-/-) MEFs. Taken together, our data demonstrate MCPH1 deficiency promotes genomic instability and increases cancer susceptibility. Our study using knockout mouse models provides convincing genetic evidence that MCPH1 is a bona fide tumor suppressor gene. Its deficiency leading to defective DNA repair in tumors can be used to develop novel targeted cancer therapies in the future.	[Liang, Y.; Gao, H.; Goss, J. A.; Li, K.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liang, Y.] Taishan Med Univ, Sch Pharmaceut Sci, Tai An, Shandong, Peoples R China; [Lin, S-Y] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Du, C.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA; [Du, C.] Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH USA	Baylor College of Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Li, K (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, ABBR, R417,MC BCM390,One Baylor Plaza, Houston, TX 77030 USA.	kli@bcm.edu	Liang, Yulong/A-2171-2013	Liang, Yulong/0000-0001-8219-9575	National Institutes of Health [R01-CA155151, R21-CA161513]; St Luke's Episcopal Hospital McDonald Research Foundation; National Natural Science Foundation of China [81372589]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA155151, R21CA161513] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St Luke's Episcopal Hospital McDonald Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health to KL (R01-CA155151 and R21-CA161513), a grant from the St Luke's Episcopal Hospital McDonald Research Foundation to KL and a grant from National Natural Science Foundation of China (to YL, 81372589). We thank BCM Cytometry and Cell Sorting Core (NCRR S10RR024574, NIAID AI036211 and NCI P30CA125123) and Molecular Morphology Core Laboratory (PHS DK56338) for technical assistance. We also thank Drs Zhijie Li, Han Lin, Ana Rodriguez (all from Baylor College of Medicine, Houston, TX, USA) and Guang Peng (UT MD Anderson Cancer Center, Houston, TX, USA) for providing anti-CD4/CD8 antibodies (ZL), assisting in NHEJ analysis (HL), editing of this manuscript (AR) and providing HR-related plasmids (GP).	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bachelier R, 2003, ONCOGENE, V22, P528, DOI 10.1038/sj.onc.1206208; Bhattacharya N, 2013, ANN SURG ONCOL, V20, pS424, DOI 10.1245/s10434-012-2715-6; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duesberg P, 2004, IUBMB LIFE, V56, P65, DOI 10.1080/15216540410001667902; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Grundy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071629; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Gurley KE, 1998, CANCER RES, V58, P3111; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin SY, 2010, YONSEI MED J, V51, P295, DOI 10.3349/ymj.2010.51.3.295; Mailloux AW, 2009, J IMMUNOL, V182, P2753, DOI 10.4049/jimmunol.0801124; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; MATSUMOTO K, 1991, IMMUNOLOGY, V72, P20; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milliken EL, 2008, ONCOGENE, V27, P1759, DOI 10.1038/sj.onc.1210815; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; Shi L, 2012, GENE, V495, P1, DOI 10.1016/j.gene.2011.12.053; Singh B, 2002, AM J PATHOL, V161, P365, DOI 10.1016/S0002-9440(10)64191-0; Singh N, 2012, J BIOL CHEM, V287, P2854, DOI 10.1074/jbc.M111.307868; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Venkatesh T, 2014, EUR J CELL BIOL, V93, P98, DOI 10.1016/j.ejcb.2014.01.005; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang B, 2013, CARCINOGENESIS, V34, P2271, DOI 10.1093/carcin/bgt190; Zhang J, 2013, ASIAN PAC J CANCER P, V14, P7295, DOI 10.7314/APJCP.2013.14.12.7295	66	17	17	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4368	4378		10.1038/onc.2014.367	http://dx.doi.org/10.1038/onc.2014.367			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25362854	Green Accepted			2022-12-26	WOS:000359494400008
J	Morhayim, J; van de Peppel, J; Demmers, JAA; Kocer, G; Nigg, AL; van Driel, M; Chiba, H; van Leeuwen, JP				Morhayim, Jess; van de Peppel, Jeroen; Demmers, Jeroen A. A.; Kocer, Gulistan; Nigg, Alex L.; van Driel, Marjolein; Chiba, Hideki; van Leeuwen, Johannes P.			Proteomic signatures of extracellular vesicles secreted by nonmineralizing and mineralizing human osteoblasts and stimulation of tumor cell growth	FASEB JOURNAL			English	Article						bioactivity; intercellular communication; prostate cancer; protein cargo	MATRIX VESICLES; RIBOSOMAL-PROTEINS; EXOSOMAL PROTEINS; MEMBRANE-VESICLES; PROSTATE-CANCER; MICROVESICLES; BONE; DIFFERENTIATION; EXPRESSION; RESOLUTION	Beyond forming bone, osteoblasts play pivotal roles in various biologic processes, including hematopoiesis and bone metastasis. Extracellular vesicles (EVs) have been implicated in intercellular communication via transfer of proteins and nucleic acids between cells. We focused on the proteomic characterization of nonmineralizing (NMOBs) and mineralizing (MOBs) human osteoblast (SV-HFOs) EVs and investigated their effect on human prostate cancer (PC3) cells by microscopic, proteomic, and gene expression analyses. Proteomic analysis showed that 97% of the proteins were shared among NMOB and MOB EVs, and 30% were novel osteoblast-specific EV proteins. Label-free quantification demonstrated mineralization stage-dependent 5-fold enrichment of 59 and 451 EV proteins in NMOBs and MOBs, respectively. Interestingly, bioinformatic analyses of the osteoblast EV proteomes and EV-regulated prostate cancer gene expression profiles showed that they converged on pathways involved in cell survival and growth. This was verified by in vitro proliferation assays where osteoblast EV uptake led to 2-fold increase in PC3 cell growth compared to cell-free culture medium-derived vesicle controls. Our findings elucidate the mineralization stage-specific protein content of osteoblast-secreted EVs, show a novel way by which osteoblasts communicate with prostate cancer, and open up innovative avenues for therapeutic intervention.	[Morhayim, Jess; van de Peppel, Jeroen; Kocer, Gulistan; van Driel, Marjolein; van Leeuwen, Johannes P.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands; [Morhayim, Jess; van de Peppel, Jeroen; Kocer, Gulistan; van Driel, Marjolein; van Leeuwen, Johannes P.] Erasmus Univ, Med Ctr, Erasmus MC Stem Cell & Regenerat Med Inst, NL-3015 CN Rotterdam, Netherlands; [Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, NL-3015 CN Rotterdam, Netherlands; [Nigg, Alex L.] Erasmus Univ, Med Ctr, Dept Pathol, NL-3015 CN Rotterdam, Netherlands; [Chiba, Hideki] Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Fukushima Medical University	van Leeuwen, JP (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	j.vanleeuwen@erasmusmusmc.nl	Demmers, Jeroen AA/F-4046-2016; van de Peppel, Jeroen/K-6683-2019; van Leeuwen, Johannes/D-5015-2014; van Driel, Marjolein/K-6745-2019	Demmers, Jeroen AA/0000-0002-8757-9611; van de Peppel, Jeroen/0000-0002-6524-727X; van Leeuwen, Johannes/0000-0002-2282-4006; Kocer, Gulistan/0000-0003-3449-7388; Morhayim, Jess/0000-0001-7610-9342				Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n; Alves RDAM, 2010, J PROTEOME RES, V9, P4688, DOI 10.1021/pr100400d; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x; Balcerzak M, 2008, PROTEOMICS, V8, P192, DOI 10.1002/pmic.200700612; Bruedigam C., 2011, CURR PROTOC STEM CEL, V17, pt1H, DOI [10.1002/9780470151808.sc01h03s17, DOI 10.1002/9780470151808.SC01H03S17]; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Ciocca DR, 2010, INT J HYPERTHER, V26, P737, DOI 10.3109/02656731003776968; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Glaschick S, 2007, J BIOL PHYS, V33, P433, DOI 10.1007/s10867-008-9084-1; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Lai MD, 2007, CURR GENOMICS, V8, P43; MARKS SC, 1988, AM J ANAT, V183, P1, DOI 10.1002/aja.1001830102; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Morhayim J, 2014, ARCH BIOCHEM BIOPHYS, V561, P38, DOI 10.1016/j.abb.2014.05.011; Nahar NN, 2008, J BONE MINER METAB, V26, P514, DOI 10.1007/s00774-008-0859-z; Oh S, 2013, CANCER RES, V73, P5110, DOI 10.1158/0008-5472.CAN-13-0578; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shifrin DA, 2013, MOL BIOL CELL, V24, P1253, DOI 10.1091/mbc.E12-08-0572; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Stoop MP, 2008, J PROTEOME RES, V7, P4841, DOI 10.1021/pr800489a; Sun Nian-Kang, 2005, Chang Gung Med J, V28, P673; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; Urano T, 2004, BIOCHEM BIOPH RES CO, V319, P795, DOI 10.1016/j.bbrc.2004.05.056; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; van Cappellen A. W., 2012, ENHANCEMENT OPTICAL; van Dommelen SM, 2012, J CONTROL RELEASE, V161, P635, DOI 10.1016/j.jconrel.2011.11.021; Varga Z, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23298; Wang M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-6; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Zhang YQ, 2014, BIOMATERIALS, V35, P4390, DOI 10.1016/j.biomaterials.2014.02.003	54	48	50	3	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					274	285		10.1096/fj.14-261404	http://dx.doi.org/10.1096/fj.14-261404			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25359493	Green Submitted			2022-12-26	WOS:000347378600026
J	Amado, NG; Predes, D; Fonseca, BF; Cerqueira, DM; Reis, AH; Dudenhoeffer, AC; Borges, HL; Mendes, FA; Abreu, JG				Amado, Nathalia G.; Predes, Danilo; Fonseca, Barbara F.; Cerqueira, Debora M.; Reis, Alice H.; Dudenhoeffer, Ana C.; Borges, Helena L.; Mendes, Fabio A.; Abreu, Jose G.			Isoquercitrin Suppresses Colon Cancer Cell Growth in Vitro by Targeting the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Catenin (B-Catenin); Colon Cancer; Flavonoid; Wnt Signaling; Xenopus; Quercetin	BETA-CATENIN; XENOPUS EMBRYOS; QUERCETIN; WNT; EXPRESSION; FLAVONOIDS; AXIS; POLYPHENOLS; DISEASE; BMP	Flavonoids are plant-derived polyphenolic molecules that have potential biological effects including anti-oxidative, anti-inflammatory, anti-viral, and anti-tumoral effects. These effects are related to the ability of flavonoids to modulate signaling pathways, such as the canonical Wnt signaling pathway. This pathway controls many aspects of embryonic development and tissue maintenance and has been found to be deregulated in a range of human cancers. We performed several in vivo assays in Xenopus embryos, a functional model of canonical Wnt signaling studies, and also used in vitro models, to investigate whether isoquercitrin affects Wnt/-catenin signaling. Our data provide strong support for an inhibitory effect of isoquercitrin on Wnt/-catenin, where the flavonoid acts downstream of -catenin translocation to the nuclei. Isoquercitrin affects Xenopus axis establishment, reverses double axes and the LiCl hyperdorsalization phenotype, and reduces Xnr3 expression. In addition, this flavonoid shows anti-tumoral effects on colon cancer cells (SW480, DLD-1, and HCT116), whereas exerting no significant effect on non-tumor colon cell (IEC-18), suggesting a specific effect in tumor cells in vitro. Taken together, our data indicate that isoquercitrin is an inhibitor of Wnt/-catenin and should be further investigated as a potential novel anti-tumoral agent.	[Amado, Nathalia G.; Predes, Danilo; Fonseca, Barbara F.; Cerqueira, Debora M.; Reis, Alice H.; Dudenhoeffer, Ana C.; Borges, Helena L.; Mendes, Fabio A.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Cell & Dev Biol, BR-21949590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Cell & Dev Biol, Ave Carlos Chagas Filho,373,Bloco F2 Sala 15, BR-21949590 Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Borges, Helena/W-7533-2019; Abreu, Jose G/ABB-1199-2021; Borges, Helena L/E-5044-2013; Predes, Danilo/J-7558-2015; Borges, Helena/AAG-3701-2020; Abreu, Jose G/G-6159-2010; Cerqueira, Debora Malta/AAB-6204-2020; Cerqueira, Debora Malta/CAF-4323-2022; Mendes, Fabio/J-6911-2015	Borges, Helena/0000-0003-2866-4223; Abreu, Jose G/0000-0002-1363-1755; Borges, Helena L/0000-0003-2866-4223; Predes, Danilo/0000-0003-1864-0324; Abreu, Jose G/0000-0002-9875-7786; Fonseca, Barbara/0000-0001-6403-4099; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606; Reis, Alice/0000-0002-7431-5502	CNPq (National Council of Technological and Scientific Development); FAPERJ (Rio de Janeiro State Foundation for Research and Development); CAPES (Federal Agency for Higher Education)	CNPq (National Council of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State Foundation for Research and Development)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Federal Agency for Higher Education)	This work was supported by CNPq (National Council of Technological and Scientific Development), FAPERJ (Rio de Janeiro State Foundation for Research and Development), and CAPES (Federal Agency for Higher Education).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferry DR, 1996, CLIN CANCER RES, V2, P659; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Haramoto Y, 2007, DEV GENES EVOL, V217, P29, DOI 10.1007/s00427-006-0115-2; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Lee J, 2010, LIFE SCI, V86, P416, DOI 10.1016/j.lfs.2010.01.012; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nieuwkoop PD, 1956, NORMAL TABLE XENOPUS, V22; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Okamoto T, 2005, INT J MOL MED, V16, P275; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Reis AH, 2012, DEV BIOL, V365, P350, DOI 10.1016/j.ydbio.2012.03.003; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P200, DOI 10.1016/S0753-3322(02)00178-6; Tarapore RS, 2012, CARCINOGENESIS, V33, P483, DOI 10.1093/carcin/bgr305; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	40	66	68	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35456	35467		10.1074/jbc.M114.621599	http://dx.doi.org/10.1074/jbc.M114.621599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359775	hybrid, Green Published			2022-12-26	WOS:000346660200035
J	Malik, MQ; Bertke, MM; Huber, PW				Malik, Mariam Q.; Bertke, Michelle M.; Huber, Paul W.			Small Ubiquitin-like Modifier (SUMO)-mediated Repression of the Xenopus Oocyte 5 S rRNA Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; RNA Polymerase III; SUMOylation; Transcription Repressor; Xenopus; 5 S rRNA Genes; PIAS2b; TFIIIA; XCtBP	TRANSCRIPTION FACTOR IIIA; VG1 MESSENGER-RNA; AT-RICH FLANKS; HISTONE H1; IN-VITRO; MULTIPROTEIN COMPLEX; CHROMATIN-STRUCTURE; POLYMERASE-III; LAEVIS OOCYTE; ZINC FINGERS	The 5 S rRNA gene-specific transcription factor IIIA (TFIIIA) interacts with the small ubiquitin-like modifier (SUMO) E3 ligase PIAS2b and with one of its targets, the transcriptional corepressor, XCtBP. PIAS2b is restricted to the cytoplasm of Xenopus oocytes but relocates to the nucleus immediately after fertilization. Following the midblastula transition, PIAS2b and XCtBP are present on oocyte-type, but not somatic-type, 5 S rRNA genes up through the neurula stage, as is a limiting amount of TFIIIA. Histone H3 methylation, coincident with the binding of XCtBP, also occurs exclusively on the oocyte-type genes. Immunohistochemical staining of embryos confirms the occupancy of a subset of the oocyte-type genes by TFIIIA that become positioned at the nuclear periphery shortly after the midblastula transition. Inhibition of SUMOylation activity relieves repression of oocyte-type 5 S rRNA genes and is correlated with a decrease in methylation of H3K9 and H3K27 and disruption of subnuclear localization. These results reveal a novel function for TFIIIA as a negative regulator that recruits histone modification activity through the CtBP repressor complex exclusively to the oocyte-type 5 S rRNA genes, leading to their terminal repression.	[Malik, Mariam Q.; Bertke, Michelle M.; Huber, Paul W.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Huber, PW (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	huber.1@nd.edu			National Institutes of Health [GM38200]; Office of Research (University of Notre Dame); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research (University of Notre Dame); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM38200. This work was also supported by the Office of Research (University of Notre Dame).	ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; ANDREWS MT, 1991, DEV BIOL, V146, P250, DOI 10.1016/0012-1606(91)90466-G; ANDREWS MT, 1987, CELL, V51, P445, DOI 10.1016/0092-8674(87)90640-4; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Boddy MN, 1996, ONCOGENE, V13, P971; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; Brannon M, 1999, DEVELOPMENT, V126, P3159; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; Burn B, 2011, DEV DYNAM, V240, P2120, DOI 10.1002/dvdy.22701; BUSBY SJ, 1982, DEV BIOL, V91, P458, DOI 10.1016/0012-1606(82)90052-5; CAMIER S, 1995, P NATL ACAD SCI USA, V92, P9338, DOI 10.1073/pnas.92.20.9338; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G., 2006, CTBP FAMILY PROTEINS, P1; CHIPEV CC, 1992, MOL CELL BIOL, V12, P45, DOI 10.1128/MCB.12.1.45; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Damjanovski Sashko, 2002, Methods Mol Biol, V202, P153; DIMITROV S, 1993, DEV BIOL, V160, P214, DOI 10.1006/dbio.1993.1299; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; DWORKINRASTL E, 1994, DEV BIOL, V161, P425, DOI 10.1006/dbio.1994.1042; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; FLYNN JM, 1980, DEV BIOL, V75, P222, DOI 10.1016/0012-1606(80)90157-8; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Ghose R, 2004, MOL CELL BIOL, V24, P2467, DOI 10.1128/MCB.24.6.2467-2477.2004; GOTTESFELD JM, 1980, CELL, V21, P751, DOI 10.1016/0092-8674(80)90438-9; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; HARPER ME, 1983, NUCLEIC ACIDS RES, V11, P2313, DOI 10.1093/nar/11.8.2313; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Howe L, 1998, J BIOL CHEM, V273, P20693, DOI 10.1074/jbc.273.33.20693; Howe L, 1998, BIOCHEMISTRY-US, V37, P7077, DOI 10.1021/bi980410o; Howe LW, 1998, MOL CELL BIOL, V18, P1156, DOI 10.1128/MCB.18.3.1156; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; JERZMANOWSKI A, 1990, J BIOL CHEM, V265, P10726; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; KANDOLF H, 1994, P NATL ACAD SCI USA, V91, P7257, DOI 10.1073/pnas.91.15.7257; Kay B. K., 1991, XENOPUS LAEVIS PRACT; KLOCKE B, 1995, MOL CELL BIOCHEM, V142, P49, DOI 10.1007/BF00928913; Kolev NG, 2003, MOL CELL, V11, P745, DOI 10.1016/S1097-2765(03)00071-6; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; MAO XZ, 1993, MOL CELL BIOL, V13, P7496, DOI 10.1128/MCB.13.12.7496; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; MCCONKEY GA, 1988, GENE DEV, V2, P205, DOI 10.1101/gad.2.2.205; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nieuwkoop P. D., 1956, NORMAL TABLES XENOPU; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; PARDUE ML, 1973, CHROMOSOMA, V42, P191, DOI 10.1007/BF00320940; PECK LJ, 1987, MOL CELL BIOL, V7, P3503, DOI 10.1128/MCB.7.10.3503; PELHAM HRB, 1981, P NATL ACAD SCI-BIOL, V78, P1760, DOI 10.1073/pnas.78.3.1760; PERKOWSKA E, 1968, NATURE, V217, P649, DOI 10.1038/217649a0; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Pozzebon Mariaelena, 2009, V497, P285, DOI 10.1007/978-1-59745-566-4_19; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; SCHLISSEL MS, 1984, CELL, V37, P903, DOI 10.1016/0092-8674(84)90425-2; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sera T, 1998, MOL CELL BIOL, V18, P3668, DOI 10.1128/MCB.18.7.3668; SHASTRY BS, 1984, J BIOL CHEM, V259, P1373; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Sun LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04365; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tomaszewski R, 1998, NUCLEIC ACIDS RES, V26, P5596, DOI 10.1093/nar/26.24.5596; Tomaszewski R, 1997, NUCLEIC ACIDS RES, V25, P458, DOI 10.1093/nar/25.3.458; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Westmark CJ, 2002, BIOCHEM J, V362, P375, DOI 10.1042/0264-6021:3620375; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; WOLFFE AP, 1989, EMBO J, V8, P527, DOI 10.1002/j.1460-2075.1989.tb03407.x; WOLFFE AP, 1988, SCIENCE, V241, P1626, DOI 10.1126/science.3420414; WORMINGTON WM, 1983, DEV BIOL, V99, P248, DOI 10.1016/0012-1606(83)90273-7; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; YOUNG D, 1983, MOL CELL BIOL, V3, P720, DOI 10.1128/MCB.3.4.720; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	86	4	4	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35468	35481		10.1074/jbc.M114.609123	http://dx.doi.org/10.1074/jbc.M114.609123			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368327	hybrid, Green Published			2022-12-26	WOS:000346660200036
J	van Bel, N; Das, AT; Cornelissen, M; Abbink, TEM; Berkhout, B				van Bel, Nikki; Das, Atze T.; Cornelissen, Marion; Abbink, Truus E. M.; Berkhout, Ben			A Short Sequence Motif in the 5 ' Leader of the HIV-1 Genome Modulates Extended RNA Dimer Formation and Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1 Protease; Molecular Evolution; Reverse Transcription; RNA Structure; Virology; HIV-1 RNA; HIV-1 RNA Packaging; RNA Dimerization; Virus Evolution	DIMERIZATION INITIATION SITE; INFECTIOUS MOLECULAR CLONES; 1ST STRAND TRANSFER; REVERSE TRANSCRIPTION; TYPE-1 RNA; IN-VITRO; SECONDARY STRUCTURE; KISSING COMPLEX; TAR HAIRPIN; VIRAL INFECTIVITY	The 5 leader of the HIV-1 RNA genome encodes signals that control various steps in the replication cycle, including the dimerization initiation signal (DIS) that triggers RNA dimerization. The DIS folds a hairpin structure with a palindromic sequence in the loop that allows RNA dimerization via intermolecular kissing loop (KL) base pairing. The KL dimer can be stabilized by including the DIS stem nucleotides in the intermolecular base pairing, forming an extended dimer (ED). The role of the ED RNA dimer in HIV-1 replication has hardly been addressed because of technical challenges. We analyzed a set of leader mutants with a stabilized DIS hairpin for in vitro RNA dimerization and virus replication in T cells. In agreement with previous observations, DIS hairpin stability modulated KL and ED dimerization. An unexpected previous finding was that mutation of three nucleotides immediately upstream of the DIS hairpin significantly reduced in vitro ED formation. In this study, we tested such mutants in vivo for the importance of the ED in HIV-1 biology. Mutants with a stabilized DIS hairpin replicated less efficiently than WT HIV-1. This defect was most severe when the upstream sequence motif was altered. Virus evolution experiments with the defective mutants yielded fast replicating HIV-1 variants with second site mutations that (partially) restored the WT hairpin stability. Characterization of the mutant and revertant RNA molecules and the corresponding viruses confirmed the correlation between in vitro ED RNA dimer formation and efficient virus replication, thus indicating that the ED structure is important for HIV-1 replication.	[van Bel, Nikki; Das, Atze T.; Cornelissen, Marion; Abbink, Truus E. M.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Abbink, Truus E. M.] Addenbrookes Hosp, Dept Med, Cambridge CB2 0SP, England	University of Amsterdam; Academic Medical Center Amsterdam; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Abbink, TEM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Child Neurol, NL-1081 HZ Amsterdam, Netherlands.	G.Abbink@vumc.nl; Berkhout@amc.uva.nl	Abbink, Truus/N-4990-2018	van Bel, Nikki/0000-0003-0070-4043	Netherlands Organization for Scientific Research, Chemical Sciences Division [700.59.301]; Intra-European Marie Curie Fellowship [220092]	Netherlands Organization for Scientific Research, Chemical Sciences Division; Intra-European Marie Curie Fellowship(European Commission)	This work was supported by Netherlands Organization for Scientific Research, Chemical Sciences Division Grant 700.59.301.; Supported by Intra-European Marie Curie Fellowship 220092. To whom correspondence may be addressed: Dept. of Pediatrics/Child Neurology, VU Medical Centre, 1081 HZ Amsterdam, The Netherlands. E-mail: G.Abbink@vumc.nl.	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Abd El-Wahab EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5304; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Baig TT, 2009, J VIROL, V83, P802, DOI 10.1128/JVI.01521-08; Baig TT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-65; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; BERKHOUT B, 1995, J MOL BIOL, V252, P59, DOI 10.1006/jmbi.1994.0475; Berkhout B, 1998, VIROLOGY, V249, P211, DOI 10.1006/viro.1998.9321; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout Ben, 2009, V485, P435, DOI 10.1007/978-1-59745-170-3_30; Chen JB, 2009, P NATL ACAD SCI USA, V106, P13535, DOI 10.1073/pnas.0906822106; Chin MPS, 2005, P NATL ACAD SCI USA, V102, P9002, DOI 10.1073/pnas.0502522102; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 1997, J VIROL, V71, P2346, DOI 10.1128/JVI.71.3.2346-2356.1997; Das AT, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-59; Das AT, 2010, PHILOS T R SOC B, V365, P1965, DOI 10.1098/rstb.2010.0072; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DESTEFANO JJ, 1994, J MOL BIOL, V243, P558, DOI 10.1016/0022-2836(94)90030-2; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; Greatorex J, 1998, J GEN VIROL, V79, P2877, DOI 10.1099/0022-1317-79-12-2877; Haddrick M, 1996, J MOL BIOL, V259, P58, DOI 10.1006/jmbi.1996.0301; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Huthoff H, 2002, BIOCHEMISTRY-US, V41, P10439, DOI 10.1021/bi025993n; Huthoff H, 2001, NUCLEIC ACIDS RES, V29, P2594, DOI 10.1093/nar/29.12.2594; Jalalirad M, 2010, VIROLOGY, V407, P225, DOI 10.1016/j.virol.2010.08.013; Jeeninga RE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-64; Jones KL, 2008, NUCLEIC ACIDS RES, V36, P1578, DOI 10.1093/nar/gkm1149; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; King SR, 2008, J VIROL, V82, P2376, DOI 10.1128/JVI.02100-07; KLAVER B, 1994, EMBO J, V13, P2650, DOI 10.1002/j.1460-2075.1994.tb06555.x; Kuiken C., 2013, 1326007 LAUR LOS AL; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; L'Hernault A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-90; L'Hernault A, 2012, J VIROL, V86, P5867, DOI 10.1128/JVI.00124-12; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1996, BIOCHEMISTRY-US, V35, P1589, DOI 10.1021/bi951838f; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Moore MD, 2007, J VIROL, V81, P4002, DOI 10.1128/JVI.02589-06; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Moore MD, 2009, AIDS REV, V11, P91; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; Nikolaitchik OA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003249; Nikolaitchik OA, 2011, J MOL BIOL, V407, P521, DOI 10.1016/j.jmb.2011.01.052; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Sakuragi J, 2003, J VIROL, V77, P4060, DOI 10.1128/JVI.77.7.4060-4069.2003; Sakuragi J, 2012, NUCLEIC ACIDS RES, V40, P5012, DOI 10.1093/nar/gks156; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; St Louis DC, 1998, J VIROL, V72, P3991; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Theilleux-Delalande V, 2000, EUR J BIOCHEM, V267, P2711, DOI 10.1046/j.1432-1327.2000.01292.x; van Bel N, 2014, J VIROL, V88, P1870, DOI 10.1128/JVI.02942-13; van Wamel JLB, 1998, VIROLOGY, V244, P245, DOI 10.1006/viro.1998.9096; Vrolijk MM, 2008, NUCLEIC ACIDS RES, V36, P4352, DOI 10.1093/nar/gkn364; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096	80	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35061	35074		10.1074/jbc.M114.621425	http://dx.doi.org/10.1074/jbc.M114.621425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368321	hybrid, Green Published			2022-12-26	WOS:000346660200002
J	Kelesidis, T; Roberts, CK; Huynh, D; Martinez-Maza, O; Currier, JS; Reddy, ST; Yang, OO				Kelesidis, Theodoros; Roberts, Christian K.; Huynh, Diana; Martinez-Maza, Otoniel; Currier, Judith S.; Reddy, Srinivasa T.; Yang, Otto O.			A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX CAPACITY; APOLIPOPROTEIN-A-I; SUBCLINICAL ATHEROSCLEROSIS; ANTIINFLAMMATORY PROPERTIES; INFLAMMATORY PROPERTIES; OXIDIZED PHOSPHOLIPIDS; ANTIOXIDANT PROPERTIES; METHIONINE SULFOXIDE; REACTIVE OXYGEN	Current cell-based assays for determining the functional properties of high-density lipoproteins (HDL) have limitations. We report here the development of a new, robust fluorometric cell-free biochemical assay that measures HDL lipid peroxidation (HDLox) based on the oxidation of the fluorochrome Amplex Red. HDLox correlated with previously validated cell-based (r = 0.47, p<0.001) and cell-free assays (r = 0.46, p<0.001). HDLox distinguished dysfunctional HDL in established animal models of atherosclerosis and Human Immunodeficiency Virus (HIV) patients. Using an immunoaffinity method for capturing HDL, we demonstrate the utility of this novel assay for measuring HDLox in a high throughput format. Furthermore, HDLox correlated significantly with measures of cardiovascular diseases including carotid intima media thickness (r = 0.35, p<0.01) and subendocardial viability ratio (r = -0.21, p = 0.05) and physiological parameters such as metabolic and anthropometric parameters (p<0.05). In conclusion, we report the development of a new fluorometric method that offers a reproducible and rapid means for determining HDL function/quality that is suitable for high throughput implementation.	[Kelesidis, Theodoros; Huynh, Diana; Currier, Judith S.; Reddy, Srinivasa T.; Yang, Otto O.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Roberts, Christian K.] Univ Calif Los Angeles, Sch Nursing, Exercise & Metab Dis Res Lab, Translat Sci Sect, Los Angeles, CA 90024 USA; [Martinez-Maza, Otoniel; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Martinez-Maza, Otoniel; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kelesidis, T (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	tkelesidis@mednet.ucla.edu	Kelesidis, Theodoros/AAE-1961-2020; Martinez-Maza, Otoniel/B-2667-2009	Martinez-Maza, Otoniel/0000-0003-1364-0675; Kelesidis, Theodoros/0000-0002-8463-3811	RO1 grants [HL095132, HL082823, HL71776]; K08 grant [K08AI08272]; UCLA AIDS Institute; UCLA Center for AIDS Research [AI28697]; University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center [5R01HL095126]; American Heart Association [BGIA 0765139Y]; National Heart, Lung and Blood Institute [P50 HL105188]; National Institute of Diabetes and Digestive and Kidney Diseases [DK090406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082823, R01HL095126, R01HL095132, P50HL105188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI108272, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090406] Funding Source: NIH RePORTER	RO1 grants; K08 grant; UCLA AIDS Institute; UCLA Center for AIDS Research; University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center; American Heart Association(American Heart Association); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by RO1 grants HL095132 (JSC) and HL082823 and HL71776 (STR), K08 grant K08AI08272 (TK) and UCLA AIDS Institute and the UCLA Center for AIDS Research (AI28697). Partial funding for laboratory work was provided by the University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center (5R01HL095126). The exercise work was supported by the American Heart Association (BGIA 0765139Y to CKR), the National Heart, Lung and Blood Institute (P50 HL105188 to CKR), and the National Institute of Diabetes and Digestive and Kidney Diseases (DK090406 to CKR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or other granting agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Borja MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071541; Boulton F, 2008, TRANSFUSION MED, V18, P13, DOI 10.1111/j.1365-3148.2007.00818.x; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Gutheil WG, 2000, ANAL BIOCHEM, V287, P196, DOI 10.1006/abio.2000.4835; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Imaizumi Satoshi, 2010, Drug Metab Lett, V4, P139; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jayaraman S, 2007, BIOCHEMISTRY-US, V46, P5790, DOI 10.1021/bi700225a; Ji X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091089, 10.1371/journal.pone.0107460]; Kagramanov V, 2001, JAMA-J AM MED ASSOC, V285, P881, DOI 10.1001/jama.285.7.881; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelesidis T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-23; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Kelesidis T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-87; Kelesidis T, 2011, J LIPID RES, V52, P2341, DOI 10.1194/jlr.D018937; Khera AV, 2013, J AM COLL CARDIOL, V62, P1909, DOI 10.1016/j.jacc.2013.07.025; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Mishin V, 2010, FREE RADICAL BIO MED, V48, P1485, DOI 10.1016/j.freeradbiomed.2010.02.030; Morgantini C, 2014, NUTR METAB CARDIOVAS, V24, P594, DOI 10.1016/j.numecd.2013.12.011; Morgantini C, 2011, DIABETES, V60, P2617, DOI 10.2337/db11-0378; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Patel PJ, 2013, EUR J HEART FAIL, V15, P1215, DOI 10.1093/eurjhf/hft084; Patel PJ, 2011, J AM COLL CARDIOL, V58, P2068, DOI 10.1016/j.jacc.2011.08.030; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Price TH, 2008, STANDARDS BLOOD BANK; Richer SC, 2001, MOL HUM REPROD, V7, P237, DOI 10.1093/molehr/7.3.237; Roberts CK, 2006, J APPL PHYSIOL, V101, P1727, DOI 10.1152/japplphysiol.00345.2006; Roberts CK, 2013, J APPL PHYSIOL, V115, P1043, DOI 10.1152/japplphysiol.00359.2013; Roberts CK, 2013, METABOLISM, V62, P725, DOI 10.1016/j.metabol.2012.12.004; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; SATTLER W, 1995, FREE RADICAL BIO MED, V18, P421, DOI 10.1016/0891-5849(94)00170-O; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Volkmann ER, 2010, ARTHRIT CARE RES, V62, P258, DOI 10.1002/acr.20076; Wang XS, 2009, J LIPID RES, V50, P586, DOI 10.1194/jlr.D800042-JLR200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; Watanabe J, 2012, ARTHRITIS RHEUM-US, V64, P1828, DOI 10.1002/art.34363; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; WIDHALM K, 1991, CLIN CHEM, V37, P238; Zanni MV, 2014, ANTIVIR THER, V19, P805, DOI 10.3851/IMP2756	77	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111716	10.1371/journal.pone.0111716	http://dx.doi.org/10.1371/journal.pone.0111716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368900	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000090
J	Leitao, MDG; Coimbra, EC; de Lima, RDP; Guimaraes, MD; Heraclio, SD; Neto, JDS; de Freitas, AC				Gomes Leitao, Maria da Conceicao; Coimbra, Eliane Campos; Pereira de Lima, Rita de Cassia; Guimaraes, Marilea de Lima; Heraclio, Sandra de Andrade; Silva Neto, Jacinto da Costa; de Freitas, Antonio Carlos			Quantifying mRNA and MicroRNA with qPCR in Cervical Carcinogenesis: A Validation of Reference Genes to Ensure Accurate Data	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; HUMAN-PAPILLOMAVIRUS; RELATIVE QUANTIFICATION; HOUSEKEEPING GENES; PCR DATA; CANCER; IDENTIFICATION; EXPRESSION; NORMALIZATION; BIOMARKERS	A number of recent studies have catalogued global gene expression patterns in a panel of normal, tumoral cervical tissues so that potential biomarkers can be identified. The qPCR has been one of the most widely used technologies for detecting these potential biomarkers. However, few studies have investigated a correct strategy for the normalization of data in qPCR assays for cervical tissues. The aim of this study was to validate reference genes in cervical tissues to ensure accurate quantification of mRNA and miRNA levels in cervical carcinogenesis. For this purpose, some issues for obtaining reliable qPCR data were evaluated such as the following: geNorm analysis with a set of samples which meet all of the cervical tissue conditions (Normal + CIN1 + CIN2 + CIN3 + Cancer); the use of individual Ct values versus pooled Ct values; and the use of a single (or multiple) reference genes to quantify mRNA and miRNA expression levels. Two different data sets were put on the geNorm to assess the expression stability of the candidate reference genes: the first dataset comprised the quantities of the individual Ct values; and the second dataset comprised the quantities of the pooled Ct values. Moreover, in this study, all the candidate reference genes were analyzed as a single "normalizer''. The normalization strategies were assessed by measuring p16(INK4a) and miR-203 transcripts in qPCR assays. We found that the use of pooled Ct values, can lead to a misinterpretation of the results, which suggests that the maintenance of inter-individual variability is a key factor in ensuring the reliability of the qPCR data. In addition, it should be stressed that a proper validation of the suitability of the reference genes is required for each experimental setting, since the indiscriminate use of a reference gene can also lead to discrepant results.	[Gomes Leitao, Maria da Conceicao; Coimbra, Eliane Campos; Pereira de Lima, Rita de Cassia; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Lab Mol Studies & Expt Therapy LEMTE, Dept Genet, Ctr Biol Sci, Recife, PE, Brazil; [Guimaraes, Marilea de Lima] Univ Fed Pernambuco, Clin Hosp, Recife, PE, Brazil; [Heraclio, Sandra de Andrade] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil; [Silva Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol, Mol & Cytol Res Lab, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade Federal de Pernambuco	de Freitas, AC (corresponding author), Univ Fed Pernambuco, Lab Mol Studies & Expt Therapy LEMTE, Dept Genet, Ctr Biol Sci, Recife, PE, Brazil.	acf_ufpe@yahoo.com.br	Freitas, Antonio/G-1843-2012; Silva Neto, Jacinto da Costa/R-5602-2017	Freitas, Antonio/0000-0002-4957-9549; Silva Neto, Jacinto da Costa/0000-0003-4418-801X	CNPq-Universal [474837/2013-0]; FACEPE/PPSUS [APQ-0247-2.02/13]	CNPq-Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE/PPSUS(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work is funded by CNPq-Universal/2013:no 474837/2013-0 and FACEPE/PPSUS:APQ-0247-2.02/13 (CNPq: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, FACEPE: Fundacao de Apoio a Ciencia do Estado de Pernambuco, PPSUS: Programa Pesquisa para o Sistema Unico de Saude). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Cheah PL, 2012, ASIAN PAC J CANCER P, V13, P469, DOI 10.7314/APJCP.2012.13.2.469; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Freitas AC, 2014, BBA-REV CANCER, V1845, P91, DOI 10.1016/j.bbcan.2013.12.004; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hu Y, 2011, J INT MED RES, V39, P712, DOI 10.1177/147323001103900303; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Ma MZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-71; Martin Cara M., 2009, V511, P333, DOI 10.1007/978-1-59745-447-6_15; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nishio S, 2013, J GYNECOL ONCOL, V24, P215, DOI 10.3802/jgo.2013.24.3.215; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pettengill Emily A, 2012, BMC Res Notes, V5, P366, DOI 10.1186/1756-0500-5-366; Pinto Alvaro P, 2010, Diagn Histopathol (Oxf), V16, P445; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Saviozzi S, 2006, BMC CANCER, V26, P1; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Shen Y, 2013, BRIT J CANCER, V109, P92, DOI 10.1038/bjc.2013.308; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Sheng J, 2010, CHINESE MED J-PEKING, V123, P1000, DOI 10.3760/cma.j.issn.0366-6999.2010.08.005; Soto-Reyes E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-40; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Xia SS, 2014, ONCOL LETT, V7, P1889, DOI 10.3892/ol.2014.2023; Yao TT, 2012, BBA-MOL BASIS DIS, V1822, P248, DOI 10.1016/j.bbadis.2011.09.018; Yu JJ, 2012, J CANCER RES CLIN, V138, P671, DOI 10.1007/s00432-012-1147-9; Zhang SD, 2005, BIOINFORMATICS, V21, P4378, DOI 10.1093/bioinformatics/bti717; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	52	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111021	10.1371/journal.pone.0111021	http://dx.doi.org/10.1371/journal.pone.0111021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365304	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100043
J	Kollenberg, M; Winter, S; Gotz, M				Kollenberg, Mario; Winter, Stephan; Goetz, Monika			Quantification and Localization of Watermelon Chlorotic Stunt Virus and Tomato Yellow Leaf Curl Virus (Geminiviridae) in Populations of Bemisia tabaci (Hemiptera, Aleyrodidae) with Differential Virus Transmission Characteristics	PLOS ONE			English	Article							CIRCULATIVE TRANSMISSION; WHITEFLY-TRANSMISSION; ENDOSYMBIOTIC BACTERIA; SARDINIA-VIRUS; SWEET-POTATO; RAPID SPREAD; HOST-RANGE; B-BIOTYPE; VECTOR; PLANT	Bemisia tabaci (Gennadius) is one of the economically most damaging insects to crops in tropical and subtropical regions. Severe damage is caused by feeding and more seriously by transmitting viruses. Those of the genus begomovirus (Geminiviridae) cause the most significant crop diseases and are transmitted by B. tabaci in a persistent circulative mode, a process which is largely unknown. To analyze the translocation and to identify critical determinants for transmission, two populations of B. tabaci MEAM1 were compared for transmitting Watermelon chlorotic stunt virus (WmCSV) and Tomato yellow leaf curl virus (TYLCV). Insect populations were chosen because of their high and respectively low virus transmission efficiency to compare uptake and translocation of virus through insects. Both populations harbored Rickettsia, Hamiltonella and Wolbachia in comparable ratios indicating that endosymbionts might not contribute to the different transmission rates. Quantification by qPCR revealed that WmCSV uptake and virus concentrations in midguts and primary salivary glands were generally higher than TYLCV due to higher virus contents of the source plants. Both viruses accumulated higher in insects from the efficiently compared to the poorly transmitting population. In the latter, virus translocation into the hemolymph was delayed and virus passage was impeded with limited numbers of viruses translocated. FISH analysis confirmed these results with similar virus distribution found in excised organs of both populations. No virus accumulation was found in the midgut lumen of the poor transmitter because of a restrained virus translocation. Results suggest that the poorly transmitting population comprised insects that lacked transmission competence. Those were selected to develop a population that lacks virus transmission. Investigations with insects lacking transmission showed that virus concentrations in midguts were reduced and only negligible virus amounts were found at the primary salivary glands indicating for a missing or modified receptor responsible for virus attachment or translocation.	[Kollenberg, Mario; Winter, Stephan; Goetz, Monika] Leibniz Inst DSMZ German Collect Microorganisms &, Plant Virus Dept, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Gotz, M (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Plant Virus Dept, Braunschweig, Germany.	monika.goetz@jki.bund.de	Kollenberg, Mario/GLR-0218-2022	Kollenberg, Mario/0000-0003-1607-1527; Gotz, Monika/0000-0001-6089-1851	German-Israeli Foundation (GIF) [908-42.12/2006]	German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This research was supported by Research Grants No. 908-42.12/2006 from the German-Israeli Foundation (GIF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi I, 2004, J APPL ENTOMOL, V128, P81, DOI 10.1046/j.1439-0418.2003.00793.x; Al-Musa A, 2011, VIRUS GENES, V43, P79, DOI 10.1007/s11262-011-0594-8; Bananej K, 2002, J PHYTOPATHOL, V150, P423, DOI 10.1046/j.1439-0434.2002.00769.x; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BEDFORD ID, 1994, EUR J PLANT PATHOL, V100, P243, DOI 10.1007/BF01876239; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Brault V, 2007, MICRON, V38, P302, DOI 10.1016/j.micron.2006.04.005; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Caciagli P, 2009, J VIROL, V83, P5784, DOI 10.1128/JVI.02267-08; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P261, DOI 10.1603/AN10075; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; COSTA HS, 1991, ENTOMOL EXP APPL, V61, P211, DOI 10.1007/BF00187724; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Czosnek H, 2001, ADV VIRUS RES, V57, P291, DOI 10.1016/S0065-3527(01)57006-2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Ghanim M, 2001, PHYTOPATHOLOGY, V91, P188, DOI 10.1094/PHYTO.2001.91.2.188; Ghanim M, 2009, J VIROL METHODS, V159, P311, DOI 10.1016/j.jviromet.2009.04.017; Gil-Salas FM, 2007, J VIROL METHODS, V146, P45, DOI 10.1016/j.jviromet.2007.05.032; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; GOODMAN RM, 1977, VIROLOGY, V83, P171, DOI 10.1016/0042-6822(77)90220-3; Goodman RM, 1979, ASS APPL BIOL; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; GRIMSLEY N, 1986, P NATL ACAD SCI USA, V83, P3282, DOI 10.1073/pnas.83.10.3282; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Harris KF, 1996, ZOOMORPHOLOGY, V116, P143; Hemayet SM, 2012, CURR RES AGR LIFE SC, V30, P124; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hunter WB, 1998, PLANT DIS, V82, P1147, DOI 10.1094/PDIS.1998.82.10.1147; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiggins FM, 2011, SCIENCE, V332, P185, DOI 10.1126/science.1205386; Kheyr-Pour A, 2000, PHYTOPATHOLOGY, V90, P629, DOI 10.1094/PHYTO.2000.90.6.629; Kliot A, 2014, J VIROL, V88, P5652, DOI 10.1128/JVI.00071-14; Kliot A, 2013, VIRUSES-BASEL, V5, P1516, DOI 10.3390/v5061516; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Maruthi MN, 2004, SYST ENTOMOL, V29, P560, DOI 10.1111/j.0307-6970.2004.00272.x; Maruthi MN, 2002, VIRUS RES, V86, P71, DOI 10.1016/S0168-1702(02)00051-5; Medina V, 2006, J PLANT PATHOL, V88, P299; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; NAVOT N, 1991, VIROLOGY, V185, P151, DOI 10.1016/0042-6822(91)90763-2; Ohnishi J, 2009, J GEN PLANT PATHOL, V75, P131, DOI 10.1007/s10327-009-0147-3; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Papayiannis LC, 2010, J VIROL METHODS, V165, P238, DOI 10.1016/j.jviromet.2010.02.003; POLSTON JE, 1990, PHYTOPATHOLOGY, V80, P850, DOI 10.1094/Phyto-80-850; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Reinbold C, 2003, J GEN VIROL, V84, P3473, DOI 10.1099/vir.0.19415-0; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Rosell RC, 1999, PHYTOPATHOLOGY, V89, P239, DOI 10.1094/PHYTO.1999.89.3.239; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SHAHJAHAN RM, 1995, BIOTECHNIQUES, V19, P332; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2010, ISR J PLANT SCI, V58, P103, DOI 10.1560/IJPS.58.2.103; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Sufrin-Ringwald T, 2011, PHYTOPATHOLOGY, V101, P281, DOI 10.1094/PHYTO-06-10-0159; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607	84	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111968	10.1371/journal.pone.0111968	http://dx.doi.org/10.1371/journal.pone.0111968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365330	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100141
J	Li, L; Ye, WH; Wei, SG; Lian, JY; Huang, ZL				Li, Lin; Ye, Wan Hui; Wei, Shi Guang; Lian, Ju Yu; Huang, Zhong Liang			Spatial Patterns and Associations between Species Belonging to Four Genera of the Lauraceae Family	PLOS ONE			English	Article							SUBTROPICAL FOREST; DIVERSITY; AGGREGATION; COMPETITION; FACILITATION; DEMOGRAPHY; RICHNESS; PLANTS; TREES	Spatial distribution pattern of biological related species present unique opportunities and challenges to explain species coexistence. In this study, we explored the spatial distributions and associations among congeneric species at both the species and genus levels to explain their coexistence through examining the similarities and differences at these two levels. We first used DNA and cluster analysis to confirmed the relative relationship of eight species within a 20 ha subtropical forest in southern China. We compared Diameter at breast height ( DBH) classes, aggregation intensities and spatial patterns, associations, and distributions of four closely related species pairs to reveal similarities and differences at the species and genus levels. These comparisons provided insight into the mechanisms of coexistence of these congeners. O- ring statistics were used to measure spatial patterns of species. Omega(0-10), the mean conspecific density within 10 m of a tree, was used as a measure of the intensity of aggregation of a species, and g- function was used to analyze spatial associations. Our results suggested that spatial aggregations were common, but the differences between spatial patterns were reduced at the genus level. Aggregation intensity clearly reduced at the genus level. Negative association frequencies decreased at the genus level, such that independent association was commonplace among all four genera. Relationships between more closely related species appeared to be more competitive at both the species and genus levels. The importance of competition on interactions is most likely influenced by similarity in lifestyle, and the habitat diversity within the species' distribution areas. Relatives with different lifestyles likely produce different distribution patterns through different interaction process. In order to fully understand the mechanisms generating spatial distributions of coexisting siblings, further research is required to determine the spatial patterns and associations at other classification levels.	[Li, Lin; Wei, Shi Guang] Guilin Univ Elect Technol, Guilin, Peoples R China; [Ye, Wan Hui; Lian, Ju Yu; Huang, Zhong Liang] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Guilin University of Electronic Technology; Chinese Academy of Sciences; South China Botanical Garden, CAS	Ye, WH (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	why@scbg.ac.cn; weishig@mails.ucas.ac.cn		Wei, ShiGuang/0000-0002-0273-4978	National Nature Science Foundation of China [31200326, 31200412, 31460155]; Scientific Research and Technological Development of GuangXi [gkg1140002-2-4]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-Z]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Technological Development of GuangXi; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was funded by the National Nature Science Foundation of China (31200326, 31200412, 31460155), The Project of Scientific Research and Technological Development of GuangXi (No.gkg1140002-2-4), and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran E, 2012, ANN BOT-LONDON, V110, P1369, DOI 10.1093/aob/mcs089; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CONNELL J H, 1971, P298; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; Debussche M, 2003, ACTA OECOL, V24, P35, DOI 10.1016/S1146-609X(02)00006-1; Du XG, 2011, J THEOR BIOL, V278, P127, DOI 10.1016/j.jtbi.2011.03.003; Garcia-Serrana H, 2007, ACTA OECOL, V31, P69, DOI 10.1016/j.actao.2006.09.005; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Li L, 2008, J INTEGR PLANT BIOL, V50, P1140, DOI 10.1111/j.1744-7909.2008.00690.x; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Lloyd KM, 2002, CONSERV BIOL, V16, P975, DOI 10.1046/j.1523-1739.2002.01033.x; Manabe T, 2000, PLANT ECOL, V151, P181, DOI 10.1023/A:1026512404110; Medail F, 1997, BIOL CONSERV, V80, P269, DOI 10.1016/S0006-3207(96)00055-9; Mitsui H, 2000, ECOL RES, V15, P93, DOI 10.1046/j.1440-1703.2000.00328.x; Mooney KA, 2008, OIKOS, V117, P450, DOI 10.1111/j.2007.0030-1299.16284.x; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Queenborough SA, 2007, PLANT ECOL, V192, P193, DOI 10.1007/s11258-007-9328-3; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; RABINOWITZ D, 1984, ECOLOGY, V65, P1144, DOI 10.2307/1938322; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Raven P.H., 1978, ORIGIN RELATIONSHIPS; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Sfenthourakis S, 2006, GLOBAL ECOL BIOGEOGR, V15, P39, DOI 10.1111/j.1466-822x.2005.00192.x; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Stoyan D., 1994, FRACTALS RANDOM SHAP; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tanaka H, 2008, J VEG SCI, V19, P127, DOI 10.3170/2007-8-18342; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Wang ZF, 2012, OIKOS, V121, P2044, DOI 10.1111/j.1600-0706.2012.20483.x; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhang J, 2010, ACTA OECOL, V36, P29, DOI 10.1016/j.actao.2009.09.005	47	7	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111500	10.1371/journal.pone.0111500	http://dx.doi.org/10.1371/journal.pone.0111500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365507	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100072
J	Pan, WT; Cheng, GX; Xing, HX; Shi, J; Lu, C; Wei, JY; Li, LC; Zhou, CC; Yuan, QP; Zhou, LQ; Yang, M				Pan, Wenting; Cheng, Guangxia; Xing, Huaixin; Shi, Juan; Lu, Chao; Wei, Jinyu; Li, Lichao; Zhou, Changchun; Yuan, Qipeng; Zhou, Liqing; Yang, Ming			Leukocyte Telomere Length-Related rs621559 and rs398652 Genetic Variants Influence Risk of HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIGARETTE-SMOKING; CANCER; SUSCEPTIBILITY; LOCUS; CONTRIBUTE; POLYMORPHISMS; DYSFUNCTION; 14Q21; TERC	Recent genome-wide association studies (GWAS) have identified eleven leukocyte telomere length (LTL)-related single nucleotide polymorphisms (SNPs). Since LTL has been associated with risk of many malignancies, LTL-related SNPs may contribute to cancer susceptibility. To test this hypothesis in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we genotyped these eleven LTL-related SNPs in a case-control set including 1186 HBV-related HCC cases, 508 chronic HBV carriers and 1308 healthy controls at the discovery stage. The associations of HCC risk with these SNPs were further confirmed in an independent case-control set. We found that 1p34.2 rs621559 and 14q21 rs398652 were significantly associated with HBV-related HCC risk (both P<0.005 after Bonferroni corrections). There was no significant difference of either rs621559 or rs398652 genotypes between chronic HBV carriers and healthy controls, demonstrating that the association was not due to predisposition to HBV infection. In the pooled analyses (1806 HBV-related HCC cases and 1954 controls), we observed a decreased HCC risk, 0.72-times, associated with the 1p34.2 rs621559 AA genotype compared to the GG genotype (P = 1.6 x 10(-6)). Additionally, there was an increased HCC risk, 1.27-fold, associated with the rs398652 GG genotype (P = 3.3 x 10(-6)). A statistical joint effect between the rs621559 GG and rs398652 GG genotypes may exist in elevating risk of HBV-related HCC. We show, for the first time, that rs398652 and rs621559 might be marker genetic variants for risk of HBV-related HCC in the Chinese population.	[Pan, Wenting; Shi, Juan; Lu, Chao; Wei, Jinyu; Li, Lichao; Yuan, Qipeng; Yang, Ming] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing Lab Biomed Mat, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Cheng, Guangxia] Shandong Univ, Jinan Infect Dis Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Xing, Huaixin] Shandong Acad Med Sci, Shandong Canc Hosp, Dept Anesthesiol, Jinan, Shandong, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China	Beijing University of Chemical Technology; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, LQ (corresponding author), Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China.	zlq-hill@163.com; yangm@mail.buct.edu.cn	Yang, Ming/G-4705-2012; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; 	National Natural Science Foundation of China [81201586, 31271382]; Beijing Natural Science Foundation [5122020]; open project of State Key Laboratory of Molecular Oncology [SKL-KF-2013-03]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]; Beijing City Talent Training Project [2012D009016000002]; Shandong Provincial Natural Science Foundation [Y2008C36]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); open project of State Key Laboratory of Molecular Oncology; Beijing Higher Education Young Elite Teacher Project; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing City Talent Training Project; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by the National Natural Science Foundation of China (81201586 & 31271382); Beijing Natural Science Foundation (5122020); the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2013-03); Beijing Higher Education Young Elite Teacher Project (YETP0521); Program for Changjiang Scholars and Innovative Research Team in University (IRT13045); Beijing City Talent Training Project (2012D009016000002); Shandong Provincial Natural Science Foundation (Y2008C36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Liu J, 2011, CANCER-AM CANCER SOC, V117, P4247, DOI 10.1002/cncr.26015; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Masi S, 2011, FREE RADICAL BIO MED, V50, P730, DOI 10.1016/j.freeradbiomed.2010.12.031; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zheng YL, 2011, HUM MOL GENET, V20, P378, DOI 10.1093/hmg/ddq461; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110863	10.1371/journal.pone.0110863	http://dx.doi.org/10.1371/journal.pone.0110863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365256	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100030
J	Autelitano, F; Loyaux, D; Roudieres, S; Deon, C; Guette, F; Fabre, P; Ping, QG; Wang, S; Auvergne, R; Badarinarayana, V; Smith, M; Guillemot, JC; Goldman, SA; Natesan, S; Ferrara, P; August, P				Autelitano, Francois; Loyaux, Denis; Roudieres, Sebastien; Deon, Catherine; Guette, Frederique; Fabre, Philippe; Ping, Qinggong; Wang, Su; Auvergne, Romane; Badarinarayana, Vasudeo; Smith, Michael; Guillemot, Jean-Claude; Goldman, Steven A.; Natesan, Sridaran; Ferrara, Pascual; August, Paul			Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics	PLOS ONE			English	Article							TITANIUM-DIOXIDE CHROMATOGRAPHY; TYROSINE-PHOSPHATASE-ZETA; MONOCLONAL-ANTIBODY; IN-VITRO; THERAPEUTIC TARGET; ADHESION MOLECULE; MALIGNANT GLIOMAS; PHASE-II; IMMUNOTOXIN; EXPRESSION	Glioblastoma multiform (GBM) remains clinical indication with significant "unmet medical need''. Innovative new therapy to eliminate residual tumor cells and prevent tumor recurrences is critically needed for this deadly disease. A major challenge of GBM research has been the identification of novel molecular therapeutic targets and accurate diagnostic/prognostic biomarkers. Many of the current clinical therapeutic targets of immunotoxins and ligand-directed toxins for high-grade glioma (HGG) cells are surface sialylated glycoproteins. Therefore, methods that systematically and quantitatively analyze cell surface sialoglycoproteins in human clinical tumor samples would be useful for the identification of potential diagnostic markers and therapeutic targets for malignant gliomas. In this study, we used the bioorthogonal chemical reporter strategy (BOCR) in combination with label-free quantitative mass spectrometry (LFQ-MS) to characterize and accurately quantify the individual cell surface sialoproteome in human GBM tissues, in fetal, adult human astrocytes, and in human neural progenitor cells (NPCs). We identified and quantified a total of 843 proteins, including 801 glycoproteins. Among the 843 proteins, 606 (72%) are known cell surface or secreted glycoproteins, including 156 CD-antigens, all major classes of cell surface receptor proteins, transporters, and adhesion proteins. Our findings identified several known as well as new cell surface antigens whose expression is predominantly restricted to human GBM tumors as confirmed by microarray transcription profiling, quantitative RT-PCR and immunohistochemical staining. This report presents the comprehensive identification of new biomarkers and therapeutic targets for the treatment of malignant gliomas using quantitative sialoglycoproteomics with clinically relevant, patient derived primary glioma cells.	[Autelitano, Francois; Loyaux, Denis; Roudieres, Sebastien; Deon, Catherine; Guette, Frederique; Fabre, Philippe; Guillemot, Jean-Claude; Ferrara, Pascual] Ctr Toulouse, Sanofi Aventis Rech & Dev, Toulouse, France; [Ping, Qinggong] ALS Therapy Dev Inst, Cambridge, MA USA; [Wang, Su; Auvergne, Romane; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; [Natesan, Sridaran] Sanofi US, Cambridge, MA USA; [Badarinarayana, Vasudeo; Smith, Michael; August, Paul] Sanofi Tucson Res Ctr, Oro Valley, AZ USA	Sanofi-Aventis; Sanofi France; University of Rochester; Sanofi-Aventis	Autelitano, F (corresponding author), Ctr Toulouse, Sanofi Aventis Rech & Dev, Toulouse, France.	francois.autelitano@sanofi.com	Auvergne, Romane M/N-2624-2016	Auvergne, Romane M/0000-0002-9497-0184; Goldman, Steven/0000-0002-5498-4303; Cornwell, Adam/0000-0002-0572-3107; Autelitano, Francois/0000-0001-6269-2629	Adelson Medical Research Foundation; New York State Stem Cell Research Program (NYSTEM); Sanofi; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578, R01MH104701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345] Funding Source: NIH RePORTER	Adelson Medical Research Foundation; New York State Stem Cell Research Program (NYSTEM); Sanofi; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the Steven A Goldman lab was supported by the Adelson Medical Research Foundation and the New York State Stem Cell Research Program (NYSTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sanofi supported in part the work performed in the Steven A Goldman lab by providing technical assistance and research materials. Co-authors Francois Autelitano, Denis Loyaux, Sebastien Roudieres, Catherine Deon, Frederique Guette, Philippe Fabre, Jean-Claude Guillemot and Pascual Ferrara are employed by Sanofi-Aventis Recherche & Developpement. Co-author Sridaran Natesan is employed by Sanofi US. Co-authors Vasudeo Badarinarayana, Michael Smith and Paul August are employed by Sanofi Tucson Research Center. Sanofi provided support in the form of salaries for authors FA, DL, SR, CD, FG, PF, J-CG, PF, SN, VB, MS and PA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Auvergne RM, 2013, CELL REP, V3, P2127, DOI 10.1016/j.celrep.2013.04.035; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Buzy A, 2011, ANN M 6 JOURN SPECTR; Calvano CD, 2008, J PROTEOMICS, V71, P304, DOI 10.1016/j.jprot.2008.06.013; Candolfi M, 2010, P NATL ACAD SCI USA, V107, P20021, DOI 10.1073/pnas.1008261107; Chandramohan V, 2013, CLIN CANCER RES, V19, P4717, DOI 10.1158/1078-0432.CCR-12-3891; Chandramohan V, 2013, INT J CANCER, V132, P2339, DOI 10.1002/ijc.27919; Chandramohan V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/480429; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Gahmberg C, 1996, TRENDS BIOCHEM SCI, V21, P491; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hagglund P, 2004, J PROTEOME RES, V3, P556, DOI 10.1021/pr034112b; He JT, 2011, J PROTEOME RES, V10, P330, DOI 10.1021/pr101158p; Hjortland GO, 2004, J NEUROSURG, V100, P320, DOI 10.3171/jns.2004.100.2.0320; HOPKINS K, 1995, RADIOTHER ONCOL, V34, P121, DOI 10.1016/0167-8140(95)01514-H; Howley R, 2012, EXP CELL RES, V318, P2245, DOI 10.1016/j.yexcr.2012.06.007; Kalinina J, 2011, NEURO-ONCOLOGY, V13, P926, DOI 10.1093/neuonc/nor078; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Konya C, 2011, NEUROCHEM INT, V59, P251, DOI 10.1016/j.neuint.2011.05.012; Kuan CT, 2010, INT J CANCER, V127, P598, DOI 10.1002/ijc.25062; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Kunwar S, 2010, NEURO-ONCOLOGY, V12, P871, DOI 10.1093/neuonc/nop054; Larsen MR, 2007, MOL CELL PROTEOMICS, V6, P1778, DOI 10.1074/mcp.M700086-MCP200; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Li CB, 2002, PROTEIN ENG, V15, P419, DOI 10.1093/protein/15.5.419; Li LN, 2010, J NEUROSURG, V113, P192, DOI 10.3171/2010.2.JNS091211; Liu TF, 2005, CLIN CANCER RES, V11, P329; Liu Yashu, 2013, Methods Mol Biol, V951, P69, DOI 10.1007/978-1-62703-146-2_6; Luther N, 2010, MOL CANCER THER, V9, P1039, DOI 10.1158/1535-7163.MCT-09-0996; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MARUNO M, 1994, J NEURO-ONCOL, V19, P155, DOI 10.1007/BF01306457; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Mut M, 2008, EXPERT OPIN BIOL TH, V8, P805, DOI 10.1517/14712598.8.6.805 ; Niclou SP, 2010, J PROTEOMICS, V73, P1823, DOI 10.1016/j.jprot.2010.03.007; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Oh S, 2011, J NEUROSURG, V114, P1662, DOI 10.3171/2010.11.JNS101214; Oh S, 2009, J NEURO-ONCOL, V95, P331, DOI 10.1007/s11060-009-9932-2; Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Panico F, 2009, ADV CANCER RES, V105, P63, DOI 10.1016/S0065-230X(09)05004-0; PAPANASTASSIOU V, 1993, BRIT J CANCER, V67, P144, DOI 10.1038/bjc.1993.25; Piao HL, 2013, MABS-AUSTIN, V5, P748, DOI 10.4161/mabs.25860; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Potter NE, 2009, EXP CELL RES, V315, P2835, DOI 10.1016/j.yexcr.2009.06.003; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pucci S, 2009, AM J GASTROENTEROL, V104, P2807, DOI 10.1038/ajg.2009.412; Rainov NG, 2006, REV RECENT CLIN TRIA, V1, P119, DOI 10.2174/157488706776876454; Rajcevic U, 2009, MOL CELL PROTEOMICS, V8, P2595, DOI 10.1074/mcp.M900124-MCP200; Reardon DA, 2007, EXPERT REV ANTICANC, V7, P675, DOI 10.1586/14737140.7.5.675; Ren H, 2007, REV RECENT CLIN TRIA, V2, P87, DOI 10.2174/157488707780599384; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; RICHARDSON RB, 1986, EUR J NUCL MED, V12, P313, DOI 10.1007/BF00263810; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Rustamzadeh E, 2007, INT J CANCER, V120, P411, DOI 10.1002/ijc.22278; Sampson JH, 2008, NEURO-ONCOLOGY, V10, P320, DOI 10.1215/15228517-2008-012; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Sasaki H, 1998, CANCER, V82, P1921, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1921::AID-CNCR16>3.0.CO;2-V; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro WR, 2006, EXPERT OPIN BIOL TH, V6, P539, DOI 10.1517/14712598.6.5.539; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sim FJ, 2009, NEURON GLIA BIOL, V5, P45, DOI 10.1017/S1740925X09990317; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Solomon DA, 2009, CANCER RES, V69, P5630, DOI 10.1158/0008-5472.CAN-09-1055; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Teicher BA, 2009, CURR CANCER DRUG TAR, V9, P982, DOI 10.2174/156800909790192365; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; Vitolo D, 1996, HISTOPATHOLOGY, V28, P521, DOI 10.1046/j.1365-2559.1996.d01-471.x; Wadhwa S, 2003, J BIOSCIENCES, V28, P181, DOI 10.1007/BF02706217; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; Weber F, 2003, J NEURO-ONCOL, V64, P125, DOI 10.1023/A:1024901501173; Whittle IR, 2007, BRIT J NEUROSURG, V21, P576, DOI 10.1080/02688690701721691; Witusik-Perkowska M, 2011, J NEURO-ONCOL, V102, P395, DOI 10.1007/s11060-010-0352-0; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamamoto H, 2001, CANCER RES, V61, P6822; Yamanaka R, 2009, ANN NEUROL, V66, P717, DOI 10.1002/ana.21793; Yang ZP, 2005, J CHROMATOGR A, V1070, P57, DOI 10.1016/j.chroma.2005.02.034; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	97	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110316	10.1371/journal.pone.0110316	http://dx.doi.org/10.1371/journal.pone.0110316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360666	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700030
J	Deepthi, A; Liew, CW; Liang, ZX; Swaminathan, K; Lescar, J				Deepthi, Angeline; Liew, Chong Wai; Liang, Zhao-Xun; Swaminathan, Kunchithapadam; Lescar, Julien			Structure of a Diguanylate Cyclase from Thermotoga maritima: Insights into Activation, Feedback Inhibition and Thermostability	PLOS ONE			English	Article							C-DI-GMP; ALLOSTERIC CONTROL; PROTEIN THERMOSTABILITY; PHOSPHODIESTERASE; DETERMINANTS; DISRUPTION; MECHANISM; MOLECULE; GENOMICS; DOMAINS	Large-scale production of bis-39-59-cyclic-di-GMP (c-di-GMP) would facilitate biological studies of numerous bacterial signaling pathways and phenotypes controlled by this second messenger molecule, such as virulence and biofilm formation. C-di-GMP constitutes also a potentially interesting molecule as a vaccine adjuvant. Even though chemical synthesis of c-di-GMP can be done, the yields are incompatible with mass-production. tDGC, a stand-alone diguanylate cyclase (DGC or GGDEF domain) from Thermotoga maritima, enables the robust enzymatic production of large quantities of c-di-GMP. To understand the structural correlates of tDGC thermostability, its catalytic mechanism and feedback inhibition, we determined structures of an active-like dimeric conformation with both active (A) sites facing each other and of an inactive dimeric conformation, locked by c-di-GMP bound at the inhibitory (I) site. We also report the structure of a single mutant of tDGC, with the R158A mutation at the I-site, abolishing product inhibition and unproductive dimerization. A comparison with structurally characterized DGC homologues from mesophiles reveals the presence of a higher number of salt bridges in the hyperthermophile enzyme tDGC. Denaturation experiments of mutants disrupting in turn each of the salt bridges unique to tDGC identified three salt-bridges critical to confer thermostability.	[Deepthi, Angeline; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Liew, Chong Wai; Liang, Zhao-Xun; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lescar, Julien] CHU Pitie Salpetriere, Fac Med Pierre & Marie Curie, Ctr Immunol & Malad Infect, Paris, France	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsks@nus.edu.sg; julien@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011	Liang, Zhao-Xun/0000-0002-3128-1330	National Research Foundation [CRP2008]	National Research Foundation	Supported by Competitive Research Programme Grant CRP2008 from the National Research Foundation (to the J. L. laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kiburu I, 2008, MOL BIOSYST, V4, P518, DOI 10.1039/b719423d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; PACE CN, 1992, J MOL BIOL, V226, P29, DOI 10.1016/0022-2836(92)90121-Y; Pappenberger G, 1997, J MOL BIOL, V274, P676, DOI 10.1006/jmbi.1997.1421; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Robinson-Rechavi M, 2005, STRUCTURE, V13, P857, DOI 10.1016/j.str.2005.03.011; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1990, J BIOL CHEM, V265, P18933; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schrodinger L., 2020, PYMOL; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Vorobiev Sergey M., 2012, Journal of Structural and Functional Genomics, V13, P177, DOI 10.1007/s10969-012-9136-4; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026	34	19	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110912	10.1371/journal.pone.0110912	http://dx.doi.org/10.1371/journal.pone.0110912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360685	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700052
J	Whidden, CE; DeZeeuw, KG; Zorz, JK; Joy, AP; Barnett, DA; Johnson, MS; Zhaxybayeva, O; Cockshutt, AM				Whidden, Caroline E.; DeZeeuw, Katrina G.; Zorz, Jackie K.; Joy, Andrew P.; Barnett, David A.; Johnson, Milo S.; Zhaxybayeva, Olga; Cockshutt, Amanda M.			Quantitative and Functional Characterization of the Hyper-Conserved Protein of Prochlorococcus and Marine Synechococcus	PLOS ONE			English	Article							TRANSCRIPTIONAL START SITES; HYPERCONSERVED PROTEIN; SEQUENCE; ECOTYPES; PHOTOSYNTHESIS; PHYTOPLANKTON; ACQUISITION; SEARCH; LIGHT	A large fraction of any bacterial genome consists of hypothetical protein-coding open reading frames (ORFs). While most of these ORFs are present only in one or a few sequenced genomes, a few are conserved, often across large phylogenetic distances. Such conservation provides clues to likely uncharacterized cellular functions that need to be elucidated. Marine cyanobacteria from the Prochlorococcus/marine Synechococcus clade are dominant bacteria in oceanic waters and are significant contributors to global primary production. A Hyper Conserved Protein (PSHCP) of unknown function is 100% conserved at the amino acid level in genomes of Prochlorococcus/marine Synechococcus, but lacks homologs outside of this clade. In this study we investigated Prochlorococcus marinus strains MED4 and MIT 9313 and Synechococcus sp. strain WH 8102 for the transcription of the PSHCP gene using RT-Q-PCR, for the presence of the protein product through quantitative immunoblotting, and for the protein's binding partners in a pull down assay. Significant transcription of the gene was detected in all strains. The PSHCP protein content varied between 8 +/- 1 fmol and 26 +/- 9 fmol per ug total protein, depending on the strain. The 50 S ribosomal protein L2, the Photosystem I protein PsaD and the Ycf48-like protein were found associated with the PSHCP protein in all strains and not appreciably or at all in control experiments. We hypothesize that PSHCP is a protein associated with the ribosome, and is possibly involved in photosystem assembly.	[Whidden, Caroline E.; DeZeeuw, Katrina G.; Zorz, Jackie K.; Cockshutt, Amanda M.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Joy, Andrew P.; Barnett, David A.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Johnson, Milo S.; Zhaxybayeva, Olga] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Zhaxybayeva, Olga] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA	Mount Allison University; Dartmouth College; Dartmouth College	Zhaxybayeva, O (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	olga.zhaxybayeva@dartmouth.edu; acockshutt@mta.ca		Barnett, David/0000-0001-9205-058X; Joy, Andrew/0000-0002-5477-1615; Zhaxybayeva, Olga/0000-0002-1809-3909	Marjorie Young Bell Faculty Fellow Award; Mount Allison President's Research and Creative Activity Fund; Natural Science and Engineering Research Council (NSERC) Discovery Team grant; NSERC; Mount Allison University; start-up funds from Dartmouth College; Dartmouth College Dean of Faculty start-up funds; Walter and Constance Burke Research Initiation Award	Marjorie Young Bell Faculty Fellow Award; Mount Allison President's Research and Creative Activity Fund; Natural Science and Engineering Research Council (NSERC) Discovery Team grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mount Allison University; start-up funds from Dartmouth College; Dartmouth College Dean of Faculty start-up funds; Walter and Constance Burke Research Initiation Award	This work was supported by the Marjorie Young Bell Faculty Fellow Award, the Mount Allison President's Research and Creative Activity Fund (www.mta.ca) and the Natural Science and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca) Discovery Team grant to AMC. JKZ and CEW received Undergraduate Summer Research Awards from NSERC (http://www.nserc-crsng.gc.ca) and Mount Allison University (www.mta.ca). OZ was supported in part by a research stipend from Mount Allison University and by start-up funds from Dartmouth College. The study was in part supported by Dartmouth College Dean of Faculty start-up funds and Walter and Constance Burke Research Initiation Award to OZ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, BERGEYS MANUAL SYSTE; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Gierga G, 2012, ISME J, V6, P1544, DOI 10.1038/ismej.2011.215; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2012, PLANT PHYSIOL, V158, P476, DOI 10.1104/pp.111.184184; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kutovaya OA, 2010, J BASIC MICROB, V50, P227, DOI 10.1002/jobm.200900337; Luo HW, 2011, MOL BIOL EVOL, V28, P2751, DOI 10.1093/molbev/msr081; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Petrov AS, 2013, NUCLEIC ACIDS RES, V41, P7522, DOI 10.1093/nar/gkt513; Pittera J, 2014, ISME J, V8, P1221, DOI 10.1038/ismej.2013.228; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P2890, DOI 10.1093/nar/gkg398; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; WILMOTTE A., 2001, BERGEYS MANUAL SYSTE; Zhaxybayeva O, 2007, FEMS MICROBIOL LETT, V274, P30, DOI 10.1111/j.1574-6968.2007.00806.x; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	47	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109327	10.1371/journal.pone.0109327	http://dx.doi.org/10.1371/journal.pone.0109327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360678	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700010
J	Winer, LSP; Wu, M				Winer, Lisa S. Pike; Wu, Min			Rapid Analysis of Glycolytic and Oxidative Substrate Flux of Cancer Cells in a Microplate	PLOS ONE			English	Article							C-MYC; METABOLISM; INHIBITION; EXPRESSION; WARBURG; GROWTH; TUMORS	Cancer cells exhibit remarkable alterations in cellular metabolism, particularly in their nutrient substrate preference. We have devised several experimental methods that rapidly analyze the metabolic substrate flux in cancer cells: glycolysis and the oxidation of major fuel substrates glucose, glutamine, and fatty acids. Using the XF Extracellular Flux analyzer, these methods measure, in real-time, the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of living cells in a microplate as they respond to substrates and metabolic perturbation agents. In proof-of-principle experiments, we analyzed substrate flux and mitochondrial bioenergetics of two human glioblastoma cell lines, SF188s and SF188f, which were derived from the same parental cell line but proliferate at slow and fast rates, respectively. These analyses led to three interesting observations: 1) both cell lines respired effectively with substantial endogenous substrate respiration; 2) SF188f cells underwent a significant shift from glycolytic to oxidative metabolism, along with a high rate of glutamine oxidation relative to SF188s cells; and 3) the mitochondrial proton leak-linked respiration of SF188f cells increased significantly compared to SF188s cells. It is plausible that the proton leak of SF188f cells may play a role in allowing continuous glutamine-fueled anaplerotic TCA cycle flux by partially uncoupling the TCA cycle from oxidative phosphorylation. Taken together, these rapid, sensitive and high-throughput substrate flux analysis methods introduce highly valuable approaches for developing a greater understanding of genetic and epigenetic pathways that regulate cellular metabolism, and the development of therapies that target cancer metabolism.	[Winer, Lisa S. Pike; Wu, Min] Seahorse Biosci Inc, North Billerica, MA USA		Wu, M (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mwu13@mgh.harvard.edu			Seahorse Bioscience	Seahorse Bioscience	This work was conducted in and funded by Seahorse Bioscience. LSPW is an employee and MW was an employee at the time of the work in the company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artemov D, 1998, NMR BIOMED, V11, P395, DOI 10.1002/(SICI)1099-1492(199812)11:8<395::AID-NBM536>3.0.CO;2-R; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brooks GA, 2010, J APPL PHYSIOL, V108, P1450, DOI 10.1152/japplphysiol.00308.2010; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Ibrahim-Hashim A., 2011, J CANC SCI THER, VSuppl 1, pJCST, DOI [DOI 10.4172/1948-5956.S1-004, 10.4172/1948-5956.S1-004]; Ipata PB, 2012, METABOLOMICS, V8; Kemp G, 2005, AM J PHYSIOL-REG I, V289, pR895, DOI 10.1152/ajpregu.00641.2004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lane AN, 2009, METABOLOMICS, V5, P163, DOI 10.1007/s11306-008-0142-2; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Medina MA, 2001, J NUTR, V131, p2539S, DOI 10.1093/jn/131.9.2539S; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pike LS, 2010, BIOCH BIOPHYS ACTA; Rivenzon-Segal D, 2003, INT J CANCER, V107, P177, DOI 10.1002/ijc.11387; Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Swift AL, 2011, F1000 POSTERS, V2, P52; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P35; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	45	80	80	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109916	10.1371/journal.pone.0109916	http://dx.doi.org/10.1371/journal.pone.0109916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360519	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700021
J	Parker, CS; Deligianni, F; Cardoso, MJ; Daga, P; Modat, M; Dayan, M; Clark, CA; Ourselin, S; Clayden, JD				Parker, Christopher S.; Deligianni, Fani; Cardoso, M. Jorge; Daga, Pankaj; Modat, Marc; Dayan, Michael; Clark, Chris A.; Ourselin, Sebastien; Clayden, Jonathan D.			Consensus between Pipelines in Structural Brain Networks	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; HUMAN CEREBRAL-CORTEX; CONNECTIVITY PATTERNS; TRACTOGRAPHY; TENSOR; REGISTRATION; OPTIMIZATION; ARCHITECTURE; DENSITY; ATLAS	Structural brain networks may be reconstructed from diffusion MRI tractography data and have great potential to further our understanding of the topological organisation of brain structure in health and disease. Network reconstruction is complex and involves a series of processesing methods including anatomical parcellation, registration, fiber orientation estimation and whole-brain fiber tractography. Methodological choices at each stage can affect the anatomical accuracy and graph theoretical properties of the reconstructed networks, meaning applying different combinations in a network reconstruction pipeline may produce substantially different networks. Furthermore, the choice of which connections are considered important is unclear. In this study, we assessed the similarity between structural networks obtained using two independent state-of-the-art reconstruction pipelines. We aimed to quantify network similarity and identify the core connections emerging most robustly in both pipelines. Similarity of network connections was compared between pipelines employing different atlases by merging parcels to a common and equivalent node scale. We found a high agreement between the networks across a range of fiber density thresholds. In addition, we identified a robust core of highly connected regions coinciding with a peak in similarity across network density thresholds, and replicated these results with atlases at different node scales. The binary network properties of these core connections were similar between pipelines but showed some differences in atlases across node scales. This study demonstrates the utility of applying multiple structural network reconstrution pipelines to diffusion data in order to identify the most important connections for further study.	[Parker, Christopher S.; Cardoso, M. Jorge; Daga, Pankaj; Modat, Marc; Ourselin, Sebastien] UCL, Ctr Med Image Comp, London, England; [Parker, Christopher S.; Deligianni, Fani; Dayan, Michael; Clark, Chris A.; Clayden, Jonathan D.] UCL Inst Child Hlth, Imaging & Biophys Unit, London, England; [Ourselin, Sebastien] UCL, Dementia Res Ctr, London, England; [Dayan, Michael] Weill Cornell Med Coll, Dept Radiol, New York, NY USA	University of London; University College London; University of London; University College London; University of London; University College London; Cornell University	Parker, CS (corresponding author), UCL, Ctr Med Image Comp, London, England.	christopher.parker.10@ucl.ac.uk	Deligianni, Fani/M-9116-2018; Clayden, Jonathan D/C-1894-2008; Dayan, Michael/G-4760-2016; Cardoso, M. Jorge/N-5511-2018; Ourselin, Sebastien/K-6960-2015	Deligianni, Fani/0000-0003-1306-5017; Clayden, Jonathan D/0000-0002-6608-0619; Dayan, Michael/0000-0002-2666-0969; Cardoso, M. Jorge/0000-0003-1284-2558; Ourselin, Sebastien/0000-0002-5694-5340; Modat, Marc/0000-0002-5277-8530	EPSRC [EP/J016292/1, EP/H046410/1, EP/J020990/1, EP/K005278]; EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL; CBRC Strategic Investment Award [168]; MRC [MR/J01107X/1]; EU-FP7 project VPH-DARE@IT [FP7-ICT-2011-9-601055]; NIHR Biomedical Research Unit (Dementia) at UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative); UCL Leonard Wolfson Experimental Neurology Centre; KCL [C1519AO]; MRC [G0300117, G1002276] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046410/1, EP/J016292/1, EP/J020990/1] Funding Source: researchfish; Medical Research Council [G0300117, MR/J01107X/1, G1002276] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CBRC Strategic Investment Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-FP7 project VPH-DARE@IT; NIHR Biomedical Research Unit (Dementia) at UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative)(General Electric); UCL Leonard Wolfson Experimental Neurology Centre; KCL; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FD and JDC were supported by the EPSRC (EP/J016292/1). PD was funded by EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL and KCL (grant number C1519AO). SO and MJC were supported by both the EPSRC (EP/H046410/1) and the CBRC Strategic Investment Award (Ref. 168). SO receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1), the EU-FP7 project VPH-DARE@IT (FP7-ICT-2011-9-601055), the NIHR Biomedical Research Unit (Dementia) at UCL and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative). MM is supported by the UCL Leonard Wolfson Experimental Neurology Centre. The Dementia Research Centre is an Alzheimers Research Trust Co-ordinating centre and has also received equipment founded by the Alzheimers Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardoso MJ, 2013, MED IMAGE ANAL, V17, P671, DOI 10.1016/j.media.2013.02.006; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Cheng H, 2012, J NEUROSCI METH, V203, P264, DOI 10.1016/j.jneumeth.2011.09.021; Clayden JD, 2011, J STAT SOFTW, V44, P1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Echtermeyer Christoph, 2011, Front Neuroinform, V5, P10, DOI 10.3389/fninf.2011.00010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li LC, 2012, HUM BRAIN MAPP, V33, P1894, DOI 10.1002/hbm.21332; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shao JM, 2012, NEUROBIOL AGING, V33, P2756, DOI 10.1016/j.neurobiolaging.2012.01.017; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Team RC, 2012, R LANG ENV STAT COMP; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	58	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111262	10.1371/journal.pone.0111262	http://dx.doi.org/10.1371/journal.pone.0111262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356977	Green Published, gold, Green Accepted			2022-12-26	WOS:000346765000049
J	Rodrigues, TB; Khajuria, C; Wang, HC; Matz, N; Cardoso, DC; Valicente, FH; Zhou, XG; Siegfried, B				Rodrigues, Thais Barros; Khajuria, Chitvan; Wang, Haichuan; Matz, Natalie; Cardoso, Danielle Cunha; Valicente, Fernando Hercos; Zhou, Xuguo; Siegfried, Blair			Validation of Reference Housekeeping Genes for Gene Expression Studies in Western Corn Rootworm (Diabrotica virgifera virgifera)	PLOS ONE			English	Article							PCR REFERENCE GENES; QUANTITATIVE PCR; FIELD-RESISTANCE; APIS-MELLIFERA; SELECTION; IDENTIFICATION; PROTEINS; BORER	Quantitative Real-time PCR (qRT-PCR) is a powerful technique to investigate comparative gene expression. In general, normalization of results using a highly stable housekeeping gene (HKG) as an internal control is recommended and necessary. However, there are several reports suggesting that regulation of some HKGs is affected by different conditions. The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte (Coleoptera: Chrysomelidae), is a serious pest of corn in the United States and Europe. The expression profile of target genes related to insecticide exposure, resistance, and RNA interference has become an important experimental technique for study of western corn rootworms; however, lack of information on reliable HKGs under different conditions makes the interpretation of qRT-PCR results difficult. In this study, four distinct algorithms (Genorm, NormFinder, BestKeeper and delta-CT) and five candidate HKGs to genes of reference (beta-actin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; beta-tubulin; RPS9, ribosomal protein S9; EF1a, elongation factor-1 alpha) were evaluated to determine the most reliable HKG under different experimental conditions including exposure to dsRNA and Bt toxins and among different tissues and developmental stages. Although all the HKGs tested exhibited relatively stable expression among the different treatments, some differences were noted. Among the five candidate reference genes evaluated, beta-actin exhibited highly stable expression among different life stages. RPS9 exhibited the most similar pattern of expression among dsRNA treatments, and both experiments indicated that EF1a was the second most stable gene. EF1a was also the most stable for Bt exposure and among different tissues. These results will enable researchers to use more accurate and reliable normalization of qRT-PCR data in WCR experiments.	[Rodrigues, Thais Barros] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Rodrigues, Thais Barros] Univ Fed Lavras, Lavras, MG, Brazil; [Khajuria, Chitvan; Wang, Haichuan; Matz, Natalie; Siegfried, Blair] Univ Nebraska, Dept Entomol, Lincoln, NE USA; [Cardoso, Danielle Cunha] Agron Inst Campinas, Campinas, SP, Brazil; [Valicente, Fernando Hercos] Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade Federal de Lavras; University of Nebraska System; University of Nebraska Lincoln; Instituto Agronomico de Campinas (IAC); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Kentucky	Rodrigues, TB (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	thaisbarros.bio@gmail.com	Rodrigues, Thais Barros/G-3367-2014; Barros Rodrigues, Thais/F-6380-2010	Rodrigues, Thais Barros/0000-0003-3857-3114; Barros Rodrigues, Thais/0000-0003-3857-3114	CAPES Foundation (Ministry of Education of Brazil, Brasilia, Brazil) [DF 70040-020]; USDA National Institute of Food and Agriculture [2011-33522-30749]	CAPES Foundation (Ministry of Education of Brazil, Brasilia, Brazil); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by CAPES Foundation (Ministry of Education of Brazil, Brasilia - DF 70040-020, Brazil) for TBR's scholarship. This work was also partially supported by Biotechnology Risk Assessment Grant Program Competitive Grant No. 2011-33522-30749 from the USDA National Institute of Food and Agriculture. These funding programs did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bustin Stephen A, 2010, Expert Rev Mol Diagn, V10, P713, DOI 10.1586/erm.10.65; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Docimo Teresa, 2013, F1000Res, V2, P37, DOI 10.12688/f1000research.2-37.v1; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; METCALF RL, 1986, METHODS STUDY PEST D; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Rudeen ML, 2013, PEST MANAG SCI, V69, P709, DOI 10.1002/ps.3425; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xu YY, 2012, BIOCHEM BIOPH RES CO, V424, P398, DOI 10.1016/j.bbrc.2012.06.119	41	55	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109825	10.1371/journal.pone.0109825	http://dx.doi.org/10.1371/journal.pone.0109825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356627	Green Published, gold			2022-12-26	WOS:000346765000007
J	Soundararajan, R; Won, J; Stearns, TM; Charette, JR; Hicks, WL; Collin, GB; Naggert, JK; Krebs, MP; Nishina, PM				Soundararajan, Ramani; Won, Jungyeon; Stearns, Timothy M.; Charette, Jeremy R.; Hicks, Wanda L.; Collin, Gayle B.; Naggert, Juergen K.; Krebs, Mark P.; Nishina, Patsy M.			Gene Profiling of Postnatal Mfrp(rd6) Mutant Eyes Reveals Differential Accumulation of Prss56, Visual Cycle and Phototransduction mRNAs	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; POSTERIOR MICROPHTHALMOS; SERINE-PROTEASE; MFRP; MUTATION; MOUSE; NANOPHTHALMOS; MICE	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice. To better understand MFRP function, microarray analysis was performed on eyes of homozygous Mfrp(rd6) and C57BL/6J mice at postnatal days (P) 0 and P14, prior to photoreceptor loss. Data analysis revealed no changes at P0 but significant differences in RPE and retina-specific transcripts at P14, suggesting a postnatal influence of the Mfrp(rd6) allele. A subset of these transcripts was validated by quantitative real-time PCR (qRT-PCR). In Mfrp(rd6) eyes, a significant 1.5- to 2.0- fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2). Levels of RPE65 were significantly decreased by 2.0-fold. Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrp(rd6) eyes by 17-fold. Validation by qRT-PCR indicated a 3.5-, 14- and 70-fold accumulation of Prss56 transcripts relative to controls at P7, P14 and P21, respectively. This trend was not observed in other RPE or photoreceptor mutant mouse models with similar disease progression, suggesting that Prss56 upregulation is a specific attribute of the disruption of Mfrp. Prss56 and Glul in situ hybridization directly identified Muller glia in the inner nuclear layer as the cell type expressing Prss56. In summary, the Mfrp(rd6) allele causes significant postnatal changes in transcript and protein levels in the retina and RPE. The link between Mfrp deficiency and Prss56 up-regulation, together with the genetic association of human MFRP or PRSS56 variants and ocular size, raises the possibility that these genes are part of a regulatory network influencing postnatal posterior eye development.	[Soundararajan, Ramani; Stearns, Timothy M.; Charette, Jeremy R.; Hicks, Wanda L.; Collin, Gayle B.; Naggert, Juergen K.; Krebs, Mark P.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Won, Jungyeon] Natl Disaster Management Inst, Seoul, South Korea	Jackson Laboratory	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org		Stearns, Timothy/0000-0002-5533-6076; Krebs, Mark/0000-0001-9017-6066	National Institutes of Health (NIH) [EY011996]; National Institutes of Health Cancer Center Support (CORE) [5P30CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support (CORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Institutes of Health (NIH) grant EY011996 awarded to P.M.N. and National Institutes of Health Cancer Center Support (CORE) grant 5P30CA034196 to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; Ayala-Ramirez R, 2006, MOL VIS, V12, P1483; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; Cheng Christiana L, 2013, Mol Vis, V19, P955; Crespi J, 2008, AM J OPHTHALMOL, V146, P323, DOI 10.1016/j.ajo.2008.04.029; Dinculescu A, 2012, HUM GENE THER, V23, P367, DOI 10.1089/hum.2011.169; Fogerty J, 2011, INVEST OPHTH VIS SCI, V52, P7256, DOI 10.1167/iovs.11-8112; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gal A, 2011, AM J HUM GENET, V88, P382, DOI 10.1016/j.ajhg.2011.02.006; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; Kameya S, 2002, HUM MOL GENET, V11, P1879, DOI 10.1093/hmg/11.16.1879; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Liu H, 2000, GENETICS, V154, P1735; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mukhopadhyay R, 2010, MOL VIS, V16, P540; Nair KS, 2011, NAT GENET, V43, P579, DOI 10.1038/ng.813; Neri A, 2012, MOL VIS, V18, P2623; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Said MB, 2013, GENE, V528, P288, DOI 10.1016/j.gene.2013.06.045; Sharma YV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031371; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Sundin OH, 2008, OPHTHALMIC GENET, V29, P1, DOI 10.1080/13816810701651241; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Won J, 2008, VISUAL NEUROSCI, V25, P563, DOI 10.1017/S0952523808080723; Won JY, 2014, EXP EYE RES, V118, P30, DOI 10.1016/j.exer.2013.10.020; Won J, 2012, ADV EXP MED BIOL, V723, P391, DOI 10.1007/978-1-4614-0631-0_50; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Yokokura S, 2005, INVEST OPHTH VIS SCI, V46, P2905, DOI 10.1167/iovs.04-0856; Zenteno JC, 2009, MOL VIS, V15, P1794	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110299	10.1371/journal.pone.0110299	http://dx.doi.org/10.1371/journal.pone.0110299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357075	gold, Green Submitted, Green Published			2022-12-26	WOS:000346765000014
J	Hu, JD; Wang, TT; Wang, S; Chen, MW; Wang, MP; Mu, LY; Chen, HY; Hu, XR; Liang, H; Zhu, JH; Jiang, M				Hu, Jiandong; Wang, Tingting; Wang, Shun; Chen, Mingwen; Wang, Manping; Mu, Linying; Chen, Hongyin; Hu, Xinran; Liang, Hao; Zhu, Juanhua; Jiang, Min			Development of a Surface Plasmon Resonance Biosensing Approach for the Rapid Detection of Porcine Circovirus Type2 in Sample Solutions	PLOS ONE			English	Article							REAL-TIME PCR; PARVOVIRUS; DIAGNOSIS; DISEASES; VIRUS; PCV2	A sensitive and label-free analytical approach for the detection of porcine circovirus type 2 (PCV2) instead of PCV2 antibody in serum sample was systematically investigated in this research based on surface plasmon resonance (SPR) with an establishment of special molecular identification membrane. The experimental device for constructing the biosensing analyzer is composed of an integrated biosensor, a home-made microfluidic module, and an electrical control circuit incorporated with a photoelectric converter. In order to detect the PCV2 using the surface plasmon resonance immunoassay, the mercaptopropionic acid has been used to bind the Au film in advance through the known form of the strong S-Au covalent bonds formed by the chemical radical of the mercaptopropionic acid and the Au film. PCV2 antibodies were bonded with the mercaptopropionic acid by covalent -CO-NH- amide bonding. For the purpose of evaluating the performance of this approach, the known concentrations of PCV2 Cap protein of 10 mu g/mL, 7.5 mu g/mL, 5 mu g/mL, 2.5 mu g/mL, 1 mu g/mL, and 0.5 mu g/mL were prepared by diluting with PBS successively and then the delta response units (Delta RUs) were measured individually. Using the data collected from the linear CCD array, the Delta RUs gave a linear response over a wide concentration range of standard known concentrations of PCV2 Cap protein with the R-Squared value of 0.99625. The theoretical limit of detection was calculated to be 0.04 mu g/mL for the surface plasmon resonance biosensing approach. Correspondingly, the recovery rate ranged from 81.0% to 89.3% was obtained. In contrast to the PCV2 detection kits, this surface plasmon resonance biosensing system was validated through linearity, precision and recovery, which demonstrated that the surface plasmon resonance immunoassay is reliable and robust. It was concluded that the detection method which is associated with biomembrane properties is expected to contribute much to determine the PCV2 in sample solutions instead of PCV2 antibody in serum samples quantitatively.	[Hu, Jiandong; Wang, Tingting; Wang, Shun; Wang, Manping; Mu, Linying; Zhu, Juanhua] Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China; [Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Chen, Mingwen] Zhengzhou Oriole Elect Grp Joint Stock Co Ltd, Zhengzhou, Peoples R China; [Chen, Hongyin] Henan Agr Univ, Coll Anim Husb & Vet, Zhengzhou, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Ste Anne De Bellevue, PQ, Canada; [Liang, Hao] Univ Gavle, Dept Elect & Telecommun, Gavle, Sweden; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; McGill University; University of Gavle; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China.	jiandonghu@163.com	wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [U1304305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was also performed in State Key Laboratory of Wheat and Maize Crop Science and funded by National Natural Science Foundation of China (No. U1304305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang GN, 2010, J MICROBIOL IMMUNOL, V43, P85, DOI 10.1016/S1684-1182(10)60014-X; [车勇良 Che Yongliang], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P290; Chen HT, 2008, J VIROL METHODS, V149, P264, DOI 10.1016/j.jviromet.2008.01.023; Chul Park, 2011, [Korean Journal of Veterinary Service, 한국가축위생학회지], V34, P1; Fossum C, 2014, J VIROL METHODS, V196, P185, DOI 10.1016/j.jviromet.2013.10.042; Ge XN, 2012, VIRUS RES, V164, P100, DOI 10.1016/j.virusres.2011.10.005; Grau-Roma L, 2011, VET J, V187, P23, DOI 10.1016/j.tvjl.2010.01.018; Hu JD, 2012, BIOSENS BIOELECTRON, V31, P475, DOI 10.1016/j.bios.2011.11.019; Hu JD, 2009, BIOSENS BIOELECTRON, V24, P1974, DOI 10.1016/j.bios.2008.10.033; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Huang LP, 2011, J VIROL METHODS, V171, P26, DOI 10.1016/j.jviromet.2010.09.023; Huang YL, 2014, RES VET SCI, V96, P187, DOI 10.1016/j.rvsc.2013.11.020; McClenahan SD, 2011, VACCINE, V29, P4745, DOI 10.1016/j.vaccine.2011.04.087; Pejsak Z, 2010, COMP IMMUNOL MICROB, V33, pE1, DOI 10.1016/j.cimid.2009.09.006; Perez LJ, 2012, J VIROL METHODS, V179, P233, DOI 10.1016/j.jviromet.2011.11.009; Rodriguez-Carino C, 2010, J COMP PATHOL, V142, P291, DOI 10.1016/j.jcpa.2009.12.001; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Vidigal PMP, 2012, VIRUS RES, V163, P320, DOI 10.1016/j.virusres.2011.10.019; Vilcek S, 2010, J VIROL METHODS, V165, P216, DOI 10.1016/j.jviromet.2010.01.023; Vlasakova M, 2012, J VIROL METHODS, V179, P311, DOI 10.1016/j.jviromet.2011.11.014; [张文通 Zhang Wentong], 2012, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V34, P728; Zheng LL, 2013, J VIROL METHODS, V187, P15, DOI 10.1016/j.jviromet.2012.06.024	22	55	56	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111292	10.1371/journal.pone.0111292	http://dx.doi.org/10.1371/journal.pone.0111292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354302	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200068
J	Woloszyk, A; Dircksen, SH; Bostanci, N; Muller, R; Hofmann, S; Mitsiadis, TA				Woloszyk, Anna; Dircksen, Sabrina Holsten; Bostanci, Nagihan; Mueller, Ralph; Hofmann, Sandra; Mitsiadis, Thimios A.			Influence of the Mechanical Environment on the Engineering of Mineralised Tissues Using Human Dental Pulp Stem Cells and Silk Fibroin Scaffolds	PLOS ONE			English	Article							IN-VITRO; BONE-MARROW; TOOTH DEVELOPMENT; OXYGEN GRADIENTS; STROMAL CELLS; ILIAC CREST; DIFFERENTIATION; MECHANOTRANSDUCTION; RADIATION; REPAIR	Teeth constitute a promising source of stem cells that can be used for tissue engineering and regenerative medicine purposes. Bone loss in the craniofacial complex due to pathological conditions and severe injuries could be treated with new materials combined with human dental pulp stem cells (hDPSCs) that have the same embryonic origin as craniofacial bones. Optimising combinations of scaffolds, cells, growth factors and culture conditions still remains a great challenge. In the present study, we evaluate the mineralisation potential of hDPSCs seeded on porous silk fibroin scaffolds in a mechanically dynamic environment provided by spinner flask bioreactors. Cell-seeded scaffolds were cultured in either standard or osteogenic media in both static and dynamic conditions for 47 days. Histological analysis and micro-computed tomography of the samples showed low levels of mineralisation when samples were cultured in static conditions (0.16 +/- 0.1 BV/TV%), while their culture in a dynamic environment with osteogenic medium and weekly mu CT scans (4.9 +/- 1.6 BV/TV%) significantly increased the formation of homogeneously mineralised structures, which was also confirmed by the elevated calcium levels (4.5 +/- 1.0 vs. 8.8 +/- 1.7 mg/mL). Molecular analysis of the samples showed that the expression of tooth correlated genes such as Dentin Sialophosphoprotein and Nestin were downregulated by a factor of 6.7 and 7.4, respectively, in hDPSCs when cultured in presence of osteogenic medium. This finding indicates that hDPSCs are able to adopt a nondental identity by changing the culture conditions only. Also an increased expression of Osteocalcin (1.4x) and Collagen type I (1.7x) was found after culture under mechanically dynamic conditions in control medium. In conclusion, the combination of hDPSCs and silk scaffolds cultured under mechanical loading in spinner flask bioreactors could offer a novel and promising approach for bone tissue engineering where appropriate and rapid bone regeneration in mechanically loaded tissues is required.	[Woloszyk, Anna; Bostanci, Nagihan; Mitsiadis, Thimios A.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Dircksen, Sabrina Holsten; Mueller, Ralph; Hofmann, Sandra] ETH, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Sci, NL-5600 MB Eindhoven, Netherlands	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Eindhoven University of Technology	Mitsiadis, TA (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	thimios.mitsiadis@zzm.uzh.ch	Müller, Ralph/A-1198-2008; Mitsiadis, Thimios/B-5564-2016; Hofmann, Sandra/F-2832-2010; Bostanci, Nagihan/ABD-5524-2020	Müller, Ralph/0000-0002-5811-7725; Mitsiadis, Thimios/0000-0002-9812-9982; Hofmann, Sandra/0000-0002-2568-8388; Bostanci, Nagihan/0000-0002-6742-3556; Woloszyk, Anna/0000-0002-8850-0397	University of Zurich; ETH Zurich	University of Zurich; ETH Zurich(ETH Zurich)	This work was supported by funds from University of Zurich, funds from ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Michele, 2013, Muscles Ligaments Tendons J, V3, P63, DOI 10.11138/mltj/2013.3.2.063; Abe S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt43; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Camps J, 2002, CONNECT TISSUE RES, V43, P396, DOI 10.1080/03008200290001069; Caton J, 2011, J CELL MOL MED, V15, P1054, DOI 10.1111/j.1582-4934.2010.01251.x; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; GRAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2; Han MJ, 2008, BIOTECHNOL BIOPROC E, V13, P410, DOI [10.1007/s12257-008-0146-9, 10.1007/S12257-008-0146-9]; Hata M, 2013, TISSUE ENG PT A, V19, P625, DOI 10.1089/ten.tea.2012.0099; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729; Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Hung BP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt158; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; Kraehenbuehl TP, 2010, BIOMED TECH, V55, P245, DOI 10.1515/BMT.2010.031; Krishnan L, 2014, ANN BIOMED ENG, V42, P432, DOI 10.1007/s10439-014-0969-9; Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; Mitsiadis T A, 2011, Adv Dent Res, V23, P275, DOI 10.1177/0022034511405386; Mitsiadis TA, 2004, J DENT RES, V83, P896, DOI 10.1177/154405910408301202; Mitsiadis TA, 2012, NANOMEDICINE-UK, V7, P1743, DOI [10.2217/NNM.12.146, 10.2217/nnm.12.146]; Mitsiadis TA, 2011, REGEN MED, V6, P135, DOI 10.2217/RME.10.101; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Muthna D, 2010, STEM CELLS DEV, V19, P1855, DOI 10.1089/scd.2009.0449; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Orsini G, 2012, REV NATURE ROLE FU 1, P1; Pagella P, 2014, CELL MOL LIFE SCI, V71, P2241, DOI 10.1007/s00018-013-1549-0; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; Rauh J, 2011, TISSUE ENG PART B-RE, V17, P263, DOI [10.1089/ten.teb.2010.0612, 10.1089/ten.TEB.2010.0612]; Remedios A, 1999, VET CLIN N AM-SMALL, V29, P1029, DOI 10.1016/S0195-5616(99)50101-0; Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Sittichokechaiwut A, 2010, EUR CELLS MATER, V20, P45; Steward AJ, 2014, J MECH BEHAV BIOMED, V38, P174, DOI 10.1016/j.jmbbm.2013.07.020; Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; VEIS A, 1993, J BONE MINER RES, V8, pS493; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x; Wang X, 2013, ORGANOGENESIS, V9, P280, DOI 10.4161/org.26080; Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013; Yu V, 2009, BIOCHEM BIOPH RES CO, V386, P661, DOI 10.1016/j.bbrc.2009.06.106	63	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111010	10.1371/journal.pone.0111010	http://dx.doi.org/10.1371/journal.pone.0111010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354351	Green Published, gold, Green Accepted			2022-12-26	WOS:000345204200051
J	Morrison, A; Chen, L; Wang, JL; Zhang, M; Yang, H; Ma, YN; Budanov, A; Lee, JH; Karin, M; Li, J				Morrison, Alex; Chen, Li; Wang, Jinli; Zhang, Ming; Yang, Hui; Ma, Yina; Budanov, Andrei; Lee, Jun Hee; Karin, Michael; Li, Ji			Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart	FASEB JOURNAL			English	Article						AMP-activated protein kinase; scaffold protein; ischemia	PROTEIN-KINASE; REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; SENESCENT HEART; GLUCOSE-UPTAKE; TROPONIN-I; STRESS; LKB1; PHOSPHORYLATION; IDENTIFICATION	The regulation of AMPK in the ischemic heart remains incompletely understood. Recent evidence implicates the role of Sestrin2 in the AMPK signaling pathway, and it is hypothesized that Sestrin2 plays an influential role during myocardial ischemia to promote AMPK activation. Sestrin2 protein was found to be expressed in adult cardiomyocytes and accumulated in the heart during ischemic conditions. Sestrin2 knockout (KO) mice were used to determine the importance of Sestrin2 during ischemia and reperfusion (I/R) injury. When wild-type (WT) and Sestrin2 KO mice were subjected to in vivo I/R, myocardial infarct size was significantly greater in Sestrin2 KO compared with WT hearts. Similarly, Langendorff perfused hearts indicated exacerbated postischemic contractile function in Sestrin2 KO hearts compared with WT. Ischemic AMPK activation was found to be impaired in the Sestrin2 KO hearts. Immunoprecipitation of Sestrin2 demonstrated an association with AMPK. Moreover, liver kinase B1 (LKB1), a major AMPK upstream kinase, was associated with the Sestrin2-AMPK complex in a time-dependent manner during ischemia, whereas this interaction was nearly abolished in Sestrin2 KO hearts. Thus, Sestrin2 plays an important role in cardioprotection against I/R injury, serving as an LKB1-AMPK scaffold to initiate AMPK activation during ischemic insults.	[Morrison, Alex; Wang, Jinli; Ma, Yina; Li, Ji] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Chen, Li; Zhang, Ming] Jilin Univ, Dept Pharmacol, Coll Basic Med, Changchun, Jilin, Peoples R China; [Yang, Hui] Capital Med Univ, Dept Pathol, Sch Basic Med Sci, Beijing, Peoples R China; [Budanov, Andrei] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Lee, Jun Hee] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Jilin University; Capital Medical University; Virginia Commonwealth University; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Li, J (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 3435 Main St, Buffalo, NY 14214 USA.	jli23@buffalo.edu	Budanov, Andrei V/HGD-5487-2022; Zhang, Ming/E-4888-2016	Budanov, Andrei V/0000-0002-7943-1000; Lee, Jun Hee/0000-0002-2200-6011	American Heart Association [12GRNT11620029, 14IRG18290014]; American Diabetes Association Basic Sciences [1-14-BS-131]; U.S. National Institutes of Health National Cancer Institute Grant [5R01CA172660]; National Natural Science Foundation of China Grant [81200195]; Ellison Foundation; NATIONAL CANCER INSTITUTE [R01CA172660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049835, R21AG044820] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association Basic Sciences; U.S. National Institutes of Health National Cancer Institute Grant; National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge Xingchi Chen and Yanqing Wang for excellent contributions in testing the AICAR-treated HeLa cells and performing real-time RT-PCR to measure Sestrin2 mRNA levels. This work was supported by American Heart Association Grants 12GRNT11620029 and 14IRG18290014, American Diabetes Association Basic Sciences Grant 1-14-BS-131, U.S. National Institutes of Health National Cancer Institute Grant 5R01CA172660, National Natural Science Foundation of China Grant 81200195, and the Ellison Foundation. This work was presented in part at the 2011 and 2012 American Heart Association Scientific Sessions and at the 2013 Experimental Biology Meeting.	Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chen S, 2014, LIFE SCI, V98, P75, DOI 10.1016/j.lfs.2014.01.006; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Costa R, 2012, J THROMB HAEMOST, V10, P1736, DOI 10.1111/j.1538-7836.2012.04833.x; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Essler S, 2009, FEBS LETT, V583, P3531, DOI 10.1016/j.febslet.2009.10.017; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Moussa A, 2012, ACTA PHARM SIN B, V2, P368, DOI 10.1016/j.apsb.2012.06.001; Olson N, 2011, AM J PHYSIOL-LUNG C, V301, pL993, DOI 10.1152/ajplung.00250.2011; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Wang J, 2013, J THROMB HAEMOST, V11, P1020, DOI 10.1111/jth.12243; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang JY, 2013, CIRCULATION, V128, P225, DOI 10.1161/CIRCULATIONAHA.112.000862; Young LH, 2008, CIRCULATION, V117, P832, DOI 10.1161/CIRCULATIONAHA.107.713115	41	129	138	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					408	417		10.1096/fj.14-258814	http://dx.doi.org/10.1096/fj.14-258814			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25366347	Green Published, Green Submitted			2022-12-26	WOS:000349370400007
J	Wen, L; Fu, LZ; Guo, XG; Chen, YL; Shi, YB				Wen, Luan; Fu, Liezhen; Guo, Xiaogang; Chen, Yonglong; Shi, Yun-Bo			Histone methyltransferase Dot1L plays a role in postembryonic development in Xenopus tropicalis	FASEB JOURNAL			English	Article						epigenetics; histone modification; activation mark; organogenesis	THYROID-HORMONE RECEPTOR; EFFECTOR NUCLEASES TALENS; INTESTINAL STEM-CELLS; SET-DOMAIN; H3K79 METHYLATION; HUMAN GENOME; TRANSCRIPTION; GENE; CHROMATIN; H3	Histone methylations have been implicated to play important roles in diverse cellular processes. Of particular interest is the methylation of histone H3K79, which is catalyzed by an evolutionarily conserved methyltransferase, disruptor of telomeric silencing (Dot1)-like (Dot1L). To investigate the role of Dot1L during vertebrate development, we have generated a Dot1L-specific transcription activator-like effector nuclease (TALEN) nuclease to knockdown endogenous Dot1L in Xenopus tropicalis, a diploid species highly related to the well-known developmental model Xenopus laevis, a pseudotetraploid amphibian. We show that the TALEN was extremely efficient in mutating Dot1L when expressed in fertilized eggs, creating essentially Dot1L knockout embryos with little H3K79 methylation. Importantly, we observed that Dot1L knockdown had no apparent effect on embryogenesis because normally feeding tadpoles were formed, consistent with the lack of maternal Dot1L expression. On the other hand, Dot1L knockdown severely retarded the growth of the tadpoles and led to tadpole lethality prior to metamorphosis. These findings suggest that Dot1L and H3K79 methylation play an important role for tadpole growth and development prior to metamorphosis into a frog. Our findings further reveal interesting similarities and differences between Xenopus and mouse development and suggest the existence of 2 separate phases of vertebrate development with distinct requirements for epigenetic modifications.	[Wen, Luan; Fu, Liezhen; Shi, Yun-Bo] NICHHD, NIH, Program Cellular Regulat & Metab, Sect Mol Morphogenesis, Bethesda, MD 20892 USA; [Guo, Xiaogang; Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Shi, YB (corresponding author), NICHHD, NIH, Bldg 18T Room 106,18 Lib Dr MSC 5431, Bethesda, MD 20892 USA.	shi@helix.nih.gov	Wen, Luan/ABH-3991-2020	Wen, Luan/0000-0001-9408-8709; Wen, Luan/0000-0001-5080-0469; Shi, Yun-Bo/0000-0002-6330-0639	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health. The authors declare no conflicts of interest.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Barry ER, 2010, EXPERT OPIN THER TAR, V14, P405, DOI 10.1517/14728221003623241; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao Y, 2001, MECH DEVELOP, V102, P243, DOI 10.1016/S0925-4773(01)00295-7; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hasebe T, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-18; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-42; Singer MS, 1998, GENETICS, V150, P613; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wen LA, 2010, DEV DYNAM, V239, P2198, DOI 10.1002/dvdy.22356	33	22	23	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					385	393		10.1096/fj.14-252171	http://dx.doi.org/10.1096/fj.14-252171			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25366346	Green Published			2022-12-26	WOS:000349370400005
J	Lin, M; Zhang, BL; Yu, CN; Li, JL; Zhang, L; Sun, H; Gao, F; Zhou, GH				Lin, Meng; Zhang, Bolin; Yu, Changning; Li, Jiaolong; Zhang, Lin; Sun, Hui; Gao, Feng; Zhou, Guanghong			L-Glutamate Supplementation Improves Small Intestinal Architecture and Enhances the Expressions of Jejunal Mucosa Amino Acid Receptors and Transporters in Weaning Piglets	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; MONOSODIUM GLUTAMATE; TASTE RECEPTORS; DIGESTIVE PHYSIOLOGY; NUTRIENT ABSORPTION; DIETARY GLUTAMATE; METABOLIC-FATE; ARGININE; OCCLUDIN; CALCIUM	L-Glutamate is a major oxidative fuel for the small intestine. However, few studies have demonstrated the effect of L-glutamate on the intestinal architecture and signaling of amino acids in the small intestine. The aim of this study was to investigate the effects of dietary L-glutamate supplementation on the intestinal architecture and expressions of jejunal mucosa amino acid receptors and transporters in weaning piglets. A total of 120 weaning piglets aged 35 +/- 1 days with an average body weight at 8.91 +/- 0.45 kg were randomly allocated to two treatments with six replicates of ten piglets each, fed with diets containing 1.21% alanine, or 2% L-glutamate. L-Glutamate supplementation increased the activity of glutamate oxaloacetate transaminase (GOT) in the jejunal mucosa. Also, the mRNA expression level of jejunal mucosa glutamine synthetase (GS) was increased by L-glutamate supplementation. The height of villi in duodenal and jejunal segments, and the relative mRNA expression of occludin and zonula occludens protein-1 (ZO-1) in jejunal mucosa were increased by dietary L-glutamate supplementation. L-Glutamate supplementation increased plasma concentrations of glutamate, arginine, histidine, isoleucine, leucine, methionine, phenylalanine and threonine. L-Glutamate supplementation also increased the relative mRNA expression of the jejunal mucosa Ca2+-sensing receptor (CaR), metabotropic glutamate receptor 1 (mGluR1) and metabotropic glutamate receptor 4 (mGluR4), and neutral amino acid transporter B-0-like (SLC1A5) in the jejunal mucosa. These findings suggest that dietary addition of 2% L-glutamate improves the intestinal integrity and influences the expression of amino acid receptors and transporters in the jejunum of weaning, which is beneficial for the improvement of jejunal nutrients for digestion and absorption.	[Lin, Meng; Zhang, Bolin; Yu, Changning; Li, Jiaolong; Zhang, Lin; Gao, Feng; Zhou, Guanghong] Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Sun, Hui] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China	Nanjing Agricultural University; Jilin Agricultural University	Gao, F (corresponding author), Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	gaofeng0629@sina.com	Zhang, Lin/AAL-3573-2020; Zhang, bolin/GZN-2017-2022	Zhang, Lin/0000-0003-1555-1086; 	National Key Basic Research Program of China [2013CB127306]	National Key Basic Research Program of China(National Basic Research Program of China)	The present study was supported by National Key Basic Research Program of China (no. 2013CB127306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Akiba Y, 2009, AM J CLIN NUTR, V90, p826S, DOI 10.3945/ajcn.2009.27462U; Amagase K, 2012, J PHARMACOL SCI, V118, P131, DOI 10.1254/jphs.11R03FM; Beutheu S, 2014, CLIN NUTR, V33, P694, DOI 10.1016/j.clnu.2013.09.003; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2011, AM J PHYSIOL-GASTR L, V300, pG137, DOI 10.1152/ajpgi.00299.2010; Broer A, 2000, BIOCHEM J, V349, P787, DOI 10.1042/bj3490787; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Brosnan JT, 2013, AMINO ACIDS, V45, P413, DOI 10.1007/s00726-012-1280-4; Burrin DG, 2009, AM J CLIN NUTR, V90, p850S, DOI 10.3945/ajcn.2009.27462Y; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Gabriel AS, 2009, J MED INVESTIG, V56, P209, DOI 10.2152/jmi.56.209; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Haynes TE, 2009, AMINO ACIDS, V37, P131, DOI 10.1007/s00726-009-0243-x; He LQ, 2013, AMINO ACIDS, V45, P383, DOI 10.1007/s00726-013-1514-0; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kirchgessner Annette L., 2001, Current Opinion in Pharmacology, V1, P591, DOI 10.1016/S1471-4892(01)00101-1; Li N, 2009, J NUTR, V139, P710, DOI 10.3945/jn.108.101485; Li XL, 2011, AMINO ACIDS, V40, P1159, DOI 10.1007/s00726-010-0740-y; Liou AP, 2013, J ANIM SCI, V91, P1946, DOI 10.2527/jas.2012-5910; Liu Y, 2000, J CELL SCI, V113, P2363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mace OJ, 2013, J ANIM SCI, V91, P1932, DOI 10.2527/jas.2012-5906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; McCarthy KM, 1996, J CELL SCI, V109, P2287; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; National Research Council, 2012, NUTR REQ SWIN, P373; Nguyen CA, 2012, CURR MED CHEM, V19, P28; Nose K, 2010, J INTERF CYTOK RES, V30, P67, DOI 10.1089/jir.2009.0046; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Riedijk MA, 2007, PEDIATR RES, V62, P468, DOI 10.1203/PDR.0b013e31813cbeba; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Thomas S, 2005, SURGERY, V137, P48, DOI 10.1016/j.surg.2004.04.038; Vermeulen MAR, 2011, WORLD J GASTROENTERO, V17, P1569, DOI 10.3748/wjg.v17.i12.1569; WINDMUELLER HG, 1976, ARCH BIOCHEM BIOPHYS, V175, P670, DOI 10.1016/0003-9861(76)90558-0; Wu G, 2013, AMINO ACIDS: BIOCHEMISTRY AND NUTRITION, P1, DOI 10.1201/b14661; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; WU GY, 1995, AM J PHYSIOL-REG I, V269, pR621, DOI 10.1152/ajpregu.1995.269.3.R621; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	51	41	48	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111950	10.1371/journal.pone.0111950	http://dx.doi.org/10.1371/journal.pone.0111950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368996	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000130
J	Niedojadlo, J; Kubicka, E; Kalich, B; Smolinski, DJ				Niedojadlo, Janusz; Kubicka, Ewa; Kalich, Beata; Smolinski, Dariusz J.			Poly(A) RNAs Including Coding Proteins RNAs Occur in Plant Cajal Bodies	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA; INTERCHROMATIN GRANULES; NUCLEAR DOMAINS; COILED BODIES; SMN; IDENTIFICATION; ORGANIZATION; METHYLATION; EXPRESSION	The localisation of poly(A) RNA in plant cells containing either reticular (Allium cepa) or chromocentric (Lupinus luteus, Arabidopsis thaliana) nuclei was studied through in situ hybridisation. In both types of nuclei, the amount of poly(A) RNA was much greater in the nucleus than in the cytoplasm. In the nuclei, poly(A) RNA was present in structures resembling nuclear bodies. The molecular composition as well as the characteristic ultrastructure of the bodies containing poly(A) RNA demonstrated that they were Cajal bodies. We showed that some poly(A) RNAs in Cajal bodies code for proteins. However, examination of the localisation of active RNA polymerase II and in situ run-on transcription assays both demonstrated that CBs are not sites of transcription and that BrU-containing RNA accumulates in these structures long after synthesis. In addition, it was demonstrated that accumulation of poly(A) RNA occurs in the nuclei and CBs of hypoxia-treated cells. Our findings indicated that CBs may be involved in the later stages of poly(A) RNA metabolism, playing a role storage or retention.	[Niedojadlo, Janusz; Kubicka, Ewa; Kalich, Beata; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland	Nicolaus Copernicus University	Niedojadlo, J (corresponding author), Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland.	janiaszn@umk.pl	Smolinski, Dariusz/M-3794-2014; Smolinski, Dariusz Jan/AAV-8969-2021; Niedojadło, Janusz/O-3211-2015	Smolinski, Dariusz/0000-0002-8272-0196; Smolinski, Dariusz Jan/0000-0002-8272-0196; Niedojadlo, Janusz/0000-0003-3550-9854; Kubicka, Ewa/0000-0002-6856-959X				Akef A, 2013, NUCLEUS-PHILA, V4, P326, DOI 10.4161/nucl.26052; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; BEVEN AF, 1995, J CELL SCI, V108, P509; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; Cevher MA, 2010, WIRES RNA, V1, P193, DOI 10.1002/wrna.20; CLEVENGER CV, 1984, EXP CELL RES, V151, P194, DOI 10.1016/0014-4827(84)90368-9; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Cui P, 2003, PLANTA, V217, P21, DOI 10.1007/s00425-002-0966-3; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Deckert J, 1997, ACTA BIOCHIM POL, V44, P37; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Gohring J, 2014, PLANT CELL, V26, P754, DOI 10.1105/tpc.113.118075; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2013, INT J BIOCHEM CELL B, V45, P1314, DOI 10.1016/j.biocel.2013.03.019; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Jackson MB, 2005, ANN BOT-LONDON, V96, P501, DOI 10.1093/aob/mci205; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kolowerzo A, 2009, PROTOPLASMA, V236, P13, DOI 10.1007/s00709-009-0042-y; Lorkovic ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003989; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Makarov V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053571; Melcak I, 2001, MOL BIOL CELL, V12, P393, DOI 10.1091/mbc.12.2.393; Muthuswamy S, 2011, PLANTA, V233, P201, DOI 10.1007/s00425-010-1278-7; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Niedojadlo J, 2008, PROTOPLASMA, V234, P77, DOI 10.1007/s00709-008-0018-3; Niedojadlo J, 2012, PLANTA, V236, P715, DOI 10.1007/s00425-012-1640-z; Niedojadlo J, 2011, EXP CELL RES, V317, P433, DOI 10.1016/j.yexcr.2010.10.026; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Novotny I, 2011, MOL BIOL CELL, V22, P513, DOI 10.1091/mbc.E10-07-0560; Palanca A, 2014, BBA-MOL BASIS DIS, V1842, P848, DOI 10.1016/j.bbadis.2013.11.016; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schul W, 1998, MOL BIOL CELL, V9, P1025, DOI 10.1091/mbc.9.5.1025; Smolinski DJ, 2012, CHROMOSOMA, V121, P37, DOI 10.1007/s00412-011-0339-4; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; TURNER BM, 1987, J CELL SCI, V87, P269; VISA N, 1993, EXP CELL RES, V208, P19, DOI 10.1006/excr.1993.1218; Vuletic M, 2005, ANN NY ACAD SCI, V1048, P244, DOI 10.1196/annals.1342.022; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111780	10.1371/journal.pone.0111780	http://dx.doi.org/10.1371/journal.pone.0111780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369024	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000099
J	Zhai, JF; Dong, YY; Sun, YP; Wang, Q; Wang, N; Wang, FW; Liu, WC; Li, XW; Chen, H; Yao, N; Guan, LL; Chen, K; Cui, XY; Yang, MY; Li, HY				Zhai, Junfeng; Dong, Yuanyuan; Sun, Yepeng; Wang, Qi; Wang, Nan; Wang, Fawei; Liu, Weican; Li, Xiaowei; Chen, Huan; Yao, Na; Guan, Lili; Chen, Kai; Cui, Xiyan; Yang, Meiying; Li, Haiyan			Discovery and Analysis of MicroRNAs in Leymus chinensis under Saline-Alkali and Drought Stress Using High-Throughput Sequencing	PLOS ONE			English	Article							SMALL RNAS; IDENTIFICATION; EXPRESSION; GENE; SALT; TARGETS; MIRNAS; NETWORKS; MIRBASE	Leymus chinensis (Trin.) Tzvel. is a perennial rhizome grass of the Poaceae (also called Gramineae) family, which adapts well to drought, saline and alkaline conditions. However, little is known about the stress tolerance of L. chinensis at the molecular level. microRNAs (miRNAs) are known to play critical roles in nutrient homeostasis, developmental processes, pathogen responses, and abiotic stress in plants. In this study, we used Solexa sequencing technology to generate high-quality small RNA data from three L. chinensis groups: a control group, a saline-alkaline stress group (100 mM NaCl and 200 mM NaHCO3), and a drought stress group (20% polyethylene glycol 2000). From these data we identified 132 known miRNAs and 16 novel miRNAs candidates. For these miRNAs we also identified target genes that encode a broad range of proteins that may be correlated with abiotic stress regulation. This is the first study to demonstrate differentially expressed miRNAs in L. chinensis under saline-alkali and drought stress. These findings may help explain the saline-alkaline and drought stress responses in L. chinensis.	[Zhai, Junfeng; Dong, Yuanyuan; Sun, Yepeng; Wang, Nan; Wang, Fawei; Liu, Weican; Li, Xiaowei; Chen, Huan; Yao, Na; Guan, Lili; Chen, Kai; Li, Haiyan] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Zhai, Junfeng; Cui, Xiyan; Yang, Meiying; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wang, Qi] NE Normal Univ, High Sch, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Northeast Normal University - China	Li, HY (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	hyli99@163.com	yao, na/HDL-8772-2022		Program for the Special Program for Research of Transgenic Plants [2011ZX08010-002]; National Natural Science Foundation of China [30971804, 31101091, 31271746, 31201144]; State Key Laboratory of Crop Biology at Shandong Agricultural University, China [2010KF02]; Program for Young Scientific and Technological Talents & Outstanding Innovation Team [20111815]; National High Technology Research and Development Program of China (863 Program) [2011AA100606]	Program for the Special Program for Research of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Biology at Shandong Agricultural University, China; Program for Young Scientific and Technological Talents & Outstanding Innovation Team; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for the Special Program for Research of Transgenic Plants (Grant No. 2011ZX08010-002), the National Natural Science Foundation of China (Grant Nos. 30971804, 31101091, 31271746, 31201144), the State Key Laboratory of Crop Biology at Shandong Agricultural University, China (Grant No. 2010KF02), the Program for Young Scientific and Technological Talents & Outstanding Innovation Team (Grant No. 20111815), and the National High Technology Research and Development Program of China (863 Program) (Grant No. 2011AA100606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Feng H, 2013, PLANT MOL BIOL, V83, P433, DOI 10.1007/s11103-013-0101-9; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Huang ZH, 2004, ANN BOT-LONDON, V93, P295, DOI 10.1093/aob/mch044; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao GH, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26753; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Mutum RD, 2013, FEBS J, V280, P1717, DOI 10.1111/febs.12186; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Shu QY, 2005, PLANT CELL REP, V24, P36, DOI 10.1007/s00299-004-0908-6; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Spanudakis E, 2014, J EXP BOT, V65, P365, DOI 10.1093/jxb/ert453; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang ST, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091357, 10.1371/journal.pone.0104745, 10.1371/journal.pone.0089848]; Windels D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095972; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Zhang HY, 2013, PLANT J, V74, P98, DOI 10.1111/tpj.12107; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980; Zhu JF, 2013, PLANT CELL REP, V32, P1339, DOI 10.1007/s00299-013-1446-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	48	13	13	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e105417	10.1371/journal.pone.0105417	http://dx.doi.org/10.1371/journal.pone.0105417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369004	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000002
J	Kumar, A; Pate, KM; Moss, MA; Dean, DN; Rangachari, V				Kumar, Amit; Pate, Kayla M.; Moss, Melissa A.; Dean, Dexter N.; Rangachari, Vijayaraghavan			Self-Propagative Replication of A beta Oligomers Suggests Potential Transmissibility in Alzheimer Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASES; FIBRIL FORMATION; IN-VITRO; PROTEIN; PRIONS; AGGREGATION; ELONGATION; PEPTIDE; SCRAPIE	The aggregation of amyloid-beta (A beta) peptide and its deposition in parts of the brain form the central processes in the etiology of Alzheimer disease (AD). The low-molecular weight oligomers of A beta aggregates (2 to 30 mers) are known to be the primary neurotoxic agents whose mechanisms of cellular toxicity and synaptic dysfunction have received substantial attention in the recent years. However, how these toxic agents proliferate and induce widespread amyloid deposition throughout the brain, and what mechanism is involved in the amplification and propagation of toxic oligomer species, are far from clear. Emerging evidence based on transgenic mice models indicates a transmissible nature of A beta aggregates and implicates a prion-like mechanism of oligomer propagation, which manifests as the dissemination and proliferation of A beta toxicity. Despite accumulating evidence in support of a transmissible nature of A beta aggregates, a clear, molecular-level understanding of this intriguing mechanism is lacking. Recently, we reported the characterization of unique replicating oligomers of A beta 42 (12-24 mers) in vitro called Large Fatty Acid-derived Oligomers (LFAOs) (Kumar et al., 2012, J. Biol. Chem). In the current report, we establish that LFAOs possess physiological activity by activating NF-kappa B in human neuroblastoma cells, and determine the experimental parameters that control the efficiency of LFAO replication by self-propagation. These findings constitute the first detailed report on monomer - oligomer lateral propagation reactions that may constitute potential mechanism governing transmissibility among Ab oligomers. These data support the previous reports on transmissible mechanisms observed in transgenic animal models.	[Kumar, Amit; Dean, Dexter N.; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Pate, Kayla M.; Moss, Melissa A.] Univ So Calif, Dept Chem Engn, Columbia, SC USA	University of Southern Mississippi; University of Southern California	Rangachari, V (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	Vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Dean, Dexter N./0000-0002-2279-3393	National Center for Research Resources [5P20RR016476-11]; National Institute of General Medical Sciences from the National Institutes of Health through INBRE [8 P20 GM103476-11]; National Institutes of Health, National Institute of General Medical Sciences through COBRE [P20GM103641]; American Heart Association [10GRNT4190124]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641, P20GM103476] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health through INBRE; National Institutes of Health, National Institute of General Medical Sciences through COBRE; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly funded by National Center for Research Resources (5P20RR016476-11) and the National Institute of General Medical Sciences (8 P20 GM103476-11) from the National Institutes of Health for funding through INBRE (to VR), National Institutes of Health, National Institute of General Medical Sciences for funding through COBRE (P20GM103641) (to MAM), and American Heart Association (10GRNT4190124) (to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Ghosh P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S24; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x; Wong HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057288; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287	45	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111492	10.1371/journal.pone.0111492	http://dx.doi.org/10.1371/journal.pone.0111492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365422	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100071
J	Wai, CYY; Leung, NYH; Ho, MHK; Gershwin, LJ; Shu, SA; Leung, PSC; Chu, KH				Wai, Christine Y. Y.; Leung, Nicki Y. H.; Ho, Marco H. K.; Gershwin, Laurel J.; Shu, Shang An; Leung, Patrick S. C.; Chu, Ka Hou			Immunization with Hypoallergens of Shrimp Allergen Tropomyosin Inhibits Shrimp Tropomyosin Specific IgE Reactivity	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; BIRCH POLLEN ALLERGEN; MOUSE MODEL; MOLECULAR CHARACTERIZATION; ORAL IMMUNOTHERAPY; FOOD ALLERGY; MURINE MODEL; IDENTIFICATION; EPITOPES; ANTIBODIES	Designer proteins deprived of its IgE-binding reactivity are being sought as a regimen for allergen-specific immunotherapy. Although shrimp tropomyosin (Met e 1) has long been identified as the major shellfish allergen, no immunotherapy is currently available. In this study, we aim at identifying the Met e 1 IgE epitopes for construction of hypoallergens and to determine the IgE inhibitory capacity of the hypoallergens. IgE-binding epitopes were defined by three online computational models, ELISA and dot-blot using sera from shrimp allergy patients. Based on the epitope data, two hypoallergenic derivatives were constructed by site-directed mutagenesis (MEM49) and epitope deletion (MED171). Nine regions on Met e 1 were defined as the major IgE-binding epitopes. Both hypoallergens MEM49 and MED171 showed marked reduction in their in vitro reactivity towards IgE from shrimp allergy patients and Met e 1-sensitized mice, as well as considerable decrease in induction of mast cell degranulation as demonstrated in passive cutaneous anaphylaxis assay. Both hypoallergens were able to induce Met e 1-recognizing IgG antibodies in mice, specifically IgG(2a) antibodies, that strongly inhibited IgE from shrimp allergy subjects and Met e 1-sensitized mice from binding to Met e 1. These results indicate that the two designer hypoallergenic molecules MEM49 and MED171 exhibit desirable preclinical characteristics, including marked reduction in IgE reactivity and allergenicity, as well as ability to induce blocking IgG antibodies. This approach therefore offers promises for development of immunotherapeutic regimen for shrimp tropomyosin allergy.	[Wai, Christine Y. Y.; Leung, Nicki Y. H.; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Ho, Marco H. K.] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Gershwin, Laurel J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Shu, Shang An; Leung, Patrick S. C.] Univ Calif Davis, Sch Med, Div Rheumatol Allergy, Davis, CA 95616 USA	Chinese University of Hong Kong; University of Hong Kong; University of California System; University of California Davis; University of California System; University of California Davis	Chu, KH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kahouchu@cuhk.edu.hk	Chu, Ka Hou/B-8010-2011	Chu, Ka Hou/0000-0001-8107-5415; Ho, Marco/0000-0003-1802-2120	Research Grants Council, Hong Kong Special Administrative Region, China [CUHK 463911]	Research Grants Council, Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was fully supported by a research grant from the Research Grants Council, Hong Kong Special Administrative Region, China (CUHK 463911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Ayuso R, 2008, J ALLERGY CLIN IMMUN, V122, P795, DOI 10.1016/j.jaci.2008.07.023; Ayuso R, 2010, J ALLERGY CLIN IMMUN, V125, P1286, DOI 10.1016/j.jaci.2010.03.010; Ayuso R, 2009, J ALLERGY CLIN IMMUN, V124, P114, DOI 10.1016/j.jaci.2009.04.016; Bauer R, 2006, J ALLERGY CLIN IMMUN, V118, P269, DOI 10.1016/j.jaci.2006.03.033; Bauermeister K, 2011, MOL IMMUNOL, V48, P1983, DOI 10.1016/j.molimm.2011.06.216; Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Chen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034627; Chu KH, 2000, MAR BIOTECHNOL, V2, P499; Clark S, 2011, J ALLERGY CLIN IMMUN, V127, P682, DOI 10.1016/j.jaci.2010.10.040; Cromwell O, 2011, J ALLERGY CLIN IMMUN, V127, P865, DOI 10.1016/j.jaci.2011.01.047; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; DAUL CB, 1994, INT ARCH ALLERGY IMM, V105, P49, DOI 10.1159/000236802; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hajeb P, 2012, CLIN REV ALLERG IMMU, V42, P365, DOI 10.1007/s12016-011-8284-9; Harduar-Morano L, 2011, J ALLERGY CLIN IMMUN, V128, P594, DOI 10.1016/j.jaci.2011.04.049; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Ho MHK, 2012, ASIAN PAC J ALLERGY, V30, P275; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jutel M, 2013, ALLERGOL INT, V62, P425, DOI 10.2332/allergolint.13-RAI-0608; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Landsman-Blumberg PB, 2013, J ALLER CL IMM-PRACT, V1, P595, DOI 10.1016/j.jaip.2013.07.003; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leung NYH, 2014, CLIN REV ALLERG IMMU, V46, P180, DOI 10.1007/s12016-012-8336-9; Leung PSC, 2008, INT ARCH ALLERGY IMM, V147, P305, DOI 10.1159/000144038; Leung PSC, 1998, J ALLERGY CLIN IMMUN, V102, P847, DOI 10.1016/S0091-6749(98)70027-2; Leung PSC, 1998, MOL MAR BIOL BIOTECH, V7, P12; Leung PSC, 1996, J ALLERGY CLIN IMMUN, V98, P954, DOI 10.1016/S0091-6749(96)80012-1; LEUNG PSC, 1994, J ALLERGY CLIN IMMUN, V94, P882, DOI 10.1016/0091-6749(94)90156-2; Leung PSC, 2001, CLIN EXP ALLERGY, V31, P1287, DOI 10.1046/j.1365-2222.2001.01165.x; LI KW, 1988, ANAL BIOCHEM, V174, P97, DOI 10.1016/0003-2697(88)90523-4; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Linhart B, 2012, VACCINE, V30, P4328, DOI 10.1016/j.vaccine.2011.11.011; Liu R, 2013, CLIN EXP ALLERGY, V43, P365, DOI 10.1111/cea.12056; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Mine Y, 2003, PROTEIN ENG, V16, P747, DOI 10.1093/protein/gzg095; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Nowak RM, 2014, AM J MED, V127, pS34, DOI 10.1016/j.amjmed.2013.09.012; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; Reese G, 2005, J IMMUNOL, V175, P8354, DOI 10.4049/jimmunol.175.12.8354; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Saarne T, 2011, ALLERGY, V66, P255, DOI 10.1111/j.1398-9995.2010.02468.x; Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199; SHANTI KN, 1993, J IMMUNOL, V151, P5354; Shiomi K, 2008, INT ARCH ALLERGY IMM, V146, P91, DOI 10.1159/000113512; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Smarr CB, 2013, CRIT REV IMMUNOL, V33, P389, DOI 10.1615/CritRevImmunol.2013007046; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Sun XL, 2013, FOOD CHEM TOXICOL, V56, P254, DOI 10.1016/j.fct.2013.02.014; Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290; Tsabouri S, 2012, PEDIAT ALLERG IMM-UK, V23, P608, DOI 10.1111/j.1399-3038.2012.01275.x; Uermosi C, 2014, ALLERGY, V69, P338, DOI 10.1111/all.12327; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; van Hage-Hamsten M, 2002, CLIN EXP ALLERGY, V32, P1448, DOI 10.1046/j.1365-2745.2002.01495.x; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; Wai CYY, 2012, J ALLER THER, V3; Walgraffe D, 2009, J ALLERGY CLIN IMMUN, V123, P1150, DOI 10.1016/j.jaci.2008.11.038; Wiedermann U, 2001, INT ARCH ALLERGY IMM, V124, P391, DOI 10.1159/000053767; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445; Yuan HC, 2012, INT ARCH ALLERGY IMM, V157, P125, DOI 10.1159/000327544; Zheng LN, 2011, FOOD CHEM TOXICOL, V49, P2954, DOI 10.1016/j.fct.2011.07.043	74	41	43	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111649	10.1371/journal.pone.0111649	http://dx.doi.org/10.1371/journal.pone.0111649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365343	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100094
J	Arslan, M; Afzal, M; Amin, I; Iqbal, S; Khan, QM				Arslan, Muhammad; Afzal, Muhammad; Amin, Imran; Iqbal, Samina; Khan, Qaiser M.			Nutrients Can Enhance the Abundance and Expression of Alkane Hydroxylase CYP153 Gene in the Rhizosphere of Ryegrass Planted in Hydrocarbon-Polluted Soil	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; INOCULUM PRETREATMENT; PHYTOREMEDIATION; COLONIZATION; DEGRADATION; SURVIVAL; GROWTH	Plant-bacteria partnership is a promising strategy for the remediation of soil and water polluted with hydrocarbons. However, the limitation of major nutrients (N, P and K) in soil affects the survival and metabolic activity of plant associated bacteria. The objective of this study was to explore the effects of nutrients on survival and metabolic activity of an alkane degrading rhizo-bacterium. Annual ryegrass (Lolium multiflorum) was grown in diesel-contaminated soil and inoculated with an alkane degrading bacterium, Pantoea sp. strain BTRH79, in greenhouse experiments. Two levels of nutrients were applied and plant growth, hydrocarbon removal, and gene abundance and expression were determined after 100 days of sowing of ryegrass. Results obtained from these experiments showed that the bacterial inoculation improved plant growth and hydrocarbon degradation and these were further enhanced by nutrients application. Maximum plant biomass production and hydrocarbon mineralization was observed by the combined use of inoculum and higher level of nutrients. The presence of nutrients in soil enhanced the colonization and metabolic activity of the inoculated bacterium in the rhizosphere. The abundance and expression of CYP153 gene in the rhizosphere of ryegrass was found to be directly associated with the level of applied nutrients. Enhanced hydrocarbon degradation was associated with the population of the inoculum bacterium, the abundance and expression of CYP153 gene in the rhizosphere of ryegrass. It is thus concluded that the combination between vegetation, inoculation with pollutant-degrading bacteria and nutrients amendment was an efficient approach to reduce hydrocarbon contamination.	[Arslan, Muhammad; Afzal, Muhammad; Iqbal, Samina; Khan, Qaiser M.] Natl Inst Biotechnol & Genet Engn, Soil & Environm Biotechnol Div, Faisalabad, Pakistan; [Amin, Imran] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan; [Arslan, Muhammad] King Fahd Univ Petr & Minerals, Dept Earth Sci, Dhahran 31261, Saudi Arabia	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; King Fahd University of Petroleum & Minerals	Arslan, M (corresponding author), Natl Inst Biotechnol & Genet Engn, Soil & Environm Biotechnol Div, Faisalabad, Pakistan.	arsilan324@gmail.com	Arslan, Muhammad/E-3931-2019; Khan, Qaiser Mahmood/I-6401-2015; Alotaibi, Majed/GZG-1828-2022; Afzal, Muhammad/G-2699-2011	Arslan, Muhammad/0000-0002-9620-6710; Afzal, Muhammad/0000-0003-1511-816X	Higher Education Commission of Pakistan (HEC) [20-1997/RD/11/9210]	Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan)	The work was supported by the Higher Education Commission of Pakistan (HEC-No. 20-1997/R&D/11/9210). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adesemoye AO, 2008, CAN J MICROBIOL, V54, P876, DOI [10.1139/W08-081, 10.1139/w08-081]; Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Afzal M., 2013, MOL MICROBIAL ECOLOG, V92, P975, DOI DOI 10.1002/9781118297674.CH92; Afzal M, 2014, CHEMOSPHERE, V117, P232, DOI 10.1016/j.chemosphere.2014.06.078; Afzal M, 2013, INT BIODETER BIODEGR, V85, P331, DOI 10.1016/j.ibiod.2013.08.022; Afzal M, 2012, INT J PHYTOREMEDIAT, V14, P35, DOI 10.1080/15226514.2011.552928; Afzal M, 2011, J HAZARD MATER, V186, P1568, DOI 10.1016/j.jhazmat.2010.12.040; Andria V, 2009, ENVIRON POLLUT, V157, P3347, DOI 10.1016/j.envpol.2009.08.023; Arshad M, 2007, TRENDS BIOTECHNOL, V25, P356, DOI 10.1016/j.tibtech.2007.05.005; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Batty LC, 2013, CRIT REV ENV SCI TEC, V43, P217, DOI 10.1080/10643389.2011.604254; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Cebron A, 2009, APPL ENVIRON MICROB, V75, P6322, DOI 10.1128/AEM.02862-08; Chen LS, 2013, PLANT SOIL, V368, P355, DOI 10.1007/s11104-012-1517-8; Cunliffe M, 2006, FEMS MICROBIOL ECOL, V58, P364, DOI 10.1111/j.1574-6941.2006.00167.x; Glick BR, 2011, INT J PHYTOREMEDIAT, V13, P4, DOI 10.1080/15226514.2011.568533; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Ho CH, 2007, INT J PHYTOREMEDIAT, V9, P107, DOI 10.1080/15226510701232765; Hutchinson SL, 2003, ENVIR SC T, P355; Juhanson J, 2009, FEMS MICROBIOL ECOL, V70, P446, DOI 10.1111/j.1574-6941.2009.00754.x; Khan S, 2013, CHEMOSPHERE, V91, P663, DOI 10.1016/j.chemosphere.2013.01.025; Khan S, 2013, CHEMOSPHERE, V90, P1317, DOI 10.1016/j.chemosphere.2012.09.045; Mehmood R, 2013, J APPL STAT, V40, P483, DOI 10.1080/02664763.2012.740624; Merkl N, 2005, WATER AIR SOIL POLL, V165, P195, DOI 10.1007/s11270-005-4979-y; Merkl Nicole, 2004, Bioremediation Journal, V8, P177, DOI 10.1080/10889860490887527; Nerandzic MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-120; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Ololade IA, 2010, B ENVIRON CONTAM TOX, V85, P238, DOI 10.1007/s00128-010-0090-1; Patil G.P., 1994, HANDB STAT, P167; Tara N, 2014, INT J PHYTOREMEDIAT, V16, P1268, DOI 10.1080/15226514.2013.828013; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Yousaf S, 2010, J APPL MICROBIOL, V109, P1389, DOI 10.1111/j.1365-2672.2010.04768.x; Yousaf S, 2011, ENVIRON POLLUT, V159, P2675, DOI 10.1016/j.envpol.2011.05.031; Zhang N, 2014, PLANT SOIL, V374, P689, DOI 10.1007/s11104-013-1915-6	38	62	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111208	10.1371/journal.pone.0111208	http://dx.doi.org/10.1371/journal.pone.0111208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360680	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700073
J	Goncharova, EA; James, ML; Kudryashova, TV; Goncharov, DA; Krymskaya, VP				Goncharova, Elena A.; James, Melane L.; Kudryashova, Tatiana V.; Goncharov, Dmitry A.; Krymskaya, Vera P.			Tumor Suppressors TSC1 and TSC2 Differentially Modulate Actin Cytoskeleton and Motility of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS LAM; REPRODUCTIVE-TRACT LEIOMYOMATA; TUBEROUS SCLEROSIS COMPLEX; MUSCLE-CELL-MIGRATION; CURRENT CHALLENGES; RODENT MODEL; PHOSPHORYLATION; ACTIVATION; MTOR; GTPASE	TSC1 and TSC2 mutations cause neoplasms in rare disease pulmonary LAM and neuronal pathfinding in hamartoma syndrome TSC. The specific roles of TSC1 and TSC2 in actin remodeling and the modulation of cell motility, however, are not well understood. Previously, we demonstrated that TSC1 and TSC2 regulate the activity of small GTPases RhoA and Rac1, stress fiber formation and cell adhesion in a reciprocal manner. Here, we show that Tsc1(-/-) MEFs have decreased migration compared to littermate-derived Tsc1(+/+) MEFs. Migration of Tsc1(-/-) MEFs with re-expressed TSC1 was comparable to Tsc1(+/+) MEF migration. In contrast, Tsc2(-/-) MEFs showed an increased migration compared to Tsc2(+/+) MEFs that were abrogated by TSC2 re-expression. Depletion of TSC1 and TSC2 using specific siRNAs in wild type MEFs and NIH 3T3 fibroblasts also showed that TSC1 loss attenuates cell migration while TSC2 loss promotes cell migration. Morphological and immunochemical analysis demonstrated that Tsc1(-/-) MEFs have a thin protracted shape with a few stress fibers; in contrast, Tsc2(-/-) MEFs showed a rounded morphology and abundant stress fibers. Expression of TSC1 in either Tsc1(-/-) or Tsc2(-/-) MEFs promoted stress fiber formation, while TSC2 re-expression induced stress fiber disassembly and the formation of cortical actin. To assess the mechanism(s) by which TSC2 loss promotes actin re-arrangement and cell migration, we explored the role of known downstream effectors of TSC2, mTORC1 and mTORC2. Increased migration of Tsc2(-/-) MEFs is inhibited by siRNA mTOR and siRNA Rictor, but not siRNA Raptor. siRNA mTOR or siRNA Rictor promoted stress fiber disassembly in TSC2-null cells, while siRNA Raptor had little effect. Overexpression of kinase-dead mTOR induced actin stress fiber disassembly and suppressed TSC2-deficient cell migration. Our data demonstrate that TSC1 and TSC2 differentially regulate actin stress fiber formation and cell migration, and that only TSC2 loss promotes mTOR-and mTORC2-dependent pro-migratory cell phenotype.	[Goncharova, Elena A.; James, Melane L.; Kudryashova, Tatiana V.; Goncharov, Dmitry A.; Krymskaya, Vera P.] Univ Penn, Perelman Sch Med, Dept Med, Airways Biol Initiat,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Krymskaya, VP (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Airways Biol Initiat,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	krymskay@mail.med.upenn.edu			NIH/NHLBI [RO1 HL090829, 2RO1 HL071106, RO1 HL114085]; DOD IDEA [TS030012]; LAM Foundation; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114085, R01HL110551, R01HL113178, R01HL071106] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DOD IDEA; LAM Foundation; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grants from the NIH/NHLBI RO1 HL090829 (V.P.K.), 2RO1 HL071106 (V.P.K.), and RO1 HL114085 (V.P.K.), DOD IDEA TS030012 (V.P.K.), the LAM Foundation (V.P.K. and E.A.G.), and the American Thoracic Society (E.A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian C. S., 2011, PHYS BIOL, V8; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chang KC, 2013, MOD PATHOL; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; EKER R, 1981, DIAGN HISTOPATHOL, V4, P99; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goncharova EA, 2003, AM J RESP CELL MOL, V29, P19, DOI 10.1165/rcmb.2002-0254OC; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Goncharova EA, 2002, BIOL CHEM, V383, P115, DOI 10.1515/BC.2002.012; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Goncharova EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003840; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; HOWE SR, 1995, AM J PATHOL, V146, P1568; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Krymskaya VP, 2012, AM J RESP CELL MOL, V46, P563, DOI 10.1165/rcmb.2011-0381ED; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Kumasaka T, 2005, AM J SURG PATHOL, V29, P1356, DOI 10.1097/01.pas.0000172192.25295.45; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Nellist M, 2001, HUM MOL GENET, V10, P2889, DOI 10.1093/hmg/10.25.2889; Rivera LB, 2013, CANCER CELL, V24, P687, DOI 10.1016/j.ccr.2013.11.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	43	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111476	10.1371/journal.pone.0111476	http://dx.doi.org/10.1371/journal.pone.0111476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360538	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700105
J	Mbaka, JG; Somlai, C; Kopfer, D; Maeck, A; Lorke, A; Schafer, RB				Mbaka, John Gichimu; Somlai, Celia; Koepfer, Denis; Maeck, Andreas; Lorke, Andreas; Schaefer, Ralf B.			Methane-Derived Carbon in the Benthic Food Web in Stream Impoundments	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; CHIRONOMID LARVAE; WATER; PRESERVATION; EMISSIONS; OXIDATION; BACTERIA; DIPTERA; CYCLE; LAKES	Methane gas (CH4) has been identified as an important alternative source of carbon and energy in some freshwater food webs. CH4 is oxidized by methane oxidizing bacteria (MOB), and subsequently utilized by chironomid larvae, which may exhibit low delta C-13 values. This has been shown for chironomid larvae collected from lakes, streams and backwater pools. However, the relationship between CH4 concentrations and delta C-13 values of chironomid larvae for in-stream impoundments is unknown. CH4 concentrations were measured in eleven in-stream impoundments located in the Queich River catchment area, South-western Germany. Furthermore, the delta C-13 values of two subfamilies of chironomid larvae (i.e. Chironomini and Tanypodinae) were determined and correlated with CH4 concentrations. Chironomini larvae had lower mean delta C-13 values (-29.2 to 225.5 parts per thousand), than Tanypodinae larvae (226.9 to 225.3 parts per thousand). No significant relationships were established between CH4 concentrations and delta C-13 values of chironomids (p. 0.05). Mean delta C-13 values of chironomid larvae (mean: 226.8 parts per thousand, range: 2 29.2 parts per thousand to 225.3 parts per thousand) were similar to those of sedimentary organic matter (SOM) (mean: 228.4 parts per thousand, range: -29.3 parts per thousand to 227.1 parts per thousand) and tree leaf litter (mean: 229.8 parts per thousand, range: 230.5 parts per thousand to 229.1 parts per thousand). We suggest that CH4 concentration has limited influence on the benthic food web in stream impoundments.	[Mbaka, John Gichimu; Somlai, Celia; Koepfer, Denis; Maeck, Andreas; Lorke, Andreas; Schaefer, Ralf B.] Univ Koblenz Landau, Inst Environm Sci, Landau, Rhineland Palat, Germany	University of Koblenz & Landau	Mbaka, JG (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Rhineland Palat, Germany.	mbakagichimu@gmail.com	Schaefer, Ralf/E-1926-2011; Lorke, Andreas/B-9195-2008	Schaefer, Ralf/0000-0003-3510-1701; Lorke, Andreas/0000-0001-5533-1817; Somlai, Celia/0000-0003-0405-237X	German Academic Exchange service (DAAD) [A/12/91652]	German Academic Exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	JGM was funded by the German Academic Exchange service (DAAD) (Grant number: A/12/91652). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Ashe P., 2009, WORLD CATALOGUE CH 1; Baird AJ, 2010, ECOHYDROLOGY, V3, P360, DOI 10.1002/eco.109; BAKER AS, 1979, HYDROBIOLOGIA, V62, P283, DOI 10.1007/BF00043546; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Berg M.B., 1995, P136; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; CHRISTIAN JR, 1995, MAR ECOL PROG SER, V123, P217, DOI 10.3354/meps123217; Crawford JT, 2014, GLOBAL CHANGE BIOL, V20, P3408, DOI 10.1111/gcb.12614; Deborde J, 2010, ESTUAR COAST SHELF S, V89, P256, DOI 10.1016/j.ecss.2010.07.013; Deines P, 2007, AQUAT MICROB ECOL, V46, P273, DOI 10.3354/ame046273; Deines P, 2006, ARCH HYDROBIOL, V167, P317, DOI 10.1127/0003-9136/2006/0167-0317; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DILLON P M, 1985, Freshwater Invertebrate Biology, V4, P22, DOI 10.2307/1467195; Eller G, 2005, FEMS MICROBIOL ECOL, V54, P339, DOI 10.1016/j.femsec.2005.04.006; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; Frouz J, 2002, J AM MOSQUITO CONTR, V18, P222; Fuentes N, 2013, INT REV HYDROBIOL, V98, P1, DOI 10.1002/iroh.201201532; GORDON ND, 1994, STREAM HYDROLOGY INT; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Guerin F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027929; Hauke J, 2011, QUAEST GEOGR, V30, P87, DOI 10.2478/v10117-011-0021-1; Hershey AE, 2010, INT VER THEOR ANGEW, V30, P1321; Hofmann H, 2010, LIMNOL OCEANOGR, V55, P1990, DOI 10.4319/lo.2010.55.5.1990; Jones RI, 2004, BOREAL ENVIRON RES, V9, P17; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Kajan R, 1999, FEMS MICROBIOL ECOL, V28, P121, DOI 10.1111/j.1574-6941.1999.tb00567.x; Kelly A, 2004, J N AM BENTHOL SOC, V23, P287, DOI 10.1899/0887-3593(2004)023&lt;0287:SIAPFI&gt;2.0.CO;2; Khalil MAK, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000461; Kiyashko SI, 2001, AQUAT MICROB ECOL, V24, P203, DOI 10.3354/ame024203; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Maeck A, 2013, ENVIRON SCI TECHNOL, V47, P8130, DOI 10.1021/es4003907; MEILI M, 1992, HYDROBIOLOGIA, V229, P23, DOI 10.1007/BF00006988; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; MINAMI K, 1994, CLIMATIC CHANGE, V27, P13, DOI 10.1007/BF01098470; Orendt C., 2012, CHIRONOMINI DIPTERA; Orendt C, 2012, CHIRONOMUS MEIGEN KE; Orendt C, 2012, CHIRONOMIDAE LARVAE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; R Core Team, 2021, R LANGUAGE ENV STAT; Rueda F, 2006, ECOL MODEL, V191, P260, DOI 10.1016/j.ecolmodel.2005.04.030; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; Shelley F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2854; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Teh YA, 2006, J GEOPHYS RES-BIOGEO, V111, pG2; Trimmer M, 2010, LIMNOL OCEANOGR, V55, P560, DOI 10.4319/lo.2009.55.2.0560; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P1541, DOI 10.4319/lo.2009.54.5.1541; van Hardenbroek M, 2013, QUATERNARY SCI REV, V66, P74, DOI 10.1016/j.quascirev.2012.04.009; van Hardenbroek M, 2012, FRESHWATER BIOL, V57, P166, DOI 10.1111/j.1365-2427.2011.02710.x; Van Looy K, 2014, ECOL INDIC, V37, P10, DOI 10.1016/j.ecolind.2013.10.006; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Yasuno N, 2013, LIMNOLOGY, V14, P239, DOI 10.1007/s10201-013-0400-5; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2; Zemskaya TI, 2012, GEO-MAR LETT, V32, P437, DOI 10.1007/s00367-012-0297-8	56	3	3	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111392	10.1371/journal.pone.0111392	http://dx.doi.org/10.1371/journal.pone.0111392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360609	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700099
J	Zhou, XY; Yang, J; Lin, ZH; Zhang, JP				Zhou, Xueyan; Yang, Jing; Lin, Zehong; Zhang, Jianpei			ITEPE: A Source Tracing Algorithm for the Microblog	PLOS ONE			English	Article								Finding the true source of a social network is a crucial component of social network information tracing. Using the new media microblog as an example, this paper provides a source tracing algorithm ITEPE (Initiators and Early Participants Extraction) to solve this problem. First, the cascade (session tree) is built according to the retweeting of a microblog, after which the cascade set (session forest) is clustered by topical relevance. Second, real initiators are identified through the user relationship network and information cascade network. The influence index and conformity index of every node is then iteratively calculated according to text sentiment analysis and information cascades and the early important participants are extracted. Finally, the real initiators and early participants are evaluated through an experiment.	[Zhou, Xueyan; Yang, Jing; Zhang, Jianpei] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Zhou, Xueyan; Lin, Zehong] Harbin Univ, Coll Engn, Harbin, Peoples R China	Harbin Engineering University; Harbin University	Yang, J (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	yangjing@hrbeu.edu.cn			National Natural Science Foundation of China [61370083, 61073043, 61073041, 61402126]; Specialized Research Fund for the Doctoral Program of Higher Education [20112304110011, 20122304110012]; Research Fund for the Harbin Science and Technology Innovative Talents [2014RFQXJ081]; Heilongjiang Education Scientific Research Youth Subject [GBD1213045]; Education Department humanities social sciences Fund [12542083]; Harbin University Subject Development Youth Fund [HUYF2013-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Fund for the Harbin Science and Technology Innovative Talents; Heilongjiang Education Scientific Research Youth Subject; Education Department humanities social sciences Fund; Harbin University Subject Development Youth Fund	The work was supported by The National Natural Science Foundation of China (No. 61370083, No. 61073043, No. 61073041 and and 61402126), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20112304110011, No. 20122304110012), Research Fund for the Harbin Science and Technology Innovative Talents (No. 2014RFQXJ081), Heilongjiang Education Scientific Research Youth Subject (GBD1213045), Education Department humanities social sciences Fund(12542083) and Harbin University Subject Development Youth Fund (No. HUYF2013-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Carrington P. J., 2005, MODELS METHODS SOCIA; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Dabeer O, 2011, TIMING TWEETS INCREA, P105; Degenne A., 1999, INTRO SOCIAL NETWORK, DOI 10.4135/9781849209373; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Leskovec J, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P551; Li H, 2014, DATA MIN KNOWL DISC, V28, P442, DOI 10.1007/s10618-013-0307-0; Macskassy S. A., 2011, P 5 INT AAAI C WEBL, P209; Pal A., 2011, P 4 ACM INT C WEB SE, P45, DOI DOI 10.1145/1935826.1935843; Sabidussi G, 1996, PSYCHOMETRIKA, V31, P581; Tsur O, 2012, P 5 ACM INT C WEB SE, P643, DOI [10.1145/2124295.2124320, DOI 10.1145/2124295.2124320]; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Welch M.J., P 4 ACM INT C WEB SE, P327, DOI DOI 10.1145/1935826.1935882; Yang J, 2010, ICIM 2010: PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON INDUSTRIAL MANAGEMENT, P356; Yang J, 2010, 2010 IEEE INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATIONS, NETWORKING AND INFORMATION SECURITY (WCNIS), VOL 2, P593, DOI 10.1109/ICCSIT.2010.5564008; Yang Zi, 2010, P 19 ACM INT C INFOR, P1633, DOI DOI 10.1145/1871437.1871691; Zhaoyun D, 2014, J COMPUTER RES DEV, V51, P691; Zhou X, 2014, J COMPUTATIONAL INFO, V10, P2571	21	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111380	10.1371/journal.pone.0111380	http://dx.doi.org/10.1371/journal.pone.0111380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360751	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700095
J	Gruber, S; Zeilinger, S				Gruber, Sabine; Zeilinger, Susanne			The Transcription Factor Ste12 Mediates the Regulatory Role of the Tmk1 MAP Kinase in Mycoparasitism and Vegetative Hyphal Fusion in the Filamentous Fungus Trichoderma atroviride	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FUSARIUM-OXYSPORUM; CELL-FUSION; APPRESSORIUM FORMATION; SIGNAL-TRANSDUCTION; BIOCONTROL ACTIVITY; SCLEROTIUM-ROLFSII; PLANT INFECTION; ENCODING GENE; EXPRESSION	Mycoparasitic species of the fungal genus Trichoderma are potent antagonists able to combat plant pathogenic fungi by direct parasitism. An essential step in this mycoparasitic fungus-fungus interaction is the detection of the fungal host followed by activation of molecular weapons in the mycoparasite by host-derived signals. The Trichoderma atroviride MAP kinase Tmk1, a homolog of yeast Fus3/Kss1, plays an essential role in regulating the mycoparasitic host attack, aerial hyphae formation and conidiation. However, the transcription factors acting downstream of Tmk1 are hitherto unknown. Here we analyzed the functions of the T. atroviride Ste12 transcription factor whose orthologue in yeast is targeted by the Fus3 and Kss1 MAP kinases. Deletion of the ste12 gene in T. atroviride not only resulted in reduced mycoparasitic overgrowth and lysis of host fungi but also led to loss of hyphal avoidance in the colony periphery and a severe reduction in conidial anastomosis tube formation and vegetative hyphal fusion events. The transcription of several orthologues of Neurospora crassa hyphal fusion genes was reduced upon ste12 deletion; however, the Delta ste12 mutant showed enhanced expression of mycoparasitism-relevant chitinolytic and proteolytic enzymes and of the cell wall integrity MAP kinase Tmk2. Based on the comparative analyses of Delta ste12 and Delta tmk1 mutants, an essential role of the Ste12 transcriptional regulator in mediating outcomes of the Tmk1 MAPK pathway such as regulation of the mycoparasitic activity, hyphal fusion and carbon source-dependent vegetative growth is suggested. Aerial hyphae formation and conidiation, in contrast, were found to be independent of Ste12.	[Gruber, Sabine; Zeilinger, Susanne] Vienna Univ Technol, Inst Chem Engn, Res Area Biotechnol & Microbiol, Vienna, Austria	Technische Universitat Wien	Zeilinger, S (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Area Biotechnol & Microbiol, Vienna, Austria.	szeiling@mail.tuwien.ac.at	Zeilinger, Susanne/AAX-6578-2020; Gruber, Sabine/AAD-5734-2021	Zeilinger, Susanne/0000-0003-3112-0948; Gruber, Sabine/0000-0001-6232-763X	Vienna Science and Technology Fund WWTF [LS09-036]; Austrian Science Fund FWF [V139]; Austrian Science Fund (FWF) [V 139] Funding Source: researchfish	Vienna Science and Technology Fund WWTF; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The Vienna Science and Technology Fund WWTF (www.wwtf.at, grant number LS09-036 to SZ) and the Austrian Science Fund FWF (www.fwf.ac.at, grant number V139 to SZ) are acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Bauer R, 2004, MYCOLOGIA, V96, P960, DOI 10.2307/3762080; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Chang YC, 2004, MOL MICROBIOL, V53, P1385, DOI 10.1111/j.1365-2958.2004.04188.x; Cortes C, 1998, MOL GEN GENET, V260, P218, DOI 10.1007/s004380050889; DENNIS C, 1971, T BRIT MYCOL SOC, V57, P25, DOI 10.1016/S0007-1536(71)80077-3; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; ELAD Y, 1983, PHYTOPATHOLOGY, V73, P85, DOI 10.1094/Phyto-73-85; Fleissner Andre, 2008, V475, P21, DOI 10.1007/978-1-59745-250-2_2; Flores A, 1997, CURR GENET, V31, P30, DOI 10.1007/s002940050173; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; FURLANETO MC, 1992, FEMS MICROBIOL LETT, V90, P191, DOI 10.1111/j.1574-6968.1992.tb05150.x; Garcia-Pedrajas MD, 2008, FUNGAL GENET BIOL, V45, P379, DOI 10.1016/j.fgb.2007.11.001; Glass NL, 2004, TRENDS MICROBIOL, V12, P135, DOI 10.1016/j.tim.2004.01.007; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Gruber S, 2011, GLYCOBIOLOGY, V21, P122, DOI 10.1093/glycob/cwq142; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Hoi JWS, 2007, MOL MICROBIOL, V64, P68, DOI 10.1111/j.1365-2958.2007.05639.x; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; INBAR J, 1994, MICROBIOL-SGM, V140, P651, DOI 10.1099/00221287-140-3-651; Jin QC, 2013, GENE EXPR PATTERNS, V13, P133, DOI 10.1016/j.gep.2013.02.003; KELLNER M, 1993, CURR GENET, V23, P334, DOI 10.1007/BF00310895; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kumar A, 2010, BIOCHEM BIOPH RES CO, V398, P765, DOI 10.1016/j.bbrc.2010.07.020; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Lev S, 2003, PLANT CELL, V15, P835, DOI 10.1105/tpc.010546; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; Lu ZX, 2004, APPL ENVIRON MICROB, V70, P3073, DOI 10.1128/AEM.70.5.3073-3081.2004; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MANCZINGER L, 1985, APPL MICROBIOL BIOT, V22, P72; Mead O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078368; Mendoza-Mendoza A, 2003, P NATL ACAD SCI USA, V100, P15965, DOI 10.1073/pnas.2136716100; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; Mukherjee PK, 2013, ANNU REV PHYTOPATHOL, V51, P105, DOI 10.1146/annurev-phyto-082712-102353; Omero C, 1999, MYCOL RES, V103, P1637, DOI 10.1017/S0953756299008886; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park JY, 2009, PLANT PHYSIOL, V149, P474, DOI 10.1104/pp.108.129536; Peterbauer CK, 2002, MOL GENET GENOMICS, V267, P162, DOI 10.1007/s00438-001-0620-y; Peterbauer CK, 2002, MOL GENET GENOMICS, V268, P223, DOI 10.1007/s00438-002-0732-z; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reithrier B, 2007, FUNGAL GENET BIOL, V44, P1123, DOI 10.1016/j.fgb.2007.04.001; Rispail Nicolas, 2010, Commun Integr Biol, V3, P327; Rispail N, 2009, MOL PLANT MICROBE IN, V22, P830, DOI 10.1094/MPMI-22-7-0830; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; SAMBROOK E, 1989, MOL CLONING LAB MANU; Schamber A, 2010, MOL PLANT PATHOL, V11, P105, DOI [10.1111/j.1364-3703.2009.00579.x, 10.1111/j.1364-3703.2009.00579.X]; Seidl V, 2006, MICROBIOL-SGM, V152, P2003, DOI 10.1099/mic.0.28897-0; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; Seo J, 2002, COMPUTER, V35, P80; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Trushina N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-138; Vallim MA, 2000, MOL MICROBIOL, V36, P290, DOI 10.1046/j.1365-2958.2000.01874.x; Wang LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019162; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8; Zeilinger S, 2005, APPL ENVIRON MICROB, V71, P1591, DOI 10.1128/AEM.71.3.1591-1597.2005; Zeilinger S, 1999, FUNGAL GENET BIOL, V26, P131, DOI 10.1006/fgbi.1998.1111; Zeilinger S, 2007, GENE REGUL SYST BIO, V1, P227; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x	77	32	33	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111636	10.1371/journal.pone.0111636	http://dx.doi.org/10.1371/journal.pone.0111636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356841	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000072
J	Neri, F; Dettori, D; Incarnato, D; Krepelova, A; Rapelli, S; Maldotti, M; Parlato, C; Paliogiannis, P; Oliviero, S				Neri, F.; Dettori, D.; Incarnato, D.; Krepelova, A.; Rapelli, S.; Maldotti, M.; Parlato, C.; Paliogiannis, P.; Oliviero, S.			TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway	ONCOGENE			English	Article							EMBRYONIC STEM-CELLS; LARGE GENE LISTS; DNA METHYLATION; EPIGENETIC INACTIVATION; BREAST-CANCER; MAMMALIAN DEVELOPMENT; COLORECTAL-CANCER; POTENTIAL ROLES; 5-HYDROXYMETHYLCYTOSINE; MUTATIONS	Ten eleven translocation (TET) enzymes catalyse the oxidative reactions of 5-methylcytosine (5mC) to promote the demethylation process. The reaction intermediate 5-hydroxymethylcytosine (5hmC) has been shown to be abundant in embryonic stem cells and tissues but strongly depleted in human cancers. Genetic mutations of TET2 gene were associated with leukaemia, whereas TET1 downregulation has been shown to promote malignancy in breast cancer. Here we report that TET1 is downregulated in colon tumours from the initial stage. TET1 silencing in primary epithelial colon cells increase their cellular proliferation while its re-expression in colon cancer cells inhibits their proliferation and the growth of tumour xenografts even at later stages. We found that TET1 binds to the promoter of the DKK gene inhibitors of the WNT signalling to maintain them hypomethylated. Downregulation of TET1 during colon cancer initiation leads to repression, by DNA methylation, the promoters of the inhibitors of the WNT pathway resulting in a constitutive activation of the WNT pathway. Thus the DNA hydroxymethylation mediated by TET1 controlling the WNT signalling is a key player of tumour growth. These results provide new insights for understanding how tumours escape cellular controls.	[Neri, F.; Dettori, D.; Incarnato, D.; Krepelova, A.; Rapelli, S.; Maldotti, M.; Parlato, C.; Oliviero, S.] Human Genet Fdn HuGeF, Epigenet, Turin, Italy; [Incarnato, D.; Krepelova, A.; Rapelli, S.] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Paliogiannis, P.] Univ Sassari, Dipartimento Sci Chirurg Microchirurg & Med, I-07100 Sassari, Italy; [Oliviero, S.] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy	University of Siena; University of Sassari; University of Turin	Oliviero, S (corresponding author), Human Genet Fdn, Epigenet, Via Nizza52, I-10126 Turin, Italy.	salvatore.oliviero@hugef-torino.org	Neri, Francesco/A-3321-2014; Paliogiannis, Panagiotis/M-6870-2016; oliviero, salvatore/R-6657-2019	Neri, Francesco/0000-0003-3903-1974; Paliogiannis, Panagiotis/0000-0001-5485-6056; oliviero, salvatore/0000-0002-3405-765X; Krepelova, Anna/0000-0002-2775-1336; PARLATO, CATERINA/0000-0001-5304-3117; Maldotti, Mara/0000-0002-3299-9053	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 2011/11982]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) IG 2011/11982. We thank Carola Ponzetto and Riccardo Taulli for the critical reading of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Evellin S, 2013, MOL CELL BIOL, V33, P1198, DOI 10.1128/MCB.01054-12; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Incarnato D, 2013, NUCLEIC ACIDS RES, V41, P8421, DOI 10.1093/nar/gkt629; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ivanov M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r83; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Krepelova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088933; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pfeifer GP, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-10; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rhee JK, 2013, NUCLEIC ACIDS RES, V41, P8464, DOI 10.1093/nar/gkt643; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	49	130	140	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4168	4176		10.1038/onc.2014.356	http://dx.doi.org/10.1038/onc.2014.356			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25362856	Green Submitted			2022-12-26	WOS:000359199800003
J	Chen, YQ; Su, PT; Chen, YH; Wei, MT; Huang, CH; Osterday, K; del Alamo, JC; Syu, WJ; Chiou, A				Chen, Yin-Quan; Su, Pin-Tzu; Chen, Yu-Hsuan; Wei, Ming-Tzo; Huang, Chien-Hsiu; Osterday, Kathryn; del Alamo, Juan C.; Syu, Wan-Jr; Chiou, Arthur			The Effect of Enterohemorrhagic E-coli Infection on the Cell Mechanics of Host Cells	PLOS ONE			English	Article							CYTOSKELETAL TENSION; EXTRACELLULAR-MATRIX; STRESS FIBERS; FLUID; SHEAR; RHO; DIFFERENTIATION; MICRORHEOLOGY; DEFORMABILITY; NANORHEOLOGY	Enterohaemorrhagic E. coli (EHEC) is a type of human pathogenic bacteria. The main virulence characteristics of EHEC include the formation of attaching and effacing lesions (A/E lesions) and the production of one or more Shiga-like toxins, which may induce human uremic complications. When EHEC infects host cells, it releases translocated intimin receptor (Tir) and effector proteins inside the host cells, inducing the rearrangement and accumulation of the F-actin cytoskeleton, a phenotype leading to the formation of pedestals in the apical cell surface, and the growth of stress fibers at the base of the cells. To examine the effect of EHEC infection on cell mechanics, we carried out a series of experiments to examine HeLa cells with and without EHEC infection to quantify the changes in (1) focal adhesion area, visualized by anti-vinculin staining; (2) the distribution and orientation of stress fibers; and (3) the intracellular viscoelasticity, via directional video particle tracking microrheology. Our results indicated that in EHEC-infected HeLa cells, the focal adhesion area increased and the actin stress fibers became thicker and more aligned. The cytoskeletal reorganization induced by EHEC infection mediated a dramatic increase in the cytoplasmic elastic shear modulus of the infected cells, and a transition in the viscoelastic behavior of the cells from viscous-like to elastic-like. These changes in mechanobiological characteristics might modulate the attachments between EHEC and the host cell to withstand exfoliation, and between the host cell and the extracellular matrix, and might also alter epithelial integrity.	[Chen, Yin-Quan; Huang, Chien-Hsiu; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Su, Pin-Tzu; Syu, Wan-Jr; Chiou, Arthur] Natl Yang Ming Univ, BMIRC, Taipei 112, Taiwan; [Wei, Ming-Tzo] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [del Alamo, Juan C.] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Lehigh University; University of California System; University of California San Diego	del Alamo, JC (corresponding author), Dept Mech & Aerosp Engn, San Diego, CA 92161 USA.	jalamo@ucsd.edu; wjsyu@ym.edu.tw; aechiou@ym.edu.tw	del Alamo, Juan C./ABB-7702-2021	del Alamo, Juan C./0000-0001-5683-0239; Chen, YinQuan/0000-0002-7278-3855	National Science Council, Taiwan, ROC [NSC101-2815-C-010-008-E, NSC101-2320-B-010-048-MY2]; National Science Council, Taiwan, ROC (I-RiCE Program Project) [NSC100-2911-I-009-101]; Ministry of Education (The Top University Project); Taiwan National Science Council I-RICE Program [NSC-100-2911-I-009-101]; NSF CAREER grant [CBET-1055697]; NIH grant [1R01GM084227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084227] Funding Source: NIH RePORTER	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan, ROC (I-RiCE Program Project); Ministry of Education (The Top University Project); Taiwan National Science Council I-RICE Program; NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is jointly supported by The National Science Council, Taiwan, ROC (NSC101-2815-C-010-008-E, NSC101-2320-B-010-048-MY2, I-RiCE Program Project No. NSC100-2911-I-009-101) and by the Ministry of Education (The Top University Project). JCA and KO were partially supported by the Taiwan National Science Council I-RICE Program (NSC-100-2911-I-009-101), NSF CAREER grant CBET-1055697 and NIH grant 1R01GM084227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chen YQ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011008; del Alamo JC, 2008, P NATL ACAD SCI USA, V105, P15411, DOI 10.1073/pnas.0804573105; DeRycke J, 1997, INFECT IMMUN, V65, P2555, DOI 10.1128/IAI.65.7.2555-2563.1997; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Golde T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.044601; Gomez-Gonzalez M, 2013, J FLUID MECH, V725, P299, DOI 10.1017/jfm.2013.156; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasnain IA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031901; Hatami-Marbini H, 2011, STUD MECHANOBIOL TIS, V4, P3, DOI 10.1007/8415_2010_35; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Lee JSH, 2006, J CELL SCI, V119, P1760, DOI 10.1242/jcs.02899; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mathur AB, 2007, ANN BIOMED ENG, V35, P1120, DOI 10.1007/s10439-007-9288-8; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Pourati J, 1998, AM J PHYSIOL-CELL PH, V274, pC1283, DOI 10.1152/ajpcell.1998.274.5.C1283; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Saxton MJ, 2014, NAT METHODS, V11, P247, DOI 10.1038/nmeth.2851; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436; Yi CR, 2009, P NATL ACAD SCI USA, V106, P6431, DOI 10.1073/pnas.0902773106; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zar J.H., 2010, BIOSTAT ANAL; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	54	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112137	10.1371/journal.pone.0112137	http://dx.doi.org/10.1371/journal.pone.0112137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369259	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000142
J	Wang, H; Lei, T; Liu, J; Li, MZ; Nan, HZ; Liu, Q				Wang, Hui; Lei, Tao; Liu, Jing; Li, Muzi; Nan, Huizhu; Liu, Qun			A Nuclear Factor of High Mobility Group Box Protein in Toxoplasma gondii	PLOS ONE			English	Article							4-WAY JUNCTION DNA; CELL-CYCLE; PLASMODIUM-FALCIPARUM; GENETIC-ANALYSIS; LINKER HISTONES; HMGB PROTEINS; ACIDIC TAIL; BINDING; TRANSFORMATION; TACHYZOITE	High mobility group box 1 (HMGB1) is a nuclear factor that usually binds DNA and modulates gene expression in multicellular organisms. Three HMGB1 orthologs were predicted in the genome of Toxoplasma gondii, an obligate intracellular protozoan pathogen, termed TgHMGB1a, b and c. Phylogenetic and bioinformatic analyses indicated that these proteins all contain a single HMG box and which shared in three genotypes. We cloned TgHMGB1a, a 33.9 kDa protein that can stimulates macrophages to release TNF-alpha, and, we demonstrated that the TgHMGB1a binds distorted DNA structures such as cruciform DNA in electrophoretic mobility shift assays (EMSA). Immunofluorescence assay indicated TgHMGB1a concentrated in the nucleus of intracellular tachyzoites but translocated into the cytoplasm while the parasites release to extracellular. There were no significant phenotypic changes when the TgHMGB1a B box was deleted, while transgenic parasites that overexpressed TgHMGB1a showed slower intracellular growth and caused delayed death in mouse, further quantitative RT-PCR analyses showed that the expression levels of many important genes, including virulence factors, increased when TgHMGB1a was overexpressed, but no significant changes were observed in TgHMGB1a B box-deficient parasites. Our findings demonstrated that TgHMGB1a is indeed a nuclear protein that maintains HMG box architectural functions and is a potential proinflammatory factor during the T. gondii infection. Further studies that clarify the functions of TgHMGB1s will increase our knowledge of transcriptional regulation and parasite virulence, and might provide new insight into host-parasite interactions for T. gondii infection.	[Wang, Hui; Lei, Tao; Liu, Jing; Li, Muzi; Nan, Huizhu; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, Q (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100094, Peoples R China.	qunliu@cau.edu.cn			National Natural Science Foundation of China [31372424]; National Key Basic Research Program (973 program) of China [2015CB150300]; Research Fund for the Doctoral Program of Higher Education of China [20110008110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (973 program) of China(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the National Natural Science Foundation of China (Grant No. 31372424), the National Key Basic Research Program (973 program) of China (Grant No. 2015CB150300) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110008110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2008, EUKARYOT CELL, V7, P1565, DOI 10.1128/EC.00123-08; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Appleford PJ, 1997, ACTA TROP, V65, P97, DOI 10.1016/S0001-706X(97)00656-6; Assenberg R, 2008, BIOCHEM J, V411, P553, DOI 10.1042/BJ20071613; de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Cribb P, 2011, INT J PARASITOL, V41, P1149, DOI 10.1016/j.ijpara.2011.06.009; Cui X, 2012, PARASITOLOGY, V139, P998, DOI 10.1017/S0031182012000285; DALRYMPLE BP, 1992, BIOCHEM BIOPH RES CO, V184, P31, DOI 10.1016/0006-291X(92)91153-H; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; El Hajj H, 2008, EUKARYOT CELL, V7, P1019, DOI 10.1128/EC.00413-07; FERRARI S, 1994, J BIOL CHEM, V269, P28803; Gaji RY, 2011, MOL MICROBIOL, V79, P192, DOI 10.1111/j.1365-2958.2010.07441.x; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gnanasekar M, 2006, MOL BIOCHEM PARASIT, V145, P137, DOI 10.1016/j.molbiopara.2005.09.013; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; Kumar K, 2008, PARASITOL INT, V57, P150, DOI 10.1016/j.parint.2007.11.005; KUN JFJ, 1995, MOL BIOCHEM PARASIT, V71, P249, DOI 10.1016/0166-6851(94)00047-Q; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; MORALES M, 1992, J CELL BIOCHEM, V50, P279, DOI 10.1002/jcb.240500308; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Nardelli SC, 2013, MBIO, V4, DOI 10.1128/mBio.00922-13; Osmanov T, 2013, BIOCHEM BIOPH RES CO, V432, P231, DOI 10.1016/j.bbrc.2013.02.008; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Thirugnanam S, 2012, PARASITOL RES, V111, P619, DOI 10.1007/s00436-012-2878-x; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; VARGAWEISZ P, 1994, BIOCHEM BIOPH RES CO, V203, P1904, DOI 10.1006/bbrc.1994.2410; Wong B, 2002, BIOCHEMISTRY-US, V41, P5404, DOI 10.1021/bi012077l; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	55	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111993	10.1371/journal.pone.0111993	http://dx.doi.org/10.1371/journal.pone.0111993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369210	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000134
J	Driscoll, DL; Chakravarty, A; Bowman, D; Shinde, V; Lasky, K; Shi, J; Vos, T; Stringer, B; Amidon, B; D'Amore, N; Hyer, ML				Driscoll, Denise L.; Chakravarty, Arijit; Bowman, Doug; Shinde, Vaishali; Lasky, Kerri; Shi, Judy; Vos, Tricia; Stringer, Bradley; Amidon, Ben; D'Amore, Natalie; Hyer, Marc L.			Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines	PLOS ONE			English	Article							POLO-LIKE KINASE-1; TERMINAL PROLIFERATION ARREST; ONCOGENE-INDUCED SENESCENCE; SMALL-MOLECULE INHIBITOR; HUMAN CANCER-CELLS; GROWTH IN-VIVO; ANTITUMOR-ACTIVITY; MITOTIC BLOCK; CHROMOSOME SEGREGATION; SELECTIVE INHIBITOR	Plk1 is a checkpoint protein whose role spans all of mitosis and includes DNA repair, and is highly conserved in eukaryotes from yeast to man. Consistent with this wide array of functions for Plk1, the cellular consequences of Plk1 disruption are diverse, spanning delays in mitotic entry, mitotic spindle abnormalities, and transient mitotic arrest leading to mitotic slippage and failures in cytokinesis. In this work, we present the in vitro and in vivo consequences of Plk1 inhibition in cancer cells using potent, selective small-molecule Plk1 inhibitors and Plk1 genetic knock-down approaches. We demonstrate for the first time that cellular senescence is the predominant outcome of Plk1 inhibition in some cancer cell lines, whereas in other cancer cell lines the dominant outcome appears to be apoptosis, as has been reported in the literature. We also demonstrate strong induction of DNA double-strand breaks in all six lines examined (as assayed by gamma H2AX), which occurs either during mitotic arrest or mitotic-exit, and may be linked to the downstream induction of senescence. Taken together, our findings expand the view of Plk1 inhibition, demonstrating the occurrence of a non-apoptotic outcome in some settings. Our findings are also consistent with the possibility that mitotic arrest observed as a result of Plk1 inhibition is at least partially due to the presence of unrepaired double-strand breaks in mitosis. These novel findings may lead to alternative strategies for the development of novel therapeutic agents targeting Plk1, in the selection of biomarkers, patient populations, combination partners and dosing regimens.	[Driscoll, Denise L.; Chakravarty, Arijit; Bowman, Doug; Shinde, Vaishali; Lasky, Kerri; Shi, Judy; Vos, Tricia; Stringer, Bradley; Amidon, Ben; D'Amore, Natalie; Hyer, Marc L.] Takeda Pharmaceut Int Co, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Hyer, ML (corresponding author), Takeda Pharmaceut Int Co, Cambridge, MA 02139 USA.	marc.hyer@takeda.com			Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co.	The author(s) received no specific funding for this work. All authors are employees of Takeda Pharmaceuticals International Co. Takeda Pharmaceuticals International Co. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Guerrero AA, 2010, P NATL ACAD SCI USA, V107, P4159, DOI 10.1073/pnas.0912143106; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chen XH, 2006, WORLD J GASTROENTERO, V12, P29, DOI 10.3748/wjg.v12.i1.29; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duffey MO, 2012, J MED CHEM, V55, P197, DOI 10.1021/jm2011172; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hikichi Y, 2012, MOL CANCER THER, V11, P700, DOI 10.1158/1535-7163.MCT-11-0762; Hood EA, 2012, MOL BIOL CELL, V23, P2264, DOI 10.1091/mbc.E11-12-1013; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON IS, 1963, CANCER RES, V23, P1390; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kim HJ, 2013, J GERONTOL A-BIOL, V68, P1145, DOI 10.1093/gerona/glt017; Klein LE, 2005, CELL CYCLE, V4, P501, DOI 10.4161/cc.4.3.1550; Kubara PM, 2012, BIOCHEM J, V446, P373, DOI 10.1042/BJ20120385; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee HJ, 2010, CELL CYCLE, V9, P2389, DOI 10.4161/cc.9.12.11904; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Roninson IB, 2003, CANCER RES, V63, P2705; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schmit TL, 2009, J INVEST DERMATOL, V129, P2843, DOI 10.1038/jid.2009.172; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi JQ, 2012, MOL CANCER THER, V11, P2045, DOI 10.1158/1535-7163.MCT-11-1036; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; te Poele RH, 2002, CANCER RES, V62, P1876; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Ullrich E, 2007, CANCER RES, V67, P851, DOI 10.1158/0008-5472.CAN-06-3766; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Yuan JP, 2011, AM J PATHOL, V179, P2091, DOI 10.1016/j.ajpath.2011.06.031; Zhang W, 2005, J BIOL CHEM, V280, P42994, DOI 10.1074/jbc.M505450200	60	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111060	10.1371/journal.pone.0111060	http://dx.doi.org/10.1371/journal.pone.0111060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365521	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100048
J	Ou, HS; Li, YM; Kang, M				Ou, Hesheng; Li, Yumei; Kang, Min			Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; LUNG-CANCER; MICRORNA-21 TARGETS; EXPRESSION; INVASION; PATHWAYS; GROWTH; OVEREXPRESSION; TRANSCRIPTION	The present study is to investigate the role of microRNA-21 (miR-21) in nasopharyngeal carcinoma (NPC) and the mechanisms of regulation of PTEN by miR-21. Fifty-four tissue samples were collected from 42 patients with NPC and 12 healthy controls. Human NPC cell lines CNE-1, CNE-2, TWO3 and C666-1 were used for cell assays. To investigate the expression of miR-21, RT-PCR was employed. RT-PCR, Western blotting, and immunohistochemistry were used to measure the expression of STAT3 mRNA and STAT3 protein. To test the effect of miR-21 on the cell growth and apoptosis of NPC cells in vitro, transfection of CNE1 and CNE2 cell lines and flow cytometry were performed. TUNEL assay was used to detect DNA fragmentation. To validate whether miR-21 directly recognizes the 39-UTRs of PTEN mRNA, luciferase reporter assay was employed. miR-21 expression was increased in NPC tissues compared with control and the same result was found in NPC cell lines. Notably, increased expression of miR-21 was directly related to advanced clinical stage and lymph node metastasis. STAT3, a transcription factor activated by IL-6, directly activated miR-21 in transformed NPC cell lines. Furthermore, miR-21 markedly inhibited PTEN tumor suppressor, leading to increased AKT activity. Both in vitro and in vivo assays revealed that miR-21 enhanced NPC cell proliferation and suppressed apoptosis. miR-21, activated by STAT3, induced proliferation and suppressed apoptosis in NPC by targeting PTEN-AKT pathway.	[Ou, Hesheng; Li, Yumei] Guangxi Med Univ, Coll Pharm, Nanning, Guangxi Provinc, Peoples R China; [Kang, Min] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University; Guangxi Medical University	Kang, M (corresponding author), Guangxi Med Univ, Coll Pharm, Nanning, Guangxi Provinc, Peoples R China.	km10192013@126.com			National Natural Science Foundation of China [81373403]; Research Foundation of the Education Department of Guangxi Province, China [2013YB049]; Research Foundation from the Regional Health Department of Guangxi Province, China [Z2012066]; Youth Foundation of Guangxi Medical University, China [02604001020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Education Department of Guangxi Province, China; Research Foundation from the Regional Health Department of Guangxi Province, China; Youth Foundation of Guangxi Medical University, China	This study was supported by grants from the National Natural Science Foundation of China (No. 81373403, Hesheng Ou), Research Foundation of the Education Department of Guangxi Province, China (No. 2013YB049, Hesheng Ou), Research Foundation from the Regional Health Department of Guangxi Province, China (No. Z2012066, Min Kang), and Youth Foundation of Guangxi Medical University, China (No. 02604001020, Min Kang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2012, INT J BIOL MARKER, V27, pE132, DOI 10.5301/JBM.2012.9146; Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHERN CJ, 1976, AM J HUM GENET, V28, P9; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Dai BB, 2011, CANCER RES, V71, P3658, DOI 10.1158/0008-5472.CAN-10-3647; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Demaria M, 2012, ONCOTARGET, V3, P359; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ettl T, 2012, HUM PATHOL, V43, P921, DOI 10.1016/j.humpath.2011.08.006; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jeannel D, 1999, CANCER SURV, V33, P125; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kurose K, 2001, AM J PATHOL, V158, P2097, DOI 10.1016/S0002-9440(10)64681-0; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Netto GJ, 2010, PATHOLOGY, V42, P384, DOI 10.3109/00313021003779145; Ou HS, 2005, ARTERIOSCL THROM VAS, V25, P2509, DOI 10.1161/01.ATV.0000189306.99112.4c; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Pensa S, 2009, JAK STAT PATHWAY DIS, V100; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shodeinde AL, 2012, ONCOTARGETS THER, V5, P119, DOI 10.2147/OTT.S32559; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang LH, 2007, CLIN CANCER RES, V13, P102, DOI 10.1158/1078-0432.CCR-06-1467; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu L, 2008, MOL CANCER THER, V7, P222, DOI 10.1158/1535-7163.MCT-07-0382; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056114; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yan LM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070658, 10.1371/journal.pone.0072548]; Yan LM, 2011, MOL CELL BIOCHEM, V357, P9, DOI 10.1007/s11010-011-0870-x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	70	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109929	10.1371/journal.pone.0109929	http://dx.doi.org/10.1371/journal.pone.0109929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365510	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100012
J	Parsons, MB; Gillespie, TR; Lonsdorf, EV; Travis, D; Lipende, I; Gilagiza, B; Kamenya, S; Pintea, L; Vazquez-Prokopec, GM				Parsons, Michele B.; Gillespie, Thomas R.; Lonsdorf, Elizabeth V.; Travis, Dominic; Lipende, Iddi; Gilagiza, Baraka; Kamenya, Shadrack; Pintea, Lilian; Vazquez-Prokopec, Gonzalo M.			Global Positioning System Data-Loggers: A Tool to Quantify Fine-Scale Movement of Domestic Animals to Evaluate Potential for Zoonotic Transmission to an Endangered Wildlife Population	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; CRYPTOSPORIDIUM-PARVUM; GIARDIA; VIRUS; RISK; INFECTION; PARASITES; PATTERNS; DISEASES; HABITAT	Domesticated animals are an important source of pathogens to endangered wildlife populations, especially when anthropogenic activities increase their overlap with humans and wildlife. Recent work in Tanzania reports the introduction of Cryptosporidium into wild chimpanzee populations and the increased risk of ape mortality associated with SIVcpz-Cryptosporidium co-infection. Here we describe the application of novel GPS technology to track the mobility of domesticated animals (27 goats, 2 sheep and 8 dogs) with the goal of identifying potential routes for Cryptosporidium introduction into Gombe National Park. Only goats (5/27) and sheep (2/2) were positive for Cryptosporidium. Analysis of GPS tracks indicated that a crop field frequented by both chimpanzees and domesticated animals was a potential hotspot for Cryptosporidium transmission. This study demonstrates the applicability of GPS data-loggers in studies of fine-scale mobility of animals and suggests that domesticated animal-wildlife overlap should be considered beyond protected boundaries for long-term conservation strategies.	[Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA; [Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA; [Parsons, Michele B.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Travis, Dominic] Univ Minnesota, Coll Vet Med, Minneapolis, MN 55455 USA; [Lipende, Iddi; Gilagiza, Baraka; Kamenya, Shadrack; Pintea, Lilian] Jane Goodall Inst, Kigoma, Tanzania	Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Franklin & Marshall College; University of Minnesota System; University of Minnesota Twin Cities	Gillespie, TR (corresponding author), Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA.	thomas.gillespie@emory.edu; gmvazqu@emory.edu	Gillespie, Thomas R/A-5132-2010	Gillespie, Thomas R/0000-0002-7901-7248	Morris Animal Foundation [MAF D09ZO-041, MAF D09ZO-634]; Emory University Global Health Institute; Arcus Foundation; Leo S. Guthman Foundation; National Institutes of Health [R01 AI58715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058715] Funding Source: NIH RePORTER	Morris Animal Foundation; Emory University Global Health Institute; Arcus Foundation; Leo S. Guthman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study comes from the Morris Animal Foundation (MAF D09ZO-041 and MAF D09ZO-634), the Emory University Global Health Institute, the Arcus Foundation, the Leo S. Guthman Foundation and the National Institutes of Health (R01 AI58715). QuickBird satellite imagery was kindly contributed to the Jane Goodall Institute at no cost by DigitalGlobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	Appelbee AJ, 2005, TRENDS PARASITOL, V21, P370, DOI 10.1016/j.pt.2005.06.004; Biggins DE MB, 2006, RECOVERY BLACK FOOTE, P175; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; CRAIGHEAD FC, 1982, TRACK GRIZZLY; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Gillespie TR, 2010, AM J PHYS ANTHROPOL, V143, P534, DOI 10.1002/ajpa.21348; Gillespie TR, 2001, BEHAV ECOL SOCIOBIOL, V50, P329, DOI 10.1007/s002650100371; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Great Outdoor Recreation Pages, 2010, GOMB STREAM NAT PARK; Gurtler RE, 2007, PARASITOLOGY, V134, P69, DOI 10.1017/S0031182006001259; Hagen IJ, 2011, J HERPETOL, V45, P36, DOI 10.1670/10-074.1; Hanski I, 2012, ANN NY ACAD SCI, V1249, P1, DOI 10.1111/j.1749-6632.2011.06419.x; Hunter PR, 2005, INT J PARASITOL, V35, P1181, DOI 10.1016/j.ijpara.2005.07.009; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pintea L., 2007, APPL SATELLITE IMAGE; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Rudnick DA, 2012, 16 EC SOC AM, P1; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Schwartz Charles C., 1999, Ursus, V11, P261; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Smith HV, 2007, VET PARASITOL, V149, P29, DOI 10.1016/j.vetpar.2007.07.015; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Tilman D, 1997, SPATIAL ECOLOGY ROLE; TZIPORI S, 1988, ADV PARASIT, V27, P63, DOI 10.1016/S0065-308X(08)60353-X; United States Department of Defense, 2000, GLOB POS SYST STAND; Vazquez-Prokopec GM, 2009, AM J TROP MED HYG, V81, P230; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Weyher AH, 2006, INT J PRIMATOL, V27, P1519, DOI 10.1007/s10764-006-9089-1; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	46	24	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110984	10.1371/journal.pone.0110984	http://dx.doi.org/10.1371/journal.pone.0110984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365070	Green Published, gold			2022-12-26	WOS:000345558100040
J	Chatterjee, D; Addya, S; Khan, RS; Kenyon, LC; Choe, A; Cohrs, RJ; Shindler, KS; Das Sarma, J				Chatterjee, Dhriti; Addya, Sankar; Khan, Reas S.; Kenyon, Lawrence C.; Choe, Alexander; Cohrs, Randall J.; Shindler, Kenneth S.; Das Sarma, Jayasri			Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERFERON-STIMULATED GENES; IFN-GAMMA; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; CORONAVIRUS; EXPRESSION; NEUROINFLAMMATION; CYTOKINE; ALPHA	Neurotropic recombinant strain of Mouse Hepatitis Virus, RSA59, induces meningo-encephalitis, myelitis and demyelination following intracranial inoculation. RSA59 induced neuropathology is partially caused by activation of CNS resident microglia, as demonstrated by changes in cellular morphology and increased expression of a microglia/macrophage specific calcium ion binding factor, Iba1. Affymetrix Microarray analysis for mRNA expression data reveals expression of inflammatory mediators that are known to be released by activated microglia. Microglia-specific cell surface molecules, including CD11b, CD74, CD52 and CD68, are significantly upregulated in contrast to CD4, CD8 and CD19. Protein analysis of spinal cord extracts taken from mice 6 days post-inoculation, the time of peak inflammation, reveals robust expression of IFN-gamma, IL-12 and mKC. Data suggest that activated microglia and inflammatory mediators contribute to a local CNS microenvironment that regulates viral replication and IFN-gamma production during the acute phase of infection, which in turn can cause phagolysosome maturation and phagocytosis of the myelin sheath, leading to demyelination.	[Chatterjee, Dhriti; Das Sarma, Jayasri] IISER K, Dept Biol Sci, Mohanpur, W Bengal, India; [Addya, Sankar] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Khan, Reas S.; Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Khan, Reas S.; Shindler, Kenneth S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Kenyon, Lawrence C.] Thomas Jefferson Univ, Dept Anat, Philadelphia, PA 19107 USA; [Kenyon, Lawrence C.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [Choe, Alexander; Cohrs, Randall J.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Choe, Alexander; Cohrs, Randall J.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Jefferson University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Shindler, KS (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.	Kenneth.Shindler@uphs.upenn.edu; dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020	majumder, dhriti/0000-0001-9292-6430; Kenyon, Lawrence/0000-0002-3719-9565	Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India [BT/PR14260/MED/30/437/2010]; NIH [EY015014]; ASM-IUSSTF Indo-US Research Professorship Award; University Grant Commission (UGC), India; NATIONAL EYE INSTITUTE [R01EY019014, R43EY015014] Funding Source: NIH RePORTER	Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM-IUSSTF Indo-US Research Professorship Award; University Grant Commission (UGC), India(University Grants Commission, India); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by Research Grant (BT/PR14260/MED/30/437/2010) from Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India start up Fund to JDS and NIH grant (EY015014) to KSS. This work is also partially supported by 2013 ASM-IUSSTF Indo-US Research Professorship Award to JDS and RC to develop bi-lateral research relationship between India and US. We thank University Grant Commission (UGC), India, for providing the research support to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bell JE, 1998, REV NEUROL-FRANCE, V154, P816; Butchi NB, 2014, J VIROL, V88, P1051, DOI 10.1128/JVI.02272-13; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chatterjee D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/510396; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; COCKFIELD SM, 1993, J IMMUNOL, V150, P342; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI [10.1080/13550280290100815, 10.1080/13550280260422686]; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4; Das Sarma Jayasri, 2010, Interdiscip Perspect Infect Dis, V2010, P109239, DOI 10.1155/2010/109239; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Das Sarma S., 2013, ISRN IMMUNOLOGY, V2013, P10, DOI [10.1155/2013/205431, DOI 10.1155/2013/205431]; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elliott R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075346; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Gessani S, 1998, CYTOKINE GROWTH F R, V9, P117, DOI 10.1016/S1359-6101(98)00007-0; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Lane TE, 1998, J IMMUNOL, V160, P970; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Matthews AE, 2002, J NEUROVIROL, V8, P257, DOI 10.1080/13550280290049697; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Mogensen S C, 1987, Interferon, V8, P55; Muse M, 2008, VIROLOGY, V382, P132, DOI 10.1016/j.virol.2008.09.032; Phillips JJ, 1999, J VIROL, V73, P7752, DOI 10.1128/JVI.73.9.7752-7760.1999; Phillips JJ, 2002, VIROLOGY, V301, P109, DOI 10.1006/viro.2002.1551; Phillips JJ, 2001, J NEUROVIROL, V7, P421; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarma J Das, 2013, ONLINE J BIOSCIENCES, V4, P64; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Shindler KS, 2011, J NEUROPATH EXP NEUR, V70, P470, DOI 10.1097/NEN.0b013e31821da499; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Streit WJ, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00022; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Versijpt JJ, 2003, EUR NEUROL, V50, P39, DOI 10.1159/000070857; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; Zhao L, 2013, J VIROL, V87, P8408, DOI 10.1128/JVI.00769-13	54	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111351	10.1371/journal.pone.0111351	http://dx.doi.org/10.1371/journal.pone.0111351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360880	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700089
J	Zarei, S; Mirtar, A; Rohwer, F; Salamon, P				Zarei, Sara; Mirtar, Ali; Rohwer, Forest; Salamon, Peter			Stochastic Tracking of Infection in a CF Lung	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; CYSTIC-FIBROSIS; INFLAMMATION; MRI	Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scan are the two ubiquitous imaging sources that physicians use to diagnose patients with Cystic Fibrosis (CF) or any other Chronic Obstructive Pulmonary Disease (COPD). Unfortunately the cost constraints limit the frequent usage of these medical imaging procedures. In addition, even though both CT scan and MRI provide mesoscopic details of a lung, in order to obtain microscopic information a very high resolution is required. Neither MRI nor CT scans provide micro level information about the location of infection in a binary tree structure the binary tree structure of the human lung. In this paper we present an algorithm that enhances the current imaging results by providing estimated micro level information concerning the location of the infection. The estimate is based on a calculation of the distribution of possible mucus blockages consistent with available information using an offline Metropolis-Hastings algorithm in combination with a real-time interpolation scheme. When supplemented with growth rates for the pockets of mucus, the algorithm can also be used to estimate how lung functionality as manifested in spirometric tests will change in patients with CF or COPD.	[Zarei, Sara] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Mirtar, Ali] Univ Calif San Diego, Dept Elect & Comp Eng, San Diego, CA 92103 USA; [Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Salamon, Peter] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA	California State University System; San Diego State University; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Zarei, S (corresponding author), San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA.	sara.zarei@alumni.ucsd.edu	Rohwer, Forest/AAC-5315-2019	Rohwer, Forest/0000-0003-1548-5429	National Institutes of Health [56586B]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material is based upon work supported by the National Institutes of Health under Grant no. 56586B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2005, J APPL PHYSIOL, V98, P850, DOI 10.1152/japplphysiol.00801.2004; Eichinger M, 2006, RADIOLOGE, V46, P275, DOI 10.1007/s00117-005-1308-9; FIEL SB, 1987, CHEST, V91, P181, DOI 10.1378/chest.91.2.181; Glenny RW, 2000, J APPL PHYSIOL, V89, P742, DOI 10.1152/jappl.2000.89.2.742; Hopkins SR, 2007, J APPL PHYSIOL, V102, P1244, DOI 10.1152/japplphysiol.00738.2006; Kitaoka H, 1997, J APPL PHYSIOL, V82, P968, DOI 10.1152/jappl.1997.82.3.968; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lim YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064285; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Marieb EN, 2010, HUMAN ANATOMY PHYSL; McPhail GL, 2013, DRUG TODAY, V49, P253, DOI 10.1358/dot.2013.49.4.1940984; Richey M, 2010, AM MATH MON, V117, P383, DOI 10.4169/000298910X485923; Saeta PN, 2004, METROPOLIS ALGORITHM; Salamon P, 2002, FACTS CONJECTURE IMP; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Tirouvanziam R, 2006, DRUG NEWS PERSPECT, V19, P609, DOI 10.1358/dnp.2006.19.10.1068008; Voit EO, 2014, BBA-PROTEINS PROTEOM, V1844, P258, DOI 10.1016/j.bbapap.2013.03.023; Weibel ER, 1991, LUNG SCI FDN, V1, P1061; WEST BJ, 1990, ANN BIOMED ENG, V18, P135, DOI 10.1007/BF02368426; Whiteson KL, 2014, ISME J; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zarei S, 2012, J COMP MATH METH MED; Zarei S, 2013, J NON-EQUIL THERMODY, V38, P119, DOI 10.1515/jnetdy-2012-0019	25	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111245	10.1371/journal.pone.0111245	http://dx.doi.org/10.1371/journal.pone.0111245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360611	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700078
J	Zicari, AM; Duse, M; Occasi, F; Luzzi, V; Ortolani, E; Bardanzellu, F; Bertin, S; Polimeni, A				Zicari, Anna Maria; Duse, Marzia; Occasi, Francesca; Luzzi, Valeria; Ortolani, Emanuela; Bardanzellu, Flaminia; Bertin, Serena; Polimeni, Antonella			Cephalometric Pattern and Nasal Patency in Children with Primary Snoring: The Evidence of a Direct Correlation	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; DENTOFACIAL MORPHOLOGY; DIMENSIONS; ADENOIDS; SENSITIVITY; INFANCY; HISTORY; TONSILS; GROWTH; AIRWAY	Introduction: Sleep disordered breathing (SDB) might affect craniofacial growth and children with obstructive sleep apnea syndrome present an increase in total and lower anterior heights of the face and a more anterior and inferior position of the hyoid bone when compared to nasal breathers. Objective: To investigate the correlation between rhinomanometric and cephalometric parameters in children with primary snoring (PS), without apnea or gas exchange abnormalities. Materials and Methods: Thirty children with habitual snoring (16 females and 14 males) aged 4-8 years (mean age 6.85 +/- 1.51 years) were selected by a SDB validate questionnaire. All subjects underwent lateral cephalometric, panoramic radiographies. Results: In our sample 10 children (33%) had snoring 3 nights/week, 11 (37%) 4-6 nights/week and 9 (30%) every night/week. Overall 7 patients (23.3%) were affected by adenoid hypertrophy (AH), 4 (13.3%) by tonsillar hypertrophy (TH) and 13 (43.3%) by AH and TH. We found a more vertical position of the hyoid bone to the mandibular plane (HHVT) in patients with a higher frequency (7.3 +/- 2.7 vs 7.6 +/- 3.7 vs 10.9 +/- 2.5 in children snoring 3 nights/week, 4-6 nights/week and every night/week respectively; p = 0.032). Concerning nasal patency significant correlations were found with ANB (maxillary and jaw position with respect to the cranial base), (NSAr)-Ar-boolean AND (growth predictor), sumangle, FMA (total divergence), SnaSnp(boolean AND)GoMe (inferior divergence), BaN(boolean AND)PtGn (facial growth pattern), Phw1_PsP (posterosuperior airway space), AHC3H (the horizontal distance between the most anterosuperior point of the hyoid bone and the third cervical vertebra). Conclusion: The present study supports the relationship between nasal obstruction and specific craniofacial characteristics in children with primary snoring and lead us to hypothesize that nasal obstruction might explain the indirect link between snoring and cephalometric alterations.	[Zicari, Anna Maria; Duse, Marzia; Occasi, Francesca; Bardanzellu, Flaminia] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Luzzi, Valeria; Polimeni, Antonella] Univ Roma La Sapienza, Dept Oral & Maxillofacial Sci, I-00185 Rome, Italy; [Ortolani, Emanuela] George Eastman Odontoiatr Hosp, Rome, Italy; [Bertin, Serena] Univ Roma La Sapienza, Dept Pediat Otorhinolaryngol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Occasi, F (corresponding author), Univ Roma La Sapienza, Dept Pediat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	occasi.f@gmail.com	ZICARI, Anna Maria/K-7921-2018	ZICARI, Anna Maria/0000-0002-2476-1790				Akpinar ME, 2011, EUR ARCH OTO-RHINO-L, V268, P1053, DOI 10.1007/s00405-010-1448-z; Balasubramanian S, 2004, J IND ORTHOD SOC, V37, P89; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; BROUILETTE R, 1984, J PEDIATR-US, V105, P10, DOI 10.1016/S0022-3476(84)80348-0; Brouillette RT, 2000, PEDIATRICS, V105, P405, DOI 10.1542/peds.105.2.405; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Cassano P, 2003, INT J PEDIATR OTORHI, V67, P1303, DOI 10.1016/j.ijporl.2003.07.018; CHENG MC, 1988, ANGLE ORTHOD, V58, P309; Clement P A, 1984, Rhinology, V22, P151; Franco LP, 2013, AM J ORTHOD DENTOFAC, V144, P341, DOI 10.1016/j.ajodo.2013.03.025; Frasson Jussara Marinho Dias, 2006, Braz J Otorhinolaryngol, V72, P72; Harari D, 2010, LARYNGOSCOPE, V120, P2089, DOI 10.1002/lary.20991; Kulnis R, 2000, CHEST, V118, P596, DOI 10.1378/chest.118.3.596; Linder-Aronson S, 1970, Acta Otolaryngol Suppl, V265, P1; Nixon GM, 2004, PEDIATRICS, V113, pE19, DOI 10.1542/peds.113.1.e19; ORYAN FS, 1982, AM J ORTHOD DENTOFAC, V82, P403, DOI 10.1016/0002-9416(82)90189-0; Piteo AM, 2011, SLEEP MED, V12, P787, DOI 10.1016/j.sleep.2011.01.019; PRACHARKTAM N, 1994, ANGLE ORTHOD, V64, P63; Rizzi M, 2002, INT J PEDIATR OTORHI, V65, P7, DOI 10.1016/S0165-5876(02)00119-2; Sin S, 2014, LARYNGOSCOP IN PRESS; SORENSEN H, 1980, ACTA OTO-LARYNGOL, V89, P227, DOI 10.3109/00016488009127132; SUBTELNY JD, 1975, ANN OTO RHINOL LARYN, V84, P50; Trotman CA, 1997, ANGLE ORTHOD, V67, P425; Urschitz MS, 2004, CHEST, V126, P790, DOI 10.1378/chest.126.3.790; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; Vieira BB, 2012, INT J PEDIATR OTORHI, V76, P1140, DOI 10.1016/j.ijporl.2012.04.019; Vig KWL, 1998, AM J ORTHOD DENTOFAC, V113, P603, DOI 10.1016/S0889-5406(98)70219-7; VIG PS, 1991, AM J ORTHOD DENTOFAC, V99, P354, DOI 10.1016/0889-5406(91)70018-R; Zapletal A, 2002, PEDIATR PULM, V33, P174, DOI 10.1002/ppul.10066	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111675	10.1371/journal.pone.0111675	http://dx.doi.org/10.1371/journal.pone.0111675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360610	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700141
J	Colombo, M; Priori, D; Trevisi, P; Bosi, P				Colombo, Michela; Priori, Davide; Trevisi, Paolo; Bosi, Paolo			Differential Gene Expression in the Oxyntic and Pyloric Mucosa of the Young Pig	PLOS ONE			English	Article							H+-K+-ATPASE; AE2 CL-/HCO3-EXCHANGER; ACID-SECRETION; CELLS; PROTEIN; CHANNEL; TRANSLOCATION; MICE; RNA	The stomach is often considered a single compartment, although morphological differences among specific areas are well known. Oxyntic mucosa (OXY) and pyloric mucosa (PYL, in other species called antral mucosa) are primarily equipped for acid secretion and gastrin production, respectively, while it is not yet clear how the remainder of genes expressed differs in these areas. Here, the differential gene expression between OXY and PYL mucosa was assessed in seven starter pigs. Total RNA expression was analyzed by whole genome Affymetrix Porcine Gene 1.1_ST array strips. Exploratory functional analysis of gene expression values was done by Gene Set Enrichment Analysis, comparing OXY and PYL. Normalized enrichment scores (NESs) were calculated for each gene (statistical significance defined when False Discovery Rate % < 25 and P-values of NES<0.05). Expression values were selected for a set of 44 genes and the effect of point of gastric sample was tested by analysis of variance with the procedure for repeated measures. In OXY, HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY gene set was the most enriched set compared to PYL, including the two genes for H+/K+-ATPase. Pathways related to mitochondrial activity and feeding behavior were also enriched (primarily cholecystokinin receptors and ghrelin). Aquaporin 4 was the top-ranking gene. In PYL, two gene sets were enriched compared with OXY: LYMPHOCYTE ACTIVATION and LIPID RAFT, a gene set involved in cholesterol-rich microdomains of the plasma membrane. The single most differentially expressed genes were gastrin and secretoglobin 1A, member 1, presumably located in the epithelial line, to inactivate inflammatory mediators. Several genes related to mucosal integrity, immune response, detoxification and epithelium renewal were also enriched in PYL (P<0.05). The data indicate that there is significant differential gene expression between OXY of the young pig and PYL and further functional studies are needed to confirm their physiological importance.	[Colombo, Michela; Priori, Davide; Trevisi, Paolo; Bosi, Paolo] Univ Bologna, Dipartimento Sci & Tecnol Agroalimentari, Bologna, Italy	University of Bologna	Bosi, P (corresponding author), Univ Bologna, Dipartimento Sci & Tecnol Agroalimentari, Bologna, Italy.	paolo.bosi@unibo.it		TREVISI, PAOLO/0000-0001-7019-6828	European Union [227549]	European Union(European Commission)	Research funded by the European Union (Interplay project, Grant agreement no. 227549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bosi P, 2006, J NUTR, V136, P1229, DOI 10.1093/jn/136.5.1229; Broeckaert F, 2000, ANN NY ACAD SCI, V923, P68; Chu SJ, 2012, CURR OPIN GASTROEN, V28, P587, DOI 10.1097/MOG.0b013e328358e5cc; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Da Costa LA, 2012, ANN NUTR METAB, V60, P27, DOI 10.1159/000337311; Du GM, 2007, RES VET SCI, V82, P99, DOI 10.1016/j.rvsc.2006.06.004; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Goebel M, 2011, PHYSIOL GENOMICS, V43, P237, DOI 10.1152/physiolgenomics.00193.2010; He WJ, 2011, AM J PHYSIOL-GASTR L, V301, pG591, DOI 10.1152/ajpgi.00460.2010; Hoffmann W, 2012, CURR MED CHEM, V19, P5975; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; LAMBRECHT N, 1993, GASTROENTEROLOGY, V104, P1371, DOI 10.1016/0016-5085(93)90345-D; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Ma L, 2000, LIFE SCI, V66, pPL213; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; Mazzoni M, 2008, J NUTR, V138, P1426, DOI 10.1093/jn/138.8.1426; Mukherjee A B, 1988, Adv Exp Med Biol, V231, P135; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; PATEL S, 1993, GUT, V34, P893, DOI 10.1136/gut.34.7.893; Puccinelli E, 2011, CURR DRUG METAB, V12, P507; Rao R, 2004, CYTOKINE GROWTH F R, V15, P103, DOI 10.1016/j.cytogfr.2004.01.003; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; San Roman AK, 2011, EXP CELL RES, V317, P2711, DOI 10.1016/j.yexcr.2011.07.011; Shi ZM, 2005, WORLD J GASTROENTERO, V11, P6707, DOI 10.3748/wjg.v11.i42.6707; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Wang J, 2011, MOL CELL PROTEOMICS, V10; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yuan Y, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099952	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111447	10.1371/journal.pone.0111447	http://dx.doi.org/10.1371/journal.pone.0111447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357124	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000062
J	Kudo, H; Wada, H; Sasaki, H; Tsuji, H; Otsuka, R; Baghdadi, M; Kojo, S; Chikaraishi, T; Seino, K				Kudo, Hiroya; Wada, Haruka; Sasaki, Hajime; Tsuji, Hyuma; Otsuka, Ryo; Baghdadi, Muhammad; Kojo, Satoshi; Chikaraishi, Tatsuya; Seino, Ken-ichiro			Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival	PLOS ONE			English	Article							MISMATCHED RENAL-TRANSPLANTATION; PLURIPOTENT STEM-CELLS; DENDRITIC CELLS; T-CELLS; MAINTENANCE IMMUNOSUPPRESSION; ACTIVATION; TOLERANCE; DIFFERENTIATION; GENERATION; COSTIMULATION	Recent progress in regenerative medicine has enabled the utilization of pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) as a donor resource for transplantation. However, immune suppression is still needed when the donor-recipient combination is allogeneic. Protection of ESCs-derived grafts from host immune response might be achieved thought the utilization of immunosuppressive cells generated from ESCs. In the present study, we show that a certain fraction of immunosuppressive cells can be generated from ESCs and help to suppress immune response against allogeneic grafts. ESCs-derived suppressor cells (ES-SCs) resembled macrophages in terms of cell surface molecule and gene expressions. Furthermore, gene expression analysis including microarray showed that ES-SCs have M1/M2 hybrid phenotype with high expression of genes correlated to immunosuppression of T cell response. Indeed, ES-SCs were effective to block allogeneic T cell proliferation in a nitric oxide-dependent manner, and prolonged the survival of ESCs-derived embryoid bodies or cardiomyocytes grafts transplanted into mouse kidney capsule. Thus, we consider the potential use of these ESCs-derived macrophage-like immunosuppressive cells as cellular therapies to promote long-term graft survival in future therapies.	[Kudo, Hiroya; Wada, Haruka; Sasaki, Hajime; Tsuji, Hyuma; Otsuka, Ryo; Baghdadi, Muhammad; Kojo, Satoshi; Seino, Ken-ichiro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan; [Kudo, Hiroya; Chikaraishi, Tatsuya] St Marianna Univ, Sch Med, Dept Urol, Miyamae Ku, Kawasaki, Kanagawa, Japan	Hokkaido University; Saint Marianna University	Seino, K (corresponding author), Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan.	seino@igm.hokudai.ac.jp	Kojo, Satoshi/N-7135-2018	Kojo, Satoshi/0000-0002-9263-8831; Otsuka, Ryo/0000-0002-3730-9867; Baghdadi, Muhammad/0000-0002-2347-8889	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [26640066] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HW and KS. This work was also supported in part by the Uehara Memorial Foundation to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Bashuda H, 2005, J CLIN INVEST, V115, P1896, DOI 10.1172/JCI23743; Brem-Exner BG, 2008, J IMMUNOL, V180, P335, DOI 10.4049/jimmunol.180.1.335; Cyranoski D, 2012, NATURE, V488, P139, DOI 10.1038/488139a; DENIS M, 1994, J LEUKOCYTE BIOL, V55, P682, DOI 10.1002/jlb.55.5.682; Dreymueller D, 2013, WOUND REPAIR REGEN, V21, P44, DOI 10.1111/j.1524-475X.2012.00858.x; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kawai T, 2013, NEW ENGL J MED, V368, P1850, DOI 10.1056/NEJMc1213779; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pilat N, 2012, CURR OPIN ORGAN TRAN, V17, P368, DOI 10.1097/MOT.0b013e328355fc94; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wada H, 2011, INT IMMUNOL, V23, P65, DOI 10.1093/intimm/dxq458; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111826	10.1371/journal.pone.0111826	http://dx.doi.org/10.1371/journal.pone.0111826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356669	Green Published, gold			2022-12-26	WOS:000346765000080
J	Yermalovich, MA; Semeiko, GV; Samoilovich, EO; Svirchevskaya, EY; Muller, CP; Hubschen, JM				Yermalovich, Marina A.; Semeiko, Galina V.; Samoilovich, Elena O.; Svirchevskaya, Ekaterina Y.; Muller, Claude P.; Huebschen, Judith M.			Etiology of Maculopapular Rash in Measles and Rubella Suspected Patients from Belarus	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; SURVEILLANCE; INFECTION; FEVER; ILLNESSES; CHILDREN	As a result of successful implementation of the measles/rubella elimination program, the etiology of more and more double negative cases remains elusive. The present study determined the role of different viruses as causative agents in measles or rubella suspected cases in Belarus. A total of 856 sera sent to the WHO National Laboratory between 2009 and 2011 were tested for specific IgM antibodies to measles virus (MV), rubella virus (RV) and human parvovirus B19 (B19V). The negatives were further investigated for antibodies to enterovirus (EV) and adenovirus (AdV). Children of up to 3 years were tested for IgM antibodies to human herpesvirus 6 (HHV6). A viral etiology was identified in 451 (52.7%) cases, with 6.1% of the samples being positive for MV; 2.6% for RV; 26.2% for B19V; 9.7% for EV; 4.6% for AdV; and 3.6% for HHV6. Almost all measles and rubella cases occurred during limited outbreaks in 2011 and nearly all patients were at least 15 years old. B19V, EV and AdV infections were prevalent both in children and adults and were found throughout the 3 years. B19V occurred mainly in 3-10 years old children and 20-29 years old adults. EV infection was most common in children up to 6 years of age and AdV was confirmed mainly in 3-6 years old children. HHV6 infection was mostly detected in 6-11 months old infants. Laboratory investigation of measles/rubella suspected cases also for B19V, EV, AdV and HHV6 allows diagnosing more than half of all cases, thus strengthening rash/fever disease surveillance in Belarus.	[Yermalovich, Marina A.; Semeiko, Galina V.; Samoilovich, Elena O.; Svirchevskaya, Ekaterina Y.] Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS; [Muller, Claude P.; Huebschen, Judith M.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg	Luxembourg Institute of Health	Yermalovich, MA (corresponding author), Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS.	yermalovich@mail.ru	Hübschen, Judith/AAF-5113-2020; Hübschen, Judith/ABA-7931-2021	Hübschen, Judith/0000-0002-5001-2128	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	The authors wish to thank the Ministry of Cooperation and the Centre de Recherche Public de la Sante in Luxembourg for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidkin I, 1998, J INFECT DIS, V178, P1567, DOI 10.1086/314513; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; Vianna RAD, 2008, PEDIATR INFECT DIS J, V27, P533, DOI 10.1097/INF.0b013e3181673c50; El-Mahallawy Hadir A, 2005, J Egypt Natl Canc Inst, V17, P121; Irons B, 2011, J INFECT DIS, V204, pS622, DOI 10.1093/infdis/jir437; Kramkimel N, 2010, J EUR ACAD DERMATOL, V24, P1468, DOI 10.1111/j.1468-3083.2010.03672.x; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Pedranti MS, 2012, EPIDEMIOL INFECT, V140, P454, DOI 10.1017/S0950268811000823; Ramsay M, 2002, ARCH DIS CHILD, V87, P202, DOI 10.1136/adc.87.3.202; Samoilovich EO, 2011, ZDRAVOOKHRANENIE, V12, P32; Samoilovich EO, 2012, ZH MIKROBIOL EPIDEMI, V1, P21; Siennicka Joanna, 2011, Przegl Epidemiol, V65, P39; Velicko I, 2008, VACCINE, V26, P6980, DOI 10.1016/j.vaccine.2008.09.012; Wananukul S, 2003, ASIAN PAC J ALLERGY, V21, P217; Wang YHJ, 2007, EPIDEMIOL INFECT, V135, P1363, DOI 10.1017/S095026880700828X; WHO, 2012, SURV GUID MEASL RUB; World Health Organization (WHO), 2014, RUB REP CAS; Yermalovich MA, 2012, J MED VIROL, V84, P973, DOI 10.1002/jmv.23294; Zaki MES, 2008, CURR MICROBIOL, V56, P105, DOI 10.1007/s00284-007-9054-z; Zhang Hui, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P686	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111541	10.1371/journal.pone.0111541	http://dx.doi.org/10.1371/journal.pone.0111541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356680	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000068
J	Bjorkgren, I; Gylling, H; Turunen, H; Huhtaniemi, I; Strauss, L; Poutanen, M; Sipila, P				Bjorkgren, Ida; Gylling, Helena; Turunen, Heikki; Huhtaniemi, Ilpo; Strauss, Leena; Poutanen, Matti; Sipila, Petra			Imbalanced lipid homeostasis in the conditional Dicer1 knockout mouse epididymis causes instability of the sperm membrane	FASEB JOURNAL			English	Article						RNA interference; infertility; sperm maturation; cholesterol; polyunsaturated fatty acids	POLYUNSATURATED FATTY-ACIDS; PLASMA-MEMBRANE; IN-VITRO; TYROSINE PHOSPHORYLATION; CHOLESTEROL HOMEOSTASIS; MAMMALIAN SPERMATOZOA; LUTEINIZING-HORMONE; MATURATION; CAPACITATION; SPHINGOMYELIN	During epididymal sperm maturation, the lipid content of the sperm membrane is modified, which facilitates sperm motility and fertility. However, little is known about the mechanisms regulating the maturation process. By generating a conditional knockout (cKO) of Dicer1 in the proximal part of the mouse epididymis, we studied the role of RNA interference in epididymal functions. The Dicer1 cKO epididymis displayed an altered lipid homeostasis associated with a 0.6-fold reduction in the expression of the gene elongation of very long chain fatty acids-like 2, an enzyme needed for production of long-chain polyunsaturated fatty acids (PUFAs). Furthermore, the expression of several factors involved in cholesterol synthesis was up-regulated. Accordingly, the Dicer1 cKO sperm membrane showed a 0.7-fold decrease in long-chain PUFAs, whereas the amount of cholesterol in acrosome-reacted sperm displayed a 1.7-fold increase. The increased cholesterol:PUFA ratio of the sperm membrane caused breakage of the neck and acrosome region and immotility of sperm. Dicer1 cKO mice sperm also displayed reduced ability to bind to and fertilize the oocyte in vitro. This study thus shows that Dicer1 is critical for lipid synthesis in the epididymis, which directly affects sperm membrane integrity and male fertility.	[Bjorkgren, Ida; Turunen, Heikki; Strauss, Leena; Poutanen, Matti] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Bjorkgren, Ida] Turku Doctoral Programme Biomed Sci, Turku, Finland; [Gylling, Helena] Univ Eastern Finland, Dept Clin Nutr, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Gylling, Helena] Univ Helsinki, Dept Med, Div Internal Med, FIN-00014 Helsinki, Finland; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Strauss, Leena; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Poutanen, Matti] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Sipila, Petra] Univ Helsinki, Inst Biomed, Dept Physiol, FIN-00014 Helsinki, Finland; [Sipila, Petra] Univ Helsinki, Lab Anim Ctr, FIN-00014 Helsinki, Finland	University of Turku; University of Eastern Finland; University of Helsinki; Imperial College London; University of Turku; University of Gothenburg; University of Helsinki; University of Helsinki	Sipila, P (corresponding author), Univ Helsinki, POB 63, FIN-00014 Helsinki, Finland.	petra.sipila@helsinki.fi	Poutanen, Matti/I-1700-2018; Strauss, Leena/AAY-8824-2021; Sipilä, Petra/GYE-3323-2022	Poutanen, Matti/0000-0002-8953-1734; Bjorkgren, Ida/0000-0001-6678-2672; Strauss, Leena/0000-0002-5682-205X; Sipila, Petra/0000-0001-8187-7143				Aksoy Y, 2006, PROSTAG LEUKOTR ESS, V75, P75, DOI 10.1016/j.plefa.2006.06.002; Am-In N, 2011, THERIOGENOLOGY, V75, P897, DOI 10.1016/j.theriogenology.2010.10.032; AVELDANO MI, 1992, BIOCHEM J, V283, P235, DOI 10.1042/bj2830235; AWANO M, 1993, J REPROD FERTIL, V99, P375, DOI 10.1530/jrf.0.0990375; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Castellini C, 2003, REPROD NUTR DEV, V43, P91, DOI 10.1051/rnd:2003008; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Christova Y, 2002, J ANDROL, V23, P384; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cross NL, 2000, BIOL REPROD, V63, P1129, DOI 10.1095/biolreprod63.4.1129; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; Cross NL, 2003, BIOL REPROD, V69, P529, DOI 10.1095/biolreprod.102.013052; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; EVANS RW, 1979, J REPROD FERTIL, V57, P189, DOI 10.1530/jrf.0.0570189; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Haidl G, 1997, HUM REPROD, V12, P2720, DOI 10.1093/humrep/12.12.2720; HALL JC, 1991, J ANDROL, V12, P76; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kerkhofs S, 2012, FASEB J, V26, P4360, DOI 10.1096/fj.11-202283; Kronke M, 1999, CHEM PHYS LIPIDS, V101, P109, DOI 10.1016/S0009-3084(99)00059-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Lin Y, 1996, BIOL REPROD, V55, P1133, DOI 10.1095/biolreprod55.5.1133; Mann T., 1964, BIOCH SEMEN MALE REP, DOI 10.5694/j.1326-5377.1965.tb72030.x; MANN T, 1981, MALE REPRODUCTIVE FU, P212; MIETTINEN TA, 1988, J LIPID RES, V29, P43; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Mourvaki E, 2010, THERIOGENOLOGY, V73, P629, DOI 10.1016/j.theriogenology.2009.10.019; NIKOLOPOULOU M, 1985, BIOCHIM BIOPHYS ACTA, V815, P486, DOI 10.1016/0005-2736(85)90377-3; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; Ouvrier A, 2009, J LIPID RES, V50, P1766, DOI 10.1194/jlr.M800657-JLR200; PARKS JE, 1985, BIOL REPROD, V32, P653, DOI 10.1095/biolreprod32.3.653; PORN MI, 1993, J LIPID RES, V34, P1385; Pyttel S, 2014, THERIOGENOLOGY, V82, P396, DOI 10.1016/j.theriogenology.2014.04.017; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Robaire B, 2000, E SCHERING RES FDN W, P229; ROBINSON BS, 1992, J BIOL CHEM, V267, P1746; Rooke JA, 2001, REPRODUCTION, V121, P315, DOI 10.1530/rep.0.1210315; Safarinejad MR, 2011, ANDROLOGIA, V43, P38, DOI 10.1111/j.1439-0272.2009.01013.x; Schwarz A, 2013, CELL TISSUE RES, V353, P549, DOI 10.1007/s00441-013-1633-7; Sipila P, 2002, MOL ENDOCRINOL, V16, P2603, DOI 10.1210/me.2002-0100; SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1025, P152; SonnenbergRiethmacher E, 1996, GENE DEV, V10, P1184, DOI 10.1101/gad.10.10.1184; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; SUZUKI F, 1988, J ULTRA MOL STRUCT R, V100, P39, DOI 10.1016/0889-1605(88)90057-2; Tavilani H, 2006, ANDROLOGIA, V38, P173, DOI 10.1111/j.1439-0272.2006.00735.x; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; Turunen HT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092403; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Wang Y, 2008, J LIPID RES, V49, P1538, DOI 10.1194/jlr.M800123-JLR200; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zanetti SR, 2010, BIOCHIMIE, V92, P1886, DOI 10.1016/j.biochi.2010.08.015	68	40	42	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					433	442		10.1096/fj.14-259382	http://dx.doi.org/10.1096/fj.14-259382			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25366345				2022-12-26	WOS:000349370400009
J	Dhanasekaran, S; Biswas, M; Vignesh, AR; Ramya, R; Raj, GD; Tirumurugaan, KG; Raja, A; Kataria, RS; Parida, S; Subbiah, E				Dhanasekaran, Sakthivel; Biswas, Moanaro; Vignesh, Ambothi R.; Ramya, R.; Raj, Gopal Dhinakar; Tirumurugaan, Krishnaswamy G.; Raja, Angamuthu; Kataria, Ranjit S.; Parida, Satya; Subbiah, Elankumaran			Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION MOLECULE; BLOOD MONONUCLEAR-CELLS; IMMUNE-RESPONSES; BOVINE; SHEEP; OUTBREAK; TLR7; REPLICATION; INFECTION; CATTLE	Ovine rinderpest or goat plague is an economically important and contagious viral disease of sheep and goats, caused by the Peste des petits ruminants virus (PPRV). Differences in susceptibility to goat plague among different breeds and water buffalo exist. The host innate immune system discriminates between pathogen associated molecular patterns and self antigens through surveillance receptors known as Toll like receptors (TLR). We investigated the role of TLR and cytokines in differential susceptibility of goat breeds and water buffalo to PPRV. We examined the replication of PPRV in peripheral blood mononuclear cells (PBMC) of Indian domestic goats and water buffalo and demonstrated that the levels of TLR3 and TLR7 and downstream signalling molecules correlation with susceptibility vs resistance. Naturally susceptible goat breeds, Barbari and Tellichery, had dampened innate immune responses to PPRV and increased viral loads with lower basal expression levels of TLR 3/7. Upon stimulation of PBMC with synthetic TLR3 and TLR7 agonists or PPRV, the levels of proinflammatory cytokines were found to be significantly higher while immunosuppressive interleukin (IL) 10 levels were lower in PPRV resistant Kanni and Salem Black breeds and water buffalo at transcriptional level, correlating with reduced viralloads in infected PBMC. Water buffalo produced higher levels of interferon (IFN) alpha in comparison with goats at transcriptional and translational levels. Pre-treatment of Vero cells with human IFN alpha resulted in reduction of PPRV replication, confirming the role of IFN alpha in limiting PPRV replication. Treatment with IRS66, a TLR7 antagonist, resulted in the reduction of IFN alpha levels, with increased PPRV replication confirming the role of TLR7. Single nucleotide polymorphism analysis of TLR7 of these goat breeds did not show any marked nucleotide differences that might account for susceptibility vs resistance to PPRV. Analyzing other host genetic factors might provide further insights on susceptibility to PPRV and genetic polymorphisms in the host.	[Dhanasekaran, Sakthivel; Vignesh, Ambothi R.; Ramya, R.; Raj, Gopal Dhinakar; Tirumurugaan, Krishnaswamy G.; Raja, Angamuthu] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Biswas, Moanaro; Subbiah, Elankumaran] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Ctr Mol Med & Infect Dis, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Kataria, Ranjit S.] Natl Bur Anim Genet Resources, Div Anim Genet, Karnal, Haryana, India; [Parida, Satya] Pirbright Inst, FMD Vaccine Differentiat Grp, Surrey, England	Tamil Nadu Veterinary & Animal Sciences University; Virginia Polytechnic Institute & State University; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Parida, S (corresponding author), Pirbright Inst, FMD Vaccine Differentiat Grp, Surrey, England.	satya.parida@pirbright.ac.uk; kumarans@vt.edu	Rathinasamy, Vignesh/K-1267-2019; Parida, Satya/E-5463-2015; Kataria, RS/P-2105-2017; Hegde, Nagendra/J-5920-2014	Rathinasamy, Vignesh/0000-0002-4032-3424; Parida, Satya/0000-0001-8253-9461; Kataria, RS/0000-0003-2845-7486; Hegde, Nagendra/0000-0001-5260-2159; Sakthivel, Dhanasekaran/0000-0003-2894-2545; Biswas, Moanaro/0000-0002-2889-5905; Angamuthu, Raja/0000-0002-5477-2730; Gopal, Dhinakar Raj/0000-0003-0254-926X	TLR.NAIP; BBSRC [BB/L004801/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L004801/1] Funding Source: researchfish	TLR.NAIP; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by TLR.NAIP (http://www.naiptlr.com/NAIP-TLR.pdf). The sponsors have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON E C, 1975, Journal of Wildlife Diseases, V11, P248; Banerjee P, 2012, DHR IJBLS, V3, P137; Bannerman DD, 2008, J DAIRY SCI, V91, P2225, DOI 10.3168/jds.2008-1013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Booth JS, 2010, DEV COMP IMMUNOL, V34, P572, DOI 10.1016/j.dci.2009.12.018; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buza J, 2008, VET IMMUNOL IMMUNOP, V126, P273, DOI 10.1016/j.vetimm.2008.08.001; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; Diop M, 2005, EPIDEMIOL INFECT, V133, P711, DOI 10.1017/S0950268805003729; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Gopinath VP, 2011, J VIROL METHODS, V171, P98, DOI 10.1016/j.jviromet.2010.10.007; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Goyal S, 2012, ANIM BIOTECHNOL, V23, P194, DOI 10.1080/10495398.2012.684417; Harrison SM, 2007, AVIAN PATHOL, V36, P109, DOI 10.1080/03079450601156083; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jagtap SP, 2012, MICROB PATHOGENESIS, V52, P217, DOI 10.1016/j.micpath.2012.01.003; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kedmi M, 2011, VET MICROBIOL, V148, P408, DOI 10.1016/j.vetmic.2010.09.015; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; Kuchipudi SV, 2012, IMMUNOL CELL BIOL, V90, P116, DOI 10.1038/icb.2011.17; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Mikula I, 2010, VET IMMUNOL IMMUNOP, V138, P51, DOI 10.1016/j.vetimm.2010.06.015; MORNET P., 1956, Revue de l'Elevage. Productions animales - Productions fourrageres, V9, P313; Nanda YP, 1996, VET MICROBIOL, V51, P207, DOI 10.1016/0378-1135(96)00025-9; Narayanan R, 2008, VET WORLD, V1, P81; PANIGRAHI P, 1988, ARCH VIROL, V98, P107, DOI 10.1007/BF01321011; Pawar RM, 2008, ACTA VIROL, V52, P231; Pawar RM, 2008, VIRUS RES, V136, P118, DOI 10.1016/j.virusres.2008.04.026; Raj GD, 2000, J VIROL METHODS, V89, P89, DOI 10.1016/S0166-0934(00)00206-8; ROEDER PL, 1994, TROP ANIM HEALTH PRO, V26, P69, DOI 10.1007/BF02239901; Roy P, 2010, INT J APPL RES VET M, V8, P155; Saeed IK, 2010, TROP ANIM HEALTH PRO, V42, P89, DOI 10.1007/s11250-009-9389-5; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Sentsui H, 1998, J VET MED SCI, V60, P1329, DOI 10.1292/jvms.60.1329; SHAILA MS, 1989, VET REC, V125, P602; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; TAYLOR WP, 1979, RES VET SCI, V26, P94; Taylor WP, 2002, PREV VET MED, V52, P305, DOI 10.1016/S0167-5877(01)00254-9; Tirumurugaan KG, 2010, VET IMMUNOL IMMUNOP, V133, P296, DOI 10.1016/j.vetimm.2009.08.015; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vignesh AR, 2012, VET IMMUNOL IMMUNOP, V147, P51, DOI 10.1016/j.vetimm.2012.02.009; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yesilbag K, 2005, VET REC, V157, P260, DOI 10.1136/vr.157.9.260	55	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111609	10.1371/journal.pone.0111609	http://dx.doi.org/10.1371/journal.pone.0111609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369126	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000077
J	Matsushita, H; Yahata, T; Sheng, Y; Nakamura, Y; Muguruma, Y; Matsuzawa, H; Tanaka, M; Hayashi, H; Sato, T; Damdinsuren, A; Onizuka, M; Ito, M; Miyachi, H; Pandolfi, PP; Ando, K				Matsushita, Hiromichi; Yahata, Takashi; Sheng, Yin; Nakamura, Yoshihiko; Muguruma, Yukari; Matsuzawa, Hideyuki; Tanaka, Masayuki; Hayashi, Hideki; Sato, Tadayuki; Damdinsuren, Anar; Onizuka, Makoto; Ito, Mamoru; Miyachi, Hayato; Pandolfi, Pier Paolo; Ando, Kiyoshi			Establishment of a Humanized APL Model via the Transplantation of PML-RARA-Transduced Human Common Myeloid Progenitors into Immunodeficient Mice	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA FUSION PROTEIN; HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL CAPACITY; EX-VIVO EXPANSION; PML/RAR-ALPHA; TRANSGENIC MICE; MOUSE MODEL; NULL MICE; EXPRESSION	Recent advances in cancer biology have revealed that many malignancies possess a hierarchal system, and leukemic stem cells (LSC) or leukemia-initiating cells (LIC) appear to be obligatory for disease progression. Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia characterized by the formation of a PML-RAR alpha fusion protein, leads to the accumulation of abnormal promyelocytes. In order to understand the precise mechanisms involved in human APL leukemogenesis, we established a humanized in vivo APL model involving retroviral transduction of PML-RARA into CD34(+) hematopoietic cells from human cord blood and transplantation of these cells into immunodeficient mice. The leukemia well recapitulated human APL, consisting of leukemic cells with abundant azurophilic abnormal granules in the cytoplasm, which expressed CD13, CD33 and CD117, but not HLA-DR and CD34, were clustered in the same category as human APL samples in the gene expression analysis, and demonstrated sensitivity to ATRA. As seen in human APL, the induced APL cells showed a low transplantation efficiency in the secondary recipients, which was also exhibited in the transplantations that were carried out using the sorted CD34(-) fraction. In order to analyze the mechanisms underlying APL initiation and development, fractionated human cord blood was transduced with PML-RARA. Common myeloid progenitors (CMP) from CD34(+)/CD38(+) cells developed APL. These findings demonstrate that CMP are a target fraction for PML-RARA in APL, whereas the resultant CD34(-) APL cells may share the ability to maintain the tumor.	[Matsushita, Hiromichi; Yahata, Takashi; Sheng, Yin; Nakamura, Yoshihiko; Muguruma, Yukari; Matsuzawa, Hideyuki; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Canc Stem Cell, Isehara, Kanagawa 25911, Japan; [Matsushita, Hiromichi; Yahata, Takashi; Ando, Kiyoshi] Tokai Univ, Med Res Inst, Isehara, Kanagawa 25911, Japan; [Matsushita, Hiromichi; Damdinsuren, Anar; Miyachi, Hayato] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 25911, Japan; [Yahata, Takashi] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan; [Matsuzawa, Hideyuki; Tanaka, Masayuki; Hayashi, Hideki; Sato, Tadayuki] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa 25911, Japan; [Onizuka, Makoto; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Res Inst,Dept Med, Boston, MA 02215 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Res Inst,Dept Pathol, Boston, MA 02215 USA	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Matsushita, H (corresponding author), Tokai Univ, Sch Med, Res Ctr Canc Stem Cell, Isehara, Kanagawa 25911, Japan.	hmatsu@is.ic.cc.u-tokai.ac.jp; andok@keyaki.cc.u-tokai.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630; ONIZUKA, MAKOTO/0000-0003-3864-0823; Tanaka, Masayuki/0000-0002-8682-8719; Pandolfi, Pier Paolo/0000-0002-5352-5295	Ministry of Education, Culture, Sports, Science and Technology of Japan [24591411, 24390248]; Tokai University School of Medicine; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26430094, 24591411] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokai University School of Medicine; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Hiromichi Matsushita received funding from a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (#24591411, URL http://www.jsps.go.jp/english/e-grants/), Tokai University School of Medicine Project Research (http://www.med.u-tokai.ac.jp/web/international/about_us/message_from_the_dean.html), and the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html). Kiyoshi Ando received support from a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (#24390248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2006, BLOOD, V107, P3371, DOI 10.1182/blood-2005-08-3108; Becker MW, 2011, BLOOD REV, V25, P75, DOI 10.1016/j.blre.2010.11.001; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Grimwade D, 2004, LEUKEMIA, V18, P375, DOI 10.1038/sj.leu.2403234; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kawada H, 1999, EXP HEMATOL, V27, P904, DOI 10.1016/S0301-472X(99)00012-0; Kerbauy DMB, 2004, BLOOD, V104, P2202, DOI 10.1182/blood-2004-04-1518; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Matsushita H, 2006, J EXP MED, V203, P821, DOI 10.1084/jem.20050616; Muguruma Y, 2011, HAEMATOL-HEMATOL J, V96, P543, DOI 10.3324/haematol.2010.027557; Paietta E, 2003, BEST PRACT RES CL HA, V16, P369, DOI 10.1016/S1521-6926(03)00042-2; Paietta E, 2004, CYTOM PART B-CLIN CY, V59B, P1, DOI 10.1002/cyto.b.20001; Patel S, 2012, LEUKEMIA, V26, P2432, DOI 10.1038/leu.2012.154; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Puccetti E, 2004, LEUKEMIA, V18, P1169, DOI 10.1038/sj.leu.2403367; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Wartman LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046529; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Welch JS, 2011, J CLIN INVEST, V121, P1636, DOI 10.1172/JCI42953; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wojiski S, 2009, LEUKEMIA, V23, P1462, DOI 10.1038/leu.2009.63; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111082	10.1371/journal.pone.0111082	http://dx.doi.org/10.1371/journal.pone.0111082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369030	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000035
J	Petukh, M; Wu, BH; Stefl, S; Smith, N; Hyde-Volpe, D; Wang, L; Alexov, E				Petukh, Marharyta; Wu, Bohua; Stefl, Shannon; Smith, Nick; Hyde-Volpe, David; Wang, Li; Alexov, Emil			Chronic Beryllium Disease: Revealing the Role of Beryllium Ion and Small Peptides Binding to HLA-DP2	PLOS ONE			English	Article							CD4(+) T-CELLS; HLA-DP; CONFORMATIONAL FLEXIBILITY; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; PROTEIN; SUSCEPTIBILITY; IDENTIFICATION; SENSITIZATION; RECOGNITION	Chronic Beryllium (Be) Disease (CBD) is a granulomatous disorder that predominantly affects the lung. The CBD is caused by Be exposure of individuals carrying the HLA-DP2 protein of the major histocompatibility complex class II (MHCII). While the involvement of Be in the development of CBD is obvious and the binding site and the sequence of Be and peptide binding were recently experimentally revealed [1], the interplay between induced conformational changes and the changes of the peptide binding affinity in presence of Be were not investigated. Here we carry out in silico modeling and predict the Be binding to be within the acidic pocket (Glu26, Glu68 and Glu69) present on the HLA-DP2 protein in accordance with the experimental work [1]. In addition, the modeling indicates that the Be ion binds to the HLA-DP2 before the corresponding peptide is able to bind to it. Further analysis of the MD generated trajectories reveals that in the presence of the Be ion in the binding pocket of HLA-DP2, all the different types of peptides induce very similar conformational changes, but their binding affinities are quite different. Since these conformational changes are distinctly different from the changes caused by peptides normally found in the cell in the absence of Be, it can be speculated that CBD can be caused by any peptide in presence of Be ion. However, the affinities of peptides for Be loaded HLA-DP2 were found to depend of their amino acid composition and the peptides carrying acidic group at positions 4 and 7 are among the strongest binders. Thus, it is proposed that CBD is caused by the exposure of Be of an individual carrying the HLA-DP2*0201 allele and that the binding of Be to HLA-DP2 protein alters the conformational and ionization properties of HLA-DP2 such that the binding of a peptide triggers a wrong signaling cascade.	[Petukh, Marharyta; Stefl, Shannon; Smith, Nick; Wang, Li; Alexov, Emil] Clemson Univ, Computat Biophys & Bioinformat Phys Dept, Clemson, SC 29634 USA; [Wu, Bohua] Clemson Univ, Sch Nursing, Clemson, SC USA; [Hyde-Volpe, David] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University; Clemson University	Petukh, M (corresponding author), Clemson Univ, Computat Biophys & Bioinformat Phys Dept, Clemson, SC 29634 USA.	mpetukh@g.clemson.edu			NIH, NIGMS [R01GM093937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER	NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work of MP, SS, NS, LW and EA was supported by a grant from NIH, NIGMS grant number R01GM093937. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Amicosante M, 2001, HUM IMMUNOL, V62, P686, DOI 10.1016/S0198-8859(01)00261-0; Bill JR, 2005, J IMMUNOL, V175, P7029, DOI 10.4049/jimmunol.175.10.7029; Bowerman N, 2013, J IMMUNOLOGY, V190; Bowerman NA, 2014, J IMMUNOL; Bowerman N, 2011, J IMMUNOL, V186; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; Chain JL, 2013, J IMMUNOL, V191, P1648, DOI 10.4049/jimmunol.1300282; Clayton GM, 2014, CELL, V158, P132, DOI 10.1016/j.cell.2014.04.048; Dai SD, 2013, CURR OPIN IMMUNOL, V25, P775, DOI 10.1016/j.coi.2013.07.012; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; Doytchinova I, 2011, PROTEIN SCI, V20, P1918, DOI 10.1002/pro.732; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Li C, 2013, J COMPUTATIONAL CHEM; Li M, 2014, J CHEM THEORY COMPUT; Maier LA, 2012, RESP MED, V106, P1810, DOI 10.1016/j.rmed.2012.08.014; Martin AK, 2011, J ALLERGY CLIN IMMUN, V128, P1100, DOI 10.1016/j.jaci.2011.08.022; Mayer AS, 2013, J OCCUP ENVIRON MED, V55, P746, DOI 10.1097/JOM.0b013e3182972f1b; Morris D, 2014, GENES IMMUNITY; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066273; Onufriev AV, 2013, Q REV BIOPHYS, V46, P181, DOI 10.1017/S0033583513000024; Patronov A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-32; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petukh M, 2013, CURR PHARM DESIGN, V19, P4182, DOI 10.2174/1381612811319230004; Petukh M, 2013, BIOINFORMATICS, V29, P805, DOI 10.1093/bioinformatics/btt032; Petukh M, 2012, BIOPHYS J, V102, P2885, DOI 10.1016/j.bpj.2012.05.013; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pimentel-Santos FM, 2013, TISSUE ANTIGENS, V82, P374, DOI 10.1111/tan.12238; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Salvator H, 2013, EUR RESPIR J, V41, P234, DOI 10.1183/09031936.00095712; Scott BL, 2003, J INORG BIOCHEM, V94, P5, DOI 10.1016/S0162-0134(02)00628-1; Seidler A, 2012, OCCUP MED-OXFORD, V62, P506, DOI 10.1093/occmed/kqs069; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Thomas CA, 2013, AM J IND MED, V56, P733, DOI 10.1002/ajim.22175; Van Dyke MV, 2011, OCCUP ENVIRON MED, V68, P842, DOI 10.1136/oem.2010.064220; Van Dyke MV, 2011, AM J RESP CRIT CARE, V183, P1680, DOI 10.1164/rccm.201002-0254OC; Wang Y, 2013, IMMUNOL RES, V55, P83, DOI 10.1007/s12026-012-8351-1; Welch LS, 2013, AM J IND MED, V56, P1125, DOI 10.1002/ajim.22202; Yucesoy B, 2014, J OCCUP ENVIRON MED, V56, P382, DOI 10.1097/JOM.0000000000000138; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhang Z, 2012, BIOINFORMATICS, V28, P664, DOI 10.1093/bioinformatics/bts005; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111604	10.1371/journal.pone.0111604	http://dx.doi.org/10.1371/journal.pone.0111604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369028	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000075
J	Ye, LM; Hildebrand, F; Dingemans, J; Ballet, S; Laus, G; Matthijs, S; Berendsen, R; Cornelis, P				Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Ballet, Steven; Laus, George; Matthijs, Sandra; Berendsen, Roeland; Cornelis, Pierre			Draft Genome Sequence Analysis of a Pseudomonas putida W15Oct28 Strain with Antagonistic Activity to Gram-Positive and Pseudomonas sp Pathogens	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; PUTISOLVIN-II; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; PYOVERDINE BIOSYNTHESIS; BIOFILM FORMATION; EFFLUX PUMPS; FLUORESCENS; IDENTIFICATION; AERUGINOSA	Pseudomonas putida is a member of the fluorescent pseudomonads known to produce the yellow-green fluorescent pyoverdine siderophore. P. putida W15Oct28, isolated from a stream in Brussels, was found to produce compound(s) with antimicrobial activity against the opportunistic pathogens Staphylococcus aureus, Pseudomonas aeruginosa, and the plant pathogen Pseudomonas syringae, an unusual characteristic for P. putida. The active compound production only occurred in media with low iron content and without organic nitrogen sources. Transposon mutants which lost their antimicrobial activity had the majority of insertions in genes involved in the biosynthesis of pyoverdine, although purified pyoverdine was not responsible for the antagonism. Separation of compounds present in culture supernatants revealed the presence of two fractions containing highly hydrophobic molecules active against P. aeruginosa. Analysis of the draft genome confirmed the presence of putisolvin biosynthesis genes and the corresponding lipopeptides were found to contribute to the antimicrobial activity. One cluster of ten genes was detected, comprising a NAD-dependent epimerase, an acetylornithine aminotransferase, an acyl CoA dehydrogenase, a short chain dehydrogenase, a fatty acid desaturase and three genes for a RND efflux pump. P. putida W15Oct28 genome also contains 56 genes encoding TonB-dependent receptors, conferring a high capacity to utilize pyoverdines from other pseudomonads. One unique feature of W15Oct28 is also the presence of different secretion systems including a full set of genes for type IV secretion, and several genes for type VI secretion and their VgrG effectors.	[Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, Microbiol Res Grp, Brussels, Belgium; [Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Cornelis, Pierre] VIB Struct Biol Brussels, Brussels, Belgium; [Ballet, Steven; Laus, George] Vrije Univ Brussel, Dept Chem, B-1050 Brussels, Belgium; [Matthijs, Sandra] Inst Rech Microbiol Wiame, Brussels, Belgium; [Berendsen, Roeland] Univ Utrecht, Utrecht, Netherlands	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Utrecht University	Cornelis, P (corresponding author), Vrije Univ Brussel, Dept Bioengn Sci, Microbiol Res Grp, Brussels, Belgium.	pcornel@vub.ac.be	Cornelis, Pierre/H-3058-2019; Berendsen, Roeland L/I-1594-2016; Hildebrand, Falk/K-1914-2014	Berendsen, Roeland L/0000-0003-2707-8919; Ye, Lumeng/0000-0001-8337-7118; Dingemans, Jozef/0000-0001-8079-3087; Hildebrand, Falk/0000-0002-0078-8948	European Research Council (ERC) [269072]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by the European Research Council (ERC) [ERC Advanced Grant agreement number 269072 - PLANTIMMUSYS]. LY received a CSC-VUB fellowship for her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Dubern JF, 2008, MICROBIOL-SGM, V154, P2070, DOI 10.1099/mic.0.2008/016444-0; Dubern JF, 2006, FEMS MICROBIOL LETT, V263, P169, DOI 10.1111/j.1574-6968.2006.00406.x; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Espinosa-Urgel M, 2004, APPL ENVIRON MICROB, V70, P5190, DOI 10.1128/AEM.70.9.5190-5198.2004; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Gao JW, 2012, J BACTERIOL, V194, P4121, DOI 10.1128/JB.00688-12; Garg RP, 2002, MOL MICROBIOL, V46, P505, DOI 10.1046/j.1365-2958.2002.03169.x; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Guillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079111; Guillon L, 2012, ENVIRON MICROBIOL, V14, P1982, DOI 10.1111/j.1462-2920.2012.02741.x; Hartney SL, 2013, J BACTERIOL, V195, P765, DOI 10.1128/JB.01639-12; Iqbal A, 2011, ORG BIOMOL CHEM, V9, P6219, DOI 10.1039/c1ob05554b; Jin W, 2003, ORG LETT, V5, P2095, DOI 10.1021/ol034575n; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062946; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Matthijs S, 2009, BIOMETALS, V22, P951, DOI 10.1007/s10534-009-9247-y; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Molina L, 2013, GENOME A, VA1; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Mulet M, 2013, RES MICROBIOL, V164, P351, DOI 10.1016/j.resmic.2013.01.009; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ohji S, 2014, GENOME A, V2; Palleroni NJ, 2010, ENVIRON MICROBIOL, V12, P1377, DOI 10.1111/j.1462-2920.2009.02041.x; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; Penfold CN, 2012, BIOCHEM SOC T, V40, P1433, DOI 10.1042/BST20120253; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Rokni-Zadeh H, 2013, ENV MICROBIOL REP, V5, P160, DOI 10.1111/1758-2229.12015; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Velasco A, 2005, MOL MICROBIOL, V56, P144, DOI 10.1111/j.1365-2958.2004.04433.x; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Ye LM, 2014, BIOMETALS, V27, P633, DOI 10.1007/s10534-014-9734-7; Ye LM, 2013, BIOMETALS, V26, P561, DOI 10.1007/s10534-013-9653-z; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002	60	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110038	10.1371/journal.pone.0110038	http://dx.doi.org/10.1371/journal.pone.0110038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369289	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000015
J	Bouet-Cararo, C; Contreras, V; Caruso, A; Top, S; Szelechowski, M; Bergeron, C; Viarouge, C; Desprat, A; Relmy, A; Guibert, JM; Dubois, E; Thiery, R; Breard, E; Bertagnoli, S; Richardson, J; Foucras, G; Meyer, G; Schwartz-Cornil, I; Zientara, S; Klonjkowski, B				Bouet-Cararo, Coraline; Contreras, Vanessa; Caruso, Agathe; Top, Sokunthea; Szelechowski, Marion; Bergeron, Corinne; Viarouge, Cyril; Desprat, Alexandra; Relmy, Anthony; Guibert, Jean-Michel; Dubois, Eric; Thiery, Richard; Breard, Emmanuel; Bertagnoli, Stephane; Richardson, Jennifer; Foucras, Gilles; Meyer, Gilles; Schwartz-Cornil, Isabelle; Zientara, Stephan; Klonjkowski, Bernard			Expression of VP7, a Bluetongue Virus Group Specific Antigen by Viral Vectors: Analysis of the Induced Immune Responses and Evaluation of Protective Potential in Sheep	PLOS ONE			English	Article							SMALL RUMINANTS; CORE PROTEIN; VACCINE; CHALLENGE; INFECTION; CELLS; EFFICACY; GENOME; STRAIN	Bluetongue virus (BTV) is an economically important Orbivirus transmitted by biting midges to domestic and wild ruminants. The need for new vaccines has been highlighted by the occurrence of repeated outbreaks caused by different BTV serotypes since 1998. The major group-reactive antigen of BTV, VP7, is conserved in the 26 serotypes described so far, and its role in the induction of protective immunity has been proposed. Viral-based vectors as antigen delivery systems display considerable promise as veterinary vaccine candidates. In this paper we have evaluated the capacity of the BTV-2 serotype VP7 core protein expressed by either a non-replicative canine adenovirus type 2 (Cav-VP7 R-0) or a leporipoxvirus (SG33-VP7), to induce immune responses in sheep. Humoral responses were elicited against VP7 in almost all animals that received the recombinant vectors. Both Cav-VP7 R-0 and SG33-VP7 stimulated an antigen-specific CD4(+) response and Cav-VP7 R-0 stimulated substantial proliferation of antigen-specific CD8(+) lymphocytes. Encouraged by the results obtained with the Cav-VP7 R-0 vaccine vector, immunized animals were challenged with either the homologous BTV-2 or the heterologous BTV-8 serotype and viral burden in plasma was followed by real-time RT-PCR. The immune responses triggered by Cav-VP7 R-0 were insufficient to afford protective immunity against BTV infection, despite partial protection obtained against homologous challenge. This work underscores the need to further characterize the role of BTV proteins in cross-protective immunity.	[Bouet-Cararo, Coraline; Bergeron, Corinne; Viarouge, Cyril; Desprat, Alexandra; Relmy, Anthony; Breard, Emmanuel; Richardson, Jennifer; Zientara, Stephan; Klonjkowski, Bernard] UPE, ANSES, INRA, UMR ANSES INRA ENVA 1161, Maisons Alfort, France; [Contreras, Vanessa; Schwartz-Cornil, Isabelle] UR 892 INRA, Jouy En Josas, France; [Caruso, Agathe; Top, Sokunthea; Bertagnoli, Stephane; Foucras, Gilles; Meyer, Gilles] Univ Toulouse, INRA, IHAP, UMR1225,INP,ENVT, Toulouse, France; [Szelechowski, Marion] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, CNRS, INSERM, F-31062 Toulouse, France; [Guibert, Jean-Michel; Dubois, Eric] ANSES, Unite Pathol Petits Ruminants, Sophia Antipolis, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Klonjkowski, B (corresponding author), UPE, ANSES, INRA, UMR ANSES INRA ENVA 1161, Maisons Alfort, France.	bklonjkowski@vet-alfort.fr	Zientara, Stephan/AAA-7661-2021; FOUCRAS, Gilles/A-3061-2014; Klonjkowski, Bernard/N-7785-2019; breard, emmanuel/E-2123-2011; Zientara, Stephan/A-5336-2016; schwartz-cornil, isabelle/D-8547-2011; Szelechowski, Marion/X-7343-2019; Thiery, Richard/GRR-1496-2022	Zientara, Stephan/0000-0002-6733-8503; FOUCRAS, Gilles/0000-0002-0363-0337; Zientara, Stephan/0000-0003-0089-8175; Klonjkowski, Bernard/0000-0003-3372-0656; Thiery, Richard/0000-0003-2049-918X; Dubois, Eric/0000-0003-1035-2782; Richardson, Jennifer/0000-0002-4137-3984; Contreras, Vanessa/0000-0003-4072-9819; , Szelechowski/0000-0002-2929-7413	FP7 project ORBIVAC [245266]; UE Network of Excellence, EPIZONE [FOOD-CT-2006-016236]	FP7 project ORBIVAC; UE Network of Excellence, EPIZONE	This work was supported by the FP7 project ORBIVAC (contract N o. 245266) and the UE Network of Excellence, EPIZONE (Contract N o. FOOD-CT-2006-016236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Bouet-Cararo C, 2011, VACCINE, V29, P1304, DOI 10.1016/j.vaccine.2010.11.068; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Brun A, 2008, VACCINE, V26, P6508, DOI 10.1016/j.vaccine.2008.09.044; Calvo-Pinilla E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034735; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hamers C, 2009, VACCINE, V27, P2789, DOI 10.1016/j.vaccine.2009.02.099; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Jabbar TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060574; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; JEGGO MH, 1984, RES VET SCI, V36, P81, DOI 10.1016/S0034-5288(18)32007-1; JEGGO MH, 1984, IMMUNOLOGY, V52, P403; Kar AK, 2005, J VIROL, V79, P11487, DOI 10.1128/JVI.79.17.11487-11495.2005; Klonjkowski B, 2009, VACCINE, V27, P928, DOI 10.1016/j.vaccine.2008.11.086; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; MACLACHLAN N J, 1985, P79; Millar J, 2007, CELL IMMUNOL, V250, P55, DOI 10.1016/j.cellimm.2008.01.005; Murray PK, 1996, AUST VET J, V73, P207, DOI 10.1111/j.1751-0813.1996.tb10036.x; Perez de Diego AC, 2012, SCI WORLD J, V2012; Perrin A, 2007, VACCINE, V25, P6774, DOI 10.1016/j.vaccine.2007.06.052; Pignolet B, 2008, J GEN VIROL, V89, P1371, DOI 10.1099/vir.0.83595-0; Rojas JM, 2011, VACCINE, V29, P6848, DOI 10.1016/j.vaccine.2011.07.061; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Spiller OB, 2002, J GEN VIROL, V83, P45, DOI 10.1099/0022-1317-83-1-45; Stewart M, 2012, VACCINE, V30, P2131, DOI 10.1016/j.vaccine.2012.01.042; Szelechowski M, 2009, J GEN VIROL, V90, P1215, DOI 10.1099/vir.0.007773-0; TAKAMATSU H, 1989, IMMUNOLOGY, V66, P258; Top S, 2012, VACCINE, V30, P1609, DOI 10.1016/j.vaccine.2011.12.108; Tordo N, 2008, DEV BIOLOGICALS, V131, P467; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; WadeEvans AM, 1996, VIROLOGY, V220, P227, DOI 10.1006/viro.1996.0306; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6; Zientara S, 2002, VET REC, V150, P598, DOI 10.1136/vr.150.19.598	42	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111605	10.1371/journal.pone.0111605	http://dx.doi.org/10.1371/journal.pone.0111605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364822	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100086
J	Cabral, LG; Holland, B				Cabral, Larry G.; Holland, Brett			Courtship Song Does Not Increase the Rate of Adaptation to a Thermally Stressful Environment in a Drosophila melanogaster Laboratory Population	PLOS ONE			English	Article							REDUCING MUTATION LOAD; SEMINAL FLUID PROTEIN; SEXUAL SELECTION; EXPERIMENTAL REMOVAL; GENETIC QUALITY; CONFLICT; EVOLUTION; COSTS; INDICATOR; STRENGTH	Courtship song in D. melanogaster contributes substantially to male mating success through female selection. We used experimental evolution to test whether this display trait is maintained through adaptive female selection because it indicates heritable male quality for thermal stress tolerance. We used non-displaying, outbred populations of D. melanogaster (nub 1) mutants and measured their rate of adaptation to a new, thermally stressful environment, relative to wild-type control populations that retained courtship song. This design retains sexually selected conflict in both treatments. Thermal stress should select across genomes for newly beneficial alleles, increasing the available genetic and phenotypic variation and, therefore, the magnitude of female benefit derived from courtship song. Following introduction to the thermally stressful environment, net reproductive rate decreased 50% over four generations, and then increased 19% over the following 16 generations. There were no differences between the treatments. Possible explanations for these results are discussed.	[Cabral, Larry G.; Holland, Brett] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Cabral, LG (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	lgcabral@uci.edu			CSUS grants: Goethe Foundation Grants [100237, 100247]; Research and Creative Activities Grant [06-07-070]	CSUS grants: Goethe Foundation Grants; Research and Creative Activities Grant	This work was supported by CSUS grants: Goethe Foundation Grants (100237 and 100247), and Research and Creative Activities Grant (06-07-070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Almbro M, 2014, EVOLUTION, V68, P295, DOI 10.1111/evo.12238; Arbuthnott D, 2012, EVOLUTION, V66, P2127, DOI 10.1111/j.1558-5646.2012.01584.x; Arnqvist Goran, 2005, pUnpaginated; Ashburner M., 1989, DROSOPHILA LAB HDB; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clark SCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037351; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; David J. R., 1983, GENET BIOL DROSOPHIL, P107; EWING AW, 1964, ANIM BEHAV, V12, P316, DOI 10.1016/0003-3472(64)90018-1; Feder ME, 1997, FUNCT ECOL, V11, P90, DOI 10.1046/j.1365-2435.1997.00060.x; Firman RC, 2012, ECOL LETT, V15, P42, DOI 10.1111/j.1461-0248.2011.01706.x; Forsman A, 2006, EVOLUTION, V60, P2148, DOI 10.1111/j.0014-3820.2006.tb01852.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Friberg U, 2005, EVOLUTION, V59, P1540; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Holland B, 2002, EVOLUTION, V56, P721, DOI 10.1554/0014-3820(2002)056[0721:SSFTPA]2.0.CO;2; Hollis B, 2011, J EVOLUTION BIOL, V24, P1918, DOI 10.1111/j.1420-9101.2011.02323.x; Hollis B, 2009, EVOLUTION, V63, P324, DOI 10.1111/j.1558-5646.2008.00551.x; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Lew TA, 2005, EVOL ECOL RES, V7, P633; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Lung O, 2002, GENETICS, V160, P211; Martin OY, 2003, EVOLUTION, V57, P2765, DOI 10.1111/j.0014-3820.2003.tb01518.x; McGuigan K, 2011, EVOLUTION, V65, P2816, DOI 10.1111/j.1558-5646.2011.01346.x; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; NG M, 1995, DEVELOPMENT, V121, P589; Parker G.A., 1979, P123; PARTRIDGE L, 1980, NATURE, V283, P290, DOI 10.1038/283290a0; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Perea D, 2013, MECH DEVELOP, V130, P467, DOI 10.1016/j.mod.2013.06.002; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Pischedda A, 2005, J EVOLUTION BIOL, V18, P1115, DOI 10.1111/j.1420-9101.2005.00915.x; Plesnar A, 2011, EVOL ECOL RES, V13, P209; Proulx SR, 1999, AM NAT, V154, P89, DOI 10.1086/303218; Radwan J, 2004, ECOL LETT, V7, P1149, DOI 10.1111/j.1461-0248.2004.00681.x; Radwan J, 2004, J EVOLUTION BIOL, V17, P94, DOI 10.1046/j.1420-9101.2003.00646.x; Rice WR, 2006, PHILOS T R SOC B, V361, P287, DOI 10.1098/rstb.2005.1787; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rundle HD, 2006, EVOLUTION, V60, P2218, DOI 10.1111/j.0014-3820.2006.tb01859.x; RYAN M.J., 1990, OXFORD SURV EVOL BIO, V7, P156; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Sakaluk SK, 2006, AM NAT, V167, P94, DOI 10.1086/498279; Sharp NP, 2008, EVOLUTION, V62, P857, DOI 10.1111/j.1558-5646.2008.00333.x; Shorey HH, 1962, SCIENCE; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; SPIETH HERMAN T., 1952, BULL AMER MUS NAT HIST, V99, P395; Stewart AD, 2008, J EVOLUTION BIOL, V21, P1808, DOI 10.1111/j.1420-9101.2008.01593.x; Stewart AD, 2005, P ROY SOC B-BIOL SCI, V272, P2029, DOI 10.1098/rspb.2005.3182; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Talyn Becky, 2003, Drosophila Information Service, V86, P148; von Schilcher F., 1977, Behavior Genet, V7, P251; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; WHITE FN, 1982, PHYSIOL REV, V62, P40, DOI 10.1152/physrev.1982.62.1.40; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wigby S, 2004, EVOLUTION, V58, P1028; Williams G. C., 1966, P307; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; [No title captured]	76	1	1	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111148	10.1371/journal.pone.0111148	http://dx.doi.org/10.1371/journal.pone.0111148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365209	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100053
J	Chitrala, KN; Yeguvapalli, S				Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha			Computational Prediction and Analysis of Breast Cancer Targets for 6-Methyl-1, 3, 8-Trichlorodibenzofuran	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ESTROGEN; ALPHA; CELLS	Breast cancer is one of the most known cancer types caused to the women around the world. Dioxins on the other hand are a wide range of chemical compounds known to cause the effects on human health. Among them, 6-Methyl-1,3,8-trichlorodibenzofuran ( MCDF) is a relatively non toxic prototypical alkyl polychlorinated dibenzofuran known to act as a highly effective agent for inhibiting hormone-responsive breast cancer growth in animal models. In this study, we have developed a multi-level computational approach to identify possible new breast cancer targets for MCDF. We used PharmMapper Server to predict breast cancer target proteins for MCDF. Search results showed crystal Structure of the Antagonist Form of Glucocorticoid Receptor with highest fit score and AutoLigand analysis showed two potential binding sites, site-A and site-B for MCDF. A molecular docking was performed on these two sites and based on binding energy site-B was selected. MD simulation studies on Glucocorticoid receptor-MCDF complex revealed that MCDF conformation was stable at site-B and the intermolecular interactions were maintained during the course of simulation. In conclusion, our approach couples reverse pharmacophore analysis, molecular docking and molecular dynamics simulations to identify possible new breast cancer targets for MCDF.	[Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha] Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India	Sri Venkateswara University	Yeguvapalli, S (corresponding author), Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India.	ysuneethareddy4@gmail.com	Chitrala, Kumara Swamy Naidu/U-1617-2019; Yeguvapalli, Suneetha/ADT-5493-2022	Chitrala, Kumaraswamy naidu/0000-0003-0663-9529; YEGUVAPALLI, SUNEETHA/0000-0002-3035-7196				BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Castro-Rivera E, 1999, MOL CELL ENDOCRINOL, V150, P11, DOI 10.1016/S0303-7207(99)00041-6; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; Conde I, 2008, HISTOL HISTOPATHOL, V23, P77, DOI 10.14670/HH-23.77; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; Dallakyan S., 2008, PYRX PYTHON PRESCRIP; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Mora-Santos M, 2011, J BIOL CHEM, V286, P30047, DOI 10.1074/jbc.M111.232330; Olivero-Verbel J, 2010, CHEMOSPHERE, V80, P1160, DOI 10.1016/j.chemosphere.2010.06.020; Pearce ST, 2004, CANCER RES, V64, P2889, DOI 10.1158/0008-5472.CAN-03-1770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsutsumi T, 2001, CHEMOSPHERE, V45, P1129, DOI 10.1016/S0045-6535(01)00151-5; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; Walker MK, 2000, COMP BIOCHEM PHYS C, V126, P305, DOI 10.1016/S0742-8413(00)00119-5; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109185	10.1371/journal.pone.0109185	http://dx.doi.org/10.1371/journal.pone.0109185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365309	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100008
J	Xu, XB; Jiang, QH; Ma, XY; Ying, QC; Shen, B; Qian, YS; Song, HM; Wang, HZ				Xu, Xiangbin; Jiang, Qinghua; Ma, Xiuyan; Ying, Qicai; Shen, Bo; Qian, Yongsheng; Song, Hongmiao; Wang, Huizhong			Deep Sequencing Identifies Tissue-Specific MicroRNAs and Their Target Genes Involving in the Biosynthesis of Tanshinones in Salvia miltiorrhiza	PLOS ONE			English	Article							ACID B PROTECTS; ISOPRENOID BIOSYNTHESIS; SMALL RNAS; MEVALONATE PATHWAY; ACETOACETYL-COA; HAIRY ROOTS; ARABIDOPSIS; PLANTS; MIRNAS; BIOGENESIS	Salvia miltiorrhiza is one of the most popular traditional medicinal herbs in Asian nations. Its dried root contains a number of tanshinones, protocatechuic aldehyde, salvianolic acid B and rosmarinic, and is used for the treatment of various diseases. The finding of microRNAs (miRNAs) and their target genes will help understand their biological role on the biosynthesis of tanshinones in S. miltiorrhiza. In the present study, a total of 452 known miRNAs corresponding to 589 precursor miRNAs (pre-miRNAs), and 40 novel miRNAs corresponding to 24 pre-miRNAs were identified in different tissues of S. miltiorrhiza by high-throughput sequencing, respectively. Among them, 62 miRNAs express only in root, 95 miRNAs express only in stem, 19 miRNAs express only in leaf, and 71 miRNAs express only in flower, respectively. By the degradome analysis, 69 targets potentially cleaved by 25 miRNAs were identified. Among them, acetyl-CoA C-acetyltransferase was cleaved by miR5072, and involved in the biosynthesis of tanshinones. This study provided valuable information for understanding the tissue-specific expression patterns of miRNAs in S. miltiorrhiza, and offered a foundation for future studies of the miRNA-mediated biosynthesis of tanshinones.	[Xu, Xiangbin; Jiang, Qinghua; Ma, Xiuyan; Ying, Qicai; Shen, Bo; Qian, Yongsheng; Song, Hongmiao; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Song, HM (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	hmsongibcas@126.com; whz62@163.com	SHEN, BO/GOK-2179-2022	SHEN, BO/0000-0003-0490-2071	Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology [ZK-14]	Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology	This study was supported by the open foundation (ZK-14) of the Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Cao EH, 1996, FREE RADICAL BIO MED, V20, P801, DOI 10.1016/0891-5849(95)02211-2; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HISER L, 1994, J BIOL CHEM, V269, P31383; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang DG, 2004, LIFE SCI, V75, P1801, DOI 10.1016/j.lfs.2004.02.034; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Pereto J, 2005, J MOL EVOL, V61, P65, DOI 10.1007/s00239-004-0280-8; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; THOMPSON SL, 1990, J BIOL CHEM, V265, P5731; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Wu SJ, 2009, BIOTECHNOL APPL BIOC, V52, P89, DOI 10.1042/BA20080004; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; Yan XM, 2009, ACTA PHYSIOL PLANT, V31, P1015, DOI 10.1007/s11738-009-0320-5; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Yuan Y, 2009, Z NATURFORSCH C, V64, P557; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhong GX, 2009, J AGR FOOD CHEM, V57, P6879, DOI 10.1021/jf901462s; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	44	21	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111679	10.1371/journal.pone.0111679	http://dx.doi.org/10.1371/journal.pone.0111679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365305	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100103
J	Coulibaly, M; Meda, N; Yonaba, C; Ouedraogo, S; Congo, M; Barry, M; Thio, E; Siribie, I; Koueta, F; Ye, D; Kam, L; Blanche, S; Van De Perre, P; Leroy, V				Coulibaly, Malik; Meda, Nicolas; Yonaba, Caroline; Ouedraogo, Sylvie; Congo, Malika; Barry, Mamoudou; Thio, Elisabeth; Siribie, Issa; Koueta, Fla; Ye, Diarra; Kam, Ludovic; Blanche, Stephane; Van De Perre, Phillipe; Leroy, Valeriane		MONOD Study Grp ANRS 12206	Missed Opportunities for Early Access to Care of HIV-Infected Infants in Burkina Faso	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SERVICE UTILIZATION; COTE-DIVOIRE; AFRICA; MORTALITY; PREVENTION; DIAGNOSIS; PROGRAM; OUTCOMES	Objective: The World Health Organization (WHO) has recommended a universal antiretroviral therapy (ART) for all HIV-infected children before the age of two since 2010, but this implies an early identification of these infants. We described the Prevention of Mother-to-Child HIV Transmission (PMTCT) cascade, the staffing and the quality of infrastructures in pediatric HIV care facilities, in Ouagadougou, Burkina Faso. Methods: We conducted a cross-sectional survey in 2011 in all health care facilities involved in PMTCT and pediatric HIV care in Ouagadougou. We assessed them according to their coverage in pediatric HIV care and WHO standards, through a desk review of medical registers and a semi-structured questionnaire administered to health-care workers (HCW). Results: In 2011, there was no offer of care in primary health care facilities for HIV-infected children in Ouagadougou. Six district hospitals and two university hospitals provided pediatric HIV care. Among the 67 592 pregnant women attending antenatal clinics in 2011, 85.9% were tested for HIV. The prevalence of HIV was 1.8% (95% Confidence Interval: 1.7%-1.9%). Among the 1 064 HIV-infected pregnant women attending antenatal clinics, 41.4% received a mother-to-child HIV transmission prevention intervention. Among the HIV-exposed infants, 313 (29.4%) had an early infant HIV test, and 306 (97.8%) of these infants tested received their result within a four-month period. Among the 40 children initially tested HIV-infected, 33 (82.5%) were referred to a health care facility, 3 (9.0%) were false positive, and 27 (90.0%) were initiated on ART. Although health care facilities were adequately supplied with HIV drugs, they were hindered by operational challenges such as shortage of infrastructures, laboratory reagents, and trained HCW. Conclusions: The PMTCT cascade revealed bottle necks in PMTCT intervention and HIV early infant diagnosis. The staffing in HIV care and quality of health care infrastructures were also insufficient in 2011 in Ouagadougou.	[Coulibaly, Malik; Meda, Nicolas; Thio, Elisabeth; Siribie, Issa] Univ Ouagadougou, Site ANRS Burkina, Ctr Rech Int Sante, Projet MONOD ANRS 12206, Ouagadougou, Burkina Faso; [Meda, Nicolas] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Yonaba, Caroline; Kam, Ludovic] CHU Yalgado Ouedraogo, Serv Pediat, Ouagadougou, Burkina Faso; [Ouedraogo, Sylvie; Koueta, Fla; Ye, Diarra] CHU Charles Gaulle, Serv Pediat Med, Ouagadougou, Burkina Faso; [Congo, Malika] CHU Yalgado Ouedraogo, Lab Bacteriol Virol, Ouagadougou, Burkina Faso; [Barry, Mamoudou] CHU Charles Gaulle, Lab Serv, Ouagadougou, Burkina Faso; [Blanche, Stephane] Grp Hosp Necker Enfants Malades, Paris, France; [Van De Perre, Phillipe] Univ Montpellier I, INSERM, U1058, Montpellier, France; [Leroy, Valeriane] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev ISPED, INSERM, U897, Bordeaux, France	Centre Muraz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Coulibaly, M (corresponding author), Univ Ouagadougou, Site ANRS Burkina, Ctr Rech Int Sante, Projet MONOD ANRS 12206, Ouagadougou, Burkina Faso.	coulmalik@yahoo.fr	Leroy, Valeriane/GQB-1102-2022; Van de Perre, Philippe/B-9692-2008; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/AAO-5175-2020; treluyer, Jean-Marc/F-8036-2010; Anglaret, Xavier/F-7333-2013; Urien, Saïk/G-3240-2013	Leroy, Valeriane/0000-0003-3542-8616; Van de Perre, Philippe/0000-0002-3912-0427; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Urien, Saïk/0000-0002-1065-0600; Odette, Ky-Zerbo/0000-0002-0018-1580; Moussa, OUEDRAOGO/0000-0002-3534-8301; Anglaret, Xavier/0000-0003-3319-8423; Seguin-Devaux, Carole/0000-0003-0636-5222	MONOD ANRS - European and Developing Countries Clinical Trial Partnership (EDCTP) [12206]; CRP-sante in Luxembourg; French ANRS-Inserm; MONOD consortium	MONOD ANRS - European and Developing Countries Clinical Trial Partnership (EDCTP); CRP-sante in Luxembourg; French ANRS-Inserm; MONOD consortium	The study was supported in part by the MONOD ANRS 12206 project granted by the European and Developing Countries Clinical Trial Partnership (EDCTP), the CRP-sante in Luxembourg and the French ANRS-Inserm. Dr. Malik Coulibaly is a fellow PhD candidate of the Doctoral School of Society, Politics and Public Health, Bordeaux, France funded by the MONOD consortium. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2013, JAIDS-J ACQ IMM DEF, V62, pE7, DOI 10.1097/QAI.0b013e3182706401; Bland RM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f550; Brou H, 2008, AIDS CARE, V20, P413, DOI 10.1080/09540120701867065; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; Desmonde S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-182; Folquet-Amonissani M, 2012, IVORY COAST 2011; Forthofer R. N., 2006, BIOSTATISTICS GUIDE; Goetghebuer T, 2012, CLIN INFECT DIS, V54, P878, DOI 10.1093/cid/cir950; Institut National de la Statistique et de la Demographie Burkina Faso, 2011, REG CTR CHIFFR; Institut National de la Statistique et de la Demographie Burkina Faso, 2013, TABLEAU 05 34 EVOLUT; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; Ministere de l'Economie et des Finances Burkina Faso, 2011, ENQ DEM SANT IND MUL; Ministere de la Sante Comite Ministeriel de Lutte contre le SIDA Burkina Faso, 2008, NORM PROT PRIS CHARG; Ministere de la Sante du Burkina Faso, 2011, ANN STAT 2010; Ministere Sante-Burkina Faso, 2012, ANN STAT 2011; Ndondoki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067996; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Nielsen K, 2000, PEDIATR CLIN N AM, V47, P39, DOI 10.1016/S0031-3955(05)70194-2; Nigatu T, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-6; Oga MA, 2011, JAIDS-J ACQ IMM DEF, V57, pS16, DOI 10.1097/QAI.0b013e31821fd487; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Tchidjou HK, 2012, J TROP PEDIATRICS, V58, P451, DOI 10.1093/tropej/fms015; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; Van Rompaey S, 2011, AIDS CARE, V23, P686, DOI 10.1080/09540121.2010.532538; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2014, MARCH 2014 S 2013 CO; World Health Organization, 2008, OP MAN DEL HIV PREV; World Health Organization, 2010, WHO REC DIAGN HIV IN; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	35	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111240	10.1371/journal.pone.0111240	http://dx.doi.org/10.1371/journal.pone.0111240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360551	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700077
J	Ernstbrunner, M; Kostner, L; Kimberger, O; Wabel, P; Saemann, M; Markstaller, K; Fleischmann, E; Kabon, B; Hecking, M				Ernstbrunner, Matthaeus; Kostner, Lisa; Kimberger, Oliver; Wabel, Peter; Saeemann, Marcus; Markstaller, Klaus; Fleischmann, Edith; Kabon, Barbara; Hecking, Manfred			Bioimpedance Spectroscopy for Assessment of Volume Status in Patients before and after General Anaesthesia	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; MAJOR ABDOMINAL-SURGERY; HEMODIALYSIS-PATIENTS; DILUTION METHODS; FLUID BALANCE; EXCESS FLUID; BODY; TISSUE; OPTIMIZATION	Background: Technically assisted assessment of volume status before surgery may be useful to direct intraoperative fluid administration. We therefore tested a recently developed whole-body bioimpedance spectroscopy device to determine pre-to postoperative fluid distribution. Methods: Using a three-compartment physiologic tissue model, the body composition monitor (BCM, Fresenius Medical Care, Germany) measures total body fluid volume, extracellular volume, intracellular volume and fluid overload as surplus or deficit of 'normal' extracellular volume. BCM-measurements were performed before and after standardized general anaesthesia for gynaecological procedures (laparotomies, laparoscopies and vaginal surgeries). BCM results were blinded to the attending anaesthesiologist and data analysed using the 2-sided, paired Student's t-test and multiple linear regression. Results: In 71 females aged 45 +/- 15 years with body weight 67 +/- 13 kg and duration of anaesthesia 154 +/- 68 min, pre-to postoperative fluid overload increased from -0.7 +/- 1.1 L to 0.1 +/- 1.0 L, corresponding to 25.1 +/- 7.5% and 0.8 +/- 6.7% of normal extracellular volume, respectively (both p<0.001), after patients had received 1.9 +/- 0.9 L intravenous crystalloid fluid. Perioperative urinary excretion was 0.4 +/- 0.3 L. The increase in extracellular volume was paralleled by an increase in total body fluid volume, while intracellular volume increased only slightly and without reaching statistical significance (p = 0.15). Net perioperative fluid balance (administered fluid volume minus urinary excretion) was significantly associated with change in extracellular volume (r(2) = 0.65), but was not associated with change in intracellular volume (r(2) = 0.01). Conclusions: Routine intraoperative fluid administration results in a significant, and clinically meaningful increase in the extracellular compartment. BCM-measurements yielded plausible results and may become useful to guide intraoperative fluid therapy in future studies.	[Ernstbrunner, Matthaeus; Kostner, Lisa; Kimberger, Oliver; Markstaller, Klaus; Fleischmann, Edith; Kabon, Barbara; Hecking, Manfred] Med Univ Vienna, Dept Anaesthesiol & Crit Care Med, Vienna, Austria; [Wabel, Peter] Fresenius Med Care, Bad Homburg, Germany; [Saeemann, Marcus; Hecking, Manfred] Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hecking, M (corresponding author), Med Univ Vienna, Dept Anaesthesiol & Crit Care Med, Vienna, Austria.	manfred.hecking@meduniwien.ac.at	Hecking/AAK-7399-2021	Kimberger, Oliver/0000-0002-9766-1360; Kabon, Barbara/0000-0002-9269-4657; Hecking, Manfred/0000-0002-8047-2395				[Anonymous], 2010, MILLERS ANESTHESIA; [Anonymous], 2012, US MAN FRESN MED CAR; Bracco D, 1998, CRIT CARE MED, V26, P1065, DOI 10.1097/00003246-199806000-00029; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Cagini L, 2011, EUR J CARDIO-THORAC, V40, pE71, DOI 10.1016/j.ejcts.2011.03.030; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; COLE KS, 1969, EXP NEUROL, V24, P459, DOI 10.1016/0014-4886(69)90149-6; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S1; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Doherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171; Elliott S, 1998, EUR J ANAESTH, V15, P50, DOI 10.1097/00003643-199801000-00010; FLECK A, 1985, LANCET, V1, P781; Forbes GB, 1987, TECHNIQUES ESTIMATIN; Frumento RJ B-GE, 2003, PERIOPERATIVE ORGAN, P1; Gulec B, 2006, ANZ J SURG, V76, P904, DOI 10.1111/j.1445-2197.2006.03906.x; Hecking M, 2013, AM J NEPHROL, V38, P78, DOI 10.1159/000353104; Holte K, 2003, ANESTH ANALG, V96, P1504, DOI 10.1213/01.ANE.0000055820.56129.EE; Holte K, 2006, J AM COLL SURGEONS, V202, P971, DOI 10.1016/j.jamcollsurg.2006.01.003; Itobi E, 2006, BRIT J SURG, V93, P354, DOI 10.1002/bjs.5259; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lang K, 2001, ANESTH ANALG, V93, P405, DOI 10.1097/00000539-200108000-00034; LJUNGGREN H, 1957, Acta Endocrinol Suppl (Copenh), V25, P1; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; LOWELL JA, 1990, CRIT CARE MED, V18, P728, DOI 10.1097/00003246-199007000-00010; Lyons FM, 1997, INT ANESTHESIOL CLIN, V35, P1, DOI 10.1097/00004311-199703540-00002; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Moissl U, 2008, NDT PLUS S2, V1, P215; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Moller AM, 2002, EUR J ANAESTH, V19, P57, DOI 10.1017/S0265021502000091; Morgan GEM, 2005, FLUID MANAGEMENT TRA; MORSE WI, 1963, METABOLISM, V12, P99; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Passauer J, 2010, NEPHROL DIAL TRANSPL, V25, P545, DOI 10.1093/ndt/gfp517; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Piccoli A, 2014, KIDNEY INT, V85, P738, DOI 10.1038/ki.2013.434; Raimann JG, 2014, KIDNEY INT, V85, P898, DOI 10.1038/ki.2013.358; Rasmussen L A, 1996, Ugeskr Laeger, V158, P5286; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Sheeran P, 1997, BRIT J ANAESTH, V78, P201, DOI 10.1093/bja/78.2.201; Sinclair S, 1997, BMJ-BRIT MED J, V315, P909; Smith TPC, 2009, BODY FLUIDS FUNDAMEN; Tatara T, 1998, CRIT CARE MED, V26, P470, DOI 10.1097/00003246-199803000-00017; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082566; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2007, NEPHROL DIAL TRAN S6, V22, pVI129; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; WANG J, 1976, J NUTR, V106, P1687, DOI 10.1093/jn/106.12.1687; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707	51	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111139	10.1371/journal.pone.0111139	http://dx.doi.org/10.1371/journal.pone.0111139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360698	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700065
J	Jacobs, S; Cui, ZZ; Feng, RB; Wang, HM; Wang, DH; Tsien, JZ				Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Wang, Huimin; Wang, Deheng; Tsien, Joe Z.			Molecular and Genetic Determinants of the NMDA Receptor for Superior Learning and Memory Functions	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; NR2B TRANSGENIC MICE; MOTOR PROTEIN KIF17; SYNAPTIC PLASTICITY; BRAIN MAGNESIUM; ION CHANNELS; HIPPOCAMPAL; DEPRESSION; RAT	The opening-duration of the NMDA receptors implements Hebb's synaptic coincidence-detection and is long thought to be the rate-limiting factor underlying superior memory. Here, we investigate the molecular and genetic determinants of the NMDA receptors by testing the "synaptic coincidence-detection time-duration" hypothesis vs. "GluN2B intracellular signaling domain" hypothesis. Accordingly, we generated a series of GluN2A, GluN2B, and GluN2D chimeric subunit transgenic mice in which C-terminal intracellular domains were systematically swapped and overexpressed in the forebrain excitatory neurons. The data presented in the present study supports the second hypothesis, the "GluN2B intracellular signaling domain" hypothesis. Surprisingly, we found that the voltage-gated channel opening-durations through either GluN2A or GluN2B are sufficient and their temporal differences are marginal. In contrast, the C-terminal intracellular domain of the GluN2B subunit is necessary and sufficient for superior performances in long-term novel object recognition and cued fear memories and superior flexibility in fear extinction. Intriguingly, memory enhancement correlates with enhanced long-term potentiation in the 10-100 Hz range while requiring intact long-term depression capacity at the 1-5 Hz range.	[Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30901 USA; [Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Wang, Huimin] E China Normal Univ, Shanghai Inst Funct Gen, Shanghai 200062, Peoples R China; [Wang, Deheng] Banna Biomed Res Inst, Xi Shuang Ban Na Prefect, Yunnan, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; East China Normal University	Tsien, JZ (corresponding author), Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30901 USA.	jtsien@gru.edu	wang, huimin/HDM-8421-2022	Wang, Deheng/0000-0001-7979-9756	National Institute of Mental Health [MH060236]; National Institute on Aging [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025918, R01AG024022, R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute of Mental Health (MH060236), National Institute on Aging (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2013, BEHAV PHARMACOL, V24, P255, DOI 10.1097/FBP.0b013e32836357c7; Abumaria N, 2011, J NEUROSCI, V31, P14871, DOI 10.1523/JNEUROSCI.3782-11.2011; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Clayton DA, 2002, J NEUROSCI, V22, P3628; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Cui ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01036; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cyranoski D, 2012, NATURE NEWS; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; FALLS WA, 1992, J NEUROSCI, V12, P854; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Gerkin RC, 2007, J NEUROPHYSIOL, V97, P2851, DOI 10.1152/jn.00860.2006; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Jacobs SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036387; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kennedy PR, 1997, BRAIN RES, V760, P251, DOI 10.1016/S0006-8993(97)00051-6; Kohr G, 2003, J NEUROSCI, V23, P10791; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Liu HN, 2004, J NEUROPHYSIOL, V92, P1077, DOI 10.1152/jn.00602.2003; LYNCH MA, 1983, NATURE, V303, P175, DOI 10.1038/303175a0; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Punnakkal P, 2012, NEUROPHARMACOLOGY, V62, P1985, DOI 10.1016/j.neuropharm.2011.12.018; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shipton OA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0163; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stevens CF, 1998, CURR BIOL, V8, pR151, DOI 10.1016/S0960-9822(98)70097-1; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Zhang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079454; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018	73	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111865	10.1371/journal.pone.0111865	http://dx.doi.org/10.1371/journal.pone.0111865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360708	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700157
J	Jia, ZY; Yi, Y; Liu, JH; Cao, JY; Zhang, Y; Tian, RG; Yu, T; Wang, H; Wang, XY; Su, QD; Zhou, WT; Cui, FQ; Liang, XF; Bi, SL				Jia, Zhiyuan; Yi, Yao; Liu, Jianhua; Cao, Jingyuan; Zhang, Yong; Tian, Ruiguang; Yu, Tao; Wang, Hao; Wang, Xinying; Su, Qiudong; Zhou, Wenting; Cui, Fuqiang; Liang, Xiaofeng; Bi, Shengli			Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006	PLOS ONE			English	Article							GENERAL-POPULATION; E VACCINE; SEROPREVALENCE; ANTIBODIES; INFECTION; JAPAN; SEROEPIDEMIOLOGY; ANIMALS; HUMANS; INDIA	In China, hepatitis E virus (HEV) is prevalent and causes disease, but its epidemiological profile is not well understood. We used a commercial enzyme-linked immunosorbent assay to detect total antibodies to hepatitis E virus in 15,862 serum samples collected during the Third National Viral Hepatitis Prevalence Survey. The results were analyzed to calculate estimates of HEV seroprevalence and to examine the effects of some putative risk factors. The seroprevalence of HEV in the general Chinese population during the period from 2005 through 2006 was 23.46% (95% confidence interval [CI], 18.41%-28.50%). The farming population, the age group of 15-60 year olds, and those living in the Midwest or Mideast region and in Xinjiang province had the highest seroprevalence estimates. The prevalence of HEV is high in China. The seroprevalence rate of HEV shows an unbalanced distribution among areas with different geographic location and economic development levels. The characteristics of the distribution associated may be due to the route of HEV transmission (via contaminated water or animal reservoirs). Within the same region, the seroprevalence of HEV is generally increased with age.	[Jia, Zhiyuan; Yi, Yao; Cao, Jingyuan; Zhang, Yong; Tian, Ruiguang; Yu, Tao; Wang, Hao; Wang, Xinying; Su, Qiudong; Zhou, Wenting; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Virol Dis Control & Prevent, Beijing, Peoples R China; [Liu, Jianhua] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Cui, Fuqiang; Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Virol Dis Control & Prevent, Beijing, Peoples R China.	jiazy@chinacdc.cn		Wang, Hao/0000-0001-9425-4666; Bi, Shengli/0000-0002-0380-5790; Wang, Hao/0000-0001-7988-6120	China Centers for Disease Control and Prevention; China Ministry of Health; Ministry of Science and Technology [2004BA718B01]	China Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); China Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the China Centers for Disease Control and Prevention, China Ministry of Health and Ministry of Science and Technology (NO: 2004BA718B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, HEPATOL INT, V2, P308, DOI 10.1007/s12072-008-9071-4; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; Bawazir AA, 2010, T ROY SOC TROP MED H, V104, P801, DOI 10.1016/j.trstmh.2010.08.007; Cai JL, 2010, J TROPICAL MED, V10, P90; Chiu DMY, 2013, J MED VIROL, V85, P459, DOI 10.1002/jmv.23429; El-Tras WF, 2013, ZOONOSES PUBLIC HLTH, V60, P244, DOI 10.1111/j.1863-2378.2012.01516.x; Emerson SU, 2006, HEPATITIS E VIRUS FI, P3047; Faramawi MF, 2011, EPIDEMIOL INFECT, V139, P1145, DOI 10.1017/S0950268810002177; Fogeda M, 2012, J MED VIROL, V84, P71, DOI 10.1002/jmv.22270; Geng JB, 2012, WORLD J GASTROENTERO, V18, P965, DOI 10.3748/wjg.v18.i9.965; GQea Zhicheng Dai, 1997, VIRAL HEPATITIS CHIN; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111; Krumbholz A, 2012, MED MICROBIOL IMMUN, V201, P239, DOI 10.1007/s00430-011-0210-5; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2009, AM J TROP MED HYG, V81, P875, DOI 10.4269/ajtmh.2009.09-0352; Li K, 2002, CHINESE MED J-PEKING, V115, P1058; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li WG, 2011, ARCH VIROL, V156, P1989, DOI 10.1007/s00705-011-1089-6; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Majumdar M, 2013, J MED VIROL, V85, P823, DOI 10.1002/jmv.23529; Meader E, 2010, ZOONOSES PUBLIC HLTH, V57, P504, DOI 10.1111/j.1863-2378.2009.01254.x; Mohebbi SR, 2012, T ROY SOC TROP MED H, V106, P528, DOI 10.1016/j.trstmh.2012.05.013; Villalba MCM, 2010, T ROY SOC TROP MED H, V104, P772, DOI 10.1016/j.trstmh.2010.08.006; Romano L, 2011, J HEPATOL, V54, P34, DOI 10.1016/j.jhep.2010.06.017; Scotto G, 2013, J MED VIROL, V85, P261, DOI 10.1002/jmv.23400; Takahashi M, 2010, J MED VIROL, V82, P271, DOI 10.1002/jmv.21678; Taniguchi M, 2009, J INFECTION, V58, P232, DOI 10.1016/j.jinf.2009.01.011; Verhoef L, 2012, EPIDEMIOL INFECT, V140, P1838, DOI 10.1017/S0950268811002913; Vivek R, 2010, T ROY SOC TROP MED H, V104, P307, DOI 10.1016/j.trstmh.2009.07.017; Wu T, 2012, HUM VACC IMMUNOTHER, V8, P823, DOI 10.4161/hv.20042; XU ZY, 1992, VACCINE, V10, pS67, DOI 10.1016/0264-410X(92)90547-W; Xue-feng ZJ, 2008, ACTA U MED NANJING N, V3, P360; Yan J, 2012, HEPATOL RES, V42, P974, DOI 10.1111/j.1872-034X.2012.01009.x; Yao G B, 1989, Zhonghua Yi Xue Za Zhi, V69, P113; Yu YH, 2009, INFECT GENET EVOL, V9, P554, DOI 10.1016/j.meegid.2009.02.008; Zhang J, 2013, CLIN MICROBIOL INFEC; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; ZHUANG H, 1991, GASTROENTEROL JPN, V26, P135	43	32	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110837	10.1371/journal.pone.0110837	http://dx.doi.org/10.1371/journal.pone.0110837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360522	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700049
J	Kubota, H; Sakai, T; Gawad, A; Makino, H; Akiyama, T; Ishikawa, E; Oishi, K				Kubota, Hiroyuki; Sakai, Takafumi; Gawad, Agata; Makino, Hiroshi; Akiyama, Takuya; Ishikawa, Eiji; Oishi, Kenji			Development of TaqMan-Based Quantitative PCR for Sensitive and Selective Detection of Toxigenic Clostridium difficile in Human Stools	PLOS ONE			English	Article							TERM-CARE FACILITIES; REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; RIBOSOMAL-RNA MOLECULES; TOXIN-B GENE; RAPID DETECTION; DIARRHEA; CULTURE; INFECTION; STRAINS	Background: Clostridium difficile is the main cause of nosocomial diarrhea, but is also found in asymptomatic subjects that are potentially involved in transmission of C. difficile infection. A sensitive and accurate detection method of C. difficile, especially toxigenic strains is indispensable for the epidemiological investigation. Methods: TaqMan-based quantitative-PCR (qPCR) method for targeting 16S rRNA, tcdB, and tcdA genes of C. difficile was developed. The detection limit and accuracy of qPCR were evaluated by analyzing stool samples spiked with known amounts of C. difficile. A total of 235 stool specimens collected from 82 elderly nursing home residents were examined by qPCR, and the validity was evaluated by comparing the detection result with that by C. difficile selective culture (CDSC). Results: The analysis of C. difficile-spiked stools confirmed that qPCR quantified whole C. difficile (TcdA(+)TcdB(+), TcdA(-)TcdB(+), and TcdA(-)TcdB(-) types), TcdB-producing strains (TcdA(+)TcdB(+) and TcdA(-)TcdB(+) types), and TcdA-producing strains (TcdA(+)TcdB(+) type), respectively, with a lower detection limit of 10(3) cells/g of stool. Of the 235 specimens examined, 12 specimens (5.1%) were C. difficile-positive by qPCR: TcdA(+)TcdB(+) strain in six specimens and TcdA(-)TcdB(-) strain in the other six. CDSC detected C. difficile in 9 of the 12 specimens, and toxigenic types of the isolates from the 9 specimens were consistent with those identified by qPCR, supporting the validity of our qPCR method. Moreover, the qPCR examination revealed that the carriage rate of whole C. difficile and that of toxigenic strains in the 82 subjects over a 6-month period ranged from 2.4 to 6.8% and 1.2 to 3.8%, respectively. An average qPCR count of C. difficile detected was 10(4.5) cells/g of stool, suggesting that C. difficile constituted a very small fraction of intestinal microbiota. Conclusion: Our qPCR method should be an effective tool for both clinical diagnosis and epidemiological investigation of C. difficile.	[Kubota, Hiroyuki; Gawad, Agata; Akiyama, Takuya; Oishi, Kenji] Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium; [Kubota, Hiroyuki; Sakai, Takafumi; Makino, Hiroshi; Akiyama, Takuya; Ishikawa, Eiji; Oishi, Kenji] Yakult Cent Inst, Tokyo, Japan	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited	Kubota, H (corresponding author), Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium.	hiroyuki.kubota@yher.be		Ishikawa, Eiji/0000-0002-4179-9010	Yakult Honsha European Research Center for Microbiology ESV	Yakult Honsha European Research Center for Microbiology ESV	This work was funded by Yakult Honsha European Research Center for Microbiology ESV (http://institute.yakult.co.jp/english/about/labo/). The funder provided support in the form of salaries for authors [HK, TS, AG, HM, TA, EI, KO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso R, 1999, J HOSP INFECT, V41, P145, DOI 10.1016/S0195-6701(99)90052-X; Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; Belanger SD, 2003, J CLIN MICROBIOL, V41, P730, DOI 10.1128/JCM.41.2.730-734.2003; Dionne LL, 2013, J CLIN MICROBIOL, V51, P3624, DOI 10.1128/JCM.01444-13; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Guilbault C, 2002, J CLIN MICROBIOL, V40, P2288, DOI 10.1128/JCM.40.6.2288-2290.2002; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Huang HH, 2009, J CLIN MICROBIOL, V47, P3729, DOI 10.1128/JCM.01280-09; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Makris AT, 2007, J AM MED DIR ASSOC, V8, P290, DOI 10.1016/j.jamda.2007.01.098; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Pancholi P, 2012, J CLIN MICROBIOL, V50, P1331, DOI 10.1128/JCM.06597-11; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; Pituch H, 2005, J MED MICROBIOL, V54, P143, DOI 10.1099/jmm.0.45799-0; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Sambol SP, 2000, INFECT IMMUN, V68, P5480, DOI 10.1128/IAI.68.10.5480-5487.2000; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; Simor AE, 2010, J AM GERIATR SOC, V58, P1556, DOI 10.1111/j.1532-5415.2010.02958.x; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Wren M, 2010, METHODS MOL BIOL, V646, P39, DOI 10.1007/978-1-60327-365-7_3	35	16	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111684	10.1371/journal.pone.0111684	http://dx.doi.org/10.1371/journal.pone.0111684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360662	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943700142
J	Li, X; Yang, Q; Dierckens, K; Milton, DL; Defoirdt, T				Li, Xuan; Yang, Qian; Dierckens, Kristof; Milton, Debra L.; Defoirdt, Tom			RpoS and Indole Signaling Control the Virulence of Vibrio anguillarum towards Gnotobiotic Sea Bass (Dicentrarchus labrax) Larvae	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; CHALLENGE TEST; FISH; IDENTIFICATION; TRYPTOPHANASE; REQUIRES; HOST; BIOSYNTHESIS; PREVENTION	Quorum sensing, bacterial cell-to-cell communication with small signal molecules, controls the virulence of many pathogens. In contrast to other vibrios, neither the VanI/VanR acylhomoserine lactone quorum sensing system, nor the three-channel quorum sensing system affects virulence of the economically important aquatic pathogen Vibrio anguillarum. Indole is another molecule that recently gained attention as a putative signal molecule. The data presented in this study indicate that indole signaling and the alternative sigma factor RpoS have a significant impact on the virulence of V. anguillarum. Deletion of rpoS resulted in increased expression of the indole biosynthesis gene tnaA and in increased production of indole. Both rpoS deletion and the addition of exogenous indole (50-100 mu M) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene wbfD. Further, indole inhibitors increased the virulence of the rpoS deletion mutant, suggesting that indole acts downstream of RpoS. Finally, in addition to the phenotypes found to be affected by indole, the rpoS deletion mutant also showed increased motility and decreased sensitivity to oxidative stress.	[Li, Xuan; Yang, Qian; Dierckens, Kristof; Defoirdt, Tom] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Li, Xuan; Yang, Qian; Dierckens, Kristof; Defoirdt, Tom] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Milton, Debra L.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Defoirdt, Tom] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Umea University; Ghent University	Defoirdt, T (corresponding author), Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium.	Tom.Defoirdt@UGent.be	Defoirdt, Tom/A-5120-2009; dierckens, kristof/GWM-4184-2022	Defoirdt, Tom/0000-0002-7446-2246; Yang, Qian/0000-0001-9538-936X	Scientific Research Fund of Flanders (FWO-Vlaanderen) [1.5.013.12N]; Ghent University (GOA) [BOF12/GOA/022]; China Scholarship Council; Ghent University	Scientific Research Fund of Flanders (FWO-Vlaanderen)(FWO); Ghent University (GOA)(Ghent University); China Scholarship Council(China Scholarship Council); Ghent University(Ghent University)	This work was financially supported by the Scientific Research Fund of Flanders (FWO-Vlaanderen project n o 1.5.013.12N) and the Special Research Fund of Ghent University (GOA project n o BOF12/GOA/022). XL and QY are doctoral researchers funded by a China Scholarship Council grant and a Special Research Grant (BOF-UGent) of Ghent University. TD is a postdoctoral fellow of FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Austin B., 2012, BACTERIAL FISH PATHO; Bansal T, 2009, P NATL ACAD SCI; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; CROSA JH, 1980, NATURE, V284, P566, DOI 10.1038/284566a0; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Defoirdt T, 2013, ANTIMICROB AGENTS CH, V57, P2870, DOI 10.1128/AAC.00401-13; Dierckens K, 2009, ENVIRON MICROBIOL, V11, P526, DOI 10.1111/j.1462-2920.2008.01794.x; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P648, DOI 10.1074/mcp.M600191-MCP200; Li X, 2014, DIS AQUAT ORGAN, V108, P211, DOI 10.3354/dao02722; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2009, FEMS MICROBIOL ECOL, V70, P286, DOI 10.1111/j.1574-6941.2009.00713.x; McGee K, 1996, J BACTERIOL, V178, P5188, DOI 10.1128/jb.178.17.5188-5198.1996; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Natrah FMI, 2011, VET MICROBIOL, V154, P124, DOI 10.1016/j.vetmic.2011.06.024; NEWTON WA, 1965, J BACTERIOL, V89, P355, DOI 10.1128/JB.89.2.355-364.1965; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Scherzer R, 2009, J ENZYM INHIB MED CH, V24, P350, DOI [10.1080/14756360802187612, 10.1080/14756360802187612 ]; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080604; Stork M, 2007, J BACTERIOL, V189, P3479, DOI 10.1128/JB.00619-06; Wang X, 2011, FISH SHELLFISH IMMUN, V30, P944, DOI 10.1016/j.fsi.2011.01.019; Weber B, 2008, MICROBIOL-SGM, V154, P767, DOI 10.1099/mic.0.2007/014167-0; Yang H, 2007, FEMS MICROBIOL LETT, V267, P56, DOI 10.1111/j.1574-6968.2006.00533.x	33	29	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111801	10.1371/journal.pone.0111801	http://dx.doi.org/10.1371/journal.pone.0111801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360804	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700152
J	Lieberman, LA; Tsokos, GC				Lieberman, Linda A.; Tsokos, George C.			Lupus-Prone Mice Fail to Raise Antigen-Specific T Cell Responses to Intracellular Infection	PLOS ONE			English	Article							TOXOPLASMA-GONDII; IFN-GAMMA; ERYTHEMATOSUS; INTERFERON; AUTOIMMUNITY; INTERLEUKIN-12; POLYMORPHISMS; MORTALITY; BLOCKADE; VAL14MET	Systemic lupus erythematosus (SLE) is characterized by multiple cellular abnormalities culminating in the production of autoantibodies and immune complexes, resulting in tissue inflammation and organ damage. Besides active disease, the main cause of morbidity and mortality in SLE patients is infections, including those from opportunistic pathogens. To understand the failure of the immune system to fend off infections in systemic autoimmunity, we infected the lupus-prone murine strains B6.lpr and BXSB with the intracellular parasite Toxoplasma gondii and survival was monitored. Furthermore, mice were sacrificed days post infection and parasite burden and cellular immune responses such as cytokine production and cell activation were assessed. Mice from both strains succumbed to infection acutely and we observed greater susceptibility to infection in older mice. Increased parasite burden and a defective antigen-specific IFN-gamma response were observed in the lupus-prone mice. Furthermore, T cell: dendritic cell co-cultures established the presence of an intrinsic T cell defect responsible for the decreased antigen-specific response. An antigen-specific defect in IFN-gamma production prevents lupus-prone mice from clearing infection effectively. This study reveals the first cellular insight into the origin of increased susceptibility to infections in SLE disease and may guide therapeutic approaches.	[Lieberman, Linda A.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02138 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	National Institutes of Health - NIH [AI049954]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049954, R01AI049954] Funding Source: NIH RePORTER	National Institutes of Health - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health - NIH AI049954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chen M, 2004, INT IMMUNOL, V16, P937, DOI 10.1093/intimm/dxh095; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Goldblatt F, 2009, LUPUS, V18, P682, DOI 10.1177/0961203308101019; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Iliopoulos AG, 1996, SEMIN ARTHRITIS RHEU, V25, P318, DOI 10.1016/S0049-0172(96)80018-7; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Maddur MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001077; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nakashima H, 1999, FEBS LETT, V453, P187, DOI 10.1016/S0014-5793(99)00701-2; NICKELL SP, 1985, PARASITE IMMUNOL, V7, P377, DOI 10.1111/j.1365-3024.1985.tb00084.x; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; SHARMA SD, 1983, J IMMUNOL, V131, P977; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tanaka Y, 1999, IMMUNOGENETICS, V49, P266, DOI 10.1007/s002510050492; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Tucci M, 2008, CLIN EXP IMMUNOL, V154, P247, DOI 10.1111/j.1365-2249.2008.03758.x; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WILCOX MH, 1990, ANN RHEUM DIS, V49, P254, DOI 10.1136/ard.49.4.254; Yao X, 2007, ARCH DERMATOL RES, V299, P367, DOI 10.1007/s00403-007-0741-1; Zamir D, 1999, MAYO CLIN PROC, V74, P575, DOI 10.4065/74.6.575	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111382	10.1371/journal.pone.0111382	http://dx.doi.org/10.1371/journal.pone.0111382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360768	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700096
J	Madkhali, AM; Alkurbi, MO; Szestak, T; Bengtsson, A; Patil, PR; Wu, Y; Alharthi, S; Jensen, ATR; Pleass, R; Craig, AG				Madkhali, Aymen M.; Alkurbi, Mohammed O.; Szestak, Tadge; Bengtsson, Anja; Patil, Pradeep R.; Wu, Yang; Alharthi, Saeed; Jensen, Anja T. R.; Pleass, Richard; Craig, Alister G.			An Analysis of the Binding Characteristics of a Panel of Recently Selected ICAM-1 Binding Plasmodium falciparum Patient Isolates	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; N-TERMINAL DOMAIN; INFECTED ERYTHROCYTES; SEVERE MALARIA; ENDOTHELIAL ACTIVATION; CEREBRAL MALARIA; IN-VITRO; RECEPTOR; CD36; CYTOADHERENCE	The basis of severe malaria pathogenesis in part includes sequestration of Plasmodium falciparum-infected erythrocytes (IE) from the peripheral circulation. This phenomenon is mediated by the interaction between several endothelial receptors and one of the main parasite-derived variant antigens (PfEMP1) expressed on the surface of the infected erythrocyte membrane. One of the commonly used host receptors is ICAM-1, and it has been suggested that ICAM-1 has a role in cerebral malaria pathology, although the evidence to support this is not conclusive. The current study examined the cytoadherence patterns of lab-adapted patient isolates after selecting on ICAM-1. We investigated the binding phenotypes using variant ICAM-1 proteins including ICAM-1(Ref), ICAM-1(Kilifi), ICAM-1(S22/A), ICAM-1(L42/A) and ICAM-1(L44/A) using static assays. The study also examined ICAM-1 blocking by four anti-ICAM-1 monoclonal antibodies (mAb) under static conditions. We also characterised the binding phenotypes using Human Dermal Microvascular Endothelial Cells (HDMEC) under flow conditions. The results show that different isolates have variant-specific binding phenotypes under both static and flow conditions, extending our previous observations that this variation might be due to variable contact residues on ICAM-1 being used by different parasite PfEMP1 variants.	[Madkhali, Aymen M.; Alkurbi, Mohammed O.; Szestak, Tadge; Patil, Pradeep R.; Wu, Yang; Pleass, Richard; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Madkhali, Aymen M.] Jazan Univ, Coll Appl Med Sci, Dept Med Labs Technol, Jazan, Saudi Arabia; [Alkurbi, Mohammed O.; Alharthi, Saeed] Umm Al Qura Univ, Coll Appl Med Sci, Dept Lab Med, Makkah Al Mukarramah, Saudi Arabia; [Bengtsson, Anja; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	Liverpool School of Tropical Medicine; University of Liverpool; Jazan University; Umm Al Qura University; University of Copenhagen	Craig, AG (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.	alister.craig@lstmed.ac.uk	Pleass, Richard J/L-4148-2015; Madkhali, Aymen/AAC-5660-2021; Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Jensen, Anja Ramstedt/AAL-3119-2021; Pleass, Richard/N-7831-2019	Pleass, Richard J/0000-0001-7438-8296; Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Jensen, Anja Ramstedt/0000-0002-4004-7554; Pleass, Richard/0000-0001-7438-8296; Craig, Alister/0000-0003-0914-6164; Bengtsson, Anja/0000-0001-9523-8369	Wellcome Trust [095507]; Jazan University, Saudi Arabia; Medical Research Council [G0400417, MC_PC_12017] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0006249] Funding Source: researchfish; MRC [G0400417, MC_PC_12017] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Jazan University, Saudi Arabia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust (Ref 095507) and Jazan University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Brown A, 2013, J BIOL CHEM, V288, P5992, DOI 10.1074/jbc.M112.416347; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chilongola J, 2009, TROP MED INT HEALTH, V14, P810, DOI 10.1111/j.1365-3156.2009.02298.x; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Cortes A, 2005, MOL BIOCHEM PARASIT, V142, P252, DOI 10.1016/j.molbiopara.2005.03.016; Davis SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003590; Dormeyer M, 2006, ANTIMICROB AGENTS CH, V50, P724, DOI 10.1128/AAC.50.2.724-730.2006; Esser C, 2014, CELL MICROBIOL, V16, P701, DOI 10.1111/cmi.12270; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Gray C, 2002, INFECT IMMUN, V70, P3962, DOI 10.1128/IAI.70.7.3962-3964.2002; GREENWALT DE, 1992, BLOOD, V80, P1105; Gullingsrud J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061323; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Patil PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-348; Poyomtip T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-7; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traub S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003520; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004	57	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111518	10.1371/journal.pone.0111518	http://dx.doi.org/10.1371/journal.pone.0111518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360558	Green Published, gold, Green Accepted			2022-12-26	WOS:000343943700112
J	Martinez-Nunez, RT; Bondanese, VP; Louafi, F; Francisco-Garcia, AS; Rupani, H; Bedke, N; Holgate, S; Howarth, PH; Davies, DE; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Bondanese, Victor P.; Louafi, Fethi; Francisco-Garcia, Ana S.; Rupani, Hitasha; Bedke, Nicole; Holgate, Stephen; Howarth, Peter H.; Davies, Donna E.; Sanchez-Elsner, Tilman			A MicroRNA Network Dysregulated in Asthma Controls IL-6 Production in Bronchial Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENOME-WIDE SEARCH; AIRWAY INFLAMMATION; TGF-BETA; EXPRESSION; TARGETS; ANTAGONISM; INTERLEUKIN-8; SUPPRESSOR; MANAGEMENT	MicroRNAs are short non-coding single stranded RNAs that regulate gene expression. While much is known about the effects of individual microRNAs, there is now growing evidence that they can work in co-operative networks. MicroRNAs are known to be dysregulated in many diseases and affect pathways involved in the pathology. We investigated dysregulation of microRNA networks using asthma as the disease model. Asthma is a chronic inflammatory disease of the airways characterized by bronchial hyperresponsiveness and airway remodelling. The airway epithelium is a major contributor to asthma pathology and has been shown to produce an excess of inflammatory and pro-remodelling cytokines such as TGF-beta, IL-6 and IL-8 as well as deficient amounts of anti-viral interferons. After performing microRNA arrays, we found that microRNAs -18a, -27a, -128 and -155 are down-regulated in asthmatic bronchial epithelial cells, compared to cells from healthy donors. Interestingly, these microRNAs are predicted in silico to target several components of the TGF-beta, IL-6, IL-8 and interferons pathways. Manipulation of the levels of individual microRNAs in bronchial epithelial cells did not have an effect on any of these pathways. Importantly, knock-down of the network of microRNAs miR-18a, -27a, -128 and -155 led to a significant increase of IL-8 and IL-6 expression. Interestingly, despite strong in silico predictions, down-regulation of the pool of microRNAs did not have an effect on the TGF-beta and Interferon pathways. In conclusion, using both bioinformatics and experimental tools we found a highly relevant potential role for microRNA dysregulation in the control of IL-6 and IL-8 expression in asthma. Our results suggest that microRNAs may have different roles depending on the presence of other microRNAs. Thus, interpretation of in silico analysis of microRNA function should be confirmed experimentally in the relevant cellular context taking into account interactions with other microRNAs when studying disease.	[Martinez-Nunez, Rocio T.; Bondanese, Victor P.; Louafi, Fethi; Francisco-Garcia, Ana S.; Rupani, Hitasha; Bedke, Nicole; Holgate, Stephen; Howarth, Peter H.; Davies, Donna E.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton, Hants, England; [Howarth, Peter H.] Southampton Gen Hosp, Southampton Ctr Biomed Res MP218, Southampton Resp Biomed Res Unit, NIHR, Southampton SO9 4XY, Hants, England	University of Southampton; University of Southampton	Sanchez-Elsner, T (corresponding author), Univ Southampton, Sch Med, Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton, Hants, England.	T.Sanchez-Elsner@soton.ac.uk	Davies, Donna E/H-2993-2012	Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council (MRC) [G0801984, MR/K001035/1]; MRC [G0801984, MR/K001035/1, G1000351]; MRC [G0900453, G0501506, G0800649] Funding Source: UKRI; Medical Research Council [G0900453, G1000351, MR/K001035/1, G0501506, G0800649, G0801984] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from the Medical Research Council (MRC) grants to TSE (G0801984 and MR/K001035/1). VPB and FL were supported by MRC grant G0801984. RTMN was supported by MRC grant MR/K001035/1. HR is supported by an MRC Clinical Research Fellowship (G1000351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi S, 2001, JPN J CANCER RES, V92, P257, DOI 10.1111/j.1349-7006.2001.tb01090.x; Baines KJ, 2014, J ALLERGY CLIN IMMUN, V133, P997, DOI 10.1016/j.jaci.2013.12.1091; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blumenthal MN, 2006, J ALLERGY CLIN IMMUN, V117, P79, DOI 10.1016/j.jaci.2005.09.038; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Devalia JL, 1999, INT ARCH ALLERGY IMM, V118, P437, DOI 10.1159/000024157; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Fukuyama S, 2009, AM J RESP CRIT CARE, V179, P992, DOI 10.1164/rccm.200806-992OC; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kumar RK, 2004, CLIN EXP ALLERGY, V34, P567, DOI 10.1111/j.1365-2222.2004.1917.x; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Manuyakorn W, 2013, ASIAN PAC J ALLERGY, V31, P3; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; Provost V, 2013, J LEUKOCYTE BIOL, V94, P213, DOI 10.1189/jlb.0212074; Reddel R.R., 1989, U.S. Patent, Patent No. [4,885,238, 4885238]; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rothenberg ME, 2011, J IMMUNOL, V187, P4873, DOI 10.4049/jimmunol.1004159; Rupani H, 2013, EUR RESPIR J, V41, P695, DOI 10.1183/09031936.00212011; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Shu JM, 2012, RNA BIOL, V9, P1275, DOI 10.4161/rna.21998; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082	62	57	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111659	10.1371/journal.pone.0111659	http://dx.doi.org/10.1371/journal.pone.0111659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360780	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000343943700139
J	Pan, XF; Zhao, ZM; Sun, J; Chen, F; Wen, QL; Liu, K; Song, GQ; Zhang, JJ; Wen, Y; Fu, CJ; Yang, CX				Pan, Xiong-Fei; Zhao, Zhi-Mei; Sun, Jing; Chen, Feng; Wen, Qing-Lian; Liu, Kang; Song, Gui-Qin; Zhang, Jing-Jing; Wen, Ying; Fu, Chun-Jing; Yang, Chun-Xia			Acceptability and Correlates of Primary and Secondary Prevention of Cervical Cancer among Medical Students in Southwest China: Implications for Cancer Education	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; VISUAL INSPECTION; VACCINE INTRODUCTION; SCREENING BEHAVIOR; MULTICENTER SURVEY; ACETIC-ACID; KNOWLEDGE; WOMEN; ATTITUDES; PERCEPTIONS	Objectives: To understand knowledge about, and acceptability of, cervical cancer screening and HPV vaccines among medical students; and to explore potential factors that influence their acceptability in China. Methods: We conducted a survey among medical students at six universities across southwest China using a 58-item questionnaire regarding knowledge and perceptions of HPV, cervical cancer, and HPV vaccines. Results: We surveyed 1878 medical students with a mean age of 20.8 years (standard deviation: 1.3 years). Of these, 48.8% and 80.1% believed cervical cancer can be prevented by HPV vaccines and screening respectively, while 60.2% and 71.2% would like to receive or recommend HPV vaccines and screening. 35.4% thought HPV vaccines ought to be given to adolescents aged 13-18 years. 32% stated that women should start to undergo screening from the age of 25. 49.2% felt that women should receive screening every year. Concern about side effects (38.3% and 39.8%), and inadequate information (42.4% and 35.0%) were the most cited barriers to receiving or recommending HPV vaccination and cervical cancer screening. Females were more likely to accept HPV vaccines (OR, 1.86; 95% CI: 1.47-2.35) or cervical cancer screening (OR, 3.69; 95% CI: 2.88-4.74). Students with a higher level of related knowledge were much more willing to receive or recommend vaccines (P<0.001) or screening (P<0.001). Students who showed negative or uncertain attitudes towards premarital sex were less likely to accept either HPV vaccines (OR, 0.67; 95% CI: 0.47-0.96), or screening (OR, 0.68; 0.47-0.10). Non-clinical students showed lower acceptability of cervical screening compared to students in clinical medicine (OR, 0.74; 95% CI: 0.56-0.96). Conclusions: The acceptability of HPV vaccines and cervical cancer screening is relatively low among medical students in southwest China. Measures should be taken to improve knowledge about cervical cancer and awareness of HPV vaccines and screening among medical students at university.	[Pan, Xiong-Fei; Zhao, Zhi-Mei; Wen, Ying; Yang, Chun-Xia] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol, Chengdu 610064, Peoples R China; [Sun, Jing] Chengdu Med Coll, Dept Pathol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu, Peoples R China; [Chen, Feng] Deyang Peoples Hosp, Dept Prevent Healthcare & Hosp Infect Control, Deyang, Peoples R China; [Wen, Qing-Lian] Luzhou Med Coll, Affiliated Hosp, Dept Oncol, Luzhou, Peoples R China; [Liu, Kang] North Sichuan Med Coll, Clin Hosp 2, Inst Tissue Engn & Stem Cells, Nanchong, Peoples R China; North Sichuan Med Coll, Dept Biol, Nanchong, Peoples R China; [Zhang, Jing-Jing] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China; [Fu, Chun-Jing] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China	Sichuan University; Chengdu Medical College; Southwest Medical University; North Sichuan Medical University; North Sichuan Medical University; Kunming Medical University; Chongqing Medical University	Yang, CX (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol, Chengdu 610064, Peoples R China.	chunxia815@aliyun.com	Pan, Xiongfei/G-7882-2011; Liu, Kang/AAE-9964-2020	Pan, Xiongfei/0000-0002-9350-9230; Liu, Kang/0000-0002-4640-0849				Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; Agorastos T, 2009, VACCINE, V27, P7270, DOI 10.1016/j.vaccine.2009.09.097; [Anonymous], 2009, Lancet, V374, P358, DOI 10.1016/S0140-6736(09)61394-5; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Chang IJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-916; Chelimo C, 2009, NEW ZEAL MED J, V122, P33; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Dempsey AF, 2006, AM J MANAG CARE, V12, pS484; Deng L, 2014, LANCET ONCOL, V15, pE300, DOI 10.1016/S1470-2045(14)70278-5; Deng L, 2011, ASIAN PAC J CANCER P, V12, P2801; Dijkstra MG, 2014, ANN ONCOL; Dong Z, 2005, RECOMMENDAT IN PRESS; Ferlay J, 2013, IARC CANCERBASE; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Gu C, 2013, EUR J ONCOL NURS, V17, P154, DOI 10.1016/j.ejon.2012.04.005; Gu C, 2012, PSYCHO-ONCOLOGY, V21, P1299, DOI 10.1002/pon.2037; Gu C, 2010, CANCER NURS, V33, P445, DOI 10.1097/NCC.0b013e3181e456dc; Hong Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-696; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Kuznetsov L, 2012, INT J PUBLIC HEALTH, V57, P651, DOI 10.1007/s00038-012-0351-3; Kwan TTC, 2011, PATIENT EDUC COUNS, V84, P118, DOI 10.1016/j.pec.2010.06.018; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Li R, 2013, TROP DOCT, V43, P96, DOI 10.1177/0049475513495615; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073; Marek E, 2011, VACCINE, V29, P5122, DOI 10.1016/j.vaccine.2011.05.048; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; McCusker SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-264; Mehta Sumita, 2013, Indian J Community Med, V38, P92, DOI 10.4103/0970-0218.112438; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; Paul P, 2013, ONCOLOGIST, V18, P1278, DOI 10.1634/theoncologist.2013-0253; Rashwan HH, 2012, ASIAN PAC J CANCER P, V13, P2279, DOI 10.7314/APJCP.2012.13.5.2279; Sauvageau C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-304; Shetty P, 2014, NATURE, V507, pS12, DOI 10.1038/507S12a; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377; Wei Min-xi, 2009, Chinese Journal of Virology, V25, P245; Wen Y, 2014, ASIAN PAC J CANCER P, V15, P5773, DOI 10.7314/APJCP.2014.15.14.5773; Who, 2009, Biologicals, V37, P338, DOI 10.1016/j.biologicals.2009.04.005; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang SK, 2013, VACCINE, V31, P3244, DOI 10.1016/j.vaccine.2013.05.046; Zhao FH, 2012, ASIAN PAC J CANCER P, V13, P2369, DOI 10.7314/APJCP.2012.13.5.2369; Zhao FH, 2012, CANCER EPIDEMIOL, V36, P384, DOI 10.1016/j.canep.2012.01.009; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	53	10	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110353	10.1371/journal.pone.0110353	http://dx.doi.org/10.1371/journal.pone.0110353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360743	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700032
J	Royer, C; Koch, S; Qin, X; Zak, J; Buti, L; Dudziec, E; Zhong, S; Ratnayaka, I; Srinivas, S; Lu, X				Royer, Christophe; Koch, Sofia; Qin, Xiao; Zak, Jaroslav; Buti, Ludovico; Dudziec, Ewa; Zhong, Shan; Ratnayaka, Indrika; Srinivas, Shankar; Lu, Xin			ASPP2 Links the Apical Lateral Polarity Complex to the Regulation of YAP Activity in Epithelial Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; PHOSPHORYLATION; APOPTOSIS; ANGIOMOTIN; YORKIE; P53	The Hippo pathway, by tightly controlling the phosphorylation state and activity of the transcription cofactors YAP and TAZ is essential during development and tissue homeostasis whereas its deregulation may lead to cancer. Recent studies have linked the apicobasal polarity machinery in epithelial cells to components of the Hippo pathway and YAP and TAZ themselves. However the molecular mechanism by which the junctional pool of YAP proteins is released and activated in epithelial cells remains unknown. Here we report that the tumour suppressor ASPP2 forms an apical-lateral polarity complex at the level of tight junctions in polarised epithelial cells, acting as a scaffold for protein phosphatase 1 (PP1) and junctional YAP via dedicated binding domains. ASPP2 thereby directly induces the dephosphorylation and activation of junctional YAP. Collectively, this study unearths a novel mechanistic paradigm revealing the critical role of the apical-lateral polarity complex in activating this localised pool of YAP in vitro, in epithelial cells, and in vivo, in the murine colonic epithelium. We propose that this mechanism may commonly control YAP functions in epithelial tissues.	[Royer, Christophe; Koch, Sofia; Qin, Xiao; Zak, Jaroslav; Buti, Ludovico; Dudziec, Ewa; Zhong, Shan; Ratnayaka, Indrika; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England; [Royer, Christophe; Srinivas, Shankar] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Ludwig Institute for Cancer Research; University of Oxford; University of Oxford	Royer, C (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England.	royer@dpag.ox.ac.uk; xin.lu@ludwig.ox.ac.uk		Lu, Xin/0000-0002-6587-1152; Srinivas, Shankar/0000-0001-5726-7791; Royer, Christophe/0000-0002-9882-7676	Oxford Stem Cell Institute Fellowship from the Oxford Martin School; Medical Research Council [MR/J000930/1]; BBSRC [BB/F011512/1, BB/J00989X/1] Funding Source: UKRI; MRC [MR/J000930/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00989X/1, BB/F011512/1] Funding Source: researchfish	Oxford Stem Cell Institute Fellowship from the Oxford Martin School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CR was supported by an Oxford Stem Cell Institute Fellowship from the Oxford Martin School (http://www.oxfordmartin.ox.ac.uk/institutes/stem_cells/). XL was supported by the Medical Research Council (MR/J000930/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Llanos S, 2011, J BIOL CHEM, V286, P43039, DOI 10.1074/jbc.M111.270751; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Skene-Arnold TD, 2013, BIOCHEM J, V449, P649, DOI 10.1042/BJ20120506; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	32	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111384	10.1371/journal.pone.0111384	http://dx.doi.org/10.1371/journal.pone.0111384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360797	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700097
J	Nussbaum, I; Weindling, E; Jubran, R; Cohen, A; Bar-Nun, S				Nussbaum, Inbal; Weindling, Esther; Jubran, Ritta; Cohen, Aviv; Bar-Nun, Shoshana			Deteriorated Stress Response in Stationary-Phase Yeast: Sir2 and Yap1 Are Essential for Hsf1 Activation by Heat Shock and Oxidative Stress, Respectively	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; GLUCOSE STARVATION; BINDING-PROTEIN; GENE-EXPRESSION; KEY FEATURES; LONGEVITY	Stationary-phase cultures have been used as an important model of aging, a complex process involving multiple pathways and signaling networks. However, the molecular processes underlying stress response of non-dividing cells are poorly understood, although deteriorated stress response is one of the hallmarks of aging. The budding yeast Saccharomyces cerevisiae is a valuable model organism to study the genetics of aging, because yeast ages within days and are amenable to genetic manipulations. As a unicellular organism, yeast has evolved robust systems to respond to environmental challenges. This response is orchestrated largely by the conserved transcription factor Hsf1, which in S. cerevisiae regulates expression of multiple genes in response to diverse stresses. Here we demonstrate that Hsf1 response to heat shock and oxidative stress deteriorates during yeast transition from exponential growth to stationary-phase, whereas Hsf1 activation by glucose starvation is maintained. Overexpressing Hsf1 does not significantly improve heat shock response, indicating that Hsf1 dwindling is not the major cause for Hsf1 attenuated response in stationary-phase yeast. Rather, factors that participate in Hsf1 activation appear to be compromised. We uncover two factors, Yap1 and Sir2, which discretely function in Hsf1 activation by oxidative stress and heat shock. In Delta yap1 mutant, Hsf1 does not respond to oxidative stress, while in Delta sir2 mutant, Hsf1 does not respond to heat shock. Moreover, excess Sir2 mimics the heat shock response. This role of the NAD(+)-dependent Sir2 is supported by our finding that supplementing NAD(+) precursors improves Hsf1 heat shock response in stationary-phase yeast, especially when combined with expression of excess Sir2. Finally, the combination of excess Hsf1, excess Sir2 and NAD(+) precursors rejuvenates the heat shock response.	[Nussbaum, Inbal; Weindling, Esther; Jubran, Ritta; Cohen, Aviv; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bar-Nun, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il			Israel Science Foundation [384/11]	Israel Science Foundation(Israel Science Foundation)	Israel Science Foundation (www.isf.org.il) grant no. 384/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Cohen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044785; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; HOJ A, 1994, EMBO J, V13, P2617; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu Xiao-Dong, 1996, Genes and Development, V10, P592, DOI 10.1101/gad.10.5.592; Longo V.D., 2004, SCI AGING KNOWLEDGE, V2004, ppe6; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078; Raynes R, 2012, J BIOL CHEM, V287, P29045, DOI 10.1074/jbc.M112.353714; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SEWELL AK, 1995, J BIOL CHEM, V270, P25079, DOI 10.1074/jbc.270.42.25079; Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; TUITE MF, 1988, NUCLEIC ACIDS RES, V16, P11845, DOI 10.1093/nar/16.24.11845; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang CL, 2008, GENETICS, V180, P1955, DOI 10.1534/genetics.108.094516; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200	74	11	11	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111505	10.1371/journal.pone.0111505	http://dx.doi.org/10.1371/journal.pone.0111505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356557	gold, Green Submitted, Green Published			2022-12-26	WOS:000346765000065
J	Yan, L; DeMars, LC				Yan, Lin; DeMars, Lana C.			Effects of a High-Fat Diet on Spontaneous Metastasis of Lewis Lung Carcinoma in Plasminogen Activator Inhibitor-1 Deficient and Wild-Type Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NEGATIVE BREAST-CANCER; FACTOR-ALPHA; PROSTATE-CANCER; ADIPOSE-TISSUE; IN-VIVO; RADICAL PROSTATECTOMY; METHYLSELENINIC ACID; CELL-ADHESION; OBESITY	This study investigated the effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma (LLC) in plasminogen activator inhibitor-1 deficient (PAI-1(-/-)) and wild-type mice. The high-fat diet increased the number of pulmonary metastases by 60% (p<0.01), tumor cross-sectional area by 82% (p<0.05) and tumor volume by 130% (p<0.05) compared to the AIN93G diet. Deficiency in PAI-1 reduced the number of metastases by 35% (p<0.01) compared to wildtype mice. In mice fed the high-fat diet, PAI-1 deficiency reduced tumor cross-sectional area by 52% (p<0.05) and tumor volume by 61% (p<0.05) compared to their wild-type counterparts; however, PAI-1 deficiency affected neither area nor volume in mice fed the AIN93G diet. Adipose and plasma concentrations of PAI-1 were significantly higher in high-fat fed wild-type mice than in their AIN93G-fed counterparts. Adipose and plasma PAI-1 were not detectable in PAI-1(-/-) mice regardless of the diet. Mice deficient in PAI-1 showed significantly greater plasma concentrations of monocyte chemotactic protein-1, tumor necrosis factor-alpha, leptin, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-1 and insulin compared to wild-type mice, indicating a compensatory overproduction of inflammatory cytokines, angiogenic factors and insulin in the absence of PAI-1. We conclude that PAI-1 produced by the host, including that by adipose tissue, promotes high-fat enhanced metastasis of LLC.	[Yan, Lin; DeMars, Lana C.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA	United States Department of Agriculture (USDA)	Yan, L (corresponding author), USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA.	lin.yan@ars.usda.gov		yan, lin/0000-0003-3646-6374	U.S. Department of Agriculture, ARS, Research project [5450-51000-045-00D]	U.S. Department of Agriculture, ARS, Research project	Funding for this work was provided by the U.S. Department of Agriculture, ARS, Research project 5450-51000-045-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1994, CANCER RES, V54, P2372; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Algamas-Dimantov A, 2012, J LIPID RES, V53, P1056, DOI 10.1194/jlr.M021949; Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bassett WW, 2005, UROLOGY, V66, P1060, DOI 10.1016/j.urology.2005.05.040; Blake CM, 2009, OLIGONUCLEOTIDES, V19, P117, DOI 10.1089/oli.2008.0177; BRODT P, 1986, CANCER RES, V46, P2442; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Corn Refiners Association, 2006, CORN OIL; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; DANIELL HW, 1988, CANCER, V62, P429, DOI 10.1002/1097-0142(19880715)62:2<429::AID-CNCR2820620230>3.0.CO;2-4; Dool CJ, 2011, ENDOCR-RELAT CANCER, V18, P699, DOI 10.1530/ERC-11-0136; Eitzman DT, 1996, BLOOD, V87, P4718; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Fidler IJ, 1978, METHOD CANCER RES, P399; Fierz Y, 2010, DIABETES, V59, P686, DOI 10.2337/db09-1291; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Gutierrez LS, 2000, CANCER RES, V60, P5839; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hennan JK, 2005, J PHARMACOL EXP THER, V314, P710, DOI 10.1124/jpet.105.084129; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; JANICKE F, 1993, BREAST CANCER RES TR, V24, P195, DOI 10.1007/BF01833260; Kido A, 1999, CANCER LETT, V137, P209, DOI 10.1016/S0304-3835(98)00368-1; Kimura Y, 2007, NUTR CANCER, V59, P207, DOI 10.1080/01635580701499537; Kockx M, 1999, THROMB HAEMOSTASIS, V82, P1490; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; KRUITHOF EKO, 1988, THROMB HAEMOSTASIS, V59, P7; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; LIU GH, 1995, INT J CANCER, V60, P501, DOI 10.1002/ijc.2910600413; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Maillard CM, 2008, CARCINOGENESIS, V29, P2236, DOI 10.1093/carcin/bgn204; Mavri A, 1999, ARTERIOSCL THROM VAS, V19, P1582, DOI 10.1161/01.ATV.19.6.1582; MCGILL JB, 1994, DIABETES, V43, P104, DOI 10.2337/diabetes.43.1.104; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; OKAHARA H, 1994, CANCER RES, V54, P3233; Ortega FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033233; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; QUAX PHA, 1990, J BIOL CHEM, V265, P15560; Ree AH, 1997, CLIN CANCER RES, V3, P1623; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seetoo DQ, 2003, J SURG ONCOL, V82, P184, DOI 10.1002/jso.10210; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Tsuchiya H, 1997, ANTICANCER RES, V17, P313; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; WELCH DR, 1983, INVAS METAST, V3, P65; Yan L, 2014, CARCINOGENESIS, V35, P2308, DOI 10.1093/carcin/bgu153; Yan L, 2013, J AGR FOOD CHEM, V61, P9373, DOI 10.1021/jf401588h; Yan L, 2012, INT J CANCER, V131, P1260, DOI 10.1002/ijc.27355; Yan L, 2012, NUTR RES, V32, P458, DOI 10.1016/j.nutres.2012.05.006; Yan L, 2010, CLIN EXP METASTAS, V27, P581, DOI 10.1007/s10585-010-9347-7	62	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110869	10.1371/journal.pone.0110869	http://dx.doi.org/10.1371/journal.pone.0110869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356654	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000031
J	Meek, PD; Ballard, GA; Fleming, PJS; Schaefer, M; Williams, W; Falzon, G				Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Schaefer, Michael; Williams, Warwick; Falzon, Greg			Camera Traps Can Be Heard and Seen by Animals	PLOS ONE			English	Article							COLOR-VISION; WILDLIFE; COYOTES; RAT; EAR; LOCALIZATION; SENSITIVITY; THRESHOLDS; AUDIOGRAM; ABUNDANCE	Camera traps are electrical instruments that emit sounds and light. In recent decades they have become a tool of choice in wildlife research and monitoring. The variability between camera trap models and the methods used are considerable, and little is known about how animals respond to camera trap emissions. It has been reported that some animals show a response to camera traps, and in research this is often undesirable so it is important to understand why the animals are disturbed. We conducted laboratory based investigations to test the audio and infrared optical outputs of 12 camera trap models. Camera traps were measured for audio outputs in an anechoic chamber; we also measured ultrasonic (n = 5) and infrared illumination outputs (n = 7) of a subset of the camera trap models. We then compared the perceptive hearing range (n = 21) and assessed the vision ranges (n = 3) of mammals species (where data existed) to determine if animals can see and hear camera traps. We report that camera traps produce sounds that are well within the perceptive range of most mammals' hearing and produce illumination that can be seen by many species.	[Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Falzon, Greg] Invas Anim CRC, Coffs Harbour, NSW, Australia; [Meek, Paul D.; Ballard, Guy-Anthony] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Armidale, NSW, Australia; [Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Schaefer, Michael] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Fleming, Peter J. S.] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW, Australia; [Falzon, Greg] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Schaefer, Michael] CSIRO, Canberra, ACT, Australia; [Williams, Warwick] Natl Acoust Lab, Sydney, NSW, Australia	NSW Department of Primary Industries; University of New England; NSW Department of Primary Industries; University of New England; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Acoustic Laboratories	Meek, PD (corresponding author), Invas Anim CRC, Coffs Harbour, NSW, Australia.	paul.meek@invasiveanimals.com	Meek, Paul D/R-5019-2016; Falzon, Greg A/A-2657-2012	Falzon, Greg A/0000-0002-1989-9357; Ballard, Guy/0000-0002-0287-9720; Meek, Paul/0000-0002-3792-5723; Fleming, Peter/0000-0002-3490-6148				AITKIN LM, 1994, J COMP NEUROL, V349, P377, DOI 10.1002/cne.903490305; Arrese C, 2002, J ZOOL, V256, P151, DOI 10.1017/S0952836902000183; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bies DA, 2009, ENG NOISE CONTROL TH; Caughley G., 1977, ANAL VERTEBRATE POPU; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Cuevas A, 2006, COMPUT STAT DATA AN, V51, P1063, DOI 10.1016/j.csda.2005.10.012; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Ewer R.F., 1998, CARNIVORES; Gekeler F, 2006, VISION RES, V46, P357, DOI 10.1016/j.visres.2005.06.023; Gibeau M.L., 2009, WILDLIFE PROFESSIONA, V2009, P35; Gogoleva SS, 2008, BIOACOUSTICS, V18, P99, DOI 10.1080/09524622.2008.9753595; GRIFFIN DR, 1947, J OPT SOC AM, V37, P546, DOI 10.1364/JOSA.37.000546; GUNTER R, 1951, J PHYSIOL-LONDON, V114, P8, DOI 10.1113/jphysiol.1951.sp004599; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; HEFFNER HE, 1983, BEHAV NEUROSCI, V97, P310, DOI 10.1037/0735-7044.97.2.310; HEFFNER HE, 1969, J AUD RES, V9, P12; HEFFNER HE, 1985, J COMP PSYCHOL, V99, P275, DOI 10.1037/0735-7036.99.3.275; Heffner H, 2010, J ACOUST SOC AM, V127, pEL111, DOI 10.1121/1.3284546; HEFFNER RS, 1992, J COMP NEUROL, V317, P219, DOI 10.1002/cne.903170302; HEFFNER RS, 1985, HEARING RES, V19, P85, DOI 10.1016/0378-5955(85)90100-5; HEFFNER RS, 1983, BEHAV NEUROSCI, V97, P299, DOI 10.1037/0735-7044.97.2.299; Hemmi JM, 2000, VISION RES, V40, P591, DOI 10.1016/S0042-6989(99)00210-2; Huang GT, 2000, J COMP PHYSIOL A, V186, P447, DOI 10.1007/s003590050444; Huang GT, 2002, J COMP PHYSIOL A, V188, P663, DOI 10.1007/s00359-002-0332-8; ISLEY TE, 1975, J MAMMAL, V56, P397, DOI 10.2307/1379369; Jackson LL, 1997, J COMP PSYCHOL, V111, P100, DOI 10.1037/0735-7036.111.1.100; Jacobs GH, 2010, OPHTHAL PHYSL OPT, V30, P422, DOI 10.1111/j.1475-1313.2010.00719.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; LEHNER PN, 1976, J WILDLIFE MANAGE, V40, P145, DOI 10.2307/3800169; Long RA, 2008, NONINVASIVE SURVEY M; Mahon PS, 1998, WILDLIFE RES, V25, P217, DOI 10.1071/WR97007_CO; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Meek PD, 2013, AUST MAMMAL, V35, P123, DOI 10.1071/AM12014; Newbold HG, 2009, WILDLIFE RES, V36, P309, DOI 10.1071/WR08083; Newton-Fisher Nick, 1993, Bioacoustics, V5, P1; Pater L, 2000, TERRA BOREALIS, P22; PRICE MA, 1988, J ACOUST SOC AM, V84, P1836, DOI 10.1121/1.397150; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Sathyakumar S, 2011, MAMMALIA, V75, P257, DOI 10.1515/MAMM.2011.023; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Sequin ES, 2003, CAN J ZOOL, V81, P2015, DOI 10.1139/Z03-204; Signal T, 2001, PHYSIOL BEHAV, V73, P195, DOI 10.1016/S0031-9384(01)00446-2; SLINEY DH, 1976, J OPT SOC AM, V66, P339, DOI 10.1364/JOSA.66.000339; Sumner P, 2005, J EXP BIOL, V208, P1803, DOI 10.1242/jeb.01610; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; WEBSTER DB, 1971, BRAIN BEHAV EVOLUT, V4, P310, DOI 10.1159/000125441; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; Windberg LA, 1996, CAN J ZOOL, V74, P2248, DOI 10.1139/z96-255	55	77	83	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110832	10.1371/journal.pone.0110832	http://dx.doi.org/10.1371/journal.pone.0110832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354356	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200042
J	Liu, JB; Chen, RZ; Wang, ZM; An, JC; Hyyppa, J				Liu, Jingbin; Chen, Ruizhi; Wang, Zemin; An, Jiachun; Hyyppa, Juha			Long-Term Prediction of the Arctic Ionospheric TEC Based on Time-Varying Periodograms	PLOS ONE			English	Article							TOTAL ELECTRON-CONTENT; CAP HARMONIC-ANALYSIS; SOLAR-ACTIVITY; CYCLE; SYSTEM; MODEL; MAPS	Knowledge of the polar ionospheric total electron content (TEC) and its future variations is of scientific and engineering relevance. In this study, a new method is developed to predict Arctic mean TEC on the scale of a solar cycle using previous data covering 14 years. The Arctic TEC is derived from global positioning system measurements using the spherical cap harmonic analysis mapping method. The study indicates that the variability of the Arctic TEC results in highly time-varying periodograms, which are utilized for prediction in the proposed method. The TEC time series is divided into two components of periodic oscillations and the average TEC. The newly developed method of TEC prediction is based on an extrapolation method that requires no input of physical observations of the time interval of prediction, and it is performed in both temporally backward and forward directions by summing the extrapolation of the two components. The backward prediction indicates that the Arctic TEC variability includes a 9 years period for the study duration, in addition to the well-established periods. The long-term prediction has an uncertainty of 4.8-5.6 TECU for different period sets.	[Liu, Jingbin; Hyyppa, Juha] Finnish Geodet Inst, Dept Remote Sensing & Photogrammetry, Masala, Finland; [Chen, Ruizhi] Texas A&M Univ, Conrad Blucher Inst Surveying & Sci, Corpus Christi, TX USA; [Wang, Zemin; An, Jiachun] Wuhan Univ, Chinese Antarctic Ctr Surveying & Mapping, Wuhan 430072, Peoples R China	The National Land Survey of Finland; Finnish Geospatial Research Institute (FGI); Texas A&M University System; Wuhan University	Liu, JB (corresponding author), Finnish Geodet Inst, Dept Remote Sensing & Photogrammetry, Masala, Finland.	jingbin.liu@fgi.fi	Liu, Jingbin/AAE-8803-2020; An, Jiachun/ABG-4275-2020; ZeMin, Wang/AAU-3422-2020; Hyyppä, Juha M./ABH-1852-2021	Hyyppa, Juha/0000-0001-5360-4017	Finnish Centre of Excellence in Laser Scanning Research - Academy of Finland [272195]; National Natural Science Foundation of China [41174029, 41204028, 41231064]	Finnish Centre of Excellence in Laser Scanning Research - Academy of Finland; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Finnish Centre of Excellence in Laser Scanning Research, which is funded under project 272195 (JH) by the Academy of Finland (http://www.aka.fi). This work was also supported in part by the National Natural Science Foundation of China (grants 41174029(ZW), 41204028(JA), and 41231064(ZW))(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich EL, 2008, ANN GEOPHYS-GERMANY, V26, P335, DOI 10.5194/angeo-26-335-2008; Bilitza D, 2011, J GEODESY, V85, P909, DOI 10.1007/s00190-010-0427-x; Dikpati M, 2008, ANN GEOPHYS-GERMANY, V26, P259, DOI 10.5194/angeo-26-259-2008; FRIISCHRISTENSEN E, 1991, SCIENCE, V254, P698, DOI 10.1126/science.254.5032.698; Garcia-Rigo A, 2011, RADIO SCI, V46, DOI 10.1029/2010RS004643; Garner TW, 2008, ADV SPACE RES, V42, P720, DOI 10.1016/j.asr.2008.02.025; Ghoddousi-Fard R, 2011, SPACE WEATHER, V9, DOI 10.1029/2010SW000621; Gulyaeva TL, 2013, ADV SPACE RES, V52, P1837, DOI 10.1016/j.asr.2012.09.038; Gulyaeva TL, 2013, J ATMOS SOL-TERR PHY, V102, P329, DOI 10.1016/j.jastp.2013.06.011; HAINES GV, 1985, J GEOPHYS RES, V90, P2583, DOI 10.1029/JB090iB03p02583; Hemandez-Pajares M, 2014, J GEOPHYS RES SOLID, V119, P3823, DOI [10.1002/2013JB010568, DOI 10.1002/2013JB010568]; Hernandez-Pajares M, 2012, RADIO SCI, V47, DOI 10.1029/2011RS004951; Hernandez-Pajares M, 2009, J GEODESY, V83, P263, DOI 10.1007/s00190-008-0266-1; Ivanov-Kholodny G. S., 1986, PREDICTION IONOSPHER; Jakowski N, 2011, J GEODESY, V85, P965, DOI 10.1007/s00190-011-0455-1; Komjathy A., 1997, THESIS U NEW BRUNSWI; Lean JL, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016567; Lean JL, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016378; Liu J, 2010, J GLOBAL POSITIONING, V9, P22, DOI DOI 10.5081/JGPS.9.1.22; Liu JB, 2014, J GEOPHYS RES-SPACE, V119, P601, DOI 10.1002/2013JA019501; Liu JB, 2011, GPS SOLUT, V15, P109, DOI 10.1007/s10291-010-0174-8; [柳景斌 LIU Jingbin], 2008, [武汉大学学报. 信息科学版, Geomatics and Information Science of Wuhan University], V33, P792; Liu Jingbin, 2008, Geomatics and Information Science of Wuhan University, V33, P479; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014244; Mannucci AJ, 1998, RADIO SCI, V33, P565, DOI 10.1029/97RS02707; National Research Council, 2003, SUN EARTH AND DEC RE; National Space Weather Strategic Plan, 1995, NAT SPAC WEATH STRAT; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; Pesnell WD, 2012, SOL PHYS, V281, P507, DOI 10.1007/s11207-012-9997-5; Pietrella M, 2009, ADV SPACE RES, V43, P1611, DOI 10.1016/j.asr.2008.01.022; Rishbeth H, 1969, INT GEOPHYS SERIES, V14; SARDON E, 1994, RADIO SCI, V29, P577, DOI 10.1029/94RS00449; Schaer S, 1999, THESIS U BERN; Schaer S, 1998, IONEX IONOSPHERE MAP; Scharroo R, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014719; Strangeways HJ, 2009, ANN GEOPHYS-ITALY, V52, P255; WILSON BD, 1995, RADIO SCI, V30, P639, DOI 10.1029/94RS03186; Wu Y, 2010, ADV SPACE RES, V46, P144, DOI 10.1016/j.asr.2009.11.007; Zahra B., 2010, 38 COSPAR SCI ASS BR; Zolesi B, 2014, SPRINGER GEOPHYS SER, VXII	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111497	10.1371/journal.pone.0111497	http://dx.doi.org/10.1371/journal.pone.0111497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369066	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000060
J	Madsen, DE; Hansen, S; Gram, J; Bygum, A; Drouet, C; Sidelmann, JJ				Madsen, Daniel Elenius; Hansen, Soren; Gram, Jorgen; Bygum, Anette; Drouet, Christian; Sidelmann, Johannes Jakobsen			Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema	PLOS ONE			English	Article							C1 INHIBITOR; Z ALPHA(1)-ANTITRYPSIN; ANGIONEUROTIC EDEMA; SERPIN DOMAIN; POLYMERIZATION; DEFICIENCY; PROTEINS	Hereditary angioedema (HAE) is a potentially life-threatening disease caused by mutations in the gene encoding the serine protease inhibitor (serpin) C1 inhibitor (C1-inh). The mutations cause decreased functional plasma levels of C1-inh, which triggers unpredictable recurrent edema attacks. Subjects suffering from HAE have been classified in type I patients with decreased functional and antigenic levels of C1-inh, and type II patients with decreased functional but normal antigenic C1-inh levels. However, a few reports have demonstrated that some mutations cause C1-inh polymerization in vitro, and it is speculated that C1-inh polymers may exist in patient plasma, challenging the current classification of HAE patients. To investigate the presence of C1-inh polymers in patient plasma samples, we developed an immunological method, where monoclonal antibodies produced against polymerized C1-inh were applied in native PAGE western blotting. Using this approach we analyzed genuine plasma samples from 31 Danish HAE families, and found that plasma samples from three genotypically distinct HAE type I families (classified upon C1-inh plasma concentrations) contained C1-inh polymers. Identical C1-inh polymerization phenotypes were observed in four affected family members from one of these families. Genotyping of the families revealed that the polymerogenic mutations of two families were located in proximity to the reactive center loop insertion site in C1-inh (p.Ile271Thr and p.Ser258_Pro260del), and one mutation affected helix C (p. Thr167Asn). In conclusion, we demonstrate that C1-inh polymers are present in the plasma of a subgroup of HAE type I patients.	[Madsen, Daniel Elenius; Gram, Jorgen; Sidelmann, Johannes Jakobsen] Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Esbjerg, Denmark; [Hansen, Soren] Univ Southern Denmark, Inst Mol Med Canc & Inflammat Res, Odense C, Denmark; [Bygum, Anette] Odense Univ Hosp, Dept Dermatol, Hereditary Angioedema Ctr Denmark, DK-5000 Odense C, Denmark; [Bygum, Anette] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense C, Denmark; [Drouet, Christian] Univ Grenoble 1, Natl Reference Ctr Angioedema, Grenoble, France	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Madsen, DE (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Esbjerg, Denmark.	daniel@elenius.eu	DROUET, Christian/AAE-5682-2020; DROUET, Christian/J-8775-2019	DROUET, Christian/0000-0003-1318-4278; DROUET, Christian/0000-0003-1318-4278; Hansen, Soren/0000-0002-8186-4630; Bygum, Anette/0000-0002-3004-0180; Sidelmann, Johannes Jakobsen/0000-0001-6376-1796; Gram, Jorgen Brodersen/0000-0002-0203-1965	Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; Region, Syddanmarks Forskningsfond, Kgl; Hofbuntmager Aage Bangs Fond; Asthma-Allergi, Forbundet; Forskningsfond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Hans og Nora Buchards Fond; Messerschmidt og Hustrus Fond; PREHAEAT EU concerted action 2001 Programme; Lundbeck Foundation [R100-2011-9316] Funding Source: researchfish	Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; Region, Syddanmarks Forskningsfond, Kgl; Hofbuntmager Aage Bangs Fond; Asthma-Allergi, Forbundet; Forskningsfond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Hans og Nora Buchards Fond; Messerschmidt og Hustrus Fond; PREHAEAT EU concerted action 2001 Programme; Lundbeck Foundation(Lundbeckfonden)	Karola Jorgensens Forskningsfond, Edith og Vagn Hedegaard Jensens Fond, Region, Syddanmarks Forskningsfond, Kgl. Hofbuntmager Aage Bangs Fond, Asthma-Allergi, Forbundet, Augustinus Fonden, Dansk Dermatologisk Selskabs Forskningsfond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Hans og Nora Buchards Fond, P. A. Messerschmidt og Hustrus Fond and the PREHAEAT EU concerted action 2001 Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULAK KS, 1993, J BIOL CHEM, V268, P18088; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; Bossi F, 2009, J ALLERGY CLIN IMMUN, V124, P1303, DOI 10.1016/j.jaci.2009.08.007; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; Cicardi M, 2014, ALLERGY, V69, P602, DOI 10.1111/all.12380; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; Elliott PR, 1998, AM J RESP CELL MOL, V18, P670, DOI 10.1165/ajrcmb.18.5.3065; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Galfre G, 1981, Methods Enzymol, V73, P3; Gompels MM, 2005, CLIN EXP IMMUNOL, V139, P379, DOI 10.1111/j.1365-2249.2005.02726.x; Kaplan AP, 2010, J ALLERGY CLIN IMMUN, V126, P918, DOI 10.1016/j.jaci.2010.08.012; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Osler W, 1888, AM J MED SCI, V95, P362; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; Zahedi R, 1996, J BIOL CHEM, V271, P24307, DOI 10.1074/jbc.271.39.24307	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112051	10.1371/journal.pone.0112051	http://dx.doi.org/10.1371/journal.pone.0112051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369003	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000138
J	Thompson, ACS; Bruss, MD; Nag, N; Kharitonenkov, A; Adams, AC; Hellerstein, MK				Thompson, Airlia C. S.; Bruss, Matthew D.; Nag, Nitish; Kharitonenkov, Alexei; Adams, Andrew C.; Hellerstein, Marc K.			Fibroblast Growth Factor 21 Is Not Required for the Reductions in Circulating Insulin-Like Growth Factor-1 or Global Cell Proliferation Rates in Response to Moderate Calorie Restriction in Adult Mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; FATAL NEOPLASTIC DISEASES; IGF-BINDING-PROTEINS; LIFE-SPAN EXTENSION; DIETARY RESTRICTION; PPAR-ALPHA; DELAYED OCCURRENCE; FACTOR SYSTEM; DWARF MICE; HORMONE	Calorie restriction (CR) delays aging and extends lifespan in numerous organisms, including mice. Down-regulation of the somatotropic axis, including a reduction in insulin-like growth factor-1 (IGF-1), likely plays an important role in CR-induced lifespan extension, possibly by reducing cell proliferation rates, thereby delaying replicative senescence and inhibiting tumor promotion. Accordingly, elucidating the mechanism(s) by which IGF-1 is reduced in response to CR holds therapeutic potential in the fight against age-related diseases. Up-regulation of fibroblast growth factor 21 (FGF21) is one possible mechanism given that FGF21 expression is induced in response to nutritional deprivation and has been implicated as a negative regulator of IGF-1 expression. Here we investigated alterations in hepatic growth hormone (GH)-mediated IGF-1 production and signaling as well as the role of FGF21 in the regulation of IGF-1 levels and cell proliferation rates in response to moderate CR in adult mice. We found that in response to moderate CR, circulating GH and hepatic janus kinase 2 (JAK2) phosphorylation levels are unchanged but that hepatic signal transducer and activator of transcription 5 (STAT5) phosphorylation levels are reduced, identifying STAT5 phosphorylation as a potential key site of CR action within the somatotropic axis. Circadian measurements revealed that the relative level of FGF21 expression is both higher and lower in CR vs. ad libitum (AL)-fed mice, depending on the time of measurement. Employing FGF21-knockout mice, we determined that FGF21 is not required for the reduction in IGF-1 levels or cell proliferation rates in response to moderate CR. However, compared to AL-fed WT mice, AL-fed FGF21-knockout mice exhibited higher basal rates of cell proliferation, suggesting antimitotic effects of FGF21. This work provides insights into both GH-mediated IGF-1 production in the context of CR and the complex network that regulates FGF21 and IGF-1 expression and cell proliferation rates in response to nutritional status.	[Thompson, Airlia C. S.; Bruss, Matthew D.; Nag, Nitish; Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kharitonenkov, Alexei; Adams, Andrew C.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hellerstein, Marc K.] KineMed Inc, Emeryville, CA USA	University of California System; University of California Berkeley; Eli Lilly	Thompson, ACS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	airlia.thompson@gmail.com; march@berkeley.edu	Nag, Nitish/H-8033-2016	Nag, Nitish/0000-0002-8409-1223	College of Natural Resources at the University of California at Berkeley; KineMed, Inc.; Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061918, P30DK026743] Funding Source: NIH RePORTER	College of Natural Resources at the University of California at Berkeley; KineMed, Inc.; Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the College of Natural Resources at the University of California at Berkeley. MKH is an employee of KineMed, Inc., and received salary from them. ACA is currently and AK was previously employed at Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720; Alderman JM, 2009, EXP GERONTOL, V44, P26, DOI 10.1016/j.exger.2008.05.014; ARMARIO A, 1987, ANN NUTR METAB, V31, P81, DOI 10.1159/000177254; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BIELSCHOWSKY F, 1961, BRIT J CANCER, V15, P257, DOI 10.1038/bjc.1961.32; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Bruss MD, 2011, AM J PHYSIOL-ENDOC M, V300, pE735, DOI 10.1152/ajpendo.00661.2010; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Chacon F, 2005, CHRONOBIOL INT, V22, P253, DOI 10.1081/CBI-200053522; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; de Magalhaes JP, 2008, BIOESSAYS, V30, P567, DOI 10.1002/bies.20760; Dunn SE, 1997, CANCER RES, V57, P4667; Ferry RJ, 1999, HORM RES, V51, P53; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Herington AC, 2012, OPEN ENDOCRINOLOGY J, V6, P13, DOI DOI 10.2174/1874216501206010013; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsieh EA, 2005, AM J PHYSIOL-ENDOC M, V288, pE965, DOI 10.1152/ajpendo.00368.2004; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; HURSTING SD, 1993, CANCER RES, V53, P2750; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Katewa SD, 2010, AGING CELL, V9, P105, DOI 10.1111/j.1474-9726.2010.00552.x; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kubicky RA, 2012, ENDOCRINOLOGY, V153, P2287, DOI 10.1210/en.2011-1909; Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lips MA, 2014, CLIN ENDOCRINOL, V81, P862, DOI 10.1111/cen.12496; LOK E, 1990, CANCER LETT, V51, P67, DOI 10.1016/0304-3835(90)90232-M; LOK E, 1988, CANCER LETT, V38, P249, DOI 10.1016/0304-3835(88)90016-X; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McCarty MF, 1997, MED HYPOTHESES, V48, P297, DOI 10.1016/S0306-9877(97)90098-0; Mendenhall CL, 1997, ALCOHOL CLIN EXP RES, V21, P1; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; SONNTAG WE, 1995, NEUROENDOCRINOLOGY, V61, P601, DOI 10.1159/000126885; Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092; Wu SF, 2013, J BIOL CHEM, V288, P27375, DOI 10.1074/jbc.M113.462218; Xu J, 2009, AM J PHYSL ENDOCRINO; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	62	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111418	10.1371/journal.pone.0111418	http://dx.doi.org/10.1371/journal.pone.0111418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369265	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000055
J	van Bracht, E; Versteegden, LRM; Stolle, S; Verdurmen, WPR; Woestenenk, R; Raave, R; Hafmans, T; Oosterwijk, E; Brock, R; van Kuppevelt, TH; Daamen, WF				van Bracht, Etienne; Versteegden, Luuk R. M.; Stolle, Sarah; Verdurmen, Wouter P. R.; Woestenenk, Rob; Raave, Rene; Hafmans, Theo; Oosterwijk, Egbert; Brock, Roland; van Kuppevelt, Toin H.; Daamen, Willeke F.			Enhanced Cellular Uptake of Albumin-Based Lyophilisomes when Functionalized with Cell-Penetrating Peptide TAT in HeLa Cells	PLOS ONE			English	Article							DRUG-DELIVERY; CANCER THERAPEUTICS; CONTRAST AGENT; IN-VIVO; NANOPARTICLES; EFFICACY; PACLITAXEL; PROTEIN; INTERNALIZATION; CYTOTOXICITY	Lyophilisomes are a novel class of biodegradable proteinaceous nano/micrometer capsules with potential use as drug delivery carrier. Cell-penetrating peptides (CPPs) including the TAT peptide have been successfully implemented for intracellular delivery of a broad variety of cargos including various nanoparticulate pharmaceutical carriers. In the present study, lyophilisomes were modified using CPPs in order to achieve enhanced cellular uptake. Lyophilisomes were prepared by a freezing, annealing, and lyophilization method and a cystein-elongated TAT peptide was conjugated to the lyophilisomes using a heterobifunctional linker. Fluorescent-activated cell sorting (FACS) was utilized to acquire a lyophilisome population with a particle diameter smaller than 1000 nm. Cultured HeLa, OVCAR-3, Caco-2 and SKOV-3 cells were exposed to unmodified lyophilisomes and TAT-conjugated lyophilisomes and examined with FACS. HeLa cells were investigated in more detail using a trypan blue quenching assay, confocal microscopy, and transmission electron microscopy. TAT-conjugation strongly increased binding and cellular uptake of lyophilisomes in a time-dependent manner in vitro, as assessed by FACS. These results were confirmed by confocal microscopy. Transmission electron microscopy indicated rapid cellular uptake of TAT-conjugated lyophilisomes via phagocytosis and/or macropinocytosis. In conclusion, TAT-peptides conjugated to albumin-based lyophilisomes are able to enhance cellular uptake of lyophilisomes in HeLa cells.	[van Bracht, Etienne; Versteegden, Luuk R. M.; Stolle, Sarah; Verdurmen, Wouter P. R.; Raave, Rene; Hafmans, Theo; Brock, Roland; van Kuppevelt, Toin H.; Daamen, Willeke F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Woestenenk, Rob] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [Oosterwijk, Egbert] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Daamen, WF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	Willeke.Daamen@radboudumc.nl	Raave, Rene/R-3193-2019; Brock, Roland/O-9411-2019; Oosterwijk, Egbert/P-5466-2014; Woestenenk, Rob/C-6119-2016; Brock, Roland/K-2590-2012; Verdurmen, Wouter/H-7457-2016; Daamen, Willeke F./D-5854-2015; Raavé, René/E-2860-2016; van Kuppevelt, A.H.M.S.M./L-4463-2015	Raave, Rene/0000-0002-5234-0707; Brock, Roland/0000-0003-1395-6127; Verdurmen, Wouter/0000-0002-2463-277X; Daamen, Willeke F./0000-0003-3155-3030; Raavé, René/0000-0001-6066-4448; 	Radboud university medical centre	Radboud university medical centre	The research project was funded by the Radboud university medical centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Brandhonneur N, 2009, EUR J PHARM SCI, V36, P474, DOI 10.1016/j.ejps.2008.11.013; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Daamen WF, 2007, ADV MATER, V19, P673, DOI 10.1002/adma.200601947; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Elzoghby A.O., 2012, J CONTROL RELEASE; Elzoghby A.O., 2011, J CONTROL RELEASE; FEINSTEIN SB, 1990, J AM COLL CARDIOL, V16, P316, DOI 10.1016/0735-1097(90)90580-I; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; Fretz MM, 2004, BBA-BIOMEMBRANES, V1665, P48, DOI 10.1016/j.bbamem.2004.06.022; Garza-Licudine E, 2010, IEEE ENG MED BIO, P5736, DOI 10.1109/IEMBS.2010.5627861; GEISOW MJ, 1984, EXP CELL RES, V150, P29, DOI 10.1016/0014-4827(84)90698-0; GENY B, 1993, J AM COLL CARDIOL, V22, P1193, DOI 10.1016/0735-1097(93)90437-6; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Lei TJ, 2011, NANOMED-NANOTECHNOL, V7, P324, DOI 10.1016/j.nano.2010.11.004; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P6534, DOI 10.1166/jnn.2010.2637; MacEwan SR, 2013, WIRES NANOMED NANOBI, V5, P31, DOI 10.1002/wnan.1197; Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jconrel.2005.08.007; Nuutila J, 2005, CYTOM PART A, V65A, P93, DOI 10.1002/cyto.a.20139; Oh E, 2011, ACS NANO, V5, P6434, DOI 10.1021/nn201624c; Orr G, 2009, TOXICOL APPL PHARM, V236, P210, DOI 10.1016/j.taap.2009.01.022; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Qin Y, 2011, INT J PHARMACEUT, V420, P304, DOI 10.1016/j.ijpharm.2011.09.008; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Sawant RR, 2009, INT J PHARMACEUT, V374, P114, DOI 10.1016/j.ijpharm.2009.02.022; Tario Joseph D Jr, 2007, Immunol Invest, V36, P861, DOI 10.1080/08820130701712933; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; van Bracht E, 2014, EUR J PHARM BIOPHARM; van Bracht E, 2012, INT J PHARMACEUT, V439, P127, DOI 10.1016/j.ijpharm.2012.10.008; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wallace PK, 2008, CYTOM PART A, V73A, P1019, DOI 10.1002/cyto.a.20619; Wang J, 2011, SMALL, V7, P1919, DOI 10.1002/smll.201100442; Xia H, 2012, INT J PHARM	49	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110813	10.1371/journal.pone.0110813	http://dx.doi.org/10.1371/journal.pone.0110813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369131	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000029
J	Lee, HN; Lee, NO; Han, SJ; Ko, IJ; Oh, JI				Lee, Ha-Na; Lee, Na-On; Han, Seung J.; Ko, In-Jeong; Oh, Jeong-Il			Regulation of the ahpC Gene Encoding Alkyl Hydroperoxide Reductase in Mycobacterium smegmatis	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; CAMP RECEPTOR PROTEIN; ANTIOXIDANT DEFENSE SYSTEM; CYCLIC-AMP; ESCHERICHIA-COLI; CATALASE-PEROXIDASE; NITRIC-OXIDE; TRANSCRIPTION ACTIVATION; CRYSTAL-STRUCTURE; FUR PROTEIN	The ahpC (MSMEG_4891) gene encodes alkyl hydroperoxide reductase C in Mycobacterium smegmatis mc(2)155 and its expression is induced under oxidative stress conditions. Two well-defined inverted repeat sequences (IR1 and IR2) were identified in the upstream region of ahpC. Using a crp (cAMP receptor protein: MSMEG_6189) mutant and in vitro DNA-binding assay, it was demonstrated that the IR1 sequence serves as a Crp-binding site and that Crp functions as an activator in the regulation of ahpC expression. The expression level of ahpC was shown to be proportional to intracellular cAMP levels. Intracellular levels of cAMP were increased in M. smegmatis, when it was treated with oxidative stress inducers. The IR2 sequence is very similar to the known consensus sequence of FurA-binding sites and involved in the negative regulation of ahpC expression. Taken together, these results suggest that the induction of ahpC expression under oxidative stress conditions probably results from a combinatory effect of both inactivation of FurA by oxidative stress and activation of Crp in response to increased levels of cAMP.	[Lee, Ha-Na; Lee, Na-On; Oh, Jeong-Il] Pusan Natl Univ, Dept Microbiol, Pusan, South Korea; [Han, Seung J.] Yonsei Univ, Dept Microbiol, Seoul 120749, South Korea; [Han, Seung J.] Yonsei Univ, Inst Immunol & Immunol Dis, Seoul 120749, South Korea; [Ko, In-Jeong] Korea Adv Inst Sci & Technol, Korea Sci Acad, Pusan, South Korea	Pusan National University; Yonsei University; Yonsei University; Korea Advanced Institute of Science & Technology (KAIST)	Oh, JI (corresponding author), Pusan Natl Univ, Dept Microbiol, Pusan, South Korea.	joh@pusan.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A2004243]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program to JIO through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A2004243). The authors hereby declare that the funder, which is supporting the research related to this manuscript, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung HL, 2014, J BACTERIOL, V196, P3091, DOI 10.1128/JB.01771-14; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chauhan R, 2002, BIOCHEM J, V367, P255, DOI 10.1042/BJ20020545; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choudhary E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089759; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty A, 2011, J BACTERIOL, V193, P6824, DOI 10.1128/JB.05492-11; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jeong Ji-A, 2013, [Journal of Life Science, 생명과학회지], V23, P290, DOI 10.5352/JLS.2013.23.2.290; Jessee J., 1986, FOCUS, V8, P9; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Kriakov J, 2003, J BACTERIOL, V185, P4983, DOI 10.1128/JB.185.16.4983-4991.2003; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Mouncey NJ, 1998, J BACTERIOL, V180, P5612, DOI 10.1128/JB.180.21.5612-5618.1998; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Oh JI, 2010, J BACTERIOL, V192, P3925, DOI 10.1128/JB.00286-10; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sambrook J., 2001, MOL CLONING LAB MANU; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x	66	15	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111680	10.1371/journal.pone.0111680	http://dx.doi.org/10.1371/journal.pone.0111680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365321	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100104
J	Savanur, MA; Eligar, SM; Pujari, R; Chen, C; Mahajan, P; Borges, A; Shastry, P; Ingle, A; Kalraiya, RD; Swamy, BM; Rhodes, JM; Yu, LG; Inamdar, SR				Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Pujari, Radha; Chen, Chen; Mahajan, Pravin; Borges, Anita; Shastry, Padma; Ingle, Arvind.; Kalraiya, Rajiv D.; Swamy, Bale M.; Rhodes, Jonathan M.; Yu, Lu-Gang; Inamdar, Shashikala R.			Sclerotium rolfsii Lectin Induces Stronger Inhibition of Proliferation in Human Breast Cancer Cells than Normal Human Mammary Epithelial Cells by Induction of Cell Apoptosis	PLOS ONE			English	Article							FRIEDENREICH CARBOHYDRATE ANTIGEN; PLANT-LECTINS; TF-ANTIGEN; ACTIVATION; GLYCOPROTEIN; MECHANISMS	Scleratium rolfsii lectin (SRL) isolated from the phytopathogenic fungus Scierotiurn rolfsii has exquisite binding towards O-linked, Thomsen-Freidenreich (Gal beta 1-3GaINAc alpha l-Ser/Thr, TF) associated glycans. This study invest nfluence of SRL on proliferation of human breast cancer cells (MCF-7 and ZR-75), non-turriorigenic breast epithelial cells MCF-10A) and normal mammary epithelial cells (HMECs). SRL caused marked, dose-dependent, inhibition of proliferation of CF-7 and ZR-75 cells but only weak inhibition of proliferation of non-tumorigenic MCF-10A and HMEC cells. The inhibitory effect of SRL on cancer cell proliferation was shown to be a consequence of SRL. cell surface binding and subsequent induction of cellular apoptosis, an effect that was largely prevented by the presence of inhibitors against caspases -8, or histochemistry using biotin-labelled SRL showed little binding of SRL to normal human breast tissue but intense Lies. In conclusion, SRL inhibits he growth of human breast cancer cells via induction of cell apoptosis but has subs ally less effect on normal epithelial cells. As a lectin that binds specifically to a cancer-associated glycan, has potential to be developed as an anti-cancer agent	[Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Swamy, Bale M.; Inamdar, Shashikala R.] Karnatak Univ, Dept Studies Biochem, Dharwad, Karnataka, India; [Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Chen, Chen; Swamy, Bale M.; Rhodes, Jonathan M.; Yu, Lu-Gang; Inamdar, Shashikala R.] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Ingle, Arvind.; Kalraiya, Rajiv D.] Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumabi, India; [Mahajan, Pravin; Borges, Anita] SL Raheja Hosp, Bombay, Maharashtra, India; [Pujari, Radha; Shastry, Padma] Natl Ctr Cell Sci, Pune, Maharashtra, India	Karnatak University; University of Liverpool; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Inamdar, SR (corresponding author), Karnatak Univ, Dept Studies Biochem, Dharwad, Karnataka, India.	pinkisri2001@yahoo.co.in			UKIERI from British Council [5A006/2008]; Department of Bio-Technology (DBT), New-Delhi, India [BT/PR11017/MED/ 30/122/2008]; UGC; UPE; CPEPA programme	UKIERI from British Council; Department of Bio-Technology (DBT), New-Delhi, India(Department of Biotechnology (DBT) India); UGC(University Grants Commission, India); UPE; CPEPA programme	This work was supported by UKIERI (5A006/2008) from British Council, Department of Bio-Technology (DBT), New-Delhi, India (No. BT/PR11017/MED/ 30/122/2008) and received partial support from UGC sponsored UPE and CPEPA programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BOLAND CR, 1991, CANCER RES, V51, P657; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Chachadi VB, 2011, GLYCOCONJ J, V28, P2849; Cruijsen HV, 2009, BMC CANCER, V9, P180; DUK M, 1994, ANAL BIOCHEM, V221, P266, DOI 10.1006/abio.1994.1410; Eligar SM, 2012, CELL PROLIFERAT, V45, P397, DOI 10.1111/j.1365-2184.2012.00831.x; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gambi N, 2008, BIOCHEM PHARMACOL, V75, P2356, DOI 10.1016/j.bcp.2008.03.015; Goldman M., 1968, FLUORESCENT ANTIBODY, P101; GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4; Hanisch FG, 1997, HISTOL HISTOPATHOL, V12, P263; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Inamdar SR, 2012, GLYCOBIOLOGY, V22, P1227, DOI 10.1093/glycob/cws090; Leonidas DD, 2007, J MOL BIOL, V368, P1145, DOI 10.1016/j.jmb.2007.02.092; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Swamy BM, 2004, GLYCOBIOLOGY, V14, P951, DOI 10.1093/glycob/cwh130; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	27	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110107	10.1371/journal.pone.0110107	http://dx.doi.org/10.1371/journal.pone.0110107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364905	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100015
J	Zhang, XL; Wang, N; Chen, P; Gao, MM; Liu, J; Wang, YF; Zhao, TJ; Li, Y; Gai, JY				Zhang, Xiaolian; Wang, Ning; Chen, Pei; Gao, Mengmeng; Liu, Juge; Wang, Yufeng; Zhao, Tuanjie; Li, Yan; Gai, Junyi			Overexpression of a Soybean Ariadne-Like Ubiquitin Ligase Gene GmARl1 Enhances Aluminum Tolerance in Arabidopsis	PLOS ONE			English	Article							DNA-DAMAGE; OXIDATIVE STRESS; RBR FAMILY; E3 LIGASE; RING; ACID; PARKIN; GROWTH; TOXICITY; DETOXIFICATION	Ariadne (ARI) subfamily of RBR (Ring Between Ring fingers) proteins have been found as a group of putative E3 ubiquitin ligases containing RING (Really Interesting New Gene) finger domains in fruitfly, mouse, human and Arabidopsis. Recent studies showed several RING-type E3 ubiquitin ligases play important roles in plant response to abiotic stresses, but the function of ARI in plants is largely unknown. In this study, an ariadne-like E3 ubiquitin ligase gene was isolated from soybean, Glycine max (L.) Merr., and designated as GmARI1. It encodes a predicted protein of 586 amino acids with a RBR supra-domain. Subcellular localization studies using Arabidopsis protoplast cells indicated GmARI protein was located in nucleus. The expression of GmARI1 in soybean roots was induced as early as 2-4 h after simulated stress treatments such as aluminum, which coincided with the fact of aluminum toxicity firstly and mainly acting on plant roots. In vitro ubiquitination assay showed GmARI1 protein has E3 ligase activity. Overexpression of GmARI1 significantly enhanced the aluminum tolerance of transgenic Arabidopsis. These findings suggest that GmARI1 encodes a RBR type E3 ligase, which may play important roles in plant tolerance to aluminum stress.	[Zhang, Xiaolian; Wang, Ning; Chen, Pei; Gao, Mengmeng; Liu, Juge; Wang, Yufeng; Zhao, Tuanjie; Li, Yan; Gai, Junyi] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Key Lab Biol & Genet Improvement Soybean, Natl Ctr Soybean Improvement,Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Li, Y (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Key Lab Biol & Genet Improvement Soybean, Natl Ctr Soybean Improvement,Minist Agr, Nanjing, Jiangsu, Peoples R China.	yanli1@njau.edu.cn; sri@njau.edu.cn	Li, Yan/AAF-5886-2019	Li, Yan/0000-0002-1627-7763	National Hightech R & D Program of China [2013AA102602]; National Key Basic Research Program of China [2011CB1093]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT13073]; Program for New Century Excellent Talents in University [NCET-12-0891]; MOE 111 Project [B08025]; Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province; Jiangsu Higher Education PAPD Program	National Hightech R & D Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE 111 Project(Ministry of Education, China - 111 Project); Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province; Jiangsu Higher Education PAPD Program	This work was supported by the National Hightech R & D Program of China (2013AA102602), the National Key Basic Research Program of China (2011CB1093), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT13073), the Program for New Century Excellent Talents in University (NCET-12-0891), the MOE 111 Project (B08025), the Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province, and the Jiangsu Higher Education PAPD Program. The funders had no role in study design, data collection and analysis, decision or preparation of the manuscript.	Achary VMM, 2008, ECOTOX ENVIRON SAFE, V70, P300, DOI 10.1016/j.ecoenv.2007.10.022; Achary VMM, 2010, MUTAGENESIS, V25, P201, DOI 10.1093/mutage/gep063; Aguilera M, 2000, GENETICS, V155, P1231; Ardie SW, 2009, J EXP BOT, V60, P3491, DOI 10.1093/jxb/erp184; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Bartocci Cristina, 2013, Frontiers in Genetics, V4, P128, DOI 10.3389/fgene.2013.00128; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromann PA, 2004, GENE EXPR PATTERNS, V4, P77, DOI 10.1016/S1567-133X(03)00146-7; Cheng MC, 2012, PLANT PHYSIOL, V158, P363, DOI 10.1104/pp.111.189738; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Du QL, 2010, MOL BIOL REP, V37, P685, DOI 10.1007/s11033-009-9535-1; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Foy CD, 1996, J PLANT NUTR, V19, P1361, DOI 10.1080/01904169609365205; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang BQ, 2001, CHINESE B BOT, V18, P385; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kunihiro S, 2011, PLANT SIGNAL BEHAV, V6, P611, DOI 10.4161/psb.6.5.14895; Lang-Mladek C, 2012, PHYSIOL PLANTARUM, V145, P527, DOI 10.1111/j.1399-3054.2011.01561.x; Lee DH, 2011, PLANT PHYSIOL, V156, P2011, DOI 10.1104/pp.111.177568; Liang CY, 2013, PLANT PHYSIOL, V161, P1347, DOI 10.1104/pp.112.208934; Liu Qiang, 2004, Yingyong Shengtai Xuebao, V15, P1641; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2003, J INORG BIOCHEM, V97, P46, DOI 10.1016/S0162-0134(03)00245-9; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Markkanen E, 2012, CELL CYCLE, V11, P1070, DOI 10.4161/cc.11.6.19448; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Nezames CD, 2012, PLANT CELL, V24, P608, DOI 10.1105/tpc.112.095596; Nian H, 1998, SOYBEAN SCI, V16, P191; NORUSIS MJ, 1990, SPSS ADV STAT USERS; Panda SK, 2013, MOL BIOTECHNOL, V54, P551, DOI 10.1007/s12033-012-9595-7; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; SAPRA VT, 1982, AGRON J, V74, P687, DOI 10.2134/agronj1982.00021962007400040022x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; TAYLOR GJ, 1988, COMMUN SOIL SCI PLAN, V19, P1179, DOI 10.1080/00103628809368004; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yin LN, 2010, PLANT PHYSIOL, V152, P1406, DOI 10.1104/pp.109.151449; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	52	15	16	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111120	10.1371/journal.pone.0111120	http://dx.doi.org/10.1371/journal.pone.0111120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364908	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100051
J	Ouedraogo, S; Traore, B; Bi, ZABN; Yonli, FT; Kima, D; Bonane, P; Congo, L; Traore, RO; Ye, D; Marguet, C; Plantier, JC; Vabret, A; Gueudin, M				Ouedraogo, Solange; Traore, Blaise; Bi, Zah Ange Brice Nene; Yonli, Firmin Tiandama; Kima, Donatien; Bonane, Pierre; Congo, Lassane; Traore, Rasmata Ouedraogo; Ye, Diarra; Marguet, Christophe; Plantier, Jean-Christophe; Vabret, Astrid; Gueudin, Marie			Viral Etiology of Respiratory Tract Infections in Children at the Pediatric Hospital in Ouagadougou (Burkina Faso)	PLOS ONE			English	Article							SYNCYTIAL VIRUS; SOUTH-AFRICA; EPIDEMIOLOGY; INFANTS; MALARIA; COINFECTIONS; SEASONALITY; SEVERITY; ILLNESS; KENYA	Background: Acute respiratory infections (ARIs) are a major cause of morbidity and mortality in children in Africa. The circulation of viruses classically implicated in ARIs is poorly known in Burkina Faso. The aim of this study was to identify the respiratory viruses present in children admitted to or consulting at the pediatric hospital in Ouagadougou. Methods: From July 2010 to July 2011, we tested nasal aspirates of 209 children with upper or lower respiratory infection for main respiratory viruses (respiratory syncytial virus (RSV), metapneumovirus, adenovirus, parainfluenza viruses 1, 2 and 3, influenza A, B and C, rhinovirus/enterovirus), by immunofluorescence locally in Ouagadougou, and by PCR in France. Bacteria have also been investigated in 97 samples. Results: 153 children (73.2%) carried at least one virus and 175 viruses were detected. Rhinoviruses/enteroviruses were most frequently detected (rhinovirus n = 88; enterovirus n = 38) and were found to circulate throughout the year. An epidemic of RSV infections (n = 25) was identified in September/October, followed by an epidemic of influenza virus (n = 13), mostly H1N1pdm09. This epidemic occurred during the period of the year in which nighttime temperatures and humidity were at their lowest. Other viruses tested were detected only sporadically. Twenty-two viral co-infections were observed. Bacteria were detected in 29/97 samples with 22 viral/bacterial co-infections. Conclusions: This study, the first of its type in Burkina Faso, warrants further investigation to confirm the seasonality of RSV infection and to improve local diagnosis of influenza. The long-term objective is to optimize therapeutic management of infected children.	[Ouedraogo, Solange; Traore, Blaise; Bi, Zah Ange Brice Nene; Yonli, Firmin Tiandama; Kima, Donatien; Bonane, Pierre; Congo, Lassane; Traore, Rasmata Ouedraogo; Ye, Diarra] Charles Gaulle Pediat Univ Hosp, Ouagadougou, Burkina Faso; [Marguet, Christophe] Rouen Univ Hosp Charles Nicolle, INSERM, CIC204, EA3830,Allergy & CF Unit Resp Dis, Rouen, France; [Plantier, Jean-Christophe] Rouen Univ Hosp Charles Nicolle, GRAM EA 2656, Virol Lab, Rouen, France; [Vabret, Astrid] Caen Univ Hosp Clemenceau, Lab Human & Mol Virol, F-14032 Caen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie	Gueudin, M (corresponding author), Rouen Univ Hosp Charles Nicolle, GRAM EA 2656, Virol Lab, Rouen, France.	Marie.Gueudin@chu-rouen.fr		VABRET, Astrid/0000-0002-8940-7645; PLANTIER, Jean-Christophe/0000-0001-6417-4083	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur funded this study in its entirety. The funder approved the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Ho A, 2010, J INFECTION, V60, P83, DOI 10.1016/j.jinf.2009.11.001; Karakitsos P, 2012, CLIN MICROBIOL INFEC; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; Laurent C, 2012, PEDIATR INFECT DIS J, V31, P827, DOI 10.1097/INF.0b013e3182566005; Laxminarayan R., 2006, ACUTE RESP INFECT CH; Lillie PJ, 2012, TRAVEL MED INFECT DI, V10, P192, DOI 10.1016/j.tmaid.2012.03.008; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Marcone DN, 2013, PEDIATR INFECT DIS J, V32, pE105, DOI 10.1097/INF.0b013e31827cd06f; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Okiro EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052520; Onyango CO, 2012, J MED VIROL, V84, P823, DOI 10.1002/jmv.23251; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; TALL FR, 1994, ARCH PEDIATRIE, V1, P249; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	29	33	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110435	10.1371/journal.pone.0110435	http://dx.doi.org/10.1371/journal.pone.0110435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360527	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700035
J	Al Olaby, RR; Cocquerel, L; Zemla, A; Saas, L; Dubuisson, J; Vielmetter, J; Marcotrigiano, J; Khan, AG; Catalan, FV; Perryman, AL; Freundlich, JS; Forli, S; Levy, S; Balhorn, R; Azzazy, HM				Al Olaby, Reem R.; Cocquerel, Laurence; Zemla, Adam; Saas, Laure; Dubuisson, Jean; Vielmetter, Jost; Marcotrigiano, Joseph; Khan, Abdul Ghafoor; Catalan, Felipe Vences; Perryman, Alexander L.; Freundlich, Joel S.; Forli, Stefano; Levy, Shoshana; Balhorn, Rod; Azzazy, Hassan M.			Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; N-LINKED GLYCANS; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; RECOMBINANT VACCINIA; AUTODOCK VINA; PROTEIN E2; CD81; BINDING; EXPRESSION	Hepatitis C Virus (HCV) infects 200 million individuals worldwide. Although several FDA approved drugs targeting the HCV serine protease and polymerase have shown promising results, there is a need for better drugs that are effective in treating a broader range of HCV genotypes and subtypes without being used in combination with interferon and/or ribavirin. Recently, two crystal structures of the core of the HCV E2 protein (E2c) have been determined, providing structural information that can now be used to target the E2 protein and develop drugs that disrupt the early stages of HCV infection by blocking E2' s interaction with different host factors. Using the E2c structure as a template, we have created a structural model of the E2 protein core (residues 421-645) that contains the three amino acid segments that are not present in either structure. Computational docking of a diverse library of 1,715 small molecules to this model led to the identification of a set of 34 ligands predicted to bind near conserved amino acid residues involved in the HCV E2: CD81 interaction. Surface plasmon resonance detection was used to screen the ligand set for binding to recombinant E2 protein, and the best binders were subsequently tested to identify compounds that inhibit the infection of Huh-7 cells by HCV. One compound, 281816, blocked E2 binding to CD81 and inhibited HCV infection in a genotype-independent manner with IC50' s ranging from 2.2 mu M to 4.6 mu M. 281816 blocked the early and late steps of cell-free HCV entry and also abrogated the cell-to-cell transmission of HCV. Collectively the results obtained with this new structural model of E2c suggest the development of small molecule inhibitors such as 281816 that target E2 and disrupt its interaction with CD81 may provide a new paradigm for HCV treatment.	[Al Olaby, Reem R.; Azzazy, Hassan M.] Amer Univ Cairo, Dept Chem, New Cairo, Egypt; [Cocquerel, Laurence; Saas, Laure; Dubuisson, Jean] Univ Lille North France, Pasteur Inst Lille, CNRS, Ctr Infect & Immun Lille,CNRS UMR8204,Inserm U019, Lille, France; [Zemla, Adam] Lawrence Livermore Natl Lab, Livermore, CA USA; [Vielmetter, Jost] CALTECH, Prot Express Ctr, Beckman Inst, Pasadena, CA 91125 USA; [Marcotrigiano, Joseph; Khan, Abdul Ghafoor] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Catalan, Felipe Vences; Levy, Shoshana] Stanford Univ, Ctr Med, Dept Med, Stanford, CA 94305 USA; [Perryman, Alexander L.; Freundlich, Joel S.] Rutgers State Univ, New Jersey Med Sch, Ctr Emerging & Reemerging Pathogens, Dept Med,Div Infect Dis, Newark, NJ USA; [Freundlich, Joel S.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ USA; [Forli, Stefano] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Balhorn, Rod] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA	Egyptian Knowledge Bank (EKB); American University Cairo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; California Institute of Technology; Rutgers State University New Brunswick; Stanford University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Scripps Research Institute; University of California System; University of California Davis	Balhorn, R (corresponding author), SHAL Technol Inc, Livermore, CA 94550 USA.	rod@shaltech.com	Forli, Stefano/AFR-7638-2022; Marcotrigiano, Joseph/K-6697-2016; Cocquerel, Laurence/P-1951-2016; Azzazy, Hassan M. E./G-6831-2013; Khan, Abdul/P-1569-2016; Dubuisson, Jean/E-6813-2016	Forli, Stefano/0000-0002-5964-7111; Marcotrigiano, Joseph/0000-0003-0346-3353; Cocquerel, Laurence/0000-0002-2136-5178; Khan, Abdul/0000-0001-8600-8254; Azzazy, Hassan/0000-0003-2047-4222; Dubuisson, Jean/0000-0003-1626-7693	Yousif Jameel PhD Fellowship from The American University in Cairo; Alberta Innovates [201201140] Funding Source: researchfish	Yousif Jameel PhD Fellowship from The American University in Cairo(American University Cairo); Alberta Innovates	This work was conducted as part of the first authors PhD thesis work. This work was supported by a Yousif Jameel PhD Fellowship from The American University in Cairo awarded to Reem Al Olaby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel Golo, 2013, Immune Netw, V13, P168, DOI 10.4110/in.2013.13.5.168; Allen MH, 2011, J CLIN PSYCHIAT, V72, P1313, DOI 10.4088/JCP.10m06011yel; Anwar MI, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-351; Asselah T, 2014, EXPERT OPIN PHARMACO, V15, P121, DOI 10.1517/14656566.2014.857656; BAN TA, 1982, INT PHARMACOPSYCHIAT, V17, P18, DOI 10.1159/000468553; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brazzoli M, 2005, VIROLOGY, V332, P438, DOI 10.1016/j.virol.2004.11.034; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Carlsen THR, 2013, J VIROL, V87, P1385, DOI 10.1128/JVI.00684-12; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Colombo M, 2014, GUT, V63, P1150, DOI 10.1136/gutjnl-2013-305667; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; El-Awady MK, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-66; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Ferrer M, 1998, CLIN EXP IMMUNOL, V113, P346; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064221; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; HORMAZABAL L, 1985, PSYCHOPHARMACOLOGY, V86, P205, DOI 10.1007/BF00431710; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kwentus J, 2012, BIPOLAR DISORD, V14, P31, DOI 10.1111/j.1399-5618.2011.00975.x; LANFORD RE, 1993, VIROLOGY, V197, P225, DOI 10.1006/viro.1993.1583; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Li YP, 2006, WORLD J GASTROENTERO, V12, P7126, DOI 10.3748/wjg.v12.i44.7126; Liu J, 2001, BIOTECHNOL APPL BIOC, V34, P109, DOI 10.1042/BA20010036; Luo RF, 2010, HUM PATHOL, V41, P271, DOI 10.1016/j.humpath.2009.07.022; Maher Alicia R, 2012, J Manag Care Pharm, V18, pS1; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Marks KM, 2012, ANTIVIR THER, V17, P1119, DOI 10.3851/IMP2424; Martinez-Donato G, 2007, MOL BIOTECHNOL, V35, P225, DOI 10.1007/BF02686008; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; *NIH MOL LIBR PROB, QHTS FOR INHIBITORS; *NIH MOL LIBR PROB, HTS ASSAY FOR ALLOST; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perryman AL, 2014, J COMPUT AID MOL DES, V28, P429, DOI 10.1007/s10822-014-9709-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Potel J, 2013, CELL MICROBIOL, V15, P1234, DOI 10.1111/cmi.12112; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rodriguez-Rodriguez M, 2009, VIRUS RES, V139, P91, DOI 10.1016/j.virusres.2008.10.013; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; *SO RES I, HIGH THROUGHPUT SCRE; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Thase M. E., 2008, NEUROPSYCH DIS TREAT, V4, P21; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UHLIR F, 1975, ACTIV NERV SUPER, V17, P215; VanCompernolle SE, 2003, VIROLOGY, V314, P371, DOI 10.1016/S0042-6822(03)00406-9; Vausselin T, 2013, HEPATOLOGY, V58, P86, DOI 10.1002/hep.26273; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P899, DOI 10.1001/archneurol.2011.139; Whidby J, 2009, J VIROL, V83, P11078, DOI 10.1128/JVI.00800-09; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Yi MK, 1997, VIROLOGY, V231, P119, DOI 10.1006/viro.1997.8516; Yurkova MS, 2004, PROTEIN EXPRES PURIF, V37, P119, DOI 10.1016/j.pep.2004.05.016; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zemla AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-226; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhang YY, 2010, J VIROL, V84, P3396, DOI 10.1128/JVI.02391-09	99	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111333	10.1371/journal.pone.0111333	http://dx.doi.org/10.1371/journal.pone.0111333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357246	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000346765000052
J	Doron, L; Coppenhagen-Glazer, S; Ibrahim, Y; Eini, A; Naor, R; Rosen, G; Bachrach, G				Doron, Lior; Coppenhagen-Glazer, Shunit; Ibrahim, Yara; Eini, Amir; Naor, Ronit; Rosen, Graciela; Bachrach, Gilad			Identification and Characterization of Fusolisin, the Fusobacterium nucleatum Autotransporter Serine Protease	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; ESCHERICHIA-COLI; PERIODONTAL BACTERIA; TREPONEMA-DENTICOLA; OUTER-MEMBRANE; PRETERM BIRTH; SECRETION; COAGGREGATION; PLAQUE	Fusobacterium nucleatum is an oral anaerobe associated with periodontal disease, adverse pregnancy outcomes and colorectal carcinoma. A serine endopeptidase of 61-65 kDa capable of damaging host tissue and of inactivating immune effectors was detected previously in F. nucleatum. Here we describe the identification of this serine protease, named fusolisin, in three oral F. nucleatum sub-species. Gel zymogram revealed fusobacterial proteolytic activity with molecular masses ranging from 55-101 kDa. All of the detected proteases were inhibited by the serine protease inhibitor PMSF. analysis revealed that all of the detected proteases are encoded by genes encoding an open reading frame (ORF) with a calculated mass of approximately 115 kDa. Bioinformatics analysis of the identified ORFs demonstrated that they consist of three domains characteristic of autotransporters of the type Va secretion system. Our results suggest that the F. nucleatum fusolisins are derived from a precursor of approximately 115 kDa. After crossing the cytoplasmic membrane and cleavage of the leader sequence, the C-terminal autotransporter domain of the remaining 96-113 kDa protein is embedded in the outer membrane and delivers the N-terminal S8 serine protease passenger domain to the outer cell surface. In most strains the N-terminal catalytic 55-65 kDa domain self cleaves and liberates itself from the autotransporter domain after its transfer across the outer cell membrane. In F. nucleatum ATCC 25586 this autocatalytic activity is less efficient resulting in a full length membrane-anchored serine protease. The mature serine protease was found to cleave after Thr, Gly, Ala and Leu residues at the P1 position. Growth of F. nucleatum in complex medium was inhibited when serine protease inhibitors were used. Additional experiments are needed to determine whether fusolisin might be used as a target for controlling fusobacterial infections.	[Doron, Lior; Coppenhagen-Glazer, Shunit; Ibrahim, Yara; Eini, Amir; Naor, Ronit; Rosen, Graciela; Bachrach, Gilad] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Inst Dent Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Bachrach, G (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	giladba@ekmd.huji.ac.il		Bachrach, Gilad/0000-0003-1350-2280	Israel Science Foundation [208/10]; United States-Israel Binational Science Foundation [2005084]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Israel Science Foundation (grant 208/10) and in part by the United States-Israel Binational Science Foundation (grant number 2005084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach G, 2004, APPL ENVIRON MICROB, V70, P6957, DOI 10.1128/AEM.70.12.6957-6962.2004; Bachrach G, 2004, ORAL MICROBIOL IMMUN, V19, P155, DOI 10.1111/j.0902-0055.2004.00132.x; BAKKEN V, 1989, SCAND J DENT RES, V97, P42; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BROKSTAD KA, 1990, FEMS MICROBIOL LETT, V66, P235; BROKSTAD KA, 1991, SCAND J DENT RES, V99, P20; Canizalez-Roman A, 2003, MOL MICROBIOL, V48, P947, DOI 10.1046/j.1365-2958.2003.03492.x; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Eini A, 2013, ANAEROBE, V22, P20, DOI 10.1016/j.anaerobe.2013.04.014; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; GHARBIA SE, 1991, ORAL MICROBIOL IMMUN, V6, P264, DOI 10.1111/j.1399-302X.1991.tb00489.x; GHARBIA SE, 1992, INT J SYST BACTERIOL, V42, P296, DOI 10.1099/00207713-42-2-296; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Haake SK, 2006, PLASMID, V55, P27, DOI 10.1016/j.plasmid.2005.06.002; Haake SK, 2000, J BACTERIOL, V182, P1176, DOI 10.1128/JB.182.4.1176-1180.2000; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Henderson IR, 2000, TRENDS MICROBIOL, V8, P534, DOI 10.1016/S0966-842X(00)01884-9; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Higgins D G, 1994, Methods Mol Biol, V25, P307; HILL GB, 1993, CLIN INFECT DIS, V16, pS423, DOI 10.1093/clinids/16.Supplement_4.S423; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan A, 2014, MICROB ECOL; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lievin-Le Moal V, 2011, CELL MICROBIOL, V13, P992, DOI 10.1111/j.1462-5822.2011.01595.x; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Ogawa AT, 2006, J ENDODONT, V32, P521, DOI 10.1016/j.joen.2005.10.045; Orth D, 2010, INFECT IMMUN, V78, P4294, DOI 10.1128/IAI.00488-10; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; ROGERS AH, 1991, ORAL MICROBIOL IMMUN, V6, P250, DOI 10.1111/j.1399-302X.1991.tb00486.x; Rogers AH, 1998, ANAEROBE, V4, P111, DOI 10.1006/anae.1997.0140; Rosen G, 2006, FEMS MICROBIOL LETT, V256, P304, DOI 10.1111/j.1574-6968.2006.00131.x; Rosen G, 2003, INFECT IMMUN, V71, P3652, DOI 10.1128/IAI.71.6.3652-3656.2003; Rosen G, 2012, INFECT IMMUN, V80, P1107, DOI 10.1128/IAI.05903-11; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Shah H N, 1987, Chemioterapia, V6, P16; SHAH HN, 1989, INFECTION, V17, P264, DOI 10.1007/BF01639537; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Siezen RJ, 2007, PROTEINS, V67, P681, DOI 10.1002/prot.21290; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sol A, 2014, J BIOL CHEM; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; Wilkins MR, 1999, METH MOL B, V112, P531; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Wing HJ, 2005, INFECT IMMUN, V73, P1217, DOI 10.1128/IAI.73.2.1217-1220.2005; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoneda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099263	68	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111329	10.1371/journal.pone.0111329	http://dx.doi.org/10.1371/journal.pone.0111329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357190	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000051
J	Liao, KL; Bai, XF; Friedman, A				Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner			Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis	PLOS ONE			English	Article							REGULATORY T-CELLS; EPSTEIN-BARR-VIRUS; TGF-BETA; PERIPHERAL-BLOOD; HIV-1 INFECTION; BREAST-CANCER; GM-CSF; IL-35; EXPRESSION; MACROPHAGES	Interleukin-35 (IL-35), a cytokine from the Interleukin-12 cytokine family, has been considered as an anti-inflammatory cytokine which promotes tumor progression and tumor immune evasion. It has also been demonstrated that IL-35 is secreted by regulatory T cells. Recent mouse experiments have shown that IL-35 produced by cancer cells promotes tumor growth via enhancing myeloid cell accumulation and angiogenesis, and reducing the infiltration of activated CD8(+) T cells into tumor microenvironment. In the present paper we develop a mathematical model based on these experimental results. We include in the model an anti-IL-35 drug as treatment. The extended model (with drug) is used to design protocols of anti-IL-35 injections for treatment of cancer. We find that with a fixed total amount of drug, continuous injection has better efficacy than intermittent injections in reducing the tumor load while the treatment is ongoing. We also find that the percentage of tumor reduction under anti-IL-35 treatment improves when the production of IL-35 by cancer is increased.	[Liao, Kang-Ling; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liao, KL (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	liao.92@mbi.osu.edu	Bai, Xue-feng/E-2681-2011; Bai, Xue-Feng/H-5164-2013	Bai, Xue-Feng/0000-0001-9476-8376	National Science Council of Taiwan, R. O. C. [NSC 101-2917-I-564-062]; National Science Foundation, Division of Mathematical Sciences [DMS. 0931642]; National Cancer Institute [R01CA138427]; American Cancer Society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Science Council of Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); National Science Foundation, Division of Mathematical Sciences(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by the National Science Council of Taiwan, R. O. C. (http://web1.nsc.gov.tw/) under No. NSC 101-2917-I-564-062, the National Science Foundation, Division of Mathematical Sciences (http://www.nsf.gov/) under Agreement DMS. 0931642, the National Cancer Institute (http:// www.cancer.gov/) under R01CA138427, and American Cancer Society (http://www.cancer. org/) under RSG-09-188-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Baek HJ, 2006, BIOCHEM BIOPH RES CO, V346, P1150, DOI 10.1016/j.bbrc.2006.05.195; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Breward CJW, 2001, EUR J APPL MATH, V12, P529, DOI 10.1017/S095679250100448X; BUTTERWORTH AE, 1967, BRIT J CANCER, V21, P373, DOI 10.1038/bjc.1967.43; CASCIARI JJ, 1988, CANCER RES, V48, P3905; Chaplain MAJ, 1995, ACTA BIOTHEOR, V43, P387, DOI 10.1007/BF00713561; CHAPLAIN MAJ, 1995, J MATH BIOL, V33, P744; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; DiLeo MV, 2009, ANN BIOMED ENG, V37, P222, DOI 10.1007/s10439-008-9587-8; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Freeman BJ, 1999, BLOOD, V94, P2142, DOI 10.1182/blood.V94.6.2142.418k16_2142_2150; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Hengel RL, 1999, J IMMUNOL, V163, P3539; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jeng C-J, 2011, ISRN IMMUNOL, V2011, DOI DOI 10.5402/2011/497397; Kendall M, 1998, DYING LIVE OUR BODIE; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Kross KW, 2007, ACTA OTO-LARYNGOL, V127, P532, DOI 10.1080/00016480600951384; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Lee SM, 1996, BLOOD, V88, P945; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Lin YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052490; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Long J, 2013, BIOCHEM BIOPH RES CO, V430, P364, DOI 10.1016/j.bbrc.2012.11.004; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Nicholl MB, 2014, CYTOKINE IN PRESS; Niedobitek G, 2002, J PATHOL, V198, P310, DOI 10.1002/path.1217; Nishino R, 2011, CLIN CANCER RES, V17, P6272, DOI 10.1158/1078-0432.CCR-11-0060; Oren H, 2001, PEDIATRICS, V108, P329, DOI 10.1542/peds.108.2.329; Owen MR, 1997, J THEOR BIOL, V189, P63, DOI 10.1006/jtbi.1997.0494; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Quatromoni JG, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-30; Robertson, 1996, Oncologist, V1, P88; Robertson MJ, 1999, CLIN CANCER RES, V5, P9; Robertson-Tessi M, 2011, J THEOR BIOL, V10, P294; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sanchez-Hernandez Carla, 2010, BMC Res Notes, V3, P151, DOI 10.1186/1756-0500-3-151; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SPRENT J, 1973, CELL IMMUNOL, V7, P40, DOI 10.1016/0008-8749(73)90181-0; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Tang SS, 2000, CHINESE SCI BULL, V45, P1697, DOI 10.1007/BF02898990; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Tiemessen MM, 2003, INT IMMUNOL, V15, P1495, DOI 10.1093/intimm/dxg147; Todorovic-Rakovic N., 2003, ARCH ONCOL, V11, P131; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Utting JC, 2010, CELL BIOCHEM FUNCT, V28, P374, DOI 10.1002/cbf.1660; Vaupel P, 2003, CANCER RES, V63, P7634; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; WAGNER H, 1982, CLIN HAEMATOL, V11, P607; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Xu M, 2010, CLIN DEV IMMUNOL, V14; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Yates A, 2001, DISCRETE CONT DYN-B, V1, P43; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Zeng JC, 2013, INT J CLIN EXP PATHO, V6, P1806	90	30	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110126	10.1371/journal.pone.0110126	http://dx.doi.org/10.1371/journal.pone.0110126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356878	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000012
J	Welk, A; Welk, E; Bruelheide, H				Welk, Astrid; Welk, Erik; Bruelheide, Helge			Biotic Interactions Overrule Plant Responses to Climate, Depending on the Species' Biogeography	PLOS ONE			English	Article							GEOGRAPHIC DISTRIBUTIONS; POSITIVE INTERACTIONS; RANGE LIMITS; HERBIVORY; GRADIENT; COMMUNITIES; TEMPERATURE; DEMOGRAPHY; GRASSLAND; EVOLUTION	This study presents an experimental approach to assess the relative importance of climatic and biotic factors as determinants of species' geographical distributions. We asked to what extent responses of grassland plant species to biotic interactions vary with climate, and to what degree this variation depends on the species' biogeography. Using a gradient from oceanic to continental climate represented by nine common garden transplant sites in Germany, we experimentally tested whether congeneric grassland species of different geographic distribution (oceanic vs. continental plant range type) responded differently to combinations of climate, competition and mollusc herbivory. We found the relative importance of biotic interactions and climate to vary between the different components of plant performance. While survival and plant height increased with precipitation, temperature had no effect on plant performance. Additionally, species with continental plant range type increased their growth in more benign climatic conditions, while those with oceanic range type were largely unable to take a similar advantage of better climatic conditions. Competition generally caused strong reductions of aboveground biomass and growth. In contrast, herbivory had minor effects on survival and growth. Against expectation, these negative effects of competition and herbivory were not mitigated under more stressful continental climate conditions. In conclusion we suggest variation in relative importance of climate and biotic interactions on broader scales, mediated via species-specific sensitivities and factor-specific response patterns. Our results have important implications for species distribution models, as they emphasize the large-scale impact of biotic interactions on plant distribution patterns and the necessity to take plant range types into account.	[Welk, Astrid; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Germany; [Welk, Erik; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Welk, A (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Germany.	astrid.welk@botanik.uni-halle.de	WELK, Erik/AGL-4971-2022; Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356	Graduate School of Saxony-Anhalt; DFG [BR 1698/14-1]	Graduate School of Saxony-Anhalt; DFG(German Research Foundation (DFG))	Graduate School of Saxony-Anhalt and the DFG Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories'' (BR 1698/14-1) supported the study financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Bruelheide H, 2002, FLORA, V197, P475, DOI 10.1078/0367-2530-00064; Bruelheide H, 1999, J ECOL, V87, P839, DOI 10.1046/j.1365-2745.1999.00403.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Butof A, 2011, PRESLIA, V83, P205; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; COLWELL RK, 1975, ANNU REV ECOL SYST, V6, P281, DOI 10.1146/annurev.es.06.110175.001433; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ellenberg H., 1953, BER DT BOT GES, V65, P351, DOI 10.1111/j.1438-8677.1953.tb00671.x; Engels JG, 2010, OIKOS, V119, P679, DOI 10.1111/j.1600-0706.2009.17940.x; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Gaston JK, 2003, STRUCTURE DYNAMICS G; Godsoe W, 2010, OIKOS, V119, P53, DOI 10.1111/j.1600-0706.2009.17630.x; Hector A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043358; Hennenberg KJ, 2003, PLANT ECOL, V166, P167, DOI 10.1023/A:1023280109225; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofmann M, 2013, PRESLIA, V85, P1; Hunt R., 1990, BASIC GROWTH ANAL; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jager EJ, 1968, FEDDES REPERT, V79, P157, DOI 10.1002/fedr.19680790302; Jager EJ, 2005, WERNER ROTHMALER EXK; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; le Roux PC, 2013, ECOLOGY, V94, P671, DOI 10.1890/12-1482.1; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Louda S. M., 1990, Perspectives on plant competition., P413; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maurer K, 2003, BASIC APPL ECOL, V4, P307, DOI 10.1078/1439-1791-00162; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Rodriguez-Castaneda G, 2013, GLOBAL ECOL BIOGEOGR, V22, P118, DOI 10.1111/j.1466-8238.2012.00795.x; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Salisbury EJ, 1926, GEOGR J, V67, P312, DOI 10.2307/1782828; Scheidel U, 2001, OECOLOGIA, V129, P75, DOI 10.1007/s004420100695; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	42	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111023	10.1371/journal.pone.0111023	http://dx.doi.org/10.1371/journal.pone.0111023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356912	Green Published, Green Submitted, gold			2022-12-26	WOS:000346765000036
J	Scheidt, SN; Hurlbert, AH				Scheidt, Spencer N.; Hurlbert, Allen H.			Range Expansion and Population Dynamics of an Invasive Species: The Eurasian Collared-Dove (Streptopelia decaocto)	PLOS ONE			English	Article							MODEL; DISPERSAL; SPREAD	Invasive species offer ecologists the opportunity to study the factors governing species distributions and population growth. The Eurasian Collared-Dove (Streptopelia decaocto) serves as a model organism for invasive spread because of the wealth of abundance records and the recent development of the invasion. We tested whether a set of environmental variables were related to the carrying capacities and growth rates of individual populations by modeling the growth trajectories of individual populations of the Collared-Dove using Breeding Bird Survey (BBS) and Christmas Bird Count (CBC) data. Depending on the fit of our growth models, carrying capacity and growth rate parameters were extracted and modeled using historical, geographical, land cover and climatic predictors. Model averaging and individual variable importance weights were used to assess the strength of these predictors. The specific variables with the greatest support in our models differed between data sets, which may be the result of temporal and spatial differences between the BBS and CBC. However, our results indicate that both carrying capacity and population growth rates are related to developed land cover and temperature, while growth rates may also be influenced by dispersal patterns along the invasion front. Model averaged multivariate models explained 35-48% and 41-46% of the variation in carrying capacities and population growth rates, respectively. Our results suggest that widespread species invasions can be evaluated within a predictable population ecology framework. Land cover and climate both have important effects on population growth rates and carrying capacities of Collared-Dove populations. Efforts to model aspects of population growth of this invasive species were more successful than attempts to model static abundance patterns, pointing to a potentially fruitful avenue for the development of improved invasive distribution models.	[Scheidt, Spencer N.; Hurlbert, Allen H.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Scheidt, SN (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA.	spencer.scheidt@gmail.com		Hurlbert, Allen/0000-0002-5678-9907				Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Best L.B., 1981, Studies in Avian Biology, P252; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Bonter DN, 2010, ECOGRAPHY, V33, P494, DOI 10.1111/j.1600-0587.2009.06017.x; Breiman L., 1984, CLASSIFICATION REGRE; Bruno JF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P13; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bystrak D., 1981, Studies in Avian Biology, P34; COOMBS CFB, 1981, J APPL ECOL, V18, P41, DOI 10.2307/2402478; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; ELTON CS, 1958, ECOLOGY INVASIONS PL; Eraud C, 2007, J BIOGEOGR, V34, P1077, DOI 10.1111/j.1365-2699.2006.01673.x; Fisher J., 1953, British Birds, V46, P153; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fujisaki I, 2010, IBIS, V152, P622, DOI 10.1111/j.1474-919X.2010.01038.x; HENGEVELD R, 1988, J BIOGEOGR, V15, P819, DOI 10.2307/2845342; HENGEVELD R, 1993, J FIELD ORNITHOL, V64, P477; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hooten MB, 2008, ENVIRON ECOL STAT, V15, P59, DOI 10.1007/s10651-007-0040-1; Hudson R., 1972, British Birds, V65, P139; Kinlan BP, 2005, RATES POPULATION SPR, P381; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; McKinney ML, 2007, GLOBAL ECOL BIOGEOGR, V16, P394, DOI 10.1111/j.1466-8238.2007.00296.x; National Audubon Society, 2010, CHRISTM BIRD COUNT H; Poling TD, 2006, J WILDLIFE MANAGE, V70, P998, DOI 10.2193/0022-541X(2006)70[998:DOAFCB]2.0.CO;2; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, V5; Ricklefs RE, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P165; Romagosa CM, 2000, J FIELD ORNITHOL, V71, P159, DOI 10.1648/0273-8570-71.1.159; Romagosa CM, 2012, BIRDS N AM ONLINE; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Telford RJ, 2005, QUATERNARY SCI REV, V24, P2173, DOI 10.1016/j.quascirev.2005.05.001; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	40	24	26	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111510	10.1371/journal.pone.0111510	http://dx.doi.org/10.1371/journal.pone.0111510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354270	Green Submitted, gold, Green Published			2022-12-26	WOS:000345204200086
J	Shi, GL; Dutta, S; Paul, S; Wang, B; Jacques, FMB				Shi, Gongle; Dutta, Suryendu; Paul, Swagata; Wang, Bo; Jacques, Frederic M. B.			Terpenoid Compositions and Botanical Origins of Late Cretaceous and Miocene Amber from China	PLOS ONE			English	Article							EOCENE FUSHUN AMBER; PALEOBOTANICAL ORIGIN; DIVERSE PALEOBIOTA; FOSSIL; RESIN; DIPTEROCARPACEAE; SESQUITERPENOIDS; IDENTIFICATION; DITERPENOIDS; INCLUSIONS	The terpenoid compositions of the Late Cretaceous Xixia amber from Central China and the middle Miocene Zhangpu amber from Southeast China were analyzed by gas chromatography-mass spectrometry (GC-MS) to elucidate their botanical origins. The Xixia amber is characterized by sesquiterpenoids, abietane and phyllocladane type diterpenoids, but lacks phenolic abietanes and labdane derivatives. The molecular compositions indicate that the Xixia amber is most likely contributed by the conifer family Araucariaceae, which is today distributed primarily in the Southern Hemisphere, but widely occurred in the Northern Hemisphere during the Mesozoic according to paleobotanical evidence. The middle Miocene Zhangpu amber is characterized by amyrin and amyrone-based triterpenoids and cadalene-based sesquiterpenoids. It is considered derived from the tropical angiosperm family Dipterocarpaceae based on these compounds and the co-occurring fossil winged fruits of the family in Zhangpu. This provides new evidence for the occurrence of a dipterocarp forest in the middle Miocene of Southeast China. It is the first detailed biomarker study for amber from East Asia.	[Shi, Gongle; Wang, Bo] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Dutta, Suryendu; Paul, Swagata] Indian Inst Technol, Dept Earth Sci, Bombay, Maharashtra, India; [Wang, Bo] Univ Bonn, Steinmann Inst, Bonn, Germany; [Jacques, Frederic M. B.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China	Chinese Academy of Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Bonn; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Shi, GL (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.	glshi@nigpas.ac.cn	Shi, Gongle/E-3840-2012; Wang, Bo/AAU-1329-2021	Shi, Gongle/0000-0003-3374-6637; Wang, Bo/0000-0001-8947-8526; Dutta, Suryendu/0000-0003-2969-116X	973 Project of China [2012CB821900]; National Natural Science Foundation of China [41206173]; Humboldt Research Fellowship for Postdoctoral Researchers	973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humboldt Research Fellowship for Postdoctoral Researchers	This work was supported by the 973 Project of China (2012CB821900, http://program.most.gov.cn/), National Natural Science Foundation of China (41206173, http://www.nsfc.gov.cn/), and the Humboldt Research Fellowship for Postdoctoral Researchers to BW (http://www.humboldt-foundation.de/web/humboldt-fellowship-postdoc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Anderson JM, 2007, STRELITZIA, V20, P1; ANDERSON KB, 1992, ORG GEOCHEM, V18, P829, DOI 10.1016/0146-6380(92)90051-X; Ashton P. S., 1982, Flora Malesiana, I, Spermatophyta, V9, P237; Bohme M., 2013, ZITTELIANA A, V53, P120; Bray PS, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-3; Cao Meizhen, 2011, Acta Micropalaeontologica Sinica, V28, P98; Chen Jin-hua, 2007, Acta Palaeontologica Sinica, V46, P299; Cox RE, 2007, BIOCHEM SYST ECOL, V35, P342, DOI 10.1016/j.bse.2006.09.013; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Dutta S, 2011, REV PALAEOBOT PALYNO, V166, P63, DOI 10.1016/j.revpalbo.2011.05.002; Dutta S, 2011, INT J COAL GEOL, V85, P49, DOI 10.1016/j.coal.2010.09.006; Dutta S, 2010, J EARTH SYST SCI, V119, P711, DOI 10.1007/s12040-010-0041-6; Dutta S, 2009, INT J COAL GEOL, V80, P44, DOI 10.1016/j.coal.2009.07.006; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; GRANTHAM PJ, 1980, GEOCHIM COSMOCHIM AC, V44, P1801, DOI 10.1016/0016-7037(80)90229-X; Ho KS, 2003, CHEM GEOL, V197, P287, DOI 10.1016/S0009-2541(02)00399-6; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Li G, 2009, CRETACEOUS RES, V30, P477, DOI 10.1016/j.cretres.2008.09.002; Mallick M, 2014, INT J COAL GEOL, V121, P129, DOI 10.1016/j.coal.2013.11.013; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; McKellar RC, 2011, P ROY SOC B-BIOL SCI, V278, P3219, DOI 10.1098/rspb.2011.0276; Menor-Salvan C, 2010, ORG GEOCHEM, V41, P1089, DOI 10.1016/j.orggeochem.2010.06.013; Morley Robert J., 2011, Smithsonian Contributions to Botany, P21; NOBLE RA, 1986, ORG GEOCHEM, V10, P825, DOI 10.1016/S0146-6380(86)80019-5; Otto A, 2002, SCIENCE, V297, P1543, DOI 10.1126/science.1074225; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; Penalver E, 2007, CRETACEOUS RES, V28, P791, DOI 10.1016/j.cretres.2006.12.004; Pereira R, 2009, ORG GEOCHEM, V40, P863, DOI 10.1016/j.orggeochem.2009.05.002; PHILIPPE M., 2005, HIST BIOL, V17, P1; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Rudra A, 2014, J EARTH SYST SCI, V123, P935, DOI 10.1007/s12040-014-0443-y; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Schmidt AR, 2006, NATURE, V444, P835, DOI 10.1038/444835a; Schmidt AR, 2012, P NATL ACAD SCI USA, V109, P14796, DOI 10.1073/pnas.1208464109; Shi GL, 2014, REV PALAEOBOT PALYNO, V200, P97, DOI 10.1016/j.revpalbo.2013.09.003; Shi GL, 2010, REV PALAEOBOT PALYNO, V162, P599, DOI 10.1016/j.revpalbo.2010.08.001; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; van der Ham RWJM, 2010, PALAEOGEOGR PALAEOCL, V291, P469, DOI 10.1016/j.palaeo.2010.03.017; VANAARSSEN BGK, 1994, GEOCHIM COSMOCHIM AC, V58, P223, DOI 10.1016/0016-7037(94)90459-6; Wang B, 2014, CURR BIOL, V24, P1606, DOI 10.1016/j.cub.2014.05.048; Wang B, 2011, J PALEONTOL, V85, P1154; Wang De-You, 2006, Acta Palaeontologica Sinica, V45, P494; Wolfe AP, 2009, P R SOC B, V276, P3403, DOI 10.1098/rspb.2009.0806; Wu, 1980, VEGETATION CHINA; Zheng Y.H., 1994, ACTA PALAEONTOL SIN, V33, P200; Zhong H, 1995, CHINA GEMS JADES, V4, P58; Zhou S, 2005, MINERAL RESOURCES GE, V19, P57	51	22	23	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111303	10.1371/journal.pone.0111303	http://dx.doi.org/10.1371/journal.pone.0111303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354364	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200069
J	Fan, K; Wang, M; Miao, Y; Ni, M; Bibi, N; Yuan, SN; Li, F; Wang, XD				Fan, Kai; Wang, Ming; Miao, Ying; Ni, Mi; Bibi, Noreen; Yuan, Shuna; Li, Feng; Wang, Xuede			Molecular Evolution and Expansion Analysis of the NAC Transcription Factor in Zea mays	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; FACTOR GENE FAMILY; STRESS-RESPONSIVE GENES; NO-APICAL-MERISTEM; COMPREHENSIVE ANALYSIS; EXPRESSION ANALYSIS; MAIZE NAC; ARABIDOPSIS; PROTEIN; DOMAIN	NAC (NAM, ATAF1, 2 and CUC2) family is a plant-specific transcription factor and it controls various plant developmental processes. In the current study, 124 NAC members were identified in Zea mays and were phylogenetically clustered into 13 distinct subfamilies. The whole genome duplication (WGD), especially an additional WGD event, may lead to expanding ZmNAC members. Different subfamily has different expansion rate, and NAC subfamily preference was found during the expansion in maize. Moreover, the duplication events might occur after the divergence of the lineages of Z. mays and S. italica, and segmental duplication seemed to be the dominant pattern for the gene duplication in maize. Furthermore, the expansion of ZmNAC members may be also related to gain and loss of introns. Besides, the restriction of functional divergence was discovered after most of the gene duplication events. These results could provide novel insights into molecular evolution and expansion analysis of NAC family in maize, and advance the NAC researches in other plants, especially polyploid plants.	[Fan, Kai; Wang, Ming; Ni, Mi; Bibi, Noreen; Yuan, Shuna; Li, Feng; Wang, Xuede] Zhejiang Univ, Coll Agr & Biotechnol, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Miao, Ying] Fujian Agr & Forestry Univ, Coll Life Sci, Ctr Mol Cell & Syst Biol, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Fujian Agriculture & Forestry University	Wang, XD (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdwang@zju.edu.cn		Ni, Mi/0000-0002-8930-6887	Ministry of Agriculture [2009ZX08009-061B]; National Natural Science Foundation of China [31171616]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Agriculture (2009ZX08009-061B) and the National Natural Science Foundation of China (no. 31171616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cenci A, 2014, PLANT MOL BIOL, P1; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; de Oliveira TM, 2011, TREE GENET GENOMES, V7, P1123, DOI 10.1007/s11295-011-0400-8; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Faria JAQA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-129; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang GQ, 2013, PLANT GROWTH REGUL, V71, P101, DOI 10.1007/s10725-013-9811-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Ma J, 2014, SCI HORTIC-AMSTERDAM, V165, P82, DOI 10.1016/j.scienta.2013.11.005; Meng QC, 2007, J PLANT PHYSIOL, V164, P1002, DOI 10.1016/j.jplph.2006.05.019; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park KC, 2010, GENES GENOM, V32, P570, DOI 10.1007/s13258-010-0076-8; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ricachenevsky FK, 2010, MOL BIOL REP, V37, P3735, DOI 10.1007/s11033-010-0027-0; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Su HY, 2013, PLANT PHYSIOL BIOCH, V71, P11, DOI 10.1016/j.plaphy.2013.06.022; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van Camp W, 2005, CURR OPIN BIOTECH, V16, P147, DOI 10.1016/j.copbio.2005.03.002; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang ZY, 2013, ACTA PHYSIOL PLANT, V35, P1397, DOI 10.1007/s11738-012-1195-4; Welner DH, 2012, BIOCHEM J, V444, P395, DOI 10.1042/BJ20111742; Yoon HK, 2008, MOL CELLS, V25, P438; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003	71	43	50	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111837	10.1371/journal.pone.0111837	http://dx.doi.org/10.1371/journal.pone.0111837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369196	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000110
J	Napoli, PE; Coronella, F; Satta, GM; Fossarello, M				Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Fossarello, Maurizio			A Novel Technique of Contrast-Enhanced Optical Coherence Tomography Imaging in Evaluation of Clearance of Lipids in Human Tears	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; DRY EYE DISEASE; ARTIFICIAL TEARS; CORNEAL SURFACE; OCULAR SURFACE; FILM; EVAPORATION; TURNOVER; LAYER; FLUOROPHOTOMETRY	Purpose: The aim of this work was to gather preliminary data in different conditions of healthy eyes, aqueous tear deficient dry eyes, obstructive meibomian gland disease (MGD) and non-obvious obstructive MGD (NOMGD) individuals, using a new, contrast-enhanced optical coherence tomography (OCT) imaging method to evaluate the clearance of lipids in human tears. Methods: Eighty-two adult patients presenting with complaints of ocular irritation were studied for abnormalities of the ocular surface and classified as healthy (n = 21), aqueous tear deficient dry eyes (n = 20), obstructive MGD (n = 15) and NOMGD (n = 26) individuals. A lipid-based tracer, containing an oil-in-water emulsion, was used to obtain an enhanced OCT imaging of the lower tear meniscus. After instillation, a dramatic initial increase of reflectivity of the lower tear meniscus was detected by OCT, followed by a decay back to baseline values over time. Based on this finding, the clearance of lipids was measured in real-time by Fourier-domain anterior segment OCT. Results: The differences in the clearance of lipids among the four groups as well as the correlations between symptom questionnaire score, standardized visual scale test, fluorescein break-up time, ocular surface fluorescein staining score, Schirmer I test scores were found to be statistically significant. The individual areas under the curve of the clearance of lipids calculated by the receiver operating characteristic curve technique ranged from 0.66 to 0.98, suggesting reliable sensitivity and specificity of lipid-enhanced OCT imaging. Conclusions: This new technique of contrast-enhanced OCT imaging of the tear film following lipid-based tracer instillation provides a measure of the clearance of lipids. The quantitative values found are in agreement with other methods of evaluation of the lacrimal system. An improvement of the clinician's ability in the diagnosis and understanding of abnormalities of the ocular surface may be achieved by this simple approach.	[Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Fossarello, Maurizio] Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy	University of Cagliari	Napoli, PE (corresponding author), Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Napoli, Pietro Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760				Amano S, 2010, J EYE ATARASHII GANK, V27, P627; [Anonymous], 2007, OCUL SURF, V5, P108; Blackie CA, 2010, CORNEA, V29, P1333, DOI 10.1097/ICO.0b013e3181d4f366; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; Craig JP, 1997, OPTOMETRY VISION SCI, V74, P8, DOI 10.1097/00006324-199701000-00014; De La Lagrima TS, 2006, ARCH SOC ESP OFTALMO, V81, P365; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Gasymov OK, 2005, INVEST OPHTH VIS SCI, V46, P3589, DOI 10.1167/iovs.05-0569; Glasgow BJ, 1999, INVEST OPHTH VIS SCI, V40, P3100; Gobbels M, 1992, Ger J Ophthalmol, V1, P350; KUPPENS EVMJ, 1992, INVEST OPHTH VIS SCI, V33, P3442; Lemp M. A, 1992, DRY EYE COMPREHENSIV, P101; Macri A, 2000, OPHTHALMOLOGY, V107, P1338, DOI 10.1016/S0161-6420(00)00101-9; Mathers W, 2004, EXP EYE RES, V78, P389, DOI 10.1016/S0014-4835(03)00199-4; Mathers WD, 1996, OPHTHALMOLOGY, V103, P664, DOI 10.1016/S0161-6420(96)30637-4; Mathers WD, 1996, CORNEA, V15, P229, DOI 10.1097/00003226-199605000-00001; McNamara NA, 1998, OPTOMETRY VISION SCI, V75, P316, DOI 10.1097/00006324-199805000-00020; MISHIMA S., 1966, INVEST OPHTHALMOL, V5, P264; MISHIMA S, 1965, ARCH OPHTHALMOL-CHIC, V73, P233; Mochizuki H, 2008, BRIT J OPHTHALMOL, V92, P108, DOI 10.1136/bjo.2007.121533; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003; Nichols JJ, 2002, OPTOMETRY VISION SCI, V79, P363, DOI 10.1097/00006324-200206000-00009; Pearce EI, 2001, OPTOMETRY VISION SCI, V78, P30, DOI 10.1097/00006324-200101010-00011; Redl B, 2000, BBA-PROTEIN STRUCT M, V1482, P241, DOI 10.1016/S0167-4838(00)00142-4; TIFFANY JM, 1987, ADV LIPID RES, V22, P1; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; VANBEST JA, 1995, GRAEF ARCH CLIN EXP, V233, P1; Walt JRM., 1997, DRUG INF J, V31, P1436; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P4349, DOI 10.1167/iovs.05-1654; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P3325, DOI 10.1167/iovs.06-0055	35	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109843	10.1371/journal.pone.0109843	http://dx.doi.org/10.1371/journal.pone.0109843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369027	gold, Green Published, Green Submitted			2022-12-26	WOS:000344402000011
J	Feng, J; Wang, T; Zhang, S; Shi, WL; Zhang, Y				Feng, Jie; Wang, Ting; Zhang, Shuo; Shi, Wanliang; Zhang, Ying			An Optimized SYBR Green I/PI Assay for Rapid Viability Assessment and Antibiotic Susceptibility Testing for Borrelia burgdorferi	PLOS ONE			English	Article							3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL TETRAZOLIUM BROMIDE; MYCOBACTERIUM-TUBERCULOSIS; QUANTIFICATION; BACTERIA; GROWTH	Lyme disease caused by Borrelia burgdorferi is the most common tick-borne disease in the US and Europe. Unlike most bacteria, measurements of growth and viability of B. burgdorferi are challenging. The current B. burgdorferi viability assays based on microscopic counting and PCR are cumbersome and tedious and cannot be used in a high throughput format. Here, we evaluated several commonly used viability assays including MTT and XTT assays, fluorescein diacetate assay, Sytox Green/Hoechst 33342 assay, the commercially available LIVE/DEAD BacLight assay, and SYBR Green I/PI assay by microscopic counting and by automated 96-well plate reader for rapid viability assessment of B. burgdorferi. We found that the optimized SYBR Green I/PI assay based on green to red fluorescence ratio is superior to all the other assays for measuring the viability of B. burgdorferi in terms of sensitivity, accuracy, reliability, and speed in automated 96-well plate format and in comparison with microscopic counting. The BSK-H medium which produced a high background for the LIVE/DEAD BacLight assay did not affect the SYBR Green I/PI assay, and the viability of B. burgdorferi culture could be directly measured using a microtiter plate reader. The SYBR Green I/PI assay was found to reliably assess the viability of planktonic as well as biofilm B. burgdorferi and could be used as a rapid antibiotic susceptibility test. Thus, the SYBR Green I/PI assay provides a more sensitive, rapid and convenient method for evaluating viability and antibiotic susceptibility of B. burgdorferi and can be used for high-throughput drug screens.	[Feng, Jie; Wang, Ting; Zhang, Shuo; Shi, Wanliang; Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, Y (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	yzhang@jhsph.edu	Feng, Jie/AAZ-1723-2021	Feng, Jie/0000-0001-8358-5654	Lyme Research Alliance (lymedisease.org)	Lyme Research Alliance (lymedisease.org)	Support was provided by the Lyme Research Alliance (lymedisease.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Barbesti S, 2000, CYTOMETRY, V40, P214, DOI 10.1002/1097-0320(20000701)40:3<214::AID-CYTO6>3.0.CO;2-M; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Brorson O, 2009, P NATL ACAD SCI USA, V106, P18656, DOI 10.1073/pnas.0908236106; Centers for Disease Control, 2014, LYM DIS; Cerca F, 2011, CAN J MICROBIOL, V57, P850, DOI [10.1139/W11-078, 10.1139/w11-078]; Cornell KA, 2009, J ANTIMICROB CHEMOTH, V63, P1163, DOI 10.1093/jac/dkp129; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Feng J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.53; Gabrielson J, 2002, J MICROBIOL METH, V50, P63, DOI 10.1016/S0167-7012(02)00011-8; Hunfeld KP, 2006, WIEN KLIN WOCHENSCHR, V118, P659, DOI 10.1007/s00508-006-0693-z; Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214, DOI 10.1128/JCM.36.5.1214-1219.1998; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Sapi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048277; Sapi Eva, 2011, Infect Drug Resist, V4, P97, DOI 10.2147/IDR.S19201; Sun ZH, 1999, J BACTERIOL, V181, P7626, DOI 10.1128/JB.181.24.7626-7628.1999; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004	19	63	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111809	10.1371/journal.pone.0111809	http://dx.doi.org/10.1371/journal.pone.0111809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365247	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100126
J	Mazzoni, E; Pietrobon, S; Masini, I; Rotondo, JC; Gentile, M; Fainardi, E; Casetta, I; Castellazzi, M; Granieri, E; Caniati, ML; Tola, MR; Guerra, G; Martini, F; Tognon, M				Mazzoni, Elisa; Pietrobon, Silvia; Masini, Irene; Rotondo, John Charles; Gentile, Mauro; Fainardi, Enrico; Casetta, Ilaria; Castellazzi, Massimiliano; Granieri, Enrico; Caniati, Maria Luisa; Tola, Maria Rosaria; Guerra, Giovanni; Martini, Fernanda; Tognon, Mauro			Significant Low Prevalence of Antibodies Reacting with Simian Virus 40 Mimotopes in Serum Samples from Patients Affected by Inflammatory Neurologic Diseases, Including Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN BRAIN-TUMORS; LARGE T-ANTIGEN; SV40 ANTIBODIES; JC VIRUS; BK VIRUS; INFECTION; ASSOCIATION; HUMANS; MESOTHELIOMA	Many investigations were carried out on the association between viruses and multiple sclerosis (MS). Indeed, early studies reported the detections of neurotropic virus footprints in the CNS of patients with MS. In this study, sera from patients affected by MS, other inflammatory (OIND) and non-inflammatory neurologic diseases (NIND) were analyzed for antibodies against the polyomavirus, Simian Virus 40 (SV40). An indirect enzyme-linked immunosorbent assay (ELISA), with two synthetic peptides, which mimic SV40 antigens, was employed to detect specific antibodies in sera from patients affected by MS, OIND, NIND and healthy subjects (HS). Immunologic data indicate that in sera from MS patients antibodies against SV40 mimotopes are detectable with a low prevalence, 6%, whereas in HS of the same mean age, 40 yrs, the prevalence was 22%. The difference is statistically significant (P = 0.001). Significant is also the difference between MS vs. NIND patients (6% vs. 17%; P = 0.0254), whereas no significant difference was detected between MS vs OIND (6% vs 10%; P > 0.05). The prevalence of SV40 antibodies in MS patients is 70% lower than that revealed in HS.	[Mazzoni, Elisa; Pietrobon, Silvia; Masini, Irene; Rotondo, John Charles; Martini, Fernanda; Tognon, Mauro] Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Fainardi, Enrico] Univ Hosp Ferrara, Unit Neuroradiol, Ferrara, Italy; [Gentile, Mauro; Casetta, Ilaria; Castellazzi, Massimiliano; Granieri, Enrico] Univ Ferrara, Sch Med, Neurol Sect, I-44100 Ferrara, Italy; [Caniati, Maria Luisa; Tola, Maria Rosaria] Univ Hosp Ferrara, Neurol Unit, Ferrara, Italy; [Guerra, Giovanni] Univ Hosp Ferrara, Clin Lab Anal, Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna	Martini, F (corresponding author), Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.	mrf@unife.it; tgm@unife.it	Castellazzi, Massimiliano/X-3499-2019; Casetta, Ilaria/K-5289-2016; Rotondo, John Charles/A-4540-2017; gentile, mauro/AAC-4595-2021; Castellazzi, Massimiliano/K-5083-2016; Mazzoni, Elisa/K-6313-2016	Castellazzi, Massimiliano/0000-0001-6555-6075; Casetta, Ilaria/0000-0003-4099-8875; Rotondo, John Charles/0000-0001-5179-1525; gentile, mauro/0000-0002-6912-8868; Castellazzi, Massimiliano/0000-0001-6555-6075; Mazzoni, Elisa/0000-0001-6829-8569; Granieri, Enrico/0000-0003-4038-3192	University of Ferrara; FAR Projects; University Hospital of Ferrara; Regione Emilia Romagna; ERMES; MS project; Fondazione Cassa di Risparmio di Ferrara; Fondazione Cassa di Risparmio di Cento	University of Ferrara; FAR Projects; University Hospital of Ferrara; Regione Emilia Romagna(Regione Emilia Romagna); ERMES; MS project; Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Fondazione Cassa di Risparmio di Cento	This study was sponsored, in part, by grants from The University of Ferrara, FAR Projects, University Hospital of Ferrara, Regione Emilia Romagna, ERMES, MS project to E.G., F.M. and M.T., Fondazione Cassa di Risparmio di Ferrara to E.G., and Fondazione Cassa di Risparmio di Cento to F.M. and M.T. Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; Barbanti-Brodano G, 1998, ADV VIRUS RES, V50, P69, DOI 10.1016/S0065-3527(08)60806-4; Broccolo F, 2013, SCI WORLD J, DOI 10.1155/2013/867389; Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232; Comar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104848; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Corallini A, 2012, HUM IMMUNOL, V73, P502, DOI 10.1016/j.humimm.2012.02.009; de la Hera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090182; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Giovannoni G, 2006, LANCET NEUROL, V5, P887, DOI 10.1016/S1474-4422(06)70577-4; Granieri E, 1997, NEUROLOGY, V49, pS2, DOI 10.1212/WNL.49.2_Suppl_2.S2; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Hoffmann Franziska, 2014, Eur J Immunol, V44, P1247, DOI 10.1002/eji.201470045; HORVATH CJ, 1992, AM J PATHOL, V140, P1431; Kaliyaperumal S, 2013, AM J PATHOL, V183, P1910, DOI 10.1016/j.ajpath.2013.08.007; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kjaerheim K, 2007, INT J CANCER, V120, P2459, DOI 10.1002/ijc.22592; Kvistad S, 2014, MULTIPLE SCLEROSIS; Libbey JE, 2013, INT REV IMMUNOLOGY; Lundstig A, 2005, J GEN VIROL, V86, P1703, DOI 10.1099/vir.0.80783-0; Mameli G, 2013, J NEUROIMMUNOL, V264, P120, DOI 10.1016/j.jneuroim.2013.07.017; Martini F, 1996, CANCER RES, V56, P4820; MARTINI F, 1995, J NATL CANCER I, V87, P1331, DOI 10.1093/jnci/87.17.1331; Martini F, 1998, INT J CANCER, V78, P669, DOI 10.1002/(SICI)1097-0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B; Martini Fernanda, 2007, Infect Agent Cancer, V2, P13, DOI 10.1186/1750-9378-2-13; Mazzoni E, 2013, J INFECTION, V67, P356, DOI 10.1016/j.jinf.2013.06.002; Mazzoni E, 2014, NEURO-ONCOLOGY, V16, P513, DOI 10.1093/neuonc/not217; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Pakpoor J, 2013, EXPERT REV NEUROTHER, V13, P287, DOI [10.1586/ERN.13.6, 10.1586/ern.13.6]; Ribeiro T, 2010, NEUROL SCI, V31, P517, DOI 10.1007/s10072-010-0353-y; Taronna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061182; Tognon M, 1996, CANCER GENET CYTOGEN, V90, P17, DOI 10.1016/0165-4608(96)00067-2; Viscidi RP, 2003, CLIN DIAGN LAB IMMUN, V10, P278, DOI 10.1128/CDLI.10.2.278-285.2003	34	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110923	10.1371/journal.pone.0110923	http://dx.doi.org/10.1371/journal.pone.0110923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365364	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100035
J	Noda, K; Nakajima, S; Godo, S; Saito, H; Ikeda, S; Shimizu, T; Enkhjargal, B; Fukumoto, Y; Tsukita, S; Yamada, T; Katagiri, H; Shimokawa, H				Noda, Kazuki; Nakajima, Sota; Godo, Shigeo; Saito, Hiroki; Ikeda, Shohei; Shimizu, Toru; Enkhjargal, Budbazar; Fukumoto, Yoshihiro; Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki; Shimokawa, Hiroaki			Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LONG-TERM INHIBITION; PROTEIN-KINASE; SKELETAL-MUSCLE; METFORMIN; PHOSPHORYLATION; ADAPTATION; MECHANISM; UPSTREAM; SURVIVAL	Background: Metabolic disorders, caused by excessive calorie intake and low physical activity, are important cardiovascular risk factors. Rho-kinase, an effector protein of the small GTP-binding protein RhoA, is an important cardiovascular therapeutic target and its activity is increased in patients with metabolic syndrome. We aimed to examine whether Rho-kinase inhibition improves high-fat diet (HFD)-induced metabolic disorders, and if so, to elucidate the involvement of AMP-activated kinase (AMPK), a key molecule of metabolic conditions. Methods and Results: Mice were fed a high-fat diet, which induced metabolic phenotypes, such as obesity, hypercholesterolemia and glucose intolerance. These phenotypes are suppressed by treatment with selective Rho-kinase inhibitor, associated with increased whole body O-2 consumption and AMPK activation in the skeletal muscle and liver. Moreover, Rho-kinase inhibition increased mRNA expression of the molecules linked to fatty acid oxidation, mitochondrial energy production and glucose metabolism, all of which are known as targets of AMPK in those tissues. In systemic overexpression of dominant-negative Rho-kinase mice, body weight, serum lipid levels and glucose metabolism were improved compared with littermate control mice. Furthermore, in AMPK alpha 2-deficient mice, the beneficial effects of fasudil, a Rho-kinase inhibitor, on body weight, hypercholesterolemia, mRNA expression of the AMPK targets and increase of whole body O-2 consumption were absent, whereas glucose metabolism was restored by fasudil to the level in wild-type mice. In cultured mouse myocytes, pharmacological and genetic inhibition of Rho-kinase increased AMPK activity through liver kinase b1 (LKB1), with up-regulation of its targets, which effects were abolished by an AMPK inhibitor, compound C. Conclusions: These results indicate that Rho-kinase inhibition ameliorates metabolic disorders through activation of the LKB1/AMPK pathway, suggesting that Rho-kinase is also a novel therapeutic target of metabolic disorders.	[Noda, Kazuki; Nakajima, Sota; Godo, Shigeo; Saito, Hiroki; Ikeda, Shohei; Shimizu, Toru; Enkhjargal, Budbazar; Fukumoto, Yoshihiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Dept Metab Dis, Ctr Metab Dis, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp		Shimokawa, Hiroaki/0000-0001-7534-4826; Godo, Shigeo/0000-0002-4985-7828	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Grant-in-Aid for Scientific Research on Innovative Areas (Signaling Functions of Reactive Oxygen Species), the Grant-in-Aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine, and the Grants-in-Aid for Scientific Research, all of which are from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kikuchi Y, 2007, J ENDOCRINOL, V192, P595, DOI 10.1677/JOE-06-0045; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee SH, 2014, AM J PHYSIOL-ENDOC M, V306, pE332, DOI 10.1152/ajpendo.00619.2013; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Nakajima S, 2012, CIRC RES, V111, P87, DOI 10.1161/CIRCRESAHA.112.270215; Noda K, 2012, TOHOKU J EXP MED, V228, P305, DOI 10.1620/tjem.228.305; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shimokawa H, 2001, CARDIOVASC RES, V51, P169, DOI 10.1016/S0008-6363(01)00291-7; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang YY, 2012, LIVER TRANSPLANT, V18, P1371, DOI 10.1002/lt.23520; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110446	10.1371/journal.pone.0110446	http://dx.doi.org/10.1371/journal.pone.0110446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365359	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100022
J	Zadra, JR; Proffitt, DR				Zadra, Jonathan R.; Proffitt, Dennis R.			Implicit Associations Have a Circadian Rhythm	PLOS ONE			English	Article							BLOOD-GLUCOSE; SELF-CONTROL; AUTOMATIC ATTITUDES; EXECUTIVE FUNCTION; INSULIN-SECRETION; DIURNAL-VARIATION; COGNITIVE DEMAND; STRENGTH MODEL; EGO DEPLETION; ENERGY	The current study shows that people's ability to inhibit implicit associations that run counter to their explicit views varies in a circadian pattern. The presence of this rhythmic variation suggests the involvement of a biological process in regulating automatic associations-specifically, with the current data, associations that form undesirable social biases. In 1998, Greenwald, McGhee, and Schwartz introduced the Implicit Association Test as a means of measuring individual differences in implicit cognition. The IAT is a powerful tool that has become widely used. Perhaps most visibly, studies employing the IAT demonstrate that people generally hold implicit biases against social groups, which often conflict with their explicitly held views. The IAT engages inhibitory processes similar to those inherent in self-control tasks. Because the latter processes are known to be resource-limited, we considered whether IAT scores might likewise be resource dependent. Analyzing IAT performance from over a million participants across all times of day, we found a clear circadian pattern in scores. This finding suggests that the IAT measures not only the strength of implicit associations, but also the effect of variations in the physiological resources available to inhibit their undesirable influences on explicit behavior.	[Zadra, Jonathan R.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Zadra, Jonathan R.; Proffitt, Dennis R.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	Utah System of Higher Education; University of Utah; University of Virginia	Zadra, JR (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	j.zadra@utah.edu						Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Benton D, 1996, J BIOSOC SCI, V28, P463, DOI 10.1017/S0021932000022537; Benton D, 2001, PHYSIOL BEHAV, V74, P559, DOI 10.1016/S0031-9384(01)00601-1; BENTON D, 1992, BIOL PSYCHOL, V33, P207, DOI 10.1016/0301-0511(92)90032-P; BODENHAUSEN GV, 1990, PSYCHOL SCI, V1, P319, DOI 10.1111/j.1467-9280.1990.tb00226.x; BOLLI GB, 1984, DIABETES, V33, P1150, DOI 10.2337/diabetes.33.12.1150; CARROLL KF, 1973, DIABETES, V22, P333, DOI 10.2337/diab.22.5.333; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Donohoe RT, 1999, PSYCHOPHARMACOLOGY, V145, P378, DOI 10.1007/s002130051071; Donohoe RT, 2000, PHYSIOL BEHAV, V71, P395, DOI 10.1016/S0031-9384(00)00359-0; Fairclough SH, 2004, BIOL PSYCHOL, V66, P177, DOI 10.1016/j.biopsycho.2003.10.001; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Gailliot MT, 2009, J EXP SOC PSYCHOL, V45, P288, DOI 10.1016/j.jesp.2008.09.003; Gailliot MT, 2008, PERSPECT PSYCHOL SCI, V3, P245, DOI 10.1111/j.1745-6924.2008.00077.x; Gordijn EH, 2004, PERS SOC PSYCHOL B, V30, P212, DOI 10.1177/0146167203259935; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hofmann W, 2007, J EXP SOC PSYCHOL, V43, P497, DOI 10.1016/j.jesp.2006.05.004; Hucklebridge FH, 1999, LIFE SCI, V64, P931, DOI 10.1016/S0024-3205(99)00019-3; Ingwersen J, 2007, APPETITE, V49, P240, DOI 10.1016/j.appet.2006.06.009; JARRETT RJ, 1972, BRIT MED J, V1, P199, DOI 10.1136/bmj.1.5794.199; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; Lai CK, J EXP PSYCHOL GEN; McGrath JE., 1986, TIME HUMAN INTERACTI; MESSIER C, 1987, BEHAV NEURAL BIOL, V48, P104, DOI 10.1016/S0163-1047(87)90634-0; Miller HC, 2013, J PSYCHOPHARMACOL, V27, P645, DOI 10.1177/0269881112473790; Miller HC, 2012, BEHAV PROCESS, V91, P313, DOI 10.1016/j.beproc.2012.09.012; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Ostafin BD, 2008, BEHAV RES THER, V46, P1210, DOI 10.1016/j.brat.2008.08.003; Owens DS, 1997, PHYSIOL BEHAV, V62, P471, DOI 10.1016/S0031-9384(97)00156-X; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Richeson JA, 2005, J PERS SOC PSYCHOL, V88, P934, DOI 10.1037/0022-3514.88.6.934; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Scholey AB, 2001, PHYSIOL BEHAV, V73, P585, DOI 10.1016/S0031-9384(01)00476-0; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Townsend J. T., 1992, COGNITION INFORMATIO, P105; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VANCAUTER E, 1992, AM J PHYSIOL, V262, pE467, DOI 10.1152/ajpendo.1992.262.4.E467; Wallace HM, 2002, SELF IDENTITY, V1, P35, DOI 10.1080/152988602317232786; WENK GL, 1989, PSYCHOPHARMACOLOGY, V99, P431, DOI 10.1007/BF00589888	52	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110149	10.1371/journal.pone.0110149	http://dx.doi.org/10.1371/journal.pone.0110149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365254	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100018
J	Devauges, V; Matthews, DR; Aluko, J; Nedbal, J; Levitt, JA; Poland, SP; Coban, O; Weitsman, G; Monypenny, J; Ng, T; Ameer-Beg, SM				Devauges, Viviane; Matthews, Daniel R.; Aluko, Justin; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.			Steady-State Acceptor Fluorescence Anisotropy Imaging under Evanescent Excitation for Visualisation of FRET at the Plasma Membrane	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; RESONANCE ENERGY-TRANSFER; NUMERICAL-APERTURE OBJECTIVES; LIVING CELLS; IMMUNOLOGICAL SYNAPSE; BREAST-CANCER; RHO-GTPASE; LIVE CELLS; STRUCTURED ILLUMINATION; POLARIZATION MICROSCOPY	We present a novel imaging system combining total internal reflection fluorescence (TIRF) microscopy with measurement of steady-state acceptor fluorescence anisotropy in order to perform live cell Forster Resonance Energy Transfer (FRET) imaging at the plasma membrane. We compare directly the imaging performance of fluorescence anisotropy resolved TIRF with epifluorescence illumination. The use of high numerical aperture objective for TIRF required correction for induced depolarization factors. This arrangement enabled visualisation of conformational changes of a Raichu-Cdc42 FRET biosensor by measurement of intramolecular FRET between eGFP and mRFP1. Higher activity of the probe was found at the cell plasma membrane compared to intracellularly. Imaging fluorescence anisotropy in TIRF allowed clear differentiation of the Raichu-Cdc42 biosensor from negative control mutants. Finally, inhibition of Cdc42 was imaged dynamically in live cells, where we show temporal changes of the activity of the Raichu-Cdc42 biosensor.	[Devauges, Viviane; Matthews, Daniel R.; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.] Kings Coll London, Div Canc Studies, Richard Dimbleby Canc Res Lab, London WC2R 2LS, England; [Devauges, Viviane; Matthews, Daniel R.; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Aluko, Justin] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Ng, Tony] UCL, UCL Canc Inst, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London	Ameer-Beg, SM (corresponding author), Kings Coll London, Div Canc Studies, Richard Dimbleby Canc Res Lab, London WC2R 2LS, England.	simon.ameer-beg@kcl.ac.uk		Ng, Tony/0000-0003-3894-5619; Ameer-Beg, Simon/0000-0001-5227-575X	Biotechnology and Biological Sciences Research Council UK [BB/G007160/1, BB/I022074/1]; Cancer Research UK; Engineering and Physical Sciences Research Council (UK); Medical Research Council (UK); Department of Health (UK); KCL/UCL Comprehensive Cancer Imaging Centre; Dimbleby Cancer Care endowment fund; Biotechnology and Biological Sciences Research Council [BB/G007160/1, BB/I022074/1] Funding Source: researchfish; Cancer Research UK [16463] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1413605] Funding Source: researchfish; BBSRC [BB/G007160/1, BB/I022074/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (UK); KCL/UCL Comprehensive Cancer Imaging Centre; Dimbleby Cancer Care endowment fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Biotechnology and Biological Sciences Research Council UK, http://www.bbsrc.ac.uk, BB/G007160/1 (TN, SMA) and BB/I022074/1 (SMA, DRM, TN), Cancer Research UK, Engineering and Physical Sciences Research Council (UK), Medical Research Council (UK) and Department of Health (UK), KCL/UCL Comprehensive Cancer Imaging Centre, and by The Dimbleby Cancer Care endowment fund to King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2012, CANCER SCI, V103, P614, DOI 10.1111/j.1349-7006.2011.02196.x; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Axelrod D, 2013, BIOPHYS J, V104, P1401, DOI 10.1016/j.bpj.2013.02.044; Axelrod D, 2012, J MICROSC-OXFORD, V247, P147, DOI 10.1111/j.1365-2818.2012.03625.x; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bahlmann K, 2000, APPL PHYS LETT, V77, P612, DOI 10.1063/1.127061; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BALLEW RM, 1989, ANAL CHEM, V61, P30, DOI 10.1021/ac00176a007; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Barroca T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218101; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BERBERANSANTOS MN, 1991, J CHEM PHYS, V95, P8048, DOI 10.1063/1.461285; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Beutler M, 2008, EUR BIOPHYS J BIOPHY, V38, P69, DOI 10.1007/s00249-008-0361-5; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BREMARD C, 1985, APPL SPECTROSC, V39, P1036, DOI 10.1366/0003702854249754; Brunstein M, 2014, BIOPHYS J, V106, P1044, DOI 10.1016/j.bpj.2013.12.051; Brunstein M, 2013, OPT EXPRESS, V21, P26162, DOI 10.1364/OE.21.026162; BURGHARDT TP, 1984, BIOPHYS J, V46, P729, DOI 10.1016/S0006-3495(84)84071-0; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carlin LM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001729; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Devauges V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044434; Elson DS, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/180; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Enderlein J, 2011, OPT EXPRESS, V19, P8011, DOI 10.1364/OE.19.008011; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Fisz JJ, 2007, J PHYS CHEM A, V111, P8606, DOI 10.1021/jp072113b; Fisz JJ, 2005, CHEM PHYS LETT, V412, P263, DOI 10.1016/j.cplett.2005.06.108; Forkey JN, 2005, BIOPHYS J, V89, P1261, DOI 10.1529/biophysj.104.053470; FORSTER T, 1946, NATURWISSENSCHAFTEN, V33, P166, DOI 10.1007/BF00585226; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fruhwirth GO, 2011, CHEMPHYSCHEM, V12, P442, DOI 10.1002/cphc.201000866; Fruhwirth GO, 2010, OPT EXPRESS, V18, P11148, DOI 10.1364/OE.18.011148; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gee ML, 2004, EUR BIOPHYS J BIOPHY, V33, P130, DOI 10.1007/s00249-003-0360-5; Gliko O, 2008, BIOMEDICAL OPTICS BI; Godfrey TM, 1953, GLYCEROL; Grant DM, 2007, OPT EXPRESS, V15, P15656, DOI 10.1364/OE.15.015656; Guo F, 2011, PLOS ONE, V6; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; HELLEN EH, 1987, J OPT SOC AM B, V4, P337, DOI 10.1364/JOSAB.4.000337; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kikuchi K, 2011, FEBS LETT, V585, P286, DOI 10.1016/j.febslet.2010.12.010; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; Marquer C, 2011, FASEB J, P1; Matthews DR, 2010, J MICROSC-OXFORD, V237, P51, DOI 10.1111/j.1365-2818.2009.03301.x; Matthews DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033231; Mattheyses AL, 2004, BIOPHYS J, V87, P2787, DOI 10.1529/biophysj.103.036194; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; MIKI T, 1995, METHOD ENZYMOL, V256, P90; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morishita H, 2000, J RAMAN SPECTROSC, V31, P455, DOI 10.1002/1097-4555(200006)31:6<455::AID-JRS551>3.0.CO;2-Q; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Perrin F, 1926, J PHYS-PARIS, V7, P390, DOI 10.1051/jphysrad:01926007012039000; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Scholes CA, 2011, J PHYS CHEM B, V115, P6329, DOI 10.1021/jp201332w; Shribak M, 2002, OPT ENG, V41, P943, DOI 10.1117/1.1467669; Siegel J, 2003, REV SCI INSTRUM, V74, P182, DOI 10.1063/1.1519934; Smith TA, 2005, REV FLUORESCENCE, V2, P245; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Suzuki Y, 2013, DIRECT MOL INTERACTI; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Torok P, 1998, OPT COMMUN, V148, P300, DOI 10.1016/S0030-4018(97)00576-2; Tramier M, 2008, METHOD CELL BIOL, V85, P395, DOI 10.1016/S0091-679X(08)85017-0; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Zhu XW, 2000, INT J DEV NEUROSCI, V18, P433, DOI 10.1016/S0736-5748(00)00010-1; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	102	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110695	10.1371/journal.pone.0110695	http://dx.doi.org/10.1371/journal.pone.0110695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360776	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700041
J	Ipinza, F; Collao, B; Monsalva, D; Bustamante, VH; Luraschi, R; Alegria-Arcos, M; Almonacid, DE; Aguayo, D; Calderon, IL; Gil, F; Santiviago, CA; Morales, EH; Calva, E; Saavedra, CP				Ipinza, Francisco; Collao, Bernardo; Monsalva, Debbie; Bustamante, Victor H.; Luraschi, Roberto; Alegria-Arcos, Melissa; Almonacid, Daniel E.; Aguayo, Daniel; Calderon, Ivan L.; Gil, Fernando; Santiviago, Carlos A.; Morales, Eduardo H.; Calva, Edmundo; Saavedra, Claudia P.			Participation of the Salmonella OmpD Porin in the Infection of RAW264.7 Macrophages and BALB/c Mice	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NADPH PHAGOCYTE OXIDASE; IN-VIVO; ANTIMICROBIAL ACTIONS; ESCHERICHIA-COLI; METHYL VIOLOGEN; PROTEIN; GENE; EXPRESSION; VIRULENCE	Salmonella Typhimurium is the etiological agent of gastroenteritis in humans and enteric fever in mice. Inside these hosts, Salmonella must overcome hostile conditions to develop a successful infection, a process in which the levels of porins may be critical. Herein, the role of the Salmonella Typhimurium porin OmpD in the infection process was assessed for adherence, invasion and proliferation in RAW264.7 mouse macrophages and in BALB/c mice. In cultured macrophages, a Delta ompD strain exhibited increased invasion and proliferation phenotypes as compared to its parental strain. In contrast, overexpression of ompD caused a reduction in bacterial proliferation but did not affect adherence or invasion. In the murine model, the Delta ompD strain showed increased ability to survive and replicate in target organs of infection. The ompD transcript levels showed a down-regulation when Salmonella resided within cultured macrophages and when it colonized target organs in infected mice. Additionally, cultured macrophages infected with the Delta ompD strain produced lower levels of reactive oxygen species, suggesting that down-regulation of ompD could favor replication of Salmonella inside macrophages and the subsequent systemic dissemination, by limiting the reactive oxygen species response of the host.	[Ipinza, Francisco; Collao, Bernardo; Monsalva, Debbie; Luraschi, Roberto; Calderon, Ivan L.; Gil, Fernando; Saavedra, Claudia P.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile; [Bustamante, Victor H.; Calva, Edmundo] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Alegria-Arcos, Melissa; Almonacid, Daniel E.; Aguayo, Daniel] Univ Andres Bello, Fac Ciencias Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile; [Santiviago, Carlos A.] Univ Chile, Fac Ciencias Quim & Farm, Dept Bioquim & Biol Mol, Lab Microbiol, Santiago, Chile; [Morales, Eduardo H.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Morales, Eduardo H.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA	Universidad Andres Bello; Universidad Nacional Autonoma de Mexico; Universidad Andres Bello; Universidad de Chile; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Saavedra, CP (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile.	csaavedra@unab.cl	Bustamante, Victor/GXF-0780-2022; Santiviago, Carlos/N-9991-2018; Luraschi, Roberto/AAI-7965-2021	Santiviago, Carlos/0000-0002-7043-7908; Luraschi, Roberto/0000-0001-5611-4320; Almonacid, Daniel E/0000-0002-1788-2084; Alegria-Arcos, Melissa/0000-0002-9372-9153	FONDECYT [1085131, 1120384, 1110172, 1140754, 11130576]; Nucleo UNAB DI [222-12/N]; CONACYT Mexico [179946]; MECESUP [UAB0802]; Universidad Andres Bello [DI -UNAB DI-187-12/I]; CONICYT	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Nucleo UNAB DI; CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MECESUP; Universidad Andres Bello; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was financed by grants from FONDECYT #1085131 and #1120384 and Nucleo UNAB DI 222-12/N (to C. P. S.), CONACYT Mexico #179946 and MECESUP UAB0802 (to E. B. C.). F. I. was supported by grants DI -UNAB DI-187-12/I from Universidad Andres Bello. B. C. received doctoral fellowships by CONICYT. C. A. S. was supported by FONDECYT grants 1110172 and 1140754. D. A. was supported by grant FONDECYT #11130576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Alberti S, 1996, INFECT IMMUN, V64, P4719; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Calderon IL, 2011, RES MICROBIOL, V162, P214, DOI 10.1016/j.resmic.2010.11.001; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; Gil-Cruz C, 2004, P NATL ACAD SCI USA, V106, P9803; Hara-Kaonga B, 2004, CAN J MICROBIOL, V50, P719, DOI 10.1139/W04-056; He X, 2011, INT J FOOD SCI TECH, V46, P2164, DOI 10.1111/j.1365-2621.2011.02732.x; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LISSNER CR, 1983, J IMMUNOL, V131, P3006; Liu YF, 2012, INFECT IMMUN, V80, P1815, DOI 10.1128/IAI.06395-11; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; Lukk T, 2012, P NATL ACAD SCI USA, V109, P4122, DOI 10.1073/pnas.1112081109; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Meyer PN, 1998, INFECT IMMUN, V66, P387, DOI 10.1128/IAI.66.1.387-390.1998; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Negm RS, 1998, FEMS IMMUNOL MED MIC, V20, P191, DOI 10.1016/S0928-8244(98)00011-X; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez-Morales O, 2006, INFECT IMMUN, V74, P1398, DOI 10.1128/IAI.74.2.1398-1402.2006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Santiviago CA, 2003, J BACTERIOL, V185, P5901, DOI 10.1128/JB.185.19.5901-5905.2003; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Santiviago CA, 2001, MICROBIOL-SGM, V147, P1897, DOI 10.1099/00221287-147-7-1897; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Torii I, 2008, J IMMUNOL, V181, P4229, DOI 10.4049/jimmunol.181.6.4229; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10; Zou Y, 2012, LETT APPL MICROBIOL, V55, P274, DOI 10.1111/j.1472-765X.2012.03288.x	47	15	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111062	10.1371/journal.pone.0111062	http://dx.doi.org/10.1371/journal.pone.0111062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360745	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700060
J	Quan, LQ; Chen, YQ; Song, J; Yan, QM; Zhang, QJ; Lai, SS; Fan, NN; Xin, JG; Zou, QJ; Lai, LX				Quan, Longquan; Chen, Yongqiang; Song, Jun; Yan, Quanmei; Zhang, Quanjun; Lai, Sisi; Fan, Nana; Xin, Jige; Zou, Qingjian; Lai, Liangxue			Establishment of a Rabbit Oct4 Promoter-Based EGFP Reporter System	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER EMBRYOS; FLUORESCENT PROTEIN; POU5F1 GENE; EXPRESSION; GENERATION	Rabbits are commonly used as laboratory animal models to investigate human diseases and phylogenetic development. However, pluripotent stem cells that contribute to germline transmission have yet to be established in rabbits. The transcription factor Oct4, also known as Pou5f1, is considered essential for the maintenance of the pluripotency of stem cells. Hence, pluripotent cells can be identified by monitoring Oct4 expression using a well-established Oct4 promoter-based reporter system. This study developed a rabbit Oct4 promoter-based enhanced green fluorescent protein (EGFP) reporter system by transfecting pROP2-EGFP into rabbit fetal fibroblasts (RFFs). The transgenic RFFs were used as donor cells for somatic cell nuclear transfer (SCNT). The EGFP expression was detected in the blastocysts and genital ridges of SCNT fetuses. Fibroblasts and neural stem cells (NSCs) were derived from the SCNT fetuses. EGFP was also reactivated in blastocysts after the second SCNT, and induced pluripotent stem cells (iPSCs) were obtained after reprogramming using Yamanaka's factors. The results above indicated that a rabbit reporter system used to monitor the differentiating status of cells was successfully developed.	[Quan, Longquan; Xin, Jige; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Chen, Yongqiang; Song, Jun; Yan, Quanmei; Zhang, Quanjun; Lai, Sisi; Fan, Nana; Zou, Qingjian; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zou, QJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	zou_qingjian@gibh.ac.cn; lai_liangxue@gibh.ac.cn	Song, Jun/A-3487-2013	Song, Jun/0000-0002-6128-6378	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA010201070]; Ministry of Science and Technology, National Basic Research Program of China (973 Program) [2010CB945402]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology, National Basic Research Program of China (973 Program)	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (http://www.cas.cn/) Grant XDA010201070 and by Ministry of Science and Technology (http://www.most.gov.cn/index.htm) National Basic Research Program of China (973 Program) Grants 2010CB945402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Hao R, 2007, REPROD FERT DEVELOP, V19, P137, DOI 10.1071/RDv19n1Ab38; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Huang LZ, 2011, CELL REPROGRAM, V13, P93, DOI 10.1089/cell.2010.0069; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JB, 2008, NATURE; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kobolak J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-88; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Miyoshi K, 2009, J REPROD DEVELOP, V55, P661, DOI 10.1262/jrd.09-089A; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Osteil P, 2013, BIOL OPEN, V2, P613, DOI 10.1242/bio.20134242; Ritter DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035202; Shi JJ, 2008, DNA SEQUENCE, V19, P56, DOI 10.1080/10425170701388834; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Tsung HC, 2003, CELL RES, V13, P195, DOI 10.1038/sj.cr.7290164; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yin MR, 2013, INT J DEV BIOL, V57, P845, DOI 10.1387/ijdb.130128sl; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	30	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109728	10.1371/journal.pone.0109728	http://dx.doi.org/10.1371/journal.pone.0109728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360692	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700017
J	Zhang, TH; Jiang, YZ; Qu, X; Shen, HC; Liu, Q; Du, JJ				Zhang, Tiehong; Jiang, Yuanzhu; Qu, Xiao; Shen, Hongchang; Liu, Qi; Du, Jiajun			Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; POOR SURVIVAL; NEUTROPHIL; THROMBOCYTOSIS; LEUKOCYTOSIS; INFLAMMATION; ASSOCIATION; PROTEIN	Background: The aims of this study were to investigate whether the preoperative hematologic markers, the neutrophillymphocyte ratio (NLR) or the platelet-lymphocyte ratio (PLR) were prognostic indicators and to develop a novel risk stratification model in pN0 non-small-cell lung cancer (NSCLC). Methods: We performed a retrospective analysis of 400 consecutive pN0 NSCLC patients. Prognostic values were evaluated by Cox proportional hazard model analyses and patients were stratified according to relative risks for patients' survival. Results: During the follow-up, 117 patients had cancer recurrence, and 86 patients died. In univariate analysis, age, gender, smoke status and tumor size as well as WBC, NEU, LYM, PLR and NLR were significantly associated with patients' prognosis. In multivariate analysis, age, tumor size and NLR were independent predictors for patients' overall survival (P = 0.024, 0.001, and 0.002 respectively). PLR didn't associated with patients' survival in multivariate analysis. Patients were stratified into 3 risk groups and the differences among the groups were significant according to disease free survival and overall survival (P = 0.000 and 0.000 respectively). Conclusions: We confirmed that NLR other than PLR was an independent prognostic factor. Combination of NLR, age and tumor size could stratify pN0 NSCLC patients into 3 risk groups and enabled us to develop a novel risk stratification model.	[Zhang, Tiehong; Qu, Xiao; Shen, Hongchang; Liu, Qi; Du, Jiajun] Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Jiang, Yuanzhu; Du, Jiajun] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong University; Shandong University	Liu, Q (corresponding author), Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			Provincial Science and Technology Development Planning of Shandong [2011GGH21819, 2012G0021836]; Provincial Natural Science Foundation of Shandong [ZR2011HM077]	Provincial Science and Technology Development Planning of Shandong; Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	The work was supported by Provincial Science and Technology Development Planning of Shandong (2011GGH21819), Provincial Science and Technology Development Planning of Shandong (2012G0021836) and Provincial Natural Science Foundation of Shandong (ZR2011HM077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis MG, 2002, RESP MED, V96, P553, DOI 10.1053/rmed.2002.1328; Arrieta O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-50; Asahi Y, 1996, JPN J CANCER RES, V87, P451, DOI 10.1111/j.1349-7006.1996.tb00245.x; Azab B, 2013, MED ONCOL, V30, P1; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Gorczyca W, 2011, POL J PATHOL, V62, P189; He W, 2013, MED ONCOL, V30, P1; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Kim D, 2012, EUROPEAN J SURG ONCO, V38, P861; Kobayashi N, 2012, LUNG CANCER, V75, P223, DOI 10.1016/j.lungcan.2011.06.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Metz CE, 1978, BASIC PRINCIPLES ROC, P283; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tomita M, 2012, ANTICANCER RES, V32, P3535; Tomita M, 2011, ANTICANCER RES, V31, P2995; Tomita M, 2009, ANTICANCER RES, V29, P2687; VANDERSCHOUW YT, 1992, FAM PRACT, V9, P506, DOI 10.1093/fampra/9.4.506; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Yao Y., 2013, P 2013 C LAS EL OPT, P1	26	21	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111494	10.1371/journal.pone.0111494	http://dx.doi.org/10.1371/journal.pone.0111494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360716	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700108
J	Salvo, SAGD; Hirsch, CN; Buell, CR; Kaeppler, SM; Kaeppler, HF				Salvo, Stella A. G. D.; Hirsch, Candice N.; Buell, C. Robin; Kaeppler, Shawn M.; Kaeppler, Heidi F.			Whole Transcriptome Profiling of Maize during Early Somatic Embryogenesis Reveals Altered Expression of Stress Factors and Embryogenesis-Related Genes	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; STEM-CELL MAINTENANCE; POLAR AUXIN TRANSPORT; PLANT-REGENERATION; EMBRYO DEVELOPMENT; MOLECULAR CHARACTERIZATION; REGULATORY NETWORK; ARABIDOPSIS; WUSCHEL; IDENTIFICATION	Embryogenic tissue culture systems are utilized in propagation and genetic engineering of crop plants, but applications are limited by genotype-dependent culture response. To date, few genes necessary for embryogenic callus formation have been identified or characterized. The goal of this research was to enhance our understanding of gene expression during maize embryogenic tissue culture initiation. In this study, we highlight the expression of candidate genes that have been previously regarded in the literature as having important roles in somatic embryogenesis. We utilized RNA based sequencing (RNA-seq) to characterize the transcriptome of immature embryo explants of the highly embryogenic and regenerable maize genotype A188 at 0, 24, 36, 48, and 72 hours after placement of explants on tissue culture initiation medium. Genes annotated as functioning in stress response, such as glutathione-S-transferases and germin-like proteins, and genes involved with hormone transport, such as PINFORMED, increased in expression over 8-fold in the study. Maize genes with high sequence similarity to genes previously described in the initiation of embryogenic cultures, such as transcription factors BABY BOOM, LEAFY COTYLEDON, and AGAMOUS, and important receptor-like kinases such as SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASES and CLAVATA, were also expressed in this time course study. By combining results from whole genome transcriptome analysis with an in depth review of key genes that play a role in the onset of embryogenesis, we propose a model of coordinated expression of somatic embryogenesis-related genes, providing an improved understanding of genomic factors involved in the early steps of embryogenic culture initiation in maize and other plant species.	[Salvo, Stella A. G. D.; Kaeppler, Shawn M.; Kaeppler, Heidi F.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Hirsch, Candice N.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Buell, C. Robin] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Michigan State University; United States Department of Energy (DOE)	Kaeppler, HF (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	hfkaeppl@wisc.edu		Kaeppler, Shawn/0000-0002-5964-1668; Buell, C Robin/0000-0002-6727-4677	National Institute of Food and Agriculture, United States Department of Agriculture [WIS01226]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this research was provided by National Institute of Food and Agriculture, United States Department of Agriculture Hatch funding (WIS01226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiev EV, 2009, CHROMOSOMA, V118, P157, DOI 10.1007/s00412-008-0191-3; ARMSTRONG CL, 1992, THEOR APPL GENET, V84, P755, DOI 10.1007/BF00224181; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Baudino S, 2001, PLANTA, V213, P1, DOI 10.1007/s004250000471; Borlaug NE, 2000, PLANT PHYSIOL, V124, P487, DOI 10.1104/pp.124.2.487; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Caliskan M, 2004, PLANTA, V219, P132, DOI 10.1007/s00425-003-1199-9; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Chintamanani S, 2010, GENETICS, V184, P813, DOI 10.1534/genetics.109.111880; CHU CC, 1975, SCI SINICA, V18, P659; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DEJONG AJ, 1992, PLANT CELL, V4, P425, DOI 10.2307/3869444; Delporte F, 2012, PLANT SIGNAL BEHAV, V7, P1608, DOI 10.4161/psb.22424; Deng W, 2009, PLANT SCI, V177, P43, DOI 10.1016/j.plantsci.2009.03.009; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Feher Attila, 2008, Acta Biologica Szegediensis, V52, P53; Forestan C, 2012, MOL PLANT, V5, P787, DOI 10.1093/mp/ssr103; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Frame B, 2011, METHODS MOL BIOL, V710, P327, DOI 10.1007/978-1-61737-988-8_22; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Galland R, 2007, PLANT SIGNAL BEHAV, V2, P343, DOI 10.4161/psb.2.5.4652; Gambino G, 2011, J EXP BOT, V62, P1089, DOI 10.1093/jxb/erq349; GRAY DJ, 1991, CRIT REV PLANT SCI, V10, P33, DOI 10.1080/07352689109382306; GREEN CE, 1975, CROP SCI, V15, P417, DOI 10.2135/cropsci1975.0011183X001500030040x; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; Heidmann I, 2011, PLANT CELL REP, V30, P1107, DOI 10.1007/s00299-011-1018-x; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; HODGES TK, 1986, BIO-TECHNOL, V4, P219, DOI 10.1038/nbt0386-219; Hoenemann C, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-9; HUYNH QK, 1992, J BIOL CHEM, V267, P6635; Jia HY, 2014, WIRES DEV BIOL, V3, P135, DOI 10.1002/wdev.126; Karami O, 2010, MOL BIOL REP, V37, P2493, DOI 10.1007/s11033-009-9764-3; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Landi P, 2002, MAYDICA, V47, P21; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledwon A, 2011, PLANT GROWTH REGUL, V65, P157, DOI 10.1007/s10725-011-9585-y; Ledwon A, 2009, PLANT CELL REP, V28, P1677, DOI 10.1007/s00299-009-0767-2; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mena M, 1996, SCIENCE, V274, P1537, DOI 10.1126/science.274.5292.1537; Murray SC, 2013, NAT BIOTECHNOL, V31, P877, DOI 10.1038/nbt.2707; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Passarinho P, 2008, PLANT MOL BIOL, V68, P225, DOI 10.1007/s11103-008-9364-y; Perry SE, 1999, PLANT PHYSIOL, V120, P121, DOI 10.1104/pp.120.1.121; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Sang Y, 2009, SEMIN CELL DEV BIOL, V20, P1143, DOI 10.1016/j.semcdb.2009.09.006; SCHMIDT RJ, 1993, PLANT CELL, V5, P729, DOI 10.1105/tpc.5.7.729; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032237; SLATER A, 2007, PLANT BIOTECHNOLOGY, P37; SONGSTAD DD, 1991, PLANT CELL REP, V9, P699, DOI 10.1007/BF00235361; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Targonska M, 2013, PLANT CELL REP, V32, P1, DOI 10.1007/s00299-012-1342-9; Thakare D, 2008, PLANT PHYSIOL, V146, P1663, DOI 10.1104/pp.108.115832; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Zavattieri MA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-4; Zeng FC, 2007, GENOMICS, V90, P620, DOI 10.1016/j.ygeno.2007.07.007; Zhang SB, 2002, PLANTA, V215, P191, DOI 10.1007/s00425-002-0735-3; Zhang SZ, 2011, PLANT CELL TISS ORG, V105, P29, DOI 10.1007/s11240-010-9834-1; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	81	49	50	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111407	10.1371/journal.pone.0111407	http://dx.doi.org/10.1371/journal.pone.0111407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356773	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000058
J	Cigoli, MS; Avemaria, F; De Benedetti, S; Gesu, GP; Accorsi, LG; Parmigiani, S; Corona, MF; Capra, V; Mosca, A; Giovannini, S; Notturno, F; Ciccocioppo, F; Volpi, L; Estienne, M; De Michele, G; Antenora, A; Bilo, L; Tavoni, A; Zamponi, N; Alfei, E; Baranello, G; Riva, D; Penco, S				Cigoli, Maria Sole; Avemaria, Francesca; De Benedetti, Stefano; Gesu, Giovanni P.; Accorsi, Lucio Giordano; Parmigiani, Stefano; Corona, Maria Franca; Capra, Valeria; Mosca, Andrea; Giovannini, Simona; Notturno, Francesca; Ciccocioppo, Fausta; Volpi, Lilia; Estienne, Margherita; De Michele, Giuseppe; Antenora, Antonella; Bilo, Leda; Tavoni, Antonietta; Zamponi, Nelia; Alfei, Enrico; Baranello, Giovanni; Riva, Daria; Penco, Silvana			PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations	PLOS ONE			English	Article							VASCULAR MALFORMATIONS; NATURAL-HISTORY; GCKIII PROTEINS; RECENT INSIGHTS; ITALIAN FAMILY; ENCODING KRIT1; CCM3; IDENTIFICATION; ANGIOMAS; DISEASE	Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been identified causing familial CCM: KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3. Aim of this study is to report additional PDCD10/CCM3 families poorly described so far which account for 10-15% of hereditary cerebral cavernous malformations. Our group investigated 87 consecutive Italian affected individuals (i.e. positive Magnetic Resonance Imaging) with multiple/familial CCM through direct sequencing and Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis. We identified mutations in over 97.7% of cases, and PDCD10/CCM3 accounts for 13.1%. PDCD10/CCM3 molecular screening revealed four already known mutations and four novel ones. The mutated patients show an earlier onset of clinical manifestations as compared to CCM1/CCM2 mutated patients. The study of further families carrying mutations in PDCD10/CCM3 may help define a possible correlation between genotype and phenotype; an accurate clinical follow up of the subjects would help define more precisely whether mutations in PDCD10/CCM3 lead to a characteristic phenotype.	[Cigoli, Maria Sole; Avemaria, Francesca; De Benedetti, Stefano; Gesu, Giovanni P.; Penco, Silvana] Osped Niguarda Ca Granda, Med Genet Unit, Dept Lab Med, Milan, Italy; [Accorsi, Lucio Giordano] Childrens Hosp Brescia, Reg Ctr Epilepsy Childhood & Adolescence, Brescia, Italy; [Parmigiani, Stefano; Corona, Maria Franca] Eastern Liguria Hosp, Paediat & Neonatol Unit, La Spezia, Italy; [Capra, Valeria] G Gaslini Inst Children, Neurosurg Unit, Genoa, Italy; [Mosca, Andrea] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Giovannini, Simona] AUSL Bologna, Child Neurol & Psychiat Unit, Bologna, Italy; [Notturno, Francesca; Ciccocioppo, Fausta] Univ G DAnnunzio, Inst Aging, Dept Human Motor Sci, Chieti, Italy; [Notturno, Francesca; Ciccocioppo, Fausta] Univ G DAnnunzio, Inst Aging, Neuromuscular Dis Unit, Chieti, Italy; [Volpi, Lilia] Bellaria Pizzardi Hosp, AUSL Bologna, Neurol Unit, Bologna, Italy; [Estienne, Margherita; Alfei, Enrico; Baranello, Giovanni; Riva, Daria] Fdn IRCCS Neurol Inst Carlo Besta, Milan, Italy; [De Michele, Giuseppe; Antenora, Antonella; Bilo, Leda] Univ Naples Federico II, Naples, Italy; [Tavoni, Antonietta; Zamponi, Nelia] AOU United Hosp Ancona, Ancona, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; AUSL di Bologna; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; AUSL di Bologna; IRCCS Istituto Neurologico Besta; University of Naples Federico II	Penco, S (corresponding author), Osped Niguarda Ca Granda, Med Genet Unit, Dept Lab Med, Milan, Italy.	silvana.penco@ospedaleniguarda.it	Bilo, Leonilda/AHH-0365-2022; Estienne, Margherita/AAI-9393-2021; Valeria, Capra/AAB-1501-2019; Parmigiani, Stefano/AAC-2624-2021; De Benedetti, Stefano/N-3662-2015; capra, valeria/N-4367-2013	Bilo, Leonilda/0000-0002-9817-4193; Estienne, Margherita/0000-0002-6769-5631; Parmigiani, Stefano/0000-0002-4127-5911; De Benedetti, Stefano/0000-0002-7787-9645; capra, valeria/0000-0002-3097-0388; Penco, Silvana/0000-0003-1050-095X; Notturno, Francesca/0000-0002-4191-6619	Massimo Collice Foundation	Massimo Collice Foundation	MSC was partially financed by Massimo Collice Foundation. No other funds financed the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistini S, 2007, ARCH NEUROL-CHICAGO, V64, P843, DOI 10.1001/archneur.64.6.843; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; BICKNELL JM, 1978, ARCH NEUROL-CHICAGO, V35, P746, DOI 10.1001/archneur.1978.00500350050010; Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Chen L, 2009, STROKE, V40, P1474, DOI 10.1161/STROKEAHA.108.527135; Choe CU, 2010, J NEUROL, V257, P2097, DOI 10.1007/s00415-010-5648-7; Choquet H, 2014, CEREBROVASC DIS, V37, P57, DOI 10.1159/000356839; Coban A, 2008, NEUROLOGIST, V14, P46, DOI 10.1097/NRL.0b013e31813e343f; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gaetzner S, 2007, NEUROSURG REV, V30, P155, DOI 10.1007/s10143-006-0057-1; Gault J, 2006, NEUROSURGERY, V59, P1278, DOI 10.1227/01.NEU.0000249188.38409.03; Gianfrancesco F, 2007, AM J MED GENET B, V144B, P691, DOI 10.1002/ajmg.b.30381; GOMORI JM, 1986, RADIOLOGY, V158, P707, DOI 10.1148/radiology.158.3.3945744; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guarnieri V, 2007, NEUROGENETICS, V8, P29, DOI 10.1007/s10048-006-0056-y; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lee ST, 2008, J NEUROL SCI, V267, P177, DOI 10.1016/j.jns.2007.10.018; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2008, NEUROGENETICS, V9, P25, DOI 10.1007/s10048-007-0109-x; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Marini V, 2003, J NEUROL SCI, V212, P75, DOI 10.1016/S0022-510X(03)00108-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mosca L, 2012, J MOL NEUROSCI, V47, P475, DOI 10.1007/s12031-012-9741-5; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Nannucci S, 2009, NEUROL SCI, V30, P143, DOI 10.1007/s10072-009-0020-3; Penco S, 2009, J NEUROSURG, V110, P929, DOI 10.3171/2008.8.17640; Pileggi S, 2010, J MOL NEUROSCI, V42, P235, DOI 10.1007/s12031-010-9360-y; Porter PJ, 1997, J NEUROSURG, V87, P190, DOI 10.3171/jns.1997.87.2.0190; Riant F, 2013, MOL SYNDROMOL, V4, P165, DOI 10.1159/000350042; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Verlaan DJ, 2005, NEUROLOGY, V65, P1982, DOI 10.1212/01.wnl.0000188903.75144.49; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; WILKINS RH, 1985, NEUROSURGERY, V16, P421, DOI 10.1227/00006123-198503000-00026; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; You C, 2013, J CELL MOL MED, V17, P407, DOI 10.1111/jcmm.12022; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhu YA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS1090	51	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110438	10.1371/journal.pone.0110438	http://dx.doi.org/10.1371/journal.pone.0110438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354366	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200024
J	Genovese, F; Karsdal, MA; Leeming, DJ; Scholze, A; Tepel, M				Genovese, Federica; Karsdal, Morten A.; Leeming, Diana J.; Scholze, Alexandra; Tepel, Martin			Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEART-DISEASE; CALCIFICATION; PROTEOGLYCANS; HYPERTROPHY; DIALYSIS	Objective: Cardiovascular diseases are among the most common causes of mortality in renal failure patients undergoing haemodialysis. A high turnover rate of the proteoglycan versican, represented by the increased presence of its fragmentation products in plasma, has previously been associated with cardiovascular diseases. The objective of the study was to investigate the association of versican turnover assessed in plasma with survival in haemodialysis patients. Methods: A specific matrix metalloproteinase-generated neo-epitope fragment of versican (VCANM) was measured in plasma of 364 haemodialysis patients with a 5-years follow-up, using a robust competitive enzyme-linked immunosorbent assays. Association between VCANM plasma concentration and survival was assessed by Kaplan-Meier analysis and adjusted Cox model. Results: Haemodialysis patients with plasma VCANM concentrations in the lowest quartile had increased risk of death (odds ratio, as compared to the highest quartile: 7.1, p < 0.001), with a reduced survival of 152 days compared to 1295 days for patients with plasma VCANM in the highest quartile. Multivariate analysis showed that low VCANM (p < 0.001) and older age (p < 0.001) predicted death in haemodialysis patients. Conclusions: Low concentrations of the versican fragment VCANM in plasma were associated with higher risk of death among haemodialysis patients. A possible protective role for the examined versican fragment is suggested.	[Genovese, Federica; Karsdal, Morten A.; Leeming, Diana J.] Nord Biosci, Fibrosis Biol & Biomarkers, Herlev, Denmark; [Scholze, Alexandra; Tepel, Martin] Univ Southern Denmark, Odense Univ Hosp, Dept Nephrol, Inst Mol Med Cardiovasc & Renal Res,Inst Clin Res, Odense, Denmark	Nordic Bioscience; University of Southern Denmark; Odense University Hospital	Genovese, F (corresponding author), Nord Biosci, Fibrosis Biol & Biomarkers, Herlev, Denmark.	fge@nordicbioscience.com	Scholze, Alexandra/ABD-2442-2020; Tepel, Martin/GRS-9581-2022	Scholze, Alexandra/0000-0002-3100-8692; Genovese, Federica/0000-0003-1984-1881; Tepel, Martin/0000-0002-0086-0997; Karsdal, Morten/0000-0001-5026-8740	Danish Research Fund (Den Danske Forskningfond); Nordic Bioscience	Danish Research Fund (Den Danske Forskningfond); Nordic Bioscience	The authors acknowledge the Danish Research Fund (Den Danske Forskningfond) for providing the funding for this research. FG, DJL, and MAK are full-time employees at Nordic Bioscience. Nordic Bioscience provided support in the form of salaries for authors FG, DJL, and MAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Dadah Ashraf, 2012, Adv Perit Dial, V28, P56; Barascuk N, 2013, INT J CLIN EXP MED, V6, P174; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Merrilees MJ, 2012, ELSEVIER CURRENT OPI, DOI [10.1016/j.ceb.2013.01.001, DOI 10.1016/J.CEB.2013.01.001]; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Rudnicki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044891; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Stokes MB, 2001, KIDNEY INT, V59, P532, DOI 10.1046/j.1523-1755.2001.059002532.x; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111134	10.1371/journal.pone.0111134	http://dx.doi.org/10.1371/journal.pone.0111134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354390	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200060
J	Eibinger, M; Ganner, T; Bubner, P; Rosker, S; Kracher, D; Haltrich, D; Ludwig, R; Plank, H; Nidetzky, B				Eibinger, Manuel; Ganner, Thomas; Bubner, Patricia; Rosker, Stephanie; Kracher, Daniel; Haltrich, Dietmar; Ludwig, Roland; Plank, Harald; Nidetzky, Bernd			Cellulose Surface Degradation by a Lytic Polysaccharide Monooxygenase and Its Effect on Cellulase Hydrolytic Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; IN-SITU-OBSERVATION; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; LIGNOCELLULOSIC BIOMASS; STRUCTURAL-DYNAMICS; NEUROSPORA-CRASSA; NATIVE CELLULOSE; PICHIA-PASTORIS; ENZYMES	Lytic polysaccharide monooxygenase (LPMO) represents a unique principle of oxidative degradation of recalcitrant insoluble polysaccharides. Used in combination with hydrolytic enzymes, LPMO appears to constitute a significant factor of the efficiency of enzymatic biomass depolymerization. LPMO activity on different cellulose substrates has been shown from the slow release of oxidized oligosaccharides into solution, but an immediate and direct demonstration of the enzyme action on the cellulose surface is lacking. Specificity of LPMO for degrading ordered crystalline and unordered amorphous cellulose material of the substrate surface is also unknown. We show by fluorescence dye adsorption analyzed with confocal laser scanning microscopy that a LPMO (from Neurospora crassa) introduces carboxyl groups primarily in surface-exposed crystalline areas of the cellulosic substrate. Using time-resolved in situ atomic force microscopy we further demonstrate that cellulose nano-fibrils exposed on the surface are degraded into shorter and thinner insoluble fragments. Also using atomic force microscopy, we show that prior action of LPMO enables cellulases to attack otherwise highly resistant crystalline substrate areas and that it promotes an overall faster and more complete surface degradation. Overall, this study reveals key characteristics of LPMO action on the cellulose surface and suggests the effects of substrate morphology on the synergy between LPMO and hydrolytic enzymes in cellulose depolymerization.	[Eibinger, Manuel; Bubner, Patricia; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Ganner, Thomas; Rosker, Stephanie; Plank, Harald] Inst Electron Microscopy & Nanoanal, A-8010 Graz, Austria; [Plank, Harald] Graz Ctr Electron Microscopy, A-8010 Graz, Austria; [Kracher, Daniel; Haltrich, Dietmar; Ludwig, Roland] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, A-1190 Vienna, Austria; [Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology	Plank, H (corresponding author), Inst Electron Microscopy & Nanoanal, Steyrergasse 17, A-8010 Graz, Austria.	harald.plank@felmi-zfe.at; bernd.nidetzky@tugraz.at	Kracher, Daniel/H-6667-2019; Haltrich, Dietmar/N-2624-2019	Kracher, Daniel/0000-0002-3856-3170; Haltrich, Dietmar/0000-0002-8722-8176; Nidetzky, Bernd/0000-0002-5030-2643; Ludwig, Roland/0000-0002-5058-5874	Austrian Science Fund FWF Grant [P 24156-B21]; Doctoral program BioToP-Molecular Technology of Proteins Grant [W1224]; Austrian Science Fund (FWF) [P 24156] Funding Source: researchfish	Austrian Science Fund FWF Grant(Austrian Science Fund (FWF)); Doctoral program BioToP-Molecular Technology of Proteins Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF Grant P 24156-B21 (to B. N.) and Doctoral program BioToP-Molecular Technology of Proteins Grant W1224 (to D. K.).	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ahola S, 2008, LANGMUIR, V24, P11592, DOI 10.1021/la801550j; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p; Bubner P, 2013, BIOTECHNOL BIOENG, V110, P1529, DOI 10.1002/bit.24884; Bubner P, 2012, J BIOL CHEM, V287, P2759, DOI 10.1074/jbc.M111.257717; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Dimarogona M, 2013, APPL MICROBIOL BIOT, V97, P8455, DOI 10.1007/s00253-013-5197-y; Eibinger M, 2014, FEBS J, V281, P275, DOI 10.1111/febs.12594; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Ganner T, 2014, CELLULOSE, V21, P3927, DOI 10.1007/s10570-014-0419-8; Ganner T, 2012, J BIOL CHEM, V287, P43215, DOI 10.1074/jbc.M112.419952; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kim IJ, 2014, APPL MICROBIOL BIOT, V98, P8469, DOI 10.1007/s00253-014-6001-3; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Lu P, 2010, CARBOHYD POLYM, V82, P329, DOI 10.1016/j.carbpol.2010.04.073; Medve J, 1998, J CHROMATOGR A, V808, P153, DOI 10.1016/S0021-9673(98)00132-0; Mellitzer A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-61; Novy V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-49; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rodiger S, 2011, ANAL CHEM, V83, P3379, DOI 10.1021/ac103277s; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Wang JP, 2013, LANGMUIR, V29, P14997, DOI 10.1021/la403401c; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wildberger P, 2011, FEBS LETT, V585, P499, DOI 10.1016/j.febslet.2010.12.041; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	48	173	180	9	132	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35929	35938		10.1074/jbc.M114.602227	http://dx.doi.org/10.1074/jbc.M114.602227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361767	hybrid, Green Published			2022-12-26	WOS:000346897900024
J	Huang, QY; Briggs, BR; Dong, HL; Jiang, HC; Wu, G; Edwardson, C; De Vlaminck, I; Quake, S				Huang, Qiuyuan; Briggs, Brandon R.; Dong, Hailiang; Jiang, Hongchen; Wu, Geng; Edwardson, Christian; De Vlaminck, Iwijn; Quake, Stephen			Taxonomic and Functional Diversity Provides Insight into Microbial Pathways and Stress Responses in the Saline Qinghai Lake, China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TIBETAN PLATEAU; PHOTOSYSTEM-II; CLIMATE-CHANGE; DYNAMICS; BACTERIA; ARCHAEA; WATER; SYNECHOCOCCUS; ENVIRONMENT	Microbe-mediated biogeochemical cycles contribute to the global climate system and have sensitive responses and feedbacks to environmental stress caused by climate change. Yet, little is known about the effects of microbial biodiversity (i.e., taxonmic and functional diversity) on biogeochemical cycles in ecosytems that are highly sensitive to climate change. One such sensitive ecosystem is Qinghai Lake, a high-elevation (3196 m) saline (1.4%) lake located on the Tibetan Plateau, China. This study provides baseline information on the microbial taxonomic and functional diversity as well as the associated stress response genes. Illumina metagenomic and metatranscriptomic datasets were generated from lake water samples collected at two sites (B and E). Autotrophic Cyanobacteria dominated the DNA samples, while heterotrophic Proteobacteria dominated the RNA samples at both sites. Photoheterotrophic Loktanella was also present at both sites. Photosystem II was the most active pathway at site B; while, oxidative phosphorylation was most active at site E. Organisms that expressed photosystem II or oxidative phosphorylation also expressed genes involved in photoprotection and oxidative stress, respectively. Assimilatory pathways associated with the nitrogen cycle were dominant at both sites. Results also indicate a positive relationship between functional diversity and the number of stress response genes. This study provides insight into the stress resilience of microbial metabolic pathways supported by greater taxonomic diversity, which may affect the microbial community response to climate change.	[Huang, Qiuyuan; Briggs, Brandon R.; Dong, Hailiang] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Dong, Hailiang] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Dong, Hailiang; Jiang, Hongchen; Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Huang, Qiuyuan; Edwardson, Christian] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [De Vlaminck, Iwijn; Quake, Stephen] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Quake, Stephen] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Quake, Stephen] Howard Hughes Med Inst, Stanford, CA USA	University System of Ohio; Miami University; China University of Geosciences; China University of Geosciences; University System of Georgia; University of Georgia; Stanford University; Stanford University; Howard Hughes Medical Institute	Dong, HL (corresponding author), Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA.	dongh@miamioh.edu	De Vlaminck, Iwijn/P-6479-2015; Jiang, Hongchen/I-5838-2016; WU, Geng/F-8840-2010; Wu, Geng/G-9740-2018; Jiang, Hongchen/Y-9471-2018; Edwardson, Christian F/U-8604-2017	De Vlaminck, Iwijn/0000-0001-6085-7311; WU, Geng/0000-0002-7259-1044; Jiang, Hongchen/0000-0003-1271-7028; Edwardson, Christian F/0000-0001-7524-7209; Briggs, Brandon/0000-0002-3808-8269; Edwardson, Charlotte/0000-0001-6485-9330; Dong, Hailiang/0000-0002-7468-1350	National Natural Science Foundation of China [41030211, 41002123]; Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing); State Key Laboratory of Biogeology and Environmental Geology; China University of Geosciences [GBL11201]; Fundamental Research Funds for National University, China University of Geosciences (Wuhan); NSF IOS [1238801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing); State Key Laboratory of Biogeology and Environmental Geology; China University of Geosciences; Fundamental Research Funds for National University, China University of Geosciences (Wuhan); NSF IOS(National Science Foundation (NSF))	This research was supported by the National Natural Science Foundation of China (Grant Nos. 41030211 and 41002123), the Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing), State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences (No. GBL11201), and the Fundamental Research Funds for National University, China University of Geosciences (Wuhan). This work was fostered by NSF IOS grant 1238801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Chowdhury N, 2011, PLANT SOIL, V344, P241, DOI 10.1007/s11104-011-0743-9; Cravo-Laureau C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00039; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dong H., 2010, GSA TODAY GEOL SOC A, V20, P4, DOI [10.1130/GSATG75A.1, DOI 10.1130/GSATG75A.1]; Dong HL, 2006, MICROB ECOL, V51, P65, DOI 10.1007/s00248-005-0228-6; FAHNENSTIEL GL, 1991, LIMNOL OCEANOGR, V36, P219, DOI 10.4319/lo.1991.36.2.0219; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Guo DL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016545; Hallin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051962; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hollibaugh JT, 2011, ISME J, V5, P866, DOI 10.1038/ismej.2010.172; Huang QY, 2013, FEMS MICROBIOL ECOL, V85, P452, DOI 10.1111/1574-6941.12134; Jiang HC, 2008, ENVIRON MICROBIOL, V10, P2355, DOI 10.1111/j.1462-2920.2008.01661.x; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Jiang HC, 2009, GEOMICROBIOL J, V26, P289, DOI 10.1080/01490450902892662; Jiang HC, 2009, GEOMICROBIOL J, V26, P199, DOI 10.1080/01490450902744004; Jiang HC, 2009, FEMS MICROBIOL ECOL, V67, P268, DOI 10.1111/j.1574-6941.2008.00616.x; Jimenez DJ, 2012, PLOS ONE, V7; JOINT I R, 1986, Canadian Bulletin of Fisheries and Aquatic Sciences, P287; Kara EL, 2013, ISME J, V7, P680, DOI 10.1038/ismej.2012.118; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei YB, 2012, J GLACIOL, V58, P177, DOI 10.3189/2012JoG11J025; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; Liu JS, 2009, GLOBAL PLANET CHANGE, V67, P209, DOI 10.1016/j.gloplacha.2009.03.010; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Mella-Flores Daniella, 2012, Front Microbiol, V3, P285; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller C.B., 2004, BIOL OCEANOGRAPHY; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Oksanen J., 2016, R PACKAG; Pernthaler J, 1998, APPL ENVIRON MICROB, V64, P4299; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Qiu J, 2008, NATURE, V468, P141; R Development Core Team, 2012, R LANG ENV STAT COMP; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P1908, DOI 10.1016/j.soilbio.2011.05.013; Severin I, 2012, ARCH MICROBIOL, V194, P483, DOI 10.1007/s00203-011-0787-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang HY, 2013, ORG GEOCHEM, V54, P69, DOI 10.1016/j.orggeochem.2012.09.011; Xing P, 2009, APPL ENVIRON MICROB, V75, P7017, DOI 10.1128/AEM.01544-09; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183	65	39	43	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111681	10.1371/journal.pone.0111681	http://dx.doi.org/10.1371/journal.pone.0111681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365331	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100105
J	Ilie, M; Hofman, V; Long-Mira, E; Selva, E; Vignaud, JM; Padovani, B; Mouroux, J; Marquette, CH; Hofman, P				Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Selva, Eric; Vignaud, Jean-Michel; Padovani, Bernard; Mouroux, Jerome; Marquette, Charles-Hugo; Hofman, Paul			"Sentinel" Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SENESCENCE; RISK; METASTASIS; STATISTICS; MORTALITY; INVASION; INSIGHTS; COPD; SIZE	Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. Migration of circulating tumor cells (CTCs) into the blood stream is an early event that occurs during carcinogenesis. We aimed to examine the presence of CTCs in complement to CT-scan in COPD patients without clinically detectable lung cancer as a first step to identify a new marker for early lung cancer diagnosis. The presence of CTCs was examined by an ISET filtration-enrichment technique, for 245 subjects without cancer, including 168 (68.6%) COPD patients, and 77 subjects without COPD (31.4%), including 42 control smokers and 35 non-smoking healthy individuals. CTCs were identified by cytomorphological analysis and characterized by studying their expression of epithelial and mesenchymal markers. COPD patients were monitored annually by low-dose spiral CT. CTCs were detected in 3% of COPD patients (5 out of 168 patients). The annual surveillance of the CTC-positive COPD patients by CT-scan screening detected lung nodules 1 to 4 years after CTC detection, leading to prompt surgical resection and histopathological diagnosis of early-stage lung cancer. Follow-up of the 5 patients by CT-scan and ISET 12 month after surgery showed no tumor recurrence. CTCs detected in COPD patients had a heterogeneous expression of epithelial and mesenchymal markers, which was similar to the corresponding lung tumor phenotype. No CTCs were detected in control smoking and non-smoking healthy individuals. CTCs can be detected in patients with COPD without clinically detectable lung cancer. Monitoring "sentinel" CTC-positive COPD patients may allow early diagnosis of lung cancer.	[Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Hofman, Paul] Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France; [Ilie, Marius; Hofman, Veronique; Selva, Eric; Hofman, Paul] Pasteur Hosp, Human Biobank BB 0033 00025, Nice, France; [Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Marquette, Charles-Hugo; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med Nice, UMR CNRS 7284, INSERM U1081,IRCAN Team 3, F-06189 Nice, France; [Vignaud, Jean-Michel] Univ Nancy, Cent Hosp, Dept Pathol, Nancy, France; [Padovani, Bernard] Pasteur Hosp, Dept Radiol, Nice, France; [Mouroux, Jerome] Pasteur Hosp, Dept Thorac Surg, Nice, France; [Marquette, Charles-Hugo] Pasteur Hosp, Dept Pulm Med, Nice, France	CHU Nice; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Nancy; Universite de Lorraine; CHU Nice; CHU Nice; CHU Nice	Hofman, P (corresponding author), Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France.	hofman.p@chu-nice.fr	Ilié, Marius/M-7964-2019; Marquette, Charles Hugo/O-4084-2016; Hofman, Paul/P-7654-2018	Ilié, Marius/0000-0002-2014-1236; Marquette, Charles Hugo/0000-0002-0846-9941; Hofman, Paul/0000-0003-0431-9353; long, elodie/0000-0002-1923-6713; Mouroux, Jerome/0000-0003-0877-4679; veronique, HOFMAN/0000-0003-0943-1627	Canceropole PACA; "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France; Fondation Lefort-Beaumont de l'Institut de France; INSERM Unit, Paris	Canceropole PACA(Region Grand-Est); "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France; Fondation Lefort-Beaumont de l'Institut de France; INSERM Unit, Paris	The authors wish to thank the "Canceropole PACA" (Procan 2012-2015, Axe C) and the "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France for their financial support. MI was supported by the "Fondation Lefort-Beaumont de l'Institut de France" through collaboration with INSERM Unit 807, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Blanchon F, 2006, LANCET ONCOL, V7, P829, DOI 10.1016/S1470-2045(06)70868-3; Boelens MC, 2011, LUNG CANCER, V72, P177, DOI 10.1016/j.lungcan.2010.08.014; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Deisboeck TS, 2006, MED HYPOTHESES, V67, P1338, DOI 10.1016/j.mehy.2006.05.029; Farlow EC, 2010, BRIT J CANCER, V103, P1221, DOI 10.1038/sj.bjc.6605865; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; KOHN EC, 1995, CANCER RES, V55, P1856; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Mazzone P, 2012, RESP MED, V106, P473, DOI 10.1016/j.rmed.2011.10.016; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Michaelson JS, 2005, BRIT J CANCER, V93, P1244, DOI 10.1038/sj.bjc.6602848; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Parimon T, 2007, AM J RESP CRIT CARE, V175, P712, DOI 10.1164/rccm.200608-1125OC; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rodriguez-Roisin Roberto, 2008, Proc Am Thorac Soc, V5, P842, DOI 10.1513/pats.200807-075TH; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schwartz AG, 2009, J THORAC ONCOL, V4, P291, DOI 10.1097/JTO.0b013e3181951cd1; Sekine Y, 2007, ANN THORAC SURG, V84, P946, DOI 10.1016/j.athoracsur.2007.04.038; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Witney TH, 2014, CANCER RES, V74, P1319, DOI 10.1158/0008-5472.CAN-13-2768; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yu JQ, 2011, J NUCL MED, V52, P1501, DOI 10.2967/jnumed.111.097683	47	229	246	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111597	10.1371/journal.pone.0111597	http://dx.doi.org/10.1371/journal.pone.0111597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360587	Green Published, gold			2022-12-26	WOS:000343943700127
J	Ishikawa, G; Nakamura, K; Ito, H; Saito, M; Sato, M; Jinno, H; Yoshimura, Y; Nishimura, T; Maejima, H; Uehara, Y; Kobayashi, F; Nakamura, T				Ishikawa, Goro; Nakamura, Kazuhiro; Ito, Hiroyuki; Saito, Mika; Sato, Mikako; Jinno, Hironobu; Yoshimura, Yasuhiro; Nishimura, Tsutomu; Maejima, Hidekazu; Uehara, Yasushi; Kobayashi, Fuminori; Nakamura, Toshiki			Association Mapping and Validation of QTLs for Flour Yield in the Soft Winter Wheat Variety Kitahonami	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; QUALITY TRAITS; MOLECULAR-GENETICS; BAKING QUALITY; MILLING YIELD; DIVERSITY; PUROINDOLINES; POPULATION; IMPROVEMENT	The winter wheat variety Kitahonami shows a superior flour yield in comparison to other Japanese soft wheat varieties. To map the quantitative trait loci (QTL) associated with this trait, association mapping was performed using a panel of lines from Kitahonami's pedigree, along with leading Japanese varieties and advanced breeding lines. Using a mixed linear model corrected for kernel types and familial relatedness, 62 marker-trait associations for flour yield were identified and classified into 21 QTLs. In eighteen of these, Kitahonami alleles showed positive effects. Pedigree analysis demonstrated that a continuous pyramiding of QTLs had occurred throughout the breeding history of Kitahonami. Linkage analyses using three sets of doubled haploid populations from crosses in which Kitahonami was used as a parent were performed, leading to the validation of five of the eight QTLs tested. Among these, QTLs on chromosomes 3B and 7A showed highly significant and consistent effects across the three populations. This study shows that pedigree-based association mapping using breeding materials can be a useful method for QTL identification at the early stages of breeding programs.	[Ishikawa, Goro; Nakamura, Kazuhiro; Ito, Hiroyuki; Saito, Mika; Nakamura, Toshiki] NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan; [Nakamura, Kazuhiro] NARO Kyusyu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan; [Saito, Mika; Sato, Mikako; Jinno, Hironobu; Yoshimura, Yasuhiro] Hokkaido Res Org, Kitami Agr Expt Stn, Memuro, Hokkaido, Japan; [Sato, Mikako] Hokkaido Res Org, Cent Agr Expt Stn, Memuro, Hokkaido, Japan; [Nishimura, Tsutomu] Hokkaido Res Org, Kamikawa Agr Expt Stn, Memuro, Hokkaido, Japan; [Maejima, Hidekazu; Uehara, Yasushi] Nagano Agr Expt Stn, Suzaka, Nagano, Japan; [Kobayashi, Fuminori] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan	Ishikawa, G (corresponding author), NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan.	goro@affrc.go.jp; tnaka@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [TRG-1009, NGB-1002, NGB-2004]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was partially supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (TRG-1009, NGB-1002 and NGB-2004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fox GP, 2013, EUPHYTICA, V192, P453, DOI 10.1007/s10681-013-0885-3; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Lehmensiek A, 2006, AUST J AGR RES, V57, P1115, DOI 10.1071/AR05375; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Parker GD, 1999, MOL BREEDING, V5, P561, DOI 10.1023/A:1009678023431; Rosyara UR, 2009, THEOR APPL GENET, V118, P1617, DOI 10.1007/s00122-009-1010-9; Smith AB, 2001, AUST J AGR RES, V52, P1207, DOI 10.1071/AR01058; Smith N, 2011, CROP SCI, V51, P1424, DOI 10.2135/cropsci2010.04.0193; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stodart BJ, 2007, AUST J AGR RES, V58, P1174, DOI 10.1071/AR07010; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; White J, 2008, THEOR APPL GENET, V116, P439, DOI 10.1007/s00122-007-0681-3; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Yanagisawa A., 2007, Bulletin of Hokkaido Prefectural Agricultural Experiment Stations, P1; Zhang KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057853	39	17	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111337	10.1371/journal.pone.0111337	http://dx.doi.org/10.1371/journal.pone.0111337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360619	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700085
J	Waschbusch, D; Michels, H; Strassheim, S; Ossendorf, E; Kessler, D; Gloeckner, CJ; Barnekow, A				Waschbuesch, Dieter; Michels, Helen; Strassheim, Swantje; Ossendorf, Edith; Kessler, Daniel; Gloeckner, Christian Johannes; Barnekow, Angelika			LRRK2 Transport Is Regulated by Its Novel Interacting Partner Rab32	PLOS ONE			English	Article							REPEAT KINASE 2; PARKINSON-DISEASE; PROTEIN; EXPRESSION; TRAFFICKING; PREDICTION; ENDOSOMES; MUTATION; GTPASES; IDENTIFICATION	Leucine-rich repeat kinase 2 (LRRK2) is a multi-domain 280 kDa protein that is linked to Parkinson's disease (PD). Mutations especially in the GTPase and kinase domains of LRRK2 are the most common causes of heritable PD and are also found in sporadic forms of PD. Although the cellular function of LRRK2 is largely unknown there is increasing evidence that these mutations cause cell death due to autophagic dysfunction and mitochondrial damage. Here, we demonstrate a novel mechanism of LRRK2 binding and transport, which involves the small GTPases Rab32 and Rab38. Rab32 and its closest homologue Rab38 are known to organize the trans-Golgi network and transport of key enzymes in melanogenesis, whereas their function in non-melanogenic cells is still not well understood. Cellular processes such as autophagy, mitochondrial dynamics, phagocytosis or inflammatory processes in the brain have previously been linked to Rab32. Here, we demonstrate that Rab32 and Rab38, but no other GTPase tested, directly interact with LRRK2. GFP-Trap analyses confirmed the interaction of Rab32 with the endogenous LRRK2. In yeast two-hybrid experiments we identified a predicted coiled-coil motif containing region within the aminoterminus of LRRK2 as the possible interacting domain. Fluorescence microscopy demonstrated a co-localization of Rab32 and LRRK2 at recycling endosomes and transport vesicles, while overexpression of a constitutively active mutant of Rab32 led to an increased co-localization with Rab7/9 positive perinuclear late endosomes/MVBs. Subcellular fractionation experiments supported the novel role of Rab32 in LRRK2 late endosomal transport and sorting in the cell. Thus, Rab32 may regulate the physiological functions of LRRK2.	[Waschbuesch, Dieter; Michels, Helen; Strassheim, Swantje; Ossendorf, Edith; Kessler, Daniel; Barnekow, Angelika] Univ Munster, Dept Expt Tumorbiol, Munster, Germany; [Gloeckner, Christian Johannes] Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Gloeckner, Christian Johannes] Eberhard Karls Univ Tubingen, Med Proteome Ctr, Inst Ophthalm Res, Tubingen, Germany	University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Waschbusch, D (corresponding author), Univ Munster, Dept Expt Tumorbiol, Munster, Germany.	d.waschbuesch@uni-muenster.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944; Waschbusch, Dieter/0000-0002-8953-2585	LRRK2 Biology LEAPS award of the Michael J. Fox Foundation; Verband der chemischen Industrie; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Muenster	LRRK2 Biology LEAPS award of the Michael J. Fox Foundation; Verband der chemischen Industrie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Muenster	This work was supported by the LRRK2 Biology LEAPS 2012 award of the Michael J. Fox Foundation to CJG and from the Verband der chemischen Industrie to AB. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gillardon F, 2013, J NEUROSCI METH, V214, P62, DOI 10.1016/j.jneumeth.2012.12.015; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gomez-Suaga P, 2014, HUM MOL GENET; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; HAUGEN A, 1989, BIOL TRACE ELEM RES, V21, P451, DOI 10.1007/BF02917288; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Kail Mark, 2008, V440, P111, DOI 10.1007/978-1-59745-178-9_9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang YJ, 2012, NEUROSCI LETT, V527, P110, DOI 10.1016/j.neulet.2012.08.039; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mills RD, 2014, HUM MUTAT, V35, P395, DOI 10.1002/humu.22515; Mills RD, 2012, BIOCHEM SOC T, V40, P1086, DOI 10.1042/BST20120088; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Parisiadou L, 2014, NAT NEUROSCI, V17, P367, DOI 10.1038/nn.3636; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Santpere G, 2009, ACTA NEUROPATHOL, V117, P227, DOI 10.1007/s00401-008-0478-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Thyrock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064149; Vivier PH, 2010, PEDIATR RADIOL, V40, P739, DOI 10.1007/s00247-009-1536-7; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Yamamoto Shuji, 2009, Nihon Hoshasen Gijutsu Gakkai Zasshi, V65, P1680	66	65	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111632	10.1371/journal.pone.0111632	http://dx.doi.org/10.1371/journal.pone.0111632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360523	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700133
J	Yang, CC; Huang, EY; Li, HC; Su, PY; Shih, C				Yang, Ching-Chun; Huang, Er-Yi; Li, Hung-Cheng; Su, Pei-Yi; Shih, Chiaho			Nuclear Export of Human Hepatitis B Virus Core Protein and Pregenomic RNA Depends on the Cellular NXF1-p15 Machinery	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATORY ELEMENT; REVERSE TRANSCRIPTION; IMMATURE SECRETION; HIGHLY FREQUENT; ANTIGEN; TREX; CONTAINS; BINDING; DOMAIN; REV	Hepatitis B virus (HBV) core protein (HBc) can shuttle between nucleus and cytoplasm. Cytoplasm-predominant HBc is clinically associated with severe liver inflammation. Previously, we found that HBc arginine-rich domain (ARD) can associate with a host factor NXF1 (TAP) by coimmunoprecipitation. It is well known that NXF1-p15 heterodimer can serve as a major export receptor of nuclear mRNA as a ribonucleoprotein complex (RNP). In the NXF1-p15 pathway, TREX (transcription/export) complex plays an important role in coupling nuclear pre-mRNA processing with mRNA export in mammalian cells. Here, we tested the hypothesis whether HBc and HBV specific RNA can be exported via the TREX and NXF1-p15 mediated pathway. We demonstrated here that HBc can physically and specifically associate with TREX components, and the NXF1-p15 export receptor by coimmunoprecipitation. Accumulation of HBc protein in the nucleus can be induced by the interference with TREX and NXF1-p15 mediated RNA export machinery. HBV transcripts encodes a non-spliced 3.5 kb pregenomic RNA (pgRNA) which can serve as a template for reverse transcription. Cytoplasmic HBV pgRNA appeared to be reduced by siRNA treatment specific for the NXF1-p15 complex by quantitative RT-qPCR and Northern blot analyses. This result suggests that the pgRNA was also exported via the NXF1-p15 machinery. We entertain the hypothesis that HBc protein can be exported as an RNP cargo via the mRNA export pathway by hijacking the TREX and NXF1-p15 complex. In our current and previous studies, HBc is not required for pgRNA accumulation in the cytoplasm. Furthermore, HBc ARD can mediate nuclear export of a chimeric protein containing HBc ARD in a pgRNA-independent manner. Taken together, it suggests that while both pgRNA and HBc protein exports are dependent on NXF1-p15, they are using the same export machinery in a manner independent of each other.	[Yang, Ching-Chun; Su, Pei-Yi] Natl Yang Ming Univ, TIGP Mol Med, Taipei 112, Taiwan; [Yang, Ching-Chun; Su, Pei-Yi] Acad Sinica, Taipei 115, Taiwan; [Yang, Ching-Chun; Huang, Er-Yi; Li, Hung-Cheng; Su, Pei-Yi; Shih, Chiaho] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shih, C (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	cshih@ibms.sinica.edu	Shih, Chiaho/S-7017-2018; Su, Pei-Yi/AAS-9792-2021	Su, Pei-Yi/0000-0002-6354-2152	Academia Sinica, Taiwan; National Health Research Institute (NHRI Taiwan) Grant [NHRI-EX102-10203BI]; Ministry of Science and Technology (MOST Taiwan) grant	Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Health Research Institute (NHRI Taiwan) Grant; Ministry of Science and Technology (MOST Taiwan) grant	Funding sources include a grant to CS from Academia Sinica, Taiwan (http://www.sinica.edu.tw/main_e.shtml); National Health Research Institute (NHRI Taiwan) Grant Number: NHRI-EX102-10203BI to CS (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do); and Ministry of Science and Technology (MOST Taiwan) grant to CS. (http://www.most.gov.tw/mp.aspx?mp=7) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bodem J, 2011, J VIROL, V85, P2333, DOI 10.1128/JVI.01518-10; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Chen HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034116; Chi BK, 2014, NUCLEIC ACIDS RES, V42, P7305, DOI 10.1093/nar/gku350; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Chu CM, 1987, GASTROENTEROLOGY, V92, P220, DOI 10.1016/0016-5085(87)90863-8; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Heise T, 2006, NUCLEIC ACIDS RES, V34, P353, DOI 10.1093/nar/gkj440; Herold A, 2001, RNA, V7, P1768; HSU HC, 1987, J HEPATOL, V5, P45, DOI 10.1016/S0168-8278(87)80060-0; Huang C, 2011, FEBS J, V278, P1533, DOI 10.1111/j.1742-4658.2011.08077.x; HUANG JK, 1993, MOL CELL BIOL, V13, P7476, DOI 10.1128/MCB.13.12.7476; HUANG ZM, 1994, J VIROL, V68, P3193, DOI 10.1128/JVI.68.5.3193-3199.1994; HUANG ZM, 1995, MOL CELL BIOL, V15, P3864; Jackson BR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002138; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Le Pogam S, 2002, J VIROL, V76, P6510, DOI 10.1128/JVI.76.13.6510-6517.2002; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ning B, 2004, J VIROL, V78, P13653, DOI 10.1128/JVI.78.24.13653-13668.2004; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ou JH, 1997, J GASTROEN HEPATOL, V12, pS178, DOI 10.1111/j.1440-1746.1997.tb00499.x; Popa I, 2002, MOL CELL BIOL, V22, P2057, DOI 10.1128/MCB.22.7.2057-2067.2002; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Roth J, 1997, J VIROL, V71, P8933, DOI 10.1128/JVI.71.11.8933-8939.1997; Sakuma T, 2014, J VIROL, V88, P4069, DOI 10.1128/JVI.03584-13; Schmid M, 2012, J VIROL, V86, P2282, DOI 10.1128/JVI.06275-11; Selth Luke A, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5234; Sherer NM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002395; Shih C, 2013, CHRONIC HEPATITIS B AND C: BASIC SCIENCE TO CLINICAL APPLICATIONS, P1; Smith GJ, 1998, NUCLEIC ACIDS RES, V26, P4818, DOI 10.1093/nar/26.21.4818; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Stieler JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091279; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; Tunnicliffe RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003907; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Verheggen C, 2012, NUCLEUS-AUSTIN, V3, P132, DOI 10.4161/nucl.19266; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Williams BJL, 2005, BIOCHEM J, V387, P295, DOI 10.1042/BJ20041223; Yuan TTT, 1999, J VIROL, V73, P5731, DOI 10.1128/JVI.73.7.5731-5740.1999; Yuan TTT, 1999, J VIROL, V73, P10122, DOI 10.1128/JVI.73.12.10122-10128.1999; YUAN TTT, 1995, VIROLOGY, V211, P144, DOI 10.1006/viro.1995.1387; Zang WQ, 1999, VIROLOGY, V259, P299, DOI 10.1006/viro.1999.9777; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	65	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e106683	10.1371/journal.pone.0106683	http://dx.doi.org/10.1371/journal.pone.0106683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360769	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700005
J	Le, PT; Pearce, MM; Zhang, SB; Campbell, EM; Fok, CS; Mueller, ER; Brincat, CA; Wolfe, AJ; Brubaker, L				Le, Phong T.; Pearce, Meghan M.; Zhang, Shubin; Campbell, Edward M.; Fok, Cynthia S.; Mueller, Elizabeth R.; Brincat, Cynthia A.; Wolfe, Alan J.; Brubaker, Linda			IL22 Regulates Human Urothelial Cell Sensory and Innate Functions through Modulation of the Acetylcholine Response, Immunoregulatory Cytokines and Antimicrobial Peptides: Assessment of an In Vitro Model	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; RECURRENT BACTERIAL CYSTITIS; INTESTINAL EPITHELIAL-CELLS; ADULT FEMALE BLADDER; URINARY-TRACT; GENE-EXPRESSION; FIMH-ADHESIN; UROPLAKIN-IA; INFECTION; RECEPTOR	Human urinary disorders are generally studied in rodent models due to limitations of functional in vitro culture models of primary human urothelial cells (HUCs). Current HUC culture models are often derived from immortalized cancer cell lines, which likely have functional characteristics differ from healthy human urothelium. Here, we described a simple explant culture technique to generate HUCs and assessed their in vitro functions. Using transmission electron microscopy, we assessed morphology and heterogeneity of the generated HUCs and characterized their intercellular membrane structural proteins relative to ex vivo urothelium tissue. We demonstrated that our cultured HUCs are free of fibroblasts. They are also heterogeneous, containing cells characteristic of both immature basal cells and mature superficial urothelial cells. The cultured HUCs expressed muscarinic receptors (MR1 and MR2), carnitine acetyltransferase (CarAT), immunoregulatory cytokines IL7, IL15, and IL23, as well as the chemokine CCL20. HUCs also expressed epithelial cell-specific molecules essential for forming intercellular structures that maintain the functional capacity to form the physiological barrier of the human bladder urothelium. A subset of HUCs, identified by the high expression of CD44, expressed the Toll-like receptor 4 (TLR4) along with its co-receptor CD14. We demonstrated that HUCs express, at the mRNA level, both forms of the IL22 receptor, the membrane-associated (IL22RA1) and the secreted soluble (IL22RA2) forms; in turn, IL22 inhibited expression of MR1 and induced expression of CarAT and two antimicrobial peptides (S100A9 and lipocalin-2). While the cellular sources of IL22 have yet to be identified, the HUC cytokine and chemokine profiles support the concept that IL22-producing cells are present in the human bladder mucosa tissue and that IL22 plays a regulatory role in HUC functions. Thus, the described explant technique is clearly capable of generating functional HUCs suitable for the study of human urinary tract disorders, including interactions between urothelium and IL22-producing cells.	[Le, Phong T.; Pearce, Meghan M.; Zhang, Shubin; Campbell, Edward M.; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Mueller, Elizabeth R.; Brincat, Cynthia A.; Brubaker, Linda] Loyola Univ Chicago, Stritch Sch Med, Dept Obstet & Gynecol, Maywood, IL USA; [Fok, Cynthia S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA	Loyola University Chicago; Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities	Le, PT (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA.	ple@luc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589	Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University [LU205650, LU203919, LU202567]	Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University	Funding provided by the Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University LU205650 and LU203919 (PTL), LU202567 (AJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudette-Zlatanova BC, 2011, EXP HEMATOL, V39, P570, DOI 10.1016/j.exphem.2011.01.014; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Bschleipfer T, 2007, LIFE SCI, V80, P2303, DOI 10.1016/j.lfs.2007.01.053; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; De Vita D, 2013, INT UROGYNECOL J, V24, P545, DOI 10.1007/s00192-012-1957-y; De Vita D, 2012, INT UROGYNECOL J, V23, P1707, DOI 10.1007/s00192-012-1794-z; Dokun OY, 2008, INT J CANCER, V123, P2798, DOI 10.1002/ijc.23893; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; ESHDAT Y, 1981, INFECT IMMUN, V34, P980, DOI 10.1128/IAI.34.3.980-986.1981; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022; Guimond M, 2005, J IMMUNOTHER, V28, P289, DOI 10.1097/01.cji.0000165356.03924.e7; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lips KS, 2007, EUR UROL, V51, P1042, DOI 10.1016/j.eururo.2006.10.028; Liu AY, 2012, CELL TISSUE RES, V348, P589, DOI 10.1007/s00441-012-1383-y; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; SOUTHGATE J, 1994, LAB INVEST, V71, P583; SOUTHGATE J, 1995, INT J CANCER, V62, P449, DOI 10.1002/ijc.2910620415; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Trzpis M, 2008, TRANSGENIC RES, V17, P229, DOI 10.1007/s11248-007-9141-8; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Tu L, 2000, MOL BIOL CELL, V13, P4221; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Yoshida M, 2006, UROLOGY, V67, P425, DOI 10.1016/j.urology.2005.08.014; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang JP, 1996, SCIENCE, V273, P1234, DOI 10.1126/science.273.5279.1234; Zhou G, 2001, J CELL SCI, V114, P4095; Zook EC, 2013, J IMMUNOL, V191, P5583, DOI 10.4049/jimmunol.1202278	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111375	10.1371/journal.pone.0111375	http://dx.doi.org/10.1371/journal.pone.0111375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354343	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200077
J	Borahay, MA; Kilic, GS; Yallampalli, C; Snyder, RR; Hankins, GDV; Al-Hendy, A; Boehning, D				Borahay, Mostafa A.; Kilic, Gokhan S.; Yallampalli, Chandrasekha; Snyder, Russell R.; Hankins, Gary D. V.; Al-Hendy, Ayman; Boehning, Darren			Simvastatin Potently Induces Calcium-dependent Apoptosis of Human Leiomyoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calcium; Calcium Channel; Cell Proliferation; Inositol Trisphosphate Receptor (InsP3R); Tumor; Tumor Cell Biology; Statin; Leiomyoma	HMG-COA REDUCTASE; SMOOTH-MUSCLE-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HUMAN UTERINE LEIOMYOMA; CANCER CELLS; ENDOPLASMIC-RETICULUM; GROWTH-FACTORS; STATINS; PROLIFERATION; EXPRESSION	Statins are drugs commonly used for the treatment of high plasma cholesterol levels. Beyond these well known lipid-lowering properties, they possess broad-reaching effects in vivo, including antitumor effects. Statins inhibit the growth of multiple tumors. However, the mechanisms remain incompletely understood. Here we show that simvastatin inhibits the proliferation of human leiomyoma cells. This was associated with decreased mitogen-activated protein kinase signaling and multiple changes in cell cycle progression. Simvastatin potently stimulated leiomyoma cell apoptosis in a manner mechanistically dependent upon apoptotic calcium release from voltage-gated calcium channels. Therefore, simvastatin possesses antitumor effects that are dependent upon the apoptotic calcium release machinery.	[Borahay, Mostafa A.; Kilic, Gokhan S.; Snyder, Russell R.; Hankins, Gary D. V.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Borahay, Mostafa A.; Boehning, Darren] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Yallampalli, Chandrasekha] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Al-Hendy, Ayman] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA 30912 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University System of Georgia; Augusta University	Borahay, MA (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	maboraha@utmb.edu; Darren.F.Boehning@uth.tmc.edu	Borahay, Mostafa/AAJ-6582-2020; Yallampalli, Chandra/B-7655-2014; Al-hendy, Ayman/J-9324-2019; Boehning, Darren/I-8539-2015	Borahay, Mostafa/0000-0002-0554-132X; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [5K12HD001269-12, 1R01GM081685-01, 3R01GM081685-03S1]; Institute for Translational Sciences at the University of Texas Medical Branch by NCATS, National Institutes of Health CTSA [UL1TR000071]; University of Texas Health Science Center at Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001269] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Sciences at the University of Texas Medical Branch by NCATS, National Institutes of Health CTSA; University of Texas Health Science Center at Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the following grants to M. A. B.: National Institutes of Health K12 Career Development Award 5K12HD001269-12 and by an award from the Institute for Translational Sciences at the University of Texas Medical Branch supported in part by NCATS, National Institutes of Health Grant CTSA UL1TR000071. This work was also supported by the following grants to D. B.: National Institutes of Health Grants 1R01GM081685-01 and 3R01GM081685-03S1 and startup funds provided by the University of Texas Health Science Center at Houston.	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; Blanks AM, 2007, J PHYSIOL-LONDON, V581, P915, DOI 10.1113/jphysiol.2007.132126; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bruner-Tran KL, 2009, J CLIN ENDOCR METAB, V94, P2489, DOI 10.1210/jc.2008-2802; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P736, DOI 10.1210/jc.78.3.736; Burroughs KD, 2002, J ENDOCRINOL, V172, P83, DOI 10.1677/joe.0.1720083; Cafforio P, 2005, CARCINOGENESIS, V26, P883, DOI 10.1093/carcin/bgi036; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cho SJ, 2008, INT J CANCER, V123, P951, DOI 10.1002/ijc.23593; Clunn GF, 2010, INT J CARDIOL, V139, P2, DOI 10.1016/j.ijcard.2009.05.019; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Dalrymple A, 2004, J CLIN ENDOCR METAB, V89, P1291, DOI 10.1210/jc.2003-031428; De Smet P, 1999, CELL CALCIUM, V26, P9; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Islam MS, 2013, FERTIL STERIL, V100, P178, DOI 10.1016/j.fertnstert.2013.03.007; Jeschke MG, 2009, J CELL MOL MED, V13, P1857, DOI 10.1111/j.1582-4934.2009.00644.x; Kato S, 2010, J CELL MOL MED, V14, P1180, DOI 10.1111/j.1582-4934.2009.00771.x; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Malik M, 2012, FERTIL STERIL, V97, P1287, DOI 10.1016/j.fertnstert.2012.02.037; Marsh EE, 2006, OBSTET GYN CLIN N AM, V33, P59, DOI 10.1016/j.ogc.2005.12.001; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Muck AO, 2004, INT J CLIN PHARM TH, V42, P695; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Peng L, 2009, FERTIL STERIL, V91, P2664, DOI 10.1016/j.fertnstert.2007.10.083; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Ramakrishna S, 2012, CHEST, V142, p925A; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Rombouts K, 2003, J HEPATOL, V38, P564, DOI 10.1016/S0168-8278(03)00051-5; ROSSI MJ, 1992, ENDOCRINOLOGY, V130, P1716, DOI 10.1210/en.130.3.1716; Salama SA, 2008, INT J CANCER, V123, P1246, DOI 10.1002/ijc.23653; Salama SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007356; Schmidmaier R, 2007, EUR J HAEMATOL, V79, P240, DOI 10.1111/j.1600-0609.2007.00902.x; Seeger H, 2003, EXP CLIN ENDOCR DIAB, V111, P47, DOI 10.1055/s-2003-37501; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shozu M, 2004, SEMIN REPROD MED, V22, P51; Shozu M, 2003, FERTIL STERIL, V79, P628, DOI 10.1016/S0015-0282(02)04761-1; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Stamm JA, 2005, ONCOLOGY-NY, V19, P739; Steinmann C, 2008, J BIOL CHEM, V283, P13506, DOI 10.1074/jbc.C800029200; Stieren ES, 2011, J BIOL CHEM, V286, P35689, DOI 10.1074/jbc.M111.243147; Tanaka T, 2004, J AM SOC NEPHROL, V15, P2320, DOI 10.1097/01.ASN.0000138287.46849.82; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; van der Spek E, 2006, HAEMATOLOGICA, V91, P542; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wildburger NC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-44; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196	71	48	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35075	35086		10.1074/jbc.M114.583575	http://dx.doi.org/10.1074/jbc.M114.583575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359773	Green Published, hybrid			2022-12-26	WOS:000346660200003
J	Parua, PK; Dombek, KM; Young, ET				Parua, Pabitra K.; Dombek, Kenneth M.; Young, Elton T.			Yeast 14-3-3 Protein Functions as a Comodulator of Transcription by Inhibiting Coactivator Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 Protein; Gene Regulation; Gene Transcription; RNA Polymerase II; Transcription Coactivator; Adr1; Cat8; Oaf1; Pip2; Combinatorial Regulation	GLUCOSE-REPRESSED GENES; MESSENGER-RNA SYNTHESIS; DNA-BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; ADH2 EXPRESSION; PEROXISOME PROLIFERATION; ACTIVATE TRANSCRIPTION; GLUCONEOGENIC GENES; MEDIATOR COMPLEX; IDENTIFY GENES	In eukaryotes combinatorial activation of transcription is an important component of gene regulation. In the budding yeast Saccharomyces cerevisiae, Adr1-Cat8 and Adr1-Oaf1/Pip2 are pairs of activators that act together to regulate two diverse sets of genes. Transcription activation of both sets is regulated positively by the yeast AMP-activated protein kinase homolog, Snf1, in response to low glucose or the presence of a non-fermentable carbon source and negatively by two redundant 14-3-3 isoforms, Bmh1 and Bmh2. Bmh regulates the function of these pairs at a post-promoter binding step by direct binding to Adr1. However, how Bmh regulates transcription after activator binding remains unknown. In the present study we analyzed Bmh-mediated regulation of two sets of genes activated independently by these pairs of activators. We report that Bmh inhibits mRNA synthesis when the second activator is absent. Using gene fusions we show that Bmh binding to the Adr1 regulatory domain inhibits an Adr1 activation domain but not a heterologous activation domain or artificially recruited Mediator, consistent with Bmh acting at a step in transcription downstream of activator binding. Bmh inhibits the assembly and the function of a preinitiation complex (PIC). Gene expression studies suggest that Bmh regulates Adr1 activity through the coactivators Mediator and Swi/Snf. Mediator recruitment appeared to occur normally, but PIC formation and function were defective, suggesting that Bmh inhibits a step between Mediator recruitment and PIC activation.	[Parua, Pabitra K.; Dombek, Kenneth M.; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA.	ety@uw.edu		Parua, Pabitra/0000-0002-1125-4052	National Institutes of Health Grant [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM26079 (to E. T. Y.).	Abate G, 2012, BBA-GENE REGUL MECH, V1819, P419, DOI 10.1016/j.bbagrm.2012.01.009; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Braun KA, 2013, MOL CELL BIOL, V33, P712, DOI 10.1128/MCB.01226-12; Bridges D., 2005, SCI STKE, V296, pre10, DOI DOI 10.1126/STKE.2962005RE10; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Collart M. A., 2001, CURRENT PROTOCOLS MO; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COUSENS DJ, 1989, EMBO J, V8, P2337, DOI 10.1002/j.1460-2075.1989.tb08361.x; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dombek KM, 2004, J BIOL CHEM, V279, P39165, DOI 10.1074/jbc.M400433200; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lottersberger F, 2003, GENETICS, V165, P1717; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; Parua PK, 2014, EUKARYOT CELL, V13, P21, DOI 10.1128/EC.00240-13; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; Walther K, 2001, MICROBIOL-SGM, V147, P2037, DOI 10.1099/00221287-147-8-2037; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2012, J BIOL CHEM, V287, P29021, DOI 10.1074/jbc.M112.380147; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	60	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35542	35560		10.1074/jbc.M114.592287	http://dx.doi.org/10.1074/jbc.M114.592287			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355315	Green Published, hybrid			2022-12-26	WOS:000346660200042
J	Halimi, H; Rigato, A; Byrne, D; Ferracci, G; Sebban-Kreuzer, C; ElAntak, L; Guerlesquin, F				Halimi, Hubert; Rigato, Annafrancesca; Byrne, Deborah; Ferracci, Geraldine; Sebban-Kreuzer, Corinne; ElAntak, Latifa; Guerlesquin, Francoise			Glycan Dependence of Galectin-3 Self-Association Properties	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; PROTEIN; PHOSPHORYLATION	Human Galectin-3 is found in the nucleus, the cytoplasm and at the cell surface. This lectin is constituted of two domains: an unfolded N-terminal domain and a C-terminal Carbohydrate Recognition Domain (CRD). There are still uncertainties about the relationship between the quaternary structure of Galectin-3 and its carbohydrate binding properties. Two types of self-association have been described for this lectin: a C-type self-association and a N-type self-association. Herein, we have analyzed Galectin-3 oligomerization by Dynamic Light Scattering using both the recombinant CRD and the full length lectin. Our results proved that LNnT induces N-type self-association of full length Galectin-3. Moreover, from Nuclear Magnetic Resonance (NMR) and Surface Plasmon Resonance experiments, we observed no significant specificity or affinity variations for carbohydrates related to the presence of the N-terminal domain of Galectin-3. NMR mapping clearly established that the N-terminal domain interacts with the CRD. We propose that LNnT induces a release of the N-terminal domain resulting in the glycan-dependent self-association of Galectin-3 through N-terminal domain interactions.	[Halimi, Hubert; Rigato, Annafrancesca; Sebban-Kreuzer, Corinne; ElAntak, Latifa; Guerlesquin, Francoise] Aix Marseille Univ, CNRS, Lab Ingn Syst Mol, UMR 7255, Marseille, France; [Rigato, Annafrancesca] Aix Marseille Univ, INSERM, U1006, Marseille, France; [Byrne, Deborah] Aix Marseille Univ, CNRS, FR 3479, Inst Microbiol Mediterranee, Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Guerlesquin, F (corresponding author), Aix Marseille Univ, CNRS, Lab Ingn Syst Mol, UMR 7255, Marseille, France.	guerlesquin@imm.cnrs.fr	ELANTAK, Latifa/S-7004-2019					Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Balan V, 2012, J BIOL CHEM, V287, P5192, DOI 10.1074/jbc.C111.331686; Barboni EAM, 2000, GLYCOBIOLOGY, V10, P1201, DOI 10.1093/glycob/10.11.1201; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Collins PM, 2013, J MOL BIOL, V2836, P743; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Gong HC, 1999, CANCER RES, V59, P6239; Ippel H, 2015, BIOMOL NMR ASSIGN, V9, P59, DOI 10.1007/s12104-014-9545-3; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Song L, 2014, CLIN CHIM ACTA, V431, P185, DOI 10.1016/j.cca.2014.01.019; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Umemoto K, 2001, J BIOMOL NMR, V20, P91, DOI 10.1023/A:1011269008175; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c	19	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111836	10.1371/journal.pone.0111836	http://dx.doi.org/10.1371/journal.pone.0111836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369125	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000109
J	Karlsson, I; Friberg, H; Steinberg, C; Persson, P				Karlsson, Ida; Friberg, Hanna; Steinberg, Christian; Persson, Paula			Fungicide Effects on Fungal Community Composition in the Wheat Phyllosphere	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; PHYLLOPLANE MICROFLORA; RIBOSOMAL-RNA; WINTER-WHEAT; GRAIN-YIELD; DIVERSITY; YEASTS; DIOSZEGIA; MICROORGANISMS; AZOXYSTROBIN	The fungicides used to control diseases in cereal production can have adverse effects on non-target fungi, with possible consequences for plant health and productivity. This study examined fungicide effects on fungal communities on winter wheat leaves in two areas of Sweden. High-throughput 454 sequencing of the fungal ITS2 region yielded 235 operational taxonomic units (OTUs) at the species level from the 18 fields studied. It was found that commonly used fungicides had moderate but significant effect on fungal community composition in the wheat phyllosphere. The relative abundance of several saprotrophs was altered by fungicide use, while the effect on common wheat pathogens was mixed. The fungal community on wheat leaves consisted mainly of basidiomycete yeasts, saprotrophic ascomycetes and plant pathogens. A core set of six fungal OTUs representing saprotrophic species was identified. These were present across all fields, although overall the difference in OTU richness was large between the two areas studied.	[Karlsson, Ida; Persson, Paula] Swedish Univ Agr Sci, SLU, Dept Crop Prod Ecol, Uppsala, Sweden; [Friberg, Hanna] SLU, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Steinberg, Christian] INRA, UMR Agroecol 1347, F-21034 Dijon, France	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Karlsson, I (corresponding author), Swedish Univ Agr Sci, SLU, Dept Crop Prod Ecol, Uppsala, Sweden.	ida.karlsson@slu.se	Steinberg, Christian/AAU-8872-2020; Karlsson, Ida/F-4192-2017	Steinberg, Christian/0000-0002-5447-5349; Karlsson, Ida/0000-0002-5598-1200	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2010-1945]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (http://www.formas.se/en/), registration number 2010-1945. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Agrios G., 2004, PLANT PATHOLOGY; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bates D, 2014, ARXIV14065823; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; Birzele B, 2002, EUR J PLANT PATHOL, V108, P667, DOI 10.1023/A:1020632816441; BLAKEMAN JP, 1982, ANNU REV PHYTOPATHOL, V20, P167, DOI 10.1146/annurev.py.20.090182.001123; Blixt E, 2010, EUR J PLANT PATHOL, V126, P373, DOI 10.1007/s10658-009-9542-z; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Castoria R, 2001, POSTHARVEST BIOL TEC, V22, P7, DOI 10.1016/S0925-5214(00)00186-1; Cromey MG, 2004, CROP PROT, V23, P1019, DOI 10.1016/j.cropro.2004.03.002; Crous PW, 2006, STUD MYCOL, P53, DOI 10.3114/sim.55.1.53; De Curtis F, 2012, FIELD CROP RES, V134, P36, DOI 10.1016/j.fcr.2012.04.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DICKINSON CH, 1973, T BRIT MYCOL SOC, V60, P423, DOI 10.1016/S0007-1536(73)80027-0; DICKINSON CH, 1976, T BRIT MYCOL SOC, V67, P103, DOI 10.1016/S0007-1536(76)80014-9; Durling MB, 2011, SCATA EFFICIEN UNPUB; European Network for Durable Exploitation of crop protection strategies (ENDURE), 2008, DEL DR 1 2 BEST CONT; FOKKEMA N J, 1988, P91; Fokkema N. J., 1981, EPPO Bulletin, V11, P303, DOI 10.1111/j.1365-2338.1981.tb01937.x; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Goetz J, 2006, PAC NW FUNGI, V1; Halekoh U, 2014, J STAT SOFTW, V59, P1; Henriksen B, 2005, J PHYTOPATHOL, V153, P214, DOI 10.1111/j.1439-0434.2005.00955.x; Herdina, 2004, FEMS MICROBIOL ECOL, V47, P143, DOI 10.1016/S0168-6496(03)00255-1; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; IKAI K, 1991, J ANTIBIOT, V44, P925, DOI 10.7164/antibiotics.44.925; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; LAST F. T., 1955, TRANS BRIT MYCOL SOC, V38, P221; Levetin E, 2006, AEROBIOLOGIA, V22, P3, DOI 10.1007/s10453-005-9012-9; Lindner DL, 2013, ECOL EVOL, V3, P1751, DOI 10.1002/ece3.586; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MAGAN N, 1986, ANN APPL BIOL, V109, P117, DOI 10.1111/j.1744-7348.1986.tb03190.x; MALESZKA R, 1993, YEAST, V9, P53, DOI 10.1002/yea.320090107; Morton V., 2008, SHORT HIST FUNGICIDE, DOI DOI 10.1094/APSNETFEATURE-2008-0308; Moulas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/969750; Newton AC, 2010, ANN APPL BIOL, V157, P343, DOI 10.1111/j.1744-7348.2010.00437.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petit AN, 2012, PHOTOSYNTH RES, V111, P315, DOI 10.1007/s11120-012-9719-8; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; RODLAND KD, 1982, BIOCHIM BIOPHYS ACTA, V697, P162, DOI 10.1016/0167-4781(82)90072-0; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Southwell RJ, 1999, AUSTRALAS PLANT PATH, V28, P139, DOI 10.1071/AP99024; Statistiska centralbyran, 2011, VAXTSK JORD TRADG 20; Sverige Statens jordbruksverk Sverige Statistiska centralbyran, 2012, JORDBR ARSB 2012 MED; Sylla J, 2013, AGRONOMY-BASEL, V3, P704, DOI 10.3390/agronomy3040704; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Wang QM, 2008, ANTON LEEUW INT J G, V93, P391, DOI 10.1007/s10482-007-9216-9; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	67	85	91	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111786	10.1371/journal.pone.0111786	http://dx.doi.org/10.1371/journal.pone.0111786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369054	Green Published, gold, Green Accepted			2022-12-26	WOS:000344402000100
J	Neller, MA; Lai, MHL; Lanagan, CM; O'Connor, LE; Pritchard, AL; Martinez, NR; Schmidt, CW				Neller, Michelle A.; Lai, Michael H. -L.; Lanagan, Catherine M.; O'Connor, Linda E.; Pritchard, Antonia L.; Martinez, Nathan R.; Schmidt, Christopher W.			High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells	PLOS ONE			English	Article							HUMAN NAIVE; IN-VITRO; MELANOMA; MEMORY; AVIDITY; CTL; LYMPHOCYTES; EXPRESSION; CLONES; CYTOMEGALOVIRUS	While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to be made about the function and phenotype of a clone's in vivo precursor, nor can precise cloning efficiencies be calculated. Additionally, there is currently no general method for cloning antigen-specific effector T cells directly from peripheral blood mononuclear cells, without the need for prior expansion in vitro. Here we describe an efficient method for cloning effector T cells ex vivo. Functional T cells are detected using optimised interferon gamma capture following stimulation with viral or tumour cell-derived antigen. In combination with multiple phenotypic markers, single effector T cells are sorted using a flow cytometer directly into multi-well plates, and cloned using standard, non antigen-specific expansion methods. We provide examples of this novel technology to generate antigen-reactive clones from healthy donors using Epstein-Barr virus and cytomegalovirus as representative viral antigen sources, and from two melanoma patients using autologous melanoma cells. Cloning efficiency, clonality, and retention/loss of function are described. Ex vivo effector cell cloning provides a rapid and effective method of deriving antigen-specific T cells clones with traceable in vivo precursor function and phenotype.	[Neller, Michelle A.; Lai, Michael H. -L.; Lanagan, Catherine M.; O'Connor, Linda E.; Martinez, Nathan R.; Schmidt, Christopher W.] QIMR Berghofer Med Res Inst, Canc Immunotherapy Lab, Brisbane, Qld, Australia; [Pritchard, Antonia L.] QIMR Berghofer Med Res Inst, Oncogenom Lab, Brisbane, Qld, Australia; [Neller, Michelle A.] Univ Queensland, Queensland Mayne Med Sch, Sch Med, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland	Schmidt, CW (corresponding author), QIMR Berghofer Med Res Inst, Canc Immunotherapy Lab, Brisbane, Qld, Australia.	Chris.Schmidt@qimrberghofer.edu.au	Pritchard, Antonia/F-4288-2010; Schmidt, Christopher/A-4353-2009	Pritchard, Antonia/0000-0001-5336-0454; Schmidt, Christopher/0000-0002-3955-5076; Neller, Michelle/0000-0002-2457-1508	National Health and Medical Research Council of Australia [290358]; Rio Tinto Ride to Conquer Cancer QIMR Berghofer Medical Research Institute Flagship grant; Cure Cancer Australia Foundation; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rio Tinto Ride to Conquer Cancer QIMR Berghofer Medical Research Institute Flagship grant; Cure Cancer Australia Foundation; Australian Postgraduate Award(Australian Government)	This work was supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au) (Grant 290358 to CWS); Rio Tinto Ride to Conquer Cancer (www.conquercancer.org.au) QIMR Berghofer Medical Research Institute Flagship grant to ALP and CWS; Cure Cancer Australia Foundation (www.cure.org.au) fellowship to ALP; and Australian Postgraduate Award to MAN (www.uq.edu.au/grad-school/apa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.22317, 10.1002/cyto.a.22317]; Campbell JDM, 2003, METHODS, V31, P150, DOI 10.1016/S1046-2023(03)00125-7; Doyle AG, 1999, J EXP MED, V190, P1081, DOI 10.1084/jem.190.8.1081; Dunbar PR, 1999, J IMMUNOL, V162, P6959; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Haney D, 2011, J IMMUNOL METHODS, V369, P33, DOI 10.1016/j.jim.2011.04.003; Ho WY, 2006, J IMMUNOL METHODS, V310, P40, DOI 10.1016/j.jim.2005.11.023; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kim M, 2006, INT IMMUNOL, V18, P435, DOI 10.1093/intimm/dxh383; Leggatt GR, 2004, J LEUKOCYTE BIOL, V76, P787, DOI 10.1189/jlb.0104026; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Martinuzzi E, 2011, BLOOD, V118, P2128, DOI 10.1182/blood-2010-12-326231; MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113; O'Rourke MGE, 2003, CANCER IMMUNOL IMMUN, V52, P387, DOI 10.1007/s00262-003-0375-x; Ogg GS, 1998, CURR OPIN IMMUNOL, V10, P393, DOI 10.1016/S0952-7915(98)80110-6; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Plunkett FJ, 2005, MECH AGEING DEV, V126, P855, DOI 10.1016/j.mad.2005.03.006; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; RIDDELL SR, 1992, SCIENCE, V257, P238; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Yee C, 1999, J IMMUNOL, V162, P2227; Zhou D, 2006, LAB INVEST, V86, P314, DOI 10.1038/labinvest.3700381	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110741	10.1371/journal.pone.0110741	http://dx.doi.org/10.1371/journal.pone.0110741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368986	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000026
J	Qi, SQ; Zeng, QH; Luo, YM; Duan, HJ; Ding, C; Hu, WP; Li, H				Qi, Senqing; Zeng, Qinghong; Luo, Yangmei; Duan, Haijun; Ding, Cody; Hu, Weiping; Li, Hong			Impact of Working Memory Load on Cognitive Control in Trait Anxiety: An ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DORSOLATERAL PREFRONTAL CORTEX; SELECTIVE ATTENTION; STATE; PERFORMANCE; ADAPTATION; CAPACITY; DEFICITS; INDEXES; THREAT	Whether trait anxiety is associated with a general impairment of cognitive control is a matter of debate. This study investigated whether and how experimentally manipulated working memory (WM) load modulates the relation between trait anxiety and cognitive control. This question was investigated using a dual-task design in combination with event-related potentials. Participants were required to remember either one (low WM load) or six letters (high WM load) while performing a flanker task. Our results showed that a high WM load disrupted participants' ability to overcome distractor interference and this effect was exacerbated for the high trait-anxious (HTA) group. This exacerbation was reflected by larger interference effects (i.e., incongruent minus congruent) on reaction times (RTs) and N2 amplitudes for the HTA group than for the low trait-anxious group under high WM load. The two groups, however, did not differ in their ability to inhibit task-irrelevant distractors under low WM load, as indicated by both RTs and N2 amplitudes. These findings underscore the significance of WM-related cognitive demand in contributing to the presence (or absence) of a general cognitive control deficit in trait anxiety. Furthermore, our findings show that when limited WM resources are depleted by high WM load, HTA individuals exhibit less efficient recruitments of cognitive control required for the inhibition of distractors, therefore resulting in a greater degree of response conflict.	[Qi, Senqing; Duan, Haijun; Hu, Weiping] Shaanxi Normal Univ, MOE Key Lab Modern Teaching Technol, Xian, Peoples R China; [Zeng, Qinghong] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Luo, Yangmei] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Ding, Cody] Liaoning Univ Engn & Technol, Inst Safety Psychol, Fuxing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China	Shaanxi Normal University; Chinese University of Hong Kong; Shaanxi Normal University; Shenzhen University	Hu, WP (corresponding author), Shaanxi Normal Univ, MOE Key Lab Modern Teaching Technol, Xian, Peoples R China.	weipinghu@163.com; lihongwrm@vip.sina.com	Zeng, Ginger Qinghong/AAH-1066-2022; Zeng, Ginger Qinghong/AEX-3916-2022	Luo, Yangmei/0000-0002-4440-6980	National Natural Science Foundation of China [NSFC31271110, NSFC31470977, NSFC81171289, NSFC30770727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (Grant Nos. NSFC31271110, NSFC31470977, NSFC81171289, and NSFC30770727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043101; Amir N, 2011, J ABNORM PSYCHOL, V120, P504, DOI 10.1037/a0022849; Ansari TL, 2011, NEUROPSYCHOLOGIA, V49, P1146, DOI 10.1016/j.neuropsychologia.2011.01.019; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Basten U, 2011, J COGNITIVE NEUROSCI, V23, P3132, DOI 10.1162/jocn_a_00003; Berggren N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00188; Berggren N, 2013, BIOL PSYCHOL, V92, P440, DOI 10.1016/j.biopsycho.2012.03.007; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Caparos S, 2012, EMOTION, V12, P8, DOI 10.1037/a0026310; Chun MM, 2011, NEURON, V72, P520, DOI 10.1016/j.neuron.2011.10.026; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, BIOL PSYCHOL, V87, P282, DOI 10.1016/j.biopsycho.2011.03.011; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Dennis TA, 2009, PSYCHOPHYSIOLOGY, V46, P122, DOI 10.1111/j.1469-8986.2008.00758.x; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Morgan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038116; Moriya J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034244, 10.1371/journal.pone.0047221]; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Nieuwenhuis S, 2013, J EXP PSYCHOL HUMAN, V39, P1797, DOI 10.1037/a0033980; Osinsky R, 2012, BIOL PSYCHOL, V89, P252, DOI 10.1016/j.biopsycho.2011.10.016; Osinsky R, 2010, COGN AFFECT BEHAV NE, V10, P372, DOI 10.3758/CABN.10.3.372; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Qi SQ, 2014, COGN AFFECT BEHAV NE, V14, P253, DOI 10.3758/s13415-013-0203-5; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; Sadeh N, 2011, COGNITION EMOTION, V25, P747, DOI 10.1080/02699931.2010.500566; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Spielberger C.D, 1979, UNDERSTANDING STRESS; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stout DM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00058; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	47	17	20	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111791	10.1371/journal.pone.0111791	http://dx.doi.org/10.1371/journal.pone.0111791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369121	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000101
J	Adams, IP; Skelton, A; Macarthur, R; Hodges, T; Hinds, H; Flint, L; Nath, PD; Boonham, N; Fox, A				Adams, Ian P.; Skelton, Anna; Macarthur, Roy; Hodges, Tobias; Hinds, Howard; Flint, Laura; Nath, Palash Deb; Boonham, Neil; Fox, Adrian			Carrot yellow leaf virus Is Associated with Carrot Internal Necrosis	PLOS ONE			English	Article							GENERIC METHOD; SEQUENCE; RNA; IDENTIFICATION	Internal necrosis of carrot has been observed in UK carrots for at least 10 years, and has been anecdotally linked to virus infection. In the 2009 growing season some growers had up to 10% of yield with these symptoms. Traditional diagnostic methods are targeted towards specific pathogens. By using a metagenomic approach with high throughput sequencing technology, other, as yet unidentified causes of root necrosis were investigated. Additionally a statistical analysis has shown which viruses are most closely associated with disease symptoms. Carrot samples were collected from a crop exhibiting root necrosis (102 Affected: 99 Unaffected) and tested for the presence of the established carrot viruses: Carrot red leaf virus (CtRLV), Carrot mottle virus (CMoV), Carrot red leaf associated viral RNA (CtRLVaRNA) and Parsnip yellow fleck virus (PYFV). The presence of these viruses was not associated with symptomatic carrot roots either as single viruses or in combinations. A sub-sample of carrots of mixed symptom status was subjected to MiSeq sequencing. The results from these tests suggested Carrot yellow leaf virus (CYLV) was associated with symptomatic roots. Additionally a novel Torradovirus, a novel Closterovirus and two novel Betaflexiviradae related plant viruses were detected. A specific diagnostic test was designed for CYLV. Of the 102 affected carrots, 98% were positive for CYLV compared to 22% of the unaffected carrots. From these data we conclude that although we have yet to practically demonstrate a causal link, CYLV appears to be strongly associated with the presence of necrosis of carrots.	[Adams, Ian P.; Skelton, Anna; Macarthur, Roy; Hodges, Tobias; Flint, Laura; Boonham, Neil; Fox, Adrian] Food & Environm Res Agcy, Ctr Crop Protect, York, N Yorkshire, England; [Hinds, Howard] RootCrop Ltd, Hoveringham, Notts, England; [Hodges, Tobias] Univ York, York YO10 5DD, N Yorkshire, England; [Nath, Palash Deb] Assam Agr Univ, Dept Plant Pathol, Jorhat, Assam, India	Food & Environment Research Agency; University of York - UK; Assam Agricultural University	Fox, A (corresponding author), Food & Environm Res Agcy, Ctr Crop Protect, York, N Yorkshire, England.	adrian.fox@fera.gsi.gov.uk		fox, Adrian/0000-0003-1280-1836; Adams, Ian/0000-0002-5589-6460; Boonham, Neil/0000-0002-8886-5708	Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board [FV382a]	Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board	This work was funded by the Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board, as project FV382a. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Permission was required to allow submission of the manuscript.	Adams IP, 2013, PLANT PATHOL, V62, P741, DOI 10.1111/j.1365-3059.2012.02690.x; Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; BEM F, 1979, ANN APPL BIOL, V92, P237, DOI 10.1111/j.1744-7348.1979.tb03869.x; BEM F, 1979, ANN APPL BIOL, V92, P243, DOI 10.1111/j.1744-7348.1979.tb03870.x; Boonham N, 2003, J VIROL METHODS, V108, P181, DOI 10.1016/S0166-0934(02)00284-7; Botermans M, 2013, J VIROL METHODS, V187, P43, DOI 10.1016/j.jviromet.2012.09.004; Brunt A.A., 1996, PLANT VIRUSES ONLINE; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carnegie SF, 2010, POTATO RES, V53, P17, DOI 10.1007/s11540-010-9147-0; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Fox A, 2011, SYMPTOMATIC SURVEY V; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harju V, 2011, WATERCRESS NEW DIS R; Hill S.A., 1984, METHODS PLANT PATHOL, VVolume 1, P86; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; King E., 2011, VIRUS TAXONOMY; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Menzel W, 2009, ARCH VIROL, V154, P1343, DOI 10.1007/s00705-009-0428-3; Morgan D, 2004, PARSNIP YELLOW FLECK; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Morton A, 2003, PLANT PATHOL, V52, P795, DOI 10.1111/j.1365-3059.2003.00904.x; Murant AF, 1982, HELPER DEPENDENT TRA, P191; Murant AF, 1983, 189 SCOTT CROP RES I; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANDIJK P, 1989, NETH J PLANT PATHOL, V95, P1; VANDIJK P, 1985, NETH J PLANT PATHOL, V91, P169, DOI 10.1007/BF02009678; Verbeek M, 2008, ARCH VIROL, V153, P127, DOI 10.1007/s00705-007-1076-0; Verbeek M, 2010, ARCH VIROL, V155, P751, DOI 10.1007/s00705-010-0640-1; Vercruysse P, 2000, J VIROL METHODS, V88, P153, DOI 10.1016/S0166-0934(00)00196-8; Yamashita S, 1976, ANN PHYTOPATHOL SOC, V42, P382	33	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109125	10.1371/journal.pone.0109125	http://dx.doi.org/10.1371/journal.pone.0109125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365290	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558100007
J	Fonseca, CG; Pires, W; Lima, MRM; Guimaraes, JB; Lima, NRV; Wanner, SP				Fonseca, Cletiana Goncalves; Pires, Washington; Malheiros Lima, Milene Rodrigues; Guimaraes, Juliana Bohnen; Viana Lima, Nilo Resende; Wanner, Samuel Penna			Hypothalamic Temperature of Rats Subjected to Treadmill Running in a Cold Environment	PLOS ONE			English	Article							BRAIN TEMPERATURE; PROLONGED EXERCISE; BLOOD-FLOW; CARDIOVASCULAR ADJUSTMENTS; MUSCARINIC CHOLINOCEPTORS; METABOLIC-RESPONSES; PERCEIVED EXERTION; DYNAMIC EXERCISE; FATIGUE; PERFORMANCE	Different strategies for cooling the body prior to or during physical exercise have been shown to improve prolonged performance. Because of ethical and methodological issues, no studies conducted in humans have evaluated the changes in brain temperature promoted by cooling strategies. Therefore, our first aim sought to measure the hypothalamic temperature (T-hyp) of rats subjected to treadmill running in a cold environment. Moreover, evidence suggests that T-hyp and abdominal temperature (T-abd) are regulated by different physiological mechanisms. Thus, this study also investigated the dynamics of exercise-induced changes in T-hyp and T-abd at two ambient temperatures: 25 degrees C (temperate environment) and 12 degrees C (cold). Adult male Wistar rats were used in these experiments. The rats were implanted with a guide cannula in the hypothalamus and a temperature sensor in the abdominal cavity. After recovery from this surgery, the rats were familiarized with running on a treadmill and were then subjected to the two experimental trials: constant-speed running (20 m/min) at 12 degrees C and 25 degrees C. Both T-hyp and T-abd increased during exercise at 25 degrees C. In contrast, T-hyp and T-abd remained unchanged during fatiguing exercise at 12 degrees C. The temperature differential (i.e., T-hyp - T-abd) increased during the initial min of running at 25 degrees C and thereafter decreased toward pre-exercise values. Interestingly, external cooling prevented this early increase in the temperature differential from the 2nd to the 8th min of running. In addition, the time until volitional fatigue was higher during the constant exercise at 12 degrees C compared with 25 degrees C. Together, our results indicate that T-hyp and T-abd are regulated by different mechanisms in running rats and that external cooling affected the relationship between both temperature indexes observed during exercise without environmental thermal stress. Our data also suggest that attenuated hypothalamic hyperthermia may contribute to improved performance in cold environments.	[Fonseca, Cletiana Goncalves; Pires, Washington; Malheiros Lima, Milene Rodrigues; Guimaraes, Juliana Bohnen; Viana Lima, Nilo Resende; Wanner, Samuel Penna] Univ Fed Minas Gerais, Exercise Physiol Lab, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Guimaraes, Juliana Bohnen] Univ Estadual Minas Gerais, Inst Super Educ Anisio Teixeira, Ibirite, MG, Brazil	Universidade Federal de Minas Gerais; Universidade do Estado de Minas Gerais	Wanner, SP (corresponding author), Univ Fed Minas Gerais, Exercise Physiol Lab, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil.	samuelwanner@eeffto.ufmg.br	Malheiros-Lima, Milene R/F-9323-2017; Wanner, Samuel P./F-9654-2012	Wanner, Samuel P./0000-0002-4659-1032; Malheiros-Lima, Milene Rodrigues/0000-0001-5163-8424	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil)	The authors are indebted to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais for financial support. C.G.F. received a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and M.R.M.L. and W.P. received fellowships from the Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS R, 1964, AM J PHYSIOL, V206, P641, DOI 10.1152/ajplegacy.1964.206.3.641; Ansley L, 2008, PHYSIOL RES, V57, P863, DOI 10.33549/physiolres.931260; Baffi JS, 2000, NEUROENDOCRINOLOGY, V72, P102, DOI 10.1159/000054577; CAPUTA M, 1986, PFLUG ARCH EUR J PHY, V406, P184, DOI 10.1007/BF00586681; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; Crewe H, 2008, EUR J APPL PHYSIOL, V103, P569, DOI 10.1007/s00421-008-0741-7; DONHOFFER S, 1959, NATURE, V184, P993, DOI 10.1038/184993a0; Fuller A, 1998, J APPL PHYSIOL, V84, P877, DOI 10.1152/jappl.1998.84.3.877; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Gisolf CV, 2000, HOT BRAIN SURVIVAL T; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Guimaraes JB, 2013, SCAND J MED SCI SPOR, V23, P46, DOI 10.1111/j.1600-0838.2011.01350.x; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Ho CW, 1997, J APPL PHYSIOL, V82, P1126, DOI 10.1152/jappl.1997.82.4.1126; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2002, J NEUROSCI, V22, P1072, DOI 10.1523/JNEUROSCI.22-03-01072.2002; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; KIYOHARA T, 1995, BRAIN RES BULL, V38, P193, DOI 10.1016/0361-9230(95)00093-T; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Kunstetter AC, 2014, BRAZ J MED BIOL RES, V47, P679, DOI 10.1590/1414-431X20143561; Laughlin MH, 1999, ADV PHYSIOL EDUC, V22, pS244, DOI 10.1152/advances.1999.277.6.S244; Lima NRV, 1998, PHYSIOL BEHAV, V64, P69, DOI 10.1016/S0031-9384(98)00024-9; Makinen T, 1996, COMP BIOCHEM PHYS A, V114, P57, DOI 10.1016/0300-9629(95)02088-8; MERCER JB, 1978, PFLUG ARCH EUR J PHY, V374, P179, DOI 10.1007/BF00581299; Miki K, 2002, EXP PHYSIOL, V87, P33, DOI 10.1113/eph8702281; MORAINE JJ, 1993, EUR J APPL PHYSIOL O, V67, P35, DOI 10.1007/BF00377701; Nielsen B, 2001, PFLUG ARCH EUR J PHY, V442, P41, DOI 10.1007/s004240100515; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Nybo L, 2001, J APPL PHYSIOL, V91, P2017, DOI 10.1152/jappl.2001.91.5.2017; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PINKEL D, 1958, CANCER RES, V18, P853; Pires W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072005; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Ross M, 2013, SPORTS MED, V43, P207, DOI 10.1007/s40279-012-0014-9; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; SCHEURINK AJW, 1988, AM J PHYSIOL, V255, pR547, DOI 10.1152/ajpregu.1988.255.4.R547; Shafton Anthony D, 2014, Temperature (Austin), V1, P37, DOI 10.4161/temp.29597; Tang JS, 2010, OXID MED CELL LONGEV, V3, P332, DOI 10.4161/oxim.3.5.13184; VISSING J, 1989, AM J PHYSIOL, V256, pR1019, DOI 10.1152/ajpregu.1989.256.5.R1019; Wanner SP, 2010, PHYSIOL RES, V59, P165, DOI 10.33549/physiolres.931649; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004; Wanner SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075733; Wanner SP, 2011, NEUROSCI LETT, V488, P210, DOI 10.1016/j.neulet.2010.11.031	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111501	10.1371/journal.pone.0111501	http://dx.doi.org/10.1371/journal.pone.0111501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365556	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100073
J	Gao, JF; Tian, HJ; Yang, Y; Yu, XL; Li, CH; Rao, NN				Gao, Junfeng; Tian, Hongjun; Yang, Yong; Yu, Xiaolin; Li, Chenhong; Rao, Nini			A Novel Algorithm to Enhance P300 in Single Trials: Application to Lie Detection Using F-Score and SVM	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CONCEALED INFORMATION TEST; EVENT-RELATED POTENTIALS; SUPPORT VECTOR MACHINES; BCI COMPETITION 2003; DATA SET IIB; WAVELET TRANSFORM; ARTIFACT REMOVAL; SELECTION; ICA	The investigation of lie detection methods based on P300 potentials has drawn much interest in recent years. We presented a novel algorithm to enhance signal-to-noise ratio (SNR) of P300 and applied it in lie detection to increase the classification accuracy. Thirty-four subjects were divided randomly into guilty and innocent groups, and the EEG signals on 14 electrodes were recorded. A novel spatial denoising algorithm (SDA) was proposed to reconstruct the P300 with a high SNR based on independent component analysis. The differences between the proposed method and our/other early published methods mainly lie in the extraction and feature selection method of P300. Three groups of features were extracted from the denoised waves; then, the optimal features were selected by the F-score method. Selected feature samples were finally fed into three classical classifiers to make a performance comparison. The optimal parameter values in the SDA and the classifiers were tuned using a grid-searching training procedure with cross-validation. The support vector machine (SVM) approach was adopted to combine with an F-score because this approach had the best performance. The presented model F-score_SVM reaches a significantly higher classification accuracy for P300 (specificity of 96.05%) and non-P300 (sensitivity of 96.11%) compared with the results obtained without using SDA and compared with the results obtained by other classification models. Moreover, a higher individual diagnosis rate can be obtained compared with previous methods, and the presented method requires only a small number of stimuli in the real testing application.	[Gao, Junfeng; Li, Chenhong] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Tian, Hongjun] Nanjing Fullshare Superconducting Technol Co Ltd, Nanjing, Jiangsu, Peoples R China; [Yang, Yong] Jiangxi Univ Finance & Econ, Sch Informat Technol, Nanchang, Peoples R China; [Gao, Junfeng; Rao, Nini] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	South Central Minzu University; Jiangxi University of Finance & Economics; University of Electronic Science & Technology of China	Li, CH (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	lichen@mail.scuec.edu.cn; raonini@uestc.edu.cn			National Nature Science Foundation of China [81271659, 61262034, 61302011, 81171411, 30972848]; Academic Team of South Central University for Nationalities: Biomedical Signals Processing [XTZ09002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Team of South Central University for Nationalities: Biomedical Signals Processing	This work was supported by National Nature Science Foundation of China (No. 81271659, 61262034, 61302011, 81171411 and 30972848), and Academic Team of South Central University for Nationalities: Biomedical Signals Processing (No. XTZ09002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abootalebi V, 2006, INT J PSYCHOPHYSIOL, V62, P309, DOI 10.1016/j.ijpsycho.2006.05.009; Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Ademoglu A, 1997, IEEE T BIO-MED ENG, V44, P881, DOI 10.1109/10.623057; Ambach W, 2010, INT J PSYCHOPHYSIOL, V75, P258, DOI 10.1016/j.ijpsycho.2009.12.007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chen FL, 2010, EXPERT SYST APPL, V37, P4902, DOI 10.1016/j.eswa.2009.12.025; Chiang LH, 2000, CHEMOMETR INTELL LAB, V50, P243, DOI 10.1016/S0169-7439(99)00061-1; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Demiralp T, 1999, BRAIN LANG, V66, P108, DOI 10.1006/brln.1998.2027; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Friedrichs F, 2005, NEUROCOMPUTING, V64, P107, DOI 10.1016/j.neucom.2004.11.022; Gamer M, 2010, PSYCHOPHYSIOLOGY, V47, P355, DOI 10.1111/j.1469-8986.2009.00933.x; Gao JF, 2010, BRAIN TOPOGR, V23, P105, DOI 10.1007/s10548-009-0131-4; Gao JF, 2012, CLIN EEG NEUROSCI, V43, P54, DOI 10.1177/1550059411428715; Gao JF, 2011, COMPUT METH PROG BIO, V104, P410, DOI 10.1016/j.cmpb.2010.10.002; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hsu WY, 2007, J NEUROSCI METH, V163, P145, DOI 10.1016/j.jneumeth.2007.02.004; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Hung CI, 2005, ANN BIOMED ENG, V33, P1053, DOI 10.1007/s10439-005-5772-1; Ito A, 2011, NEUROSCI RES, V69, P121, DOI 10.1016/j.neures.2010.11.001; Jouve PE, 2005, LECT NOTES COMPUT SC, V3488, P583; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 1998, ADV NEUR IN, V10, P894; Kalatzis I, 2004, COMPUT METH PROG BIO, V75, P11, DOI 10.1016/j.cmpb.2003.09.003; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lin CT, 2007, IEEE T BIO-MED ENG, V54, P1349, DOI 10.1109/TBME.2007.891164; Makeig S, 1996, ADV NEUR IN, V8, P145; Matsuda I, 2013, PSYCHOPHYSIOLOGY, V50, P617, DOI 10.1111/psyp.12046; Matsuda I, 2011, PSYCHOPHYSIOLOGY, V48, P1701, DOI 10.1111/j.1469-8986.2011.01266.x; Matsuda I, 2009, INT J PSYCHOPHYSIOL, V74, P58, DOI 10.1016/j.ijpsycho.2009.07.004; Meijer EH, 2007, INT J PSYCHOPHYSIOL, V66, P231, DOI 10.1016/j.ijpsycho.2007.08.001; Mrzagora AC, 2006, P 28 IEEE EMBS ANN I; Parra L, 2004, J MACH LEARN RES, V4, P1261; Peterson DA, 1999, LECT NOTES COMPUT SC, V1607, P265; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Polat K, 2009, EXPERT SYST APPL, V36, P10367, DOI 10.1016/j.eswa.2009.01.041; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Quiroga RQ, 2001, BRAIN RES PROTOC, V8, P16, DOI 10.1016/S1385-299X(01)00077-0; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; Rosenfeld JP, 2002, HDB POLYGRAPH TESTIN, P265; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Shoker L, 2005, IEEE SIGNAL PROC LET, V12, P721, DOI 10.1109/LSP.2005.855539; Soskins M, 2001, INT J PSYCHOPHYSIOL, V40, P173, DOI 10.1016/S0167-8760(00)00154-9; Tang AC, 2006, NEUROIMAGE, V29, P335, DOI 10.1016/j.neuroimage.2005.07.058; Tang AC, 2000, NEUROCOMPUTING, V32, P1115, DOI 10.1016/S0925-2312(00)00286-1; Tarassenko L, 1998, IEE P-SCI MEAS TECH, V145, P270, DOI 10.1049/ip-smt:19982328; UNSER M, 1992, IEEE T INFORM THEORY, V38, P864, DOI 10.1109/18.119742; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x; Wu CH, 2009, EXPERT SYST APPL, V36, P4725, DOI 10.1016/j.eswa.2008.06.046; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yong YPA, 2005, EUR SIGNAL PROCESS	60	14	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109700	10.1371/journal.pone.0109700	http://dx.doi.org/10.1371/journal.pone.0109700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365325	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100009
J	Ji, RJ; Liu, YH; Diao, RQ; Xu, CC; Li, XP; Cai, BP; Zhang, YZ				Ji, Renjie; Liu, Yonghong; Diao, Ruiqiang; Xu, Chenchen; Li, Xiaopeng; Cai, Baoping; Zhang, Yanzhen			Influence of Electrical Resistivity and Machining Parameters on Electrical Discharge Machining Performance of Engineering Ceramics	PLOS ONE			English	Article								Engineering ceramics have been widely used in modern industry for their excellent physical and mechanical properties, and they are difficult to machine owing to their high hardness and brittleness. Electrical discharge machining (EDM) is the appropriate process for machining engineering ceramics provided they are electrically conducting. However, the electrical resistivity of the popular engineering ceramics is higher, and there has been no research on the relationship between the EDM parameters and the electrical resistivity of the engineering ceramics. This paper investigates the effects of the electrical resistivity and EDM parameters such as tool polarity, pulse interval, and electrode material, on the ZnO/Al2O3 ceramic's EDM performance, in terms of the material removal rate (MRR), electrode wear ratio (EWR), and surface roughness (SR). The results show that the electrical resistivity and the EDM parameters have the great influence on the EDM performance. The ZnO/Al2O3 ceramic with the electrical resistivity up to 3410 Omega.cm can be effectively machined by EDM with the copper electrode, the negative tool polarity, and the shorter pulse interval. Under most machining conditions, the MRR increases, and the SR decreases with the decrease of electrical resistivity. Moreover, the tool polarity, and pulse interval affect the EWR, respectively, and the electrical resistivity and electrode material have a combined effect on the EWR. Furthermore, the EDM performance of ZnO/Al2O3 ceramic with the electrical resistivity higher than 687 Omega.cm is obviously different from that with the electrical resistivity lower than 687 Omega.cm, when the electrode material changes. The microstructure character analysis of the machined ZnO/Al2O3 ceramic surface shows that the ZnO/Al2O3 ceramic is removed by melting, evaporation and thermal spalling, and the material from the working fluid and the graphite electrode can transfer to the workpiece surface during electrical discharge machining ZnO/Al2O3 ceramic.	[Ji, Renjie; Liu, Yonghong; Diao, Ruiqiang; Xu, Chenchen; Li, Xiaopeng; Cai, Baoping; Zhang, Yanzhen] China Univ Petr, Coll Electromech Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Ji, RJ (corresponding author), China Univ Petr, Coll Electromech Engn, Qingdao, Shandong, Peoples R China.	jirenjie@upc.edu.cn	Zhang, Yanzhen/L-6446-2018	Zhang, Yanzhen/0000-0002-9802-2843; Liu, Yonghong/0000-0002-4339-6389	National Natural Science Foundation of China [51205411]; Shandong Provincial Natural Science Foundation of China [ZR2012EEL15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The study was financially supported by the National Natural Science Foundation of China under grant number 51205411, and Shandong Provincial Natural Science Foundation of China under grant number ZR2012EEL15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SG, 2013, INT J ADV MANUF TECH, V66, P431, DOI 10.1007/s00170-012-4338-2; Feng J, 2013, INT J ADV MANUF TECH, V68, P1039, DOI 10.1007/s00170-013-4895-z; Hanaoka D, 2013, PROC CIRP, V6, P95, DOI 10.1016/j.procir.2013.03.033; Ji RJ, 2011, MATER MANUF PROCESS, V26, P1050, DOI 10.1080/10426914.2010.529590; Ku┬nig W., 1988, ANN CIRP, V37, P623, DOI [DOI 10.1016/S0007-8506(07)60759-8, 10.1016/S0007-8506(07)60759-8]; Lalchhuanvela H, 2013, INT J ADV MANUF TECH, V67, P1683, DOI 10.1007/s00170-012-4601-6; Liang XH, 2012, APPL SURF SCI, V258, P6406, DOI 10.1016/j.apsusc.2012.03.050; Liu CC, 2003, MAT SCI ENG A-STRUCT, V363, P221, DOI 10.1016/S0921-5093(03)00630-0; Liu YH, 2008, INT J MACH TOOL MANU, V48, P1504, DOI 10.1016/j.ijmachtools.2008.03.012; Liu YHH, 2009, J ALLOY COMPD, V472, P406, DOI 10.1016/j.jallcom.2008.04.072; Okada A, 2008, J EUR CERAM SOC, V28, P1097, DOI 10.1016/j.jeurceramsoc.2007.09.016; Patel KM, 2010, INT J ADV MANUF TECH, V47, P1137, DOI 10.1007/s00170-009-2249-7; Puertas I, 2012, INT J ADV MANUF TECH, V59, P575, DOI 10.1007/s00170-011-3509-x; Qiu MB, 2013, PRECIS ENG, V37, P902, DOI 10.1016/j.precisioneng.2013.05.009; Tak HS, 2011, T NONFERR METAL SOC, V21, pS28, DOI 10.1016/S1003-6326(11)61055-8; Wei C, 2013, INT J ADV MANUF TECH, V64, P187, DOI 10.1007/s00170-012-3995-5	16	19	19	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110775	10.1371/journal.pone.0110775	http://dx.doi.org/10.1371/journal.pone.0110775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364912	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558100027
J	Merlin, JS; Walcott, M; Ritchie, C; Herbey, I; Kertesz, SG; Chamot, E; Saag, M; Turan, JM				Merlin, Jessica S.; Walcott, Melonie; Ritchie, Christine; Herbey, Ivan; Kertesz, Stefan G.; Chamot, Eric; Saag, Michael; Turan, Janet M.			'Two Pains Together': Patient Perspectives on Psychological Aspects of Chronic Pain while Living with HIV	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; CHRONIC BACK-PAIN; MUSCULOSKELETAL PAIN; NONCANCER PAIN; OPIOID USE; GENERAL-POPULATION; DEPRESSION; MANAGEMENT; COMORBIDITY; ADULTS	Objective: Chronic pain is common in HIV-infected individuals. Understanding HIV-infected patients' chronic pain experience not just from a biological, but also from a psychological perspective, is a critical first step toward improving care for this population. Our objective was to explore HIV-infected patients' perspectives on psychological aspects of chronic pain using in-depth qualitative interviews. Methods: Investigators engaged in an iterative process of independent and group coding until theme saturation was reached. Results: Of the 25 patients with chronic pain interviewed, 20 were male, 15 were younger than age 50, and 15 were African-American. Key themes that emerged included the close relationship between mood and pain; mood and pain in the context of living with HIV; use of alcohol/drugs to self-medicate for pain; and the challenge of receiving prescription pain medications while dealing with substance use disorders. Conclusions: The results suggest that psychological approaches to chronic pain treatment may be well received by HIV-infected patients.	[Merlin, Jessica S.; Walcott, Melonie; Herbey, Ivan; Saag, Michael] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Merlin, Jessica S.] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Ritchie, Christine] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; [Ritchie, Christine] Jewish Home San Francisco Ctr Res Aging, San Francisco, CA USA; [Kertesz, Stefan G.] Birmingham VA Med Ctr, Birmingham, AL USA; [Kertesz, Stefan G.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Chamot, Eric; Turan, Janet M.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Merlin, JS (corresponding author), Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA.	jmerlin@uab.edu	Harding, Richard/G-9729-2012	Turan, Janet/0000-0002-7802-6206	University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR); National Institutes of Health funded program [P30 A1027767]; Agency for Healthcare Research and Quality [1K12HS02169401]; National Institute on Aging [7K07AG031779]; Mary Fisher CARE Fund at UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG031779] Funding Source: NIH RePORTER	University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR); National Institutes of Health funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mary Fisher CARE Fund at UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR), an National Institutes of Health funded program (P30 A1027767) that was made possible by the following institutes: National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, National Institute on Aging, and the NIH Office of AIDS Research. JSM is supported by 1K12HS02169401 (Agency for Healthcare Research and Quality). CSR is supported by 7K07AG031779 (National Institute on Aging). Funding was also provided by the Mary Fisher CARE Fund at UAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RH, 2009, J PSYCHOSOM RES, V67, P607, DOI 10.1016/j.jpsychores.2009.08.008; Alok R, 2011, CLIN EXP RHEUMATOL, V29, pS70; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bergman AA, 2013, PAIN MED; Dominick CH, 2012, PAIN, V153, P293, DOI 10.1016/j.pain.2011.09.018; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub2; Edelman EJ, 2013, J GEN INTERN MED, V28, P82, DOI 10.1007/s11606-012-2189-z; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Galvan FH, 2003, J PSYCHOACTIVE DRUGS, P153, DOI 10.1080/02791072.2003.10400510; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gaynes BN, 2013, 8 INT C HIV PREV TRE; Gaynes BN, 2008, PSYCHOSOM MED, V70, P505, DOI 10.1097/PSY.0b013e31816aa0cc; Gudin J, 2012, J PAIN SYMPTOM MANAG, V44, pS4, DOI 10.1016/j.jpainsymman.2012.08.013; Kenny DT, 2004, PATIENT EDUC COUNS, V52, P297, DOI 10.1016/S0738-3991(03)00105-8; Koeppe J, 2010, CLIN J PAIN, V26, P190, DOI 10.1097/AJP.0b013e3181b91624; Kroenke K, 2007, GEN HOSP PSYCHIAT, V29, P506, DOI 10.1016/j.genhosppsych.2007.08.005; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Lum PJ, 2011, JAIDS-J ACQ IMM DEF, V56, pS91, DOI 10.1097/QAI.0b013e31820a9a82; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Matthias MS, 2013, PATIENT EDUC COUNS, V93, P197, DOI 10.1016/j.pec.2013.06.021; Merlin JS, 2012, JAIDS-J ACQ IMM DEF, V61, P164, DOI 10.1097/QAI.0b013e3182662215; Merlin JS, 2012, J PAIN SYMPTOM MANAG, V43, P638, DOI 10.1016/j.jpainsymman.2011.04.019; Merlin JS, 2013, PAIN MED; Merlin JS, 2014, AIDS PATIENT CARE ST; Merlin JS, 2013, PAIN PRACT; Miaskowski C, 2011, J PAIN, V12, P1004, DOI 10.1016/j.jpain.2011.04.002; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Morasco BJ, 2011, J PAIN, V12, P352, DOI 10.1016/j.jpain.2010.07.010; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Reddy RG, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4462; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; Servan-Schreiber D, 2000, AM FAM PHYSICIAN, V61, P1423; Silverberg MJ, 2012, CLIN J PAIN, V28, P39, DOI 10.1097/AJP.0b013e3182201a0f; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Verra ML, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-145; VERVEST ACM, 1988, PAIN, V34, P318, DOI 10.1016/0304-3959(88)90129-7; Vivian CT, 2007, BRIT MED J, V335, P900, DOI 10.1136/bmj.39381.514780.BE	44	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111765	10.1371/journal.pone.0111765	http://dx.doi.org/10.1371/journal.pone.0111765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365306	Green Published, gold			2022-12-26	WOS:000345558100116
J	Roark, AM; Bjorndal, KA				Roark, Alison M.; Bjorndal, Karen A.			Bridging Developmental Boundaries: Lifelong Dietary Patterns Modulate Life Histories in a Parthenogenetic Insect	PLOS ONE			English	Article							RESOURCE-ALLOCATION; FOOD LIMITATION; SPAN EXTENSION; PHENOTYPIC PLASTICITY; CALORIC RESTRICTION; TRADE-OFFS; BODY-SIZE; FRUIT-FLY; REPRODUCTION; FECUNDITY	Determining the effects of lifelong intake patterns on performance is challenging for many species, primarily because of methodological constraints. Here, we used a parthenogenetic insect (Carausius morosus) to determine the effects of limited and unlimited food availability across multiple life-history stages. Using a parthenogen allowed us to quantify intake by juvenile and adult females and to evaluate the morphological, physiological, and life-history responses to intake, all without the confounding influences of pair-housing, mating, and male behavior. In our study, growth rate prior to reproductive maturity was positively correlated with both adult and reproductive lifespans but negatively correlated with total lifespan. Food limitation had opposing effects on lifespan depending on when it was imposed, as it protracted development in juveniles but hastened death in adults. Food limitation also constrained reproduction regardless of when food was limited, although decreased fecundity was especially pronounced in individuals that were food-limited as late juveniles and adults. Additional carry-over effects of juvenile food limitation included smaller adult size and decreased body condition at the adult molt, but these effects were largely mitigated in insects that were switched to ad libitum feeding as late juveniles. Our data provide little support for the existence of a trade-off between longevity and fecundity, perhaps because these functions were fueled by different nutrient pools. However, insects that experienced a switch to the limited diet at reproductive maturity seem to have fueled egg production by drawing down body stores, thus providing some evidence for a life-history trade-off. Our results provide important insights into the effects of food limitation and indicate that performance is modulated by intake both within and across life-history stages.	[Roark, Alison M.] Furman Univ, Dept Biol, Greenville, SC 29613 USA; [Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Roark, AM (corresponding author), Furman Univ, Dept Biol, Greenville, SC 29613 USA.	alison.roark@furman.edu		Bjorndal, Karen/0000-0002-6286-1901	National Science Foundation Doctoral Dissertation Improvement Grant [0508592]	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This project was funded by a National Science Foundation Doctoral Dissertation Improvement Grant (project number 0508592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala BK, 2008, APPL ENTOMOL ZOOL, V43, P183, DOI 10.1303/aez.2008.183; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; AUSTAD SN, 1989, EXP GERONTOL, V24, P83, DOI 10.1016/0531-5565(89)90037-5; Ban S, 2009, J EXP BIOL, V212, P3174, DOI 10.1242/jeb.031518; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bauerfeind SS, 2008, BASIC APPL ECOL, V9, P443, DOI 10.1016/j.baae.2007.05.005; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Blanckenhorn WU, 2006, J ZOOL, V268, P17, DOI 10.1111/j.1469-7998.2005.00018.x; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; BRADLEY JT, 1995, COMP BIOCHEM PHYS B, V110, P255, DOI 10.1016/0305-0491(94)00100-9; Carey JR, 2002, AGING CELL, V1, P140, DOI 10.1046/j.1474-9728.2002.00019.x; Carey JR, 1998, FUNCT ECOL, V12, P359, DOI 10.1046/j.1365-2435.1998.00197.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; DeClercq P, 1997, ANN ENTOMOL SOC AM, V90, P121, DOI 10.1093/aesa/90.2.121; Dixon AFG, 2002, ECOL ENTOMOL, V27, P433, DOI 10.1046/j.1365-2311.2002.00429.x; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Dudycha JL, 2005, EVOLUTION, V59, P565; Fanson BG, 2012, AGE, V34, P1361, DOI 10.1007/s11357-011-9308-3; Foster SP, 1999, ENTOMOL EXP APPL, V91, P287, DOI 10.1023/A:1003674529752; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Glazier DS, 2002, EVOLUTION, V56, P1696, DOI 10.1111/j.0014-3820.2002.tb01481.x; Gribble KE, 2013, J GERONTOL A-BIOL, V68, P349, DOI 10.1093/gerona/gls170; Hatle JD, 2006, J COMP PHYSIOL B, V176, P27, DOI 10.1007/s00360-005-0028-9; Hatle JD, 2003, INTEGR COMP BIOL, V43, P635, DOI 10.1093/icb/43.5.635; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Joshi A, 1998, EVOL ECOL, V12, P363, DOI 10.1023/A:1006508418493; Juliano SA, 2004, ECOLOGY, V85, P2986, DOI 10.1890/03-0814; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; LEVINS RICHARD, 1968; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Meats A, 2004, PHYSIOL ENTOMOL, V29, P176, DOI 10.1111/j.1365-3032.2004.00383.x; Medeiros MN, 2011, J INSECT PHYSIOL, V57, P945, DOI 10.1016/j.jinsphys.2011.04.010; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Moehrlin GS, 1998, OECOLOGIA, V115, P492, DOI 10.1007/s004420050546; Morgan IJ, 2001, P ROY SOC B-BIOL SCI, V268, P295, DOI 10.1098/rspb.2000.1365; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Olijnyk AM, 2013, FUNCT ECOL, V27, P165, DOI 10.1111/1365-2435.12015; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; PERRIN N, 1992, AM NAT, V139, P1344, DOI 10.1086/285390; PERRIN N, 1990, OIKOS, V59, P70, DOI 10.2307/3545124; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; PIJNACKER LP, 1966, CHROMOSOMA, V19, P99, DOI 10.1007/BF00332794; Price P.W., 2011, INSECT ECOLOGY BEHAV; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roark AM, 2009, EXP GERONTOL, V44, P413, DOI 10.1016/j.exger.2009.03.004; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; SIBLY R, 1984, J THEOR BIOL, V111, P463, DOI 10.1016/S0022-5193(84)80234-9; Sibly R. M., 1986, PHYSL ECOLOGY ANIMAL; SMITH JNM, 1981, EVOLUTION, V35, P1142, DOI 10.1111/j.1558-5646.1981.tb04985.x; Speakman JR, 2005, J COMP PHYSIOL B, V175, P375, DOI 10.1007/s00360-005-0013-3; Stearns S.C., 1992, pi; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Walker PW, 2010, ENTOMOL EXP APPL, V136, P290, DOI 10.1111/j.1570-7458.2010.01028.x; Weindruch R., 1988, RETARDATION AGING DI; Welsch R, 1980, REGRESSION DIAGNOSTI; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	77	2	2	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111654	10.1371/journal.pone.0111654	http://dx.doi.org/10.1371/journal.pone.0111654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365446	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100096
J	Yang, Y; Dang, YY; Li, Q; Lu, JJ; Li, XW; Wang, YT				Yang Yang; Dang Yuanye; Li Qing; Lu Jinjian; Li Xiwen; Wang Yitao			Complete Chloroplast Genome Sequence of Poisonous and Medicinal Plant Datura stramonium: Organizations and Implications for Genetic Engineering	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GREEN FLUORESCENT PROTEIN; PLASTID GENOME; CODON USAGE; TRANSFORMATION; EXPRESSION; DNA; TOBACCO; OVEREXPRESSION; SCOPOLAMINE	Datura stramonium is a widely used poisonous plant with great medicinal and economic value. Its chloroplast (cp) genome is 155,871 bp in length with a typical quadripartite structure of the large (LSC, 86,302 bp) and small (SSC, 18,367 bp) single-copy regions, separated by a pair of inverted repeats (IRs, 25,601 bp). The genome contains 113 unique genes, including 80 protein-coding genes, 29 tRNAs and four rRNAs. A total of 11 forward, 9 palindromic and 13 tandem repeats were detected in the D. stramonium cp genome. Most simple sequence repeats (SSR) are AT-rich and are less abundant in coding regions than in non-coding regions. Both SSRs and GC content were unevenly distributed in the entire cp genome. All preferred synonymous codons were found to use A/T ending codons. The difference in GC contents of entire genomes and of the three-codon positions suggests that the D. stramonium cp genome might possess different genomic organization, in part due to different mutational pressures. The five most divergent coding regions and four non-coding regions (trnH-psbA, rps4-trnS, ndhD-ccsA, and ndhI-ndhG) were identified using whole plastome alignment, which can be used to develop molecular markers for phylogenetics and barcoding studies within the Solanaceae. Phylogenetic analysis based on 68 protein-coding genes supported Datura as a sister to Solanum. This study provides valuable information for phylogenetic and cp genetic engineering studies of this poisonous and medicinal plant.	[Yang Yang; Dang Yuanye; Lu Jinjian; Li Xiwen; Wang Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Li Qing] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China; [Li Xiwen] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	University of Macau; Naval Medical University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Li, XW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	xiweijia2004@aliyun.com; ytwang@umac.mo	Lu, Jinjian/X-2083-2019; xiwen, li/W-1990-2019; Lu, Jinjian/R-6207-2019; Wang, Yitao/O-5184-2016	Lu, Jinjian/0000-0001-6703-3120; 	Macau Science and Technology Development Fund [077/2011/A3, 074/2012/A3]; Research committee of University of Macau [MYRG208A (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS]; National Natural Science Foundation of China [81202860, 81303160]	Macau Science and Technology Development Fund; Research committee of University of Macau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Macau Science and Technology Development Fund (http://www.fdct.gov.mo/) (077/2011/A3, 074/2012/A3), Research committee of University of Macau (http://www.umac.mo/research/research_committee.html) (MYRG208A (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS) and the National Natural Science Foundation of China (81202860, 81303160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgard M, 2001, J MOL EVOL, V53, P465, DOI 10.1007/s002390010236; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Christhudas IVSN, 2013, CURR MICROBIOL, V67, P69, DOI 10.1007/s00284-013-0329-2; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dufourmantel N, 2007, PLANT BIOTECHNOL J, V5, P118, DOI 10.1111/j.1467-7652.2006.00226.x; Eftekhar F, 2005, FITOTERAPIA, V76, P118, DOI 10.1016/j.fitote.2004.10.004; Fan Y, 2007, HOU HAN SHU HUA TUO; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gaire BP, 2013, J INTEGR MED-JIM, V11, P73, DOI 10.3736/jintegrmed2013016; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gupta Sonika, 2010, Asian Journal of Experimental Biological Sciences, V1, P151; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hagemann R, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P93, DOI 10.1007/978-1-4020-3166-3_4; Hanson MR, 2013, J EXP BOT, V64, P731, DOI 10.1093/jxb/ers325; Heifetz PB, 2001, CURR OPIN PLANT BIOL, V4, P157, DOI 10.1016/S1369-5266(00)00153-9; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Iannacone R, 1997, PLANT MOL BIOL, V34, P485, DOI 10.1023/A:1005876323398; Jakabova S, 2012, J CHROMATOGR A, V1232, P295, DOI 10.1016/j.chroma.2012.02.036; Kawata M, 1997, CURR GENET, V31, P179, DOI 10.1007/s002940050193; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Kurtz S, 2004, GENOME BIOL, P5; Lacy BE, 2013, SCAND J GASTROENTERO, V48, P926, DOI 10.3109/00365521.2013.804117; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Li Xi-wen, 2012, Yaoxue Xuebao, V47, P124; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Li XW, 2013, SCI CHINA LIFE SCI, V56, P189, DOI 10.1007/s11427-012-4430-8; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu S, 2013, CNS DRUGS, V27, P1093, DOI 10.1007/s40263-013-0111-9; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lutz KA, 2001, PLANT PHYSIOL, V125, P1585, DOI 10.1104/pp.125.4.1585; Mariotti R, 2010, BMC PLANT BIOL, V10; Mdee LK, 2009, S AFR J BOT, V75, P375, DOI 10.1016/j.sajb.2009.02.003; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morton BR, 2003, J MOL EVOL, V56, P616, DOI 10.1007/s00239-002-2430-1; Moyano E, 2003, J EXP BOT, V54, P203, DOI 10.1093/jxb/erg014; Moyano E, 2007, J PLANT PHYSIOL, V164, P521, DOI 10.1016/j.jplph.2006.06.012; Nair RR, 2012, BIOINFORMATION, V8, P1096, DOI 10.6026/97320630081096; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nie XJ, 2012, PLOS ONE, P7; Palazon J, 2008, MOLECULES, V13, P1722, DOI 10.3390/molecules13081722; Peredery O, 2004, PHYTOTHER RES, V18, P700, DOI 10.1002/ptr.1511; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Pramod KK, 2010, PLANT PHYSIOL BIOCH, V48, P966, DOI 10.1016/j.plaphy.2010.09.003; Pretorius E, 2006, ENVIRON TOXICOL PHAR, V21, P331, DOI 10.1016/j.etap.2005.10.006; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Rasila Devi M, 2011, ASSAM U J SCI TECHNO, V7, P139; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Rouwendal GJA, 1997, PLANT MOL BIOL, V33, P989, DOI 10.1023/A:1005740823703; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Sharma A, 2009, INDIAN J PHARMACOL, V41, P129, DOI 10.4103/0253-7613.55212; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Singh AK, 2010, TRANSGENIC RES, V19, P113, DOI 10.1007/s11248-009-9290-z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Swofford D.L., 2003, PHYLOGENETIC HDB PRA, P160; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HH, 2009, J GENET GENOMICS, V36, P387, DOI 10.1016/S1673-8527(08)60128-9; Weissman B, 2011, TOXICOLOGY, V290, P149, DOI 10.1016/j.tox.2011.09.004; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu JW, 2003, SCI CHINA SER C, V46, P561, DOI 10.1360/02yc0120; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zhang L, 2004, P NATL ACAD SCI USA, V101, P6786, DOI 10.1073/pnas.0401391101; Zhang T., 2012, P 10 ASIA PACIFIC C, P7, DOI DOI 10.1145/2350046.2350150; Zubko MK, 2004, TRANSGENIC RES, V13, P523, DOI 10.1007/s11248-004-2374-x	92	34	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110656	10.1371/journal.pone.0110656	http://dx.doi.org/10.1371/journal.pone.0110656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365514	gold, Green Published			2022-12-26	WOS:000345558100024
J	Faisy, C; Grassin-Delyle, S; Blouquit-Laye, S; Brollo, M; Naline, E; Chapelier, A; Devillier, P				Faisy, Christophe; Grassin-Delyle, Stanislas; Blouquit-Laye, Sabine; Brollo, Marion; Naline, Emmanuel; Chapelier, Alain; Devillier, Philippe			Wnt/beta-Catenin Signaling Modulates Human Airway Sensitization Induced by beta(2)-Adrenoceptor Stimulation	PLOS ONE			English	Article							BETA-CATENIN; WNT; PATHWAY; EXPRESSION; RECEPTORS; CELLS; INHIBITION; MECHANISMS; EPITHELIUM; AGONIST	Background: Regular use of beta(2)-agonists may enhance non-specific airway responsiveness. The wingless/integrated (Wnt) signaling pathways are responsible for several cellular processes, including airway inflammation and remodeling while cAMP-PKA cascade can activate the Wnt signaling. We aimed to investigate whether the Wnt signaling pathways are involved in the bronchial hyperresponsiveness induced by prolonged exposure to beta(2)-adrenoceptor agonists in human isolated airways. Methods: Bronchi were surgically removed from 44 thoracic surgery patients. After preparation, bronchial rings and primary cultures of bronchial epithelial cells were incubated with fenoterol (0.1 mu M, 15 hours, 37 degrees C), a beta(2)-agonist with high intrinsic efficacy. The effects of inhibitors/blockers of Wnt signaling on the fenoterol-induced airway sensitization were examined and the impact of fenoterol exposure on the mRNA expression of genes interacting with Wnt signaling or cAMP-PKA cascade was assessed in complete bronchi and in cultured epithelial cells. Results: Compared to paired controls, fenoterol-sensitization was abolished by inhibition/blockage of the Wnt/beta-catenin signaling, especially the cell-surface LRP5/6 co-receptors or Fzd receptors (1 mu M SFRP1 or 1 mu M DKK1) and the nuclear recruitment of TCF/LEF transcriptions factors (0.3 mu M FH535). Wnt proteins secretion did not seem to be involved in the fenoterol-induced sensitization since the mRNA expression of Wnt remained low after fenoterol exposure and the inactivator of Wnt secretion (1 mu M IWP2) had no effect on the fenoterol-sensitization. Fenoterol exposure did not change the mRNA expression of genes regulating Wnt signaling or cAMP-PKA cascade. Conclusions: Collectively, our pharmacological investigations indicate that fenoterol-sensitization is modulated by the inhibition/blockage of canonical Wnt/beta-catenin pathway, suggesting a phenomenon of biased agonism in connection with the beta(2)-adrenoceptor stimulation. Future experiments based on the results of the present study will be needed to determine the impact of prolonged fenoterol exposure on the extra-and intracellular Wnt signaling pathways at the protein expression level.	[Faisy, Christophe; Grassin-Delyle, Stanislas; Blouquit-Laye, Sabine; Brollo, Marion; Naline, Emmanuel; Devillier, Philippe] Univ Versailles St Quentin, Unite Propre Rech Enseignement Super, Equipe Accueil 220, Hop Foch, Suresnes, France; [Faisy, Christophe] Hop Europeen Georges Pompidou, AP HP, Med Intens Care Unit, Paris, France; [Chapelier, Alain] Hop Foch, Dept Thorac Surg, Suresnes, France	Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch	Faisy, C (corresponding author), Univ Versailles St Quentin, Unite Propre Rech Enseignement Super, Equipe Accueil 220, Hop Foch, Suresnes, France.	christophe.faisy@egp.aphp.fr	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix)	French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix)	This research was funded by the French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Blouquit S, 2002, AM J RESP CELL MOL, V27, P503, DOI 10.1165/rcmb.4869; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Faisy C, 2004, N-S ARCH PHARMACOL, V370, P167, DOI 10.1007/s00210-004-0974-x; Faisy C, 2002, AM J PHYSIOL-LUNG C, V283, pL1033, DOI 10.1152/ajplung.00063.2002; Faisy C, 2011, CRIT CARE, V15, DOI 10.1186/cc10443; Faisy C, 2010, PHARMACOL RES, V61, P121, DOI 10.1016/j.phrs.2009.08.003; Gallegos TF, 2012, DEV BIOL, V364, P11, DOI 10.1016/j.ydbio.2012.01.014; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; Hahne G, 2013, BIOORGAN MED CHEM, V21, P4020, DOI 10.1016/j.bmc.2013.02.050; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim GH, 2013, BIOCHEM BIOPH RES CO, V435, P182, DOI 10.1016/j.bbrc.2013.04.088; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Levanen B, 2011, RESP MED, V105, P282, DOI 10.1016/j.rmed.2010.11.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Panza A, 2013, BBA-MOL CELL RES, V1833, P1853, DOI 10.1016/j.bbamcr.2013.04.004; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roth HM, 2012, PULM PHARMACOL THER, V25, P420, DOI 10.1016/j.pupt.2012.09.004; Saini S, 2011, NAT REV UROL, V8, P690, DOI 10.1038/nrurol.2011.146; Sears MR, 2002, J ALLERGY CLIN IMMUN, V110, P322; Shi QP, 2013, BIOMED PHARMACOTHER, V67, P745, DOI 10.1016/j.biopha.2013.04.002; Spina D, 1998, AM J RESP CRIT CARE, V158, pS141, DOI 10.1164/ajrccm.158.supplement_2.13tac100a; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Verkaar F, 2009, CELL SIGNAL, V21, P22, DOI 10.1016/j.cellsig.2008.09.008; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111350	10.1371/journal.pone.0111350	http://dx.doi.org/10.1371/journal.pone.0111350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360795	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700088
J	Iturrieta-Gonzalez, IA; Padovan, ACB; Bizerra, FC; Hahn, RC; Colombo, AL				Iturrieta-Gonzalez, Isabel Antonieta; Barbosa Padovan, Ana Carolina; Bizerra, Fernando Cesar; Hahn, Rosane Christine; Colombo, Arnaldo Lopes			Multiple Species of Trichosporon Produce Biofilms Highly Resistant to Triazoles and Amphotericin B	PLOS ONE			English	Article							GLOBAL ANTIFUNGAL SURVEILLANCE; MOLECULAR-IDENTIFICATION; CANDIDA-PARAPSILOSIS; VIRULENCE FACTORS; WHITE PIEDRA; ASAHII; SUSCEPTIBILITY; VORICONAZOLE; FLUCONAZOLE; INFECTIONS	Invasive infections caused by Trichosporon spp. have increased considerably in recent years, especially in neutropenic and critically ill patients using catheters and antibiotics. The genus presents limited sensitivity to different antifungal agents, but triazoles are the first choice for treatment. Here, we investigated the biofilm production and antifungal susceptibility to triazoles and amphotericin B of 54 Trichosporon spp. isolates obtained from blood samples (19), urine (20) and superficial mycosis (15). All isolates and 7 reference strains were identified by sequence analysis and phylogenetic inferences of the IGS1 region of the rDNA. Biofilms were grown on 96-well plates and quantitation was performed using crystal violet staining, complemented with Scanning Electron Microscopy (SEM). Susceptibility tests for fluconazole, itraconazole, voriconazole and amphotericin B were processed using the microdilution broth method (CLSI) for planktonic cells and XTT reduction assay for biofilm-forming cells. Our results showed that T. asahii was the most frequent species identified (66.7%), followed by T. faecale (11.1%), T. asteroides (9.3%), T. inkin (7.4%), T. dermatis (3.7%) and one T. coremiiforme (1.8%). We identified 4 genotypes within T. asahii isolates (G1, G3, G4 and G5) and 2 genotypes within T. faecale (G1 and G3). All species exhibited high adhesion and biofilm formation capabilities, mainly T. inkin, T. asteroides and T. faecale. Microscopy images of high biofilm-producing isolates showed that T. asahii presented mainly hyphae and arthroconidia, whereas T. asteroides exhibited mainly short arthroconidia and few filaments. Voriconazole exhibited the best in vitro activity against all species tested. Biofilm-forming cells of isolates and reference strains were highly resistant to all antifungals tested. We concluded that levels of biofilm formation by Trichosporon spp. were similar or even greater than those described for the Candida genus. Biofilm-forming cells were at least 1,000 times more resistant to antifungals than planktonic cells, especially to voriconazole.	[Iturrieta-Gonzalez, Isabel Antonieta; Barbosa Padovan, Ana Carolina; Bizerra, Fernando Cesar; Colombo, Arnaldo Lopes] Univ Fed Sao Paulo, Lab Especial Micol, Disciplina Infectol, Sao Paulo, Brazil; [Barbosa Padovan, Ana Carolina] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Microbiol & Immunol, Alfenas, MG, Brazil; [Hahn, Rosane Christine] Univ Fed Mato Grosso, Fac Med, Microbiol Lab, Cuiaba, MT, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alfenas; Universidade Federal de Mato Grosso	Colombo, AL (corresponding author), Univ Fed Sao Paulo, Lab Especial Micol, Disciplina Infectol, Sao Paulo, Brazil.	arnaldolcolombo@gmail.com	Colombo, Arnaldo Lopes/H-4397-2012; Padovan, Ana Carolina B/D-3619-2013; González, Isabel Iturrieta/AAE-9251-2021; Colombo, Arnaldo Lopes/V-4417-2019	González, Isabel Iturrieta/0000-0001-8426-9530; Colombo, Arnaldo Lopes/0000-0003-0793-8491; Bizerra, Fernando Cesar/0000-0002-5070-1089	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2007/08575-1, 2010/17179-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [PNPD 02640-09-0]; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	This study received funds through A.L.C. from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (grant 2007/08575-1) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. I.A.I.G. received a master training fellowship from CNPq; A.C.B.P. received a postdoctoral fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (PNPD 02640-09-0). F.C.B. received a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (2010/17179-5). R.C.H. received funds from the the Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, J MED MICROBIOL, V54, P639, DOI 10.1099/jmm.0.45972-0; ANAISSIE E, 1992, CLIN INFECT DIS, V15, P781, DOI 10.1093/clind/15.5.781; ANDO M, 1995, INTERNAL MED, V34, P707, DOI 10.2169/internalmedicine.34.707; Arikan S, 2002, DIAGN MICR INFEC DIS, V43, P107, DOI 10.1016/S0732-8893(02)00376-0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; da Silva Rodrigues Gustavo, 2006, Revista Iberoamericana de Micologia, V23, P85; Dag Aylin, 2006, Mikrobiyoloji Bulteni, V40, P225; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Freydiere AM, 2001, MED MYCOL, V39, P9, DOI 10.1080/714030980; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hazirolan G, 2013, ANTIMICROB AGENTS CH, V57, P4841, DOI 10.1128/AAC.00850-13; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Karashima R, 2002, J MED MICROBIOL, V51, P423, DOI 10.1099/0022-1317-51-5-423; Kiken DA, 2006, J AM ACAD DERMATOL, V55, P956, DOI 10.1016/j.jaad.2005.11.1033; Kontoyiannis DP, 2004, SCAND J INFECT DIS, V36, P564, DOI 10.1080/00365540410017563; Larone DH., 1995, MED IMPORTANT FUNGI; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magalhaes AR, 2008, MEM I OSWALDO CRUZ, V103, P786, DOI 10.1590/S0074-02762008000800008; Martinez LR, 2007, APPL ENVIRON MICROB, V73, P4592, DOI 10.1128/AEM.02506-06; Mekha N, 2010, MYCOPATHOLOGIA, V169, P67, DOI 10.1007/s11046-009-9225-5; Melo ASA, 2006, GENET MOL RES, V5, P664; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Nunes JM, 2013, ANTIMICROB AGENTS CH, V57, P382, DOI 10.1128/AAC.01647-12; Paphitou NI, 2002, ANTIMICROB AGENTS CH, V46, P1144, DOI 10.1128/AAC.46.4.1144-1146.2002; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P5848, DOI 10.1128/JCM.43.12.5848-5859.2005; Ribeiro MA, 2008, REV IBEROAM MICOL, V25, P221, DOI 10.1016/S1130-1406(08)70053-6; Rodriguez-Tudela JL, 2005, ANTIMICROB AGENTS CH, V49, P4026, DOI 10.1128/AAC.49.10.4026-4034.2005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; Santos DWCL, 2013, MYCOPATHOLOGIA, V175, P445, DOI 10.1007/s11046-012-9608-x; Silva Victor, 2003, Revista Iberoamericana de Micologia, V20, P21; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Sugita T, 2002, J CLIN MICROBIOL, V40, P1826, DOI 10.1128/JCM.40.5.1826-1830.2002; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; Suzuki K, 2010, EUR J HAEMATOL, V84, P441, DOI 10.1111/j.1600-0609.2010.01410.x; Taj-Aldeen SJ, 2004, MED MYCOL, V42, P87, DOI 10.1080/1369378032000141453; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x; WATSON KC, 1970, J MED MICROBIOL, V3, P191, DOI 10.1099/00222615-3-1-191; Xia ZK, 2012, MYCOPATHOLOGIA, V173, P127, DOI 10.1007/s11046-011-9478-7	46	61	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109553	10.1371/journal.pone.0109553	http://dx.doi.org/10.1371/journal.pone.0109553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360765	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700013
J	Patel, M; Palani, S; Chakravarty, A; Yang, J; Shyu, WC; Mettetal, JT				Patel, Mayankbhai; Palani, Santhosh; Chakravarty, Arijit; Yang, Johnny; Shyu, Wen Chyi; Mettetal, Jerome T.			Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED MYELOSUPPRESSION; BREAST-CANCER PATIENTS; CELL LUNG-CANCER; HEMATOLOGICAL TOXICITY; 3-WEEKLY DOCETAXEL; PEMETREXED THERAPY; ORAL ETOPOSIDE; OVARIAN-CANCER; SOLID TUMORS; PK/PD MODEL	Toxicity often limits the utility of oncology drugs, and optimization of dose schedule represents one option for mitigation of this toxicity. Here we explore the schedule-dependency of neutropenia, a common dose-limiting toxicity. To this end, we analyze previously published mathematical models of neutropenia to identify a pharmacokinetic (PK) predictor of the neutrophil nadir, and confirm this PK predictor in an in vivo experimental system. Specifically, we find total AUC and C-max are poor predictors of the neutrophil nadir, while a PK measure based on the moving average of the drug concentration correlates highly with neutropenia. Further, we confirm this PK parameter for its ability to predict neutropenia in vivo following treatment with different doses and schedules. This work represents an attempt at mechanistically deriving a fundamental understanding of the underlying pharmacokinetic drivers of neutropenia, and provides insights that can be leveraged in a translational setting during schedule selection.	[Patel, Mayankbhai; Palani, Santhosh; Chakravarty, Arijit; Yang, Johnny; Shyu, Wen Chyi; Mettetal, Jerome T.] Takeda Pharmaceut Int Co, Drug Metab & Pharmacokinet, Cambridge, MA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Mettetal, JT (corresponding author), Takeda Pharmaceut Int Co, Drug Metab & Pharmacokinet, Cambridge, MA USA.	mettetal@alum.mit.edu						Amadori S, 2012, BRIT J HAEMATOL, V156, P205, DOI 10.1111/j.1365-2141.2011.08940.x; Ando M, 1999, CLIN CANCER RES, V5, P1690; Arakawa Atsushi, 2001, International Journal of Clinical Oncology, V6, P248, DOI 10.1007/PL00012113; Brain EGC, 2008, BRIT J CLIN PHARMACO, V65, P607, DOI 10.1111/j.1365-2125.2007.03095.x; Bria E, 2006, CANCER TREAT REV, V32, P583, DOI 10.1016/j.ctrv.2006.07.003; DuBois SG, 2012, CANCER CHEMOTH PHARM, V69, P1021, DOI 10.1007/s00280-011-1798-2; Duffull SB, 1997, CLIN PHARMACOKINET, V33, P161, DOI 10.2165/00003088-199733030-00002; EGORIN MJ, 1984, CANCER RES, V44, P5432; Fetterly GJ, 2001, BIOPHARM DRUG DISPOS, V22, P251, DOI 10.1002/bdd.283; Friberg LE, 2000, J PHARMACOL EXP THER, V295, P734; Friberg LE, 2010, INVEST NEW DRUG, V28, P744, DOI 10.1007/s10637-009-9308-7; GIANNI L, 1995, J CLIN ONCOL, V13, P180, DOI 10.1200/JCO.1995.13.1.180; HANDE KR, 1993, J CLIN ONCOL, V11, P374, DOI 10.1200/JCO.1993.11.2.374; Hansson EK, 2012, CANCER CHEMOTH PHARM, V69, P881, DOI 10.1007/s00280-011-1769-7; Hansson EK, 2010, CANCER CHEMOTH PHARM, V65, P839, DOI 10.1007/s00280-009-1089-3; Henningsson A, 2003, EUR J CANCER, V39, P1105, DOI 10.1016/S0959-8049(03)00126-6; Hikichi Y, 2012, MOL CANCER THER, V11, P700, DOI 10.1158/1535-7163.MCT-11-0762; Huang TC, 2012, CANCER TREAT REV, V38, P613, DOI 10.1016/j.ctrv.2011.10.008; HUIZING MT, 1993, J CLIN ONCOL, V11, P2127, DOI 10.1200/JCO.1993.11.11.2127; JAKOBSEN P, 1991, CANCER CHEMOTH PHARM, V28, P465, DOI 10.1007/BF00685824; JODRELL DI, 1992, J CLIN ONCOL, V10, P520, DOI 10.1200/JCO.1992.10.4.520; Karlsson MO, 1998, CLIN PHARMACOL THER, V63, P11, DOI 10.1016/S0009-9236(98)90117-5; Kloft C, 2006, CLIN CANCER RES, V12, P5481, DOI 10.1158/1078-0432.CCR-06-0815; Latz J, 2006, CANCER CHEMOTH PHARM, V57, P412, DOI 10.1007/s00280-005-0077-5; Latz JE, 2006, CANCER CHEMOTH PHARM, V57, P427, DOI 10.1007/s00280-005-0035-2; Leger F, 2004, CLIN PHARMACOL THER, V76, P567, DOI 10.1016/j.clpt.2004.08.008; Link BK, 2001, CANCER-AM CANCER SOC, V92, P1354, DOI 10.1002/1097-0142(20010915)92:6<1354::AID-CNCR1458>3.0.CO;2-P; MILLER AA, 1995, J CLIN ONCOL, V13, P1871, DOI 10.1200/JCO.1995.13.8.1871; OOSTERHUIS B, 1984, J PHARMACOL EXP THER, V229, P539; Qi M, 2010, BREAST CANCER RES TR, V123, P197, DOI 10.1007/s10549-010-1000-2; Sandstrom M, 1999, CANCER CHEMOTH PHARM, V44, P469, DOI 10.1007/s002800051120; Sandstrom M, 2005, J CLIN ONCOL, V23, P413, DOI 10.1200/JCO.2005.09.161; Sandstrom M, 2006, CANCER CHEMOTH PHARM, V58, P143, DOI 10.1007/s00280-005-0140-2; Silber JH, 1998, J CLIN ONCOL, V16, P2392, DOI 10.1200/JCO.1998.16.7.2392; Socinski M A, 1999, Oncologist, V4, P408; Tabernero J, 2004, ANN ONCOL, V15, P1358, DOI 10.1093/annonc/mdh349; Testart-Paillet D, 2007, CRIT REV ONCOL HEMAT, V63, P1, DOI 10.1016/j.critrevonc.2007.01.005; Toffoli G, 2004, CLIN PHARMACOKINET, V43, P441, DOI 10.2165/00003088-200443070-00002; Troconiz IF, 2006, CANCER CHEMOTH PHARM, V57, P727, DOI 10.1007/s00280-005-0112-6; van Kesteren C, 2005, INVEST NEW DRUG, V23, P225, DOI 10.1007/s10637-005-6730-3; VANGROENINGEN CJ, 1988, CANCER RES, V48, P6956; Walker LG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-179; Wallin JE, 2010, BASIC CLIN PHARMACOL, V106, P234, DOI 10.1111/j.1742-7843.2009.00520.x; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Zandvliet AS, 2008, CLIN PHARMACOL THER, V83, P829, DOI 10.1038/sj.clpt.6100344	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109892	10.1371/journal.pone.0109892	http://dx.doi.org/10.1371/journal.pone.0109892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360756	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700019
J	Salloum, RH; Yurosko, C; Santiago, L; Sandridge, SA; Kaltenbach, JA				Salloum, Rony H.; Yurosko, Christopher; Santiago, Lia; Sandridge, Sharon A.; Kaltenbach, James A.			Induction of Enhanced Acoustic Startle Response by Noise Exposure: Dependence on Exposure Conditions and Testing Parameters and Possible Relevance to Hyperacusis	PLOS ONE			English	Article							COCHLEAR ROOT NEURONS; INDUCED HEARING-LOSS; INTENSE SOUND EXPOSURE; AUDITORY BRAIN-STEM; GUINEA-PIG; RETICULAR-FORMATION; BACKGROUND-NOISE; GENE-EXPRESSION; GIANT-NEURONS; TINNITUS	There has been a recent surge of interest in the development of animal models of hyperacusis, a condition in which tolerance to sounds of moderate and high intensities is diminished. The reasons for this decreased tolerance are likely multifactorial, but some major factors that contribute to hyperacusis are increased loudness perception and heightened sensitivity and/or responsiveness to sound. Increased sound sensitivity is a symptom that sometimes develops in human subjects after acoustic insult and has recently been demonstrated in animals as evidenced by enhancement of the acoustic startle reflex following acoustic over-exposure. However, different laboratories have obtained conflicting results in this regard, with some studies reporting enhanced startle, others reporting weakened startle, and still others reporting little, if any, change in the amplitude of the acoustic startle reflex following noise exposure. In an effort to gain insight into these discrepancies, we conducted measures of acoustic startle responses (ASR) in animals exposed to different levels of sound, and repeated such measures on consecutive days using a range of different startle stimuli. Since many studies combine measures of acoustic startle with measures of gap detection, we also tested ASR in two different acoustic contexts, one in which the startle amplitudes were tested in isolation, the other in which startle amplitudes were measured in the context of the gap detection test. The results reveal that the emergence of chronic hyperacusis-like enhancements of startle following noise exposure is highly reproducible but is dependent on the post-exposure thresholds, the time when the measures are performed and the context in which the ASR measures are obtained. These findings could explain many of the discrepancies that exist across studies and suggest guidelines for inducing in animals enhancements of the startle reflex that may be related to hyperacusis.	[Salloum, Rony H.; Yurosko, Christopher; Kaltenbach, James A.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Santiago, Lia; Sandridge, Sharon A.; Kaltenbach, James A.] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kaltenbach, JA (corresponding author), Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA.	kaltenj@ccf.org			National Institutes of Health [DC R01-009097]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health Grant # DC R01-009097 to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2002, INT J AUDIOL, V41, P545, DOI 10.3109/14992020209056075; Asako M, 2005, J NEUROSCI RES, V81, P102, DOI 10.1002/jnr.20542; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Baguley DM, 2014, SEM HEARING, V35, P4; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Carlson S, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P83; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; DAVIS M, 1982, J NEUROSCI, V2, P791; Davis M., 1984, P287; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Emmerich E, 2005, HEARING RES, V201, P90, DOI 10.1016/j.heares.2004.09.009; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; FREDELIUS L, 1987, HEARING RES, V30, P157, DOI 10.1016/0378-5955(87)90133-X; GERRARD RL, 1990, J EXP PSYCHOL-ANIM B, V16, P106, DOI 10.1037/0097-7403.16.1.106; Gomez-Nieto R, 2008, J COMP NEUROL, V506, P452, DOI 10.1002/cne.21554; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; HARRISON JM, 1962, SCIENCE, V138, P893, DOI 10.1126/science.138.3543.893; Hebert S, 2013, J NEUROSCI, V33, P2356, DOI 10.1523/JNEUROSCI.3461-12.2013; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 1997, BEHAV NEUROSCI, V111, P1335, DOI 10.1037/0735-7044.111.6.1335; ISON JR, 1973, J COMP PHYSIOL PSYCH, V83, P324, DOI 10.1037/h0034423; Jastreboff P. J., 2004, TINNITUS RETRAINING, P1; KALTENBACH JA, 1992, HEARING RES, V60, P205, DOI 10.1016/0378-5955(92)90022-F; KANDLER K, 1991, BRAIN RES, V562, P230, DOI 10.1016/0006-8993(91)90626-7; Kim J, 1997, HEAR RES, V103, P169; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lee YL, 1996, J NEUROSCI, V16, P3775; Li S, 2013, P NATL ACAD SCI USA, V110, P9980, DOI 10.1073/pnas.1302770110; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; LINGENHOHL K, 1992, J COMP NEUROL, V325, P473, DOI 10.1002/cne.903250403; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2012, BRAIN RES, V1485, P54, DOI 10.1016/j.brainres.2012.02.067; Lopez DE, 1999, J COMP NEUROL, V415, P160; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Meloni EG, 1998, HEARING RES, V119, P69, DOI 10.1016/S0378-5955(98)00040-9; MERCHAN MA, 1988, J NEUROCYTOL, V17, P711, DOI 10.1007/BF01260998; Morest DK, 1997, HEARING RES, V103, P151, DOI 10.1016/S0378-5955(96)00172-4; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; Nodal FR, 2003, J COMP NEUROL, V460, P80, DOI 10.1002/cne.10656; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; PELLET J, 1990, PHYSIOL BEHAV, V48, P727, DOI 10.1016/0031-9384(90)90218-S; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rubinstein B, 1993, Swed Dent J Suppl, V95, P1; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Sinex DG, 2001, HEARING RES, V158, P28, DOI 10.1016/S0378-5955(01)00293-3; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Stebbins W C, 1979, Am J Otolaryngol, V1, P15, DOI 10.1016/S0196-0709(79)80004-6; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Tyler R. S., 2009, HDB CLIN AUDIOLOGY, P726; Tyler RS, 2014, AM J AUDIOL; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Weber H, 2002, MULT SCLER, V8, P505, DOI 10.1191/1352458502ms814oa; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	65	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111747	10.1371/journal.pone.0111747	http://dx.doi.org/10.1371/journal.pone.0111747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360877	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700146
J	Zenk, J; Schulman, R				Zenk, John; Schulman, Rebecca			An Assembly Funnel Makes Biomolecular Complex Assembly Efficient	PLOS ONE			English	Article							MOLECULAR ARCHITECTURE; NANOSCALE SHAPES; DNA; BINDING; DESIGN; PRINCIPLES; JUNCTIONS; KINETICS	Like protein folding and crystallization, the self-assembly of complexes is a fundamental form of biomolecular organization. While the number of methods for creating synthetic complexes is growing rapidly, most require empirical tuning of assembly conditions and/or produce low yields. We use coarse-grained simulations of the assembly kinetics of complexes to identify generic limitations on yields that arise because of the many simultaneous interactions allowed between the components and intermediates of a complex. Efficient assembly occurs when nucleation is fast and growth pathways are few, i.e. when there is an assembly "funnel''. For typical complexes, an assembly funnel occurs in a narrow window of conditions whose location is highly complex specific. However, by redesigning the components this window can be drastically broadened, so that complexes can form quickly across many conditions. The generality of this approach suggests assembly funnel design as a foundational strategy for robust biomolecular complex synthesis.	[Zenk, John; Schulman, Rebecca] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Schulman, R (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	rschulm3@jhu.edu		Zenk, Johannes/0000-0003-3281-6189	National Science Foundation [1161941, 1445749]; Turing Centenary Fellowship	National Science Foundation(National Science Foundation (NSF)); Turing Centenary Fellowship	This study was supported by National Science Foundation award #1161941, National Science Foundation award #1445749, Turing Centenary Fellowship (http://www.mathcomp.leeds.ac.uk/turing2012/give-page.php?704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deeds EJ, 2012, P NATL ACAD SCI USA, V109, P2348, DOI 10.1073/pnas.1113095109; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Evans CG, 2012, J AM CHEM SOC, V134, P10485, DOI 10.1021/ja301026z; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grant J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3662140; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hormoz S, 2011, P NATL ACAD SCI USA, V108, P5193, DOI 10.1073/pnas.1014094108; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jankowski E, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223834; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kim AJ, 2009, NAT MATER, V8, P52, DOI 10.1038/NMAT2338; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Neumann MA, 2008, ANGEW CHEM INT EDIT, V47, P2427, DOI 10.1002/anie.200704247; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Petsko GA, 1999, NATURE, V401, P115, DOI 10.1038/43565; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Recht MI, 2001, J MOL BIOL, V313, P35, DOI 10.1006/jmbi.2001.5018; Reinhardt A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.238103; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sweeney B, 2008, BIOPHYS J, V94, P772, DOI 10.1529/biophysj.107.107284; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Villar G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118106; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Whitelam S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.265506; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wilber AW, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2759922; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	51	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111233	10.1371/journal.pone.0111233	http://dx.doi.org/10.1371/journal.pone.0111233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360818	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700076
J	Bhutta, MS; Roy, B; Gould, GW; McInerny, CJ				Bhutta, Musab S.; Roy, Brinta; Gould, Gwyn W.; McInerny, Christopher J.			A Complex Network of Interactions between Mitotic Kinases, Phosphatases and ESCRT Proteins Regulates Septation and Membrane Trafficking in S-pombe	PLOS ONE			English	Article							FISSION YEAST; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MULTIVESICULAR BODIES; GENE-EXPRESSION; CYTOKINESIS; ABSCISSION; TRANSCRIPTION; MACHINERY; CLP1P	Cytokinesis and cell separation are critical events in the cell cycle. We show that Endosomal Sorting Complex Required for Transport (ESCRT) genes are required for cell separation in Schizosaccharomyces pombe. We identify genetic interactions between ESCRT proteins and polo and aurora kinases and Cdc14 phosphatase that manifest as impaired growth and exacerbated defects in septation, suggesting that the encoded proteins function together to control these processes. Furthermore, we observed defective endosomal sorting in mutants of plo1, ark1 and clp1, as has been reported for ESCRT mutants, consistent with a role for these kinases in the control of ESCRT function in membrane traffic. Multiple observations indicate functional interplay between polo and ESCRT components: firstly, two-hybrid in vivo interactions are reported between Plo1p and Sst4p, Vps28p, Vps25p, Vps20p and Vps32p; secondly, co-immunoprecipitation of human homologues of Vps20p, Vps32p, Vps24p and Vps2p by human Plk1; and thirdly, in vitro phosphorylation of budding yeast Vps32p and Vps20p by polo kinase. Two-hybrid analyses also identified interactions between Ark1p and Vps20p and Vps32p, and Clp1p and Vps28p. These experiments indicate a network of interactions between ESCRT proteins, plo1, ark1 and clp1 that coordinate membrane trafficking and cell separation in fission yeast.	[Bhutta, Musab S.; Roy, Brinta; Gould, Gwyn W.; McInerny, Christopher J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Glasgow, Lanark, Scotland	University of Glasgow	Gould, GW (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow, Lanark, Scotland.	Gwyn.Gould@Glasgow.ac.uk; Chris.McInerny@Glasgow.ac.uk	Gould, Gwyn/AAF-6721-2019	Gould, Gwyn/0000-0001-6571-2875; /0000-0002-9201-3479	Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow [BB/F016735/1]; Cancer Research UK [13082] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow; Cancer Research UK(Cancer Research UK)	The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow (BB/F016735/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Clifford DM, 2008, J CELL BIOL, V181, P79, DOI 10.1083/jcb.200709060; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Halova L, 2011, J CELL SCI, V124, P3441, DOI 10.1242/jcs.083683; Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058; Iwaki T, 2007, MICROBIOL-SGM, V153, P2753, DOI 10.1099/mic.0.2007/006072-0; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Leverson JD, 2002, MOL BIOL CELL, V13, P1132, DOI 10.1091/mbc.01-07-0330; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; McMurray MA, 2011, BIOL CHEM, V392, P699, DOI 10.1515/BC.2011.091; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Sambrook J., 2001, MOL CLONING LAB MANU; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111789	10.1371/journal.pone.0111789	http://dx.doi.org/10.1371/journal.pone.0111789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356547	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000346765000077
J	Kaiser, JC; Meckbach, R; Jacob, P				Kaiser, Jan Christian; Meckbach, Reinhard; Jacob, Peter			Genomic Instability and Radiation Risk in Molecular Pathways to Colon Cancer	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; HEREDITARY COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; MULTISTAGE CARCINOGENESIS; ADENOMATOUS-POLYPOSIS; UNITED-STATES; IN-VIVO; MODEL	Colon cancer is caused by multiple genomic alterations which lead to genomic instability (GI). GI appears in molecular pathways of microsatellite instability (MSI) and chromosomal instability (CIN) with clinically observed case shares of about 15-20% and 80-85%. Radiation enhances the colon cancer risk by inducing GI, but little is known about different outcomes for MSI and CIN. Computer-based modelling can facilitate the understanding of the phenomena named above. Comprehensive biological models, which combine the two main molecular pathways to colon cancer, are fitted to incidence data of Japanese a-bomb survivors. The preferred model is selected according to statistical criteria and biological plausibility. Imprints of cell-based processes in the succession from adenoma to carcinoma are identified by the model from age dependences and secular trends of the incidence data. Model parameters show remarkable compliance with mutation rates and growth rates for adenoma, which has been reported over the last fifteen years. Model results suggest that CIN begins during fission of intestinal crypts. Chromosomal aberrations are generated at a markedly elevated rate which favors the accelerated growth of premalignant adenoma. Possibly driven by a trend of Westernization in the Japanese diet, incidence rates for the CIN pathway increased notably in subsequent birth cohorts, whereas rates pertaining to MSI remained constant. An imbalance between number of CIN and MSI cases began to emerge in the 1980s, whereas in previous decades the number of cases was almost equal. The CIN pathway exhibits a strong radio-sensitivity, probably more intensive in men. Among young birth cohorts of both sexes the excess absolute radiation risk related to CIN is larger by an order of magnitude compared to the MSI-related risk. Observance of pathway-specific risks improves the determination of the probability of causation for radiation-induced colon cancer in individual patients, if their exposure histories are known.	[Kaiser, Jan Christian; Meckbach, Reinhard; Jacob, Peter] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Radiat Protect, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kaiser, JC (corresponding author), Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Radiat Protect, Neuherberg, Germany.	christian.kaiser@helmholtz-muenchen.de		Kaiser, Jan Christian/0000-0003-0359-2251	European Commission [269553, Fission-2010-3.1.1]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under FP7 project EpiRadBio (Fission-2010-3.1.1, project no. 269553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; Council NR, 2006, HLTH RISKS EXP LOW L, DOI DOI 10.17226/11340; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Diergaarde B, 2003, CANCER EPIDEM BIOMAR, V12, P1130; FELLER W, 1971, INTRO PROBABILITY TH, V1; Foster PA, 2013, INT J COLORECTAL DIS, V28, P737, DOI 10.1007/s00384-012-1628-y; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Heidenreich WE, 2008, RADIAT RES, V170, P613, DOI 10.1667/RR0957.1; Heidenreich WF, 2007, RADIAT RES, V168, P750, DOI 10.1667/RR0919.1; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Hornsby C, 2008, AM J PATHOL, V172, P1062, DOI 10.2353/ajpath.2008.070724; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Iwama T, 2001, JPN J CLIN ONCOL, V31, P185, DOI 10.1093/jjco/hye042; Jacob P, 2010, MUTAT RES-FUND MOL M, V687, P34, DOI 10.1016/j.mrfmmm.2010.01.005; James F., 1994, MINUIT FUNCTION MINI; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kaiser JC, 2012, RADIAT ENVIRON BIOPH, V51, P1, DOI 10.1007/s00411-011-0387-4; Kaiser J.C., 2010, MECAN SOFTWARE PACKA; Kaiser JC, 2013, RADIAT ENVIRON BIOPH, V52, P17, DOI 10.1007/s00411-012-0437-6; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kocher DC, 2008, HEALTH PHYS, V95, P119, DOI 10.1097/01.HP.0000291191.49583.f7; Koike M, 1996, J SURG ONCOL, V62, P97, DOI 10.1002/(SICI)1096-9098(199606)62:2<97::AID-JSO5>3.0.CO;2-L; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Little MP, 2008, RADIAT PROT DOSIM, V132, P156, DOI 10.1093/rpd/ncn264; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008915; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Lynch HT, 2008, FAM CANCER, V7, P27, DOI 10.1007/s10689-007-9165-5; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Meza R, 2010, CANCER RES, V70, P5419, DOI 10.1158/0008-5472.CAN-09-4417; MOOLGAVKAR SH, 1992, J NATL CANCER I, V84, P610, DOI 10.1093/jnci/84.8.610; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Muleris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001632; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakaji S, 2003, INT J COLORECTAL DIS, V18, P481, DOI 10.1007/s00384-003-0485-0; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Potten CS, 2003, CELL PROLIFERAT, V36, P115, DOI 10.1046/j.1365-2184.2003.00264.x; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PRESTON D. L., 1993, EPICURE USERS GUIDE; Sampson JR, 2005, BIOCHEM SOC T, V33, P679, DOI 10.1042/BST0330679; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takachi R, 2011, ASIA PAC J CLIN NUTR, V20, P603; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; UNSCEAR, 2008, 1 UNSCEAR; Valentin J, 2007, 2007 RECOMMENDATIONS; Yang K, 1998, CANCER RES, V58, P5713; Yiu HY, 2004, INT J CANCER, V109, P777, DOI 10.1002/ijc.20030	66	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111024	10.1371/journal.pone.0111024	http://dx.doi.org/10.1371/journal.pone.0111024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356998	Green Submitted, Green Published, gold			2022-12-26	WOS:000346765000037
J	Oh, M; Ahn, J; Yoon, Y				Oh, Min; Ahn, Jaegyoon; Yoon, Youngmi			A Network-Based Classification Model for Deriving Novel Drug-Disease Associations and Assessing Their Molecular Actions	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BREAST-CANCER; BETA-BLOCKERS; BRAIN; PROTEIN; SURVIVAL	The growing number and variety of genetic network datasets increases the feasibility of understanding how drugs and diseases are associated at the molecular level. Properly selected features of the network representations of existing drug-disease associations can be used to infer novel indications of existing drugs. To find new drug-disease associations, we generated an integrative genetic network using combinations of interactions, including protein-protein interactions and gene regulatory network datasets. Within this network, network adjacencies of drug-drug and disease-disease were quantified using a scored path between target sets of them. Furthermore, the common topological module of drugs or diseases was extracted, and thereby the distance between topological drug-module and disease (or disease-module and drug) was quantified. These quantified scores were used as features for the prediction of novel drug-disease associations. Our classifiers using Random Forest, Multilayer Perceptron and C4.5 showed a high specificity and sensitivity (AUC score of 0.855, 0.828 and 0.797 respectively) in predicting novel drug indications, and displayed a better performance than other methods with limited drug and disease properties. Our predictions and current clinical trials overlap significantly across the different phases of drug development. We also identified and visualized the topological modules of predicted drug indications for certain types of cancers, and for Alzheimer's disease. Within the network, those modules show potential pathways that illustrate the mechanisms of new drug indications, including propranolol as a potential anticancer agent and telmisartan as treatment for Alzheimer's disease.	[Oh, Min; Yoon, Youngmi] Gachon Univ, Dept Comp Engn, Songnam, South Korea; [Ahn, Jaegyoon] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	Gachon University; University of California System; University of California Los Angeles	Yoon, Y (corresponding author), Gachon Univ, Dept Comp Engn, Songnam, South Korea.	ymyoon@gachon.ac.kr	Oh, Min/AAJ-5094-2020	Oh, Min/0000-0002-0938-9046	Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0008639]	Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2010-0008639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; Al-Wadei HAN, 2012, PHARMACOL RES, V66, P33, DOI 10.1016/j.phrs.2012.03.014; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V69, P1632, DOI 10.1001/archneurol.2012.1010; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kume K, 2012, GERIATR GERONTOL INT, V12, P207, DOI 10.1111/j.1447-0594.2011.00746.x; Kummer MP, 2008, PPAR RES, V2008, P8; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Shindo T, 2012, BIOL PHARM BULL, V35, P2141, DOI 10.1248/bpb.b12-00387; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Zhao SW, 2012, BIOINFORMATICS, V28, P955, DOI 10.1093/bioinformatics/bts057	44	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111668	10.1371/journal.pone.0111668	http://dx.doi.org/10.1371/journal.pone.0111668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356910	gold, Green Published, Green Submitted			2022-12-26	WOS:000346765000073
J	Shanzer, M; Ricardo-Lax, I; Keshet, R; Reuven, N; Shaul, Y				Shanzer, M.; Ricardo-Lax, I.; Keshet, R.; Reuven, N.; Shaul, Y.			The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner	ONCOGENE			English	Article							CELL CONTACT INHIBITION; MAMMARY-TUMORS; SIZE-CONTROL; TAZ; YAP; PHOSPHORYLATION; INDUCTION; IDENTIFICATION; TRANSFORMATION; PROLIFERATION	The polyomavirus middle T antigen (PyMT) is an oncogene that activates the non-receptor tyrosine kinase, c-Src, and physically interacts with Taz (WWTR1). Taz is a pro-oncogenic transcription coactivator of the Tead transcription factors. The Hippo tumor suppressor pathway activates the kinase Lats, which phosphorylates Taz, leading to its nuclear exclusion and blunting Tead coactivation. We found that Taz was required for transformation by PyMT, but counter-intuitively, Taz was exclusively cytoplasmic in the presence of PyMT. We demonstrate that in the presence of PyMT, wild-type Taz was phosphorylated by Lats, in a Src-dependent manner. Consistently, a Lats refractory Taz mutant did not undergo cytoplasmic retention by PyMT. We show that Yap, the Taz paralog, and Shp2 phosphatase were nuclear excluded as well. Our findings describe a noncanonical activation of Lats, and an unprecedented Tead-independent role for Taz and Yap in viral-mediated oncogenesis.	[Shanzer, M.; Ricardo-Lax, I.; Keshet, R.; Reuven, N.; Shaul, Y.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Herzel 1, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Reuven, Nina/AAM-8711-2020; Ricardo-Lax, Inna/ABE-7179-2020	Reuven, Nina/0000-0003-1569-3818; Ricardo-Lax, Inna/0000-0002-9590-9692	Israel Science Foundation [551/11]; Minerva Foundation; Federal German Ministry for Education and Research	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	We thank Drs R Bassel-Duby for pCDNA3-Flag-mTaz, pCDNA-myc-mTaz and pCDNA-myc-mTazWA plasmids; M Sudol for pCMV-Yap1 plasmid; J Zhang for pBP-GFP-hTaz-4SA plasmid; H Sasaki for pBS-8xGTIIC-Luc (8xGTIIC) Tead reporter plasmid; A Elson for mSrc sequence; M Oren for Myc-tagged human Lats2 constructs; and XJ Yang for HA-tagged Lats2, Lats-KM, Mst1 and WW45 constructs; B Neel for Shp2 C459S and E76K constructs. We thank Dr Z Porat for his help with ImageStream technology. This work was supported by grants from the Israel Science Foundation (grant No. 551/11), Israel Cancer Research Fund and from the Minerva Foundation with funding from the Federal German Ministry for Education and Research.	CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Carey MF, 2009, COLD SPRING HARB PRO, V2009; COOK DN, 1990, J VIROL, V64, P1879, DOI 10.1128/JVI.64.5.1879-1887.1990; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; Dilworth Stephen M., 1995, Trends in Microbiology, V3, P31, DOI 10.1016/S0966-842X(00)88866-6; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; GLENN GM, 1995, J VIROL, V69, P3729, DOI 10.1128/JVI.69.6.3729-3736.1995; Gottlieb KA, 2001, MICROBIOL MOL BIOL R, V65, P288, DOI 10.1128/MMBR.65.2.288-318.2001; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; HARVEY R, 1984, MOL CELL BIOL, V4, P1334, DOI 10.1128/MCB.4.7.1334; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; O'Shea CC, 2005, CURR OPIN GENET DEV, V15, P18, DOI 10.1016/j.gde.2004.12.010; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Primo L, 2000, ONCOGENE, V19, P3632, DOI 10.1038/sj.onc.1203708; RAPTIS L, 1985, MOL CELL BIOL, V5, P2476, DOI 10.1128/MCB.5.9.2476; SCHAFFHAUSEN B, 1981, J VIROL, V40, P184, DOI 10.1128/JVI.40.1.184-196.1981; Schaffhausen BS, 2009, VIROLOGY, V384, P304, DOI 10.1016/j.virol.2008.09.042; Tian Y, 2004, J VIROL, V78, P12657, DOI 10.1128/JVI.78.22.12657-12664.2004; TREISMAN R, 1981, NATURE, V292, P595, DOI 10.1038/292595a0; Tsutsumi R, 2013, DEV CELL, V26, P658, DOI 10.1016/j.devcel.2013.08.013; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Yang Y, 2011, VIROLOGY, V409, P204, DOI 10.1016/j.virol.2010.09.032; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	39	15	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4190	4198		10.1038/onc.2014.347	http://dx.doi.org/10.1038/onc.2014.347			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25362852				2022-12-26	WOS:000359199800005
J	Wang, Y				Wang, Yu			RING Finger Protein 4 (RNF4) Derepresses Gene Expression from DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Protein Turnover; RING Finger Protein 4 (RNF4); Transcription; Ubiquitylation (Ubiquitination); Methyl CpG-binding Protein 2 (MeCP2)	MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; IDENTIFICATION; TRANSCRIPTION; COREGULATOR; CONVERSION	Background: RNF4 is a transcription activator, yet the mechanism is unknown. Results: RNF4 mediates ubiquitination and turnover of MeCP2 and thus derepresses transcription from DNA methylation. Conclusion: RNF4 regulates transcription by creating a permissive epigenetic environment. Significance: This study lays the basis for better understanding the role of RNF4 in epigenetics and transcription. RNF4 is an E3 ubiquitin ligase originally identified as a transcription co-activator. The mechanism by which RNF4 promotes transcription remains unclear. In this study, I found that RNF4 antagonizes transcriptional repression mediated by DNA methylation. RNF4 does not promote DNA demethylation, but mediates the ubiquitination of MeCP2, a methyl-CpG-binding domain (MBD) protein. Removal of MeCP2 from gene promoters activates transcription. This study thus not only uncovers how RNF4 functions as a transcription activator, but also reveals the mechanism by which MeCP2 protein stability is regulated.	[Wang, Yu] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wang, Yu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Wang, Y (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, WAB 164,200 Longwood Ave, Boston, MA 02115 USA.	yu.wang@childrens.harvard.edu			American Heart Association	American Heart Association(American Heart Association)	Supported by a postdoctoral fellowship from American Heart Association. To whom correspondence should be addressed: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, WAB-164, 200 Longwood Ave., Boston, MA 02115. E-mail: yu.wang@childrens.harvard.edu.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	21	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33808	33813		10.1074/jbc.C114.611558	http://dx.doi.org/10.1074/jbc.C114.611558			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25355316	Green Published, hybrid			2022-12-26	WOS:000346077600008
J	Huang, YD; Duerr, A; Frahm, N; Zhang, LL; Moodie, Z; De Rosa, S; McElrath, MJ; Gilbert, PB				Huang, Yunda; Duerr, Ann; Frahm, Nicole; Zhang, Lily; Moodie, Zoe; De Rosa, Steve; McElrath, M. Juliana; Gilbert, Peter B.			Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-gamma Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; GAG/POL/NEF VACCINE; DOUBLE-BLIND; STEP TRIAL; ACQUISITION; RESPONSES; PARTICIPANTS; EXPOSURE; DESIGNS; WOMEN	Background: Elevated risk of HIV-1 infection among recipients of an adenovirus serotype 5 (Ad5)-vectored HIV-1 vaccine was previously reported in the Step HIV-1 vaccine efficacy trial. We assessed pre-infection cellular immune responses measured at 4 weeks after the second vaccination to determine their roles in HIV-1 infection susceptibility among Step study male participants. Methods: We examined ex vivo interferon-gamma (IFN-gamma) secretion from peripheral blood mononuclear cells (PBMC) using an ELISpot assay in 112 HIV-infected and 962 uninfected participants. In addition, we performed flow cytometric assays to examine T-cell activation, and ex vivo IFN-gamma and interleukin-2 secretion from CD4(+) and CD8(+) T cells. We accounted for the sub-sampling design in Cox proportional hazards models to estimate hazard ratios (HRs) of HIV-1 infection per 1-log(e) increase of the immune responses. Findings: We found that HIV-specific immune responses were not associated with risk of HIV-1 infection. However, each 1-log(e) increase of mock responses measured by the ELISpot assay (i.e., IFN-gamma secretion in the absence of antigen-specific stimulation) was associated with a 62% increase of HIV-1 infection risk among vaccine recipients (HR = 1.62, 95% CI: (1.28, 2.04), p < 0.001). This association remains after accounting for CD4(+) or CD8(+) T-cell activation. We observed a moderate correlation between ELISpot mock responses and CD4(+) T-cells secreting IFN-gamma (rho = 0.33, p = 0.007). In addition, the effect of the Step vaccine on infection risk appeared to vary with ELISpot mock response levels, especially among participants who had pre-existing anti-Ad5 antibodies (interaction p = 0.04). Conclusions: The proportion of cells, likely CD4(+) T-cells, producing IFN-gamma without stimulation by exogenous antigen appears to carry information beyond T-cell activation and baseline characteristics that predict risk of HIV-1 infection. These results motivate additional investigation to understand the potential link between IFN-gamma secretion and underlying causes of elevated HIV-1 infection risk among vaccine recipients in the Step study.	[Huang, Yunda; Duerr, Ann; Frahm, Nicole; Zhang, Lily; Moodie, Zoe; De Rosa, Steve; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Huang, Yunda; Duerr, Ann; Moodie, Zoe; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Duerr, Ann; Frahm, Nicole; McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Duerr, Ann] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [De Rosa, Steve; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huang, YD (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	yunda@scharp.org		Huang, Yunda/0000-0003-1546-6172	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI068635, UM1AI068618]; Bill and Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, UM1AI068618, UM1AI068635] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1AI068635 (YH, LZ, ZM, PG) and UM1AI068618 (AD, NF, SD, JM) and by Bill and Melinda Gates Foundation grant OPP1032317 (YH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (www.nih.org) or the Gates Foundation (www.gatesfoundation.org). The authors thank the James B. Pendleton Charitable Trust for their generous equipment donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huang YD, 2012, STAT MED, V31, P3748, DOI 10.1002/sim.5446; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Naranbhai V, 2013, JAIDS-J ACQ IMM DEF, V63, P294, DOI 10.1097/QAI.0b013e31828e604b; Naranbhai V, 2012, AIDS, V26, P1745, DOI 10.1097/QAD.0b013e328357724f; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Therneau TM, 1999, LIFETIME DATA ANAL, V5, P99, DOI 10.1023/A:1009691327335	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108631	10.1371/journal.pone.0108631	http://dx.doi.org/10.1371/journal.pone.0108631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369172	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000005
J	Santarlasci, A; Martelloni, G; Frizzi, F; Santini, G; Bagnoli, F				Santarlasci, Alisa; Martelloni, Gianluca; Frizzi, Filippo; Santini, Giacomo; Bagnoli, Franco			Modeling Warfare in Social Animals: A "Chemical" Approach	PLOS ONE			English	Article							LANCHESTER MODELS	We present here a general method for modelling the dynamics of battles among social animals. The proposed method exploits the procedures widely used to model chemical reactions, but still uncommon in behavioural studies. We applied this methodology to the interpretation of experimental observations of battles between two species of ants (Lasius neglectus and Lasius paralienus), but this scheme may have a wider applicability and can be extended to other species as well. We performed two types of experiment labelled as interaction and mortality. The interaction experiments are designed to obtain information on the combat dynamics and lasted one hour. The mortality ones provide information on the casualty rates of the two species and lasted five hours. We modelled the interactions among ants using a chemical model which considers the single ant individuals and fighting groups analogously to atoms and molecules. The mean-field behaviour of the model is described by a set of non-linear differential equations. We also performed stochastic simulations of the corresponding agent-based model by means of the Gillespie event-driven integration scheme. By fitting the stochastic trajectories with the deterministic model, we obtained the probability distribution of the reaction parameters. The main result that we obtained is a dominance phase diagram, that gives the average trajectory of a generic battle, for an arbitrary number of opponents. This phase diagram was validated with some extra experiments. With respect to other war models (e. g., Lanchester's ones), our chemical model considers all phases of the battle and not only casualties. This allows a more detailed description of the battle (with a larger number of parameters), allowing the development of more sophisticated models (e. g., spatial ones), with the goal of distinguishing collective effects from the strategic ones.	[Santarlasci, Alisa] Univ Florence, Dept Informat Engn, Florence, Italy; [Martelloni, Gianluca; Bagnoli, Franco] Univ Florence, Dept Phys & Astron, Sesto Fiorentino, FI, Italy; [Santarlasci, Alisa; Martelloni, Gianluca; Bagnoli, Franco] Univ Florence, CSDC, Sesto Fiorentino, FI, Italy; [Frizzi, Filippo; Santini, Giacomo] Univ Florence, Dept Biol, Sesto Fiorentino, FI, Italy; [Bagnoli, Franco] Natl Inst Nucl Phys, Sez Firenze, Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence; Istituto Nazionale di Fisica Nucleare (INFN)	Bagnoli, F (corresponding author), Univ Florence, Dept Phys & Astron, Sesto Fiorentino, FI, Italy.	franco.bagnoli@unifi.it	Bagnoli, Franco/K-6904-2015; Frizzi, Filippo/GYE-2065-2022; Santini, Giacomo/H-7366-2013	Bagnoli, Franco/0000-0002-6293-0305; Frizzi, Filippo/0000-0002-1419-0445; 				Adams ES, 2003, BEHAV ECOL, V14, P719, DOI 10.1093/beheco/arg061; Batchelor TP, 2012, ANIM BEHAV, V83, P111, DOI 10.1016/j.anbehav.2011.10.014; Batchelor TP, 2010, ANIM BEHAV, V80, P443, DOI 10.1016/j.anbehav.2010.05.030; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; BRACKEN J, 1995, NAV RES LOG, V42, P559, DOI 10.1002/1520-6750(199506)42:4<559::AID-NAV3220420405>3.0.CO;2-R; Cheney D.L., 1987, P267; Connors K., 1991, CHEM KINETICS STUDY; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Johnson IR, 2011, NAV RES LOG, V58, P210, DOI 10.1002/nav.20328; Jr RDF, 1998, NAV RES LOG, V45, P1; Kress M, 2012, SCIENCE, V336, P865, DOI 10.1126/science.1217724; Lanchester FW, 1916, AIRCRAFT WARFARE; Lanchester FW., 1956, WORLD MATH, V4, P2138; MARSILILIBELLI S, 1992, ECOL MODEL, V62, P233, DOI 10.1016/0304-3800(92)90001-U; McGlynn TP, 2000, BEHAV ECOL, V11, P686, DOI 10.1093/beheco/11.6.686; Nelder JA, 1965, COMPUT J, V62, P233; Plowes NJR, 2005, P ROY SOC B-BIOL SCI, V272, P1809, DOI 10.1098/rspb.2005.3162; Seifert Bernhard, 1992, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V66, P1; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; Wilson ML, 2001, P ROY SOC LOND B BIO, V269, P1107; Zabel Cynthia J., 1992, P113	24	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111310	10.1371/journal.pone.0111310	http://dx.doi.org/10.1371/journal.pone.0111310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369269	Green Published, Green Submitted, gold			2022-12-26	WOS:000344402000047
J	Tang, SS; Zhang, R; Jiang, F; Wang, J; Chen, M; Peng, DF; Yan, J; Bao, YQ; Hu, C; Jia, WP				Tang, Shanshan; Zhang, Rong; Jiang, Feng; Wang, Jie; Chen, Miao; Peng, Danfeng; Yan, Jing; Bao, Yuqian; Hu, Cheng; Jia, Weiping			An Interaction between a FNDC5 Variant and Obesity Modulates Glucose Metabolism in a Chinese Han Population	PLOS ONE			English	Article							DIABETES-MELLITUS; SKELETAL-MUSCLE; IRISIN; EXERCISE; FAT; HOMEOSTASIS; PLASMA; SERUM; GENE; MEN	Background: To investigate the impact of common variants of FNDC5 on type 2 diabetes and clinical traits related to glucose metabolism in a large Chinese population sample. Methods: Three tagging single nucleotide polymorphisms within the region of the FNDC5 gene were selected and genotyped in 6822 participants. Detailed clinical investigations and biochemistry measurements were carried out in all of the participants. Subjects without diabetes were classified into normal weight and overweight/obese subgroups according to body mass index (BMI). Results: None of the SNPs were associated with either the risk of type 2 diabetes in all of the participants or with any of the clinical quantitative traits in the controls with normal glucose regulation. Subgroup analysis showed that in controls with normal weight (BMI <25 kg/m(2)), the rs16835198 major allele G was significantly associated with fasting insulin levels, and that each additional copy of the allele resulted in a 0.0178 mU/L increment of the values (p = 0.046). Moreover, after adjusting for confounding variables, there were trends towards correlation of rs16835198 with HOMA-insulin resistance (HOMA-IR) (p = 0.057) and low-density lipoprotein cholesterol (LDL-C) levels (p = 0.083). In overweight/obese subjects (BMI >= 25 Kg/m(2)), we noted rs16835198 showed trends towards association with fasting insulin (p = 0.057) and HOMA-IR levels (p = 0.091), both of which declined with additional copies of the major allele G. Moreover, rs16835198 was significantly associated with high-density lipoprotein cholesterol (HDL-C) levels (p = 0.013), and HOMA-beta cell function (p = 0.028) in the overweight/obese subjects. Finally, we observed a significant interaction between BMI-rs16835198 and fasting insulin levels in the control group (p = 0.003). Conclusions: Our data indicate that the effect of the common FNDC5 SNP rs16835198 on fasting insulin was significantly modified by BMI in the Chinese Han population.	[Tang, Shanshan; Zhang, Rong; Jiang, Feng; Wang, Jie; Chen, Miao; Peng, Danfeng; Yan, Jing; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab,Shan, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab,Shan, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012; 严, 婧/HHN-4334-2022	Hu, Cheng/0000-0003-4314-2386; 	Shanghai Municipality [11JC1409600]; National 863 program [2012AA02A509]; National Science Foundation of China [81322010, 81170735, 81200582, 81300691]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2011ZX09307-001-02]; Key Discipline of Public Health of Shanghai [12GWZX0104]; Shanghai Jiao Tong University School of Medicine [BXJ201340]; Shanghai Talent Development Grant [2012041]; National Young Top Talent Supporting Program; Excellent Young Medical Expert of Shanghai [XYQ2011041]	Shanghai Municipality; National 863 program(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development''; Key Discipline of Public Health of Shanghai; Shanghai Jiao Tong University School of Medicine; Shanghai Talent Development Grant; National Young Top Talent Supporting Program; Excellent Young Medical Expert of Shanghai	This work was funded by grants from the Key Program of the Shanghai Municipality for Basic Research (11JC1409600), National 863 program (2012AA02A509), National Science Foundation of China (81322010, 81170735, 81200582 and 81300691), National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (2011ZX09307-001-02) and Key Discipline of Public Health of Shanghai (12GWZX0104), the Innovation Fund for PhD Students (BXJ201340) from the Shanghai Jiao Tong University School of Medicine, Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Talent Development Grant (2012041), and National Young Top Talent Supporting Program. The authors appreciate all the participants of this research study. The authors gratefully acknowledge the skillful technical support of all nursing and medical staff at the Shanghai Clinical Center for Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Hu CX, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013318, 10.1371/journal.pone.0015542]; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jiang S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-22; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Polyzos SA, 2014, METABOLISM, V63, P207, DOI 10.1016/j.metabol.2013.09.013; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roque FR, 2013, CURR HYPERTENS REP, V15, P204, DOI 10.1007/s11906-013-0336-5; Staiger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061903; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Tanisawa K, 2014, METABOLISM, V63, P574, DOI 10.1016/j.metabol.2014.01.005; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109957	10.1371/journal.pone.0109957	http://dx.doi.org/10.1371/journal.pone.0109957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369206	Green Published, gold, Green Submitted			2022-12-26	WOS:000344402000014
J	Zabala, G; Vodkin, LO				Zabala, Gracia; Vodkin, Lila O.			Methylation Affects Transposition and Splicing of a Large CACTA Transposon from a MYB Transcription Factor Regulating Anthocyanin Synthase Genes in Soybean Seed Coats	PLOS ONE			English	Article							MOLECULAR ANALYSIS; FUNCTIONAL-CHARACTERIZATION; DOMAIN PROTEIN; MESSENGER-RNA; ZEA-MAYS; FAMILY; IDENTIFICATION; EXPRESSION; ELEMENTS; BIOSYNTHESIS	We determined the molecular basis of three soybean lines that vary in seed coat color at the R locus which is thought to encode a MYB transcription factor. RM55-r(m) is homozygous for a mutable allele (r(m)) that specifies black and brown striped seeds; RM30-R* is a stable black revertant isoline derived from the mutable line; and RM38-r has brown seed coats due to a recessive r allele shown to translate a truncated MYB protein. Using long range PCR, 454 sequencing of amplicons, and whole genome re-sequencing, we determined that the variegated RM55-r(m) line had a 13 kb CACTA subfamily transposon insertion (designated TgmR*) at a position 110 bp from the beginning of Intron2 of the R locus, Glyma09g36983. Although the MYB encoded by R was expressed at only very low levels in older seed coats of the black revertant RM30-R* line, it upregulated expression of anthocyanidin synthase genes (ANS2, ANS3) to promote the synthesis of anthocyanins. Surprisingly, the RM30-R* revertant also carried the 13 kb TgmR* insertion in Intron2. Using RNA-Seq, we showed that intron splicing was accurate, albeit at lower levels, despite the presence of the 13 kb TgmR* element. As determined by whole genome methylation sequencing, we demonstrate that the TgmR* sequence was relatively more methylated in RM30-R* than in the mutable RM55-r(m) progenitor line. The stabilized and more methylated RM30-R* revertant line apparently lacks effective binding of a transposae to its subterminal repeats, thus allowing intron splicing to proceed resulting in sufficient MYB protein to stimulate anthocyanin production and thus black seed coats. In this regard, the TgmR* element in soybean resembles McClintock's Spm-suppressible and change-of-state alleles of maize. This comparison explains the opposite effects of the TgmR* element on intron splicing of the MYB gene in which it resides depending on the methylation state of the element.	[Zabala, Gracia; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; Illinois Soybean Association; USDA	United Soybean Board; Illinois Soybean Association; USDA(United States Department of Agriculture (USDA))	The research was funded by grants from the United Soybean Board, the Illinois Soybean Association and the USDA. The funders had no role in the design of the study, the data collection and analysis, the decision to publish nor the manuscript preparation.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; AKADA S, 1993, PLANT PHYSIOL, V102, P321, DOI 10.1104/pp.102.1.321; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BANKS JA, 1988, GENE DEV, V2, P1364, DOI 10.1101/gad.2.11.1364; CHANDLEE JM, 1989, THEOR APPL GENET, V77, P587, DOI 10.1007/BF00274285; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dellaporta SL, 1993, MAIZE HDB, P522; FEDOROFF NV, 1989, CELL, V56, P181, DOI 10.1016/0092-8674(89)90891-X; FRANKEN P, 1994, PLANT J, V6, P21, DOI 10.1046/j.1365-313X.1994.6010021.x; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; GOFF SA, 1991, GENE DEV, V5, P298, DOI 10.1101/gad.5.2.298; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; JOFUKU KD, 1989, PLANT CELL, V1, P427, DOI 10.1105/tpc.1.4.427; Kovinich N, 2012, J AGR FOOD CHEM, V60, P574, DOI 10.1021/jf2033939; Kovinich N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-381; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; PAZARES J, 1990, EMBO J, V9, P315, DOI 10.1002/j.1460-2075.1990.tb08113.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; RHODES PR, 1985, P NATL ACAD SCI USA, V82, P493, DOI 10.1073/pnas.82.2.493; RHODES PR, 1988, GENETICS, V120, P597; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; VODKIN LO, 1983, CELL, V34, P1023, DOI 10.1016/0092-8674(83)90560-3; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wang CS, 1993, THESIS U ILLINOIS; WESSLER SR, 1988, SCIENCE, V242, P399, DOI 10.1126/science.2845581; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2003, GENETICS, V163, P295; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	49	30	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111959	10.1371/journal.pone.0111959	http://dx.doi.org/10.1371/journal.pone.0111959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369033	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000131
J	Cao, LM; Han, G; Gu, B; Yin, HF				Cao, Limin; Han, Gang; Gu, Ben; Yin, HaiFang			Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							MORPHOLINO OLIGOMER TREATMENT; MDX MICE; MUSCLE PATHOLOGY; GENE-THERAPY; RESTORATION; EXPRESSION; RNA; INSIGHTS; PROVIDE; RESCUE	A readily available animal model is essential for rapidly identifying effective treatments for Duchenne muscular dystrophy (DMD), a devastating neuromuscular disorder caused by the lack of dystrophin protein, which results from frame-disrupting mutations in the DMD gene. Currently, the mdx mouse is the most commonly used model for antisense oligonucleotide (AO)-mediated exon skipping pre-clinical studies, with a mild phenotype. However, the accessibility of mdx mouse colonies particularly in developing countries can constrain research. Therefore in this study we explore the feasibility of using wildtype mice as models to establish exon-skipping efficiency of various DMD AO chemistries and their conjugates. Four different strains of wild-type mice and six different AO chemistries were investigated intramuscularly and the results indicated that the same exon-skipping efficiency was achieved for all tested AOs as that from mdx mice. Notably, levels of exon-skipping obtained in C57BL6 and C3H and mdx mice were most closely matched, followed by ICR and BALB/C mice. Systemic validation revealed that wild-type mice are less responsive to AO-mediated exon skipping than mdx mice. Our study provides evidence for the first time that wild-type mice can be appropriate models for assessing DMD AO exon-skipping efficiency with similar sensitivity to that of mdx mice and this finding can further accelerate the development of effective DMD AOs.	[Yin, HaiFang] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; Tianjin Med Univ, Dept Cell Biol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	haifangyin@tmu.edu.cn			National Natural Science Foundation of China [81361128013, 81273420, 81101340]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]; Program for New Century Excellent Talents [NCET-10-0957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant No. 81361128013, 81273420, and 81101340), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111202110002) and Program for New Century Excellent Talents (NCET-10-0957). The funding sources had no involvement in study design, the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ahmad A, 2000, HUM MOL GENET, V9, P2507, DOI 10.1093/hmg/9.17.2507; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Angelini Corrado, 2012, Acta Myol, V31, P9; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328; Bhattacharya S, 2004, BIOTECHNOL BIOENG, V86, P37, DOI 10.1002/bit.20042; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Extance A, 2009, NAT REV DRUG DISCOV, V8, P917, DOI 10.1038/nrd3069; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Goyenvalle A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-8; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Heemskerk H, 2010, MOL THER, V18, P1210, DOI 10.1038/mt.2010.72; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Islamian Jalil Pirayesh, 2014, Cancer Biology Medicine, V11, P78, DOI 10.7497/j.issn.2095-3941.2014.02.002; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Moulton HM, 2010, BBA-BIOMEMBRANES, V1798, P2296, DOI 10.1016/j.bbamem.2010.02.012; Rafael JA, 2000, HUM MOL GENET, V9, P1357, DOI 10.1093/hmg/9.9.1357; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang QS, 2010, J GENE MED, V12, P354, DOI 10.1002/jgm.1446; Wu B, 2012, AM J PATHOL, V181, P392, DOI 10.1016/j.ajpath.2012.04.006; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061584; Yin HF, 2008, MOL THER, V16, P38, DOI 10.1038/sj.mt.6300329; Yin HF, 2011, MOL THER, V19, P1295, DOI 10.1038/mt.2011.79; Yin HF, 2010, MOL THER, V18, P819, DOI 10.1038/mt.2009.310; Yin HF, 2009, HUM MOL GENET, V18, P4405, DOI 10.1093/hmg/ddp395; Zheng Hong, 2013, Cancer Biology Medicine, V10, P123, DOI 10.7497/j.issn.2095-3941.2013.03.001	42	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111079	10.1371/journal.pone.0111079	http://dx.doi.org/10.1371/journal.pone.0111079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365558	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558100049
J	Cappelletti, C; Galbardi, B; Kapetis, D; Vattemi, G; Guglielmi, V; Tonin, P; Salerno, F; Morandi, L; Tomelleri, G; Mantegazza, R; Bernasconi, P				Cappelletti, Cristina; Galbardi, Barbara; Kapetis, Dimos; Vattemi, Gaetano; Guglielmi, Valeria; Tonin, Paola; Salerno, Franco; Morandi, Lucia; Tomelleri, Giuliano; Mantegazza, Renato; Bernasconi, Pia			Autophagy, Inflammation and Innate Immunity in Inflammatory Myopathies	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IN-VITRO; MUSCLE; EXPRESSION; CELLS; POLYMYOSITIS; ANTIGEN; HMGB1; HEAT-SHOCK-PROTEIN-60; TOLL-LIKE-RECEPTOR-4	Autophagy has a large range of physiological functions and its dysregulation contributes to several human disorders, including autoinflammatory/autoimmune diseases such as inflammatory myopathies (IIMs). In order to better understand the pathogenetic mechanisms of these muscular disorders, we sought to define the role of autophagic processes and their relation with the innate immune system in the three main subtypes of IIM, specifically sporadic inclusion body myositis (sIBM), polymyositis (PM), dermatomyositis (DM) and juvenile dermatomyositis (JDM). We found that although the mRNA transcript levels of the autophagy-related genes BECN1, ATG5 and FBXO32 were similar in IIM and controls, autophagy activation in all IIM subgroups was suggested by immunoblotting results and confirmed by immunofluorescence. TLR4 and TLR3, two potent inducers of autophagy, were highly increased in IIM, with TLR4 transcripts significantly more expressed in PM and DM than in JDM, sIBM and controls, and TLR3 transcripts highly up-regulated in all IIM subgroups compared to controls. Co-localization between autophagic marker, LC3, and TLR4 and TLR3 was observed not only in sIBM but also in PM, DM and JDM muscle tissues. Furthermore, a highly association with the autophagic processes was observed in all IIM subgroups also for some TLR4 ligands, endogenous and bacterial HSP60, other than the high-mobility group box 1 (HMGB1). These findings indicate that autophagic processes are active not only in sIBM but also in PM, DM and JDM, probably in response to an exogenous or endogenous 'danger signal'. However, autophagic activation and regulation, and also interaction with the innate immune system, differ in each type of IIM. Better understanding of these differences may lead to new therapies for the different IIM types.	[Cappelletti, Cristina; Galbardi, Barbara; Kapetis, Dimos; Salerno, Franco; Morandi, Lucia; Mantegazza, Renato; Bernasconi, Pia] Fdn Ist Neurol Carlo Besta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Milan, Italy; [Vattemi, Gaetano; Guglielmi, Valeria; Tonin, Paola; Tomelleri, Giuliano] Univ Verona, Dept Neurol & Movement Sci, Sect Clin Neurol, I-37100 Verona, Italy	IRCCS Istituto Neurologico Besta; University of Verona	Bernasconi, P (corresponding author), Fdn Ist Neurol Carlo Besta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Milan, Italy.	pbernasconi@istituto-besta.it	Bernasconi, Pia/AAB-7590-2019; Salerno, Franco/J-9198-2016; Vattemi, Gaetano/AAC-4668-2022; Tonin, Paola/AAC-5052-2022; Galbardi, Barbara/ABH-4699-2020; Mantegazza, Renato/AAB-7569-2019; Cappelletti, Cristina/AAH-5493-2021	Salerno, Franco/0000-0003-0811-4443; Mantegazza, Renato/0000-0002-9810-5737; Cappelletti, Cristina/0000-0002-4855-3136; GUGLIELMI, Valeria/0000-0003-0968-0498; Bernasconi, Pia/0000-0003-0869-2104; Vattemi, Gaetano/0000-0003-3412-8339	Italian Ministry of Health; Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus	This work was supported by the Italian Ministry of Health 2012-2013 (Annual Research Funding to PB and RM), and the Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus (AIM) to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Askanas Valerie, 2011, Presse Med, V40, pe219, DOI 10.1016/j.lpm.2010.11.024; BENNETT MR, 1990, POSTGRAD MED J, V66, P47, DOI 10.1136/pgmj.66.771.47; Bernasconi P, 2005, AM J PATHOL, V167, P129, DOI 10.1016/S0002-9440(10)62960-4; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Brunn A, 2012, J NEUROPATH EXP NEUR, V71, P855, DOI 10.1097/NEN.0b013e31826bf7f3; Cappelletti C, 2011, NEUROLOGY, V76, P2079, DOI 10.1212/WNL.0b013e31821f440a; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Elst EF, 2008, ARTHRITIS RHEUM-US, V58, P547, DOI 10.1002/art.23202; Girolamo F, 2013, NEUROPATH APPL NEURO, V39, P736, DOI 10.1111/nan.12040; Grundtman C, 2010, FASEB J, V24, P570, DOI 10.1096/fj.09-144782; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Kim GT, 2010, CLIN RHEUMATOL, V29, P273, DOI 10.1007/s10067-009-1316-7; Kim H, 2009, BIOCHEM BIOPH RES CO, V388, P339, DOI 10.1016/j.bbrc.2009.08.007; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Perez C, 1999, SCAND J RHEUMATOL, V28, P125; Sachdev U, 2012, J VASC SURG, V55, P180, DOI 10.1016/j.jvs.2011.07.072; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scarlatti F, 2008, AUTOPHAGY, V4, P1083, DOI 10.4161/auto.7068; Seay MD, 2007, CELL HOST MICROBE, V2, P69, DOI 10.1016/j.chom.2007.07.008; Strawbridge AB, 2007, CURR OPIN IMMUNOL, V19, P87, DOI 10.1016/j.coi.2006.11.009; Tian J, 2013, CARDIOVASC RES, V98, P391, DOI 10.1093/cvr/cvt047; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wang HJ, 2013, AM J PHYSIOL-CELL PH, V304, pC617, DOI 10.1152/ajpcell.00296.2012; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zampieri S, 2006, AUTOIMMUNITY, V39, P191, DOI 10.1080/08916930600622348; Zong M, 2013, ANN RHEUM DIS, V72, P1390, DOI 10.1136/annrheumdis-2012-202207; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	49	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111490	10.1371/journal.pone.0111490	http://dx.doi.org/10.1371/journal.pone.0111490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365350	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100070
J	Deng, W; Xu, HG; Ding, W; Liang, HJ				Deng, Wei; Xu, Huaguo; Ding, Wei; Liang, Haojun			DNA Logic Gate Based on Metallo-Toehold Strand Displacement	PLOS ONE			English	Article							MULTIPLEXED ANALYSIS; IONS; DRIVEN; HG2+; AG+; COMPUTATION; MERCURY(II); DESIGN; SENSOR; PROBE	DNA is increasingly being used as an ideal material for the construction of nanoscale structures, circuits, and machines. Toehold-mediated DNA strand displacement reactions play a very important role in these enzyme-free constructions. In this study, the concept of metallo-toehold was utilized to further develop a mechanism for strand displacement driven by Ag+ ions, in which the intercalation of cytosine-cytosine mismatched base pairs on the toeholds provides additional control by varying of the concentration of Ag+ ions. The characteristics of displacement reaction in response to different concentration of Ag+ ions are investigated by fluorescence spectral and non-denaturing polyacrylamide gel electrophoresis. The reaction can successfully occur when the concentration of Ag+ ions is suitabe; excess Ag+ ions block the reaction. Furthermore, the displacement reaction can be tuned and controlled most efficiently under the condition of two C: C mismatched base pairs placed on the six-nt toehold. Based on our research, a mechanism was developed to construct Boolean logic gate AND and OR by employing strand displacement reaction as a tool, Ag+ and Hg2+ as input.	[Deng, Wei; Xu, Huaguo; Ding, Wei; Liang, Haojun] Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Liang, Haojun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liang, HJ (corresponding author), Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	hjliang@ustc.edu.cn	Liang, Haojun/F-5960-2010		National Natural Science Foundation of China [20934004, 91127046]; National Basic Research Program of China [2012CB821500, 2010CB934500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Funding provided by the National Natural Science Foundation of China (Grant Nos. 20934004 and 91127046) and the National Basic Research Program of China (Grant Nos. 2012CB821500 and 2010CB934500). The funding sources had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data.	Aich P, 1999, J MOL BIOL, V294, P477, DOI 10.1006/jmbi.1999.3234; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Clever GH, 2007, ANGEW CHEM INT EDIT, V46, P6226, DOI 10.1002/anie.200701185; Clever GH, 2010, COORDIN CHEM REV, V254, P2391, DOI 10.1016/j.ccr.2010.04.014; Ding W, 2013, CHEM COMMUN, V49, P9953, DOI 10.1039/c3cc45373a; Elbaz J, 2009, NANO LETT, V9, P4510, DOI 10.1021/nl902859m; Freeman R, 2009, ANGEW CHEM INT EDIT, V48, P7818, DOI 10.1002/anie.200902395; Genot AJ, 2011, J AM CHEM SOC, V133, P2177, DOI 10.1021/ja1073239; Graf N, 2006, ANGEW CHEM INT EDIT, V45, P4013, DOI 10.1002/anie.200504319; He XX, 2012, ANAL METHODS-UK, V4, P345, DOI 10.1039/c2ay05823e; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Kanayama N, 2013, CHEM-EUR J, V19, P10794, DOI 10.1002/chem.201301995; LEE JS, 1993, BIOCHEM CELL BIOL, V71, P162, DOI 10.1139/o93-026; Lin ZZ, 2011, ANAL CHEM, V83, P6896, DOI 10.1021/ac2014096; Lu N, 2009, ANALYST, V134, P1822, DOI 10.1039/b908018j; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P5464, DOI 10.1002/anie.200501214; Ono A, 2004, ANGEW CHEM INT EDIT, V43, P4300, DOI 10.1002/anie.200454172; Ono A, 2008, CHEM COMMUN, P4825, DOI 10.1039/b808686a; Ono A, 2011, CHEM SOC REV, V40, P5855, DOI 10.1039/c1cs15149e; PANYUTIN IG, 1994, FASEB J, V8, pA1395; Park KS, 2010, ANGEW CHEM INT EDIT, V49, P9757, DOI 10.1002/anie.201004406; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007; Song TJ, 2012, J AM CHEM SOC, V134, P10803, DOI 10.1021/ja304746k; Stojanovic MN, 2005, J AM CHEM SOC, V127, P6914, DOI 10.1021/ja043003a; Switzer C, 2005, ANGEW CHEM INT EDIT, V44, P1529, DOI 10.1002/anie.200462047; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587; Tang W, 2013, J AM CHEM SOC, V135, P13628, DOI 10.1021/ja406053b; Tian Y, 2004, J AM CHEM SOC, V126, P11410, DOI 10.1021/ja046507h; Torigoe H, 2012, THERMOCHIM ACTA, V532, P28, DOI 10.1016/j.tca.2011.03.018; Urata H, 2011, CHEM COMMUN, V47, P941, DOI 10.1039/c0cc04091f; Wang Y, 2012, CHEM COMMUN, V48, P2873, DOI 10.1039/c2cc16279b; Wang ZG, 2011, NANO LETT, V11, P304, DOI 10.1021/nl104088s; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xiao ZY, 2013, CHEM COMMUN, V49, P3573, DOI 10.1039/c3cc40333e; Xu XW, 2014, CHEM COMMUN, V50, P805, DOI 10.1039/c3cc47102k; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhang GY, 2012, ANALYST, V137, P2687, DOI 10.1039/c2an35180c	46	4	5	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111650	10.1371/journal.pone.0111650	http://dx.doi.org/10.1371/journal.pone.0111650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365381	Green Published, gold			2022-12-26	WOS:000345558100095
J	Vercelloni, J; Caley, MJ; Kayal, M; Low-Choy, S; Mengersen, K				Vercelloni, Julie; Caley, M. Julian; Kayal, Mohsen; Low-Choy, Samantha; Mengersen, Kerrie			Understanding Uncertainties in Non-Linear Population Trajectories: A Bayesian Semi-Parametric Hierarchical Approach to Large-Scale Surveys of Coral Cover	PLOS ONE			English	Article							SPECIES RICHNESS; REEF; RESILIENCE; MODELS; DECLINE; ECOLOGY; FUTURE	Recently, attempts to improve decision making in species management have focussed on uncertainties associated with modelling temporal fluctuations in populations. Reducing model uncertainty is challenging; while larger samples improve estimation of species trajectories and reduce statistical errors, they typically amplify variability in observed trajectories. In particular, traditional modelling approaches aimed at estimating population trajectories usually do not account well for nonlinearities and uncertainties associated with multi-scale observations characteristic of large spatio-temporal surveys. We present a Bayesian semi-parametric hierarchical model for simultaneously quantifying uncertainties associated with model structure and parameters, and scale-specific variability over time. We estimate uncertainty across a four-tiered spatial hierarchy of coral cover from the Great Barrier Reef. Coral variability is well described; however, our results show that, in the absence of additional model specifications, conclusions regarding coral trajectories become highly uncertain when considering multiple reefs, suggesting that management should focus more at the scale of individual reefs. The approach presented facilitates the description and estimation of population trajectories and associated uncertainties when variability cannot be attributed to specific causes and origins. We argue that our model can unlock value contained in large-scale datasets, provide guidance for understanding sources of uncertainty, and support better informed decision making.	[Vercelloni, Julie; Low-Choy, Samantha; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Vercelloni, Julie; Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Kayal, Mohsen] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	Queensland University of Technology (QUT); Australian Institute of Marine Science; University of California System; University of California Santa Barbara	Vercelloni, J (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	julie.vercelloni@gmail.com	Mengersen, Kerrie/AHC-4096-2022; Caley, Julian/A-4042-2008	Kayal, Mohsen/0000-0003-3675-9855; Mengersen, Kerrie/0000-0001-8625-9168; Caley, Julian/0000-0001-5739-749X; Vercelloni, Julie/0000-0001-5227-014X; Low Choy, Samantha/0000-0002-1722-4428				Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connolly S, 2014, ANZIAM J IN PRESS; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fisher R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026556; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2006, TECHNOMETRICS, V48, P432, DOI 10.1198/004017005000000661; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hadfield JD, 2010, AM NAT, V175, P116, DOI 10.1086/648604; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jonker M., 2008, LONG TERM MONITORING; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; MacNeil MA, 2009, ECOLOGY, V90, P252, DOI 10.1890/07-0487.1; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Miao ShiLi, 2009, P1, DOI 10.1007/978-0-387-77942-3_1; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rao P.V., 1998, STAT RES METHODS LIF; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sweatman H, 2011, CORAL REEFS, V30, P661, DOI 10.1007/s00338-011-0794-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2; Wood SN, 2001, ECOL MONOGR, V71, P1, DOI 10.1890/0012-9615(2001)071[0001:PSEM]2.0.CO;2; Wu JG, 2002, ECOL MODEL, V153, P7, DOI 10.1016/S0304-3800(01)00499-9	55	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110968	10.1371/journal.pone.0110968	http://dx.doi.org/10.1371/journal.pone.0110968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364915	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558100039
J	Wang, WG; Tang, XY; Zhu, QL; Pan, K; Hu, QC; He, MX; Li, JT				Wang, Wenguo; Tang, Xiaoyu; Zhu, Qili; Pan, Ke; Hu, Qichun; He, Mingxiong; Li, Jiatang			Predicting the Impacts of Climate Change on the Potential Distribution of Major Native Non-Food Bioenergy Plants in China	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; MARGINAL LAND; ENERGY PLANTS; MAXENT; BIOFUELS; CROPS; PERFORMANCE; BIODIESEL; GRASSES; YIELD	Planting non-food bioenergy crops on marginal lands is an alternative bioenergy development solution in China. Native non-food bioenergy plants are also considered to be a wise choice to reduce the threat of invasive plants. In this study, the impacts of climate change (a consensus of IPCC scenarios A2a for 2080) on the potential distribution of nine non-food bioenergy plants native to China (viz., Pistacia chinensis, Cornus wilsoniana, Xanthoceras sorbifolia, Vernicia fordii, Sapium sebiferum, Miscanthus sinensis, M. floridulus, M. sacchariflorus and Arundo donax) were analyzed using a MaxEnt species distribution model. The suitable habitats of the nine non-food plants were distributed in the regions east of the Mongolian Plateau and the Tibetan Plateau, where the arable land is primarily used for food production. Thus, the large-scale cultivation of those plants for energy production will have to rely on the marginal lands. The variables of "precipitation of the warmest quarter" and "annual mean temperature" were the most important bioclimatic variables for most of the nine plants according to the MaxEnt modeling results. Global warming in coming decades may result in a decrease in the extent of suitable habitat in the tropics but will have little effect on the total distribution area of each plant. The results indicated that it will be possible to grow these plants on marginal lands within these areas in the future. This work should be beneficial for the domestication and cultivation of those bioenergy plants and should facilitate land-use planning for bioenergy crops in China.	[Wang, Wenguo; Tang, Xiaoyu; Zhu, Qili; Pan, Ke; Hu, Qichun; He, Mingxiong] Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610064, Peoples R China; [Li, Jiatang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610064, Peoples R China	Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Wang, WG (corresponding author), Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610064, Peoples R China.	wangwenguo@caas.cn; lijt@cib.ac.cn	Li, Jia-Tang/AAC-7626-2020; he, mingxiong/D-6683-2017	he, mingxiong/0000-0002-9780-6865	National Natural Science Foundation of China [51108239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 51108239). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou E, 2008, BIOMASS BIOENERG, V32, P926, DOI 10.1016/j.biombioe.2008.01.015; Axmacher JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064173; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brosse N, 2012, BIOFUEL BIOPROD BIOR, V6, P580, DOI 10.1002/bbb.1353; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Caspeta L, 2013, ENERG ENVIRON SCI, V6, P1077, DOI 10.1039/c3ee24403b; Chen SL, 2006, FLORA CHINA, V22, P582; Dalgaard T, 2006, SCIENCE, V312, P1743; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evans JM, 2010, GCB BIOENERGY, V2, P63, DOI 10.1111/j.1757-1707.2010.01040.x; Flory SL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045904; Garcia A, 2014, ENVIRON CONSERV, V41, P1, DOI 10.1017/S0376892913000349; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gordon DR, 2011, BIOMASS BIOENERG, V35, P74, DOI 10.1016/j.biombioe.2010.08.029; Hedhly A, 2009, TRENDS PLANT SCI, V14, P30, DOI 10.1016/j.tplants.2008.11.001; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Herrera AM, 2003, BIOL INVASIONS, V5, P167, DOI 10.1023/A:1026190115521; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang CL, 2011, BIOMASS BIOENERG, V35, P1873, DOI 10.1016/j.biombioe.2011.01.032; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li BT, 2008, FLORA CHINA, V22, P266; Li J, 2012, BIORESOURCE TECHNOL, V108, P112, DOI 10.1016/j.biortech.2011.12.129; Li XF, 2010, ENVIRON MANAGE, V46, P579, DOI 10.1007/s00267-010-9443-0; Liang XY, 2013, J CLEAN PROD, V39, P24, DOI 10.1016/j.jclepro.2012.08.003; Liu L, 2006, FLORA CHINA, V22, P448; Lu L, 2012, ENERGIES, V5, P2165, DOI 10.3390/en5072165; Mangan ME, 2011, AGRON J, V103, P509, DOI 10.2134/agronj2010.0360; Mendu V, 2012, P NATL ACAD SCI USA, V109, P4014, DOI 10.1073/pnas.1112757109; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Radic V, 2011, J CLIMATE, V24, P5257, DOI 10.1175/JCLI-D-11-00011.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Shao HB, 2008, BIOMASS BIOENERG, V32, P283, DOI 10.1016/j.biombioe.2007.10.001; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tang Y, 2010, J INTEGR PLANT BIOL, V52, P112, DOI 10.1111/j.1744-7909.2010.00903.x; Trabucco A, 2010, GCB BIOENERGY, V2, P139, DOI 10.1111/j.1757-1707.2010.01049.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Tuck G, 2006, BIOMASS BIOENERG, V30, P183, DOI 10.1016/j.biombioe.2005.11.019; Villamil MB, 2012, RENEW SUST ENERG REV, V16, P3604, DOI 10.1016/j.rser.2012.03.033; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Wu CZ, 2010, ENERGY, V35, P4445, DOI 10.1016/j.energy.2009.04.006; Wu Z.Y., 2008, FLORA CHINA, V11, P335; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia NH, 2007, FLORA CHINA, V22, P6; Xiang QY, 2005, FLORA CHINA, V22, P215; Xiong SJ, 2008, BIORESOURCE TECHNOL, V99, P479, DOI 10.1016/j.biortech.2007.01.034; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Zamora DS, 2013, BIOMASS BIOENERG, V49, P222, DOI 10.1016/j.biombioe.2012.12.031; Zank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094625; Zhou D, 2012, J AGR SCI-CAMBRIDGE, V150, P179, DOI 10.1017/S0021859611000396; Zhu TP, 2007, PLANT RESOURCES CHIN, p[90, 404, 409, 418, 437]; Zhuang DF, 2011, RENEW SUST ENERG REV, V15, P1050, DOI 10.1016/j.rser.2010.11.041	64	17	19	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111587	10.1371/journal.pone.0111587	http://dx.doi.org/10.1371/journal.pone.0111587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365425	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558100082
J	Capala, ME; Vellenga, E; Schuringa, JJ				Capala, Marta E.; Vellenga, Edo; Schuringa, Jan Jacob			ELMO1 Is Upregulated in AML CD34+Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GUANOSINE TRIPHOSPHATASES REPRESENT; GENE-EXPRESSION PROFILES; STEM-CELLS; STEM/PROGENITOR CELLS; SELF-RENEWAL; BCR-ABL; CANCER; TRANSFORMATION; ACTIVATION	Both normal as well leukemic hematopoietic stem cells critically depend on their microenvironment in the bone marrow for processes such as self-renewal, survival and differentiation, although the exact pathways that are involved remain poorly understood. We performed transcriptome analysis on primitive CD34(+) acute myeloid leukemia (AML) cells (n = 46), their more differentiated CD34(-) leukemic progeny, and normal CD34(+) bone marrow cells (n = 31) and focused on differentially expressed genes involved in adhesion and migration. Thus, Engulfment and Motility protein 1 (ELMO1) was identified amongst the top 50 most differentially expressed genes. ELMO1 is a crucial link in the signaling cascade that leads to activation of RAC GTPases and cytoskeleton rearrangements. We confirmed increased ELMO1 expression at the mRNA and protein level in a panel of AML samples and showed that high ELMO1 expression is an independent negative prognostic factor in normal karyotype (NK) AML in three large independent patient cohorts. Downmodulation of ELMO1 in human CB CD34(+) cells did not significantly alter expansion, progenitor frequency or differentiation in stromal co-cultures, but did result in a decreased frequency of stem cells in LTC-IC assays. In BCR-ABL-transduced human CB CD34(+) cells depletion of ELMO1 resulted in a mild decrease in proliferation, but replating capacity of progenitors was severely impaired. Downregulation of ELMO1 in a panel of primary CD34(+) AML cells also resulted in reduced long-term growth in stromal co-cultures in two out of three cases. Pharmacological inhibition of the ELMO1 downstream target RAC resulted in a severely impaired proliferation and survival of leukemic cells. Finally, ELMO1 depletion caused a marked decrease in SDF1-induced chemotaxis of leukemic cells. Taken together, these data show that inhibiting the ELMO1-RAC axis might be an alternative way to target leukemic cells.	[Capala, Marta E.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl			Netherlands Organization for Scientific Research [NWO-VIDI 91796312]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VIDI 91796312) to JJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bonardi F, 2013, MOL CELL PROTEOMICS, V12, P626, DOI 10.1074/mcp.M112.021931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; de Jonge HJM, 2011, LEUKEMIA, V25, P1825, DOI 10.1038/leu.2011.172; de Jonge HJM, 2010, BLOOD, V116, P1747, DOI 10.1182/blood-2010-03-270991; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Muller LUW, 2008, LEUKEMIA, V22, P1803, DOI 10.1038/leu.2008.196; Nieborowska-Skorska M, 2012, BLOOD, V119, P4253, DOI 10.1182/blood-2011-10-385658; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rozenveld-Geugien M, 2007, EXP HEMATOL, V35, P782, DOI 10.1016/j.exphem.2007.02.006; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Schepers H, 2007, BLOOD, V110, P1317, DOI 10.1182/blood-2006-10-052175; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shimazaki A, 2006, KIDNEY INT, V70, P1769, DOI 10.1038/sj.ki.5001939; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wang J, 2014, INT J GYNECOLOGICAL, V24; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111568	10.1371/journal.pone.0111568	http://dx.doi.org/10.1371/journal.pone.0111568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360637	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943700121
J	Debelec-Butuner, B; Alapinar, C; Ertunc, N; Gonen-Korkmaz, C; Yorukoglu, K; Korkmaz, KS				Debelec-Butuner, Bilge; Alapinar, Cansu; Ertunc, Nursah; Gonen-Korkmaz, Ceren; Yorukoglu, Kutsal; Korkmaz, Kemal Sami			TNF alpha-Mediated Loss of beta-Catenin/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; WNT; PHOSPHORYLATION; ADHESION; INHIBITION; ADENOCARCINOMA; ACTIVATION; RECEPTOR; PATHWAY	Inflammation-induced carcinogenesis is associated with increased proliferation and migration/invasion of various types of tumor cells. In this study, altered beta-catenin signaling upon TNF alpha exposure, and relation to loss of function of the tumor suppressor NKX3.1 was examined in prostate cancer cells. We used an in vitro prostate inflammation model to demonstrate altered sub-cellular localization of beta-catenin following increased phosphorylation of Akt((S473)) and GSK3 beta((S9)). Consistently, we observed that subsequent increase in beta-catenin transactivation enhanced c-myc, cyclin D1 and MMP2 expressions. Consequently, it was also observed that the beta-catenin-E-cadherin association at the plasma membrane was disrupted during acute cytokine exposure. Additionally, it was demonstrated that disrupting cell-cell interactions led to increased migration of LNCaP cells in real-time migration assay. Nevertheless, ectopic expression of NKX3.1, which is degraded upon proinflammatory cytokine exposure in inflammation, was found to induce the degradation of beta-catenin by inhibiting Akt((S473)) phosphorylation, therefore, partially rescued the disrupted beta-catenin-E-cadherin interaction as well as the cell migration in LNCaP cells upon cytokine exposure. As, the disrupted localization of beta-catenin at the cell membrane as well as increased Akt((S308)) priming phosphorylation was observed in human prostate tissues with prostatic inflammatory atrophy (PIA), high-grade prostatic intraepithelial neoplasia (H-PIN) and carcinoma lesions correlated with loss of NKX3.1 expression. Thus, the data indicate that the beta-catenin signaling; consequently sub-cellular localization is deregulated in inflammation, associates with prostatic atrophy and PIN pathology.	[Debelec-Butuner, Bilge; Alapinar, Cansu; Ertunc, Nursah; Korkmaz, Kemal Sami] Ege Univ, Fac Engn, Canc Biol Lab, Dept Bioengn, Izmir, Turkey; [Debelec-Butuner, Bilge] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, Izmir, Turkey; [Gonen-Korkmaz, Ceren] Ege Univ, Dept Pharmacol, Izmir, Turkey; [Yorukoglu, Kutsal] Dokuz Eylul Univ, Fac Med, Dept Pathol, Izmir, Turkey	Ege University; Ege University; Ege University; Dokuz Eylul University	Korkmaz, KS (corresponding author), Ege Univ, Fac Engn, Canc Biol Lab, Dept Bioengn, Izmir, Turkey.	ks_korkmaz@yahoo.com	Korkmaz, Kemal Sami/ABI-5112-2020; Butuner, Bilge Debelec/ABB-5370-2020	Korkmaz, Kemal Sami/0000-0003-4040-2568; Butuner, Bilge Debelec/0000-0001-8112-9241	Turkish Scientific and Technological Research Council (TUBITAK) [108S288, 210T066, 110S134, 113Z083]	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research was granted by projects from Turkish Scientific and Technological Research Council (TUBITAK) 108S288 (COST_CANGENIN), 210T066 and 110S134 and 113Z083 to KSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Debelec-Butuner B., 2012, MOL CARCINOG; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Erbaykent-Tepedelen B, 2011, BIOCHEM BIOPH RES CO, V414, P123, DOI 10.1016/j.bbrc.2011.09.035; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Hamid SM, 2014, MOL CELL ENDOCRINOL, V383, P38, DOI 10.1016/j.mce.2013.12.003; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Ho E, 2004, ARCH BIOCHEM BIOPHYS, V428, P109, DOI 10.1016/j.abb.2004.01.009; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Korkmaz KS, 2000, GENE, V260, P25, DOI 10.1016/S0378-1119(00)00453-4; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lazari P, 2013, UROL INT, V90, P109, DOI 10.1159/000345057; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu ZM, 2004, CELL CYCLE, V3, P571; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Park CS, 2004, J BIOL CHEM, V279, P19592, DOI 10.1074/jbc.M314208200; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Tindall DJ, 1999, PROSTATE, V38, P166, DOI 10.1002/(SICI)1097-0045(19990201)38:2<166::AID-PROS11>3.0.CO;2-A; Varisli L, 2011, DNA CELL BIOL, V30, P419, DOI 10.1089/dna.2010.1128; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhurinsky J, 2000, J CELL SCI, V113, P3127	44	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109868	10.1371/journal.pone.0109868	http://dx.doi.org/10.1371/journal.pone.0109868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360740	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700018
J	Koszarska, M; Kucsma, N; Kiss, K; Varady, G; Gera, M; Antalffy, G; Andrikovics, H; Tordai, A; Studzian, M; Strapagiel, D; Pulaski, L; Tani, Y; Sarkadi, B; Szakacs, G				Koszarska, Magdalena; Kucsma, Nora; Kiss, Katalin; Varady, Gyorgy; Gera, Melinda; Antalffy, Geza; Andrikovics, Hajnalka; Tordai, Attila; Studzian, Maciej; Strapagiel, Dominik; Pulaski, Lukasz; Tani, Yoshihiko; Sarkadi, Balazs; Szakacs, Gergely			Screening the Expression of ABCB6 in Erythrocytes Reveals an Unexpectedly High Frequency of Lan Mutations in Healthy Individuals	PLOS ONE			English	Article							MEMBRANE-PROTEINS; MISSENSE MUTATIONS; STROMAL CELLS; TRANSPORTER; LOCALIZES	Lan is a high-incidence blood group antigen expressed in more than 99.9% of the population. Identification of the human ABC transporter ABCB6 as the molecular basis of Lan has opened the way for studies assessing the relation of ABCB6 function and expression to health and disease. To date, 34 ABCB6 sequence variants have been described in association with reduced ABCB6 expression based on the genotyping of stored blood showing weak or no reactivity with anti-Lan antibodies. In the present study we examined the red blood cell (RBC) surface expression of ABCB6 by quantitative flow cytometry in a cohort of 47 healthy individuals. Sequencing of the entire coding region of the ABCB6 gene in low RBC ABCB6 expressors identified a new allele (IVS9+1G>A, affecting a putative splice site at the boundary of exon 9) and two nonsynonymous SNPs listed in the SNP database (R192Q (rs150221689) and G588 S (rs145526996)). The R192Q mutation showed co-segregation with reduced RBC ABCB6 expression in a family, and we found the G588 S mutation in a compound heterozygous individual with undetectable ABCB6 expression, suggesting that both mutations result in weak or no expression of ABCB6 on RBCs. Analysis of the intracellular expression pattern in HeLa cells by confocal microscopy indicated that these mutations do not compromise overall expression or the endolysosomal localization of ABCB6. Genotyping of two large cohorts, containing 235 and 1039 unrelated volunteers, confirmed the high allele frequency of Lan-mutations. Our results suggest that genetic variants linked to lower or absent cell surface expression of ABCB6/Langereis may be more common than previously thought.	[Koszarska, Magdalena; Andrikovics, Hajnalka; Tordai, Attila; Sarkadi, Balazs] Hungarian Natl Blood Transfus Serv, Budapest, Hungary; [Kucsma, Nora; Kiss, Katalin; Varady, Gyorgy; Gera, Melinda; Antalffy, Geza; Sarkadi, Balazs; Szakacs, Gergely] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Sarkadi, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Biophys Res Grp, H-1085 Budapest, Hungary; [Studzian, Maciej; Pulaski, Lukasz] Univ Lodz, Dept Mol Biophys, PL-90131 Lodz, Poland; [Strapagiel, Dominik] Univ Lodz, Dept Mol Biophys, Biobank Lab, PL-90131 Lodz, Poland; [Tani, Yoshihiko] Japanese Red Cross Kinki Block Blood Ctr, Osaka, Japan	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Semmelweis University; University of Lodz; University of Lodz	Szakacs, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	szakacs.gergely@ttk.mta.hu	Szakacs, Gergely/A-2580-2009; Sarkadi, Balazs/I-5024-2013; Strapagiel, Dominik/L-3247-2013; György, Várady/J-8118-2017; Strapagiel, Dominik/AAD-4351-2020	Szakacs, Gergely/0000-0002-9311-7827; Strapagiel, Dominik/0000-0001-9752-4270; Pulaski, Lukasz/0000-0001-8063-801X; Studzian, Maciej/0000-0002-1881-3072	Lendulet Program of the Hungarian Academy of Sciences; OTKA [83533]; Polish POIG grant - EU through the European Regional Development Fund [01.01.02-10-005/08 TESTOPLEK]; Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences	Lendulet Program of the Hungarian Academy of Sciences; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Polish POIG grant - EU through the European Regional Development Fund; Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences	This work was supported by the Lendulet Program of the Hungarian Academy of Sciences (GS), OTKA 83533 and by the Polish POIG grant 01.01.02-10-005/08 TESTOPLEK, supported by the EU through the European Regional Development Fund. Hajnalka Andrikovics is a recipient of the Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cui YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079808; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniels G., 2013, HUMAN BLOOD GROUPS; Daniels G, 2009, HUM GENET, V126, P729, DOI 10.1007/s00439-009-0738-2; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Della Valle MC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006403; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Haer-Wigman L, 2014, TRANSFUSION, V54, P1836, DOI 10.1111/trf.12544; Helias V, 2012, NAT GENET; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Kasza I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048423; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kusnierz-Alejska Grazyna, 1993, Acta Haematologica Polonica, V24, P169; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087250; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; MANDERS EMM, 1992, J CELL SCI, V103, P857; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Reid ME, 2014, TRANSFUSION, V54, P398, DOI 10.1111/trf.12285; Saison C, 2013, VOX SANG, V104, P159, DOI 10.1111/j.1423-0410.2012.01650.x; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Tanaka M, 2014, TRANSFUSION, V54, P1438, DOI 10.1111/trf.12540; Tatrai P, 2012, BIOCHEM BIOPH RES CO, V422, P28, DOI 10.1016/j.bbrc.2012.04.088; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Turk D, 2009, CURR OPIN DRUG DISC, V12, P246; Tusnady GE, 2006, FEBS LETT, V580, P1017, DOI 10.1016/j.febslet.2005.11.040; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Varady G, 2013, BIOMARK MED, V7, P803, DOI 10.2217/bmm.13.90; Wang L, 2012, AM J HUM GENET; Wu L, 2013, NATURE; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	44	15	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111590	10.1371/journal.pone.0111590	http://dx.doi.org/10.1371/journal.pone.0111590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360778	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000343943700125
J	Mei, J; Guo, QZ; Wu, Y; Li, YF				Mei, Jun; Guo, Qizhen; Wu, Yan; Li, Yunfei			Microbial Diversity of a Camembert-Type Cheese Using Freeze-Dried Tibetan Kefir Coculture as Starter Culture by Culture-Dependent and Culture-Independent Methods	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; PCR-DGGE ANALYSIS; LACTOBACILLUS-KEFIRANOFACIENS; SACCHAROMYCES-CEREVISIAE; LACTOCOCCUS-LACTIS; CHEDDAR CHEESE; VOLATILE COMPOUNDS; BRAZILIAN KEFIR; MIXED CULTURE; MILK CHEESE	The biochemical changes occurring during cheese ripening are directly and indirectly dependent on the microbial associations of starter cultures. Freeze-dried Tibetan kefir coculture was used as a starter culture in the Camembert-type cheese production for the first time. Therefore, it's necessary to elucidate the stability, organization and identification of the dominant microbiota presented in the cheese. Bacteria and yeasts were subjected to culture-dependent on selective media and culture-independent polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) analysis and sequencing of dominant bands to assess the microbial structure and dynamics through ripening. In further studies, kefir grains were observed using scanning electron microscopy (SEM) methods. A total of 147 bacteria and 129 yeasts were obtained from the cheese during ripening. Lactobacillus paracasei represents the most commonly identified lactic acid bacteria isolates, with 59 of a total of 147 isolates, followed by Lactococcus lactis (29 isolates). Meanwhile, Kazachstania servazzii (51 isolates) represented the mainly identified yeast isolate, followed by Saccharomyces cerevisiae (40 isolates). However, some lactic acid bacteria detected by sequence analysis of DGGE bands were not recovered by plating. The yeast S. cerevisiae and K. servazzii are described for the first time with kefir starter culture. SEM showed that the microbiota were dominated by a variety of lactobacilli (long and curved) cells growing in close association with a few yeasts in the inner portion of the grain and the short lactobacilli were observed along with yeast cells on the exterior portion. Results indicated that conventional culture method and PCR-DGGE should be combined to describe in maximal detail the microbiological composition in the cheese during ripening. The data could help in the selection of appropriate commercial starters for Camembert-type cheese.	[Mei, Jun; Guo, Qizhen; Wu, Yan; Li, Yunfei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai 200030, Peoples R China.	yfli@sjtu.edu.cn	Jun, MEI/AAJ-7340-2020	Mei, Jun/0000-0002-1566-0365	Ministry of Science and Technology of the People's Republic of China [2013BAD18B02]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by the Ministry of Science and Technology of the People's Republic of China with project reference no. 2013BAD18B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arfi K, 2002, APPL MICROBIOL BIOT, V58, P503, DOI 10.1007/s00253-001-0925-0; Beshkova DM, 2003, INT DAIRY J, V13, P529, DOI 10.1016/S0958-6946(03)00058-X; Bove CG, 2011, INT J FOOD MICROBIOL, V144, P569, DOI 10.1016/j.ijfoodmicro.2010.11.017; Boylston TD, 2004, INT DAIRY J, V14, P375, DOI 10.1016/j.idairyj.2003.08.008; Broadbent JR, 2013, J DAIRY SCI, V96, P4212, DOI 10.3168/jds.2012-6443; Buzzini P, 2005, ARCH MICROBIOL, V184, P187, DOI 10.1007/s00203-005-0043-y; Callon C, 2004, J DAIRY RES, V71, P231, DOI 10.1017/S0022029904000159; Cheirsilp B, 2003, J BIOSCI BIOENG, V96, P279, DOI 10.1016/S1389-1723(03)80194-9; Cheirsilp B, 2003, J BIOTECHNOL, V100, P43, DOI 10.1016/S0168-1656(02)00228-6; Chen L, 2012, APPL SOIL ECOL, V62, P24, DOI 10.1016/j.apsoil.2012.07.005; Chen YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078789; Cocolin L, 2002, INT DAIRY J, V12, P407, DOI 10.1016/S0958-6946(02)00023-7; Coppola R, 2003, LAIT, V83, P211, DOI 10.1051/lait:2003011; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; Depouilly A, 2004, LAIT, V84, P155, DOI 10.1051/lait:2003036; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976; Dimitrellou D, 2007, J APPL MICROBIOL, V103, P1170, DOI 10.1111/j.1365-2672.2007.03337.x; Dimitrellou D, 2009, FOOD MICROBIOL, V26, P809, DOI 10.1016/j.fm.2009.05.006; Hamet MF, 2013, FOOD MICROBIOL, V36, P327, DOI 10.1016/j.fm.2013.06.022; Ferreira AD, 2003, INT J FOOD MICROBIOL, V86, P131, DOI 10.1016/S0168-1605(03)00252-6; Fontana C, 2005, J MICROBIOL METH, V63, P254, DOI 10.1016/j.mimet.2005.03.010; Goncu A, 2005, INT DAIRY J, V15, P771, DOI 10.1016/j.idairyj.2004.10.008; Guzel-Seydim Z, 2005, INT J DAIRY TECHNOL, V58, P25, DOI 10.1111/j.1471-0307.2005.00177.x; Jamet E, 2012, FOOD MICROBIOL, V31, P191, DOI 10.1016/j.fm.2012.03.009; Jany JL, 2008, FOOD MICROBIOL, V25, P839, DOI 10.1016/j.fm.2008.06.003; JOLLIVET N, 1994, J DAIRY RES, V61, P241, DOI 10.1017/S0022029900028259; KAMINARIDES SE, 1992, AUST J DAIRY TECHNOL, V47, P68; Katechaki E, 2008, J AGR FOOD CHEM, V56, P5316, DOI 10.1021/jf703585y; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Kleppen HP, 2012, APPL ENVIRON MICROB, V78, P6769, DOI 10.1128/AEM.00562-12; Kourkoutas Y, 2006, APPL ENVIRON MICROB, V72, P6124, DOI 10.1128/AEM.03078-05; Leclercq-Perlat MN, 2004, J DAIRY RES, V71, P346, DOI 10.1017/S0022029904000196; LEGRAET Y, 1988, LAIT, V68, P219, DOI 10.1051/lait:1988215; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Li MY, 2006, FOOD MICROBIOL, V23, P607, DOI 10.1016/j.fm.2006.01.004; Lisdiyanti P, 2000, J GEN APPL MICROBIOL, V46, P147, DOI 10.2323/jgam.46.147; Lortal S, 2005, INT DAIRY J, V15, P857, DOI 10.1016/j.idairyj.2004.08.024; Magalhaes KT, 2010, WORLD J MICROB BIOT, V26, P1241, DOI 10.1007/s11274-009-0294-x; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Mas M, 2002, LAIT, V82, P579, DOI 10.1051/lait:2002034; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Murtaza MA, 2014, CRIT REV FOOD SCI, V54, P1309, DOI 10.1080/10408398.2011.634531; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Petersen KM, 2002, J DAIRY SCI, V85, P478, DOI 10.3168/jds.S0022-0302(02)74098-8; Phillips M, 2006, INT J FOOD MICROBIOL, V108, P276, DOI 10.1016/j.ijfoodmicro.2005.12.009; Piermaria J, 2011, FOOD HYDROCOLLOID, V25, P1261, DOI 10.1016/j.foodhyd.2010.11.024; Renouf V, 2006, FOOD MICROBIOL, V23, P136, DOI 10.1016/j.fm.2005.01.019; Roostita R, 1996, INT J FOOD MICROBIOL, V28, P393, DOI 10.1016/0168-1605(95)00018-6; Settanni L, 2013, INT DAIRY J, V32, P126, DOI 10.1016/j.idairyj.2013.04.010; TOBA T, 1990, INT J FOOD MICROBIOL, V10, P219, DOI 10.1016/0168-1605(90)90069-H; van Iersel MFM, 1999, ENZYME MICROB TECH, V24, P407, DOI 10.1016/S0141-0229(98)00146-X; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Weinrichter B, 2001, LEBENSM-WISS TECHNOL, V34, P556, DOI 10.1006/fstl.2001.0799; Zheng YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069868, 10.1371/journal.pone.0080122]; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	58	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111648	10.1371/journal.pone.0111648	http://dx.doi.org/10.1371/journal.pone.0111648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360757	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700138
J	Nguyen, TT; Yoon, S; Yang, Y; Lee, HB; Oh, S; Jeong, MH; Kim, JJ; Yee, ST; Crisan, F; Moon, C; Lee, KY; Kim, KK; Hur, JS; Kim, H				Nguyen, Thanh Thi; Yoon, Somy; Yang, Yi; Lee, Ho-Bin; Oh, Soonok; Jeong, Min-Hye; Kim, Jong-Jin; Yee, Sung-Tae; Crisan, Florin; Moon, Cheol; Lee, Kwang Youl; Kim, Kyung Keun; Hur, Jae-Seoun; Kim, Hangun			Lichen Secondary Metabolites in Flavocetraria cucullata Exhibit Anti-Cancer Effects on Human Cancer Cells through the Induction of Apoptosis and Suppression of Tumorigenic Potentials	PLOS ONE			English	Article							USNIC ACID; IN-VITRO; METASTASIS; INHIBITORS; HT-29; LINES	Lichens are symbiotic organisms which produce distinct secondary metabolic products. In the present study, we tested the cytotoxic activity of 17 lichen species against several human cancer cells and further investigated the molecular mechanisms underlying their anti-cancer activity. We found that among 17 lichens species, F. cucullata exhibited the most potent cytotoxicity in several human cancer cells. High performance liquid chromatography analysis revealed that the acetone extract of F. cucullata contains usnic acid, salazinic acid, Squamatic acid, Baeomycesic acid, d-protolichesterinic acid, and lichesterinic acid as subcomponents. MTT assay showed that cancer cell lines were more vulnerable to the cytotoxic effects of the extract than non-cancer cell lines. Furthermore, among the identified subcomponents, usnic acid treatment had a similar cytotoxic effect on cancer cell lines but with lower potency than the extract. At a lethal dose, treatment with the extract or with usnic acid greatly increased the apoptotic cell population and specifically activated the apoptotic signaling pathway; however, using sub-lethal doses, extract and usnic acid treatment decreased cancer cell motility and inhibited in vitro and in vivo tumorigenic potentials. In these cells, we observed significantly reduced levels of epithelial-mesenchymal transition (EMT) markers and phosphor-Akt, while phosphor-c-Jun and phosphor-ERK1/2 levels were only marginally affected. Overall, the anti-cancer activity of the extract is more potent than that of usnic acid alone. Taken together, F. cucullata and its subcomponent, usnic acid together with additional component, exert anti-cancer effects on human cancer cells through the induction of apoptosis and the inhibition of EMT.	[Nguyen, Thanh Thi; Yang, Yi; Oh, Soonok; Jeong, Min-Hye; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Nguyen, Thanh Thi] Tay Nguyen Univ, Fac Nat Sci & Technol, Buon Ma Thuot, Vietnam; [Yoon, Somy; Kim, Kyung Keun] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju, South Korea; [Lee, Ho-Bin; Kim, Jong-Jin; Yee, Sung-Tae; Moon, Cheol; Kim, Hangun] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Lee, Ho-Bin; Kim, Jong-Jin; Yee, Sung-Tae; Moon, Cheol; Kim, Hangun] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon, South Korea; [Crisan, Florin] Univ Babes Bolyai, Fac Biol & Geol, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea	Sunchon National University; Tay Nguyen University; Chonnam National University; Sunchon National University; Sunchon National University; Babes Bolyai University from Cluj; Chonnam National University	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea.	jshur1@sunchon.ac.kr; hangunkim@sunchon.ac.kr	Crisan, Florin/V-1240-2017	Moon, Cheol/0000-0003-2342-0860	Basic Science Research Program through the National Research Foundation of Korea [NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609]; Korea National Research Resource Center Program [NRF-2012M3A9B8021726]; Sunchon Research Center for Natural Medicine	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Resource Center Program; Sunchon Research Center for Natural Medicine	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609) and by the Korea National Research Resource Center Program (NRF-2012M3A9B8021726). This study also received support from a research grant funded by the Sunchon Research Center for Natural Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backor M, 2006, MYCOL RES, V110, P994, DOI 10.1016/j.mycres.2006.05.007; Backorova M, 2012, TOXICOL IN VITRO, V26, P462, DOI 10.1016/j.tiv.2012.01.017; Burlando B, 2009, PLANTA MED, V75, P607, DOI 10.1055/s-0029-1185329; Cardarelli M, 1997, CELL MOL LIFE SCI, V53, P667, DOI 10.1007/s000180050086; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; FAHSELT D, 1994, SYMBIOSIS, V16, P117; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Haraldsdottir S, 2004, PLANTA MED, V70, P1098, DOI 10.1055/s-2004-832657; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kumar S, 1999, J NAT PROD, V62, P817, DOI 10.1021/np9803777; KUPCHAN SM, 1975, EXPERIENTIA, V31, P625; Lecomte N, 2011, P NATL ACAD SCI USA, V108, P15074, DOI 10.1073/pnas.1015247108; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Mayer M, 2005, ANTI-CANCER DRUG, V16, P805, DOI 10.1097/01.cad.0000175588.09070.77; Molnar K, 2010, Z NATURFORSCH C, V65, P157; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ren MR, 2009, FOOD CHEM TOXICOL, V47, P2157, DOI 10.1016/j.fct.2009.05.042; Russo A, 2012, CHEM-BIOL INTERACT, V195, P1, DOI 10.1016/j.cbi.2011.10.005; Shrestha G, 2013, PHYTOCHEM REV, V12, P229, DOI 10.1007/s11101-013-9283-7; Shukla V, 2010, PHYTOCHEM REV, V9, P303, DOI 10.1007/s11101-010-9189-6; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh N, 2013, NUTR CANCER, V65, P36, DOI 10.1080/01635581.2013.785007; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; TAKAI M, 1979, J MED CHEM, V22, P1380, DOI 10.1021/jm00197a019; Wang JG, 2014, MOL CELL PROTEOMICS, V13, P876, DOI 10.1074/mcp.M113.029793; WHO, 2013, WORLD HLTH STAT; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089	30	46	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111575	10.1371/journal.pone.0111575	http://dx.doi.org/10.1371/journal.pone.0111575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360754	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700124
J	Pitts, RJ; Derryberry, SL; Pulous, FE; Zwiebel, LJ				Pitts, R. Jason; Derryberry, Stephen L., Jr.; Pulous, Fadi E.; Zwiebel, Laurence J.			Antennal-Expressed Ammonium Transporters in the Malaria Vector Mosquito Anopheles gambiae	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; OLFACTORY RECEPTORS; AMT/MEP/RH FAMILY; NH4+; PROTEIN; AMTB; IDENTIFICATION; EVOLUTION; NEURONS; CARRIER	The principal Afrotropical malaria vector mosquito, Anopheles gambiae remains a significant threat to human health. In this anthropophagic species, females detect and respond to a range of human-derived volatile kairomones such as ammonia, lactic acid, and other carboxylic acids in their quest for blood meals. While the molecular underpinnings of mosquito olfaction and host seeking are becoming better understood, many questions remain unanswered. In this study, we have identified and characterized two candidate ammonium transporter genes, AgAmt and AgRh50 that are expressed in the mosquito antenna and may contribute to physiological and behavioral responses to ammonia, which is an important host kairomone for vector mosquitoes. AgAmt transcripts are highly enhanced in female antennae while a splice variant of AgRh50 appears to be antennal-specific. Functional expression of AgAmt in Xenopus laevis oocytes facilitates inward currents in response to both ammonium and methylammonium, while AgRh50 is able to partially complement a yeast ammonium transporter mutant strain, validating their conserved roles as ammonium transporters. We present evidence to suggest that both AgAmt and AgRh50 are in vivo ammonium transporters that are important for ammonia sensitivity in An. gambiae antennae, either by clearing ammonia from the sensillar lymph or by facilitating sensory neuron responses to environmental exposure. Accordingly, AgAmt and AgRh50 represent new and potentially important targets for the development of novel vector control strategies.	[Pitts, R. Jason; Derryberry, Stephen L., Jr.; Pulous, Fadi E.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Pitts, R. Jason; Zwiebel, Laurence J.] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Dept Pharmacol,Program Dev Biol, Nashville, TN 37235 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zwiebel, LJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	l.zwiebel@vanderbilt.edu		Pulous, Fadi/0000-0002-0794-8078; Pitts, Jason/0000-0002-4863-9634; Zwiebel, Laurence/0000-0001-6686-7289	Vanderbilt University Innovation and Discovery in Engineering and Science; National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Vanderbilt University Innovation and Discovery in Engineering and Science; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Vanderbilt University Innovation and Discovery in Engineering and Science (www.vanderbilt.edu), and National Institutes of Health, National Institute of Allergy and Infectious Diseases AI056402, (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Campbell R, 2002, BIOLOGY, P925; Carey AF, 2010, NATURE, P1; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; Coutts G, 2002, EMBO J; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Day DA, 2001, CELL MOL LIFE SCI, V58, P61, DOI 10.1007/PL00000778; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Guo M, 2014, INT J BIOL SCI, V10, P1, DOI 10.7150/ijbs.7624; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang CH, 2010, CELL MOL LIFE SCI, V67, P1203, DOI 10.1007/s00018-009-0217-x; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ludewlg U, 2007, FEBS LETT, V581, P2301, DOI 10.1016/j.febslet.2007.03.034; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakhoul NL, 2013, MOL ASPECTS MED, V34, P629, DOI 10.1016/j.mam.2012.05.013; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Neuhauser B, 2014, J BIOL CHEM, V289, P11650, DOI 10.1074/jbc.C114.552802; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Omasits U, 2013, BIOINFORMATICS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schymura D, 2010, INT J BIOL SCI, V6, P614; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; Tremblay PL, 2009, MOL MICROBIOL, V71, P12, DOI 10.1111/j.1365-2958.2008.06514.x; von Wiren N, 2004, TOP CURR GENET, V9, P95; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Weiner ID, 2013, COMPR PHYSIOL, V3, P201, DOI 10.1002/cphy.c120010; WHO, 2011, WHO TECH REP SER, V959, P1; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Yakunin AF, 2002, J BACTERIOL, V184, P4081, DOI 10.1128/JB.184.15.4081-4088.2002	65	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111858	10.1371/journal.pone.0111858	http://dx.doi.org/10.1371/journal.pone.0111858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360676	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700156
J	Wang, XB; Zhang, HW; Gao, YL; Sun, GL; Zhang, WM; Qiu, LJ				Wang, Xiaobo; Zhang, Haowei; Gao, Yali; Sun, Genlou; Zhang, Wenming; Qiu, Lijuan			A Comprehensive Analysis of the Cupin Gene Family in Soybean (Glycine max)	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; SUPEROXIDE-DISMUTASE ACTIVITY; OXALATE OXIDASE; MESSENGER-RNA; WHOLE-GENOME; SEQUENCE; EVOLUTIONARY; DIVERSIFICATION; DUPLICATION; DIVERSITY	Cupin superfamily of proteins, including germin and germin-like proteins (GLPs) from higher plants, is known to play crucial roles in plant development and defense. To date, no systematic analysis has been conducted in soybean (Glycine max) incorporating genome organization, gene structure, expression compendium. In this study, 69 putative Cupin genes were identified from the whole-genome of soybean, which were non-randomly distributed on 17 of the 20 chromosomes. These Gmcupin proteins were phylogenetically clustered into ten distinct subgroups among which the gene structures were highly conserved. Eighteen pairs (52.2%) of duplicate paralogous genes were preferentially retained in duplicated regions of the soybean genome. The distributions of GmCupin genes implied that long segmental duplications contributed significantly to the expansion of the GmCupin gene family. According to the RNA-seq data analysis, most of the Gmcupins were differentially expressed in tissue-specific expression pattern and the expression of some duplicate genes were partially redundant while others showed functional diversity, suggesting the Gmcupins have been retained by substantial subfunctionalization during soybean evolutionary processes. Selective analysis based on single nucleotide polymorphisms (SNPs) in cultivated and wild soybeans revealed sixteen Gmcupins had selected site(s), with all SNPs in Gmcupin10.3 and Gmcupin07.2 genes were selected sites, which implied these genes may have undergone strong selection effects during soybean domestication. Taken together, our results contribute to the functional characterization of Gmcupin genes in soybean.	[Wang, Xiaobo; Zhang, Haowei; Gao, Yali; Sun, Genlou; Zhang, Wenming] Anhui Agr Univ, Sch Agron, Hefei, Peoples R China; [Qiu, Lijuan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat,Minist Agr, Beijing 100193, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Saint Marys University - Canada	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat,Minist Agr, Beijing 100193, Peoples R China.	qiulijuan@caas.cn	wang, xiaobo/T-7023-2019		National Natural Science Foundation of China [31201226]; National Natural Science Foundation of Anhui Province [1308085QC49]; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Anhui Province; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	This study was supported by the National Natural Science Foundation of China (31201226), the National Natural Science Foundation of Anhui Province (1308085QC49) and the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Cannon SB, 2011, BREEDING SCI, V61, P437, DOI 10.1270/jsbbs.61.437; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Carter C, 1998, PLANT MOL BIOL, V38, P929, DOI 10.1023/A:1006038117130; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dunwell J M, 1998, Microb Comp Genomics, V3, P141, DOI 10.1089/omi.1.1998.3.141; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Ham BK, 2012, PLANT CELL, V24, P3630, DOI 10.1105/tpc.112.101063; JAIKARAN ASI, 1990, J BIOL CHEM, V265, P12503; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Leon-Galvan F, 2011, INT J MOL SCI, V12, P7301, DOI 10.3390/ijms12117301; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Y, 2011, PLANT GROWTH REGUL, V63, P225, DOI 10.1007/s10725-010-9519-0; Lu M, 2010, BMC GENOMICS, P11; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Nakata M, 2002, PLANT CELL PHYSIOL, V43, pS55; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; PELAH D, 1995, TREE PHYSIOL, V15, P673, DOI 10.1093/treephys/15.10.673; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Woo EJ, 2000, ACTA CRYSTALLOGR D, V56, P1476, DOI 10.1107/S0907444900010714; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274	46	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110092	10.1371/journal.pone.0110092	http://dx.doi.org/10.1371/journal.pone.0110092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360675	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943700024
J	Yasaitis, LC; Bubolz, T; Skinner, JS; Chandra, A				Yasaitis, Laura C.; Bubolz, Thomas; Skinner, Jonathan S.; Chandra, Amitabh			Local Population Characteristics and Hemoglobin A1c Testing Rates among Diabetic Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH-CARE; RACIAL DISPARITIES; QUALITY; NEIGHBORHOOD; HOSPITALS	Background: Proposed payment reforms in the US healthcare system would hold providers accountable for the care delivered to an assigned patient population. Annual hemoglobin A1c (HbA1c) tests are recommended for all diabetics, but some patient populations may face barriers to high quality healthcare that are beyond providers' control. The magnitude of fine-grained variations in care for diabetic Medicare beneficiaries, and their associations with local population characteristics, are unknown. Methods: HbA1c tests were recorded for 480,745 diabetic Medicare beneficiaries. Spatial analysis was used to create ZIP code-level estimated testing rates. Associations of testing rates with local population characteristics that are outside the control of providers - population density, the percent African American, with less than a high school education, or living in poverty - were assessed. Results: In 2009, 83.3% of diabetic Medicare beneficiaries received HbA1c tests. Estimated ZIP code-level rates ranged from 71.0% in the lowest decile to 93.1% in the highest. With each 10% increase in the percent of the population that was African American, associated HbA1c testing rates were 0.24% lower (95% CI -0.32--0.17); for identical increases in the percent with less than a high school education or the percent living in poverty, testing rates were 0.70% lower (-0.95--0.46) and 1.6% lower (-1.8--1.4), respectively. Testing rates were lowest in the least and most densely populated ZIP codes. Population characteristics explained 5% of testing rate variations. Conclusions: HbA1c testing rates are associated with population characteristics, but these characteristics fail to explain the vast majority of variations. Consequently, even complete risk-adjustment may have little impact on some process of care quality measures; much of the ZIP code-related variations in testing rates likely result from provider-based differences and idiosyncratic local factors not related to poverty, education, or race.	[Yasaitis, Laura C.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Bubolz, Thomas; Skinner, Jonathan S.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Dartmouth College; Harvard University	Yasaitis, LC (corresponding author), Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	yasaitis@hsph.harvard.edu			National Institute of Aging [PO1 AG19783-11]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of all authors (LCY TB JSS AC) on this study was funded by a grant from the National Institute of Aging (http://www.nia.nih.gov), PO1 AG19783-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Baker LC, 2010, HEALTH AFFAIR, V29, P2068, DOI 10.1377/hlthaff.2009.0810; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Blustein J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000297; Bynum JPW, 2010, MED CARE, V48, P1057, DOI 10.1097/MLR.0b013e3181f37fcf; Casper ML, 2008, ATLAS STROKE HOSPITA; CMS, 2012, HOSP COMP DAT WHAT A; CRESSIE N, 1989, BIOMETRICAL J, V31, P699, DOI 10.1002/bimj.4710310607; Harrington DW, 2012, HEALTH PLACE, V18, P814, DOI 10.1016/j.healthplace.2012.03.011; HRSA, 2013, WHAT IS HLTH CTR; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lewis VA, 2012, HEALTH AFFAIR, V31, P1777, DOI 10.1377/hlthaff.2012.0490; National Quality Forum, 2014, RISK ADJ SOC FACT; NCQA, 2012, NCQA HEDIS QUAL MEAS; Openshaw S., 1984, MODIFIABLE AREAL UNI; Ryan AM, 2012, HEALTH SERV RES, V47, P1418, DOI 10.1111/j.1475-6773.2012.01393.x; Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Waller L.A., 2004, APPL SPATIAL STAT PU; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111119	10.1371/journal.pone.0111119	http://dx.doi.org/10.1371/journal.pone.0111119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360615	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943700064
J	Boscari, E; Pujolar, JM; Dupanloup, I; Corradin, R; Congiu, L				Boscari, Elisa; Pujolar, Jose Martin; Dupanloup, Isabelle; Corradin, Riccardo; Congiu, Leonardo			Captive Breeding Programs Based on Family Groups in Polyploid Sturgeons	PLOS ONE			English	Article							CONSERVATION GENETICS; MICROSATELLITE LOCI; ACIPENSER; MANAGEMENT; MARKERS	In species with long life cycles and discontinuous availability of individuals to reproduction, implementing a long-term captive breeding program can be difficult or impossible. In such cases, managing diversity among familiar groups instead of individuals could become a suitable approach to avoid inbreeding and increase the possibility to accomplish a breeding scheme. This is the case of several sturgeon species including the Adriatic sturgeon, whose recovery depends on the management of a few captive stocks directly descended from the same group of wild parents. In the present study, relatedness among 445 potential breeders was inferred with a novel software for pedigree reconstruction in tetraploids ("BreedingSturgeons''). This information was used to plan a breeding scheme considering familiar groups as breeding units and identifying mating priorities. A two-step strategy is proposed: a short-term breeding program, relying on the 13 remaining F0 individuals of certain wild origin; and a long-term plan based on F1 families. Simulations to evaluate the loss of alleles in the F2 generation under different pairing strategies and assess the number of individuals to breed, costs and logistical aquaculture constraints were performed. The strategy proposed is transferable to the several other tetraploid sturgeon species on the brink of extinction.	[Boscari, Elisa; Congiu, Leonardo] Univ Padua, Dept Biol, Padua, Italy; [Pujolar, Jose Martin] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Dupanloup, Isabelle] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Dupanloup, Isabelle] Swiss Inst Bioinformat, Lausanne, Switzerland; [Corradin, Riccardo] Univ Padua, Dept Stat, Padua, Italy	University of Padua; Aarhus University; University of Bern; Swiss Institute of Bioinformatics; University of Padua	Boscari, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisa.boscari@gmail.com	Congiu, Leonardo/G-7967-2011; Dupanloup, Isabelle/O-8609-2017; Dupanloup, Isabelle/AAD-5372-2020	Dupanloup, Isabelle/0000-0002-9258-6963; CONGIU, LEONARDO/0000-0002-9293-9837; pujolar, marti/0000-0002-5037-8840; CORRADIN, RICCARDO/0000-0001-5389-6873; Boscari, Elisa/0000-0001-8881-9907	"Parco Regionale Veneto del Delta del Po'' Progetto [2022EPPR12]	"Parco Regionale Veneto del Delta del Po'' Progetto	Research was funded by the "Parco Regionale Veneto del Delta del Po'' Progetto 2022EPPR12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders PJ, 2011, J APPL ICHTHYOL, V27, P3, DOI 10.1111/j.1439-0426.2011.01830.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Boscari E, 2014, J APPL ICHTHYOL, V30, P1416, DOI 10.1111/jai.12545; Boscari E, 2014, MOL ECOL RESOUR, V14, P489, DOI 10.1111/1755-0998.12203; Boscari E, 2011, AQUACULTURE, V321, P223, DOI 10.1016/j.aquaculture.2011.09.015; Bronzi P, 1999, J APPL ICHTHYOL, V15, P224, DOI 10.1111/j.1439-0426.1999.tb00239.x; Chebanov M., 2011, 570 FAO; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Congiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018249; Fontana F, 1999, GENOME, V42, P1008, DOI 10.1139/gen-42-5-1008; Forlani A, 2008, CONSERV GENET, V9, P461, DOI 10.1007/s10592-007-9335-x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Hayes B, 2006, AQUACULTURE, V255, P573, DOI 10.1016/j.aquaculture.2005.11.038; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; Hood G.M., 2010, POPTOOLS VERSION 3 2; Ivy JA, 2012, J HERED, V103, P186, DOI 10.1093/jhered/esr129; Kozfkay CC, 2008, CONSERV GENET, V9, P1421, DOI 10.1007/s10592-007-9466-0; Leus K, 2011, ZOOL MIDDLE EAST, P151; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludwig A, 2006, EUR J WILDLIFE RES, V52, P3, DOI 10.1007/s10344-005-0006-2; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; PHILIPPART JC, 1995, BIOL CONSERV, V72, P281, DOI 10.1016/0006-3207(94)00090-D; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Dyke F., 2008, CONSERVATION BIOL FD; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4; Wuertz S, 2006, AQUACULTURE, V258, P685, DOI 10.1016/j.aquaculture.2006.03.042; Zane L, 2002, MOL ECOL NOTES, V2, P586, DOI 10.1046/j.1471-8286.2002.00328.x	31	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110951	10.1371/journal.pone.0110951	http://dx.doi.org/10.1371/journal.pone.0110951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356794	Green Submitted, gold, Green Published			2022-12-26	WOS:000346765000034
J	Li, XG; Zang, XH; Ning, CY; Feng, Y; Xie, CX; He, X; Takebe, Y; Sun, LY; Guo, Q; Xing, H; Kalish, ML; Shao, YM				Li, Xingguang; Zang, Xihui; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Sun, Liuyan; Guo, Qi; Xing, Hui; Kalish, Marcia L.; Shao, Yiming			Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants	PLOS ONE			English	Article							INJECTION-DRUG-USERS; INFECTIOUS-DISEASE; SEXUAL-BEHAVIOR; SOCIAL NETWORK; MEN; PREVALENCE; SYPHILIS; SPREAD; MUNICIPALITY; DYNAMICS	Objective: To investigate the HIV-1 molecular epidemiology among newly diagnosed HIV-1 infected persons living in the Jilin province of northeastern China. Methods: Plasma samples from 189 newly diagnosed HIV-1 infected patients were collected between June 2010 and August 2011 from all nine cities of Jilin province. HIV-1 nucleotide sequences of gag P17-P24 and env C2-C4 gene regions were amplified using a multiplex RT-PCR method and sequenced. Phylogenetic and recombination analyses were used to determine the HIV-1 genotypes. Results: Based on all sequences generated, the subtype/CFR distribution was as follows: CRF01_AE (58.1%), CRF07_BC (13.2%), subtype B' (13.2%), recombinant viruses (8.1%), subtype B (3.7%), CRF02_AG (2.9%), subtype C (0.7%). In addition to finding CRF01_AE strains from previously reported transmission clusters 1, 4 and 5, a new transmission cluster was described within the CRF07_BC radiation. Among 11 different recombinants identified, 10 contained portions of gene regions from the CRF01_AE lineage. CRF02_AG was found to form a transmission cluster of 4 in local Jilin residents. Conclusions: Our study presents a molecular epidemiologic investigation describing the complex structure of HIV-1 strains co-circulating in Jilin province. The results highlight the critical importance of continuous monitoring of HIV-infections, along with detailed socio-demographic data, in order to design appropriate prevention measures to limit the spread of new HIV infections.	[Li, Xingguang; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Xing, Hui; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Xingguang; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Xing, Hui; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Xingguang] Univ Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, HIV Mol Epidemiol & Virol Res Grp, Wuhan, Hubei, Peoples R China; [Zang, Xihui; Sun, Liuyan; Guo, Qi] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Kalish, Marcia L.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Ning, Chuanyi] Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Ning, Chuanyi] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan Institute of Virology, CAS; National Institute of Infectious Diseases (NIID); Vanderbilt University; Guangxi Medical University; Guangxi Medical University	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	Ning, Chuanyi/AAF-5601-2020; Ning, Chuanyi/B-4120-2016; He, Xiang/E-7082-2013	Ning, Chuanyi/0000-0002-8748-2780; Ning, Chuanyi/0000-0002-8748-2780; He, Xiang/0000-0003-2428-5349	National Science and Technology Major Project for Infectious Diseases Control and Prevention [2008ZX10001-004, 2012ZX10001-002, 2012ZX10001-008]; National Natural Science Foundation of China [81261120379]; NIH Foundation [1R01AI094562-01]; SKLID Development Grant [2012SKLID103]; U.S. National Institute of Health [R01AI094562];  [2009DFB30420]	National Science and Technology Major Project for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SKLID Development Grant; U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This study was supported by the National Science and Technology Major Project for Infectious Diseases Control and Prevention (2008ZX10001-004, 2012ZX10001-002, and 2012ZX10001-008), National Natural Science Foundation of China (81261120379), NIH Foundation (1R01AI094562-01), International Cooperative Grant (2009DFB30420) and SKLID Development Grant (2012SKLID103). This work was also supported by U.S. National Institute of Health grants R01AI094562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Cham F, 2000, AIDS RES HUM RETROV, V16, P1915, DOI 10.1089/08892220050195874; Chen LL, 2011, AIDS RES HUM RETROV, V27, P693, DOI [10.1089/aid.2010.0264, 10.1089/AID.2010.0264]; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Council PCOutS Statistics DoPaE Statistics NBo, 2010, TAB 2010 POP CENS PE; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Guo HX, 2009, AIDS RES HUM RETROV, V25, P463, DOI 10.1089/aid.2008.0250; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Health CMo (WHO) WHO, 2011, 2011 EST HIV AIDS EP; Helleringer S, 2009, DEMOGR RES, V21, P428, DOI 10.4054/DemRes.2009.21.15; Howard DL, 2006, JAIDS-J ACQ IMM DEF, V42, P325, DOI 10.1097/01.qai.0000214819.88163.22; Huang L, 2011, CHINESE J PUBLIC HLT, V10, P515; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Kretzschmar M, 2008, AIDS, V22, P1527, DOI 10.1097/QAD.0b013e3282ff6265; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li XH, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1472-1; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Lindenburg CEA, 2006, AIDS, V20, P1771, DOI 10.1097/01.aids.0000242824.59377.53; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; LIU H, 2007, CHIN J AIDS STD, V13, P230; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mastro TD, 2006, AIDS, V20, P1451, DOI 10.1097/01.aids.0000233580.56844.c1; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Qu S, 2002, CHIN J STD AIDS PREV, V8, P145; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Z, 2009, CHINESE FRONTIER HLT, p[32, 339]; Wang L, 2010, INT J EPIDEMIOL INFE, V37, P361; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Yang Y, 2008, PRACTICE, V7, P511; Young AM, 2013, AIDS BEHAV, V17, P2341, DOI 10.1007/s10461-012-0371-2; Zhang B, 2000, CHINESE JSTD AIDS PR, V6; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhu J, 2008, CHIN J AIDS STD, V14, P111	58	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110738	10.1371/journal.pone.0110738	http://dx.doi.org/10.1371/journal.pone.0110738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356726	Green Published, gold, Green Submitted			2022-12-26	WOS:000346765000021
J	Zhang, XX; Wang, GJ; Gurley, EC; Zhou, HP				Zhang, Xiaoxuan; Wang, Guangji; Gurley, Emily C.; Zhou, Huiping			Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response through Multiple Mechanisms in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; IL-6 PRODUCTION; POSTTRANSCRIPTIONAL REGULATION; CANCER CHEMOPREVENTION; SIGNALING PATHWAYS; NATURAL-PRODUCTS; RAW264.7 CELLS	Background: Apigenin is a non-toxic natural flavonoid that is abundantly present in common fruits and vegetables. It has been reported that apigenin has various beneficial health effects such as anti-inflammation and chemoprevention. Multiple studies have shown that inflammation is an important risk factor for atherosclerosis, diabetes, sepsis, various liver diseases, and other metabolic diseases. Although it has been long realized that apigenin has anti-inflammatory activities, the underlying functional mechanisms are still not fully understood. Methodology and Principal Findings: In the present study, we examined the effect of apigenin on LPS-induced inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages and mouse J774A.1 macrophages. By using the PrimePCR array, we were able to identify the major target genes regulated by apigenin in LPS-mediated immune response. The results indicated that apigenin significantly inhibited LPS-induced production of pro-inflammatory cytokines, such as IL-6, IL-1 beta, and TNF-alpha through modulating multiple intracellular signaling pathways in macrophages. Apigenin inhibited LPS-induced IL-1 beta production by inhibiting caspase-1 activation through the disruption of the NLRP3 inflammasome assembly. Apigenin also prevented LPS-induced IL-6 and IL-1 beta production by reducing the mRNA stability via inhibiting ERK1/2 activation. In addition, apigenin significantly inhibited TNF-alpha and IL-1 beta-induced activation of NF-kappa B. Conclusion and Significance: Apigenin Inhibits LPS-induced Inflammatory Response through multiple mechanisms in macrophages. These results provided important scientific evidences for the potential application of apigenin as a therapeutic agent for inflammatory diseases.	[Zhang, Xiaoxuan; Wang, Guangji] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaoxuan; Gurley, Emily C.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zhou, Huiping] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China	China Pharmaceutical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Wenzhou Medical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015; Suinesiaputra, Avan/W-6730-2019; Bluemke, David/GYU-8169-2022	Zhou, Huiping/0000-0002-0050-372X; Lee, Daniel/0000-0001-9447-4175; Suinesiaputra, Avan/0000-0003-1165-458X; Medrano-Gracia, Pau/0000-0002-6255-4864; Young, Alistair/0000-0001-5702-4220; Zhang, Xingyu/0000-0001-8108-1997; Bluemke, David/0000-0002-8323-8086	NIH [R01 DK-057543, R01AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489, 81273589, 81202591]; Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics [NM2012012]; Project for international S&T cooperation program of China [2011DFG333380]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics; Project for international S&T cooperation program of China; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01 DK-057543 and R01AT004148, VA Merit Award 1I01BX001390, National Science Foundation of China Grants (81070245, 81270489, 81273589, and 81202591), Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics (NM2012012), and Project for international S&T cooperation program of China (2011DFG333380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen R, 2014, MOL VIS, V20, P242; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Costa SS, 2012, EXPERT OPIN THER PAT, V22, P1111, DOI 10.1517/13543776.2012.724062; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Desai P, 2011, EUR J IMMUNOL, V41, P1764, DOI 10.1002/eji.201040932; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duarte S, 2013, INT J MOL SCI, V14, P17664, DOI 10.3390/ijms140917664; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Galleano M, 2012, ANN NY ACAD SCI, V1259, P87, DOI 10.1111/j.1749-6632.2012.06511.x; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Han JM, 2010, BIOL PHARM BULL, V33, P1019, DOI 10.1248/bpb.33.1019; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Johnson JL, 2013, MOL NUTR FOOD RES, V57, P2112, DOI 10.1002/mnfr.201300307; Kim AR, 2005, ARCH PHARM RES, V28, P297, DOI 10.1007/BF02977796; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim Seewan, 2011, Chonnam Med J, V47, P104, DOI 10.4068/cmj.2011.47.2.104; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Koga T, 2011, CLIN EXP RHEUMATOL, V29, P906; Kowalski J, 2005, PHARMACOL REP, V57, P390; Li RR, 2010, IMMUNOPHARM IMMUNOT, V32, P364, DOI 10.3109/08923970903420566; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mulvihill Erin E., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P84; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nurmi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078537; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Park EJ, 2012, ANTI-CANCER AGENT ME, V12, P836, DOI 10.2174/187152012802650075; Patel D, 2007, INT J ONCOL, V30, P233; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Romano B, 2013, PHYTOTHER RES, V27, P1588, DOI 10.1002/ptr.5023; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Sharma H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091588; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Takano-Ishikawa Y, 2006, PHYTOMEDICINE, V13, P310, DOI 10.1016/j.phymed.2005.01.016; Tanaka T, 2013, NUTRIENTS, V5, P2128, DOI 10.3390/nu5062128; Wang J, 2012, INFLAMMATION, V35, P1466, DOI 10.1007/s10753-012-9460-7; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Weiss U, 2008, NATURE, V454, P427, DOI 10.1038/454427a; Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257909; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008	64	123	132	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107072	10.1371/journal.pone.0107072	http://dx.doi.org/10.1371/journal.pone.0107072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25360520	Green Published, Green Submitted, gold			2022-12-26	WOS:000347993600095
